<SEC-DOCUMENT>0000886163-23-000007.txt : 20230228
<SEC-HEADER>0000886163-23-000007.hdr.sgml : 20230228
<ACCEPTANCE-DATETIME>20230228160340
ACCESSION NUMBER:		0000886163-23-000007
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		100
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230228
DATE AS OF CHANGE:		20230228

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LIGAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000886163
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				770160744
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33093
		FILM NUMBER:		23685067

	BUSINESS ADDRESS:	
		STREET 1:		3911 SORRENTO VALLEY BLVD
		STREET 2:		SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-550-7500

	MAIL ADDRESS:	
		STREET 1:		3911 SORRENTO VALLEY BLVD
		STREET 2:		SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>lgnd-20221231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:c0902eea-a24e-41c4-9f5a-301d659aee15,g:8404f1f2-95a1-4d6b-a993-1c430637111f,d:98e6b87576d6446486a3b29533a5cf6a--><html xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:lgnd="http://www.ligand.com/20221231" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>lgnd-20221231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV80L2ZyYWc6MGQ1MDYyOGMzMzUyNDdmZmJhNDQwNTNmZTBlMTNiNzYvdGFibGU6MGVmOTcwMmU5MjkxNDU4ZmJhOGJmOGMyMDE1MDZmYmQvdGFibGVyYW5nZTowZWY5NzAyZTkyOTE0NThmYmE4YmY4YzIwMTUwNmZiZF8xLTEtMS0xLTExMjY0MA_05a89076-0442-45d1-8845-32bebc8a9b2b">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV80L2ZyYWc6MGQ1MDYyOGMzMzUyNDdmZmJhNDQwNTNmZTBlMTNiNzYvdGFibGU6MGVmOTcwMmU5MjkxNDU4ZmJhOGJmOGMyMDE1MDZmYmQvdGFibGVyYW5nZTowZWY5NzAyZTkyOTE0NThmYmE4YmY4YzIwMTUwNmZiZF8yLTEtMS0xLTExMjY0MA_4b6d00e2-84dd-43dd-ac76-47ad8ecb3999">2022</ix:nonNumeric><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV80L2ZyYWc6MGQ1MDYyOGMzMzUyNDdmZmJhNDQwNTNmZTBlMTNiNzYvdGFibGU6MGVmOTcwMmU5MjkxNDU4ZmJhOGJmOGMyMDE1MDZmYmQvdGFibGVyYW5nZTowZWY5NzAyZTkyOTE0NThmYmE4YmY4YzIwMTUwNmZiZF8zLTEtMS0xLTExMjY0MA_1aabcf18-f422-49f3-a1cd-2e1a8587a7cd">FY</ix:nonNumeric><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV80L2ZyYWc6MGQ1MDYyOGMzMzUyNDdmZmJhNDQwNTNmZTBlMTNiNzYvdGFibGU6MGVmOTcwMmU5MjkxNDU4ZmJhOGJmOGMyMDE1MDZmYmQvdGFibGVyYW5nZTowZWY5NzAyZTkyOTE0NThmYmE4YmY4YzIwMTUwNmZiZF80LTEtMS0xLTExMjY0MA_721d6096-4606-4012-be7f-ddcc66896f27">0000886163</ix:nonNumeric><ix:nonNumeric contextRef="ic67831c921904253a87bb44165f263ef_D20190101-20191231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTctMC0xLTEtMTEyNjQw_3be36137-77b0-489a-9749-cfb3e877f98b">http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201613Member</ix:nonNumeric><ix:nonNumeric contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjAtMC0xLTEtMTM1NjU0_ead01d8d-25b8-4804-af03-812067b2c1eb">http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member</ix:nonNumeric><ix:nonNumeric contextRef="idbafb024b44d43f0b4a9e4440b3833cb_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNzU2MQ_9d23c4d7-711e-44c5-af62-13230621da18">P3Y</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="i0ea94c0a78a84acbbb4c6b276629f850_D20220101-20221231" decimals="4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84NS9mcmFnOmYxYmE3MWM4ZGVmZDRjZGQ4NDVkMjQyZjYyYWZiZTFmL3RhYmxlOjE1ZWExNDA5YTQzZjQzN2I4ZjUwODY4YzA2MGEzM2ZhL3RhYmxlcmFuZ2U6MTVlYTE0MDlhNDNmNDM3YjhmNTA4NjhjMDYwYTMzZmFfMS0xLTEtMS0xMTI2NDA_5f2a2bf8-16e0-42b9-8c4e-0d20a1705d87">12.50</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i0c3c548b83e74abda3686b765b62aafc_D20220101-20221231" decimals="4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84NS9mcmFnOmYxYmE3MWM4ZGVmZDRjZGQ4NDVkMjQyZjYyYWZiZTFmL3RhYmxlOjE1ZWExNDA5YTQzZjQzN2I4ZjUwODY4YzA2MGEzM2ZhL3RhYmxlcmFuZ2U6MTVlYTE0MDlhNDNmNDM3YjhmNTA4NjhjMDYwYTMzZmFfMi0xLTEtMS0xMTI2NDA_5d587b9a-0f6b-4260-ad27-2cf8ed0ccf75">2.08</ix:nonFraction><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfMjc0ODc3OTA5MTQ4Mw_faecaf46-33bf-4086-b9d1-f6c39448988e">http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense</ix:nonNumeric><ix:nonNumeric contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzExLTAtMS0xLTExMjY0MA_a1a5fccc-ae24-4f80-98b2-5c22c6e04753">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzExLTAtMS0xLTExMjY0MA_f02bfdd2-8ed4-4dd1-a881-ebd664bece19">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="i6a379c1b7d334bdcada538a9c12cb207_D20221115-20221115" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDYvZnJhZzpkZmNmMTA2NjYxYjU0YmQxYjEwZmJiM2I1YjAxNTRkNC90YWJsZTpjZjZiMmQ5NzkyNDg0YmNlYmY4NmQyYmI1OTFlOTRkMS90YWJsZXJhbmdlOmNmNmIyZDk3OTI0ODRiY2ViZjg2ZDJiYjU5MWU5NGQxXzItMy0xLTEtMTIyMDQ4_3b59526d-b59c-44a4-b205-4033965a1849">0.004893</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i1129e67c6bf84ef883ea9a80f1135ee7_D20221115-20221115" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDYvZnJhZzpkZmNmMTA2NjYxYjU0YmQxYjEwZmJiM2I1YjAxNTRkNC90YWJsZTpjZjZiMmQ5NzkyNDg0YmNlYmY4NmQyYmI1OTFlOTRkMS90YWJsZXJhbmdlOmNmNmIyZDk3OTI0ODRiY2ViZjg2ZDJiYjU5MWU5NGQxXzItNC0xLTEtMTIyMDQ4_a00fbf93-721c-46ca-b618-dead5c8a8fe6">0.0062907</ix:nonFraction><ix:nonNumeric contextRef="idbafb024b44d43f0b4a9e4440b3833cb_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzE3MDc_277b8799-ffa7-4ac8-873b-e1ce3c67cce8">P3Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="lgnd-20221231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia41df9d4ed2a449d9d3a0d5079eee8d8_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i60e7b5cfa61b4bd3ba008a679e0b0390_I20230222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-02-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i91e01e3752fa4607875a52688c787ed4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7acccfdc49ae41ec9d81e2a77aaeab89_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8303bd1e530e4c06b3bb8c3093343f43_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if07332e474464098b61af13fe5a470f2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6747a650dc714496a27ce80ca1fde353_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i065c2ca723f44ed7b4161976d58b5fe9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a2c832b6c46461c9fa690319f44159f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6041ab2411645599b1e142a09232af6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbbf2bd60ac64c15aa70a568639f50ab_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b86bff9b54f4d76bce0d4e8b7a8fb96_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:VernalisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b297d5d47f94315a7c2461666a1e657_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:VernalisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccc4fa061bfd4f28acff3954baafb1a4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:VernalisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i357eff174d874e71a3e0da8d3f8ba240_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie900f916c5ce4b118f337c7cd5784087_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55fd66c34dcf459fa6f35389d1c92e7d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b902bcb600d40ed842e738be013d24e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i859e9607437a43d8adb4d3dc08e60773_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie94bcf078bda4c3095feb1fef072c734_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0325d2944844148b93606f4579a387f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb599d49cd844079adbdcf3fbcea1bf6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic67831c921904253a87bb44165f263ef_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib307560c9d0a46168d9fc559bfdf76db_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadc71aaacd92446fa2fa49e3a0be8871_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b2e2abd1a8f48cbb470a39e45b33d50_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d465be99a3842c397fabfc41d61594f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ea688d541394c9693a42fb9c6332aea_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1632e4f73e14852bc153b6b86f8ac63_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7184134d4134a439ed750ceb1bd33ec_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0fe34795168e4efab32422048060cbb7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie20afe7ce80947c68d760e57a457a87d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaafb881f4e07495d854952edabcc137a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i948695d093514268aa5ad004f473dbda_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d56363a509d4e11b592758da0456ba3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93f039f3e3c5453fbe65524dc44ad87a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica032a6f26e9432b8884add2372c3753_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23836cb1b26e4183bcbd3dcfe2a97c57_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief52e61130d8499e8c4dbc42893dc5b6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65b0d907ef504ee2b3d109652685018c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ba90afbe5994d2387d3257ea4ba047e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i155fa2cc21e744f28351005564253c83_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a1cc21146284996b1a957be45c91abd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33d7a741bf9e4e2d90927adfa7ef78e5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f6875eb2c49451e827356ab2addb68a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e38dd10e28e4af0b6ff937e3289a628_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>lgnd:segment</xbrli:measure></xbrli:unit><xbrli:context id="i72f4dbdc77184f48bcecf231e8e2ca80_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lgnd:PartnerAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i14ad94cabb1447e9a5f01458bd06ae4c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lgnd:PartnerAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3ecad76cf15478e978cd158a1acc62b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lgnd:PartnerAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i032f9a1963654916a1d87cdbf84a1c8c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lgnd:PartnerBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84da35f51bc941fb9605c4e27d374dc2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lgnd:PartnerBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie756c741eed64e91bbd573fd37cc5dc5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lgnd:PartnerBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i320b82dcca2f4f7c9916c6e2f9c91339_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lgnd:PartnerCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib51bff40a74549a49092eaf3d331dfb2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lgnd:PartnerCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53db40ae7eaa43a29ee0d41f7837b347_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lgnd:PartnerCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d685acb7be943ae8d15dc5799a4444a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic202f70f62e8428d9c78a4978a746eee_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbafb024b44d43f0b4a9e4440b3833cb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a1083da45f7446987097262ce780281_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id219523c2b3d4296bdc72fa8f030e324_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied0c882ba4784643aa73cead8f57f992_I20100131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisTherapeuticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2010-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="right"><xbrli:measure>lgnd:right</xbrli:measure></xbrli:unit><xbrli:context id="i708cef8824df4406829b45bafcb19aec_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoandCorMatrixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51a7db08b41d4559b10e461df7cae951_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoandCorMatrixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f4284fcd53e4be492bf1abd42007aa6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisAndDianomiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icafaf42275b04638a6eb47f7e4f9d5ae_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisAndDianomiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i753bf04acd14417f84584d364adb5bb8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fdc31d97ec44363932ea54316ee86c1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4ed1fc049264324b4138e54a53f1363_D20190501-20190531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:NovanMolluscumProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-05-01</xbrli:startDate><xbrli:endDate>2019-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e227d79f69e4aea8a7ba69a8fb5790c_I20190531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:NovanMolluscumProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if79b3620292a470e909e7af19aa0f62a_I20190531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:NovanMolluscumProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41a81ed9d20a45a39c1cfa8bf254af62_I20190531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:NovanMolluscumProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ed660187f8a4347b6987765f4320888_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:PalvellaTherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id02e516cbca146e2836770e595c232e1_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:PalvellaTherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91f484a16cb744a5b11a95592c952710_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:PalvellaTherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1454c0a0b9464c84aec81eed615b63f1_D20181201-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:PalvellaTherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i457b511b1d08453b8802d9e74dbddb90_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:PalvellaTherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa528f43c78d4e52915523cdd982ac81_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:PalvellaTherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2cce7f20f9b4fb296a7526469510cff_D20170531-20170531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-05-31</xbrli:startDate><xbrli:endDate>2017-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60474bf54aa94e98b1b7827f2c4e28ec_I20170531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a7a01e9b3e44e6d9b9d6af540a8e364_I20170531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i362045e8eca24e9b94ed9065fd915555_I20170531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad947c25f57e49ecb7709c07507fa8f5_I20170531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:CorMatrixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0566a97a54e4f9ab7c582ae4caada22_D20170531-20170531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:CorMatrixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-05-31</xbrli:startDate><xbrli:endDate>2017-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacff0d31a3c2457a9ee720c8fbcc8054_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i670101d682ab4040a9ecb714406fabd0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if715884926d24da68b91903ae544927e_I20200101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ec9717cd1d246078b4b569036ffdc49_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyKyprolisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54dbd99694aa4daab7990f243b799c03_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyKyprolisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8afb2b3d7d6642b4a6bf2a125abec1e1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyKyprolisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c92061ff9b94c6eb2d8a4a23c829de0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyEvomelaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd8f3bf9de1f4fd7beedb580d9c6cdee_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyEvomelaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33e6496921c848a79e380a93f9d05bc4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyEvomelaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b7d6c7b066c452794362e3368d3f7e3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyTeriparatideInjectionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea65617bbc2b47b48426079a24526cbe_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyTeriparatideInjectionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5493b3bc3d6c4726aa3bd80b40ca081f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyTeriparatideInjectionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fbfab2afcba47db8cd01d943434d7c7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyRylazeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ece9d53186c440cbe209564d6285e78_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyRylazeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49757f616a7c43cf861c739d9acb2ab5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyRylazeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idac514c491cc4a208f76c94595c132f5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73902d56a64240c0bf0d410617877557_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03cd5d2142d44bf7a2bcaa6d8f29b13a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65647a80fbc847cb96058a3c631b002b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCoreMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43de1a804883437584799c38ec4bbfba_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCoreMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie02c8b74a58c4e0da8c4a0da3e2af0ab_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCoreMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id131b624b01b400987332697abc2b43d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCOVIDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief5aa8a800b746d481cd0985dd7ec3d3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCOVIDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11e9985562a84328a97129345abae661_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCOVIDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08870b2004dd43bdaece251ed3f21347_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68260ef8bbec41adbf8a2108d95376f8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if88162f99d40461a9310c0ae816fd224_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1de672c0b42480eb2b6b143b340f6a5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ffe37b6e1e44b3a84fe52fd8879a67d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if42c010475e14a4099a8428492cce1cb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic38b9e57dd5b4eccb6ea203b21533a2b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e8ef293cc81451599d632430c78f16d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91b0803652084754984846b312275eec_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf61891c2afc4735abc2848c436bdd90_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndOtherProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e3529f39eae4d9e9e67e1b00baf464b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndOtherProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0132672fab9842058c3e5d0239853868_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndOtherProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2323eac91b2548d9bb0aa30d38e34f63_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i842018ac4595423692c11f2da85cf3eb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i489ca56af41b4556bad1bd319b7b8c4d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc63108210a948b5865cfb7ad3c24f5b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e24dfa538c74d94916136c2c583e53b_D20070101-20071231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2007-01-01</xbrli:startDate><xbrli:endDate>2007-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ea94c0a78a84acbbb4c6b276629f850_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:TwoThousandTwoStockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">lgnd:VestingPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c3c548b83e74abda3686b765b62aafc_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:TwoThousandTwoStockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">lgnd:VestingPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a7d01a48d59487f83e3391779612e31_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">lgnd:RestrictedStockUnitsAndPerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c0d366af0a24bf3b783d1043d41aeac_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:TwoThousandTwoStockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd7c9aa2ea5a470e8fbd4d80fce77775_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70fc66a3f20848b5bb0f70e3f866d45d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18c9bf22eb2e40bdb955de4a851b78c5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if66ef91cf250497180df8bdafb040c04_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67a5c3e26a4a41c5965dfa8c1722d00f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76c8d1f51aad42668b7908e89daf66dd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46c8bfd47e7444e6a01496cd453532d1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i710339a456f64bc8bad5a607120931a7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie30007c66bb747999bd003d8277ab95c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6f656a779984d2e9b0f895f98e24654_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6992767e8dd8406c922375c93b5376c2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1f6b297465e41fc91ec81b76fb00d45_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38815b046b134f4e89a040e922235cd3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0c506012de345dda2926c4191966e7a_I20221026"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71db46073a8c4e54a85cdb15a16cda65_I20221101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5d258c544454d8287d67c0885d9f073_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i180d8ced9233474d9767fa54ba805af7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida2ce874ab0f45d1a868ff9dc946ad7a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id10d2e678e034d80baef68bce5e0f4dd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if084a5c5e7a04c2ab6433cfecec6c5ea_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76065f9fe2324b1eab8ade930477eaf4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic19bd9bd07214754968a75ae83faf30f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">lgnd:VikingTherapeuticsInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78dcb59101a846b19a565ed0e098ef09_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">lgnd:VikingTherapeuticsInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifeea5a6633434f93bbe3e33fea893ad4_D20200101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="acquisition"><xbrli:measure>lgnd:acquisition</xbrli:measure></xbrli:unit><xbrli:context id="i4ed842cd826a473aa27b3be44b9dff45_D20201001-20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6722b1819674d1ca58d43ab78f42fee_I20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0031e41cbf7c45bbb25efe78bbbcea4a_I20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36cbb3f817354f04b57d665248187943_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0787b2990c934b468deda9c36c3f0273_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c6f37320d134abeb77221e2c28f7476_I20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lgnd:ContractualRelationshipsAlvogenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie17cc4f187524c6ab5d90741e0260c93_D20201001-20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lgnd:ContractualRelationshipsAlvogenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c16dd0f6ad94561a190f6fb614d008c_I20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lgnd:ContractualRelationshipsMerckMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0879712cff614a0b90c548a17d56dc6e_D20201001-20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lgnd:ContractualRelationshipsMerckMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0183c839f90a44d78e84690651518be4_I20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lgnd:ContractualRelationshipsJazzMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifac692c703d348d388432995b6f0fa8a_D20201001-20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lgnd:ContractualRelationshipsJazzMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i646b177827484736a084009b96add04f_I20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lgnd:ContractualRelationshipsSIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iada43374af48485cb39ed70b764ce849_D20201001-20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lgnd:ContractualRelationshipsSIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29179647d1e74e45a16db04ef1607aa3_I20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lgnd:ContractualRelationshipsArcellxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0793bd25b06b4adb80e8bcf79ba4daae_D20201001-20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lgnd:ContractualRelationshipsArcellxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56ebc06b13944fc8bae568b634e1b508_I20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8104cc1e7e204b4f9867e0af251d6d20_D20201001-20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdcdcd7c135242418722134cac4afc56_D20201001-20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id589112d140b42ffa4f049057293f7a7_D20201001-20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7eada68668c8443ba5abbd0bcde52836_D20201001-20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67ed4423d4894d809c0e43396ff89fb7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cbea891771f402ba63e1011224d9594_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic56146394448409b96d33c1403f18303_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b6118bd78b042f680823946386c507b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib96a633a4e0742be9fe13b947aa7bbf8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb1ec84b065e4c5ca2b74a1668e4e379_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4aee961123f4b77b2f7f7b245ce72b5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9dc44c4cfaf6498b9f6dc3d014f4bdf8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4de80e6e30c4350bd4abd2929927cf1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b0be75d14a440b5bcdb6664f17060fc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd4315ab1b654686b5cdda294406fe38_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2dd090c573e94ca6a2ef574f8aca0f84_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf74ed3f29894bbe89f67ce3f1638368_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id273e2ab6d4d4d30bf4734bdb2617f06_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia295c8d89c994fc1bfcfee13cdca48ce_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0f397fe74994049bf8a93a1ab577e34_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5dcb4186e044e5882d93180a92f8279_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4dcc4622d787496ea953a0a254ba9e7c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bab37c9b6cc4977ba02a28e26ed9ca5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id71f5699fd5b463690456b9be5c3a966_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b5b0d44ecc94db89ec934970defe064_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e56f08463f24218a5dd7f6e8d12a3dc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i849c3dacc5614e158a39923417210219_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i289ae7096dd54d348dbd227aaa42f5e8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id323f390108741218d29588c00e4c8a0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f8fb2e550b84e4faf3a5b2a433bea1a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb86b09115894c9fbb794f501b2d2dcf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c67973b49304b2cbbb84811600c1663_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fc3ae0a79b44517bb99fc381adc9058_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70302a79a5c24d0e881d281ae6cbe66b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7bd44fb046a40d79acd8b5094a6af2f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i057df6feb256427ebd16d5cfd07edad1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8224f6e8d10e45e78c84ba1c9a2f97a2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e70582ec04b46de89b0fe1f65dbc1e1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if16a34f8456e47dc9f5b67e39d4c9548_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i358f804697e94a7f8d741b250dbff084_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89b5b12d4524461fb990aac54d517487_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7421ded7a02748e5bd60df47f2093b9b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1fb2de098654192b5935f2063f1a97a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61cb7f2d12cc441e9bd457c78d89b1aa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7678c8eb61e14518b6fb8be69a443a07_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc472a6bccfc444c92220855618d517b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85fd2713598b4a62a7669055f5df86b4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4eab6a2ac394d7aba45f348a01f8201_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08c9b0174a48479ea68f212652608932_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5237f56ef074e7eb32dbcc66c6db515_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i379ebe35361f4afc805f81c76a89b0c4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a30b0e8302e45e3b5d48f2a7758a37e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd920ac870274bd29c5d3815db9bc027_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if01f6df650ee4787be25d17587903c8a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i430a03cc0e9c405e9df59a233c9bd258_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefe06608d69a4810b5ef7844034e3616_I20100131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2010-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="agreement"><xbrli:measure>lgnd:agreement</xbrli:measure></xbrli:unit><xbrli:context id="i800dff6c80e4444f9003b3ac53dd8573_I20100131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2010-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21d27e0d975f4344a297876b55e27170_I20100131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:Phase3ClinicalTrialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2010-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80eaf9a4b47f4c988d4ed66997f6cdfc_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33228b6719394b3784c1b537e298a756_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib390d2fa586a4871b184b3ae93ef7a46_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i749ac5b664db4f20af265ce3e3d5b538_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1566abca593746beacdf6a287d3c798c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8ae4ee0f64a46979ca5a2c15da782e7_I20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ae5acdc120c4e40981302a07b8d28a6_D20180501-20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-01</xbrli:startDate><xbrli:endDate>2018-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11b50fd2d77b498e82f14c8ee21dcc5c_D20180501-20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-01</xbrli:startDate><xbrli:endDate>2018-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="trading_day"><xbrli:measure>lgnd:trading_day</xbrli:measure></xbrli:unit><xbrli:context id="i2a146d0761cc415ba2c40a2459586b06_D20180501-20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-01</xbrli:startDate><xbrli:endDate>2018-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic965f5b4e009491284f786378035d4e1_I20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia361a8f8b6774d9f9e3b2a48a102ecb8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3316b5508b924ffc8fd7ec36b3aa455e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1dd1d35129f4cd39fb80e6800cfe252_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia99cec91b0284a4090f6d9399292f293_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbe666f5347841329bf2326c9232e329_I20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf823eb4d59c42a0a2bc0d1990fa4bc0_D20200401-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c628cd07ad342459335204c06df1ef0_I20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i111b05d5f55a49a8811a99582e5b230b_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="option"><xbrli:measure>lgnd:option</xbrli:measure></xbrli:unit><xbrli:context id="i58d85fd3024241a592f18e215570d51a_D20220801-20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">lgnd:NotesRepurchasedDuringCurrentPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54f5a452c3934a41b9d24ab5e96cffaf_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a379c1b7d334bdcada538a9c12cb207_D20221115-20221115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-15</xbrli:startDate><xbrli:endDate>2022-11-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1129e67c6bf84ef883ea9a80f1135ee7_D20221115-20221115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-15</xbrli:startDate><xbrli:endDate>2022-11-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i548f60b85719418dac5410346d1603e7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1471709cc0844e7fa518a8ce9a1cd2bb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7463bea47b82478d8f5459d601f865f3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd0bbb0bb1ab4703911061427590d10b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5437e7ad7374bbba38f616727645f32_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0615fa1d1c0f4ab3a4d0ed6cab329254_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71e35599919c4fce950d103cf2cb9a03_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04cf813834a54b609f2d0c0a39769017_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f92fad18c07418281242e26ae88ac27_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if12b1ab4a6244599831e9df4b3d630d5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie313cb8f8e784d82b8ae991a863ca12c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6696160e9f0146f7bee8c94a11813846_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic790b5e0a22343c88149b3aa20638bbe_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d6d432e3de740d2b05ca748ea45be9a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="position"><xbrli:measure>lgnd:position</xbrli:measure></xbrli:unit><xbrli:context id="iaad9f14d4ad04902a0ea102d27e11be4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b3cf5a61a1e4ab181aaf966a0f14569_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ce0655576844f1290eb9958550ec9af_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2f48884d4a143de8f95a4b3a211788e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ca7d470a3274ceaa4b0cd0f4f1c8bad_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">lgnd:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ad7defd94a44484b2144c9440eb26ff_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">lgnd:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25d3b1f41ab6459bbb46a5beb92b4ef3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67a7f28b4edc41f8a4828a6e2caa478f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07e4bdb069784c6995843f555b7fc3df_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2701c5cf7228445c8f19ae56602a97cf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i181eff0de1144e58b256d8ec0c77ad61_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide40dc66b4694626bfa8f046840911c4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i744575df31604eb09f525875d978efa1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8c9e47632c8468988399e7e93608f12_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9073dde9293463fa30e092e8acddc86_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CydexPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie069fdb21c2e4a7f9f6faafc2d873eaf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CydexPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic917cc56cbc14ef49457a08f97faabb2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CydexPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i419fb6a0c6af4050bccc7d5632925f3b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CydexPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a5eaef79f744090a57acf2dd9bc3f41_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CydexPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36ae892ec43144929bf8462e64709b35_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisTherapeuticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9a291d0bcd642c590a67f6bf07d86c7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisTherapeuticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32c3e35d3cae415a91aa7ff9a8a97fc1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisTherapeuticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if67f5d0a5e884fae8966a608bcecbc8e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisTherapeuticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf9732e8831a435d9e39b39f45cb491b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisTherapeuticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36459dab15864e27a999bdcd2e68206a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45f91b32714d4d798c728a94c1d3c363_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e5c28dda3f24c618a0e97fdb4db6a82_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58c8e37938964262a8d9fbb812dc0595_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06d744f80dd94f3190aafa087db24d87_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7ee9d97264e44b99c988c2bc5b6d24f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c0071327d664b04b5121faf1e1aafbb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0496dc8b573246759849c58cf2ee5081_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb4f9e0d157846e39f3e696539899f72_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae45ac44b4cf4613953eedfe31c7f341_D20220601-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:TwoThousandTwoStockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14ec222f5248466398774a2561f84042_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:TwoThousandTwoStockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59fa0ea34268498a977d54122e7473c5_D20220101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e08d73fd52941c8b0a838aeb83cbe3b_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb8d1e2f9bc24fa4a2bc478bc667577c_D20221101-20221101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2022-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie06ebd7de19543a9be2b5f0c195a8849_I20221101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieaaf4e1776ca4ee3b882116a392a5b8c_D20221102-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-02</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ea9d8dc84e843c18bf275e4e37eca43_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic08afe60b35d4e72a651be2308becc85_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief7b0c06377d406cb4005ea8273c1cc1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e7d98d1709e4fe5b08bdc5dac823ced_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd1f4da528084577aee7dcabc5455e87_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8df448bf131f436d8340558685040924_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id70a7d71b0a14b0abc0db27c646a2a71_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic75d320692e9481bb881a28239201125_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0206a09bd2447e0b7a819f3e88399b0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if244aca373d34599b957dd0229b16240_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53aac02f675646bc9f345ded193cb397_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeSixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida99b6789c3a4f50b772bdb7b47fa5cd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeSixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b63563893e044e48841c92b5fe75d81_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeSevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i832e5c7bccde4123b022c8bab92e41a3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeSevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b74c7e45f8c4749a8ef280613702146_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a0d0b5e84d344cfbc5b391903f924fc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1c885f91b7f4f689c7b8a8c9df23e98_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeNineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia739273d90a041b18ac1f97de8da164c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeNineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e0dbd02e5924340b2b6ef89413e73fd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeTenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2768e2bc60244b69915cbe3b77507013_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeTenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i542a16c3353248bc8dd8336f95ea2022_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id13b17e9fe134b41b5c293358c0d8d1e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70799954d0214652bfaf7cd03d05d0e7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6721b383c78a462dad20bcc6ce92e012_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1830acfcfe9d479fa705570392f59958_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:OmniabSeparationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice33364cbd56406b88429f2aa093f6cd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:OmniabSeparationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7e2f70f54f74635b9da899358a0eb40_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc03504c5b21431cb85fbddc8d239a0b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7b81ae076014d259846e22ddab69ac4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34a7906b62e04f2a93fcbf8c96e0b8c5_D20220101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b64d9bdb1cd4eceb9508d306b942d87_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ffc7c8d47654559a26bf1224c8dac2c_D20221101-20221101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2022-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82b4fc5c5a994b2db38284c45930d10d_I20221101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bbc8a04f4fe422fbc818ec598c0b7f1_D20221102-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-02</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47a751f245b748f0843958f32f5f80c0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0687f0c421e14290af9f6cd6184a6b5e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:TwoThousandTwoStockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e816eb25c2e46aa9b39c605fe0b678f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:TwoThousandTwoStockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i955aaff5ae7f47659be272a78642d979_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:OmniabSeparationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i041cfa14d0e74eefad61ffd3960940a4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:OmniabSeparationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2739bb11c12f4306b4cbdc98a749e080_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:AmendedESPPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i747d4f67a97149e1a99e9c59c6e2de2d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:AmendedESPPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf5e0295a2234a42822346d8b0a38103_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:AmendedESPPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2298a5c46c60467d9749217af84898cd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:AmendedESPPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac54b9d00e76487d9a441f663e698e18_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8364d475253b452d820d30294b040699_D20190901-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73ee438cb9984aaa8e59bf39f453f651_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lgnd:AtTheMarketEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e9e56a3dff444f1b28980b0d2c80207_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7793ca8a70014fca9041f46a2bcbbb00_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d2fbdca41684dfa9a100d455115d767_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff27bbd909ef454a889168bc2e1dc2ab_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">lgnd:CaliforniaAndNewJerseyResearchTaxCreditCarryforwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1547d40c4f44431b0ac46de39c392f7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i761a3b7f76b64061bb3f971fa489c7c9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:CapitalLossCarryforwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52ab528f20684598afd7cd8e8d6192f8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e13a6f6bcd64e4eba32eae14ed422df_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9181deee2e7d45b3a86be0f8af806dcc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4dfcde4db4a4453ae87a69ae3dc6bb1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">lgnd:CaliforniaAndNewJerseyResearchTaxCreditCarryforwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e5c23045c2d4ab0af6422e7ac56c5dd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f417214d42c4bd5a425fd3e6b350310_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:CapitalLossCarryforwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b403a13d95c4618a2a1ecf0b72f5ec3_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i897d788652aa45e480cac84774ce09ff_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f4b841dc87a45f4876ae68269b5ee3f_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1be8c52ea4fa41c8b69ccfc9a0092bb8_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i290c867cc3064c3584ca75424dac7e37_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85bfaefbe85344cbbe2d82fd78da0834_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic08f18c873f549b8b87bea293a4ae096_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i98e6b87576d6446486a3b29533a5cf6a_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">_____________________________________________________________________________________________</span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGV4dHJlZ2lvbjoyOGY3MDk2NGZhYTg0YjQ2ODE1MjdkYjcwNGUzZGI4N180MDQ5_70af6b6e-71a3-4744-b875-61943131ffce">10-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">_____________________________________________________________________________________________</span></div><div style="margin-top:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.276%"><tr><td style="width:1.0%"></td><td style="width:2.717%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGFibGU6MzY4ZjQ4ZDU2MTFlNDE0Yjk3NDkyZGQyZDcwMDRiMTUvdGFibGVyYW5nZTozNjhmNDhkNTYxMWU0MTRiOTc0OTJkZDJkNzAwNGIxNV8wLTAtMS0xLTExMjY0MA_9b920909-1775-4bcf-b781-9b9d949ff88f">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the Fiscal Year Ended <ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGV4dHJlZ2lvbjoyOGY3MDk2NGZhYTg0YjQ2ODE1MjdkYjcwNGUzZGI4N18zMDM_3bdb6b11-0a4f-4e0c-a429-6e9a0836c18b"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGV4dHJlZ2lvbjoyOGY3MDk2NGZhYTg0YjQ2ODE1MjdkYjcwNGUzZGI4N18zMDM_976ef479-d7bd-4052-86d3-e58ae2c5ef1c">December 31</ix:nonNumeric>, 2022</ix:nonNumeric></span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">OR</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.024%"><tr><td style="width:1.0%"></td><td style="width:2.857%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.943%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGFibGU6M2JjYzNlMDA5ZWM1NDY1Mzg2OGQ5NDA1ZDlhODVhMjUvdGFibGVyYW5nZTozYmNjM2UwMDllYzU0NjUzODY4ZDk0MDVkOWE4NWEyNV8wLTAtMS0xLTExMjY0MA_e4a8478d-51e1-42df-8da4-0a6f403fdc01">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the transition period from &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;.</span></div><div style="margin-top:2pt;text-align:center"><span><br/></span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commission File No.&#160;<ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGV4dHJlZ2lvbjoyOGY3MDk2NGZhYTg0YjQ2ODE1MjdkYjcwNGUzZGI4N180MDQz_4a76d553-5af5-43a3-8571-87235a6fa4bb">001-33093</ix:nonNumeric></span></div><div style="margin-top:2pt;text-align:center"><img src="lgnd-20221231_g1.jpg" alt="lgnd-20221231_g1.jpg" style="height:100px;margin-bottom:5pt;vertical-align:text-bottom;width:250px"/></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGV4dHJlZ2lvbjoyOGY3MDk2NGZhYTg0YjQ2ODE1MjdkYjcwNGUzZGI4N180MDQ0_69734c33-576e-4fe0-bb1f-c13212dd0498">LIGAND PHARMACEUTICALS INC</ix:nonNumeric>ORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.661%"><tr><td style="width:1.0%"></td><td style="width:65.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGFibGU6MWRiODE4NGNiYjliNGM4MDlkYTY3NDhhMDU1MzJhYTEvdGFibGVyYW5nZToxZGI4MTg0Y2JiOWI0YzgwOWRhNjc0OGEwNTUzMmFhMV8wLTAtMS0xLTExMjY0MA_162dcf73-b845-4cea-aaed-b83b3fb736f3">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGFibGU6MWRiODE4NGNiYjliNGM4MDlkYTY3NDhhMDU1MzJhYTEvdGFibGVyYW5nZToxZGI4MTg0Y2JiOWI0YzgwOWRhNjc0OGEwNTUzMmFhMV8wLTItMS0xLTExMjY0MA_d8606948-89eb-4dd1-bef7-ebba94da5e01">77-0160744</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(State or other jurisdiction of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">incorporation or organization)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(IRS Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Identification No.)</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGFibGU6MWRiODE4NGNiYjliNGM4MDlkYTY3NDhhMDU1MzJhYTEvdGFibGVyYW5nZToxZGI4MTg0Y2JiOWI0YzgwOWRhNjc0OGEwNTUzMmFhMV8zLTAtMS0xLTExMjY0MA_461f5be1-7dba-43e3-a1e3-702afe123b46">3911 Sorrento Valley Boulevard, Suite 110</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGFibGU6MWRiODE4NGNiYjliNGM4MDlkYTY3NDhhMDU1MzJhYTEvdGFibGVyYW5nZToxZGI4MTg0Y2JiOWI0YzgwOWRhNjc0OGEwNTUzMmFhMV80LTAtMS0xLTExMjY0MA_3dc0f92d-7dbf-4181-ad14-ffdefc31ffac">San Diego</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGFibGU6MWRiODE4NGNiYjliNGM4MDlkYTY3NDhhMDU1MzJhYTEvdGFibGVyYW5nZToxZGI4MTg0Y2JiOWI0YzgwOWRhNjc0OGEwNTUzMmFhMV81LTAtMS0xLTExMjY0MA_5c32b032-eb34-40cb-aafc-bd5d03a45aac">CA</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGFibGU6MWRiODE4NGNiYjliNGM4MDlkYTY3NDhhMDU1MzJhYTEvdGFibGVyYW5nZToxZGI4MTg0Y2JiOWI0YzgwOWRhNjc0OGEwNTUzMmFhMV81LTItMS0xLTExMjY0MA_474a5061-085c-437d-8dd6-9d65c5699dbd">92121</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Address of Principal Executive Offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGV4dHJlZ2lvbjoyOGY3MDk2NGZhYTg0YjQ2ODE1MjdkYjcwNGUzZGI4N180MDQ1_6397fcff-1e7d-4f11-8d87-0ca73c9e32e0">858</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGV4dHJlZ2lvbjoyOGY3MDk2NGZhYTg0YjQ2ODE1MjdkYjcwNGUzZGI4N180MDM4_6076db34-dbc8-4a9a-a045-c75f7d60531a">550-7500</ix:nonNumeric></span></div><div style="margin-top:2pt;text-align:center"><span><br/></span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-top:2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.482%"><tr><td style="width:1.0%"></td><td style="width:36.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.979%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.302%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Title of Each Class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Name of Each Exchange on Which Registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGFibGU6NjIwMzkzODk5N2UwNDY4ODg4NzQzYWI0YTUzY2VhODgvdGFibGVyYW5nZTo2MjAzOTM4OTk3ZTA0Njg4ODg3NDNhYjRhNTNjZWE4OF8xLTAtMS0xLTExMjY0MA_7e9b0b4e-e331-4107-ac52-f51c3b774126">Common Stock, par value $.001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGFibGU6NjIwMzkzODk5N2UwNDY4ODg4NzQzYWI0YTUzY2VhODgvdGFibGVyYW5nZTo2MjAzOTM4OTk3ZTA0Njg4ODg3NDNhYjRhNTNjZWE4OF8xLTEtMS0xLTExMjY0MA_70497721-73be-406b-9500-24fe24a514f6">LGND</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGFibGU6NjIwMzkzODk5N2UwNDY4ODg4NzQzYWI0YTUzY2VhODgvdGFibGVyYW5nZTo2MjAzOTM4OTk3ZTA0Njg4ODg3NDNhYjRhNTNjZWE4OF8xLTItMS0xLTExMjY0MA_bd2604a1-bc47-48ef-abdb-c6e87cb1b43f">The Nasdaq Global Market</ix:nonNumeric></span></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(g) of the Act:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">None</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGV4dHJlZ2lvbjoyOGY3MDk2NGZhYTg0YjQ2ODE1MjdkYjcwNGUzZGI4N180MDUw_da2a447d-1c76-44a3-a5b3-e4a8b685a254">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160;&#9744;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d) of the Securities Exchange Act of 1934.&#160;&#160;&#160;&#160;Yes&#160;&#160;&#9744;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGV4dHJlZ2lvbjoyOGY3MDk2NGZhYTg0YjQ2ODE1MjdkYjcwNGUzZGI4N180MDM5_f2b886e9-e0d6-46c8-b3f4-e033ea0fc3b2">No</ix:nonNumeric>&#160;&#160;&#9746;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ndicate by check mark whether the registrant: (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGV4dHJlZ2lvbjoyOGY3MDk2NGZhYTg0YjQ2ODE1MjdkYjcwNGUzZGI4N180MDQw_cfa1a62b-defc-4d94-bb31-1bb2c35e54f6">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGV4dHJlZ2lvbjoyOGY3MDk2NGZhYTg0YjQ2ODE1MjdkYjcwNGUzZGI4N180MDQx_b522d9a7-61bc-4a00-ac80-20e906e1ffd7">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></div><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definition of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221;  &#8220;smaller reporting company&#8221; and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">emerging growth company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> in Rule 12b-2 of the Exchange Act. </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.547%"><tr><td style="width:1.0%"></td><td style="width:15.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.055%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.055%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.857%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGFibGU6Mjg2NzAwYWI0YjU0NDQ1YWIyMjdiNTYwNWRmOThmN2UvdGFibGVyYW5nZToyODY3MDBhYjRiNTQ0NDVhYjIyN2I1NjA1ZGY5OGY3ZV8wLTAtMS0xLTExMjY0MA_1dd655e6-643f-44fb-9310-99c00ae678e5">Large Accelerated Filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated&#160;Filer </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-accelerated&#160;Filer&#160;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGFibGU6Mjg2NzAwYWI0YjU0NDQ1YWIyMjdiNTYwNWRmOThmN2UvdGFibGVyYW5nZToyODY3MDBhYjRiNTQ0NDVhYjIyN2I1NjA1ZGY5OGY3ZV8wLTgtMS0xLTExMjY0MA_6f19cd9c-e56a-4e16-8b25-41a22f785ec3">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGFibGU6Mjg2NzAwYWI0YjU0NDQ1YWIyMjdiNTYwNWRmOThmN2UvdGFibGVyYW5nZToyODY3MDBhYjRiNTQ0NDVhYjIyN2I1NjA1ZGY5OGY3ZV8wLTEwLTEtMS0xMTI2NDA_daaf5d74-b7ee-4797-afb4-cc4d46be3763">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></div><div style="margin-top:2pt;text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGV4dHJlZ2lvbjoyOGY3MDk2NGZhYTg0YjQ2ODE1MjdkYjcwNGUzZGI4N180MDQ3_0c8a82b4-9696-4a55-b657-415d33b50035">&#9746;</ix:nonNumeric></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. &#9744;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive o&#64259;cers during the relevant recovery period pursuant to &#167;240.10D-1(b). </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#9744;</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is a shell company (as defined in Exchange Act Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGV4dHJlZ2lvbjoyOGY3MDk2NGZhYTg0YjQ2ODE1MjdkYjcwNGUzZGI4N180MDQy_38ae7d20-ab86-45db-a5f6-68cc6666c952">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></div><div style="margin-top:2pt;text-indent:18pt"><span><br/></span></div><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The aggregate market value of the Registrant&#8217;s voting and non-voting stock held by non-affiliates was approximately $<ix:nonFraction unitRef="usd" contextRef="ia41df9d4ed2a449d9d3a0d5079eee8d8_I20220630" decimals="-8" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGV4dHJlZ2lvbjoyOGY3MDk2NGZhYTg0YjQ2ODE1MjdkYjcwNGUzZGI4N18yODk5_6ee2b9b6-7595-4ed7-9c93-659e42d545fa">1.0</ix:nonFraction> billion based on the last sales price of the Registrant&#8217;s Common Stock on the Nasdaq Global Market of the Nasdaq Stock Market LLC on June&#160;30, 2022. For purposes of this calculation, shares of Common Stock held by directors, officers and 10% stockholders known to the Registrant have been deemed to be owned by affiliates which should not be construed to indicate that any such person possesses the power, direct or indirect, to direct or cause the direction of the management or policies of the Registrant or that such person is controlled by or under common control with the Registrant.</span></div><div style="margin-top:2pt;text-indent:18pt"><span><br/></span></div><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of February&#160;22, 2023, the Registrant had <ix:nonFraction unitRef="shares" contextRef="i60e7b5cfa61b4bd3ba008a679e0b0390_I20230222" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGV4dHJlZ2lvbjoyOGY3MDk2NGZhYTg0YjQ2ODE1MjdkYjcwNGUzZGI4N18zNTEy_da1c55b4-cbd0-4490-8dfd-fb2a1843a4ad">17,076,658</ix:nonFraction> shares of Common Stock outstanding.</span></div><div style="margin-top:2pt;text-indent:18pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGV4dHJlZ2lvbjoyOGY3MDk2NGZhYTg0YjQ2ODE1MjdkYjcwNGUzZGI4N180MDQ2_94331132-7e40-4a5b-93d5-55c1a6bd595b" escape="true">Portions of the Proxy Statement for the Registrant&#8217;s 2023 Annual Meeting of Stockholders to be filed with the Commission within 120 days of December&#160;31, 2022 are incorporated by reference in Part&#160;III of this Annual Report on Form&#160;10-K.&#160;With the exception of those portions that are specifically incorporated by reference in this Annual Report on Form&#160;10-K, such Proxy Statement shall not be deemed filed as part of this Report or incorporated by reference herein.</ix:nonNumeric></span></div><div style="margin-top:2pt"><span><br/></span></div><div style="margin-top:2pt;text-indent:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i98e6b87576d6446486a3b29533a5cf6a_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Table of Contents</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.766%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part I</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_13">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_13">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_16">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_16">17</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_19">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_19">34</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_22">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_22">35</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_25">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_25">35</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_28">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_28">35</a></span></div></td></tr><tr style="height:15pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part II</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_34">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_34">35</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_37">[Reserved]</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_37">37</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_40">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_40">37</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_52">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_52">46</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_55">Consolidated Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_55">46</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;9.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_121">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_121">88</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;9A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_124">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_124">88</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_127">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_124">88</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_130">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_124">88</a></span></div></td></tr><tr style="height:15pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part III</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;10.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_136">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_136">92</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_139">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_139">92</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_142">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_142">92</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;13.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_145">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_145">92</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;14.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_148">Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_148">92</a></span></div></td></tr><tr style="height:15pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part IV</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_154">Exhibits, Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_154">93</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 16.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_157">Form 10-K - Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_154">93</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_160">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_160">98</a></span></div></td></tr></table></div><div style="margin-top:9pt;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:24pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.170%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">GLOSSARY OF TERMS AND ABBREVIATIONS</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Abbreviation</span></td><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definition</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023 Notes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$750.0 million aggregate principal amount of convertible senior unsecured notes due 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aldeyra</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aldeyra Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amgen</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amgen, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASC </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounting Standards Codification</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounting Standards Update </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aziyo</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aziyo Med, LLC</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Baxter</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Baxter International, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">BeiGene</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">BeiGene, Ltd.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">BendaRx</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">BendaRx Corp.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">BLA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Biologics license application</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CASI</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CASI Pharmaceuticals, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">cGMP</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current Good Manufacturing Practice</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Company</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ligand Pharmaceuticals Incorporated, including subsidiaries</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Convertible Note</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Convertible Promissory Note</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">COPD</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chronic obstructive pulmonary disease </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cormatrix</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cormatrix Cardiovascular, Inc. </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corvus</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corvus Pharmaceuticals, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CVR</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent value right</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CyDex</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CyDex Pharmaceuticals, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Daiichi Sankyo</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Daiichi Sankyo Company, Ltd.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dianomi</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Dianomi Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DMF</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Drug Master File</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ESG</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Environmental, Social and Governance</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ECM</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Extracellular matrix</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eisai</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eisai Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EPA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Environmental Protection Agency</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employee Stock Purchase Plan, as amended and restated</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EU</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">European Union</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exelixis </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exelixis, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">FASB</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financial Accounting Standards Board</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">FDA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Food and Drug Administration</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">FSGS</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Focal segmental glomerulosclerosis</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">FY 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Company's fiscal year ended December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">FY 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Company's fiscal year ended December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">FY 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Company's fiscal year ended December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">GAAP</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Generally accepted accounting principles in the United States</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">GCSF</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granulocyte-colony stimulating factor</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Gilead</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Gilead Sciences, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">HBV</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hepatitis B Virus</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Hikma</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Hikma Pharmaceuticals PLC</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hovione</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Hovione FarmCiencia, S.A.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Icagen</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Icagen, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">IM</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intramuscular</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">IND</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investigational New Drug</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">IRS</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Internal Revenue Service</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:24pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.170%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">IV</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intravenous</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Jazz</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Jazz Pharmaceuticals, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ligand</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ligand Pharmaceuticals Incorporated, including subsidiaries</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LTP</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liver targeting prodrug</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marinus </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marinus Pharmaceuticals, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Melinta</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Melinta Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Merck</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Merck &amp; Co., Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Metabasis</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Metabasis Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NDA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New Drug Application</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NOLs</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net Operating Losses</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Novan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Novan, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Novartis</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Novartis AG</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Nucorion </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Nucorion Pharmaceuticals, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">OmniAb</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">OmniAb Operations, Inc. (f/k/a OmniAb, Inc.)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">OMT</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Open Monoclonal Technology, Inc. </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ono</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ono Pharmaceutical Co., Ltd.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Opthea</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Opthea Limited</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Orange Book</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Publication identifying drug products approved by the FDA based on safety and effectiveness</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Palvella</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Palvella Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Par</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Par Pharmaceutical, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pfenex</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pfenex Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pfizer</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pfizer, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Phoenix Tissue</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Phoenix Tissue Repair</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PSU</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance stock unit</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">R&amp;D</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Research and Development</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RSU </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted stock unit</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sage</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sage Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SARM</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selective Androgen Receptor Modulator</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SEC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Securities and Exchange Commission</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sedor</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sedor Pharmaceuticals, Inc., or RODES, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Seelos</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Seelos Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selexis</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selexis, SA</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sermonix</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sermonix Pharmaceuticals, LLC</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SII</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Serum Institute of India</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">SQ Innovation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">SQ Innovation, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sunshine Lake Pharma</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sunshine Lake Pharma Co., Ltd.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Takeda</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Takeda Pharmaceuticals Company Limited</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Taurus</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Taurus Biosciences LLC</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax Act</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Tax Cuts and Jobs Act</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Teva</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd. and Actavis, LLC </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Travere</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Travere Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">TR-Beta</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thyroid hormone receptor beta</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vernalis</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vernalis plc</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Verona</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Verona Pharma plc</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Viking</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Viking Therapeutics</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">xCella Biosciences</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">xCella Biosciences, Inc.</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:24pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.170%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Xi'an Xintong</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Xi'an Xintong Medicine Research</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Zydus Cadila</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Zydus Cadila Healthcare, Ltd</span></td></tr></table></div><div style="margin-top:9pt"><span><br/></span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_10"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_13"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Cautionary Note Regarding Forward-Looking Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">: </span></div><div style="margin-top:5pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should read the following report together with the more detailed information regarding our company, our common stock and our financial statements and notes to those statements appearing elsewhere in this document. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This report contains forward-looking statements that involve a number of risks and uncertainties. Although our forward-looking statements reflect the good faith judgment of our management, these statements can only be based on facts and factors currently known by us. Consequently, these forward-looking statements are inherently subject to risks and uncertainties, and actual results and outcomes may differ materially from results and outcomes discussed in the forward-looking statements.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Forward-looking statements can be identified by the use of forward-looking words such as &#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;plan,&#8221; &#8220;intends,&#8221; &#8220;estimates,&#8221; &#8220;would,&#8221; &#8220;continue,&#8221; &#8220;seeks,&#8221; &#8220;pro forma,&#8221; or &#8220;anticipates,&#8221; or other similar words (including their use in the negative), or by discussions of future matters such as those related to our future results of operations and financial position, royalties and milestones under license agreements, Captisol material sales, product development, and product regulatory filings and approvals, and the timing thereof, Ligand's status as a high-growth company, as well as other statements that are not historical. You should be aware that the occurrence of any of the events discussed under the caption &#8220;Risk Factors&#8221; could negatively affect our results of operations and financial condition and the trading price of our stock.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The cautionary statements made in this report are intended to be applicable to all related forward-looking statements wherever they may appear in this report. We urge you not to place undue reliance on these forward-looking statements, which speak only as of the date of this report. Except as required by law, we assume no obligation to update our forward-looking statements, even if new information becomes available in the future. This caution is made under the safe harbor provisions of Section&#160;21E of the Securities Exchange Act of 1934, as amended.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">References to &#8220;Ligand Pharmaceuticals Incorporated,&#8221; &#8220;Ligand,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our&#8221; and &#8220;us&#8221; include Ligand Pharmaceuticals Incorporated and our wholly-owned subsidiaries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Partner Information</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Information regarding partnered products and programs comes from information publicly released by our partners and licensees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Trademarks</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This Annual Report on Form 10-K includes trademarks, trade names and service marks owned by us.  Ligand&#174;, Advasep&#174;, BEPro&#8482;, Bonsity&#174;, Captisol&#174;, CyDex&#174;, LTP&#174;, LTP Technology&#8482;, Pelican Expression Technology&#8482;, PeliCRM&#8482;, Pfenex Expression Technology&#8482; and XRPro&#174; are protected under applicable intellectual property laws and are our property. All other trademarks, trade names and service marks including, but not limited to OmniAb&#174; Kyprolis&#174;, Evomela&#174;, Veklury&#174;, Livogiva&#174;, Bonteo&#174;, Zulresso</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Rylaze&#174;, VAXNEUVANCE&#8482;, Pneumosil&#174;, Minnebro&#174;, Baxdela&#174;, Conbriza&#174;, Nexterone&#174;, Noxafil&#174;, Duavee&#174;, OTORIN&#8482;, FILSPARI&#8482; and LYTENAVA&#8482; are the property of their respective owners. Solely for convenience, trademarks, trade names and service marks referred to in this report may appear without the &#174;, &#8482; or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">SM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or the right of the applicable licensor to such trademarks, trade names and service marks. Use or display by us of other parties&#8217; trademarks, trade dress or products is not intended to and does not imply a relationship with, or endorsement or sponsorship of, us by the trademark or trade dress owners.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:9.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.050%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Business</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is focused on acquiring or funding programs and technologies that pharmaceutical companies use to discover and develop medicines. Our business model provides a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. The biotechnology industry is characterized by a binary clinical risk, in that, either a drug candidate is successfully developed and receives regulatory marketing approval, or the drug candidate fails in clinical trials. Our goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable and diversified manner while mitigating the binary clinical risk associated with developing a single program. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business model is focused on funding mid to late-stage drug development in return for economic rights and out-licensing our technology platforms to help partners discover and develop medicines. We partner with other pharmaceutical companies to leverage what they do best (late-stage development, regulatory management and commercialization) ultimately to generate our revenue. Our Captisol platform technology is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. Our Pelican Expression Technology is a robust, validated, cost-effective and scalable platform for recombinant protein production that is especially well-suited for complex, large-scale protein production where traditional systems are not. We have established multiple alliances, licenses and other business relationships with the world&#8217;s leading pharmaceutical companies including Amgen, Merck, Pfizer, Jazz, Takeda, Gilead Sciences and Baxter International.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue consists of three primary elements: royalties from commercialized products, sales of Captisol material, and contract revenue from license, milestone and other service payments. We selectively pursue acquisitions and drug development funding opportunities that address high unmet clinical needs to bring in new assets, pipelines, and technologies to aid in generating additional potential new revenue streams.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">OmniAb Separation and Spin-Off</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 23, 2022, we entered into an Agreement and Plan of Merger (the Merger Agreement), by and among our company, Avista Public Acquisition Corp. II (New OmniAb) and OmniAb, Inc., a Delaware corporation and then wholly-owned subsidiary of our company (OmniAb), and Orwell Merger Sub Inc. (Merger Sub), pursuant to which New OmniAb combined with OmniAb, our then-antibody discovery business (the OmniAb Business), in a Reverse Morris Trust transaction. Pursuant to a Separation and Distribution Agreement, dated as of March 23, 2022, among New OmniAb, our company and OmniAb (the Separation Agreement), we transferred the OmniAb Business, including certain of our related subsidiaries, to OmniAb and, in connection therewith, distributed (the Distribution) to Ligand stockholders 100% of the common stock of OmniAb.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immediately following the Distribution, in accordance with and subject to the terms and conditions of the Merger Agreement, Merger Sub merged with and into OmniAb (the Merger), with OmniAb continuing as the surviving company in the Merger and as a wholly-owned subsidiary of New OmniAb.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Technologies</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through a combination of research and acquisitions, we have created a partnered portfolio with a wide variety of underlying technologies. This diversification provides the added benefits of exposure to a wider variety of science, more licensing opportunities and lower impact of individual patent expiry.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Captisol Technology</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Captisol is a patent-protected, chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. This unique technology has enabled several FDA-approved products, including Gilead&#8217;s Veklury, Amgen&#8217;s Kyprolis, Baxter International&#8217;s Nexterone, Acrotech Biopharma&#8217;s and CASI Pharmaceuticals&#8217; Evomela, Melinta Therapeutics&#8217; Baxdela and Sage Therapeutics&#8217; Zulresso. There are many Captisol-enabled products currently in various stages of development. We maintain a broad global patent portfolio for Captisol with the latest expiration date in 2035. Other patent applications covering methods of making Captisol, if issued, extend to 2041.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to solid Captisol powder, we offer our partners access to cGMP manufactured aqueous Captisol concentrate. This product offering was established in 2017 to reduce cycle time and increase Captisol production capacity for large volume drug products. We maintain both Type IV and Type V DMFs with the FDA. These DMFs contain manufacturing and safety information relating to Captisol that our licensees can reference when developing Captisol-enabled drugs. We also have active DMFs in Japan, China and Canada. In 2022, commercial products using Captisol made up over half of our total royalty revenue.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Pelican Expression Technology&#8482; Platform</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pelican Expression Technology platform is a robust, validated, cost-effective and scalable platform for recombinant protein production, and is especially well-suited for complex, large-scale protein production. Global manufacturers have demonstrated consistent success with the platform and the technology is currently out-licensed for multiple commercial and development-stage programs. The versatility of the platform has been demonstrated in the production of enzymes, peptides, antibody derivatives and engineered non-natural proteins. Partners seek the platform as it contributes significant value to biopharmaceutical development programs by reducing timelines and costs associated with research and development through commercial manufacturing of therapeutics and vaccines. Given pharmaceutical industry trends toward large molecules with increased structural complexities, the Pelican Expression Technology platform is well positioned to meet these growing needs as one of the most comprehensive and broadly available, commercially validated protein production platform in the industry.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We acquired the Pelican Expression Technology through our acquisition of Pfenex in October 2020. Several of our partners have commercial products and late stage clinical product candidates utilizing Pelican Expression Technology. In 2022, commercial products acquired from the Pfenex acquisition made up over one-third of our total royalty revenue.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">HepDirect, LTP, and BEPro Technology Platform</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The HepDirect and LTP platforms are our proprietary liver-targeting prodrug technologies that can deliver many different chemical classes of drugs to the liver by using a chemical modification that renders an active pharmaceutical ingredient (API) biologically inactive until cleaved by a liver-specific enzyme. These technologies may improve the efficacy and/or safety of certain drugs and can be applied to marketed or new drug products to treat liver diseases or diseases caused by hemostasis imbalance of circulating molecules controlled by the liver. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The BEPro technology platform is a next generation prodrug technology distinct from HepDirect and LTP prodrug technologies, expanding use to non-liver related diseases. BEPro is specifically applicable to nucleotides and nucleotide analogs for the development of compounds with improved product profiles. Ligand has demonstrated improvements in cell penetration and oral, intravenous and inhaled pharmacokinetics with BEPro-enabled nucleotide analogs.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SUREtechnology Platform (owned by Selexis)</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We acquired economic rights to various SURE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">technology</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Platform programs from Selexis. The SURE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">technology</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Platform, developed and owned by Selexis, is a novel technology that improves the way that cells are utilized in the development and manufacturing of recombinant proteins and drugs. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">Recent Business Updates</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Travere Therapeutics recently received FDA accelerated approval for FILSPARI (sparsentan) for the treatment of immunoglobulin A nephropathy (IgAN). FILSPARI is the first and only dual endothelin angiotensin receptor antagonist in development for rare kidney diseases and is the first non-immunosuppressive treatment indicated for IgAN. Travere anticipates a review decision by the EMA on the potential approval for sparsentan for the treatment of IgAN in Europe in the second half of 2023. Additionally, Travere announced that they expect to report top line results from the two-year confirmatory endpoints in the ongoing Phase 3 DUPLEX Study of sparsentan in focal segmental glomerulosclerosis (FSGS) in the second quarter of 2023, with anticipated submission for full approval in the second half of 2023 in both the U.S. and Europe. Travere reported that it ended 2022 with approximately $450 million in cash, cash equivalents and marketable securities, which would be available to support the commercial launch of sparsentan.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Novan announced it has submitted an NDA to the FDA seeking marketing approval for berdazimer gel, 10.3% (SB206) for the topical treatment of molluscum contagiosum (MC). MC is an infection that causes skin lesions and affects approximately six million people in the U.S. annually. Novan anticipates a potential first quarter 2024 approval assuming the filing is accepted by the FDA and standard review timelines.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Verona Pharma announced positive results of its Phase 3 ENHANCE-1 trial evaluating nebulized ensifentrine for the maintenance treatment of COPD. The ENHANCE-1 trial met its primary and key secondary endpoints demonstrating significant improvements in lung function, symptoms and quality of life measures. In addition, ensifentrine substantially reduced the rate and risk of COPD exacerbations. Ensifentrine was well tolerated over 24 and 48 weeks. In 2022, Verona announced that the Phase 3 ENHANCE-2 trial successfully met its primary endpoint and secondary endpoints evaluating lung function and symptoms, and also significantly reduced the rate and risk of COPD exacerbations. Verona plans to file an NDA for inhaled ensifentrine for the maintenance treatment of COPD with the FDA in the first half of 2023.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viking Therapeutics announced the completion of patient enrollment in its Phase 2b clinical trial of VK2809, a novel liver-selective thyroid hormone receptor beta agonist, in patients with biopsy-confirmed non-alcoholic steatohepatitis (NASH). Viking expects to report data for the study's primary endpoint in the first half of 2023.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Palvella Therapeutics announced its initial closing of up to $37.7 million in financing with proceeds to be used to advance the development of QTORIN rapamycin for the treatment of pachyonychia congenita, microcystic lymphatic malformations (MLM), and for the prevention of basal cell carcinomas in Gorlin syndrome. Palvella expects top-line data in mid-2023 from the Phase 3 pivotal study evaluating QTORIN rapamycin in pachyonychia congenita. Palvella is currently enrolling patients in a multicenter Phase 2b clinical study in the U.S. and Europe for the prevention of basal cell carcinomas in patients with Gorlin syndrome, with data expected in the first half of 2023. Additionally, Palvella expects to report data in the first quarter of 2023 from a multicenter Phase 2 study in the U.S. investigating QTORIN rapamycin for the treatment of MLM.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, Jazz Pharmaceuticals announced FDA approval of Monday/Wednesday/Friday intramuscular dosing of Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) and submission of a supplemental BLA under the Real-time Oncology Review Program seeking approval for IV administration. Jazz also completed the Marketing Authorization Application submission to the EMA for both IV and IM administration, with a potential approval in 2023. Jazz is also advancing the program for potential submission, approval and launch in Japan.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Xi'an Xintong Pharmaceuticals announced pradefovir reached the primary and secondary endpoints in its Phase 3 clinical trial in China for the treatment of chronic hepatitis B. The 48-week statistical analysis showed that pradefovir was comparable to the first-line drug, tenofovir disoproxil fumarate, with a better safety profile. Xi'an Xintong has submitted a pre-NDA conference communication application with China&#8217;s National Medical Products Administration (NMPA) and expects to submit an NDA in the first quarter of 2023.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">China Resources Double-Crane Pharmaceuticals announced the IND for CX2101A, a small molecule, RNA-dependent RNA polymerase inhibitor of SARS-CoV-2 that utilizes Ligand's proprietary BEPro prodrug technology, was approved by the NMPA for use in clinical trials for the treatment of novel coronavirus pneumonia in China.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aldeyra announced the submission of an NDA to the FDA for topical ocular reproxalap for the treatment of signs and symptoms of dry eye disease. Reproxalap is a small-molecule modulator of RASP (reactive aldehyde species), which are elevated in ocular and systemic inflammatory disease.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Arcellx initiated a Phase 1 study of ARCL-002 in acute myeloid leukemia and myelodysplastic syndromes. ARCL-002 utilizes the Pelican Expression Technology.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Merck announced the European Medicines Agency has recommended approval of VAXNEUVANCE for active immunization for the prevention of invasive disease, pneumonia and acute otitis media caused by Streptococcus pneumoniae in individuals from 6 weeks to less than 18 years of age. VAXNEUVANCE is a 15-valent pneumococcal vaccine utilizing Ligand&#8217;s CRM197 vaccine carrier protein and is currently authorized for use in the European Union for individuals 18 years of age and older and is approved in the United States for individuals 6 weeks of age and older. In July 2022 Merck started a broad Phase 3 program for V116, their investigational 21-valent pneumococcal conjugate vaccine utilizing Ligand&#8217;s CRM197 vaccine carrier protein.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sermonix Pharmaceuticals announced results of its ELAINE 1 Phase 2 study of lasofoxifene vs. fulvestrant in postmenopausal women with locally advanced or metastatic ER+/HER2- breast cancer and an ESR1 mutation. Median progression-free survival was 6.04 months for lasofoxifene vs. 4.04 months for fulvestrant (p=0.138). Objective response rate was 13.2% for lasofoxifene vs. 2.9% for fulvestrant, (p=0.12), with 1 complete response and 4 partial responses in the lasofoxifene arm vs. no complete responses and 1 partial response in the fulvestrant arm. While the study was not powered for statistical significance, all endpoints numerically favored lasofoxifene.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, BeiGene, Ltd. announced the launch of KYPROLIS&#174; (carfilzomib) for injection in China for patients with relapsed/refractory (R/R) multiple myeloma. KYPROLIS is licensed to BeiGene in China under a strategic collaboration with Amgen, and was approved in July 2021 by the China National Medical Products Administration (NMPA) in combination with dexamethasone for the treatment of adult patients with R/R multiple myeloma who have received at least two prior therapies, including a proteasome inhibitor and an immunomodulatory agent. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outlook Therapeutics announced it submitted a BLA to the FDA for ONS-5010, an investigational ophthalmic formulation of bevacizumab for the treatment of wet age-related macular degeneration that, if approved, will be branded as LYTENAVA&#8482; (bevacizumab-vikg).</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate and Governance Highlights</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to policies and practices focused on environmental sustainability, positively impacting our social community and maintaining and cultivating good corporate governance. By focusing on such ESG policies and practices, we believe we can affect a meaningful and positive change in our community and maintain our open, collaborative corporate culture. We will continue our proactive shareholder and employee engagement in 2023.  See www.ligand.com for information about our ESG policies and practices. The information contained on our website is not intended to be part of this filing.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:27pt"><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Commercial and Clinical Stage Partnered Portfolio</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a large portfolio of assets currently generating royalties and future potential revenue-generating programs, including over 100 fully-funded by our partners. Each white dot on our partnered pipeline chart below represents a fully-funded partnered program, with each section of the chart representing a major Ligand technology or platform.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><img src="lgnd-20221231_g2.jpg" alt="lgnd-20221231_g2.jpg" style="height:363px;margin-bottom:5pt;vertical-align:text-bottom;width:648px"/></div><div style="text-indent:27pt"><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Royalties on Commercial Products</span></div><div style="margin-bottom:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We currently receive royalties on more than ten commercial products. The following table provides an overview of our current portfolio of royalties:</span></div><div style="margin-bottom:12pt;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"></td><td style="width:12.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.029%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.869%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.807%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Product</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Partner</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Therapeutic Area</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Royalty Rate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022 Royalty Revenue (in millions)</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated 2022 Product Revenue<br/>&#160;(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kyprolis</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amgen/Ono/Beigene</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancer</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5% - 3.0%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$30.1</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,275.6</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Teriparatide</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alvogen</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25%-40%&#185;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$15.8</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acrotech/CASI</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancer</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10.2</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$51.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rylaze</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jazz</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancer</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Low single digit</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$8.8</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$278.7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nexterone</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Baxter</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Low single digit</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.6</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$56.8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pneumosil</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Serum Institute</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infectious Disease</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Low single digit</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.6</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$114.7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vaxneuvance</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merck</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infectious Disease</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Low single digit</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.1</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$159.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0.3</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$18.0</span></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#185;) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">We receive tiered profit sharing of 25% on quarterly profits less than $3.75 million, 35% on quarterly profits greater than $3.75 million but less than $7.5 million and 40% on quarterly profits greater than $7.5million. If therapeutic equivalence is achieved, quarterly profit changes to 50% of quarterly profits.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Portfolio Overview</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have assembled one of the largest portfolios of biopharmaceutical assets in the industry which provides investors the opportunity to participate in the biotech industry while mitigating the clinical binary risk typically associated with the industry. Our portfolio consists of assets which currently generate revenue through royalties on commercial products as well as Captisol sales on commercial products. In addition to these assets, we have a substantial pipeline of development stage assets that currently generate contractual payments through milestone and license fees with future potential for royalties and Captisol material sales for those programs under our Captisol technology.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"><tr><td style="width:1.0%"></td><td style="width:36.051%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.325%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approved</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Partner Name</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Program</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Therapeutic Area</span></td></tr><tr style="height:8pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acrotech/CASI</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alvogen/Adalvo</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Teriparatide</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alvogen/Hikma/Nanjing King-Friend</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Voriconazole</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infectious Disease</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amgen/Beigene/Ono</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kyprolis</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aziyo</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ECM portfolio</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical device/Cardiology</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Baxter</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nexterone</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biocad</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Teberif</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inflammatory/Metabolic</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exelixis/Daiichi-Sankyo</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnebro</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gilead</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Veklury</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infectious Disease</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jazz</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rylaze</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Melinta</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Baxdela</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infectious Disease</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Menarini</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frovatriptan</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Central Nervous System</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merck</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noxafil-IV</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infectious Disease</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merck</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vaxneuvance</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infectious Disease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Par</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Posaconazole</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infectious Disease</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pfizer</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Duavee</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inflammatory/Metabolic</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pfizer</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vfend-IV</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infectious Disease</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sage</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zulresso</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Central Nervous System</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sedor/Lupin</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sesquient</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Central Nervous System</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Serum Institute of India</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pneumosil</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infectious Disease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zydus Cadila</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vivitra</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zydus Cadila</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bryxta/ZyBev</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zydus Cadila</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maropitant</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Central Nervous System</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zydus Cadila</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exemptia</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inflammatory/Metabolic</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zydus Cadila</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vortuxi</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inflammatory/Metabolic</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Phase 3/Pivotal or Regulatory Submission Stage</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Partner Name</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Program</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Therapeutic Area</span></td></tr><tr style="height:5pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aldeyra</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reproxalap</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other/Undisclosed</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BendaRx</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bendamustine</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oncology</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cantex</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CX-01</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oncology</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eisai</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FYCOMPA</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Central Nervous System</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Escape Bio</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S1P5 agonist</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TBD</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marinus</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ganaxalone IV</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Central Nervous System</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"><tr><td style="width:1.0%"></td><td style="width:36.051%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.325%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Meridian</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ML-141</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oncology</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merck</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">V116</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pneuococcal adult</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Novan</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SB206</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infectious Disease</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Novartis</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mekinist (CE-Trametinib)</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opthea</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OPT-302</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ophthalmology</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outlook Therapeutics</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ONS-5010</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other/Undisclosed</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Palvella</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PTX-022</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other/Undisclosed</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Serum Institute</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CRM197</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infectious Disease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SQ Innovation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CE-Furosemide</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular disease</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sunshine Lake</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vilazodone</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Central Nervous System</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Travere</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sparsentan</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severe and Rare</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Verona</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ensifentrine (RPL554)</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Respiratory Disease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Teriparatide</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Xi'an Xintong</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pradefovir</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infectious Disease</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Phase 2</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Partner Name</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Program</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Therapeutic Area</span></td></tr><tr style="height:6pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acrivon</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ACR-368</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corvus</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ciforadenant</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DeNovo</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lisfensine</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neurology</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merck</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">V116</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infectious Disease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oncternal</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cirmtuzumab</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phoenix Tissue</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PTR-01</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Genetic Disease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Seelos</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aplindore</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Central Nervous System</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sermonix</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lasofoxifene</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohara Pharmaceuticals</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JPH-203</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Verona</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ensifentrine</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asthma</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Verona</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ensifentrine</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cystic Fibrosis</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viking</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VK5211</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inflammatory/Metabolic</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viking</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VK2809</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inflammatory/Metabolic</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Xi'an Xintong</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MB07133</span></td><td colspan="3" style="border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancer</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Phase 1</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Partner Name</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Program</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Therapeutic Area</span></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Apotex</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Meloxicam</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Migraine</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China Resources Double Crane</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CX2101A</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID 19</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CSL</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CSL-324</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immunology</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foghorn</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FHD-609/BRD9</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jazz</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JZP-341</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long Acting Erwinia Asparaginase</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MEI Pharma</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ME-344</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merck</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">V117</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pneumococcal</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Novartis</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MIK-665</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Novartis</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BCL-201</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancer</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"><tr><td style="width:1.0%"></td><td style="width:36.051%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.325%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nucorion</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NUC-1010</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infectious disease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revision Therapeutics</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rev0100</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ophthalmology</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sage</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAGE-689</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Central Nervous System</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Takeda</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TAK-925</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severe and Rare</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Takeda</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TAK-243</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vaxxas</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nanopatch</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infectious Disease</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viking</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VK-0214</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Genetic Disease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jupiter Biomed</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viright</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancer</span></td></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisitions</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a company devoted to identifying cutting-edge science and have exhibited a track record of capital deployment to create a high growth business model that operates with an efficient and low corporate cost structure. Over the last 15 years we have deployed approximately $1 billion of capital to build our portfolio. Following the spin-off of our OmniAb antibody discovery business, our strategy is to continue to expand our pipeline by acquiring additional revenue streams on both early and late stage drug product candidates from third parties, as well as acquiring commercial stage drugs for sale. Expanding our pipeline through these acquisitions can allow for further diversification across therapeutic areas and development stages. The following is a timeline of acquisitions we've completed over the last 15 years:</span></div><div><img src="lgnd-20221231_g3.jpg" alt="lgnd-20221231_g3.jpg" style="height:211px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Selected Commercial Programs</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following programs represent important revenue-generating components of our current portfolio. For information about the royalties owed to us for these programs, see &#8220;Royalties&#8221; later in this business section.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Kyprolis (Amgen, Ono, BeiGene)</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We supply Captisol to Amgen for use with Kyprolis (carfilzomib), and granted Amgen an exclusive product-specific license under our patent rights with respect to Captisol. Kyprolis is formulated with Ligand&#8217;s Captisol technology and is approved in the United States for the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">In combination with dexamethasone, lenalidomide plus dexamethasone, daratumumab plus dexamethasone, or daratumumab and hyaluronidase-fihj and dexamethasone, or isatuximab and dexamethasone for the treatment of patients with relapsed or refractory multiple myeloma who have received one to three lines of therapy.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As a single agent for the treatment of patients with relapsed or refractory multiple myeloma who have received one or more lines of therapy.</span></div><div style="margin-bottom:3pt;padding-left:72pt"><span><br/></span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our agreement with Amgen may be terminated by either party in the event of material breach or bankruptcy, or unilaterally by Amgen with prior written notice, subject to certain surviving obligations. Absent early termination, the agreement will terminate upon expiration of the obligation to pay royalties. Under this agreement, we are entitled to receive revenue from clinical and commercial Captisol material sales and royalties on annual net sales of Kyprolis based on our patents and applications relating to the Captisol component of Kyprolis which are not expected to expire until 2033.</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Teriparatide Injection Product (PF708) (Alvogen/Adalvo)</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We acquired the Teriparatide Injection product with the acquisition of Pfenex in October 2020. Teriparatide Injection is a drug indicated for uses including the treatment of osteoporosis in certain patients at high risk for fracture. Teriparatide Injection was developed using our Pelican Expression Technology&#8482; and was approved by the FDA in 2019 in accordance with the 505(b)(2) regulatory pathway, with FORTEO as the reference product. Our commercialization partner, Alvogen launched the product in June 2020 in the United States. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our partner Alvogen has exclusively licensed the rights to commercialize and manufacture the Teriparatide Injection product in the United States, while Adalvo has the rights to commercialize in the EU, certain countries in the Middle East and North Africa (MENA), and the rest of world (ROW) territories (the latter defined as all countries outside of the EU, U.S. and MENA, excluding Mainland China, Hong Kong, Singapore, Malaysia and Thailand). In August 2020, marketing authorizationb throughout the EU was received under the trade name Livogiva and in December 2020 in Saudi Arabia under the name Bonteo. In December of 2022, we terminated a license agreement with Beijing Kangchen Biological Technology Co., Ltd. (Kangchen) thereby regaining the right to commercialize PF708 in Mainland China, Hong Kong, Singapore, Malaysia and Thailand along with a non-exclusive right to conduct development activities in such countries with respect to PF708. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with our agreements with Alvogen, we are eligible to receive tiered gross profit sharing of between 25% and 40% of quarterly profits prior to an &#8220;A&#8221; therapeutic equivalence designation, which increases to a flat 50% if an &#8220;A&#8221; rating is achieved.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with our EU, MENA and ROW agreements with Adalvo, we may be eligible to receive additional upfront and milestone payments of $1.5 million and may also be eligible to receive up to 60% of gross profit derived from product sales and regional license fees, if approved, depending on geography, cost of goods sold and sublicense fees.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evomela (Acrotech and CASI)</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We supply Captisol to, and receive royalties from, Acrotech Biopharma for sales of Evomela in the U.S., and CASI Pharmaceuticals for sales in China. Evomela received market approval by the NMPA in August of 2019. It is the only approved and commercially available melphalan product in China. Evomela is a Captisol-enabled melphalan IV formulation which is approved by the FDA for use in two indications:</span></div><div style="margin-bottom:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a high-dose conditioning treatment prior to autologous stem cell transplantation (ASCT) in patients with multiple myeloma; and </span></div><div style="margin-bottom:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Evomela has been granted Orphan Designation by the FDA for use as a high-dose conditioning regimen for patients with multiple myeloma undergoing ASCT. The Evomela formulation avoids the use of propylene glycol, which has been reported to cause renal and cardiac side-effects that limit the ability to deliver higher quantities of therapeutic compounds. The use of the Captisol technology to reformulate melphalan is anticipated to allow for longer administration durations and slower infusion rates, potentially enabling clinicians to safely achieve a higher dose intensity of pre-transplant chemotherapy.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the license agreement, Acrotech Biopharma has marketing rights worldwide excluding China and CASI Pharmaceuticals has rights to market in China. We are eligible to receive over $50 million in potential milestone payments under this agreement, royalties on global net sales of the Captisol-enabled melphalan product and revenue from Captisol material sales. Acrotech and CASI&#8217;s obligation to pay royalties will expire at the end of the life of the relevant patents or when a competing product is launched, whichever is earlier, but in no event before ten years after the commercial launch. Our patents and applications relating to the Captisol component of melphalan are not expected to expire until 2033. As described herein, we have entered into a settlement agreement with Teva and Acrotech Biopharma (the holder of the NDA for Evomela) which will allow Teva to market a generic version of Evomela in the United States in 2026, or earlier under certain circumstances. Absent early termination, the agreement will terminate upon expiration of the obligation to pay royalties. The agreement may be terminated by either party for an uncured material breach or unilaterally by Acrotech and CASI by prior written notice.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vaxneuvance (Merck) </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vaxneuvance, a 15-valent pneumococcal conjugate vaccine, also known as V114, was approved in the U.S. in July of 2021 for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F in adults 18 years of age and older, and subsequently in children 6 weeks through 17 years of age in June of 2022. Vaxneuvance was also approved in Europe in October 2022 for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae in individuals 18 years and older and in infants, children and adolescents from 6 weeks to less than 18 years of age. VAXNEUVANCE utilizes CRM197 vaccine carrier protein, which is produced using the patent-protected Pelican Expression Technology&#8482; platform. We are entitled to low single digit royalties derived from net sales </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of Vaxneuvance. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pneumosil (Serum Institute of India, SII)</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SII began commercialization of its 10-valent pneumococcal conjugate vaccine, Pneumosil, which is produced using CRM197 made in the Pelican Expression Technology platform, in the second quarter of 2020. Pneumosil is designed primarily to help fight against pneumococcal pneumonia among children, with an advantage of targeting the most prevalent serotypes of the bacterium causing serious illness in developing countries. Pneumosil achieved WHO Prequalification in December 2019, allowing the product to be procured by United Nations agencies and Gavi, the Vaccine Alliance, and subsequently achieved Indian Marketing Authorization in July 2020, and SII announced commercial launch of the product in India in December 2020. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rylaze (Jazz Pharmaceuticals)</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, Jazz announced the US launch of Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn), previously referred to as JZP458. Rylaze, which was approved by the FDA in June 2021, is a recombinant erwinia asparaginase used as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LBL) in adult and pediatric patients one month or older who have developed hypersensitivity to E. coli-derived asparaginase. Additionally, Jazz is utilizing our technology for the development of PF745 (JZP341), a long-acting Erwinia asparaginase for the treatment of ALL and other hematological malignancies. Jazz has worldwide rights to develop and commercialize PF745.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ligand is eligible to receive up to $155.5 million in milestone payments and tiered low to mid-single digit royalties based on worldwide net sales of any products resulting from this collaboration, including Rylaze.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Nexterone (Baxter)</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a license agreement with Baxter, related to Baxter's Nexterone, a Captisol-enabled formulation of amiodarone, which is marketed in the United States and Canada. We supply Captisol to Baxter for use in accordance with the terms of the license agreement under a separate supply agreement. Under the terms of the license agreement, we will continue to earn milestone payments, royalties, and revenue from Captisol material sales. We earn royalties on net sales of Nexterone through early 2033.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Veklury (Gilead)</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We supply Captisol to Gilead for sales of Veklury (remdesivir). Gilead received marketing approval from the FDA in October 2020. Veklury is an antiviral treatment of COVID-19 that is FDA approved. The product has regulatory approvals for the treatment of moderate or severe COVID-19 in over 70 countries. We are supplying Captisol to Gilead under a 10-year supply agreement. We are also supplying Captisol to Gilead&#8217;s voluntary licensing generic partners who are manufacturing remdesivir for 127 low- and middle-income countries. We receive our commercial compensation for this program through the sale of Captisol.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Zulresso (Sage)</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a license agreement with Sage, related to Sage''s Zulresso, a Captisol-enabled formulation of brexanolone for the treatment of postpartum depression (PPD). Under the terms of the agreement, we receive royalties and revenue from Captisol material sales.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Noxafil-IV (Merck)</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a supply agreement with Merck related to Merck&#8217;s NOXAFIL-IV, a Captisol-enabled formulation of posaconazole for IV use. NOXAFIL-IV is marketed in the United States, EU, Japan and Canada. We receive our commercial compensation for this program through the sale of Captisol. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Duavee or Duavive (Pfizer) </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pfizer is responsible for the marketing of bazedoxifene, a synthetic drug specifically designed to reduce the risk of osteoporotic fractures while also protecting uterine tissue. Pfizer has combined bazedoxifene with the active ingredient in Premarin to create a combination therapy for the treatment of post-menopausal symptoms in women. Pfizer is marketing the combination treatment under the brand names Duavee and Duavive in various territories. Net royalties on annual net sales of Duavee/Duavive are payable to us through the life of the relevant patent or ten years from the first commercial sale, whichever is longer, on a country by country basis.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Exemptia, Vivitra, Bryxta and Zybev (Zydus Cadila)</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zydus Cadila&#8217;s Exemptia (adalimumab biosimilar) is marketed in India for autoimmune diseases. Zydus Cadila uses the Selexis technology platform for Exemptia. We earn royalties on sales by Zydus Cadila for ten years following approval.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zydus Cadila&#8217;s Vivitra (trastuzumab biosimilar) is marketed in India for breast cancer. Zydus Cadila uses the Selexis technology platform for Vivitra. We are entitled to earn royalties on sales by Zydus Cadila for ten years following approval.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zydus Cadila&#8217;s Bryxta and Zybev (bevacizumab biosimilar) is marketed in India for various indications. Zydus Cadila uses the Selexis technology platform for Bryxta and Zybev. We earn royalties on sales by Zydus Cadila for ten years following approval.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Selected Development Stage Programs</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have multiple fully-funded partnered programs that are either in or nearing the regulatory approval process, or given the area of research or value of the license terms, we consider particularly noteworthy. We are eligible to receive milestone payments and royalties on these programs. This list does not include all of our partnered programs. In the case of Captisol-related programs, we are also eligible to receive revenue for the sale of Captisol material supply. The following table represents development stage assets with disclosed royalties:</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span><br/></span></div><div style="margin-bottom:6pt;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.298%"><tr><td style="width:1.0%"></td><td style="width:28.822%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.977%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#333399;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Development stage assets with disclosed royalties</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ff6600;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Program</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ff6600;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensee</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ff6600;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CE-Fosphenytoin</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sedor</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CE-Meloxicam</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sedor</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0% - 10.0%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ciforadenant</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corvus</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mid-single digit to low-teen royalty</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DGAT-1</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viking</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0% - 7.0%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ensifentrine (RPL554)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Verona</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Low to mid-single digit royalty</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FBPase Inhibitor (VK0612)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viking</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5% - 9.5%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lasofoxifene</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sermonix</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0% - 10.0%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MB07133</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Xi'an Xintong</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ME-344</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MEI Pharma</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Low single digit royalty</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral EPO</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viking</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5% - 8.5%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pradefovir</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Xi'an Xintong</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PTX-022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Palvella</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0% - 9.8%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARM (VK5211)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viking</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.25% - 9.25%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SB206</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Novan </span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0% - 10.0%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sparsentan</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Travere</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TR Beta (VK2809 and VK0214)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viking</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5% - 7.5%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nucorion</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0% - 9.0%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Seelos</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0% - 10.0%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sparsentan (Travere) </span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In early 2012, Ligand licensed the world-wide rights to sparsentan to Travere Therapeutics. Travere recently received FDA accelerated approval for FILSPARI (sparsentan) for the treatment of immunoglobulin A nephropathy (IgAN). FILSPARI is the first and only dual endothelin angiotensin receptor antagonist in development for rare kidney diseases and is the first non-immunosuppressive treatment indicated for IgAN. Travere anticipates a review decision by the EMA on the potential approval for sparsentan for the treatment of IgAN in Europe in the second half of 2023. Additionally, Travere announced that they expect to report top line results from the two-year confirmatory endpoints in the ongoing Phase 3 DUPLEX Study of sparsentan in focal segmental glomerulosclerosis (FSGS) in the second quarter of 2023, with anticipated submission for full approval in the second half of 2023 in both the U.S. and Europe.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Under our license agreement with Travere, we are entitled to receive over $66 million in potential milestone payments, as well as 9% in royalties on any future worldwide sales.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">TR-Beta - VK2809 and VK0214 (Viking) </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our partner, Viking, is developing VK2809, a novel selective thyroid hormone receptor beta (TR-beta) agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia and NASH. VK2809 is currently in a Phase 2b clinical trial (the VOYAGE study) in patients with biopsy-confirmed NASH. VK0214, another novel, orally available, TR-beta </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">agonist, is in development for the potential treatment of X-linked adrenoleukodystrophy (X-ALD). VK0214 is currently being evaluated in a Phase 1b clinical trial in patients with the adrenomyeloneuropathy (AMN) form of X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375 million of development, regulatory and commercial milestones and tiered royalties on potential future sales. Our TR Beta programs partnered with Viking are subject to CVR sharing and a portion of the cash received will be paid out to CVR holders.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CRM197</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CRM197 is a non-toxic mutant of diphtheria toxin. It is a well characterized protein and functions as a carrier for polysaccharides and haptens, making them immunogenic. CRM197 is used in prophylactic and therapeutic vaccine candidates. We have developed CRM197 production strains using our Protein Expression Technology platform and supply preclinical grade and cGMP CRM197 (PeliCRM&#8482;) to several vaccine development focused pharmaceutical customers. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our partners Merck and SII have exclusively licensed unique production strains for use in their conjugate vaccine products and candidates for pneumococcal and meningitis bacterial infections. Pneumococcus bacterium (Streptococcus pneumoniae) is a leading cause of severe pneumonia and major cause of morbidity and mortality worldwide. In accordance with our CRM197 commercial license agreements with Merck, we are eligible to earn an additional $8 million in development and regulatory milestones and low single digit royalties derived from net sales, depending on territory. CRM-197 made in the Pelican Expression Technology platform is also used by Merck in its investigational vaccine candidates, including V116, a 21-valent pneumococcal conjugate vaccine currently in Phase 3 clinical trials. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Ensifentrine &#8211; RPL554 (Verona)</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ensifentrine is a first-in-class, selective dual inhibitor of phosphodiesterase 3 and 4 enzymes combining bronchodilator and non-steroidal anti-inflammatory activities in one compound. Ligand obtained the rights to ensifentrine in 2018 in the acquisition of Vernalis. Our partner, Verona Pharma, recently completed the Phase 3 ENHANCE-21 and ENHANCE-12 trials evaluating nebulized ensifentrine for the maintenance treatment of chronic obstructive pulmonary disease (COPD) and plans to file a NDA with the US FDA in the first half of 2023. Under the terms of our agreement with Verona, we are entitled to development and regulatory milestones, including a &#163;5.0 million payment upon the first approval by any regulatory authority, and royalties on potential future sales.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">SARM - VK5211 (Viking) </span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Viking is also developing VK5211, a novel SARM for patients recovering from hip-fracture. SARMs retain the beneficial properties of androgens without undesired side-effects of steroids or other less selective androgens. In a Phase 2 clinical trial, VK5211 demonstrated statistically significant, dose dependent increases in lean body mass. Under the terms of the agreement with Viking, we may be entitled to up to $270 million of development, regulatory and commercial milestones as well as tiered royalties on potential future sales.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ganaxalone IV (Marinus)</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our partner, Marinus, is conducting Phase 3 clinical trials with Captisol-enabled ganaxolone IV in patients with refractory status epilepticus. Marinus has exclusive worldwide rights to Captisol-enabled ganaxolone, a GABA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:1.4pt;vertical-align:baseline">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> receptor modulator, for use in humans. We are entitled to development and regulatory milestones, revenue from Captisol material sales, and royalties on potential future sales.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Ciforadenant &#8211; CPI-444 (Corvus)</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our partner, Corvus, is conducting a Phase 1b/2 clinical trial evaluating ciforadenant as a potential first line therapy for metastatic renal cell cancer (RCC) in combination with ipilimumab (anti-CTLA-4) and nivolumab (anti-PD-1). The Phase 1b/2 study is being conducted by the Kidney Cancer Research Consortium (KCRC) and is led by The University of Texas MD Anderson Cancer Center. Under the terms of our agreement with Corvus, we are entitled to development and regulatory milestones and tiered royalties on potential future sales. The aggregate potential milestone payments from Corvus are approximately $220 million for all indications.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FYCOMPA IV (Eisai)</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our partner, Eisai, is developing an intravenous Fycompa&#174; (perampanel), formulated with Captisol, as a substitute in Japan for oral tablets as an adjunctive therapy in patients with partial onset seizures (including secondarily generalized seizures) or primary generalized tonic-clonic seizures.  In August of 2022, Eisai announced it had filed a supplementary NDA in Japan for Fycompa IV seeking approval for the injection formulation as a new route of administration. We are entitled to revenue from Captisol material sales and tiered royalties on potential future sales.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SB206 (Novan) </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We acquired certain economic rights to berdazimer gel, 10.3% (SB206) from Novan in May 2019. Berdazimer gel is a topical nitric-oxide antiviral gel for the treatment of viral skin infections, including molluscum contagiosum (MC). MC is an infection which causes skin lesions that affect approximately 6 million people in the United States annually, with the greatest incidence in children aged one to 14 years. Under a development funding and royalties agreement with Novan for berdazimer gel, Ligand is entitled to receive up to $20 million of milestone payments and tiered royalties of 7% to 10% on future worldwide sales of berdazimer gel.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">PTX-022 (Palvella)</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We acquired the economic rights to QTORIN&#8482; 3.9% rapamycin anhydrous gel (QTORIN&#8482; rapamycin, formerly PTX-022) from Palvella in December 2018. QTORIN&#8482; rapamycin is a novel, topical formulation comprising high-strength rapamycin in development for the treatment of Pachyonychia Congenita (PC), treatment of Microcystic Lymphatic Malformations (Microcystic LM), and for the prevention of Basal Cell Carcinomas (BCCs) in Gorlin Syndrome (GS). Palvella expects to report top-line results of the Phase 3 VAPAUS study in PC in mid-2023.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lasofoxifene (Sermonix) </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Lasofoxifene is a selective estrogen receptor modulator for osteoporosis treatment and other diseases, discovered through the research collaboration between Pfizer and us. Our partner, Sermonix has a license for the development of oral lasofoxifene for the United States and additional territories and is currently developing lasofoxifene as a treatment for ESR1-mutated metastatic breast cancer. Under the terms of the agreement, we are entitled to receive over $45 million in potential regulatory and commercial milestone payments as well as royalties on potential future net sales. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Pradefovir (Xi'an Xintong)</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Chinese licensee, Xi'an Xintong Medicine Research (following its acquisition of Chiva Pharmaceuticals), is developing pradefovir, an oral liver-targeting prodrug of the HBV DNA polymerase/reverse transcriptase inhibitor adefovir, for the potential treatment of HBV infection. Pradefovir was developed using Ligand&#8217;s HepDirect technology. Xi'an Xintong recently completed a Phase 3 HBV trial. We are entitled to an annual licensing maintenance fee and royalties on potential future sales.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MB07133 (Xi'an Xintong)</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chinese licensee Xi'an Xintong Medicine Research is also developing MB07133, a liver specific, HepDirect prodrug of cytarabine monophosphate, for the potential treatment of hepatocellular carcinoma and intrahepatic cholangiocarcinoma. MB07133 is currently in Phase 1 in China. We are entitled to an annual licensing maintenance fee and royalties on potential future sales.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CX2101A (China Resources Double-Crane Pharmaceutical)</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October of 2021, Ligand signed a collaboration agreement granting China Resources Double-Crane Pharmaceutical Co., Ltd. (CRDC) exclusive Asia territorial rights to develop a novel investigational oral COVID-19 antiviral therapeutic compound using Ligand&#8217;s BEPro technology. Ligand received an upfront payment in respect of the collaboration, and clinical and regulatory milestone payments, and tiered royalties on net sales. CRDC will be responsible for all costs related to the program. BEPro is a proprietary prodrug technology that is specifically applicable to nucleotides and nucleotide analogs for the development of compounds with improved product profiles. In December of 2022, CRDC announced that the IND for CX2101A received a "Notice of Drug Clinical Trial Approval" issued by the State Drug Administration (NMPA), approving clinical trials of the drug for the treatment of novel coronavirus pneumonia in China. CX2101A is a small molecule compound that acts on RdRp (RNA-dependent RNA polymerase) of SARS-CoV-2, using the BEPro prodrug technology. CRDC is conducting a Phase 1 trial in China.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ONS-5010 (Outlook Therapeutics)</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outlook Therapeutics announced in October of 2022 that the US FDA has accepted for filing a BLA for ONS-5010 / LYTENAVA&#8482; (bevacizumab-vikg), an investigational ophthalmic formulation of bevacizumab for the treatment of wet age-related macular degeneration (wet AMD). Outlook uses the Selexis technology platform for ONS-5010. The FDA set a PDUFA goal date of August 29, 2023 for the BLA. ONS-5010, if approved, is expected to receive 12 years of regulatory exclusivity in the United States. In December of 2022, Outlook announced the validation of its MAA by the EMA for ONS-5010. The decision for potential approval is expected from the European Commission in early 2024. We are entitled to earn royalties on sales of ONS-5010 by Outlook.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Milestone Payments</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our programs under license with our partners may generate milestone payments to us if our partners reach certain development, regulatory and commercial milestones. The following table represents the maximum value of our milestone payment pipeline by technology, development stage and partner (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.058%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Technology*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stage*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Partner*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pelican</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&gt;$215,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preclinical</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&gt; $1,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Viking</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1,500,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Captisol</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&gt; $170,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clinical</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&gt; $120,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Jazz</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$150,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LTP/Hep Direct/BEPro</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&gt; $310,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Regulatory</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&gt; $1,200,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Seelos</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$100,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NCE/Other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&gt; $1,850,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&gt; $1,250,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Travere</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$70,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&gt;$2,500,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&gt;$2,500,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&gt;$750,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&gt;$2,500,000</span></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">*All tables exclude any annual access fees and collaboration revenue for development work.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">Summary of selected programs available for license</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a number of unpartnered programs focused on a wide-range of potential indications or disease eligible for further development or licensing:</span></div><div style="margin-bottom:6pt;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.619%"><tr><td style="width:1.0%"></td><td style="width:44.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.452%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.944%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Program</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Development Stage</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Targeted Indication or Disease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CE-Iohexol</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Luminespib/Hsp90 Inhibitor</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oncology</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CE-Sertraline, Oral Concentrate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depression</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PF530 Interferon Beta</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase 1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immunomodulatory</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PF582 Ranibizumab</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ocular</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CCR1 Antagonist</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preclinical</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oncology</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CE-Busulfan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preclinical</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oncology</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CE-Cetirizine Injection</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preclinical</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allergy</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CE-Silymarin for Topical formulation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preclinical</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sun damage</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FLT3 Kinase Inhibitors</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preclinical</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oncology</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GCSF Receptor Agonist</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preclinical</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood disorders</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PF529 Pegfilgrastim</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preclinical</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oncology</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PF810 Recombinant Peptide</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preclinical</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endocrine System</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:17pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Manufacturing</span></div><div style="margin-bottom:6pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We contract with a third party manufacturer, Hovione, for Captisol production. Hovione operates FDA-inspected sites in the United States, Macau, Ireland and Portugal. Manufacturing operations for Captisol are performed primarily at Hovione's Portugal and Ireland facilities. We believe we maintain adequate inventory of Captisol to meet our current partner needs and that our Captisol capacity will be sufficient to meet future partner needs.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of a Captisol supply interruption, we are permitted to designate and, with Hovione&#8217;s assistance, qualify one or more alternate suppliers.&#160;If the supply interruption continues beyond a designated period, we may terminate the agreement.&#160;In addition, if Hovione cannot supply our requirements of Captisol due to an uncured force majeure event, we may also obtain Captisol from a third party and have previously identified such parties.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current term of the agreement with Hovione is through December 2024. The agreement will automatically renew for successive two year renewal terms unless either party gives written notice of its intention to terminate the agreement no less than two years prior to the expiration of the initial term or renewal term. In addition, either party may terminate the agreement for the uncured material breach or bankruptcy of the other party or an extended force majeure event. We may terminate the agreement for extended supply interruption, regulatory action related to Captisol or other specified events. We have ongoing minimum purchase commitments under the agreement.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the drugs we and our licensees and partners are developing may compete with existing therapies or other drugs in development by other companies. Furthermore, academic institutions, government agencies and other public and private organizations conducting research may seek patent protection with respect to potentially competing products or technologies and may establish collaborative arrangements with our competitors.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Captisol business may face competition from other suppliers of similar cyclodextrin excipients or other technologies that are aimed to increase solubility or stability of APIs. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our competitive position also depends upon our ability to obtain patent protection or otherwise develop proprietary products or processes. For a discussion of the risks associated with competition, see below under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Item 1A. Risk Factors.&#8221;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental, Health and Safety (EHS)</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to providing a safe and healthy workplace, promoting environmental excellence in our communities, and complying with all relevant regulations and industry standards. We establish and monitor programs to reduce pollution, prevent injuries, and maintain compliance with applicable regulations. By focusing on such practices, we believe we can affect a meaningful, positive change in our community and maintain a healthy and safe environment. During 2022, we made good progress on our ESG efforts. We have initiated a $2.5 million solar investment at Kansas University Innovation Park; modified the Captisol manufacturing process resulting in water savings and packaging reduction; made ESG related charitable donations; and commenced numerous initiatives from our ESG-focused outreach committees. We expect to continue our effort and to refine our EHS policies and practices in 2023. More information on our EHS policies and initiatives is available on our website at www.ligand.com. The information contained on our website is not intended to be part of this filing.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Regulation</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The research and development, manufacturing and marketing of pharmaceutical products are subject to regulation by numerous governmental authorities in the United States and other countries.&#160;We and our partners, depending on specific activities performed, are subject to these regulations. In the United States, pharmaceuticals are subject to regulation by both federal and various state authorities, including the FDA. The Federal Food, Drug and Cosmetic Act and the Public Health Service Act govern the testing, manufacture, safety, efficacy, labeling, storage, record keeping, approval, advertising and promotion of pharmaceutical&#160;products. These activities are subject to additional regulations that apply at the state level. There are similar regulations in other countries as well. For both currently marketed products and products in development, failure to comply with applicable regulatory requirements can, among other things, result in delays, the suspension of regulatory approvals, as well as possible civil and criminal sanctions. In addition, changes in existing regulations could have a material adverse effect on us or our partners. For a discussion of the risks associated with government regulations, see below under &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 1A. Risk Factors.&#8221;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Patents and Proprietary Rights</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that patents and other proprietary rights are important to our business. Our policy is to file patent applications to protect technology, inventions and improvements to our inventions that are considered important to the development of our business. We also rely upon trade secrets, know-how, continuing technological innovations and licensing opportunities to develop and maintain our competitive position.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patents are issued or pending for the following key products or product families. The scope and type of patent protection provided by each patent family is defined by the claims in the various patents. Patent term may vary by jurisdiction and depend on a number of factors including potential patent term adjustments, patent term extensions, and terminal disclaimers. For each product or product family, the patents and/or applications referred to are in force in at least the United States, and for most products and product families, the patents and/or applications are also in force in European jurisdictions, Japan and other jurisdictions.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Captisol</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">  </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patents and pending patent applications covering Captisol and methods of making Captisol are owned by us. The patents covering the Captisol product with the latest expiration date is set to be in 2033 (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">see, e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., U.S. Patent No. 9,493,582 (expires Feb. 27, 2033)). Other patent applications covering methods of making Captisol, if issued, potentially have terms to 2041. We have asserted U.S. Patents 8,410,077, 9,200,088, and 9,493,582 against Teva in connection with their attempt to obtain FDA approval to manufacture and sell a generic version of Evomela</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We also own several patents and pending patent applications covering drug products containing Captisol as a component. Globally, we own approximately 390 issued patents covering all of the foregoing Captisol compositions, methods and related technology. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ten Captisol patents in several families are listed in the Orange Book in connection with one or more prescription drugs currently on the market. These Captisol-enabled drugs include Nexterone (Baxter), Kyprolis (Amgen), Noxafil (Merck), </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Evomela (Acrotech/CASI), Baxdela (Melinta) and Zulresso (Sage). These patents are listed in the table below, and each patent family containing these patents has pending and/or granted counterparts in Europe, China and Japan.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:61.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Orange Book-listed Captisol Patents</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Country</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Patent No.</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Title</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Expiration (nominal)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"> &#8225;</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">United States</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">7635773</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Sulfoalkyl Ether Cyclodextrin Compositions</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">03/13/2029</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">United States</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">8410077</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Sulfoalkyl Ether Cyclodextrin Compositions</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">03/13/2029</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">United States</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">9200088</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Sulfoalkyl Ether Cyclodextrin Compositions</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">03/13/2029</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">United States</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">10117951</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Sulfoalkyl Ether Cyclodextrin Compositions</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">03/13/2029</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">United States</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">9750822</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Sulfoalkyl Ether Cyclodextrin Compositions</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">03/13/2029</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">United States</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">9493582</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Alkylated Cyclodextrin Compositions And Processes For Preparing And Using The Same</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2/27/2033</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">United States</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">10040872</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Alkylated Cyclodextrin Compositions And Processes For Preparing And Using The Same</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">10/21/2033</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">10864183</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Injectable Nitrogen Mustard Compositions Comprising A Cyclodextrin Derivative And Methods Of Making And Using The Same</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5/28/2030</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">United States</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">10940128</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Injectable Melphalan Compositions Comprising A Cyclodextrin Derivative And Methods Of Making And Using The Same</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5/28/2030</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">11020363</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Injectable Nitrogen Mustard Compositions Comprising A Cyclodextrin Derivative And Methods Of Making And Using The Same</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5/28/2030</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8225;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Expiration dates are calculated as 20 years from the earliest nonprovisional filing date to which priority is claimed, and do not take into account disclaimers or extensions that are or may be available in these jurisdictions.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Subject to compliance with the terms of the respective agreements, our rights to receive royalty payments under our licenses with our exclusive licensors typically extend for the life of the patents covering such developments. For a discussion of the risks associated with patent and proprietary rights, see below under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">&#8220;Item 1A. Risk Factors.&#8221;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Kyprolis </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patents protecting Kyprolis include those owned by Amgen and those owned by us. The United States patent listed in the Orange Book relating to Kyprolis owned by Amgen with the latest expiration date is not expected to expire until 2029. Patents and applications owned by Ligand relating to the Captisol component of Kyprolis are not expected to expire until 2033. Amgen filed suit against several generic drug companies over their applications to make generic versions of Kyprolis. Several generics have settled with Amgen on confidential terms. However, it has been publicly reported that the U.S. launch date for at least Breckenridge Pharmaceuticals&#8217; generic product will be on a date that is held as confidential in 2027 or sooner, depending on certain occurrences. One generic company, Cipla Limited/Cipla USA, Inc. chose not to settle the litigation with Amgen, and proceeded to trial. The District Court upheld the validity of patent claims from three of the patents and the judgment was upheld on appeal.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ligand UK Development Limited</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of our sale of Vernalis (R&amp;D) Limited to HitGen in December 2020, Ligand retained a portfolio of fully-funded shots on goal, which now include S65487, a Bcl-2 inhibitor, and S64315, an Mcl-1 inhibitor for treatment of cancers, both of which are partnered with Servier in collaboration with Novartis and VER250840 (an oral, selective Chk1 inhibitor for treatment of cancer). These programs and their IP are now owned by Ligand UK Development Limited, which has a worldwide patent portfolio of over 200 granted patents in over 70 countries. This patent portfolio is mature, with expected expiry dates between 2022 and 2033.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pelican Expression Technology Platform</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We acquired the Pelican Expression Technology platform through acquisition of Pfenex Inc. in October 2020. This acquisition brought a robust portfolio of patents and patent applications along with substantial know-how and trade secrets which protect various aspects of our core Pelican Expression Technology business. As of December&#160;31, 2022, we were the sole owner of a patent portfolio that consisted of over 200 patents and 40 pending patent applications worldwide that provide material coverage for our platform technology, licensed products and product candidates. Our U.S. issued patents expire during the time period beginning in 2025 and ending in 2038. Our owned and exclusively licensed patent portfolio includes claims directed to methods for recombinant protein production and methods for rapid screening of an array of expression systems, tools for protein expression such as P. fluorescens promoters, secretion leaders, plasmid maintenance systems, improved methods for non-standard amino acid incorporation and fusion partners for peptide production. In addition, our IP covers </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">methods for producing certain classes of proteins such as cytokines, growth factors and antibody derivatives, as well as expression strains and methods for production, purification and formulation of certain vaccine antigens, peptides, therapeutic enzymes, human cytokines, etc.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital Management</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize and take care of our employees by offering a wide range of competitive pay, recognition, and benefit programs. We are proud to provide our employees the opportunity to grow and advance as we invest in their education and career development. As of December&#160;31, 2022, we have 76 employees, of whom 49 are involved directly in scientific research and development activities. </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on skilled, experienced, and innovative employees to conduct the operations of our company. Our key human capital objectives include identifying, recruiting, retaining, incentivizing and integrating our existing and new employees. We frequently benchmark our compensation practices and benefits programs against those of comparable industries and in the geographic areas where our facilities are located. We believe that our compensation and employee benefits are competitive and allow us to attract and retain skilled labor throughout our organization. Our notable health, welfare and retirement benefits include:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">equity awards through our 2002 Stock Incentive Plan;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">subsidized health insurance;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">401(k) Plan with matching contributions;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">tuition assistance program; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">paid time off.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We value diversity at all levels and continue to focus on extending our diversity and inclusion initiatives across our workforce. As of December 31, 2022, approximately 26% and 14% of our workforce are Asian and Hispanic, respectively. We believe that our business benefits from the different perspectives a diverse workforce brings.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We strive to maintain an inclusive environment free from discrimination of any kind, including sexual or other discriminatory harassment. Our employees have multiple avenues available through which inappropriate behavior can be reported, including a confidential hotline. All reports of inappropriate behavior are promptly investigated with appropriate action taken to stop such behavior.</span></div><div style="margin-bottom:10pt;margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investor Information</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial and other information about us is available on our website at www.ligand.com. We make available on our website, without charge, copies of our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. You may obtain copies of these documents by visiting the SEC&#8217;s website at www.sec.gov. In addition, we use Twitter (@Ligand_LGND) and our investor relations website as a means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.  Investors should monitor our Twitter account and our website, in addition to following our press releases, SEC filings, public conference calls and webcasts. These website addresses and the information accessible through our Twitter account are not intended to function as hyperlinks, and the information contained in our website and in the SEC&#8217;s website is not intended to be a part of this filing. </span></div><div style="text-indent:27pt"><span><br/></span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_16"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RISK FACTORS</span></td></tr></table></div><div style="margin-top:5pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following is a summary description of some of the many risks we face in our business. You should carefully review these risks in evaluating our business, including the businesses of our subsidiaries. You should also consider the other information described in this report. Additional risks not presently known to us or that we currently deem immaterial also may impair our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Summary of Risks Related to our Business:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is subject to numerous risks and uncertainties, including those described below.  The principal risks and uncertainties affecting our business include, but are not limited to the following:</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Future revenue based on Kyprolis, Evomela, Teriparatide and Rylaze as well as royalties from our other partnered products, may be lower than expected;  </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Future revenue from sales of Captisol material to our license partners may be lower than expected;  </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We rely heavily on collaboration relationships to generate milestone and royalty payments and our collaboration partners have significant discretion when deciding whether to pursue any development program, and any failure by our partners to successfully develop a product candidate or a termination or breach of any of the related agreements, or a change in their strategy or the focus of their development and commercialization efforts with respect to our partnered programs, could reduce our milestone and license fee revenue, and potentially reduce future royalties;  </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our product candidates, and the product candidates of our partners, face significant development and regulatory hurdles prior to partnering and/or marketing which could delay or prevent licensing, sales-based royalties and/or milestone revenue;  </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Third party intellectual property may prevent us or our partners from developing our potential products; our and our partners&#8217; intellectual property may not prevent competition; and any intellectual property issues may be expensive and time consuming to resolve;  </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Market acceptance and sales of any approved product will depend significantly on the availability and adequacy of coverage and reimbursement from third-party payors and may be affected by existing and future healthcare reform measures; and  </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our operating results may fluctuate significantly, which makes our future operating results difficult to predict and could cause our operating results to fall below expectations or any guidance we may provide.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Risks Related to Our Business Operations and Reliance on Third Parties:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:81%">Future revenue based on Kyprolis, Evomela, Teriparatide and Rylaze as well as royalties from our other partnered products, may be lower than expected.</span></div><div style="text-indent:45pt"><span><br/></span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant portion of our royalty revenue is based on sales of Kyprolis by Amgen, sales of Evomela by Acrotech Biopharma, sales of Teriparatide by Alvogen/Adalvo  and sales of Rylaze by Jazz. Royalties, including payments from the foregoing partners, are expected to be a substantial portion of our ongoing revenues for the foreseeable future. Any setback that may occur with respect to any of our partners' products, and in particular Kyprolis, could significantly impair our operating results and/or reduce our revenue and the market price of our stock. Setbacks for the products could include problems with shipping, distribution, manufacturing, product safety, marketing, government regulation or reimbursement, licenses and approvals, intellectual property rights, including failure by any of the foregoing partners to enforce their respective intellectual property rights, competition with existing or new products and physician or patient acceptance of the products, as well as higher than expected total rebates, returns, discounts, or unfavorable exchange rates. These products also are or may become subject to generic competition. For example, we entered into a settlement agreement with Teva and Acrotech Biopharma (the holder of the NDA for Evomela) which will allow Teva to market a generic version of Evomela in the United States on June 1, 2026, or earlier under certain circumstances. The entry of generic competition for Evomela may materially and adversely affect the revenue we derive from Evomela sales. Also, Amgen has settled patent litigation related to Kyprolis on confidential terms with several parties, but it has been publicly reported that the U.S. launch date for at least Breckenridge Pharmaceuticals&#8217; applicable generic product will be &#8220;on a date that is held as confidential in 2027 or sooner, depending on certain occurrences.&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">   </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future revenue from sales of Captisol material to our license partners may be lower than expected.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from sales of Captisol material to our collaborative partners, including Amgen and Gilead, represent a significant portion of our current revenues. Any setback that may occur with respect to Captisol could significantly impair our operating results and/or reduce the market price of our stock. Setbacks for Captisol could include problems with shipping, distribution, manufacturing, product safety, marketing, government regulation or reimbursement, licenses and approvals, intellectual property rights, competition with existing or new products and physician or patient acceptance of the products using Captisol. In addition, revenue from Captisol sales related to remdesivir may continue to decrease due to a number of factors, including alternative treatments for COVID-19 that have been or will be developed by other companies and the decrease in COVID-19 infections, in which case the commercial opportunity could be materially and adversely affected. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If products or product candidates incorporating Captisol material were to cause any unexpected adverse events, the perception of Captisol safety could be seriously harmed. If this were to occur, we may not be able to sell Captisol unless and until we are able to demonstrate that the adverse event was unrelated to Captisol, which we may not be able to do. Further, the FDA could require us to submit additional information for regulatory review or approval, including data from extensive safety </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">testing or clinical testing of products using Captisol. This would be expensive and it may delay the marketing of Captisol-enabled products and receipt of revenue related to those products, which could significantly impair our operating results and/or reduce the market price of our stock.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtain Captisol from Hovione, our third party manufacturer, primarily at their facilities in Ireland and Portugal.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If Hovione were to cease to be able, for any reason, to supply Captisol to us in the amounts we require, or decline to supply Captisol to us, we would be required to seek an alternative source, which could potentially take a considerable length of time and impact our revenue and customer relationships. In the event of a Captisol supply interruption, we are permitted to designate and, with Hovione&#8217;s assistance, qualify one or more alternate suppliers, although there is no assurance that we could do so timely or at acceptable costs, if at all. In addition to manufacturing at Hovione&#8217;s facilities in Ireland and Portugal, we have  processing capacity for Captisol in both the United States and England.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain inventory of Captisol, which has a five-year shelf life, at three geographically dispersed storage locations in the United States and Europe. If we were to encounter problems maintaining our inventory, such as natural disasters, at one or more of these locations, it could lead to supply interruptions. In addition, we rely on Hovione to expand manufacturing capacity of Captisol and any failure by Hovione to timely implement such increased capacity could adversely affect our ability to supply Captisol to our partners. While we believe we maintain adequate inventory of Captisol to meet our current partner needs, and our Captisol capacity will be sufficient to meet future partner needs, our estimates and projections for Captisol demand may not be correct and any supply interruptions could materially adversely impact our operating results.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently depend on our arrangements with our partners and licensees to sell products using our Captisol technology. These agreements generally provide that our partners may terminate the agreements at will. If our partners discontinue sales of products using Captisol, fail to obtain regulatory approval for products using Captisol, fail to satisfy their obligations under their agreements with us, choose to utilize a competing product, or if we are unable to establish new licensing and marketing relationships, our financial results and growth prospects would be materially affected. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, under most of our Captisol outlicenses, the amount of royalties we receive will be reduced or will cease when the relevant patent expires. Our low-chloride patents and foreign equivalents are not expected to expire until 2033, our high purity patents and foreign equivalents, are not expected to expire until 2029 and our morphology patents and foreign equivalents are not expected to expire until 2026 in the United States, but the initially filed patents relating to Captisol expired starting in 2010 in the United States and in 2016 in most countries outside the United States. If our other intellectual property rights are not sufficient to prevent a generic form of Captisol from coming to market and if in such case our partners choose to terminate their agreements with us, our Captisol revenue may decrease significantly.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely heavily on collaboration relationships to generate milestone and royalty payments and our collaboration partners have significant discretion when deciding whether to pursue any development program, and any failure by our partners to successfully develop a product candidate or a termination or breach of any of the related agreements could reduce our milestone and license fee revenue, and potentially reduce future royalties.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our strategy for developing and commercializing many of our product candidates includes entering into collaboration agreements, outlicenses, and development funding and royalty purchase agreements with corporate partners and others. These agreements give our collaboration partners significant discretion when deciding whether or not to pursue any development program. Our existing collaborations may not continue or be successful, and we may be unable to enter into future collaboration arrangements to develop and commercialize our unpartnered assets.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our collaborators may develop products, either alone or with others that compete with the types of products they are developing with us (or that we are developing on our own). This would result in increased competition for our or our partners' programs. If product candidates are approved for marketing under our collaboration programs, revenues we receive will depend on the manufacturing, marketing and sales efforts of our collaboration partners, who generally retain commercialization rights under the collaboration agreements. Generally, our current collaboration partners also have the right to terminate their collaborations at will or under specified circumstances. If any of our collaboration partners breach (for example, by not making required payments when due, or at all) or terminate their agreements with us or otherwise fail to conduct their collaboration activities successfully, including due to insolvency events, ongoing product development under these agreements will be delayed or terminated. Disputes or litigation may also arise with our collaborators (with us and/or with one or more third parties), including those over ownership rights to intellectual property, know-how or technologies developed with our collaborators. Such disputes or litigation could adversely affect our rights to one or more of our product candidates. Any such dispute or litigation could delay, interrupt or terminate the collaboration research, development and commercialization of certain potential products, create uncertainty as to ownership rights of intellectual property, or could result in litigation or arbitration. The occurrence of any of these problems could be time-consuming and expensive and could adversely affect our business.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our collaboration partners may change their strategy or the focus of their development and commercialization efforts with respect to our partnered programs, and the success of our partnered programs could be adversely affected.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our collaboration partners terminate their collaborations with us or do not commit sufficient resources to the development, manufacture, marketing or distribution of our partnered programs, we could be required to devote additional resources to our partnered programs, seek new collaboration partners or abandon such partnered programs, all of which could reduce our revenues and otherwise have an adverse effect on our business. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, biopharmaceutical development is inherently uncertain and very few therapeutic candidates ultimately progress through clinical development and receive approval for commercialization. If our partners do not receive regulatory approval for a sufficient number of therapeutic candidates originating from our partnerships, we may not be able to sustain our business model. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our product candidates, and the product candidates of our partners, face significant development and regulatory hurdles prior to partnering and/or marketing which could delay or prevent licensing, sales-based royalties and/or milestone revenue.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before we or our partners obtain the approvals necessary to sell any of our unpartnered assets or partnered programs, we must show through preclinical studies and human testing that each potential product is safe and effective. We and/or our partners have a number of partnered programs and unpartnered assets moving toward or currently awaiting regulatory action.  Failure to show any product's safety and effectiveness could delay or prevent regulatory approval of a product and could adversely affect our business. The product development and clinical trials process is complex and uncertain.  For example, the results of preclinical studies and initial clinical trials may not necessarily predict the results from later large-scale clinical trials.  In addition, clinical trials may not demonstrate a product's safety and effectiveness to the satisfaction of the regulatory authorities. A number of companies have suffered significant setbacks in advanced clinical trials or in seeking regulatory approvals, despite promising results in earlier trials. The FDA may also require additional clinical trials after regulatory approvals are received.  Such additional trials may be expensive and time-consuming, and failure to successfully conduct those trials could jeopardize continued commercialization of a product.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The speed at which we and our partners complete our scientific studies and clinical trials depends on many factors, including, but not limited to, the ability to obtain adequate supplies of the products to be tested and patient enrollment. Patient enrollment is a function of many factors, including the size of the patient population, the proximity of patients to clinical sites, the eligibility criteria for the trial and other potential drug candidates being studied. Delays in patient enrollment for our or our partners&#8217; trials may result in increased costs and longer development times. In addition, our partners have rights to control product development and clinical programs for products developed under our collaborations. As a result, these partners may conduct these programs more slowly or in a different manner than expected.  Moreover, even if clinical trials are completed, we or our partners still may not apply for FDA or foreign regulatory approval in a timely manner or the FDA or foreign regulatory authority still may not grant approval.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our product candidate discovery, early-stage development, and product reformulation programs may require substantial additional capital to complete successfully.  Our partners&#8217; development programs may require substantial additional capital to complete successfully, arising from costs to: conduct research, preclinical testing and human studies; establish pilot scale and commercial scale manufacturing processes and facilities; and establish and develop quality control, regulatory, marketing, sales and administrative capabilities to support these programs. While we expect to fund our research and development activities from cash generated from operations to the extent possible, if we are unable to do so, we may need to complete additional equity or debt financings or seek other external means of financing. These financings could depress our stock price. If additional funds are required to support our operations and we are unable to obtain them on terms favorable to us, we may be required to cease or reduce further development or commercialization of our products, to sell some or all of our technology or assets or to merge with another entity.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If the Distribution, together with certain related transactions, fails to qualify as a reorganization under Sections 355 and 368(a)(1)(D) of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), or the Merger fails to qualify as a reorganization under Section 368(a) of the Code, we could incur significant tax liabilities.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Distribution and the Merger were conditioned upon receipt of a tax opinion from outside counsel to the effect that the Distribution would qualify as a reorganization under Sections 355 and 368(a)(1)(D) of the Code, that the Merger would not cause Section 355(e) of the Code to apply to the Distribution and that the Merger would be treated as a reorganization under Section 368(a) of the Code. The opinion was delivered in connection with the closing of the Merger and was based on, among other things, certain facts, assumptions, representations and undertakings from us, OmniAb and New OmniAb, including those regarding the past and future conduct of the companies&#8217; respective businesses and other matters. If any of these facts, assumptions, representations, or undertakings were incorrect or not satisfied, we may not be able to rely on the opinion, and we and our stockholders could be subject to significant U.S. federal income tax liabilities. In addition, the opinion is not binding on the IRS or the courts, and notwithstanding the opinion, the IRS could determine on audit that the Distribution or Merger does not qualify as a reorganization if it determines that any of the facts, assumptions, representations or undertakings on which the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">opinion is based are not correct or have been violated or that the Distribution or Merger should be taxable for other reasons, including as a result of a significant change in stock or asset ownership after the Distribution. If the Distribution, together with certain related transactions, is ultimately determined not to qualify as a reorganization, or the Merger is ultimately determined not to qualify as a reorganization, we and our stockholders that are subject to U.S. federal income tax could incur significant U.S. federal income tax liabilities.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The anticipated benefits of the Separation and Merger may not be achieved.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not be able to achieve the full strategic and financial benefits expected to result from the Separation and Merger, including the potential that the Separation and Merger will:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">allow each business to pursue its own operational and strategic priorities and more quickly respond to trends, developments and opportunities in its respective markets;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">create two separate and distinct management teams focused on each business&#8217;s unique strategic priorities, target markets and corporate development opportunities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">give each business opportunity and flexibility by pursuing its own investment, capital allocation and growth strategies consistent with its long-term objectives;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">allow investors to separately value each business based on the unique merits, performance and future prospects of each business, providing investors with two distinct investment opportunities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">enhance the ability of each business to attract and retain qualified management and to better align incentive-based compensation with the performance of each separate business; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">give each of New OmniAb and Ligand its own equity currency for use in connection with acquisitions.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not achieve the anticipated benefits of the Separation and Merger for a variety of reasons. Further, such benefits, if ultimately achieved, may be delayed. In addition, the Separation and Merger could materially and adversely affect our business, financial condition and results of operations.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Separation and Distribution may expose Ligand to potential liabilities arising out of state and federal fraudulent conveyance laws and legal dividend requirements.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Separation and Distribution are subject to review under various state and federal fraudulent conveyance laws. Fraudulent conveyance laws generally provide that an entity engages in a constructive fraudulent conveyance when (i) the entity transfers assets and does not receive fair consideration or reasonably equivalent value in return; and (ii) the entity: (a) is insolvent at the time of the transfer or is rendered insolvent by the transfer; (b) has unreasonably small capital with which to carry on its business; or (c) intends to incur or believes it will incur debts beyond its ability to repay its debts as they mature. An unpaid creditor or an entity acting on behalf of a creditor (including without limitation a trustee or debtor-in-possession in a bankruptcy by New OmniAb or Ligand or any of their respective subsidiaries) may bring an action alleging that the Separation or Distribution or any of the related transactions constituted a constructive fraudulent conveyance. If a court accepts these allegations, it could impose a number of remedies, including without limitation, voiding New OmniAb&#8217;s claims against Ligand, requiring New OmniAb stockholders to return to Ligand some or all of the shares of New OmniAb common stock issued via the Distribution and Merger, or providing Ligand with a claim for money damages against New OmniAb in an amount equal to the difference between the consideration received by Ligand and OmniAb&#8217;s fair market value at the time of the Distribution.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The measure of insolvency for purposes of the fraudulent conveyance laws will vary depending on which jurisdiction&#8217;s law is applied. Generally, an entity would be considered insolvent if (i) the present fair saleable value of its assets is less than the amount of its liabilities (including contingent liabilities); (ii) the present fair saleable value of its assets is less than its probable liabilities on its debts as such debts become absolute and matured; (iii) it cannot pay its debts and other liabilities (including contingent liabilities and other commitments) as they mature; or (iv) it has unreasonably small capital for the business in which it is engaged. We cannot assure you what standard a court would apply to determine insolvency or that a court would determine that New OmniAb or Ligand or any of their subsidiaries were solvent at the time of or after giving effect to the Distribution.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Distribution of OmniAb common stock is also subject to review under state corporate distribution statutes. Under the DGCL, a corporation may only pay dividends to its stockholders either (i) out of its surplus (net assets minus capital) or (ii) if there is no such surplus, out of its net profits for the fiscal year in which the dividend is declared or the preceding fiscal year. Although Ligand intended to make the Distribution of OmniAb common stock entirely from surplus, we cannot assure you that a court will not later determine that some or all of the Distribution to Ligand stockholders was unlawful.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Separation and the retirement of our CEO resulted in substantial changes in our Board of Directors and management.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Separation resulted in substantial changes in our Board of Directors and management. In particular, Matthew Foehr, our former President and Chief Operating Officer, and Charles Berkman, our former Senior Vice President, General Counsel and Secretary, resigned from their positions with us upon the completion of the Separation to join management positions with New OmniAb. In connection with the Separation and the departure of the foregoing officers, Ligand appointed new officers. Matthew Korenberg, our former Executive Vice President, Finance and Chief Financial Officer, was appointed our President and Chief Operating Officer. Octavio Espinoza, our former Senior Vice President, Finance, was appointed our Chief Financial Officer. Andrew Reardon, our former Vice President, Special Counsel, was appointed Chief Legal Officer and Secretary. Furthermore, Sarah Boyce, Jennifer Cochran and Sunil Patel resigned as members of our Board of Directors in connection with the Separation to join the board of directors of New OmniAb. In addition, on December 5, 2022, John Higgins retired as our Chief Executive Officer and Todd Davis was appointed to that position. Mr. Higgins also resigned as a member of our Board of Directors effective December 31, 2022. These senior officer and board level changes could be disruptive to our operations, present significant management challenges and could harm our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Risks Related to Intellectual Property:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Third party intellectual property may prevent us or our partners from developing our potential products; our and our partners&#8217; intellectual property may not prevent competition; and any intellectual property issues may be expensive and time consuming to resolve.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The manufacture, use or sale of our potential products or our licensees' products or potential products may infringe the patent rights of others.  If others obtain patents with conflicting claims, we may be required to obtain licenses to those patents or to develop or obtain alternative technology. We may not be able to obtain any such licenses on acceptable terms, or at all.  Any failure to obtain such licenses could delay or prevent us from pursuing the development or commercialization of our potential products, platform and technology.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, our success will depend on our ability and the ability of our partners to obtain and maintain patents and other intellectual property rights for our and their potential products and technologies. Our patent position is uncertain and involves complex legal and technical questions for which legal principles are unresolved.&#160;Even if we or our partners do obtain patents, such patents may not adequately protect the technology we own or have licensed.&#160; </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We permit our partners to list our patents that cover their branded products in the Orange Book. If a third party submits a new drug application (NDA) or abbreviated new drug application (ANDA) for a generic drug product that relies in whole or in part on studies contained in our partner&#8217;s NDA for their branded product, the third party will have the option to certify to the FDA that, in the opinion of that third party, the patents listed in the Orange Book for our partner&#8217;s branded product are invalid, unenforceable, or will not be infringed by the manufacture, use or sale of the third party&#8217;s generic drug product. A third party certification that a new product will not infringe Orange Book-listed patents, or that such patents are invalid, is called a paragraph IV patent certification. If the third party submits a paragraph IV patent certification to the FDA, a notice of the paragraph IV patent certification must be sent to the NDA owner and the owner of the patents that are subject to the paragraph IV patent certification notice once the third-party&#8217;s NDA or ANDA is accepted for filing by the FDA. A lawsuit may then be initiated to defend the patents identified in the notice. The filing of a patent infringement lawsuit within 45 days of the receipt of notice of a paragraph IV patent certification automatically prevents the FDA from approving the generic NDA or ANDA until the earlier of the expiration of a 30-month period, the expiration of the patents, the entry of a settlement order stating that the patents are invalid or not infringed, a decision in the infringement case that is favorable to the NDA or ANDA applicant, or such shorter or longer period as the court may order. If a patent infringement lawsuit is not initiated within the required 45-day period, the third-party&#8217;s NDA or ANDA will not be subject to the 30-month stay.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several third-parties have challenged, and additional third parties may challenge, the patents covering our partner&#8217;s branded products, including Kyprolis and Evomela, which could result in the invalidation or unenforceability of some or all of the relevant patent claims. We may from time to time become party to litigation or other proceedings as a result of Paragraph IV certifications. For example, as a result of the settlement of one such matter, Teva will be permitted to market a generic version of Evomela</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the United States on June 1, 2026 or earlier under certain circumstances. The terms of the settlement agreement are otherwise confidential. Also, as noted above, Amgen has settled patent litigation related to Kyprolis on confidential terms with several parties, but it has been publicly reported that the U.S. launch date for at least Breckenridge Pharmaceuticals&#8217; applicable generic product will be &#8220;on a date that is held as confidential in 2027 or sooner, depending on certain occurrences.&#8221; </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we cannot assure you that all of the potentially relevant prior art information that was or is deemed available to a person of skill in the relevant art prior to the priority date of the claimed invention-relating to our and our partners&#8217; patents and patent applications has been found. If such prior art exists, it can invalidate a patent or prevent a patent from issuing from a pending patent application, and we or our partners may be subject to a third party pre-issuance submission of prior art to the USPTO. Even if our patent applications do successfully issue and even if such patents cover our or our partner&#8217;s products or </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">potential products, third parties may initiate litigation or opposition, interference, re-examination, post-grant review, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> review, nullification or derivation action in court or before patent offices, or similar proceedings challenging the validity, enforceability or scope of such patents, which may result in the patent claims being narrowed or invalidated, may allow third parties to commercialize our or our partners&#8217; products and compete directly with us and our partners, without payment to us or our partners, or limit the duration of the patent protection of our and our partners&#8217; technology and products. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, similar to what other companies in our industry have experienced, we expect our competitors and others may have patents or may in the future obtain patents and claim that making, having made, using, selling, offering to sell or importing our technologies infringes these patents. Defense of infringement and other claims, regardless of their merit, would involve substantial litigation expense and would be a substantial diversion of management and employee resources from our business. Parties making claims against us may be able to sustain the costs of complex patent litigation more effectively than we can because they have substantially greater resources. Parties making claims against us may be able to obtain injunctive or other relief, which could block our ability to develop, commercialize and sell products or services and could result in the award of substantial damages against us, including treble damages, attorney&#8217;s fees, costs and expenses if we are found to have willfully infringed. In the event of a successful claim of infringement against us, we may be required to pay damages and ongoing royalties and obtain one or more licenses from third parties, or be prohibited from selling certain products or services. As discussed above, we may not be able to obtain these licenses on acceptable or commercially reasonable terms, if at all, or these licenses may be non-exclusive, which could result in our competitors gaining access to the same intellectual property. In addition, we could encounter delays in product or service introductions while we attempt to develop alternative products or services to avoid infringing third-party patents or proprietary rights. Defense of any lawsuit or failure to obtain any of these licenses could prevent us from commercializing products or services, and the prohibition of sale of any of our technologies could materially affect our business and our ability to gain market acceptance for our technology.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litigation or other proceedings to enforce or defend intellectual property rights are often very complex in nature, may be very expensive and time-consuming, may divert our management&#8217;s attention from our core business, and may result in unfavorable results that could adversely impact our ability to prevent third parties from competing with our partner&#8217;s products or technologies. Any adverse outcome of such litigation or other proceedings could result in one or more or our patents being held invalid or unenforceable, which could adversely affect our ability to successfully execute our business strategy and negatively impact our financial condition and results of operations. However, given the unpredictability inherent in litigation, we cannot predict or guarantee the outcome of these matters or any other litigation. Regardless of how these matters are ultimately resolved, these matters may be costly, time-consuming and distracting to our management, which could have a material adverse effect on our business. It may be necessary for us to pursue litigation or adversarial proceedings before the patent office in order to enforce our patent and proprietary rights or to determine the scope, coverage and validity of the proprietary rights of others. The outcome of any such litigation might not be favorable to us, and even if we were to prevail, such litigation could result in substantial costs and diversion of resources and could have a material adverse effect on our business, operating results or financial condition.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, periodic maintenance fees, renewal fees, annuity fees and various other governmental fees on patents and or applications will be due to the U.S. and various foreign patent offices at various points over the lifetime of our and our licensees&#8217; patents and/or applications. We have systems in place to remind us to pay these fees, and we rely on our outside patent annuity service to pay these fees when due. Additionally, the U.S. and various foreign patent offices require compliance with a number of procedural, documentary, fee payment and other similar provisions during the patent application process. We employ reputable law firms and other professionals to help us comply, and in many cases, an inadvertent lapse can be cured by payment of a late fee or by other means in accordance with rules applicable to the particular jurisdiction. However, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. If such an event were to occur, it could have a material adverse effect on our business.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation. In addition, during the course of this kind of litigation, there could be public announcements of the results of hearings, motions or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any conflicts with the patent rights of others could significantly reduce the coverage of our patents or limit our ability to obtain meaningful patent protection.  For example, our European patent related to Agglomerated forms of Captisol was limited during an opposition proceeding, and the rejection of our European patent application related to High Purity Captisol was upheld on appeal. In addition, any determination that our patent rights are invalid may result in early termination of our agreements with our license partners and could adversely affect our ability to enter into new license agreements. We also rely on unpatented trade secrets and know-how to protect and maintain our competitive position. We require our employees, consultants, licensees and others to sign confidentiality agreements when they begin their relationship with us. These </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">agreements may be breached, and we may not have adequate remedies for any breach.  In addition, our competitors may independently discover our trade secrets.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also need to initiate litigation, which could be time-consuming and expensive, to enforce our proprietary rights or to determine the scope and validity of others' rights.  If this occurs, a court may find our patents or those of our licensors invalid or may find that we have infringed on a competitor's rights. In addition, if any of our competitors have filed patent applications in the United States which claim technology we also have invented, the United States Patent and Trademark Office may require us to participate in expensive interference proceedings to determine who has the right to a patent for the technology.  </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our agreements with some of our partners, suppliers or other entities with whom we do business require us to defend or indemnify these parties to the extent they become involved in infringement claims, including the types of claims described above. We could also voluntarily agree to defend or indemnify third parties in instances where we are not obligated to do so if we determine it would be important to our business relationships. If we are required or agree to defend or indemnify third parties in connection with any infringement claims, we could incur significant costs and expenses that could adversely affect our business, financial condition, results of operations and prospects. The occurrence of any of the foregoing problems could be time-consuming and expensive and could adversely affect our financial position, liquidity and results of operations.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to obtain and maintain sufficient intellectual property protection for our products, platform and technology, or if the scope of the intellectual property protection obtained is not sufficiently broad, our competitors could develop and commercialize technologies or a platform similar or identical to ours, and our ability to successfully sell our platform and services may be impaired.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends in part on our ability to obtain and maintain adequate protection of the intellectual property we may own solely and jointly with others or otherwise have rights to, particularly patents, in the United States and in other countries with respect to our platform, our software and our technologies, without infringing the intellectual property rights of others.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We strive to protect and enhance the proprietary technologies that we believe are important to our business, including seeking patents intended to cover our platform and related technologies and uses thereof, as we deem appropriate. However, obtaining and enforcing patents in our industry is costly, time-consuming and complex, and we may fail to apply for patents on important products and technologies in a timely fashion or at all, or we may fail to apply for patents in potentially relevant jurisdictions. There can be no assurance that the claims of our patents (or any patent application that issues as a patent), will exclude others from making, using, importing, offering for sale, or selling products or services that are substantially similar to ours. We also rely on trade secrets to protect aspects of our business that are not amenable to, or that we do not consider appropriate for, patent protection. In countries where we have not sought and do not seek patent protection, third parties may be able to manufacture and sell our technology without our permission, and we may not be able to stop them from doing so. We may not be able to file and prosecute all necessary or desirable patent applications, or maintain, enforce and license any patents that may issue from such patent applications, at a reasonable cost or in a timely manner. It is also possible that we will fail to identify patentable aspects of our research and development output before it is too late to obtain patent protection. We may not have the right to control the preparation, filing and prosecution of patent applications, or to maintain the rights to patents licensed to third parties. Therefore, these patents and applications may not be prosecuted and enforced in a manner consistent with the best interests of our business.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is possible that none of our pending patent applications will result in issued patents in a timely fashion or at all, and even if patents are granted, they may not provide a basis for intellectual property protection of commercially viable products or services, may not provide us with any competitive advantages, or may be challenged and invalidated by third parties or deemed unenforceable by a court. It is possible that others will design around our current or future patented technologies. As a result, our owned and licensed patents and patent applications comprising our patent portfolio may not provide us with sufficient rights to exclude others from commercializing technology and products similar to any of our products, platform and technology.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may identify third party intellectual property and technology we may need to acquire or license in order to engage in our business, including to develop or commercialize new technologies. However, such licenses may not be available to us on acceptable terms or at all.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Issued patents directed to our platform and technology could be found invalid or unenforceable if challenged in court or before administrative bodies in the United States or abroad.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability. Some of our patents or patent applications (including licensed patents) may be challenged at a future point in time in opposition, derivation, reexamination, inter partes review, post-grant review or interference. Any successful third party challenge to our patents in this or any other proceeding could result in the unenforceability or invalidity of such patents or amendment to our patents in such a way that any resulting protection may lead to increased competition to our business, which could harm our business. In addition, in patent litigation in the United States, defendant counterclaims alleging invalidity or unenforceability are </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">commonplace. The outcome following legal assertions of invalidity and unenforceability during patent litigation is unpredictable. If a defendant were to prevail on a legal assertion of invalidity or unenforceability, we would lose at least part, and perhaps all, of the patent protection on certain aspects of our platform technologies. In addition, if the breadth or strength of protection provided by our patents and patent applications is threatened, regardless of the outcome, it could dissuade companies from collaborating with us to license, develop or commercialize current or future products, platform and technology.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not be aware of all third party intellectual property rights potentially relating to our products, platform and technology. Publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until approximately 18 months after filing or, in some cases, not until such patent applications issue as patents. We or our licensors might not have been the first to make the inventions included in each of our pending patent applications and we or our licensors might not have been the first to file patent applications for these inventions. There is also no assurance that all of the potentially relevant prior art relating to our patents and patent applications or licensed patents and patent applications has been found, which could be used by a third party to challenge their validity, or prevent a patent from issuing from a pending patent application. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To determine the priority of these inventions, we may have to participate in interference proceedings, derivation proceedings or other post-grant proceedings declared by the USPTO that could result in substantial cost to us. The outcome of such proceedings is uncertain. No assurance can be given that other patent applications will not have priority over our patent applications. In addition, changes to the patent laws of the United States allow for various post-grant opposition proceedings that have not been extensively tested, and their outcome is therefore uncertain. Furthermore, if third parties bring these proceedings against our patents, we could experience significant costs and management distraction.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The validity, scope and enforceability of any patents that cover our partners&#8217; biologic product candidate can be challenged by third parties.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For biologics, the Biologics Price Competition and Innovation Act of 2009, BPCIA, provides a mechanism for one or more third parties to seek FDA approval to manufacture or sell biosimilar or interchangeable versions of brand name biological products. Due to the large size and complexity of biological products, as compared to small molecules, a biosimilar must be &#8220;highly similar&#8221; to the reference product with &#8220;no clinically meaningful differences between the two.&#8221; The BPCIA does not require reference product sponsors to list patents in an Orange Book and does not include an automatic 30-month stay of FDA approval upon the timely filing of a lawsuit. The BPCIA, however, does require a formal pre-litigation process which includes the exchange of information between a biosimilar applicant and a reference biologic sponsor that includes the identification of relevant patents and each parties&#8217; basis for infringement and invalidity. After the exchange of this information, sponsors may then initiate a lawsuit within 30 days to defend the patents identified in the exchange. If the biosimilar applicant successfully challenges the asserted patent claims it could result in the invalidation of, or render unenforceable, some or all of the relevant patent claims or result in a finding of non-infringement. Such litigation or other proceedings to enforce or defend intellectual property rights are often very complex in nature, may be very expensive and time-consuming, may divert our management&#8217;s attention from our core business, and may result in unfavorable results that could limit our partners&#8217; ability to prevent third parties from competing with their products or product candidates.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on in-licenses from third parties. If we lose these rights, our business may be materially and adversely affected, our ability to develop improvements to our technology platform and antibody discovery platform may be negatively and substantially impacted, and if disputes arise, we may be subjected to future litigation, as well as the potential loss of or limitations on our ability to incorporate the technology covered by these license agreements.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are party to royalty-bearing license agreements that grant us rights to practice certain patent rights that are related to our products, platform and technology. In spite of our efforts to comply with our obligations under our in-license agreements, our licensors might conclude that we have materially breached our obligations under our license agreements and might therefore, including in connection with any aforementioned disputes, terminate the relevant license agreement, thereby removing or limiting our ability to develop and commercialize technology covered by these license agreements. If any such in-license is terminated, or if the licensed patents fail to provide the intended exclusivity, competitors or other third parties might have the freedom to market or develop technologies similar to ours. In addition, absent the rights granted to us under our license agreements, we may infringe the intellectual property rights that are the subject of those agreements, we may be subject to litigation by the licensor, and if such litigation by the licensor is successful we may be required to pay damages to our licensor, or we may be required to cease our development and commercialization activities that are deemed infringing, and in such event we may ultimately need to modify our activities or technologies to design around such infringement, which may be time- and resource-consuming, and which ultimately may not be successful. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our rights to certain components of our technology platform, may be licensed to us on a non-exclusive basis. The owners of these non-exclusively licensed technologies are therefore free to license them to third parties, including our competitors, on terms that may be superior to those offered to us, which could place us at a competitive disadvantage. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, our licensors may own or control intellectual property that has not been licensed to us and, as a result, we may be subject to claims, regardless of their merit, that we are infringing or otherwise violating the licensor&#8217;s rights. In addition, certain of our agreements with third parties may provide that intellectual property arising under these agreements, such as data that could be valuable to our business, will be owned by the third party, in which case, we may not have adequate rights to use such data or have exclusivity with respect to the use of such data, which could result in third parties, including our competitors, being able to use such data to compete with us.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to claims challenging the inventorship of our patents and other intellectual property.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We or our licensors may be subject to claims that former employees, partners or other third parties have an interest in our or our in-licensed patents, trade secrets or other intellectual property as an inventor or co-inventor. Litigation may be necessary to defend against these and other claims challenging inventorship of our or our licensors&#8217; ownership of our owned or in-licensed patents, trade secrets or other intellectual property. If we or our licensors fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, intellectual property that is important to our systems, including our software, workflows, consumables, reagents, and transgenic animals. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees, and certain partners or partners may defer engaging with us until the particular dispute is resolved. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to protect the confidentiality of our information and our trade secrets, the value of our technology could be materially and adversely affected and our business could be harmed.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on trade secrets and confidentiality agreements to protect our unpatented know-how, technology and other proprietary information, including parts of our technology platform, and to maintain our competitive position. However, trade secrets and know-how can be difficult to protect. In addition to pursuing patents on our technology, we take steps to protect our intellectual property and proprietary technology by entering into agreements, including confidentiality agreements, non-disclosure agreements and intellectual property assignment agreements, with our employees, consultants, academic institutions, corporate partners and, when needed, our advisers. However, we cannot be certain that such agreements have been entered into with all relevant parties, and we cannot be certain that our trade secrets and other confidential proprietary information will not be disclosed or that competitors will not otherwise gain access to our trade secrets or independently develop substantially equivalent information and techniques. For example, any of these parties may breach the agreements and disclose our proprietary information, including our trade secrets, and we may not be able to obtain adequate remedies for such breaches. Such agreements may not be enforceable or may not provide meaningful protection for our trade secrets or other proprietary information in the event of unauthorized use or disclosure or other breaches of the agreements, and we may not be able to prevent such unauthorized disclosure, which could adversely impact our ability to establish or maintain a competitive advantage in the market. If we are required to assert our rights against such party, it could result in significant cost and distraction.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Monitoring unauthorized disclosure and detection of unauthorized disclosure is difficult, and we do not know whether the steps we have taken to prevent such disclosure are, or will be, adequate. If we were to enforce a claim that a third party had illegally obtained and was using our trade secrets, it would be expensive and time-consuming, and the outcome would be unpredictable. In addition, some courts both within and outside the United States may be less willing, or unwilling, to protect trade secrets. Further, we may need to share our trade secrets and confidential know-how with current or future partners, collaborators, contractors and others located in countries at heightened risk of theft of trade secrets, including through direct intrusion by private parties or foreign actors, and those affiliated with or controlled by state actors.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also seek to preserve the integrity and confidentiality of our confidential proprietary information by maintaining physical security of our premises and physical and electronic security of our information technology systems, but it is possible that these security measures could be breached. If any of our confidential proprietary information were to be lawfully obtained or independently developed by a competitor or other third party, absent patent protection, we would have no right to prevent such competitor from using that technology or information to compete with us, which could harm our competitive position. If any of our trade secrets were to be disclosed to or independently discovered by a competitor or other third party, it could harm our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Risks Related to Government Regulation and Legal Proceedings:</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Market acceptance and sales of any approved product will depend significantly on the availability and adequacy of coverage and reimbursement from third-party payors and may be affected by existing and future healthcare reform measures.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of the products we license to our collaboration partners and the royalties we receive will depend in large part on the extent to which coverage and reimbursement is available from government and health administration authorities, private health </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">maintenance organizations and health insurers, and other healthcare payors. Significant uncertainty exists as to the reimbursement status of healthcare products. Healthcare payors, including Medicare, are challenging the prices charged for medical products and services. Government and other healthcare payors are increasingly attempting to contain healthcare costs by limiting both coverage and the level of reimbursement for medical products. Even if a product is approved by the FDA, insurance coverage may not be available, and reimbursement levels may be inadequate, to cover the costs associated with the research, development, marketing and sale of the product. If government and other healthcare payors do not provide adequate coverage and reimbursement levels for any product, market acceptance and any sales could be reduced.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, legislation is implemented to reign in rising healthcare expenditures. By way of example, in March 2010, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act, or collectively, the ACA, was enacted, which included a number of provisions affecting the pharmaceutical industry, including, among other things, annual, non-deductible fees on any entity that manufactures or imports some types of branded prescription drugs and increases in Medicaid rebates owed by manufacturers under the Medicaid Drug Rebate Program. Since its enactment, there have been judicial, executive and Congressional challenges to certain aspects of the ACA. On June 17, 2021, the U.S. Supreme Court dismissed the most recent judicial challenge to the ACA brought by several states without specifically ruling on the constitutionality of the ACA. Prior to the Supreme Court&#8217;s decision, President Biden had issued an executive order to initiate a special enrollment period from February 15, 2021 through August 15, 2021 for purposes of obtaining health insurance coverage through the ACA marketplace. The executive order also instructed certain governmental agencies to review and reconsider their existing policies and rules that limit access to healthcare, including among others, reexamining Medicaid demonstration projects and waiver programs that include work requirements, and policies that create unnecessary barriers to obtaining access to health insurance coverage through Medicaid or the ACA.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other legislative changes have been proposed and adopted since the ACA was enacted, including aggregate reductions of Medicare payments to providers, which was temporarily suspended from March 1, 2020 through March 31, 2022, and reduced payments to several types of Medicare providers. Moreover, there has recently been heightened governmental scrutiny over the manner in which manufacturers set prices for their marketed products, which has resulted in several Congressional inquiries and proposed bills designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for drug products. Most recently, in August 2022, the Inflation Reduction Act of 2022 (IRA), was signed into law. Among other things, the IRA requires manufacturers of certain drugs to engage in price negotiations with Medicare (beginning in 2026), with prices that can be negotiated subject to a cap; imposes rebates under Medicare Part B and Medicare Part D to penalize price increases that outpace inflation (first due in 2023); and replaces the Part D coverage gap discount program with a new discounting program (beginning in 2025). The IRA permits the Secretary of the Department of Health and Human Services (HHS) to implement many of these provisions through guidance, as opposed to regulation, for the initial years. For that and other reasons, it is currently unclear how the IRA will be effectuated, and the impact of the IRA on our business and the pharmaceutical industry cannot yet be fully determined. Individual states in the United States have also become increasingly active in implementing regulations designed to control pharmaceutical product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. We cannot predict whether other legislative changes will be adopted, if any, or how such changes would affect our operations or financial condition.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we or our commercialization partners market products in a manner that violates healthcare laws, we may be subject to civil or criminal penalties.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our collaboration partners are subject to federal and state healthcare laws, including fraud and abuse, anti-kickback, false claims, physician payment transparency and civil monetary penalties. These laws may impact, among other things, financial arrangements with physicians, sales, marketing and education programs and the manner in which any of those activities are implemented. If our operations or those of our collaboration partners are found to be in violation of any of those laws or any other applicable governmental regulations, we or our collaboration partners may be subject to penalties, including civil and criminal penalties, damages, fines, imprisonment, exclusion from government healthcare programs or the curtailment or restructuring of operations, any of which could adversely affect our ability to operate our business and our financial condition.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in and actual or perceived failures to comply with applicable data privacy, security and protection laws, regulations, standards and contractual obligations may adversely affect our business, operations and financial performance.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our partners may be subject to federal, state, and foreign laws and regulations that govern data privacy and security. The legislative and regulatory landscape for privacy and data protection continues to evolve, and there has been an increasing focus on privacy and data protection issues, which may affect our business and may increase our compliance costs and exposure to liability. In the United States, numerous federal and state laws and regulations govern the collection, use, disclosure, and protection of personal information, including state data breach notification laws, federal and state health information privacy laws, and federal and state consumer protection laws. Each of these laws is subject to varying </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">interpretations by courts and government agencies, creating complex compliance issues. If we fail to comply with applicable laws and regulations we could be subject to penalties or sanctions, including criminal penalties if we knowingly obtain or disclose individually identifiable health information from a covered entity in a manner that is not authorized or permitted by the Health Insurance Portability and Accountability Act, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, and regulations implemented thereunder (collectively, HIPAA) or applicable state laws.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain states have also adopted comparable privacy and security laws and regulations, which govern the privacy, processing and protection of health-related and other personal information. Such laws and regulations will be subject to interpretation by various courts and other governmental authorities, thus creating potentially complex compliance issues for us and our future customers and strategic partners. For example, the California Consumer Privacy Act of 2018 (CCPA) went into effect on January 1, 2020. The CCPA creates individual privacy rights for California consumers and increases the privacy and security obligations of entities handling certain personal information. The CCPA provides for civil penalties for violations, as well as a private right of action for data breaches that is expected to increase data breach litigation. Further, the California Privacy Rights Act (CPRA) passed in California, and it significantly amends the CCPA. It will impose additional data protection obligations on covered businesses, including additional consumer rights processes, limitations on data uses, new audit requirements for higher risk data, and opt outs for certain uses of sensitive data. It will also create a new California data protection agency authorized to issue substantive regulations and could result in increased privacy and information security enforcement. The majority of the provisions went into effect on January 1, 2023, and additional compliance investment and potential business process changes may be required. Similar laws have passed in Virginia, Colorado, Connecticut and Utah, and have been proposed in other states and at the federal level, reflecting a trend toward more stringent privacy legislation in the United States. The enactment of such laws could have potentially conflicting requirements that would make compliance challenging. In the event that we are subject to or affected by HIPAA, the CCPA, the CPRA or other domestic privacy and data protection laws, any liability from failure to comply with the requirements of these laws could adversely affect our financial condition.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also or may become subject to rapidly evolving data protection laws, rules and regulations in foreign jurisdictions. For example, the European Union General Data Protection Regulation (GDPR) governs certain collection and other processing activities involving personal data about individuals in the European Economic Area (EEA). Among other requirements, the GDPR regulates transfers of personal data subject to the GDPR to third countries that have not been found to provide adequate protection to such personal data, including the United States; in July 2020, the Court of Justice of the European Union (CJEU) limited how organizations could lawfully transfer personal data from the European Union/EEA to the United States by invalidating the Privacy Shield for purposes of international transfers and imposing further restrictions on the use of standard contractual clauses (SCCs). In March 2022, the United States and European Union announced a new regulatory regime intended to replace the invalidated regulations; however, this new EU-US Data Privacy Framework has not been implemented beyond an executive order signed by President Biden on October 7, 2022 on Enhancing Safeguards for United States Signals Intelligence Activities. European court and regulatory decisions subsequent to the CJEU decision of July 2020 have taken a restrictive approach to international data transfers. As supervisory authorities issue further guidance on personal data export mechanisms, including circumstances where the SCCs cannot be used, and/or start taking enforcement action, we could suffer additional costs, complaints and/or regulatory investigations or fines, and/or if we are otherwise unable to transfer personal data between and among countries and regions in which we operate, it could affect the manner in which we provide our services, the geographical location or segregation of our relevant systems and operations, and could adversely affect our financial results. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the beginning of 2021, after the end of the transition period following the United Kingdom&#8217;s departure from the European Union, we are also subject to the United Kingdom data protection regime, which imposes separate but similar obligations to those under the GDPR and comparable penalties, including fines of up to &#163;17.5 million or 4% of a noncompliant company&#8217;s global annual revenue for the preceding financial year, whichever is greater. As we continue to expand into other foreign countries and jurisdictions, we may be subject to additional laws and regulations that may affect how we conduct business. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compliance with applicable data privacy and security laws, rules and regulations could require us to take on more onerous obligations in our contracts, require us to engage in costly compliance exercises, restrict our ability to collect, use and disclose data, or in some cases, impact our or our partners&#8217; ability to operate in certain jurisdictions. Each of these constantly evolving laws can be subject to varying interpretations. If we fail to comply with any such laws, rules or regulations, we may face government investigations and/or enforcement actions, fines, civil or criminal penalties, private litigation or adverse publicity that could adversely affect our business, financial condition and results of operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in funding for the FDA and other government agencies could hinder their ability to hire and retain key leadership and other personnel, or otherwise prevent new products and services from being developed or commercialized in a timely manner, which could negatively impact our business or the business of our partners.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ability of the FDA to review and approve new products can be affected by a variety of factors, including government budget and funding levels, ability to hire and retain key personnel and accept the payment of user fees, and statutory, regulatory, and policy changes. Average review times at the FDA have fluctuated in recent years as a result. In addition, government funding of other government agencies that fund research and development activities is subject to the political process, which is inherently fluid and unpredictable.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disruptions at the FDA and other agencies may also slow the time necessary for new drugs and biologics to be reviewed and/or approved by necessary government agencies, which would adversely affect our business or the business of our partners. For example, over the last several years, the U.S. government has shut down several times and certain regulatory agencies, such as the FDA, have had to furlough critical FDA employees and stop critical activities. If a prolonged government shutdown occurs, it could significantly impact the ability of the FDA to timely review and process our regulatory submissions, which could have a material adverse effect on our business. If the timing of FDA&#8217;s review and approval of new products is delayed, the timing of our or our partners&#8217; development process may be delayed which would result in delayed milestone revenues and materially harm our operations of business.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separately, in response to the COVID-19 pandemic, the FDA postponed most inspections of domestic and foreign manufacturing facilities at various points. Even though the FDA has since resumed standard inspection operations of domestic facilities where feasible, the FDA has continued to monitor and implement changes to its inspectional activities to ensure the safety of its employees and those of the firms it regulates as it adapts to the evolving COVID-19 pandemic, and any resurgence of the virus or emergence of new variants may lead to further inspectional delays. Regulatory authorities outside the United States may adopt similar restrictions or other policy measures in response to the COVID-19 pandemic. If a prolonged government shutdown occurs, or if global health concerns continue to hinder or prevent the FDA or other regulatory authorities from conducting their regular inspections, reviews, or other regulatory activities, it could significantly impact the ability of the FDA or other regulatory authorities to timely review and process our regulatory submissions, which could have a material adverse effect on our business. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">If plaintiffs bring product liability lawsuits against us or our partners, we or our partners may incur substantial liabilities and may be required to limit commercialization of our approved products and product candidates.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As is common in our industry, our partners and we face an inherent risk of product liability as a result of the clinical testing of our product candidates in clinical trials and face an even greater risk for commercialized products. Although we are not currently a party to product liability litigation, if we are sued, we may be held liable if any product or product candidate we develop causes injury or is found otherwise unsuitable during product testing, manufacturing, marketing or sale. Regardless of merit or eventual outcome, liability claims may result in decreased demand for any product candidates, partnered products or products that we may develop, injury to our reputation, discontinuation of clinical trials, costs to defend litigation, substantial monetary awards to clinical trial participants or patients, loss of revenue and product recall or withdrawal from the market and the inability to commercialize any products that we develop. We have product liability insurance that covers our clinical trials up to a $10.0&#160;million annual limit. Our insurance coverage may not be sufficient to cover all of our product liability related expenses or losses and may not cover us for any expenses or losses we may suffer. If we are sued for any injury caused by our product candidates, partnered products or any future products, our liability could exceed our total assets.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face risks related to handling of hazardous materials and other regulations governing environmental safety.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations are subject to complex and stringent environmental, health, safety and other governmental laws and regulations that both public officials and private individuals may seek to enforce. Our activities that are subject to these regulations include, among other things, our use of hazardous materials and the generation, transportation and storage of waste. Although we have secured clearance from the EPA historically, and currently are operating in material compliance with applicable EPA rules and regulations, our business could be adversely affected if we discover that we or an acquired business is not in material compliance with these rules and regulations. In the future, we may pursue the use of other surfactant substances that will require clearance from the EPA, and we may fail to obtain such clearance. Existing laws and regulations may also be revised or reinterpreted, or new laws and regulations may become applicable to us, whether retroactively or prospectively, that may have a negative effect on our business and results of operations. It is also impossible to eliminate completely the risk of accidental environmental contamination or injury to individuals. In such an event, we could be liable for any damages that result, which could adversely affect our business.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Risk Related to Our Strategic Transactions:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any difficulties from strategic acquisitions could adversely affect our stock price, operating results and results of operations.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may acquire companies, businesses and products that complement or augment our existing business. We may not be able to integrate any acquired business successfully or operate any acquired business profitably. Integrating any newly acquired business could be expensive and time-consuming. Integration efforts often take a significant amount of time, place a significant strain on managerial, operational and financial resources and could prove to be more difficult or expensive than we predict. The diversion of our management's attention and any delay or difficulties encountered in connection with any future acquisitions we may consummate could result in the disruption of our ongoing business or inconsistencies in standards and controls that could negatively affect our ability to maintain third-party relationships. Moreover, we may need to raise additional funds through public or private debt or equity financing, or issue additional shares, to acquire any businesses or products, which may result in dilution for stockholders or the incurrence of indebtedness.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our efforts to acquire companies, business or product candidates or to enter into other significant transactions, we conduct business, legal and financial due diligence with the goal of identifying and evaluating material risks involved in the transaction. Despite our efforts, we ultimately may be unsuccessful in ascertaining or evaluating all such risks and, as a result, might not realize the intended advantages of the transaction. If we fail to realize the expected benefits from acquisitions we may consummate in the future or have consummated in the past, whether as a result of unidentified risks, integration difficulties, regulatory setbacks, litigation with current or former employees and other events, our business, results of operations and financial condition could be adversely affected. If we acquire product candidates, we will also need to make certain assumptions about, among other things, development costs, the likelihood of receiving regulatory approval and the market for such product candidates. Our assumptions may prove to be incorrect, which could cause us to fail to realize the anticipated benefits of these transactions.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we will likely experience significant charges to earnings in connection with our efforts, if any, to consummate acquisitions. For transactions that are ultimately not consummated, these charges may include fees and expenses for investment bankers, attorneys, accountants and other advisors in connection with our efforts. Even if our efforts are successful, we may incur, as part of a transaction, substantial charges for closure costs associated with elimination of duplicate operations and facilities and acquired in-process research and development charges. In either case, the incurrence of these charges could adversely affect our results of operations for particular quarterly or annual periods.</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Other Risks:</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business is subject to risks arising from epidemic diseases, such as the COVID-19 pandemic, which has impacted and could continue to impact our business.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to impact worldwide public health and economic activity. A pandemic, including COVID-19 or other public health epidemic, poses the risk that we or our employees, contractors, including our CROs, suppliers, and other partners may be prevented from conducting business activities for an indefinite period of time, including due to spread of the disease within these groups or due to shutdowns that may be requested or mandated by governmental authorities.  Although we have lifted most of the restrictions we previously imposed on in-person access to our facilities and currently do not believe the COVID-19 pandemic is having a material impact on our business, we cannot guarantee that the COVID-19 pandemic, including the emergence of variants, or a similar event, will not impact our operations in the future.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several of our partners reported that their operations were impacted, including delays in research and development programs and deprioritizing clinical trials in favor of treating patients who have contracted the virus or to prevent the spread of the virus. This may lead to clinical trial protocol deviations or to discontinuation of treatment for patients who are currently enrolled in the clinical trials being conducted by us or our partners. In addition, certain of our partners reported negative impacts on product sales which will impact our royalty revenues. Although we believe that we and our partners have adjusted our business practices to the impacts of the COVID-19 pandemic, we may experience disruptions that could severely impact our business, drug manufacturing and supply chain, nonclinical activities and clinical trials and our partners&#8217; business may be impacted in similar ways, including due to delays or difficulties in enrolling patients in clinical trials, diversion of healthcare resources away from the conduct of clinical trials, interruption of, or delays in receiving, supplies of Captisol or other product or product candidates from contract manufacturing organizations due to staffing shortages, production slowdowns or stoppages and disruptions in delivery systems, which may result in cancellations of Captisol orders or refunds if we fail to deliver Captisol timely, interruption or delays to discovery and development pipelines and difficulties launching or commercializing products, including due to reduced access to doctors as a result of social distancing protocols. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, the spread of COVID-19 has had and may continue to severely impact the trading price of shares of our common stock and could further severely impact our ability to raise additional capital on a timely basis or at all. The extent to which the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19 pandemic, or any other outbreak of an epidemic disease, impacts our results will depend on future developments that are highly uncertain and cannot be predicted, including new information that may emerge concerning the severity of the virus and the actions to contain its impact.  Further, to the extent the COVID-19 pandemic or any other outbreak of an epidemic disease adversely affects our business and financial results, it may also have the effect of heightening many of the other risks described in this section. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our operating results may fluctuate significantly, which makes our future operating results difficult to predict and could cause our operating results to fall below expectations or any guidance we may provide.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our quarterly and annual operating results may fluctuate significantly, which makes it difficult for us to predict our future operating results. These fluctuations may occur due to a variety of factors, many of which are outside of our control, including, but not limited to:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">the royalties from the sales of Kyprolis, Evomela and other products sold by our partners; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">the success of our collaboration partners&#8217; preclinical and clinical programs;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">the timing of Captisol purchases for use in clinical trials and commercial products; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">the timing and cost of, and level of investment in, research, development, regulatory approval and commercialization activities relating to our internal development programs, which may change from time to time;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">expenditures that we may incur to acquire or develop additional product candidates and platform technologies; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">future accounting pronouncements or changes in our accounting policies. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The cumulative effects of these factors could result in large fluctuations and unpredictability in our quarterly and annual operating results and revenues. This variability and unpredictability could result in our failing to meet the expectations of industry or financial analysts or investors for any period. If our revenue or operating results fall below the expectations of analysts or investors or below any forecasts we may provide to the market, or if the forecasts we provide to the market are below the expectations of analysts or investors, the price of our common stock could decline substantially. Such a stock price decline could occur even when we have met any previously publicly stated revenue or earnings guidance we may provide.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Changes or modifications in financial accounting standards, including those related to revenue recognition, may harm our results of operations.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the FASB either alone or jointly with other organizations, promulgates new accounting principles that could have an adverse impact on our results of operations. For example, in May 2014, FASB issued an accounting standard for revenue recognition-Accounting Standards Codification Topic 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or ASC 606-that supersedes most current revenue recognition guidance. The guidance requires a company to recognize revenue upon transfer of goods or services to a customer at an amount that reflects the expected consideration to be received in exchange for those goods or services.  The guidance became effective in fiscal 2018. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 606, Ligand estimates and books royalties in the same quarter that our partners report the sale of the underlying product. We rely on our partners&#8217; earning releases and other information from our partners to determine the sales of our partners&#8217; products and to estimate the related royalty revenues. If our partners report incorrect sales, or if our partners delay reporting of their earnings release, our royalty estimates may need to be revised and/or our financial reporting may be delayed. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to use our net operating loss carryforwards and certain other tax attributes to offset future taxable income may be subject to certain limitations. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, we had U.S. federal and state net operating loss carryforwards (NOLs) of approximately $81.1 million and $168.3 million, respectively.  Our federal NOLs expire through 2037 a</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nd our state NOLs begin to expire in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 2029, if not utilized. Under the Tax Act, any federal NOLs arising in taxable years ending after December 31, 2017 will carry forward indefinitely. As of December&#160;31, 2022, we had federal and California research and development tax credit carryforwards of approximately $8.5 million and $29.0 million, respectively. The federal research and development tax credit carryforwards expire in various years through 2040, if not utilized. The California research and development credit will carry forward indefinitely. Under Sections 382 and 383 of Internal Revenue Code of 1986, as amended (Code) if a corporation undergoes an &#8220;ownership change,&#8221; the corporation&#8217;s ability to use its pre-change NOLs and other pre-change tax attributes, such as research tax credits, to offset its future post-change income and taxes may be limited. In general, an &#8220;ownership change&#8221; occurs if there is a cumulative change in our ownership by &#8220;5% shareholders&#8221; that exceeds 50 percentage points over a rolling three-year period. Similar rules may apply under state tax laws. We believe we have experienced certain ownership changes in the past and have reduced our deferred tax assets related to NOLs and research and development tax credit carryforwards accordingly. In the event that it is determined that we have in the past experienced additional ownership changes, or if we experience one or more ownership changes as a result future transactions in our stock, then we may be further limited in our ability to use our NOLs and other tax assets to reduce taxes owed on the net taxable income that we earn in the event that we attain profitability. Furthermore, under the Tax Act, although the treatment of tax losses generated in tax years beginning before December 31, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2017 has generally not changed, tax losses generated in tax years beginning after December 31, 2017 may only offset 80% of our taxable income. This change may require us to pay federal income taxes in future years despite having potentially generated a loss for federal income tax purposes in prior years. Any such limitations on the ability to use our NOLs and other tax assets could adversely impact our business, financial condition and operating results.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The occurrence of a catastrophic disaster could disrupt our business, damage our facilities beyond insurance limits, increase our costs and expenses, or we could lose key data which could cause us to curtail or cease operations.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are vulnerable to damage, business disruptions and/or loss of vital data from natural or man-made disasters, such as earthquakes, tornadoes, severe weather conditions, power loss, fire, floods and similar events, as well as from accidental loss or destruction. If any disaster were to occur, our ability to operate our business could be seriously impaired. We have property, liability, and business interruption insurance which may not be adequate to cover our losses resulting from disasters or other similar significant business interruptions, and we do not plan to purchase additional insurance to cover such losses due to the cost of obtaining such coverage. Any significant losses that are not recoverable under our insurance policies could seriously impair our business, financial condition and prospects. Our ability to obtain Captisol supply from our third-party manufactures could be disrupted if the operations of these manufacturers were affected by a natural or man-made disaster or other business interruption. In addition, we rely on our partners to generate most of our revenues through royalties, Captisol sales and development activities and any disruptions to their business as a result of such disasters could negatively impact our revenues.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on information technology system and any failure, inadequacy, interruption or security lapse of our information technology systems, including any cyber security incidents, could harm our ability to operate our business effectively.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is increasingly dependent on critical, complex and interdependent information technology systems, including internet-based systems, to support business processes as well as internal and external communications. We operate some of these systems and networks, but we also rely on third-party providers for various products and services across our operations. Despite the implementation of security measures, our information technology systems and those of our partners and third party service providers are vulnerable to attack, damage, and interruption from cyber-attacks, computer viruses and malware (e.g. ransomware), security breaches, unauthorized access, natural disasters, terrorism, war, telecommunication and electrical failures, hacking, phishing attacks and other social engineering schemes, employee theft or misuse, human error, fraud, denial or degradation of service attacks, sophisticated nation-state and nation-state-supported actors or unauthorized access or use by persons inside our organization, or persons with access to systems inside our organization. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attacks upon information technology systems are increasing in their frequency, levels of persistence, sophistication and intensity, and are being conducted by sophisticated and organized groups and individuals with a wide range of motives and expertise. Furthermore, because the technologies used to obtain unauthorized access to, or to sabotage or disrupt, systems change frequently and often are not recognized until launched against a target, we may be unable to anticipate these techniques or implement adequate preventative measures. We may also experience security breaches that may remain undetected for an extended period.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if identified, we may be unable to adequately investigate or remediate incidents or breaches due to attackers increasingly using tools and techniques that are designed to circumvent controls, to avoid detection, and to remove or obfuscate forensic evidence.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the COVID-19 pandemic, or any future epidemic diseases, we may also face increased cybersecurity risks due to our reliance on internet technology and the number of our and our service providers&#8217; employees who are (and may continue to be) working remotely, which may create additional opportunities for cybercriminals to exploit vulnerabilities. The White House, SEC and other regulators have also increased their focus on companies&#8217; cybersecurity vulnerabilities and risks.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and certain of our service providers are from time to time, subject to cyberattacks and security incidents. While we do not believe that we have experienced any significant system failures, accidents or security breaches, if such an event were to occur and cause interruptions in our or our critical third parties&#8217; operations, it could lead to the loss of trade secrets or other intellectual property, as well as the public exposure of personal information of our employees and others, and could result in a material disruption of our clinical and commercialization activities and business operations, in addition to possibly requiring substantial expenditures to remedy. To the extent that any disruption or security breach were to result in a loss of, or damage to, our data or applications, or inappropriate disclosure of confidential or proprietary information, we could incur liability and our business, reputation, and financial condition could be harmed. Any losses, costs or liabilities may not be covered by, or may exceed the coverage limits of, any or all applicable insurance policies.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conversion of our outstanding convertible notes may result in losses, result in the dilution of existing stockholders, create downward pressure on the price of our common stock, and restrict our ability to take advantage of future opportunities.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, we issued $750.0 million principal amount of the 2023 Notes. The sale of the 2023 Notes may affect our earnings per share figures, as accounting procedures require that we include in our calculation of earnings per share the number of shares of our common stock into which the 2023 Notes are convertible. The convertible notes may be converted into cash and shares of our common stock, if any (subject to our right or obligation to pay cash in lieu of all or a portion of such shares).  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If shares of our common stock are issued to the holders of the convertible notes upon conversion, there will be dilution to our shareholders equity and the market price of our shares may decrease due to the additional selling pressure in the market. Any downward pressure on the price of our common stock caused by the sale or potential sale of shares issuable upon conversion of the convertible notes could also encourage short sales by third parties, creating additional selling pressure on our stock. Upon the occurrence of certain circumstances, holders of the convertible notes may require us to purchase all or a portion of their notes for cash, which may require the use of a substantial amount of cash. If such cash is not available, we may be required to sell other assets or enter into alternate financing arrangements at terms that may or may not be desirable. The existence of the convertible notes and the obligations that we incurred by issuing them may restrict our ability to take advantage of certain future opportunities, such as engaging in future debt or equity financing activities. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, we had $76.9 million aggregate principal amount of 2023 Notes. The notes are convertible into cash, and if applicable, shares of our common stock under certain circumstances, including trading price conditions related to our common stock. Upon conversion, we are required to record a gain or loss for the difference between the fair value of the notes to be extinguished and their corresponding net carrying value. The fair value of the notes to be extinguished depends on our current incremental borrowing rate. If our incremental borrowing rate at the time of conversion is lower than the implied interest rate of the notes, we will record a loss in our consolidated statement of income during the period in which the notes are converted. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment charges pertaining to goodwill, identifiable intangible assets or other long-lived assets from our mergers and acquisitions could have an adverse impact on our results of operations and the market value of our common stock.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price pertaining to our acquisitions in recent years have been allocated to net tangible assets, identifiable intangible assets, in-process research and development and goodwill. To the extent the value of goodwill or identifiable intangible assets or other long-lived assets become impaired, we will be required to incur material charges relating to the impairment. Any impairment charges could have a material adverse impact on our results of operations and the market value of our common stock.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our investments are subject to market and credit risks that could diminish their value and these risks could be greater during periods of extreme volatility or disruption in the financial and credit markets, which could adversely impact our business, financial condition, results of operations, liquidity and cash flows.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investments are subject to risks of credit defaults and changes in market values. Periods of macroeconomic weakness or recession, heightened volatility or disruption in the financial and credit markets could increase these risks, potentially resulting in other than temporary impairment of assets in our investment portfolio. Any event reducing the estimated fair value of these securities, other than on a temporary basis, could have a material and adverse effect on our business, results of operations, financial condition, liquidity and cash flows. If our investment manager, fails to react appropriately to difficult market, economic and geopolitical conditions, our investment portfolio could incur material losses.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a risk management framework in place to identify, assess and prioritize risks, including the market and credit risks to which our investments are subject. As part of that framework, we test our investment portfolio based on various market scenarios. Under certain stressed market scenarios, unrealized losses on our investment portfolio could lead to material reductions in its carrying value.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A decline in fair value below the amortized cost of a security requires management to assess whether an impairment has occurred. The decision on whether to record an impairment is determined in part by our assessment of the financial condition and prospects of a particular issuer, projections of future cash flows and recoverability of the particular security as well as management&#8217;s assertion of whether it is more likely than not that we will sell the particular security before recovery.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our charter documents and concentration of ownership may hinder or prevent change of control transactions.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provisions contained in our certificate of incorporation and bylaws may discourage transactions involving an actual or potential change in our ownership.  In addition, our Board of Directors may issue shares of common or preferred stock without any further action by the stockholders. Our directors, officers and certain of our institutional investors collectively beneficially own a significant portion of our outstanding common stock. Such provisions and issuances may have the effect of delaying or preventing a change in our ownership. If changes in our ownership are discouraged, delayed or prevented, it would be more difficult for our current Board of Directors to be removed and replaced, even if you or our other stockholders believe that such actions are in the best interests of us and our stockholders.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our amended and restated bylaws provide that the Court of Chancery of the State of Delaware will be the exclusive forum for substantially all disputes between us and our stockholders, which could limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, officers or employees.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our amended and restated bylaws provide that the Court of Chancery of the State of Delaware is the exclusive forum for (i) any derivative action or proceeding brought on our behalf, (ii) any action asserting a claim of breach of a fiduciary duty </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">owed by our directors, officers or other employees to us or our stockholders, (iii) any action asserting a claim arising pursuant to any provision of the General Corporation Law of Delaware or our amended and restated certificate of incorporation or amended and restated bylaws, or (iv) any action asserting a claim governed by the internal affairs doctrine. To the extent that any such claims may be based upon federal law claims, Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder. Furthermore, Section 22 of the Securities Act provides for concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder, and as such, the exclusive jurisdiction clauses set forth above would not apply to such suits. The choice of forum provisions in our amended and restated bylaws may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or other employees, which may discourage such lawsuits against us and our directors, officers and other employees. By agreeing to these provisions, however, stockholders will not be deemed to have waived our compliance with the federal securities laws and the rules and regulations thereunder. Furthermore, the enforceability of similar choice of forum provisions in other companies&#8217; certificates of incorporation and bylaws has been challenged in legal proceedings, and it is possible that a court could find these types of provisions to be inapplicable or unenforceable. If a court were to find the choice of forum provisions in our amended and restated bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could adversely affect our business and financial condition.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our stock price has been volatile and could experience a sudden decline in value.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market prices for securities of biotechnology and pharmaceutical companies have historically been highly volatile, and the market has experienced significant price and volume fluctuations that are unrelated to the operating performance of particular companies. Continued volatility in the overall capital markets could reduce the market price of our common stock in spite of our operating performance. Further, high stock price volatility could result in higher share-based compensation expense.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock has experienced significant price and volume fluctuations and may continue to experience volatility in the future. Many factors may have a significant impact on the market price of our common stock, including, but not limited to, the following factors: results of or delays in our preclinical studies and clinical trials; the success of our collaboration agreements; publicity regarding actual or potential medical results relating to products under development by us or others; announcements of technological innovations or new commercial products by us or others; developments in patent or other proprietary rights by us or others; market perception of the OmniAb spin-off; comments or opinions by securities analysts or major stockholders or changed securities analysts' reports or recommendations; future sales or shorting of our common stock by existing stockholders; regulatory developments or changes in regulatory guidance; litigation or threats of litigation; economic and other external factors or other disaster or crises; the departure of any of our officers, directors or key employees; period-to-period fluctuations in financial results; and price and volume fluctuations in the overall stock market.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our results of operations and liquidity needs could be materially negatively affected by market fluctuations and economic downturn.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our results of operations could be materially negatively affected by economic conditions generally, both in the United States and elsewhere around the world. Concerns over inflation, energy costs, geopolitical issues, military conflicts, including the war between Russia and Ukraine, terrorism, public health emergencies or pandemics, the availability and cost of credit, and the U.S. financial markets have in the past contributed to, and may continue in the future to contribute to, increased volatility and diminished expectations for the economy and the markets. Sanctions imposed by the United States and other countries in response to military conflicts, including the war between Russia and Ukraine, may also adversely impact the financial markets and the global economy, and any economic countermeasures by the affected countries or others could exacerbate market and economic instability. In addition, the COVID-19 pandemic affected and may continue to affect, and any future epidemic diseases may affect, worldwide equity markets. Domestic and international equity markets periodically experience heightened volatility and turmoil. These events may have an adverse effect on us. In the event of a market downturn, our results of operations could be adversely affected by those factors in many ways, including making it more difficult for us to raise funds if necessary, and our stock price may further decline. We cannot provide assurance that our investments are not subject to adverse changes in market value. If our investments experience adverse changes in market value, we may have less capital to fund our operations.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span><br/></span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_19"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:9.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.050%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;1B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unresolved Staff Comments</span></td></tr></table></div><div style="margin-top:5pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34</span></div></div></div><div id="i98e6b87576d6446486a3b29533a5cf6a_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:9.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.050%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Properties</span></td></tr></table></div><div style="margin-top:5pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our principal facilities leased as of December&#160;31, 2022, including the location and size of each facility, and their designated use. We believe our facilities are adequate for our current and near-term needs, and we will be able to locate additional facilities, as needed. </span></div><div style="margin-top:5pt;text-indent:24pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.058%"><tr><td style="width:1.0%"></td><td style="width:13.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.791%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate <br/>Square Feet</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operation</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease Expiration Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">San Diego, CA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate headquarter office and laboratory</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2032</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Las Vegas, NV</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,100</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2028</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lawrence, KS</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,700</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office and laboratory</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2032</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt;text-indent:24pt"><span><br/></span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_25"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:9.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.050%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Legal Proceedings</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 8. Financial Statements and Supplementary Data&#8212;Notes to Consolidated Financial Statements&#8212;Note (10), Commitments and Contingencies&#8212;Legal Proceedings.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div><span><br/></span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_28"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:9.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.050%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Mine Safety Disclosures</span></td></tr></table></div><div style="margin-top:5pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_31"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_34"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:9.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.050%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities</span></td></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is traded on the Nasdaq Global Market under the symbol &#8220;LGND.&#8221; As of February&#160;22, 2023, there were approximately 354 holders of record of the common stock.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except for 2007, during which we declared a cash dividend on our common stock of $2.50 per share, we have not paid any dividends on our common stock in the past and currently do not expect to pay cash dividends or make any other distributions on common stock in the future. We expect to retain our future earnings, if any, for use in the operation and expansion of our business, to pay down debt and potentially for share repurchases. Any future determination to pay dividends on common stock will be at the discretion of our Board of Directors and will depend upon our financial condition, results of operations, capital requirements and such other factors as the board deems relevant. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal year ended December&#160;31, 2022, we did not repurchase any shares of our common stock under the stock repurchase program approved by our Board of Directors in September 2019, which allowed us to acquire up to $500 million of our common stock in open market and negotiated purchases for a period of up to three years. This stock repurchase program expired in September 2022.  </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by Item 201(d) of Regulation S-K is incorporated by reference to the 2023 Annual Meeting Proxy Statement as defined in Item 10 below.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Performance Graph</span></div><div style="margin-bottom:6pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The graph below shows the five-year cumulative total stockholder return assuming the investment of $100 and is based on the returns of the component companies weighted monthly according to their market capitalization. The graph compares total stockholder returns of our common stock, of all companies traded on the Nasdaq Stock market, as represented by the Nasdaq Composite</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Index, and of the Nasdaq Biotechnology Stock Index, as prepared by The Nasdaq Stock Market Inc.</span></div><div style="margin-bottom:6pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The stockholder return shown on the graph below is not necessarily indicative of future performance and we will not make or endorse any predictions as to future stockholder returns.</span></div><div style="margin-bottom:6pt;text-indent:24pt"><img src="lgnd-20221231_g4.jpg" alt="lgnd-20221231_g4.jpg" style="height:346px;margin-bottom:5pt;vertical-align:text-bottom;width:652px"/></div><div style="margin-top:9pt;text-align:right;text-indent:24pt"><span><br/></span></div><div style="margin-top:9pt;text-align:center;text-indent:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Value of $100 Invested Over Time</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.497%"><tr><td style="width:1.0%"></td><td style="width:37.833%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.607%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.269%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.269%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.269%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.108%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.593%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.278%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12/31/2017</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12/31/2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12/31/2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12/31/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12/31/2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12/31/2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99.10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76.16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72.63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">112.80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71.62&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NASDAQ Composite-Total Return</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97.12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">132.81&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">192.47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">235.15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">158.65&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NASDAQ Biotechnology Index</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">114.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">144.15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">144.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i98e6b87576d6446486a3b29533a5cf6a_37"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:9.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.050%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">[RESERVED]</span></td></tr></table></div><div style="margin-bottom:6pt;text-indent:24pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_40"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:9.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.050%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></td></tr></table></div><div><span><br/></span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_43"></div><div style="margin-bottom:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&amp;A) will help readers understand our results of operations, financial condition, and cash flows. It is provided in addition to the accompanying consolidated financial statements and notes.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">OmniAb Separation and Spin-Off</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 23, 2022, we entered into the Merger Agreement, by and among our company, Avista Public Acquisition Corp. II (New OmniAb) and OmniAb, Inc., a Delaware corporation and then wholly-owned subsidiary of our company (OmniAb), and Orwell Merger Sub Inc. (Merger Sub), pursuant to which New OmniAb combined with OmniAb, our then-antibody discovery business (the OmniAb Business), in a Reverse Morris Trust transaction. Pursuant to the Separation Agreement, we transferred the OmniAb Business, including certain of our related subsidiaries, to OmniAb and, in connection therewith, distributed (the Distribution) to Ligand stockholders 100% of the common stock of OmniAb.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immediately following the Distribution on November 1, 2022, in accordance with and subject to the terms and conditions of the Merger Agreement, Merger Sub merged with and into OmniAb (the Merger), with OmniAb continuing as the surviving company in the Merger and as a wholly-owned subsidiary of New OmniAb. After the Distribution, we do not beneficially own any shares of common stock in OmniAb and no longer consolidate OmniAb into our financial results for periods ending after October 31, 2022. As a result, OmniAb's historical financial results through the Separation are reflected in our consolidated financial statements as discontinued operations.</span></div><div style="margin-bottom:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our MD&amp;A is organized as follows:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Results of Operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Detailed discussion of our revenue and expenses from continuing operations for twelve months ended December&#160;31, 2022, 2021 and 2020.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Liquidity and Capital Resources.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Discussion of key aspects of our consolidated statements of cash flows, changes in our financial position, and our financial commitments.</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Critical Accounting Policies and Estimates. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discussion of significant changes we believe are important to understand the assumptions and judgments underlying our consolidated financial statements.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Recent Accounting Pronouncements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For summary of recent accounting pronouncements applicable to our consolidated financial statements, see &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 8. Financial Statements and Supplementary Data&#8212;Notes to Consolidated Financial Statements&#8212;Note (1), Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FY 2022 vs. FY 2021</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:59.200%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.072%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.072%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.072%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.072%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,527&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,927&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Captisol - Core</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,994)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Captisol - COVID</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,066&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,827&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52,761)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract Revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,144)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196,245&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,544&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,299)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.</span></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue from continuing operations decreased by $45.3&#160;million, or 19%, to $196.2&#160;million in 2022 compared to $241.5&#160;million in 2021 primarily due to the $52.8&#160;million decrease in sales of COVID-related Captisol. The lower sales were due to reduced demand for remdesivir, a treatment for moderate or severe COVID-19. Core Captisol sales were $16.4&#160;million </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the year ended December 31, 2022, compared with $23.4&#160;million for the same period in 2021. The lower sales were due to the timing of customer orders. Royalty revenue increased by $23.6&#160;million, or 48%, to $72.5&#160;million in 2022 as compared to $48.9&#160;million for the same period in 2021. The increase in royalty revenue is driven primarily by increases in sales of drugs using the Pelican platform - Rylaze, Pneumosil and Teriparatide, along with an increase in sales of Kyprolis. Contract revenue decreased year over year in 2022 by $9.1 million primarily due to the timing of partner milestone events.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-indent:27pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FY 2021 vs. FY 2020</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:59.200%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.072%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.072%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.072%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.072%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,927&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,796&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Captisol - Core</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,143)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Captisol - COVID</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,827&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,434&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract Revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,544&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,562&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,982&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.</span></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue from continuing operations increased by $78.0 million, or 48%, to $241.5 million in 2021 compared to $163.6 million in 2020 primarily due to the $55.4 million increase in sales of COVID-related Captisol. The higher sales were due to increased demand for remdesivir, a treatment for moderate or severe COVID-19. Core Captisol sales were $23.4 million for the year ended December 31, 2021, compared with $24.6 million&#160;for the same period in 2020. The lower sales were due to the timing of customer orders. Royalty revenue increased by $15.1 million, or 45%, to $48.9 million in 2021 as compared to $33.8 million for the same period in 2020. The increase in royalty revenue was driven primarily by the royalties from the sale of drugs using the Pelican platform - Rylaze, Pneumosil and Teriparatide. Contract revenue increased year over year in 2021 by $8.6 million primarily due to the timing of partner milestone events.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Royalty revenue is a function of our partners' product sales and the applicable royalty rate. Kyprolis royalty rate is under a tiered royalty rate structure with the highest being 3.0%. Evomela has a contractually fixed royalty rate of 20%. Teriparatide injection has a tiered gross profit share between 25% and 40% on sales that have been adjusted for certain deductible items as defined in the respective license agreement. The Rylaze royalty rate is in the low single digits. Contract revenue includes service revenue, license fees and development, regulatory and sales based milestone payments. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents royalty revenue by program:</span></div><div style="text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.769%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 Estimated Partner Product Sales</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Royalty Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 Royalty Revenue </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021 Estimated Partner Product Sales</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Royalty Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021 Royalty Revenue</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,275.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,148.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.0%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.0%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Teriparatide injection</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.5%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.1%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rylaze</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">278.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">383.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">195.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,036.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,488.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(1) - Teriparatide injection sales have been adjusted for certain deductible items as defined in the respective license agreement, and the royalty revenue is based on a tiered gross profit share.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Costs and Expense</span></div><div style="margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FY 2022 vs. FY 2021</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.058%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.070%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.310%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.139%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of Captisol</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,827&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,176&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,349)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,082&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,977&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,790&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other operating income </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37,600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193,208&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137,693&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,515&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating costs and expenses from continuing operations for 2022 increased $55.5 million or 40% compared with 2021. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of Captisol decreased year over year in 2022 primarily due to lower sales of Captisol during 2022, partially offset by the capacity ramp-up right of use asset impairment of $9.8&#160;million recorded in the fourth quarter of 2022. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of intangibles remained steady in 2022 compared to 2021 as there have been no significant changes to the gross balance of intangible assets over these periods. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At any one time, we are working on multiple programs. As such, we generally do not track our R&amp;D expenses on a specific program basis. Our R&amp;D expenses increased by $4.0 million in 2022 compared to 2021 due to higher employee-related expenses and increased facility related expenses.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses increased by $23.3 million in 2022 compared to 2021 primarily due to increases in stock compensation expense including a one-time charge associated with the retirement of our former CEO in the fourth quarter of 2022, headcount-related expenses and legal expenses.  </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating income in 2021 was due to reducing the fair value of the CVR liability associated to the acquisition of Pfenex to zero, as the CVR payment expiration date passed on December 31, 2021 without achieving the triggering event. We did not have any other operating income in 2022.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FY 2021 vs. FY 2020</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.058%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.070%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.310%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.139%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of Captisol</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,176&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,419&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,757&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,580&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,398)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,790&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,222)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other operating income </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37,600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38,200)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,367)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137,693&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143,176&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,483)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating costs and expenses from continuing operations for 2021 decreased $5.5 million or 4% compared with 2020. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of Captisol increased year over year in 2021 primarily due to higher sales of Captisol during 2021.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of intangibles increased year over year in 2021 primarily due to the acquisition of Pfenex in October 2020.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At any one time, we are working on multiple programs. As such, we generally do not track our R&amp;D expenses on a specific program basis. Our R&amp;D expenses decreased year over year in 2021 due to the sale of Vernalis R&amp;D in October 2020.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses decreased by $13.2 million in 2022 compared to 2021 primarily due to $20.7 million in acquisition and integration related costs in 2021 associated with the Pfenex acquisition in 2020. The decrease was partially offset by additional headcount related expenses in 2021.  </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating income in 2021 was due to reducing the fair value of the CVR liability associated to the acquisition of Pfenex to zero, as the CVR payment expiration date passed on December 31, 2021 without achieving the triggering event. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not provide forward-looking estimates of costs and time to complete our ongoing research and development projects as such estimates would involve a high degree of uncertainty. Uncertainties include our inability to predict the outcome </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of research and clinical studies, regulatory requirements placed upon us by regulatory authorities such as the FDA and EMA, our inability to predict the decisions of our partners, our ability to fund research and development programs, competition from other entities of which we may become aware in future periods, predictions of market potential for products that may be derived from our work, and our ability to recruit and retain personnel or third-party contractors with the necessary knowledge and skills to perform certain research. Refer to &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 1A. Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for additional discussion of the uncertainties surrounding our research and development initiatives.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other income (expense)</span></div><div style="margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FY 2022 vs. FY 2021</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:60.404%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.339%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.749%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) from short-term investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,540&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,263)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,803&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,799)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,619)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,650)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,837&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other income (expense), net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,974&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,646)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,620&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.</span></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fluctuation in the gain (loss) from short-term investments is primarily driven by the changes in the fair value of our ownership in Viking common stock (an unrealized gain of $32.2 million in 2022 as compared to an unrealized loss of $9.6 million in 2021). </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income consists primarily of interest earned on our short-term investments. The year over year increase in 2022 is primarily due to the significant interest rate increases by the federal reserve during 2022. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense includes the 0.75% coupon cash interest expense in addition to the non-cash accretion of discount (including the amortization of debt issuance costs) on our 2023 Notes. The year over year decrease was primarily due to the adoption of ASU 2020-06 which significantly reduced the debt discount balance subject to amortization. See additional information in &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 8. Financial Statements and Supplementary Data&#8212;Notes to Consolidated Financial Statements&#8212;Note (1), Basis of Presentation and Summary of Significant Accounting Policies.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; In addition, we carried a lower average debt outstanding balance during 2022 as compared 2021.  During 2022, we repurchased $266.4 million in principal of the 2023 Notes for $261.4 million in cash, including accrued interest of $0.5 million. See additional information in  &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 8. Financial Statements and Supplementary Data&#8212;Notes to Consolidated Financial Statements&#8212;Note (7), Convertible Senior Notes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net, increased year over year in 2022 primarily due to a $4.2 million gain on our debt extinguishments in 2022 compared to $7.3 million loss on debt extinguishments in 2021. See additional information in &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 8. Financial Statements and Supplementary Data&#8212;Notes to Consolidated Financial Statements&#8212;Note (7), Convertible Senior Notes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;  </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FY 2021 vs. FY 2020</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:60.404%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.339%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.749%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) from short-term investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,263)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,933)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,670&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,078&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,192)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,619)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27,415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,650)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,712)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other income (expense), net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,646)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,208)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,562&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fluctuation in the gain (loss) from short-term investments is primarily driven by the changes in the fair value of our ownership in Viking common stock (an unrealized loss of $9.6 million in 2021 as compared to an unrealized loss of $19.0 million in 2020).</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income consists primarily of interest earned on our short-term investments. The year over year decrease in 2021 resulted from the decrease in our short-term investment balances due to the usage of funds for the 2023 Notes repurchases.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense includes the 0.75% coupon cash interest expense in addition to the non-cash accretion of discount (including the amortization of debt issuance costs) on our 2023 Notes. The year over year decrease in 2021 was primarily due to lower average debt outstanding balance as compared to the prior year. During 2021, we repurchased $152.0 million in principal of the 2023 Notes for $156.0 million in cash, including accrued interest of $0.3 million. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Item 8. Financial Statements and Supplementary Data&#8212;Notes to Consolidated Financial Statements&#8212;Note (7), Convertible Senior Notes.&#8221;</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net, increased year over year in 2021 primarily due to a $7.3 million loss on our debt extinguishments compared to $2.5 million loss on debt extinguishments in 2020. See additional information in &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 8. Financial Statements and Supplementary Data&#8212;Notes to Consolidated Financial Statements&#8212;Note (7), Convertible Senior Notes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income tax benefit (expense)</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FY 2022 vs. FY 2021</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:58.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.780%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.035%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before income tax expense (benefit) from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,011&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,205&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,194)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(41,230)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(45,378)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,094)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,219)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,353&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(81,572)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(107)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective Tax Rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate for 2022 and 2021 was 114% and (6)%, respectively. Our tax rate is affected by recurring items, such as the U.S. federal and state statutory tax rates and the relative amounts of income we earn in those jurisdictions, which we expect to be fairly consistent in the near term. It is also affected by discrete items that may occur in any given year, but are not consistent from year to year. In 2022, the variance from the U.S. federal statutory rate of 21% was primarily due to limitations on the deductibility of stock-based compensation for certain officers and a discrete tax expense of $24.8 million related to the valuation allowance established during the fourth quarter of 2022 against deferred tax assets for California research and development credits and net operating losses. Beginning in 2022, the Tax Cuts and Jobs Act of 2017 requires taxpayers to capitalize and amortize R&amp;D expenditures over five years for domestic research and fifteen years for foreign research pursuant to Section 174 of the Internal Revenue Code of 1986, as amended. We recorded an increase of $4.7&#160;million to our current federal income tax expense and deferred tax assets for continuing operations during 2022 due to the capitalization of R&amp;D under Section 174. In 2021, the variance from the U.S. federal statutory rate of 21% was attributable to the mix of earnings in jurisdictions with lower statutory rates than the U.S. federal statutory tax rate, and excess benefits from shared-based compensation. The items below also had an impact on the difference between our statutory U.S. rate.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$24.8 million (68.9%) increase from valuation allowance adjustments</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$5.9 million (16.3%) increase from Section 162(m) limitation</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$2.4 million (6.7%) decrease from the foreign-derived intangible income deduction</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$1.3 million (3.6%) increase due to excess tax benefits from share-based compensation which are recorded as a discrete item within the provision for income tax pursuant to ASU 2016-09</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$12.1 million (16.7%) decrease due to excess tax benefits from share-based compensation which are recorded as a discrete item within the provision for income tax pursuant to ASU 2016-09</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$11.2 million (15.6%) increase from valuation allowance adjustments</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$8.1 million (11.1%) decrease from tax rate and law changes in the United Kingdom</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$8.0 million (11.1%) decrease due to the revaluation of contingent value rights</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$3.2 million (4.5%) increase from Section 162(m) limitation</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$3.1 million (4.3%) decrease from net operating loss carryforwards and credit adjustments </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$1.6 million (2.3%) decrease from research and development tax credits</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Loss from Discontinued Operations</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss from discontinued operations for the years ended December 31, 2022, 2021 and 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was $28.1 million, $19.2 million and $9.6 million, respectively. See additional information in &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 8. Financial Statements and Supplementary Data&#8212;Notes to Consolidated Financial Statements&#8212;Note (2), Spin-off Of OmniAb.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="i98e6b87576d6446486a3b29533a5cf6a_46"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we had approximately $211.9&#160;million in cash, cash equivalents, and short-term investments</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Cash and cash equivalents and short-term investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">decreased by $129.2 million </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">from last year, due to factors described in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash Flow Summary</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary source of liquidity, other than our holdings of cash, cash equivalents, and investments, which decreased during 2022 primarily from extinguishment of debt, has been cash flows from operations. Our ability to generate cash from operations provides us with the financial flexibility we need to meet operating, investing, and financing needs.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we have liquidated our short-term investments and/or issued debt and equity securities to finance our business needs as a supplement to cash provided by operating activities. Our short-term investments include U.S. government debt securities, investment-grade corporate debt securities, mutual funds and certificates of deposit. We have established guidelines relative to diversification and maturities of our investments in order to provide both safety and liquidity. These guidelines are periodically reviewed and modified to take advantage of trends in yields and interest rates. Additionally, we own certain securities which are classified as short-term investments that we received as a result of a milestone and an upfront license payment as well as 6.7 million shares of common stock in Viking.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2022, we entered into an At-The-Market Equity Offering Sales Agreement (Sales Agreement) with Stifel, Nicolaus &amp; Company, Incorporated (Agent), under which we may, from time to time, sell shares of our common stock having an aggregate offering price of up to $100.0 million in &#8220;at the market&#8221; offerings through the Agent (ATM Offering). The shelf registration statement relating to such shares included a prospectus covering the offering, issuance and sale of up to $100.0 million of our common stock from time to time through the ATM Offering. The shares to be sold under the Sales Agreement may be issued and sold pursuant to the shelf registration statement. As of December 31, 2022 we have not issued any shares of common stock in the ATM Offering.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, we issued the 2023 Notes with an aggregate principal amount of $750.0 million. A portion of the proceeds from such issuance totaling $49.7 million were used to repurchase 260,000 shares of our common stock. During 2021 and 2020, we repurchased $406.7 million in principal of the 2023 Notes for $378.8 million in cash, including accrued interest of $0.9 million.  During 2022, we repurchased $266.4 million in principal of the 2023 Notes for $261.4 million in cash, including accrued interest of $0.5 million. After the repurchases, $76.9 million in principal amount of the 2023 Notes remain outstanding as of December&#160;31, 2022. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may continue to use cash on hand to repurchase additional 2023 Notes through open-market transactions, including through a Rule 10b5-1 trading plan to facilitate open-market repurchases, or otherwise, from time to time. The timing and amount of repurchase transactions will be determined by management based on the evaluation of market conditions, trading price of the 2023 Notes, legal requirements and other factors. The 2023 Notes were not convertible as of December&#160;31, 2022. It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. See detail in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Item 8. Financial Statements and Supplementary Data&#8212;Notes to Consolidated Financial Statements&#8212;Note (7), Convertible Senior Notes.&#8221;</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are obligated to make payments to operating leases, including rental commitments on leases that have not yet commenced. For information on these obligations, see detail in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Item 8. Financial Statements and Supplementary Data&#8212;Notes to Consolidated Financial Statements&#8212;Note (6), Leases.&#8221;</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have commitments under our supply agreement with Hovione for Captisol purchases. The total purchase obligation as of December&#160;31, 2022 was $28.7 million, of which $9.6 million is expected to be paid within a year and the remaining amount is expected to be paid between 1 to 3 years.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2019, our Board of Directors approved a stock repurchase program authorizing the repurchase of up to $500.0 million of our common stock from time to time over a period of up to three years.  Our prior $350.0 million stock repurchase program was terminated in connection with the approval of the new stock repurchase program.  Our $500.0 million stock repurchase program expired in September 2022, and as of December 31, 2022 we do not have a repurchase program in place. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 5. Market for Registrant's Common Equity, Related Stockholder Matters, and Issuer Purchase of Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that existing funds, cash generated from operations and existing sources of and access to financing are adequate to satisfy our needs for working capital; capital expenditure and debt service requirements; continued advancement of research and development efforts; potential stock repurchases; and other business initiatives we plan to strategically pursue, including acquisitions and strategic investments. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, we had $3.5 million in fair value of contingent consideration liabilities associated with the acquisitions to be settled in future periods.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flow Summary</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"><tr><td style="width:1.0%"></td><td style="width:58.335%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.678%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.678%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.683%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating activities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137,850&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,798&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,586&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">163,624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,523&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">231,648&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Financing activities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(275,990)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(137,761)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(310,545)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, we generated cash from operations primarily from collections on our trade receivables. We generated cash from investing activities primarily from sale and maturity of short-term investments. During the year, we used cash for financing activities, including the payments related to the extinguishment of certain 2023 Notes.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we generated cash from operations primarily due to the increase in net income. We generated cash from investing activities primarily from sale and maturity of short-term investments. During the year, we used cash for financing activities, including the payments related to the extinguishment of certain 2023 Notes, partially offset by cash received from issuance of common stock under employee stock plans and bond hedge settlement.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, we generated cash from operations primarily due to cash inflows from changes in deferred revenue. We generated cash from investing activities primarily from sale and maturity of short-term investments as well as the sale of the Vernalis R&amp;D business; partially offset by cash used for the acquisition of Pfenex, and three additional acquisitions that are part of our discontinued operations, Icagen, xCella and Taurus. During the year, we used cash for financing activities, including the payments related to the extinguishment of certain 2023 Notes and stock repurchases.</span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_49"></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="text-indent:24pt"><span><br/></span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses, and related disclosures of contingent liabilities in the consolidated financial statements and accompanying notes. The SEC has defined a company&#8217;s critical accounting policies as the ones that are most important to the portrayal of the company&#8217;s financial condition and results of operations, and which require the company to make its most difficult and subjective judgments, often as a result of the need to make estimates of matters that are inherently uncertain. Based on this definition, we have identified the critical accounting policies and judgments addressed below. We also have other key accounting policies, which involve the use of estimates, judgments, and assumptions that are significant to understanding our results. For additional information, see &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 8. Financial Statements and Supplementary Data&#8212;Notes to Consolidated Financial Statements&#8212;Note (1), Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221; Although we believe that our estimates, assumptions, and judgments are reasonable, they are based upon information presently available. Actual results may differ significantly from these estimates under different assumptions, judgments, or conditions.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply the following five-step model in accordance with ASC 606 in order to determine the revenue: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive royalty revenue on sales by our partners of products covered by patents that we or our partners own under contractual agreements. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a royalty to be recorded no sooner than the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues are adjusted in the period in which they become known, typically the following quarter. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contracts with customers often will include variable consideration in the form of contingent milestone-based payments. We include contingent milestone based payments in the estimated transaction price when it is probable a significant reversal in the amount of cumulative revenue recognized will not occur. These estimates are based on historical experience, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">anticipated results and our best judgment at the time. If the contingent milestone based payment is sales-based, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development based milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon the occurrence of the development milestone or regulatory approval. Depending on the terms of the arrangement, we may also defer a portion of the consideration received if we have to satisfy a future obligation, which typically occurs with our contracts for R&amp;D services.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For R&amp;D services we recognize revenue over time and we measure our progress using an input method. The input methods we use are based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time it will take us to complete the activities, or the costs we may incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make numerous estimates and use significant judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from Captisol sales is recognized when control of Captisol material or intellectual property license rights is transferred to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. For Captisol material, we consider our performance obligation is satisfied at a point in time, once we have transferred control of the product, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We have elected to recognize the cost of freight and shipping when control over Captisol material has transferred to the customer as an expense in Cost of Captisol. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We occasionally have sub-license obligations related to arrangements for which we receive license fees, milestones and royalties. We evaluate the determination of gross as a principal versus net as an agent reporting based on each individual agreement.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Intangible Assets &#8212; Impairment Assessments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Goodwill</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is evaluated annually for impairment using either a quantitative or qualitative analysis. Goodwill is tested for impairment at the reporting unit level, and is based on the net assets for each reporting unit, including goodwill and intangible assets.  Goodwill is assigned to each reporting unit, as this represents the lowest level that constitutes a business and is the level at which management regularly reviews the operating results. The Company performs a quantitative analysis using a discounted cash flow model and other valuation techniques, but may elect to perform a qualitative analysis.  In addition, goodwill is evaluated for impairment whenever an event occurs or circumstances change that would indicate that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. Events or circumstances that may result in an impairment review include changes in macroeconomic conditions, industry and market considerations, cost factors, overall financial performance, other relevant entity-specific events, specific events affecting the reporting unit or sustained decrease in share price.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The annual goodwill impairment test was performed using a qualitative analysis in 2022 and 2021. A qualitative analysis is performed by assessing certain trends and factors, including projected market outlook and growth rates, forecasted and actual sales and operating profit margins, discount rates, industry data, and other relevant qualitative factors. These trends and factors are compared to, and based on, the assumptions used in the most recent quantitative analysis performed for each reporting unit. The results of the qualitative analyses did not indicate a need to perform quantitative analysis. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill impairment testing was performed using quantitative analyses in 2022 for the OmniAb business and Ligand core business due to the reorganization of the Company&#8217;s business discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Item 8. Financial Statements and Supplementary Data&#8212;Notes to Consolidated Financial Statements&#8212;Note (2), Spin-off of OmniAb.&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We used the relative fair value method to reallocate goodwill.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Intangible Assets</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly perform reviews to determine if an event occurred that may indicate the carrying values of our intangible assets are impaired. If indicators of impairment exist, we assess the recoverability of the affected long-lived assets by comparing its carrying amounts to its undiscounted cash flows. If the affected assets are not recoverable, we estimate the fair value of the assets and record an impairment loss if the carrying value exceeds the fair value. Factors that may indicate potential impairment include a significant decline in our stock price and market capitalization compared to net book value, significant changes in the ability of an asset to generate positive cash flows and the pattern of utilization of a particular asset.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to estimate the fair value of identifiable intangible assets, we estimate the present value of future cash flows from those assets. The key assumptions that we use in our discounted cash flow model are the amount and timing of estimated future cash flows to be generated by the asset over an extended period of time and a rate of return that considers the relative risk of achieving the cash flows, the time value of money, and other factors that a willing market participant would consider. Significant judgment is required to estimate the amount and timing of future cash flows and the relative risk of achieving those cash flows. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assumptions and estimates about future values and remaining useful lives are complex and often subjective. They can be affected by a variety of factors, including external factors such as industry and economic trends, and internal factors such as changes in our business strategy and our internal forecasts. For example, if our future operating results do not meet current forecasts or if we experience a sustained decline in our market capitalization that is determined to be indicative of a reduction in fair value of our reporting unit, we may be required to record future impairment charges for purchased intangible assets. Impairment charges could materially decrease our future net income and result in lower asset values on our balance sheet.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">                                                                                                                                                                                          </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our provision for income taxes, deferred tax assets and liabilities, and reserves for unrecognized tax benefits reflect our best assessment of estimated future taxes to be paid. Significant judgments and estimates based on interpretations of existing tax laws or regulations in the United States are required in determining our provision for income taxes. Changes in tax laws, statutory tax rates, and estimates of our future taxable income could impact the deferred tax assets and liabilities provided for in the consolidated financial statements and would require an adjustment to the provision for income taxes. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets are regularly assessed to determine the likelihood they will be recovered from future taxable income. A valuation allowance is established when we believe it is more likely than not the future realization of all or some of a deferred tax asset will not be achieved. In evaluating our ability to recover deferred tax assets within the jurisdiction which they arise, we consider all available positive and negative evidence. Factors reviewed include the cumulative pre-tax book income for the past three years, scheduled reversals of deferred tax liabilities, our history of earnings and reliability of our forecasts, projections of pre-tax book income over the foreseeable future, and the impact of any feasible and prudent tax planning strategies. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the impact of a tax position in our financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Tax authorities regularly examine our returns in the jurisdictions in which we do business and we regularly assess the tax risk of our return filing positions. Due to the complexity of some of the uncertainties, the ultimate resolution may result in payments that are materially different from our current estimate of the tax liability. These differences, as well as any interest and penalties, will be reflected in the provision for income taxes in the period in which they are determined.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measure and recognize compensation expense for all share-based payments, including restricted stock, ESPP and stock options, based on the estimated fair value. Restricted stock unit (RSU) and performance stock unit (PSU) are all considered restricted stock. The fair value of restricted stock is determined by the closing market price of our common stock on the date of grant. We recognize share-based compensation expense based on the fair value on a straight-line basis over the requisite service periods of the awards, taking into consideration of forfeitures as they occur. A PSU generally represents a right to receive a certain number of shares of common stock based on the achievement of corporate performance goals and continued employment during the vesting period. At each reporting period, we reassess the probability of the achievement of such corporate performance goals and any expense change resulting from an adjustment in the estimated shares to be released are treated as a cumulative catch-up in the period of adjustment. A limited amount of PSUs contain a market condition dependent upon the Company&#8217;s relative and absolute total stockholder return over a three-year period, with a range of 0% to 200% of the target amount granted to be issued under the award. Share-based compensation expense for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the market conditions.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion and Modification of Equity Awards Outstanding at Separation Date</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the OmniAb Separation on November 1, 2022, under the provisions of the existing plans, we adjusted our outstanding equity awards in accordance with the Merger Agreement to preserve the intrinsic value of the awards immediately before and after the Distribution. Upon the Distribution, employees holding stock options, restricted stock units </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and performance restricted stock units denominated in pre-Distribution Ligand stock received a number of otherwise-similar awards either in post-Distribution Ligand stock or in a combination of post-Distribution Ligand stock and OmniAb stock based on conversion ratios outlined for each group of employees in the Merger Agreement that we entered into in connection with the Distribution. The equity awards that were granted prior to March 2, 2022 were converted under the shareholder method, wherein employees holding outstanding equity awards received equity awards in both Ligand and OmniAb. For equity awards granted after March 2, 2022, for Ligand employees, the number of awards that were outstanding at the Separation were proportionately adjusted into post-Distribution Ligand stock to maintain the aggregate intrinsic value of the awards at the date of the Separation; for OmniAb employees, the number of awards that were outstanding at the Separation were proportionately adjusted into post-Distribution OmniAb stock to maintain the aggregate intrinsic value of the awards at the date of the Separation. The conversion ratio was determined based on the relative values of Ligand common stock in the &#8220;regular way&#8221; and &#8220;ex-distribution&#8221; markets during the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">five-trading day period prior to the closing of the business combination.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These modified awards otherwise retained substantially the same terms and conditions, including term and vesting provisions. Additionally, we will not incur any future compensation cost related to equity awards held by OmniAb employees and directors. We will incur future compensation cost related to OmniAb equity awards held by our employees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the summary of recent accounting pronouncements applicable to our consolidated financial statements, see &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 8. Financial Statements and Supplementary Data&#8212;Notes to Consolidated Financial Statements&#8212;Note (1), Basis of Presentation and Summary of Significant Accounting Policies.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="text-indent:27pt"><span><br/></span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_52"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:9.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.050%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quantitative and Qualitative Disclosures About Market Risk</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to market risk from interest rates and equity prices which could affect our results of operations, financial condition and cash flows. We manage our exposure to these market risks through our regular operating and financing activities.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment Portfolio Risk</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, our investment portfolio included investments in available-for-sale securities of $166.9 million, including the investment in Viking common stock of $63.1 million. These securities are subject to market risk and may decline in value based on market conditions.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Price Risk</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our 2023 Notes include conversion and settlement provisions that are based on the price of our common stock at conversion or maturity of the notes, as applicable. As of December&#160;31, 2022, the &#8220;if-converted value&#8221; did not exceed the principal amount of the 2023 Notes. See detail in &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 8. Financial Statements and Supplementary Data&#8212;Notes to Consolidated Financial Statements&#8212;Note (7), Convertible Senior Notes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Risk</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our licensing and business operations, we are exposed to foreign currency risk. Foreign currency exposures arise from transactions denominated in a currency other than the functional currency and from foreign denominated revenues and profit translated into U.S. dollars. Our license partners sell our products worldwide in currencies other than the U.S. dollar. Because of this, our revenues from royalty payments are subject to risk from changes in exchange rates. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We purchase Captisol from Hovione, located in Lisbon, Portugal. Payments to Hovione are denominated and paid in U.S. dollars; however, the unit price of Captisol contains an adjustment factor which is based on the sharing of foreign currency risk between the two parties. The effect of an immediate 10% change in foreign exchange rates would not have a material impact on our financial condition, results of operations or cash flows. We do not currently hedge our exposures to foreign currency fluctuations.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to changes in interest rates related primarily to our investment portfolio. Our investment policy and strategy are focused on the preservation of capital and supporting our liquidity requirements. We use a combination of internal and external management to execute our investment strategy. We typically invest in highly rated securities, with the primary objective of minimizing the risk of principal loss. Our investment policy generally requires securities to be investment grade and limits the amount of credit exposure to any one issuer. We have historically maintained a relatively short average maturity for our investment portfolio, and we believe a hypothetical 100 basis point adverse move in interest rates across all maturities would not materially impact the fair market value of the portfolio in either period. </span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_55"></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:9.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.050%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Financial Statements and Supplementary Data</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_58"></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:94.061%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.739%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_61">Report of Independent Registered Public Accounting Firm</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (PCAOB ID: <ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV81OC9mcmFnOjFjNDE1NjZmMWJhYTRlODg4ZWIxMTE5OTkxNmQ3NGZlL3RhYmxlOmJjZTBkODY0NGM4YzQxMjI5NDdhZGZmZWY0NzMzNzYxL3RhYmxlcmFuZ2U6YmNlMGQ4NjQ0YzhjNDEyMjk0N2FkZmZlZjQ3MzM3NjFfMS0wLTEtMS0xMTI2NDAvdGV4dHJlZ2lvbjplYWJiMGE3YjgxMTk0ZTc1YjdmMjNiZThmOGE2Njg2ZV83Mg_67b74a41-13bf-4e51-8abf-2a49ac6aeff6">42</ix:nonNumeric>)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_61">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_64">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_64">50</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_67">Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_67">50</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_70">Consolidated Statements of Comprehensive Income (Loss)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_70">51</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_73">Consolidated Statements of Stockholders&#8217; Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_73">53</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_76">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_76">53</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_79">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_79">55</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="i98e6b87576d6446486a3b29533a5cf6a_61"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To the Stockholders and the Board of Directors of Ligand Pharmaceuticals Incorporated</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Ligand Pharmaceuticals Incorporated (the Company) as of December 31, 2022 and 2021, and the related consolidated statements of operations, comprehensive income (loss), stockholders&#8217; equity and cash flows for each of the three years in the period ended December 31, 2022, and the related notes, (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2022, in conformity with U.S. generally accepted accounting principles.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated February&#160;28, 2023 expressed an unqualified opinion thereon.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Critical Audit Matter</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of the critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matter or on the accounts or disclosures to which they relate.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.966%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.188%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Impairment assessment of finite-lived intangibles </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Description of the Matter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2022, the Company&#8217;s finite-lived intangible assets totaled $342.5 million. As discussed in Note 1 to the consolidated financial statements, the Company reviews finite-lived intangible assets for impairment whenever events or changes in circumstances indicate the carrying amount may not be recoverable.  The Company did not identify indicators of impairment for its finite-lived intangibles at December 31, 2022. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Auditing management&#8217;s assessment of impairment is challenging due to the degree of subjective auditor judgment necessary in evaluating management&#8217;s process to identify  potential indicators of impairment and the related assessment of the severity of such indicators in determining whether a triggering event has occurred. A high degree of auditor judgment was required to evaluate  potential triggering events which included market conditions, industry and economic trends, changes in regulations, clinical success and historical and forecasted financial results. The evaluation of triggering events could have a significant effect on the Company&#8217;s impairment assessment and the determination of whether further quantitative analysis of finite-lived intangible assets was required.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">How We Addressed the Matter in Our Audit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtained an understanding of management&#8217;s process to identify indicators of impairment, including the qualitative analysis and related inputs and assumptions used in performing the analyses. We evaluated the design and tested the operating effectiveness of the controls that address the identification of indicators of impairment. For example, we tested controls over management&#8217;s assessment of indicators of impairment. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To test the Company&#8217;s evaluation of indicators of impairment for finite-lived intangibles, our audit procedures included, among others, assessing the methodologies and testing the completeness and accuracy of the Company&#8217;s analysis of events or changes in circumstances. As part of our evaluation, we considered market conditions, industry and economic trends, changes in regulations, clinical success and historical and forecasted financial results, in assessing whether an indicator of impairments exists.</span></div><div><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assigning Goodwill in connection with the spin off of the OmniAb business <br/></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Description of the Matter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 2 to the consolidated financial statements, in March 2022, the Company entered an agreement to spin off the Company's OmniAb business.  Coinciding with the signing of the agreement, the Company reorganized its reporting structure requiring the assignment of goodwill from the existing reporting unit to two reporting units. Management assigned goodwill using a relative fair value allocation which resulted in goodwill of $75.5 million being allocated to the OmniAb business.  <br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Auditing management&#8217;s assignment  of goodwill was complex due to  the significant judgement used by management when developing the fair value measurement of the reporting units, including the subjectivity involved in the selection of key assumptions related to estimating revenue and discount rates.<br/></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">How We Addressed the Matter in Our Audit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company&#8217;s assignment of goodwill based on the relative fair value of reporting units. For example, we tested controls over management&#8217;s determination of reporting units and management&#8217;s review of the significant assumptions described above along with the completeness and accuracy of the data used in these fair value estimates.<br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To test the estimated fair value of the reporting units, our audit procedures included, among others, (i) assessing the suitability and application of the valuation methodologies selected, (ii) evaluating the significant assumptions, discussed above, and (iii) testing the underlying data used by the Company in its analysis. For example, we compared the significant assumptions used by management, to current industry and economic trends.  We assessed the historical accuracy of management&#8217;s estimates and performed a sensitivity analysis of significant assumptions to evaluate the changes in the fair value of the reporting units that result from changes in assumptions.  We also involved our valuation specialists to assist in the evaluation of the weighted-average cost of capital utilized in determining the fair value estimates.  We tested the allocation of goodwill to the reporting units.   We also evaluated the related  disclosures.</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ <ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82MS9mcmFnOjYzYjliNDM5NTU4NDQ4MjM5NGZhMmQ4NzVjMjdiMjdiL3RleHRyZWdpb246NjNiOWI0Mzk1NTg0NDgyMzk0ZmEyZDg3NWMyN2IyN2JfMzU2MQ_3c3d4c32-3136-4f2f-97c1-2beb9363ed19">Ernst&#160;&amp; Young&#160;LLP</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company's auditor since 2016.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82MS9mcmFnOjYzYjliNDM5NTU4NDQ4MjM5NGZhMmQ4NzVjMjdiMjdiL3RleHRyZWdpb246NjNiOWI0Mzk1NTg0NDgyMzk0ZmEyZDg3NWMyN2IyN2JfMzU2Mw_9bc92b44-7800-46ec-8f1e-3ab7a2ae79dc">San Diego, California</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;28, 2023</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="i98e6b87576d6446486a3b29533a5cf6a_64"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except par value)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:72.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.528%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.530%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfNC0xLTEtMS0xMTI2NDA_0ba6f04e-d6e5-4c48-b0f9-7c456478341a">45,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfNC0zLTEtMS0xMTI2NDA_623472f1-1e8a-41e3-86c4-4de1af4f5cc6">19,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfNS0xLTEtMS0xMTI2NDA_4ac9f862-5fb4-499e-8814-34081f84e689">166,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfNS0zLTEtMS0xMTI2NDA_244219af-50a5-4f66-89c6-2adae2cdc8ff">321,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfNi0xLTEtMS0xMTI2NDA_9b0bd8cd-d185-4fa4-88f8-281777c87a57">30,424</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfNi0zLTEtMS0xMTI2NDA_f1be9f7b-6d2e-4014-ac5f-bfbd3495e248">85,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfNy0xLTEtMS0xMTI2NDA_d42453db-3165-48ec-be04-0c8b0f41d38d">13,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfNy0zLTEtMS0xMTI2NDA_c1d4bc0c-5648-4797-a2d5-6f62d77bbe5d">27,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income taxes receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfOC0xLTEtMS0xMTI2NDA_029ad174-4be4-481e-b139-09b6e9979dde">4,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfOC0zLTEtMS0xMTI2NDA_fbf0a3e5-eaf6-4ab6-83d0-274d685f4e2a">6,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfOS0xLTEtMS0xMTI2NDA_11c39aaa-0452-41ad-9fe4-9d3b24e3cf42">3,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfOS0zLTEtMS0xMTI2NDA_e8074175-a335-481b-be46-2e72d5c8e581">3,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current assets of discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTAtMS0xLTEtMTE2Mzcx_42b0e1e9-31fd-4976-9bd1-87e4277d8507">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTAtMy0xLTEtMTE2Mzc0_922db2a4-ed47-4287-9a65-e72001859f63">1,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTAtMS0xLTEtMTEyNjQw_e1bdd2c2-7aaa-4402-8f5d-f198e308102b">263,601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTAtMy0xLTEtMTEyNjQw_220de77a-e8c6-40fb-bd63-c70a617bf8e9">464,751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTEtMS0xLTEtMTEyNjQw_4e1c5da5-c1b4-4465-b53d-b91a7e97ae55">8,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTEtMy0xLTEtMTEyNjQw_93cb6b22-8d72-445d-9d39-6c9b8c512b37">35,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTItMS0xLTEtMTEyNjQw_b58c5282-7c64-4d09-91a2-4d02c4170afb">342,455</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTItMy0xLTEtMTEyNjQw_e3c439d4-e2b6-4dca-bbd9-97e5170286e8">376,691</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTMtMS0xLTEtMTEyNjQw_214f38af-8913-4314-804e-7f58f16452e7">105,673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTMtMy0xLTEtMTEyNjQw_8be9cb60-24ac-4541-a904-2928d06d217d">105,673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commercial license and other economic rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="lgnd:CommercialLicenseRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTQtMS0xLTEtMTEyNjQw_1d01c7cc-d48e-4988-ade2-21b020ceed85">10,182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="lgnd:CommercialLicenseRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTQtMy0xLTEtMTEyNjQw_b0dd51b9-e82f-4d2b-b1f8-338d69421c82">10,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTUtMS0xLTEtMTEyNjQw_1752cf54-9e65-4fed-b648-d1b3708efaea">12,482</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTUtMy0xLTEtMTEyNjQw_950e22b9-a3e6-4270-a326-4ed4d1864075">13,191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTYtMS0xLTEtMTEyNjQw_ed2f4cc5-1bf2-4564-ab69-ab098933ade0">10,914</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTYtMy0xLTEtMTEyNjQw_09fefe12-65dd-4c0c-8969-ec337b201edb">3,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTctMS0xLTEtMTEyNjQw_337d761c-718f-41b0-97c6-25d11ea3d137">4,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTctMy0xLTEtMTEyNjQw_205a7bb4-8b7c-44b2-8e9c-0b3a5a59c7e2">16,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTgtMS0xLTEtMTEyNjQw_bc7f8ef5-e1e1-4487-867c-9568d1f94f83">4,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTgtMy0xLTEtMTEyNjQw_d8a070dd-01ce-4905-9887-f994924d22ee">1,251</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-current assets of discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjAtMS0xLTEtMTE2Mzc2_d0aa78d7-c6a9-4d25-9b83-8578df10b2cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjAtMy0xLTEtMTE2Mzc4_21a122b3-9bae-49e1-989b-e8a18e8c8607">270,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTktMS0xLTEtMTEyNjQw_d1d63ae0-d7c7-4ff1-a67c-73f895609635">762,668</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTktMy0xLTEtMTEyNjQw_54eb1e0a-2b2c-49ef-80cc-860cdc03f549">1,297,590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY </span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjItMS0xLTEtMTEyNjQw_9ab477df-922b-4df3-9972-622af04e65d2">5,307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjItMy0xLTEtMTEyNjQw_b5e24296-f828-48fc-8bdc-98534ee19f66">8,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjMtMS0xLTEtMTEyNjQw_8cea5c21-0438-4b16-ab4f-b2712bfcaedf">15,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjMtMy0xLTEtMTEyNjQw_ca21393b-3a52-4ed3-aa36-47594bdf8bef">17,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="lgnd:CurrentPortionOfLiabilityForContingentValueRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjQtMS0xLTEtMTEyNjQw_f7912f66-63cf-4a74-8597-ce8c32c4e2cc">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="lgnd:CurrentPortionOfLiabilityForContingentValueRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjQtMy0xLTEtMTEyNjQw_1794fbe8-488e-43e4-a2dc-6510d3bb7a2b">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Deferred revenue   </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjUtMS0xLTEtMTEyNjQw_b064a6e2-4423-435b-9325-6d5db6e1f3fe">355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjUtMy0xLTEtMTEyNjQw_1abf7827-e76e-4d13-871f-683787ad8066">654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjYtMS0xLTEtMTEyNjQw_64e9501b-f5e9-4879-94e7-467d8b73e497">670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjYtMy0xLTEtMTEyNjQw_cd92ea14-83f9-41af-ae5d-b60933b6d5c0">1,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjctMS0xLTEtMTEyNjQw_e088b548-4dc6-42c0-9cef-9fc9c325f7cd">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjctMy0xLTEtMTEyNjQw_3e7b7987-de4f-40d5-aea0-50f2a2a98ac2">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023 convertible senior notes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:ConvertibleDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzEtMS0xLTEtMTE3NzIw_d753737c-e40b-4cd6-ac7b-ad0114aff87e">76,695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:ConvertibleDebtCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzEtMy0xLTEtMTE3NzMw_4628a2f5-c6a1-46b1-90e4-ca57d0cb1eb9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current liabilities of discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzAtMS0xLTEtMTE2Mzgw_bacfcb4d-b85f-4835-9438-a4dc0b824b24">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzAtMy0xLTEtMTE2Mzgy_a9058820-67c2-468e-bfc1-067955dd1989">13,566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjgtMS0xLTEtMTEyNjQw_259610f6-c916-45e5-9ff8-46e7de2aef86">98,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjgtMy0xLTEtMTEyNjQw_77a60440-b131-492f-abb0-6b3be2647aab">41,665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023 convertible senior notes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:ConvertibleDebtNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjktMS0xLTEtMTEyNjQw_566da830-d7ed-45c6-b5f9-e05024363b9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:ConvertibleDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjktMy0xLTEtMTEyNjQw_02c16771-88cf-4298-916e-db0e730e8b21">320,717</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="lgnd:LiabilityForContingentValueRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzAtMS0xLTEtMTEyNjQw_bba470e1-ba13-4d81-9080-b70e77bd0d04">3,456</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="lgnd:LiabilityForContingentValueRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzAtMy0xLTEtMTEyNjQw_00e18046-4cb4-4fab-99c5-e0fa1ad5b2f5">3,657</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzEtMS0xLTEtMTEyNjQw_6117fd88-698a-4f4d-b616-862cce0210a3">30,615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzEtMy0xLTEtMTEyNjQw_f16ac74b-5458-42b5-896b-fc1395e48fe6">30,856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzItMS0xLTEtMTEyNjQw_40991ea0-ff98-4653-ab6e-da653e49f042">10,336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzItMy0xLTEtMTEyNjQw_0a7c524c-1751-45c4-bef0-a1c5b77e8c53">2,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzMtMS0xLTEtMTEyNjQw_67e91ed4-6910-4881-bf36-a8e35b2e6c20">21,966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzMtMy0xLTEtMTEyNjQw_6be51cd7-c7a9-4e69-91b4-3c51c852e2bf">21,752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-current liabilities of discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzctMS0xLTEtMTE2Mzg0_2c9b5649-2699-461d-a84d-5cc72c9b1a55">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzctMy0xLTEtMTE2Mzg2_98281c5e-8c96-4477-a1ca-cd4cbe22001e">55,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzQtMS0xLTEtMTEyNjQw_b4a59116-1510-4bb1-b728-a2ae5da1f75a">165,183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzQtMy0xLTEtMTEyNjQw_18aba139-1d90-4717-87ff-616ae4f57e89">476,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzUtMS0xLTEtMTEyNjQw_91a6225b-1dc5-4a80-86f7-0f2592a6bb3f"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzUtMy0xLTEtMTEyNjQw_83112bf7-e34f-49ea-81bd-cbec49453a0d"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzctMC0xLTEtMTEyNjQwL3RleHRyZWdpb246MmMyYWRjNTg1M2UwNDZjMGI2MzMxNDQ0Nzk3MWUyYmJfMjc_2929aa6b-20a2-40ca-b29c-5cdae4581b38"><ix:nonFraction unitRef="usdPerShare" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzctMC0xLTEtMTEyNjQwL3RleHRyZWdpb246MmMyYWRjNTg1M2UwNDZjMGI2MzMxNDQ0Nzk3MWUyYmJfMjc_e3f5105d-9965-424e-bb01-3cd73690e612">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzctMC0xLTEtMTEyNjQwL3RleHRyZWdpb246MmMyYWRjNTg1M2UwNDZjMGI2MzMxNDQ0Nzk3MWUyYmJfNDE_1922bf50-7070-414a-85d3-e54f3d7fd2be"><ix:nonFraction unitRef="shares" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzctMC0xLTEtMTEyNjQwL3RleHRyZWdpb246MmMyYWRjNTg1M2UwNDZjMGI2MzMxNDQ0Nzk3MWUyYmJfNDE_bf5f61ab-85f9-4599-b545-2de9cc82e3a3">5,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzctMC0xLTEtMTEyNjQwL3RleHRyZWdpb246MmMyYWRjNTg1M2UwNDZjMGI2MzMxNDQ0Nzk3MWUyYmJfNjM_429dc88b-813b-469e-85f2-c76638820e07"><ix:nonFraction unitRef="shares" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzctMC0xLTEtMTEyNjQwL3RleHRyZWdpb246MmMyYWRjNTg1M2UwNDZjMGI2MzMxNDQ0Nzk3MWUyYmJfNjM_a2e8ef2e-0b43-4030-b311-2a66a69174a3"><ix:nonFraction unitRef="shares" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzctMC0xLTEtMTEyNjQwL3RleHRyZWdpb246MmMyYWRjNTg1M2UwNDZjMGI2MzMxNDQ0Nzk3MWUyYmJfNjM_b47f5d71-6376-43dd-813c-bec606210e84"><ix:nonFraction unitRef="shares" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzctMC0xLTEtMTEyNjQwL3RleHRyZWdpb246MmMyYWRjNTg1M2UwNDZjMGI2MzMxNDQ0Nzk3MWUyYmJfNjM_de970e5f-22fb-4ff2-89af-d6910b501abb">zero</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued and outstanding at December 31, 2022 and 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzctMS0xLTEtMTEyNjQw_5a0e59f8-58ac-4de8-a458-363cec6332d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzctMy0xLTEtMTEyNjQw_947a3660-19ec-497a-91f6-d0a3e761cfda">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzgtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246ZDViOGFlNjQ2MjA0NGU3NWEwMDA1ZTkzNDMzYjBmNGFfMTk_5bf8f9f9-93b9-4341-ac07-b0fee75a20f2"><ix:nonFraction unitRef="usdPerShare" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzgtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246ZDViOGFlNjQ2MjA0NGU3NWEwMDA1ZTkzNDMzYjBmNGFfMTk_fb0ec03b-bbb2-46ec-9e2d-80894424a468">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzgtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246ZDViOGFlNjQ2MjA0NGU3NWEwMDA1ZTkzNDMzYjBmNGFfMzM_d4948ec8-e48a-4382-9f6e-b4562582d3a5"><ix:nonFraction unitRef="shares" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzgtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246ZDViOGFlNjQ2MjA0NGU3NWEwMDA1ZTkzNDMzYjBmNGFfMzM_e14a602b-786b-490d-bb04-b05fee285366">60,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzgtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246ZDViOGFlNjQ2MjA0NGU3NWEwMDA1ZTkzNDMzYjBmNGFfNTU_017f959d-eede-4bbb-9efa-2ebfb7d750ba"><ix:nonFraction unitRef="shares" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzgtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246ZDViOGFlNjQ2MjA0NGU3NWEwMDA1ZTkzNDMzYjBmNGFfNTU_285f5ac9-5c8c-4373-86dd-611d36607895">16,951</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzgtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246ZDViOGFlNjQ2MjA0NGU3NWEwMDA1ZTkzNDMzYjBmNGFfNjI_77fcb6f4-fe8d-4255-a0b5-5dc00b926592"><ix:nonFraction unitRef="shares" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzgtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246ZDViOGFlNjQ2MjA0NGU3NWEwMDA1ZTkzNDMzYjBmNGFfNjI_ab67b6aa-a5ca-4c5b-adac-772596a8c46c">16,767</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December&#160;31, 2022 and 2021, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzgtMS0xLTEtMTEyNjQw_c9b2cc39-45ea-49a7-a856-a6adb16b42cf">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzgtMy0xLTEtMTEyNjQw_0e0ee862-5620-48fd-9399-454ed8f18b2f">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzktMS0xLTEtMTEyNjQw_ffda42fb-3142-497e-a954-4f3e6ae5b64d">147,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzktMy0xLTEtMTEyNjQw_244bf965-94ec-44de-b998-95991709c7f1">372,969</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfNDAtMS0xLTEtMTEyNjQw_13c6139f-a3d9-4ab2-bde6-bdf73adcd983">984</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfNDAtMy0xLTEtMTEyNjQw_2a63ccb1-6bd6-464b-a4c1-12cfefab9762">917</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfNDEtMS0xLTEtMTEyNjQw_110d1e10-9e8b-4073-9e1b-5a9a7e17ffc4">450,862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfNDEtMy0xLTEtMTEyNjQw_0f081060-7693-461c-88c5-99336980099c">449,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfNDItMS0xLTEtMTEyNjQw_8097b87b-7e7e-4e92-b16a-0654f8a42c47">597,485</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfNDItMy0xLTEtMTEyNjQw_5a1eaf47-75d7-4dd2-870a-982c65e18477">821,159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities and stockholders&#8217; equity </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfNDMtMS0xLTEtMTEyNjQw_43eddb34-c3c6-46e0-8c3d-54469b3e513c">762,668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfNDMtMy0xLTEtMTEyNjQw_a49ab76a-cf7a-4451-90bd-7d9fa24e0720">1,297,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to these consolidated financial statements.</span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_67"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share amounts)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:62.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.370%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.373%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Royalties</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91e01e3752fa4607875a52688c787ed4_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMy0xLTEtMS0xMTI2NDA_9136db05-d6fe-433a-868a-698f154643bd">72,527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7acccfdc49ae41ec9d81e2a77aaeab89_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMy0zLTEtMS0xMTI2NDA_b399f0e4-032c-4e2d-9bc9-56df934ba1a7">48,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8303bd1e530e4c06b3bb8c3093343f43_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMy01LTEtMS0xMTI2NDA_27a82ce6-40e9-4c80-bad8-82e932c35ae2">33,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Captisol</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if07332e474464098b61af13fe5a470f2_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfNC0xLTEtMS0xMTI2NDA_2968564b-fdaa-47b4-a930-0e4af76ed839">104,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6747a650dc714496a27ce80ca1fde353_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfNC0zLTEtMS0xMTI2NDA_4de27445-2d71-4207-8058-f51d94a24bf5">164,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i065c2ca723f44ed7b4161976d58b5fe9_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfNC01LTEtMS0xMTI2NDA_86b11669-80b4-4efc-be7a-678e4d3a4910">109,959</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a2c832b6c46461c9fa690319f44159f_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfNS0xLTEtMS0xMTI2NDA_75fb1545-b874-45b0-bb6d-9ff4270f442b">19,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6041ab2411645599b1e142a09232af6_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfNS0zLTEtMS0xMTI2NDA_d44e76f9-e2d2-4bad-995f-075789cddf35">28,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbbf2bd60ac64c15aa70a568639f50ab_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfNS01LTEtMS0xMTI2NDA_3c468781-341f-4236-a3e8-538ad4d721de">19,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfNi0xLTEtMS0xMTI2NDA_795801c6-eeef-4a0a-887c-d68f08d456dd">196,245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfNi0zLTEtMS0xMTI2NDA_1f429421-fbcb-4f44-b9c9-327f791a7a6e">241,544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfNi01LTEtMS0xMTI2NDA_6b104122-f148-4cc2-9007-508d9db8a971">163,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of Captisol</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:CostDirectMaterial" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfOC0xLTEtMS0xMTI2NDA_12692914-00b1-4d0c-9996-52d5bf3ccb3c">52,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:CostDirectMaterial" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfOC0zLTEtMS0xMTI2NDA_f83f46cf-7b3d-46e9-b911-c522fce88f8f">62,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:CostDirectMaterial" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfOC01LTEtMS0xMTI2NDA_c54874e4-2151-438e-bfe1-328a861ff386">30,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfOS0xLTEtMS0xMTI2NDA_d6a3e768-2b8f-4551-a474-e71368061f8f">34,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfOS0zLTEtMS0xMTI2NDA_dccdafb9-245e-4c65-b412-5e23fd5bdfbe">34,222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfOS01LTEtMS0xMTI2NDA_08c7fbac-eaa5-4910-bacf-02e6ba22ab1d">11,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTAtMS0xLTEtMTEyNjQw_9083861c-b153-477f-b1d8-9b91cdab36f7">36,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTAtMy0xLTEtMTEyNjQw_a76eb6e9-a494-4f70-b927-7ec33d0f5dcc">32,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTAtNS0xLTEtMTEyNjQw_6ad6d67a-ccf9-4d68-b0ad-8e9e9635a090">40,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTEtMS0xLTEtMTEyNjQw_5c95e674-2662-4ab9-a836-c88337c25f18">70,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTEtMy0xLTEtMTEyNjQw_034a343b-671d-48c5-806f-2fe07a3d5409">46,790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTEtNS0xLTEtMTEyNjQw_868668ee-c1af-4c5d-a8c7-36ad20e1139f">60,012</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other operating (income) expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:OtherOperatingIncomeExpenseNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTItMS0xLTEtMTEyNjQw_f048dc48-6f73-4673-961a-e70824c13830">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:OtherOperatingIncomeExpenseNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTItMy0xLTEtMTEyNjQw_93db6c2d-caa7-4f0a-b39e-723c36d90f98">37,600</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTItNS0xLTEtMTEyNjQw_75fa9fec-510e-4842-b1d4-f9550a384cf2">600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTMtMS0xLTEtMTEyNjQw_2b8e9296-69bf-4a56-9a80-a852159919e1">193,208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTMtMy0xLTEtMTEyNjQw_7e76eff5-2f25-48ea-abcb-9104eb5a8006">137,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTMtNS0xLTEtMTEyNjQw_afa20dc3-85a4-4b59-8c52-527ae2ac8e1c">143,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain from sale of Vernalis R&amp;D</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b86bff9b54f4d76bce0d4e8b7a8fb96_D20220101-20221231" decimals="-3" name="us-gaap:GainLossOnDispositionOfIntangibleAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTQtMS0xLTEtMTEyNjQw_5b135cfa-bbc6-4653-ba3c-62b220a91f33">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b297d5d47f94315a7c2461666a1e657_D20210101-20211231" decimals="-3" name="us-gaap:GainLossOnDispositionOfIntangibleAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTQtMy0xLTEtMTEyNjQw_6e582e2e-710c-418a-9206-818a681409b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccc4fa061bfd4f28acff3954baafb1a4_D20200101-20201231" decimals="-3" name="us-gaap:GainLossOnDispositionOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTQtNS0xLTEtMTEyNjQw_a6040ee5-a047-42c3-8892-c890d4c3f561">17,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTYtMS0xLTEtMTEyNjQw_4951fddf-973c-4ee3-8f91-0f24a736914a">3,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTYtMy0xLTEtMTEyNjQw_84afe9df-422a-4667-857d-b40ec1f3d13b">103,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTYtNS0xLTEtMTEyNjQw_0256f173-c849-48e8-a92e-28bc35d0b0b8">37,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) from short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTgtMS0xLTEtMTEyNjQw_29e784e7-eda8-40db-8e46-e26374412f3e">28,540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTgtMy0xLTEtMTEyNjQw_1edc0740-1442-44d3-bbbc-29d6fc9285a5">5,263</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTgtNS0xLTEtMTEyNjQw_e9492b1e-675e-476a-a6df-c261060b4ed4">16,933</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTktMS0xLTEtMTEyNjQw_60b996ae-ad3b-44cc-bd49-24634e70166f">2,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTktMy0xLTEtMTEyNjQw_b3c371df-306b-4113-ab8a-ea0785901eae">886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTktNS0xLTEtMTEyNjQw_c3999307-efbc-4ac2-8c68-0bd2f8d1a1be">8,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjAtMS0xLTEtMTEyNjQw_a74fc40d-14c8-479a-ac2a-c25d41f5d7cd">1,799</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjAtMy0xLTEtMTEyNjQw_3c0cd6b3-e407-4e62-a7a1-9d81a1074fe8">19,619</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjAtNS0xLTEtMTEyNjQw_4ce60ef8-93a6-4fe6-a199-22181456eac1">27,415</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjEtMS0xLTEtMTEyNjQw_6725094d-f492-4885-b35d-853be892a8ef">4,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjEtMy0xLTEtMTEyNjQw_885e8416-05fb-4100-afe6-c2df17cb7ffb">7,650</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjEtNS0xLTEtMTEyNjQw_949e728d-7a0b-4b52-95e4-4a26665b8b7f">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other expense, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjItMS0xLTEtMTEyNjQw_f378a89b-3f32-4bc6-8ada-e147ceda49a6">32,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjItMy0xLTEtMTEyNjQw_506317bb-e413-42e5-b30c-940a14e276ef">31,646</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjItNS0xLTEtMTEyNjQw_b489cc50-9beb-44a9-9b0b-100331bfdd2c">36,208</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income before income tax from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjMtMS0xLTEtMTEyNjQw_ffbe9279-1ce5-4375-b684-3728ab08a089">36,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjMtMy0xLTEtMTEyNjQw_ea5c5fe8-e8bc-4dff-8394-e1875511e156">72,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjMtNS0xLTEtMTEyNjQw_1e0b7c77-d306-427f-a86e-cdb5db906d30">1,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjQtMS0xLTEtMTEyNjQw_8e6edaf3-cd82-43bb-9403-e0d75d7fe65c">41,230</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjQtMy0xLTEtMTEyNjQw_be3d2fdd-6bf1-48c6-9cdc-bda91e9e4ce7">4,148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjQtNS0xLTEtMTEyNjQw_0707fae0-12ec-476e-a828-82d31603f223">5,306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjUtMS0xLTEtMTE2NDA4_640fce1e-7ae8-40fe-a3d1-08b6cc75d4f4">5,219</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjUtMy0xLTEtMTE0NjY2_cd6b69cc-8aa9-4a73-9f87-517c8d90cad2">76,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjUtNS0xLTEtMTE0NjY3_57f8da30-a609-4efe-bf25-93006d1fd9e4">6,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjYtMS0xLTEtMTE2NDA4_7f0da51b-f7e5-49d0-9e54-87865cc6d66e">28,142</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjYtMy0xLTEtMTE0NDY4_7891a66d-7cd2-48b3-83e4-ba295824b630">19,215</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjYtNS0xLTEtMTE0Njc2_7d3959e4-58d3-450b-b291-827bc41ba761">9,583</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net income (loss):</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjUtMS0xLTEtMTEyNjQw_70098963-ea30-4b9c-a1ac-784f4adff177">33,361</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjUtMy0xLTEtMTEyNjQw_7feb0c63-e093-4cf2-be85-964e49f35626">57,138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjUtNS0xLTEtMTEyNjQw_060a35ae-e38f-40b4-90ac-d8159b45a2fb">2,985</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic net income (loss) from continuing operations per share</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjgtMS0xLTEtMTE2NDEw_2f19cc7d-b7d4-4506-be70-1672ac6a5c92">0.31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjgtMy0xLTEtMTE0Njk4_3d85e797-a1ab-41b4-bc06-f5b3005526f2">4.59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjgtNS0xLTEtMTE0Njk5_dcf6f404-7752-44aa-a33b-a13b8f146fc0">0.41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic net loss from discontinued operations per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjktMS0xLTEtMTE2NDEw_e482bc17-58e0-4fa4-9115-87fef9a286f3">1.67</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjktMy0xLTEtMTE0Njk4_b65f96ca-acdd-4bfa-ad20-2f953075e45e">1.16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjktNS0xLTEtMTE0Njk5_f60af717-674c-4daa-8412-fd73180fc338">0.59</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic net income (loss) per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjctMS0xLTEtMTEyNjQw_40937e9f-03ac-4b35-bbbf-bde99174c621">1.98</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjctMy0xLTEtMTEyNjQw_3312272f-3be5-4f7b-87cd-2b63e7419f4a">3.44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjctNS0xLTEtMTEyNjQw_c2517511-d574-42fb-9e94-0c2d5b480d20">0.18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares used in basic per share calculation</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjgtMS0xLTEtMTEyNjQw_d84f4b79-d4ec-48a8-a992-94f04dc1659e">16,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjgtMy0xLTEtMTEyNjQw_5186eaaa-80e1-4f08-a8a5-ca70ededd5c6">16,630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjgtNS0xLTEtMTEyNjQw_11b5457d-499c-47a1-b958-2abe7baceac7">16,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted net income (loss) from continuing operations per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMzMtMS0xLTEtMTE2NDEy_0ef7d14e-aece-4765-8ebf-3f80f5802a5e">0.31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMzMtMy0xLTEtMTE0NzI2_d5a801c0-bf8f-4694-8eb2-d43254182f81">4.43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMzMtNS0xLTEtMTE0NzI3_7a1479ce-60e5-4aad-bb3c-3c2f8f01bd14">0.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted net loss from discontinued operations per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMzQtMS0xLTEtMTE2NDEy_6e9badc7-3489-4a05-9b45-e837eb9b29da">1.67</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMzQtMy0xLTEtMTE0NzI2_20fd674a-305b-494f-b4cd-d0cab34d2809">1.11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMzQtNS0xLTEtMTE0NzI3_b9727723-f7ab-4c21-80be-1231bb841687">0.57</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted net income (loss) per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMzAtMS0xLTEtMTEyNjQw_e641e773-a6e3-48d4-92c7-faec9ef9fd57">1.98</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMzAtMy0xLTEtMTEyNjQw_51e2c2ee-4cd5-47a9-b046-f27e236a79cb">3.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMzAtNS0xLTEtMTEyNjQw_3d86e432-1192-44eb-9a4b-889f103d62db">0.18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares used in diluted per share calculation</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMzgtMS0xLTEtMTIwNDM1_34042a6a-1763-4f6f-beea-7fcc0fac02d1">16,868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMzgtMy0xLTEtMTIwNDM3_4da3fd83-78c6-449b-931b-87bd7767c56f">17,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMzgtNS0xLTEtMTIwNDQw_6843a985-8bef-465d-914a-a9ccde1f49d1">16,825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><span><br/></span></div><div style="margin-top:3pt"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to these consolidated financial statements.</span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_70"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:67.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83MC9mcmFnOjg2Y2RmZTczZTc3ODQ5MmM5OWZmYjg1ODM3ODA2ZjIxL3RhYmxlOjhlYmQyOGMxMzA1ZjQxOTE4MjgzZWI0ZTA4NmZmNzI1L3RhYmxlcmFuZ2U6OGViZDI4YzEzMDVmNDE5MTgyODNlYjRlMDg2ZmY3MjVfMi0xLTEtMS0xMTI2NDA_c2beb80c-5c80-40ec-a3b8-d80a066e6c94">33,361</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83MC9mcmFnOjg2Y2RmZTczZTc3ODQ5MmM5OWZmYjg1ODM3ODA2ZjIxL3RhYmxlOjhlYmQyOGMxMzA1ZjQxOTE4MjgzZWI0ZTA4NmZmNzI1L3RhYmxlcmFuZ2U6OGViZDI4YzEzMDVmNDE5MTgyODNlYjRlMDg2ZmY3MjVfMi0zLTEtMS0xMTI2NDA_5748b1c5-5dbe-45c8-851b-6a3d31f083c9">57,138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83MC9mcmFnOjg2Y2RmZTczZTc3ODQ5MmM5OWZmYjg1ODM3ODA2ZjIxL3RhYmxlOjhlYmQyOGMxMzA1ZjQxOTE4MjgzZWI0ZTA4NmZmNzI1L3RhYmxlcmFuZ2U6OGViZDI4YzEzMDVmNDE5MTgyODNlYjRlMDg2ZmY3MjVfMi01LTEtMS0xMTI2NDA_429c6b04-6379-4b0c-88a6-802075591af1">2,985</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized net gain (loss) on available-for-sale securities, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83MC9mcmFnOjg2Y2RmZTczZTc3ODQ5MmM5OWZmYjg1ODM3ODA2ZjIxL3RhYmxlOjhlYmQyOGMxMzA1ZjQxOTE4MjgzZWI0ZTA4NmZmNzI1L3RhYmxlcmFuZ2U6OGViZDI4YzEzMDVmNDE5MTgyODNlYjRlMDg2ZmY3MjVfMy0xLTEtMS0xMTI2NDA_133b5354-87c6-4d5e-a9ec-307081261dee">67</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83MC9mcmFnOjg2Y2RmZTczZTc3ODQ5MmM5OWZmYjg1ODM3ODA2ZjIxL3RhYmxlOjhlYmQyOGMxMzA1ZjQxOTE4MjgzZWI0ZTA4NmZmNzI1L3RhYmxlcmFuZ2U6OGViZDI4YzEzMDVmNDE5MTgyODNlYjRlMDg2ZmY3MjVfMy0zLTEtMS0xMTI2NDA_d3820c47-39b8-4073-83be-601cc4cacdc4">116</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83MC9mcmFnOjg2Y2RmZTczZTc3ODQ5MmM5OWZmYjg1ODM3ODA2ZjIxL3RhYmxlOjhlYmQyOGMxMzA1ZjQxOTE4MjgzZWI0ZTA4NmZmNzI1L3RhYmxlcmFuZ2U6OGViZDI4YzEzMDVmNDE5MTgyODNlYjRlMDg2ZmY3MjVfMy01LTEtMS0xMTI2NDA_0c7f3666-d6dd-40c4-ae63-92bad7260c8d">162</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83MC9mcmFnOjg2Y2RmZTczZTc3ODQ5MmM5OWZmYjg1ODM3ODA2ZjIxL3RhYmxlOjhlYmQyOGMxMzA1ZjQxOTE4MjgzZWI0ZTA4NmZmNzI1L3RhYmxlcmFuZ2U6OGViZDI4YzEzMDVmNDE5MTgyODNlYjRlMDg2ZmY3MjVfNC0xLTEtMS0xMTI2NDA_2339c26c-f908-4f40-8fb7-e8edcc15d927">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83MC9mcmFnOjg2Y2RmZTczZTc3ODQ5MmM5OWZmYjg1ODM3ODA2ZjIxL3RhYmxlOjhlYmQyOGMxMzA1ZjQxOTE4MjgzZWI0ZTA4NmZmNzI1L3RhYmxlcmFuZ2U6OGViZDI4YzEzMDVmNDE5MTgyODNlYjRlMDg2ZmY3MjVfNC0zLTEtMS0xMTI2NDA_01b69bac-2f55-4677-9f0e-3f4acf17eef3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83MC9mcmFnOjg2Y2RmZTczZTc3ODQ5MmM5OWZmYjg1ODM3ODA2ZjIxL3RhYmxlOjhlYmQyOGMxMzA1ZjQxOTE4MjgzZWI0ZTA4NmZmNzI1L3RhYmxlcmFuZ2U6OGViZDI4YzEzMDVmNDE5MTgyODNlYjRlMDg2ZmY3MjVfNC01LTEtMS0xMTI2NDA_ba704259-78ed-4cb0-b018-97861642905c">423</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83MC9mcmFnOjg2Y2RmZTczZTc3ODQ5MmM5OWZmYjg1ODM3ODA2ZjIxL3RhYmxlOjhlYmQyOGMxMzA1ZjQxOTE4MjgzZWI0ZTA4NmZmNzI1L3RhYmxlcmFuZ2U6OGViZDI4YzEzMDVmNDE5MTgyODNlYjRlMDg2ZmY3MjVfNS0xLTEtMS0xMTI2NDA_bd6b1cb7-a98b-44f3-8c42-21d01ad89f09">33,428</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83MC9mcmFnOjg2Y2RmZTczZTc3ODQ5MmM5OWZmYjg1ODM3ODA2ZjIxL3RhYmxlOjhlYmQyOGMxMzA1ZjQxOTE4MjgzZWI0ZTA4NmZmNzI1L3RhYmxlcmFuZ2U6OGViZDI4YzEzMDVmNDE5MTgyODNlYjRlMDg2ZmY3MjVfNS0zLTEtMS0xMTI2NDA_0ef577a2-6187-492c-a3c3-60e0fac63a94">57,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83MC9mcmFnOjg2Y2RmZTczZTc3ODQ5MmM5OWZmYjg1ODM3ODA2ZjIxL3RhYmxlOjhlYmQyOGMxMzA1ZjQxOTE4MjgzZWI0ZTA4NmZmNzI1L3RhYmxlcmFuZ2U6OGViZDI4YzEzMDVmNDE5MTgyODNlYjRlMDg2ZmY3MjVfNS01LTEtMS0xMTI2NDA_8b2f6ad1-2981-45b1-8b20-b05f00b04bf4">3,570</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to these consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">52</span></div></div></div><div id="i98e6b87576d6446486a3b29533a5cf6a_73"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENT OF STOCKHOLDERS&#8217; EQUITY </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.287%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Additional</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">paid-in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">capital</span></div></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">comprehensive</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">income (loss)</span></div></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Retain earnings</span></div></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">stockholders&#8217;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">equity</span></div></td></tr><tr style="height:10pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i357eff174d874e71a3e0da8d3f8ba240_I20191231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTAtMS0xLTEtMTEyNjQw_05b61c2d-a321-4a08-a236-8b62cb480f90">16,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i357eff174d874e71a3e0da8d3f8ba240_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTAtMy0xLTEtMTEyNjQw_5fc60741-ac9a-46d1-b652-2fbdb194fb62">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie900f916c5ce4b118f337c7cd5784087_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTAtNS0xLTEtMTEyNjQw_16d655ac-d0c0-483a-b160-923bd82cb760">367,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55fd66c34dcf459fa6f35389d1c92e7d_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTAtNy0xLTEtMTEyNjQw_2f712b9b-7ec5-48fe-8692-161290a7e719">216</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b902bcb600d40ed842e738be013d24e_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTAtOS0xLTEtMTEyNjQw_19f0f239-ce45-4106-a2c0-903542fba632">400,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i859e9607437a43d8adb4d3dc08e60773_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTAtMTEtMS0xLTExMjY0MA_0324a173-4fbd-4cde-9223-e22b0f9b266c">767,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie94bcf078bda4c3095feb1fef072c734_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTEtMS0xLTEtMTEyNjQw_8e4abb10-5106-43a8-b156-169e902ffbc7">190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0325d2944844148b93606f4579a387f_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTEtNS0xLTEtMTEyNjQw_45e37ad0-f995-4956-9bd4-0460baceb6a8">1,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTEtMTEtMS0xLTExMjY0MA_af3189e5-c772-440a-ac11-a61e76f3d41a">1,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0325d2944844148b93606f4579a387f_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTItNS0xLTEtMTEyNjQw_6f86643e-edde-4b49-a220-9c3965a472b0">30,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTItMTEtMS0xLTExMjY0MA_5e033a9a-603d-4f96-b922-f0952da86cff">30,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ie94bcf078bda4c3095feb1fef072c734_D20200101-20201231" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTMtMS0xLTEtMTEyNjQw_9ab58eb1-1232-4858-9402-e021898385f9">934</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie94bcf078bda4c3095feb1fef072c734_D20200101-20201231" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTMtMy0xLTEtMTEyNjQw_e8107821-1b54-4f27-92fe-d148df154e97">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0325d2944844148b93606f4579a387f_D20200101-20201231" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTMtNS0xLTEtMTEyNjQw_eaddce50-e154-4c07-911c-b8d630c7585a">77,997</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTMtMTEtMS0xLTExMjY0MA_4dfe5509-8f9d-4d57-b594-7dbff0f321a3">77,998</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Unrealized net loss on available-for-sale securities, net of deferred tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb599d49cd844079adbdcf3fbcea1bf6_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTQtNy0xLTEtMTEyNjQw_f2a2ed2a-85ac-4725-a81a-d1b7832a47f3">162</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTQtMTEtMS0xLTExMjY0MA_ed7f2217-294e-427e-b1fd-9b7b6a04da38">162</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb599d49cd844079adbdcf3fbcea1bf6_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTUtNy0xLTEtMTEyNjQw_69ab91a2-2de6-4b74-9ebf-e93242b44911">423</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTUtMTEtMS0xLTExMjY0MA_a8bbae45-c37a-4de6-a188-29d7a2a430d4">423</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Reacquisition of equity due to 2023 debt extinguishment, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0325d2944844148b93606f4579a387f_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTYtNS0xLTEtMTEyNjQw_428d374a-6ca5-4432-92ac-491689fd0af2">3,236</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTYtMTEtMS0xLTExMjY0MA_8d936c10-4ffb-4e97-b839-fa8aa9fd83e6">3,236</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTctMC0xLTEtMTEyNjQw_3be36137-77b0-489a-9749-cfb3e877f98b">Cumulative-effect adjustment from adoption of&#160;ASU 2016-13, net of tax</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib307560c9d0a46168d9fc559bfdf76db_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTctOS0xLTEtMTEyNjQw_84670c3c-0dd3-45a8-b65b-47b2c8b88b72">5,168</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadc71aaacd92446fa2fa49e3a0be8871_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTctMTEtMS0xLTExMjY0MA_417e3d01-8201-4e39-be75-ca3d0675809b">5,168</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other tax adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0325d2944844148b93606f4579a387f_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTgtNS0xLTEtMTEyNjQw_1850fc86-edbe-4dd3-8d16-69348ffcf312">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTgtMTEtMS0xLTExMjY0MA_4463d6e2-82bf-46cd-a2f7-8d0ca49fb3dc">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTktOS0xLTEtMTEyNjQw_25687bcd-709b-4158-abb4-0ebbe817da27">2,985</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTktMTEtMS0xLTExMjY0MA_12b5c522-4782-4499-aab3-6434177077c1">2,985</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8b2e2abd1a8f48cbb470a39e45b33d50_I20201231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjAtMS0xLTEtMTEyNjQw_22d733c7-86f4-4baa-90eb-bd8240cb7a1a">16,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2e2abd1a8f48cbb470a39e45b33d50_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjAtMy0xLTEtMTEyNjQw_a62789d6-b974-42a1-add1-fd789d0ffe79">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d465be99a3842c397fabfc41d61594f_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjAtNS0xLTEtMTEyNjQw_a3ee104d-bf57-43ec-a8d6-8ea1bfd7cda9">318,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ea688d541394c9693a42fb9c6332aea_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjAtNy0xLTEtMTEyNjQw_d41da730-3fb3-4417-b875-bcf7db45f842">801</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1632e4f73e14852bc153b6b86f8ac63_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjAtOS0xLTEtMTEyNjQw_c820edeb-6acf-490c-a0c7-3c741e795c43">391,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjAtMTEtMS0xLTExMjY0MA_6ac43e0d-d45c-46d4-9e20-241122d0d094">709,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id7184134d4134a439ed750ceb1bd33ec_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjEtMS0xLTEtMTEyNjQw_0171728d-41a6-4747-8ff0-172991e5c2e2">687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7184134d4134a439ed750ceb1bd33ec_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjEtMy0xLTEtMTEyNjQw_0a3e1d2e-1f73-4034-b087-74096ccc49c9">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fe34795168e4efab32422048060cbb7_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjEtNS0xLTEtMTEyNjQw_33314f87-0acc-4cb2-be44-9e02be0d4ed7">27,744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjEtMTEtMS0xLTExMjY0MA_e587f9f0-821e-4a8a-a4c6-d43e686e6c5e">27,745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fe34795168e4efab32422048060cbb7_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjItNS0xLTEtMTEyNjQw_e802d730-3118-426e-bf9b-2ec3ed966c4f">38,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjItMTEtMS0xLTExMjY0MA_4d90edf3-ca69-463f-95d8-b93edfae759f">38,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Unrealized net loss on available-for-sale securities, net of deferred tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie20afe7ce80947c68d760e57a457a87d_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjQtNy0xLTEtMTEyNjQw_96999636-b970-468c-93dc-7238cc2c1b0e">116</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjQtMTEtMS0xLTExMjY0MA_d14c3666-f8c3-4015-8858-fff9a1e6b9f6">116</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Reacquisition of equity due to 2023 debt extinguishment, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0fe34795168e4efab32422048060cbb7_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjUtNS0xLTEtMTEyNjQw_d3386399-b6cd-4c24-b275-cadf7dfbadfa">12,407</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjUtMTEtMS0xLTExMjY0MA_97d8f573-7007-476b-a894-a7234d2ba738">12,407</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Warrant and bond hedge unwind transactions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fe34795168e4efab32422048060cbb7_D20210101-20211231" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjYtNS0xLTEtMTEyNjQw_3d594dc0-a39e-42f5-bb5d-93204e58c76c">491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjYtMTEtMS0xLTExMjY0MA_88458b4c-dcaa-4dca-a08b-588fc90cdf99">491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjctOS0xLTEtMTEyNjQw_7feb0c63-e093-4cf2-be85-964e49f35626">57,138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjctMTEtMS0xLTExMjY0MA_15c85166-677a-4487-9a9d-a3b0f1c69019">57,138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaafb881f4e07495d854952edabcc137a_I20211231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjgtMS0xLTEtMTEyNjQw_b101fa76-4fcb-475b-8f0d-2b505eb89812">16,767</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaafb881f4e07495d854952edabcc137a_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjgtMy0xLTEtMTEyNjQw_90361a9b-a035-4e8c-9096-4dd0890e3a0d">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i948695d093514268aa5ad004f473dbda_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjgtNS0xLTEtMTEyNjQw_b3310e22-94b2-4b9d-8d95-a3d3d9f05c40">372,969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d56363a509d4e11b592758da0456ba3_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjgtNy0xLTEtMTEyNjQw_04a8060a-5b33-45b4-bc7a-454822ec7f7b">917</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93f039f3e3c5453fbe65524dc44ad87a_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjgtOS0xLTEtMTEyNjQw_b1c1369d-6413-4cb9-a8b8-89fb713ba585">449,090</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjgtMTEtMS0xLTExMjY0MA_415f395f-738b-46ca-8488-6135f6ae0758">821,159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjAtMC0xLTEtMTM1NjU0_ead01d8d-25b8-4804-af03-812067b2c1eb">ASU 2020-06 adoption, net of tax (Note 1)</span> </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica032a6f26e9432b8884add2372c3753_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjAtNS0xLTEtMTMwNjA2_3e6d6563-a9bb-4116-9998-8e20cbd33ba6">51,130</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23836cb1b26e4183bcbd3dcfe2a97c57_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjAtOS0xLTEtMTMwNjcw_4d5697b2-6209-408d-9e1a-d837b6745d14">35,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief52e61130d8499e8c4dbc42893dc5b6_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjAtMTEtMS0xLTEzNTYzNg_984ae54a-52f3-4717-8f37-bb7eea252991">15,997</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i65b0d907ef504ee2b3d109652685018c_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjEtMS0xLTEtMTMwNjc4_5115a16a-57e2-4ac9-94e2-cdf8f257f1ae">184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ba90afbe5994d2387d3257ea4ba047e_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjEtNS0xLTEtMTMwNjA2_7b5dcc72-313e-4175-a827-0d31cdc5de2c">5,004</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjEtMTEtMS0xLTEzNTYzNg_c95d72f5-21d3-47fc-8ecc-ac28294b3f85">5,004</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ba90afbe5994d2387d3257ea4ba047e_D20220101-20221231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjItNS0xLTEtMTMwNjA2_ff80555f-727c-4f54-80e3-95478ea690ae">60,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjItMTEtMS0xLTEzNTYzNg_818c4eec-d882-4f5a-b62b-a646821e49e3">60,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Unrealized net loss on available-for-sale securities, net of deferred tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155fa2cc21e744f28351005564253c83_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjMtNy0xLTEtMTMwNjIy_004ccd9d-e853-4458-abce-64b355f2514b">67</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjMtMTEtMS0xLTEzNTYzNg_161d9ee6-9362-4fc1-95b1-51f2c78e79c1">67</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Bond hedge transaction</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ba90afbe5994d2387d3257ea4ba047e_D20220101-20221231" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalBondHedgeTransaction" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjQtNS0xLTEtMTMwNjA2_fe6dcc9d-675a-4919-83a0-bf89a51530a3">202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalBondHedgeTransaction" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjQtMTEtMS0xLTEzNTYzNg_653e6e7c-0e17-47fa-adfb-063941c3ec8a">202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Distribution of OmniAb</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ba90afbe5994d2387d3257ea4ba047e_D20220101-20221231" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalDecreaseDueToSeparation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjUtNS0xLTEtMTMwNjA2_2aeaccc5-07c4-402c-907b-6ee6fea8ed5e">229,732</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalDecreaseDueToSeparation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjUtMTEtMS0xLTEzNTYzNg_a2d46484-0cb5-4fbe-beed-84edfa356fd6">229,732</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjYtOS0xLTEtMTMwNjQx_63817890-02d4-4156-901c-ff761430465d">33,361</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjYtMTEtMS0xLTEzNTYzNg_c674b186-4605-4a62-bc48-a5054ae0b1b0">33,361</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2a1cc21146284996b1a957be45c91abd_I20221231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjctMS0xLTEtMTM1NjQ0_e988b75b-d809-403f-81a5-22dbd44dceb2">16,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a1cc21146284996b1a957be45c91abd_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjctMy0xLTEtMTM1NjQ4_7b1f9fa2-627d-4d4d-a6f7-38e629299238">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33d7a741bf9e4e2d90927adfa7ef78e5_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjctNS0xLTEtMTM1NjUw_1ba92502-640b-4153-a5f8-27a7f27cb90c">147,590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f6875eb2c49451e827356ab2addb68a_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjctNy0xLTEtMTM1NjUy_a8ffe90d-d68b-4337-a536-5920445a218c">984</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e38dd10e28e4af0b6ff937e3289a628_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjctOS0xLTEtMTM1NjQx_94d8142e-bb7b-45ac-a1e8-89dbe56e346c">450,862</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjctMTEtMS0xLTEzNTYzNg_68b29974-089b-4ab0-8f5c-91c6c0d830c4">597,485</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to these consolidated financial statements.</span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_76"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:59.488%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.548%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year&#160;Ended&#160;December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMy0xLTEtMS0xMTI2NDA_a0a809f8-7cc1-4325-924d-3f3c71a798af">33,361</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMy0zLTEtMS0xMTI2NDA_90875934-82dc-4203-a04b-5bbb06157577">57,138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMy01LTEtMS0xMTI2NDA_36f2a782-d0bc-40a9-a1be-b7762fad4786">2,985</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain from sale of Vernalis R&amp;D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNi0xLTEtMS0xMTI2NDA_308c26b2-d476-4a25-86ae-6a1479d0397b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNi0zLTEtMS0xMTI2NDA_5211f4aa-ec63-4085-a264-92fc829d10c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNi01LTEtMS0xMTI2NDA_a976ef89-7cec-4f6d-9136-6c1aefb4f07c">17,114</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in estimated fair value of contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNy0xLTEtMS0xMTI2NDA_4f490ee2-ff08-483c-9313-5df77c975058">748</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNy0zLTEtMS0xMTI2NDA_8d989c4c-5e42-4ed0-957c-bc51a7c8b3a3">36,962</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNy01LTEtMS0xMTI2NDA_85367350-3972-4144-8b50-9f3a7b62902c">963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation of fixed assets and amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfOC0xLTEtMS0xMTI2NDA_e005ba1a-003d-4090-b3e8-31236850a02e">51,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfOC0zLTEtMS0xMTI2NDA_4939c479-7915-4fa1-8df9-1c93ca738e28">51,071</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfOC01LTEtMS0xMTI2NDA_5de231ec-bdb4-4d2e-a597-4d8d97577654">25,691</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss (gain) short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="lgnd:GainLossOnShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfOS0xLTEtMS0xMTI2NDA_676e3c17-c588-4a9e-a792-31ec781515e3">28,540</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" sign="-" name="lgnd:GainLossOnShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfOS0zLTEtMS0xMTI2NDA_91add643-149a-4dea-937d-a013d89e58b3">3,997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="lgnd:GainLossOnShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfOS01LTEtMS0xMTI2NDA_7640d606-bd4d-44b3-931d-6ee26a760e21">16,933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization/accretion of premium (discount) on investments, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTAtMS0xLTEtMTEyNjQw_31eaf841-87fc-4356-a09d-999faedb289c">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTAtMy0xLTEtMTEyNjQw_de2ce1c0-d35f-4599-9100-6dac5baea1de">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTAtNS0xLTEtMTEyNjQw_b02197d2-daa0-4661-9796-2afe68bccc89">1,479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of debt discount and issuance fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTEtMS0xLTEtMTEyNjQw_242dfd20-9a9a-4162-be2b-5c172ac76829">734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTEtMy0xLTEtMTEyNjQw_08928021-4cb3-417a-b4a7-c27c53cc4ab3">16,692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTEtNS0xLTEtMTEyNjQw_e26b2cb8-8f56-428a-b8f3-afea8a221c6f">23,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss (gain) on debt extinguishment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTItMS0xLTEtMTEyNjQw_d60ab63e-fb72-48e4-832d-d2993a439bd2">4,192</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTItMy0xLTEtMTEyNjQw_e15fcb0d-a679-41f1-bc41-0d31e8137de1">7,303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTItNS0xLTEtMTEyNjQw_1cd7f404-4187-4fa6-aecd-ac316b6d3062">2,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of commercial license and other economic rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" sign="-" name="lgnd:AmortizationOfCommercialLicenseAndOtherEconomicRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTMtMS0xLTEtMTEyNjQw_a1609f86-3d27-41aa-bdd2-8afc70733630">164</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" sign="-" name="lgnd:AmortizationOfCommercialLicenseAndOtherEconomicRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTMtMy0xLTEtMTEyNjQw_14108e0d-ddb2-419c-a4c6-31098e4a76e3">125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="lgnd:AmortizationOfCommercialLicenseAndOtherEconomicRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTMtNS0xLTEtMTEyNjQw_aedde1b5-1f18-4b00-aca2-44b79258fdc9">2,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lease amortization expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="lgnd:FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTMtMS0xLTEtMTMwNDIw_c5cb690f-6c6e-4aac-a3d3-12cde4271978">5,521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="lgnd:FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTMtMy0xLTEtMTMwMzg3_3822ecb1-2a76-4555-b1d8-9d6872d97d1e">4,840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="lgnd:FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTMtNS0xLTEtMTMwMzc4_887400f3-dce0-47a3-adb0-b632639d1377">1,609</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTQtMS0xLTEtMTEyNjQw_b02cb193-421e-45c6-8884-c0e05e92e888">60,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTQtMy0xLTEtMTEyNjQw_996d6b7b-7b49-4eac-9ce2-dafb0c1ea4ed">38,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTQtNS0xLTEtMTEyNjQw_33c413e4-ad6c-4202-b5f9-104dab4dc1bc">30,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTUtMS0xLTEtMTEyNjQw_9423294b-1690-4c87-8461-d35cdd9eee6a">20,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTUtMy0xLTEtMTEyNjQw_dd07ade1-6cef-4ea1-a1c7-6db544859319">8,618</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTUtNS0xLTEtMTEyNjQw_4945fc44-d9d6-4236-a27b-1aff1ae78471">19,053</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTYtMS0xLTEtMTEyNjQw_67c0456f-5aca-4dce-8270-f9557053b840">365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTYtMy0xLTEtMTEyNjQw_f15a108c-a9c6-4066-be13-77f79d2c1c49">1,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTYtNS0xLTEtMTEyNjQw_9a8d4e1a-4fd6-4d99-a465-827363dacc76">191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of acquisitions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTgtMS0xLTEtMTEyNjQw_758f1cf8-790e-4108-b621-c1712e831eec">55,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTgtMy0xLTEtMTEyNjQw_d3da8a4b-6d9d-4013-af1f-3a73a5ba0ab7">28,616</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTgtNS0xLTEtMTEyNjQw_bf3fa4a7-9d2b-4232-8720-f49b9b489c4d">26,061</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTktMS0xLTEtMTEyNjQw_a4b2727f-5970-4f83-aac5-f6a580c4eeea">12,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTktMy0xLTEtMTEyNjQw_d164bb7d-918a-40fd-a5cd-fd28d674d8ae">427</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTktNS0xLTEtMTEyNjQw_ed4833b0-8968-4df0-bebe-89b05a7cbc6a">17,799</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjAtMS0xLTEtMTEyNjQw_995f894b-cef1-4c2a-8e5b-9f9b17dfe019">3,340</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjAtMy0xLTEtMTEyNjQw_8d394d4c-a434-4910-9675-2b36f7d83c1e">2,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjAtNS0xLTEtMTEyNjQw_bcf51d96-a099-4b60-b776-57f49c6f665e">1,245</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income taxes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInIncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjEtMS0xLTEtMTEyNjQw_70e92ea9-17bc-4e51-8646-66efba0bee18">1,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInIncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjEtMy0xLTEtMTEyNjQw_ebcc68a7-cea4-4e24-9997-619c5e84d8be">3,976</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInIncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjEtNS0xLTEtMTEyNjQw_0302bd2e-7d65-4b9c-b5c7-29ec2d6a407f">9,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjMtMS0xLTEtMTEyNjQw_9a584055-3e67-4519-a52e-12e33e34a98f">6,281</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjMtMy0xLTEtMTEyNjQw_46dc7410-4139-42b8-9958-b691d0b6515b">17,870</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjMtNS0xLTEtMTEyNjQw_41651d20-5579-4b96-ab4f-83007cf0c0e4">29,236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets and liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjQtMS0xLTEtMTEyNjQw_c0895610-13cf-4232-bb8e-1b614578b1e8">6,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjQtMy0xLTEtMTEyNjQw_9178c18e-f2cc-4160-9c3f-483f5a988a70">8,925</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjQtNS0xLTEtMTEyNjQw_9c8e2e00-ce79-4afd-9c00-e3ddcd8f7f3f">4,948</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjUtMS0xLTEtMTEyNjQw_c502ee27-a603-4174-9e24-e174652018f8">137,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjUtMy0xLTEtMTEyNjQw_79938a16-3e20-4330-9541-272b1b60b75d">78,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjUtNS0xLTEtMTEyNjQw_fadcd62a-35f2-4fae-b6b3-512757687377">54,586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investing activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for acquisition, net of cash and restricted cash acquired</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjktMS0xLTEtMTEyNjQw_02533dae-8c28-4b9b-b71a-0702508c9d49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjktMy0xLTEtMTEyNjQw_53c37894-480a-4284-964e-09c60c840fb2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjktNS0xLTEtMTEyNjQw_36011f21-d841-435a-b118-8031cf63da27">404,884</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzAtMS0xLTEtMTEyNjQw_bc68165e-599a-4970-a553-c6b10324fdd4">17,923</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzAtMy0xLTEtMTEyNjQw_02c6b184-f26b-405c-80e4-5de96ddb850e">8,761</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzAtNS0xLTEtMTEyNjQw_8e332afe-5ac5-4537-a577-0e8562ed1cd6">4,458</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzEtMS0xLTEtMTEyNjQw_4216ca4b-d4f5-4634-9dfa-4acaea6c06e7">51,226</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzEtMy0xLTEtMTEyNjQw_0358421a-8840-404f-9cc0-b67f4a90fba6">181,325</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzEtNS0xLTEtMTEyNjQw_3233c00a-1dfd-4ca7-aebb-46bc92ac96b2">422,523</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from commercial license rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="lgnd:ProceedsFromCommercialLicenseRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzItMS0xLTEtMTEyNjQw_5f5f18f0-fc48-460c-a74b-3c6da30cc94b">92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="lgnd:ProceedsFromCommercialLicenseRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzItMy0xLTEtMTEyNjQw_a9519000-98ba-4ffa-ad73-fc88a486fa66">494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="lgnd:ProceedsFromCommercialLicenseRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzItNS0xLTEtMTEyNjQw_b39aa775-36a5-4bfa-a446-0cc3d9388fc6">1,358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzMtMS0xLTEtMTEyNjQw_6d4ea866-9392-4268-a8c6-48ca26990c98">209,561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzMtMy0xLTEtMTEyNjQw_fd0ea3d8-65ff-46cf-80e6-42f053876625">154,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzMtNS0xLTEtMTEyNjQw_b7e43dd4-c73a-47f1-b6b4-46ef1480830c">394,539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from maturity of short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzQtMS0xLTEtMTEyNjQw_30e388fb-8166-4264-a3e0-6a9f21fd2b50">24,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzQtMy0xLTEtMTEyNjQw_313e2f10-deab-4e87-af3a-5b35506ba276">67,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzQtNS0xLTEtMTEyNjQw_d02d121d-1820-40c7-b1f9-5b11a237d016">644,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for equity method investment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzYtMS0xLTEtMTEyNjQw_a6d34600-cf00-4043-b405-df9b3e4629b1">750</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzYtMy0xLTEtMTEyNjQw_0aabebf0-0f66-4aa0-9e52-e1b38e2b4c89">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzYtNS0xLTEtMTEyNjQw_85ae34a0-6a8e-46b8-ab8e-fc9d4591d4c6">500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds on sale of Vernalis R&amp;D, net </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzctMS0xLTEtMTEyNjQw_0d3e3d69-a76d-46a4-a1d6-d7fd5d9b9f11">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzctMy0xLTEtMTEyNjQw_e022436a-ac25-4054-83c8-8a259050b3d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzctNS0xLTEtMTEyNjQw_01fc91d8-e70c-47a7-a729-0fa23a6279bb">22,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzgtMS0xLTEtMTEyNjQw_e2685f60-3a40-40e3-9706-374ab827cf85">960</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzgtMy0xLTEtMTEyNjQw_95c77923-0845-4cfa-b792-79fd0668da4e">1,220</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzgtNS0xLTEtMTEyNjQw_72f0869b-df63-43a8-b473-06d7ea0f5c65">1,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzktMS0xLTEtMTEyNjQw_6678cc8a-5fa1-456f-8dc2-bb5fb91f4cd6">163,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzktMy0xLTEtMTEyNjQw_65a227f6-57dc-4a69-bd5b-87db194abc75">30,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzktNS0xLTEtMTEyNjQw_cfe8aac1-8a76-4380-b80c-6fbb2fffc9f7">231,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financing activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash transferred to OmniAb at separation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="lgnd:PaymentsForSeparation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDEtMS0xLTEtMTI5NDE2_f3330155-d99f-4c52-807d-86bf6bc2aef0">1,840</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="lgnd:PaymentsForSeparation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDAtMy0xLTEtMTM1NjY4_287044ac-5022-4414-bf75-950febaa4e0c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="lgnd:PaymentsForSeparation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDAtNS0xLTEtMTM1NjY4_4a78c8a5-0645-459d-a05f-f42bec39eee9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDEtMS0xLTEtMTEyNjQw_948d4169-39c1-4e1f-b4ed-f08faf98790f">260,949</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDEtMy0xLTEtMTEyNjQw_4e8ae48b-c60c-4568-af56-b6e380f4ce77">155,760</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDEtNS0xLTEtMTEyNjQw_665c7930-3696-4ac3-876a-182f58b5b6b7">222,209</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments under finance lease obligations </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDItMS0xLTEtMTEyNjQw_deb916e5-5195-4653-aadd-ff3940039cb0">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDItMy0xLTEtMTEyNjQw_725185ea-023d-4eb7-8a84-e259d26e58b7">9,188</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDItNS0xLTEtMTEyNjQw_1f0e1158-b96d-42b6-8db1-d9638cc0c7cf">9,549</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for OmniAb transaction costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDYtMS0xLTEtMTEyNjQw_7edc0859-c0b3-4764-bfe9-433f39146827">6,800</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDYtMy0xLTEtMTEyNjQw_2c7fc6df-d15b-43c2-a974-e6dae880bd17">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDYtNS0xLTEtMTEyNjQw_4e536d46-72d3-4a39-8ad6-246b8971fc6b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from bond hedge settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromHedgeFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDctMS0xLTEtMTEyNjQw_70111c03-c068-4c83-9947-d92923152f08">202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromHedgeFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDctMy0xLTEtMTEyNjQw_c1435230-9a1a-4432-b4e2-405ace9e9447">18,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromHedgeFinancingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDctNS0xLTEtMTEyNjQw_4d28e9f1-0d08-4301-a2d4-2b42b68fc065">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net proceeds from stock option exercises and ESPP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDktMS0xLTEtMTEyNjQw_236ce907-bac8-42d9-bac4-ec939e6fba2f">3,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDktMy0xLTEtMTEyNjQw_e023a434-086c-433d-af0c-40387d8100de">33,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDktNS0xLTEtMTEyNjQw_00c7f9c3-fe4a-41cd-ae6b-683dad7c8e67">3,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Taxes paid related to net share settlement of equity awards</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTAtMS0xLTEtMTEyNjQw_b40081dc-d31b-431a-b811-af21c1781dd2">8,236</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTAtMy0xLTEtMTEyNjQw_113db21b-8e74-44af-8b65-2f39b835ceb0">6,018</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTAtNS0xLTEtMTEyNjQw_8f157eab-7948-4eeb-a73e-782bd8b29236">1,481</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share repurchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTEtMS0xLTEtMTEyNjQw_8970f45e-1e4e-4fff-8c05-425aa358fc25">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTEtMy0xLTEtMTEyNjQw_d57a6591-af42-43a2-89b4-8d2950a72901">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTEtNS0xLTEtMTEyNjQw_4b5a2207-20be-44ac-856e-23571a591cfd">77,998</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfWarrants" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTItMS0xLTEtMTEyNjQw_c42a0041-2d60-476b-b2b2-23f91b59becf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfWarrants" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTItMy0xLTEtMTEyNjQw_9a3271d6-8e8a-41a3-b394-8a089478fa6b">18,446</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfWarrants" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTItNS0xLTEtMTEyNjQw_407043b3-7924-4ded-9256-4ac70e65cd0a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to CVR Holders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="lgnd:PaymentsToContingentValueRightHoldersFinancingActivity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTMtMS0xLTEtMTEyNjQw_0728ccb8-41a1-4d87-9a22-7786f1eb01e1">1,545</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="lgnd:PaymentsToContingentValueRightHoldersFinancingActivity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTMtMy0xLTEtMTEyNjQw_ee6924e3-e259-4bf6-b3e0-f230144290d0">1,050</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="lgnd:PaymentsToContingentValueRightHoldersFinancingActivity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTMtNS0xLTEtMTEyNjQw_e6a7b323-184f-4e95-b525-465a792c38c5">2,325</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTQtMS0xLTEtMTEyNjQw_9b58658c-a513-4107-99dc-d5e69cf6e248">275,990</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTQtMy0xLTEtMTEyNjQw_b5edb76c-3d7e-4893-bf37-bfbf52602f70">137,761</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTQtNS0xLTEtMTEyNjQw_f434e2a1-296d-4f99-9e0c-1392ee360660">310,545</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTUtMS0xLTEtMTEyNjQw_56b84fe1-cc43-428c-9c26-6cbb6f8911cf">25,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTUtMy0xLTEtMTEyNjQw_f93f1799-d5e3-4324-8a20-eed5ded9b63a">28,440</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTUtNS0xLTEtMTEyNjQw_44b6d200-452f-417c-a650-25a8369fef2f">24,311</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:59.488%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.548%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at beginning of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTctMS0xLTEtMTEyNjQw_94327c4a-760f-4ffd-8c76-ec14a7c4885c">19,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTctMy0xLTEtMTEyNjQw_604d905c-d296-4575-b755-b1abe5a739c9">47,962</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i859e9607437a43d8adb4d3dc08e60773_I20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTctNS0xLTEtMTEyNjQw_43637298-57ca-4a8b-af5b-3bd9be255bbb">72,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTgtMS0xLTEtMTEyNjQw_9b6909c7-e03f-438c-ba49-fe72c4ef24ac">45,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTgtMy0xLTEtMTEyNjQw_ba43ae8d-5283-49c7-8415-7c221ad26d04">19,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTgtNS0xLTEtMTEyNjQw_04da5a75-00f0-48ac-81b9-db6ba42ebfe2">47,962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental disclosure of cash flow information</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash paid during the year:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjEtMS0xLTEtMTEyNjQw_83f9ada2-82f4-434b-82e3-fda4cc6c946a">1,428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjEtMy0xLTEtMTEyNjQw_cfacb14c-2912-48b1-b200-b9f50627ec8b">3,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjEtNS0xLTEtMTEyNjQw_19974508-5f86-4493-8773-22b4b550e1cc">4,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Taxes paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjItMS0xLTEtMTEyNjQw_e033e316-4fd6-4957-8ae5-8f621cecccb5">11,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjItMy0xLTEtMTEyNjQw_c5a81bd8-81cb-496c-867b-5e57b46a05af">3,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjItNS0xLTEtMTEyNjQw_af76c532-ce32-4ef3-a321-db029482625a">2,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted cash in other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:RestrictedCashCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjMtMS0xLTEtMTEyNjQw_f6eef0c2-8dc0-4152-871c-c7032a389b5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:RestrictedCashCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjMtMy0xLTEtMTEyNjQw_ae2a5162-e1f2-4992-8863-0c6e8b9aec15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231" decimals="-3" name="us-gaap:RestrictedCashCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjMtNS0xLTEtMTEyNjQw_76b72452-d50a-49a1-9d4a-0b3dc6e49f09">343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental schedule of non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued inventory purchases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="lgnd:AccruedInventoryPurchases" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjUtMS0xLTEtMTEyNjQw_791e92df-9909-4e78-a7b4-38cdbe171c8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="lgnd:AccruedInventoryPurchases" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjUtMy0xLTEtMTEyNjQw_376054f1-280b-4721-9724-1e59a143b02b">1,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="lgnd:AccruedInventoryPurchases" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjUtNS0xLTEtMTEyNjQw_fd093cc4-2e8d-4cc5-9c55-988f01375bd1">1,562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized loss on available-for-sale investments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjYtMS0xLTEtMTEyNjQw_17e4dc21-d029-436b-94bf-c6881d9b7894">85</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjYtMy0xLTEtMTEyNjQw_a3c9feca-f209-4b09-a321-e1bd99258951">221</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjYtNS0xLTEtMTEyNjQw_a873229c-a751-4aa1-9882-4ed7d88f19d9">212</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of fixed assets recorded in accounts payable </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjctMS0xLTEtMTEyNjQw_efbb6d27-998d-4b86-b827-a4febebf2193">2,333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjctMy0xLTEtMTEyNjQw_fb3f71db-2834-4105-a79e-10bceb5344d4">1,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjctNS0xLTEtMTEyNjQw_2737d7a4-58bf-438a-a422-1864c820580f">249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to these consolidated financial statements.</span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_79"></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_82"></div><div style="margin-top:14pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unless the context requires otherwise, references in this report to &#8220;Ligand,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; the &#8220;Company,&#8221; and &#8220;our&#8221; refer to Ligand Pharmaceuticals Incorporated and its consolidated subsidiaries.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2ODc_26141f76-ca8a-4ba3-a0b3-5e8c7bdce9c1" continuedAt="i093099b1af754704b09a302dfa52bc64" escape="true">Basis of Presentation and Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i093099b1af754704b09a302dfa52bc64" continuedAt="i313364f4f19c4f9f8609f5a526297c5f"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="lgnd:BusinessSpinOffAndMigrationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMjc0ODc3OTE1MTc4Nw_aad64683-9bb8-4a4f-920d-1762cdd2f172" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, we completed the separation (the &#8220;Separation&#8221;) of our antibody discovery business and certain related assets and liabilities (the &#8220;OmniAb Business&#8221;) through a spin-off of OmniAb to Ligand&#8217;s shareholders of record as of October 26, 2022 on a pro rata basis (the &#8220;Distribution&#8221;) and merger (the &#8220;Merger&#8221;) of OmniAb with a wholly owned subsidiary of a separate public company, OmniAb, Inc. (formerly known as Avista Public Acquisition Corp. II (&#8220;New OmniAb&#8221;)), in a Reverse Morris Trust transaction pursuant to the Agreement and Plan of Merger, dated as of March 23, 2022 (the &#8220;Merger Agreement&#8221;), and the Separation and Distribution Agreement, dated as of March 23, 2022 (the &#8220;Separation Agreement&#8221;) (the Merger Agreement and Separation Agreement, collectively with the other related transaction documents, the &#8220;Transaction Agreements&#8221;). Pursuant to the Transaction Agreements, Ligand contributed to OmniAb cash and certain assets and liabilities constituting the OmniAb Business, including but not limited to the equity interests of Ab Initio Biotherapeutics, Inc., Crystal Bioscience, Inc., Icagen, LLC, Taurus Biosciences, LLC and xCella Biosciences, Inc.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the spin-off of our OmniAb antibody discovery business, Ligand is a revenue-generating biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. We operate in <ix:nonFraction unitRef="segment" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDQ5_1f30967b-9444-4443-8ac3-5998c95de976">one</ix:nonFraction> business segment: development and licensing of biopharmaceutical assets.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="lgnd:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2NTE_1cc4ca10-ce7b-4e40-b227-d461a414948b" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements have been prepared in accordance with U.S. GAAP and include the accounts of our parent company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</span></div></ix:nonNumeric><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:DiscontinuedOperationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMjc0ODc3OTEzMzk2OQ_af8a3856-9970-4645-b1d6-f7f6ec87acb1" continuedAt="id5dd5e19aaad47e2935c5568451eb4e8" escape="true">Discontinued operations</ix:nonNumeric></span></div><div style="margin-bottom:6pt"><ix:continuation id="id5dd5e19aaad47e2935c5568451eb4e8" continuedAt="i749beacedd5447348419fd5f4e7c23a2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined that the spin-off of the OmniAb Business in November 2022 met the criteria for classification as a discontinued operation in accordance with ASC Subtopic 205-20, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Discontinued Operations</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i749beacedd5447348419fd5f4e7c23a2"> (&#8220;ASC 205-20&#8221;). Accordingly, the accompanying consolidated financial statements for all periods presented have been updated to present the assets and liabilities associated with the OmniAb Business separately as discontinued operations on the consolidated balance sheets and the results of all discontinued operations reported as a separate component of loss in the consolidated statements of operations and comprehensive loss</ix:continuation> (see Note 2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Spin-off of OmniAb</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). All disclosures have been adjusted to reflect continuing operations.</span></div><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2NTI_596df23d-ed52-48ad-aa2d-9a1f66fe6923" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires the use of estimates and assumptions that affect the amounts reported in the consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2Nzg_17bd73c1-478a-4adb-b23d-82157cb7e615" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Business Risk</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to significant concentrations of credit risk consist primarily of cash equivalents and investments. We invest excess cash principally in United States government debt securities, investment grade corporate debt securities, mutual funds and certificates of deposit. We maintain some cash and cash equivalents balances with financial institutions that are in excess of the Federal Deposit Insurance Corporation insurance limits. We have established guidelines relative to diversification and maturities that maintain safety and liquidity. These guidelines are periodically reviewed and modified to take advantage of trends in yields and interest rates.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i313364f4f19c4f9f8609f5a526297c5f" continuedAt="ic62a68c3085d47489ca79e7f3af09a35"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2Njk_e1677363-b341-4225-99ee-b874a2327c24" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from significant partners, which is defined as 10% or more of our total revenue, was as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.524%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Partner A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i72f4dbdc77184f48bcecf231e8e2ca80_D20220101-20221231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjY0NTRlMmI1YzYyZTQ2NmRhNjMyNmRhMGI2OTA1ZGFjL3RhYmxlcmFuZ2U6NjQ1NGUyYjVjNjJlNDY2ZGE2MzI2ZGEwYjY5MDVkYWNfMi0xLTEtMS0xMTI2NDA_6a09a20f-09a8-48ce-9a3e-cccac372ed53">45</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i14ad94cabb1447e9a5f01458bd06ae4c_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjY0NTRlMmI1YzYyZTQ2NmRhNjMyNmRhMGI2OTA1ZGFjL3RhYmxlcmFuZ2U6NjQ1NGUyYjVjNjJlNDY2ZGE2MzI2ZGEwYjY5MDVkYWNfMi0zLTEtMS0xMTI2NDA_dbae888f-8d8b-4f67-b290-00889221d5d2">47</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia3ecad76cf15478e978cd158a1acc62b_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjY0NTRlMmI1YzYyZTQ2NmRhNjMyNmRhMGI2OTA1ZGFjL3RhYmxlcmFuZ2U6NjQ1NGUyYjVjNjJlNDY2ZGE2MzI2ZGEwYjY5MDVkYWNfMi01LTEtMS0xMTY2MzY_9c5a5ac6-4449-410d-8b34-86b970fdf24f">51</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Partner B</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i032f9a1963654916a1d87cdbf84a1c8c_D20220101-20221231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjY0NTRlMmI1YzYyZTQ2NmRhNjMyNmRhMGI2OTA1ZGFjL3RhYmxlcmFuZ2U6NjQ1NGUyYjVjNjJlNDY2ZGE2MzI2ZGEwYjY5MDVkYWNfMy0xLTEtMS0xMTI2NDA_6707665b-4363-4a71-ba53-143fd4a5a79e">16</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i84da35f51bc941fb9605c4e27d374dc2_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjY0NTRlMmI1YzYyZTQ2NmRhNjMyNmRhMGI2OTA1ZGFjL3RhYmxlcmFuZ2U6NjQ1NGUyYjVjNjJlNDY2ZGE2MzI2ZGEwYjY5MDVkYWNfMy0zLTEtMS0xMTI2NDA_69ae4369-d6bd-405e-ab8f-21f46173d025">12</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie756c741eed64e91bbd573fd37cc5dc5_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjY0NTRlMmI1YzYyZTQ2NmRhNjMyNmRhMGI2OTA1ZGFjL3RhYmxlcmFuZ2U6NjQ1NGUyYjVjNjJlNDY2ZGE2MzI2ZGEwYjY5MDVkYWNfMy01LTEtMS0xMTI2NDA_609fb8e3-e490-43e6-8bb3-bf12b4a3478b">17</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Partner C</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&lt;<ix:nonFraction unitRef="number" contextRef="i320b82dcca2f4f7c9916c6e2f9c91339_D20220101-20221231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjY0NTRlMmI1YzYyZTQ2NmRhNjMyNmRhMGI2OTA1ZGFjL3RhYmxlcmFuZ2U6NjQ1NGUyYjVjNjJlNDY2ZGE2MzI2ZGEwYjY5MDVkYWNfNC0xLTEtMS0xMTY2NDA_e5210e3a-8aa7-4711-b47b-5c0a33637a94">10</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&lt;<ix:nonFraction unitRef="number" contextRef="ib51bff40a74549a49092eaf3d331dfb2_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjY0NTRlMmI1YzYyZTQ2NmRhNjMyNmRhMGI2OTA1ZGFjL3RhYmxlcmFuZ2U6NjQ1NGUyYjVjNjJlNDY2ZGE2MzI2ZGEwYjY5MDVkYWNfNC0zLTEtMS0xMTY2Mzg_4f1b0f02-6d16-4599-8865-58eca9a0d6cc">10</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&lt;<ix:nonFraction unitRef="number" contextRef="i53db40ae7eaa43a29ee0d41f7837b347_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjY0NTRlMmI1YzYyZTQ2NmRhNjMyNmRhMGI2OTA1ZGFjL3RhYmxlcmFuZ2U6NjQ1NGUyYjVjNjJlNDY2ZGE2MzI2ZGEwYjY5MDVkYWNfNC01LTEtMS0xMTI2NDA_43f64ec7-6ff7-4368-9d38-8fb3d59efebb">10</ix:nonFraction>%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.</span></div></ix:nonNumeric><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtain Captisol primarily from two sites related to a single supplier, Hovione.&#160;If this supplier were not able to supply the requested amounts of Captisol from each site, and if our safety stocks of material were depleted, we would be unable to continue to derive revenues from the sale of Captisol until we obtained material from an alternative source, which could take a considerable length of time.</span></div><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="lgnd:CashCashEquivalentsandShorttermInvestmentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2NTk_079d0bb3-e661-45e7-acd3-376659277e20" continuedAt="i32836c88ac15447fbd0e15f7c2b3f3de" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Equivalents </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents consist of highly liquid investments with maturities of <ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="lgnd:MaturityPeriodOfHighlyLiquidSecuritiesMaximum" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMjY2NQ_ce22e824-f123-4ccc-aeb1-d18a25e77351">three months</ix:nonNumeric> or less from the date of acquisition. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Investments</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments primarily consist of investments in debt and equity securities. We classify our short-term investments as &#8220;available-for-sale&#8221;. Such investments are carried at fair value, with unrealized gains and losses on debt securities included in the statement of comprehensive income (loss), net of tax, and unrealized gains and losses on equity securities included the consolidated statement of operations. We determine the cost of investments based on the specific identification method. We determine the realized gains or losses on the sale of available-for-sale securities using the specific identification method and includes net realized gains and losses as a component of other income or expense within the consolidated statements of operations.  </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities consist of certificates of deposit, corporate debt securities, and securities of government-sponsored entities have effective maturities greater than&#160;three&#160;months and less than twenty-five months from the date of acquisition. Debt securities available-for-sale in an unrealized loss position are assessed for the current expected credit losses methodology. We start by assessing whether we intend to sell the security, or whether it is more likely than not that we will be required to sell the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security&#8217;s amortized cost basis is written down to fair value through earnings. For debt securities available-for-sale that do not meet the aforementioned criteria, we evaluate whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, we consider the extent to which fair value is less than amortized cost, any changes in interest rates, and any changes to the rating of the security by a rating agency, among other factors. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security is compared to the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded, limited by the amount that the fair value is less than the amortized cost basis. Any impairment that has not been recorded through an allowance for credit losses is recognized in other comprehensive income or loss, as applicable.</span></div></ix:nonNumeric><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i32836c88ac15447fbd0e15f7c2b3f3de">Equity securities are mutual funds, investments in privately held companies (non-marketable equity securities), and companies that have completed initial public offerings (marketable equity securities). Mutual funds are valued at their publicly quoted net asset value (NAV) price on the last day of the period. Our non-marketable equity securities without readily determinable market values are initially measured at cost and adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment. Our marketable equity securities are measured at fair value. Equity investments are classified as short-term investments, or non-current other assets, based on the nature of the securities and their availability for use in current operations.</ix:continuation> </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2NjA_32b2f27c-e9a3-4066-815a-efe5226aa323" continuedAt="i000f1b19caed449b89c3f0bb864b2a01" escape="true">Accounts Receivable </ix:nonNumeric></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i000f1b19caed449b89c3f0bb864b2a01">Our accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers.</ix:continuation> </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2ODQ_35ae2f75-a297-4ded-a1a9-a82c3425319b" continuedAt="i8e632b61c9d74d68963cc1f556a6e94f" escape="true">Inventory</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic62a68c3085d47489ca79e7f3af09a35" continuedAt="i59887bd26f324f2993c55fb47c64d0a9"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8e632b61c9d74d68963cc1f556a6e94f">Inventory, which consists of finished goods, is stated at the lower of cost or net realizable value. We determine cost using the specific identification method. We analyze our inventory levels periodically and write down inventory to net realizable value if it has become obsolete, has a cost basis in excess of its expected net realizable value or is in excess of expected requirements.</ix:continuation> During the year ended December 31, 2022, we recorded an obsolete inventory charge of $<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-5" name="us-gaap:InventoryWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNTQ5NzU1ODgxOTIy_38dfac5e-28c5-491a-85df-f2a4495a8b61">1.1</ix:nonFraction>&#160;million. There were <ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="INF" name="us-gaap:InventoryWriteDown" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNzE3Mw_1bb4e5f1-cdbc-48c2-87d4-41535bc01fbd"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="INF" name="us-gaap:InventoryWriteDown" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNzE3Mw_fb525606-e868-459a-8220-f6f15e3ad1ec">no</ix:nonFraction></ix:nonFraction> adjustments to inventory recorded for the years ended December&#160;31, 2021 and 2020. As of December 31, 2022 and 2021, inventory included prepayments of $<ix:nonFraction unitRef="usd" contextRef="i0d685acb7be943ae8d15dc5799a4444a_I20221231" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNzM0NA_82a192ce-b8a7-42e3-9005-f71b11670789">5.9</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ic202f70f62e8428d9c78a4978a746eee_I20211231" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNzM1MQ_6212e0eb-896b-4e4b-a44c-377e6d1305aa">24.6</ix:nonFraction>&#160;million, respectively, to our supplier for Captisol.</span></div><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2NTM_2b0e4059-58da-4407-a906-c8175d765f69" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost, subject to review for impairment, and depreciated over the estimated useful lives of the assets, which generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNzU2MQ_9d23c4d7-711e-44c5-af62-13230621da18">three</span> to <ix:nonNumeric contextRef="i5a1083da45f7446987097262ce780281_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2NTQ_e4bb9b02-006a-41ca-b467-292dce2e9875">ten years</ix:nonNumeric>, using the straight-line method. Amortization of leasehold improvements is recorded over the shorter of the lease term or estimated useful life of the related asset. Maintenance and repairs are charged to operations as incurred. When assets are sold, or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts and any gain or loss is included in operating income or expense.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:BusinessCombinationsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2NjU_08716a71-22cb-4f5b-ba54-59bc09b811ae" continuedAt="i67d4e6be42eb40b4bfa23c78de38fb3d" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We first determine whether a set of assets acquired constitute a business and should be accounted for as a business combination. If the assets acquired are not a business, we account for the transaction as an asset acquisition. Business combinations are accounted for by using the acquisition method of accounting which requires us to use significant estimates and assumptions, especially with respect to intangible assets. We record the excess consideration over the aggregate fair value of tangible and intangible assets, net of liabilities assumed, as goodwill.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the acquisition method of accounting, we recognize separately from goodwill the identifiable assets acquired, the liabilities assumed, including contingent consideration and all contractual contingencies, generally at the acquisition date fair value. Contingent purchase consideration to be settled in cash are remeasured to estimated fair value at each reporting period with the change in fair value recorded in statement of operations. Costs that we incur to complete the business combination such as investment banking, legal and other professional fees are not considered part of consideration and we charge them to general and administrative expense as they are incurred. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Should the initial accounting for a business combination be incomplete by the end of a reporting period that falls within the measurement period, we report provisional amounts in our financial statements. During the measurement period, we adjust the provisional amounts recognized at the acquisition date to reflect new information obtained about facts and circumstances that existed as of the acquisition date that, if known, would have affected the measurement of the amounts recognized as of that date and we record those adjustments to our financial statements in the period of change, if any.</span></div></ix:nonNumeric><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i67d4e6be42eb40b4bfa23c78de38fb3d">Under the acquisition method of accounting for business combinations, if we identify changes to acquired deferred tax asset valuation allowances or liabilities related to uncertain tax positions during the measurement period and they relate to new information obtained about facts and circumstances that existed as of the acquisition date, those changes are considered a measurement period adjustment and we record the offset to goodwill. We record all other changes to deferred tax asset valuation allowances and liabilities related to uncertain tax positions in current period income tax expense.</ix:continuation> </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Liabilities</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition of Pfenex in October 2020, we entered into a CVR agreement pursuant to which former equity holders of Pfenex received one nontransferable contractual right entitling such holder to receive $<ix:nonFraction unitRef="usdPerShare" contextRef="id219523c2b3d4296bdc72fa8f030e324_I20201031" decimals="INF" name="lgnd:BusinessCombinationContingentConsiderationLiabilityAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTA3MDc_1d242e55-42fd-4bc2-ba5f-8a91d5953a77">2.00</ix:nonFraction> per share (or approximately $<ix:nonFraction unitRef="usd" contextRef="id219523c2b3d4296bdc72fa8f030e324_I20201031" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTA3Mzg_0a67c573-3a86-4f72-8314-5e8a5ccb1917">77.8</ix:nonFraction>&#160;million total) in the event that Pfenex&#8217;s teriparatide injection product received notice from the FDA that such product is therapeutically equivalent with respect to FORTEO&#174; (teriparatide injection) on or before December 31, 2021. The FDA did not provide notice of such event prior to the CVR expiration date and as a result, the Pfenex CVRs expired without payment.  </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition of CyDex in January 2011, we recorded a contingent liability for amounts potentially due to holders of the CyDex CVRs and former license holders. The liability is periodically assessed based on events and circumstances related to the underlying milestones, royalties and material sales. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition of Metabasis in January 2010, we issued Metabasis stockholders <ix:nonFraction unitRef="right" contextRef="ied0c882ba4784643aa73cead8f57f992_I20100131" decimals="INF" name="lgnd:NumberOfContingentValueRightsIssued" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTE3MDE_7539fa26-fc0b-4072-a814-14fd60cfb7e1">four</ix:nonFraction> tradable CVRs for each Metabasis share. The fair values of the CVRs are remeasured at each reporting date through the term of the related agreement. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any change in fair value is recorded in our consolidated statement of operations. For additional information, see &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note (5), Fair Value Measurement and Note (8), Balance Sheet Account Details</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;   </span></div><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2ODM_47de061a-7429-4891-bd50-1d4e468e765e" continuedAt="i0d721c060960497ab2182b72c93b6ad6" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill, Intangible Assets and Other Long-Lived Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill, which has an indefinite useful life, represents the excess of cost over fair value of net assets acquired. Goodwill is reviewed for impairment at least annually during the fourth quarter, or more frequently if an event occurs indicating the potential for impairment. During the goodwill impairment review, we assess qualitative factors to determine whether it is more </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i59887bd26f324f2993c55fb47c64d0a9" continuedAt="i00e37b0f214346eb8189230abe34b1b1"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0d721c060960497ab2182b72c93b6ad6" continuedAt="i7614462cdbe4425f8304bce650edba47">likely than not that the fair value of our reporting unit is less than the carrying amount, including goodwill. The qualitative factors include, but are not limited to, macroeconomic conditions, industry and market considerations, and the overall financial performance. If, after assessing the totality of these qualitative factors, we determine that it is not more likely than not that the fair value of our reporting unit is less than the carrying amount, then no additional assessment is deemed necessary. Otherwise, we proceed to perform the quantitative assessment. We will then evaluate goodwill for impairment by comparing the estimated fair value of the reporting unit to its carrying value, including the associated goodwill. To determine the fair value, we generally use a combination of market approach based on Ligand and comparable publicly traded companies in similar lines of businesses and the income approach based on estimated discounted future cash flows. Our cash flow assumptions consider historical and forecasted revenue, operating costs and other relevant factors. We may also elect to bypass the qualitative assessment in a period and elect to proceed to perform the quantitative assessment for the goodwill impairment test. We performed the annual assessment for goodwill impairment during the fourth quarter of 2022, noting no impairment. </ix:continuation></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7614462cdbe4425f8304bce650edba47">Our identifiable intangible assets are typically composed of acquired core technologies, licensed technologies, contractual relationships, customer relationships and trade names. The cost of identifiable intangible assets with finite lives is generally amortized on a straight-line basis over the assets&#8217; respective estimated useful lives. We regularly perform reviews to determine if any event has occurred that may indicate that intangible assets with finite useful lives and other long-lived assets are potentially impaired. If indicators of impairment exist, an impairment test is performed to assess the recoverability of the affected assets by determining whether the carrying amount of such assets exceeds the undiscounted expected future cash flows. If the affected assets are not recoverable, we estimate the fair value of the assets and record an impairment loss if the carrying value of the assets exceeds the fair value. Factors that may indicate potential impairment include market conditions, industry and economic trends, changes in regulations, clinical success, historical and forecasted financial results, market capitalization, significant changes in the ability of a particular asset to generate positive cash flows, and the pattern of utilization of a particular asset.</ix:continuation> We did not identify indicators of impairment for the finite-lived intangibles at December&#160;31, 2022.</span></div><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="lgnd:CommercialLicenseRightsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2NjE_a8a42335-bcfa-4b0e-8e34-4bf55c56ddcd" continuedAt="i8125be12360f4dedb9bc9ce185a9ceda" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commercial license and other economic rights</span></div><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="lgnd:ScheduleofCommercialLicenseRightsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2NzI_cd589d2d-e666-4c6e-a2e5-e5eb680f3879" continuedAt="i9e31dd21289a4f1a98ee8cd7cf94749d" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022 and 2021, commercial license and other economic rights consist of the following (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.338%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.607%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo and CorMatrix</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i708cef8824df4406829b45bafcb19aec_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfMi0yLTEtMS0xMTI2NDA_b303165c-7a58-4267-b3dc-8f1be187a0e6">17,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i708cef8824df4406829b45bafcb19aec_I20221231" decimals="-3" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfMi00LTEtMS0xMTI2NDA_184ae151-604b-495c-a16a-45ea29d372a0">9,538</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i708cef8824df4406829b45bafcb19aec_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfMi02LTEtMS0xMTI2NDA_3fffa725-6a37-4d98-9f16-bf87f75e70f8">8,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51a7db08b41d4559b10e461df7cae951_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfMi04LTEtMS0xMTI2NDA_6c903e5c-dd90-4e45-90fa-0b099bcbfdf8">17,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i51a7db08b41d4559b10e461df7cae951_I20211231" decimals="-3" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfMi0xMC0xLTEtMTEyNjQw_0ccaae86-4830-4051-91e9-57c038d51ecb">9,461</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51a7db08b41d4559b10e461df7cae951_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfMi0xMi0xLTEtMTEyNjQw_d799b719-a635-4962-a32d-c39e0426e983">8,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis and Dianomi</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4284fcd53e4be492bf1abd42007aa6_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfMy0yLTEtMS0xMTI2NDA_bf440871-7974-4205-ad16-13dac5c7a42d">10,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f4284fcd53e4be492bf1abd42007aa6_I20221231" decimals="-3" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfMy00LTEtMS0xMTI2NDA_8dad2ae0-80a1-4237-abad-88addcb8fd71">8,578</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4284fcd53e4be492bf1abd42007aa6_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfMy02LTEtMS0xMTI2NDA_ea096cfb-9667-4a8e-8077-a9a7509e72c7">2,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icafaf42275b04638a6eb47f7e4f9d5ae_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfMy04LTEtMS0xMTI2NDA_5d757dd8-de38-4247-b69d-03198a5dbc9f">10,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icafaf42275b04638a6eb47f7e4f9d5ae_I20211231" decimals="-3" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfMy0xMC0xLTEtMTEyNjQw_7bc5a3fd-4f42-45c2-ab77-1d306f92867b">8,727</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icafaf42275b04638a6eb47f7e4f9d5ae_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfMy0xMi0xLTEtMTEyNjQw_c9a3bc66-6190-4769-90c4-bea9c4079a9b">1,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i753bf04acd14417f84584d364adb5bb8_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfNC0yLTEtMS0xMTI2NDA_da9fe0c8-321e-495c-974d-0b2bcd6f37cb">28,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i753bf04acd14417f84584d364adb5bb8_I20221231" decimals="-3" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfNC00LTEtMS0xMTI2NDA_0fb4444b-0ea1-412e-adb5-73f0cbed89a5">18,116</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i753bf04acd14417f84584d364adb5bb8_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfNC02LTEtMS0xMTI2NDA_d634e317-0168-4b90-bd32-347fd95b99eb">10,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdc31d97ec44363932ea54316ee86c1_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfNC04LTEtMS0xMTI2NDA_63130f0f-f9b5-444d-8b36-9294728b8614">28,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fdc31d97ec44363932ea54316ee86c1_I20211231" decimals="-3" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfNC0xMC0xLTEtMTEyNjQw_1f92ee51-7c21-4442-abb8-0d6f8d26e4cc">18,188</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdc31d97ec44363932ea54316ee86c1_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfNC0xMi0xLTEtMTEyNjQw_02467d91-2407-40f7-8221-8f99fb67bdac">10,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Amounts represent accumulated amortization to principal of $<ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTY0OTI2NzUwNjgwMQ_4329d5be-5379-40e8-be45-a803892e92fd">11.6</ix:nonFraction> million and credit loss adjustments of $<ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-5" name="lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTY0OTI2NzUwNjgyMA_34a2bd63-93cc-4695-9ad0-41e8f6071cac">6.5</ix:nonFraction> million as of December 31, 2022. </span></div></ix:nonNumeric><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"><ix:continuation id="i9e31dd21289a4f1a98ee8cd7cf94749d">(2) Amounts represent accumulated amortization to principal of $<ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTY0OTI2NzUwNjg0Mg_42895083-d2ae-4337-8543-a8459979de73">11.7</ix:nonFraction> million and credit loss adjustments of $<ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-5" name="lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTY0OTI2NzUwNjg1Ng_0070f537-907d-40b4-b0f8-280040652f6f">6.5</ix:nonFraction> million as of December 31, 2021.</ix:continuation> </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial license and other economic rights as of December&#160;31, 2022 represent a portfolio of future milestone and royalty payment rights acquired from Selexis in April 2013 and April 2015, CorMatrix in May 2016, and Dianomi in January 2019. Commercial license rights acquired are accounted for as financial assets, and other economic rights are accounted for as funded research and developments as further discussed below. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2019, we entered into a development funding and royalties agreement with Novan, pursuant to which we would receive certain payments at specified milestones, as well as royalties on any future net sales of SB206, a product candidate being developed to treat molluscum contagiosum, and any other Novan products used for the treatment of molluscum (&#8220;Novan Molluscum Products&#8221;). We paid Novan an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="ie4ed1fc049264324b4138e54a53f1363_D20190501-20190531" decimals="-5" name="lgnd:LicenseUpfrontPayment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTY1MDU_bd723695-ebcb-419f-889b-2f5988f3657f">12.0</ix:nonFraction> million, which Novan is required to use to fund the development of SB206. We are not obligated to provide additional funding to Novan for the development or commercialization of SB206. Pursuant to the agreement, we would receive up to $<ix:nonFraction unitRef="usd" contextRef="i7e227d79f69e4aea8a7ba69a8fb5790c_I20190531" decimals="INF" name="lgnd:AdditionalRoyaltiesReceivableUnderSalesbasedMilestones" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTY3MzU_78e55737-2a99-4435-ad1c-d3e698389617">20.0</ix:nonFraction> million of milestone payments upon the achievement by Novan of certain regulatory milestones for SB206 or any other Novan Molluscum Product and commercial milestones. In addition to the milestone payments, Novan will pay us tiered royalties from <ix:nonFraction unitRef="number" contextRef="if79b3620292a470e909e7af19aa0f62a_I20190531" decimals="INF" name="lgnd:ProductRoyaltyPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTY5NzY_cebc6118-f58f-4f89-831c-5a05a3938b62">7.0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i41a81ed9d20a45a39c1cfa8bf254af62_I20190531" decimals="INF" name="lgnd:ProductRoyaltyPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTY5ODI_699c63ff-2aed-419d-bc41-f9c9c0359647">10.0</ix:nonFraction>% based on aggregate annual net sales of SB206 or any other Novan Molluscum Product in North America. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2018, we entered into a development funding and royalties agreement with Palvella. Pursuant to the agreement, we will receive up to $<ix:nonFraction unitRef="usd" contextRef="i4ed660187f8a4347b6987765f4320888_I20181231" decimals="INF" name="lgnd:AdditionalRoyaltiesReceivableUnderSalesbasedMilestones" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTcyMzE_18e0cf41-1893-4858-b90e-cc06ef58e594">8.0</ix:nonFraction> million of milestone payments upon the achievement by Palvella of certain corporate, financing and regulatory milestones for PTX-022, a product candidate being developed to treat pachyonychia congenita. In addition to the milestone payments, Palvella will pay us tiered royalties from <ix:nonFraction unitRef="number" contextRef="id02e516cbca146e2836770e595c232e1_I20181231" decimals="INF" name="lgnd:ProductRoyaltyPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTc1MTE_5c3171db-f34d-4781-9faa-edcbee37100d">5.0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i91f484a16cb744a5b11a95592c952710_I20181231" decimals="INF" name="lgnd:ProductRoyaltyPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTc1MTc_393a92b4-769d-4a58-8a23-1cb4124da370">9.8</ix:nonFraction>% based on aggregate annual worldwide net sales of any PTX-022 products, if approved, subject to Palvella&#8217;s right to reduce the royalty rates by making payments in certain circumstances. We made an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="i1454c0a0b9464c84aec81eed615b63f1_D20181201-20181231" decimals="-5" name="lgnd:LicenseUpfrontPayment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTc3MzU_9241cfea-391b-49e0-ba7b-4dec979ba4e3">10.0</ix:nonFraction> million, which Palvella is required to use to fund the development of PTX-022. We are not obligated to provide additional funding to Palvella for development or commercialization of PTX-022. </span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i00e37b0f214346eb8189230abe34b1b1" continuedAt="ic6167f68fe5a412982c6972aa42b8a76"><ix:continuation id="i8125be12360f4dedb9bc9ce185a9ceda" continuedAt="if5083cf19ea948aa80193f47b3f2d1a8"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determined the economic rights related to Novan and Palvella should be characterized as a funded research and development arrangement, thus we account for them in accordance with ASC 730-20, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Arrangement, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and reduce our asset as the funds are expended by Novan and Palvella. As of December 31, 2019, Novan had used up the $<ix:nonFraction unitRef="usd" contextRef="ie4ed1fc049264324b4138e54a53f1363_D20190501-20190531" decimals="-5" name="lgnd:LicenseUpfrontPayment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTgyNzI_bd723695-ebcb-419f-889b-2f5988f3657f">12.0</ix:nonFraction> million upfront payment provided by us. As such, our other economic rights related to Novan had been fully amortized as of December 31, 2019. As of December 31, 2020, the fund has been fully expended by Palvella and our cost basis for the asset has been reduced to <ix:nonFraction unitRef="usd" contextRef="i457b511b1d08453b8802d9e74dbddb90_I20201231" decimals="INF" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTg1MzI_aad20ff8-bdc8-4ca6-ae80-df9ed45d8d60">zero</ix:nonFraction>, and therefore we will recognize milestones and royalties as revenue when earned. During 2020, we recorded a $<ix:nonFraction unitRef="usd" contextRef="ifa528f43c78d4e52915523cdd982ac81_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTg2NDQ_022597d9-20c3-443f-94c1-19a8b327d374">3.0</ix:nonFraction> million milestone from Palvella under contract revenue, which has been included in our consolidated statement of operations for the year ended December 31, 2020.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, we entered into a royalty agreement with Aziyo pursuant to which we will receive royalties from certain marketed products that Aziyo acquired from CorMatrix. Pursuant to the agreement, we received $<ix:nonFraction unitRef="usd" contextRef="id2cce7f20f9b4fb296a7526469510cff_D20170531-20170531" decimals="-5" name="us-gaap:ProceedsFromRoyaltiesReceived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTg5OTc_c24d1288-e306-42f8-967a-6e17af15e8a6">10.0</ix:nonFraction> million in 2017 from Aziyo to buydown the royalty rates on the products CorMatrix sold to Aziyo. The agreement closed on May 31, 2017, in connection with the closing of the asset sale from CorMatrix to Aziyo (the &#8220;CorMatrix Asset Sale&#8221;). Per the agreement, we will receive a <ix:nonFraction unitRef="number" contextRef="i60474bf54aa94e98b1b7827f2c4e28ec_I20170531" decimals="INF" name="lgnd:ProductRoyaltyPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTkyNjc_701e7c8a-4b7f-4546-b856-3df1ff45131f">5</ix:nonFraction>% royalty on the products Aziyo acquired in the CorMatrix Asset Sale, reduced from the original <ix:nonFraction unitRef="number" contextRef="i9a7a01e9b3e44e6d9b9d6af540a8e364_I20170531" decimals="INF" name="lgnd:ProductRoyaltyPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTkzNjQ_0759a1a5-2ef2-450a-85f6-92eca71a5cde">20</ix:nonFraction>% royalty from CorMatrix pursuant to the previously disclosed interest purchase agreement, dated May 3, 2016 (the &#8220;Original Interest Purchase Agreement&#8221;) between CorMatrix and us. In addition, Aziyo has agreed to pay us up to $<ix:nonFraction unitRef="usd" contextRef="i362045e8eca24e9b94ed9065fd915555_I20170531" decimals="INF" name="lgnd:AdditionalRoyaltiesReceivableUnderSalesbasedMilestones" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTk1OTE_dc6d88bc-e952-4a91-852b-bf7cb89a6aca">10.0</ix:nonFraction> million of additional milestones tied to cumulative net sales of the products Aziyo acquired in the CorMatrix Asset Sale and to extend the term on these royalties by one year. The royalty agreement will terminate on May 31, 2027. In addition, in May 2017, we entered into an amended and restated interest purchase agreement (the &#8220;Amended Interest Purchase Agreement&#8221;) with CorMatrix, which supersedes in its entirety the Original Interest Purchase Agreement. Other than removing the commercial products sold to Aziyo in the CorMatrix Sale, the terms of the Amended Interest Purchase Agreement remain unchanged with respect to the CorMatrix developmental pipeline products, including the royalty rate of <ix:nonFraction unitRef="number" contextRef="iad947c25f57e49ecb7709c07507fa8f5_I20170531" decimals="INF" name="lgnd:ProductRoyaltyPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMjAyODk_aeddb724-c008-481f-b0b9-2c51c8ff70c6">5</ix:nonFraction>% on such pipeline products. The Amended Interest Purchase Agreement will terminate <ix:nonNumeric contextRef="ia0566a97a54e4f9ab7c582ae4caada22_D20170531-20170531" name="lgnd:RoyaltyAgreementExpirationPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMjAzNzQ_434188dd-3824-47bd-b839-3e50698dadb6">10</ix:nonNumeric> years from the date of the first commercial sale of such products. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for the Aziyo commercial license right as a financial asset in accordance with ASC 310, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Receivables</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and amortize the commercial license right using the effective interest method whereby we forecast expected cash flows over the term of the arrangement to arrive at an annualized effective interest. The annual effective interest associated with the forecasted cash flows from the royalty agreement with Aziyo as of December&#160;31, 2022 is <ix:nonFraction unitRef="number" contextRef="iacff0d31a3c2457a9ee720c8fbcc8054_D20220101-20221231" decimals="3" name="lgnd:ForecastedCashFlowsEffectiveInterestRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMjA4NzI_686128fe-684a-4cc0-94cc-379e9fb3abb7">19.0</ix:nonFraction>%. Revenue is calculated by multiplying the carrying value of the commercial license right by the effective interest. The payments received in the year ended December&#160;31, 2022 and 2021 were allocated accordingly between revenue and the amortization of the commercial license rights.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to 2020, we accounted for commercial license rights related to developmental pipeline products such as Selexis and Dianomi on a non-accrual basis. These developmental pipeline products are non-commercialized, non-approved products that require FDA or other regulatory approval, and thus have uncertain cash flows. The developmental pipeline products are on a non-accrual basis as we are not yet able to forecast future cash flows given their pre-commercial stages of development. We will prospectively update the yield model under the effective interest method once the underlying products are commercialized and we can reliably forecast expected cash flows. Income will be calculated by multiplying the carrying value of the commercial license right by the effective interest rate. We regularly perform reviews to determine if any event has occurred that may indicate the carrying value of these commercial license rights are potentially impaired. If the affected commercial license rights are not recoverable, we estimate the fair value of the assets and record an impairment loss if the carrying value of the assets exceeds the fair value. During 2020, given the expected cash flow from the Selexis program, we started to account for the Selexis commercial license right as a financial asset in accordance with ASC 310, and amortize the commercial license right using the effective interest method whereby we forecast expected cash flows over the term of the arrangement to arrive at an annualized effective interest. The annual effective interest associated with the forecasted cash flows from the royalty agreement with Selexis as of December&#160;31, 2022 is <ix:nonFraction unitRef="number" contextRef="i670101d682ab4040a9ecb714406fabd0_D20220101-20221231" decimals="3" name="lgnd:ForecastedCashFlowsEffectiveInterestRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMjI3NzE_eb0158f4-c349-4cc0-b5ef-a0cb80ef7b98">24.6</ix:nonFraction>%. Revenue is calculated by multiplying the carrying value of the commercial license right by the effective interest. The payments received in the year ended December&#160;31, 2022 and 2021 were allocated accordingly between revenue and the amortization of the commercial license rights. We still accounted for commercial license rights related to Dianomi on a non-accrual basis as of December&#160;31, 2022.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For commercial license rights, we have elected a prospective approach to account for changes in estimated cash flows and selected a method for determining when an impairment would be recognized and how to measure that impairment. In circumstances where our new estimate of expected cash flows is greater than previously expected, we will update our yield prospectively. In circumstances where our new estimate of expected cash flows is less than previously expected and below our original estimated yield we record an impairment. Impairment is recognized by reducing the financial asset to an amount that represents the present value of our most recent estimate of expected cash flows discounted by the original effective interest rate.&#160;In circumstances where our new estimate of expected cash flows is less than previously expected, but not below our original estimated yield, we update our yield prospectively.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of adopting ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments &#8211; Credit Losses: Measurement of Credit losses on Financial Instruments (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we now recognize an allowance for current expected credit losses on the commercial license rights subject to credit risk. We recorded a $<ix:nonFraction unitRef="usd" contextRef="if715884926d24da68b91903ae544927e_I20200101" decimals="-5" name="lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMjQzMzQ_250e86cf-b9ba-439e-a382-4e6fbadd8981">5.5</ix:nonFraction> million pre-tax reserve for credit losses upon adoption of the standard on January 1, </span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic6167f68fe5a412982c6972aa42b8a76" continuedAt="i2b598642fc344cdd849931f774e3fca6"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if5083cf19ea948aa80193f47b3f2d1a8">2020. We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the twelve months ended December 31, 2022 and 2021, we further considered the current and expected future economic and market conditions. We concluded a reduction of $<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-5" sign="-" name="lgnd:AccountsReceivableCreditLossExpenseReversalCOVID19" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNTQ5NzU1ODgxOTcx_e2913a71-be55-4b01-9a8e-454797437417">0.3</ix:nonFraction> million and  $<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-5" sign="-" name="lgnd:AccountsReceivableCreditLossExpenseReversalCOVID19" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTY0OTI2NzUwNjg5Nw_dded8f80-bc39-46c3-9fd1-54c501aa34fd">0.5</ix:nonFraction> million to the allowance for credit losses in other expense, net, in our consolidated statements of operations for the year ended 2022 and 2021, respectively.</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2NzM_2971fe71-47ba-4513-ac5c-432d2615e26b" continuedAt="i2d779f6232fc43578563fe473ab9890e" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply the following five-step model in accordance with ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in order to determine the revenue: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalties</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive royalty revenue on sales by our partners of products covered by patents that we or our partners own under contractual agreements. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a royalty to be recorded no sooner than the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues are adjusted in the period in which they become known, typically the following quarter. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Captisol Sales</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from Captisol sales is recognized when control of Captisol material or intellectual property license rights is transferred to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. For Captisol material, we consider our performance obligation is satisfied at a point in time, once we have transferred control of the product, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We have elected to recognize the cost of freight and shipping when control over Captisol material has transferred to the customer as an expense in Cost of Captisol. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Revenue</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contracts with customers often will include variable consideration in the form of contingent milestone-based payments. We include contingent milestone based payments in the estimated transaction price when it is probable a significant reversal in the amount of cumulative revenue recognized will not occur. These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone based payment is sales-based, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development based milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon the development milestone or regulatory approval. Depending on the terms of the arrangement, we may also defer a portion of the consideration received if we have to satisfy a future obligation, which typically occurs with our contracts for R&amp;D services.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For R&amp;D services we recognize revenue over time and we measure our progress using an input method. The input methods we use are based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time it will take us to complete the activities, or the costs we may incur in a given </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2b598642fc344cdd849931f774e3fca6" continuedAt="if670f122c8154b79ab6ed972dabac421"><ix:continuation id="i2d779f6232fc43578563fe473ab9890e" continuedAt="i521083d810134955bc6005d3bd7340c5"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make numerous estimates and use significant judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We occasionally have sub-license obligations related to arrangements for which we receive license fees, milestones and royalties. We evaluate the determination of gross as a principal versus net as an agent reporting based on each individual agreement.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Revenue</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the terms of the arrangement, we may also defer a portion of the consideration received if we have to satisfy a future obligation.</span></div></ix:continuation><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i521083d810134955bc6005d3bd7340c5">The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry a contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue.</ix:continuation> During the twelve months ended December&#160;31, 2022, the amount recognized as revenue that was previously deferred at December 31, 2021 was $<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMzE4NDY_3c45aba2-2b78-4bb7-9c23-6d0c66628553">0.4</ix:nonFraction> million. During the twelve months ended December&#160;31, 2021, the amount recognized as revenue that was previously deferred at December 31, 2020 was $<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMzE5NTU_e95d9614-84ea-4e75-a11f-7d50f0ee291c">23.3</ix:nonFraction> million. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenue </span></div><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2NTY_78affdb8-b0c0-4533-ad7a-b0ce1ac57d55" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Royalty revenue for 2022, 2021 and 2020 for continuing operations are reported as below (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kyprolis</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ec9717cd1d246078b4b569036ffdc49_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfMy0yLTEtMS0xMTI2NDA_cd7a2006-5e11-4705-bdc5-eeaba3a696a1">30,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54dbd99694aa4daab7990f243b799c03_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfMy00LTEtMS0xMTI2NDA_ae262c89-3d62-4c4b-924d-d51c05d3464b">27,472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afb2b3d7d6642b4a6bf2a125abec1e1_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfMy02LTEtMS0xMTI2NDA_7d53bea2-7550-4137-8f86-19d058215231">25,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c92061ff9b94c6eb2d8a4a23c829de0_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfNC0yLTEtMS0xMTI2NDA_b6ceefce-8db9-4146-9a6a-18643abae07c">10,197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd8f3bf9de1f4fd7beedb580d9c6cdee_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfNC00LTEtMS0xMTI2NDA_77332419-8d73-40ee-8a2f-b8f04d52647e">10,079</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e6496921c848a79e380a93f9d05bc4_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfNC02LTEtMS0xMTI2NDA_286c6d89-e163-4ce6-89f6-b69e067fd158">6,377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Teriparatide injection </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b7d6c7b066c452794362e3368d3f7e3_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfNS0yLTEtMS0xMjU2NDg_341e4325-14fc-4603-8aa9-7001abd153ac">15,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea65617bbc2b47b48426079a24526cbe_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfNS00LTEtMS0xMjU5MDU_e0a0eadb-3901-4a18-bcb8-7bcab8ee40b0">5,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5493b3bc3d6c4726aa3bd80b40ca081f_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfNS02LTEtMS0xMjU5NzI_7854633b-db8f-47eb-a54a-8bf6fe289812">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rylaze </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fbfab2afcba47db8cd01d943434d7c7_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfNi0yLTEtMS0xMjU2NDg_68b419c7-55ac-4b06-8e23-afd7c8d6ab91">8,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ece9d53186c440cbe209564d6285e78_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfNi00LTEtMS0xMjU5MDU_145aa668-792a-4bc0-b635-6e804a34083f">2,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49757f616a7c43cf861c739d9acb2ab5_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfNi02LTEtMS0xMjU5NzI_53c9dcae-b5b8-444c-a003-fd49e4277e64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idac514c491cc4a208f76c94595c132f5_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfNS0yLTEtMS0xMTI2NDA_7cc3eaca-1f66-4826-a2e4-c657f635f78e">7,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73902d56a64240c0bf0d410617877557_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfNS00LTEtMS0xMTI2NDA_8317ddcd-9798-4a8e-afda-89d1530d4c59">3,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03cd5d2142d44bf7a2bcaa6d8f29b13a_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfNS02LTEtMS0xMTI2NDA_b4557738-7340-46c6-9385-02aa78672fb4">2,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91e01e3752fa4607875a52688c787ed4_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfNy0yLTEtMS0xMTI2NDA_bd690be7-26f4-4f6f-8285-28038f513b75">72,527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7acccfdc49ae41ec9d81e2a77aaeab89_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfNy00LTEtMS0xMTI2NDA_c1e723ba-c4b4-47bc-996c-517925c53e80">48,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8303bd1e530e4c06b3bb8c3093343f43_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfNy02LTEtMS0xMTI2NDA_f27f048d-c06d-41ab-ba75-edd7ce7e7a7a">33,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents disaggregation of Captisol and contract revenue for continuing operations (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Captisol</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Captisol - Core</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65647a80fbc847cb96058a3c631b002b_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfMy0yLTEtMS0xMjU3ODM_7dbc9648-f6f9-4f39-93cf-407629a53e53">16,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43de1a804883437584799c38ec4bbfba_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfMy00LTEtMS0xMjU5MTk_bed67803-634d-4d9b-a72a-3f8d1acdcdcb">23,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie02c8b74a58c4e0da8c4a0da3e2af0ab_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfMy02LTEtMS0xMjYwNDk_3710ab3e-b0a8-4339-8b27-de9b30b57d8c">24,566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Captisol - COVID</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id131b624b01b400987332697abc2b43d_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfNC0yLTEtMS0xMjU3ODk_fd9b0430-29f0-408b-b491-7ebd3885d212">88,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief5aa8a800b746d481cd0985dd7ec3d3_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfNC00LTEtMS0xMjU5MTk_7ca26503-52f1-4203-9232-690be87ef091">140,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11e9985562a84328a97129345abae661_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfNC02LTEtMS0xMjYwNDk_d54ca929-fe73-47ff-959e-03e018ac7cf0">85,393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if07332e474464098b61af13fe5a470f2_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfNS0yLTEtMS0xMzU4MDQ_f01887e1-ce94-4a36-b454-80480b8c3ad3">104,495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6747a650dc714496a27ce80ca1fde353_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfNS00LTEtMS0xMzU4MDc_b275ad37-50ee-4bff-bbdc-e4988587aa27">164,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i065c2ca723f44ed7b4161976d58b5fe9_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfNS02LTEtMS0xMzU4MTA_d0d51756-8917-4824-b7e5-bfc2338b1712">109,959</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Service Revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08870b2004dd43bdaece251ed3f21347_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfNS0yLTEtMS0xMTI2NDA_89a598d8-2869-4be0-a4fd-1d747d82630a">1,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68260ef8bbec41adbf8a2108d95376f8_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfNS00LTEtMS0xMTI2NDA_946020e5-781e-402b-ab60-94c46dd1d8d5">3,737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if88162f99d40461a9310c0ae816fd224_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfNS02LTEtMS0xMTI2NDA_cf79e818-89e6-4738-ae44-d30b9759d6d0">9,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;License Fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1de672c0b42480eb2b6b143b340f6a5_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfNi0yLTEtMS0xMTI2NDA_e51697d2-1457-4ab1-9f83-5f0e946e51b9">2,849</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ffe37b6e1e44b3a84fe52fd8879a67d_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfNi00LTEtMS0xMTI2NDA_1aa10a15-f74b-43ec-a3a0-ec7b74e176c5">634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if42c010475e14a4099a8428492cce1cb_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfNi02LTEtMS0xMTI2NDA_49c4d630-2bb6-434a-a10b-9d26ed50efd0">119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Milestone</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic38b9e57dd5b4eccb6ea203b21533a2b_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfNy0yLTEtMS0xMTI2NDA_34021eaa-347b-40b1-af7f-0ff7db8f316a">9,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e8ef293cc81451599d632430c78f16d_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfNy00LTEtMS0xMTI2NDA_946209f7-1e7f-4706-a7e7-f9a56eeb07ea">17,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91b0803652084754984846b312275eec_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfNy02LTEtMS0xMTI2NDA_d2eac504-89b3-4c78-80c5-e344025466de">5,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf61891c2afc4735abc2848c436bdd90_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfOC0yLTEtMS0xMTI2NDA_25ade74c-d6e0-4369-af12-eae3a236c04e">6,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e3529f39eae4d9e9e67e1b00baf464b_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfOC00LTEtMS0xMTI2NDA_bd9299a4-3d57-4612-8e14-e28aafb73703">6,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0132672fab9842058c3e5d0239853868_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfOC02LTEtMS0xMTI2NDA_ea5f3ce0-86a4-4e5a-9b55-39dbd06d0ca7">5,141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a2c832b6c46461c9fa690319f44159f_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfOS0yLTEtMS0xMTI2NDA_2f525de3-0c4f-4d67-88fa-91d5b2dd55da">19,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6041ab2411645599b1e142a09232af6_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfOS00LTEtMS0xMTI2NDA_110c793e-f246-4433-b088-5b815b1d546e">28,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbbf2bd60ac64c15aa70a568639f50ab_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfOS02LTEtMS0xMTI2NDA_7dab7020-d004-46cf-af39-4258cdb2c05c">19,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(a) Captisol - COVID represents revenue on Captisol supplied for use in formulation with remdesivir, an antiviral treatment for COVID-19.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if670f122c8154b79ab6ed972dabac421" continuedAt="i6855007757bc41beb12105ab40392b84"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2ODU_cebc3275-6aac-444b-ba44-92d11298a584" continuedAt="i782674eb19b34cf3878101848471dab2" escape="true">Research and Development Expenses</ix:nonNumeric></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i782674eb19b34cf3878101848471dab2">Research and development expense consists of labor, material, equipment, and allocated facilities costs of our scientific staff who are working pursuant to our collaborative agreements and other research and development projects. Also included in research and development expenses are third-party costs incurred for our research programs including in-licensing costs, contract research organization (CRO) costs and costs incurred by other research and development service vendors. We expense these costs as they are incurred. When we make payments for research and development services prior to the services being rendered, we record those amounts as prepaid assets on our consolidated balance sheet and we expense them as the services are provided.</ix:continuation> </span></div><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2NjY_7e8dd424-9002-4dca-adce-627a1a15f0de" continuedAt="i6c16769b1def41a58318d6731fef7800" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incur share-based compensation expense related to restricted stock, ESPP, and stock options.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock unit (RSU) and performance stock unit (PSU) are all considered restricted stock. The fair value of restricted stock is determined by the closing market price of our common stock on the date of grant. We recognize share-based compensation expense based on the fair value on a straight-line basis over the requisite service periods of the awards, taking into consideration of forfeitures as they occur. PSU generally represents a right to receive a certain number of shares of common stock based on the achievement of corporate performance goals and continued employment during the vesting period. At each reporting period, we reassess the probability of the achievement of such corporate performance goals and any expense change resulting from an adjustment in the estimated shares to be released are treated as a cumulative catch-up in the period of adjustment. A limited amount of PSUs contain a market condition dependent upon the Company&#8217;s relative and absolute total stockholder return over a <ix:nonNumeric contextRef="i2323eac91b2548d9bb0aa30d38e34f63_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2ODg_f1a3c611-b62b-4131-91f7-14279e42ad83">three-year</ix:nonNumeric> period, with a range of <ix:nonFraction unitRef="number" contextRef="i842018ac4595423692c11f2da85cf3eb_D20220101-20221231" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMzQwOTA_ec161f9b-2c14-4472-a4ea-5be8b84749a5">0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i489ca56af41b4556bad1bd319b7b8c4d_D20220101-20221231" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMzQwOTY_aa71b043-ca4b-47bb-9c45-b95af354e978">200</ix:nonFraction>% of the target amount granted to be issued under the award. Share-based compensation expense for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the market conditions.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes-Merton option-pricing model is used to estimate the fair value of stock purchases under our ESPP and stock options granted. The model assumptions include expected volatility, term, dividends, and the risk-free interest rate. We look to historical and implied volatility of our stock to determine the expected volatility. The expected term of an award is based on historical forfeiture experience, exercise activity, and on the terms and conditions of the stock awards. The expected dividend yield is determined to be <ix:nonFraction unitRef="number" contextRef="icc63108210a948b5865cfb7ad3c24f5b_I20221231" decimals="2" name="us-gaap:EquitySecuritiesFvNiMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMzQ4ODk_b7df06d2-3eb6-49fc-baca-8710edc232fe">0</ix:nonFraction>% given that except for 2007, during which we declared a cash dividend on our common stock of $<ix:nonFraction unitRef="usdPerShare" contextRef="i0e24dfa538c74d94916136c2c583e53b_D20070101-20071231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMzQ5ODQ_359b00b1-0707-4d59-be5c-08890c39f276">2.50</ix:nonFraction> per share, we have not paid any dividends on our common stock in the past and currently do not expect to pay cash dividends or make any other distributions on common stock in the future. The risk-free interest rate is based upon U.S. Treasury securities with remaining terms similar to the expected term of the share-based awards.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We grant options, RSUs and PSUs to employees and non-employee directors. Non-employee directors are accounted for as employees. Options and RSUs granted to certain non-employee directors typically vest one year from the date of grant. Options granted to employees typically vest 1/8 on the <ix:nonNumeric contextRef="i0ea94c0a78a84acbbb4c6b276629f850_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2NzU_47e0ca34-c23d-45cb-9e1a-dd47a60474df">six month</ix:nonNumeric> anniversary of the date of grant, and 1/48 each month thereafter for <ix:nonNumeric contextRef="i0c3c548b83e74abda3686b765b62aafc_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2ODA_b122f46f-69d1-4494-a81b-dcc69d7f79fa">forty-two months</ix:nonNumeric>. RSUs and PSUs granted to employees vest over <ix:nonNumeric contextRef="i1a7d01a48d59487f83e3391779612e31_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMzU3NDM_9fa98211-127a-4679-84b6-b66ebbc7ec63">three years</ix:nonNumeric>. All option awards generally expire <ix:nonNumeric contextRef="i7c0d366af0a24bf3b783d1043d41aeac_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMzU3ODI_90aba991-1035-4af8-b1f6-bbf5f4d5e4b1">ten years</ix:nonNumeric> from the date of grant.</span></div></ix:nonNumeric><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6c16769b1def41a58318d6731fef7800">Share-based compensation expense for awards to employees and non-employee directors is recognized on a straight-line basis over the vesting period until the last tranche vests.</ix:continuation> </span></div><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2NjI_7d652817-a618-487a-a06c-73614a40d608" continuedAt="i7b3d19c40db74d6a91b9e5ffc19051e4" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes is computed using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for the expected future tax benefit to be derived from tax loss and credit carryforwards. Deferred tax assets and liabilities are determined using the enacted tax rates in effect for the years in which those tax assets are expected to be realized. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the provision for income taxes in the period that includes the enactment date. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets are regularly assessed to determine the likelihood they will be recovered from future taxable income. A valuation allowance is established when we believe it is more likely than not the future realization of all or some of a deferred tax asset will not be achieved. In evaluating the ability to recover deferred tax assets within the jurisdiction which they arise we consider all available positive and negative evidence. Factors reviewed include the cumulative pre-tax book income for the past three years, scheduled reversals of deferred tax liabilities, history of earnings and reliable forecasting, projections of pre-tax book income over the foreseeable future, and the impact of any feasible and prudent tax planning strategies.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the impact of a tax position in our financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Tax authorities regularly examine our returns in the jurisdictions in which we do business and we regularly assess the tax risk of our return filing positions. Due to the complexity of some of the uncertainties, the ultimate resolution may result in payments that are materially </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i6855007757bc41beb12105ab40392b84" continuedAt="id640459527c04403b14f2651588d52e1"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7b3d19c40db74d6a91b9e5ffc19051e4">different from our current estimate of the tax liability. These differences, as well as any interest and penalties, will be reflected in the provision for income taxes in the period in which they are determined.</ix:continuation></span></div><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2NzY_ef4d9cb1-96eb-4b58-8a33-56dc2313a4de" continuedAt="ia10516de256840c68d96d91b436dda39" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income (Loss) Per Share</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic income (loss) per share is calculated by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Diluted income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of the Company&#8217;s common stock exceeds the applicable conversion price of the respective notes. It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for stock options and restricted stock. In loss periods, basic net loss per share and diluted net loss per share are identical since the effect of otherwise dilutive potential common shares is anti-dilutive and therefore excluded.</span></div></ix:nonNumeric><div style="margin-bottom:6pt"><ix:continuation id="ia10516de256840c68d96d91b436dda39" continuedAt="i621b1179b1054fd793d9d7897ab6b0c4"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 260, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings per Share</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i621b1179b1054fd793d9d7897ab6b0c4">, if a company had a discontinuing operation, the company uses income from continuing operations, adjusted for preferred dividends and similar adjustments, as its control number to determine whether potential common shares a dilutive.</ix:continuation> <ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2NzA_eed3067c-348c-42bf-ac5a-c16409413505" continuedAt="i7550d4369ff64d6fa789e9d67bb39d31" escape="true">The following table presents the calculation of weighted average shares used to calculate basic and diluted income (loss) per share (in thousands):</ix:nonNumeric></span><ix:continuation id="i7550d4369ff64d6fa789e9d67bb39d31"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:62.189%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.649%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmFiZGE2NmQ1MjFmYzQ0ZDJiMzEwMGVkMzUxOTQ0YjAwL3RhYmxlcmFuZ2U6YWJkYTY2ZDUyMWZjNDRkMmIzMTAwZWQzNTE5NDRiMDBfMi0xLTEtMS0xMTI2NDA_d84f4b79-d4ec-48a8-a992-94f04dc1659e">16,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmFiZGE2NmQ1MjFmYzQ0ZDJiMzEwMGVkMzUxOTQ0YjAwL3RhYmxlcmFuZ2U6YWJkYTY2ZDUyMWZjNDRkMmIzMTAwZWQzNTE5NDRiMDBfMi0zLTEtMS0xMTI2NDA_5186eaaa-80e1-4f08-a8a5-ca70ededd5c6">16,630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmFiZGE2NmQ1MjFmYzQ0ZDJiMzEwMGVkMzUxOTQ0YjAwL3RhYmxlcmFuZ2U6YWJkYTY2ZDUyMWZjNDRkMmIzMTAwZWQzNTE5NDRiMDBfMi01LTEtMS0xMTI2NDA_11b5457d-499c-47a1-b958-2abe7baceac7">16,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive potential common shares:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icd7c9aa2ea5a470e8fbd4d80fce77775_D20220101-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmFiZGE2NmQ1MjFmYzQ0ZDJiMzEwMGVkMzUxOTQ0YjAwL3RhYmxlcmFuZ2U6YWJkYTY2ZDUyMWZjNDRkMmIzMTAwZWQzNTE5NDRiMDBfNC0xLTEtMS0xMTI2NDA_ba2c9985-1718-4dbd-9ec7-0a6ddabaad42">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i70fc66a3f20848b5bb0f70e3f866d45d_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmFiZGE2NmQ1MjFmYzQ0ZDJiMzEwMGVkMzUxOTQ0YjAwL3RhYmxlcmFuZ2U6YWJkYTY2ZDUyMWZjNDRkMmIzMTAwZWQzNTE5NDRiMDBfNC0zLTEtMS0xMTI2NDA_49942c52-6cff-4b3c-94f5-75e7da7cab2d">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i18c9bf22eb2e40bdb955de4a851b78c5_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmFiZGE2NmQ1MjFmYzQ0ZDJiMzEwMGVkMzUxOTQ0YjAwL3RhYmxlcmFuZ2U6YWJkYTY2ZDUyMWZjNDRkMmIzMTAwZWQzNTE5NDRiMDBfNC01LTEtMS0xMTI2NDA_69b7a2fc-eac6-40cd-925e-0f6edfdf3097">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if66ef91cf250497180df8bdafb040c04_D20220101-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmFiZGE2NmQ1MjFmYzQ0ZDJiMzEwMGVkMzUxOTQ0YjAwL3RhYmxlcmFuZ2U6YWJkYTY2ZDUyMWZjNDRkMmIzMTAwZWQzNTE5NDRiMDBfNS0xLTEtMS0xMTI2NDA_791220ee-a2e1-481a-a708-e4e942cf6292">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i67a5c3e26a4a41c5965dfa8c1722d00f_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmFiZGE2NmQ1MjFmYzQ0ZDJiMzEwMGVkMzUxOTQ0YjAwL3RhYmxlcmFuZ2U6YWJkYTY2ZDUyMWZjNDRkMmIzMTAwZWQzNTE5NDRiMDBfNS0zLTEtMS0xMTI2NDA_d61e435c-26d4-4437-b2e0-3f83369f141b">520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i76c8d1f51aad42668b7908e89daf66dd_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmFiZGE2NmQ1MjFmYzQ0ZDJiMzEwMGVkMzUxOTQ0YjAwL3RhYmxlcmFuZ2U6YWJkYTY2ZDUyMWZjNDRkMmIzMTAwZWQzNTE5NDRiMDBfNS01LTEtMS0xMTI2NDA_031f9fc0-8dbf-4174-b746-c293d91fa07f">584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used to compute diluted income per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmFiZGE2NmQ1MjFmYzQ0ZDJiMzEwMGVkMzUxOTQ0YjAwL3RhYmxlcmFuZ2U6YWJkYTY2ZDUyMWZjNDRkMmIzMTAwZWQzNTE5NDRiMDBfOC0xLTEtMS0xMTI2NDA_2b1591b7-4cf4-4531-984e-4646da32611d">16,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmFiZGE2NmQ1MjFmYzQ0ZDJiMzEwMGVkMzUxOTQ0YjAwL3RhYmxlcmFuZ2U6YWJkYTY2ZDUyMWZjNDRkMmIzMTAwZWQzNTE5NDRiMDBfOC0zLTEtMS0xMTI2NDA_29178ffd-d04e-480f-84c3-d3fde454786c">17,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmFiZGE2NmQ1MjFmYzQ0ZDJiMzEwMGVkMzUxOTQ0YjAwL3RhYmxlcmFuZ2U6YWJkYTY2ZDUyMWZjNDRkMmIzMTAwZWQzNTE5NDRiMDBfOC01LTEtMS0xMTI2NDA_07438b4b-2295-4b51-a7a3-35cb5f78dbee">16,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potentially dilutive shares excluded from calculation due to anti-dilutive effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmFiZGE2NmQ1MjFmYzQ0ZDJiMzEwMGVkMzUxOTQ0YjAwL3RhYmxlcmFuZ2U6YWJkYTY2ZDUyMWZjNDRkMmIzMTAwZWQzNTE5NDRiMDBfOS0xLTEtMS0xMTI2NDA_649c6ec6-45cb-4707-a738-c8c938f4d35b">6,241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmFiZGE2NmQ1MjFmYzQ0ZDJiMzEwMGVkMzUxOTQ0YjAwL3RhYmxlcmFuZ2U6YWJkYTY2ZDUyMWZjNDRkMmIzMTAwZWQzNTE5NDRiMDBfOS0zLTEtMS0xMTI2NDA_276eabd1-b407-4c96-8ef2-d668ae2c0ae2">4,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmFiZGE2NmQ1MjFmYzQ0ZDJiMzEwMGVkMzUxOTQ0YjAwL3RhYmxlcmFuZ2U6YWJkYTY2ZDUyMWZjNDRkMmIzMTAwZWQzNTE5NDRiMDBfOS01LTEtMS0xMTI2NDA_55794c8c-f2ac-4187-a552-0f9ae114384f">8,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:5pt"><span><br/></span></div><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2NzE_9a0a3186-f092-4682-9fd8-9152a739011c" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Income (Loss)</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) represents net income (loss) adjusted for the change during the periods presented in unrealized gains and losses on available-for-sale debt securities, foreign currency translation adjustments, and reclassification adjustments for realized gains or losses included in net income (loss). The unrealized gains or losses are reported on the Consolidated Statements of Comprehensive Income (Loss).</span></div></ix:nonNumeric><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2Nzc_22baffd5-22e7-450e-b574-4b6fd8a8f5aa" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The British Pound Sterling was the functional currency of our subsidiary, Vernalis, which was sold in fourth quarter of the year ended December 31, 2020. For the year ended December 31, 2020, the corresponding financial statements have been translated into U.S. Dollars in accordance with ASC 830-30, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Translation of Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Assets and liabilities are translated at end-of-period rates while revenues and expenses are translated at average rates in effect during the period in which the activity took place. Equity is translated at historical rates and the resulting cumulative translation adjustments are included as a component of accumulated other comprehensive income (loss).</span></div></ix:nonNumeric><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2ODI_7feae187-b5b7-48a0-bfb4-1da42d14c507" continuedAt="icf9b2f254679494b96e3fcbdc8851301" escape="true">Accounting Standards Updates, Recently Adopted</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id640459527c04403b14f2651588d52e1"><ix:continuation id="icf9b2f254679494b96e3fcbdc8851301"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2020-06&#8221;). The guidance simplifies the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#8217;s own equity. Consequently, a convertible debt instrument, such as the Company&#8217;s 2023 Notes, will be accounted for as a single liability measured at its amortized cost, if no other features require bifurcation and recognition as derivatives. The new guidance also requires the if-converted method to be applied for all convertible instruments and requires additional disclosures. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We adopted this guidance effective January 1, 2022 under the modified retrospective approach and the comparative information has not been restated and continues to be presented according to accounting standards in effect for those periods. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption and our 2023 Notes are no longer bifurcated into separate liability and equity components. The principal amount of the 2023 Notes is classified as a single liability measured at amortized cost in the consolidated balance sheet for the period ended December 31, 2022. Upon adoption of ASU 2020-06 on January 1, 2022, we recorded an adjustment to the 2023 Notes liability component, deferred tax liabilities, additional paid-in-capital and retained earnings. This adjustment was calculated based on the carrying amount of the 2023 Notes as if it had always been treated as a single liability measured at amortized cost. Furthermore, we recorded an adjustment to the debt issuance costs contra liability and equity (additional paid-in-capital) components under the same premise, as if debt issuance costs had always been treated as a contra liability only. Under this transition method, the cumulative effect of the accounting change increased the carrying amount of the 2023 Notes by $<ix:nonFraction unitRef="usd" contextRef="i46c8bfd47e7444e6a01496cd453532d1_I20211231" decimals="-5" name="us-gaap:ConvertibleNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTY0OTI2NzUwNjIxNA_27b4583e-6c5b-47c8-8906-f5878e095b7f">20.4</ix:nonFraction> million, reduced deferred tax liabilities by $<ix:nonFraction unitRef="usd" contextRef="i46c8bfd47e7444e6a01496cd453532d1_I20211231" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTY0OTI2NzUwNjIzNg_cfaccadb-60eb-4d44-b009-93d38e9f1951">4.4</ix:nonFraction> million, reduced additional paid-in capital by $<ix:nonFraction unitRef="usd" contextRef="i710339a456f64bc8bad5a607120931a7_I20211231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTY0OTI2NzUwNjI1Nw_5331e7a0-d695-43dc-b0f2-c461541a4006">51.1</ix:nonFraction> million and increased retained earnings by $<ix:nonFraction unitRef="usd" contextRef="ie30007c66bb747999bd003d8277ab95c_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTY0OTI2NzUwNjI3OA_e8dc2f6f-2c5f-46d8-a512-d754c0c24d26">35.1</ix:nonFraction> million. The net balance of the 2023 Notes at January 1, 2022 was $<ix:nonFraction unitRef="usd" contextRef="ib6f656a779984d2e9b0f895f98e24654_I20211231" decimals="-5" name="us-gaap:ConvertibleNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTY0OTI2NzUwNjMwMA_c1756a22-55e3-43f4-a12b-7ca13677bc94">341.1</ix:nonFraction> million which included an unamortized discount of $<ix:nonFraction unitRef="usd" contextRef="ib6f656a779984d2e9b0f895f98e24654_I20211231" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTY0OTI2NzUwNjMyMA_990243d1-71a4-416a-8b5b-a8c36cd7f9bc">2.2</ix:nonFraction> million.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Standards Not Yet Adopted</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on our consolidated financial statements or disclosures.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_88"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RleHRyZWdpb246YTY5ZWNiMDEyMTk5NDkxZTg3NmMwYjhiNjM3ZjY5NjFfMjgxMw_0ca76ed5-1a86-4858-98dd-6f005b643679" continuedAt="i7f70f2ca79634984822b658d5fb0cdd5" escape="true">Spin-off of OmniAb</ix:nonNumeric></span></div><ix:continuation id="i7f70f2ca79634984822b658d5fb0cdd5" continuedAt="i9622658fa8e746f1b0f5222aa990f571"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 23, 2022, we entered into the Separation Agreement to separate our OmniAb Business and the Merger Agreement, pursuant to which Avista Public Acquisition Corp. II (&#8220;APAC&#8221;) would combine with OmniAb, and acquire Ligand's OmniAb Business, in a Reverse Morris Trust transaction (collectively, the &#8220;Transactions&#8221;). In connection with the execution of the Merger Agreement, we made organizational changes to better align our organizational structure with our strategy and operations, and management reorganized the reportable segments to better reflect how the business is evaluated by the chief operating decision maker. Beginning in the first quarter of 2022, we operated the following <ix:nonFraction unitRef="segment" contextRef="i6992767e8dd8406c922375c93b5376c2_D20220101-20220331" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RleHRyZWdpb246YTY5ZWNiMDEyMTk5NDkxZTg3NmMwYjhiNjM3ZjY5NjFfMjc0ODc3OTExMzI3OA_3c820760-14ef-4843-a566-2b2580cb5683">two</ix:nonFraction> reportable segments: (1) OmniAb business and (2) Ligand core business. The OmniAb business segment is focused on enabling the discovery of therapeutic candidates for our partners by pairing antibody repertoires generated from our proprietary transgenic animals with our OmniAb business platform screening tools. The Ligand core business segment is a biopharmaceutical business focused on developing or acquiring technologies that help pharmaceutical companies deliver and develop medicines. We performed a fair value analysis utilizing a combination of income approach and market approach to determine the fair value of each segment in order to appropriately allocate the goodwill between the segments as of the announcement date. We reassigned goodwill using a relative fair value allocation method, which resulted in goodwill of a $<ix:nonFraction unitRef="usd" contextRef="ib1f6b297465e41fc91ec81b76fb00d45_I20220331" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RleHRyZWdpb246YTY5ZWNiMDEyMTk5NDkxZTg3NmMwYjhiNjM3ZjY5NjFfMTY0OTI2NzQ4NTUwNQ_a743c972-cdd0-4451-ad94-8d2ddd91a446">105.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i38815b046b134f4e89a040e922235cd3_I20220331" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RleHRyZWdpb246YTY5ZWNiMDEyMTk5NDkxZTg3NmMwYjhiNjM3ZjY5NjFfMTY0OTI2NzQ4NTUxMw_c74b8dc9-e5cb-43da-aca3-f3b4e41a1586">75.5</ix:nonFraction> million being allocated to Ligand core business and OminAb business, respectively.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the closing date of the Transactions on November 1, 2022, the historical financial results of OmniAb have been reflected in our consolidated financial statements as discontinued operations under GAAP for all periods presented through the date of the Distribution. Pursuant to the Transaction Agreements, Ligand contributed to OmniAb cash and certain specific assets and liabilities constituting the OmniAb Business. Pursuant to the Distribution, Ligand distributed on a pro rata basis to its shareholders as of October 26, 2022 shares of the common stock of OmniAb representing <ix:nonFraction unitRef="number" contextRef="ic0c506012de345dda2926c4191966e7a_I20221026" decimals="0" name="lgnd:DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RleHRyZWdpb246YTY5ZWNiMDEyMTk5NDkxZTg3NmMwYjhiNjM3ZjY5NjFfNTQ5NzU1ODU0NDI5_a9e01a50-c024-48ee-9b97-7447029b8bc0">100</ix:nonFraction>% of Ligand&#8217;s interest in OmniAb. Immediately following the Distribution, Orwell Merger Sub Inc., a wholly-owned subsidiary of APAC, merged with and into OmniAb, with OmniAb continuing as the surviving company in the Merger and as a wholly owned subsidiary of New OmniAb. The entire transaction was completed on November 1, 2022, and following the Merger, New OmniAb is an independent, publicly traded company whose common stock trades on NASDAQ under the symbol &#8220;OABI.&#8221; After the Distribution, we do not beneficially own any shares of common stock in OmniAb and no longer consolidate OmniAb into our financial results for periods ending after November 1, 2022. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i9622658fa8e746f1b0f5222aa990f571" continuedAt="ia30af5020143459aac42dbefe1c54c56"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RleHRyZWdpb246YTY5ZWNiMDEyMTk5NDkxZTg3NmMwYjhiNjM3ZjY5NjFfMjc0ODc3OTA4MTQ4MQ_1f085e76-3cd8-4def-8c9b-cfe5d73e978d" continuedAt="i9c20a7783f624e9daaee386a9589fcd6" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transfer of assets and liabilities to OmniAb was effected through a contribution in accordance with the Merger Agreement, as summarized below (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.860%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of November 1, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMy0xLTEtMS0xMTY2NTk_028e9350-4933-47c9-ab70-138e0d6cbc8a">1,842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfOC0xLTEtMS0xMTY2NTk_71e093ef-2c2d-463e-a48e-77e682dccdfa">9,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101" decimals="-3" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMTAtMS0xLTEtMTE2NjU5_27f48204-1f73-47df-bf57-4df3fb8dae9e">10,861</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMTItMS0xLTEtMTE2NjU5_b09b6cb2-1620-4b86-b764-7693f321638b">165,422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMTMtMS0xLTEtMTE2NjU5_217769c1-0d66-462b-8265-4d2fa2cefd13">75,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMTUtMS0xLTEtMTE2NjU5_07aeb6f2-90af-4665-94a4-6057811f4895">19,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationAssetsOperatingLeaseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMTYtMS0xLTEtMTE2NjU5_0aab8d52-234c-41db-9d32-139e10849dce">21,290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMTgtMS0xLTEtMTE2NjU5_29e3ea4b-503d-4139-bab2-8f2572b90d0a">1,449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101" decimals="-3" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMjAtMS0xLTEtMTE2NjU5_19661b54-8128-4107-bfa9-89b627b2fe23">294,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY </span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current contingent liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMjUtMS0xLTEtMTE2NjYx_8c4e4976-1269-4bd9-bbdb-0e5334493d98">1,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Deferred revenue   </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMjYtMS0xLTEtMTE2NjYx_e1c110e1-8631-491c-bd2c-12e15c966bc7">8,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMjctMS0xLTEtMTE2NjYx_19a9a716-3c4b-4aab-a34d-5255f3d2fd36">1,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current finance lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMjgtMS0xLTEtMTE2NjYx_7ec0225d-8256-4ad4-bd20-efc8e3a2519a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMzAtMS0xLTEtMTE2NjYx_89ac5af9-73a6-4f0d-abb3-5fb3a8b20f40">11,762</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMzItMS0xLTEtMTE2NjYx_33430722-fb9d-4866-ac5f-df1b4075ebfb">4,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMzMtMS0xLTEtMTE2NjYx_de0331b3-0e85-4cd1-a018-87126abedc17">18,978</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationLiabilitiesOperatingLeaseNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMzQtMS0xLTEtMTE2NjYx_cb0d911b-2d50-4219-897b-9d44845a67a6">24,823</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMzUtMS0xLTEtMTE2NjYx_bf1b4358-4a8a-4ec7-bf5b-278216a8e18c">5,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMzctMS0xLTEtMTE2NjYx_4fd2aae5-9373-48e8-85d6-92df3c26b88a">64,744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net assets transferred to OmniAb</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationNetAssetsTransferred" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMzgtMS0xLTEtMTE2NjYx_b62c9153-559e-4d46-843c-106555d48684">229,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Discontinued operations</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger, the Company determined its antibody discovery business qualified for discontinued operations accounting treatment in accordance with ASC 205-20. <ix:continuation id="i9c20a7783f624e9daaee386a9589fcd6" continuedAt="iea1759bf7fc042f4889020a1c1e3606e">The following table summarizes revenue and expenses of the discontinued operations for the years ended December 31, 2022, 2021 and 2020 (in thousands):</ix:continuation></span></div><div><ix:continuation id="iea1759bf7fc042f4889020a1c1e3606e" continuedAt="ic87afe318abe4e949966c61a07db8037"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:62.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.370%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.373%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Royalties</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5d258c544454d8287d67c0885d9f073_D20220101-20221231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMy0xLTEtMS0xMTYyOTY_39344994-90b6-4e59-81d7-e43ceeb9f2cd">1,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i180d8ced9233474d9767fa54ba805af7_D20210101-20211231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMy0zLTEtMS0xMTYxNzI_5c3ed9ae-3078-40d5-af3e-072ba030f07c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2ce874ab0f45d1a868ff9dc946ad7a_D20200101-20201231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMy01LTEtMS0xMTYwNDk_4ce03c32-07d2-4120-9679-aee0b4632b9c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10d2e678e034d80baef68bce5e0f4dd_D20220101-20221231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfNC0xLTEtMS0xMTYyOTY_9c3c3647-eb04-4a86-bc73-72946820895d">25,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if084a5c5e7a04c2ab6433cfecec6c5ea_D20210101-20211231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfNC0zLTEtMS0xMTYxNzI_ba519298-2bc5-4150-a2f8-c158135219df">35,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76065f9fe2324b1eab8ade930477eaf4_D20200101-20201231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfNC01LTEtMS0xMTYwNDk_080c2688-d368-443d-ae41-2fd81745709f">22,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfNS0xLTEtMS0xMTY4Mzc_c3c9f284-b2fd-4e7d-853b-b4dd6451a317">26,564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfNS0zLTEtMS0xMTY4OTI_24fa7533-7700-4155-bb08-30fa05850226">35,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfNS01LTEtMS0xMTY4OTU_4ccc2495-d055-4d11-9533-9facaccafe1d">22,857</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating costs and expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfNy0xLTEtMS0xMTYzMDY_77798860-baee-4b11-a84b-b7b4d8b146cc">10,847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfNy0zLTEtMS0xMTYxODI_92ba0904-6603-4930-bdae-2d4e53757787">12,945</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfNy01LTEtMS0xMTYwNTY_cf67e3b1-69c1-466b-adb4-4c2e86fa4bab">11,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfOC0xLTEtMS0xMTYzMDY_67351267-27ab-4b30-b7be-dc0944886e4f">38,466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfOC0zLTEtMS0xMTYxODI_ccb2ac30-e7da-4d25-906b-faa1d0fa2177">36,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfOC01LTEtMS0xMTYwNTY_86312c10-502a-45a3-9463-de25f500395c">18,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfOS0xLTEtMS0xMTYzMDY_eaa51f5a-af83-4c07-832b-2df4b3b21878">13,383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfOS0zLTEtMS0xMTYxODI_c1ef714d-9483-4c8e-9f77-480bb2e7461f">10,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfOS01LTEtMS0xMTYwNTY_1834e323-7dbe-4f31-bfd7-7c80caaf79c8">3,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTAtMS0xLTEtMTE2ODQw_534fd5b7-4428-418d-93e9-605ba6f10389">62,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTAtMy0xLTEtMTE2ODky_069b7c56-6613-44c5-947d-43088554bfdc">60,545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTAtNS0xLTEtMTE2ODk1_174d605f-e9c5-459a-95ce-d4252fbfd7e3">34,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTEtMS0xLTEtMTE2ODQw_61451091-c4ce-4693-a2c4-a6dbe3716833">36,132</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTEtMy0xLTEtMTE2ODky_c9cbf2f7-7d1c-4794-8cb6-fa73df190ffe">24,956</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTEtNS0xLTEtMTE2ODk1_e0eaf8c2-e1b8-4a1d-bdaf-af119eb11393">11,655</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain from short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTMtMS0xLTEtMTE2MzIx_25a50fb7-779b-4ba8-8778-42eae742106d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTUtMy0xLTEtMTE2MTkz_eca17283-d029-474b-afa8-8a47817cff63">1,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTUtNS0xLTEtMTE2MDY4_e9166fcd-f9fa-44ff-8e07-7e6994e6ecbf">1,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTQtMS0xLTEtMTE2MzMx_80993c3d-cf83-4799-bc34-bed92b675846">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTYtMy0xLTEtMTE2MjA2_7183d9e9-47e7-41c7-997a-410d3a7799bd">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTctNS0xLTEtMTE2MDgw_c2264358-83fa-4b43-adf8-4755cf099d16">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTUtMS0xLTEtMTE2MzQx_1060b18f-0017-4411-8d8f-82f95fb54eb1">554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231" decimals="-3" sign="-" name="lgnd:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTctMy0xLTEtMTE2MjE2_7157fbf5-bf18-4817-a3e7-102ad6898533">1,210</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231" decimals="-3" sign="-" name="lgnd:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTgtNS0xLTEtMTE2MDkw_3ffe0cc8-b1bf-4bf6-a323-abca0938f2c6">2,070</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other expense, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTYtMS0xLTEtMTE2ODQz_800b152c-4bfe-4105-b80a-8e15a1dbbd53">554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTYtMy0xLTEtMTE2ODky_eafc17d9-35d7-4d8d-990f-eb9cd9d0bad7">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231" decimals="-3" sign="-" name="lgnd:DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTYtNS0xLTEtMTE2ODk1_e06dfddf-14f1-4cb2-aac3-09c8003e2834">175</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss before income tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTctMS0xLTEtMTE2ODQz_ae0ac7b4-d548-4b6f-9f66-14ea2196b06c">35,578</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTctMy0xLTEtMTE2ODky_903abb52-5b96-41ed-ab12-496d5bd1d9a5">24,907</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTctNS0xLTEtMTE2ODk1_01a21855-d139-489c-a2b1-3dfbf1bb4632">11,830</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTgtMS0xLTEtMTE2MzUy_0fa8eaec-24c4-400d-b56b-af99d9d37d19">7,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMjAtMy0xLTEtMTE2MjMw_9663881e-7831-4a23-944b-d751be9675cc">5,692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMjEtNS0xLTEtMTE2MTAy_c3f9543f-7f50-4ca0-b8e8-9a2d98542dc3">2,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTktMS0xLTEtMTE2ODQz_498a4885-ec26-4ec4-8460-b75b88600f31">28,142</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTktMy0xLTEtMTE2ODky_cf3d8ed0-d8b4-4cac-b92b-91b63b504f30">19,215</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTktNS0xLTEtMTE2ODk1_143bf8c9-d6a0-46a7-a9ef-a375949c5695">9,583</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia30af5020143459aac42dbefe1c54c56"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no assets and liabilities related to discontinued operations as of December&#160;31, 2022, as all balances were transferred to OmniAb upon Separation. <ix:continuation id="ic87afe318abe4e949966c61a07db8037" continuedAt="i0c321ac8693e44fbbcd22c09a57f82a6">The following table summarizes the assets and liabilities of the discontinued operations as of December&#160;31, 2021 (in thousands):</ix:continuation></span></div><ix:continuation id="i0c321ac8693e44fbbcd22c09a57f82a6"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.860%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfNC0xLTEtMS0xMTk4NDk_bf147763-fdc6-43ac-9ca7-807385f9fe9e">1,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current assets of discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231" decimals="-3" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfNC0xLTEtMS0xMjA4MzE_aa54ae4d-847e-4d6a-bf18-6237edb491a9">1,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfNi0xLTEtMS0xMTk4Njc_752b943f-4c8d-497b-bf41-d9fec6e1eed4">174,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfNy0xLTEtMS0xMTk4Njc_9784e031-201d-4818-89bf-87818946352b">75,533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfOC0xLTEtMS0xMTk4Njc_95c390d0-c15e-4528-b75f-b416bec94a5a">7,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationAssetsOperatingLeaseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfOS0xLTEtMS0xMTk4Njc_fd483444-2cc1-4bfd-a45c-3dc2aded4cb3">13,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationAssetsFinanceLeaseAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfOS0xLTEtMS0xMjA3ODA_01ef69ef-87d8-493a-9d0e-8c373d16c023">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfMTAtMS0xLTEtMTE5ODY3_7b9fbfcf-90b0-4b8b-a733-da18569719b1">243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets of discontinued operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231" decimals="-3" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfMTEtMS0xLTEtMTIwODMx_c096b5ba-e6bf-4c00-a8d4-e4197f2ba89d">271,883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">LIABILITIES</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current contingent liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfMTQtMS0xLTEtMTE5ODg1_0669f0cb-e2ca-4680-a091-e5f2c94a90fb">2,538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Deferred revenue   </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfMTUtMS0xLTEtMTE5ODg1_a0c94399-f2f5-439c-abb9-b04d46bd8d38">10,342</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfMTYtMS0xLTEtMTE5ODg1_10c2f4e4-029b-476a-a1f8-e1bcd5d9cdf2">685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current finance lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfMTctMS0xLTEtMTE5ODg1_b88272e0-24e6-4f39-8af5-453bbfc2dfbd">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current liabilities of discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfMTgtMS0xLTEtMTIwODM0_1838cefd-1185-466a-8913-0df973299d4e">13,566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfMTktMS0xLTEtMTE5OTAw_42006840-4398-4631-88d5-393b5d686cd0">4,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfMjAtMS0xLTEtMTE5OTAw_335a36c8-e5fb-41c1-8408-56161ad68af8">28,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationLiabilitiesOperatingLeaseNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfMjEtMS0xLTEtMTE5OTAw_1508ff93-d916-4a3b-b2c8-b43223f7e2c8">13,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfMjItMS0xLTEtMTE5OTAw_03aaaaf5-fb25-4482-81f3-e550107913c6">9,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total liabilities of discontinued operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfMjMtMS0xLTEtMTIwODM0_681805ba-b74a-4ff1-b53c-cf0e99c672cb">69,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the significant non-cash items, capital expenditures of the discontinued operations, and financing activities that are included in the consolidated statements of cash flows for the years ended December 31, 2022, 2021 and 2020 (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:62.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.370%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.373%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231" decimals="-3" sign="-" name="lgnd:DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfMy0xLTEtMS0xMTk5OTQ_04c83faa-0fa3-4469-83ac-ed1d7f4cac7d">554</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfMy0zLTEtMS0xMjAwMDY_1105963d-cb6e-4b80-a8b4-101065a5d22d">1,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfMy01LTEtMS0xMjAwMDY_b26c6b07-a567-469c-a965-18c9a314793a">2,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231" decimals="-3" name="us-gaap:DepreciationAndAmortizationDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfNC0xLTEtMS0xMTk5OTQ_76b31bd0-17f5-482e-bcb9-111fdccd807d">13,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationAndAmortizationDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfNC0zLTEtMS0xMjAwMDY_f60cf54b-8da3-412b-9331-23bdc56dc57b">14,553</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationAndAmortizationDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfNC01LTEtMS0xMjAwMDY_365e292e-d13a-44d5-8911-f8c662d75c2f">12,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfNS0xLTEtMS0xMTk5OTQ_889fa3b0-e81f-48e5-b317-aab06233b9bd">9,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfNS0zLTEtMS0xMjAwMDY_421c8d78-1e54-4f16-bd21-4ba507d08dce">9,457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfNS01LTEtMS0xMjAwMDY_39722631-6110-4916-8e17-5facca5d4cda">5,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for acquisition, net of cash acquired</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfOC0xLTEtMS0xMjA0OTE_4beaf1aa-20d3-489c-9fae-72e6206b9ccd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfOC0zLTEtMS0xMjA0OTE_d30d5eb1-5c07-4086-895c-fc129fd08fab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfOC01LTEtMS0xMjAyMDI_9372b01c-eb17-4b77-891b-bb33f58ae89a">27,127</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231" decimals="-3" name="us-gaap:CapitalExpenditureDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfOC0xLTEtMS0xMTk5OTQ_9453e2b5-75ea-4e56-b5e1-b2e782749e0e">5,572</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231" decimals="-3" name="us-gaap:CapitalExpenditureDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfOC0zLTEtMS0xMjAwMDY_1353c8a5-ae38-41df-9a42-7d45aec08ed1">4,070</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231" decimals="-3" name="us-gaap:CapitalExpenditureDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfOC01LTEtMS0xMjAwMDY_7fd15aa5-fe66-4b4e-a4aa-026148c4c5f0">1,753</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to CVR Holders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231" decimals="-3" name="lgnd:PaymentsToContingentValueRightHoldersInvestingActivity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfOS0xLTEtMS0xMTk5OTQ_b7324cc6-6f18-4656-af36-d66cdcfb4de8">960</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231" decimals="-3" name="lgnd:PaymentsToContingentValueRightHoldersInvestingActivity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfOS0zLTEtMS0xMjAwMDY_f93cfd6f-b51c-43cc-a1e5-0ba7f4cbca0a">720</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231" decimals="-3" name="lgnd:PaymentsToContingentValueRightHoldersInvestingActivity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfOS01LTEtMS0xMjAwMDY_c3d9826b-435a-4323-944f-d2223e2960ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to CVR Holders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231" decimals="-3" name="lgnd:PaymentsToContingentValueRightHoldersFinancingActivity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfMTMtMS0xLTEtMTIxMDk4_9f878e65-ac25-4834-9d45-598e9f914e91">1,545</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231" decimals="-3" name="lgnd:PaymentsToContingentValueRightHoldersFinancingActivity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfMTMtMy0xLTEtMTIwNTU3_2f756645-ca8b-4160-9feb-5506ce491e68">1,050</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231" decimals="-3" name="lgnd:PaymentsToContingentValueRightHoldersFinancingActivity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfMTMtNS0xLTEtMTIwMjUx_2a0cd272-10df-4b08-933b-3ec637b3e2ab">2,325</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental cash flow disclosures:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment included in accounts payable and accrued expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfMTItMS0xLTEtMTE5OTk0_b99729f4-ab2d-4c98-87f5-0036fd0c9ed8">2,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfMTItMy0xLTEtMTIwMDA2_d8b0fab6-34c0-4afa-900d-b3132f00dea2">1,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231" decimals="-3" name="lgnd:DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfMTItNS0xLTEtMTIwMDA2_eceb389a-0331-408a-8776-acf07a8886d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_91"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.  <ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:VariableInterestEntityDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85MS9mcmFnOjUwNDI1ZTQwYmIwYTQzNTBiMTM2NGVmMGVkZjRiNWMyL3RleHRyZWdpb246NTA0MjVlNDBiYjBhNDM1MGIxMzY0ZWYwZWRmNGI1YzJfMTA3Ng_c124bcda-8f21-44a7-ac6f-e97f81de2d94" continuedAt="iddad6a3930fd4da49047c63f7bcb2016" escape="true">Short-term Investments: Investment in Viking</ix:nonNumeric></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iddad6a3930fd4da49047c63f7bcb2016" continuedAt="iaa7d00f8cfe34e24acc50e11be470cb5">Our ownership in Viking was approximately <ix:nonFraction unitRef="number" contextRef="ic19bd9bd07214754968a75ae83faf30f_D20220101-20221231" decimals="3" name="us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85MS9mcmFnOjUwNDI1ZTQwYmIwYTQzNTBiMTM2NGVmMGVkZjRiNWMyL3RleHRyZWdpb246NTA0MjVlNDBiYjBhNDM1MGIxMzY0ZWYwZWRmNGI1YzJfOTc_a1aea048-8742-4a73-8b94-ce7c31ecf1e7">8.6</ix:nonFraction>% as of December&#160;31, 2022, and we account for it as an investment in available-for-sale equity securities, which is measured at fair value, with changes in fair value recognized in net income. Viking </ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iaa7d00f8cfe34e24acc50e11be470cb5"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is considered a related party as we maintain a seat on Viking's board of directors and we do not exert significant influence over Viking. </span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022 and December&#160;31, 2021, we recorded our common stock in Viking in &#8220;short-term investments&#8221; at fair value of $<ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85MS9mcmFnOjUwNDI1ZTQwYmIwYTQzNTBiMTM2NGVmMGVkZjRiNWMyL3RleHRyZWdpb246NTA0MjVlNDBiYjBhNDM1MGIxMzY0ZWYwZWRmNGI1YzJfNTc0_6bab4695-4d3d-4273-8e12-a288750dd3eb">63.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85MS9mcmFnOjUwNDI1ZTQwYmIwYTQzNTBiMTM2NGVmMGVkZjRiNWMyL3RleHRyZWdpb246NTA0MjVlNDBiYjBhNDM1MGIxMzY0ZWYwZWRmNGI1YzJfNTgx_d9154f03-b86a-4641-9ddf-c8a0cb91d9a8">30.9</ix:nonFraction> million, respectively. At December&#160;31, 2020, we owned warrants to purchase up to <ix:nonFraction unitRef="usd" contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231" decimals="-5" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85MS9mcmFnOjUwNDI1ZTQwYmIwYTQzNTBiMTM2NGVmMGVkZjRiNWMyL3RleHRyZWdpb246NTA0MjVlNDBiYjBhNDM1MGIxMzY0ZWYwZWRmNGI1YzJfNjQy_49c87c57-45be-45cf-81d4-738830ac289d">1.5</ix:nonFraction> million shares of Viking's common stock at an exercise price of  $<ix:nonFraction unitRef="usdPerShare" contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85MS9mcmFnOjUwNDI1ZTQwYmIwYTQzNTBiMTM2NGVmMGVkZjRiNWMyL3RleHRyZWdpb246NTA0MjVlNDBiYjBhNDM1MGIxMzY0ZWYwZWRmNGI1YzJfNzAy_f67ecb82-6c04-431e-9e5e-c5fcd04d011b">1.50</ix:nonFraction> per share, and during the year ended December&#160;31, 2021 we exercised all outstanding Viking warrants. As of December&#160;31, 2022 and December&#160;31, 2021, we have <ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-5" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85MS9mcmFnOjUwNDI1ZTQwYmIwYTQzNTBiMTM2NGVmMGVkZjRiNWMyL3RleHRyZWdpb246NTA0MjVlNDBiYjBhNDM1MGIxMzY0ZWYwZWRmNGI1YzJfODA5_7919faef-b5ea-4979-b74b-3d49f4e0d4b7"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-5" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85MS9mcmFnOjUwNDI1ZTQwYmIwYTQzNTBiMTM2NGVmMGVkZjRiNWMyL3RleHRyZWdpb246NTA0MjVlNDBiYjBhNDM1MGIxMzY0ZWYwZWRmNGI1YzJfODA5_ac56ba0c-0a1b-460b-9cf9-c7a208e37f05">zero</ix:nonFraction></ix:nonFraction> Viking warrants outstanding. During the year ended December&#160;31, 2021, we also sold <ix:nonFraction unitRef="shares" contextRef="i78dcb59101a846b19a565ed0e098ef09_D20210101-20211231" decimals="-5" name="lgnd:NumberOfSharesSoldOfEquityMethodInvestee" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85MS9mcmFnOjUwNDI1ZTQwYmIwYTQzNTBiMTM2NGVmMGVkZjRiNWMyL3RleHRyZWdpb246NTA0MjVlNDBiYjBhNDM1MGIxMzY0ZWYwZWRmNGI1YzJfODgw_978519f6-8788-4f06-beff-4b8facf74a8d">0.6</ix:nonFraction>&#160;million Viking shares. See further discussion in &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note (5), Fair Value Measurement.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div></ix:continuation><div><span><br/></span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_94"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.  <ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfMTMyNDE_1c0a8b3a-7872-41bf-ab24-7eb2c984afff" continuedAt="ie770f7e751654fc9b22ab438a693593d" escape="true">Acquisitions</ix:nonNumeric></span></div><ix:continuation id="ie770f7e751654fc9b22ab438a693593d" continuedAt="i472184ea5ce44c82aec813f6002d46b8"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding the impact of OmniAb, we completed <ix:nonFraction unitRef="acquisition" contextRef="ifeea5a6633434f93bbe3e33fea893ad4_D20200101-20221231" decimals="INF" name="lgnd:NumberOfAcquisitions" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfNTY_e6e8c1cd-9f36-4a5c-9a85-9fa1b5ca76d9">one</ix:nonFraction> acquisition from January 1, 2020 through December 31, 2022, where we applied the acquisition method of accounting for business combinations. Accordingly, we recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the applicable date of acquisition. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pfenex Acquisition </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2020, we acquired Pfenex, which develops next-generation and novel protein therapeutics to improve existing therapies and create new therapies for biological targets linked to critical, unmet diseases using a protein expression technology platform.  </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purchase price of $<ix:nonFraction unitRef="usd" contextRef="i4ed842cd826a473aa27b3be44b9dff45_D20201001-20201001" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfOTQ4_45beecdc-637e-4867-89ee-e18eed97de30">465.1</ix:nonFraction> million included $<ix:nonFraction unitRef="usd" contextRef="i4ed842cd826a473aa27b3be44b9dff45_D20201001-20201001" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfOTYw_7b378def-fb1f-4ffd-ab19-a0f2f0114cee">429.6</ix:nonFraction> million cash consideration paid upon acquisition, and a contingent CVR payment of up to $<ix:nonFraction unitRef="usd" contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfMTA0Mw_e7a48212-cff9-40e7-9045-9838f3515d5e">77.8</ix:nonFraction> million in cash based on a certain specified milestone with an estimated initial fair value of $<ix:nonFraction unitRef="usd" contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001" decimals="-5" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfMTEzMw_b53f8655-3cb8-482c-a50b-5f93cf21a50e">37.0</ix:nonFraction> million. The CVR will only be paid in full if the milestone is achieved by December 31, 2021. The amount of the CVR included in purchase price was reduced by $<ix:nonFraction unitRef="usd" contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001" decimals="-5" name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfMTI4Ng_f5886066-c521-4dbf-bc29-b5337385b8c2">1.5</ix:nonFraction>&#160;million which was determined to be post-combination expense. The fair value of the CVR liability was determined using a probability adjusted income approach. These cash flows were then discounted to present value using a discount rate based on market participants' cost of debt reflective of the Company, which was <ix:nonFraction unitRef="number" contextRef="i0031e41cbf7c45bbb25efe78bbbcea4a_I20201001" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfMTU5Ng_92dbb026-8cbf-4720-99ba-3f5814b34b7c">7.1</ix:nonFraction>%. The liability is periodically assessed based on events and circumstances related to the underlying milestone, and any change in fair value is recorded in our consolidated statements of operations. During the year ended December&#160;31, 2021, we wrote off the entire CVR liability of $<ix:nonFraction unitRef="usd" contextRef="i36cbb3f817354f04b57d665248187943_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfMTg2NA_703da142-1309-4efd-bb7b-1e7bd2e23c7c">37.6</ix:nonFraction>&#160;million to <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfMjc0ODc3OTA5MTQ4Mw_faecaf46-33bf-4086-b9d1-f6c39448988e">other operation income</span>, primarily due to not achieving the specific development and regulatory milestone by December 31, 2021 as defined by Pfenex CVR.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition, a portion of Pfenex's equity awards that were outstanding and unvested prior to the acquisition became fully vested per the terms of the merger agreement. The acceleration of vesting required us to allocate the fair value of the equity attributable to pre-combination service to the purchase price and the remaining amount was considered our post-combination expense. We paid $<ix:nonFraction unitRef="usd" contextRef="i4ed842cd826a473aa27b3be44b9dff45_D20201001-20201001" decimals="-5" name="lgnd:PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfMjQzNQ_7af98d81-d39d-418f-89df-f95e770c0b9b">17.3</ix:nonFraction> million in cash for equity compensation, which is attributable to pre-combination services and is reflected as a component of the total purchase price paid of $<ix:nonFraction unitRef="usd" contextRef="i4ed842cd826a473aa27b3be44b9dff45_D20201001-20201001" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfMjU4OQ_7b378def-fb1f-4ffd-ab19-a0f2f0114cee">429.6</ix:nonFraction> million. In addition, the fair value of equity compensation attributable to the post-combination service period was $<ix:nonFraction unitRef="usd" contextRef="i0787b2990c934b468deda9c36c3f0273_D20201001-20201231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfMjcwMA_81e2d66c-b797-4969-9b09-f1d51235ee92">8.7</ix:nonFraction> million. These amounts were associated with the accelerated vesting of stock options previously granted to Pfenex employees and were fully paid in cash, which was recognized as general and administrative expenses during the fourth quarter of 2020. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded $<ix:nonFraction unitRef="usd" contextRef="i4ed842cd826a473aa27b3be44b9dff45_D20201001-20201001" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfMjk1Nw_d4777a72-814f-47e6-8889-8f6ac5b2c110">20.7</ix:nonFraction> million of acquisition-related costs for legal, severance and other costs in connection with the acquisition within operating expenses in our consolidated statement of operations for 2020. <ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfMTMyNDU_32d82888-aa1d-4fa2-bcf5-395ccd25740c" continuedAt="i5761e35f5e034666a6d9d869a1817bbd" escape="true">The following table sets forth an allocation of the purchase price to the identifiable tangible and intangible assets acquired and liabilities assumed, with the excess recorded to goodwill (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i472184ea5ce44c82aec813f6002d46b8" continuedAt="i0b85e82902e84487a72eaa691cb34565"><div><ix:continuation id="i5761e35f5e034666a6d9d869a1817bbd" continuedAt="i40765e2dd784492bab2a36d88f216c6a"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.351%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOjE0MmZmMjFmNDcwZjQ4MWQ5ZTNkYzM5NTM4YTBkYWUwL3RhYmxlcmFuZ2U6MTQyZmYyMWY0NzBmNDgxZDllM2RjMzk1MzhhMGRhZTBfMC0xLTEtMS0xMTI2NDA_c5743171-709d-4898-b1ff-8b9852cd2413">51,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001" decimals="-3" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOjE0MmZmMjFmNDcwZjQ4MWQ5ZTNkYzM5NTM4YTBkYWUwL3RhYmxlcmFuZ2U6MTQyZmYyMWY0NzBmNDgxZDllM2RjMzk1MzhhMGRhZTBfMS0xLTEtMS0xMTI2NDA_091496e4-2997-4d62-b8e7-e66cacb1fc87">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts and unbilled receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOjE0MmZmMjFmNDcwZjQ4MWQ5ZTNkYzM5NTM4YTBkYWUwL3RhYmxlcmFuZ2U6MTQyZmYyMWY0NzBmNDgxZDllM2RjMzk1MzhhMGRhZTBfMi0xLTEtMS0xMTI2NDA_1bc86517-e184-4226-9aed-ea06f02a4ac0">1,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOjE0MmZmMjFmNDcwZjQ4MWQ5ZTNkYzM5NTM4YTBkYWUwL3RhYmxlcmFuZ2U6MTQyZmYyMWY0NzBmNDgxZDllM2RjMzk1MzhhMGRhZTBfMy0xLTEtMS0xMTI2NDA_1f25629b-4824-4ef5-ac79-3d09ea63a4fa">7,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001" decimals="-3" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOjE0MmZmMjFmNDcwZjQ4MWQ5ZTNkYzM5NTM4YTBkYWUwL3RhYmxlcmFuZ2U6MTQyZmYyMWY0NzBmNDgxZDllM2RjMzk1MzhhMGRhZTBfNC0xLTEtMS0xMTI2NDA_7689ba61-4bda-4ecd-8570-e798b42dbe1f">3,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOjE0MmZmMjFmNDcwZjQ4MWQ5ZTNkYzM5NTM4YTBkYWUwL3RhYmxlcmFuZ2U6MTQyZmYyMWY0NzBmNDgxZDllM2RjMzk1MzhhMGRhZTBfNS0xLTEtMS0xMTI2NDA_165ec9f0-c7e2-43dc-80dd-aa6441c8100f">1,338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001" decimals="-3" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOjE0MmZmMjFmNDcwZjQ4MWQ5ZTNkYzM5NTM4YTBkYWUwL3RhYmxlcmFuZ2U6MTQyZmYyMWY0NzBmNDgxZDllM2RjMzk1MzhhMGRhZTBfNi0xLTEtMS0xMTI2NDA_5dc29416-b788-4193-8ca1-893694c0229f">385,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOjE0MmZmMjFmNDcwZjQ4MWQ5ZTNkYzM5NTM4YTBkYWUwL3RhYmxlcmFuZ2U6MTQyZmYyMWY0NzBmNDgxZDllM2RjMzk1MzhhMGRhZTBfNy0xLTEtMS0xMTI2NDA_2cb0d189-a9ae-4beb-8f93-abfbefa14aa7">82,303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOjE0MmZmMjFmNDcwZjQ4MWQ5ZTNkYzM5NTM4YTBkYWUwL3RhYmxlcmFuZ2U6MTQyZmYyMWY0NzBmNDgxZDllM2RjMzk1MzhhMGRhZTBfOC0xLTEtMS0xMTI2NDA_103be432-d255-4166-9df9-d662c1c29208">6,814</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001" decimals="-3" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOjE0MmZmMjFmNDcwZjQ4MWQ5ZTNkYzM5NTM4YTBkYWUwL3RhYmxlcmFuZ2U6MTQyZmYyMWY0NzBmNDgxZDllM2RjMzk1MzhhMGRhZTBfOS0xLTEtMS0xMTI2NDA_1530792a-a1f2-4c63-a4fe-6ec0195f0115">9,606</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOjE0MmZmMjFmNDcwZjQ4MWQ5ZTNkYzM5NTM4YTBkYWUwL3RhYmxlcmFuZ2U6MTQyZmYyMWY0NzBmNDgxZDllM2RjMzk1MzhhMGRhZTBfMTAtMS0xLTEtMTEyNjQw_fb166224-ad59-4886-a064-b7e2357ce0c2">3,908</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001" decimals="-3" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOjE0MmZmMjFmNDcwZjQ4MWQ5ZTNkYzM5NTM4YTBkYWUwL3RhYmxlcmFuZ2U6MTQyZmYyMWY0NzBmNDgxZDllM2RjMzk1MzhhMGRhZTBfMTEtMS0xLTEtMTEyNjQw_9ea0ef81-c0ed-4f4a-a41f-4015ec145e43">3,070</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOjE0MmZmMjFmNDcwZjQ4MWQ5ZTNkYzM5NTM4YTBkYWUwL3RhYmxlcmFuZ2U6MTQyZmYyMWY0NzBmNDgxZDllM2RjMzk1MzhhMGRhZTBfMTItMS0xLTEtMTEyNjQw_471e8add-94e3-4cb0-8ec8-e570e3b49e38">1,382</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOjE0MmZmMjFmNDcwZjQ4MWQ5ZTNkYzM5NTM4YTBkYWUwL3RhYmxlcmFuZ2U6MTQyZmYyMWY0NzBmNDgxZDllM2RjMzk1MzhhMGRhZTBfMTMtMS0xLTEtMTEyNjQw_bf9beee1-149c-41b0-8dec-3836f0153ab1">42,622</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consideration</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOjE0MmZmMjFmNDcwZjQ4MWQ5ZTNkYzM5NTM4YTBkYWUwL3RhYmxlcmFuZ2U6MTQyZmYyMWY0NzBmNDgxZDllM2RjMzk1MzhhMGRhZTBfMTQtMS0xLTEtMTEyNjQw_10efcb0f-58f3-4eb6-8162-45a1d384d4fa">465,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"><ix:continuation id="i40765e2dd784492bab2a36d88f216c6a">(1) Goodwill represents the excess of the purchase price over the preliminary fair value of the underlying assets acquired and liabilities assumed. Goodwill is attributable to the assembled workforce of experienced personnel at Pfenex and expected synergies. None of the goodwill is deductible for tax purposes.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfMTMyNDY_eff8b2af-48c5-411b-8486-9b7f7365a7e4" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intangibles acquired and their weighted average useful life are as follows (in thousands, except useful lives):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate<br/>Fair Value</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated useful life<br/>(in years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual Relationships:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alvogen</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c6f37320d134abeb77221e2c28f7476_I20201001" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmYyMzI3ODc2MDMxYjRjMjQ4YTMzMWM4NjdkY2E3N2QzL3RhYmxlcmFuZ2U6ZjIzMjc4NzYwMzFiNGMyNDhhMzMxYzg2N2RjYTc3ZDNfMi0xLTEtMS0xMTI2NDA_72b5fb57-d4b1-421a-8f61-43c62cc281d4">114,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie17cc4f187524c6ab5d90741e0260c93_D20201001-20201001" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmYyMzI3ODc2MDMxYjRjMjQ4YTMzMWM4NjdkY2E3N2QzL3RhYmxlcmFuZ2U6ZjIzMjc4NzYwMzFiNGMyNDhhMzMxYzg2N2RjYTc3ZDNfMi0yLTEtMS0xMTI2NDA_b4291319-4f18-4250-ad55-7ec04ee01dfe">12</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merck</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c16dd0f6ad94561a190f6fb614d008c_I20201001" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmYyMzI3ODc2MDMxYjRjMjQ4YTMzMWM4NjdkY2E3N2QzL3RhYmxlcmFuZ2U6ZjIzMjc4NzYwMzFiNGMyNDhhMzMxYzg2N2RjYTc3ZDNfMy0xLTEtMS0xMTI2NDA_5e7a127f-d0de-4ed1-9595-73e627fb1258">117,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0879712cff614a0b90c548a17d56dc6e_D20201001-20201001" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmYyMzI3ODc2MDMxYjRjMjQ4YTMzMWM4NjdkY2E3N2QzL3RhYmxlcmFuZ2U6ZjIzMjc4NzYwMzFiNGMyNDhhMzMxYzg2N2RjYTc3ZDNfMy0yLTEtMS0xMTI2NDA_8d20f7b0-9311-4b82-bc0b-3591d284f0a0">12</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jazz</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0183c839f90a44d78e84690651518be4_I20201001" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmYyMzI3ODc2MDMxYjRjMjQ4YTMzMWM4NjdkY2E3N2QzL3RhYmxlcmFuZ2U6ZjIzMjc4NzYwMzFiNGMyNDhhMzMxYzg2N2RjYTc3ZDNfNC0xLTEtMS0xMTI2NDA_7c449bab-b857-4bb7-9878-e7af8378495a">80,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifac692c703d348d388432995b6f0fa8a_D20201001-20201001" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmYyMzI3ODc2MDMxYjRjMjQ4YTMzMWM4NjdkY2E3N2QzL3RhYmxlcmFuZ2U6ZjIzMjc4NzYwMzFiNGMyNDhhMzMxYzg2N2RjYTc3ZDNfNC0yLTEtMS0xMTI2NDA_d14be5d8-e320-40d7-9c51-4de26cb2dbe2">17</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SII</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i646b177827484736a084009b96add04f_I20201001" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmYyMzI3ODc2MDMxYjRjMjQ4YTMzMWM4NjdkY2E3N2QzL3RhYmxlcmFuZ2U6ZjIzMjc4NzYwMzFiNGMyNDhhMzMxYzg2N2RjYTc3ZDNfNS0xLTEtMS0xMTI2NDA_e28c7253-8360-4efb-9bc2-a9fba3f25c74">49,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iada43374af48485cb39ed70b764ce849_D20201001-20201001" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmYyMzI3ODc2MDMxYjRjMjQ4YTMzMWM4NjdkY2E3N2QzL3RhYmxlcmFuZ2U6ZjIzMjc4NzYwMzFiNGMyNDhhMzMxYzg2N2RjYTc3ZDNfNS0yLTEtMS0xMTI2NDA_757dcbe8-2e0c-40b1-866f-4fb9634daa81">10</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arcellx</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29179647d1e74e45a16db04ef1607aa3_I20201001" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmYyMzI3ODc2MDMxYjRjMjQ4YTMzMWM4NjdkY2E3N2QzL3RhYmxlcmFuZ2U6ZjIzMjc4NzYwMzFiNGMyNDhhMzMxYzg2N2RjYTc3ZDNfNi0xLTEtMS0xMTI2NDA_bfa43fff-cd0b-40b2-97c9-995b4a3eeb93">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0793bd25b06b4adb80e8bcf79ba4daae_D20201001-20201001" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmYyMzI3ODc2MDMxYjRjMjQ4YTMzMWM4NjdkY2E3N2QzL3RhYmxlcmFuZ2U6ZjIzMjc4NzYwMzFiNGMyNDhhMzMxYzg2N2RjYTc3ZDNfNi0yLTEtMS0xMTI2NDA_29afb9e7-3f21-4357-b8e1-4d546d730dc8">17</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired Technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56ebc06b13944fc8bae568b634e1b508_I20201001" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmYyMzI3ODc2MDMxYjRjMjQ4YTMzMWM4NjdkY2E3N2QzL3RhYmxlcmFuZ2U6ZjIzMjc4NzYwMzFiNGMyNDhhMzMxYzg2N2RjYTc3ZDNfNy0xLTEtMS0xMTI2NDA_2ee74908-ae9c-4437-bb14-5afd753b339b">23,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8104cc1e7e204b4f9867e0af251d6d20_D20201001-20201001" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmYyMzI3ODc2MDMxYjRjMjQ4YTMzMWM4NjdkY2E3N2QzL3RhYmxlcmFuZ2U6ZjIzMjc4NzYwMzFiNGMyNDhhMzMxYzg2N2RjYTc3ZDNfNy0yLTEtMS0xMTI2NDAvdGV4dHJlZ2lvbjo1Y2EzZDllN2MyMDQ0Mzg4OWZiNTNkMDY0M2Y3YWZiNF80_7e6ae8bb-c090-446e-a47e-11cb82062a6e">10</ix:nonNumeric>-<ix:nonNumeric contextRef="ifdcdcd7c135242418722134cac4afc56_D20201001-20201001" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmYyMzI3ODc2MDMxYjRjMjQ4YTMzMWM4NjdkY2E3N2QzL3RhYmxlcmFuZ2U6ZjIzMjc4NzYwMzFiNGMyNDhhMzMxYzg2N2RjYTc3ZDNfNy0yLTEtMS0xMTI2NDAvdGV4dHJlZ2lvbjo1Y2EzZDllN2MyMDQ0Mzg4OWZiNTNkMDY0M2Y3YWZiNF83_07b51734-220b-4e50-8884-111d27cd7f45">19</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmYyMzI3ODc2MDMxYjRjMjQ4YTMzMWM4NjdkY2E3N2QzL3RhYmxlcmFuZ2U6ZjIzMjc4NzYwMzFiNGMyNDhhMzMxYzg2N2RjYTc3ZDNfOC0xLTEtMS0xMTI2NDA_07823ee3-b02b-42cd-ac06-96afd0213d43">385,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the contractual relationships were based on the discounted cash flow method that estimated the present value of the potential royalties, milestones and collaboration revenue streams derived from the licensing of the related technologies over the estimated contractual relationship period. The fair values of the acquired technologies were based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, collaboration and product revenue streams derived from the licensing of the related technologies over the estimated useful lives. These projected cash flows were discounted to present value using discount rate, which varies from <ix:nonFraction unitRef="number" contextRef="id589112d140b42ffa4f049057293f7a7_D20201001-20201001" decimals="INF" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfNDQ4Mw_c3082701-a042-4ca0-aa7e-549c5491deed">12</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i7eada68668c8443ba5abbd0bcde52836_D20201001-20201001" decimals="INF" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfNDQ4OQ_1c70f903-0390-4667-bb19-dfbbbe609269">15</ix:nonFraction>%. The intangible assets acquired are being amortized on a straight-line basis over the estimated useful life. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately $<ix:nonFraction unitRef="usd" contextRef="i67ed4423d4894d809c0e43396ff89fb7_D20200101-20201231" decimals="-5" name="us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfNDYxNw_22575b21-99e4-4e24-a23a-f33ea9ece32a">2.0</ix:nonFraction> million of revenue and $<ix:nonFraction unitRef="usd" contextRef="i67ed4423d4894d809c0e43396ff89fb7_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfNDYzNQ_518d70f5-ddb7-461f-8d1e-16f2fe462244">19.3</ix:nonFraction> million of loss before income taxes of Pfenex were included in the consolidated statement of operations for the year ended December 31, 2020. The following summary presents our unaudited pro forma consolidated results of operations for the years ended December 31, 2020 and December 31, 2019 as if the Pfenex acquisition had occurred on January 1, 2019, which gives effect to certain transaction accounting adjustments, including amortization of acquired intangibles and stock based compensation expense for retained Pfenex employees. The transaction accounting adjustments do not include non-recurring adjustments related to Pfenex's executive salary, board of director compensation, and salary of Pfenex employees involved in the reduction of force as part of the acquisition, estimated to be $<ix:nonFraction unitRef="usd" contextRef="i67ed4423d4894d809c0e43396ff89fb7_D20200101-20201231" decimals="-5" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfNTQyNQ_c4a11f76-a9c7-438b-af45-9eaa6f276099">7.1</ix:nonFraction> million in 2020 and $<ix:nonFraction unitRef="usd" contextRef="i5cbea891771f402ba63e1011224d9594_D20190101-20191231" decimals="-5" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfNTQ0MA_ddc2a723-ec21-48e7-b45b-9ef0350bebbb">4.8</ix:nonFraction>&#160;million in 2019. <ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfMTMyNDc_bef30867-bf26-4f72-abc4-171056f17ffd" continuedAt="i250899be73254eec9e75aab30e6e4457" escape="true">The pro forma financial information is not necessarily indicative of the operating results that would have occurred had the acquisition been consummated as if the date indicated, nor is it necessarily indicative of future operating results (in thousands, except per share amounts):</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><ix:continuation id="i0b85e82902e84487a72eaa691cb34565"><ix:continuation id="i250899be73254eec9e75aab30e6e4457"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67ed4423d4894d809c0e43396ff89fb7_D20200101-20201231" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmUxNjUzNjhjYmNiNzQyMzM5ODI1MTZjZWFhMDVmYzMzL3RhYmxlcmFuZ2U6ZTE2NTM2OGNiY2I3NDIzMzk4MjUxNmNlYWEwNWZjMzNfMi0xLTEtMS0xMTI2NDA_bb8338b2-9d1f-49ee-bcbb-66808f3117e9">189,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cbea891771f402ba63e1011224d9594_D20190101-20191231" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmUxNjUzNjhjYmNiNzQyMzM5ODI1MTZjZWFhMDVmYzMzL3RhYmxlcmFuZ2U6ZTE2NTM2OGNiY2I3NDIzMzk4MjUxNmNlYWEwNWZjMzNfMi0yLTEtMS0xMTI2NDA_15c509d3-06fd-43b9-a61d-0a84a5b19239">170,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67ed4423d4894d809c0e43396ff89fb7_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmUxNjUzNjhjYmNiNzQyMzM5ODI1MTZjZWFhMDVmYzMzL3RhYmxlcmFuZ2U6ZTE2NTM2OGNiY2I3NDIzMzk4MjUxNmNlYWEwNWZjMzNfMy0xLTEtMS0xMTI2NDA_28da4bd8-4319-457b-8165-3828d6b5f4da">60,059</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cbea891771f402ba63e1011224d9594_D20190101-20191231" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmUxNjUzNjhjYmNiNzQyMzM5ODI1MTZjZWFhMDVmYzMzL3RhYmxlcmFuZ2U6ZTE2NTM2OGNiY2I3NDIzMzk4MjUxNmNlYWEwNWZjMzNfMy0yLTEtMS0xMTI2NDA_d35d97e3-74be-4328-a93e-6095e9a1445b">594,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) per common share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i67ed4423d4894d809c0e43396ff89fb7_D20200101-20201231" decimals="2" sign="-" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmUxNjUzNjhjYmNiNzQyMzM5ODI1MTZjZWFhMDVmYzMzL3RhYmxlcmFuZ2U6ZTE2NTM2OGNiY2I3NDIzMzk4MjUxNmNlYWEwNWZjMzNfNS0xLTEtMS0xMTI2NDA_c2e1c8b6-c5cd-48aa-984e-6f53486de9a2">3.71</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5cbea891771f402ba63e1011224d9594_D20190101-20191231" decimals="2" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmUxNjUzNjhjYmNiNzQyMzM5ODI1MTZjZWFhMDVmYzMzL3RhYmxlcmFuZ2U6ZTE2NTM2OGNiY2I3NDIzMzk4MjUxNmNlYWEwNWZjMzNfNS0yLTEtMS0xMTI2NDA_7aaf3162-2727-4dc3-af82-56e77572081c">31.32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i67ed4423d4894d809c0e43396ff89fb7_D20200101-20201231" decimals="2" sign="-" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmUxNjUzNjhjYmNiNzQyMzM5ODI1MTZjZWFhMDVmYzMzL3RhYmxlcmFuZ2U6ZTE2NTM2OGNiY2I3NDIzMzk4MjUxNmNlYWEwNWZjMzNfNi0xLTEtMS0xMTI2NDA_cbf405fb-cb9d-454c-a580-83813765078c">3.71</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5cbea891771f402ba63e1011224d9594_D20190101-20191231" decimals="2" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmUxNjUzNjhjYmNiNzQyMzM5ODI1MTZjZWFhMDVmYzMzL3RhYmxlcmFuZ2U6ZTE2NTM2OGNiY2I3NDIzMzk4MjUxNmNlYWEwNWZjMzNfNi0yLTEtMS0xMTI2NDA_36ef058f-71da-40cd-9bf6-4d5732b3bab9">30.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div><span><br/></span></div><div><span><br/></span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_97"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:FinancialInstrumentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RleHRyZWdpb246MmQxYTM0MTYwZjNlNGU1ZTliNmNiODZkZTcxZDFkMzlfNzQ3Nw_cc4d76c0-bf4d-4450-a222-678675ebfbe4" continuedAt="i67f647b79ab448339b66fb55ee633f03" escape="true">Fair Value Measurement</ix:nonNumeric></span></div><ix:continuation id="i67f647b79ab448339b66fb55ee633f03" continuedAt="i230c7f9f46154c9b92fdde9d97b864fc"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measure certain financial assets and liabilities at fair value on a recurring basis. Fair value is a market-based measurement that should be determined using assumptions that market participants would use in pricing an asset or liability. We establish a three-level hierarchy to prioritize the inputs used in measuring fair value. The levels are described in the below with level 1 having the highest priority and level 3 having the lowest:</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 - Observable inputs such as quoted prices in active markets </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 - Inputs other than the quoted prices in active markets that are observable either directly or indirectly </span></div><div style="margin-bottom:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 - Unobservable inputs in which there is little or no market data, which require the Company to develop its own assumptions</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i230c7f9f46154c9b92fdde9d97b864fc" continuedAt="ib1d35ae874634efaaafc74825c87d974"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RleHRyZWdpb246MmQxYTM0MTYwZjNlNGU1ZTliNmNiODZkZTcxZDFkMzlfNzQ4MQ_b444c8ba-9beb-4d5b-bbda-3f3e430fd2a3" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the assets and liabilities that are measured at fair value on a recurring basis as of December&#160;31, 2022 and 2021 (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurements at Reporting Date Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Active Markets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">for Identical</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Observable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic56146394448409b96d33c1403f18303_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfNC0xLTEtMS0xMTI2NDA_674f7826-93f2-412b-af9f-090b48a290d0">103,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b6118bd78b042f680823946386c507b_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfNC0zLTEtMS0xMTI2NDA_c454a0c5-6ca9-4d27-91e7-6e0ab6e08a9b">3,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib96a633a4e0742be9fe13b947aa7bbf8_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfNC01LTEtMS0xMTI2NDA_1392a855-2176-4ce3-b5e0-5b598b0f0e25">99,615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb1ec84b065e4c5ca2b74a1668e4e379_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfNC03LTEtMS0xMTI2NDA_4a66d786-d1ee-486d-b3c1-5ac75418314e">135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in Viking common stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4aee961123f4b77b2f7f7b245ce72b5_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfNS0xLTEtMS0xMTI2NDA_76e222ad-2c1a-4086-b0be-d0eef6f344ba">63,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dc44c4cfaf6498b9f6dc3d014f4bdf8_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfNS0zLTEtMS0xMTI2NDA_b29a9dd1-6e13-46fa-a201-69d7e8fc925b">63,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4de80e6e30c4350bd4abd2929927cf1_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfNS01LTEtMS0xMTI2NDA_45bab4d6-39c0-4213-83c1-df63b269bed9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b0be75d14a440b5bcdb6664f17060fc_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfNS03LTEtMS0xMTI2NDA_f812044e-ec3b-436b-9c5f-c5c2f1541a5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd4315ab1b654686b5cdda294406fe38_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfNi0xLTEtMS0xMTI2NDA_f416e5d3-77e6-4f41-bf83-a09467a2feca">166,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd090c573e94ca6a2ef574f8aca0f84_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfNi0zLTEtMS0xMTI2NDA_785d6c87-85b9-4c7b-a36a-b1e36f545dbf">67,114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf74ed3f29894bbe89f67ce3f1638368_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfNi01LTEtMS0xMTI2NDA_9af74725-f311-42ba-ad09-3687ebd7a1a2">99,615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id273e2ab6d4d4d30bf4734bdb2617f06_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfNi03LTEtMS0xMTI2NDA_89a50ec2-5e80-4637-a816-f6c861746eec">135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent liabilities - Cydex</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia295c8d89c994fc1bfcfee13cdca48ce_I20221231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfOS0xLTEtMS0xMTI2NDA_2ea8d3a0-0ebd-4be8-bd65-41584323c700">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0f397fe74994049bf8a93a1ab577e34_I20221231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfOS0zLTEtMS0xMTI2NDA_f46f6aac-e5fd-47e7-a342-c8d9cd338434">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5dcb4186e044e5882d93180a92f8279_I20221231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfOS01LTEtMS0xMTI2NDA_63a9bc4f-cfa2-42b0-a927-a895cff24d11">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dcc4622d787496ea953a0a254ba9e7c_I20221231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfOS03LTEtMS0xMTI2NDA_14fa17f6-f817-4b19-869a-674e677c2721">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent liabilities - Metabasis </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bab37c9b6cc4977ba02a28e26ed9ca5_I20221231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfMTAtMS0xLTEtMTEyNjQw_9c043fe4-5af8-4028-856f-f26c8a99d098">3,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id71f5699fd5b463690456b9be5c3a966_I20221231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfMTAtMy0xLTEtMTEyNjQw_159037c3-b758-4601-a7eb-ea27a6eb61c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5b0d44ecc94db89ec934970defe064_I20221231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfMTAtNS0xLTEtMTEyNjQw_1f43c7d9-51e0-4221-b77e-abce562374d9">3,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e56f08463f24218a5dd7f6e8d12a3dc_I20221231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfMTAtNy0xLTEtMTEyNjQw_3404dd36-2fd6-4d7a-91b8-b0ef8ababd88">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for amounts owed to a former licensor</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i849c3dacc5614e158a39923417210219_I20221231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfMTMtMS0xLTEtMTEyNjQw_6c9e9ebd-b53d-4ca9-b0eb-6143db5dd521">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i289ae7096dd54d348dbd227aaa42f5e8_I20221231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfMTMtMy0xLTEtMTEyNjQw_926c6acb-e368-4f8a-afc0-b8487d5f8022">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id323f390108741218d29588c00e4c8a0_I20221231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfMTMtNS0xLTEtMTEyNjQw_709b560e-a9bf-4852-be91-2a931a7ade10">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8fb2e550b84e4faf3a5b2a433bea1a_I20221231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfMTMtNy0xLTEtMTEyNjQw_58a489f2-eaeb-449c-924d-f8e8830b27d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd4315ab1b654686b5cdda294406fe38_I20221231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfMTQtMS0xLTEtMTEyNjQw_892cff10-e5e8-43ac-82c7-d26e3d385589">3,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd090c573e94ca6a2ef574f8aca0f84_I20221231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfMTQtMy0xLTEtMTEyNjQw_c5f1daf8-24fc-4b0b-b0b3-3fe727ea557c">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf74ed3f29894bbe89f67ce3f1638368_I20221231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfMTQtNS0xLTEtMTEyNjQw_19d87aba-d8fd-487c-8c7b-2212cf64a574">3,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id273e2ab6d4d4d30bf4734bdb2617f06_I20221231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfMTQtNy0xLTEtMTEyNjQw_fbe9579f-cb13-43e7-bb1d-f85748c9ec6d">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurements at Reporting Date Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Active Markets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">for Identical</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Observable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb86b09115894c9fbb794f501b2d2dcf_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfNC0xLTEtMS0xMTI2NDA_fcf127d3-1284-44d1-893f-900d1a11cd69">290,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c67973b49304b2cbbb84811600c1663_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfNC0zLTEtMS0xMTI2NDA_f219e046-abea-4f0a-9ea6-980c85fb5ed5">9,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fc3ae0a79b44517bb99fc381adc9058_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfNC01LTEtMS0xMTI2NDA_3a069c66-5ae9-42ea-a925-6ab3cff56cb6">280,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70302a79a5c24d0e881d281ae6cbe66b_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfNC03LTEtMS0xMTI2NDA_fc065f67-5288-45b5-89f0-2de7a98afabf">409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in Viking common stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7bd44fb046a40d79acd8b5094a6af2f_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfNS0xLTEtMS0xMTI2NDA_2041d7bf-1860-43e6-9ec7-78dbdc5230fd">30,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057df6feb256427ebd16d5cfd07edad1_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfNS0zLTEtMS0xMTI2NDA_8aef2933-418f-4aac-8f83-a33902b1c1ff">30,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8224f6e8d10e45e78c84ba1c9a2f97a2_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfNS01LTEtMS0xMTI2NDA_00b033d6-0934-4c68-b7d8-b9c533463065">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e70582ec04b46de89b0fe1f65dbc1e1_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfNS03LTEtMS0xMTI2NDA_29d36b0b-e32c-44c0-9f8b-f62c24679631">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if16a34f8456e47dc9f5b67e39d4c9548_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfNy0xLTEtMS0xMTI2NDA_9a31d2c4-fa84-42c6-8421-f11607ad1509">321,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i358f804697e94a7f8d741b250dbff084_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfNy0zLTEtMS0xMTI2NDA_753da735-d413-4a22-992d-dafa33edb94c">40,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89b5b12d4524461fb990aac54d517487_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfNy01LTEtMS0xMTI2NDA_c8ee5042-2118-4dfb-8100-71734ea6347f">280,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7421ded7a02748e5bd60df47f2093b9b_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfNy03LTEtMS0xMTI2NDA_7603051a-4f49-4133-9e17-5a22d04bbc15">409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent liabilities - Cydex</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fb2de098654192b5935f2063f1a97a_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfMTAtMS0xLTEtMTEyNjQw_05ee30a3-6f22-44d0-bba2-53bf009485b4">349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61cb7f2d12cc441e9bd457c78d89b1aa_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfMTAtMy0xLTEtMTEyNjQw_7edab1e6-9eb4-49f7-bfb7-bb70685fc5b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7678c8eb61e14518b6fb8be69a443a07_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfMTAtNS0xLTEtMTEyNjQw_e7010eaa-92d2-4f50-8941-11dbc4fc1201">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc472a6bccfc444c92220855618d517b_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfMTAtNy0xLTEtMTEyNjQw_2852df41-397b-4302-9124-1701a4a6ec7d">349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent liabilities - Metabasis </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85fd2713598b4a62a7669055f5df86b4_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfMTEtMS0xLTEtMTEyNjQw_47855d0b-466b-4bd7-862a-f0f42d2d9443">3,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eab6a2ac394d7aba45f348a01f8201_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfMTEtMy0xLTEtMTEyNjQw_0a16d435-6efd-4b32-a2de-f41036dfeab8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08c9b0174a48479ea68f212652608932_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfMTEtNS0xLTEtMTEyNjQw_de5f6bdd-0eb8-4d19-8b7e-182f5ce199a8">3,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5237f56ef074e7eb32dbcc66c6db515_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfMTEtNy0xLTEtMTEyNjQw_03b25624-ed61-4daa-8bad-75181bc4d3de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for amounts owed to a former licensor</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i379ebe35361f4afc805f81c76a89b0c4_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfMTQtMS0xLTEtMTEyNjQw_41dface8-3d66-436d-a6e1-50107b48c764">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a30b0e8302e45e3b5d48f2a7758a37e_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfMTQtMy0xLTEtMTEyNjQw_88e9324e-f85a-4438-8f92-3b05a8bc9406">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd920ac870274bd29c5d3815db9bc027_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfMTQtNS0xLTEtMTEyNjQw_64cf69ba-fc11-486b-b4bc-4293807dd7a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if01f6df650ee4787be25d17587903c8a_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfMTQtNy0xLTEtMTEyNjQw_e132aba8-ceb8-4db1-852b-3ed9821ec107">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if16a34f8456e47dc9f5b67e39d4c9548_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfMTUtMS0xLTEtMTEyNjQw_1186cc05-23f7-4281-a6c3-99102dfa8e24">3,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i358f804697e94a7f8d741b250dbff084_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfMTUtMy0xLTEtMTEyNjQw_84f1770e-c958-42e0-991e-f5aa69326606">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89b5b12d4524461fb990aac54d517487_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfMTUtNS0xLTEtMTEyNjQw_8eab5961-bf15-49f1-b3bb-3e1547538b5e">3,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430a03cc0e9c405e9df59a233c9bd258_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfMTUtNy0xLTEtMTEyNjQw_8a27a413-640f-427a-8fae-73009f2d76dd">349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2) Investment in Viking warrants, which we received as a result of Viking&#8217;s partial repayment of the Viking note receivable and our purchase of Viking common stock and warrants in April 2016, is classified as level 1 as the fair value is determined using quoted market prices in active markets for the same securities. The change of the fair value is recorded in &#8220;gain (loss) from short-term investments&#8221; in our consolidated statement of operations. See further discussion in &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Note (3), Short-term Investments: Investment in Viking.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;  </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3) In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders <ix:nonFraction unitRef="agreement" contextRef="iefe06608d69a4810b5ef7844034e3616_I20100131" decimals="INF" name="lgnd:NumberOfContingentValueRightAgreements" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RleHRyZWdpb246MmQxYTM0MTYwZjNlNGU1ZTliNmNiODZkZTcxZDFkMzlfMzMyMQ_d7ffcdc3-350b-44b5-897e-bfab0ae85d4e">four</ix:nonFraction> tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially differ than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#946; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $<ix:nonFraction unitRef="usd" contextRef="i800dff6c80e4444f9003b3ac53dd8573_I20100131" decimals="INF" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RleHRyZWdpb246MmQxYTM0MTYwZjNlNGU1ZTliNmNiODZkZTcxZDFkMzlfNDMwNA_2f5dd221-fc26-45c0-ada8-0f983efa5ffc">375.0</ix:nonFraction> million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $<ix:nonFraction unitRef="usd" contextRef="i21d27e0d975f4344a297876b55e27170_I20100131" decimals="-5" name="us-gaap:ContractWithCustomerAssetGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RleHRyZWdpb246MmQxYTM0MTYwZjNlNGU1ZTliNmNiODZkZTcxZDFkMzlfNDQxOQ_f9eeff35-a029-4204-a615-35e504041e86">10.0</ix:nonFraction> million payment upon initiation of a Phase 3 clinical trial.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="ib1d35ae874634efaaafc74825c87d974" continuedAt="i718f34d995c34fc682c6dc5564e37a44"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RleHRyZWdpb246MmQxYTM0MTYwZjNlNGU1ZTliNmNiODZkZTcxZDFkMzlfNzQ3Ng_156270e2-85a7-4731-81dd-b397172048e9" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the level 3 financial instruments as of December&#160;31, 2022 is as follows (in thousands):</span></div><div style="text-align:center;text-indent:45pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430a03cc0e9c405e9df59a233c9bd258_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjc3ZmNmYTkwNGE5NzQ3MDM4NmYxZDBmNjM3NmVkNjljL3RhYmxlcmFuZ2U6NzdmY2ZhOTA0YTk3NDcwMzg2ZjFkMGY2Mzc2ZWQ2OWNfMS0xLTEtMS0xMjM3NjA_8a27a413-640f-427a-8fae-73009f2d76dd">349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustments to contingent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80eaf9a4b47f4c988d4ed66997f6cdfc_D20220101-20221231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjc3ZmNmYTkwNGE5NzQ3MDM4NmYxZDBmNjM3NmVkNjljL3RhYmxlcmFuZ2U6NzdmY2ZhOTA0YTk3NDcwMzg2ZjFkMGY2Mzc2ZWQ2OWNfMy0xLTEtMS0xMjM3NjA_a7791ab1-8503-4cfd-b561-50bee6a53ff0">265</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of December&#160;31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33228b6719394b3784c1b537e298a756_I20221231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjc3ZmNmYTkwNGE5NzQ3MDM4NmYxZDBmNjM3NmVkNjljL3RhYmxlcmFuZ2U6NzdmY2ZhOTA0YTk3NDcwMzg2ZjFkMGY2Mzc2ZWQ2OWNfMy0xLTEtMS0xMzU4MjI_0665a36b-e5a5-4a0b-9fb1-c5c472e8e5fc">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the level 3 financial instruments as of December&#160;31, 2021 is as follows (in thousands):</span></div><div style="text-align:center;text-indent:45pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib390d2fa586a4871b184b3ae93ef7a46_I20201231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjY2YjIyYjdhODZlNjQ5NTk4M2QzZWEwZjFmMzg1ZTk1L3RhYmxlcmFuZ2U6NjZiMjJiN2E4NmU2NDk1OTgzZDNlYTBmMWYzODVlOTVfMS0xLTEtMS0xMTI2NDA_c7b7687c-7f5b-4f68-b401-47b7815cbc44">38,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to CVR holders and other contingency payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i749ac5b664db4f20af265ce3e3d5b538_D20210101-20211231" decimals="-3" name="lgnd:PaymentsToContingentValueRightHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjY2YjIyYjdhODZlNjQ5NTk4M2QzZWEwZjFmMzg1ZTk1L3RhYmxlcmFuZ2U6NjZiMjJiN2E4NmU2NDk1OTgzZDNlYTBmMWYzODVlOTVfMi0xLTEtMS0xMTI2NDA_4fc663d8-ff82-4951-a92d-cf4fcb5039cd">50</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustments to contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i749ac5b664db4f20af265ce3e3d5b538_D20210101-20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjY2YjIyYjdhODZlNjQ5NTk4M2QzZWEwZjFmMzg1ZTk1L3RhYmxlcmFuZ2U6NjZiMjJiN2E4NmU2NDk1OTgzZDNlYTBmMWYzODVlOTVfMy0xLTEtMS0xMTI2NDA_97d16891-aa10-4ad1-8ca0-a217c6664c66">37,708</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of December&#160;31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430a03cc0e9c405e9df59a233c9bd258_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjY2YjIyYjdhODZlNjQ5NTk4M2QzZWEwZjFmMzg1ZTk1L3RhYmxlcmFuZ2U6NjZiMjJiN2E4NmU2NDk1OTgzZDNlYTBmMWYzODVlOTVfNS0xLTEtMS0xMTI2NDA_98daec7b-0625-4d92-8c38-118b9f331c65">349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Measured on a Non-Recurring Basis</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to our goodwill, indefinite-lived intangible assets, and long-lived assets.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. We determine the fair value of our reporting unit based on a combination of inputs, including the market capitalization of Ligand, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. We determine the fair value of our indefinite-lived intangible assets using the income approach based on Level 3 inputs.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than the finance lease equipment discussed in &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note (6), Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;, there was <ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="INF" name="us-gaap:AssetImpairmentCharges" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RleHRyZWdpb246MmQxYTM0MTYwZjNlNGU1ZTliNmNiODZkZTcxZDFkMzlfNjU1OA_9dcde7ee-8ede-4ea6-bf9b-c4c981abb60b">no</ix:nonFraction> impairment of our goodwill, indefinite-lived assets, or long-lived assets recorded during the twelve months ended December&#160;31, 2022.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, we issued the 2023 Notes. We use quoted market rates in an inactive market, which are classified as a Level 2 input, to estimate the fair value of our 2023 Notes. The carrying value of the notes does not reflect the market rate. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note (7), Convertible Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for additional information related to the fair value.</span></div></ix:continuation><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i718f34d995c34fc682c6dc5564e37a44">In addition, our accounts receivable, accounts payable, accrued liabilities, current deferred revenue, current operating lease liabilities, current financing lease liabilities are financial instruments and are recorded at cost in the consolidated balance sheets. The estimated fair value of these financial instruments approximates their carrying value due to their short-term nature.</ix:continuation> </span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_100"></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.  <ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzQ1ODQ_b055d43a-7930-4edb-9761-01bc00310816" continuedAt="i45e6d85b4fc049dab52d357ee66ca2f7" escape="true"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:LesseeFinanceLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzQ1ODQ_f99bdfc1-2e89-472d-8476-2e8ac5ff19b2" continuedAt="i0d17f83343ec45ebba31b188a2764de8" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i45e6d85b4fc049dab52d357ee66ca2f7" continuedAt="ic3b4c0a71045497ab831f29fc67edaa0"><ix:continuation id="i0d17f83343ec45ebba31b188a2764de8" continuedAt="i16dc43b2400e42af9f4e9f2aa8ea22f0"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Finance lease</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020 and January 2021, we entered into an agreement and the first amendment with Hovione, our third-party manufacturer, to increase our manufacturing of Captisol, respectively. The agreements are considered to include an embedded finance lease under ASC 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as it provides the Company the right to use the underlying equipment to exclusively manufacture Captisol. As of December&#160;31, 2021, we have fully paid consideration of $<ix:nonFraction unitRef="usd" contextRef="ic202f70f62e8428d9c78a4978a746eee_I20211231" decimals="-5" name="lgnd:PurchaseCommitmentConsiderationPaidToDate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzE2NDkyNjc0NjE0Mjk_f0726ffb-ec04-457d-9fcd-db897f80d9d9">69.1</ix:nonFraction> million for prepaid inventory and capacity ramp-up fee. We allocated consideration in the agreements between lease and non-lease components using relative standalone prices. Since the inception of the agreements, we have allocated $<ix:nonFraction unitRef="usd" contextRef="ic202f70f62e8428d9c78a4978a746eee_I20211231" decimals="-5" name="lgnd:PurchaseCommitmentConsiderationPaidAllocatedToInventory" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzE2NDkyNjc0NjE0Mzc_6db8c0c8-02c4-49de-aa26-9b8832d21c46">50.2</ix:nonFraction> million of the consideration paid to the non-lease component which is accounted for as prepaid inventory and being amortized to cost of Captisol based on the usage.  The remaining balance of $<ix:nonFraction unitRef="usd" contextRef="i6747a650dc714496a27ce80ca1fde353_D20210101-20211231" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzE2NDkyNjc0NjE0NDU_3c64ac78-f4df-470e-92ab-ba8fef9afb42">18.9</ix:nonFraction> million was recognized as a right of use asset. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the current COVID status, our forecast for COVID-related Captisol has been significantly reduced, which triggered an indicator of impairment of the right of use asset as of December 31, 2022. We performed a recoverability test at the asset group level by comparing the sum of the estimated undiscounted future cash flows attributable to the asset group to its carrying value and identified the asset was impaired. We recorded a $<ix:nonFraction unitRef="usd" contextRef="if07332e474464098b61af13fe5a470f2_D20220101-20221231" decimals="-5" name="us-gaap:FinanceLeaseImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzU0OTc1NTgzMTIxNQ_22ae5aea-dc96-4586-bed1-e3afdba1236e">9.8</ix:nonFraction>&#160;million of impairment charge based on the fair value of the right of use asset which has been recognized in cost of Captisol in our consolidated statement of operations for the year ended December&#160;31, 2022. As of December&#160;31, 2022 the remaining right of use asset balance is $<ix:nonFraction unitRef="usd" contextRef="i0d685acb7be943ae8d15dc5799a4444a_I20221231" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzE2NDkyNjc0NDY1MTM_1467e055-18d3-4049-8d89-7cd573b7eebb">4.0</ix:nonFraction>&#160;million which will be amortized straight-line over the remaining <ix:nonNumeric contextRef="i0d685acb7be943ae8d15dc5799a4444a_I20221231" name="us-gaap:LesseeFinanceLeaseRemainingLeaseTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzQ1ODU_d7dc61aa-e1ca-4ae0-babd-eeb285eb7abc">6</ix:nonNumeric> years lease term. </span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic3b4c0a71045497ab831f29fc67edaa0" continuedAt="iaf74201f41254002a1d09e953dcb4c4d"><ix:continuation id="i16dc43b2400e42af9f4e9f2aa8ea22f0" continuedAt="i3a60f84c8c594eb094e790a4f9e29172"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating lease </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease certain office facilities and equipment primarily under various operating leases. Our operating leases have remaining contractual terms up to <ix:nonNumeric contextRef="i1566abca593746beacdf6a287d3c798c_I20221231" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzEyMjE_d06eb8b0-7b57-4e29-bab8-e3b61e177491">ten years</ix:nonNumeric>, some of which include options to extend the leases for up to <ix:nonNumeric contextRef="i1566abca593746beacdf6a287d3c798c_I20221231" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzEyODY_8003b402-f9f0-4896-9014-2002568a262d">five years</ix:nonNumeric>. Our lease agreements do not contain any material residual value guarantees, material restrictive covenants, or material termination options. Our operating lease costs are primarily related to facility leases for administration offices and research and development facilities.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate generally applicable to the location of the lease asset, unless the implicit rate is readily determinable. Lease assets also include any upfront lease payments made and lease incentives. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to base rent, certain of our operating leases require variable payments, such as insurance and common area maintenance. These variable lease costs, other than those dependent upon an index or rate, are expensed when the obligation for those payments is incurred. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The depreciable life of lease assets and leasehold improvements is limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.</span></div><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="lgnd:AssetsAndLiabilitiesLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzQ1ODY_df0d0770-8637-4586-b9c5-7164c5242204" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating and Finance Lease Assets and Liabilities (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzItMS0xLTEtMTEyNjQw_ed2f4cc5-1bf2-4564-ab69-ab098933ade0">10,914</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzItMy0xLTEtMTEyNjQw_09fefe12-65dd-4c0c-8969-ec337b201edb">3,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzMtMS0xLTEtMTEyNjQw_ee31ba1d-a63a-4f9f-bb03-6bec80d75432">4,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzMtMy0xLTEtMTEyNjQw_5511a4ba-3e2d-49cc-be20-6ae3d0cb95ac">16,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total lease assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="lgnd:LeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzQtMS0xLTEtMTEyNjQw_fb3ea923-be37-4806-a4ce-7146f31f8b85">15,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="lgnd:LeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzQtMy0xLTEtMTEyNjQw_ab2abf69-e356-406c-bce8-f52aaf22eef0">19,411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzctMS0xLTEtMTEyNjQw_64e9501b-f5e9-4879-94e7-467d8b73e497">670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzctMy0xLTEtMTEyNjQw_cd92ea14-83f9-41af-ae5d-b60933b6d5c0">1,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzgtMS0xLTEtMTEyNjQw_e088b548-4dc6-42c0-9cef-9fc9c325f7cd">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzgtMy0xLTEtMTEyNjQw_3e7b7987-de4f-40d5-aea0-50f2a2a98ac2">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="lgnd:LeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzktMS0xLTEtMTEyNjQw_45cead86-2f96-4b6c-a816-6877cca290c7">715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="lgnd:LeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzktMy0xLTEtMTEyNjQw_696f00a9-823b-4a70-a423-4dc40e503b4c">1,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzEwLTEtMS0xLTExMjY0MA_40991ea0-ff98-4653-ab6e-da653e49f042">10,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzEwLTMtMS0xLTExMjY0MA_0a7c524c-1751-45c4-bef0-a1c5b77e8c53">2,256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzExLTAtMS0xLTExMjY0MA_a1a5fccc-ae24-4f80-98b2-5c22c6e04753"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzExLTAtMS0xLTExMjY0MA_f02bfdd2-8ed4-4dd1-a881-ebd664bece19">Long-term finance lease liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzExLTEtMS0xLTExMjY0MA_d93f0f68-86b3-4e86-96c6-35b25ae7e2b3">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzExLTMtMS0xLTExMjY0MA_6fcc7bdf-c4d2-4f98-9ff6-051ee28ddbc5">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total lease liabilities   </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="lgnd:LeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzEyLTEtMS0xLTExMjY0MA_696cb15f-1107-4060-982e-014a73b1164d">11,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="lgnd:LeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzEyLTMtMS0xLTExMjY0MA_511e8427-b48f-4c70-a55b-6f9dad628664">3,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzQ1ODc_9c1ea644-9793-41c1-9d35-6e71e2d2c5fe" escape="true"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzQ1ODc_c5f3a32f-2a0e-4b66-8a2c-57c01566ab6c" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Maturity of Operating and Finance Lease Liabilities as of December&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.391%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.499%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Dates</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzEtMi0xLTEtMTEyNjQw_19e40ca6-5b15-47c7-92d5-fe32905df8b6">1,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzEtNC0xLTEtMTEyNjQw_50eac388-4e46-4bb9-a2b4-277e90b66752">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzItMi0xLTEtMTEyNjQw_e4ea925a-d4c7-4180-8ae1-48132461fd1f">1,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzItNC0xLTEtMTEyNjQw_8bccf52b-d683-4b06-aba6-4fde656aebd2">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzMtMi0xLTEtMTEyNjQw_affe4a93-b28a-4145-8aa2-828a77f8305f">1,576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzMtNC0xLTEtMTEyNjQw_f840e9fd-792b-4ebb-af29-7e6493aa0553">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzQtMi0xLTEtMTEyNjQw_69462e8d-267d-4f38-a13c-c3d6c76b5904">1,621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzQtNC0xLTEtMTEyNjQw_bf435384-3386-4ac5-b1db-59404d15f527">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzUtMi0xLTEtMTEyNjQw_f64c1324-4935-4f5d-9198-74a8d759f7ca">1,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzUtNC0xLTEtMTEyNjQw_8d90a37c-3785-4771-a882-5f2020cadd97">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzYtMi0xLTEtMTEyNjQw_8b7a4c67-1c75-425c-a569-6b107199c6e6">7,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzYtNC0xLTEtMTEyNjQw_58813d12-0961-4932-91e6-b7e882a8632f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzctMi0xLTEtMTEyNjQw_dc584939-b9f9-4d94-90bd-19c1aa86c203">15,386</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzctNC0xLTEtMTEyNjQw_2e82ee79-9da6-420a-b6ad-f6ad6c486547">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzktMi0xLTEtMTEyNjQw_2c49527f-df50-469c-9826-ff8fbeb4c5e0">4,380</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzktNC0xLTEtMTEyNjQw_a1e4845a-e3c6-47b4-b5bc-aad7515b1b58">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzEwLTItMS0xLTExMjY0MA_f07f8db7-7b51-47ad-8d34-ddbdec00806e">11,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzEwLTQtMS0xLTExMjY0MA_95a81cde-a77d-4d21-967a-538c09094689">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, our operating leases have a weighted-average remaining lease term of <ix:nonNumeric contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzE2NDkyNjc0NDcwNDM_ef935a25-882d-4610-8a8d-a05860d2ea8a">9.3</ix:nonNumeric> years and a weighted-average discount rate of <ix:nonFraction unitRef="number" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzM3MjQ_3f87ce8b-2af5-4d16-b022-9e44d5ecbb04">7.1</ix:nonFraction>%. As of December&#160;31, 2021, our operating leases have a weighted-average remaining lease term of <ix:nonNumeric contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzM4MDc_2840368d-d70e-40f7-b3dc-0141e191d6d7">2.9</ix:nonNumeric> years and a weighted-average discount rate of <ix:nonFraction unitRef="number" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzM4NTA_d3755863-78f4-4726-b975-37eb742d43a0">5.1</ix:nonFraction>%. Cash paid for amounts included in the measurement of operating lease liabilities was $<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-5" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzM5Mzk_4c06c8bc-a9df-41b0-b045-3696329de706">1.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-5" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzE2NDkyNjc0NTkxNDQ_dab98211-c84c-4114-b821-334428f9e526">1.5</ix:nonFraction> million for the twelve months ended December&#160;31, 2022 and 2021, respectively. Operating lease expense was $<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzQwMTU_179285df-9956-48bd-b37a-94082d7e11f8">0.7</ix:nonFraction> million (net of sublease income of $<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-5" name="us-gaap:SubleaseIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzQwNDU_228fa617-d043-4f6b-bf12-ea369530daa4">0.7</ix:nonFraction> million) and $<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzQwNTM_0f280dfa-005d-4a87-96d7-10e05b3f4ab1">1.0</ix:nonFraction> million (net of sublease income of $<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-5" name="us-gaap:SubleaseIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzQwODM_0b37ef42-aacc-42ca-9c7c-5e29de7eca23">0.4</ix:nonFraction> million) for the twelve months ended December&#160;31, 2022 and 2021, respectively.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iaf74201f41254002a1d09e953dcb4c4d"><ix:continuation id="i3a60f84c8c594eb094e790a4f9e29172">As of December&#160;31, 2022, our finance leases have a weighted-average remaining lease term of <ix:nonNumeric contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzQyMDM_d9d10e9c-ee18-4798-ac14-1044751a680b">1.1</ix:nonNumeric> years and a weighted-average discount rate of <ix:nonFraction unitRef="number" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzQyNDY_cd978f6b-f3b7-490a-b2ac-65cd1b2d05cb">4.1</ix:nonFraction>%. As of December&#160;31, 2021, our finance leases have a weighted-average remaining lease term of <ix:nonNumeric contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzQzMjc_a30d6103-cdb2-4356-b63b-91490fe19071">2.1</ix:nonNumeric> years and a weighted-average discount rate of <ix:nonFraction unitRef="number" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzQzNzA_c6effec0-fdcc-4099-81b1-2ba11928aa8e">4.1</ix:nonFraction>%. We excluded the Hovione equipment lease in the calculation of weighted average remaining lease term and weighted average discount rate because the Hovione lease was fully paid off as of December&#160;31, 2021. Cash paid for amounts included in the measurement of these finance lease liabilities was $<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-4" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzQ0NjM_b265d684-9bdf-46d0-9578-9949fe49c0e2">0.05</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-5" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzE2NDkyNjc0NTk1NjQ_380315c3-c0c2-4ecc-9267-5bbd648068a6">9.3</ix:nonFraction>&#160;million for the twelve months ended December&#160;31, 2022 and 2021, respectively. Finance lease expense was $<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-5" name="us-gaap:FinanceLeaseInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzQ1Mzc_f417e119-f88c-4267-91eb-4be4982b463e">2.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-5" name="us-gaap:FinanceLeaseInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzE2NDkyNjc0NTk1NzQ_5be4042d-a458-498a-a50c-ff5b5c48ed25">2.3</ix:nonFraction> million for the twelve months ended December&#160;31, 2022 and 2021, respectively.</ix:continuation></ix:continuation></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_103"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzE1ODYw_934f6bc8-b728-4ba7-867d-28c520c0b5d8" continuedAt="if65cdb015cc3492e96f8bf64301d8925" escape="true">Convertible Senior Notes</ix:nonNumeric></span></div><ix:continuation id="if65cdb015cc3492e96f8bf64301d8925" continuedAt="ie0cdf7d2a76c4b27a23ec2d9c9dee3f7"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonFraction unitRef="number" contextRef="ic8ae4ee0f64a46979ca5a2c15da782e7_I20180531" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzU0OTc1NTg1MjUwOA_fadfe2bd-2b94-4c98-85f0-a993a795fc4c">0.75</ix:nonFraction>% Convertible Senior Notes due 2023</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, we issued $<ix:nonFraction unitRef="usd" contextRef="ic8ae4ee0f64a46979ca5a2c15da782e7_I20180531" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4Xzc3MDE_e20e13e5-57a7-4a49-8d1e-8c57d7421b9a">750</ix:nonFraction> million aggregate principal amount of 2023 Notes, bearing cash interest at a rate of <ix:nonFraction unitRef="number" contextRef="ic8ae4ee0f64a46979ca5a2c15da782e7_I20180531" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4Xzc3ODE_fadfe2bd-2b94-4c98-85f0-a993a795fc4c">0.75</ix:nonFraction>% per year, payable semi-annually. The net proceeds from the offering, after deducting the initial purchasers' discount and offering expenses, were approximately $<ix:nonFraction unitRef="usd" contextRef="i8ae5acdc120c4e40981302a07b8d28a6_D20180501-20180531" decimals="-5" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4Xzc5NDQ_9fb12907-bfc8-48de-a163-ef4737135684">733.1</ix:nonFraction> million. The 2023 Notes will be convertible into cash, shares of common stock, or a combination of cash and shares of common stock, at our election, based on a conversion rate as discussed below. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2023 Notes were entitled to convert the notes at any time prior to the close of business on the business day immediately preceding November 15, 2022, under any of the following circumstances:</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) during any fiscal quarter (and only during such fiscal quarter) commencing after September 30, 2018, if, for at least <ix:nonFraction unitRef="trading_day" contextRef="i11b50fd2d77b498e82f14c8ee21dcc5c_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4Xzg1OTc_109b2442-ffc7-45da-97a4-f008b6537274">20</ix:nonFraction> trading days (whether or not consecutive) during the <ix:nonFraction unitRef="trading_day" contextRef="i11b50fd2d77b498e82f14c8ee21dcc5c_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4Xzg2NTM_7599b168-a84e-4213-ba18-6682d1a73a3a">30</ix:nonFraction> consecutive trading day period ending on the last trading day of the immediately preceding fiscal quarter, the last reported sale price of our common stock on such trading day was greater than <ix:nonFraction unitRef="number" contextRef="i11b50fd2d77b498e82f14c8ee21dcc5c_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4Xzg4NDg_817b7747-7be1-4f21-a010-6a7d3a6e6425">130</ix:nonFraction>% of the conversion price on such trading day;</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) during the <ix:nonFraction unitRef="trading_day" contextRef="i2a146d0761cc415ba2c40a2459586b06_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4Xzg5MTI_5de19ef7-21eb-49d0-856e-64bb24785127">five</ix:nonFraction> business day period immediately following any <ix:nonFraction unitRef="trading_day" contextRef="i2a146d0761cc415ba2c40a2459586b06_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4Xzg5NjE_699dea30-513d-48af-80d7-88d627d872f0">10</ix:nonFraction> consecutive trading day period, in which the trading price per $1,000 principal amount of notes was less than <ix:nonFraction unitRef="number" contextRef="i2a146d0761cc415ba2c40a2459586b06_D20180501-20180531" decimals="INF" name="lgnd:DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzkwNzQ_3ad7180e-f47c-4a30-abff-15daacb2da26">98</ix:nonFraction>% of the product of the last reported sale price of our common stock on such trading day and the conversion rate on each such trading day; or</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) upon the occurrence of certain specified corporate events as specified in the indenture governing the notes.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In advance of the Distribution of the shares of common stock of OmniAb to Ligand&#8217;s shareholders on November 1, 2022, a notice of convertibility was delivered to the holders of the 2023 Notes. No holders exercised their right to convert their 2023 Notes during the applicable period for conversion. After we completed the Separation of the OmniAb Business, on November&#160;15, 2022, the conversion rate was adjusted to 4.8390 shares of common stock per $1,000 principal amount of the 2023 Notes which represents a conversion price of approximately&#160;$<ix:nonFraction unitRef="usdPerShare" contextRef="ic8ae4ee0f64a46979ca5a2c15da782e7_I20180531" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzEwOTk1MTE2NTk0NTM_9403ba6b-231b-4e7b-a5be-9470d92498bb">206.65</ix:nonFraction> per share. The maximum conversion rate of the 2023 Notes was adjusted to 6.2907 per $1,000 principal amount of the 2023 Notes which represents a conversion price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="ic965f5b4e009491284f786378035d4e1_I20180531" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzU0OTc1NTg1MjQyMA_936b8314-2a4a-476f-aeb3-9ca6107a7232">158.97</ix:nonFraction>.  The conversion rate for the 2023 Notes was adjusted in accordance with the requirements of the Indenture based on calculations determined with reference to a valuation period of the first <ix:nonFraction unitRef="trading_day" contextRef="i2a146d0761cc415ba2c40a2459586b06_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzU0OTc1NTgzMjI0MQ_740031ff-548f-44d0-b6b3-13fc1f5c747d">10</ix:nonFraction> consecutive trading days after, and including, the ex-dividend date of the spin-off (as determined in the Indenture). The conversion rate and maximum conversion rate are subject to further adjustment under the circumstances and pursuant to the terms set forth in the Indenture.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notes will have a dilutive effect to the extent the average market price per share of common stock for a given reporting period exceeds the current conversion price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ic8ae4ee0f64a46979ca5a2c15da782e7_I20180531" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4Xzk0OTY_9403ba6b-231b-4e7b-a5be-9470d92498bb">206.65</ix:nonFraction>. In connection with the issuance of the 2023 Notes, we incurred $<ix:nonFraction unitRef="usd" contextRef="ic8ae4ee0f64a46979ca5a2c15da782e7_I20180531" decimals="-5" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4Xzk2NTQ_d2ec8951-34c6-4d9d-99c2-f451f9a5d985">16.9</ix:nonFraction> million of issuance costs, which primarily consisted of underwriting, legal and other professional fees. The portion of these costs allocated to the liability component totaling $<ix:nonFraction unitRef="usd" contextRef="ic8ae4ee0f64a46979ca5a2c15da782e7_I20180531" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedPremium" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4Xzk4Mjc_7b8e6619-d3e5-46c6-b3c2-a1b9fa436697">13.7</ix:nonFraction> million is amortized to interest expense using the effective interest method over the <ix:nonNumeric contextRef="ia361a8f8b6774d9f9e3b2a48a102ecb8_D20220101-20221231" name="us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzE2NDkyNjc0ODE2MzU_494d61a5-aeff-4b35-9ea8-32baf860c274">five years</ix:nonNumeric> expected life of the 2023 Notes, and the effective interest rate as of December 31, 2022 is <ix:nonFraction unitRef="number" contextRef="i3316b5508b924ffc8fd7ec36b3aa455e_I20221231" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzE2NDkyNjc0ODE1Nzg_dd6a4582-7c4e-4d31-83b9-ff60f495eed3">0.5</ix:nonFraction>%. During the year ended December 31, 2022 we recognized a total of $<ix:nonFraction unitRef="usd" contextRef="ia361a8f8b6774d9f9e3b2a48a102ecb8_D20220101-20221231" decimals="-5" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzU0OTc1NTg1MjMyMw_858aa7bb-98f4-4d44-8f81-796de4fe493f">1.8</ix:nonFraction> million in interest expense which includes $<ix:nonFraction unitRef="usd" contextRef="ia361a8f8b6774d9f9e3b2a48a102ecb8_D20220101-20221231" decimals="-5" name="us-gaap:InterestExpenseDebtExcludingAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzU0OTc1NTg1MjM1OA_21da1c25-fa07-4d9a-a43d-6fe6815fd968">1.1</ix:nonFraction> million in contractual interest expense and $<ix:nonFraction unitRef="usd" contextRef="ia361a8f8b6774d9f9e3b2a48a102ecb8_D20220101-20221231" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzU0OTc1NTg1MjM2Nw_3c715847-9917-4c31-8ffa-edc11dc7b502">0.7</ix:nonFraction> million in amortized issuance costs. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, we repurchased $<ix:nonFraction unitRef="usd" contextRef="id1dd1d35129f4cd39fb80e6800cfe252_I20211231" decimals="-5" name="us-gaap:DebtInstrumentRepurchaseAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzEwNzU3_0ce97b15-3028-42b4-86a6-139f607a0889">152.0</ix:nonFraction>&#160;million in principal of the 2023 Notes for $<ix:nonFraction unitRef="usd" contextRef="ia99cec91b0284a4090f6d9399292f293_D20210101-20211231" decimals="-5" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzEwNzk1_6dbeaee5-790f-4bfe-b700-2075e944c29a">156.0</ix:nonFraction>&#160;million in cash, including accrued interest of $<ix:nonFraction unitRef="usd" contextRef="ia99cec91b0284a4090f6d9399292f293_D20210101-20211231" decimals="-5" name="lgnd:RepaymentsOfNotesPayableInterestPortion" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzEwODM3_2c1e8a61-9c45-4e88-a8c3-e08fec1c4fb9">0.3</ix:nonFraction>&#160;million. We accounted for the repurchase as a debt extinguishment, which resulted in (1) a loss of $<ix:nonFraction unitRef="usd" contextRef="ia99cec91b0284a4090f6d9399292f293_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzEwOTMx_465ef6c4-6b39-4ce4-b438-51b74e3b35d3">7.3</ix:nonFraction>&#160;million reflected in other income (expense), net, in our consolidated statement of operations for the year ended December&#160;31, 2021, (2) a $<ix:nonFraction unitRef="usd" contextRef="ia99cec91b0284a4090f6d9399292f293_D20210101-20211231" decimals="-5" sign="-" name="lgnd:IncreaseDecreaseInDebtDiscount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzExMDUw_78d3351e-f469-44f3-a7cc-8ce921db8b03">13.7</ix:nonFraction>&#160;million reduction in debt discount, and (3) a $<ix:nonFraction unitRef="usd" contextRef="ia99cec91b0284a4090f6d9399292f293_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzExMDkx_814f80fc-39d4-43cf-9b01-d75559753452">10.2</ix:nonFraction>&#160;million reduction to additional paid in capital, related to the reacquisition of the equity component in our consolidated balance sheet as of December&#160;31, 2021. After the repurchases, approximately $<ix:nonFraction unitRef="usd" contextRef="id1dd1d35129f4cd39fb80e6800cfe252_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzExMjkx_65697dc1-a901-4b93-8f4b-9895182f173e">343.3</ix:nonFraction> million in principal amount of the 2023 Notes remain outstanding. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie0cdf7d2a76c4b27a23ec2d9c9dee3f7" continuedAt="i5ced1c35d61645e0a8431765694dfc2a"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, we repurchased $<ix:nonFraction unitRef="usd" contextRef="i3316b5508b924ffc8fd7ec36b3aa455e_I20221231" decimals="-5" name="us-gaap:DebtInstrumentRepurchaseAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzU0OTc1NTg0ODgyOA_e55ed531-9f24-4682-a4b9-5e4579a4d5a1">266.4</ix:nonFraction> million in principal amount of the 2023 Notes for $<ix:nonFraction unitRef="usd" contextRef="ia361a8f8b6774d9f9e3b2a48a102ecb8_D20220101-20221231" decimals="-5" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzU0OTc1NTg0ODc1OQ_2e49609d-4ccf-4b49-8d79-abd64cf61f9d">261.4</ix:nonFraction> million in cash, including accrued interest of $<ix:nonFraction unitRef="usd" contextRef="ia361a8f8b6774d9f9e3b2a48a102ecb8_D20220101-20221231" decimals="-5" name="lgnd:RepaymentsOfNotesPayableInterestPortion" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzU0OTc1NTg0ODc0MQ_d08f2062-fc06-40b8-9a4b-c87afd5a29c6">0.5</ix:nonFraction> million We accounted for the repurchase as a debt extinguishment, which resulted in a gain of $<ix:nonFraction unitRef="usd" contextRef="ia361a8f8b6774d9f9e3b2a48a102ecb8_D20220101-20221231" decimals="-5" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzU0OTc1NTg0ODc3OA_b74da5c0-475d-4101-891f-e3e4963ded8c">4.2</ix:nonFraction> million reflected in other income (expense), net, in our consolidated statement of operations for the year ended December 31, 2022, and a $<ix:nonFraction unitRef="usd" contextRef="ia361a8f8b6774d9f9e3b2a48a102ecb8_D20220101-20221231" decimals="-5" sign="-" name="lgnd:IncreaseDecreaseInDebtDiscount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzU0OTc1NTg0ODc5Mw_5e064d78-7ad5-4fc2-ae7f-b19e84b9f2f3">1.3</ix:nonFraction> million reduction in debt discount. After the repurchases, approximately $<ix:nonFraction unitRef="usd" contextRef="i3316b5508b924ffc8fd7ec36b3aa455e_I20221231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzE2NDkyNjc0ODU1NzA_f94b99bf-7840-4aaf-8aa1-116e7882b778">76.9</ix:nonFraction> million in principal amount of the 2023 Notes remain outstanding. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Bond Hedge and Warrant Transactions</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the 2023 Notes, in May 2018, we entered into convertible bond hedges and sold warrants covering <ix:nonFraction unitRef="shares" contextRef="ic8ae4ee0f64a46979ca5a2c15da782e7_I20180531" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzExNjQy_a4e40323-1ac4-4b81-9a47-b0a8ca361628">3,018,327</ix:nonFraction> shares of our common stock to minimize the impact of potential dilution to our common stock and/or offset the cash payments we are required to make in excess of the principal amount upon conversion of the 2023 Notes. The convertible bond hedges have an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ic8ae4ee0f64a46979ca5a2c15da782e7_I20180531" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzExOTE2_6708e02a-0eef-4c94-95a3-30b5ba4154e2">206.65</ix:nonFraction> per share and are exercisable when and if the 2023 Notes are converted. We paid $<ix:nonFraction unitRef="usd" contextRef="i8ae5acdc120c4e40981302a07b8d28a6_D20180501-20180531" decimals="-5" name="lgnd:PaymentsforConvertibleBondHedges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzExOTk5_b7cfed6b-248d-4549-92d7-f7e8ff069490">140.3</ix:nonFraction> million for these convertible bond hedges. If upon conversion of the 2023 Notes, the price of our common stock is above the exercise price of the convertible bond hedges, the counterparties will deliver shares of common stock and/or cash with an aggregate value approximately equal to the difference between the price of common stock at the conversion date and the exercise price, multiplied by the number of shares of common stock related to the convertible bond hedge transaction being exercised. The convertible bond hedges and warrants described below are separate transactions entered into by us and are not part of the terms of the 2023 Notes. Holders of the 2023 Notes and warrants will not have any rights with respect to the convertible bond hedges.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrently with the convertible bond hedge transactions, we entered into warrant transactions whereby we sold warrants covering <ix:nonFraction unitRef="shares" contextRef="ic8ae4ee0f64a46979ca5a2c15da782e7_I20180531" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzEyODg0_dea8e3a2-fd34-4bd0-8950-a2c2f74ea5c2">3,018,327</ix:nonFraction> shares of common stock with an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ic8ae4ee0f64a46979ca5a2c15da782e7_I20180531" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzEyOTM2_8af40687-9a6a-448f-917e-c166d718b710">315.38</ix:nonFraction> per share, subject to certain adjustments. We received $<ix:nonFraction unitRef="usd" contextRef="i8ae5acdc120c4e40981302a07b8d28a6_D20180501-20180531" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzEyOTk0_88dfd941-5869-4714-a574-18d4f0162e0a">90.0</ix:nonFraction> million for these warrants. The warrants have various expiration dates ranging from August 15, 2023 to February 6, 2024. The warrants will have a dilutive effect to the extent the market price per share of common stock exceeds the applicable exercise price of the warrants, as measured under the terms of the warrant transactions. The common stock issuable upon exercise of the warrants will be in unregistered shares, and we do not have the obligation and do not intend to file any registration statement with the SEC registering the issuance of the shares under the warrants.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, in connection with the repurchases of $<ix:nonFraction unitRef="usd" contextRef="ibbe666f5347841329bf2326c9232e329_I20200430" decimals="-5" name="us-gaap:DebtInstrumentRepurchaseAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzEzNjIx_cbb7a820-e180-44ac-86ee-3560c0551ea9">234.4</ix:nonFraction>&#160;million in principal of the 2023 Notes for $<ix:nonFraction unitRef="usd" contextRef="ibf823eb4d59c42a0a2bc0d1990fa4bc0_D20200401-20200430" decimals="-5" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzEzNjU5_485c4fc5-aff6-4c3c-8c90-714071074594">203.8</ix:nonFraction>&#160;million in cash, including accrued interest of $<ix:nonFraction unitRef="usd" contextRef="ibf823eb4d59c42a0a2bc0d1990fa4bc0_D20200401-20200430" decimals="-5" name="lgnd:RepaymentsOfNotesPayableInterestPortion" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzEzNzAx_79f9126b-c7cb-4f5e-a7c5-9e19e011af6c">0.6</ix:nonFraction>&#160;million, during the quarter ended March 31, 2020, we entered into amendments with Barclays Bank PLC, Deutsche Bank AG, London Branch, and Goldman Sachs &amp; Co. LLC to the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. The amendments provide that the options under the convertible note hedges corresponding to such repurchased 2023 Notes will remain outstanding notwithstanding such repurchase.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, in connection with the repurchases of approximately $<ix:nonFraction unitRef="usd" contextRef="i0c628cd07ad342459335204c06df1ef0_I20210131" decimals="-5" name="us-gaap:DebtInstrumentRepurchaseAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzE0MjI1_8e873dd8-c66b-49b8-95a1-1515213d7eeb">20.3</ix:nonFraction>&#160;million in principal of the 2023 Notes for approximately $<ix:nonFraction unitRef="usd" contextRef="i111b05d5f55a49a8811a99582e5b230b_D20210101-20210131" decimals="-5" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzE0Mjc3_458470b4-b4ac-41ff-977d-0d2916485986">19.1</ix:nonFraction>&#160;million in cash, including accrued interest of $<ix:nonFraction unitRef="usd" contextRef="i111b05d5f55a49a8811a99582e5b230b_D20210101-20210131" decimals="-5" name="lgnd:RepaymentsOfNotesPayableInterestPortion" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzE0MzE5_51318282-cf46-4b9f-872a-7e3d3787fc43">0.1</ix:nonFraction>&#160;million, during the quarter ended December 31, 2020, we entered into amendments with Barclays Bank PLC, Deutsche Bank AG, London Branch, and Goldman Sachs &amp; Co. LLC to the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. The amendments provide that the options under the convertible note hedges corresponding to such repurchased 2023 Notes will remain outstanding notwithstanding such repurchase.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, in connection with the repurchases of $<ix:nonFraction unitRef="usd" contextRef="id1dd1d35129f4cd39fb80e6800cfe252_I20211231" decimals="-5" name="us-gaap:DebtInstrumentRepurchaseAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzE0ODU2_0ce97b15-3028-42b4-86a6-139f607a0889">152.0</ix:nonFraction>&#160;million in principal of the 2023 Notes for $<ix:nonFraction unitRef="usd" contextRef="ia99cec91b0284a4090f6d9399292f293_D20210101-20211231" decimals="-5" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzE0ODk0_6dbeaee5-790f-4bfe-b700-2075e944c29a">156.0</ix:nonFraction>&#160;million in cash, including accrued interest of $<ix:nonFraction unitRef="usd" contextRef="ia99cec91b0284a4090f6d9399292f293_D20210101-20211231" decimals="-5" name="lgnd:RepaymentsOfNotesPayableInterestPortion" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzE0OTM2_2c1e8a61-9c45-4e88-a8c3-e08fec1c4fb9">0.3</ix:nonFraction>&#160;million, we entered into Warrant Early Unwind Agreements and Bond Hedge Unwind Agreements with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp; Co. LLC to unwind a portion of the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. We paid $<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-5" name="lgnd:PaymentsToUnwindWarrants" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzE1MjQw_5a93e3b2-f33f-446a-af4d-b45433df467e">18.4</ix:nonFraction>&#160;million as part of the Warrant Early Unwind Agreements reducing the number of shares covered by the warrants from <ix:nonFraction unitRef="shares" contextRef="ic8ae4ee0f64a46979ca5a2c15da782e7_I20180531" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzE1MzQ5_dea8e3a2-fd34-4bd0-8950-a2c2f74ea5c2">3,018,327</ix:nonFraction> to <ix:nonFraction unitRef="shares" contextRef="id1dd1d35129f4cd39fb80e6800cfe252_I20211231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzE1MzU1_a75510d4-520f-4b12-a3fb-aad55a904f1b">2,559,254</ix:nonFraction>. We received $<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-5" name="lgnd:ProceedsFromUnwindingConvertibleBondHedges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzE1Mzcx_eba60ae5-2a2e-41d7-a16a-60d5a1cc55b8">18.9</ix:nonFraction>&#160;million as part of the Bond Hedge Early Unwind Agreements reducing the number of options under the convertible bond hedges to <ix:nonFraction unitRef="option" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="INF" name="lgnd:NumberOfOptionsUnderConvertibleBondHedges" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzE1NDky_22a05259-90d0-4130-911e-15c3d7cca8b2">598,021</ix:nonFraction>. These unwind transactions resulted in a $<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzE1NTM2_d1f680d9-cf4c-4093-a0a3-81f05a1ef72a">0.5</ix:nonFraction>&#160;million net increase in additional paid-in-capital in our consolidated balance sheet as of December&#160;31, 2021.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, in connection with the repurchases of $<ix:nonFraction unitRef="usd" contextRef="i58d85fd3024241a592f18e215570d51a_D20220801-20220831" decimals="-5" name="lgnd:DebtInstrumentRepurchasedAmountDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzU0OTc1NTg1MjEzMA_f034b74b-f218-4b18-af4d-5531bd2a38d0">227.8</ix:nonFraction>&#160;million in principal of the 2023 Notes for $<ix:nonFraction unitRef="usd" contextRef="i58d85fd3024241a592f18e215570d51a_D20220801-20220831" decimals="-5" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzU0OTc1NTg1MjE0MA_041356c1-f09f-4ece-9c2d-ec1fd5590325">223.7</ix:nonFraction>&#160;million in cash, including accrued interest of $<ix:nonFraction unitRef="usd" contextRef="i54f5a452c3934a41b9d24ab5e96cffaf_D20220101-20220630" decimals="-5" name="lgnd:RepaymentsOfNotesPayableInterestPortion" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzU0OTc1NTg1MjE2NA_db109e4b-f510-4d5b-a346-9bd3c3696f40">0.4</ix:nonFraction>&#160;million made during the six months ended June 30, 2022, we entered into Bond Hedge Unwind Agreements with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp; Co. LLC to unwind a portion of the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. We received $<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-5" name="lgnd:ProceedsFromUnwindingConvertibleBondHedges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzU0OTc1NTg1MjE4MA_acea1611-a0ea-4084-b95c-4bcc89b17ac8">0.2</ix:nonFraction>&#160;million as part of these Bond Hedge Early Unwind Agreements reducing the number of options under the convertible bond hedges to <ix:nonFraction unitRef="option" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="INF" name="lgnd:NumberOfOptionsUnderConvertibleBondHedges" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzU0OTc1NTg1MjE5Mw_6e6db05c-8929-42ad-8723-95163480c65a">370,219</ix:nonFraction> as of December&#160;31, 2022. This transaction resulted in a $<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzU0OTc1NTg1MjIzNg_4e9433f7-148b-494b-b715-50bc7c51d2c6">0.2</ix:nonFraction>&#160;million net increase in additional paid-in-capital in our consolidated balance sheet as of December&#160;31, 2022.</span></div></ix:continuation><div style="margin-bottom:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i5ced1c35d61645e0a8431765694dfc2a"><div style="margin-bottom:6pt"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzE1ODYz_93846cef-6dc5-4f1e-bb40-d63fd996c378" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the equity and liability components of the 2023 Notes (in thousands).</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.499%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount of 2023 Notes outstanding</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3316b5508b924ffc8fd7ec36b3aa455e_I20221231" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90YWJsZToxZGUwMTBiYTliNTM0ODlmYTJlMGI0YWE0YjNjOTIyNC90YWJsZXJhbmdlOjFkZTAxMGJhOWI1MzQ4OWZhMmUwYjRhYTRiM2M5MjI0XzEtMS0xLTEtMTEyNjQw_afa79b0d-1817-4b30-b189-99231477433a">76,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1dd1d35129f4cd39fb80e6800cfe252_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90YWJsZToxZGUwMTBiYTliNTM0ODlmYTJlMGI0YWE0YjNjOTIyNC90YWJsZXJhbmdlOjFkZTAxMGJhOWI1MzQ4OWZhMmUwYjRhYTRiM2M5MjI0XzEtMy0xLTEtMTEyNjQw_b4397df8-7c96-465e-b9bd-169ed0f14ea6">343,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount (including unamortized debt issuance cost)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3316b5508b924ffc8fd7ec36b3aa455e_I20221231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90YWJsZToxZGUwMTBiYTliNTM0ODlmYTJlMGI0YWE0YjNjOTIyNC90YWJsZXJhbmdlOjFkZTAxMGJhOWI1MzQ4OWZhMmUwYjRhYTRiM2M5MjI0XzItMS0xLTEtMTEyNjQw_6f612d2f-0e5c-47c4-8e4c-7634a68b0081">159</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1dd1d35129f4cd39fb80e6800cfe252_I20211231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90YWJsZToxZGUwMTBiYTliNTM0ODlmYTJlMGI0YWE0YjNjOTIyNC90YWJsZXJhbmdlOjFkZTAxMGJhOWI1MzQ4OWZhMmUwYjRhYTRiM2M5MjI0XzItMy0xLTEtMTEyNjQw_8f2f7638-4e41-47bc-b806-81e2823d4f43">22,584</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total long-term portion of notes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3316b5508b924ffc8fd7ec36b3aa455e_I20221231" decimals="-3" name="us-gaap:LongTermNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90YWJsZToxZGUwMTBiYTliNTM0ODlmYTJlMGI0YWE0YjNjOTIyNC90YWJsZXJhbmdlOjFkZTAxMGJhOWI1MzQ4OWZhMmUwYjRhYTRiM2M5MjI0XzMtMS0xLTEtMTEyNjQw_d2b65d89-c528-4563-9fe5-a49b8f702974">76,695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1dd1d35129f4cd39fb80e6800cfe252_I20211231" decimals="-3" name="us-gaap:LongTermNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90YWJsZToxZGUwMTBiYTliNTM0ODlmYTJlMGI0YWE0YjNjOTIyNC90YWJsZXJhbmdlOjFkZTAxMGJhOWI1MzQ4OWZhMmUwYjRhYTRiM2M5MjI0XzMtMy0xLTEtMTEyNjQw_d75d3961-fdc4-46b3-ad89-3f455931f713">320,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of convertible senior notes outstanding (Level 2)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3316b5508b924ffc8fd7ec36b3aa455e_I20221231" decimals="-3" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90YWJsZToxZGUwMTBiYTliNTM0ODlmYTJlMGI0YWE0YjNjOTIyNC90YWJsZXJhbmdlOjFkZTAxMGJhOWI1MzQ4OWZhMmUwYjRhYTRiM2M5MjI0XzUtMS0xLTEtMTEyNjQw_0bcadc67-3f69-4dca-8969-62026f77dc29">74,789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1dd1d35129f4cd39fb80e6800cfe252_I20211231" decimals="-3" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90YWJsZToxZGUwMTBiYTliNTM0ODlmYTJlMGI0YWE0YjNjOTIyNC90YWJsZXJhbmdlOjFkZTAxMGJhOWI1MzQ4OWZhMmUwYjRhYTRiM2M5MjI0XzUtMy0xLTEtMTEyNjQw_a9218bd7-45b6-450f-bb23-27d8228428a2">341,801</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, there were no events of default or violation of any covenants under our financing obligations.</span></div></ix:continuation><div style="margin-bottom:6pt"><span><br/></span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_109"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzM3NjI_638abb43-8804-4929-a92a-ada1abe3938f" continuedAt="i56bebfe0ab584be08ae21549990e966b" escape="true">Balance Sheet Account Details</ix:nonNumeric></span></div><ix:continuation id="i56bebfe0ab584be08ae21549990e966b" continuedAt="i3af5422f14b24ef586bf17751d8d57cc"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Investments</span></div><div style="margin-bottom:6pt"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:MarketableSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzM3NTI_c3ce5de6-b805-4511-9102-d573e50a82a3" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding our investments in Viking, the following table summarizes the various investment categories at December&#160;31, 2022 and 2021 (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">gains</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">losses</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">fair value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mutual Funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i548f60b85719418dac5410346d1603e7_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzMtMS0xLTEtMTEyNjQw_e447deb0-14c9-4524-ac39-d03ee52d92e4">81,815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i548f60b85719418dac5410346d1603e7_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzMtMy0xLTEtMTEyNjQw_9cbd6ee9-62cc-4302-802a-5e9305403fd2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i548f60b85719418dac5410346d1603e7_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzMtNS0xLTEtMTEyNjQw_229766ec-4d57-46ef-a771-55b5b3869666">1050</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i548f60b85719418dac5410346d1603e7_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzMtNy0xLTEtMTEyNjQw_7dc6d62b-9cb8-4cb4-858d-06b5920fa458">80,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1471709cc0844e7fa518a8ce9a1cd2bb_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzQtMS0xLTEtMTEyNjQw_8076725e-9732-405f-be9d-0c56ed75967c">5,012</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1471709cc0844e7fa518a8ce9a1cd2bb_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzQtMy0xLTEtMTEyNjQw_5020707e-9cee-473d-86a7-3b491c682b23">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1471709cc0844e7fa518a8ce9a1cd2bb_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzQtNS0xLTEtMTEyNjQw_b132e850-a34b-4c51-93e0-ea8b82d5732e">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1471709cc0844e7fa518a8ce9a1cd2bb_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzQtNy0xLTEtMTEyNjQw_13d1380c-c9ce-4508-9f88-a05a9dbc2dd5">4,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7463bea47b82478d8f5459d601f865f3_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzUtMS0xLTEtMTEyNjQw_7d269f9c-1fc3-4db5-9fdf-2a216163616f">7,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7463bea47b82478d8f5459d601f865f3_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzUtMy0xLTEtMTEyNjQw_6df7a07f-6eb8-4ae3-963b-9b76aaeb4ac0">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7463bea47b82478d8f5459d601f865f3_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzUtNS0xLTEtMTEyNjQw_c9bc567c-32f2-44dd-8caa-c327550f0e94">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7463bea47b82478d8f5459d601f865f3_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzUtNy0xLTEtMTEyNjQw_bc4e8340-40e1-4d6e-963e-2d59aea34d56">7,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd0bbb0bb1ab4703911061427590d10b_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzYtMS0xLTEtMTEyNjQw_d234497f-acaa-4ec4-93a6-aab7c1dabb55">6,701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd0bbb0bb1ab4703911061427590d10b_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzYtMy0xLTEtMTEyNjQw_43ebc4a8-742d-4000-891c-4fd514a21ae6">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd0bbb0bb1ab4703911061427590d10b_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzYtNS0xLTEtMTEyNjQw_92981c2c-6d2e-41fe-82be-18f54dc83b24">58</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd0bbb0bb1ab4703911061427590d10b_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzYtNy0xLTEtMTEyNjQw_0a179f60-d2c7-45ad-b53c-db2fa375e501">6,656</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5437e7ad7374bbba38f616727645f32_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzctMS0xLTEtMTEyNjQw_e81eca37-dcd9-4421-86da-ca16b4cce3cb">5,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5437e7ad7374bbba38f616727645f32_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzctMy0xLTEtMTEyNjQw_28e2acbf-a374-4cc8-b75e-c6090a14f758">262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id5437e7ad7374bbba38f616727645f32_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzctNS0xLTEtMTEyNjQw_1230c666-19df-488a-ae02-272276c4ab14">4,239</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5437e7ad7374bbba38f616727645f32_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzctNy0xLTEtMTEyNjQw_08006420-e1c6-43a1-9acd-87b695d70190">1,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0615fa1d1c0f4ab3a4d0ed6cab329254_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzgtMS0xLTEtMTEyNjQw_8b60d146-0ff7-4b83-8551-01269cf11c1b">2,232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0615fa1d1c0f4ab3a4d0ed6cab329254_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzgtMy0xLTEtMTEyNjQw_8d0186a8-7e97-4b17-a8b2-630f1c4f8904">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0615fa1d1c0f4ab3a4d0ed6cab329254_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzgtNS0xLTEtMTEyNjQw_8f4186ae-2b44-4f7d-a350-ebe7c3899ee6">70</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0615fa1d1c0f4ab3a4d0ed6cab329254_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzgtNy0xLTEtMTEyNjQw_fbcfd3be-af97-4966-9052-9126980f3169">2,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71e35599919c4fce950d103cf2cb9a03_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzktMS0xLTEtMTEyNjQw_9a4548cf-dddf-4516-b014-f7e5bb0699c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71e35599919c4fce950d103cf2cb9a03_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzktMy0xLTEtMTEyNjQw_439e431f-5f52-4bbd-adef-c2d33b323ccf">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71e35599919c4fce950d103cf2cb9a03_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzktNS0xLTEtMTEyNjQw_74489445-09ea-4fb4-bed1-23e5eb14bca2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71e35599919c4fce950d103cf2cb9a03_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzktNy0xLTEtMTEyNjQw_258ba0c2-3b59-4078-bc94-a663e0df362f">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzEwLTEtMS0xLTExMjY0MA_4180af5b-2b9d-4aef-8f53-cf5dce7a49af">108,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzEwLTMtMS0xLTExMjY0MA_5dfb5542-2466-40d3-8c4b-8fb9738d587a">415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzEwLTUtMS0xLTExMjY0MA_ef3e4ce8-e2e0-4854-900b-3828ff6fb785">5,451</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzEwLTctMS0xLTExMjY0MA_54e97d66-2339-4d9b-9825-de606b94a490">103,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Mutual fund</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04cf813834a54b609f2d0c0a39769017_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzEzLTEtMS0xLTExMjY0MA_3d504a12-7d96-461c-89bc-985f5d124e69">152,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04cf813834a54b609f2d0c0a39769017_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzEzLTMtMS0xLTExMjY0MA_797b272b-43f9-4863-b830-31c914636e0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04cf813834a54b609f2d0c0a39769017_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzEzLTUtMS0xLTExMjY0MA_dd261882-8242-48f3-a5f3-809fe6eabde0">249</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04cf813834a54b609f2d0c0a39769017_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzEzLTctMS0xLTExMjY0MA_6b22649c-33ae-44ed-8b74-4861bcb553ae">151,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f92fad18c07418281242e26ae88ac27_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE0LTEtMS0xLTExMjY0MA_8c82b1b7-5348-4c5c-b806-9068f89fb38b">63,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f92fad18c07418281242e26ae88ac27_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE0LTMtMS0xLTExMjY0MA_1cac3c27-5bd8-456c-adc8-1104419744c9">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f92fad18c07418281242e26ae88ac27_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE0LTUtMS0xLTExMjY0MA_ca47a96c-c854-4262-8175-68546e4ed9fd">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f92fad18c07418281242e26ae88ac27_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE0LTctMS0xLTExMjY0MA_1d0413c7-ab20-4bca-8dbb-3f17251a92d0">63,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper  </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if12b1ab4a6244599831e9df4b3d630d5_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE1LTEtMS0xLTExMjY0MA_1ee37a8a-cd13-4cc8-b793-84c5f7471734">36,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if12b1ab4a6244599831e9df4b3d630d5_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE1LTMtMS0xLTExMjY0MA_c872b616-878f-4d6a-9eb3-75b35f0333cc">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if12b1ab4a6244599831e9df4b3d630d5_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE1LTUtMS0xLTExMjY0MA_ef397c40-2e55-4a93-aae3-e82b803ec2f2">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if12b1ab4a6244599831e9df4b3d630d5_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE1LTctMS0xLTExMjY0MA_b6d77af3-b20b-4931-837d-8b71e049657c">35,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie313cb8f8e784d82b8ae991a863ca12c_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE2LTEtMS0xLTExMjY0MA_c94438d8-d66a-4c7c-bc58-d008355d2f04">29,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie313cb8f8e784d82b8ae991a863ca12c_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE2LTMtMS0xLTExMjY0MA_3825f473-cd10-46db-aae0-19f722562a38">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie313cb8f8e784d82b8ae991a863ca12c_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE2LTUtMS0xLTExMjY0MA_9cf7f745-f503-41f5-bb84-ab07e6718501">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie313cb8f8e784d82b8ae991a863ca12c_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE2LTctMS0xLTExMjY0MA_2759d54a-3e73-4a88-86b8-a07fa2dcd80c">29,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6696160e9f0146f7bee8c94a11813846_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE4LTEtMS0xLTExMjY0MA_e0711992-3bd8-4fe4-a7eb-edaeb0ca79ce">5,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6696160e9f0146f7bee8c94a11813846_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE4LTMtMS0xLTExMjY0MA_1fe48495-c643-46f6-b668-bea9b3a1241b">402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6696160e9f0146f7bee8c94a11813846_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE4LTUtMS0xLTExMjY0MA_1f528536-63ab-45d7-ba77-68057a05ee75">2,027</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6696160e9f0146f7bee8c94a11813846_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE4LTctMS0xLTExMjY0MA_6955112d-3e26-4f67-a6e4-c9f5a46b4539">4,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic790b5e0a22343c88149b3aa20638bbe_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE5LTEtMS0xLTExMjY0MA_c562639c-1148-49ed-9de2-916ebab45b49">5,577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic790b5e0a22343c88149b3aa20638bbe_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE5LTMtMS0xLTExMjY0MA_193ce297-a278-46fe-abb4-f5b9ea39f53d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic790b5e0a22343c88149b3aa20638bbe_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE5LTUtMS0xLTExMjY0MA_4829ba7e-3cc3-49c8-a9fb-6335f2d3dc23">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic790b5e0a22343c88149b3aa20638bbe_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE5LTctMS0xLTExMjY0MA_27fb8f2d-fb41-469a-be8f-d589d1c22e34">5,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d6d432e3de740d2b05ca748ea45be9a_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzIwLTEtMS0xLTExMjY0MA_11cb418c-1627-4683-89f8-934ee0048847">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d6d432e3de740d2b05ca748ea45be9a_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzIwLTMtMS0xLTExMjY0MA_323699c0-d12b-4614-9bee-a1adf3aa9e49">408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d6d432e3de740d2b05ca748ea45be9a_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzIwLTUtMS0xLTExMjY0MA_8b64a535-b719-49d6-ad02-8316b9794af9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d6d432e3de740d2b05ca748ea45be9a_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzIwLTctMS0xLTExMjY0MA_74248354-ada6-47a0-b947-bf411c1d9126">408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzIxLTEtMS0xLTExMjY0MA_2c27a69b-2b4c-472a-851a-a3e1940e3598">292,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzIxLTMtMS0xLTExMjY0MA_bc970dc4-a0fc-433a-9247-0f16fb8ee4fc">842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzIxLTUtMS0xLTExMjY0MA_e8c76e24-9c2d-4890-903f-f27b193ee03a">2,370</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzIxLTctMS0xLTExMjY0MA_f652bd92-0b6f-46b1-895c-446b7f881bfb">290,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain (loss) from short-term investments on our consolidated statements of operations includes both realized and unrealized gain (loss) from our short-term investments in public equity and warrant securities, and realized gain (loss) from available-for-sale debt securities. </span></div><div style="margin-bottom:6pt"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzM3NjM_60ce17cb-1d2e-406b-a77c-fd93254cc53d" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyMTVlZjQyYTI4ZTA0NTQzODZkYjYzNTgwYmNlOTQwNy90YWJsZXJhbmdlOjIxNWVmNDJhMjhlMDQ1NDM4NmRiNjM1ODBiY2U5NDA3XzItMS0xLTEtMTEyNjQw_5d712024-417a-405b-ba03-a00af8e9815e">57,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyMTVlZjQyYTI4ZTA0NTQzODZkYjYzNTgwYmNlOTQwNy90YWJsZXJhbmdlOjIxNWVmNDJhMjhlMDQ1NDM4NmRiNjM1ODBiY2U5NDA3XzItMy0xLTEtMTEyNjQw_072aa2d6-85e1-4a53-80f7-3531c51b03a2">57,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyMTVlZjQyYTI4ZTA0NTQzODZkYjYzNTgwYmNlOTQwNy90YWJsZXJhbmdlOjIxNWVmNDJhMjhlMDQ1NDM4NmRiNjM1ODBiY2U5NDA3XzMtMS0xLTEtMTEyNjQw_dffd9bfb-5e8f-4d8e-8413-b38bde0b4bb8">2,794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyMTVlZjQyYTI4ZTA0NTQzODZkYjYzNTgwYmNlOTQwNy90YWJsZXJhbmdlOjIxNWVmNDJhMjhlMDQ1NDM4NmRiNjM1ODBiY2U5NDA3XzMtMy0xLTEtMTEyNjQw_914160da-b754-4f20-bb19-6ce369dd2b10">2,769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyMTVlZjQyYTI4ZTA0NTQzODZkYjYzNTgwYmNlOTQwNy90YWJsZXJhbmdlOjIxNWVmNDJhMjhlMDQ1NDM4NmRiNjM1ODBiY2U5NDA3XzUtMS0xLTEtMTEyNjQw_c5823a90-e63a-47d4-89d8-1abe8a7acac8">59,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyMTVlZjQyYTI4ZTA0NTQzODZkYjYzNTgwYmNlOTQwNy90YWJsZXJhbmdlOjIxNWVmNDJhMjhlMDQ1NDM4NmRiNjM1ODBiY2U5NDA3XzUtMy0xLTEtMTEyNjQw_471890d0-bf6e-4ff1-9d51-dbd70fe5b982">59,805</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i3af5422f14b24ef586bf17751d8d57cc" continuedAt="i5ff840a9bb3442f284b47b3d4d63f887"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzM3NTc_51b73f8f-40be-4980-9269-7025a96de90a" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities in an unrealized loss position (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.772%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12 months or greater</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1471709cc0844e7fa518a8ce9a1cd2bb_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzMtMS0xLTEtMTEyNjQw_b68390a0-c230-406e-ac70-75a945463f08">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1471709cc0844e7fa518a8ce9a1cd2bb_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzMtMy0xLTEtMTEyNjQw_5ad150d0-f78b-4d35-affc-6040d9057da8">2,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1471709cc0844e7fa518a8ce9a1cd2bb_I20221231" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzMtNS0xLTEtMTEyNjQw_52d05b11-3004-46fb-be76-c1e6c1b3de95">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1471709cc0844e7fa518a8ce9a1cd2bb_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzMtNy0xLTEtMTEyNjQw_89afa2c8-877c-4255-aee3-d1539fadebe3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1471709cc0844e7fa518a8ce9a1cd2bb_I20221231" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzMtOS0xLTEtMTEyNjQw_25050f1e-08b4-449b-9451-78d360e426dd">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1471709cc0844e7fa518a8ce9a1cd2bb_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzMtMTEtMS0xLTExMjY0MA_835a2ca0-f28f-429f-b1e8-27be5a2d4bae">2,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd0bbb0bb1ab4703911061427590d10b_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzQtMS0xLTEtMTEyNjQw_daca8a13-84cf-49dc-85be-da05a8bca8db">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd0bbb0bb1ab4703911061427590d10b_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzQtMy0xLTEtMTEyNjQw_12cdcdca-df59-421a-93f6-5332f5e680fd">3,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd0bbb0bb1ab4703911061427590d10b_I20221231" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzQtNS0xLTEtMTEyNjQw_bf2bca1f-e231-4fde-a05e-993aa5916ed8">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd0bbb0bb1ab4703911061427590d10b_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzQtNy0xLTEtMTEyNjQw_4aec8678-ab85-4ae3-8d88-c720a962e2c1">947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd0bbb0bb1ab4703911061427590d10b_I20221231" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzQtOS0xLTEtMTEyNjQw_ec331a1e-7e03-4ea5-9f28-1905e690fb5b">58</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd0bbb0bb1ab4703911061427590d10b_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzQtMTEtMS0xLTExMjY0MA_ba772596-bdab-4755-bc23-f3a7d227093b">4,834</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7463bea47b82478d8f5459d601f865f3_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzUtMS0xLTEtMTEyNjQw_3709a52a-4d41-4d9d-865b-8bd91eb789ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7463bea47b82478d8f5459d601f865f3_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzUtMy0xLTEtMTEyNjQw_ee22483c-2d35-4b29-adc6-fe39c4dcbcbe">3,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7463bea47b82478d8f5459d601f865f3_I20221231" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzUtNS0xLTEtMTEyNjQw_e54be6c2-6c68-4008-9025-39cfac989f5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7463bea47b82478d8f5459d601f865f3_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzUtNy0xLTEtMTEyNjQw_d47518a9-a2a6-4932-be39-771b4a4910f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7463bea47b82478d8f5459d601f865f3_I20221231" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzUtOS0xLTEtMTEyNjQw_d1cc0137-d7f4-4b42-a8b0-db13bccfc563">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7463bea47b82478d8f5459d601f865f3_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzUtMTEtMS0xLTExMjY0MA_78c7e2f2-a6ca-4a97-81fe-bd0d929c5418">3,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Government Securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0615fa1d1c0f4ab3a4d0ed6cab329254_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzYtMS0xLTEtMTEyNjQw_b63ac614-b147-415a-ad26-94c3235f5160">70</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0615fa1d1c0f4ab3a4d0ed6cab329254_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzYtMy0xLTEtMTEyNjQw_7eb176ea-f42b-49fe-9e26-db37f2ede84d">2,161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0615fa1d1c0f4ab3a4d0ed6cab329254_I20221231" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzYtNS0xLTEtMTEyNjQw_edebee35-d99b-4cdf-80e1-a1fb7b4082bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0615fa1d1c0f4ab3a4d0ed6cab329254_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzYtNy0xLTEtMTEyNjQw_d31c9b84-f989-4cff-99c9-bd9fd0ee164c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0615fa1d1c0f4ab3a4d0ed6cab329254_I20221231" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzYtOS0xLTEtMTEyNjQw_97e9d09d-2844-4bae-bc3b-4d564829a801">70</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0615fa1d1c0f4ab3a4d0ed6cab329254_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzYtMTEtMS0xLTExMjY0MA_05503fff-7a75-482a-91b0-697eba936da0">2,161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzctMS0xLTEtMTEyNjQw_84fd5387-9aa5-463f-a13b-2824560e6db1">125</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzctMy0xLTEtMTEyNjQw_cffeb7f2-0503-4eaa-96e2-ac6464018cd3">12,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzctNS0xLTEtMTEyNjQw_c36fb070-a758-4e62-9552-3d6684541dec">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzctNy0xLTEtMTEyNjQw_bc8fcdb6-1e12-4911-a490-a9b8c7382c34">947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzctOS0xLTEtMTEyNjQw_7d08bf37-03a1-453b-8c41-ab8d5a104424">162</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzctMTEtMS0xLTExMjY0MA_593484fd-fb71-4612-b0a0-45eef9828737">13,301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank deposits</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f92fad18c07418281242e26ae88ac27_I20211231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEwLTEtMS0xLTExMjY0MA_b9051ba0-2451-4983-9e27-77556a6c7ecb">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f92fad18c07418281242e26ae88ac27_I20211231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEwLTMtMS0xLTExMjY0MA_b5229ae0-25a0-4652-9211-136ea1f31163">20,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f92fad18c07418281242e26ae88ac27_I20211231" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEwLTUtMS0xLTExMjY0MA_88aaabef-c031-4ea8-83c0-54b731e3cac8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f92fad18c07418281242e26ae88ac27_I20211231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEwLTctMS0xLTExMjY0MA_e91122fa-dcd0-4868-84df-10ae2d3ea7d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f92fad18c07418281242e26ae88ac27_I20211231" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEwLTktMS0xLTExMjY0MA_430f895e-ecac-4076-8d1a-88c28ce07454">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f92fad18c07418281242e26ae88ac27_I20211231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEwLTExLTEtMS0xMTI2NDA_9fd4c14f-90ca-4f24-af30-4824aaa1c8be">20,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie313cb8f8e784d82b8ae991a863ca12c_I20211231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzExLTEtMS0xLTExMjY0MA_9b5bd5e7-3ee9-4984-a84a-671257f01fc5">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie313cb8f8e784d82b8ae991a863ca12c_I20211231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzExLTMtMS0xLTExMjY0MA_05d3c6e7-b357-4ecd-acab-b2715ba0423b">27,252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie313cb8f8e784d82b8ae991a863ca12c_I20211231" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzExLTUtMS0xLTExMjY0MA_269c065d-1103-4856-a2c3-887621df8dc5">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie313cb8f8e784d82b8ae991a863ca12c_I20211231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzExLTctMS0xLTExMjY0MA_c68fd5be-5969-4e8d-a75b-4bd663878000">2,996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie313cb8f8e784d82b8ae991a863ca12c_I20211231" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzExLTktMS0xLTExMjY0MA_e56f839d-8298-4bbf-ad2a-aed8266e569f">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie313cb8f8e784d82b8ae991a863ca12c_I20211231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzExLTExLTEtMS0xMTI2NDA_c7abe8ad-3bd4-4378-8848-06abdfa3623b">30,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if12b1ab4a6244599831e9df4b3d630d5_I20211231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEyLTEtMS0xLTExMjY0MA_7b901e8e-1357-4061-80b9-91fb949f0557">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if12b1ab4a6244599831e9df4b3d630d5_I20211231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEyLTMtMS0xLTExMjY0MA_b8dac2e5-81a0-41aa-9d9a-c0e4c08019c0">6,689</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if12b1ab4a6244599831e9df4b3d630d5_I20211231" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEyLTUtMS0xLTExMjY0MA_8aa42f19-4736-4a48-806c-323e7f4cad2a">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if12b1ab4a6244599831e9df4b3d630d5_I20211231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEyLTctMS0xLTExMjY0MA_1b85163a-8002-45ed-a9bd-83f7fd6d853a">10,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if12b1ab4a6244599831e9df4b3d630d5_I20211231" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEyLTktMS0xLTExMjY0MA_45fd61d9-fb5b-4360-9fc6-84c503ab9803">38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if12b1ab4a6244599831e9df4b3d630d5_I20211231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEyLTExLTEtMS0xMTI2NDA_19fe9edb-aaac-46c1-ac96-f015b1078455">16,814</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Government Securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic790b5e0a22343c88149b3aa20638bbe_I20211231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEzLTEtMS0xLTEyMTc1Mg_a2b40bdc-e19e-4456-b581-5e040e3ab334">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic790b5e0a22343c88149b3aa20638bbe_I20211231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEzLTMtMS0xLTEyMTc2MA_8a0c37e7-9f7a-4cbc-9d6a-f1b526079274">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic790b5e0a22343c88149b3aa20638bbe_I20211231" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEzLTUtMS0xLTEyMTc2Nw_93f12fb0-2e41-4550-8458-353bbf96b88f">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic790b5e0a22343c88149b3aa20638bbe_I20211231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEzLTctMS0xLTEyMTc4Ng_d3f1517a-08dd-47ce-8afb-41e593a6e56f">5,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic790b5e0a22343c88149b3aa20638bbe_I20211231" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEzLTktMS0xLTEyMjU4Mw_2eebf83e-dbe9-432a-b0db-d84956a7f153">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic790b5e0a22343c88149b3aa20638bbe_I20211231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEzLTExLTEtMS0xMjI1ODM_76338f69-526d-42be-a1d9-02fa5ded004b">5,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEzLTEtMS0xLTExMjY0MA_f6750da4-1dd5-4fd5-a451-c62abbe44a7c">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEzLTMtMS0xLTExMjY0MA_0329c750-ab87-476f-9445-d9031b9d0bb8">53,949</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEzLTUtMS0xLTExMjY0MA_f3c49226-1a6c-4e4f-8218-5a57718cbdd2">60</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEzLTctMS0xLTExMjY0MA_f8b56c83-bd25-4bb1-9459-6851923b342e">18,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEzLTktMS0xLTExMjY0MA_04f54d0a-5785-465a-bca0-5a48744a1664">94</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEzLTExLTEtMS0xMTI2NDA_dd473c9d-7435-4df2-93b2-9e58f133127f">72,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment policy is capital preservation and we only invested in U.S.-dollar denominated investments. We held a total of <ix:nonFraction unitRef="position" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzgzMw_a731bae6-e640-4a32-8c99-23f3679874aa">12</ix:nonFraction> positions which were in an unrealized loss position as of December&#160;31, 2022. We believe that we will collect the principal and interest due on our debt securities that have an amortized cost in excess of fair value. The unrealized losses are largely due to changes in interest rates and not to unfavorable changes in the credit quality associated with these securities that impacted our assessment on collectability of principal and interest. We do not intend to sell these securities nor do we believe that we will be required to sell these securities before the recovery of the amortized cost basis. Accordingly, no credit losses were recognized for the twelve months ended December&#160;31, 2022.</span></div><div style="margin-bottom:6pt"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzM3NTg_8a2f93d9-85fc-49ec-b754-844ffaa0126f" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and equipment are stated at cost and consists of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lab and office equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaad9f14d4ad04902a0ea102d27e11be4_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo5MGVjYWI5MzVhMzU0Njc4OGM5ODlhZWZiOTkzYWNmNS90YWJsZXJhbmdlOjkwZWNhYjkzNWEzNTQ2Nzg4Yzk4OWFlZmI5OTNhY2Y1XzItMS0xLTEtMTEyNjQw_98c79f9b-80a0-4b3d-af1a-cd450df70de6">14,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b3cf5a61a1e4ab181aaf966a0f14569_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo5MGVjYWI5MzVhMzU0Njc4OGM5ODlhZWZiOTkzYWNmNS90YWJsZXJhbmdlOjkwZWNhYjkzNWEzNTQ2Nzg4Yzk4OWFlZmI5OTNhY2Y1XzItMy0xLTEtMTEyNjQw_16f12484-b906-4869-8971-2e3b2618cc2f">13,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ce0655576844f1290eb9958550ec9af_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo5MGVjYWI5MzVhMzU0Njc4OGM5ODlhZWZiOTkzYWNmNS90YWJsZXJhbmdlOjkwZWNhYjkzNWEzNTQ2Nzg4Yzk4OWFlZmI5OTNhY2Y1XzMtMS0xLTEtMTEyNjQw_abf4869a-4940-4e79-8a55-65aefaf8758d">7,446</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2f48884d4a143de8f95a4b3a211788e_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo5MGVjYWI5MzVhMzU0Njc4OGM5ODlhZWZiOTkzYWNmNS90YWJsZXJhbmdlOjkwZWNhYjkzNWEzNTQ2Nzg4Yzk4OWFlZmI5OTNhY2Y1XzMtMy0xLTEtMTEyNjQw_039fb9de-c1a2-48df-a67d-3cf77171b8cb">5,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca7d470a3274ceaa4b0cd0f4f1c8bad_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo5MGVjYWI5MzVhMzU0Njc4OGM5ODlhZWZiOTkzYWNmNS90YWJsZXJhbmdlOjkwZWNhYjkzNWEzNTQ2Nzg4Yzk4OWFlZmI5OTNhY2Y1XzQtMS0xLTEtMTEyNjQw_712402a7-e381-451d-a98f-d1cdd0e6b1c4">989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad7defd94a44484b2144c9440eb26ff_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo5MGVjYWI5MzVhMzU0Njc4OGM5ODlhZWZiOTkzYWNmNS90YWJsZXJhbmdlOjkwZWNhYjkzNWEzNTQ2Nzg4Yzk4OWFlZmI5OTNhY2Y1XzQtMy0xLTEtMTEyNjQw_65e55938-9c85-4a3f-bc71-6ef49d0399a1">924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo5MGVjYWI5MzVhMzU0Njc4OGM5ODlhZWZiOTkzYWNmNS90YWJsZXJhbmdlOjkwZWNhYjkzNWEzNTQ2Nzg4Yzk4OWFlZmI5OTNhY2Y1XzUtMS0xLTEtMTEyNjQw_dc2514a8-ed14-4191-9c46-602a54b6ad0c">22,607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo5MGVjYWI5MzVhMzU0Njc4OGM5ODlhZWZiOTkzYWNmNS90YWJsZXJhbmdlOjkwZWNhYjkzNWEzNTQ2Nzg4Yzk4OWFlZmI5OTNhY2Y1XzUtMy0xLTEtMTEyNjQw_c83e6346-0dc0-406f-b9f2-b32d9383c982">19,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo5MGVjYWI5MzVhMzU0Njc4OGM5ODlhZWZiOTkzYWNmNS90YWJsZXJhbmdlOjkwZWNhYjkzNWEzNTQ2Nzg4Yzk4OWFlZmI5OTNhY2Y1XzYtMS0xLTEtMTEyNjQw_c57a19ba-63d9-411c-b8f5-fce1dbf229cf">10,125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo5MGVjYWI5MzVhMzU0Njc4OGM5ODlhZWZiOTkzYWNmNS90YWJsZXJhbmdlOjkwZWNhYjkzNWEzNTQ2Nzg4Yzk4OWFlZmI5OTNhY2Y1XzYtMy0xLTEtMTEyNjQw_79efd756-59ff-42d5-8b3b-4f75a34fd0e3">6,415</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo5MGVjYWI5MzVhMzU0Njc4OGM5ODlhZWZiOTkzYWNmNS90YWJsZXJhbmdlOjkwZWNhYjkzNWEzNTQ2Nzg4Yzk4OWFlZmI5OTNhY2Y1XzctMS0xLTEtMTEyNjQw_8d613c16-eede-49e5-84b6-59bd302bd371">12,482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo5MGVjYWI5MzVhMzU0Njc4OGM5ODlhZWZiOTkzYWNmNS90YWJsZXJhbmdlOjkwZWNhYjkzNWEzNTQ2Nzg4Yzk4OWFlZmI5OTNhY2Y1XzctMy0xLTEtMTEyNjQw_13200476-5ebb-4ddd-8aa6-10bb6401404e">13,191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation of equipment is computed using the straight-line method over the estimated useful lives of the assets which ranges from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzE3MDc_277b8799-ffa7-4ac8-873b-e1ce3c67cce8">three</span> to <ix:nonNumeric contextRef="i5a1083da45f7446987097262ce780281_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzE3MTM_90a59c9f-3c64-4d14-bc7c-df0d22b832fa">ten years</ix:nonNumeric>. Leasehold improvements are amortized using the straight-line method over their estimated useful lives or their related lease term, whichever is shorter. Depreciation expense of $<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzE4OTQ_feb06c77-89e1-4eb2-a8ca-ba24a157638b">3.8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzE4OTg_e2068cc6-8fb1-411a-ba2e-198a9582ad80">2.4</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzE5MDY_74e7f74d-2be0-4c2f-939f-d9c40a628e60">1.5</ix:nonFraction> million was recognized for the twelve months ended December&#160;31, 2022, 2021, and 2020, respectively, and was included in operating expenses.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-indent:24pt"><span><br/></span></div><ix:continuation id="i5ff840a9bb3442f284b47b3d4d63f887" continuedAt="i2ca8f268da474ecfb453d94e2090f420"><div style="margin-bottom:6pt"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzM3NTA_009c4015-c758-44b2-adaa-079792c75c78" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and identifiable intangible assets consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzMtMS0xLTEtMTEyNjQw_a2adf4da-4e4e-45ec-8fc9-41acc0ed1f09">105,673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzMtMy0xLTEtMTEyNjQw_707713d2-f206-4e20-a229-0a592b510204">105,673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Complete technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25d3b1f41ab6459bbb46a5beb92b4ef3_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzUtMS0xLTEtMTEyNjQw_ce92a02e-015e-4bec-a3da-1a02899adf64">55,211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67a7f28b4edc41f8a4828a6e2caa478f_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzUtMy0xLTEtMTEyNjQw_cb9e90b2-9449-466d-b2ac-2d13d52edc7d">55,211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25d3b1f41ab6459bbb46a5beb92b4ef3_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzYtMS0xLTEtMTEyNjQw_a6c6d8c5-6a9f-4832-9b70-2821470dfe67">22,560</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67a7f28b4edc41f8a4828a6e2caa478f_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzYtMy0xLTEtMTEyNjQw_a8d82a9f-c4e2-4b76-afe6-94e2d0e70430">18,916</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07e4bdb069784c6995843f555b7fc3df_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzctMS0xLTEtMTEyNjQw_2ab1a418-b641-46b4-9dff-db0b98537f44">2,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2701c5cf7228445c8f19ae56602a97cf_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzctMy0xLTEtMTEyNjQw_34b375e1-8b05-4420-9de4-a9043e7ef10d">2,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07e4bdb069784c6995843f555b7fc3df_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzgtMS0xLTEtMTEyNjQw_1ff68646-f442-4a5e-9963-be513961197f">1,577</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2701c5cf7228445c8f19ae56602a97cf_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzgtMy0xLTEtMTEyNjQw_7c0dae30-ad80-40e5-9918-98927021eec1">1,444</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i181eff0de1144e58b256d8ec0c77ad61_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzktMS0xLTEtMTEyNjQw_38006b28-96bd-427d-a344-0b4ec16ac97d">29,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide40dc66b4694626bfa8f046840911c4_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzktMy0xLTEtMTEyNjQw_fbf23d97-b1ff-41f5-90ee-24cffab9b11b">29,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i181eff0de1144e58b256d8ec0c77ad61_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzEwLTEtMS0xLTExMjY0MA_5d43e4e5-1a17-4c2a-9d58-3672e4721b00">17,670</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide40dc66b4694626bfa8f046840911c4_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzEwLTMtMS0xLTExMjY0MA_b2a79757-c36a-4abe-9203-5f76b27d78a6">16,184</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Contractual relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i744575df31604eb09f525875d978efa1_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzExLTEtMS0xLTExMjY0MA_72b3ee8e-b760-4dc8-9cfc-82f8888c25a2">362,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8c9e47632c8468988399e7e93608f12_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzExLTMtMS0xLTExMjY0MA_1bcb0dff-1133-428f-a5b7-71aecdae22d0">362,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i744575df31604eb09f525875d978efa1_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzEyLTEtMS0xLTExMjY0MA_0a9cb2f4-d2a1-45e4-b283-99a5f1722ac1">65,191</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie8c9e47632c8468988399e7e93608f12_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzEyLTMtMS0xLTExMjY0MA_abf25cec-d626-4233-a0ff-6ff8d15ff166">36,218</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total goodwill and other identifiable intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzEzLTEtMS0xLTExMjY0MA_c6fc88ed-c31c-47c1-af1b-7a171e1dd914">448,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzEzLTMtMS0xLTExMjY0MA_ce13535d-3647-4910-a63f-81d476e86604">482,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of finite-lived intangible assets is computed using the straight-line method over the estimated useful life of the asset of up to <ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzIyMzY_e5d458f4-35ca-46cf-8309-fbbeb41bc72c">20</ix:nonNumeric> years. Amortization expense of $<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzE2NDkyNjc0NDc5NDE_8cf97075-842e-4e56-9f01-e260238f1fda">34.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzE2NDkyNjc0NDc5NDg_53dd465d-8423-438f-8e27-0bc98bd0e647">34.2</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzE2NDkyNjc0NDc5NTU_8e24ea8c-02ce-4f67-a366-1243fc289579">11.6</ix:nonFraction> million was recognized for the years ended December&#160;31, 2022, 2021, and 2020, respectively. Estimated amortization expense for the years ending December&#160;31, 2023 through 2027 is $<ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzI0MzA_000ca473-bff6-423c-a1fe-c53b572a1c50"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzI0MzA_45ff51f8-9d9f-425d-bf9c-0a5436043a8b"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzI0MzA_741259b9-3a6c-4fd7-9512-202b5c89a905"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzI0MzA_c7e20c8d-83bc-469a-b5c6-50f9e9ccd794">34.1</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> million per year. For each of the years ended December&#160;31, 2022, 2021, and 2020, there was <ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzI0OTc_645439c4-c614-4b30-9648-76ceb003ce00"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzI0OTc_688bf3ff-fb13-4075-adbb-183bfedffc31"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzI0OTc_c17ed5be-f48e-4b41-807e-d34da8e8d111">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> material impairment of intangible assets with finite lives.</span></div><div style="margin-bottom:6pt"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzM3NTQ_e25ffc30-6899-4c25-9b43-89fc333033f6" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued liabilities consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzItMS0xLTEtMTEyNjQw_193b2747-f742-49c9-bc28-19d3938d6d98">6,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzItMy0xLTEtMTEyNjQw_0a9004fb-7c37-4500-8287-ee64aac44029">6,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzMtMS0xLTEtMTEyNjQw_7de11a29-6e2b-4d17-8bba-8b50b1a1fc32">662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzMtMy0xLTEtMTEyNjQw_cddd605c-5e63-4ec1-afb3-78267c2a2ebb">2,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts owed to former licensees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:AccruedSalesCommissionCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzQtMS0xLTEtMTEyNjQw_ba94dfed-b664-4bc7-9a4a-d80d9dcf5c5f">3,989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:AccruedSalesCommissionCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzQtMy0xLTEtMTEyNjQw_6b97c6a1-e30e-4a09-a69b-1f10c06e96c1">630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties owed to third parties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:AccruedRoyaltiesCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzUtMS0xLTEtMTEyNjQw_f6e476fe-8926-43a2-b03d-04c330623890">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:AccruedRoyaltiesCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzUtMy0xLTEtMTEyNjQw_a1828849-c8c9-4a65-9ac3-a5ae2ce4852e">149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return reserve and customer refunds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="lgnd:AccruedSalesReturns" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzYtMS0xLTEtMTEyNjQw_d3c109db-4943-4269-9be8-56fa06aed351">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="lgnd:AccruedSalesReturns" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzYtMy0xLTEtMTEyNjQw_d87e524c-46f9-4587-94cc-c5670dd2435d">2,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="lgnd:AccruedAssetAcquisitionsCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzctMS0xLTEtMTEyNjQw_2a7408ec-ac0e-40b2-827c-6e90146e762e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="lgnd:AccruedAssetAcquisitionsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzctMy0xLTEtMTEyNjQw_13d4b7dd-6e7a-4e08-a5ec-586b419d8780">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subcontractor</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="lgnd:AccruedSubcontractorExpensesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzgtMS0xLTEtMTEyNjQw_9bc4cb6d-a001-403b-8d9e-45b4da3f0b86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="lgnd:AccruedSubcontractorExpensesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzgtMy0xLTEtMTEyNjQw_47f7e64d-c909-4b3f-8099-d7e4d4013d8c">1,759</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplier</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="lgnd:AccruedSupplierExpensesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzktMS0xLTEtMTEyNjQw_0c22d952-9119-483e-a2fa-8574a4c81d5c">634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="lgnd:AccruedSupplierExpensesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzktMy0xLTEtMTEyNjQw_e9ee7ae4-1089-41d4-9289-a1b80e752315">848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzEwLTEtMS0xLTExMjY0MA_9cc66309-544e-47fc-9fb8-76f25b19b3fe">4,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzEwLTMtMS0xLTExMjY0MA_38eadd6b-f424-4517-a90c-061efc35a8bf">2,195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzExLTEtMS0xLTExMjY0MA_5d973962-6980-45c3-8ef8-0db784d54f3d">15,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzExLTMtMS0xLTExMjY0MA_043e6336-f09e-4202-b834-5e1d45e0bd1f">17,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent liabilities:</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition of CyDex in January 2011, we issued a series of CVRs and also assumed certain contingent liabilities. We may be required to make additional payments upon achievement of certain clinical and regulatory milestones to the CyDex shareholders and former license holders.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition of Metabasis in January 2010, we entered into <ix:nonFraction unitRef="agreement" contextRef="iefe06608d69a4810b5ef7844034e3616_I20100131" decimals="INF" name="lgnd:NumberOfContingentValueRightAgreements" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzMyMzY_18e8ee7f-babb-4927-9600-c60411fcf91c">four</ix:nonFraction> CVR agreements with Metabasis shareholders. The CVRs entitle the holders to cash payments as frequently as every six months as proceeds are received by us upon the sale or licensing of any of the Metabasis drug development programs and upon the achievement of specified milestones.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For CVRs associated with the Pfenex, see &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note (4), Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for more information.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="lgnd:ScheduleofContingentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzM3NTE_884124dd-89ef-496d-a7ab-bc3de5671c2d" continuedAt="i75cba3b0869b4601aef7c0f850067795" escape="true">The following table summarizes roll-forward of contingent liabilities as of December 2022 and 2021 (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><ix:continuation id="i2ca8f268da474ecfb453d94e2090f420"><ix:continuation id="i75cba3b0869b4601aef7c0f850067795"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"><tr><td style="width:1.0%"></td><td style="width:20.985%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.562%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.176%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.949%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.176%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.566%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Payments</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair Value Adjustment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Payments</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair Value Adjustment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Repurchases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cydex</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9073dde9293463fa30e092e8acddc86_I20191231" decimals="-3" name="lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzEtMS0xLTEtMTEyNjQw_b87e45bf-0f75-4824-8c40-4fbe364c52df">507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie069fdb21c2e4a7f9f6faafc2d873eaf_D20200101-20201231" decimals="-3" name="lgnd:PaymentsToContingentValueRightHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzEtMy0xLTEtMTEyNjQw_d84456f1-9a57-424a-99ab-9ddb98db4317">50</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie069fdb21c2e4a7f9f6faafc2d873eaf_D20200101-20201231" decimals="-3" sign="-" name="lgnd:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzEtNC0xLTEtMTEyNjQw_452d5154-00bd-4cd1-922e-d01d3c4eef9f">108</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic917cc56cbc14ef49457a08f97faabb2_I20201231" decimals="-3" name="lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzEtNi0xLTEtMTEyNjQw_4415e817-dd46-439d-ac2a-c6f23c58eba3">349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i419fb6a0c6af4050bccc7d5632925f3b_D20210101-20211231" decimals="-3" name="lgnd:PaymentsToContingentValueRightHolders" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzEtOS0xLTEtMTEyNjQw_54f979d9-8814-45c6-b666-002f244d6d80">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i419fb6a0c6af4050bccc7d5632925f3b_D20210101-20211231" decimals="-3" sign="-" name="lgnd:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzEtMTAtMS0xLTExMjY0MA_2d625fd8-9c7a-45e1-8bb7-a52ba25b7d1a">265</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i419fb6a0c6af4050bccc7d5632925f3b_D20210101-20211231" decimals="-3" name="lgnd:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzEtMTEtMS0xLTExMjY0MA_1f6c1c96-620c-4548-acb2-8378af9635e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a5eaef79f744090a57acf2dd9bc3f41_I20211231" decimals="-3" name="lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzEtMTItMS0xLTExMjY0MA_002a9dc4-66ca-4478-bfaf-2b3765e600ea">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36ae892ec43144929bf8462e64709b35_I20191231" decimals="-3" name="lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzItMS0xLTEtMTEyNjQw_0a18e48a-f1a0-4523-8ac3-4c14a60ae689">3,822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9a291d0bcd642c590a67f6bf07d86c7_D20200101-20201231" decimals="-3" name="lgnd:PaymentsToContingentValueRightHolders" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzItMy0xLTEtMTEyNjQw_23b3cb38-5819-4a77-8ab0-85366f768947">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie9a291d0bcd642c590a67f6bf07d86c7_D20200101-20201231" decimals="-3" sign="-" name="lgnd:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzItNC0xLTEtMTEyNjQw_294b857a-6d1a-4197-a5de-1e8212954261">464</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32c3e35d3cae415a91aa7ff9a8a97fc1_I20201231" decimals="-3" name="lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzItNi0xLTEtMTEyNjQw_252e6f6c-f6fb-4969-9a5f-6fba8acb21ca">3,358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if67f5d0a5e884fae8966a608bcecbc8e_D20210101-20211231" decimals="-3" name="lgnd:PaymentsToContingentValueRightHolders" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzItOS0xLTEtMTEyNjQw_0f93d79c-f38f-4352-8087-a8cf7f21f7d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if67f5d0a5e884fae8966a608bcecbc8e_D20210101-20211231" decimals="-3" name="lgnd:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzItMTAtMS0xLTExMjY0MA_cfd4de11-9e3c-481a-bb18-cdf2d24d58bb">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if67f5d0a5e884fae8966a608bcecbc8e_D20210101-20211231" decimals="-3" name="lgnd:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzItMTEtMS0xLTExMjY0MA_5c914ae3-cc31-4a13-a05f-2dd83ed3839f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf9732e8831a435d9e39b39f45cb491b_I20211231" decimals="-3" name="lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzItMTItMS0xLTExMjY0MA_64271445-a36b-49fe-9027-d1ea6cee84e4">3,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pfenex</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36459dab15864e27a999bdcd2e68206a_I20191231" decimals="-3" name="lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzUtMS0xLTEtMTEyNjQw_2f10a5bb-6e88-4ebe-a836-7af00492be35">37,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67ed4423d4894d809c0e43396ff89fb7_D20200101-20201231" decimals="-3" name="lgnd:PaymentsToContingentValueRightHolders" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzUtMy0xLTEtMTEyNjQw_c0418e0d-4838-430a-8485-9d097f108cb4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67ed4423d4894d809c0e43396ff89fb7_D20200101-20201231" decimals="-3" sign="-" name="lgnd:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzUtNC0xLTEtMTEyNjQw_c715cda2-7df6-435c-9df0-ae14d517f4e9">37,600</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45f91b32714d4d798c728a94c1d3c363_I20201231" decimals="-3" name="lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzUtNi0xLTEtMTEyNjQw_e36be3d4-1314-4614-9703-ed16c5e72474">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36cbb3f817354f04b57d665248187943_D20210101-20211231" decimals="-3" name="lgnd:PaymentsToContingentValueRightHolders" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzUtOS0xLTEtMTEyNjQw_c8db2809-4650-4bcb-b8f3-856cc6e45e8f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36cbb3f817354f04b57d665248187943_D20210101-20211231" decimals="-3" name="lgnd:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzUtMTAtMS0xLTExMjY0MA_90aceaab-ebb7-47fb-b8f2-2731d82bea12">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36cbb3f817354f04b57d665248187943_D20210101-20211231" decimals="-3" name="lgnd:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzUtMTEtMS0xLTExMjY0MA_bd710ab6-f1ab-47b2-b905-5a367b7d48a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e5c28dda3f24c618a0e97fdb4db6a82_I20211231" decimals="-3" name="lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzUtMTItMS0xLTExMjY0MA_c68dbd2e-c0dd-47fd-8e97-8058adcda4cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i859e9607437a43d8adb4d3dc08e60773_I20191231" decimals="-3" name="lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzctMS0xLTEtMTEyNjQw_269389a7-2393-47b9-9348-888db1f55f7b">41,929</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="lgnd:PaymentsToContingentValueRightHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzctMy0xLTEtMTEyNjQw_d05708d7-0a27-4fba-ae88-f811c9e38279">50</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="lgnd:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzctNC0xLTEtMTEyNjQw_bdc7733a-8a0d-4250-a257-8ebfc315338a">38,172</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231" decimals="-3" name="lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzctNi0xLTEtMTEyNjQw_b55ea5e2-10e1-4a3b-a051-8571c6d68406">3,707</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="lgnd:PaymentsToContingentValueRightHolders" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzctOS0xLTEtMTEyNjQw_0f7c010b-d85a-4200-b0ea-9f60fc37af46">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" sign="-" name="lgnd:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzctMTAtMS0xLTExMjY0MA_ff34c611-5c23-4dda-a853-8d2c3359aa20">194</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="lgnd:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzctMTEtMS0xLTExMjY0MA_853c1571-4a62-4bef-bce3-eb13f26006c6">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzctMTItMS0xLTExMjY0MA_74c6287b-b730-467c-a172-a8bd6b64a8a4">3,513</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div id="i98e6b87576d6446486a3b29533a5cf6a_112"></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzMxMTE_24d19e90-cc40-4f29-ac9b-0a9108f96c9e" continuedAt="if1e67892c22443978451ecd31f7e67a3" escape="true">Stockholders&#8217; Equity</ix:nonNumeric></span></div><ix:continuation id="if1e67892c22443978451ecd31f7e67a3" continuedAt="i6b7494c1758f4fdcb43efc9f995799b7"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-based Compensation Expense</span></div><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzMxMTI_be4b0835-dd22-4fcb-bb41-e759d842c934" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes share-based compensation expense from continuing operations (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.869%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense as a component of:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58c8e37938964262a8d9fbb812dc0595_D20220101-20221231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3MzEyNDRlOTViMTY0ZjFjYWU1MGYxZTY2ZmE0ODIzNS90YWJsZXJhbmdlOjczMTI0NGU5NWIxNjRmMWNhZTUwZjFlNjZmYTQ4MjM1XzMtMS0xLTEtMTI0MTUz_e237f7d7-2141-4722-8c15-a3b82ce0a801">10,970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06d744f80dd94f3190aafa087db24d87_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3MzEyNDRlOTViMTY0ZjFjYWU1MGYxZTY2ZmE0ODIzNS90YWJsZXJhbmdlOjczMTI0NGU5NWIxNjRmMWNhZTUwZjFlNjZmYTQ4MjM1XzMtMS0xLTEtMTEyNjQw_7f965e17-c576-4e4a-b957-3d834a29e399">9,341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7ee9d97264e44b99c988c2bc5b6d24f_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3MzEyNDRlOTViMTY0ZjFjYWU1MGYxZTY2ZmE0ODIzNS90YWJsZXJhbmdlOjczMTI0NGU5NWIxNjRmMWNhZTUwZjFlNjZmYTQ4MjM1XzMtMy0xLTEtMTEyNjQw_d4bb062b-81e4-4cab-b953-6cf498a6dd45">8,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c0071327d664b04b5121faf1e1aafbb_D20220101-20221231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3MzEyNDRlOTViMTY0ZjFjYWU1MGYxZTY2ZmE0ODIzNS90YWJsZXJhbmdlOjczMTI0NGU5NWIxNjRmMWNhZTUwZjFlNjZmYTQ4MjM1XzQtMS0xLTEtMTI0MTUz_d691039e-dfed-460a-a559-80300f602623">39,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0496dc8b573246759849c58cf2ee5081_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3MzEyNDRlOTViMTY0ZjFjYWU1MGYxZTY2ZmE0ODIzNS90YWJsZXJhbmdlOjczMTI0NGU5NWIxNjRmMWNhZTUwZjFlNjZmYTQ4MjM1XzQtMS0xLTEtMTEyNjQw_3565d97b-3ef8-4f42-97be-cf95db817512">19,985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb4f9e0d157846e39f3e696539899f72_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3MzEyNDRlOTViMTY0ZjFjYWU1MGYxZTY2ZmE0ODIzNS90YWJsZXJhbmdlOjczMTI0NGU5NWIxNjRmMWNhZTUwZjFlNjZmYTQ4MjM1XzQtMy0xLTEtMTEyNjQw_b18d1998-9fbf-47b2-a94f-880f96ff6711">16,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3MzEyNDRlOTViMTY0ZjFjYWU1MGYxZTY2ZmE0ODIzNS90YWJsZXJhbmdlOjczMTI0NGU5NWIxNjRmMWNhZTUwZjFlNjZmYTQ4MjM1XzUtMS0xLTEtMTI0MTYz_f1a6728f-e25c-4c50-8fe5-0269bc7a0b6a">50,881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3MzEyNDRlOTViMTY0ZjFjYWU1MGYxZTY2ZmE0ODIzNS90YWJsZXJhbmdlOjczMTI0NGU5NWIxNjRmMWNhZTUwZjFlNjZmYTQ4MjM1XzUtMS0xLTEtMTEyNjQw_ea50ea40-aca9-4a19-a97a-c72f6db760ef">29,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3MzEyNDRlOTViMTY0ZjFjYWU1MGYxZTY2ZmE0ODIzNS90YWJsZXJhbmdlOjczMTI0NGU5NWIxNjRmMWNhZTUwZjFlNjZmYTQ4MjM1XzUtMy0xLTEtMTEyNjQw_9ea2b0e6-b150-4c72-9e6a-ca4ed7d69b15">25,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.</span></div></ix:nonNumeric><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conversion and Modification of Equity Awards Outstanding at Separation Date</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the OmniAb Separation on November 1, 2022, under the provisions of the existing plans, we adjusted our outstanding equity awards in accordance with the Merger Agreement to preserve the intrinsic value of the awards immediately before and after the Distribution. Upon the Distribution, employees holding stock options, restricted stock units and performance restricted stock units denominated in pre-Distribution Ligand stock received a number of otherwise-similar awards either in post-Distribution Ligand stock or in a combination of post-Distribution Ligand stock and OmniAb stock based on conversion ratios outlined for each group of employees in the Merger Agreement that we entered into in connection with the Distribution. The equity awards that were granted prior to March 2, 2022 were converted under the shareholder method, wherein employees holding outstanding equity awards received equity awards in both Ligand and OmniAb. For equity awards granted after March 2, 2022, for Ligand employees, the number of awards that were outstanding at the Separation were proportionately adjusted into post-Distribution Ligand stock to maintain the aggregate intrinsic value of the awards at the date of the Separation; for OmniAb employees, the number of awards that were outstanding at the Separation were proportionately adjusted into post-Distribution OmniAb stock to maintain the aggregate intrinsic value of the awards at the date of the Separation. The conversion ratio was determined based on the relative values of Ligand common stock in the &#8220;regular way&#8221; and &#8220;ex-distribution&#8221; markets during the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">five-trading day period prior to the closing of the business combination.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These modified awards otherwise retained substantially the same terms and conditions, including term and vesting provisions. Additionally, we will not incur any future compensation cost related to equity awards held by OmniAb employees and directors. We will incur future compensation cost related to OmniAb equity awards held by our employees.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Plans</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, our stockholders approved the amendment and restatement of the Ligand Pharmaceuticals Incorporated 2002 Stock Incentive Plan (the &#8220;2002 Plan&#8221;). The amended and restated 2002 Plan, which is referred to herein as the &#8220;Restated Plan&#8221; was amended to increase the shares available for issuance by <ix:nonFraction unitRef="shares" contextRef="iae45ac44b4cf4613953eedfe31c7f341_D20220601-20220630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzE2NDkyNjc0NDg3MTU_25080fca-73be-488b-a4ee-35253c9fd0f5">1.0</ix:nonFraction> million. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 29, 2022, our board of directors (the &#8220;Board&#8221;) approved the Ligand Pharmaceuticals Incorporated 2022 Employment Inducement Plan (the &#8220;2022 Inducement Plan&#8221;). The terms of the 2022 Inducement Plan are substantially similar to the terms of the Restated Plan with the exception that incentive stock options may not be issued under the 2022 Inducement Plan and awards under the 2022 Inducement Plan may only be issued to eligible recipients under the applicable Nasdaq Listing Rules. The 2022 Inducement Plan was adopted by the Board without stockholder approval pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules. The Board has initially reserved 300,000 shares of the Company&#8217;s common stock for issuance pursuant to awards granted under the 2022 Inducement Plan. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, there were <ix:nonFraction unitRef="shares" contextRef="i14ec222f5248466398774a2561f84042_I20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzM4NDgyOTA3MTI0NTE_5358c1e8-db3d-48ab-b593-ee63f4301d75">1.3</ix:nonFraction> million shares available for future option grants or direct issuance under the Restated Plan and the 2022 Inducement Plan.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i6b7494c1758f4fdcb43efc9f995799b7" continuedAt="ia8d9ba27ce1b4d4fadbe55a8434ba1e5"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzMxMTQ_561dba41-6670-4ec8-9c41-82dfe07c0cc4" continuedAt="i549c7529b0fd41949431315b222c1146" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following is a summary of our stock option plan activity and related information:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:49.120%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.244%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Price</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Remaining</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contractual</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Term in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intrinsic</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January&#160;1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i859e9607437a43d8adb4d3dc08e60773_I20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzctMS0xLTEtMTEyNjQw_50e74837-89c1-4c40-8c21-7f74ffa662b9">1,956,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i859e9607437a43d8adb4d3dc08e60773_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzctMy0xLTEtMTEyNjQw_19e0ceee-629a-4b3d-87d3-7d9fdf467709">77.54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic67831c921904253a87bb44165f263ef_D20190101-20191231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzctNS0xLTEtMTEyNjQw_dd1816ab-c3e3-4f0f-9730-28a747dfc2f8">5.45</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i859e9607437a43d8adb4d3dc08e60773_I20191231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzctNy0xLTEtMTEyNjQw_d11ff704-a6c9-4259-88d0-139211d86895">72,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzgtMS0xLTEtMTEyNjQw_2569f7c7-970e-4c8c-8b85-3850b0473c57">806,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzgtMy0xLTEtMTEyNjQw_65d1413d-6086-41c1-91cd-51089080bc2e">92.93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzktMS0xLTEtMTEyNjQw_5307bccf-03bc-46ec-8f93-f9ca7b506d65">156,845</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzktMy0xLTEtMTEyNjQw_b90ed4f3-54b6-4d92-9e0e-fd1caf2ef18a">21.26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzEwLTEtMS0xLTExMjY0MA_5d2aea25-7d98-473c-9c5b-c94ad9239adf">44,012</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzEwLTMtMS0xLTExMjY0MA_55ce430b-f0d6-49e9-b883-c1810944a3a3">91.30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzExLTEtMS0xLTExMjY0MA_b6087154-ea0a-4521-863b-4fa455ec51ba">2,561,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzExLTMtMS0xLTExMjY0MA_e00494bc-2553-4467-b4cd-fe406f67dfdf">85.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzExLTUtMS0xLTExMjY0MA_53dfabd5-65ff-4f04-a692-762ce68ff032">6.09</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzExLTctMS0xLTExMjY0MA_920e1e72-a5d4-4754-a94c-cc00d6076950">59,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December&#160;31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzEyLTEtMS0xLTExMjY0MA_5a7f528e-89bb-4202-9e20-52f5c88f2bb0">1,611,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzEyLTMtMS0xLTExMjY0MA_630d7e50-8fab-464d-9c0a-71927430c4f8">76.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzEyLTUtMS0xLTExMjY0MA_4ccb5a24-ab4e-4e85-8f6d-40963258f6b2">4.54</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzEyLTctMS0xLTExMjY0MA_bdfbe237-1811-4e8b-ad08-c4ff740f2662">53,286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest as of December&#160;31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzEzLTEtMS0xLTExMjY0MA_58adc081-26ee-42b1-a45d-76884d9e4c32">2,561,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzEzLTMtMS0xLTExMjY0MA_cca51fbb-7983-4f84-b744-c4e23c3f9a38">85.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzEzLTUtMS0xLTExMjY0MA_97dfc029-9193-4950-b990-c645f24b2866">6.09</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzEzLTctMS0xLTExMjY0MA_d6a9aee9-33ff-4aaa-8f0c-438ca30dae03">59,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE0LTEtMS0xLTExMjY0MA_553e7c68-481f-42c4-884a-3f62898797ac">393,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE0LTMtMS0xLTExMjY0MA_348e371e-3e78-404e-879b-9930ee801c8f">159.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE1LTEtMS0xLTExMjY0MA_d052b649-844c-4a9c-af1d-318d16d37439">619,731</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE1LTMtMS0xLTExMjY0MA_8e686eb2-b82f-4e1f-a9fc-da0338dd34e9">54.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE2LTEtMS0xLTExMjY0MA_48f4dbe7-4441-482f-bdf4-8b9ad22a762b">136,082</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE2LTMtMS0xLTExMjY0MA_e2042277-e36a-4cbc-9954-b4ce8aefead1">110.83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021 </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE3LTEtMS0xLTExMjY0MA_cbec92e6-8868-4242-a246-6f508900621a">2,199,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE3LTMtMS0xLTExMjY0MA_12c29e7e-2f79-4b94-bf3c-7cb2db163fba">106.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE3LTUtMS0xLTExMjY0MA_e085f382-4a96-4545-8ab5-9e614c897ee4">6.34</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE3LTctMS0xLTExMjY0MA_9e0335ff-3b98-47e3-8e6d-b400dcea0b85">113,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December&#160;31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE4LTEtMS0xLTExMjY0MA_f7d42ca4-fd85-4eaf-aad5-1f249d312822">1,391,952</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE4LTMtMS0xLTExMjY0MA_d63244d8-a35d-40f2-bbb1-04946ea630da">98.16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE4LTUtMS0xLTExMjY0MA_04e021dd-5180-411f-96fa-db9ae09b8338">5.12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE4LTctMS0xLTExMjY0MA_58a86fee-4eaa-4c0c-b77c-3bc4f77514fa">80,849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest as of December&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE5LTEtMS0xLTExMjY0MA_06a6b8bf-88a9-4d7c-99f1-c206d1c62cef">2,199,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE5LTMtMS0xLTExMjY0MA_70502e31-4202-458f-b65b-ea2205576c91">106.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE5LTUtMS0xLTExMjY0MA_e38c0287-0720-4c00-aafa-7c8c08e07857">6.34</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE5LTctMS0xLTExMjY0MA_6e1272fe-1bee-4e7e-9918-eb686cf9779a">113,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i59fa0ea34268498a977d54122e7473c5_D20220101-20221031" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE0LTEtMS0xLTEyMTQ5OQ_81456e2f-edbe-4b9e-bf59-1a951bf4b322">863,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i59fa0ea34268498a977d54122e7473c5_D20220101-20221031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE0LTMtMS0xLTEyMTQ5OQ_33b16cf8-24b7-4722-956d-0945be7a2740">91.34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i59fa0ea34268498a977d54122e7473c5_D20220101-20221031" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE1LTEtMS0xLTEyMTQ5OQ_db7b8387-7960-4e7d-8d76-5530401469d8">34,941</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i59fa0ea34268498a977d54122e7473c5_D20220101-20221031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE1LTMtMS0xLTEyMTQ5OQ_fefe898d-1e9e-43da-9e47-8269f4ebf54f">38.56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i59fa0ea34268498a977d54122e7473c5_D20220101-20221031" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE2LTEtMS0xLTEyMTQ5OQ_7c751a96-f108-401e-8776-360097ab8149">40,069</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i59fa0ea34268498a977d54122e7473c5_D20220101-20221031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE2LTMtMS0xLTEyMTQ5OQ_d2f6736d-4407-4568-88d6-c54911a6e766">78.46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at October 31, 2022 </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1e08d73fd52941c8b0a838aeb83cbe3b_I20221031" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE3LTEtMS0xLTEyMTY4Mg_6b81cfe7-76aa-4dee-9d3d-ea1d57a58864">2,987,833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1e08d73fd52941c8b0a838aeb83cbe3b_I20221031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE3LTMtMS0xLTEyMTUxMQ_3edeb388-df48-478c-9cdc-8f9aa0e8ca4c">102.92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i59fa0ea34268498a977d54122e7473c5_D20220101-20221031" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE3LTUtMS0xLTEyMTU5Nw_c326ddf1-20dd-4faf-b0f3-6a30375edd1a">0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e08d73fd52941c8b0a838aeb83cbe3b_I20221031" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE3LTctMS0xLTEyMTU5Nw_3ee1c124-f8df-4b28-9db4-8ac078373d2f">14,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at October 31, 2022 </span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1e08d73fd52941c8b0a838aeb83cbe3b_I20221031" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE4LTEtMS0xLTEyMTUxOA_aefbe20e-b756-4e9c-bd94-814525843d5a">1,769,629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1e08d73fd52941c8b0a838aeb83cbe3b_I20221031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE4LTMtMS0xLTEyMTUxMQ_daacd09b-910a-4be2-81da-5b6f4b209c1b">102.38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i59fa0ea34268498a977d54122e7473c5_D20220101-20221031" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE4LTUtMS0xLTEyMTU5Nw_b95bd79e-2b49-4396-9ce5-dacbcc562844">0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e08d73fd52941c8b0a838aeb83cbe3b_I20221031" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE4LTctMS0xLTEyMTU5Nw_faf70ebc-660b-4092-8cb7-d3cf5f2dc3bc">13,722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest as of October 31, 2022, before Separation and Regrant</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1e08d73fd52941c8b0a838aeb83cbe3b_I20221031" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE5LTEtMS0xLTEyMTY4NA_6160733d-e9c3-4d02-9923-cea495fae090">2,987,833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1e08d73fd52941c8b0a838aeb83cbe3b_I20221031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE5LTMtMS0xLTEyMTY4OQ_e1d0e79c-ee52-43ff-84a2-339d50c85099">102.92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i59fa0ea34268498a977d54122e7473c5_D20220101-20221031" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE5LTUtMS0xLTEyMTY5NA_a40ca74d-5d6b-42b7-a01e-70ec2797d0f4">0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e08d73fd52941c8b0a838aeb83cbe3b_I20221031" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE5LTctMS0xLTEyMTY5Ng_203be641-66de-482a-b6b5-c6746a5dc28c">14,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation due to Separation, Before Regrant</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ifb8d1e2f9bc24fa4a2bc478bc667577c_D20221101-20221101" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzIwLTEtMS0xLTEyNzA0NQ_0d1efb63-d4b8-4ae5-b675-285b9bfbfb02">2,987,833</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at November 1, 2022, Before Regrant</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie06ebd7de19543a9be2b5f0c195a8849_I20221101" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzIxLTEtMS0xLTEyNzA0OA_ee269a64-0f98-43fc-bc94-65008a649806">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieaaf4e1776ca4ee3b882116a392a5b8c_D20221102-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzIwLTEtMS0xLTEyMTU1Mg_e0ccdd37-c173-4339-8043-bd599c4bc4e9">3,584,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ieaaf4e1776ca4ee3b882116a392a5b8c_D20221102-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzIwLTMtMS0xLTEyMTU0MQ_190c25d2-cef0-4c47-9fd9-7b1466129b83">60.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ieaaf4e1776ca4ee3b882116a392a5b8c_D20221102-20221231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzIxLTEtMS0xLTEyMTU1Mg_898d01f1-22a3-421f-b92e-62e2e0ab55ea">50,449</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ieaaf4e1776ca4ee3b882116a392a5b8c_D20221102-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzIxLTMtMS0xLTEyMTU0MQ_dbf4e010-c08f-4f24-9b69-9a756bc62511">30.24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ieaaf4e1776ca4ee3b882116a392a5b8c_D20221102-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzIyLTEtMS0xLTEyMTU1Mg_cb9bd89c-39da-4319-9d35-1b7b31b0d1b2">542,838</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ieaaf4e1776ca4ee3b882116a392a5b8c_D20221102-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzIyLTMtMS0xLTEyMTU0MQ_6ea41632-f932-4198-9f02-905df8501faf">56.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzIzLTEtMS0xLTEyMTY4Ng_1d763b70-5350-4ead-af57-c99ed74a4ec3">2,991,473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzIzLTMtMS0xLTEyMTU0MQ_fe5effba-3a4c-43a5-ab7e-4e87fe417d3f">61.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ieaaf4e1776ca4ee3b882116a392a5b8c_D20221102-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzIzLTUtMS0xLTEyMTYxMQ_6d7ae13c-56d1-466e-a1b4-7be04419ff7e">6.07</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzIzLTctMS0xLTEyMTYxMQ_415b942d-ad8e-45f3-844d-0abab32b0dd5">30,477</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzI0LTEtMS0xLTEyMTU2OA_a3c9f731-58fa-4236-9fca-ac369f7a9cac">1,559,662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzI0LTMtMS0xLTEyMTU2OA_6a489d1d-2127-467b-8e5a-4c97fc743d1c">60.83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ieaaf4e1776ca4ee3b882116a392a5b8c_D20221102-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzI0LTUtMS0xLTEyMTU4MQ_2e7e80c7-f9ef-43d3-88e0-6ac46ae322d3">4.51</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzI0LTctMS0xLTEyMTU4MQ_c5934bb2-a77a-40ee-a5d7-5e2091945d47">17,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest as of December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzI1LTEtMS0xLTEyMTY4Ng_a3f539fc-a0e5-4391-9854-60253a107ebe">2,991,473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzI1LTMtMS0xLTEyMTY5MQ_7086c301-712f-4408-b4f5-ebe0592022da">61.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ieaaf4e1776ca4ee3b882116a392a5b8c_D20221102-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzI1LTUtMS0xLTEyMTU4MQ_06fd6641-e70e-42bf-9e66-c26b9cb8c2cc">6.07</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzI1LTctMS0xLTEyMTU4MQ_cb045d8d-2e88-415d-8cdd-21da95fcdad4">30,477</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"><ix:continuation id="i549c7529b0fd41949431315b222c1146">(1) Options granted primarily relate to the modifications in connection with the Separation which resulted in new stock option grants at the modification date fair value.</ix:continuation> </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant-date fair value of all stock options granted during 2022, 2021 and 2020 was $<ix:nonFraction unitRef="usdPerShare" contextRef="if66ef91cf250497180df8bdafb040c04_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzU0OTc1NTgxNzIxNA_656b2bd7-f99b-4f7c-929d-289818ab7cd0">28.90</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="i67a5c3e26a4a41c5965dfa8c1722d00f_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzU5Ng_e7a6109b-b021-45fa-a4aa-d12ffad60589">80.08</ix:nonFraction>, and $<ix:nonFraction unitRef="usdPerShare" contextRef="i76c8d1f51aad42668b7908e89daf66dd_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzYwMA_0f9795da-599f-4db6-a875-183f7a413b73">41.39</ix:nonFraction> per share, respectively. The total intrinsic value of all options exercised during 2022, 2021 and 2020 was approximately $<ix:nonFraction unitRef="usd" contextRef="if66ef91cf250497180df8bdafb040c04_D20220101-20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzU0OTc1NTgxNzQ1Ng_e44fe5d0-1ad6-450b-a275-ea65d6beb51c">4.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i67a5c3e26a4a41c5965dfa8c1722d00f_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzcyNQ_bfeb5aed-5a53-43e5-bd55-f900d693e778">77.3</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i76c8d1f51aad42668b7908e89daf66dd_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzcyOQ_f2e18485-356f-4e98-9f78-cd436431fb35">11.9</ix:nonFraction> million, respectively. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash received from options exercised, net of fees paid, in 2022, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="if66ef91cf250497180df8bdafb040c04_D20220101-20221231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzU0OTc1NTgxNzQ2Nw_f727bb45-8709-4f8e-a0d2-f3ba9a20ebf5">2.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i67a5c3e26a4a41c5965dfa8c1722d00f_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzgzMg_25e69397-f991-4262-a818-1c38662ce328">33.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i76c8d1f51aad42668b7908e89daf66dd_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzgzNg_e52ec8ae-7665-4d95-aaf4-6a0ab1341f79">2.5</ix:nonFraction> million, respectively. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia8d9ba27ce1b4d4fadbe55a8434ba1e5" continuedAt="i65331534b73745f6aa834f54979d4217"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzMxMTU_bc33442c-99ef-4a10-8001-913f197d2733" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following is a further breakdown of the options outstanding as of December&#160;31, 2022:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.057%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.057%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.057%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.057%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.212%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Range of exercise prices</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">outstanding</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">remaining&#160; life</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">in&#160;years</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">exercise price</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">exercisable</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">exercise&#160;price</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i3ea9d8dc84e843c18bf275e4e37eca43_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzEtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246OWU2MGFhMzc2YmM1NGE1MWE5MDIxYmM5YjkzZjQ2NmZfNA_9663a72b-6a07-4f32-a683-335068370daa">12.78</ix:nonFraction>-$<ix:nonFraction unitRef="usdPerShare" contextRef="i3ea9d8dc84e843c18bf275e4e37eca43_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzEtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246OWU2MGFhMzc2YmM1NGE1MWE5MDIxYmM5YjkzZjQ2NmZfNw_caf25dee-2c6b-45d5-9d47-2823fa40f73a">43.36</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic08afe60b35d4e72a651be2308becc85_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzEtMS0xLTEtMTEyNjQw_c0e35443-8b47-4d3e-9fcf-696b657a7edb">395,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3ea9d8dc84e843c18bf275e4e37eca43_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzEtMy0xLTEtMTEyNjQw_e739888f-f5e7-4705-b20d-7fe17691b08f">2.32</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic08afe60b35d4e72a651be2308becc85_I20221231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzEtNS0xLTEtMTEyNjQw_9e76de47-fe42-4b7d-9b71-d019344c3992">35.76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic08afe60b35d4e72a651be2308becc85_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzEtNy0xLTEtMTEyNjQw_ecd0ea67-e016-45d6-a1a5-876589cdca72">366,426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic08afe60b35d4e72a651be2308becc85_I20221231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzEtOS0xLTEtMTEyNjQw_0da126f6-e4bd-4964-8ef9-75deaadc3fa5">35.44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ief7b0c06377d406cb4005ea8273c1cc1_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzItMC0xLTEtMTEyNjQwL3RleHRyZWdpb246Y2MyZDI4YzRiZWMzNGViMDgyMjVhYmZhMDc3Y2UyZjhfNA_d9b20596-5edf-417b-81dc-131607d3c6ca">46.20</ix:nonFraction>-$<ix:nonFraction unitRef="usdPerShare" contextRef="ief7b0c06377d406cb4005ea8273c1cc1_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzItMC0xLTEtMTEyNjQwL3RleHRyZWdpb246Y2MyZDI4YzRiZWMzNGViMDgyMjVhYmZhMDc3Y2UyZjhfNw_ccd1cba8-15c4-4c48-b944-9e462d985d49">52.78</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3e7d98d1709e4fe5b08bdc5dac823ced_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzItMS0xLTEtMTEyNjQw_be530aef-23de-459b-843f-558bca744055">279,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ief7b0c06377d406cb4005ea8273c1cc1_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzItMy0xLTEtMTEyNjQw_ad539628-4060-4829-8c30-73add1a6e4a2">6.63</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3e7d98d1709e4fe5b08bdc5dac823ced_I20221231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzItNS0xLTEtMTEyNjQw_3791ad90-6e30-4776-87ed-bde31f8f4819">50.24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3e7d98d1709e4fe5b08bdc5dac823ced_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzItNy0xLTEtMTEyNjQw_b18584ee-f858-41da-bdc4-e1a6b178ded4">122,734</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3e7d98d1709e4fe5b08bdc5dac823ced_I20221231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzItOS0xLTEtMTEyNjQw_fc12fbe1-f57c-48a7-aff6-4ec0014e8bee">50.18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ibd1f4da528084577aee7dcabc5455e87_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzMtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246NWMxNDhlMTE4MjQ5NGI0MmIwMzJmNTU0MDZmNmFlYTNfNA_d6cc7264-b944-4135-98c0-944b3d5bb37b">52.84</ix:nonFraction>-$<ix:nonFraction unitRef="usdPerShare" contextRef="ibd1f4da528084577aee7dcabc5455e87_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzMtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246NWMxNDhlMTE4MjQ5NGI0MmIwMzJmNTU0MDZmNmFlYTNfNw_96c9df10-2b39-4330-89e9-750b896b5628">52.84</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8df448bf131f436d8340558685040924_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzMtMS0xLTEtMTEyNjQw_78d509a4-f5fa-478a-a791-8ba6ddb81324">580,629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibd1f4da528084577aee7dcabc5455e87_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzMtMy0xLTEtMTEyNjQw_1a1c622a-e573-40df-bfdd-d89289785e9d">7.59</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8df448bf131f436d8340558685040924_I20221231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzMtNS0xLTEtMTEyNjQw_83cff767-82bd-4a9a-83b2-a5f1303084be">52.84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8df448bf131f436d8340558685040924_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzMtNy0xLTEtMTEyNjQw_7aa9a72a-d0d9-4e5d-b36a-22c9ac011e1a">88,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8df448bf131f436d8340558685040924_I20221231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzMtOS0xLTEtMTEyNjQw_4d550723-498c-4585-b8e7-717a5006c4f9">52.84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="id70a7d71b0a14b0abc0db27c646a2a71_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzQtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246YzAyMDJhMDZlNzI3NGEwMDlkNjFiZDE2MjI3NWI5NGVfNTQ5NzU1ODEzOTAy_755db3e0-98d6-4862-bc55-d1b3f726dd51">54.81</ix:nonFraction>-$<ix:nonFraction unitRef="usdPerShare" contextRef="id70a7d71b0a14b0abc0db27c646a2a71_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzQtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246YzAyMDJhMDZlNzI3NGEwMDlkNjFiZDE2MjI3NWI5NGVfNTQ5NzU1ODEzODk4_963801cd-017b-41bc-9c7a-87bb32502256">57.22</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic75d320692e9481bb881a28239201125_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzQtMS0xLTEtMTEyNjQw_634127f9-a8ab-473f-b319-63cd06641c5e">391,280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id70a7d71b0a14b0abc0db27c646a2a71_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzQtMy0xLTEtMTEyNjQw_f23062f7-5ebe-496f-94eb-332e7d20aac7">6.47</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic75d320692e9481bb881a28239201125_I20221231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzQtNS0xLTEtMTEyNjQw_89d9f650-0b5b-4893-a4b8-9bce30653d6a">56.24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic75d320692e9481bb881a28239201125_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzQtNy0xLTEtMTEyNjQw_b801e37f-9c2d-4062-907f-234411afd8e6">198,283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic75d320692e9481bb881a28239201125_I20221231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzQtOS0xLTEtMTEyNjQw_6ec51a1d-2716-443e-931a-cdfa13a83452">56.26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="if0206a09bd2447e0b7a819f3e88399b0_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzUtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246YjEzYWMzMTEyOTU5NDc0N2I0ZjhmMmY4NzI0MzI0N2JfNA_51c41bfa-5dac-4aa1-9949-010857d4c79e">58.28</ix:nonFraction>-$<ix:nonFraction unitRef="usdPerShare" contextRef="if0206a09bd2447e0b7a819f3e88399b0_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzUtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246YjEzYWMzMTEyOTU5NDc0N2I0ZjhmMmY4NzI0MzI0N2JfNw_1c13aa3e-c6e1-495b-82d8-fa4d8d978db8">67.03</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if244aca373d34599b957dd0229b16240_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzUtMS0xLTEtMTEyNjQw_8c188c33-d27c-486c-b0e5-51aed520337b">477,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if0206a09bd2447e0b7a819f3e88399b0_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzUtMy0xLTEtMTEyNjQw_777493c8-9207-49d9-95d5-56abbdd540a2">5.78</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if244aca373d34599b957dd0229b16240_I20221231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzUtNS0xLTEtMTEyNjQw_6f04ca67-8fcc-4d95-a79b-054dfd71dd9c">64.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if244aca373d34599b957dd0229b16240_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzUtNy0xLTEtMTEyNjQw_65bb09e2-943c-4fc7-9f57-7758ca935bc9">274,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if244aca373d34599b957dd0229b16240_I20221231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzUtOS0xLTEtMTEyNjQw_84850e5d-dd7b-4d19-85b8-8db0d71754f1">62.90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i53aac02f675646bc9f345ded193cb397_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzYtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246MDgwNDczMmFiNTVlNDFjMzkyOWE0YmMyMjk2NTBlYWRfNA_ecf7d1fa-ba54-4e4b-8647-9f9d40e183e1">67.24</ix:nonFraction>-$<ix:nonFraction unitRef="usdPerShare" contextRef="i53aac02f675646bc9f345ded193cb397_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzYtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246MDgwNDczMmFiNTVlNDFjMzkyOWE0YmMyMjk2NTBlYWRfNw_78808955-56e3-4da3-9091-c5fc2036105e">69.70</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ida99b6789c3a4f50b772bdb7b47fa5cd_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzYtMS0xLTEtMTEyNjQw_afc23f75-ff5e-4027-b65b-3f7266482e13">403,187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i53aac02f675646bc9f345ded193cb397_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzYtMy0xLTEtMTEyNjQw_2eff08eb-5be2-438a-bf38-9878f3f87cb7">6.93</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ida99b6789c3a4f50b772bdb7b47fa5cd_I20221231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzYtNS0xLTEtMTEyNjQw_85940fa8-60bc-4c37-a1d3-13d001731d9f">68.98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ida99b6789c3a4f50b772bdb7b47fa5cd_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzYtNy0xLTEtMTEyNjQw_74a0a745-5127-4d39-9f72-61769221efb1">207,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ida99b6789c3a4f50b772bdb7b47fa5cd_I20221231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzYtOS0xLTEtMTEyNjQw_f9341407-f25b-41a5-98ba-0f027b82ceec">68.60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i6b63563893e044e48841c92b5fe75d81_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzctMC0xLTEtMTEyNjQwL3RleHRyZWdpb246OGE5MDVlZTIwMTM1NGRkNGExMzE3MDk4M2Y1Y2JjYzFfNTQ5NzU1ODEzODk4_119f76f8-88e2-40a2-a345-895ec636caeb">70.04</ix:nonFraction>-$<ix:nonFraction unitRef="usdPerShare" contextRef="i6b63563893e044e48841c92b5fe75d81_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzctMC0xLTEtMTEyNjQwL3RleHRyZWdpb246OGE5MDVlZTIwMTM1NGRkNGExMzE3MDk4M2Y1Y2JjYzFfNTQ5NzU1ODEzOTAy_75d6586f-6e84-4413-87fe-92c0f8c7a5ef">93.12</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i832e5c7bccde4123b022c8bab92e41a3_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzctMS0xLTEtMTEyNjQw_45dcaba9-ebd8-4c4d-b6d3-3f96ce430c38">254,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6b63563893e044e48841c92b5fe75d81_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzctMy0xLTEtMTEyNjQw_3fef2bab-332c-4a56-aba4-91f023cd7581">5.56</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i832e5c7bccde4123b022c8bab92e41a3_I20221231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzctNS0xLTEtMTEyNjQw_454bfae6-69f1-4f52-9d07-5ff7e932b825">87.72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i832e5c7bccde4123b022c8bab92e41a3_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzctNy0xLTEtMTEyNjQw_a5a9b5bf-ebd5-4ad8-b3e2-37bf03fc011b">204,332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i832e5c7bccde4123b022c8bab92e41a3_I20221231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzctOS0xLTEtMTEyNjQw_bb109aa5-bdb8-4158-a378-001db43b3f6b">89.21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i6b74c7e45f8c4749a8ef280613702146_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzgtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246ZDg5MGRmY2U5ZTlkNDBlNmE3ZDk3ODM4MGQwN2I1NzJfNA_94e531b7-3fef-4ab9-affc-2856186f5125">99.80</ix:nonFraction>-$<ix:nonFraction unitRef="usdPerShare" contextRef="i6b74c7e45f8c4749a8ef280613702146_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzgtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246ZDg5MGRmY2U5ZTlkNDBlNmE3ZDk3ODM4MGQwN2I1NzJfNw_17185860-0664-43a6-b6c0-5b29c808f5a4">99.80</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3a0d0b5e84d344cfbc5b391903f924fc_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzgtMS0xLTEtMTEyNjQw_f61215e7-b681-40d4-b2e7-e1bd72025a53">3,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6b74c7e45f8c4749a8ef280613702146_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzgtMy0xLTEtMTEyNjQw_4b445f36-a709-4b3c-aec1-e0b38c22c7d4">5.84</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3a0d0b5e84d344cfbc5b391903f924fc_I20221231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzgtNS0xLTEtMTEyNjQw_210e1ab3-4d2f-461f-bbbf-dbe6dd0e7bfb">99.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3a0d0b5e84d344cfbc5b391903f924fc_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzgtNy0xLTEtMTEyNjQw_40a9fda8-ce14-4daf-bf32-9aea8d430f27">3,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3a0d0b5e84d344cfbc5b391903f924fc_I20221231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzgtOS0xLTEtMTEyNjQw_4cc9b916-9db9-47ba-af96-c0c58e652f02">99.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ia1c885f91b7f4f689c7b8a8c9df23e98_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzktMC0xLTEtMTEyNjQwL3RleHRyZWdpb246ZjgwNzA3Zjc5M2ZkNGZjYTg4NjAyYWY1YzhlMGRhNjJfNA_d000edc0-6558-4ae8-b043-de1282d5a826">103.42</ix:nonFraction>-$<ix:nonFraction unitRef="usdPerShare" contextRef="ia1c885f91b7f4f689c7b8a8c9df23e98_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzktMC0xLTEtMTEyNjQwL3RleHRyZWdpb246ZjgwNzA3Zjc5M2ZkNGZjYTg4NjAyYWY1YzhlMGRhNjJfNw_80e61160-37e3-4590-a3bc-23a896f0fd10">103.42</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia739273d90a041b18ac1f97de8da164c_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzktMS0xLTEtMTEyNjQw_d261f46e-2af3-4626-9013-9cf98b708761">193,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia1c885f91b7f4f689c7b8a8c9df23e98_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzktMy0xLTEtMTEyNjQw_08f050d9-9332-4a9f-9218-0d738e218550">7.26</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia739273d90a041b18ac1f97de8da164c_I20221231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzktNS0xLTEtMTEyNjQw_114a0c71-a558-40c3-ad1c-1f2c39da2da4">103.42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia739273d90a041b18ac1f97de8da164c_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzktNy0xLTEtMTEyNjQw_7cdba969-8c83-4d52-a2ef-0a1812cce9aa">80,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia739273d90a041b18ac1f97de8da164c_I20221231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzktOS0xLTEtMTEyNjQw_942b938b-0393-4bb0-b245-d9e532db7ca9">103.42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i9e0dbd02e5924340b2b6ef89413e73fd_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzEwLTAtMS0xLTExMjY0MC90ZXh0cmVnaW9uOjNkODgyYmE1YTc4OTRlNDRiNzZjMjRjNmUzZjJhNWE5XzQ_746f1083-d087-4246-a4de-73179112e51b">114.15</ix:nonFraction>-$<ix:nonFraction unitRef="usdPerShare" contextRef="i9e0dbd02e5924340b2b6ef89413e73fd_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzEwLTAtMS0xLTExMjY0MC90ZXh0cmVnaW9uOjNkODgyYmE1YTc4OTRlNDRiNzZjMjRjNmUzZjJhNWE5Xzc_8a9ca1ea-7afa-4145-bc93-1a38ac5a717a">114.15</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2768e2bc60244b69915cbe3b77507013_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzEwLTEtMS0xLTExMjY0MA_74b8d33b-e5fc-4690-821e-0ca9a8723e2e">12,966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9e0dbd02e5924340b2b6ef89413e73fd_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzEwLTMtMS0xLTExMjY0MA_88ee96cb-62c7-4967-bdba-642b65adc623">5.47</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2768e2bc60244b69915cbe3b77507013_I20221231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzEwLTUtMS0xLTExMjY0MA_d3b790d7-88ed-48f4-a16c-22300441ab4d">114.15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2768e2bc60244b69915cbe3b77507013_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzEwLTctMS0xLTExMjY0MA_d48f79fb-f36b-4a3b-ad11-5b00667a1370">12,966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2768e2bc60244b69915cbe3b77507013_I20221231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzEwLTktMS0xLTExMjY0MA_5fbc96e5-f04e-43e5-a4fb-1b21b3adb4d8">114.15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzExLTEtMS0xLTExMjY0MA_745d112a-6f2e-45b6-8a68-8cc3d4f9a1d4">2,991,473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzExLTMtMS0xLTExMjY0MA_7f69754b-5a8f-4c70-ae6d-1d44b07cb50b">6.07</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzExLTUtMS0xLTExMjY0MA_08ff5f41-68f3-4e7e-a1d4-32fca349785c">61.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzExLTctMS0xLTExMjY0MA_ee6649fd-55b6-4d02-9e47-4fad709e6595">1,559,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzExLTktMS0xLTExMjY0MA_bb41496a-ebf0-4b87-859e-4c4dc1248d3b">60.83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzMxMjA_0f5a03ff-f740-4b4c-b032-cf73fd01c559" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assumptions used for the specified reporting periods and the resulting estimates of weighted-average grant date fair value per share of options granted:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.701%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.227%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.227%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idbafb024b44d43f0b4a9e4440b3833cb_D20220101-20221231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzItMS0xLTEtMTIyOTgzL3RleHRyZWdpb246ZTFjYzFkZTEyOTgzNGNhMDhlNjg2MDA0ZTkxNmNhMDJfNTQ5NzU1ODEzOTI0_270caf86-8b05-4e92-a27d-818f0bb8257d">1.4</ix:nonFraction>%-<ix:nonFraction unitRef="number" contextRef="i5a1083da45f7446987097262ce780281_D20220101-20221231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzItMS0xLTEtMTIyOTgzL3RleHRyZWdpb246ZTFjYzFkZTEyOTgzNGNhMDhlNjg2MDA0ZTkxNmNhMDJfNTQ5NzU1ODEzOTM1_ae5851eb-3356-4c7c-b720-08634a766fbc">4.3</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i542a16c3353248bc8dd8336f95ea2022_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzItMS0xLTEtMTEyNjQwL3RleHRyZWdpb246Y2UzOTM4NDA0YjVmNGFmNWEwNWNmMDA0ZDJlYWEzNzFfNA_7f752006-72b8-4c49-97d2-d773f70f0781">0.4</ix:nonFraction>%-<ix:nonFraction unitRef="number" contextRef="id13b17e9fe134b41b5c293358c0d8d1e_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzItMS0xLTEtMTEyNjQwL3RleHRyZWdpb246Y2UzOTM4NDA0YjVmNGFmNWEwNWNmMDA0ZDJlYWEzNzFfNw_c6180f75-27b9-4b64-8565-5c0cbe73bfeb">1.2</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i70799954d0214652bfaf7cd03d05d0e7_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzItMy0xLTEtMTEyNjQwL3RleHRyZWdpb246ZGM2MTlkZWIwMWZlNDFjMjk1Y2UwNzg0Y2ZlMzQ1NzFfNA_b2868c5f-e6ea-44ec-9126-ff4014cf2f49">0.2</ix:nonFraction>%-<ix:nonFraction unitRef="number" contextRef="i6721b383c78a462dad20bcc6ce92e012_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzItMy0xLTEtMTEyNjQwL3RleHRyZWdpb246ZGM2MTlkZWIwMWZlNDFjMjk1Y2UwNzg0Y2ZlMzQ1NzFfNw_5c3ddf55-0569-401a-9a9e-4737732ff026">1.4</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idbafb024b44d43f0b4a9e4440b3833cb_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzMtMS0xLTEtMTIzMDUyL3RleHRyZWdpb246YWIyNjdkNjVhNjI3NGM4Zjk1NWNiNThjOWUyNDAwZTZfNTQ5NzU1ODEzODky_448d385e-351c-4c19-9895-fdf12584d960">49</ix:nonFraction>%-<ix:nonFraction unitRef="number" contextRef="i5a1083da45f7446987097262ce780281_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzMtMS0xLTEtMTIzMDUyL3RleHRyZWdpb246YWIyNjdkNjVhNjI3NGM4Zjk1NWNiNThjOWUyNDAwZTZfNTQ5NzU1ODEzODk4_1558865e-58de-4954-bb0a-184e345a0bd8">55</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i542a16c3353248bc8dd8336f95ea2022_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzMtMS0xLTEtMTEyNjQwL3RleHRyZWdpb246Y2E2ZWVkN2RmYmNkNDJkMWE4MmU5OGI3NTlmZTM0ODdfNA_4b32d4f6-5ba4-45b4-893c-afe597946827">47</ix:nonFraction>%-<ix:nonFraction unitRef="number" contextRef="id13b17e9fe134b41b5c293358c0d8d1e_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzMtMS0xLTEtMTEyNjQwL3RleHRyZWdpb246Y2E2ZWVkN2RmYmNkNDJkMWE4MmU5OGI3NTlmZTM0ODdfNw_03830ff9-8b74-4a98-8923-627fa8a9f186">63</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i70799954d0214652bfaf7cd03d05d0e7_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzMtMy0xLTEtMTEyNjQwL3RleHRyZWdpb246Y2ZmODdlNzk5ZTgxNGU0Y2ExNDkzNTM1ZWU0ODg4MzBfNA_216be01b-37aa-49de-a41e-9f86dc11cd36">47</ix:nonFraction>%-<ix:nonFraction unitRef="number" contextRef="i6721b383c78a462dad20bcc6ce92e012_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzMtMy0xLTEtMTEyNjQwL3RleHRyZWdpb246Y2ZmODdlNzk5ZTgxNGU0Y2ExNDkzNTM1ZWU0ODg4MzBfNw_aac52ca3-bffc-4949-91db-ce16822a4863">71</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idbafb024b44d43f0b4a9e4440b3833cb_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzQtMS0xLTEtMTIzMDY1L3RleHRyZWdpb246MDJkYTVmYTRiMzQwNDQwYWJkMDQ2YTIzZmZiYTkzMjVfNTQ5NzU1ODEzOTA3_a5ae4de1-2326-44bc-8e77-dbb8125d4f01">2</ix:nonNumeric>.0 to <ix:nonNumeric contextRef="i5a1083da45f7446987097262ce780281_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzQtMS0xLTEtMTIzMDY1L3RleHRyZWdpb246MDJkYTVmYTRiMzQwNDQwYWJkMDQ2YTIzZmZiYTkzMjVfNTQ5NzU1ODEzOTAw_bc3e3d9a-c52b-4f64-bf70-85264c100b92">6.5</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i542a16c3353248bc8dd8336f95ea2022_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzQtMS0xLTEtMTEyNjQwL3RleHRyZWdpb246NjFlZTJiODE3MzFlNGM5ZTgwZTIxMGY2ZWVmYTFiMTdfNA_9c14b843-9f95-4243-9d80-e15151a8b429">4.7</ix:nonNumeric> to <ix:nonNumeric contextRef="id13b17e9fe134b41b5c293358c0d8d1e_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzQtMS0xLTEtMTEyNjQwL3RleHRyZWdpb246NjFlZTJiODE3MzFlNGM5ZTgwZTIxMGY2ZWVmYTFiMTdfMTA_77188983-6bff-46f1-82e7-698d24486bd2">6.3</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i70799954d0214652bfaf7cd03d05d0e7_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzQtMy0xLTEtMTEyNjQwL3RleHRyZWdpb246YWJkZTc2Zjc3YzQ0NGRhNWFkN2IwODNjNjM0MTlkZjZfNA_ca0fb31b-d604-48bf-a2b0-7d446a9156ae">4.7</ix:nonNumeric> to <ix:nonNumeric contextRef="i6721b383c78a462dad20bcc6ce92e012_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzQtMy0xLTEtMTEyNjQwL3RleHRyZWdpb246YWJkZTc2Zjc3YzQ0NGRhNWFkN2IwODNjNjM0MTlkZjZfMTA_39f74fde-0d5f-4046-bd83-847b31dfc4e1">5.1</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-indent:27pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, there was $<ix:nonFraction unitRef="usd" contextRef="i14ec222f5248466398774a2561f84042_I20221231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzExMTY_1d42255c-a763-4fbe-a359-1b06bd733b04">32.7</ix:nonFraction> million of total unrecognized compensation cost related to non-vested stock options under the 2002 Plan. That cost is expected to be recognized over a weighted average period of <ix:nonNumeric contextRef="i7c0d366af0a24bf3b783d1043d41aeac_D20220101-20221231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzEyNzA_d63e78ef-b5a3-4d7b-bd75-267ecada3a54">2.7</ix:nonNumeric> years.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, there was $<ix:nonFraction unitRef="usd" contextRef="i1830acfcfe9d479fa705570392f59958_I20221231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzU0OTc1NTgyODA1MA_4b721945-8b55-4ce6-b109-d24512aacbe8">4.8</ix:nonFraction>&#160;million of total unrecognized compensation cost related to non-vested OmniAb stock options received upon aforementioned spin-off conversion. That cost is expected to be recognized over a weighted average period of <ix:nonNumeric contextRef="ice33364cbd56406b88429f2aa093f6cd_D20220101-20221231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzM4NDgyOTA3MTE0NTc_f167adb0-bdfb-4cc4-ae7f-763424ecd29a">1.8</ix:nonNumeric> years. </span></div></ix:continuation><div style="margin-bottom:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i65331534b73745f6aa834f54979d4217" continuedAt="i9e53bffafb964b0493cdac25f214f4eb"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Activity</span></div><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzMxMjE_d2508cf2-73d7-4001-930c-2a2ffbd6ade7" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our restricted stock activity and related information:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:69.721%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.830%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Grant&#160;Date Fair</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic7e2f70f54f74635b9da899358a0eb40_I20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzItMS0xLTEtMTEyNjQw_5ff9e401-0893-4ccf-b5ad-62d8741224fa">147,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic7e2f70f54f74635b9da899358a0eb40_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzItMy0xLTEtMTEyNjQw_8c5adb96-f2df-4582-90f2-cf8f8ce787f4">125.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i18c9bf22eb2e40bdb955de4a851b78c5_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzMtMS0xLTEtMTEyNjQw_d3f13a3f-35f2-4f8a-aa79-34af6db129b9">111,306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i18c9bf22eb2e40bdb955de4a851b78c5_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzMtMy0xLTEtMTEyNjQw_b3ae8877-48da-4feb-b641-43573a15ee9b">89.73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i18c9bf22eb2e40bdb955de4a851b78c5_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzQtMS0xLTEtMTEyNjQw_74953300-f6f0-45cc-ac48-eac3f7fd572d">52,363</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i18c9bf22eb2e40bdb955de4a851b78c5_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzQtMy0xLTEtMTEyNjQw_81e636d3-8cce-4e1e-b116-e8bb9c8f3cb3">121.69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i18c9bf22eb2e40bdb955de4a851b78c5_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzUtMS0xLTEtMTEyNjQw_a72769ca-cb95-473d-9783-9dbca6e10e8f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i18c9bf22eb2e40bdb955de4a851b78c5_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzUtMy0xLTEtMTEyNjQw_d363348d-d2bd-4364-b064-bd1fd6a7538e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifc03504c5b21431cb85fbddc8d239a0b_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzYtMS0xLTEtMTEyNjQw_d2a21922-9cc3-4a07-8d12-40f643f45ded">206,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifc03504c5b21431cb85fbddc8d239a0b_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzYtMy0xLTEtMTEyNjQw_f68894e8-2d4f-4228-af93-d1f3eb93e5bd">106.88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i70fc66a3f20848b5bb0f70e3f866d45d_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzctMS0xLTEtMTEyNjQw_421661ab-5c29-4adc-93cc-b3bfe0199fbe">167,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i70fc66a3f20848b5bb0f70e3f866d45d_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzctMy0xLTEtMTEyNjQw_665df8a5-c873-4051-b413-78ba6520faba">169.63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i70fc66a3f20848b5bb0f70e3f866d45d_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzgtMS0xLTEtMTEyNjQw_78475939-1b75-4f02-86fb-91d4f9aa96d3">98,501</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i70fc66a3f20848b5bb0f70e3f866d45d_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzgtMy0xLTEtMTEyNjQw_1ec72de0-1431-4427-b3df-6527cd4679b2">125.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i70fc66a3f20848b5bb0f70e3f866d45d_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzktMS0xLTEtMTEyNjQw_2257c153-f279-44c8-8be4-512e05b11c4e">10,850</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i70fc66a3f20848b5bb0f70e3f866d45d_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzktMy0xLTEtMTEyNjQw_40de1b8b-27b9-48bd-8ec9-69429fa6b727">141.85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id7b81ae076014d259846e22ddab69ac4_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzEwLTEtMS0xLTExMjY0MA_e2424297-0dea-480a-a00b-d8133efb381d">264,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id7b81ae076014d259846e22ddab69ac4_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzEwLTMtMS0xLTExMjY0MA_f685ebb3-4f16-44e3-8c6b-2e3a1fe0f183">138.21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i34a7906b62e04f2a93fcbf8c96e0b8c5_D20220101-20221031" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzExLTEtMS0xLTExMjY0MA_aa7d090f-6029-4a6a-a3be-4817661553e5">260,577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i34a7906b62e04f2a93fcbf8c96e0b8c5_D20220101-20221031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzExLTMtMS0xLTExMjY0MA_1880533e-0f10-4788-8467-bbb61da381ef">89.99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i34a7906b62e04f2a93fcbf8c96e0b8c5_D20220101-20221031" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzEyLTEtMS0xLTExMjY0MA_5ecc115e-6271-42d7-82bb-605d686c9cbe">138,867</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i34a7906b62e04f2a93fcbf8c96e0b8c5_D20220101-20221031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzEyLTMtMS0xLTExMjY0MA_8ddbe6fc-0c36-4ea7-946e-f951a6267088">120.57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i34a7906b62e04f2a93fcbf8c96e0b8c5_D20220101-20221031" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzEzLTEtMS0xLTExMjY0MA_f9cb7ebb-1b81-4de0-845d-58abf0598d8b">19,383</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i34a7906b62e04f2a93fcbf8c96e0b8c5_D20220101-20221031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzEzLTMtMS0xLTExMjY0MA_c487d890-ce6c-40ae-9ca7-f7bb936d999b">58.45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at October 31, 2022, before Separation and Regrant</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0b64d9bdb1cd4eceb9508d306b942d87_I20221031" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzE0LTEtMS0xLTExMjY0MA_8420b04b-99fc-43b5-9136-df246201dcf0">366,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0b64d9bdb1cd4eceb9508d306b942d87_I20221031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzE0LTMtMS0xLTExMjY0MA_8d21d5e7-23bf-4710-8e0d-4958c271ec42">114.83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited due to Separation, Before Regrant</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2ffc7c8d47654559a26bf1224c8dac2c_D20221101-20221101" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzE1LTEtMS0xLTEzNDI1NQ_1537d734-6ff2-4aa3-94e2-b98a7fe50798">366,470</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at November 1, 2022, Before Regrant</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i82b4fc5c5a994b2db38284c45930d10d_I20221101" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzE2LTEtMS0xLTEzNTg1MA_881aeaee-065a-4e16-b067-756fccf13191">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6bbc8a04f4fe422fbc818ec598c0b7f1_D20221102-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzE3LTEtMS0xLTEyMjUzOQ_1f7ab0dc-5ef3-403e-aeec-71afac7cc570">424,473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6bbc8a04f4fe422fbc818ec598c0b7f1_D20221102-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzE3LTMtMS0xLTEyMjUzOQ_e31a28a5-1b6a-4b45-b976-a7ee8c0f0877">75.61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i6bbc8a04f4fe422fbc818ec598c0b7f1_D20221102-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzE4LTEtMS0xLTEyMjUzOQ_83a77471-d0c8-422c-b8e1-673877343848">73,385</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6bbc8a04f4fe422fbc818ec598c0b7f1_D20221102-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzE4LTMtMS0xLTEyMjUzOQ_76012a4b-bd14-4771-9f66-c4df1289878d">75.17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i6bbc8a04f4fe422fbc818ec598c0b7f1_D20221102-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzE5LTEtMS0xLTEyMjUzOQ_b051dc27-dc0a-40db-b69d-f94102c33948">2,635</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6bbc8a04f4fe422fbc818ec598c0b7f1_D20221102-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzE5LTMtMS0xLTEyMjUzOQ_f72def91-371d-447d-96c7-81a2fdea8ef9">89.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i47a751f245b748f0843958f32f5f80c0_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzIwLTEtMS0xLTEzNTg0Ng_5e14c36f-c18d-4777-918d-79305c57cd0f">348,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i47a751f245b748f0843958f32f5f80c0_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzIwLTMtMS0xLTEyMjU0OQ_c1c63328-5670-4bd8-890a-b2728a7d016a">75.60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, unrecognized compensation cost related to non-vested stock awards under the 2002 Plan amounted to $<ix:nonFraction unitRef="usd" contextRef="i0687f0c421e14290af9f6cd6184a6b5e_I20221231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzE0NzY_3605e09a-5434-4641-ab6a-2c6c73044169">12.4</ix:nonFraction>&#160;million. That cost is expected to be recognized over a weighted average period of <ix:nonNumeric contextRef="i5e816eb25c2e46aa9b39c605fe0b678f_D20220101-20221231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzE1NTM_d1cc31a5-a030-4b9e-90e0-1016dbdc2775">1.7</ix:nonNumeric> years.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, there was $<ix:nonFraction unitRef="usd" contextRef="i955aaff5ae7f47659be272a78642d979_I20221231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzU0OTc1NTgyODA5Ng_2a587d80-fda0-44c6-900d-e18d254b13d7">1.2</ix:nonFraction>&#160;million of total unrecognized compensation cost related to non-vested OmniAb stock awards received upon aforementioned spin-off conversion. That cost is expected to be recognized over a weighted average period of <ix:nonNumeric contextRef="i041cfa14d0e74eefad61ffd3960940a4_D20220101-20221231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzM4NDgyOTA3MTE0NjM_82af9a8d-19bb-45f2-a839-2b2ab14c4f86">1.0</ix:nonNumeric> years.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, <ix:nonFraction unitRef="shares" contextRef="i2739bb11c12f4306b4cbdc98a749e080_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzE1OTg_d39fa261-0f56-424c-9657-f9fb9ae331d1">35,881</ix:nonFraction> shares of our common stock are available for future issuance under the Amended Employee Stock Purchase Plan, or ESPP. The ESPP permits eligible employees to purchase up to <ix:nonFraction unitRef="shares" contextRef="i747d4f67a97149e1a99e9c59c6e2de2d_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzE3NzM_a4f60d17-0c07-47b1-8a0e-b3d6190e067c">1,250</ix:nonFraction> shares of Ligand common stock per calendar year at a discount through payroll deductions. The price at which stock is purchased under the ESPP is equal to <ix:nonFraction unitRef="number" contextRef="i747d4f67a97149e1a99e9c59c6e2de2d_D20220101-20221231" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzE5MzE_8274eda5-8e64-44ad-a91d-8d94ae719917">85</ix:nonFraction>% of the fair market value of the common stock on the first of a six month offering period or purchase date, whichever is lower. There were <ix:nonFraction unitRef="shares" contextRef="i747d4f67a97149e1a99e9c59c6e2de2d_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzU0OTc1NTgxNzQ5MQ_5c9dfd1a-7406-42d9-a5ac-9757cb8e123d">8,479</ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="icf5e0295a2234a42822346d8b0a38103_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzIwNzI_62a46b00-447c-40c9-96ab-c9e999907e66">8,448</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i2298a5c46c60467d9749217af84898cd_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzIwNzY_f7e6ac45-73d8-4848-a41e-9af095994748">6,455</ix:nonFraction> shares issued under the ESPP in 2022, 2021 and 2020, respectively. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2019, our Board of Directors approved a stock repurchase program authorizing the repurchase of up to $<ix:nonFraction unitRef="usd" contextRef="iac54b9d00e76487d9a441f663e698e18_I20190930" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzIyODc_72d66d47-ede1-473f-8468-c584f4df2c5f">500.0</ix:nonFraction> million of our common stock from time to time over a period of up to <ix:nonNumeric contextRef="i8364d475253b452d820d30294b040699_D20190901-20190930" name="us-gaap:StockRepurchaseProgramPeriodInForce1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzIzNDI_e2f438c3-ad2e-489e-868e-096de38a833f">three years</ix:nonNumeric>. This repurchase program expired in September 2022.   During the year ended December&#160;31, 2022 and 2021, we did <ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzI5ODQ_7b19a186-3446-4aca-831f-5525a51812a8"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzI5ODQ_a8ffe9ee-f192-4534-bde0-4d77f5cb7d0f">no</ix:nonFraction></ix:nonFraction>t repurchase any common stock, respectively. During the year ended December&#160;31, 2020, we repurchased <ix:nonFraction unitRef="shares" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzMwNTc_f3093cf5-04c5-405c-b6b6-ca182078f2e9">934,079</ix:nonFraction> shares for $<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzMwNzE_97a3d343-eb7e-4dfa-b0bc-2eab1180bb04">78.0</ix:nonFraction> million.  </span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">At-the Market Equity Offering Program</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2022, we filed a registration statement on Form S-3 (the &#8220;Shelf Registration Statement&#8221;), which became automatically effective upon filing, covering the offering of common stock, preferred stock, debt securities, warrants and units. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2022, we also entered into an At-The-Market Equity Offering Sales Agreement (the &#8220;Sales Agreement&#8221;) with Stifel, Nicolaus &amp; Company, Incorporated (the &#8220;Agent&#8221;), under which we may, from time to time, sell shares of our common stock having an aggregate offering price of up to $<ix:nonFraction unitRef="usd" contextRef="i73ee438cb9984aaa8e59bf39f453f651_I20220930" decimals="-3" name="lgnd:SaleOfStockAuthorizedOfferingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzEwOTk1MTE2NDExNzI_a694121d-763b-4c0b-9985-eeb24d46af16">100.0</ix:nonFraction>&#160;million in &#8220;at the market&#8221; offerings through the Agent (the </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9e53bffafb964b0493cdac25f214f4eb">&#8220;ATM Offering&#8221;). The Shelf Registration Statement included a prospectus covering the offering, issuance and sale of up to $<ix:nonFraction unitRef="usd" contextRef="i73ee438cb9984aaa8e59bf39f453f651_I20220930" decimals="-3" name="lgnd:SaleOfStockAuthorizedOfferingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzEwOTk1MTE2NDExODg_c232053d-1913-419d-bc18-b2690139d4ad">100.0</ix:nonFraction>&#160;million of our common stock from time to time through the ATM Offering. The shares to be sold under the Sales Agreement may be issued and sold pursuant to the Shelf Registration Statement. To date, we have not issued any shares of common stock in the ATM Offering.</ix:continuation></span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_115"></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.  <ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTUvZnJhZzozODBjZDU4MTZiMWI0NGRmYTdhNTdjMDViZTViODBmYS90ZXh0cmVnaW9uOjM4MGNkNTgxNmIxYjQ0ZGZhN2E1N2MwNWJlNWI4MGZhXzY3ODY_2bdab6cb-5bf4-4921-8d7c-2d70238a3592" continuedAt="ib6c6217c638a47ee954f344cb30ed50b" escape="true">Commitment and Contingencies: Legal Proceedings</ix:nonNumeric></span></div><ix:continuation id="ib6c6217c638a47ee954f344cb30ed50b"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record an estimate of a loss when the loss is considered probable and estimable. Where a liability is probable and there is a range of estimated loss and no amount in the range is more likely than any other number in the range, we record the minimum estimated liability related to the claim in accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As additional information becomes available, we assess the potential liability related to our pending litigation and revises our estimates. Revisions in our estimates of potential liability could materially impact our results of operations. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 31, 2019, we received three civil complaints filed in the U.S. District Court for the Northern District of Ohio on behalf of several Indian tribes. The Northern District of Ohio is the Court that the Judicial Panel on Multi-District Litigation (&#8220;JPML&#8221;) has assigned more than one thousand civil cases which have been designated as a Multi-District Litigation (&#8220;MDL&#8221;) and captioned In Re: National Prescription Opiate Litigation. The allegations in these complaints focus on the activities of defendants other than the Company and no individualized factual allegations have been advanced against us in any of the three complaints. We reject all claims raised in the complaints and intend to vigorously defend these matters. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CyDex, a wholly owned subsidiary of Ligand, and Baxter Healthcare Corp. (&#8220;Baxter&#8221;) are parties to a license agreement relating to Ligand&#8217;s Captisol&#174; technology and, more specifically, relating to Captisol&#174;-enabled Nexterone&#174; (amiodarone HCl premixed injection). CyDex contended that Baxter has not paid all of the royalties due to CyDex under the terms of the license agreement and Baxter contends that it has overpaid royalties for several years. On April 6, 2021, Baxter initiated an arbitration with AAA pursuant to the arbitration provision of the license agreement. On April 21, 2021, CyDex filed an answering statement and counterdemand. On December 2, 2021, Baxter filed an Amended Notice of Arbitration Demand seeking a declaration limiting the &#8220;royalty term&#8221; of the license agreement to &#8220;the later of i) the expiration of the licensed [p]atent; or ii) when there are no longer any CyDex patents listed in the Orange Book for [Nexterone&#174;].&#8221; Baxter later clarified its position, and asserted that royalties should have ceased being due upon the May 4, 2022 expiry of CyDex&#8217;s U.S. Patent No. 6,869,939. The parties conducted a three-day arbitration hearing May 24-26, 2022. In a September 9, 2022 Final Award, the Tribunal ruled in CyDex&#8217;s favor by (1) denying Baxter&#8217;s request for a partial refund of previously paid royalties, (2) granting CyDex&#8217;s request for underpaid royalties, and (3) concluding that &#8220;[g]oing forward Baxter shall pay CyDex&#8221; a royalty consistent with CyDex&#8217;s construction of the license agreement until, at least, the March 13, 2029 expiry of CyDex&#8217;s U.S. Patent No. 7,635,773. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 22, 2022, Pfenex Inc. (&#8220;Pfenex&#8221;), a wholly owned subsidiary of Ligand, received a notice of alleged breach from Beijing Kangchen Biological Technology Co., Ltd. (&#8220;Kangchen&#8221;) with respect to a Development and License Agreement , dated April 18, 2018, between Pfenex and Kangchen (&#8220;License Agreement&#8221;) pertaining to the development and commercialization of teriparatide in certain Southeast Asian countries. The allegations in the notice focused on the activities of Pfenex and other parties. On June 16, 2022, we rejected all claims raised by Kangchen in the notice. On June 24, 2022, Kangchen served Pfenex a notice of termination of the License Agreement and demanded initiation of the dispute resolution process in accordance with the License Agreement. On June 29, 2022, we again rejected all claims raised by Kangchen in the notice of termination and agreed to engage in the applicable dispute resolution process, including good faith negotiations between the parties. On October 20, 2022, we agreed to make a single lump sum payment to Kangchen in connection with a termination agreement that, among other things, terminates the License Agreement and releases all claims between the parties arising from the License Agreement. The payment was recorded as general and administrative expense during the year ended December&#160;31, 2022. A termination agreement between Pfenex and Kangchen went into effect in December 2022. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may also become subject to other legal proceedings or claims arising in the ordinary course of our business. We currently believe that none of the claims or actions pending against us is likely to have, individually or in the aggregate, a material adverse effect on our business, financial condition or results of operations. Given the unpredictability inherent in litigation, however, we cannot predict the outcome of these matters.</span></div></ix:continuation><div id="i98e6b87576d6446486a3b29533a5cf6a_118"></div><div style="margin-bottom:6pt;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzQ4NjM_f29b3e13-68a0-4a9d-99ee-99e5ae918ca5" continuedAt="i4418038da0fb4c219e430f49320e63ba" escape="true">Income Taxes</ix:nonNumeric></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4418038da0fb4c219e430f49320e63ba" continuedAt="i8961459d76c0422cbcfc3454b691ef94"><div style="margin-bottom:6pt"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzQ4NjQ_2f3c5e3b-5c82-4cc1-8ee3-a545ce15230c" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the income tax expense (benefit) for continuing operations are as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:66.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.092%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.833%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.092%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.686%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.094%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current expense (benefit):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzMtMS0xLTEtMTEyNjQw_b9573318-7ee3-4517-90d8-e0c9d2a5f992">10,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzMtMy0xLTEtMTEyNjQw_a709f56c-9e83-4fd3-a061-6fd8c6fc2712">460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzMtNS0xLTEtMTEyNjQw_8307aefc-def7-4343-a749-13712f29154f">10,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzQtMS0xLTEtMTEyNjQw_363068d3-6ab0-4b27-a201-b468e526379a">193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzQtMy0xLTEtMTEyNjQw_f62d1bf7-8bc0-4140-8fa4-8d19ff97944d">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzQtNS0xLTEtMTEyNjQw_503812ca-daa6-430d-9586-67d6a55ee032">541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzUtMS0xLTEtMTEyNjQw_a207bab6-9ad3-4b02-8a77-6ecc0815f06d">452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzUtMy0xLTEtMTEyNjQw_7b0d75e4-2024-4a87-993b-25382167597a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzUtNS0xLTEtMTEyNjQw_59e67a74-0961-42eb-83a9-7458d5324ac6">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzYtMS0xLTEtMTEyNjQw_2f540271-39fd-43a5-9248-7c8a09561ac1">10,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzYtMy0xLTEtMTEyNjQw_03a568ff-32f1-4960-b856-354890e31a29">438</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzYtNS0xLTEtMTEyNjQw_b8400e06-fa34-438f-976b-0884ea30e390">11,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred expense (benefit):</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzgtMS0xLTEtMTEyNjQw_7f84fdbe-d608-4852-8fca-e57a619f87da">3,656</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzgtMy0xLTEtMTEyNjQw_cdaf260c-33bf-468f-8147-ebc9904b128d">2,901</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzgtNS0xLTEtMTEyNjQw_9a5ea8ff-4818-4a52-a081-893c4c6d98f1">13,456</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzktMS0xLTEtMTEyNjQw_b1f66634-7b45-4695-bfa6-ba6a7843b535">34,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzktMy0xLTEtMTEyNjQw_1309601e-ba28-4b85-ab8f-182b1c46fb5a">1,685</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzktNS0xLTEtMTEyNjQw_06166449-0c1b-43f2-ae1b-86afe5ef212a">3,234</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzEwLTEtMS0xLTExMjY0MA_825fbe05-b16a-4eff-af49-c62ddc112644">30,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzEwLTMtMS0xLTExMjY0MA_852e95dc-05e6-43a9-a84b-2c9585602063">4,586</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzEwLTUtMS0xLTExMjY0MA_a0bdf08a-f244-4a19-8be0-a6a1ca75caef">16,690</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax expense (benefit)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzExLTEtMS0xLTExMjY0MA_b3dec597-bb33-48f6-bd0a-5af7a7310a72">41,230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzExLTMtMS0xLTExMjY0MA_fa17537a-821e-409f-a77b-0710d8574d9b">4,148</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzExLTUtMS0xLTExMjY0MA_cbd0470e-e84a-4f1d-9835-e420ac81730e">5,306</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzQ4NjY_54085fca-97af-4551-8e1f-48697cd520c2" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of income tax expense (benefit) from continuing operations to the amount computed by applying the statutory federal income tax rate to the net income (loss) from continuing operations is summarized as follows (in thousands):</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:66.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.048%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax at federal statutory rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzItMS0xLTEtMTEyNjQw_7490f567-4deb-4909-aebc-f3517063aae6">7,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzItMy0xLTEtMTEyNjQw_547c2b85-bbcb-493d-8086-8cffcedc8e00">15,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzItNS0xLTEtMTEyNjQw_c7b2b1e2-e612-453a-8aee-6fc8ea44b51d">272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzMtMS0xLTEtMTEyNjQw_5340467b-a148-4aa3-b77e-fdce617a4e05">264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzMtMy0xLTEtMTEyNjQw_14a3a635-7590-4ad9-a0c0-fd7813216bd2">82</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzMtNS0xLTEtMTEyNjQw_89c94d5d-d329-4aff-9a5e-66ef609cc063">1,231</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FDII</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:EffectiveIncomeTaxRateReconciliationFdiiAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzQtMS0xLTEtMTQxMzE0_fc513c1a-ecdc-4b55-bfa9-384af50b68c8">2,395</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:EffectiveIncomeTaxRateReconciliationFdiiAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzQtMy0xLTEtMTQxMzE0_c6a98e47-d158-479e-8414-8f41d25503fe">637</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:EffectiveIncomeTaxRateReconciliationFdiiAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzQtNS0xLTEtMTQxMzE0_4667b1a2-ced7-4941-b489-aa938e739104">1,652</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate change for changes in federal, foreign or state law</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzUtMS0xLTEtMTQxMzI0_65fd1631-498d-4d4d-842e-aa5214c84577">535</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzUtMy0xLTEtMTQxMzI0_9e7d3e1b-c625-4135-b966-2d61d3375b5b">7,963</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzUtNS0xLTEtMTQxMzI0_cfec9402-73cd-48f1-9eb1-098aed77c2db">164</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="lgnd:EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzYtMS0xLTEtMTQxMzM0_ac220273-5a83-459e-a6db-a2a5c88696ef">158</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" sign="-" name="lgnd:EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzYtMy0xLTEtMTQxMzM0_e3c85b01-bc90-4603-9cde-0206418c93a9">480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="lgnd:EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzYtNS0xLTEtMTQxMzM0_41e2e8a1-fff7-4033-8f94-d092b31ccbe7">673</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale of Vernalis R&amp;D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxReconciliationDispositionOfBusiness" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzctMS0xLTEtMTEyNjQw_58d270bf-35f1-40e1-a9e1-e16c4437cc93">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationDispositionOfBusiness" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzctMy0xLTEtMTEyNjQw_eb0fbe29-5dc3-435e-ae48-3ab9da297886">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationDispositionOfBusiness" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzctNS0xLTEtMTEyNjQw_2c48fbda-cfaf-4281-b8fd-a68c86249c8c">127,372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="lgnd:IncomeTaxReconciliationContingentValueRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzgtMS0xLTEtMTEyNjQw_1b977afd-a031-4e1c-81fe-ed6d7abb4583">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" sign="-" name="lgnd:IncomeTaxReconciliationContingentValueRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzgtMy0xLTEtMTEyNjQw_c691afba-3e09-47ad-84c2-0f6f5d90fee3">7,993</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="lgnd:IncomeTaxReconciliationContingentValueRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzgtNS0xLTEtMTEyNjQw_6a921937-0d9c-4f1f-8cba-d3aeae73dc27">266</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax differential on income/loss of foreign subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzktMS0xLTEtMTEyNjQw_05c355ed-a124-4a5d-8525-1b341552db91">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzktMy0xLTEtMTEyNjQw_a3479493-b59b-44ed-b32f-e755965dd9cc">114</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzktNS0xLTEtMTEyNjQw_a96cd0e0-8df6-417e-9da0-a9c75f4b4fc4">3,839</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="lgnd:EffectiveIncomeTaxRateReconciliationExpiredTaxCreditsResearch" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzEwLTEtMS0xLTExMjY0MA_b827b851-87bf-4392-b947-852675ea6b59">256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" sign="-" name="lgnd:EffectiveIncomeTaxRateReconciliationExpiredTaxCreditsResearch" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzEwLTMtMS0xLTExMjY0MA_878dc462-9ce1-498d-bf9b-d2653daec16f">1,628</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="lgnd:EffectiveIncomeTaxRateReconciliationExpiredTaxCreditsResearch" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzEwLTUtMS0xLTExMjY0MA_ac970280-5ba6-44e8-89f2-6c06a048c9e1">168</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="lgnd:EffectiveIncomeTaxRateReconciliationDebtRepurchasesAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzExLTEtMS0xLTExMjY0MA_668863e2-14d5-4512-abfc-5c330993859f">626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="lgnd:EffectiveIncomeTaxRateReconciliationDebtRepurchasesAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzExLTMtMS0xLTExMjY0MA_788edf00-1135-4542-9d82-b59a26e782cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="lgnd:EffectiveIncomeTaxRateReconciliationDebtRepurchasesAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzExLTUtMS0xLTExMjY0MA_f2ead9c8-25e7-4b66-b891-a248b3e3c96d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subpart F income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="lgnd:EffectiveIncomeTaxRateReconciliationOtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzEyLTEtMS0xLTExMjY0MA_ce22b93e-c6b8-43e8-931f-61def4901039">853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="lgnd:EffectiveIncomeTaxRateReconciliationOtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzEyLTMtMS0xLTExMjY0MA_6f047e18-4ede-49ed-a210-be4ae2741585">1,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="lgnd:EffectiveIncomeTaxRateReconciliationOtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzEyLTUtMS0xLTExMjY0MA_f84e316b-45e8-4818-9675-4c3b8076fcf8">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzE2LTEtMS0xLTE0MTA4MA_432e80ef-58b3-4ff6-9bca-b41e01650ffc">1,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzE2LTMtMS0xLTE0MTEzMQ_56e30abf-5718-46be-9bf6-e82fb58a5d5d">12,080</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzE2LTUtMS0xLTE0MTEzOA_f4b78a06-2fa4-49c2-95fc-4007391acd13">623</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision to return adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" sign="-" name="lgnd:EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzE3LTEtMS0xLTE0MTA4Nw_af2e7d16-c515-4ff3-8bdc-c358992b8982">2,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="lgnd:EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzE3LTMtMS0xLTE0MTA5NA_e08de744-92c2-4297-9693-5f82667d3a11">1,347</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="lgnd:EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzE3LTUtMS0xLTE0MTEwMQ_2f0504c3-31cd-4eb8-8d7a-9c7260c2f0b1">5,920</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Officer compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="lgnd:EffectiveIncomeTaxRateReconciliationOfficerCompensationAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzE4LTEtMS0xLTE0MTEwOA_dc6c60c0-e0aa-44c4-9e93-a0933319ff44">5,869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="lgnd:EffectiveIncomeTaxRateReconciliationOfficerCompensationAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzE4LTMtMS0xLTE0MTExNw_daf83051-cb1a-4c31-9d79-110cdc8a3b63">3,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="lgnd:EffectiveIncomeTaxRateReconciliationOfficerCompensationAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzE4LTUtMS0xLTE0MTEyNA_4d44aaf6-d6f3-407f-af2f-710b951ea81a">2,410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzE2LTEtMS0xLTExMjY0MA_89835f26-0699-4ba4-bc48-752c0881c0bf">24,799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzE2LTMtMS0xLTExMjY0MA_578e7a59-291b-4a0b-bf10-1680cc88ea91">11,245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzE2LTUtMS0xLTExMjY0MA_0f53f36d-a29b-4beb-b8ad-2acd5e652dc1">121,864</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzIxLTEtMS0xLTE0MTM0NA_6a54da90-f6d7-4964-969c-126c26fede8f">460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzIxLTMtMS0xLTE0MTM0NA_5232d83d-1b67-4e79-a4f8-1bcc23042a45">3,823</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzIxLTUtMS0xLTE0MTM0NA_87c0a685-b911-43a3-828d-d6e322c1a2a0">1,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzE3LTEtMS0xLTExMjY0MA_24dc9b24-d5df-4c82-a792-b013bbb50ae0">41,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzE3LTMtMS0xLTExMjY0MA_89854f17-24bd-4eb7-b838-1fc335a82e3d">4,148</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzE3LTUtMS0xLTExMjY0MA_058f6545-2b80-40e8-b0f9-b8d1098b0dee">5,306</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We remeasured certain deferred tax assets and liabilities based on the rates at which they are expected to reverse in the future, which is generally 21%. Significant components of our deferred tax assets and liabilities as of December&#160;31, 2022 and 2021 are shown below. We assess the positive and negative evidence to determine if sufficient future taxable income will be generated to use the existing deferred tax assets. Our evaluation of evidence resulted in management concluding that the majority of our deferred tax assets will be realized. However, we maintain a valuation allowance to offset certain net deferred tax assets as management believes realization of such assets are uncertain as of December&#160;31, 2022, 2021 and 2020. The valuation allowance increased $<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzExMTI_a51ff14e-109a-4474-9b82-3856072d9bb1">21.5</ix:nonFraction> million in 2022, increased $<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzExMzQ_5343ccd5-e994-43a1-9de9-3fdb78a985dd">11.4</ix:nonFraction> million in 2021 and decreased $<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzExNTk_6107ca0c-71c1-4696-93bc-9d145cc5f876">116.5</ix:nonFraction> million in 2020.  </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offset all deferred tax assets and liabilities by jurisdiction, as well as any related valuation allowance, and present them on our consolidated balance sheet as a non-current deferred income tax asset or liability (as applicable). <ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzQ4NjA_baea4a84-45fc-43f6-8040-c781c5a475cb" continuedAt="id91a17036fb4483393a12c024a94d4b2" escape="true">Deferred tax assets </ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i8961459d76c0422cbcfc3454b691ef94" continuedAt="ic5709243997048c3b9e96a92b05900d6"><div style="margin-bottom:6pt"><ix:continuation id="id91a17036fb4483393a12c024a94d4b2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(liabilities) are comprised of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.807%"><tr><td style="width:1.0%"></td><td style="width:76.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.662%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.813%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzQtMS0xLTEtMTEyNjQw_792df382-e415-43b0-82ab-bcad0b7c97bf">53,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzQtMy0xLTEtMTEyNjQw_45f83502-b146-498e-b665-940bd74e8a17">63,471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzUtMS0xLTEtMTEyNjQw_a43493d0-eda2-4896-bbf7-cb25c9591708">26,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzUtMy0xLTEtMTEyNjQw_3634ed4f-210b-4888-8ae1-fc0ea083e0d4">26,908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzYtMS0xLTEtMTEyNjQw_7d317011-3e5d-4dc6-8da0-f1151165bc77">11,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzYtMy0xLTEtMTEyNjQw_4da5e617-edbb-4f48-8fde-be0f188233e0">9,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzctMS0xLTEtMTEyNjQw_7af50f17-f308-4fa3-9491-5d919192e62c">19,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzctMy0xLTEtMTEyNjQw_f84178ff-c451-4960-9a99-f4d6bac7cf82">12,989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzgtMS0xLTEtMTEyNjQw_52c06fd9-063d-4373-a8a7-973c1bda02c9">110,969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzgtMy0xLTEtMTEyNjQw_2dd8b681-7c12-4846-b5e5-3a27e297c9e9">113,111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance for deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzktMS0xLTEtMTEyNjQw_571e29ed-c480-4516-b9fc-b8bd486316a3">57,472</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzktMy0xLTEtMTEyNjQw_1e9f2bfa-fcec-4196-b967-1858070ea02f">35,931</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzEwLTEtMS0xLTExMjY0MA_b7849a31-9577-4933-9448-33254f7e80a3">53,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzEwLTMtMS0xLTExMjY0MA_1ce126d9-fd48-45bd-855f-c8d897ffe4b3">77,180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:13pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identified intangibles</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="lgnd:DeferredTaxLiabilitiesFiniteLivedIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzEzLTEtMS0xLTExMjY0MA_f8758714-ff65-4b6d-bba6-95ae1b697459">64,696</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="lgnd:DeferredTaxLiabilitiesFiniteLivedIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzEzLTMtMS0xLTExMjY0MA_153a0a76-1c18-429d-b050-01654c6f7fa5">66,848</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzE0LTEtMS0xLTExMjY0MA_b593224d-6ed3-4f91-8e54-37c2cf08f0df">10,886</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzE0LTMtMS0xLTExMjY0MA_799dd124-1ded-43f2-9520-64c39765609b">5,459</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzE1LTEtMS0xLTExMjY0MA_98a29762-6a02-447e-97f4-d4a410e51d9e">75,582</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzE1LTMtMS0xLTExMjY0MA_ee2bea64-6646-492b-8fa4-8ba6771823ca">72,307</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:13pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzE3LTEtMS0xLTExMjY0MA_0d7763ba-3845-434f-8e61-dcf288444d20">22,085</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzE3LTMtMS0xLTExMjY0MA_a03aec17-9c7a-4730-80f6-b8e5ffa3e34e">4,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in 2022, the Tax Cuts and Jobs Act of 2017 requires taxpayers to capitalize and amortize R&amp;D expenditures over five years for domestic research and 15 years for foreign research pursuant to Section 174 of the Internal Revenue Code of 1986, as amended. We recorded an increase of $<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-5" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzQzOTgwNDY1MjE5MzA_790148a9-824f-4edf-98c6-0b08cae1d922">4.7</ix:nonFraction>&#160;million to our current federal income tax expense and deferred tax assets for continuing operations during 2022 due to the capitalization of R&amp;D under Section 174. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of December&#160;31, 2022, we had federal net operating loss carryforwards set to expire through 2037 of $<ix:nonFraction unitRef="usd" contextRef="i4e9e56a3dff444f1b28980b0d2c80207_I20221231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzE1NjM_2b402356-73ff-4072-b46c-1347f945f9cf">81.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7793ca8a70014fca9041f46a2bcbbb00_I20221231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzE1NzA_cda957a5-3ff8-4537-9978-d5b4f5f5384a">168.3</ix:nonFraction> million of state net operating loss carryforwards that begin to expire in 2028. We also have $<ix:nonFraction unitRef="usd" contextRef="i4d2fbdca41684dfa9a100d455115d767_I20221231" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzE2NTY_b9709fb4-48a0-492f-85f4-c9ac575cb1fd">8.5</ix:nonFraction> million of federal research and development credit carryforwards, which expire through 2040. We have $<ix:nonFraction unitRef="usd" contextRef="iff27bbd909ef454a889168bc2e1dc2ab_I20221231" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzE3NTA_c8c06cf2-e05d-43a3-aa98-761f42bb85fc">29.0</ix:nonFraction> million of California research and development credit carryforwards that have no expiration date. In addition, we have approximately $<ix:nonFraction unitRef="usd" contextRef="ia1547d40c4f44431b0ac46de39c392f7_I20221231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzE4Nzg_d94b34a2-df63-4c02-98e5-237da68f376e">96.1</ix:nonFraction> million of non-U.S. net operating loss carryovers and approximately $<ix:nonFraction unitRef="usd" contextRef="i761a3b7f76b64061bb3f971fa489c7c9_I20221231" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzE5NDE_76f6618b-dacd-4c92-829f-aadf27ebc911">15.6</ix:nonFraction> million of non-U.S. capital loss carryovers that have no expiration date. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021 we had federal net operating loss carryforwards set to expire through 2037 of  $<ix:nonFraction unitRef="usd" contextRef="i52ab528f20684598afd7cd8e8d6192f8_I20211231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzIwNTI_6a2a2681-8d5e-4316-a802-04f091d4988a">117.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i1e13a6f6bcd64e4eba32eae14ed422df_I20211231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzIxMTU_43836ae3-a2b3-497e-a563-711378abddc0">170.1</ix:nonFraction>&#160;million of state net operating loss carryforwards that begin to expire in 2028. We also had $<ix:nonFraction unitRef="usd" contextRef="i9181deee2e7d45b3a86be0f8af806dcc_I20211231" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzU0OTc1NTgyMTEwNQ_f703d922-47e6-44ab-9a8b-396ad37ec2e6">9.3</ix:nonFraction> million in federal research and development credit carryforwards, which expire through 2040, and $<ix:nonFraction unitRef="usd" contextRef="ib4dfcde4db4a4453ae87a69ae3dc6bb1_I20211231" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzU0OTc1NTgyMTIzNw_4250dcc6-4c20-4760-9794-360fe09e8f22">29.0</ix:nonFraction> million of California research and development credit carryforwards that have no expiration date. In addition, we had approximately $<ix:nonFraction unitRef="usd" contextRef="i8e5c23045c2d4ab0af6422e7ac56c5dd_I20211231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzU0OTc1NTgyMTQwMQ_8b6a4046-1e15-4c69-82cc-81c6e338deaf">101.6</ix:nonFraction> million of non-U.S. capital loss carryovers and approximately $<ix:nonFraction unitRef="usd" contextRef="i6f417214d42c4bd5a425fd3e6b350310_I20211231" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzU0OTc1NTgyMTY0Mw_b8726df6-b605-4424-839f-c2e5379f17d2">17.5</ix:nonFraction> million of non-U.S. capital loss carryovers that have no expiration date. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Section 382 and 383 of the Internal Revenue Code of 1986, as amended, utilization of our net operating losses and credits may be subject to annual limitations in the event of any significant future changes in its ownership structure. These annual limitations may result in the expiration of net operating losses and credits prior to utilization. The deferred tax assets as of December&#160;31, 2022 are net of any previous limitations due to Section 382 and 383.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for income taxes by evaluating a probability threshold that a tax position must meet before a financial statement benefit is recognized. The minimum threshold is a tax position that is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. Our remaining liabilities for uncertain tax positions are presented net of the deferred tax asset balances on the accompanying consolidated balance sheet.</span></div><div style="margin-bottom:6pt"><ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzQ4NjI_7acae623-6281-488c-aff1-7c9d848b0b4f" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the amount of unrecognized tax benefits at December&#160;31, 2022, 2021 and 2020 is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo3Y2EwN2RmNGY1OTg0ZDU4YWU4MWI3OWE3NzZlMzYwZi90YWJsZXJhbmdlOjdjYTA3ZGY0ZjU5ODRkNThhZTgxYjc5YTc3NmUzNjBmXzItMS0xLTEtMTM4NTg1_6ed09bc2-c090-44cf-8e07-01d982797fca">29,550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo3Y2EwN2RmNGY1OTg0ZDU4YWU4MWI3OWE3NzZlMzYwZi90YWJsZXJhbmdlOjdjYTA3ZGY0ZjU5ODRkNThhZTgxYjc5YTc3NmUzNjBmXzItMS0xLTEtMTEyNjQw_22eb46a5-5189-437a-8a78-f076c3c14a0d">31,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i859e9607437a43d8adb4d3dc08e60773_I20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo3Y2EwN2RmNGY1OTg0ZDU4YWU4MWI3OWE3NzZlMzYwZi90YWJsZXJhbmdlOjdjYTA3ZGY0ZjU5ODRkNThhZTgxYjc5YTc3NmUzNjBmXzItMy0xLTEtMTEyNjQw_6cc5d6b6-d56f-4b86-9da9-b095a592077c">28,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Additions based on tax positions related to the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo3Y2EwN2RmNGY1OTg0ZDU4YWU4MWI3OWE3NzZlMzYwZi90YWJsZXJhbmdlOjdjYTA3ZGY0ZjU5ODRkNThhZTgxYjc5YTc3NmUzNjBmXzMtMS0xLTEtMTM3MjY4_15c0e019-22c0-4267-9d02-8779790523fc">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo3Y2EwN2RmNGY1OTg0ZDU4YWU4MWI3OWE3NzZlMzYwZi90YWJsZXJhbmdlOjdjYTA3ZGY0ZjU5ODRkNThhZTgxYjc5YTc3NmUzNjBmXzMtMS0xLTEtMTEyNjQw_f15a61e3-6552-453e-b743-e11149f6a333">252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo3Y2EwN2RmNGY1OTg0ZDU4YWU4MWI3OWE3NzZlMzYwZi90YWJsZXJhbmdlOjdjYTA3ZGY0ZjU5ODRkNThhZTgxYjc5YTc3NmUzNjBmXzMtMy0xLTEtMTEyNjQw_2ca48ce7-34f4-4f9c-9b16-4ff4cbe33d72">3,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Additions for tax positions of prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo3Y2EwN2RmNGY1OTg0ZDU4YWU4MWI3OWE3NzZlMzYwZi90YWJsZXJhbmdlOjdjYTA3ZGY0ZjU5ODRkNThhZTgxYjc5YTc3NmUzNjBmXzQtMS0xLTEtMTM3MjY4_8ea570af-a9f4-4ce1-a1bf-c20d89c3778e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo3Y2EwN2RmNGY1OTg0ZDU4YWU4MWI3OWE3NzZlMzYwZi90YWJsZXJhbmdlOjdjYTA3ZGY0ZjU5ODRkNThhZTgxYjc5YTc3NmUzNjBmXzQtMS0xLTEtMTEyNjQw_fc5e7f58-f2f2-4f78-961f-91490cc3edc5">751</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo3Y2EwN2RmNGY1OTg0ZDU4YWU4MWI3OWE3NzZlMzYwZi90YWJsZXJhbmdlOjdjYTA3ZGY0ZjU5ODRkNThhZTgxYjc5YTc3NmUzNjBmXzQtMy0xLTEtMTEyNjQw_bd339102-10d1-4fce-bf96-a191f5fc209c">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Reductions for tax positions of prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo3Y2EwN2RmNGY1OTg0ZDU4YWU4MWI3OWE3NzZlMzYwZi90YWJsZXJhbmdlOjdjYTA3ZGY0ZjU5ODRkNThhZTgxYjc5YTc3NmUzNjBmXzUtMS0xLTEtMTM3MjY4_939613db-e7c6-4ed4-9ce7-88c0ba1a13e7">512</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo3Y2EwN2RmNGY1OTg0ZDU4YWU4MWI3OWE3NzZlMzYwZi90YWJsZXJhbmdlOjdjYTA3ZGY0ZjU5ODRkNThhZTgxYjc5YTc3NmUzNjBmXzUtMS0xLTEtMTEyNjQw_58174f2a-5c38-414d-8856-f84412db3ea0">3,072</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo3Y2EwN2RmNGY1OTg0ZDU4YWU4MWI3OWE3NzZlMzYwZi90YWJsZXJhbmdlOjdjYTA3ZGY0ZjU5ODRkNThhZTgxYjc5YTc3NmUzNjBmXzUtMy0xLTEtMTEyNjQw_dca67072-e84e-48d7-b1ea-b9b166ae172a">954</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo3Y2EwN2RmNGY1OTg0ZDU4YWU4MWI3OWE3NzZlMzYwZi90YWJsZXJhbmdlOjdjYTA3ZGY0ZjU5ODRkNThhZTgxYjc5YTc3NmUzNjBmXzYtMS0xLTEtMTM4NTg1_fd3ff5c2-8562-40ec-b241-4db25dc2de6a">29,096</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo3Y2EwN2RmNGY1OTg0ZDU4YWU4MWI3OWE3NzZlMzYwZi90YWJsZXJhbmdlOjdjYTA3ZGY0ZjU5ODRkNThhZTgxYjc5YTc3NmUzNjBmXzYtMS0xLTEtMTEyNjQw_519d014e-67fb-4297-846a-a6986c607537">29,550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo3Y2EwN2RmNGY1OTg0ZDU4YWU4MWI3OWE3NzZlMzYwZi90YWJsZXJhbmdlOjdjYTA3ZGY0ZjU5ODRkNThhZTgxYjc5YTc3NmUzNjBmXzYtMy0xLTEtMTEyNjQw_22eb46a5-5189-437a-8a78-f076c3c14a0d">31,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="text-indent:24pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic5709243997048c3b9e96a92b05900d6"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in the balance of unrecognized tax benefits at December&#160;31, 2022 is $<ix:nonFraction unitRef="usd" contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzM4MTQ_52109afa-148d-453e-9dd2-82ac44ce3f98">27.3</ix:nonFraction> million of tax benefits that, if recognized would impact the effective rate. There are no positions for which it is reasonably possible that the uncertain tax benefit will significantly increase or decrease within twelve months.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We recognize interest and penalties related to uncertain tax positions in income tax expense. As of December&#160;31, 2022 and December&#160;31, 2021, we recognized an immaterial amount of interest and penalties. We file income tax returns in the United States, various state jurisdictions, United Kingdom, and Canada with varying statutes of limitations. The federal statute of limitation remains open for the 2019 tax year to the present.&#160;The state income tax returns generally remain open for the 2018 tax year through the present.&#160;Net operating loss and research credit carryforwards arising prior to these years are also open to examination if and when utilized. The Ligand California tax returns for 2019 and 2020 are currently under audit. We believe our reserve for unrecognized tax benefits and contingent tax issues is adequate with respect to all open years.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">86</span></div></div></div><div id="i98e6b87576d6446486a3b29533a5cf6a_742"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:QuarterlyFinancialInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90ZXh0cmVnaW9uOjBhMzU5M2RhMTgzMjQzNmY5MGM0NmVlNjVjYjBhMWFjXzI3NDg3NzkwNzIzOTI_258627c1-c4f4-4a38-944a-7f23983a716b" continuedAt="i883ee12301864a4b960bd9132d405822" escape="true">Selected Quarterly Financial Data (Unaudited)</ix:nonNumeric></span></div><ix:continuation id="i883ee12301864a4b960bd9132d405822"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table contains quarterly financial information for 2022 and 2021. The Company believes that the following information reflects all normal recurring adjustments necessary for a fair presentation of the information for the periods presented. <ix:nonNumeric contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" name="us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90ZXh0cmVnaW9uOjBhMzU5M2RhMTgzMjQzNmY5MGM0NmVlNjVjYjBhMWFjXzI3NDg3NzkwNzIzOTM_0b61ffb2-711b-46b2-8411-12c412b3a745" continuedAt="ia931a479bba940feb475aad07d85ed38" escape="true">The operating results for any quarter are not necessarily indicative of results for any future period.</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ia931a479bba940feb475aad07d85ed38"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.832%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.313%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.313%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.313%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.313%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.316%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except per share data)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6992767e8dd8406c922375c93b5376c2_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzMtMS0xLTEtMTI0NDE1_a63f24d3-caa9-430b-bfa1-ae9cf3f42aeb">36,516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b403a13d95c4618a2a1ecf0b72f5ec3_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzMtMi0xLTEtMTI0NDE1_578bc1fb-d4d7-440f-a5f3-2e0461e4ff1f">50,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d788652aa45e480cac84774ce09ff_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzMtMy0xLTEtMTI0NDE1_e21f7742-8f30-41ea-9603-ba1a78596772">59,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f4b841dc87a45f4876ae68269b5ee3f_D20221001-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzMtNC0xLTEtMTI0NDE1_c46b1d54-c745-4ac5-8418-e0ebb48e25e2">50,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzMtNS0xLTEtMTI0NDE1_86d9af69-325a-44cd-b819-5e8558498e70">196,245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6992767e8dd8406c922375c93b5376c2_D20220101-20220331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzUtMS0xLTEtMTQwNDI0_b2227538-b803-4dc1-88a1-4d9c7f84a831">9,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b403a13d95c4618a2a1ecf0b72f5ec3_D20220401-20220630" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzUtMi0xLTEtMTQwNDI0_ffd0e0d6-dc4a-4621-b2ed-19cb37bc62e6">8,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d788652aa45e480cac84774ce09ff_D20220701-20220930" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzUtMy0xLTEtMTQwNDI0_0a9a523c-1c2d-4679-9e39-66f6bf4b4096">9,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f4b841dc87a45f4876ae68269b5ee3f_D20221001-20221231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzUtNC0xLTEtMTQwNDI0_953a013d-1761-4547-9360-74fc9bcbf133">9,197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzUtNS0xLTEtMTQwNzIz_ddf01d79-b4a5-47f3-8e5a-b5b1b3b79081">36,082</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6992767e8dd8406c922375c93b5376c2_D20220101-20220331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzYtMS0xLTEtMTQwNDI0_d1eb6e07-629c-4f28-9e40-c6d8fe08b724">11,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b403a13d95c4618a2a1ecf0b72f5ec3_D20220401-20220630" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzYtMi0xLTEtMTQwNDI0_44b20c72-ba6e-4238-901b-ee265f7fa9f8">12,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d788652aa45e480cac84774ce09ff_D20220701-20220930" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzYtMy0xLTEtMTQwNDI0_a781219b-b44b-4dd0-a454-8305650f7f26">14,920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f4b841dc87a45f4876ae68269b5ee3f_D20221001-20221231" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzYtNC0xLTEtMTQwNDI0_495f0acf-6396-4f3e-84e9-6ab012779053">31,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzYtNS0xLTEtMTQwNzIz_45401ac3-9f93-449d-8b95-be99a9406813">70,062</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6992767e8dd8406c922375c93b5376c2_D20220101-20220331" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzQtMS0xLTEtMTI0NDE1_6a265b1b-23be-4735-b9ff-86cef5fb622a">34,383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b403a13d95c4618a2a1ecf0b72f5ec3_D20220401-20220630" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzQtMi0xLTEtMTI0NDE1_b3e10cce-b58b-42d0-a10c-9ee181ed0231">41,464</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d788652aa45e480cac84774ce09ff_D20220701-20220930" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzQtMy0xLTEtMTI0NDE1_2b05e2ad-6b00-406a-af7e-dff690f80127">46,880</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f4b841dc87a45f4876ae68269b5ee3f_D20221001-20221231" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzQtNC0xLTEtMTI0NDE1_9b18a231-1a9f-4ccd-bbbc-55ebaa654605">70,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzQtNS0xLTEtMTI0NDE1_28eed8cc-6ceb-4ad5-9174-99fa0081fa95">193,208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6992767e8dd8406c922375c93b5376c2_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzYtMS0xLTEtMTI0NDE1_925389f8-54d7-4e68-bf2a-a538e2784c35">12,929</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b403a13d95c4618a2a1ecf0b72f5ec3_D20220401-20220630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzYtMi0xLTEtMTI0NDE1_61e52ea8-333a-408d-8ae1-360b8453c6c5">12,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d788652aa45e480cac84774ce09ff_D20220701-20220930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzYtMy0xLTEtMTI0NDE1_48cce4ef-38b0-4125-89d8-e23f6a751cf7">9,645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f4b841dc87a45f4876ae68269b5ee3f_D20221001-20221231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzYtNC0xLTEtMTI0NDE1_103e4b41-ff1f-4916-b231-2440cc295f54">14,534</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzYtNS0xLTEtMTI0NDE1_574da136-56ec-4273-b27d-7bb1e59d9d57">5,219</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss from discontinued operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6992767e8dd8406c922375c93b5376c2_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzctMS0xLTEtMTI0NDE1_7213a0a5-9846-46a5-8b4b-b06ea50855b4">2,456</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b403a13d95c4618a2a1ecf0b72f5ec3_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzctMi0xLTEtMTI0NDE1_589a941a-ded7-4f6e-8cc7-515bab7005b2">13,494</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d788652aa45e480cac84774ce09ff_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzctMy0xLTEtMTI0NDE1_76a8faee-8369-4578-b9b9-78cb7d30c139">9,241</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f4b841dc87a45f4876ae68269b5ee3f_D20221001-20221231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzctNC0xLTEtMTI0NDE1_92679411-9af0-47ce-8529-e8edb2649b54">2,951</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzctNS0xLTEtMTI0NDE1_ed7a978a-f8a1-4a14-bd1f-4061765f30a2">28,142</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6992767e8dd8406c922375c93b5376c2_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzgtMS0xLTEtMTI0NDE1_2ed89e6a-53cb-46dd-8d28-41bda84c8650">15,385</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b403a13d95c4618a2a1ecf0b72f5ec3_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzgtMi0xLTEtMTI0NDE1_feeb465b-18dc-441b-a6c2-fc03224cd628">895</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d788652aa45e480cac84774ce09ff_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzgtMy0xLTEtMTI0NDE1_ea49655d-48fe-48e5-b917-641dc912fe20">404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f4b841dc87a45f4876ae68269b5ee3f_D20221001-20221231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzgtNC0xLTEtMTI0NDE1_d58eb7e6-eeb2-444b-88f7-a4f0bd5d79ee">17,485</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzgtNS0xLTEtMTI0NDE1_30039bff-2b88-44cd-90ec-0834719cdbbc">33,361</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic net income (loss) from continuing operations per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i6992767e8dd8406c922375c93b5376c2_D20220101-20220331" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzktMS0xLTEtMTI0NDE1_8f3b4cba-59f5-4f58-ac06-1a2de0a8d453"><ix:nonFraction unitRef="usdPerShare" contextRef="i6992767e8dd8406c922375c93b5376c2_D20220101-20220331" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzktMS0xLTEtMTI0NDE1_c1aaea08-458d-42ef-a16b-3ba72095e6af">0.77</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2b403a13d95c4618a2a1ecf0b72f5ec3_D20220401-20220630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzktMi0xLTEtMTI0NDE1_57747f5b-c903-4ffe-8588-28a7c09e685b"><ix:nonFraction unitRef="usdPerShare" contextRef="i2b403a13d95c4618a2a1ecf0b72f5ec3_D20220401-20220630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzktMi0xLTEtMTI0NDE1_fa0ca5c3-3c18-40c0-be5c-b56ca2eed121">0.75</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i897d788652aa45e480cac84774ce09ff_D20220701-20220930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzktMy0xLTEtMTI0NDE1_53b35d2e-d70c-445a-9240-0244318b62f6"><ix:nonFraction unitRef="usdPerShare" contextRef="i897d788652aa45e480cac84774ce09ff_D20220701-20220930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzktMy0xLTEtMTI0NDE1_6c4b6145-26a2-410d-a87a-4343bc1d20e8">0.57</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9f4b841dc87a45f4876ae68269b5ee3f_D20221001-20221231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzktNC0xLTEtMTI0NDE1_bdbb93b3-a446-4e8a-ae19-a4a8ce5b057f"><ix:nonFraction unitRef="usdPerShare" contextRef="i9f4b841dc87a45f4876ae68269b5ee3f_D20221001-20221231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzktNC0xLTEtMTI0NDE1_e0bb6f3e-c2ca-4f78-a680-50ea56462252">0.86</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzktNS0xLTEtMTI0NDE1_71898ad9-67c6-4674-9164-d6b05e8be192"><ix:nonFraction unitRef="usdPerShare" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzktNS0xLTEtMTI0NDE1_799255c5-cccf-4136-a82f-0078788d835a">0.31</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic net loss from discontinued operations per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i6992767e8dd8406c922375c93b5376c2_D20220101-20220331" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzEwLTEtMS0xLTEyNDQxNQ_22e2ad92-3ce8-4a5c-beb4-f29227c164b2"><ix:nonFraction unitRef="usdPerShare" contextRef="i6992767e8dd8406c922375c93b5376c2_D20220101-20220331" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzEwLTEtMS0xLTEyNDQxNQ_e2fd0ee1-ddf9-4a3f-bfc5-0bba96a6d176">0.15</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i2b403a13d95c4618a2a1ecf0b72f5ec3_D20220401-20220630" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzEwLTItMS0xLTEyNDQxNQ_2a41f966-f9e9-4ded-9fcb-4ece6866024e"><ix:nonFraction unitRef="usdPerShare" contextRef="i2b403a13d95c4618a2a1ecf0b72f5ec3_D20220401-20220630" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzEwLTItMS0xLTEyNDQxNQ_b786f5f5-c2ff-497c-932b-2e6b9ca4abb8">0.80</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i897d788652aa45e480cac84774ce09ff_D20220701-20220930" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzEwLTMtMS0xLTEyNDQxNQ_5a58cb9a-8177-480d-b899-08e341cc2109"><ix:nonFraction unitRef="usdPerShare" contextRef="i897d788652aa45e480cac84774ce09ff_D20220701-20220930" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzEwLTMtMS0xLTEyNDQxNQ_b682ffae-58eb-4cc8-978d-9a04351fb631">0.55</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9f4b841dc87a45f4876ae68269b5ee3f_D20221001-20221231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzEwLTQtMS0xLTEyNDQxNQ_5b212ab5-16ee-4f5e-be80-4f6ba3342e6a"><ix:nonFraction unitRef="usdPerShare" contextRef="i9f4b841dc87a45f4876ae68269b5ee3f_D20221001-20221231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzEwLTQtMS0xLTEyNDQxNQ_e28bafce-edfe-4459-a68b-c0a1aa7b964a">0.17</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzEwLTUtMS0xLTEyNDQxNQ_614e920e-7a87-4eb0-bb4f-96052564e804"><ix:nonFraction unitRef="usdPerShare" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzEwLTUtMS0xLTEyNDQxNQ_ce6e8e90-670d-407c-b63d-64e9f4e11d99">1.67</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted net income (loss) from continuing operations per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.86)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted net loss from discontinued operations per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.79)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.67)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares used in the computation of basic  net income (loss) per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6992767e8dd8406c922375c93b5376c2_D20220101-20220331" decimals="INF" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzE1LTEtMS0xLTE0MTU0Mg_2554957f-2c9b-49ed-9814-4a1e4f7d795e">16,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2b403a13d95c4618a2a1ecf0b72f5ec3_D20220401-20220630" decimals="INF" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzE1LTItMS0xLTE0MTU0Mg_2e01f794-d39f-4573-bde3-4b2d4e148dd6">16,868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i897d788652aa45e480cac84774ce09ff_D20220701-20220930" decimals="INF" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzE1LTMtMS0xLTE0MTU0Mg_d15dba41-c0f3-42e2-a927-d7dad8459bd9">16,888</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9f4b841dc87a45f4876ae68269b5ee3f_D20221001-20221231" decimals="INF" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzE1LTQtMS0xLTE0MTU0Mg_67eb6ad7-4cdc-4042-b4a3-6bf3594695af">16,890</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231" decimals="INF" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzE1LTUtMS0xLTE0MTU0Mg_f112d4c5-bbb9-4fd1-9233-c36c836bfd1b">16,868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares used in the computation of diluted  net income (loss) per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,058&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.832%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.313%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.313%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.313%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.313%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.316%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except per share data)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1be8c52ea4fa41c8b69ccfc9a0092bb8_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzQtMS0xLTEtMTMwMDA5_57174592-c55c-4c27-928d-32a55cecd487">46,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i290c867cc3064c3584ca75424dac7e37_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzQtMi0xLTEtMTMwMDA5_29e4a5c2-8964-4ad8-b315-606bbe3586ff">78,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85bfaefbe85344cbbe2d82fd78da0834_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzQtMy0xLTEtMTMwMDA5_e655bdf9-2e44-4e8a-a3ee-be0be14a5557">59,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic08f18c873f549b8b87bea293a4ae096_D20211001-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzQtNC0xLTEtMTMwMDA5_b2adade0-290c-4e25-94de-ddf85393f96b">56,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzQtNS0xLTEtMTM1ODcy_c1b3e1f8-5149-441d-9068-8df98557c4c8">241,544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1be8c52ea4fa41c8b69ccfc9a0092bb8_D20210101-20210331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzUtMS0xLTEtMTQwNDM0_4e0bef9c-c236-4c95-a646-cc79ead083db">9,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i290c867cc3064c3584ca75424dac7e37_D20210401-20210630" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzUtMi0xLTEtMTQwNDM0_91fbd95d-0685-41b5-8fd9-370dc82499c5">7,482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85bfaefbe85344cbbe2d82fd78da0834_D20210701-20210930" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzUtMy0xLTEtMTQwNDM0_50c8958e-9b20-4d7f-8e08-f7929346eb1a">7,430</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic08f18c873f549b8b87bea293a4ae096_D20211001-20211231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzUtNC0xLTEtMTQwNDM0_771b89d4-f56a-4b0f-9747-48d3429a4afd">8,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzUtNS0xLTEtMTQwNzI1_c1d124df-c22c-4fa4-ad6c-10e449a6a500">32,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1be8c52ea4fa41c8b69ccfc9a0092bb8_D20210101-20210331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzYtMS0xLTEtMTQwNDM0_2d36784d-e3f9-4f19-9305-5d552b2d2ac9">10,815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i290c867cc3064c3584ca75424dac7e37_D20210401-20210630" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzYtMi0xLTEtMTQwNDM0_c3cc1fd4-4ba6-4b46-acee-447ccfa4e80e">12,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85bfaefbe85344cbbe2d82fd78da0834_D20210701-20210930" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzYtMy0xLTEtMTQwNDM0_f241ace6-477a-48ba-8b9c-3035000a6315">10,967</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic08f18c873f549b8b87bea293a4ae096_D20211001-20211231" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzYtNC0xLTEtMTQwNDM0_d1a4e4ec-9ccf-439a-b511-79096f29c9a1">12,596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzYtNS0xLTEtMTQwNzI1_f4fd23c8-74cc-4771-9aa1-3774bb46a262">46,790</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1be8c52ea4fa41c8b69ccfc9a0092bb8_D20210101-20210331" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzUtMS0xLTEtMTMwMjMw_22295aa8-4e82-4653-99ee-525bb83b893b">36,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i290c867cc3064c3584ca75424dac7e37_D20210401-20210630" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzUtMi0xLTEtMTMwMjMw_df312fee-ca7e-42b3-9248-80d4f60e4716">24,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85bfaefbe85344cbbe2d82fd78da0834_D20210701-20210930" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzUtMy0xLTEtMTMwMjMw_ea139fb5-b9af-4f42-974a-86ac832d0eef">34,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic08f18c873f549b8b87bea293a4ae096_D20211001-20211231" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzUtNC0xLTEtMTMwMjMw_9ca31e38-b93b-4afa-86a4-06aa8d7c0a76">41,280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzUtNS0xLTEtMTMwMjMw_f304518c-afd3-4693-a918-5b63b0cd7846">137,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1be8c52ea4fa41c8b69ccfc9a0092bb8_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzYtMS0xLTEtMTMwMjMw_0a7ecf0d-5df8-4de6-a9eb-141a2ea4cf9f">22,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i290c867cc3064c3584ca75424dac7e37_D20210401-20210630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzYtMi0xLTEtMTMwMjMw_cce9dae9-49bc-4688-9de5-3f1cd2768f7b">36,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85bfaefbe85344cbbe2d82fd78da0834_D20210701-20210930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzYtMy0xLTEtMTMwMjMw_a63eaa7b-0c13-4642-915a-75b0cdcf20b0">20,338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic08f18c873f549b8b87bea293a4ae096_D20211001-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzYtNC0xLTEtMTMwMjMw_6651ff51-d2e0-4ef1-bf3a-6ed9a1ac609a">3,194</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzYtNS0xLTEtMTMwMjMw_b1225244-5df5-45f9-ba03-9249354fb487">76,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss from discontinued operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1be8c52ea4fa41c8b69ccfc9a0092bb8_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzctMS0xLTEtMTMwMjUw_dd57b433-d15f-4ed0-9d11-a1fa7f8f3d9c">4,660</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i290c867cc3064c3584ca75424dac7e37_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzctMi0xLTEtMTMwMjUw_f8612669-70c9-45f6-9d7f-2aa69e7fa522">5,717</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i85bfaefbe85344cbbe2d82fd78da0834_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzctMy0xLTEtMTMwMjUw_1cc3f0c7-ee27-488a-ab1b-20ccc6f5248f">6,615</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic08f18c873f549b8b87bea293a4ae096_D20211001-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzctNC0xLTEtMTMwMjUw_1da9654d-80b0-4c1b-bab3-9ff16c10783c">2,223</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzctNS0xLTEtMTM1ODcy_a3ae0e9c-b849-451c-a730-899c3ccbdcd6">19,215</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1be8c52ea4fa41c8b69ccfc9a0092bb8_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzgtMS0xLTEtMTMwMjUw_2d8e4d1c-a94f-4614-b2fc-5eadac0f1b29">18,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i290c867cc3064c3584ca75424dac7e37_D20210401-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzgtMi0xLTEtMTMwMjUw_4fd37cab-5743-48d5-9ebe-2da7a6471a57">30,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85bfaefbe85344cbbe2d82fd78da0834_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzgtMy0xLTEtMTMwMjUw_c6c970bf-0b70-4f05-84f3-fd095646f9cb">13,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic08f18c873f549b8b87bea293a4ae096_D20211001-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzgtNC0xLTEtMTMwMjUw_97297db2-be71-4b9e-bece-9b93f4a48c66">5,417</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzgtNS0xLTEtMTM1ODcy_193a13c9-1896-475c-aebf-b57c1e627aef">57,138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic net income (loss) from continuing operations per share </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1be8c52ea4fa41c8b69ccfc9a0092bb8_D20210101-20210331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzktMS0xLTEtMTMwMjU3_df8b0e62-0f4b-45bf-bdf8-cba9448eedba">1.39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i290c867cc3064c3584ca75424dac7e37_D20210401-20210630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzktMi0xLTEtMTMwMjU3_c827596f-00de-4b2c-91f5-00636e0e6cb2">2.19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i85bfaefbe85344cbbe2d82fd78da0834_D20210701-20210930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzktMy0xLTEtMTMwMjU3_842dcae8-6b5a-45a2-8fa6-f64d57bae4b3">1.22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic08f18c873f549b8b87bea293a4ae096_D20211001-20211231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzktNC0xLTEtMTMwMjU3_f22c8804-5fd2-42ae-8371-6805be5554b6">0.19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzktNS0xLTEtMTMwMjU3_3f168c5b-40ce-4666-bd90-5f6adeb6060c">4.59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic net loss from discontinued operations per share </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i1be8c52ea4fa41c8b69ccfc9a0092bb8_D20210101-20210331" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzEwLTEtMS0xLTEzMDI1Nw_97e5107d-ec2c-4ff5-9c3c-dc2f8b565de5">0.28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i290c867cc3064c3584ca75424dac7e37_D20210401-20210630" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzEwLTItMS0xLTEzMDI1Nw_2cb32623-a717-459c-82ce-2e200776c7d2">0.34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i85bfaefbe85344cbbe2d82fd78da0834_D20210701-20210930" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzEwLTMtMS0xLTEzMDI1Nw_83dc8c5f-493f-4361-88ac-5c55782cd673">0.40</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic08f18c873f549b8b87bea293a4ae096_D20211001-20211231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzEwLTQtMS0xLTEzMDI1Nw_c01cb890-f76e-46ad-ba68-5f6cbc108537">0.13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzEwLTUtMS0xLTEzMDI1Nw_f5be0ac5-1c8f-4a70-929b-54782e571744">1.16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted net income (loss) from continuing operations per share </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1be8c52ea4fa41c8b69ccfc9a0092bb8_D20210101-20210331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzExLTEtMS0xLTEzMDI1Nw_02fb4ddc-20ec-4d2d-8caf-4e7b40e6e3e1">1.32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i290c867cc3064c3584ca75424dac7e37_D20210401-20210630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzExLTItMS0xLTEzMDI1Nw_554cbf8a-3071-41df-bf34-0350d77ff094">2.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i85bfaefbe85344cbbe2d82fd78da0834_D20210701-20210930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzExLTMtMS0xLTEzMDI1Nw_b7864234-6b65-41e0-b894-e4ca69d9558c">1.19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic08f18c873f549b8b87bea293a4ae096_D20211001-20211231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzExLTQtMS0xLTEzMDI1Nw_aea6ef35-e97a-4cb6-9c0b-9b5dd74b57bb">0.19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzExLTUtMS0xLTEzMDI1Nw_7b4fef08-4dbb-4c6c-8fe6-b9c177939cb5">4.43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted net loss from discontinued operations per share </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i1be8c52ea4fa41c8b69ccfc9a0092bb8_D20210101-20210331" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzEyLTEtMS0xLTEzMDI1Nw_eab4e6dd-adca-453f-b5fc-ecec2bc7f5d9">0.27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i290c867cc3064c3584ca75424dac7e37_D20210401-20210630" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzEyLTItMS0xLTEzMDI1Nw_6c994cef-c2dd-4d09-9fcc-ac8629edbb14">0.33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i85bfaefbe85344cbbe2d82fd78da0834_D20210701-20210930" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzEyLTMtMS0xLTEzMDI1Nw_a9f4c9f0-7498-4aee-89a9-9bfb5e862ab3">0.39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic08f18c873f549b8b87bea293a4ae096_D20211001-20211231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzEyLTQtMS0xLTEzMDI1Nw_0e0b15d7-dc18-4b94-83b8-f8f0494fe306">0.13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzEyLTUtMS0xLTEzMDI1Nw_8c89e5ea-1c64-4941-84ea-f964af82e9af">1.11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares used in the computation of basic net income (loss) per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1be8c52ea4fa41c8b69ccfc9a0092bb8_D20210101-20210331" decimals="INF" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzEzLTEtMS0xLTEyOTk5Ng_f6064fd2-fe24-4603-8e48-1cf0c4226b24">16,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i290c867cc3064c3584ca75424dac7e37_D20210401-20210630" decimals="INF" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzEzLTItMS0xLTEyOTk5Ng_04cd9f1e-8d14-4b6e-93e4-1b68a23cd489">16,659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i85bfaefbe85344cbbe2d82fd78da0834_D20210701-20210930" decimals="INF" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzEzLTMtMS0xLTEyOTk5Ng_bacb38d0-0652-4862-b5c7-934b6aa1d598">16,688</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic08f18c873f549b8b87bea293a4ae096_D20211001-20211231" decimals="INF" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzEzLTQtMS0xLTEyOTk5Ng_abdfb500-9211-425b-8157-064708fcc840">16,733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="INF" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzEzLTUtMS0xLTEyOTk5Ng_904cb74a-ba73-4140-b221-6d800bd8e71d">16,630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares used in the computation of diluted net income (loss) per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1be8c52ea4fa41c8b69ccfc9a0092bb8_D20210101-20210331" decimals="INF" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzE0LTEtMS0xLTEyOTk5Ng_4b1c5032-2bf4-481b-a896-0d578f068b9e">17,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i290c867cc3064c3584ca75424dac7e37_D20210401-20210630" decimals="INF" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzE0LTItMS0xLTEyOTk5Ng_b3e2bd80-d0ed-4e4b-863e-36261df170f6">17,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i85bfaefbe85344cbbe2d82fd78da0834_D20210701-20210930" decimals="INF" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzE0LTMtMS0xLTEyOTk5Ng_0fe8a0b5-66c8-47b2-92cf-3ead6240f2a4">17,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic08f18c873f549b8b87bea293a4ae096_D20211001-20211231" decimals="INF" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzE0LTQtMS0xLTEyOTk5Ng_5dac1355-25c9-495c-99c8-1f782d620a80">16,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231" decimals="INF" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzE0LTUtMS0xLTEyOTk5Ng_02e206a7-017a-4727-93bd-e94b72dfefde">17,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">87</span></div></div></div><div id="i98e6b87576d6446486a3b29533a5cf6a_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:9.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.050%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;9.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></td></tr></table></div><div style="margin-top:5pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_124"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:9.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.050%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;9A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Controls and Procedures</span></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a) Evaluation of Disclosure Controls and Procedures</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are responsible for maintaining disclosure controls and procedures designed to provide reasonable assurance that information required to be disclosed in reports we file under the Exchange Act is recorded, processed, summarized and reported within the specified time periods and accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. The design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected. As of the end of the period covered by this Annual Report on Form 10-K, we have carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, and have concluded our disclosure controls and procedures were effective at a reasonable assurance level as of December&#160;31, 2022.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes in our internal control over financial reporting that occurred during the quarter ended December&#160;31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b) Management&#8217;s Report on Internal Control Over Financial Reporting</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management is responsible for establishing and maintaining adequate internal control over financial reporting for the Company. Internal control over financial reporting is a process to provide reasonable assurance regarding the reliability of our financial reporting for external purposes in accordance with accounting principles generally accepted in the United States of America. Internal control over financial reporting includes maintaining records that in reasonable detail accurately and fairly reflect our transactions; providing reasonable assurance that transactions are recorded as necessary for preparation of our financial statements in accordance with generally accepted accounting principles; providing reasonable assurance that receipts and expenditures are made in accordance with our management and directors; and providing reasonable assurance that</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">unauthorized acquisition, use or disposition of company assets that could have a material effect on our financial statements would be prevented or detected on a timely basis. Because of its inherent limitations, internal control over financial reporting is not intended to provide absolute assurance that a misstatement of our financial statements would be prevented or detected.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework established by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) as set forth in the 2013 Internal Control-Integrated Framework. Based on our evaluation under the 2013 framework in Internal Control - Integrated Framework, management concluded that our internal controls over financial reporting were effective as of December&#160;31, 2022.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ernst&#160;&amp; Young LLP, an independent registered public accounting firm, has audited the Company&#8217;s consolidated financial statements included in this Annual Report on Form 10-K and has issued an attestation report, included herein, on the effectiveness of our internal control over financial reporting as of December&#160;31, 2022.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Stockholders and Board of Directors of Ligand Pharmaceuticals Incorporated</span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on Internal Control Over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited Ligand Pharmaceuticals Incorporated&#8217;s internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, Ligand Pharmaceuticals Incorporated (the Company) maintained, in all material respects, effective internal control over financial reporting as of December 31, 2022, based on the COSO criteria.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2022 and 2021, the related consolidated statements of operations, comprehensive income (loss), stockholders&#8217; equity and cash flows for each of the three years in the period ended December 31, 2022, and the related notes and our report dated February 28, 2023 expressed an unqualified opinion thereon.</span></div><div><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management&#8217;s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion. </span></div><div><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control Over Financial Reporting </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Ernst &amp; Young LLP</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">San Diego, California</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;28, 2023</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">89</span></div></div></div><div id="i98e6b87576d6446486a3b29533a5cf6a_127"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.198%"><tr><td style="width:1.0%"></td><td style="width:28.330%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:69.470%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 9B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Information</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">      None</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">90</span></div></div></div><div id="i98e6b87576d6446486a3b29533a5cf6a_130"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.391%"><tr><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.111%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 9C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">91</span></div></div></div><div id="i98e6b87576d6446486a3b29533a5cf6a_133"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part III</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_136"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:9.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.050%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;10.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Directors, Executive Officers and Corporate Governance</span></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Code of Conduct</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Board of Directors has adopted a Code of Conduct and Ethics Policy (&#8220;Code of Conduct&#8221;) that applies to all officers, directors and employees. The Company will promptly disclose (1) the nature of any amendment to the Code of Conduct that applies to our principal executive officer, principal financial officer, principal accounting officer or controller or persons performing similar functions and (2) the nature of any waiver, including an implicit waiver, from a provision of our Code of Conduct that is granted to one of these specified officers, the name of such person who is granted the waiver and the date of the waiver on our website in the future. The Code of Conduct can be accessed via our website (http://www.ligand.com), Corporate Overview page. You may also request a free copy by writing to: Investor Relations, Ligand Pharmaceuticals Incorporated, 3911 Sorrento Valley Boulevard, Suite 110, San Diego, CA 92121.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The other information under Item&#160;10 is hereby incorporated by reference to Ligand&#8217;s Definitive Proxy Statement to be filed with the SEC within 120 days of December&#160;31, 2022.&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_139"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:9.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.050%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Executive Compensation</span></td></tr></table></div><div style="margin-top:5pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;11 is hereby incorporated by reference to Ligand&#8217;s Definitive Proxy Statement to be filed with the SEC within 120 days of December&#160;31, 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_142"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:9.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.050%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></td></tr></table></div><div style="margin-top:5pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;12 is hereby incorporated by reference to Ligand&#8217;s Definitive Proxy Statement to be filed with the SEC within 120 days of December&#160;31, 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_145"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:9.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.050%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;13.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Certain Relationships and Related Transactions, and Director Independence</span></td></tr></table></div><div style="margin-top:5pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;13 is hereby incorporated by reference to Ligand&#8217;s Definitive Proxy Statement to be filed with the SEC within 120 days of December&#160;31, 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_148"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:9.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.050%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;14.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Principal Accountant Fees and Services</span></td></tr></table></div><div style="margin-top:5pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;14 is hereby incorporated by reference to Ligand&#8217;s Definitive Proxy Statement to be filed with the SEC within 120 days of December&#160;31, 2022.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">92</span></div></div></div><div id="i98e6b87576d6446486a3b29533a5cf6a_151"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_154"></div><div style="-sec-extract:summary"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:9.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.050%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibits and Financial Statement Schedule</span></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a) The following documents are included as part of this Annual Report on Form 10-K.</span></div><div style="margin-top:9pt;padding-left:58.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Financial statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:91.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.672%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_58">Index to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_58">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_61">Report of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_61">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_64">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_64">50</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_67">Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_67">50</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_70">Consolidated Statements of Comprehensive Income (Loss)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_70">51</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_73">Consolidated Statements of Stockholders&#8217; Equity </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_73">53</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_76">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_76">53</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_79">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i98e6b87576d6446486a3b29533a5cf6a_79">55</a></span></div></td></tr></table></div><div style="margin-top:9pt;padding-left:58.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) Schedules not included herein have been omitted because they are not applicable or the required information is in the consolidated financial statements or notes thereto.</span></div><div style="margin-top:9pt;padding-left:58.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) The following exhibits are filed as part of this Form 10-K and this list includes the Exhibit Index.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.260%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exhibit</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Description of Exhibit</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">File Number</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date of Filing</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exhibit </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Filed </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Herewith</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616319000043/ex218k3519.htm">2.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset Purchase Agreement, dated March 5, 2019, by and among Ligand Pharmaceuticals Incorporated and RPI Financial Trust</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 5, 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000119312520215346/d79922dex21.htm">2.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Agreement and Plan of Merger, dated as of August 10, 2020, by and among Pfenex Inc., Ligand Pharmaceuticals Incorporated and Pelican Acquisition Sub, Inc.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 11, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616320000108/exhibit21vineyard-spae.htm">2.3*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Agreement for the Sale and Purchase of the Entire Issued Share Capital of Vernalis (R&amp;D) Limited, dated as of October 11, 2020, by and among Ligand Pharmaceuticals Incorporated, Vernalis Limited, HitGen UK Ltd and HitGen Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 13, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000119312522083443/d337089dex21.htm">2.4*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Agreement and Plan of Merger, dated as of March, 23, 2022, by and among Avista Public Acquisition Corp. II, Ligand Pharmaceuticals Incorporated, OmniAb, Inc. and Orwell Merger Sub Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 24, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000119312522083443/d337089dex22.htm">2.5*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Separation and Distribution Agreement, dated as of March 23, 2022, by and among Avista Public Acquisition Corp. II, Ligand Pharmaceuticals Incorporated and OmniAb, Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 24, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/0000936392-98-001000.txt">3.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amended and Restated Certificate of Incorporation of the Company. </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">S-4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">333-58823</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 9, 1998</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616301000008/0000886163-01-000008-0002.txt">3.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificate of Amendment of the Amended and Restated Certificate of Incorporation of the Company, dated June 14, 2000 </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0-20720</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 29, 2001</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616304000015/ex3-6.txt">3.3</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificate of Amendment of the Amended and Restated Certificate of Incorporation of the Company, dated June 30, 2004 </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0-20720</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 5, 2004</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000119312510264942/dex31.htm">3.4</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificate of Amendment of the Amended and Restated Certificate of Incorporation of the Company, dated November 17, 2010</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November&#160;19, 2010</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616319000157/exhibit36.htm">3.5</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificate of Amendment of the Amended and Restated Certification of Incorporation of the Company, dated June 19, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">S-8</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">333-233130</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 8, 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616320000116/exhibit31-ligandxfourt.htm">3.6</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fourth Amended and Restated Bylaws of the Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 30, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.260%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616318000030/lgndexhibi41.htm">4.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Specimen stock certificate for shares of the common stock of the Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 1, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616318000076/exhibit41.htm">4.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indenture, dated as of May 22, 2018, between the Company and Wilmington Trust, National Association, as trustee, including the form of 0.75% Convertible Senior Notes due 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 22, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616321000050/exhibit43_ligand-descripti.htm">4.3</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description of Registered Securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 24, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616322000038/ligand-2022annualmeetingpr.htm#i858b093ea9a44e01b80bfe450a9cebf2_350">10.1#</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2002 Stock Incentive Plan (as amended and restated effective June 10, 2022)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DEF 14A</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 22, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appendix A</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616319000063/lgnd-2019annualmeetingproxy.htm#sb6e62536bc644ccb9ea4178e9b4c6808">10.2#</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2002 Employee Stock Purchase Plan (as amended and restated effective June 6, 2019)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 24, 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appendix B</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616314000031/lgnd-ex105_optionagreement.htm">10.3#</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Form of Stock Option Grant Notice and Stock Option Agreement under the Company&#8217;s 2002 Stock Incentive Plan</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 24, 2014</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000095013706000420/a16037orexv10w289.txt">10.4#</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Form of Stock Issuance Agreement for non-employee directors under the Company&#8217;s 2002 Stock Incentive Plan</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">S-1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">333-131029</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January&#160;13, 2006</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.289</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616318000030/formofrsugrantnoticeexhibi.htm">10.5#</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement under the Company&#8217;s 2002 Stock Incentive Plan </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 1, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616318000030/lgnd-rsugrantnoticeperform.htm">10.6#</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement under the Company&#8217;s 2002 Stock Incentive Plan - Performance-Based RSU Form</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 1, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.7</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616307000132/ex10-1.txt">10.7#</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Form of Executive Officer Change in Control Severance Agreement </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August&#160;22, 2007</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit_108xligand-amended.htm">10.8#</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amended and Restated Severance Plan, effective November 1, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit_109xliganddirector.htm">10.9#</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director Compensation and Stock Ownership Policy, as amended and restated, effective April 13, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616322000117/exhibit_102xligand-2022ind.htm">10.10#*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022 Employment Inducement Plan</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 9, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616322000117/exhibit_103xligand-formofs.htm">10.11#*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Form of Stock Option Agreement under the Company&#8217;s 2022 Employment Inducement Plan</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 9, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616322000117/exhibit104_ligand-formofrs.htm">10.12#*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Form of Restricted Stock Unit Award Agreement under the Company&#8217;s 2022 Employment Inducement Plan</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 9, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616322000117/exhibit_105xligand-formofp.htm">10.13#*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Form of Performance-Based Restricted Stock Unit Award Agreement under the Company&#8217;s 2022 Employment Inducement Plan</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 9, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1014_ligand-separat.htm">10.14#*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Separation Agreement , effective December 12, 2022, by and between Ligand Pharmaceuticals Incorporated and John Higgins</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1015_ligand-severan.htm">10.15#**</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Severance Agreement, effective December 5, 2022, by and between Ligand Pharmaceuticals Incorporated and Todd C. Davis</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616322000129/exhibit101-taxmattersagree.htm">10.16</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax Matters Agreement, dated as of November 1, 2022, by and among OmniAb, Inc.(f/k/a Avista Public Acquisition Corp. II) Ligand Pharmaceuticals Incorporated and OmniAb Operations, Inc. (f/k/a OmniAb, Inc.)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 4, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616322000135/exhibit101-aremployeematte.htm">10.17*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amended and Restated Employee Matters Agreement, dated as of August 18, 2022, by and among Ligand Pharmaceuticals Incorporated, OmniAb Operations, Inc. (f/k/a OmniAb, Inc.), OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) and Orwell Merger Sub Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 8, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.260%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000119312510015242/dex102.htm">10.18</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">TR Beta Contingent Value Rights Agreement, dated January 27, 2010, among the Company, Metabasis Therapeutics, Inc., David F. Hale and Mellon Investor Services LLC </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January&#160;28, 2010</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000119312510015242/dex104.htm">10.19</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General Contingent Value Rights Agreement, dated January 27, 2010, among the Company, Metabasis Therapeutics, Inc., David F. Hale and Mellon Investor Services LLC </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January&#160;28, 2010</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000119312511018895/dex101.htm">10.20</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amendment of General Contingent Value Rights Agreement, dated January 26, 2011, among the Company, Metabasis Therapeutics, Inc., David F. Hale and Mellon Investor Services LLC </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January&#160;31, 2011</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616314000057/amendment_ofxgeneralxcvrxa.htm">10.21</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amendment of General Contingent Value Rights Agreement dated May 20, 2014 among the Company, Metabasis Therapeutics, Inc., David F. Hale and Computershare Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 22, 2014</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616314000057/amendment_ofxtrxbetaxcvrxa.htm">10.22</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amendment of TR Beta Contingent Value Rights Agreement dated May 20, 2014 among the Company, Metabasis Therapeutics, Inc., David F. Hale and Computershare, Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 22, 2014</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000119312511055119/dex10100.htm">10.23&#8224;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Captisol&#174; Supply Agreement, dated December&#160;20, 2002, among CyDex, Inc., Hovione&#160;LLC, Hovione FarmaCiencia&#160;S.A., Hovione Pharmascience Limited and Hovione International Limited </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2011</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000119312511055119/dex10101.htm">10.24&#8224;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1st Amendment to Captisol&#174; Supply Agreement, dated July&#160;29, 2005, among CyDex, Inc., Hovione&#160;LLC, Hovione FarmaCiencia&#160;S.A., Hovione Pharmascience Limited and Hovione International Limited </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2011</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.101</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000119312511055119/dex10102.htm">10.25</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2nd&#160;Amendment to Captisol&#174; Supply Agreement, dated March&#160;1, 2007, among CyDex, Inc., Hovione&#160;LLC, Hovione FarmaCiencia&#160;S.A., Hovione Pharmascience Limited, and Hovione International Limited </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2011</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.102</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000119312511055119/dex10103.htm">10.26&#8224;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3rd&#160;Amendment to Captisol&#174; Supply Agreement, dated January&#160;25, 2008, among CyDex, Inc., Hovione&#160;LLC, Hovione FarmaCiencia&#160;S.A., Hovione Pharmascience Limited, and Hovione International Limited </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2011</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.103</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000119312511055119/dex10104.htm">10.27&#8224;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4th&#160;Amendment to Captisol&#174; Supply Agreement, dated September 28, 2009, among CyDex Pharmaceuticals, Inc., Hovione&#160;LLC, Hovione FarmaCiencia&#160;S.A., Hovione Pharmascience Limited and Hovione International Limited </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2011</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.104</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000119312511055119/dex10105.htm">10.28&#8224;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License Agreement, dated September&#160;3, 1993, between CyDex L.C. and The University of Kansas </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2011</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.105</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000119312511055119/dex10106.htm">10.29</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">First Amendment to License Agreement, dated February 24, 1998, between CyDex, Inc. and The University of Kansas</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2011</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.106</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000119312511055119/dex10107.htm">10.30&#8224;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Second Amendment to License Agreement, dated August&#160;4, 2004, between CyDex, Inc. and The University of Kansas </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2011</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.107</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000119312511055119/dex10111.htm">10.31&#8224;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acknowledgement Agreement, dated February 22, 2008, between CyDex, Inc. and The University of Kansas </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2011</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.111</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000119312511055119/dex10108.htm">10.32&#8224;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exclusive License Agreement, dated June&#160;4, 1996, between Pfizer,&#160;Inc. and The University of Kansas </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2011</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.108</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000119312511055119/dex10110.htm">10.33&#8224;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Addendum to Nonexclusive License Agreement, dated December&#160;11, 2001, between CyDex, Inc. and Pfizer,&#160;Inc. </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2011</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.11</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616313000040/spectrumlicenseagreement-e.htm">10.34&#8224;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License Agreement, by and between CyDex Pharmaceuticals, Inc. and Spectrum Pharmaceuticals, Inc., dated as of March 8, 2013 </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 8, 2013</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616313000040/spectrumsupplyagreement-ex.htm">10.35&#8224;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supply Agreement, by and between CyDex Pharmaceuticals, Inc. and Spectrum Pharmaceuticals, Inc., dated as of March 8, 2013 </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 8, 2013</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.260%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616313000078/ligand-selexisroyaltystrea.htm">10.36&#8224;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalty Stream and Milestone Payments Purchase Agreement, dated April 29, 2013, between the Company and Selexis S.A. </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 1, 2013</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616314000090/ligand-vikingxmasterlicens.htm">10.37&#8224;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Master License Agreement dated May 21, 2014 among the Company, Metabasis Therapeutics, Inc. and Viking Therapeutics, Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 5, 2014</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616314000110/lgnd-vikingxamendmentno1to.htm">10.38&#8224;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">First Amendment to Master License Agreement dated September 6, 2014 among the Company, Metabasis Therapeutics, Inc. and Viking Therapeutics, Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 31, 2014</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616315000085/lgndvikingmasterlicenseagr.htm">10.39&#8224;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Second Amendment to Master License Agreement, dated April 8, 2015, among the Company, Metabasis Therapeutics, Inc. and Viking Therapeutics, Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 5, 2015</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000119312514313479/d775802dex102.htm">10.40</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Letter Agreement, dated as of August 12, 2014, between Bank of America, N.A. and the Company regarding the Base Issuer Warrant Transaction </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 18, 2014</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000119312514313479/d775802dex104.htm">10.41</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Letter Agreement, dated as of August 12, 2014, between Deutsche Bank AG, London Branch and the Company regarding the Base Issuer Warrant Transaction </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 18, 2014</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000119312514313479/d775802dex106.htm">10.42</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Letter Agreement, dated as of August 14, 2014, between Bank of America, N.A. and the Company regarding the Additional Issuer Warrant Transaction </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 18, 2014</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000119312514313479/d775802dex108.htm">10.43</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Letter Agreement, dated as of August 14, 2014, between Deutsche Bank AG, London Branch and the Company regarding the Additional Issuer Warrant Transaction </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 18, 2014</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616319000041/lgnd123118exhibit1048-.htm">10.44&#8224;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Development Funding and Royalties Agreement, dated December 13, 2018, by and between Ligand Pharmaceuticals Incorporated and Palvella Therapeutics, Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 28, 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.48</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616322000030/lgnd_123121xexhibit1037.htm">10.45**</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sublicense Agreement between the Company, Pharmacopeia, Inc. and Retrophin LLC dated as of February 16, 2012, as amended through Amendment No. 5 to Sublicense Agreement, dated March 20, 2018.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 28, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.37</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000119312516582835/d178557dex101.htm">10.4</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000119312516582835/d178557dex101.htm">6</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000119312516582835/d178557dex101.htm">&#8224;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest Purchase Agreement, dated May 3, 2016, between the Company and CorMatrix Cardiovascular, Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 9, 2016</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616317000091/ex102lgndcormatrixarinte.htm">10.4</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616317000091/ex102lgndcormatrixarinte.htm">7</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amended and Restated Interest Purchase Agreement, dated May 31, 2017, between the Company and CorMatrix Cardiovascular, Inc. </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-033093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 9, 2017</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616318000076/ex101-basebondhedgebc.htm">10.4</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616318000076/ex101-basebondhedgebc.htm">8</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Letter Agreement, dated as of May 17, 2018, between Barclays Capital Inc. and the Company regarding the Base Convertible Note Hedge Transaction</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-00393</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 22, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616318000076/ex102-basewarrantbc.htm">10.4</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616318000076/ex102-basewarrantbc.htm">9</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Letter Agreement, dated as of May 17, 2018, between Barclays Capital Inc. and the Company regarding the Base Issuer Warrant Transaction </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-00393</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 22, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616318000076/ex103-basebondhedgedb.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616318000076/ex103-basebondhedgedb.htm">50</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Letter Agreement, dated as of May 17, 2018, between Deutsche Bank AG and the Company regarding the Base Convertible Note Hedge Transaction</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-00393</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 22, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616318000076/ex104-basewarrantdb.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616318000076/ex104-basewarrantdb.htm">51</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Letter Agreement, dated as of May 17, 2018, between Deutsche Bank AG and the Company regarding the Base Issuer Warrant Transaction</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-00393</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 22, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616318000076/ex105-basebondhedgegs.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616318000076/ex105-basebondhedgegs.htm">52</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Letter Agreement, dated as of May 17, 2018, between Goldman Sachs &amp; Co. LLC and the Company regarding the Base Convertible Note Hedge Transaction</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-00393</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 22, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616318000076/ex106-basewarrantgs.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616318000076/ex106-basewarrantgs.htm">53</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Letter Agreement, dated as of May 17, 2018, between Goldman Sachs &amp; Co. LLC and the Company regarding the Base Issuer Warrant Transaction</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-00393</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 22, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.260%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616318000076/ex107-bondhedgebc.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616318000076/ex107-bondhedgebc.htm">54</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Letter Agreement, dated as of May 18, 2018, between Barclays Capital Inc. and the Company regarding the Additional Convertible Note Hedge Transaction</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-00393</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 22, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.7</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616318000076/ex108-additionalwarrantbc.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616318000076/ex108-additionalwarrantbc.htm">55</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Letter Agreement, dated as of May 18, 2018, between Barclays Capital Inc. and the Company regarding the Additional Warrant Transaction</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-00393</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 22, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616318000076/ex109-bondhedgedb.htm">10.5</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616318000076/ex109-bondhedgedb.htm">6</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Letter Agreement, dated as of May 18, 2018, between Deutsche Bank AG and the Company regarding the Additional Convertible Note Hedge Transaction</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-00393</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 22, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616318000076/ex1010-additionalwarrantdb.htm">10.5</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616318000076/ex1010-additionalwarrantdb.htm">7</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Letter Agreement, dated as of May 18, 2018, between Deutsche Bank AG and the Company regarding the Additional Warrant Transaction</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-00393</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 22, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.10</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616318000076/ex1011-bondhedgegs.htm">10.5</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616318000076/ex1011-bondhedgegs.htm">8</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Letter Agreement, dated as of May 18, 2018, between Goldman Sachs &amp; Co. LLC and the Company regarding the Additional Convertible Note Hedge Transaction</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-00393</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 22, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.11</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616318000076/ex1012-additionalwarrantgs.htm">10.5</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616318000076/ex1012-additionalwarrantgs.htm">9</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Letter Agreement, dated as of May 18, 2018, between Goldman Sachs &amp; Co. LLC and the Company regarding the Additional Warrant Transaction </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-00393</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 22, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.12</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616318000030/indemnificationagreement-d.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616318000030/indemnificationagreement-d.htm">60</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616318000030/indemnificationagreement-d.htm">#</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Form of Indemnification Agreement between the Company and each of its directors</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 1, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.60</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616318000030/indemnificationagreement-o.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616318000030/indemnificationagreement-o.htm">61</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616318000030/indemnificationagreement-o.htm">#</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Form of Indemnification Agreement between the Company and each of its officers</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 1, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.61</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616319000156/exhibit101ligand-amend.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616319000156/exhibit101ligand-amend.htm">6</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616319000156/exhibit101ligand-amend.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616319000156/exhibit101ligand-amend.htm">&#8224;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Addendum, dated May 22, 2019, by and among Ligand Pharmaceuticals Incorporated, CyDex Pharmaceuticals, Inc., and Acrotech Biopharma LLC (as successor-in-interest to Spectrum Pharmaceuticals, Inc.), to that certain License Agreement between Ligand Pharmaceuticals Incorporated and Spectrum Pharmaceuticals, Inc., dated March 8, 2013</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 8, 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616320000061/ligand-exhibit101tofor.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616320000061/ligand-exhibit101tofor.htm">63</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Call Option Amendment Agreement, dated April 6, 2020, between the Registrant and Barclays Bank PLC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 8, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616320000061/ligand-exhibit102tofor.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616320000061/ligand-exhibit102tofor.htm">64</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Call Option Amendment Agreement, dated April 6, 2020, between the Registrant and Deutsche Bank AG, London Branch</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 8, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616320000061/ligand-exhibit103tofor.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616320000061/ligand-exhibit103tofor.htm">6</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616320000061/ligand-exhibit103tofor.htm">5</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Call Option Amendment Agreement, dated April 6, 2020, between the Registrant and Goldman Sachs &amp; Co. LLC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 8, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616321000050/exhibit1067_bondhedgexbarc.htm">10.6</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616321000050/exhibit1067_bondhedgexbarc.htm">6</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Call Option Amendment Agreement, dated January 28, 2021, between the Registrant and Barclays Bank PLC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 24, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.67</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616321000050/exhibit1068.htm">10.6</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616321000050/exhibit1068.htm">7</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Call Option Amendment Agreement, dated January 28, 2021, between the Registrant and Deutsche Bank AG, London Branch</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 24, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.68</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616321000050/ligand-ex1069xbondhedgeame.htm">10.6</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616321000050/ligand-ex1069xbondhedgeame.htm">8</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Call Option Amendment Agreement, dated January 28, 2021, between the Registrant and Goldman Sachs &amp; Co. LLC</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 24, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.69</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616321000050/ligandcydexex1072_gileadsu.htm">10.6</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616321000050/ligandcydexex1072_gileadsu.htm">9</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supply agreement, dated December 22, 2015, by and between Cydex Pharmaceuticals, Inc. and Gilead Sciences, Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 24, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.72</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616320000122/exhibit102ligandcydexg.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/886163/000088616320000122/exhibit102ligandcydexg.htm">70</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amendment to Supply Agreement, dated September 21, 2020, by and between Cydex Pharmaceuticals, Inc. and Gilead Sciences, Inc., which amends that certain Supply Agreement, dated December 2, 2015, by and between Cydex Pharmaceuticals, Inc. and Gilead Sciences, Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 6, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="lgnd_123122xexhibit211.htm">21.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subsidiaries of the Company </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="lgnd_123122xexhibit231.htm">23.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consent of Independent Registered Public Accounting Firm</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.260%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="lgnd_123122xexhibit311.htm">31.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certification by Principal Executive Officer, Pursuant to Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="lgnd_123122xexhibit312.htm">31.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certification by Principal Financial Officer, Pursuant to Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="lgnd_123122xexhibit321.htm">32.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certifications by Principal Executive Officer and Principal Financial Officer, Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The following financial information from our Annual Report on Form 10-K for the fiscal year ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">, formatted in iXBRL (inline eXtensible Business Reporting Language): (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Operations, (iii) Consolidated Statement of Comprehensive Income, (iv) Consolidated Statements of Stockholders' Equity, (v) Consolidated Statements of Cash Flows, and (vi) the Notes to Consolidated Financial Statements. </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The cover page from the Company's Annual Report on Form 10-K for the fiscal year ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">, formatted in Inline XBRL and contained in Exhibit 101.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr></table></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Confidential treatment has been requested for portions of this exhibit. These portions have been omitted and submitted separately to the Securities and Exchange Commission.</span></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">#&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicates management contract or compensatory plan.</span></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">*&#160;&#160;&#160;&#160;Certain schedules and annexes have been omitted in accordance with Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule and/or annex will be furnished as a supplement to the U.S. Securities and Exchange Commission upon request.</span></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">**&#160;&#160;&#160;&#160;Pursuant to Item 601(b)(10) of Regulation S-K, certain confidential portions of this exhibit were omitted by means of marking such portions with an asterisk because the identified confidential portions (i) are not material and (ii) would be competitively harmful if publicly disclosed.</span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_157"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.198%"><tr><td style="width:1.0%"></td><td style="width:28.330%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:69.470%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 16.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Form 10-K Summary</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None</span></div><div id="i98e6b87576d6446486a3b29533a5cf6a_160"></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.695%"><tr><td style="width:1.0%"></td><td style="width:11.696%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.104%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIGAND&#160;PHARMACEUTICALS&#160;INCORPORATED</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/&#160;&#160;&#160;&#160;T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ODD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> C. D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AVIS&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Todd C. Davis,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Chief Executive Officer</span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: February&#160;28, 2023 </span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:38.253%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.229%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Signature</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Title</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Date</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;TODD C. DAVIS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and Director (Principal Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Todd C. Davis</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160; OCTAVIO ESPINOZA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer (Principal Financial and Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Octavio Espinoza</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;JOHN W. KOZARICH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director and Chairman of the Board</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">John W. Kozarich</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;JASON M. ARYEH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jason M. Aryeh</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;NANCY R. GRAY</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nancy R. Gray</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160; JASON HAAS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jason Haas</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;JOHN L. LAMATTINA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">John L. LaMattina</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;STEPHEN L. SABBA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stephen L. Sabba</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">99</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.8
<SEQUENCE>2
<FILENAME>exhibit_108xligand-amended.htm
<DESCRIPTION>EX-10.8
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i5f2d03cd949a4cbcb506c747e7fd841b_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 10.8</font></div></div><div style="margin-top:9.5pt;padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">LIGAND PHARMACEUTICALS INCORPORATED</font></div><div style="margin-top:4.55pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">AMENDED AND RESTATED SEVERANCE PLAN </font></div><div style="margin-top:4.55pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">AND SUMMARY PLAN DESCRIPTION</font></div><div style="margin-top:9.5pt;padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Effective Date&#58; November 1, 2022</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-right:7.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline"> Purpose</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The purpose of this Ligand Pharmaceuticals Incorporated Amended and Restated Severance Plan (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is to provide certain Severance Payments and Benefits (as defined below) to designated employees of the Company in the event of a termination of their employment in certain specified circumstances. This Plan is an &#8220;employee welfare benefit plan,&#8221; as defined in Section 3(1) of ERISA. This Plan is governed by ERISA and, to the extent applicable, the laws of the State of California. This document constitutes both the written instrument under which this Plan is maintained and the required summary plan description for this Plan.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="padding-right:7.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline"> Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The following definitions are applicable for purposes of this Plan, in addition to terms defined in Section 1 above&#58;</font></div><div style="margin-top:0.05pt;text-indent:36pt"><font><br></font></div><div style="margin-top:0.05pt;padding-right:7.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Accrued Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for an Eligible Employee, the Eligible Employee&#8217;s (i) base salary otherwise payable through the Date of Termination, (ii) unreimbursed business expenses reimbursable under Company policies then in effect, and (iii) earned and accrued vacation pay and&#47;or paid time off, if applicable, to the extent not theretofore paid.</font></div><div style="margin-top:0.5pt;text-indent:36pt"><font><br></font></div><div style="padding-right:7.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">means the Company, whether or not acting through the Committee or another duly constituted committee of members of the Board, or any person or persons to whom the Administrator has delegated any authority or responsibility with respect to this Plan.</font></div><div style="margin-top:0.05pt;text-indent:36pt"><font><br></font></div><div style="padding-right:7.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means with respect to a specified Person, a Person that directly, or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with, the specified Person.</font></div><div style="margin-top:0.4pt;text-indent:36pt"><font><br></font></div><div style="padding-right:7.25pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Base Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (i) with respect to any Eligible Employee who is compensated on a salaried basis, the Eligible Employee&#8217;s annual base salary as of the Date of Termination, and (ii) with respect to any Eligible Employee who is compensated on an hourly basis, the product of (x) the Eligible Employee&#8217;s hourly wage rate as of the Date of Termination (determined without regard to overtime) and (y) the Eligible Employee&#8217;s annual scheduled hours determined on the Date of Termination.  Base Salary will not include any bonus, incentive compensation, benefits or expense reimbursements or equity awards.</font></div><div style="padding-left:36pt;padding-right:7.25pt;text-align:justify"><font><br></font></div><div style="margin-top:0.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Board of Directors of the Company.</font></div><div style="margin-top:0.05pt;padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-top:0.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means that, in the reasonable determination of the Company, an Eligible Employee&#58; (i) has been convicted of (or entered a plea of no contest to) any felony or any other criminal act&#59; (ii) committed any act of fraud or embezzlement&#59; (iii) permitted or allowed any unauthorized use or disclosure of confidential or proprietary information or trade secrets of the Company or its subsidiaries&#59; (iv) committed any material violation of the Company&#8217;s policies&#59; or (v) committed any other intentional misconduct which adversely affects the business or affairs of the Company in a material manner.</font></div><div style="margin-top:0.15pt;padding-left:36pt;padding-right:7.1pt;text-align:justify"><font><br></font></div><div style="padding-right:7.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">COBRA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the continuation coverage requirements for &#8220;group health plans&#8221; under Title X of the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended, and as codified in Code Section 4980B and ERISA Sections 601 through 608, each as amended from time to time, including rules thereunder and successor provisions and rules thereto.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="padding-right:7.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Internal Revenue Code of 1986, as amended from time to time, and all regulations, interpretations, and administrative guidance issued thereunder.</font></div><div style="margin-top:0.55pt;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Code Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Section 409A of the Code.</font></div><div style="margin-top:0.05pt;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:4.55pt;padding-right:7.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Human Capital Management and Compensation Committee of the Board, or its designee.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="padding-right:6.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Ligand Pharmaceuticals Incorporated, a Delaware corporation, including all of its Affiliates, collectively (and any successors or assigns thereto), and any successor that assumes the obligations of the Company under this Plan, by way of merger, acquisition, consolidation or other transaction.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="padding-right:7.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Date of Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for an Eligible Employee, the date of the Eligible Employee&#8217;s Separation from Service.</font></div><div style="padding-left:36pt;padding-right:7.1pt;text-align:justify"><font><br></font></div><div style="margin-top:0.05pt;padding-right:7.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Distribution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the distribution of OmniAb&#8217;s common stock then owned directly by the Company to the Company&#8217;s stockholders in furtherance of the spin-off of OmniAb from the Company, as more fully described in that certain Separation and Distribution Agreement, dated as of March 23, 2022, by and among the Company, OmniAb, Avista Public Acquisition Corp. II, and Orwell Merger Sub Inc., as amended from time to time.</font></div><div style="margin-top:0.05pt;padding-left:36pt;padding-right:7.1pt;text-align:justify"><font><br></font></div><div style="margin-top:0.05pt;padding-right:7.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Eligible Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an employee of the Company or any Subsidiary who has been designated by the Administrator to participate in the Plan and has executed and delivered such Participation Agreement to the Company&#59; provided, that, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Eligible Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; will not include any employees of OmniAb. An employee will be considered an Eligible Employee if he or she is on a Company-approved leave of absence immediately prior to the Date of Termination and he or she was employed full-time immediately prior to the commencement of such leave. For the avoidance of doubt, an employee will not be eligible for benefits under this Plan if he or she (a) is a party to any individual change in control severance agreement, employment agreement or other arrangement providing severance benefits, in each case, as approved by the Board or the Committee in effect as of the Date of Termination, (b) voluntarily terminates employment with the Company, (c) is discharged by the Company for Cause, or (d) declines an offer by the Company or any successor to the Company (or any acquirer of any of the Company&#8217;s assets or product lines) made to him or her at the time of termination of employment of a similar or better position in job content and base compensation, provided that the location of the offered position is not more than 75 miles from his or her principal work location at the time of his or her termination of employment.</font></div><div style="margin-top:0.5pt;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Equity Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an equity incentive plan maintained by the Company.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(p)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Employee Retirement Income Security Act of 1974, as amended.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:7pt;text-align:justify;text-indent:29pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(q)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Merger</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the transactions contemplated by that certain Agreement and Plan of Merger, dated as of March 23, 2022, by and among the Company, OmniAb, Avista Public Acquisition Corp. II, and Orwell Merger Sub Inc., as amended from time to time.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:7pt;text-align:justify;text-indent:29pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(r)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">OmniAb</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means OmniAb, Inc., a Delaware corporation and Subsidiary of the Company. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:7pt;text-align:justify;text-indent:29pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(s)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.4pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Participation Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the individual agreement (a form of which is shown in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Appendix A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), which may be in an electronic format, provided by the Administrator to an employee of the Company designating such employee as an Eligible Employee under the Plan, which has been signed and accepted by the employee. </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(t)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an individual, corporation, partnership, limited liability company, association, trust, other entity, group or organization include a governmental authority.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(u)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Qualifying Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a termination of an Eligible Employee&#8217;s employment by the Company without Cause.  Termination due to death or disability shall not be treated as a Qualifying Termination.  For the avoidance of doubt, neither (i) the transfer of an Eligible Employee&#8217;s employment from the Company to OmniAb or any subsidiary of OmniAb, (ii) the consummation of the Distribution or the Merger or (iii) an Eligible Employee&#8217;s objection to the transfer of employment from </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the Company to OmniAb and the subsequent termination of employment by the Company, shall, in each case, constitute a Qualifying Termination.</font></div><div style="padding-left:36pt;padding-right:7.15pt;text-align:justify"><font><br></font></div><div style="padding-right:7.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in Section 6.</font></div><div style="padding-right:7.15pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-right:7.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(w)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Release Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in Section 6.</font></div><div style="padding-right:7.15pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Separation from Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a separation from service within the meaning of Code Section&#160;409A.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(y)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Severance Payments and Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means all benefits provided or payments made by the Company to or for the benefit of an Eligible Employee under this Plan as a result of a Qualifying Termination.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(z)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Severance Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; will be equal to (a)&#160;two months plus (b)&#160;one week for each of the Eligible Employee&#8217;s Years of Service as of the Date of Termination.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(aa)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.92pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Stock Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means all stock options, restricted stock, restricted stock units and such other awards granted pursuant to any Equity Plan and any shares of stock issued upon exercise or settlement thereof.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(bb)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any entity (other than the Company), whether domestic or foreign, in an unbroken chain of entities beginning with the Company if each of the entities other than the last entity in the unbroken chain beneficially owns, at the time of the determination, securities or interests representing at least 50% of the total combined voting power of all classes of securities or interests in one of the other entities in such chain.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(cc)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.92pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Year of Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means each 12-month period of an Eligible Employee&#8217;s continuous and uninterrupted service with the Company or an Affiliate (or, in the event of a partial year of service, to the extent an Eligible Employee provided continuous and uninterrupted service to the Company or an Affiliate for at least six months and one day during such year, such year shall count as a full &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Year of Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; for purposes of this Plan).  </font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline"> Eligibility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. An Eligible Employee shall be eligible for Severance Payments and Benefits under this Plan, subject to the terms and conditions described herein, only if he or she (a) experiences a Qualifying Termination, (b) is an Eligible Employee on his or her Date of Termination and (c) is not subject to disciplinary action or on a formal performance improvement plan on his or her Date of Termination.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-top:0.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline"> Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Plan shall be interpreted, administered and operated by the Administrator, which shall have complete authority, subject to the express provisions of this Plan, to interpret this Plan, to prescribe, amend and rescind rules and regulations relating to this Plan, to determine eligibility for benefits under this Plan, and to make all other determinations necessary or advisable for the administration of this Plan.  Such authority shall include the powers to resolve ambiguities, inconsistencies, and omissions, and to amend the Plan to correct any scrivener&#8217;s error. The Administrator may delegate any of its duties hereunder to a subcommittee, or to such person or persons from time to time as it may designate. All decisions, interpretations and other actions of the Administrator shall be final, conclusive and binding on all parties who have an interest in this Plan.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-top:0.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline"> Termination of Employment for any Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Subject to the terms and conditions hereof, in the event of an Eligible Employee&#8217;s termination of employment with the Company for any reason&#58;</font></div><div style="margin-top:0.55pt;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The Company shall pay the Eligible Employee the Accrued Obligations, payable on the dates such amounts would have been payable under the Company&#8217;s policies if the Eligible Employee&#8217;s employment had not terminated.</font></div><div style="margin-top:0.05pt;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">All outstanding Stock Awards held by the Eligible Employee as of the Date of Termination shall be governed by the terms and conditions of the applicable Equity Plan(s) and award agreements evidencing such Stock Awards.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.5pt;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The Eligible Employee&#8217;s benefits and rights under the Company&#8217;s benefit plans shall be determined in accordance with the applicable provisions of such plans, in each case as in effect and amended from time to time.</font></div><div style="margin-top:0.05pt;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline"> Qualifying Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In addition to the payments and benefits set forth in Section 5, if an Eligible Employee&#8217;s termination of employment with the Company is a Qualifying Termination, the Eligible Employee shall also be entitled to receive the following payments and benefits, subject to the Eligible Employee timely executing a release of claims agreement in substantially the form attached as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Appendix B-1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">B-2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereto, as applicable (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and such Release becoming effective, enforceable and irrevocable no later than sixty (60) days following the Eligible Employee&#8217;s Date of Termination (such period, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Release Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and subject to the Eligible Employee&#8217;s continued compliance with Section 8 below&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The Eligible Employee shall be entitled to receive severance pay in an amount equal to the Eligible Employee&#8217;s Base Salary for the Severance Period, paid in a lump sum within ten (10) days following the effective date of the Eligible Employee&#8217;s Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#59; and</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">If the Eligible Employee, and any spouse and&#47;or dependents of the Eligible Employee has coverage on the Eligible Employee&#8217;s Date of Termination under a group health plan sponsored by the Company and timely and properly elects to receive continued group health plan coverage under COBRA, the Company will pay the portion of the premiums for such COBRA coverage (other than for coverage under a health flexible spending account) that exceeds the contributions required by the Eligible Employee immediately prior to the Date of Termination (based on elections in effect for the Eligible Employee and any spouse and&#47;or dependents of the Eligible Employee, in each case, on the Date of Termination), for the period beginning on the Date of Termination and ending on the earlier of the last day of the Severance Period and the date on which the Eligible Employee becomes eligible to receive benefits under a &#8220;group health plan&#8221; (within the meaning of Section 4980B of the Code) of a subsequent employer of the Eligible Employee. Notwithstanding the foregoing, in the event that the Company determines, in its sole discretion, that the Company cannot provide the foregoing benefits in a manner that is exempt from Section 409A (as defined below) or that is otherwise compliant with applicable law (including, without limitation, Code Section 105(h) or Section 2716 of the Public Health Service Act), the Company shall instead pay to the Eligible Employee the foregoing monthly amount as a taxable monthly payment for the foregoing COBRA coverage period (or any remaining portion thereof).&#160; An Eligible Employee shall be solely responsible for all matters relating to continuation of coverage pursuant to COBRA, including, without limitation, the election of such coverage and the timely payment of premiums.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">  Other Provisions Applicable to Severance Payments and Benefits&#59; Non-Duplication of Payments or Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.55pt;text-indent:36pt"><font><br></font></div><div style="margin-top:0.05pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Anything in this Plan to the contrary notwithstanding, a transfer of employment from the Company to an Affiliate or vice versa shall not be considered a termination of employment for purposes of this Plan.</font></div><div style="margin-top:0.05pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="margin-top:0.05pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">An Eligible Employee shall not be entitled to any Severance Payment or Benefit under this Plan which duplicates a payment or benefit received or receivable by the Eligible Employee under any employment or severance agreement, or any other plan, program or arrangement of the Company or any severance required by applicable law or regulation, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">including, without limitation, the Worker Adjustment and Retraining Notification Act (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">WARN</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#8221;) or any similar state or local statute, rule or regulation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. If an Eligible Employee has a right to payments or benefits that duplicate the Severance Payment or Benefit under this Plan, the benefit under this Plan shall be reduced, dollar for dollar, by the amount of the duplicate payment(s) and benefit(s).  The benefits provided under this Plan are intended to satisfy, in whole or in part, any and all statutory obligations that may arise out of an Eligible Employee&#8217;s termination of employment, and the Company shall so construe and enforce the terms of this Plan.  The Administrator&#8217;s decision to waive all or a portion of such reductions to the severance benefits of one employee and the amount of such reductions shall in no way obligate the Administrator to waive the same reductions in the same amounts to the severance benefits of any other employees, even if similarly situated.  Such reductions may be applied on a retroactive basis, with </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.05pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">severance benefits previously paid being recharacterized as payments pursuant to a statutory obligation of the Company.</font></div><div style="margin-top:0.05pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Each Eligible Employee hereby expressly confirms his or her continuing obligations to the Company and its Affiliates pursuant to the confidentiality provisions of any code of conduct of the Company or its Affiliates, the Company&#8217;s standard employee confidentiality and inventions agreement and&#47;or other agreements regarding non-competition, non-solicitation, non-disparagement, confidentiality, assignment of inventions or other similar covenants between such Eligible Employee and the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Special Rules for Compliance with Code Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Section 9 serves to ensure compliance with applicable requirements of Code Section 409A. If the terms of this Section 9 conflict with other terms of this Plan, the terms of this Section 9 shall control.</font></div><div style="margin-top:0.5pt;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">To the extent applicable, this Plan shall be interpreted in accordance with Code Section 409A and Department of Treasury regulations and other interpretive guidance issued thereunder. The intent of the parties is that payments and benefits under this Agreement comply with, or be exempt from Code Section 409A and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in compliance with such intention. To the extent that any provision in this Agreement is ambiguous as to its compliance with or exemption from Code Section 409A, the provision shall be read in such a manner that no payments payable under this Agreement shall be subject to an &#8220;additional tax&#8221; as defined in Section 409A(a)(1)(B) of the Code.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Each installment in a series of Severance Payments and Benefits shall be deemed a separate payment for purposes of Code Section 409A. For purposes of this Plan, all references to an Eligible Employee&#8217;s &#8220;termination of employment&#8221; shall mean his or her Separation from Service. </font></div><div style="margin-top:0.55pt;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If an Eligible Employee is a &#8220;specified employee&#8221; (as determined by the Administrator or its designee in accordance with Treasury Regulation &#167; 1.409A-1(i)) as of his or her Date of Termination, then all Severance Payments and Benefits that are subject to the requirements of Code Section 409A (determined after taking into account the &#8220;short-term deferral&#8221; rule in Treasury Regulation &#167; 1.409A-1(b)(4), the &#8220;two-year, two-time&#8221; rule described in Treasury Regulation &#167; 1.409A-1(b)(9), and any other available exception from such requirements) shall be subject to the six-month delay rule of Code Section 409A(a)(2)(B)(i). Each payment that is subject to such six-month delay rule shall be made, without interest, on the later of (i) the Company&#8217;s first payroll date that is at least six months after the Eligible Employee&#8217;s Date of Termination (or, if earlier, as soon as practicable after the Eligible Employee&#8217;s death) or (ii) the date when such payment would otherwise be due under the terms of the Plan.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">To the extent that the payments or benefits under this Plan are &#8220;non-qualified deferred compensation&#8221; subject to Code Section 409A, if the Release Period spans two calendar years, the payment of any Severance Payments and Benefits shall occur (or commence) on the later of (i) January 1 of the second calendar year, or (ii) the first regularly-scheduled payroll date following the date the Release becomes effective.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">To the extent required by Code Section 409A, any reimbursement or in-kind benefit provided under this Plan shall be provided in accordance with the following&#58; (i) the amount of expenses eligible for reimbursement, or in-kind benefits provided during each calendar year cannot affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other calendar year&#59; (ii) any payments in lieu of the benefits shall be paid no later than the end of Eligible Employee&#8217;s taxable year next following Eligible Employee&#8217;s taxable year in which the benefit or expense was due to be paid&#59; and (iii) any right to reimbursements or in-kind benefits under this Plan shall not be subject to liquidation or exchange for another benefit.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt;text-decoration:underline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Company and its employees and agents make no representation and are providing no advice regarding the taxation of the payments and benefits under this Plan, including with respect to taxes, interest and penalties under Code Section 409A and similar liabilities under state and local tax laws. No indemnification or gross-up is payable under this Plan with respect to any such tax, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">interest, or penalty under Code Section 409A or similar liability under state or local tax laws applicable to any Eligible Employee.</font></div><div style="margin-top:0.55pt;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline"> Claims Procedures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Normally, an Eligible Employee does not need to present a formal claim to receive benefits payable under this Plan. If any person (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Claimant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) believes that benefits are being denied improperly, that this Plan is not being operated properly, that fiduciaries of this Plan have breached their duties, or that the Claimant&#8217;s legal rights are being violated with respect to this Plan, the Claimant must file a formal claim, in writing, with the Administrator.  A formal claim must be filed within 60 days after the date the Claimant first knew or should have known of the facts on which the claim is based, unless the Administrator in writing consents otherwise or the deadline to file a claim is temporarily extended under the rules described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Appendix C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Administrator has adopted procedures for considering claims (which are set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Appendix C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), which it may amend from time to time, as it sees fit.  These procedures shall comply with all applicable legal requirements, and the Administrator shall provide a Claimant, on request, with a copy of such amended claims procedures. The right to receive benefits under this Plan is contingent on a Claimant using the prescribed claims procedures to resolve any claim.  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Best Pay Provision</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;In the event that any payment or benefit received or to be received by the Eligible Employee pursuant to the terms of any plan, arrangement or agreement (including any payment or benefit received in connection with a change in ownership or control or the termination of the Eligible Employee&#8217;s employment) (all such payments and benefits being hereinafter referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Total Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) would be subject (in whole or part) to the excise tax (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Excise Tax</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) imposed under Section 4999 of the Code, then the Total Payments shall be reduced to the extent necessary so that no portion of the Total Payments is subject to the Excise Tax but only if (A) the net amount of such Total Payments, as so reduced (after subtracting the amount of federal, state and local income taxes on such reduced Total Payments and after taking into account the phase out of itemized deductions and personal exemptions attributable to such reduced Total Payments) is greater than or equal to (B) the net amount of such Total Payments without such reduction (after subtracting the net amount of federal, state and local income taxes on such Total Payments and the amount of Excise Tax to which the Eligible Employee would be subject in respect of such unreduced Total Payments and after taking into account the phase out of itemized deductions and personal exemptions attributable to such unreduced Total Payments).  Except to the extent that an alternative reduction order would result in a greater economic benefit to the Eligible Employee on an after-tax basis, the parties intend that the Total Payments shall be reduced in the following order&#58; (w) reduction of any cash severance payments otherwise payable to the Eligible Employee that are exempt from Section 409A of the Code, (x) reduction of any other cash payments or benefits otherwise payable to the Eligible Employee that are exempt from Section 409A of the Code, but excluding any payment attributable to the acceleration of vesting or payment with respect to any equity award that is exempt from Section 409A of the Code, (y) reduction of any other payments or benefits otherwise payable to the Eligible Employee on a pro-rata basis or such other manner that complies with Section 409A of the Code, but excluding any payment attributable to the acceleration of vesting and payment with respect to any equity award that is exempt from Section 409A of the Code, and (z) reduction of any payments attributable to the acceleration of vesting or payment with respect to any equity award that is exempt from Section 409A of the Code&#59; provided, in case of clauses (x), (y) and (z), that reduction of any payments or benefits attributable to the acceleration of vesting of Company equity awards shall be first applied to equity awards with later vesting dates&#59; provided, further, that, notwithstanding the foregoing, any such reduction shall be undertaken in a manner that complies with and does not result in the imposition of additional taxes on the Eligible Employee under Section&#160;409A of the Code.  The foregoing reductions shall be made in a manner that results in the maximum economic benefit to the Eligible Employee on an after-tax basis and, to the extent economically equivalent payments or benefits are subject to reduction, in a pro rata manner. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;All determinations regarding the application of this Section 11 shall be made by an independent accounting firm or consulting group with nationally recognized standing and substantial expertise and experience in performing calculations regarding the applicability of Section 280G of the Code and the Excise Tax retained by the Company prior to the date of the applicable change in ownership or control (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">280G Firm</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  For purposes of determining whether and the extent to which the Total </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Payments will be subject to the Excise Tax, (i) no portion of the Total Payments shall be taken into account which (x) does not constitute a &#8220;parachute payment&#8221; within the meaning of Section 280G(b)(2) of the Code (including by reason of Section 280G(b)(4)(A) of the Code) and, in calculating the Excise Tax, or (y) constitutes reasonable compensation for services actually rendered, within the meaning of Section 280G(b)(4)(B) of the Code, in excess of the &#8220;base amount&#8221; (as defined in Section 280G(b)(3) of the Code) allocable to such reasonable compensation, (ii) no portion of the Total Payments the receipt or enjoyment of which an Eligible Employee shall have waived at such time and in such manner as not to constitute a &#8220;payment&#8221; within the meaning of Section 280G(b) of the Code shall be taken into account, and (iii) the value of any non-cash benefit or any deferred payment or benefit included in the Total Payments shall be determined by the 280G Firm in accordance with the principles of Sections 280G(d)(3) and (4) of the Code.  All determinations related to the calculations to be performed pursuant to this &#8220;Section 280G Treatment&#8221; section shall be done by the 280G Firm.  The 280G Firm will be directed to submit its determination and detailed supporting calculations to both the Eligible Employee and the Company within fifteen (15) days after notification from either the Company or the Eligible Employee that the Eligible Employee may receive payments which may be &#8220;parachute payments.&#8221;  The Eligible Employee and the Company will each provide the 280G Firm access to and copies of any books, records, and documents as may be reasonably requested by the 280G Firm, and otherwise cooperate with the 280G Firm in connection with the preparation and issuance of the determinations and calculations contemplated by this Agreement.  The fees and expenses of the 280G Firm for its services in connection with the determinations and calculations contemplated by this Agreement will be borne solely by the Company.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.05pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;margin-top:0.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline"> Assignment&#59; Non-transferability&#59; Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. No right of an Eligible Employee to any payment or benefit under this Plan shall be subject to assignment, anticipation, alienation, sale, transfer, assignment, pledge, encumbrance, attachment, or garnishment by creditors of the Eligible Employee or of any beneficiary of the Eligible Employee. Any successor to the Company (whether direct or indirect and whether by purchase, lease, merger, consolidation, liquidation or otherwise) to all or substantially all of the Company&#8217;s business and&#47;or assets shall assume the obligations under this Plan and agree expressly to perform any of the Company&#8217;s obligations under this Plan.  For all purposes under this Plan, the term &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall include any successor to the Company&#8217;s business and&#47;or assets which executes and delivers an assumption agreement or which becomes bound by the terms of the Plan by operation of law.  All of an Eligible Employee&#8217;s rights hereunder shall inure to the benefit of, and be enforceable by, his or her personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.</font></div><div style="margin-top:0.05pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Company shall have the right to deduct from all payments hereunder all taxes that the Company determines are required by law to be withheld therefrom. Regardless of the amount withheld, the recipient of payments, benefits, or other income (including imputed income) under the Plan shall be solely responsible for all taxes owed with respect to such payments, benefits, and other income.</font></div><div style="margin-top:0.1pt;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline"> No Right To Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Nothing in this Plan shall be construed as giving any person the right to be retained in the employment of the Company, nor shall it affect the right of the Company to dismiss an Eligible Employee without any liability except as required by this Plan. </font></div><div style="margin-top:0.5pt;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline"> Amendment and Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Administrator shall have the power to amend or terminate this Plan from time to time in its discretion and for any reason (or no reason).&#160; In no event shall any amendment or termination of this Plan affect the Severance Payments and Benefits payable under this Plan to any Eligible Employee whose Qualifying Termination has occurred prior to the effective date of the amendment or termination of this Plan.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline"> Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Plan is a welfare plan subject to ERISA and it shall be interpreted, administered, and enforced in accordance with that law.  To the extent that state law is applicable, the validity, construction and effect of this Plan and any rules and regulations relating to this Plan shall be determined in accordance with the laws of the State of California, without giving effect to principles of conflicts of laws. If any provision hereof shall be held by a court of competent jurisdiction to be invalid and unenforceable, the remaining provisions shall continue to be fully effective.</font></div><div style="margin-top:0.35pt;text-indent:72pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt;text-decoration:underline"> Venue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. For purposes of settling any dispute or controversy arising hereunder, the Company and the Eligible Employee hereby consent to the jurisdiction of any or all of the following courts&#58; (i) the United States District Court for the Southern District of California or (ii) any of the courts of the State of California. The Company and the Eligible Employee hereby waive, to the fullest extent permitted by applicable law, any objection which it may now or hereafter have to such courts&#8217; jurisdiction and any defense of inconvenient forum with respect to such courts. This Section 12(f) shall not apply to any claims of violation of any federal or state employment discrimination laws.</font></div><div style="margin-top:0.55pt;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline"> No Duty to Mitigate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. No employee shall be required to mitigate, by seeking employment or otherwise, the amount of any payment that the Company becomes obligated to make under this Plan, and, except as expressly provided in this Plan, amounts or other benefits to be paid or provided to an Eligible Employee pursuant to this Plan shall not be reduced by reason of the Eligible Employee&#8217;s obtaining other employment or receiving similar payments or benefits from another employer.</font></div><div style="margin-top:0.05pt;text-indent:72pt"><font><br></font></div><div style="padding-right:7.15pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline"> Employment at Will</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Nothing contained in this Plan shall give any employee the right to be retained in the employment of the Company or shall otherwise modify the employee&#8217;s at will employment relationship with the Company. This Plan is not a contract of employment between the Company and any employee.</font></div><div style="margin-top:0.4pt;text-indent:72pt"><font><br></font></div><div style="padding-right:7.2pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt;text-decoration:underline">Complete Statement of Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Plan document (which incorporates the applicable Appendix(ces) by reference) contains a complete statement of the Plan&#8217;s terms and supersedes all prior statements with respect to the Plan&#8217;s terms. No other evidence, whether written or oral, shall be taken into account in interpreting the provisions of the Plan. In the event of a conflict between a provision in this Plan document and any booklet, brochure, presentation, or other communication (whether written or oral), the provision of this Plan document shall control. This Plan shall be the only plan, agreement or arrangement with respect to which benefits may be provided to an Eligible Employee upon a Qualifying Termination and supersedes all prior agreements, arrangements or related communications of the Company relating to separation benefits or accelerated vesting benefits for the Eligible Employees, whether formal or informal, or written or unwritten. </font></div><div style="padding-right:7.2pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="padding-right:7.2pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt;text-decoration:underline">Documentation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each Eligible Employee&#8217;s participation in the Plan will be evidenced in a Participation Agreement, which may be written or electronic, as the Administrator determines.  Each Participation Agreement may contain terms and conditions in addition to those set forth in the Plan. </font></div><div style="padding-left:72pt;padding-right:7.2pt;text-align:justify"><font><br></font></div><div style="padding-right:7.2pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">No Third-Party Beneficiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Plan shall not give any rights or remedies to any person other than Eligible Employees hereunder (or their estates or beneficiaries, in the event of an eligible employee&#8217;s death) and the Company.</font></div><div style="padding-right:7.2pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="padding-right:7.2pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt;text-decoration:underline">Funding and Payment of Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Plan shall be maintained in a manner to be considered &#8220;unfunded&#8221; for purposes of ERISA.  The Company shall be required to make payments only as benefits become due and payable.  No person shall have any right, other than the right of an unsecured general creditor against the Company, with respect to the benefits payable hereunder, or which may be payable hereunder, to any employee.  If the Company, acting in its sole discretion, establishes a reserve or other fund associated with this Plan, no person shall have any right to or interest in any specific amount or asset of such reserve or fund by reason of amounts which may be payable to such person under this Plan, nor shall such person have any right to receive any payment under this Plan except as and to the extent expressly provided in this Plan.  The assets in any such reserve or fund shall be part of the general assets of the Company, subject to the control of the Company.  </font></div><div style="padding-left:72pt;padding-right:7.2pt;text-align:justify"><font><br></font></div><div style="padding-right:7.2pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt;text-decoration:underline">Notices.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;Any notice required or permitted by this Plan shall be in writing and shall be delivered as follows with notice deemed given as indicated&#58; (a)&#160;by personal delivery when delivered personally&#59; (b)&#160;by overnight courier upon written verification of receipt&#59; (c)&#160;by telecopy or facsimile transmission upon acknowledgment of receipt of electronic transmission&#59; or (d)&#160;by certified or registered mail, return receipt requested, upon verification of receipt. Notice shall be sent to an Eligible Employee at the most recent address on the Company&#8217;s personnel records and to the Company at its principal place of business, or such other address as either party may specify in writing.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;padding-right:7.2pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">*  *  *  *  *  *  *  *</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><div id="i5f2d03cd949a4cbcb506c747e7fd841b_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 10.8</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">APPENDIX A</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">LIGAND PHARMACEUTICALS INCORPORATED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">AMENDED AND RESTATED SEVERANCE PLAN </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">PARTICIPATION AGREEMENT </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Participation Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) with respect to participation in the Ligand Pharmaceuticals Incorporated Amended and Restated Severance Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is made as of _______ by and between Ligand Pharmaceuticals Incorporated (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and _________ (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). Capitalized terms not otherwise defined herein shall have the meanings given to them in the Plan. </font></div><div style="text-align:justify;text-indent:24.5pt"><font><br></font></div><div style="text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, the Company has adopted and sponsors the Plan, a copy of which is attached hereto. </font></div><div style="text-align:justify;text-indent:24.5pt"><font><br></font></div><div style="text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, Employee has been selected to participate in the Plan in accordance with and subject to the terms of the Plan and this Agreement. </font></div><div style="text-align:justify;text-indent:24.5pt"><font><br></font></div><div style="text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NOW, THEREFORE, in consideration of the mutual promises made herein, the parties hereby agree as follows&#58; </font></div><div style="text-align:justify;text-indent:24.5pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1. &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Participation in the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Employee has been designated as an Eligible Employee in the Plan, subject to Employee executing this Agreement.  The terms and conditions of Employee&#8217;s participation in the Plan are as set forth in the Plan.  In the event of Employee&#8217;s Qualifying Termination, subject to satisfaction of the conditions set forth in the Plan, Employee will be eligible to receive the Severance Payments and Benefits set forth in Section&#160;6 of the Plan as follows&#58; </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:70.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #666666;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Cash Severance&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #666666;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">An amount equal to annual base salary, or annualized hourly wage rate, as applicable for (a)&#160;two months plus (b)&#160;one week for each 12-month period of continuous and uninterrupted (or, in the event of a partial year of service, continuous and uninterrupted service for at least six months and one day during such year) (such period, the &#8220;Severance Period&#8221;).</font></div></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:0.5pt solid #666666;border-top:0.5pt solid #666666;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Continued Health Benefits&#58;</font></td><td colspan="3" style="background-color:#cccccc;border-bottom:0.5pt solid #666666;border-top:0.5pt solid #666666;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">An amount equal to the portion of the COBRA coverage premiums that exceeds the employee contributions immediately prior to termination for the period beginning on the termination date and ending on the earlier of the last day of the Severance Period and the date on which the Employee becomes eligible to receive benefits under a &#8220;group health plan&#8221; of a subsequent employer.</font></div></td></tr></table></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The severance benefits and payments provided under the Plan are intended to be and are exclusive and in lieu of any other severance benefits and payments to which Employee may otherwise be entitled, either at law, tort, or contract, in equity, or under the Plan, in the event of any termination of Employee&#8217;s employment unless otherwise specifically agreed to by the Employee and the Company in an agreement entered into after the effective date of the Plan. Employee hereby waives his or her rights to any severance benefits provided under any other agreement with the Company or arrangement or plan sponsored by the Company.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2. &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Additional Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement and the Plan, constitute the entire agreement of the parties with respect to the subject matter hereof and supersede all prior agreements, written or oral. This Agreement may only be amended in writing signed by the parties hereto.  In the event of any conflict between this Agreement and the Plan, the Plan shall control. This Agreement may be executed in counterparts, and each counterpart shall have the same force and effect as an original and shall constitute an effective, binding agreement on the part of each of the undersigned. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Acknowledgment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  By his or her signature below, Employee agrees that participation in the Plan is governed by this Agreement and by the provisions of the Plan, a copy of which is attached hereto and made a part of this document. Employee acknowledges receipt of a copy of the Plan, represents that Employee has read and is familiar with its provisions and the provisions of this </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Agreement, and acknowledges that decisions and determinations by the Administrator under the Plan shall be final and binding on Employee.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(Signature Page Follows) </font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By electronically accepting and signing this Agreement, each of the Company and Employee hereby acknowledges, accepts and agrees to the terms of the Agreement as of the date first set forth above.</font></div><div style="text-indent:24.5pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">LIGAND PHARMACEUTICALS </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">INCORPORATED&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;EMPLOYEE&#58;</font></div><div style="text-indent:24.5pt"><font><br></font></div><div style="text-indent:24.5pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Print Name&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">APPENDIX B-1</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">RELEASE OF CLAIMS</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">&#91;FOR EMPLOYEES 40 AND OVER&#93;</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#91;The Release of Claims is subject to revision by the Company based on changes in applicable law or local law requirements based on Employee&#8217;s location or other updates based on best practices, as determined by the Administrator, in its sole discretion.&#93;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;This Release of Claims (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is entered into as of _________________, 20__, between &#91;__________&#93; (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and Ligand Pharmaceuticals Incorporated, a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; and, together with Employee, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), effective eight days after Employee&#8217;s signature hereto (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), unless Employee revokes Employee&#8217;s acceptance of this Release as provided in Paragraph 1(c), below.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Employee&#8217;s Release of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Employee agrees not to sue, or otherwise file any claim against, the Company or its parent companies, subsidiaries or affiliates, and any of their respective successors, assigns, directors, officers, managers, employees, attorneys, insurers, or agents, each in their respective capacities as such (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Company Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), for any reason whatsoever based on anything that has occurred at any time up to and including the  execution date of this Release as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">On behalf of Employee and Employee&#8217;s executors, administrators, heirs and assigns, Employee hereby releases and forever discharge the Company Parties, and all persons acting by, through, under or in concert with them, or any of them, of and from any and all manner of action or actions, cause or causes of action, in law or in equity, suits, debts, liens, contracts, agreements, promises, liability, claims, demands, damages, loss, cost or expense, of any nature whatsoever, known or unknown, fixed or contingent (hereinafter called &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), which Employee now have or may hereafter have against any of the Company Parties by reason of any matter, cause, or thing whatsoever from the beginning of time through and including the execution date of this Release, including, without limiting the generality of the foregoing&#58; any Claims arising directly or indirectly out of, relating to, or in any other way involving in any manner whatsoever Employee&#8217;s employment by the Company or its affiliates or the separation thereof, including without limitation any and all Claims arising under federal, state, or local laws relating to employment&#59; any Claims of any kind that may be brought in any court or administrative agency&#59; any Claims arising under the Age Discrimination in Employment Act, the Older Workers Benefits Protection Act, the Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1991, the Equal Pay Act, the Civil Rights Act of 1866, Section 1981, 42 U.S.C. &#167; 1981, the Family and Medical Leave Act of 1993, the Americans with Disabilities Act of 1990, the False Claims Act, the Employee Retirement Income Security Act, the Worker Adjustment and Retraining Notification Act, the Fair Labor Standards Act, the Sarbanes-Oxley Act of 2002, the National Labor Relations Act of 1935, the Uniformed Services Employment and Reemployment Rights Act of 1994, Fair Credit Reporting Act, or any similar state law,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> each of the foregoing as may have been amended, and any other federal, state, or local statute, regulation, ordinance, constitution, or order concerning labor or employment, termination of labor or employment, wages and benefits, retaliation, leaves of absence, or any other term or condition of employment&#59; Claims for breach of contract&#59; Claims for unfair business practices&#59; Claims arising in tort, including, without limitation, Claims of wrongful dismissal or discharge, discrimination, harassment, retaliation, fraud, misrepresentation, defamation, libel, infliction of emotional distress, violation of public policy, and&#47;or breach of the implied covenant of good faith and fair dealing&#59; and Claims for damages or other remedies of any sort, including, without limitation, compensatory damages, punitive damages, injunctive relief and attorney&#8217;s fees. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Notwithstanding the generality of the foregoing, Employee does not release any Claims that cannot be released as a matter of law including, without limitation, (i) </font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> NTD&#58; To include applicable state statutes based on participant&#8217;s state of employment.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Employee&#8217;s right to file for unemployment insurance benefits or any state disability insurance benefits pursuant to the terms of applicable state law&#59; (ii) Employee&#8217;s right to file claims for workers&#8217; compensation insurance benefits under the terms of any worker&#8217;s compensation insurance policy or fund of the Company&#59; (iii) Employee&#8217;s right to file a charge of discrimination, harassment, interference with leave rights, failure to accommodate, or retaliation with the Equal Employment Opportunity Commission or any other federal, state or local government agency, or to cooperate with or participate in any investigation conducted by such agency&#59; provided, however, that Employee hereby releases Employee&#8217;s right to receive damages in any such proceeding brought by Employee or on Employee&#8217;s behalf&#59; (iv) Employee&#8217;s right to communicate directly with the U.S. Securities and Exchange Commission, the U.S. Commodity Futures Trading Commission, the U.S. Department of Justice or similar agency, or to cooperate with or participate in any investigation by such agency&#59; or (v) Employee&#8217;s right to make any disclosure that are protected under the whistleblower provisions of applicable law.  For the avoidance of doubt, Employee does not need to notify or obtain the prior authorization of the Company to exercise any of the foregoing rights.  Furthermore, Employee does not release hereby any rights that Employee may have relating to (A) indemnification by the Company or its affiliates under any indemnification agreement with the Company, the Company&#8217;s Bylaws or any applicable law or under any applicable insurance policy with respect to Employee&#8217;s liability as an employee of the Company&#59; (B) Employee&#8217;s vested accrued benefits under the Company&#8217;s respective benefits and compensation plans&#59; and (C) any severance payment entitlements to which Employee is specifically entitled to as of the date of termination pursuant to the Ligand Pharmaceuticals Incorporated Amended and Restated Severance Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Severance Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">EMPLOYEE ACKNOWLEDGES THAT EMPLOYEE HAS BEEN ADVISED OF AND IS FAMILIAR WITH THE PROVISIONS OF CALIFORNIA CIVIL CODE SECTION 1542, WHICH PROVIDES AS FOLLOWS&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#8220;A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY, AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.&#8221;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BEING AWARE OF SAID CODE SECTION, EMPLOYEE HEREBY EXPRESSLY WAIVES ANY RIGHTS HE OR SHE MAY HAVE THEREUNDER, AS WELL AS UNDER ANY OTHER STATUTES OR COMMON LAW PRINCIPLES OF SIMILAR EFFECT.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Employee acknowledges that the General Release of Claims set forth in Section 1(a) above includes a release of Claims under the Age Discrimination in Employment Act (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">ADEA Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). In accordance with the Older Workers Benefit Protection Act, Employee acknowledges as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">Employee has been advised to consult an attorney of Employee&#8217;s choice before signing this Release and Employee either has so consulted with counsel or voluntarily decided not to consult with counsel&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">Employee has been granted &#91;twenty-one (21)&#93; &#91;forty-five (45)&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> days after Employee is presented with this Release to decide whether or not to sign it. Employee agrees that such period shall not be extended due to any material or immaterial changes to the Release. If Employee executes this Release prior to the expiration of such period, Employee does so voluntarily and after having had the opportunity to consult with an attorney, and hereby waive the remainder of the &#91;twenty-one (21)&#93; &#91;forty-five (45)&#93; day period&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">Employee has carefully reviewed and considered and fully understand the terms set forth in this Release, including all exhibits hereto&#59; </font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> NTD&#58; To be 45 days for a group termination and 21 days for a non-group termination.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">&#91;Employee understands that </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Attachment 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> to this Release is a list of the job titles and ages for all individuals in Employee&#8217;s decisional unit who have been selected for the program, as well as the job titles and ages of all individuals in Employee&#8217;s decisional unit who have not been selected for the program, as of &#91;_____&#93;, the date the Company provided this Release to Employee&#59;&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Employee has the right to revoke Employee&#8217;s ADEA Release within seven (7) calendar days of signing this Release. If Employee wishes to revoke Employee&#8217;s ADEA Release, Employee must deliver written notice stating Employee&#8217;s intent to so revoke to &#91;Insert Name&#47;Contact Information&#93;, on or before 5&#58;00 p.m. on the seventh (7th) day after the date on which Employee signs this Release.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Employee acknowledges that Employee will not be entitled to the severance benefits under the Severance Plan unless this Release is effective within &#91;____&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> days following the Employee&#8217;s Date of Termination (as defined in the Severance Plan).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Employee Representations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Employee represents and warrants that&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Employee has returned to the Company all Company property in Employee&#8217;s possession (other than any property that the Company has specifically permitted the Employee to keep following his or her Date of Termination in writing), including without limitation, any cell phone, laptop computer or tablet&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Employee is not owed wages, commissions, bonuses or other compensation, other than wages through the Date of Termination of Employee&#8217;s employment and any accrued, unused vacation or paid time off earned through such date, other than as set forth in the Severance Plan&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">During the course of Employee&#8217;s employment, Employee did not sustain any injuries for which Employee might be entitled to compensation pursuant to worker&#8217;s compensation law or Employee has disclosed any injuries of which Employee is currently, reasonably aware for which Employee might be entitled to compensation pursuant to worker&#8217;s compensation law&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Employee has not initiated any adversarial proceedings of any kind against the Company or its affiliates or, in their capacities as such, against any other person or entity released herein, nor will Employee do so in the future, except as specifically allowed by this Release.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Restrictive Covenants&#59; Cooperation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Employee reaffirms Employee&#8217;s continuing obligations under Section 8 of the Plan.  In addition, Employee shall cooperate with the Company and its affiliates, upon the Company&#8217;s reasonable request, with respect to any internal investigation or administrative, regulatory or judicial proceeding involving matters within the scope of Employee&#8217;s duties and responsibilities to the Company or its affiliates during Employee&#8217;s employment with the Company (including, without limitation, Employee being available to the Company upon reasonable notice for interviews and factual investigations, appearing at the Company&#8217;s reasonable request to give testimony without requiring service of a subpoena or other legal process, and turning over to the Company all relevant Company documents which are or may have come into Employee&#8217;s possession during his or her employment)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that any such request by the Company shall not be unduly burdensome or interfere with Employee&#8217;s personal schedule&#160;or ability to engage in gainful employment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:27.75pt;text-decoration:underline">WARN Offset</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  Without limiting Section 7(b) of the Severance Plan, Employee acknowledges and agrees that, unless otherwise determined by the Administrator (as defined in the Severance Plan), Employee&#8217;s severance benefits pursuant to the Severance Plan shall be reduced, in whole or in part, by any other severance benefits, pay in lieu of notice, or other </font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> NTD&#58; To be included for group termination.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> NTD&#58; To be 55 days for a group termination and 30 days for a non-group termination.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">similar benefits payable to Employee by the Company that become payable in connection with Employee&#8217;s termination of employment pursuant to any applicable legal requirement, including, without limitation, the Worker Adjustment and Retraining Notification Act or any similar state or local statute, rule or regulation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The provisions of this Release are severable.  If any provision is held to be invalid or unenforceable, it shall not affect the validity or enforceability of any other provision.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Choice of Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Release shall in all respects be governed and construed in accordance with the laws of the State of &#91;____&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, including all matters of construction, validity and performance, without regard to conflicts of law principles.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Integration Clause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Release, and the Severance Plan contain the Parties&#8217; entire agreement with regard to the separation of Employee&#8217;s employment, and supersede and replace any prior agreements as to those matters, whether oral or written. This Release may not be changed or modified, in whole or in part, except by an instrument in writing signed by Employee and a duly authorized officer or director of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Execution in Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Release may be executed in counterparts with the same force and effectiveness as though executed in a single document.  Facsimile signatures shall have the same force and effectiveness as original signatures.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Intent to be Bound</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Parties have carefully read this Release in its entirety&#59; fully understand and agree to its terms and provisions&#59; and intend and agree that it is final and binding on all Parties.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(Signature Page Follows)</font></div><div style="margin-top:14.4pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> NTD&#58; To be the employee&#8217;s state of employment.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, and intending to be legally bound, the Parties have executed the foregoing on the dates shown below.</font></div><div style="text-align:center"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">EMPLOYEE</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">LIGAND PHARMACEUTICALS INCORPORATED</font></td></tr><tr style="height:66pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:8pt;padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="margin-bottom:8pt;padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="margin-bottom:8pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:8pt;padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="margin-bottom:8pt;padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="margin-bottom:8pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58;</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">ATTACHMENT 1 TO APPENDIX B-1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Older Worker Benefit Protection Act Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#93;</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;To be included if applicable&#93;</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><div id="i5f2d03cd949a4cbcb506c747e7fd841b_7"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">APPENDIX B-2</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">RELEASE OF CLAIMS</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">&#91;FOR EMPLOYEES UNDER 40&#93;</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#91;The Release of Claims is subject to revision by the Company based on changes in applicable law or local law requirements based on Employee&#8217;s location or other updates based on best practices, as determined by the Administrator, in its sole discretion.&#93;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;This Release of Claims (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is entered into as of _________________, 20__, between &#91;__________&#93; (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and Ligand Pharmaceuticals Incorporated, a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; and, together with Employee, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), effective as of Employee&#8217;s signature hereto (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Employee&#8217;s Release of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Employee agrees not to sue, or otherwise file any claim against, the Company or its parent companies, subsidiaries or affiliates, and any of their respective successors, assigns, directors, officers, managers, employees, attorneys, insurers, or agents, each in their respective capacities as such (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Company Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), for any reason whatsoever based on anything that has occurred at any time up to and including the  execution date of this Release as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">On behalf of Employee and Employee&#8217;s executors, administrators, heirs and assigns, Employee hereby releases and forever discharge the Company Parties, and all persons acting by, through, under or in concert with them, or any of them, of and from any and all manner of action or actions, cause or causes of action, in law or in equity, suits, debts, liens, contracts, agreements, promises, liability, claims, demands, damages, loss, cost or expense, of any nature whatsoever, known or unknown, fixed or contingent (hereinafter called &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), which Employee now have or may hereafter have against any of the Company Parties by reason of any matter, cause, or thing whatsoever from the beginning of time through and including the execution date of this Release, including, without limiting the generality of the foregoing&#58; any Claims arising directly or indirectly out of, relating to, or in any other way involving in any manner whatsoever Employee&#8217;s employment by the Company or its affiliates or the separation thereof, including without limitation any and all Claims arising under federal, state, or local laws relating to employment&#59; any Claims of any kind that may be brought in any court or administrative agency&#59; any Claims arising under the Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1991, the Equal Pay Act, the Civil Rights Act of 1866, Section 1981, 42 U.S.C. &#167; 1981, the Family and Medical Leave Act of 1993, the Americans with Disabilities Act of 1990, the False Claims Act, the Employee Retirement Income Security Act, the Worker Adjustment and Retraining Notification Act, the Fair Labor Standards Act, the Sarbanes-Oxley Act of 2002, the National Labor Relations Act of 1935, the Uniformed Services Employment and Reemployment Rights Act of 1994, Fair Credit Reporting Act, or any similar state law,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> each of the foregoing as may have been amended, and any other federal, state, or local statute, regulation, ordinance, constitution, or order concerning labor or employment, termination of labor or employment, wages and benefits, retaliation, leaves of absence, or any other term or condition of employment&#59; Claims for breach of contract&#59; Claims for unfair business practices&#59; Claims arising in tort, including, without limitation, Claims of wrongful dismissal or discharge, discrimination, harassment, retaliation, fraud, misrepresentation, defamation, libel, infliction of emotional distress, violation of public policy, and&#47;or breach of the implied covenant of good faith and fair dealing&#59; and Claims for damages or other remedies of any sort, including, without limitation, compensatory damages, punitive damages, injunctive relief and attorney&#8217;s fees. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Notwithstanding the generality of the foregoing, Employee does not release any Claims that cannot be released as a matter of law including, without limitation, (i) Employee&#8217;s right to file for unemployment insurance benefits or any state disability insurance benefits pursuant to the terms of applicable state law&#59; (ii) Employee&#8217;s right to file claims for workers&#8217; compensation insurance benefits under the terms of any worker&#8217;s compensation insurance policy or fund of the Company&#59; (iii) Employee&#8217;s right to file a charge of discrimination, harassment, interference with leave rights, failure to accommodate, or retaliation with the Equal Employment Opportunity Commission or any other federal, state or local government agency, or to cooperate with or </font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> NTD&#58; To include applicable state statutes based on participant&#8217;s state of employment.</font></div><div style="height:58.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">participate in any investigation conducted by such agency&#59; provided, however, that Employee hereby releases Employee&#8217;s right to receive damages in any such proceeding brought by Employee or on Employee&#8217;s behalf&#59; (iv) Employee&#8217;s right to communicate directly with the U.S. Securities and Exchange Commission, the U.S. Commodity Futures Trading Commission, the U.S. Department of Justice or similar agency, or to cooperate with or participate in any investigation by such agency&#59; or (v) Employee&#8217;s right to make any disclosure that are protected under the whistleblower provisions of applicable law.  For the avoidance of doubt, Employee does not need to notify or obtain the prior authorization of the Company to exercise any of the foregoing rights.  Furthermore, Employee does not release hereby any rights that Employee may have relating to (A) indemnification by the Company or its affiliates under any indemnification agreement with the Company, the Company&#8217;s Bylaws or any applicable law or under any applicable insurance policy with respect to Employee&#8217;s liability as an employee of the Company&#59; (B) Employee&#8217;s vested accrued benefits under the Company&#8217;s respective benefits and compensation plans&#59; and (C) any severance payment entitlements to which Employee is specifically entitled to as of the date of termination pursuant to the Ligand Pharmaceuticals Incorporated Amended and Restated Severance Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Severance Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">EMPLOYEE ACKNOWLEDGES THAT EMPLOYEE HAS BEEN ADVISED OF AND IS FAMILIAR WITH THE PROVISIONS OF CALIFORNIA CIVIL CODE SECTION 1542, WHICH PROVIDES AS FOLLOWS&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#8220;A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.&#8221;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BEING AWARE OF SAID CODE SECTION, EMPLOYEE HEREBY EXPRESSLY WAIVES ANY RIGHTS HE OR SHE MAY HAVE THEREUNDER, AS WELL AS UNDER ANY OTHER STATUTES OR COMMON LAW PRINCIPLES OF SIMILAR EFFECT.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Employee acknowledges that Employee will not be entitled to the severance benefits under the Severance Plan unless this Release is effective within 10 days following the Employee&#8217;s Date of Termination (as defined in the Severance Plan).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Employee Representations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Employee represents and warrants that&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Employee has returned to the Company all Company property in Employee&#8217;s possession (other than any property that the Company has specifically permitted the Employee to keep following his or her Date of Termination in writing), including without limitation, any cell phone, laptop computer or tablet&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Employee is not owed wages, commissions, bonuses or other compensation, other than wages through the Date of Termination of Employee&#8217;s employment and any accrued, unused vacation or paid time off earned through such date, other than as set forth in the Severance Plan&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">During the course of Employee&#8217;s employment, Employee did not sustain any injuries for which Employee might be entitled to compensation pursuant to worker&#8217;s compensation law or Employee has disclosed any injuries of which Employee is currently, reasonably aware for which Employee might be entitled to compensation pursuant to worker&#8217;s compensation law&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Employee has not initiated any adversarial proceedings of any kind against the Company or its affiliates or, in their capacities as such, against any other person or entity released herein, nor will Employee do so in the future, except as specifically allowed by this Release.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Restrictive Covenants&#59; Cooperation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Employee reaffirms Employee&#8217;s continuing obligations under Section 8 of the Plan.  In addition, Employee shall cooperate with the Company and its affiliates, upon the Company&#8217;s reasonable request, with respect to any internal investigation or </font></div><div style="height:58.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">administrative, regulatory or judicial proceeding involving matters within the scope of Employee&#8217;s duties and responsibilities to the Company or its affiliates during Employee&#8217;s employment with the Company (including, without limitation, Employee being available to the Company upon reasonable notice for interviews and factual investigations, appearing at the Company&#8217;s reasonable request to give testimony without requiring service of a subpoena or other legal process, and turning over to the Company all relevant Company documents which are or may have come into Employee&#8217;s possession during his or her employment)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that any such request by the Company shall not be unduly burdensome or interfere with Employee&#8217;s personal schedule&#160;or ability to engage in gainful employment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:27.75pt;text-decoration:underline">WARN Offset</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  Without limiting Section 7(b) of the Severance Plan, Employee acknowledges and agrees that, unless otherwise determined by the Administrator (as defined in the Severance Plan), Employee&#8217;s severance benefits pursuant to the Severance Plan shall be reduced, in whole or in part, by any other severance benefits, pay in lieu of notice, or other similar benefits payable to Employee by the Company that become payable in connection with Employee&#8217;s termination of employment pursuant to any applicable legal requirement, including, without limitation, the Worker Adjustment and Retraining Notification Act or any similar state or local statute, rule or regulation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The provisions of this Release are severable.  If any provision is held to be invalid or unenforceable, it shall not affect the validity or enforceability of any other provision.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Choice of Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Release shall in all respects be governed and construed in accordance with the laws of the State of &#91;____&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, including all matters of construction, validity and performance, without regard to conflicts of law principles.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Integration Clause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Release, and the Severance Plan contain the Parties&#8217; entire agreement with regard to the separation of Employee&#8217;s employment, and supersede and replace any prior agreements as to those matters, whether oral or written. This Release may not be changed or modified, in whole or in part, except by an instrument in writing signed by Employee and a duly authorized officer or director of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Execution in Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Release may be executed in counterparts with the same force and effectiveness as though executed in a single document.  Facsimile signatures shall have the same force and effectiveness as original signatures.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Intent to be Bound</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Parties have carefully read this Release in its entirety&#59; fully understand and agree to its terms and provisions&#59; and intend and agree that it is final and binding on all Parties.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(Signature Page Follows)</font></div><div style="margin-top:14.4pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> NTD&#58; To be the employee&#8217;s state of employment.</font></div><div style="height:58.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, and intending to be legally bound, the Parties have executed the foregoing on the dates shown below.</font></div><div style="text-align:center"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.014%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">EMPLOYEE</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">LIGAND PHARMACEUTICALS INCORPORATED</font></td></tr><tr style="height:66pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:8pt;padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="margin-bottom:8pt;padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="margin-bottom:8pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:8pt;padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="margin-bottom:8pt;padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="margin-bottom:8pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58;</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:58.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><div id="i5f2d03cd949a4cbcb506c747e7fd841b_10"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">APPENDIX C</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">DETAILED CLAIMS PROCEDURES</font></div><div style="margin-top:3.9pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:27.75pt">Claims Procedure</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Claims for benefits under the Plan shall be administered in accordance with Section 503 of ERISA and the Department of Labor Regulations thereunder. The Administrator shall make all determinations as to the rights of any Claimant.  A Claimant may authorize a representative to act on his or her behalf with respect to any claim under the Plan.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Initial Claims</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">All claims shall be presented to the Administrator in writing at the address in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Appendix D</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Within ninety (90) days after receiving a claim, a claims official appointed by the Administrator shall consider the claim and issue his or her determination thereon in writing.  If the Administrator or claims official determines that an extension of time is necessary, the claims official may extend the determination period for up to an additional ninety (90) days by giving the Claimant written notice indicating the special circumstances requiring the extension of time prior to the termination of the initial ninety (90) day period and the date by which the Administrator expects to render a decision.  Any claims that the Claimant does not pursue in good faith through the initial claims stage, such as by failing to file a timely claim, shall be treated as having been irrevocably waived.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Claims Decisions</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If the claim is granted, the benefits or relief the Claimant seeks shall be provided.  If the claim is wholly or partially denied, the claims official shall, within ninety (90) days (or a longer period, as described above), provide the Claimant with written notice of the denial, setting forth, in a manner calculated to be understood by the Claimant&#58; (1) the specific reason or reasons for the denial&#59; (2) specific references to the Plan provisions on which the denial is based&#59; (3) a description of any additional material or information necessary for the Claimant to perfect the claim, together with an explanation of why the material or information is necessary&#59; and (4) an explanation of the procedures for appealing denied claims and time limits applicable to such procedures, including a statement of the Claimant&#8217;s right to bring an action under Section 502(a) of ERISA after receiving a final adverse benefit determination upon appeal.  If the Claimant can establish that the claims official has failed to respond to the claim in a timely manner, the Claimant may treat the claim as having been denied by the claims official.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Appeals of Denied Claims</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each Claimant shall have the opportunity to appeal the claims official&#8217;s denial of a claim. All appeals shall be presented to the Administrator in writing at the address in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Appendix D</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The appeal will be reviewed by the Administrator or its designee (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">appeals official</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). A Claimant must appeal a denied claim within sixty (60) days after receipt of written notice of denial of the claim, or within sixty (60) days after it was due if the Claimant did not receive it by its due date, subject to the temporary extension of deadlines described in the paragraph below.  The Claimant shall have the opportunity to submit written comments, documents, records and other information relating to the Claimant&#8217;s claim.  The Claimant (or the Claimant&#8217;s duly authorized representative) shall be provided upon request and free of charge, reasonable access to, and copies of, all documents, records and other information relevant to the Claimant&#8217;s claim.  The appeals official shall take into account during its review all comments, documents, records and other information submitted by the Clamant relating to the claim, without regard to whether such information was submitted or considered in the initial benefits review.  Any claims that the Claimant does not pursue in good faith through the appeals stage, such as by failing to file a timely appeal request, shall be treated as having been irrevocably waived.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Temporary Extension of Deadlines to File Claims and Appeals</font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Employee Benefits Security Administration, Department of Labor, Internal Revenue Service and Department of the Treasury (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Agencies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) issued COVID-19-related relief to temporarily extend the deadlines to file ERISA claims and appeals.  Under this relief, the period from March 1, 2020 until sixty (60) days after the announced end of the national emergency (or such other date announced by the Agencies) will be disregarded in determining the deadlines for a Claimant to file claims and appeals under Section 14.3 and this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Appendix C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, provided, however, that no more than one (1) year will be disregarded in determining a given deadline.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Appeals Decisions</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The decision by the appeals official shall be made not later than sixty (60) days after the written appeal is received by the Administrator, however, if the appeals official determines that an extension of time is necessary, the appeals official may extend the determination period for up to an additional sixty (60) days by giving the Claimant written notice prior to the termination of the initial sixty (60) day period indicating the special circumstances requiring the extension of time and the date by which a determination on appeal is expected to be rendered. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">However, if the appeals official is a committee that meets at least quarterly, then the decision by the appeals official shall be made not later than the date of the meeting that immediately follows the Plan&#8217;s receipt of an appeal request, unless the appeal request is filed within thirty (30) days preceding the date of such meeting. In such case, a benefit determination may be made by no later than the date of the second meeting following the Plan&#8217;s receipt of the appeal request.  If special circumstances require a further extension of time for processing, a benefit determination shall be rendered no later than the third meeting of the appeals official following the Plan&#8217;s receipt of the appeal request.  If such an extension of time for review is required, the appeals official shall provide the Claimant with written notice of the extension, describing the special circumstances and the date as of which the benefit determination will be made, prior to the commencement of the extension. The appeals official shall notify the Claimant of the benefit determination as soon as possible but not later than five (5) days after it has been made.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The appeal decision shall be in writing, shall be set forth in a manner calculated to be understood by the Claimant and shall include the following&#58; (1) the specific reason or reasons for the denial&#59; (2) specific references to the Plan provisions on which the denial is based&#59; (3) a statement that the Claimant is entitled to receive, upon request and free of charge, reasonable access to, and copies of, all documents, records and other information relevant to the Claimant&#8217;s claim&#59; and (4) a statement of the employee&#8217;s right to bring an action under Section 502(a) of ERISA.  If a Claimant does not receive the appeal decision by the date it is due, the Claimant may deem the appeal to have been denied.  Subject to applicable law, any decision made in accordance with the claims procedures in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Appendix C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> is final and binding on all parties and shall be given the maximum possible deference allowed by law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Procedures</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Administrator shall adopt procedures by which initial claims shall be considered and appeals shall be resolved&#59; different procedures may be established for different claims.  All procedures shall be designed to afford a Claimant full and fair consideration of his or her claim and appeal.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhaustion&#59; Judicial Proceedings</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No action at law or in equity shall be brought to recover benefits under the Plan until the claim and appeal rights described in the Plan have been exercised and the Plan benefits requested in such appeal have been denied in whole or in part. If any judicial proceeding is undertaken to appeal the denial of a claim, the evidence presented may be strictly limited to the evidence timely presented to the Administrator and the appeals official. Any such judicial proceeding must be filed by the earlier of&#58; (a) one year after the final decision regarding the appeal or (b) one year after the Participant or other Claimant commenced payment of the Plan benefits at issue in the judicial proceeding.</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">APPENDIX D</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ADDITIONAL INFORMATION</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RIGHTS UNDER ERISA</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">As a participant in the Plan, you are entitled to certain rights and protections under ERISA.  ERISA provides that all Plan participants will be entitled to&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Receive Information About Your Plan and Benefits</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt">Examine, without charge, at the Company&#8217;s headquarters, all documents governing the Plan, and a copy of the latest annual report (Form 5500 Series) filed by the Plan with U.S. Department of Labor and available at the Public Disclosure Room of the Pension and Welfare Benefit Administration, if any.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt">Obtain, upon written request to the Administrator, copies of documents governing the operation of the Plan, including copies of the latest annual report (Form 5500 Series), if any, and updated summary plan description.  The Administrator may make a reasonable charge for the copies.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt">Receive a summary of the Plan&#8217;s annual financial report, if any.  The Administrator is required by law to furnish each participant with a copy of this summary annual report.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Prudent Actions by Plan Fiduciaries</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In addition to creating rights for Plan participants, ERISA imposes duties upon the people who are responsible for the operation of the employee benefit plan. The people who operate your Plan, called &#8220;fiduciaries&#8221; of the Plan, have a duty to do so prudently and in the interest of you and other Plan participants and beneficiaries.  No one, including the Company, or any other person, may fire you or otherwise discriminate against you in any way to prevent you from obtaining a welfare benefit or exercising your right under ERISA.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Enforce Your Rights</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If your claim for a welfare benefit is denied or ignored, in whole or in part, you have a right to know why this was done, to obtain copies of documents relating to the decision without charge, and to appeal any denial, all within certain time schedules.  Under ERISA, there are steps you can take to enforce the above rights.  For instance, if you request a copy of plan documents or the latest annual report from the Plan and do not receive them within thirty (30) days, you may file suit in a Federal court.  In such a case, the court may require the Administrator to provide the materials and pay you up to $110 a day until you receive the materials, unless the materials were not sent because of reasons beyond the control of the Administrator.  If you have a claim for benefits, which is denied or ignored, in whole or in part, you may file suit in a state or Federal court.  If it should happen that Plan fiduciaries misuse the Plan&#8217;s money, or if you are discriminated against for asserting your rights, you may seek assistance from the U.S. Department of Labor, or you may file suit in a federal court.  The court will decide who should pay court costs and legal fees.  If you are successful, the court may order the person you have sued to pay these costs and fees.  If you lose, the court may order you to pay these costs and fees, for example, if it finds your claim is frivolous.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Assistance with Your Questions</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If you have any questions about your Plan, you should contact the Administrator.  If you should have any questions about this statement or about your rights under ERISA, or if you need assistance in obtaining documents from the Administrator, you should contact the nearest office of the Employee Benefits Security Administration, U.S.&#160;Department of Labor, listed in your telephone directory or the Division of Technical Assistance and Inquiries, Employee Benefits Security Administration, U.S. Department of Labor, 200 Constitution Avenue N.W., Washington, D.C. 20210.  You may also obtain certain publications about your rights and responsibilities under ERISA by calling the publications hotline of the Employee Benefits Security Administration.</font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.502%"><tr><td style="width:1.0%"></td><td style="width:36.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:61.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Administrative Information</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name of Plan&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ligand Pharmaceuticals Incorporated Amended and Restated Severance Plan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Plan Sponsor&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ligand Pharmaceuticals Incorporated</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3911 Sorrento Valley Blvd, Suite 110</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">San Diego, CA 92121-1457</font></div><div style="margin-bottom:6pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Tel&#58; (858) 550-7500</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Plan Administrator&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Human Capital Management and Compensation Committee of the Board of Directors of Ligand Pharmaceuticals Incorporated</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3911 Sorrento Valley Blvd, Suite 110</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">San Diego, CA 92121-1457</font></div><div style="margin-bottom:6pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Tel&#58; (858) 550-7500</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Type of Administration&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Self-Administered</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Type of Plan&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Severance Pay Employee Welfare Benefit Plan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Employer Identification Number&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">77-0160744</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Direct Questions Regarding the Plan to&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">General Counsel</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ligand Pharmaceuticals Incorporated</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3911 Sorrento Valley Blvd, Suite 110</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">San Diego, CA 92121-1457</font></div><div style="margin-bottom:6pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Tel&#58; (858) 550-7500</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Agent for Service of Legal Process&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">General Counsel</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ligand Pharmaceuticals Incorporated</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3911 Sorrento Valley Blvd, Suite 110</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">San Diego, CA 92121-1457</font></div><div style="margin-bottom:6pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Tel&#58; (858) 550-7500</font></div><div style="margin-bottom:6pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Service of Legal Process may also be made upon the Plan Administrator.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Plan Year End&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Plan Number&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">502</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Funding&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Plan is unfunded. Plan benefits are paid as needed from the general assets of the Company.</font></td></tr><tr style="height:19pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:3.9pt"><font><br></font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.9
<SEQUENCE>3
<FILENAME>exhibit_109xliganddirector.htm
<DESCRIPTION>EX-10.9
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ib49773a0b34b481ebe33574825c243c4_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.9</font></div></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIGAND PHARMACEUTICALS INCORPORATED </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DIRECTOR COMPENSATION AND STOCK OWNERSHIP POLICY </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Amended and Restated Effective April 13, 2020) </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">I. DIRECTOR COMPENSATION </font></div><div style="margin-top:9pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-employee members of the board of directors (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) of Ligand Pharmaceuticals Incorporated (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) shall be eligible to receive cash and equity compensation effective as of April 13, 2020 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Restatement Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), as set forth in this Director Compensation Policy. The cash compensation and stock awards described in this Director Compensation Policy shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Independent Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) who may be eligible to receive such cash compensation or stock awards, unless such Independent Director declines the receipt of such cash compensation or stock awards by written notice to the Chairman of the Board. This Director Compensation Policy shall remain in effect until it is revised or rescinded by further action of the Board. The terms and conditions of this Director Compensation Policy shall supersede any prior cash or equity compensation arrangements between the Company and its directors. </font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt;text-decoration:underline">Cash Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:11.07pt;text-decoration:underline">Annual Retainer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Each Independent Director shall be eligible to receive an annual retainer of $50,000 for service on the Board. In addition, an Independent Director serving as&#58; </font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:3.73pt">chairman of the Board shall be eligible to receive an additional annual retainer of $30,000 for such service&#59; </font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:0.96pt">chairman of the Audit Committee shall be eligible to receive an additional annual retainer of $20,000 for such service&#59; </font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:34.19pt">members (other than the chairman) of the Audit Committee shall be eligible to receive an additional annual retainer of $10,000 for such service&#59;</font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:34.73pt">chairman of the Compensation Committee shall be eligible to receive an additional annual retainer of $15,000 for such service&#59; </font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:1.5pt">members (other than the chairman) of the Compensation Committee shall be eligible to receive an additional annual retainer of $7,500 for such service&#59; </font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">vi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:34.73pt">chairman of the Nominating and Corporate Governance Committee shall be eligible to receive an additional annual retainer of $10,000 for such service&#59; and </font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">vii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:31.96pt">members (other than the chairman) of the Nominating and Corporate Governance Committee shall be eligible to receive an additional annual retainer of $5,000 for such service. </font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt;text-decoration:underline">Payment of Cash Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Annual retainer fees shall be paid after each annual meeting of the Company&#8217;s stockholders in advance for the upcoming year of service and shall be prorated for the period of the year served for Independent Directors who are elected or appointed to the Board at a time other than the date of the annual meeting of the Company&#8217;s stockholders&#59; provided, however, that an Independent Director may elect in writing prior to the date of an annual meeting to receive all or a portion of his annual retainer fee in the form of such number of fully vested shares of the Company&#8217;s common stock as is equal to (i) the amount of the annual retainer the Independent Director has elected to receive in the form of shares of the Company&#8217;s common stock, divided by (ii) the closing price per share of the Company&#8217;s common stock on the Nasdaq Global Market (or such other established stock exchange or national quotation system on which the stock is quoted) on the date of the annual meeting. Committee retainer fees shall also be paid annually after each annual meeting of the Company&#8217;s stockholders in advance for the upcoming year of service and shall be prorated for any partial quarters served for Independent Directors who serve on a committee for a partial year.</font></div><div style="padding-left:72pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt;text-decoration:underline">Equity Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The Independent Directors shall be granted the following stock awards. The stock awards described below shall be granted under and shall be subject to the terms and provisions of the Company&#8217;s 2002 Stock Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">2002 Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) and shall be granted subject to the execution and delivery of award agreements, including attached exhibits, in substantially the same forms previously approved by the Board. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:11.07pt;text-decoration:underline">Initial Stock Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. A person who is initially elected or appointed to the Board on or after the Restatement Effective Date, and who was or is an Independent Director at the time of such initial election or appointment, shall be eligible to receive the following stock awards on the date of such initial election or appointment (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Initial Stock Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;)&#58; </font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:3.73pt">that number of restricted stock units determined by dividing (A) $145,000, by (B) the average closing price per share of the Company&#8217;s common stock on the Nasdaq Global Market (or such other established stock exchange or national quotation system on which the stock is quoted) for the 60-calendar day period prior to the date of grant&#59; and </font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:0.96pt">that number of stock options having a value of $280,000, calculated on the grant date in accordance with the Black-Scholes option pricing model (utilizing the same assumptions that the Company utilizes in preparation of its financial statements). </font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt;text-decoration:underline">Subsequent Stock Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. A person who is an Independent Director as of the date of each annual meeting of the Company&#8217;s stockholders and who is re-elected for another year of service as an Independent Director at such annual meeting automatically shall be eligible to receive the following stock awards on the date of each such annual meeting of the Company&#8217;s stockholders on or after the Restatement Effective Date (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Subsequent Stock Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;)&#58; </font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:3.73pt">that number of restricted stock units determined by dividing (A) $85,000, by (B) the average closing price per share of the Company&#8217;s common stock on the Nasdaq Global Market (or such other established stock exchange or national quotation system on which the stock is quoted) for the 60-calendar day period prior to the date of grant&#59; and </font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:0.96pt">that number of stock options having a value of $175,000, calculated on the grant date in accordance with the Black-Scholes option pricing model (utilizing the same assumptions that the Company utilizes in preparation of its financial statements). </font></div><div style="margin-top:9pt;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">An Independent Director elected for the first time to the Board at an annual meeting of stockholders shall only receive an Initial Restricted Stock grant in connection with such election, and shall not receive a Subsequent Restricted Stock grant on the date of such meeting as well. The stock awards described in this clause shall be referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Subsequent Stock Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.&#8221; </font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:11.07pt;text-decoration:underline">Termination of Employment of Employee Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Members of the Board who are employees of the Company or any parent or subsidiary of the Company who subsequently terminate their employment with the Company and any parent or subsidiary of the Company and remain on the Board will not receive any Initial Stock Awards pursuant to clause 2(a) above, but to the extent that they are otherwise eligible, will be eligible to receive, after termination from employment with the Company and any parent or subsidiary of the Company, Subsequent Stock Awards as described in clause 2(b) above. </font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt;text-decoration:underline">Vesting of Stock Awards Granted to Independent Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. </font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:3.73pt">Initial Stock Awards granted hereunder shall vest in three (3) equal annual installments on each of the first three (3) anniversaries following the date of grant, subject to the Independent Director&#8217;s continuing service on the Board through each such vesting date. </font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:0.96pt">Subsequent Stock Awards granted hereunder shall vest in full on the earlier of (A) the date of the annual meeting of the Company&#8217;s stockholders next following the grant date (it being understood that the Subsequent Stock Awards shall vest on the date of such annual meeting whether or not the Independent Director is re-elected at such meeting, so long as the Independent Director serves through such meeting) and (B) on the first anniversary of the date of grant, subject to the Independent Director&#8217;s continuing service on the Board through each such vesting date. </font></div><div style="padding-left:108pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:108pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:34.19pt">Any stock awards granted hereunder shall vest in full in the event of a Change in Control or a Hostile Take-Over (each as defined in the 2002 Plan) to the extent the Independent Director is serving on the Board at the time of such transaction or in the event an Independent Director ceases to serve on the Board by reason of death or Permanent Disability as defined in the 2002 Plan. </font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:34.73pt">Any unvested stock awards will be forfeited to the Company in the event an Independent Director ceases to serve on the Board prior to the vesting of such awards.</font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:11.07pt;text-decoration:underline">Effect of Termination of Board Service on Stock Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. An Independent Director shall be able to exercise his or her stock options that were vested at the time of his or her cessation of Board service until the first to occur of (i) the third anniversary of the date of his or her cessation of Board service, or (ii) the original expiration date of the term of such stock options. </font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:12.17pt;text-decoration:underline">Term of Stock Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Each stock option granted hereunder shall have a term of ten (10) years measured from the date of grant. </font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt;text-decoration:underline">Exercise Price of Stock Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The exercise price per share of any stock options granted hereunder shall be equal to one hundred percent (100%) of the Fair Market Value (as defined in the 2002 Plan) of the common stock on the date of grant. </font></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">II. DIRECTOR STOCK OWNERSHIP GUIDELINES </font></div><div style="margin-top:9pt;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Independent Directors are expected to own and hold shares of the Company&#8217;s common stock with a value equal to three times the annual cash retainer for service as an Independent Director (without regard to any retainers paid for committee service or service as chairman of the Board). The stock ownership level should be achieved by each Independent Director on or before April 30, 2014 or, if later, within three years after the Independent Director&#8217;s first appointment to the Board. </font></div><div style="margin-top:9pt;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock that counts toward satisfaction of these guidelines include&#58; shares of common stock owned outright by the Independent Director and his or her immediate family members who share the same household, whether held individually or jointly&#59; restricted stock where the restrictions have lapsed&#59; shares acquired upon stock option exercise&#59; shares purchased in the open market&#59; and shares held in trust for the benefit of the Independent Director or his or her family. Restricted stock units, which represent the right to receive shares, do not count towards satisfaction of these guidelines. Shares held in trust may be included. Due to the complexities of trust accounts, requests to include shares held in trust should be submitted to the Secretary of the Company and the Chairman of the Board will make the final decision as to whether to include those shares. </font></div><div style="margin-top:9pt;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">An Independent Director will be deemed to be in compliance with these guidelines if the Fair Market Value (as defined in the 2002 Plan) of the shares of the Company&#8217;s common stock held by such Independent Director on any date prior to the deadline for his or her compliance equals or exceeds the required multiple of his or her annual cash retainer. After meeting the requirements set forth in these guidelines, any subsequent decreases in the market value of the Company&#8217;s common stock shall not be considered, so long as the Independent Director continues to hold at least the same number of shares of the Company&#8217;s common stock as he or she did when the guidelines were first met or exceeded by such Independent Director. </font></div><div style="margin-top:9pt;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The guidelines may be waived for Independent Directors, at the discretion of the Board, if compliance would create hardship or prevent an Independent Director from complying with a court order, as in the case of a divorce settlement. </font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.14
<SEQUENCE>4
<FILENAME>exhibit1014_ligand-separat.htm
<DESCRIPTION>EX-10.14
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i6f5fb700acab458bb7537fa46ba70c13_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 10.14</font></div></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">SEPARATION AGREEMENT</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Separation Agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is made by and between Ligand Pharmaceuticals Incorporated (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and John Higgins (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), effective as of the Effective Date (as defined below). The Company and Executive are sometimes collectively referred to herein as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; and individually referred to as a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#8221;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">RECITALS</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, Executive is a party to that certain offer letter dated as of January 10, 2007, with the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Offer Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), that certain change in control severance agreement dated as of August 17, 2007, with the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Change in Control Severance Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and that certain proprietary information and inventions agreement dated as of January 16, 2007, with the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">PIIA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Executive was employed by the Company until December 5, 2022, when Executive&#8217;s employment terminated (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Executive has agreed to enter into a general release of claims in favor of the Company as a condition to receiving the Termination Benefits (as defined below) described in this Agreement&#59; and</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the Parties wish to resolve any and all disputes, claims, complaints, grievances, charges, actions, petitions and demands that Executive may have against the Company and any of the Releasees (as defined below), including, but not limited to, any and all claims arising out of or in any way related to Executive&#8217;s employment relationship with the Company and the termination of that relationship.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">NOW THEREFORE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">for good and valuable consideration, including the mutual promises and covenants made herein, the Company and Executive hereby agree as follows&#58;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">AGREEMENT</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Executive&#8217;s employment with the Company will terminate on the Termination Date.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Termination Date will be the termination date of Executive&#8217;s employment with the Company and any of its affiliates for all purposes, including active participation in and coverage under all benefit plans and programs sponsored by or through the Company and its affiliates, except as provided in this Agreement.  Executive hereby confirms his resignation from all positions he holds with the Company and any of its affiliates, including his position as Chief Executive Officer of the Company, effective as of the Termination Date.  In addition, Executive hereby irrevocably resigns as a member of the board of directors of the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), effective December 31, 2022.  In the event Executive&#8217;s service as a member of the Board does not terminate effective December 31, 2022, Executive shall not be eligible for any of the Termination Benefits hereunder, all of which shall be immediately forfeited. Executive shall execute any additional documentation necessary to effectuate the foregoing.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Payment of Salary and Receipt of All Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Accrued Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  On the first regularly scheduled payroll date following the Termination Date (or such earlier time required by applicable law), the Company will pay Executive all accrued but unpaid wages, including any accrued, unused vacation or paid time off, through the Termination Date.  Executive shall receive any other benefits due to Executive under any Company-provided plans, policies, and arrangements in accordance with such plans, policies or arrangement. Executive acknowledges and represents that, other than the consideration to be paid in accordance with this Section 2 or Section 3 below, the Company has paid or provided all salary, wages, bonuses, accrued vacation&#47;paid time off, premiums, leaves, housing allowances, relocation costs, interest, severance, outplacement costs, fees, reimbursable expenses, commissions, draws, stock, stock options or other equity awards (including restricted stock unit awards), vesting, and any and all other benefits and compensation due to Executive and that no other reimbursements or compensation are owed to Executive, including </font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">under the Company&#8217;s Amended and Restated Severance Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Severance Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and the Offer Letter.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Company will reimburse Executive for any and all reasonable and necessary business expenses incurred by Executive in connection with the performance of his job duties prior to the Termination Date in accordance with the Company&#8217;s policies, which expenses shall be submitted to the Company with supporting receipts and&#47;or documentation no later than thirty (30) days after the Termination Date.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(c) &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Subject to Section 3 below, and except as otherwise required by applicable law, Executive&#8217;s entitlement to health benefits from the Company, and eligibility to participate in the Company&#8217;s health benefit plans, shall cease on the last day of the calendar month during which the Termination Date occurs, except to the extent Executive elects to and is eligible to receive continued healthcare coverage pursuant to the provisions of the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">COBRA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), for himself and any covered dependents. Executive&#8217;s entitlement to other benefits from the Company, and eligibility to participate in the Company&#8217;s other benefit plans and programs, shall cease on the Termination Date.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Director Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary in the Company&#8217;s Director Compensation and Stock Ownership Policy, you will not be eligible for any compensation thereunder for the period commencing on the Termination Date and December 31, 2022.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Termination Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  In consideration for Executive&#8217;s agreement to be bound by the terms of this Agreement, including but not limited to the release of claims in Section 4, but subject to Executive&#8217;s continued compliance with the terms of this Agreement, including Section 9, and Executive&#8217;s resignation as a member of the Board effective December 31, 2022 in accordance with Section 1, the Company agrees to provide Executive with the following termination benefits (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Termination Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Subject to Sections 15(b) and (c), Executive shall be eligible to receive continued payment of Executive&#8217;s base salary at the rate in effect on the Termination Date ($730,455.12 per year) for a period of </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">eighteen (18) months following the Termination Date, in accordance with the Company&#8217;s then-current payroll policies and practices.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For the avoidance of doubt, Executive will not be entitled to any bonus, or pro-rated portion thereof, for fiscal year 2022.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Equity Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Notwithstanding any language to the contrary set forth in any award agreements issued to Executive under Company&#8217;s 2002 Stock Incentive Plan, upon the later of (i) the Effective Date or (ii) January 1, 2023, for awards the vesting of which is solely time-based and not subject to the satisfaction of a performance condition, the unvested portion of any such unvested stock option or restricted stock unit granted to Executive shall vest.  As of the later of (i) the Effective Date or (ii) January 1, 2023, all equity awards that are subject to the satisfaction of a performance condition (including, without limitation, all performance stock units granted to Executive), shall vest at the &#8220;target&#8221; levels and any remaining portion of such award not eligible to vest pursuant to this Section 3(b) shall terminate immediately upon the Termination Date. Executive&#8217;s equity awards as of the Termination Date are set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. For the avoidance of doubt, the foregoing acceleration pursuant to this Section 3(b) shall only apply to outstanding awards issued by the Company and shall not apply to any awards issued to Executive by OmniAb, Inc. (including any such awards issued to Executive by OmniAb, Inc. upon the conversion or adjustment of Company equity awards pursuant to that certain Amended and Restated Employee Matters Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Employee Matters Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), by and among the Company, OmniAb, Inc., Avista Public Acquisition Corp. II and Orwell Merger Sub Inc., dated as of August 18, 2022, or that certain Agreement and Plan of Merger, by and among the Company, OmniAb, Inc., Avista Public Acquisition Corp. II and Orwell Merger Sub Inc., a Delaware corporation, dated March 23, 2022) (together, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">OmniAb Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), which OmniAb Awards are not governed by the terms of this Agreement and shall instead be governed by the terms and conditions of the equity award agreements and the equity plan under which such equity awards were granted and the Employee Matters Agreement (including any accelerated vesting thereof as a result of Executive&#8217;s termination of employment with the Company and the accelerated vesting of his Company equity awards pursuant to this Section 3(b) in accordance with the equity award agreements and the equity plan under which such </font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">equity awards were granted and the Employee Matters Agreement). With respect to any tax withholding obligation arising in connection with the vesting and settlement of the restricted stock units or performance stock units held by Executive, the vesting of which will accelerate pursuant to this Section 3(b), such tax withholding obligation shall be automatically satisfied by means of the surrender or withholding of a net number of vested shares of Company common stock subject to such awards having a then current fair market value not exceeding the amount necessary to satisfy the tax withholding obligation of the Company based on the minimum applicable statutory withholding rates for federal, state and local income tax and payroll tax purposes, in accordance with the terms of the Company&#8217;s 2002 Stock Incentive Plan pursuant to which such equity awards were granted. Except as provided in Section 3(c), Executive&#8217;s vested Company equity awards shall be governed by the terms and conditions of the equity award agreements and the Company&#8217;s 2002 Stock Incentive Plan under which such equity awards were granted.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Extension of Post-Termination Exercise Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Notwithstanding anything to the contrary contained in the Company&#8217;s 2002 Stock Incentive Plan and the equity award agreements under which Executive&#8217;s outstanding stock options were granted&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(i)&#160;&#160;&#160;&#160;Subject to the terms and conditions contained in, and Executive&#8217;s continued compliance with, this Section 3(c), the period of time during which Executive may exercise his vested stock options following the Termination Date (after giving effect to the acceleration pursuant to Section 3(b) above) shall be extended to the earliest of (A) the second anniversary of the Termination Date or (B) the original ten-year expiration date of such options (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Exercise Period Extension</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  </font></div><div style="margin-bottom:3pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(ii)&#160;&#160;&#160;&#160;It shall be a condition to the Exercise Period Extension that Executive not sell, pledge, assign, hypothecate, transfer, or otherwise dispose of (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) on any single trading day occurring during the period commencing on the Termination Date and ending on the second anniversary of the Termination Date, shares of the Company&#8217;s common stock (including shares issuable upon vesting, settlement or exercise of stock options, restricted stock units or performance stock units) in an amount that is in excess of five percent (5%) of the average daily trading volume of the Company&#8217;s common stock for the preceding calendar week, other than Permitted Transfers.  For purposes of this Agreement, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Permitted Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; will include (A) the Transfer of any or all of the shares during Executive&#8217;s lifetime or upon Executive&#8217;s death by will or intestacy to Executive&#8217;s Immediate Family or a trust for the benefit of Executive&#8217;s Immediate Family (provided that such Immediate Family or trust agrees to be bound by the restrictions in this Section 3(c)), (B) any Transfer upon the occurrence of, and in connection with, a change in control of the Company, (C) any Transfer approved in writing by the Board, (D) any Transfer pursuant to the written trading plan adopted by the Executive on September 22, 2022, in accordance with Rule 10b5-1, or (E) any Transfer to the Company in connection with tax withholding by the Company as described in Section 3(b) above.  As used herein, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Immediate Family</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean Executive&#8217;s spouse, lineal descendant or antecedent, father, mother, brother or sister or stepchild (whether or not adopted). </font></div><div style="margin-bottom:3pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(iii)&#160;&#160;&#160;&#160;It shall be a further condition to the Exercise Period Extension that Executive not Transfer any of the shares of the Company&#8217;s common stock currently held by Executive in a brokerage account at Morgan Stanley or E*Trade (or any shares issuable upon vesting, settlement or exercise of stock options or restricted stock units after the Termination Date) to another account without the prior written consent of the Company.  Executive acknowledges and agrees that the Company may place restrictions on any such brokerage account to ensure Executive&#8217;s compliance with the restrictions in this Section 3(c).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(iv)&#160;&#160;&#160;&#160;In the event Executive breaches this Section 3(c) or Section 9, Executive&#8217;s ability to exercise his vested stock options shall immediately cease and all of Executive&#8217;s vested stock options shall cease to be exercisable on the date of such breach and shall be forfeited.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(v)&#160;&#160;&#160;&#160;Executive acknowledges that, as a result of the foregoing Exercise Period Extension, any outstanding stock option classified as an &#8220;incentive stock option&#8221; under Section 422 of the Internal Revenue Code of 1986, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), may be immediately reclassified as a non-qualified stock option, and that Executive, and not the Company, shall be solely responsible for any tax </font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">consequences relating to such reclassification (including as a result of any loss of incentive stock option treatment with respect to any outstanding stock options).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(vi)&#160;&#160;&#160;&#160;For the avoidance of doubt, the Exercise Period Extension shall only apply to outstanding awards issued by the Company and shall not apply to any OmniAb Awards, which OmniAb Awards are not governed by this Agreement and shall instead be governed by the terms and conditions of the equity award agreements and the equity plan under which such equity awards were granted and the Employee Matters Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Continuation Coverage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If Executive elects continuation coverage pursuant to COBRA within the time period prescribed pursuant to COBRA for Executive and Executive&#8217;s eligible dependents, then the Company will reimburse Executive for the COBRA premiums for such coverage (at the coverage levels in effect immediately prior to Executive&#8217;s termination) until the earlier of (i) a period of eighteen (18) months from the Termination Date or (ii) the date upon which Executive becomes covered under similar plans of a subsequent employer.  The reimbursements will be made by the Company to Executive consistent with the Company&#8217;s normal expense reimbursement policy.  Notwithstanding the first sentence of this Section 3(d), if the Company determines in its sole discretion that it cannot provide the foregoing benefit without potentially violating, or being subject to an excise tax under, applicable law (including, without limitation, Section 2716 of the Public Health Service Act), the Company will in lieu thereof provide to Executive a taxable monthly payment, payable on the last day of a given month, in an amount equal to the monthly COBRA premium that Executive would be required to pay to continue Executive&#8217;s group health coverage in effect on the termination of employment date (which amount will be based on the premium for the first month of COBRA coverage), which payments will be made regardless of whether Executive elects COBRA continuation coverage and will commence on the month following Executive&#8217;s termination of employment and will end on the earlier of (x) the date upon which Executive obtains other employment or (y) the date the Company has paid an amount equal to eighteen (18) such payments.  For the avoidance of doubt, the taxable payments in lieu of COBRA reimbursements may be used for any purpose, including, but not limited to continuation coverage under COBRA, and will be subject to all applicable tax withholdings.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Release of Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Executive agrees that the consideration to be paid in accordance with Section 3 of this Agreement represents settlement in full of all outstanding obligations owed to Executive by the Company and its current and former officers, directors, employees, agents, investors, attorneys, stockholders, administrators, affiliates, benefit plans, plan administrators, insurers, trustees, divisions, and subsidiaries, and predecessor and successor corporations and assigns (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Releasees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). Executive, on Executive&#8217;s own behalf and on behalf of Executive&#8217;s respective heirs, family members, executors, agents, and assigns, hereby and forever releases the Releasees from, and agrees not to sue concerning, or in any manner to institute, prosecute, or pursue, any claim, complaint, charge, duty, obligation, demand, or cause of action relating to any matters of any kind, whether presently known or unknown, suspected or unsuspected, that Executive may possess against any of the Releasees arising from any omissions, acts, facts, or damages that have occurred up until and including the date of Executive&#8217;s execution of this Agreement, including, without limitation the following&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;any and all claims relating to or arising from Executive&#8217;s employment relationship with the Company and the termination of that relationship&#59;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;any and all claims relating to, or arising from, Executive&#8217;s right to purchase, or actual purchase of shares of stock of the Company, including, without limitation, any claims for fraud, misrepresentation, breach of fiduciary duty, breach of duty under applicable state corporate law, and securities fraud under any state or federal law&#59;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)           any and all claims for wrongful discharge of employment&#59; termination in violation of public policy&#59; discrimination&#59; harassment&#59; retaliation&#59; breach of contract, both express and implied&#59; breach of covenant of good faith and fair dealing, both express and implied&#59; promissory estoppel&#59; negligent or intentional infliction of emotional distress&#59; fraud&#59; negligent or intentional misrepresentation&#59; negligent or intentional interference with contract or prospective economic advantage&#59; unfair business practices&#59; defamation&#59; libel&#59; slander&#59; negligence&#59; personal injury&#59; assault&#59; battery&#59; invasion of privacy&#59; false imprisonment&#59; conversion&#59; and disability benefits&#59;</font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;any and all claims for violation of any federal, state, or municipal statute, including, but not limited to, Title VII of the Civil Rights Act of 1964&#59; the Civil Rights Act of 1991&#59; the Rehabilitation Act of 1973&#59; the Americans with Disabilities Act of 1990&#59; the Equal Pay Act&#59; the Fair Labor Standards Act&#59; the Fair Credit Reporting Act&#59; the Age Discrimination in Employment Act of 1967&#59; the Older Workers Benefit Protection Act&#59; the Employee Retirement Income Security Act of 1974&#59; the Worker Adjustment and Retraining Notification Act&#59; the Family and Medical Leave Act&#59; the Sarbanes-Oxley Act of 2002&#59; the California Fair Employment and Housing Act, as amended, Cal. Lab. Code &#167; 12940 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">et seq.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; the California Equal Pay Law, as amended, Cal. Lab. Code &#167;&#167; 1197.5(a),1199.5&#59; the Moore-Brown-Roberti Family Rights Act of 1991, as amended, Cal. Gov&#8217;t Code &#167;&#167; 12945.2, 19702.3&#59; the California Labor Code&#59; the California Business &#38; Professions Code&#59; the California WARN Act, Cal. Lab. Code &#167; 1400 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">et seq.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; the California False Claims Act, Cal. Gov&#8217;t Code &#167; 12650 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">et seq.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; and the California Corporate Criminal Liability Act, Cal. Penal Code &#167; 387&#59;</font><font style="color:#000000;font-family:'Calibri Light',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the Minnesota&#160;Human Rights Act, Minn. Stat. Ann. &#167;&#167; 363A.01&#160;to&#160;363A.50&#59; the&#160;Minnesota&#160;Equal Pay for Equal Work Law, Minn. Stat. Ann. &#167;&#167; 181.66&#160;to&#160;181.71&#59; Minnesota&#8217;s age discrimination statute, Minn. Stat. Ann. &#167; 181.81&#59; Retaliatory discharge related to workers' compensation, Minn. Stat. Ann. &#167; 176.82, subdiv. 1&#59; Minnesota&#8217;s whistleblower protection statutes, Minn. Stat. Ann. &#167;&#167; 181.932&#160;and&#160;181.935&#59; Minnesota&#8217;s family leave statute, Minn. Stat. Ann. &#167;&#167; 181.940&#160;to&#160;181.944&#59; Minnesota&#8217;s personnel record access statutes, Minn. Stat. Ann. &#167;&#167; 181.960&#160;to&#160;181.967&#59;</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(e)           any and all claims for violation of the federal, or any state, constitution&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)      any and all claims arising out of any other laws and regulations relating to employment or employment discrimination&#59;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)           any claim for any loss, cost, damage, or expense arising out of any dispute over the non-withholding or other tax treatment of any of the proceeds received by Executive as a result of this Agreement&#59; and</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)           any and all claims for attorneys&#8217; fees and costs.</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Executive agrees that the release set forth in this Section 4 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) will be and remain in effect in all respects as a complete general release as to the matters released. The Release does not release claims that cannot be released as a matter of law. Executive represents that Executive has made no assignment or transfer of any right, claim, complaint, charge, duty, obligation, demand, cause of action, or other matter waived or released by this Section 4. Nothing in this Agreement waives (i) Executive&#8217;s rights to indemnification or any payments under any fiduciary insurance policy, if any, provided by any act or agreement of the Company, state or federal law or policy of insurance, or any other indemnification rights to which Executive may be entitled under the Company&#8217;s Certificate of Incorporation or Bylaws, by contract, as a matter of law, or otherwise, or under any power that the Company may have to indemnify Executive or hold Executive harmless&#59; (ii) any vested rights Executive may have under the employee benefit plans, programs, or policies of the Company and its affiliates&#59; (iii) Executive&#8217;s right to enforce the terms of this Agreement&#59; and (iv) any right that may not be waived by private agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Acknowledgment of Waiver of Claims under ADEA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Executive acknowledges that Executive is waiving and releasing any rights Executive may have under the Age Discrimination in Employment Act of 1967 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">ADEA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and that this waiver and release is knowing and voluntary. Executive agrees that this waiver and release does not apply to any rights or claims that may arise under the ADEA after the date on which Executive executes this Agreement. Executive acknowledges that the consideration given for this waiver and release Agreement is in addition to anything of value to which Executive was already entitled. Executive further acknowledges that Executive is hereby advised by this writing that (a) Executive should consult with an attorney </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">prior</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> to executing this Agreement&#59; (b) Executive has at least twenty-one (21) days within which to consider this Agreement&#59; (c) Executive has seven (7) days following the execution of this Agreement by the Parties to revoke the Agreement&#59; (d) this Agreement will not be effective until the revocation period has expired&#59; and (e) nothing in this Agreement prevents or precludes Executive from challenging or seeking a determination in good faith of the validity of this waiver under the ADEA, nor does it impose any condition precedent, penalties or costs for doing so, unless specifically authorized by federal law. In the event Executive signs this Agreement and delivers </font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">it to the Company in less than the twenty-one (21)-day period identified above, Executive hereby acknowledges that Executive has freely and voluntarily chosen to waive the time period allotted for considering this Agreement. Executive acknowledges and understands that revocation must be accomplished by a written notification to the Chief Legal Officer of the Company that is received prior to the Effective Date.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Unknown Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Executive acknowledges that Executive has been advised to consult with legal counsel and is familiar with the provisions of California Civil Code Section 1542, a statute that otherwise prohibits the release of unknown claims, which provides as follows&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="padding-left:72pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, THAT IF KNOWN BY HIM OR HER WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Executive, being aware of California Civil Code Section 1542, agrees to expressly waive any rights Executive may have thereunder, as well as under any other statute or common law principles of similar effect.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">No Pending or Future Lawsuits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Executive represents that Executive has no lawsuits, claims, or actions pending in Executive&#8217;s name, or on behalf of any other person or entity, against the Company or any of the other Releasees. Executive also represents that Executive does not intend to bring any claims on Executive&#8217;s own behalf or on behalf of any other person or entity against the Company or any of the other Releasees. Executive confirms that Executive has no knowledge of any wrongdoing involving improper or false claims against a federal or state governmental agency, or any other wrongdoing that involves Executive or any other present or former Company employees, including violations of the federal and state securities laws.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sufficiency of Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Executive hereby acknowledges and agrees that Executive has received good and sufficient consideration for every promise, duty, release, obligation, agreement and right contained in this Agreement and the Release contained in Section 4.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Executive reaffirms and agrees to observe and abide by the terms of the PIIA, specifically including the provisions therein regarding nondisclosure of the Company&#8217;s trade secrets and confidential and proprietary information, which agreement will continue in force and agrees that such obligations shall survive the Termination Date.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Solicitation of Employees and Independent Contractors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. For one (1) year following the Termination Date, Executive will not, either directly or through others, solicit or attempt to solicit any employee, independent contractor or consultant of the Company to terminate his or her relationship with the Company in order to become an employee, consultant or independent contractor to or for any other person or entity, or otherwise encourage or solicit any employee of the Company to leave the Company for any reason or to devote less than all of any such employee&#8217;s efforts to the affairs of the Company.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Return of Company Property&#59; Passwords and Password-protected Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Executive confirms that Executive has returned to the Company in good working order all keys, files, records (and copies thereof), equipment (including, but not limited to, computer hardware, software and printers, wireless handheld devices, cellular phones and pagers), access or credit cards, Company identification, and any other Company-owned property in Executive&#8217;s possession or control, provided that Executive may retain his personal copies of (i) his compensation records, (ii) materials distributed to stockholders generally and (iii) any written agreement to which Executive is a party. Executive further confirms that Executive has cancelled all accounts for Executive&#8217;s benefit, if any, in the Company&#8217;s name, including, but not limited to, credit cards, telephone charge cards, cellular phone and&#47;or pager </font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">accounts and computer accounts&#59; provided, however, that Executive shall be permitted to retain his Company-provided laptop until December 31, 2022 in order to coordinate the transition of his personal files and emails from such laptop, subject to Executive&#8217;s cooperation with the Company&#8217;s information technology department in such transition.  The Company shall keep Executive&#8217;s Company email active through December 31, 2022, or such later date as mutually agreed with the Company&#59; provided that Executive will immediately forward any work-related emails that he receives at his Company email address to the Chief Executive Officer of the Company. Executive also confirms that Executive has delivered all passwords in use by Executive at the time of Executive&#8217;s termination, a list of any documents that Executive created or of which Executive is otherwise aware that are password-protected, along with the password(s) necessary to access such password-protected documents.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Nondisparagement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Subject to Section 11 of this Agreement, Executive agrees that Executive will not make any negative or disparaging statements or comments, either as fact or as opinion, about Company, its employees, officers, directors, shareholders, vendors, products or services, business, technologies, market position or performance.  The Company agrees that it shall not, and shall cause its directors and executive officers not to, make any negative or disparaging statements or comments, either as fact or as opinion, about Executive.  Nothing in this paragraph will prohibit Executive or the Company from providing truthful information in response to a subpoena or other legal process.  &#160;&#160;&#160;&#160;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Reformation of Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If it is determined by a court of competent jurisdiction in any state that any restriction in this Section&#160;9 is excessive in duration or scope or is unreasonable or unenforceable under the laws of that state, it is the intention of the parties that such restriction may be modified or amended by the court to render it enforceable to the maximum extent permitted by the law of that state.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Remedies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  It is expressly agreed that the Company and its subsidiaries and affiliates will or would suffer irreparable injury if Executive were to breach any of the provisions of this Section&#160;9 and that the Company and its subsidiaries and affiliates would by reason of any such breach be entitled to injunctive relief in a court of competent jurisdiction without the need to post a bond or other security and without the need to demonstrate special damages.  The aforementioned injunctive relief is and shall be in addition to any other remedies that may be available to the Company and its subsidiaries and affiliates under this Agreement or otherwise.  In addition to all other rights and remedies available to the Company under law or in equity, the Company shall be entitled to withhold all Termination Benefits from Executive in the event of his breach of this Section 9.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">No Cooperation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Subject to Section 11 of this Agreement, Executive agrees that Executive will not knowingly encourage, counsel, or assist any attorneys or their clients in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints by any third party against any of the Releasees, unless under a subpoena or other court order to do so or as related directly to the ADEA waiver in this Agreement. Executive agrees both to immediately notify the Company upon receipt of any such subpoena or court order, and to furnish, within three (3) business days of its receipt, a copy of such subpoena or other court order. If approached by anyone for counsel or assistance in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints against any of the Releasees, Executive will state no more than that Executive cannot provide any such counsel or assistance.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Protected Activities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Notwithstanding anything herein to the contrary, nothing in this Agreement or the PIIA shall (a) prohibit Executive from filing a charge with the Equal Employment Opportunity Commission, the National Labor Relations Board, the Occupational Safety and Health Administration, the Securities and Exchange Commission or any other comparable federal agency, state agency or securities regulatory body (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Government Agencies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; (b) prohibit Executive from reporting possible violations of law to an appropriate Government Agency in a confidential manner without notice to the Company as authorized in any whistleblower protection provisions of any federal or state law or regulation&#59; (c) communicating directly with any governmental, law enforcement, regulatory or self-regulatory body&#59; (d) limit Executive&#8217;s lawful opportunity to cooperate with or participate in any administrative proceeding or investigation that may be conducted by a Government Agency&#59; (e) receive awards from a Government Agency as a result of reporting or cooperation&#59; or (f) discussing or disclosing </font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">information about unlawful acts in the workplace, such as harassment or discrimination or any other conduct that Executive has reason to believe is unlawful. With respect to any information disclosed pursuant to this protected activity exception that may constitute confidential or proprietary information, Executive agrees to take all reasonable precautions to prevent any unauthorized use or disclosure to any parties other than the relevant agency or authority. Except as prohibited by applicable law, rule, or regulation, the payments paid to pursuant to this Agreement will be the sole monetary relief available to Executive, and Executive will not be entitled to recover, and agrees to waive, any additional personal monetary relief that may be sought from or awarded against the Company in the future without regard to who filed or brought such claim. However, this Agreement does not waive Executive&#8217;s right to receive an award for original information from any Government Agency, including but not limited to any such award pursuant to Section 21F of the Securities Exchange Act of 1934. Further, Executive&#8217;s participation in an investigation or other legal matter may include a disclosure of trade secret information provided that it must comply with the restrictions in the Defend Trade Secrets Act of 2016 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">DTSA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  The DTSA provides that no individual will be held criminally or civilly liable under Federal or State trade secret law for the disclosure of a trade secret that&#58; (i) is made in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney&#59; and made solely for the purpose of reporting or investigating a suspected violation of law&#59; or, (ii) is made in a complaint or other document if such filing is under seal so that it is not made public. Also, an individual who pursues a lawsuit for retaliation by an employer for reporting a suspected violation of the law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal, and does not disclose the trade secret, except as permitted by court order.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">No Admission of Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Executive understands and acknowledges that this Agreement constitutes a compromise and settlement of any and all actual or potential disputed claims by Executive. No action taken by the Company hereto, either previously or in connection with this Agreement, will be deemed or construed to be (a) an admission of the truth or falsity of any actual or potential claims or (b) an acknowledgment or admission by the Company of any fault or liability whatsoever to Executive or to any third party.</font></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13.        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Parties will each bear their own costs, attorneys&#8217; fees and other fees incurred in connection with the preparation of this Agreement.</font></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14.        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Arbitration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement to Arbitrate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; The Company and Executive hereby agree to resolve by final and binding arbitration any and all claims or controversies in any way arising out of, relating to or associated with Executive&#8217;s employment with the Company or any of its parents, affiliates, or subsidiaries, or the termination of such employment or any breach of this Agreement. This mutual agreement to arbitrate includes any claims that the Company may have against Executive, or that Executive may have against the Company or against any of its officers, directors, employees, agents, successors, or parent, subsidiary, or affiliated entities so long as such claim is related to Executive&#8217;s employment with the Company. The Company and Executive agree that arbitration, as provided for in this Agreement, shall be the exclusive forum for the resolution of any covered dispute between the Parties. The Company and Executive agree that their mutual agreement to arbitrate shall constitute sufficient consideration by each Party for the promises made in this Section 14.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Scope of Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;The claims covered by this Section 14 include, but are not limited to, claims for breach of any contract or covenant, express or implied&#59; claims for breach of any fiduciary duty or other duty owed to Executive by Company or to Company by Executive&#59; tort claims&#59; claims for wages or other compensation due&#59; claims for discrimination or harassment, including but not limited to discrimination or harassment based on race, sex, pregnancy, religion, national origin, ancestry, age, marital status, physical disability, mental disability, medical condition, or sexual orientation&#59; and claims for violation of any federal, state or other governmental constitution, statute, ordinance or regulation (as originally enacted and as amended), including but not limited to claims under Title VII of the Civil Rights Act of 1964 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Title VII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the Fair Labor Standards Act, the Employee Retirement Income Security Act, the Consolidated Omnibus Budget Reconciliation Act (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">COBRA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and the Family and Medical Leave Act .</font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Procedure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; Executive&#8217;s request to arbitrate must be directed to the Board at the Company&#8217;s principal place of business. A request submitted by the Company shall be sent to the Executive at the Executive&#8217;s address as reflected on the Company&#8217;s personnel records. Any arbitration shall be conducted before a single arbitrator of JAMS under the Employment Arbitration Rules and Procedures (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Rules</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) of JAMS then in effect. Executive can obtain a copy of the Rules on the website of JAMS, which is www.jamsadr.com and a copy will be provided to Executive upon request. JAMS has previously maintained the Rules at this URL&#58; http&#58;&#47;&#47;www.jamsadr.com&#47;rules-employment-arbitration. The arbitration will be conducted in San Diego, California, and Executive and the Company consent to jurisdiction in California and venue in San Diego, California.  If Executive is making a claim, the Company will pay any arbitration filing fee in excess of the amount Executive would have been required to pay (if any) to file the claim in court, and the Company will pay all of the arbitrator&#8217;s fees and other arbitration expenses. If the Company is making a claim, the Company will pay all filing fees and all expenses of the arbitration, including the arbitrator&#8217;s fees. Each Party shall bear its, his, or her own costs of legal representation&#59; provided, however, if any Party prevails on a claim entitling the prevailing Party to attorneys&#8217; fees and&#47;or costs, the arbitrator may award reasonable fees and&#47;or costs to the prevailing Party in accordance with such claim. The arbitrator shall have the authority to order such discovery by way of deposition, interrogatory, document production, or otherwise, as the arbitrator considers necessary to a full and fair exploration of the issues in dispute, consistent with the expedited nature of arbitration. The arbitrator shall issue a written decision that reveals the essential findings and conclusions on which the decision is based, and the arbitrator&#8217;s decision shall be subject to such judicial review as is provided by law. The mutual agreement to arbitrate claims as set forth in this Section 14 is enforceable under and governed by the Federal Arbitration Act, 9 U.S.C. &#167; 1 et seq. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">FAA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), but if the FAA is held not to apply to this Agreement for any reason, this mutual agreement to arbitrate claims shall be enforced under the laws of the State of California.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Administrative Relief</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; This Section 14 does not limit Executive&#8217;s right to file an administrative charge with the National Labor Relations Board, the Equal Employment Opportunity Commission, or any state agency charged with enforcement of fair employment practice laws, but Executive agrees to arbitrate under this Agreement all rights to any form of recovery or relief, including monetary or other damages. This agreement also does not apply to or cover claims for workers&#8217; compensation benefits or compensation, claims for unemployment compensation benefits, or claims based upon an employee pension or benefit plan the terms of which contain an arbitration or other non-judicial dispute resolution procedure, in which case the provisions of such plan shall apply.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Voluntary Nature of Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; Executive acknowledges and agrees that Executive is executing this Agreement voluntarily and without any duress or undue influence by the Company or anyone else.&#160; Executive further acknowledges and agrees that Executive has carefully read this Agreement and that Executive has asked any questions needed for Executive to understand the terms, consequences and binding effect of this Section 14 of this Agreement and fully understands it, including that </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">EXECUTIVE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">EXPLICITLY WAIVES THE RIGHT TO TRIAL BY JURY </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">of any claim subject to arbitration.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The parties agree that any claim asserted in arbitration may be made only on an individual basis, and the parties may not assert claims on a representative, class or other collective basis. Finally, Executive agrees that Executive has been provided an opportunity to seek the advice of an attorney of Executive&#8217;s choice before signing this Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;Notwithstanding anything to the contrary in this Agreement, no severance pay or benefits to be paid or provided to Executive, if any, pursuant to this Agreement that, when considered together with any other severance payments or separation benefits, are considered deferred compensation subject to and not exempt from Section 409A of the Code, and the final regulations and any guidance promulgated thereunder (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) (together, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Deferred</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) will be paid or otherwise provided until Executive has a &#8220;separation from service&#8221; within the meaning of Section 409A. The Company and Executive acknowledge and agree that the Termination Date will be the date of Executive&#8217;s &#8220;separation from service&#8221; within the meaning of Section 409A.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;Any severance payments or benefits under this Agreement will be paid on, or, in the case of installments, will not commence until, the date that is sixty (60) days following the Termination Date, or, if later, such time as required by Section 15(c). Except as required by Section 15(c), any installment payments that would have been made to Executive during the period immediately following Executive&#8217;s separation from service but for the preceding sentence will be paid to Executive with the initial installment commencing with the date that is sixty (60) days following the Termination Date and the remaining payments will be made as provided in this Agreement.  In any case where Executive&#8217;s separation from service and the last day of the period during which Executive may deliver this Agreement fall in two separate calendar years, any amount required to be paid to Executive that is conditioned on the effectiveness of the Release and is treated as a Deferred Payment shall be paid in the later calendar year.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;Notwithstanding anything to the contrary in this Agreement, if Executive is a &#8220;specified employee&#8221; within the meaning of Section 409A on the Termination Date, then the Deferred Payments that are payable within the first six (6) months following Executive&#8217;s separation from service will become payable on the first payroll date that occurs on or after the date six (6) months and one (1) day following the date of Executive&#8217;s separation from service. All subsequent Deferred Payments, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit.  Notwithstanding anything herein to the contrary, if Executive dies following Executive&#8217;s separation from service, but before the six (6) month anniversary of the separation from service, then any payments delayed in accordance with this Section 15(c) will be payable in a lump sum as soon as administratively practicable after the date of Executive&#8217;s death and all other Deferred Payments will be payable in accordance with the payment schedule applicable to each payment or benefit.  Each payment and benefit payable under this Agreement is intended to constitute a separate payment under Section 1.409A-2(b)(2) of the Treasury Regulations. The Company has determined that the severance payments payable to Executive pursuant to Section 3(a) are Deferred Payments subject to delay pursuant to this Section 15(c)&#59; accordingly, the foregoing delay shall apply to such payments.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(d)&#160;&#160;&#160;&#160;Any reimbursement of expenses or in-kind benefits payable under this Agreement shall be made in accordance with Treasury Regulation Section 1.409A-3(i)(1)(iv) and shall be paid on or before the last day of Executive&#8217;s taxable year following the taxable year in which Executive incurred the expenses. The amount of expenses reimbursed or in-kind benefits payable in one year shall not affect the amount eligible for reimbursement or in-kind benefits payable in any other taxable year of Executive&#8217;s, and Executive&#8217;s right to reimbursement for such amounts shall not be subject to liquidation or exchange for any other benefit.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(e)&#160;&#160;&#160;&#160;The foregoing provisions are intended to comply with the requirements of Section 409A so that none of the severance payments and benefits to be provided hereunder will be subject to the additional tax imposed under Section 409A, and any ambiguities herein will be interpreted to so comply. The Company and Executive agree to work together in good faith to consider amendments to this Agreement and to take such reasonable actions which are necessary, appropriate or desirable to avoid imposition of any additional tax or income recognition before actual payment to Executive under Section 409A. Notwithstanding any other provision of this Agreement, </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the Company makes no representation or warranty and shall have no liability to Executive or to any other person if any provisions of this Agreement are determined to constitute deferred compensation subject to Section 409A but do not satisfy an exemption from, or the conditions of, that section. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">16.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Company represents and warrants that the undersigned has the authority to act on behalf of the Company and to bind the Company and all who may claim through it to the terms and conditions of this Agreement. Executive represents and warrants that Executive has the capacity to act on Executive&#8217;s own behalf and on behalf of all who might claim through Executive to bind them to the terms and conditions of this Agreement. Each Party warrants and represents that there are no liens or claims of lien or assignments in law or equity or otherwise of or against any of the claims or causes of action released herein.</font></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">17.        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">No Representations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Executive represents that Executive has had the opportunity to consult with an attorney, and has carefully read and understands the scope and effect of the provisions of </font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">this Agreement. Executive has relied upon any representations or statements made by the Company that are not specifically set forth in this Agreement.</font></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">18.        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In the event that any provision or any portion of any provision hereof or any surviving agreement made a part hereof becomes or is declared by a court of competent jurisdiction or arbitrator to be illegal, unenforceable, or void, this Agreement will continue in full force and effect without said provision or portion of provision.</font></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">19.   &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement represents the entire agreement and understanding between the Company and Executive concerning the subject matter of this Agreement and Executive&#8217;s employment with and separation from the Company and the events leading thereto and associated therewith, and supersedes and replaces any and all prior agreements and understandings concerning the subject matter of this Agreement and Executive&#8217;s relationship with the Company, including, without limitation, the Severance Plan, the Offer Letter and the Change in Control Severance Agreement&#59; provided, however, that the PIIA and any of Executive&#8217;s written equity compensation agreements with the Company are not superseded by this Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">20.        &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">No Oral Modification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement may only be amended in writing signed by Executive and a member of the Board.</font></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">21.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Governing Law&#59; Venue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement will be governed by the laws of the State of California, without regard for choice-of-law provisions. Executive consents to personal and exclusive jurisdiction and venue in the State of California. Any claims or legal actions by one Party against the other arising out of the relationship between the Parties contemplated herein (whether or not arising under this Agreement) will be commenced or maintained in any state or federal court located in San Diego County, California, and Executive and the Company hereby submit to the jurisdiction and venue of any such court.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">22.        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Executive understands that this Agreement will be null and void if not executed by Executive no later the end of the twenty-first (21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) calendar day after the Agreement is provided to Executive for consideration. Executive has seven (7) days after he signs this Agreement to revoke it. This Agreement will become effective on the eighth (8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) day after Executive signs this Agreement, so long as it has been signed by the Parties and has not been revoked by Executive before that date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Executive acknowledges and agrees that he will not be eligible for any of the Termination Benefits unless the Effective Date occurs within thirty (30) days following the Termination Date.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Parties agree that any material or immaterial changes to this Agreement shall not extend the deadline for the occurrence of the Effective Date.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. All payments made pursuant to this Agreement will be subject to withholding of applicable income, employment and other taxes.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">24.&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement may be executed in counterparts and by facsimile, and each counterpart and facsimile will have the same force and effect as an original and will constitute an effective, binding agreement on the part of each of the undersigned.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;25.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  All notices or other communications required or permitted to be given under this Agreement shall be in writing and shall be deemed to have been duly given when delivered personally or one</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> business day after being sent by a nationally recognized overnight delivery service, charges prepaid. Notices also may be given electronically via PDF and shall be effective on the date transmitted if confirmed within forty-eight (48) hours thereafter by a signed original sent in the manner provided in the preceding sentence.  Notice to Executive shall be sent to his most recent residence and personal email address on file with the Company.  Notice to the Company shall be sent to its principal executive office and addressed to the Chief Legal Officer at the email address provided by the Company for such person.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;26.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Voluntary Execution of Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Executive understands and agrees that Executive executed this Agreement voluntarily, without any duress or undue influence on the part or behalf of the </font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Company or any third party, with the full intent of releasing all of Executive&#8217;s claims against the Company and any of the other Releasees. Executive expressly acknowledges that&#58;</font></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)        Executive has read this Agreement&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)       Executive has been represented in the preparation, negotiation, and execution of this Agreement by legal counsel of Executive&#8217;s own choice or has elected not to retain legal counsel&#59;</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)       Executive understands the terms and consequences of this Agreement and of the releases it contains&#59; and</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)        Executive is fully aware of the legal and binding effect of this Agreement.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">* * * * *</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Signature page to follow</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#93;</font></div><div style="text-align:center"><font><br></font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">IN WITNESS WHEREOF, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the Parties have executed this Agreement on the respective dates set forth below.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.025%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.849%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.191%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">COMPANY</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">LIGAND PHARMACEUTICALS INCORPORATED</font></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#47;s&#47; Andrew T. Reardon</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Name&#58;</font></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Andrew T. Reardon</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Title&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Chief Legal Officer and Secretary</font></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Dated&#58;</font></td><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">December 4, 2022</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">EXECUTIVE</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">John Higgins, an individual</font></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#47;s&#47; John Higgins</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt 2px 86.5pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">(Signature)</font></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Dated&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">December 4, 2022</font></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:8pt;text-align:center"><font><br></font></div><div style="margin-bottom:8pt;text-align:center"><font><br></font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:center"><font><br></font></div><div style="margin-bottom:8pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Exhibits and schedules omitted in accordance with Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule and&#47;or annex will be furnished as a supplement to the U.S. Securities and Exchange Commission upon request. </font></div><div style="margin-bottom:8pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">EXHIBIT A - PROPRIETARY INFORMATION AND INVENTIONS AGREEMENT</font></div><div style="margin-bottom:8pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">EXHIBIT B &#8211; EQUITY AWARDS</font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14</font></div><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.15
<SEQUENCE>5
<FILENAME>exhibit1015_ligand-severan.htm
<DESCRIPTION>EX-10.15
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="id730237a9cb14108981d69aa442026fe_1"></div><div style="min-height:57.6pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 10.15</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SEVERANCE AGREEMENT</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Severance Agreement (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is made effective as of December 5, 2022, by and between Ligand Pharmaceuticals Incorporated, a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and Todd C. Davis (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The parties agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  For purposes of this Agreement, the following terms shall have the following meanings&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any of the following&#58; (i)&#160;Employee&#8217;s conviction of, or plea of &#8220;guilty&#8221; or &#8220;no contest&#8221; to, a felony under the laws of the United States or any state thereof&#59; (ii) Employee&#8217;s willful and material breach of any obligation or duty under this Agreement, the PIIA (as defined below) or the Company&#8217;s written employment or other written policies that have previously been furnished to Employee, which breach is not cured within thirty (30) days after written notice thereof is received by Employee, if such breach is capable of cure&#59; (iii) Employee&#8217;s gross negligence or willful misconduct, including without limitation, fraud, dishonesty or embezzlement, in the performance of his or her duties&#59; or (iv)&#160;Employee&#8217;s continuing failure or refusal to perform his or her assigned duties or to comply with reasonable directives of the Board of Directors that are consistent with Employee&#8217;s job duties (which directives are not in conflict with applicable law), which failure is not cured within thirty (30) days after written notice thereof is received by Employee.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean a change in ownership or control of the Company effected through any of the following transactions&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(i) &#160;&#160;&#160;&#160;a merger, consolidation or other reorganization approved by the Company&#8217;s stockholders, unless securities representing more than fifty percent (50%) of the total combined voting power of the voting securities of the successor corporation are immediately thereafter beneficially owned, directly or indirectly and in substantially the same proportion, by the persons who beneficially owned the Company&#8217;s outstanding voting securities immediately prior to such transaction&#59; or </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">                  &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(ii) &#160;&#160;&#160;&#160;the sale, license, transfer or other disposition (including establishing a royalty trust) of an asset or assets in one transaction or a series of related transactions which the Board of Directors determines, in its sole discretion, represent more than fifty percent (50%) of the aggregate value of the Company&#8217;s assets&#59; or</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">                  &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(iii) &#160;&#160;&#160;&#160;the acquisition, directly or indirectly by any person or related group of persons (other than the Company or a person that directly or indirectly controls, is controlled by, or is under common control with, the Company), of beneficial ownership (within the meaning of Rule 13d-3 of the 1934 Act) of securities possessing more than fifty percent (50%) of the total combined voting power of the Company&#8217;s outstanding securities pursuant to a tender or exchange offer made directly to the Company&#8217;s stockholders.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Notwithstanding the foregoing, no transaction, event or occurrence shall constitute a Change in Control for purposes of this Agreement, unless such transaction, event or occurrence also constitutes a &#8220;change in control event&#8221; as defined in Treasury Regulation Section 1.409A-3(i)(5).</font></div><div><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the occurrence of any of the following events or conditions without Employee&#8217;s written consent&#58;  </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(i)&#160;&#160;&#160;&#160;a material diminution in Employee&#8217;s authority, duties or responsibilities&#59;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(ii)&#160;&#160;&#160;&#160;a material diminution in Employee&#8217;s base compensation&#59; </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(iii)&#160;&#160;&#160;&#160;a material change in the geographic location at which Employee must perform his or her duties&#59; or</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(iv)&#160;&#160;&#160;&#160;any other action or inaction that constitutes a material breach by the Company or any successor or affiliate of its obligations to Employee under this Agreement.</font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Employee must provide written notice to the Company of the occurrence of any of the foregoing events or conditions without Employee&#8217;s written consent within ninety (90) days of the occurrence of such event.  The Company or any successor or affiliate shall have a period of thirty (30) days to cure such event or condition after receipt of written notice of such event from Employee.  Any voluntary termination of Employee&#8217;s employment for &#8220;Good Reason&#8221; following such thirty (30) day cure period must occur no later than the date that is six (6) months following the initial occurrence of one of the foregoing events or conditions without Employee&#8217;s written consent.</font></div><div><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Permanent Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Employee&#8217;s inability to perform the essential functions of his or her position, with or without reasonable accommodation, for a period of at least one hundred twenty (120) consecutive days because of a physical or mental impairment.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Stock Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means all stock options, restricted stock and such other awards granted pursuant to the Company&#8217;s stock option and equity award plans or agreements and any shares of stock issued upon exercise thereof.  </font></div><div><font><br></font></div><div style="padding-right:-9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="padding-right:-9pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;If Employee&#8217;s employment is terminated by the Company without Cause or by Employee for Good Reason, then subject to the requirements of this Section 2 and Employee&#8217;s continued compliance with Section 3, Employee shall be entitled to receive, in lieu of any severance benefits to which Employee may otherwise be entitled, including under any Other Arrangement (as defined below), the benefits provided below&#58;</font></div><div style="padding-right:-9pt;text-indent:72pt"><font><br></font></div><div style="padding-right:-9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(i)&#160;&#160;&#160;&#160;The Company shall pay to Employee (A) his or her fully earned but unpaid base salary, when due, through the date of termination at the rate then in effect, (B) his or her accrued but unpaid vacation or paid time off through the date of termination, when due, plus (C) all other amounts or benefits to which Employee is entitled under any compensation, retirement or benefit plan or practice of the Company at the time of termination in accordance with the terms of such plans or practices, including, without limitation, any continuation of benefits required by the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">COBRA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) or applicable law (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Accrued Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="padding-right:-9pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(ii)&#160;&#160;&#160;&#160;(A) &#160;&#160;&#160;&#160;If such termination occurs prior to a Change in Control or more than twenty-four (24) months following a Change in Control, Employee shall be entitled to receive severance pay in an amount equal to Employee&#8217;s monthly base salary as in effect immediately prior to the date of termination for the eighteen (18)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">month</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">period following the date of termination&#59; or</font></div><div style="padding-right:-9pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(B) &#160;&#160;&#160;&#160;If such termination occurs within twenty-four (24) months following a Change in Control, in lieu of the benefits in clause (ii)(A) above, Employee shall be entitled to receive severance pay in an amount equal to the sum of&#58;</font></div><div style="padding-right:-9pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(1)&#160;&#160;&#160;&#160;Employee&#8217;s monthly base salary as in effect immediately prior to the date of termination for the twenty-four (24)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">month</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">period following the date of termination, plus</font></div><div style="padding-right:-9pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(2)&#160;&#160;&#160;&#160;Two (2) multiplied by the greater of (x) Employee&#8217;s maximum target bonus for the fiscal year during which the date of termination occurs or (y) Employee&#8217;s maximum target bonus for the fiscal year during which the Change in Control occurs, </font></div><div style="padding-right:-9pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">payable, in the case of both clauses (A) and (B), in a lump sum within ten (10) days following the effective date of Employee&#8217;s Release, but in no event later than two and one-half (2 &#189;) months following the last day of the calendar year in which the date of Employee&#8217;s termination of employment occurs&#59;</font></div><div style="padding-right:-9pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-right:-15.3pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(iii) &#160;&#160;&#160;&#160;Employee shall be entitled to receive a lump sum cash payment equal to (A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">eighteen (18) multiplied by (B) the monthly premium Employee would be required to pay for continuation coverage pursuant to COBRA for Employee and his or her eligible dependents who were covered under the Company&#8217;s health plans as of the date of Employee&#8217;s termination such that Employee&#8217;s premiums are the same as for active employees (calculated by reference to the premium as of the date of termination) (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that Employee shall be solely responsible for all matters relating to his or her continuation of coverage pursuant to COBRA, including, without limitation, his or her election of such coverage and his or her timely payment of premiums), which payment shall be paid within ten (10) days following the effective date of </font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-15.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Employee&#8217;s Release, but in no event later than two and one-half (2 &#189;) months following the last day of the calendar year in which the date of Employee&#8217;s termination of employment occurs&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the multiplier in clause (A) shall be increased to twenty-four (24) in the event such termination occurs within twenty-four (24) months following a Change in Control&#59; </font></div><div style="margin-bottom:12pt;padding-right:-15.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(iv)&#160;&#160;&#160;&#160;The vesting and&#47;or exercisability of any outstanding unvested portions of Employee&#8217;s Stock Awards the vesting of which is solely time-based and not subject to the satisfaction of a performance condition shall be automatically accelerated on the effective date of Employee&#8217;s Release&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that, any Stock Awards that vest in whole or in part based on the attainment of performance-vesting conditions shall be governed by the terms of the applicable Stock Award agreement.  Except as provided in Section 2(a)(v), Employee&#8217;s vested Stock Awards shall be governed by the terms and conditions of the Stock Award agreements and the Company&#8217;s equity plan under which such Stock Awards were granted.  Notwithstanding the foregoing, in the event the Stock Award agreement or the equity plan pursuant to which the Stock Awards were granted provides for more favorable treatment of Employee&#8217;s Stock Awards, nothing in this Agreement is intended to limit Employee&#8217;s right to such more favorable treatment as provided in such Stock Award agreement or equity plan&#59; and</font></div><div style="margin-bottom:12pt;padding-right:-15.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(v) &#160;&#160;&#160;&#160;Notwithstanding anything to the contrary contained in the Company&#8217;s equity plan and the Stock Award agreements under which Employee&#8217;s outstanding Stock Awards were granted&#58;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(A)&#160;&#160;&#160;&#160;Subject to the terms and conditions contained in, and Employee&#8217;s continued compliance with, this Section 2(a)(v), the period of time during which Employee may exercise his vested stock options following the date of Employee&#8217;s termination of employment (after giving effect to the acceleration pursuant to Section 2(a)(iv) above) shall be extended to the earliest of (1) the second anniversary of the date of Employee&#8217;s termination of employment or (2) the original ten-year expiration date of such options (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Exercise Period Extension</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(B)&#160;&#160;&#160;&#160;It shall be a condition to the Exercise Period Extension that Employee not sell, pledge, assign, hypothecate, transfer, or otherwise dispose of (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) on any single trading day occurring during the period commencing on the date of Employee&#8217;s termination of employment and ending on the second anniversary of the date of Employee&#8217;s termination of employment, shares of the Company&#8217;s common stock (including shares issuable upon vesting, settlement or exercise of Stock Awards) in an amount that is in excess of five percent (5%) of the average daily trading volume of the Company&#8217;s common stock for the preceding calendar week, other than Permitted Transfers.  For purposes of this Agreement, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Permitted Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; will include (1) the Transfer of any or all of the shares during Employee&#8217;s lifetime or upon Employee&#8217;s death by will or intestacy to Employee&#8217;s Immediate Family or a trust for the benefit of Employee&#8217;s Immediate Family (provided that such Immediate Family or trust agrees to be bound by the restrictions in this Section 2(a)(v)), (2) any Transfer upon the occurrence of, and in connection with, a Change in Control, (3) any Transfer approved in writing by the Board, (4) any Transfer pursuant to the written trading plan adopted by Employee prior to the date of Employee&#8217;s termination of employment in accordance with Rule 10b5-1, or (5) any Transfer to the Company in connection with tax withholding by the Company.  As used herein, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Immediate Family</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean Employee&#8217;s spouse, lineal descendant or antecedent, father, mother, brother or sister or stepchild (whether or not adopted)&#59;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(C)&#160;&#160;&#160;&#160;It shall be a further condition to the Exercise Period Extension that, during the period commencing on the date of Employee&#8217;s termination of employment and ending on the second anniversary of the date of Employee&#8217;s termination of employment, Employee not Transfer any of the shares of the Company&#8217;s common stock held by Employee as of the date of Employee&#8217;s termination of employment in a brokerage account at Morgan Stanley or E*Trade (or any shares issuable upon vesting, settlement or exercise of Stock Awards after the date of Employee&#8217;s termination of employment) to another account without the prior written consent of the Company.  Employee acknowledges and agrees that the Company may place restrictions on any such brokerage account to ensure Employee&#8217;s compliance with the restrictions in this Section 2(a)(v)&#59;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(D)&#160;&#160;&#160;&#160;In the event Employee breaches this Section 2(a)(v) or Section 3, Employee&#8217;s ability to exercise his vested stock options shall immediately cease and all of Employee&#8217;s vested stock options shall cease to be exercisable on the date of such breach and shall be forfeited&#59; and</font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-right:-15.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(E)&#160;&#160;&#160;&#160;Notwithstanding the foregoing, in the event the Stock Award agreement or the equity plan pursuant to which the Stock Awards were granted provides for more favorable </font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-15.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">treatment of Employee&#8217;s Stock Awards, nothing in this Agreement is intended to limit Employee&#8217;s right to such more favorable treatment as provided in such Stock Award agreement or equity plan. </font></div><div style="padding-right:-9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Other Terminations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If Employee&#8217;s employment is terminated at any time by the Company for Cause, by Employee without Good Reason, or as a result of Employee&#8217;s death or Permanent Disability, the Company shall not have any other or further obligations to Employee under this Agreement (including any financial obligations) except that Employee shall be entitled to receive the Accrued Obligations and any rights Employee may have to severance under the Company&#8217;s standard severance policy.  The foregoing shall be in addition to, and not in lieu of, any and all other rights and remedies which may be available to the Company under the circumstances, whether at law or in equity.</font></div><div style="padding-right:-9pt;text-indent:72pt"><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  As a condition to Employee&#8217;s receipt of any post-termination benefits pursuant to Section 2(a) above, Employee shall execute and not revoke a general release of all claims in favor of the Company and its affiliates (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) in the form attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Employee&#8217;s Release shall be deemed effective on the day following the expiration of any applicable revocation period.  In the event the Release does not become effective within the fifty-five (55) day period following the date of Employee&#8217;s termination of employment, Employee shall not be entitled to the aforesaid payments and benefits.</font></div><div style="text-indent:72pt"><font><br></font></div><div style="margin-bottom:12pt;padding-right:-2.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exclusive Remedy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Except as otherwise expressly required by law (e.g., COBRA) or as specifically provided herein, all of Employee&#8217;s rights to salary, severance, benefits, bonuses and other amounts hereunder (if any) accruing after the termination of Employee&#8217;s employment shall cease upon such termination.  In addition, the severance payments provided for in Section 2(a) above are intended to be the exclusive severance benefits payable to Employee, and such severance payments shall be paid in lieu of any severance payments Employee may otherwise be entitled to receive under any other plan, program, policy or agreement with the Company or any of its affiliates (including, without limitation, the Company&#8217;s Amended and Restated Severance Plan) (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Other Arrangements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  Therefore, in the event Employee becomes entitled to receive the severance payments and benefits provided under Section 2(a) of this Agreement, he or she shall receive the amounts provided under that section of this Agreement and shall not be entitled to receive any severance payments or severance benefits pursuant to any Other Arrangements.  In the event of a termination of Employee&#8217;s employment with the Company, Employee&#8217;s sole remedy shall be to receive the payments and benefits described in this Section 2.  Employee acknowledges that he will not be an eligible participant under the Company&#8217;s Amended and Restated Severance Plan.</font></div><div style="margin-bottom:12pt;padding-right:-2.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">No Mitigation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Employee shall not be required to mitigate the amount of any payment provided for in this Section 2 by seeking other employment or otherwise, nor shall the amount of any payment or benefit provided for in this Section 2 be reduced by any compensation earned by Employee as the result of employment by another employer or self-employment or by retirement benefits&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that loans, advances or other amounts owed by Employee to the Company may be offset by the Company against amounts payable to Employee under this Section 2.    </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Return of the Company&#8217;s Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If Employee&#8217;s employment is terminated for any reason, the Company shall have the right, at its option, to require Employee to vacate his or her offices prior to or on the effective date of termination and to cease all activities on the Company&#8217;s behalf.  Upon the termination of his or her employment in any manner, as a condition to Employee&#8217;s receipt of any post-termination benefits described in this Agreement, Employee shall immediately surrender to the Company all lists, books and records of, or in connection with, the Company&#8217;s business, and all other property belonging to the Company, it being distinctly understood that all such lists, books and records, and other documents, are the property of the Company.  Employee shall deliver to the Company a signed statement certifying compliance with this Section 2(f) prior to the receipt of any post-termination benefits described in this Agreement.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Best Pay Provision</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">In the event that any payment or benefit received or to be received by Employee pursuant to the terms of any plan, arrangement or agreement (including any payment or benefit received in connection with a change in ownership or control or the termination of the Employee&#8217;s employment) (all such payments and benefits being hereinafter referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Total Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) would be subject (in whole or part) to the excise tax (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Excise Tax</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) imposed under Section 4999 of the Internal Revenue Code of 1986, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), then the Total Payments shall be reduced </font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">to the extent necessary so that no portion of the Total Payments is subject to the Excise Tax but only if (A) the net amount of such Total Payments, as so reduced (after subtracting the amount of federal, state and local income taxes on such reduced Total Payments and after taking into account the phase out of itemized deductions and personal exemptions attributable to such reduced Total Payments) is greater than or equal to (B) the net amount of such Total Payments without such reduction (after subtracting the net amount of federal, state and local income taxes on such Total Payments and the amount of Excise Tax to which Employee would be subject in respect of such unreduced Total Payments and after taking into account the phase out of itemized deductions and personal exemptions attributable to such unreduced Total Payments).  Except to the extent that an alternative reduction order would result in a greater economic benefit to Employee on an after-tax basis, the parties intend that the Total Payments shall be reduced in the following order&#58; (w) reduction of any cash severance payments otherwise payable to Employee that are exempt from Section 409A of the Code, (x) reduction of any other cash payments or benefits otherwise payable to Employee that are exempt from Section 409A of the Code, but excluding any payment attributable to the acceleration of vesting or payment with respect to any equity award that is exempt from Section 409A of the Code, (y) reduction of any other payments or benefits otherwise payable to Employee on a pro-rata basis or such other manner that complies with Section 409A of the Code, but excluding any payment attributable to the acceleration of vesting and payment with respect to any equity award that is exempt from Section 409A of the Code, and (z) reduction of any payments attributable to the acceleration of vesting or payment with respect to any equity award that is exempt from Section 409A of the Code&#59; provided, in case of clauses (x), (y) and (z), that reduction of any payments or benefits attributable to the acceleration of vesting of Company equity awards shall be first applied to equity awards with later vesting dates&#59; provided, further, that, notwithstanding the foregoing, any such reduction shall be undertaken in a manner that complies with and does not result in the imposition of additional taxes on Employee under Section&#160;409A of the Code.  The foregoing reductions shall be made in a manner that results in the maximum economic benefit to Employee on an after-tax basis and, to the extent economically equivalent payments or benefits are subject to reduction, in a pro rata manner. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(ii)&#160;&#160;&#160;&#160;All determinations regarding the application of this Section 2(g) shall be made by an independent accounting firm or consulting group with nationally recognized standing and substantial expertise and experience in performing calculations regarding the applicability of Section 280G of the Code and the Excise Tax retained by the Company prior to the date of the applicable change in ownership or control (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">280G Firm</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  For purposes of determining whether and the extent to which the Total Payments will be subject to the Excise Tax, (A) no portion of the Total Payments shall be taken into account which (x) does not constitute a &#8220;parachute payment&#8221; within the meaning of Section 280G(b)(2) of the Code (including by reason of Section 280G(b)(4)(A) of the Code) and, in calculating the Excise Tax, or (y) constitutes reasonable compensation for services actually rendered, within the meaning of Section 280G(b)(4)(B) of the Code, in excess of the &#8220;base amount&#8221; (as defined in Section 280G(b)(3) of the Code) allocable to such reasonable compensation, (B) no portion of the Total Payments the receipt or enjoyment of which Employee shall have waived at such time and in such manner as not to constitute a &#8220;payment&#8221; within the meaning of Section 280G(b) of the Code shall be taken into account, and (C) the value of any non-cash benefit or any deferred payment or benefit included in the Total Payments shall be determined by the 280G Firm in accordance with the principles of Sections 280G(d)(3) and (4) of the Code.  All determinations related to the calculations to be performed pursuant to this &#8220;Best Pay Provision&#8221; section shall be done by the 280G Firm.  The 280G Firm will be directed to submit its determination and detailed supporting calculations to both Employee and the Company within fifteen (15) days after notification from either the Company or Employee that Employee may receive payments which may be &#8220;parachute payments.&#8221;  Employee and the Company will each provide the 280G Firm access to and copies of any books, records, and documents as may be reasonably requested by the 280G Firm, and otherwise cooperate with the 280G Firm in connection with the preparation and issuance of the determinations and calculations contemplated by this Agreement.  The fees and expenses of the 280G Firm for its services in connection with the determinations and calculations contemplated by this Agreement will be borne solely by the Company.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  All compensation and benefits to Employee hereunder shall be reduced by all federal, state, local and other withholdings and similar taxes and payments required by applicable law.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Deemed Resignation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Upon termination of Employee&#8217;s employment for any reason, Employee shall be deemed to have resigned from all offices and directorships, if any, then held with the Company or any of its subsidiaries, including his position as a member of the Board, if applicable,</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and shall take all actions reasonably requested by the Company to effectuate the foregoing.  </font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Employee&#8217;s resignation from all such positions shall be a condition to receive of the severance payments to Employee under Section 2(a).</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">PIIA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Employee and the Company have executed the Company&#8217;s proprietary information and inventions agreement, a copy of which is attached to this Agreement as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and incorporated herein by reference (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">PIIA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  The Company shall be entitled to cease all severance payments to Employee in the event of his or his or her breach of this Section 3.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt;text-decoration:underline">Protected Activities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Notwithstanding anything herein to the contrary, nothing in this Agreement or the PIIA shall (i) prohibit Employee from filing a charge with the Equal Employment Opportunity Commission, the National Labor Relations Board, the Occupational Safety and Health Administration, the Securities and Exchange Commission or any other comparable federal agency, state agency or securities regulatory body (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Government Agencies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; (ii) prohibit Employee from reporting possible violations of law to an appropriate Government Agency in a confidential manner without notice to the Company as authorized in any whistleblower protection provisions of any federal or state law or regulation&#59; (iii) communicating directly with any governmental, law enforcement, regulatory or self-regulatory body&#59; (iv) limit Employee&#8217;s lawful opportunity to cooperate with or participate in any administrative proceeding or investigation that may be conducted by a Government Agency&#59; (v) receive awards from a Government Agency as a result of reporting or cooperation&#59; or (vi) prohibit Employee from discussing or disclosing information about unlawful acts in the workplace, such as harassment or discrimination or any other conduct that Employee has reason to believe is unlawful. With respect to any information disclosed pursuant to this protected activity exception that may constitute confidential or proprietary information, Employee agrees to take all reasonable precautions to prevent any unauthorized use or disclosure to any parties other than the relevant agency or authority. Except as prohibited by applicable law, rule, or regulation, the payments paid to pursuant to this Agreement will be the sole monetary relief available to Employee, and Employee will not be entitled to recover, and agrees to waive, any additional personal monetary relief that may be sought from or awarded against the Company in the future without regard to who filed or brought such claim. However, this Agreement does not waive Employee&#8217;s right to receive an award for original information from any Government Agency, including but not limited to any such award pursuant to Section 21F of the Securities Exchange Act of 1934. Further, Employee&#8217;s participation in an investigation or other legal matter may include a disclosure of trade secret information provided that it must comply with the restrictions in the Defend Trade Secrets Act of 2016 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">DTSA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  The DTSA provides that no individual will be held criminally or civilly liable under Federal or State trade secret law for the disclosure of a trade secret that&#58; (x) is made in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney&#59; and made solely for the purpose of reporting or investigating a suspected violation of law&#59; or (y) is made in a complaint or other document if such filing is under seal so that it is not made public. Also, an individual who pursues a lawsuit for retaliation by an employer for reporting a suspected violation of the law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal, and does not disclose the trade secret, except as permitted by court order.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">  </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Dispute Resolution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Any controversy, claim or dispute arising out of or relating to this Agreement, shall be settled solely and exclusively by binding arbitration in accordance with the arbitration provisions contained in the Mutual Agreement to Arbitrate between Employee and the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Arbitration Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), a copy of which is attached to this Agreement as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and incorporated herein by reference. This Section 4 is intended to be the exclusive method for resolving any and all claims by the parties against each other for payment of damages under this Agreement or relating to Employee&#8217;s employment&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that neither this Agreement nor the submission to mediation or arbitration shall limit the parties&#8217; right to seek provisional relief, including without limitation injunctive relief, in any court of competent jurisdiction pursuant to California Code of Civil Procedure &#167; 1281.8 or any similar statute of an applicable jurisdiction.  Seeking any such relief shall not be deemed to be a waiver of such party&#8217;s right to compel arbitration.  Both Employee and the Company expressly waive their right to a jury trial.  The parties agree that any claim asserted in arbitration may be made only on an individual basis, and the parties may not assert claims on a representative, class or other collective basis. Finally, Employee agrees that Employee has been provided an opportunity to seek the advice of an attorney of Employee&#8217;s choice before signing this Agreement.</font></div><div style="padding-right:-9pt"><font><br></font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">At-Will Employment Relationship</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Employee&#8217;s employment with the Company is at-will and not for any specified period and may be terminated at any time, with or without Cause or advance notice, by either Employee or the Company.  Any change to the at-will employment relationship must be by specific, written agreement signed by Employee and an authorized representative of the Company.  Nothing in this Agreement is intended to or should be construed to contradict, modify or alter this at-will relationship. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">General Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The rights of the Company under this Agreement may, without the consent of Employee, be assigned by the Company, in its sole and unfettered discretion, to any person, firm, corporation or other business entity which at any time, whether by purchase, merger or otherwise, directly or indirectly, acquires all or substantially all of the assets or business of the Company.  The Company will require any successor (whether direct or indirect, by purchase, merger or otherwise) to all or substantially all of the business or assets of the Company expressly to assume and to agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that no such assumption shall relieve the Company of its obligations hereunder. &#160;As used in this Agreement, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the Company as hereinbefore defined and any successor to its business and&#47;or assets as aforesaid which assumes and agrees to perform this Agreement by operation of law or otherwise. Employee shall not be entitled to assign any of Employee&#8217;s rights or obligations under this Agreement.  This Agreement shall inure to the benefit of and be enforceable by Employee&#8217;s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  In the event any provision of this Agreement is found to be unenforceable by an arbitrator or court of competent jurisdiction, such provision shall be deemed modified to the extent necessary to allow enforceability of the provision as so limited, it being intended that the parties shall receive the benefit contemplated herein to the fullest extent permitted by law.  If a deemed modification is not satisfactory in the judgment of such arbitrator or court, the unenforceable provision shall be deemed deleted, and the validity and enforceability of the remaining provisions shall not be affected thereby. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Interpretation&#59; Construction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The headings set forth in this Agreement are for convenience only and shall not be used in interpreting this Agreement.  This Agreement has been drafted by legal counsel representing the Company, but Employee has participated in the negotiation of its terms.  Furthermore, Employee acknowledges that Employee has had an opportunity to review and revise the Agreement and have it reviewed by legal counsel, if desired, and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of this Agreement.  Either party&#8217;s failure to enforce any provision of this Agreement shall not in any way be construed as a waiver of any such provision, or prevent that party thereafter from enforcing each and every other provision of this Agreement.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Governing Law and Venue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Agreement will be governed by and construed in accordance with the laws of the United States and the State of California applicable to contracts made and to be performed wholly within such State, and without regard to the conflicts of laws principles thereof.  Any suit brought hereon shall be brought in the state or federal courts sitting in San Diego County, California, the Parties hereby waiving any claim or defense that such forum is not convenient or proper.  Each party hereby agrees that any such court shall have in personam jurisdiction over it and consents to service of process in any manner authorized by California law.</font></div><div style="text-indent:72pt"><font><br></font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Notices.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  Any notice required or permitted by this Agreement shall be in writing and shall be delivered as follows with notice deemed given as indicated&#58;  (i) by personal delivery when delivered personally&#59; (ii) by overnight courier upon written verification of receipt&#59; (iii) by telecopy or facsimile transmission upon acknowledgment of receipt of electronic transmission&#59; or (iv) by certified or registered mail, return receipt requested, upon verification of receipt.  Notice shall be sent to Employee at his most recent residence and personal email address on file with the Company and to the Company at its principal place of business, or such other address as either party may specify in writing.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt;text-decoration:underline">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Sections 1 (&#8220;Definitions&#8221;), 2 (&#8220;Severance&#8221;), 3 (&#8220;Restrictive Covenants&#8221;), 4 (&#8220;Dispute Resolution&#8221;) and 6 (&#8220;General Provisions&#8221;) of this Agreement&#160;shall survive termination of Employee&#8217;s employment by the Company.</font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Agreement, the Arbitration Agreement and the PIIA incorporated herein by reference together constitute the entire agreement between the parties in respect of the subject matter contained herein and therein and supersede all prior or simultaneous representations, discussions, negotiations, and agreements, whether written or oral&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that for the avoidance of doubt, all Other Arrangements (as such Other Arrangements may be amended, modified or terminated from time to time) shall remain in effect in accordance with their terms, subject to Section 2(d) hereof.  This Agreement may be amended or modified only with the written consent of Employee and an authorized representative of the Company.  No oral waiver, amendment or modification will be effective under any circumstances whatsoever.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Code Section 409A Exempt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">To the extent applicable, this Agreement shall be interpreted in accordance with Section 409A of the Code and the regulations and guidance promulgated thereunder (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). The intent of the parties is that payments and benefits under this Agreement comply with, or be exempt from Code Section 409A and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in compliance with such intention. To the extent that any provision in this Agreement is ambiguous as to its compliance with or exemption from Code Section 409A, the provision shall be read in such a manner that no payments payable under this Agreement shall be subject to an &#8220;additional tax&#8221; as defined in Section 409A(a)(1)(B) of the Code.  If the Company and Employee determine that any compensation or benefits payable under this Agreement may be or become subject to Code Section 409A and related Department of Treasury guidance, the Company and Employee agree to amend this Agreement or adopt other policies or procedures (including amendments, policies and procedures with retroactive effect), or take such other actions as the Company and Employee deem necessary or appropriate to (A) exempt the compensation and benefits payable under this Agreement from Code Section 409A and&#47;or preserve the intended tax treatment of the compensation and benefits provided with respect to this Agreement, or (B) comply with the requirements of Code Section 409A and related Department of Treasury guidance.   </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">For purposes of Section 409A of the Code, any right to a series of installment payments under this Agreement shall be treated as a right to a series of separate payments. For purposes of this Agreement, to the extent necessary to ensure that the payments hereunder comply with or are exempt from Code Section 409A, all references to Employee&#8217;s &#8220;termination of employment&#8221; shall mean his &#8220;separation from service&#8221; (as defined in Treasury Regulation Section 1.409A-1(h)).  </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">Notwithstanding anything in this Agreement to the contrary, if Employee is deemed by the Company at the time of Employee&#8217;s separation from service to be a &#8220;specified employee&#8221; for purposes of Section 409A, to the extent delayed commencement of any portion of the benefits to which Employee is entitled under this Agreement is required in order to avoid a prohibited distribution under Section 409A, such portion of Employee&#8217;s benefits shall not be provided to Employee prior to the earlier of (A)&#160;the expiration of the six-month period measured from the date of Employee&#8217;s separation from service with the Company or (B) the date of Employee&#8217;s death.  Upon the first business day following the expiration of the applicable Section 409A period, all payments deferred pursuant to the preceding sentence shall be paid in a lump sum to Employee (or Employee&#8217;s estate or beneficiaries), and any remaining payments due to Employee under this Agreement shall be paid as otherwise provided herein.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">In the event that the amounts payable under this Agreement constitute &#8220;non-qualified deferred compensation&#8221; subject to Code Section 409A, and the timing of the delivery of Employee&#8217;s Release could cause the severance benefits described in Section 2(a) to be paid in one or another calendar year, then notwithstanding the payment timing set forth in such section, such amounts shall not be payable until the later of (A) January 1 of the second calendar year, or (B) the payment date set forth in Section 2(a). </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">To the extent required by Code Section 409A, any reimbursement or in-kind benefit provided under this Agreement shall be provided in accordance with the following&#58; (A) the amount of expenses eligible for reimbursement, or in-kind benefits provided during each calendar year cannot affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other calendar year&#59; (B) any payments in lieu of the benefits shall be paid no later than the end of Employee&#8217;s taxable year next following Employee&#8217;s taxable year in which the benefit or expense was due to be paid&#59; </font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and (C) any right to reimbursements or in-kind benefits under this Agreement shall not be subject to liquidation or exchange for another benefit.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Agreement may be executed in multiple counterparts, each of which shall be deemed an original but all of which together shall constitute one and the same instrument. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(Signature Page Follows)</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;THE PARTIES TO THIS AGREEMENT HAVE READ THE FOREGOING AGREEMENT AND FULLY UNDERSTAND EACH AND EVERY PROVISION CONTAINED HEREIN. WHEREFORE, THE PARTIES HAVE EXECUTED THIS AGREEMENT ON THE DATES SHOWN BELOW.</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Ligand Pharmaceuticals Incorporated</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Dated&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;December 4, 2022&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Andrew T. Reardon&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:180pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Name&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Andrew T. Reardon&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:180pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Title&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Chief Legal Officer and Secretary &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:180pt"><font><br></font></div><div style="padding-left:180pt"><font><br></font></div><div style="padding-left:180pt"><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Employee</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Dated&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;December 4, 2022 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Todd C. Davis&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Todd C. Davis</font></div><div style="padding-left:216pt;text-indent:36pt"><font><br></font></div><div style="padding-left:216pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Address&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10</font></div><div><font><br></font></div></div></div><div id="id730237a9cb14108981d69aa442026fe_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibits and schedules omitted in accordance with Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule and&#47;or annex will be furnished as a supplement to the U.S. Securities and Exchange Commission upon request. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EXHIBIT A - GENERAL RELEASE OF CLAIMS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EXHIBIT B - PROPRIETARY INFORMATION AND INVENTIONS AGREEMENT</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EXHIBIT C - MUTUAL ARBITRATION AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>6
<FILENAME>lgnd_123122xexhibit211.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i92a251ec813047a0acbcc30fc62012cb_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 21.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIST OF SUBSIDIARIES</font></div><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.250%"><tr><td style="width:1.0%"></td><td style="width:49.984%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.477%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Incorporation</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allergan Ligand Retinoid Therapeutics, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aramed Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cita NeuroPharmaceuticals Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CyDex Pharmaceuticals, Inc. &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glycomed Incorporated &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ligand Biopharmaceuticals Incorporated</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ligand Holdings UK Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England and Wales</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ligand JVR, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ligand Pharmaceuticals (Canada) Incorporated</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ligand Pharmaceuticals International, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ligand Pharmaceuticals UK Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ligand UK Development Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England and Wales</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ligand UK Group Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England and Wales</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ligand UK Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England and Wales</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ligand UK Research Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England and Wales</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Metabasis Therapeutics, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neurogen Corporation</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pfenex Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacopeia, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Seragen Incorporated</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Seragen Technology, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vernalis Therapeutics Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Verrow Pharmaceuticals</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kansas</font></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>7
<FILENAME>lgnd_123122xexhibit231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i8f54d2ed296e49ffb05ae158dfa77e0c_1"></div><div style="min-height:40.5pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 23.1</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consent of Independent Registered Public Accounting Firm</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consent to the incorporation by reference in the following Registration Statements&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Registration Statement (Form S-3ASR No. 333-267678) of Ligand Pharmaceuticals Incorporated,</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) Registration Statement (Form S-8 No. 333-266737) pertaining to the 2022 Employment Inducement Plan of Ligand Pharmaceuticals Incorporated,</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) Registration Statement (Form S-8 No. 333-265545) pertaining to the 2002 Stock Incentive Plan, as amended and restated of Ligand Pharmaceuticals Incorporated,</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4) Registration Statement (Form S-8 No. 333-252480) pertaining to the 2002 Stock Incentive Plan, as amended and restated of Ligand Pharmaceuticals Incorporated,</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5) Registration Statement (Form S-8 No. 333-233130) pertaining to the 2002 Stock Incentive Plan, as amended and restated of Ligand Pharmaceuticals Incorporated,</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6) Registration Statement (Form S-8 No. 333-212775) pertaining to the 2002 Stock Incentive Plan, as amended and restated of Ligand Pharmaceuticals Incorporated, </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7) Registration Statement (Form S-8 No. 333-182547) pertaining to the 2002 Stock Incentive Plan, as amended and restated of Ligand Pharmaceuticals Incorporated, </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8) Registration Statement (Form S-8 No. 333-160132) pertaining to the 2002 Stock Incentive Plan, as amended and restated, and Employee Stock Purchase Plan, as amended and restated of Ligand Pharmaceuticals Incorporated, and</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9) Registration Statement (Form S-8 No. 333-131029) pertaining to the 2002 Stock Incentive Plan and 2002 Employee Stock Purchase Plan of Ligand Pharmaceuticals Incorporated&#59; </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of our reports dated February&#160;28, 2023, with respect to the consolidated financial statements of Ligand Pharmaceuticals Incorporated and the effectiveness of internal control over financial reporting of Ligand Pharmaceuticals Incorporated included in this Annual Report (Form 10-K) of Ligand Pharmaceuticals Incorporated for the year ended December&#160;31, 2022.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Ernst &#38; Young LLP</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">San Diego, California</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;28, 2023</font></div><div><font><br></font></div><div style="height:130.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>8
<FILENAME>lgnd_123122xexhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ia4a11642b9a14322af516af9c1c35bfa_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:173%">I, Todd C. Davis, certify that&#58;</font></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.064%"><tr><td style="width:1.0%"></td><td style="width:11.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.089%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:36pt;padding-right:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:3pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Annual Report on Form 10-K of Ligand Pharmaceuticals Incorporated&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:36pt;padding-right:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:3pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:36pt;padding-right:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:3pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:36pt;padding-right:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:3pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:72pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:3pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:72pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:3pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:72pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:3pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:72pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:3pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:36pt;padding-right:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:3pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:72pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:3pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:72pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:3pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">            </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58;&#160;&#160;February&#160;28, 2023</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.557%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:14pt;padding-right:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Todd C. Davis</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:14pt;padding-right:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Todd C. Davis</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:12pt;padding-right:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:12pt;padding-right:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>9
<FILENAME>lgnd_123122xexhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ie858144db55d49d592f4d79e6348a331_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:173%">I, Octavio Espinoza, certify that&#58;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:36pt;padding-right:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:3pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Annual Report on Form 10-K of Ligand Pharmaceuticals Incorporated&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:36pt;padding-right:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:3pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:36pt;padding-right:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:3pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:36pt;padding-right:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:3pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:72pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:3pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:72pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:3pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:72pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:3pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:72pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:3pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:36pt;padding-right:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:3pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:72pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:3pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:72pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:3pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></td></tr></table></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-bottom:7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58;&#160;&#160;&#160;&#160;February&#160;28, 2023</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.839%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2pt;padding-right:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Octavio Espinoza</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2pt;padding-right:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Octavio Espinoza</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2pt;padding-right:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2pt;padding-right:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>10
<FILENAME>lgnd_123122xexhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i8c88ddaf027c40f6b2909c503ea412ee_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:173%">Exhibit 32.1</font></div><div style="text-align:right"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:173%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:173%">In connection with the Annual Report of Ligand Pharmaceuticals Incorporated (the &#8220;Company&#8221;) on Form 10-K for the year ended December&#160;31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Todd C. Davis, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font></div><div style="margin-bottom:7pt;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"></td><td style="width:8.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.223%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:3pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:10.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.334%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.866%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.944%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;padding-left:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2pt;padding-right:2pt;text-indent:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Todd C. Davis</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2pt;padding-right:2pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Todd C. Davis</font></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2pt;padding-right:2pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer</font></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2pt;padding-right:2pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</font></div></td></tr></table></div><div style="margin-top:6pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:173%">The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:173%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:173%">In connection with the Annual Report of Ligand Pharmaceuticals Incorporated (the &#8220;Company&#8221;) on Form 10-K for the year ended December&#160;31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Octavio Espinoza, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font></div><div style="margin-bottom:7pt;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:10.208%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.592%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:3pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:10.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.068%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.230%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.206%"></td><td style="width:0.1%"></td></tr><tr style="height:13pt"><td colspan="15" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;padding-left:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2pt;padding-right:2pt;text-indent:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Octavio Espinoza</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2pt;padding-right:2pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Octavio Espinoza</font></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2pt;padding-right:2pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2pt;padding-right:2pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</font></div></td></tr></table></div><div style="margin-top:6pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:173%">The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>lgnd-20221231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:c0902eea-a24e-41c4-9f5a-301d659aee15,g:8404f1f2-95a1-4d6b-a993-1c430637111f-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lgnd="http://www.ligand.com/20221231" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.ligand.com/20221231">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.ligand.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.ligand.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>0000003 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" roleURI="http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS">
        <link:definition>0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" roleURI="http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY">
        <link:definition>0000007 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPolicies" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies">
        <link:definition>0000009 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SpinoffofOmniAb" roleURI="http://www.ligand.com/role/SpinoffofOmniAb">
        <link:definition>0000010 - Disclosure - Spin-off of OmniAb</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShorttermInvestmentsInvestmentinViking" roleURI="http://www.ligand.com/role/ShorttermInvestmentsInvestmentinViking">
        <link:definition>0000011 - Disclosure - Short-term Investments: Investment in Viking</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Acquisitions" roleURI="http://www.ligand.com/role/Acquisitions">
        <link:definition>0000012 - Disclosure - Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurement" roleURI="http://www.ligand.com/role/FairValueMeasurement">
        <link:definition>0000013 - Disclosure - Fair Value Measurement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.ligand.com/role/Leases">
        <link:definition>0000014 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotes" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotes">
        <link:definition>0000015 - Disclosure - Convertible Senior Notes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetAccountDetails" roleURI="http://www.ligand.com/role/BalanceSheetAccountDetails">
        <link:definition>0000016 - Disclosure - Balance Sheet Account Details</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.ligand.com/role/StockholdersEquity">
        <link:definition>0000017 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesLegalProceedings" roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings">
        <link:definition>0000018 - Disclosure - Commitment and Contingencies: Legal Proceedings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.ligand.com/role/IncomeTaxes">
        <link:definition>0000019 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SelectedQuarterlyFinancialDataUnaudited" roleURI="http://www.ligand.com/role/SelectedQuarterlyFinancialDataUnaudited">
        <link:definition>0000020 - Disclosure - Selected Quarterly Financial Data (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>0000021 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables">
        <link:definition>0000022 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SpinoffofOmniAbTables" roleURI="http://www.ligand.com/role/SpinoffofOmniAbTables">
        <link:definition>0000023 - Disclosure - Spin-off of OmniAb (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsTables" roleURI="http://www.ligand.com/role/AcquisitionsTables">
        <link:definition>0000024 - Disclosure - Acquisitions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementTables" roleURI="http://www.ligand.com/role/FairValueMeasurementTables">
        <link:definition>0000025 - Disclosure - Fair Value Measurement (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.ligand.com/role/LeasesTables">
        <link:definition>0000026 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotesTables" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesTables">
        <link:definition>0000027 - Disclosure - Convertible Senior Notes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetAccountDetailsTables" roleURI="http://www.ligand.com/role/BalanceSheetAccountDetailsTables">
        <link:definition>0000028 - Disclosure - Balance Sheet Account Details (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://www.ligand.com/role/StockholdersEquityTables">
        <link:definition>0000029 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.ligand.com/role/IncomeTaxesTables">
        <link:definition>0000030 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SelectedQuarterlyFinancialDataUnauditedTables" roleURI="http://www.ligand.com/role/SelectedQuarterlyFinancialDataUnauditedTables">
        <link:definition>0000031 - Disclosure - Selected Quarterly Financial Data (Unaudited) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>0000032 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuefromSignificantPartnersDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuefromSignificantPartnersDetails">
        <link:definition>0000033 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Revenue from Significant Partners (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails">
        <link:definition>0000034 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Commercial License Rights (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesRoyaltyRevenueDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRoyaltyRevenueDetails">
        <link:definition>0000035 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Royalty Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesCalculationofEarningsperShareDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCalculationofEarningsperShareDetails">
        <link:definition>0000036 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Calculation of Earnings per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SpinoffofOmniAbNarrativeDetails" roleURI="http://www.ligand.com/role/SpinoffofOmniAbNarrativeDetails">
        <link:definition>0000037 - Disclosure - Spin-off of OmniAb - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails" roleURI="http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails">
        <link:definition>0000038 - Disclosure - Spin-off of OmniAb - Schedule of transfers of assets and liabilities to OmniAb (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails" roleURI="http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails">
        <link:definition>0000039 - Disclosure - Spin-off of OmniAb - Schedule of revenue and expenses of the discontinued operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails" roleURI="http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails">
        <link:definition>0000040 - Disclosure - Spin-off of OmniAb - Schedule of non-cash items and capital expenditures of the discontinued operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShorttermInvestmentsInvestmentinVikingNarrativeDetails" roleURI="http://www.ligand.com/role/ShorttermInvestmentsInvestmentinVikingNarrativeDetails">
        <link:definition>0000041 - Disclosure - Short-term Investments: Investment in Viking - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsNarrativeDetails" roleURI="http://www.ligand.com/role/AcquisitionsNarrativeDetails">
        <link:definition>0000042 - Disclosure - Acquisitions - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails" roleURI="http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails">
        <link:definition>0000043 - Disclosure - Acquisitions - Assets Acquired and Liabilities Assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsIntangiblesAcquiredandWeightedAverageUsefulLifeDetails" roleURI="http://www.ligand.com/role/AcquisitionsIntangiblesAcquiredandWeightedAverageUsefulLifeDetails">
        <link:definition>0000044 - Disclosure - Acquisitions - Intangibles Acquired and Weighted Average Useful Life (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsProFormaFinancialInformationDetails" roleURI="http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails">
        <link:definition>0000045 - Disclosure - Acquisitions - Pro Forma Financial Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" roleURI="http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails">
        <link:definition>0000046 - Disclosure - Fair Value Measurement - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementReconciliationofLevel3FinancialInstrumentsDetails" roleURI="http://www.ligand.com/role/FairValueMeasurementReconciliationofLevel3FinancialInstrumentsDetails">
        <link:definition>0000047 - Disclosure - Fair Value Measurement - Reconciliation of Level 3 Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.ligand.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>0000048 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.ligand.com/role/LeasesNarrativeDetails">
        <link:definition>0000049 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails" roleURI="http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails">
        <link:definition>0000050 - Disclosure - Leases - Operating and Finance Lease Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails" roleURI="http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails">
        <link:definition>0000051 - Disclosure - Leases - Maturities of Operating and Finance Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1" roleURI="http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1">
        <link:definition>0000051 - Disclosure - Leases - Maturities of Operating and Finance Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotesNarrativeDetails" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails">
        <link:definition>0000052 - Disclosure - Convertible Senior Notes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotesEquityandLiabilityComponentsofFinancingArrangementsDetails" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesEquityandLiabilityComponentsofFinancingArrangementsDetails">
        <link:definition>0000053 - Disclosure - Convertible Senior Notes - Equity and Liability Components of Financing Arrangements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetAccountDetailsInvestmentCategoriesDetails" roleURI="http://www.ligand.com/role/BalanceSheetAccountDetailsInvestmentCategoriesDetails">
        <link:definition>0000054 - Disclosure - Balance Sheet Account Details - Investment Categories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetAccountDetailsNarrativeDetails" roleURI="http://www.ligand.com/role/BalanceSheetAccountDetailsNarrativeDetails">
        <link:definition>0000055 - Disclosure - Balance Sheet Account Details - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" roleURI="http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesbyContractualMaturityDetails">
        <link:definition>0000056 - Disclosure - Balance Sheet Account Details - Available-for-Sale Debt Securities by Contractual Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails" roleURI="http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails">
        <link:definition>0000057 - Disclosure - Balance Sheet Account Details - Available-for-Sale Debt Securities in an Unrealized Loss Position (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetAccountDetailsPropertyandEquipmentDetails" roleURI="http://www.ligand.com/role/BalanceSheetAccountDetailsPropertyandEquipmentDetails">
        <link:definition>0000058 - Disclosure - Balance Sheet Account Details - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetAccountDetailsGoodwillandOtherIntangibleAssetsDetails" roleURI="http://www.ligand.com/role/BalanceSheetAccountDetailsGoodwillandOtherIntangibleAssetsDetails">
        <link:definition>0000059 - Disclosure - Balance Sheet Account Details - Goodwill and Other Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetAccountDetailsAccruedLiabilitiesDetails" roleURI="http://www.ligand.com/role/BalanceSheetAccountDetailsAccruedLiabilitiesDetails">
        <link:definition>0000060 - Disclosure - Balance Sheet Account Details - Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetAccountDetailsContingentLiabilitiesDetails" roleURI="http://www.ligand.com/role/BalanceSheetAccountDetailsContingentLiabilitiesDetails">
        <link:definition>0000061 - Disclosure - Balance Sheet Account Details - Contingent Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityShareBasedCompensationDetails" roleURI="http://www.ligand.com/role/StockholdersEquityShareBasedCompensationDetails">
        <link:definition>0000062 - Disclosure - Stockholders' Equity - Share-Based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityNarrativeDetails" roleURI="http://www.ligand.com/role/StockholdersEquityNarrativeDetails">
        <link:definition>0000063 - Disclosure - Stockholders' Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockOptionPlanActivityDetails" roleURI="http://www.ligand.com/role/StockholdersEquityStockOptionPlanActivityDetails">
        <link:definition>0000064 - Disclosure - Stockholders' Equity - Stock Option Plan Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityBreakdownofOptionsOutstandingDetails" roleURI="http://www.ligand.com/role/StockholdersEquityBreakdownofOptionsOutstandingDetails">
        <link:definition>0000065 - Disclosure - Stockholders' Equity - Breakdown of Options Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityAssumptionsDetails" roleURI="http://www.ligand.com/role/StockholdersEquityAssumptionsDetails">
        <link:definition>0000066 - Disclosure - Stockholders' Equity - Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityRestrictedStockActivityDetails" roleURI="http://www.ligand.com/role/StockholdersEquityRestrictedStockActivityDetails">
        <link:definition>0000067 - Disclosure - Stockholders' Equity - Restricted Stock Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.ligand.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>0000068 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails" roleURI="http://www.ligand.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails">
        <link:definition>0000069 - Disclosure - Income Taxes - Components of Income Tax Expense (Benefit) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails" roleURI="http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails">
        <link:definition>0000070 - Disclosure - Income Taxes - Reconciliation of Income Tax Expense (Benefit) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDeferredTaxesDetails" roleURI="http://www.ligand.com/role/IncomeTaxesDeferredTaxesDetails">
        <link:definition>0000071 - Disclosure - Income Taxes - Deferred Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails" roleURI="http://www.ligand.com/role/IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails">
        <link:definition>0000072 - Disclosure - Income Taxes - Reconciliation of Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SelectedQuarterlyFinancialDataUnauditedSummaryDetails" roleURI="http://www.ligand.com/role/SelectedQuarterlyFinancialDataUnauditedSummaryDetails">
        <link:definition>0000073 - Disclosure - Selected Quarterly Financial Data (Unaudited) - Summary (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="lgnd_BasisOfPresentationTable" abstract="true" name="BasisOfPresentationTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ContractualRelationshipsJazzMember" abstract="true" name="ContractualRelationshipsJazzMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_VikingTherapeuticsInc.Member" abstract="true" name="VikingTherapeuticsInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_AdjustmentsToAdditionalPaidInCapitalBondHedgeTransaction" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalBondHedgeTransaction" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" abstract="true" name="BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_IncreaseDecreaseInDebtDiscount" abstract="false" name="IncreaseDecreaseInDebtDiscount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AziyoandCorMatrixMember" abstract="true" name="AziyoandCorMatrixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_ExercisePriceRangeSevenMember" abstract="true" name="ExercisePriceRangeSevenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract" abstract="true" name="DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_RoyaltyOtherMember" abstract="true" name="RoyaltyOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_MaterialSalesCaptisolCoreMember" abstract="true" name="MaterialSalesCaptisolCoreMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_CashPaidDuringTheYearAbstract" abstract="true" name="CashPaidDuringTheYearAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_LeaseLiability" abstract="false" name="LeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireBusinessesNetOfCashAcquired" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireBusinessesNetOfCashAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ExercisePriceRangeNineMember" abstract="true" name="ExercisePriceRangeNineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_EffectiveIncomeTaxRateReconciliationExpiredTaxCreditsResearch" abstract="false" name="EffectiveIncomeTaxRateReconciliationExpiredTaxCreditsResearch" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ExercisePriceRangeFourMember" abstract="true" name="ExercisePriceRangeFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesNoncurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsFinanceLeaseAssets" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationAssetsFinanceLeaseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_VestingPeriodOneMember" abstract="true" name="VestingPeriodOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_ContractRevenueMember" abstract="true" name="ContractRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_TwoThousandTwoStockIncentivePlanMember" abstract="true" name="TwoThousandTwoStockIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_ExercisePriceRangeTenMember" abstract="true" name="ExercisePriceRangeTenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_ContractualRelationshipsAlvogenMember" abstract="true" name="ContractualRelationshipsAlvogenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_NumberOfAcquisitions" abstract="false" name="NumberOfAcquisitions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsAbstract" abstract="true" name="DisposalGroupIncludingDiscontinuedOperationAssetsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_RepaymentsOfNotesPayableInterestPortion" abstract="false" name="RepaymentsOfNotesPayableInterestPortion" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_PaymentsToUnwindWarrants" abstract="false" name="PaymentsToUnwindWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" abstract="true" name="LiabilityForContingentValueRightsCompanyMetabasisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_CommercialLicenseRights" abstract="false" name="CommercialLicenseRights" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_CommercialLicenseRightsPolicyTextBlock" abstract="false" name="CommercialLicenseRightsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lgnd_MaterialSalesCaptisolMember" abstract="true" name="MaterialSalesCaptisolMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_PaymentsToContingentValueRightHolders" abstract="false" name="PaymentsToContingentValueRightHolders" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ScheduleofCommercialLicenseRightsTableTextBlock" abstract="false" name="ScheduleofCommercialLicenseRightsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lgnd_CurrentPortionOfLiabilityForContingentValueRights" abstract="false" name="CurrentPortionOfLiabilityForContingentValueRights" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilitiesCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRights" abstract="false" name="LiabilityForContingentValueRights" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_PartnerCMember" abstract="true" name="PartnerCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_EffectiveIncomeTaxRateReconciliationOfficerCompensationAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationOfficerCompensationAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_MetabasisTherapeuticsMember" abstract="true" name="MetabasisTherapeuticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_ExercisePriceRangeEightMember" abstract="true" name="ExercisePriceRangeEightMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_BasisOfPresentationLineItems" abstract="true" name="BasisOfPresentationLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities" abstract="false" name="FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ExercisePriceRangeOneMember" abstract="true" name="ExercisePriceRangeOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_AccruedSubcontractorExpensesCurrent" abstract="false" name="AccruedSubcontractorExpensesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions" abstract="false" name="EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" abstract="false" name="PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LeaseLiabilityCurrent" abstract="false" name="LeaseLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_PartnerBMember" abstract="true" name="PartnerBMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_MaterialSalesCaptisolCOVIDMember" abstract="true" name="MaterialSalesCaptisolCOVIDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_AccruedAssetAcquisitionsCurrent" abstract="false" name="AccruedAssetAcquisitionsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_NumberOfContingentValueRightsIssued" abstract="false" name="NumberOfContingentValueRightsIssued" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_EmployeeStockPurchasePlanAbstract" abstract="true" name="EmployeeStockPurchasePlanAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_MaturityPeriodOfHighlyLiquidSecuritiesMaximum" abstract="false" name="MaturityPeriodOfHighlyLiquidSecuritiesMaximum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lgnd_RestrictedStockUnitsAndPerformanceSharesMember" abstract="true" name="RestrictedStockUnitsAndPerformanceSharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_OmniabSeparationMember" abstract="true" name="OmniabSeparationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_RoyaltyAgreementExpirationPeriod" abstract="false" name="RoyaltyAgreementExpirationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lgnd_LicenseFeesMember" abstract="true" name="LicenseFeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_ComputerEquipmentAndSoftwareMember" abstract="true" name="ComputerEquipmentAndSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_SaleOfStockAuthorizedOfferingAmount" abstract="false" name="SaleOfStockAuthorizedOfferingAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_PalvellaTherapeuticsIncMember" abstract="true" name="PalvellaTherapeuticsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndStockholdersEquityAbstract" abstract="true" name="DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndStockholdersEquityAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" abstract="true" name="LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_AziyoMember" abstract="true" name="AziyoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_AdjustmentsToAdditionalPaidInCapitalDecreaseDueToSeparation" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalDecreaseDueToSeparation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ExercisePriceRangeThreeMember" abstract="true" name="ExercisePriceRangeThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_SelexisAndDianomiMember" abstract="true" name="SelexisAndDianomiMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_PfenexMember" abstract="true" name="PfenexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_PaymentsForSeparation" abstract="false" name="PaymentsForSeparation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BusinessCombinationContingentConsiderationLiabilityAmountPerShare" abstract="false" name="BusinessCombinationContingentConsiderationLiabilityAmountPerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="lgnd_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lgnd_AccruedInventoryPurchases" abstract="false" name="AccruedInventoryPurchases" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LicenseUpfrontPayment" abstract="false" name="LicenseUpfrontPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_PurchaseCommitmentConsiderationPaidAllocatedToInventory" abstract="false" name="PurchaseCommitmentConsiderationPaidAllocatedToInventory" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_MilestoneMember" abstract="true" name="MilestoneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivesAbstract" abstract="true" name="NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_LigandCoreBusinessMember" abstract="true" name="LigandCoreBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" abstract="false" name="PaymentsToContingentValueRightHoldersFinancingActivity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" abstract="false" name="ForecastedCashFlowsEffectiveInterestRatePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod" abstract="false" name="BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ContractualRelationshipsSIIMember" abstract="true" name="ContractualRelationshipsSIIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" abstract="false" name="BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lgnd_ProductRoyaltyPercentage" abstract="false" name="ProductRoyaltyPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AccountsReceivableCreditLossExpenseReversalCOVID19" abstract="false" name="AccountsReceivableCreditLossExpenseReversalCOVID19" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ProceedsFromCommercialLicenseRights" abstract="false" name="ProceedsFromCommercialLicenseRights" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract" abstract="true" name="DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_BusinessSpinOffAndMigrationPolicyTextBlock" abstract="false" name="BusinessSpinOffAndMigrationPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_RoyaltyRylazeMember" abstract="true" name="RoyaltyRylazeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_ContingentLiabilityRollForward" abstract="true" name="ContingentLiabilityRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_DeferredTaxLiabilitiesFiniteLivedIntangibleAssets" abstract="false" name="DeferredTaxLiabilitiesFiniteLivedIntangibleAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_GainLossOnShortTermInvestments" abstract="false" name="GainLossOnShortTermInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesOperatingLeaseNoncurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationLiabilitiesOperatingLeaseNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_NumberOfSharesSoldOfEquityMethodInvestee" abstract="false" name="NumberOfSharesSoldOfEquityMethodInvestee" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="lgnd_PurchaseCommitmentConsiderationPaidToDate" abstract="false" name="PurchaseCommitmentConsiderationPaidToDate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ScheduleofContingentLiabilitiesTableTextBlock" abstract="false" name="ScheduleofContingentLiabilitiesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember" abstract="true" name="NotesRepurchasedDuringCurrentPeriodTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_AmendedESPPMember" abstract="true" name="AmendedESPPMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_ExercisePriceRangeFiveMember" abstract="true" name="ExercisePriceRangeFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRightsCompanyCydexMember" abstract="true" name="LiabilityForContingentValueRightsCompanyCydexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_CashCashEquivalentsandShorttermInvestmentsPolicyTextBlock" abstract="false" name="CashCashEquivalentsandShorttermInvestmentsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lgnd_AccruedSalesReturns" abstract="false" name="AccruedSalesReturns" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_DisposalGroupIncludingDiscontinuedOperationNetAssetsTransferred" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationNetAssetsTransferred" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AccruedSupplierExpensesCurrent" abstract="false" name="AccruedSupplierExpensesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_RoyaltyTeriparatideInjectionMember" abstract="true" name="RoyaltyTeriparatideInjectionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_IncomeTaxReconciliationContingentValueRights" abstract="false" name="IncomeTaxReconciliationContingentValueRights" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_PaymentsToContingentValueRightHoldersInvestingActivity" abstract="false" name="PaymentsToContingentValueRightHoldersInvestingActivity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_DebtInstrumentRepurchasedAmountDuringPeriod" abstract="false" name="DebtInstrumentRepurchasedAmountDuringPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AtTheMarketEquityOfferingMember" abstract="true" name="AtTheMarketEquityOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments" abstract="false" name="FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_NumberOfContingentValueRightAgreements" abstract="false" name="NumberOfContingentValueRightAgreements" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_ContractualRelationshipsArcellxMember" abstract="true" name="ContractualRelationshipsArcellxMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsOperatingLeaseAssets" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationAssetsOperatingLeaseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ExercisePriceRangeSixMember" abstract="true" name="ExercisePriceRangeSixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" abstract="true" name="DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_NumberOfOptionsUnderConvertibleBondHedges" abstract="false" name="NumberOfOptionsUnderConvertibleBondHedges" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_VernalisMember" abstract="true" name="VernalisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_RoyaltyKyprolisMember" abstract="true" name="RoyaltyKyprolisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="lgnd_ContractualRelationshipsMerckMember" abstract="true" name="ContractualRelationshipsMerckMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" abstract="false" name="FiniteLivedIntangibleAssetsCreditLossAdjustments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_PaymentsforConvertibleBondHedges" abstract="false" name="PaymentsforConvertibleBondHedges" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_SelexisMember" abstract="true" name="SelexisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_OtherBalanceSheetDetailsAbstract" abstract="true" name="OtherBalanceSheetDetailsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_CydexPharmaceuticalsIncMember" abstract="true" name="CydexPharmaceuticalsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_AdditionalRoyaltiesReceivableUnderSalesbasedMilestones" abstract="false" name="AdditionalRoyaltiesReceivableUnderSalesbasedMilestones" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" abstract="false" name="FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_Phase3ClinicalTrialMember" abstract="true" name="Phase3ClinicalTrialMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_RoyaltyEvomelaMember" abstract="true" name="RoyaltyEvomelaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_CorporateShareRepurchaseAbstract" abstract="true" name="CorporateShareRepurchaseAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" abstract="false" name="BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" abstract="false" name="NonCashChangeInEstimatedFairValueOfContingentValueRights" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_CorMatrixMember" abstract="true" name="CorMatrixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_PartnerAMember" abstract="true" name="PartnerAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" abstract="false" name="DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lgnd_LeaseRightOfUseAsset" abstract="false" name="LeaseRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ExercisePriceRangeTwoMember" abstract="true" name="ExercisePriceRangeTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_ProceedsFromUnwindingConvertibleBondHedges" abstract="false" name="ProceedsFromUnwindingConvertibleBondHedges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_CaliforniaAndNewJerseyResearchTaxCreditCarryforwardMember" abstract="true" name="CaliforniaAndNewJerseyResearchTaxCreditCarryforwardMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_EffectiveIncomeTaxRateReconciliationDebtRepurchasesAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationDebtRepurchasesAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ConvertibleSeniorNotesDue2023Member" abstract="true" name="ConvertibleSeniorNotesDue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_VestingPeriodTwoMember" abstract="true" name="VestingPeriodTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract" abstract="true" name="NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_LicenseFeesMilestonesAndOtherProductOtherMember" abstract="true" name="LicenseFeesMilestonesAndOtherProductOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" abstract="false" name="AmortizationOfCommercialLicenseAndOtherEconomicRights" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_NovanMolluscumProductsMember" abstract="true" name="NovanMolluscumProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_EffectiveIncomeTaxRateReconciliationOtherIncome" abstract="false" name="EffectiveIncomeTaxRateReconciliationOtherIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>12
<FILENAME>lgnd-20221231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:c0902eea-a24e-41c4-9f5a-301d659aee15,g:8404f1f2-95a1-4d6b-a993-1c430637111f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="lgnd-20221231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_589aa956-5eac-45df-ba22-e5df967c1d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0037bc49-6a25-4a3c-a784-be93f5f6290a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_589aa956-5eac-45df-ba22-e5df967c1d3d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0037bc49-6a25-4a3c-a784-be93f5f6290a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_f645f825-6488-46e6-a14e-a2a0620e02d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_589aa956-5eac-45df-ba22-e5df967c1d3d" xlink:to="loc_us-gaap_IncomeTaxesReceivable_f645f825-6488-46e6-a14e-a2a0620e02d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_991af11f-b771-4407-8db0-5b915383613f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_589aa956-5eac-45df-ba22-e5df967c1d3d" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_991af11f-b771-4407-8db0-5b915383613f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_96f985bd-94c8-49da-848d-0a95fb24498e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_589aa956-5eac-45df-ba22-e5df967c1d3d" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_96f985bd-94c8-49da-848d-0a95fb24498e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_825062e7-1264-49cf-9d57-f435a63173aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_589aa956-5eac-45df-ba22-e5df967c1d3d" xlink:to="loc_us-gaap_InventoryNet_825062e7-1264-49cf-9d57-f435a63173aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_2c3166ca-32a2-4fd2-916b-7b11d22581f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_589aa956-5eac-45df-ba22-e5df967c1d3d" xlink:to="loc_us-gaap_OtherAssetsCurrent_2c3166ca-32a2-4fd2-916b-7b11d22581f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_7b2f4934-cb7e-4b35-bc24-0b492bd2785c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_589aa956-5eac-45df-ba22-e5df967c1d3d" xlink:to="loc_us-gaap_ShortTermInvestments_7b2f4934-cb7e-4b35-bc24-0b492bd2785c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_11949755-4080-408d-8d86-7b013835782b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRights_ed9917b4-107a-4529-9505-e7d36a978260" xlink:href="lgnd-20221231.xsd#lgnd_CommercialLicenseRights"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_11949755-4080-408d-8d86-7b013835782b" xlink:to="loc_lgnd_CommercialLicenseRights_ed9917b4-107a-4529-9505-e7d36a978260" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_b1a535e8-885d-4565-aada-2e9b3592c8bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_11949755-4080-408d-8d86-7b013835782b" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_b1a535e8-885d-4565-aada-2e9b3592c8bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_db8d3edc-b8d7-4efd-a1bc-c1b18cdf9640" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_11949755-4080-408d-8d86-7b013835782b" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_db8d3edc-b8d7-4efd-a1bc-c1b18cdf9640" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_ff7b2219-285b-4fc7-9a32-539e7d77bfd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_11949755-4080-408d-8d86-7b013835782b" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_ff7b2219-285b-4fc7-9a32-539e7d77bfd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_9cd76cad-95c0-4220-b7c2-c539e83605af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_11949755-4080-408d-8d86-7b013835782b" xlink:to="loc_us-gaap_AssetsCurrent_9cd76cad-95c0-4220-b7c2-c539e83605af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_f378a6de-34a4-42ba-b74a-06e6f60818b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_11949755-4080-408d-8d86-7b013835782b" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_f378a6de-34a4-42ba-b74a-06e6f60818b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_55cb3afd-2f6a-43ec-9f3e-abba016c75cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_11949755-4080-408d-8d86-7b013835782b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_55cb3afd-2f6a-43ec-9f3e-abba016c75cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ba701a30-890a-485a-9b7c-c642fe3102a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_11949755-4080-408d-8d86-7b013835782b" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ba701a30-890a-485a-9b7c-c642fe3102a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_18a17417-1172-4be2-903b-675c043d7ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_11949755-4080-408d-8d86-7b013835782b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_18a17417-1172-4be2-903b-675c043d7ec5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0acb4e60-654e-4efe-9760-3cebf7aeda35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_11949755-4080-408d-8d86-7b013835782b" xlink:to="loc_us-gaap_Goodwill_0acb4e60-654e-4efe-9760-3cebf7aeda35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_39abf5f4-b982-42eb-8321-32c3b8226502" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRights_7127d182-0e25-498c-86a7-d8e9e600d0c8" xlink:href="lgnd-20221231.xsd#lgnd_LiabilityForContingentValueRights"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_39abf5f4-b982-42eb-8321-32c3b8226502" xlink:to="loc_lgnd_LiabilityForContingentValueRights_7127d182-0e25-498c-86a7-d8e9e600d0c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_62c65547-6530-4416-9e9a-c57ca3c2794d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_39abf5f4-b982-42eb-8321-32c3b8226502" xlink:to="loc_us-gaap_LiabilitiesCurrent_62c65547-6530-4416-9e9a-c57ca3c2794d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_30e083f7-b841-4937-86f3-e38441ba619c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_39abf5f4-b982-42eb-8321-32c3b8226502" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_30e083f7-b841-4937-86f3-e38441ba619c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_63855a7a-4ace-48fa-bb52-bf22b7d21b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_39abf5f4-b982-42eb-8321-32c3b8226502" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_63855a7a-4ace-48fa-bb52-bf22b7d21b9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_33ea08b1-6204-42ce-9984-4208ee385691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_39abf5f4-b982-42eb-8321-32c3b8226502" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_33ea08b1-6204-42ce-9984-4208ee385691" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_3a49647c-f584-49bd-8a87-d62f875d03e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_39abf5f4-b982-42eb-8321-32c3b8226502" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_3a49647c-f584-49bd-8a87-d62f875d03e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4c54b741-1d17-44f6-955f-308b1f9be47f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_39abf5f4-b982-42eb-8321-32c3b8226502" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4c54b741-1d17-44f6-955f-308b1f9be47f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_be2f5e48-d085-445f-a467-78a6a3a04a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_9d9e6fce-d630-430b-a374-75095552f00c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_be2f5e48-d085-445f-a467-78a6a3a04a8a" xlink:to="loc_us-gaap_PreferredStockValue_9d9e6fce-d630-430b-a374-75095552f00c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_1141f516-fb74-4d9e-8713-b6670efc4ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_be2f5e48-d085-445f-a467-78a6a3a04a8a" xlink:to="loc_us-gaap_CommonStockValue_1141f516-fb74-4d9e-8713-b6670efc4ad1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_7f62892c-7384-4a7b-a489-9375815f934d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_be2f5e48-d085-445f-a467-78a6a3a04a8a" xlink:to="loc_us-gaap_AdditionalPaidInCapital_7f62892c-7384-4a7b-a489-9375815f934d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a1220202-d867-4a88-b49e-cf9ad4061c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_be2f5e48-d085-445f-a467-78a6a3a04a8a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a1220202-d867-4a88-b49e-cf9ad4061c9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2148b9df-284d-4cad-99a4-631dbb24d862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_be2f5e48-d085-445f-a467-78a6a3a04a8a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2148b9df-284d-4cad-99a4-631dbb24d862" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_a9dcf9a9-c191-41ca-a0ae-7f3ea51c1058" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_1b666e2d-d10c-4104-886b-028f9079175b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a9dcf9a9-c191-41ca-a0ae-7f3ea51c1058" xlink:to="loc_us-gaap_Liabilities_1b666e2d-d10c-4104-886b-028f9079175b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_02256319-9291-47e2-a978-0087b3f5b77a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a9dcf9a9-c191-41ca-a0ae-7f3ea51c1058" xlink:to="loc_us-gaap_CommitmentsAndContingencies_02256319-9291-47e2-a978-0087b3f5b77a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3b83e953-b411-443f-8c70-e32f2bf72a12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a9dcf9a9-c191-41ca-a0ae-7f3ea51c1058" xlink:to="loc_us-gaap_StockholdersEquity_3b83e953-b411-443f-8c70-e32f2bf72a12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_11780a07-a2f6-4eb0-8c8c-cb581a8260f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_9cf15843-0913-4580-8392-411a347ee2d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_11780a07-a2f6-4eb0-8c8c-cb581a8260f1" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_9cf15843-0913-4580-8392-411a347ee2d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtCurrent_8852dcaa-e4e7-46e6-bc28-a38756575bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_11780a07-a2f6-4eb0-8c8c-cb581a8260f1" xlink:to="loc_us-gaap_ConvertibleDebtCurrent_8852dcaa-e4e7-46e6-bc28-a38756575bfc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_b80b9e3e-e86d-4ec7-a60f-e604649f1d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_11780a07-a2f6-4eb0-8c8c-cb581a8260f1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_b80b9e3e-e86d-4ec7-a60f-e604649f1d9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_5c387358-23c9-4228-89d5-04007c708743" xlink:href="lgnd-20221231.xsd#lgnd_CurrentPortionOfLiabilityForContingentValueRights"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_11780a07-a2f6-4eb0-8c8c-cb581a8260f1" xlink:to="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_5c387358-23c9-4228-89d5-04007c708743" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_a1bec14b-d852-4c83-ba15-ad13a5d84bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_11780a07-a2f6-4eb0-8c8c-cb581a8260f1" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_a1bec14b-d852-4c83-ba15-ad13a5d84bb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_80354bb1-b206-4ae9-a79a-a293f5188e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_11780a07-a2f6-4eb0-8c8c-cb581a8260f1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_80354bb1-b206-4ae9-a79a-a293f5188e7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_739c6a88-3dd8-492f-9aac-b20c3ea9a2a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_11780a07-a2f6-4eb0-8c8c-cb581a8260f1" xlink:to="loc_us-gaap_AccountsPayableCurrent_739c6a88-3dd8-492f-9aac-b20c3ea9a2a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_dbda9601-8177-49af-a854-64269dff50a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_11780a07-a2f6-4eb0-8c8c-cb581a8260f1" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_dbda9601-8177-49af-a854-64269dff50a2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="lgnd-20221231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_0c7f24ee-7b57-40d7-9a5b-6f1f7eb74e45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_856caf6a-4f34-46bc-9a15-d58a7209d8df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_0c7f24ee-7b57-40d7-9a5b-6f1f7eb74e45" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_856caf6a-4f34-46bc-9a15-d58a7209d8df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_50891270-eb44-4c99-9178-fb31f0f966c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_0c7f24ee-7b57-40d7-9a5b-6f1f7eb74e45" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_50891270-eb44-4c99-9178-fb31f0f966c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_e57d80cb-cf50-400f-a74d-4239bcdb58da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_0c7f24ee-7b57-40d7-9a5b-6f1f7eb74e45" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_e57d80cb-cf50-400f-a74d-4239bcdb58da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial_65933255-0258-4d7c-8423-625a61d8cf26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostDirectMaterial"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_0c7f24ee-7b57-40d7-9a5b-6f1f7eb74e45" xlink:to="loc_us-gaap_CostDirectMaterial_65933255-0258-4d7c-8423-625a61d8cf26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_d02d02ce-a4b2-49e5-9cb5-8ad111265c08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_0c7f24ee-7b57-40d7-9a5b-6f1f7eb74e45" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_d02d02ce-a4b2-49e5-9cb5-8ad111265c08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_f28e2842-9990-4cf7-8690-d778c07778b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9be0a4e6-6122-4863-883d-961b229e8f19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_f28e2842-9990-4cf7-8690-d778c07778b0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9be0a4e6-6122-4863-883d-961b229e8f19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b4f8e0a7-0e19-45c5-8e42-d3c6c259d319" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_f28e2842-9990-4cf7-8690-d778c07778b0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b4f8e0a7-0e19-45c5-8e42-d3c6c259d319" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_2a6d80fd-fd11-44fa-a411-c5f654d9d251" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_9a39c451-77ba-45c3-be5a-64fe3794a450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_2a6d80fd-fd11-44fa-a411-c5f654d9d251" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_9a39c451-77ba-45c3-be5a-64fe3794a450" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_a06a6b00-c06c-4942-94f5-a6196eede55d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_2a6d80fd-fd11-44fa-a411-c5f654d9d251" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_a06a6b00-c06c-4942-94f5-a6196eede55d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_568e8b1c-35e1-4832-92a2-571acda3730a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_54e9cc8d-98d0-42bf-8365-366832597fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_568e8b1c-35e1-4832-92a2-571acda3730a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_54e9cc8d-98d0-42bf-8365-366832597fdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_3668e271-4934-42c5-b5ad-1b29a0116f21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_568e8b1c-35e1-4832-92a2-571acda3730a" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_3668e271-4934-42c5-b5ad-1b29a0116f21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets_27d6af62-8ea7-4213-9574-74ce62c6a670" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_568e8b1c-35e1-4832-92a2-571acda3730a" xlink:to="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets_27d6af62-8ea7-4213-9574-74ce62c6a670" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_a10d38fa-06c1-447b-892f-43d76b3a3611" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_7ea2f11d-df1f-4967-a51b-16db29c0ecc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_a10d38fa-06c1-447b-892f-43d76b3a3611" xlink:to="loc_us-gaap_GainLossOnInvestments_7ea2f11d-df1f-4967-a51b-16db29c0ecc4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_27c0e26e-0fa2-4621-8bc5-c614c3990fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_a10d38fa-06c1-447b-892f-43d76b3a3611" xlink:to="loc_us-gaap_InvestmentIncomeInterest_27c0e26e-0fa2-4621-8bc5-c614c3990fb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_dc577ede-2bba-410b-a1f9-200ca0040d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_a10d38fa-06c1-447b-892f-43d76b3a3611" xlink:to="loc_us-gaap_InterestExpense_dc577ede-2bba-410b-a1f9-200ca0040d6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_323b7b0b-e7bb-4665-949c-0b0228099a65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_a10d38fa-06c1-447b-892f-43d76b3a3611" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_323b7b0b-e7bb-4665-949c-0b0228099a65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3d479fe8-f02f-4cc8-9ecf-04d063cf458a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_db18b4e0-1915-4f87-ae7f-05c245c580d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_3d479fe8-f02f-4cc8-9ecf-04d063cf458a" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_db18b4e0-1915-4f87-ae7f-05c245c580d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_bf86efc8-03d7-4394-94fe-2f447b364766" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_3d479fe8-f02f-4cc8-9ecf-04d063cf458a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_bf86efc8-03d7-4394-94fe-2f447b364766" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_808c56bd-e80a-4083-956e-8f3798f88b75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_482b1f20-4cde-4fd3-a08b-9a6c07de28dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_808c56bd-e80a-4083-956e-8f3798f88b75" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_482b1f20-4cde-4fd3-a08b-9a6c07de28dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_6f14ab91-0666-4f6d-b622-3fe39b0bbf2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_808c56bd-e80a-4083-956e-8f3798f88b75" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_6f14ab91-0666-4f6d-b622-3fe39b0bbf2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_39d52905-8eb2-47e9-9e31-1e15dc706a66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_ab347e16-90a1-4733-9da5-f085dbfe4331" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_39d52905-8eb2-47e9-9e31-1e15dc706a66" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_ab347e16-90a1-4733-9da5-f085dbfe4331" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_63e998f8-43eb-44ad-8997-0fdf097bec24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_39d52905-8eb2-47e9-9e31-1e15dc706a66" xlink:to="loc_us-gaap_OperatingIncomeLoss_63e998f8-43eb-44ad-8997-0fdf097bec24" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="lgnd-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_847add80-9f71-4b2d-b0e8-c3c56302471e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_39e8bad6-bc1a-4448-bfb7-07bba8ec22a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_847add80-9f71-4b2d-b0e8-c3c56302471e" xlink:to="loc_us-gaap_NetIncomeLoss_39e8bad6-bc1a-4448-bfb7-07bba8ec22a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_46262c54-1f76-49a3-9239-a676ebef3869" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_847add80-9f71-4b2d-b0e8-c3c56302471e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_46262c54-1f76-49a3-9239-a676ebef3869" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_673f9972-da67-4113-b2cd-94aa46c68f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_847add80-9f71-4b2d-b0e8-c3c56302471e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_673f9972-da67-4113-b2cd-94aa46c68f8f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="lgnd-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_48ce810e-5763-434a-9b08-f021add3aad5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_4b418e9c-f1f4-4a06-b459-f8b5b1e11b38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_48ce810e-5763-434a-9b08-f021add3aad5" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_4b418e9c-f1f4-4a06-b459-f8b5b1e11b38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_da73ef4d-4997-45e5-b76b-f373e53fe3e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_48ce810e-5763-434a-9b08-f021add3aad5" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_da73ef4d-4997-45e5-b76b-f373e53fe3e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_4b0340ee-2e0c-47fb-8629-82ecf78df1f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_48ce810e-5763-434a-9b08-f021add3aad5" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_4b0340ee-2e0c-47fb-8629-82ecf78df1f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ProceedsFromCommercialLicenseRights_452f2065-e0b3-4659-9484-ea2f69c6a96e" xlink:href="lgnd-20221231.xsd#lgnd_ProceedsFromCommercialLicenseRights"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_48ce810e-5763-434a-9b08-f021add3aad5" xlink:to="loc_lgnd_ProceedsFromCommercialLicenseRights_452f2065-e0b3-4659-9484-ea2f69c6a96e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_f17f2572-bedf-4bca-b58f-df4e5591393b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_48ce810e-5763-434a-9b08-f021add3aad5" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_f17f2572-bedf-4bca-b58f-df4e5591393b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_611e69ae-e641-4381-89a3-d3eefe7659b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_48ce810e-5763-434a-9b08-f021add3aad5" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_611e69ae-e641-4381-89a3-d3eefe7659b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_e925181f-dab6-4a5b-a915-ff405c6da1c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_48ce810e-5763-434a-9b08-f021add3aad5" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_e925181f-dab6-4a5b-a915-ff405c6da1c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_c961b6e5-337d-41e7-bb98-6f97521aa796" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_48ce810e-5763-434a-9b08-f021add3aad5" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_c961b6e5-337d-41e7-bb98-6f97521aa796" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_f5752b37-cfd8-496c-a5c4-e16cb6661413" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_48ce810e-5763-434a-9b08-f021add3aad5" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_f5752b37-cfd8-496c-a5c4-e16cb6661413" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c6bb5b0d-f63b-4aa2-ab65-9a041664d78c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeFinancingActivities_2c2d4339-1f37-46f8-bd7b-ff70f4592364" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromHedgeFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c6bb5b0d-f63b-4aa2-ab65-9a041664d78c" xlink:to="loc_us-gaap_ProceedsFromHedgeFinancingActivities_2c2d4339-1f37-46f8-bd7b-ff70f4592364" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_56a364c3-f0ac-482a-a306-489928e695e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c6bb5b0d-f63b-4aa2-ab65-9a041664d78c" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_56a364c3-f0ac-482a-a306-489928e695e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_4fa54a10-9465-4803-b116-3ace859c9544" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c6bb5b0d-f63b-4aa2-ab65-9a041664d78c" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_4fa54a10-9465-4803-b116-3ace859c9544" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_bf0190fb-d720-435d-9215-da128e242a12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c6bb5b0d-f63b-4aa2-ab65-9a041664d78c" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_bf0190fb-d720-435d-9215-da128e242a12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_795d1334-ab1d-4687-aa5e-8cf1c002b1a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c6bb5b0d-f63b-4aa2-ab65-9a041664d78c" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_795d1334-ab1d-4687-aa5e-8cf1c002b1a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2fea3f2a-3f32-44c9-b2ec-e34542581f50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c6bb5b0d-f63b-4aa2-ab65-9a041664d78c" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2fea3f2a-3f32-44c9-b2ec-e34542581f50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfWarrants_fc6f5a06-ab3a-4b40-af08-f873f243593d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfWarrants"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c6bb5b0d-f63b-4aa2-ab65-9a041664d78c" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfWarrants_fc6f5a06-ab3a-4b40-af08-f873f243593d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsForSeparation_ff1eefcb-d4f0-4743-8f3c-49ea5b3af83a" xlink:href="lgnd-20221231.xsd#lgnd_PaymentsForSeparation"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c6bb5b0d-f63b-4aa2-ab65-9a041664d78c" xlink:to="loc_lgnd_PaymentsForSeparation_ff1eefcb-d4f0-4743-8f3c-49ea5b3af83a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_ff240db6-2f44-49a6-a763-5b0764aaa728" xlink:href="lgnd-20221231.xsd#lgnd_PaymentsToContingentValueRightHoldersFinancingActivity"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c6bb5b0d-f63b-4aa2-ab65-9a041664d78c" xlink:to="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_ff240db6-2f44-49a6-a763-5b0764aaa728" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_a1027738-e420-4407-94ce-8a1a1652009d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c6bb5b0d-f63b-4aa2-ab65-9a041664d78c" xlink:to="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_a1027738-e420-4407-94ce-8a1a1652009d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2ec41321-6208-438d-b4da-f194124abf77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_fcb97ca5-c628-4bb3-ac53-cef0cc7d3ffe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2ec41321-6208-438d-b4da-f194124abf77" xlink:to="loc_us-gaap_ProfitLoss_fcb97ca5-c628-4bb3-ac53-cef0cc7d3ffe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_98c087d3-180a-481a-9a63-9c1b03485b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2ec41321-6208-438d-b4da-f194124abf77" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_98c087d3-180a-481a-9a63-9c1b03485b0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_145fcca3-08d7-414c-8c20-8f8dc9e391fb" xlink:href="lgnd-20221231.xsd#lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2ec41321-6208-438d-b4da-f194124abf77" xlink:to="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_145fcca3-08d7-414c-8c20-8f8dc9e391fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_e92ad709-1817-47ce-bef9-03fbcb99cc3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2ec41321-6208-438d-b4da-f194124abf77" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_e92ad709-1817-47ce-bef9-03fbcb99cc3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_GainLossOnShortTermInvestments_27978652-e68c-4973-8a58-1e29b42f079f" xlink:href="lgnd-20221231.xsd#lgnd_GainLossOnShortTermInvestments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2ec41321-6208-438d-b4da-f194124abf77" xlink:to="loc_lgnd_GainLossOnShortTermInvestments_27978652-e68c-4973-8a58-1e29b42f079f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_14c5e527-eac9-4266-a4e5-50edde1efb46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2ec41321-6208-438d-b4da-f194124abf77" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_14c5e527-eac9-4266-a4e5-50edde1efb46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_eaafb88f-56a0-4f01-a6c6-b21dc32966ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2ec41321-6208-438d-b4da-f194124abf77" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_eaafb88f-56a0-4f01-a6c6-b21dc32966ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_237e1b64-639f-4fe5-b778-27bcb5855c6d" xlink:href="lgnd-20221231.xsd#lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2ec41321-6208-438d-b4da-f194124abf77" xlink:to="loc_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_237e1b64-639f-4fe5-b778-27bcb5855c6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ee7f16ad-8bb9-4135-83e8-2d6b08cc5ada" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2ec41321-6208-438d-b4da-f194124abf77" xlink:to="loc_us-gaap_ShareBasedCompensation_ee7f16ad-8bb9-4135-83e8-2d6b08cc5ada" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_a2b7cf97-d927-46b6-8ed2-923f5b7ecae1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2ec41321-6208-438d-b4da-f194124abf77" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_a2b7cf97-d927-46b6-8ed2-923f5b7ecae1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_a79261c1-a035-4adc-afcc-251179e0995d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2ec41321-6208-438d-b4da-f194124abf77" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_a79261c1-a035-4adc-afcc-251179e0995d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_de3ff702-b7bb-4ae3-95f5-8780a0b5d6dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2ec41321-6208-438d-b4da-f194124abf77" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_de3ff702-b7bb-4ae3-95f5-8780a0b5d6dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_c4c2d7f6-17f6-48c9-b159-c4e18809911b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2ec41321-6208-438d-b4da-f194124abf77" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_c4c2d7f6-17f6-48c9-b159-c4e18809911b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_b750646c-fafd-49c0-8b44-774e7224a00d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2ec41321-6208-438d-b4da-f194124abf77" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_b750646c-fafd-49c0-8b44-774e7224a00d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_2d30e9c0-e210-4e9d-b179-4ee8db1e223b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2ec41321-6208-438d-b4da-f194124abf77" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_2d30e9c0-e210-4e9d-b179-4ee8db1e223b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_ebfc4170-3c95-4f10-b300-04d4aca3ca84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2ec41321-6208-438d-b4da-f194124abf77" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_ebfc4170-3c95-4f10-b300-04d4aca3ca84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_9fa8e472-841a-427e-ab98-a31fd72c9e42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2ec41321-6208-438d-b4da-f194124abf77" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_9fa8e472-841a-427e-ab98-a31fd72c9e42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_978dc5ef-d8d1-4101-9a47-fdbc6abd8bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="18" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2ec41321-6208-438d-b4da-f194124abf77" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_978dc5ef-d8d1-4101-9a47-fdbc6abd8bfe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization_11e5d4c6-6953-4008-88d3-75de2a063a5d" xlink:href="lgnd-20221231.xsd#lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="19" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2ec41321-6208-438d-b4da-f194124abf77" xlink:to="loc_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization_11e5d4c6-6953-4008-88d3-75de2a063a5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_bc91945a-449c-455c-8e49-8de0ded0767c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4720e66e-e4ab-4bec-8e0e-d8fa4b8e8d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_bc91945a-449c-455c-8e49-8de0ded0767c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4720e66e-e4ab-4bec-8e0e-d8fa4b8e8d6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_05dc17dc-1f4d-44f1-9eec-8b4f40686d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_bc91945a-449c-455c-8e49-8de0ded0767c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_05dc17dc-1f4d-44f1-9eec-8b4f40686d2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4dd40391-7e97-460c-8eb9-e4f14d99ca8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_bc91945a-449c-455c-8e49-8de0ded0767c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4dd40391-7e97-460c-8eb9-e4f14d99ca8c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_895e08e5-dde1-4eb3-94b0-78ca6e9cd70a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_63c3614d-765c-423e-a2f4-3a39a3857e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_895e08e5-dde1-4eb3-94b0-78ca6e9cd70a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_63c3614d-765c-423e-a2f4-3a39a3857e1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments_8c716c51-9491-400d-b739-b72d7b32ff1e" xlink:href="lgnd-20221231.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_895e08e5-dde1-4eb3-94b0-78ca6e9cd70a" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments_8c716c51-9491-400d-b739-b72d7b32ff1e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCalculationofEarningsperShareDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesCalculationofEarningsperShareDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCalculationofEarningsperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_615f87d3-00ad-43aa-9011-b5e22dc7c8c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_e570cfb4-9310-403a-95d0-ccacf2984fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_615f87d3-00ad-43aa-9011-b5e22dc7c8c6" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_e570cfb4-9310-403a-95d0-ccacf2984fcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b17ad0f1-3625-4337-8ecd-0e19b9ca6e37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_615f87d3-00ad-43aa-9011-b5e22dc7c8c6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b17ad0f1-3625-4337-8ecd-0e19b9ca6e37" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_cb1e3a0a-5057-4a77-a9c2-9c771b9d4778" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_75ac5793-8c4d-410b-add9-e8a040ad8fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_cb1e3a0a-5057-4a77-a9c2-9c771b9d4778" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_75ac5793-8c4d-410b-add9-e8a040ad8fc3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_7ea478ce-ba83-47fb-80c1-201364f6f50b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_cb1e3a0a-5057-4a77-a9c2-9c771b9d4778" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_7ea478ce-ba83-47fb-80c1-201364f6f50b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_1fcc5b79-7b62-4c17-adbe-802f3cbf22fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_efa75171-53ab-4ba1-8df9-aca4a0d146ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_1fcc5b79-7b62-4c17-adbe-802f3cbf22fd" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_efa75171-53ab-4ba1-8df9-aca4a0d146ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_95589a87-82bf-469e-9f5a-474cdf083b36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_1fcc5b79-7b62-4c17-adbe-802f3cbf22fd" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_95589a87-82bf-469e-9f5a-474cdf083b36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_2bd5ad70-bd8e-4388-a018-62c5e2a2adbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_1fcc5b79-7b62-4c17-adbe-802f3cbf22fd" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_2bd5ad70-bd8e-4388-a018-62c5e2a2adbf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsFinanceLeaseAssets_70e2c215-d45a-439d-be00-f6a1df7fc11d" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsFinanceLeaseAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_1fcc5b79-7b62-4c17-adbe-802f3cbf22fd" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsFinanceLeaseAssets_70e2c215-d45a-439d-be00-f6a1df7fc11d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsOperatingLeaseAssets_895c6381-f04a-42bf-b9cf-b069ad2166ee" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsOperatingLeaseAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_1fcc5b79-7b62-4c17-adbe-802f3cbf22fd" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsOperatingLeaseAssets_895c6381-f04a-42bf-b9cf-b069ad2166ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent_cefd55f1-202f-4099-bc5a-df90e8790319" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_1fcc5b79-7b62-4c17-adbe-802f3cbf22fd" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent_cefd55f1-202f-4099-bc5a-df90e8790319" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_37483b2b-4900-4798-a5d5-68f3ecb87929" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_1fcc5b79-7b62-4c17-adbe-802f3cbf22fd" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_37483b2b-4900-4798-a5d5-68f3ecb87929" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_0840a22b-e1e0-4c00-aedc-b4d4f3bb2c85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_747bf2e6-c5a8-4f72-a9aa-e22342584b55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_0840a22b-e1e0-4c00-aedc-b4d4f3bb2c85" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_747bf2e6-c5a8-4f72-a9aa-e22342584b55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_503a9c38-372e-40c0-b42d-104e31d8e149" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_0840a22b-e1e0-4c00-aedc-b4d4f3bb2c85" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_503a9c38-372e-40c0-b42d-104e31d8e149" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_57824156-6334-4030-93bd-10ef9739ed66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_0840a22b-e1e0-4c00-aedc-b4d4f3bb2c85" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_57824156-6334-4030-93bd-10ef9739ed66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesOperatingLeaseNoncurrent_6e393205-a1f0-43a0-9ccc-3f5658c3589d" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesOperatingLeaseNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_0840a22b-e1e0-4c00-aedc-b4d4f3bb2c85" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesOperatingLeaseNoncurrent_6e393205-a1f0-43a0-9ccc-3f5658c3589d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesNoncurrent_b64674ba-f697-4081-944f-cc22e3ef3489" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_0840a22b-e1e0-4c00-aedc-b4d4f3bb2c85" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesNoncurrent_b64674ba-f697-4081-944f-cc22e3ef3489" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_e4151815-8357-4ff7-8e81-caa92c2bb19b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilitiesCurrent_e8674427-2762-483a-96a9-6eda42bb79a1" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_e4151815-8357-4ff7-8e81-caa92c2bb19b" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilitiesCurrent_e8674427-2762-483a-96a9-6eda42bb79a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesCurrent_ada48711-906f-4534-ab78-0a89ceb117e7" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_e4151815-8357-4ff7-8e81-caa92c2bb19b" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesCurrent_ada48711-906f-4534-ab78-0a89ceb117e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent_a6fab77d-c062-43e7-91c1-72633e2da9b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_e4151815-8357-4ff7-8e81-caa92c2bb19b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent_a6fab77d-c062-43e7-91c1-72633e2da9b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent_22fa1c18-ee4c-40a7-a5f7-01989343e8e9" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_e4151815-8357-4ff7-8e81-caa92c2bb19b" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent_22fa1c18-ee4c-40a7-a5f7-01989343e8e9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationNetAssetsTransferred_f84250cb-ee84-4789-a4fa-202a729175c1" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationNetAssetsTransferred"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_a498e073-029f-403a-8e45-1c27941c3cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationNetAssetsTransferred_f84250cb-ee84-4789-a4fa-202a729175c1" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_a498e073-029f-403a-8e45-1c27941c3cdc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_62f32d98-cbcf-4973-9610-67eeb96d26b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationNetAssetsTransferred_f84250cb-ee84-4789-a4fa-202a729175c1" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_62f32d98-cbcf-4973-9610-67eeb96d26b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_872a33aa-648b-437b-9476-6bcbe8e0ed29" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_d1f8b428-a3bd-4786-b6ab-6b2f9ede8296" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_872a33aa-648b-437b-9476-6bcbe8e0ed29" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_d1f8b428-a3bd-4786-b6ab-6b2f9ede8296" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments_98d2cb57-c847-483a-a4e7-7b8f99afbf4a" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_872a33aa-648b-437b-9476-6bcbe8e0ed29" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments_98d2cb57-c847-483a-a4e7-7b8f99afbf4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_29794a4d-9175-4ac9-805e-627e502e46d6" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_872a33aa-648b-437b-9476-6bcbe8e0ed29" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_29794a4d-9175-4ac9-805e-627e502e46d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_1ccf1ac1-c83f-4839-be4a-77e582bfc8ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_6c8cffbf-a7b7-4e5a-8761-f7b33bacedaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_1ccf1ac1-c83f-4839-be4a-77e582bfc8ca" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_6c8cffbf-a7b7-4e5a-8761-f7b33bacedaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_e102c152-9148-4568-b529-5f4cffc6ab67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_1ccf1ac1-c83f-4839-be4a-77e582bfc8ca" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_e102c152-9148-4568-b529-5f4cffc6ab67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_5c779df0-9614-4f13-89d5-7272a00ceeb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_5b7f9cf6-e9a5-4129-8434-03f52ef8d208" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_5c779df0-9614-4f13-89d5-7272a00ceeb9" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_5b7f9cf6-e9a5-4129-8434-03f52ef8d208" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_29b27d67-adef-42f4-a189-8a388923d1fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_5c779df0-9614-4f13-89d5-7272a00ceeb9" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_29b27d67-adef-42f4-a189-8a388923d1fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_77bdf4c1-c091-44eb-8642-fe37c53d55d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_8792c834-1341-494b-8061-d59820337169" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_77bdf4c1-c091-44eb-8642-fe37c53d55d9" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_8792c834-1341-494b-8061-d59820337169" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_cd758720-60ff-4f16-bbb7-bd97166b2ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_77bdf4c1-c091-44eb-8642-fe37c53d55d9" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_cd758720-60ff-4f16-bbb7-bd97166b2ef8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_6f6d4150-9a0b-4472-b39b-5d9e84ff1565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_02cdb679-40e5-4d31-8c50-89413a8d4bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_6f6d4150-9a0b-4472-b39b-5d9e84ff1565" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_02cdb679-40e5-4d31-8c50-89413a8d4bf5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_9742abbc-5c32-47f9-9d91-77c1ce04d921" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_6f6d4150-9a0b-4472-b39b-5d9e84ff1565" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_9742abbc-5c32-47f9-9d91-77c1ce04d921" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment_8d11e8db-dc5a-46d6-85a5-0b7ecd9245c1" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_6f6d4150-9a0b-4472-b39b-5d9e84ff1565" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment_8d11e8db-dc5a-46d6-85a5-0b7ecd9245c1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_25366083-8cdb-440c-b2cb-8abeafd2f7a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_f510cd52-b22d-400d-a161-cc3e94d9f4c3" xlink:href="lgnd-20221231.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_25366083-8cdb-440c-b2cb-8abeafd2f7a0" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_f510cd52-b22d-400d-a161-cc3e94d9f4c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_685a6596-6785-4f88-83df-333ec0480a1e" xlink:href="lgnd-20221231.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_25366083-8cdb-440c-b2cb-8abeafd2f7a0" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_685a6596-6785-4f88-83df-333ec0480a1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_210ebe3f-08eb-4e0f-a0b5-1cb01f36e42b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_25366083-8cdb-440c-b2cb-8abeafd2f7a0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_210ebe3f-08eb-4e0f-a0b5-1cb01f36e42b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_20a773da-32d5-4fcb-84b8-68eec5ba6d5e" xlink:href="lgnd-20221231.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_25366083-8cdb-440c-b2cb-8abeafd2f7a0" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_20a773da-32d5-4fcb-84b8-68eec5ba6d5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_05c6c836-2f8f-4aeb-a93a-46a747d80099" xlink:href="lgnd-20221231.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_25366083-8cdb-440c-b2cb-8abeafd2f7a0" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_05c6c836-2f8f-4aeb-a93a-46a747d80099" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_4c71f46f-bfed-45ab-b8d6-1627f176fe47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_25366083-8cdb-440c-b2cb-8abeafd2f7a0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_4c71f46f-bfed-45ab-b8d6-1627f176fe47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_ee1a4749-2b3f-461d-8de3-c8e3acb1e986" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_25366083-8cdb-440c-b2cb-8abeafd2f7a0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_ee1a4749-2b3f-461d-8de3-c8e3acb1e986" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_d450df21-2e80-41bf-b492-e275a84928d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_25366083-8cdb-440c-b2cb-8abeafd2f7a0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_d450df21-2e80-41bf-b492-e275a84928d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_2ac7dce4-c554-44b6-87bf-ec9af7ac6159" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_25366083-8cdb-440c-b2cb-8abeafd2f7a0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_2ac7dce4-c554-44b6-87bf-ec9af7ac6159" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_292409ad-0ada-4507-a4c7-3125b01a0b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_25366083-8cdb-440c-b2cb-8abeafd2f7a0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_292409ad-0ada-4507-a4c7-3125b01a0b5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_fdd0053d-77bf-4d8f-86c9-04de27e3d40f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_25366083-8cdb-440c-b2cb-8abeafd2f7a0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_fdd0053d-77bf-4d8f-86c9-04de27e3d40f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0049c2f9-9a71-49dc-9112-b75384cf452c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_25366083-8cdb-440c-b2cb-8abeafd2f7a0" xlink:to="loc_us-gaap_Goodwill_0049c2f9-9a71-49dc-9112-b75384cf452c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_c9994f3a-a1f4-43c6-8491-69bbf0e0dac9" xlink:href="lgnd-20221231.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_25366083-8cdb-440c-b2cb-8abeafd2f7a0" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_c9994f3a-a1f4-43c6-8491-69bbf0e0dac9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_d0b2836e-3028-4a83-a3d7-77548b17681e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_25366083-8cdb-440c-b2cb-8abeafd2f7a0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_d0b2836e-3028-4a83-a3d7-77548b17681e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiability_a54fe8df-9ecd-4d56-8f75-e44c93f2ad8b" xlink:href="lgnd-20221231.xsd#lgnd_LeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiabilityCurrent_a3fccd99-8ec0-4835-8c1b-d216f38c6fa3" xlink:href="lgnd-20221231.xsd#lgnd_LeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseLiability_a54fe8df-9ecd-4d56-8f75-e44c93f2ad8b" xlink:to="loc_lgnd_LeaseLiabilityCurrent_a3fccd99-8ec0-4835-8c1b-d216f38c6fa3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7e9d3931-aefa-4dff-9540-ccf879f14c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseLiability_a54fe8df-9ecd-4d56-8f75-e44c93f2ad8b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7e9d3931-aefa-4dff-9540-ccf879f14c4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_5f9fd5f1-2e17-4ffc-b5b9-d49c125d2a21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseLiability_a54fe8df-9ecd-4d56-8f75-e44c93f2ad8b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_5f9fd5f1-2e17-4ffc-b5b9-d49c125d2a21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseRightOfUseAsset_bb8eab98-af15-4a20-803d-1d5638fe41b2" xlink:href="lgnd-20221231.xsd#lgnd_LeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_3099949e-1ac8-4026-88ce-e56d2ef349b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseRightOfUseAsset_bb8eab98-af15-4a20-803d-1d5638fe41b2" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_3099949e-1ac8-4026-88ce-e56d2ef349b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_4b420ce3-a11d-4347-b97c-2149893203ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseRightOfUseAsset_bb8eab98-af15-4a20-803d-1d5638fe41b2" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_4b420ce3-a11d-4347-b97c-2149893203ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiabilityCurrent_583abaca-aac0-44d1-84e1-a8abc45e8c0f" xlink:href="lgnd-20221231.xsd#lgnd_LeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_f7b43eff-3d27-4872-9be3-f454bb98713d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseLiabilityCurrent_583abaca-aac0-44d1-84e1-a8abc45e8c0f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_f7b43eff-3d27-4872-9be3-f454bb98713d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_4d5c9976-1034-4703-895e-fa1ab167f870" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseLiabilityCurrent_583abaca-aac0-44d1-84e1-a8abc45e8c0f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_4d5c9976-1034-4703-895e-fa1ab167f870" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_96a310ae-b642-4414-b371-bbad6c78d8fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f909fc06-14ec-4117-9962-1a8141a1df40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_96a310ae-b642-4414-b371-bbad6c78d8fb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f909fc06-14ec-4117-9962-1a8141a1df40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_ab59f5e6-1d0b-4494-9055-141c0fe80ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_96a310ae-b642-4414-b371-bbad6c78d8fb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_ab59f5e6-1d0b-4494-9055-141c0fe80ba8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_64538126-38af-4b66-9136-eb00e29e8553" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_96a310ae-b642-4414-b371-bbad6c78d8fb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_64538126-38af-4b66-9136-eb00e29e8553" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_6e037542-51f3-4f75-b95a-907a271ddf33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_96a310ae-b642-4414-b371-bbad6c78d8fb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_6e037542-51f3-4f75-b95a-907a271ddf33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_66912bc4-98f1-4b92-8db5-172acc8a8205" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_96a310ae-b642-4414-b371-bbad6c78d8fb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_66912bc4-98f1-4b92-8db5-172acc8a8205" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_ccadd4ed-4caf-44a0-b5b3-ec612b81b6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_96a310ae-b642-4414-b371-bbad6c78d8fb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_ccadd4ed-4caf-44a0-b5b3-ec612b81b6f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_e8f91e6f-511e-423f-89bf-71a4d50abadb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_c08f8f4c-876c-436a-bb90-4705852c188a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_e8f91e6f-511e-423f-89bf-71a4d50abadb" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_c08f8f4c-876c-436a-bb90-4705852c188a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_a93a539b-a93b-4750-ace4-1fd495fe1e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_e8f91e6f-511e-423f-89bf-71a4d50abadb" xlink:to="loc_us-gaap_FinanceLeaseLiability_a93a539b-a93b-4750-ace4-1fd495fe1e8c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="lgnd-20221231.xsd#LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_795b84c7-f577-465f-9a35-b0e46e5bf761" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c00c1c44-0a2f-4a50-9cb4-1e26cef73da1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_795b84c7-f577-465f-9a35-b0e46e5bf761" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c00c1c44-0a2f-4a50-9cb4-1e26cef73da1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_c8884e07-3aca-48c9-97a6-1f281de737c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_795b84c7-f577-465f-9a35-b0e46e5bf761" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_c8884e07-3aca-48c9-97a6-1f281de737c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_934f779d-cd33-4370-aee8-28ec90b10e40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_795b84c7-f577-465f-9a35-b0e46e5bf761" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_934f779d-cd33-4370-aee8-28ec90b10e40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_df0b9be0-f66a-4902-bd1c-52af4cf2909d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_795b84c7-f577-465f-9a35-b0e46e5bf761" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_df0b9be0-f66a-4902-bd1c-52af4cf2909d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_e64dc0c5-c8ce-45b2-a822-c0d274304d85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_795b84c7-f577-465f-9a35-b0e46e5bf761" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_e64dc0c5-c8ce-45b2-a822-c0d274304d85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_bd988182-0319-4bfc-89a1-fc646431d770" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_795b84c7-f577-465f-9a35-b0e46e5bf761" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_bd988182-0319-4bfc-89a1-fc646431d770" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_50a8aaec-28b5-487e-9f88-1578f9a3215d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_a13dde45-7fb1-47ca-b1b7-cd02a7c3f7ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_50a8aaec-28b5-487e-9f88-1578f9a3215d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_a13dde45-7fb1-47ca-b1b7-cd02a7c3f7ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_a88cab52-53e0-47bf-95d7-96e8cd7256e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_50a8aaec-28b5-487e-9f88-1578f9a3215d" xlink:to="loc_us-gaap_OperatingLeaseLiability_a88cab52-53e0-47bf-95d7-96e8cd7256e3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesEquityandLiabilityComponentsofFinancingArrangementsDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#ConvertibleSeniorNotesEquityandLiabilityComponentsofFinancingArrangementsDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesEquityandLiabilityComponentsofFinancingArrangementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_db2512d0-f14f-4885-abc5-67e7aa66fcfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_b31b1918-02a0-4740-826a-19aaf76df74d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermNotesPayable_db2512d0-f14f-4885-abc5-67e7aa66fcfc" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_b31b1918-02a0-4740-826a-19aaf76df74d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_346767f5-e6fd-40a9-b0f3-79cbccb488af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermNotesPayable_db2512d0-f14f-4885-abc5-67e7aa66fcfc" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_346767f5-e6fd-40a9-b0f3-79cbccb488af" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BalanceSheetAccountDetailsInvestmentCategoriesDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BalanceSheetAccountDetailsInvestmentCategoriesDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BalanceSheetAccountDetailsInvestmentCategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f3e89630-085d-465d-bf5c-68435d446b95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a35acfe0-4258-4512-8535-358ea294a3b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f3e89630-085d-465d-bf5c-68435d446b95" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a35acfe0-4258-4512-8535-358ea294a3b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_6b9e37e1-9fe7-4edd-b33e-796b6918ab67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f3e89630-085d-465d-bf5c-68435d446b95" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_6b9e37e1-9fe7-4edd-b33e-796b6918ab67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_e3b6d0e1-ef11-426b-8f0d-497b29ea8fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f3e89630-085d-465d-bf5c-68435d446b95" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_e3b6d0e1-ef11-426b-8f0d-497b29ea8fd1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_c0284fb3-520b-435b-853f-eafc10b8eeae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_a14fe30f-9a53-4f07-ba1a-7b31b4b9bde4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_c0284fb3-520b-435b-853f-eafc10b8eeae" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_a14fe30f-9a53-4f07-ba1a-7b31b4b9bde4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_bc3b8eab-f03a-4c46-b193-f3c63983a619" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_c0284fb3-520b-435b-853f-eafc10b8eeae" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_bc3b8eab-f03a-4c46-b193-f3c63983a619" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_9cf5a315-6165-4f71-988a-a3885e4c9a67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_26d7c920-73cd-4551-8b1a-a6b637f4b41c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_9cf5a315-6165-4f71-988a-a3885e4c9a67" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_26d7c920-73cd-4551-8b1a-a6b637f4b41c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_53ba6824-2bfe-4bf2-862b-f6551b890865" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_9cf5a315-6165-4f71-988a-a3885e4c9a67" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_53ba6824-2bfe-4bf2-862b-f6551b890865" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss_5d304a5d-542c-45ef-8d67-34b58e5adee6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_568e370c-466f-4acd-a9d5-5123896cbaa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss_5d304a5d-542c-45ef-8d67-34b58e5adee6" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_568e370c-466f-4acd-a9d5-5123896cbaa3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0f027f13-326a-4425-a83c-13b0adf4c309" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss_5d304a5d-542c-45ef-8d67-34b58e5adee6" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0f027f13-326a-4425-a83c-13b0adf4c309" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_7c37f236-012b-4035-a24f-341dcf31c75f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_87f51890-93c7-4ccf-af6d-a4f906879db7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_7c37f236-012b-4035-a24f-341dcf31c75f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_87f51890-93c7-4ccf-af6d-a4f906879db7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_383c10a3-495c-4bb0-b793-52a93c9f8222" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_7c37f236-012b-4035-a24f-341dcf31c75f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_383c10a3-495c-4bb0-b793-52a93c9f8222" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BalanceSheetAccountDetailsPropertyandEquipmentDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BalanceSheetAccountDetailsPropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BalanceSheetAccountDetailsPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_075a7beb-2597-4906-a29c-f4b6a4ac2a68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_0f6e958e-3587-4777-a75b-14712aad2363" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_075a7beb-2597-4906-a29c-f4b6a4ac2a68" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_0f6e958e-3587-4777-a75b-14712aad2363" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_903bf62d-4f26-47f2-ab5f-bd691cea155b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_075a7beb-2597-4906-a29c-f4b6a4ac2a68" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_903bf62d-4f26-47f2-ab5f-bd691cea155b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BalanceSheetAccountDetailsGoodwillandOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BalanceSheetAccountDetailsGoodwillandOtherIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BalanceSheetAccountDetailsGoodwillandOtherIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_9f27d1c1-bda0-4bb0-8e48-84e4a38ddcbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_258c0355-1b12-49de-87af-271ba3119a05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_9f27d1c1-bda0-4bb0-8e48-84e4a38ddcbc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_258c0355-1b12-49de-87af-271ba3119a05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_387468b8-8941-43d4-bc4a-ea1a98d27c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_9f27d1c1-bda0-4bb0-8e48-84e4a38ddcbc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_387468b8-8941-43d4-bc4a-ea1a98d27c5a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BalanceSheetAccountDetailsAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BalanceSheetAccountDetailsAccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BalanceSheetAccountDetailsAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_e50b5a74-b3a9-4d57-84bb-e24ba80c32f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_0d13e3f8-ccce-41f4-bb33-32982c78bad2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_e50b5a74-b3a9-4d57-84bb-e24ba80c32f8" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_0d13e3f8-ccce-41f4-bb33-32982c78bad2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSalesReturns_2065619c-468b-43d9-822f-5109723ab89d" xlink:href="lgnd-20221231.xsd#lgnd_AccruedSalesReturns"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_e50b5a74-b3a9-4d57-84bb-e24ba80c32f8" xlink:to="loc_lgnd_AccruedSalesReturns_2065619c-468b-43d9-822f-5109723ab89d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_2843ba11-baba-4649-b568-14b1de4a5153" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRoyaltiesCurrentAndNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_e50b5a74-b3a9-4d57-84bb-e24ba80c32f8" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_2843ba11-baba-4649-b568-14b1de4a5153" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedAssetAcquisitionsCurrent_b835830f-5f38-4760-8db4-3dd5016a2b43" xlink:href="lgnd-20221231.xsd#lgnd_AccruedAssetAcquisitionsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_e50b5a74-b3a9-4d57-84bb-e24ba80c32f8" xlink:to="loc_lgnd_AccruedAssetAcquisitionsCurrent_b835830f-5f38-4760-8db4-3dd5016a2b43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSubcontractorExpensesCurrent_7411889e-243c-4d48-9ee1-96abdde076aa" xlink:href="lgnd-20221231.xsd#lgnd_AccruedSubcontractorExpensesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_e50b5a74-b3a9-4d57-84bb-e24ba80c32f8" xlink:to="loc_lgnd_AccruedSubcontractorExpensesCurrent_7411889e-243c-4d48-9ee1-96abdde076aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_9ff15ad7-d13b-4abb-b021-fb97fc3edd1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_e50b5a74-b3a9-4d57-84bb-e24ba80c32f8" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_9ff15ad7-d13b-4abb-b021-fb97fc3edd1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSupplierExpensesCurrent_93f284cd-29ba-4fcc-b7d8-11b419eea13e" xlink:href="lgnd-20221231.xsd#lgnd_AccruedSupplierExpensesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_e50b5a74-b3a9-4d57-84bb-e24ba80c32f8" xlink:to="loc_lgnd_AccruedSupplierExpensesCurrent_93f284cd-29ba-4fcc-b7d8-11b419eea13e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_2f21b7a3-a254-47f2-9d2e-b6be0ac58cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalesCommissionCurrentAndNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_e50b5a74-b3a9-4d57-84bb-e24ba80c32f8" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_2f21b7a3-a254-47f2-9d2e-b6be0ac58cdc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_83a23d15-478a-4b17-b20d-00c040142b75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_e50b5a74-b3a9-4d57-84bb-e24ba80c32f8" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_83a23d15-478a-4b17-b20d-00c040142b75" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a70e4d57-de6b-4d40-b507-d962e9a743c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_e84e76b0-3220-4703-9f54-6ea3bd6cef06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a70e4d57-de6b-4d40-b507-d962e9a743c9" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_e84e76b0-3220-4703-9f54-6ea3bd6cef06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2ee89036-0ef4-46c1-ac46-683b2ceb0341" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a70e4d57-de6b-4d40-b507-d962e9a743c9" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2ee89036-0ef4-46c1-ac46-683b2ceb0341" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c52f9432-8de1-458e-8fde-3e6f6f4b0380" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_a9bebb1b-a2eb-4375-80a6-07f36494cf80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c52f9432-8de1-458e-8fde-3e6f6f4b0380" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_a9bebb1b-a2eb-4375-80a6-07f36494cf80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_2d503d9e-85d2-453d-9c55-f251105cb401" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c52f9432-8de1-458e-8fde-3e6f6f4b0380" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_2d503d9e-85d2-453d-9c55-f251105cb401" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_56b60f52-a990-47b0-831f-349eb83e03b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_fa107994-2d59-400e-bae1-774caa45007d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_56b60f52-a990-47b0-831f-349eb83e03b2" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_fa107994-2d59-400e-bae1-774caa45007d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_9680e402-5274-4b65-a1f5-41c6bdbbe777" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_56b60f52-a990-47b0-831f-349eb83e03b2" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_9680e402-5274-4b65-a1f5-41c6bdbbe777" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_e9e9ff61-56ac-4781-913d-1c8112996375" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_56b60f52-a990-47b0-831f-349eb83e03b2" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_e9e9ff61-56ac-4781-913d-1c8112996375" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ac72d368-6544-4e6b-8f82-974a702708b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EffectiveIncomeTaxRateReconciliationOtherIncome_74fadbcb-c8c6-48c9-918a-849b499a9af2" xlink:href="lgnd-20221231.xsd#lgnd_EffectiveIncomeTaxRateReconciliationOtherIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ac72d368-6544-4e6b-8f82-974a702708b2" xlink:to="loc_lgnd_EffectiveIncomeTaxRateReconciliationOtherIncome_74fadbcb-c8c6-48c9-918a-849b499a9af2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_740f03eb-d427-4f14-b33c-ce2b16bb5e22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ac72d368-6544-4e6b-8f82-974a702708b2" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_740f03eb-d427-4f14-b33c-ce2b16bb5e22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_ef2ee079-a2eb-4372-aae3-67e0ca695d1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ac72d368-6544-4e6b-8f82-974a702708b2" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_ef2ee079-a2eb-4372-aae3-67e0ca695d1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_85d9f046-4ebe-4d94-be84-ffd231e2fade" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ac72d368-6544-4e6b-8f82-974a702708b2" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_85d9f046-4ebe-4d94-be84-ffd231e2fade" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions_c92e9acb-2731-45f8-887c-2fe42359a163" xlink:href="lgnd-20221231.xsd#lgnd_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ac72d368-6544-4e6b-8f82-974a702708b2" xlink:to="loc_lgnd_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions_c92e9acb-2731-45f8-887c-2fe42359a163" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EffectiveIncomeTaxRateReconciliationDebtRepurchasesAmount_8191bbda-0532-4766-83e7-db3513249685" xlink:href="lgnd-20221231.xsd#lgnd_EffectiveIncomeTaxRateReconciliationDebtRepurchasesAmount"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ac72d368-6544-4e6b-8f82-974a702708b2" xlink:to="loc_lgnd_EffectiveIncomeTaxRateReconciliationDebtRepurchasesAmount_8191bbda-0532-4766-83e7-db3513249685" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_3c4a2c5b-acfc-4304-a3d6-ab331d840618" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ac72d368-6544-4e6b-8f82-974a702708b2" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_3c4a2c5b-acfc-4304-a3d6-ab331d840618" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsAmount_13f4d87c-18c7-4bd7-83fe-9237993a5d28" xlink:href="lgnd-20221231.xsd#lgnd_EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsAmount"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ac72d368-6544-4e6b-8f82-974a702708b2" xlink:to="loc_lgnd_EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsAmount_13f4d87c-18c7-4bd7-83fe-9237993a5d28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EffectiveIncomeTaxRateReconciliationOfficerCompensationAmount_c0e77d36-bf6b-48df-b55e-3448ee136ff9" xlink:href="lgnd-20221231.xsd#lgnd_EffectiveIncomeTaxRateReconciliationOfficerCompensationAmount"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ac72d368-6544-4e6b-8f82-974a702708b2" xlink:to="loc_lgnd_EffectiveIncomeTaxRateReconciliationOfficerCompensationAmount_c0e77d36-bf6b-48df-b55e-3448ee136ff9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_d2a202bd-1151-4250-958b-f49da305fb0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationDispositionOfBusiness"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ac72d368-6544-4e6b-8f82-974a702708b2" xlink:to="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_d2a202bd-1151-4250-958b-f49da305fb0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount_a833101f-5f34-48f5-8b88-d909c400a554" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ac72d368-6544-4e6b-8f82-974a702708b2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount_a833101f-5f34-48f5-8b88-d909c400a554" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_99630600-1584-43e7-8cec-bb66042bb8ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ac72d368-6544-4e6b-8f82-974a702708b2" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_99630600-1584-43e7-8cec-bb66042bb8ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IncomeTaxReconciliationContingentValueRights_3690a40e-f686-4867-8b61-a94cc99b584c" xlink:href="lgnd-20221231.xsd#lgnd_IncomeTaxReconciliationContingentValueRights"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ac72d368-6544-4e6b-8f82-974a702708b2" xlink:to="loc_lgnd_IncomeTaxReconciliationContingentValueRights_3690a40e-f686-4867-8b61-a94cc99b584c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_baff3af6-7538-4622-b5fc-e6423e0d618e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ac72d368-6544-4e6b-8f82-974a702708b2" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_baff3af6-7538-4622-b5fc-e6423e0d618e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_07feef6a-6d8d-4ddd-9cad-166b96086ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ac72d368-6544-4e6b-8f82-974a702708b2" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_07feef6a-6d8d-4ddd-9cad-166b96086ae7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EffectiveIncomeTaxRateReconciliationExpiredTaxCreditsResearch_dde13e05-25b6-4fe7-9fda-2d699cbf4365" xlink:href="lgnd-20221231.xsd#lgnd_EffectiveIncomeTaxRateReconciliationExpiredTaxCreditsResearch"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ac72d368-6544-4e6b-8f82-974a702708b2" xlink:to="loc_lgnd_EffectiveIncomeTaxRateReconciliationExpiredTaxCreditsResearch_dde13e05-25b6-4fe7-9fda-2d699cbf4365" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTaxesDeferredTaxesDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#IncomeTaxesDeferredTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/IncomeTaxesDeferredTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_e0520fcc-a4c5-4670-b645-63bf8982283e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_9c4b55d1-7a90-4591-9338-4bc4f567564c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_e0520fcc-a4c5-4670-b645-63bf8982283e" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_9c4b55d1-7a90-4591-9338-4bc4f567564c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_ab5aed27-f969-4665-b40d-6fca9fd1cd57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_e0520fcc-a4c5-4670-b645-63bf8982283e" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_ab5aed27-f969-4665-b40d-6fca9fd1cd57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_8652b89d-a87e-4b5b-a4fb-90dd2c4fbfe3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_213b1262-4250-4e67-9b25-2018de07101b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_8652b89d-a87e-4b5b-a4fb-90dd2c4fbfe3" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_213b1262-4250-4e67-9b25-2018de07101b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_3ee46174-d834-4d46-a60b-2d4c150cbfd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_8652b89d-a87e-4b5b-a4fb-90dd2c4fbfe3" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_3ee46174-d834-4d46-a60b-2d4c150cbfd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_48841a7f-fee5-4cf1-b43b-4d44fc694f06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_eddde71a-f854-4f71-9546-f266dd98175f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_48841a7f-fee5-4cf1-b43b-4d44fc694f06" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_eddde71a-f854-4f71-9546-f266dd98175f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_d2f921a4-284b-4ba2-acb8-be8e72e6fc5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_48841a7f-fee5-4cf1-b43b-4d44fc694f06" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_d2f921a4-284b-4ba2-acb8-be8e72e6fc5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_95f5917f-11e8-4cee-8715-91ffb2d5b29c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_48841a7f-fee5-4cf1-b43b-4d44fc694f06" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_95f5917f-11e8-4cee-8715-91ffb2d5b29c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_293e1f74-e32e-429b-a299-902ae23285c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_48841a7f-fee5-4cf1-b43b-4d44fc694f06" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_293e1f74-e32e-429b-a299-902ae23285c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_42396fe3-5ce2-452f-be75-5becd4bacd18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_adb59eb8-6812-4e4f-883a-72a520276d26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_42396fe3-5ce2-452f-be75-5becd4bacd18" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_adb59eb8-6812-4e4f-883a-72a520276d26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_373bab97-9dfe-45f2-84d1-a6d51520c1ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_42396fe3-5ce2-452f-be75-5becd4bacd18" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_373bab97-9dfe-45f2-84d1-a6d51520c1ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_1860f81c-5ce3-441f-9d6c-0f153e283201" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DeferredTaxLiabilitiesFiniteLivedIntangibleAssets_1edcfa99-3be7-4df2-971d-7a8d377a1bca" xlink:href="lgnd-20221231.xsd#lgnd_DeferredTaxLiabilitiesFiniteLivedIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_1860f81c-5ce3-441f-9d6c-0f153e283201" xlink:to="loc_lgnd_DeferredTaxLiabilitiesFiniteLivedIntangibleAssets_1edcfa99-3be7-4df2-971d-7a8d377a1bca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_f698aecf-31bf-447f-b367-c9e56a3278f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_1860f81c-5ce3-441f-9d6c-0f153e283201" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_f698aecf-31bf-447f-b367-c9e56a3278f8" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>13
<FILENAME>lgnd-20221231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:c0902eea-a24e-41c4-9f5a-301d659aee15,g:8404f1f2-95a1-4d6b-a993-1c430637111f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="lgnd-20221231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended" id="ib8be86ba7c804912afe837ff9cbf4a70_CONSOLIDATEDSTATEMENTSOFOPERATIONS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f9216a69-882f-4d73-a2a5-654d82db66b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_224774d3-9ffb-41cb-bca4-1be460ac43c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f9216a69-882f-4d73-a2a5-654d82db66b5" xlink:to="loc_us-gaap_RevenuesAbstract_224774d3-9ffb-41cb-bca4-1be460ac43c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_61b51a73-93af-443d-a40d-a518701774f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_224774d3-9ffb-41cb-bca4-1be460ac43c9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_61b51a73-93af-443d-a40d-a518701774f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_911641b7-1763-4b0a-ba4d-06dab93dd4cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f9216a69-882f-4d73-a2a5-654d82db66b5" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_911641b7-1763-4b0a-ba4d-06dab93dd4cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial_274f2c10-d388-4386-b913-cfea234b5e60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostDirectMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_911641b7-1763-4b0a-ba4d-06dab93dd4cf" xlink:to="loc_us-gaap_CostDirectMaterial_274f2c10-d388-4386-b913-cfea234b5e60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_3460d243-1db2-474d-a3ab-681c375b920a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_911641b7-1763-4b0a-ba4d-06dab93dd4cf" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_3460d243-1db2-474d-a3ab-681c375b920a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_affe2908-aaef-46c1-bbaa-eb0a706ba60b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_911641b7-1763-4b0a-ba4d-06dab93dd4cf" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_affe2908-aaef-46c1-bbaa-eb0a706ba60b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_1a58f99e-acae-4d68-94e9-6aff64cc12a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_911641b7-1763-4b0a-ba4d-06dab93dd4cf" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_1a58f99e-acae-4d68-94e9-6aff64cc12a7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_c4032b79-829c-49f4-8bf4-5dbb04556663" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_911641b7-1763-4b0a-ba4d-06dab93dd4cf" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_c4032b79-829c-49f4-8bf4-5dbb04556663" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_50ccde9f-04a8-4ebe-8950-5c4dfc8a9f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_911641b7-1763-4b0a-ba4d-06dab93dd4cf" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_50ccde9f-04a8-4ebe-8950-5c4dfc8a9f9e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets_d04372c8-709b-4145-89a5-ad18be008b46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f9216a69-882f-4d73-a2a5-654d82db66b5" xlink:to="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets_d04372c8-709b-4145-89a5-ad18be008b46" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5dbd1bdc-e47d-469f-a379-9cfd28f03861" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f9216a69-882f-4d73-a2a5-654d82db66b5" xlink:to="loc_us-gaap_OperatingIncomeLoss_5dbd1bdc-e47d-469f-a379-9cfd28f03861" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_add9a2a1-7f20-4769-af15-a6a49abe1431" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f9216a69-882f-4d73-a2a5-654d82db66b5" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_add9a2a1-7f20-4769-af15-a6a49abe1431" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_dc62d477-2acc-43c4-9626-fe83d071322e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_add9a2a1-7f20-4769-af15-a6a49abe1431" xlink:to="loc_us-gaap_GainLossOnInvestments_dc62d477-2acc-43c4-9626-fe83d071322e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_1c6bf68c-df30-430d-b9ca-21aed029fc8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_add9a2a1-7f20-4769-af15-a6a49abe1431" xlink:to="loc_us-gaap_InvestmentIncomeInterest_1c6bf68c-df30-430d-b9ca-21aed029fc8d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_563ee41d-c175-4d45-9c4c-6ad744a4b75e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_add9a2a1-7f20-4769-af15-a6a49abe1431" xlink:to="loc_us-gaap_InterestExpense_563ee41d-c175-4d45-9c4c-6ad744a4b75e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_4610eb17-0250-4e94-9c8d-8d22e3cbd72e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_add9a2a1-7f20-4769-af15-a6a49abe1431" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_4610eb17-0250-4e94-9c8d-8d22e3cbd72e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_1f20b7a9-14e6-4cd5-8702-8c19e5873f87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_add9a2a1-7f20-4769-af15-a6a49abe1431" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_1f20b7a9-14e6-4cd5-8702-8c19e5873f87" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3e7b6c3b-b0cd-4cca-8819-6053196191a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f9216a69-882f-4d73-a2a5-654d82db66b5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3e7b6c3b-b0cd-4cca-8819-6053196191a0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9635ea7e-7402-474b-9632-f2bfbfa28a09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f9216a69-882f-4d73-a2a5-654d82db66b5" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9635ea7e-7402-474b-9632-f2bfbfa28a09" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_ce7c3cc3-9720-4802-ac27-d59695c1f2cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f9216a69-882f-4d73-a2a5-654d82db66b5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_ce7c3cc3-9720-4802-ac27-d59695c1f2cb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_31d4dcd2-f236-4cae-b1a2-be006e5e56bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f9216a69-882f-4d73-a2a5-654d82db66b5" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_31d4dcd2-f236-4cae-b1a2-be006e5e56bf" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_111250e4-baac-4e06-b6d0-bedfe14a1396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f9216a69-882f-4d73-a2a5-654d82db66b5" xlink:to="loc_us-gaap_NetIncomeLoss_111250e4-baac-4e06-b6d0-bedfe14a1396" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_75299772-74c4-4d2a-8518-48e1ca9109c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f9216a69-882f-4d73-a2a5-654d82db66b5" xlink:to="loc_us-gaap_EarningsPerShareAbstract_75299772-74c4-4d2a-8518-48e1ca9109c0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_c402bc00-6b4c-491b-8e36-3ef722429111" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_75299772-74c4-4d2a-8518-48e1ca9109c0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_c402bc00-6b4c-491b-8e36-3ef722429111" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_f0b30650-c8aa-4086-b646-c65988a9dbf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_75299772-74c4-4d2a-8518-48e1ca9109c0" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_f0b30650-c8aa-4086-b646-c65988a9dbf3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_96a81bb5-dd44-4ce3-a7df-29c2352ed983" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_75299772-74c4-4d2a-8518-48e1ca9109c0" xlink:to="loc_us-gaap_EarningsPerShareBasic_96a81bb5-dd44-4ce3-a7df-29c2352ed983" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_64904732-8fab-4b85-bab7-cac066d63320" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_75299772-74c4-4d2a-8518-48e1ca9109c0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_64904732-8fab-4b85-bab7-cac066d63320" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_c0bcdb73-f7fc-4896-907d-7ab8da38b984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_75299772-74c4-4d2a-8518-48e1ca9109c0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_c0bcdb73-f7fc-4896-907d-7ab8da38b984" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_2b93d109-ec5f-4c27-bc16-fe5d556a7ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_75299772-74c4-4d2a-8518-48e1ca9109c0" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_2b93d109-ec5f-4c27-bc16-fe5d556a7ec3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_80661e75-3d89-4ac1-b6fa-ec9114ca9f76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_75299772-74c4-4d2a-8518-48e1ca9109c0" xlink:to="loc_us-gaap_EarningsPerShareDiluted_80661e75-3d89-4ac1-b6fa-ec9114ca9f76" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_989268e1-892f-43ff-8e02-f441f91d43f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_75299772-74c4-4d2a-8518-48e1ca9109c0" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_989268e1-892f-43ff-8e02-f441f91d43f2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_603d4b6c-0f0e-4368-b4ef-7eae2c6e5945" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_f9216a69-882f-4d73-a2a5-654d82db66b5" xlink:to="loc_us-gaap_StatementTable_603d4b6c-0f0e-4368-b4ef-7eae2c6e5945" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_03024c06-9ca0-4b7a-a9c3-b5709abc3354" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_603d4b6c-0f0e-4368-b4ef-7eae2c6e5945" xlink:to="loc_srt_ProductOrServiceAxis_03024c06-9ca0-4b7a-a9c3-b5709abc3354" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_03024c06-9ca0-4b7a-a9c3-b5709abc3354_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_03024c06-9ca0-4b7a-a9c3-b5709abc3354" xlink:to="loc_srt_ProductsAndServicesDomain_03024c06-9ca0-4b7a-a9c3-b5709abc3354_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ce70a3ae-c9ee-403d-9b56-aafe43d5dfb2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_03024c06-9ca0-4b7a-a9c3-b5709abc3354" xlink:to="loc_srt_ProductsAndServicesDomain_ce70a3ae-c9ee-403d-9b56-aafe43d5dfb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_a553e6d3-2334-4100-b8b3-6ca977f3cc11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ce70a3ae-c9ee-403d-9b56-aafe43d5dfb2" xlink:to="loc_us-gaap_RoyaltyMember_a553e6d3-2334-4100-b8b3-6ca977f3cc11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_db5e043b-8eab-4e96-a5e6-75f280f9897e" xlink:href="lgnd-20221231.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ce70a3ae-c9ee-403d-9b56-aafe43d5dfb2" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_db5e043b-8eab-4e96-a5e6-75f280f9897e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_19e632e6-89ad-467c-834c-cc906d88cf76" xlink:href="lgnd-20221231.xsd#lgnd_ContractRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ce70a3ae-c9ee-403d-9b56-aafe43d5dfb2" xlink:to="loc_lgnd_ContractRevenueMember_19e632e6-89ad-467c-834c-cc906d88cf76" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_VernalisMember_14da9509-a831-4570-a94c-796eb663dad0" xlink:href="lgnd-20221231.xsd#lgnd_VernalisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ce70a3ae-c9ee-403d-9b56-aafe43d5dfb2" xlink:to="loc_lgnd_VernalisMember_14da9509-a831-4570-a94c-796eb663dad0" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="lgnd-20221231.xsd#CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="i3e9197ddf6c84888b827c274b293bfbf_CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c14696ee-6034-408b-ba47-3089470b02f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c14696ee-6034-408b-ba47-3089470b02f0" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_ee5dc7f8-1ac6-47d8-ab6a-061a30342cd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:to="loc_us-gaap_SharesOutstanding_ee5dc7f8-1ac6-47d8-ab6a-061a30342cd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0444e584-b6ef-4a5f-ad17-7b81c61c53d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:to="loc_us-gaap_StockholdersEquity_0444e584-b6ef-4a5f-ad17-7b81c61c53d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_50272452-2dfc-405f-ac65-72e60829d26a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_50272452-2dfc-405f-ac65-72e60829d26a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_5bb65204-0ccc-4f02-a5df-61e91077aa4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_5bb65204-0ccc-4f02-a5df-61e91077aa4d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c2ca4fa1-e251-4f4c-b1ba-44f8d7eeb7e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c2ca4fa1-e251-4f4c-b1ba-44f8d7eeb7e8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_f11a5f66-7fa2-48d8-bb4c-c84579e26532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_f11a5f66-7fa2-48d8-bb4c-c84579e26532" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_3ec2b401-4b6c-4172-a337-fb6fe3962a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_3ec2b401-4b6c-4172-a337-fb6fe3962a2d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_fa0e4c14-7882-4800-bd08-4a9f4cee46f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_fa0e4c14-7882-4800-bd08-4a9f4cee46f7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_67100666-48cb-4b35-8ef7-fc90b1149eec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_67100666-48cb-4b35-8ef7-fc90b1149eec" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_be1d9838-8bbd-4392-9b0b-62ffebc4b4c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_be1d9838-8bbd-4392-9b0b-62ffebc4b4c3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_c9265c36-943b-44c9-8f79-bedf028c6be0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_c9265c36-943b-44c9-8f79-bedf028c6be0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_a4aca484-8c1c-4c52-86f8-28b453b16587" xlink:href="lgnd-20221231.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_a4aca484-8c1c-4c52-86f8-28b453b16587" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalBondHedgeTransaction_e4179a9e-4089-4081-a4f6-7c7bfb1544f6" xlink:href="lgnd-20221231.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalBondHedgeTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalBondHedgeTransaction_e4179a9e-4089-4081-a4f6-7c7bfb1544f6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalDecreaseDueToSeparation_3872078d-f5fc-4141-a13e-2ad9b465e3dc" xlink:href="lgnd-20221231.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalDecreaseDueToSeparation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalDecreaseDueToSeparation_3872078d-f5fc-4141-a13e-2ad9b465e3dc" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_3e9d6427-362a-4f0e-9cb9-6943878b22d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_3e9d6427-362a-4f0e-9cb9-6943878b22d9" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1d4c237a-4826-4550-aea6-8a3cb3c8b7bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:to="loc_us-gaap_NetIncomeLoss_1d4c237a-4826-4550-aea6-8a3cb3c8b7bc" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_66e4aa7a-f293-4c6f-acad-7bc2f0b1f50c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7ae52778-e459-40f6-916f-2acb62138b78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f694b28d-047c-418b-b8e1-9e643b1dfb05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_c14696ee-6034-408b-ba47-3089470b02f0" xlink:to="loc_us-gaap_StatementTable_f694b28d-047c-418b-b8e1-9e643b1dfb05" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_714fc0f4-6b9a-4ff0-9bc2-e431aff1968b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f694b28d-047c-418b-b8e1-9e643b1dfb05" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_714fc0f4-6b9a-4ff0-9bc2-e431aff1968b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_714fc0f4-6b9a-4ff0-9bc2-e431aff1968b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_714fc0f4-6b9a-4ff0-9bc2-e431aff1968b" xlink:to="loc_us-gaap_EquityComponentDomain_714fc0f4-6b9a-4ff0-9bc2-e431aff1968b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c59d16ef-ae86-40eb-a0ca-35890d9aa95b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_714fc0f4-6b9a-4ff0-9bc2-e431aff1968b" xlink:to="loc_us-gaap_EquityComponentDomain_c59d16ef-ae86-40eb-a0ca-35890d9aa95b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_38c09d7e-3dad-43c3-b63a-c5813c7f3214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c59d16ef-ae86-40eb-a0ca-35890d9aa95b" xlink:to="loc_us-gaap_CommonStockMember_38c09d7e-3dad-43c3-b63a-c5813c7f3214" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_241d63f1-1a84-41b4-b91e-0de42407164d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c59d16ef-ae86-40eb-a0ca-35890d9aa95b" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_241d63f1-1a84-41b4-b91e-0de42407164d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4e987748-7e56-451d-8aea-5ccebc4bb47c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c59d16ef-ae86-40eb-a0ca-35890d9aa95b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4e987748-7e56-451d-8aea-5ccebc4bb47c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_8005f8c8-7f36-4106-af41-833b0b7ba223" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c59d16ef-ae86-40eb-a0ca-35890d9aa95b" xlink:to="loc_us-gaap_RetainedEarningsMember_8005f8c8-7f36-4106-af41-833b0b7ba223" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8edb1346-1d89-49e0-9992-8dd4db6a5bbb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f694b28d-047c-418b-b8e1-9e643b1dfb05" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8edb1346-1d89-49e0-9992-8dd4db6a5bbb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8edb1346-1d89-49e0-9992-8dd4db6a5bbb_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8edb1346-1d89-49e0-9992-8dd4db6a5bbb" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8edb1346-1d89-49e0-9992-8dd4db6a5bbb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0cd52b82-4a16-4aa0-ad72-1bd1f83381c7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8edb1346-1d89-49e0-9992-8dd4db6a5bbb" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0cd52b82-4a16-4aa0-ad72-1bd1f83381c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_0fe533b0-4448-4578-962a-e493002cf860" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0cd52b82-4a16-4aa0-ad72-1bd1f83381c7" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_0fe533b0-4448-4578-962a-e493002cf860" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="ic3b65839efa24ad7b4728d3ebdf8e1b5_BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:href="lgnd-20221231.xsd#lgnd_BasisOfPresentationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_94ba85f0-63e4-448f-b997-3ba94bb5c8bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_NumberOfOperatingSegments_94ba85f0-63e4-448f-b997-3ba94bb5c8bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaturityPeriodOfHighlyLiquidSecuritiesMaximum_b519c0bd-2378-4e8e-a6e2-ea32e0c968ef" xlink:href="lgnd-20221231.xsd#lgnd_MaturityPeriodOfHighlyLiquidSecuritiesMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_lgnd_MaturityPeriodOfHighlyLiquidSecuritiesMaximum_b519c0bd-2378-4e8e-a6e2-ea32e0c968ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_276aec50-d205-4ba6-a373-bf4099364aca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_InventoryWriteDown_276aec50-d205-4ba6-a373-bf4099364aca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_ccc725ba-0254-40ea-b211-0c87745ba6ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_InventoryNet_ccc725ba-0254-40ea-b211-0c87745ba6ac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_e4577a6f-f53c-487d-b62f-67fdba3de82e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_e4577a6f-f53c-487d-b62f-67fdba3de82e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityAmountPerShare_c9551ab5-2f9b-491e-a652-fd9b27f39216" xlink:href="lgnd-20221231.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityAmountPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityAmountPerShare_c9551ab5-2f9b-491e-a652-fd9b27f39216" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_99cc97ac-f17c-4e8d-8d94-fc893cc75137" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_99cc97ac-f17c-4e8d-8d94-fc893cc75137" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfContingentValueRightsIssued_ebe97c01-352f-4b45-9eae-9bcdea8aad82" xlink:href="lgnd-20221231.xsd#lgnd_NumberOfContingentValueRightsIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_lgnd_NumberOfContingentValueRightsIssued_ebe97c01-352f-4b45-9eae-9bcdea8aad82" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseUpfrontPayment_d7efad4b-a706-446c-b605-6bda6118615f" xlink:href="lgnd-20221231.xsd#lgnd_LicenseUpfrontPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_lgnd_LicenseUpfrontPayment_d7efad4b-a706-446c-b605-6bda6118615f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdditionalRoyaltiesReceivableUnderSalesbasedMilestones_296e8678-d3d0-4d83-8675-6bddd25c6a79" xlink:href="lgnd-20221231.xsd#lgnd_AdditionalRoyaltiesReceivableUnderSalesbasedMilestones"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_lgnd_AdditionalRoyaltiesReceivableUnderSalesbasedMilestones_296e8678-d3d0-4d83-8675-6bddd25c6a79" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ProductRoyaltyPercentage_8d9ec38e-e1af-47ac-8cee-f91b30020b4a" xlink:href="lgnd-20221231.xsd#lgnd_ProductRoyaltyPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_lgnd_ProductRoyaltyPercentage_8d9ec38e-e1af-47ac-8cee-f91b30020b4a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_07e15e5e-2e67-4a01-939f-3ece90e1238a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_07e15e5e-2e67-4a01-939f-3ece90e1238a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3948cb39-4446-4155-8b73-94b3f627531b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3948cb39-4446-4155-8b73-94b3f627531b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived_0c75a31a-b721-42f8-88b5-eb3a8c844ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_ProceedsFromRoyaltiesReceived_0c75a31a-b721-42f8-88b5-eb3a8c844ffa" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyAgreementExpirationPeriod_9cde90bf-2c1d-4adc-979e-3095322692a3" xlink:href="lgnd-20221231.xsd#lgnd_RoyaltyAgreementExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_lgnd_RoyaltyAgreementExpirationPeriod_9cde90bf-2c1d-4adc-979e-3095322692a3" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_5bd6b198-28ac-4da3-9179-f4d95d3fa2b6" xlink:href="lgnd-20221231.xsd#lgnd_ForecastedCashFlowsEffectiveInterestRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_5bd6b198-28ac-4da3-9179-f4d95d3fa2b6" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_0b97a369-ce86-498a-b4dc-7f3a61acb891" xlink:href="lgnd-20221231.xsd#lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_0b97a369-ce86-498a-b4dc-7f3a61acb891" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccountsReceivableCreditLossExpenseReversalCOVID19_18ee074b-ad38-4af8-88c0-617ab4ab5ca3" xlink:href="lgnd-20221231.xsd#lgnd_AccountsReceivableCreditLossExpenseReversalCOVID19"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_lgnd_AccountsReceivableCreditLossExpenseReversalCOVID19_18ee074b-ad38-4af8-88c0-617ab4ab5ca3" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_c0ae5486-1309-42e9-8ecf-09f6c37dab3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_c0ae5486-1309-42e9-8ecf-09f6c37dab3b" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_52587af7-1d49-4a0e-afc8-9057d21bc740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_52587af7-1d49-4a0e-afc8-9057d21bc740" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_37851f70-66b0-4ac4-9f6e-0624d1972047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_37851f70-66b0-4ac4-9f6e-0624d1972047" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiMeasurementInput_7aa510ad-3359-41cd-8e5b-9271b1ed85bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_EquitySecuritiesFvNiMeasurementInput_7aa510ad-3359-41cd-8e5b-9271b1ed85bb" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_54eef744-83f5-4933-91e2-1a2c81e3d9b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_54eef744-83f5-4933-91e2-1a2c81e3d9b0" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dafce638-8907-48b4-91ad-3d875fbb77f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dafce638-8907-48b4-91ad-3d875fbb77f6" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable_49c2a2c6-8781-4496-bd2b-ee4f40eddcbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_ConvertibleNotesPayable_49c2a2c6-8781-4496-bd2b-ee4f40eddcbe" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_b41accbe-d511-4314-a928-3e9cc2c51671" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_b41accbe-d511-4314-a928-3e9cc2c51671" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_eb820841-2674-410d-92c7-f9689e1c3a14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_StockholdersEquity_eb820841-2674-410d-92c7-f9689e1c3a14" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_58d0bd2f-59a4-49b3-a384-6c99093fa832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_58d0bd2f-59a4-49b3-a384-6c99093fa832" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationTable_3e24e419-4002-4988-be23-31992016a302" xlink:href="lgnd-20221231.xsd#lgnd_BasisOfPresentationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_lgnd_BasisOfPresentationTable_3e24e419-4002-4988-be23-31992016a302" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_3690d44d-c7f2-46f8-b998-299a16670c54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_lgnd_BasisOfPresentationTable_3e24e419-4002-4988-be23-31992016a302" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_3690d44d-c7f2-46f8-b998-299a16670c54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_3690d44d-c7f2-46f8-b998-299a16670c54_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_3690d44d-c7f2-46f8-b998-299a16670c54" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_3690d44d-c7f2-46f8-b998-299a16670c54_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_b941c633-ba00-4404-ab66-775ba9fbd59b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_3690d44d-c7f2-46f8-b998-299a16670c54" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_b941c633-ba00-4404-ab66-775ba9fbd59b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_11a8c842-2792-4fa9-ab09-e6e2e95cca04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_b941c633-ba00-4404-ab66-775ba9fbd59b" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_11a8c842-2792-4fa9-ab09-e6e2e95cca04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_a58b472d-bc1f-401a-b624-676f1850c517" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_lgnd_BasisOfPresentationTable_3e24e419-4002-4988-be23-31992016a302" xlink:to="loc_srt_CounterpartyNameAxis_a58b472d-bc1f-401a-b624-676f1850c517" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a58b472d-bc1f-401a-b624-676f1850c517_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_a58b472d-bc1f-401a-b624-676f1850c517" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a58b472d-bc1f-401a-b624-676f1850c517_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a57cf8d3-ac34-4d02-b01e-262b69f8c4a8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_a58b472d-bc1f-401a-b624-676f1850c517" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a57cf8d3-ac34-4d02-b01e-262b69f8c4a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NovanMolluscumProductsMember_f027c7c0-e3a6-41ea-8a9c-93a3524abcf9" xlink:href="lgnd-20221231.xsd#lgnd_NovanMolluscumProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a57cf8d3-ac34-4d02-b01e-262b69f8c4a8" xlink:to="loc_lgnd_NovanMolluscumProductsMember_f027c7c0-e3a6-41ea-8a9c-93a3524abcf9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PalvellaTherapeuticsIncMember_cc2a6c49-0372-4dc3-b4f4-c7f144252076" xlink:href="lgnd-20221231.xsd#lgnd_PalvellaTherapeuticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a57cf8d3-ac34-4d02-b01e-262b69f8c4a8" xlink:to="loc_lgnd_PalvellaTherapeuticsIncMember_cc2a6c49-0372-4dc3-b4f4-c7f144252076" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoMember_6de583af-c57f-4964-a1ce-a1549db984a8" xlink:href="lgnd-20221231.xsd#lgnd_AziyoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a57cf8d3-ac34-4d02-b01e-262b69f8c4a8" xlink:to="loc_lgnd_AziyoMember_6de583af-c57f-4964-a1ce-a1549db984a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CorMatrixMember_bf6ba029-73f3-4a82-93e7-f871a409685f" xlink:href="lgnd-20221231.xsd#lgnd_CorMatrixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a57cf8d3-ac34-4d02-b01e-262b69f8c4a8" xlink:to="loc_lgnd_CorMatrixMember_bf6ba029-73f3-4a82-93e7-f871a409685f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisMember_cd4ce613-b4fd-4cde-9630-f78603735d30" xlink:href="lgnd-20221231.xsd#lgnd_SelexisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a57cf8d3-ac34-4d02-b01e-262b69f8c4a8" xlink:to="loc_lgnd_SelexisMember_cd4ce613-b4fd-4cde-9630-f78603735d30" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7891aa68-1a44-4656-b070-4920663d55d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_lgnd_BasisOfPresentationTable_3e24e419-4002-4988-be23-31992016a302" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7891aa68-1a44-4656-b070-4920663d55d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7891aa68-1a44-4656-b070-4920663d55d8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7891aa68-1a44-4656-b070-4920663d55d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7891aa68-1a44-4656-b070-4920663d55d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_57ace918-a9f3-421a-bf12-fc5dc45a07b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7891aa68-1a44-4656-b070-4920663d55d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_57ace918-a9f3-421a-bf12-fc5dc45a07b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyAgreementsMember_68afae2b-943a-499c-aa22-762d201ce3a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_57ace918-a9f3-421a-bf12-fc5dc45a07b8" xlink:to="loc_us-gaap_RoyaltyAgreementsMember_68afae2b-943a-499c-aa22-762d201ce3a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_f43bf9ad-35ad-4028-8b9a-b3c98baf4357" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_57ace918-a9f3-421a-bf12-fc5dc45a07b8" xlink:to="loc_us-gaap_LicensingAgreementsMember_f43bf9ad-35ad-4028-8b9a-b3c98baf4357" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3e3fcbe8-d970-42c9-8415-c90741d18161" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_lgnd_BasisOfPresentationTable_3e24e419-4002-4988-be23-31992016a302" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3e3fcbe8-d970-42c9-8415-c90741d18161" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3e3fcbe8-d970-42c9-8415-c90741d18161_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3e3fcbe8-d970-42c9-8415-c90741d18161" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3e3fcbe8-d970-42c9-8415-c90741d18161_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dfde5c4e-90c2-460d-b1c7-d487e1c92233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3e3fcbe8-d970-42c9-8415-c90741d18161" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dfde5c4e-90c2-460d-b1c7-d487e1c92233" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_3b2b1e19-41e3-441b-bc57-1f38cbc6bd24" xlink:href="lgnd-20221231.xsd#lgnd_PfenexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dfde5c4e-90c2-460d-b1c7-d487e1c92233" xlink:to="loc_lgnd_PfenexMember_3b2b1e19-41e3-441b-bc57-1f38cbc6bd24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MetabasisTherapeuticsMember_a25b5252-74e6-4bcd-833f-037d346b7ce2" xlink:href="lgnd-20221231.xsd#lgnd_MetabasisTherapeuticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dfde5c4e-90c2-460d-b1c7-d487e1c92233" xlink:to="loc_lgnd_MetabasisTherapeuticsMember_a25b5252-74e6-4bcd-833f-037d346b7ce2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2a38c760-9f36-4abc-9cef-c62cb62e3d58" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_lgnd_BasisOfPresentationTable_3e24e419-4002-4988-be23-31992016a302" xlink:to="loc_srt_RangeAxis_2a38c760-9f36-4abc-9cef-c62cb62e3d58" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2a38c760-9f36-4abc-9cef-c62cb62e3d58_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_2a38c760-9f36-4abc-9cef-c62cb62e3d58" xlink:to="loc_srt_RangeMember_2a38c760-9f36-4abc-9cef-c62cb62e3d58_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_99c2f395-c038-4884-87a1-81a6d993cf9d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_2a38c760-9f36-4abc-9cef-c62cb62e3d58" xlink:to="loc_srt_RangeMember_99c2f395-c038-4884-87a1-81a6d993cf9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d4b19c01-e65f-4c39-b1a4-5f204832cc65" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_99c2f395-c038-4884-87a1-81a6d993cf9d" xlink:to="loc_srt_MinimumMember_d4b19c01-e65f-4c39-b1a4-5f204832cc65" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_be4234f3-00b3-467a-9615-74a8a1cbb90d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_99c2f395-c038-4884-87a1-81a6d993cf9d" xlink:to="loc_srt_MaximumMember_be4234f3-00b3-467a-9615-74a8a1cbb90d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d845814b-2055-4cb5-840c-a55b85013986" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_lgnd_BasisOfPresentationTable_3e24e419-4002-4988-be23-31992016a302" xlink:to="loc_us-gaap_AwardTypeAxis_d845814b-2055-4cb5-840c-a55b85013986" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d845814b-2055-4cb5-840c-a55b85013986_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_d845814b-2055-4cb5-840c-a55b85013986" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d845814b-2055-4cb5-840c-a55b85013986_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8655ee89-1f52-4b85-b794-ea5062cf15db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_d845814b-2055-4cb5-840c-a55b85013986" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8655ee89-1f52-4b85-b794-ea5062cf15db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e9139c73-823c-4963-b841-6f4114d8d27c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8655ee89-1f52-4b85-b794-ea5062cf15db" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e9139c73-823c-4963-b841-6f4114d8d27c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RestrictedStockUnitsAndPerformanceSharesMember_949745ca-9620-45f3-9402-95d1302ad43e" xlink:href="lgnd-20221231.xsd#lgnd_RestrictedStockUnitsAndPerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8655ee89-1f52-4b85-b794-ea5062cf15db" xlink:to="loc_lgnd_RestrictedStockUnitsAndPerformanceSharesMember_949745ca-9620-45f3-9402-95d1302ad43e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_58d1068f-371f-4015-af39-4efba9321511" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_RestrictedStockUnitsAndPerformanceSharesMember_949745ca-9620-45f3-9402-95d1302ad43e" xlink:to="loc_us-gaap_PerformanceSharesMember_58d1068f-371f-4015-af39-4efba9321511" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_662db579-5412-46a0-8344-392261ad910e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_lgnd_BasisOfPresentationTable_3e24e419-4002-4988-be23-31992016a302" xlink:to="loc_us-gaap_VestingAxis_662db579-5412-46a0-8344-392261ad910e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_662db579-5412-46a0-8344-392261ad910e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_662db579-5412-46a0-8344-392261ad910e" xlink:to="loc_us-gaap_VestingDomain_662db579-5412-46a0-8344-392261ad910e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_0aa13c38-44f1-494e-852e-42c4e79e98c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_662db579-5412-46a0-8344-392261ad910e" xlink:to="loc_us-gaap_VestingDomain_0aa13c38-44f1-494e-852e-42c4e79e98c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_VestingPeriodOneMember_8d1b419e-e5a6-48c8-b04e-2cc664b92359" xlink:href="lgnd-20221231.xsd#lgnd_VestingPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_0aa13c38-44f1-494e-852e-42c4e79e98c5" xlink:to="loc_lgnd_VestingPeriodOneMember_8d1b419e-e5a6-48c8-b04e-2cc664b92359" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_VestingPeriodTwoMember_f321fb79-4894-48dc-83e1-98cf567a14b9" xlink:href="lgnd-20221231.xsd#lgnd_VestingPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_0aa13c38-44f1-494e-852e-42c4e79e98c5" xlink:to="loc_lgnd_VestingPeriodTwoMember_f321fb79-4894-48dc-83e1-98cf567a14b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_4da96513-7b3d-4c78-bcc3-2e3fef195136" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_lgnd_BasisOfPresentationTable_3e24e419-4002-4988-be23-31992016a302" xlink:to="loc_us-gaap_PlanNameAxis_4da96513-7b3d-4c78-bcc3-2e3fef195136" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_4da96513-7b3d-4c78-bcc3-2e3fef195136_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_4da96513-7b3d-4c78-bcc3-2e3fef195136" xlink:to="loc_us-gaap_PlanNameDomain_4da96513-7b3d-4c78-bcc3-2e3fef195136_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_9cddc78e-82b6-486c-8a13-1e5b388a5f33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_4da96513-7b3d-4c78-bcc3-2e3fef195136" xlink:to="loc_us-gaap_PlanNameDomain_9cddc78e-82b6-486c-8a13-1e5b388a5f33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_TwoThousandTwoStockIncentivePlanMember_bd9964e6-a340-44d2-9fd2-41eba7baa555" xlink:href="lgnd-20221231.xsd#lgnd_TwoThousandTwoStockIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_9cddc78e-82b6-486c-8a13-1e5b388a5f33" xlink:to="loc_lgnd_TwoThousandTwoStockIncentivePlanMember_bd9964e6-a340-44d2-9fd2-41eba7baa555" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_29cfdf1d-c6bd-461a-8a09-f3ec01077cdd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_lgnd_BasisOfPresentationTable_3e24e419-4002-4988-be23-31992016a302" xlink:to="loc_srt_ProductOrServiceAxis_29cfdf1d-c6bd-461a-8a09-f3ec01077cdd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_29cfdf1d-c6bd-461a-8a09-f3ec01077cdd_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_29cfdf1d-c6bd-461a-8a09-f3ec01077cdd" xlink:to="loc_srt_ProductsAndServicesDomain_29cfdf1d-c6bd-461a-8a09-f3ec01077cdd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_530ffbce-ee1f-45ae-986e-b2b939a3c56b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_29cfdf1d-c6bd-461a-8a09-f3ec01077cdd" xlink:to="loc_srt_ProductsAndServicesDomain_530ffbce-ee1f-45ae-986e-b2b939a3c56b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_eceb8091-1dcb-4ff3-bff1-79a3e121828f" xlink:href="lgnd-20221231.xsd#lgnd_ContractRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_530ffbce-ee1f-45ae-986e-b2b939a3c56b" xlink:to="loc_lgnd_ContractRevenueMember_eceb8091-1dcb-4ff3-bff1-79a3e121828f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_39452a78-d1b0-4e9e-9a39-600782cb9f32" xlink:href="lgnd-20221231.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_530ffbce-ee1f-45ae-986e-b2b939a3c56b" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_39452a78-d1b0-4e9e-9a39-600782cb9f32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_172fc8d9-459f-4ffc-9e53-6bd812b77d34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_lgnd_BasisOfPresentationTable_3e24e419-4002-4988-be23-31992016a302" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_172fc8d9-459f-4ffc-9e53-6bd812b77d34" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_172fc8d9-459f-4ffc-9e53-6bd812b77d34_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_172fc8d9-459f-4ffc-9e53-6bd812b77d34" xlink:to="loc_us-gaap_TypeOfAdoptionMember_172fc8d9-459f-4ffc-9e53-6bd812b77d34_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_2770afe8-cefe-463b-a725-a0c7d1002920" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_172fc8d9-459f-4ffc-9e53-6bd812b77d34" xlink:to="loc_us-gaap_TypeOfAdoptionMember_2770afe8-cefe-463b-a725-a0c7d1002920" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_efe03acc-43c1-4a19-b540-aaee31a492d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_2770afe8-cefe-463b-a725-a0c7d1002920" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_efe03acc-43c1-4a19-b540-aaee31a492d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_d6fd4263-c976-42ce-8e6e-0c89557c4fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_2770afe8-cefe-463b-a725-a0c7d1002920" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_d6fd4263-c976-42ce-8e6e-0c89557c4fb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_9f87b940-4ea7-40f0-a2f1-847088f42a45" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_lgnd_BasisOfPresentationTable_3e24e419-4002-4988-be23-31992016a302" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_9f87b940-4ea7-40f0-a2f1-847088f42a45" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_9f87b940-4ea7-40f0-a2f1-847088f42a45_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_9f87b940-4ea7-40f0-a2f1-847088f42a45" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_9f87b940-4ea7-40f0-a2f1-847088f42a45_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_af40a30d-b47d-4c32-ba02-1e5f9ecf50df" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_9f87b940-4ea7-40f0-a2f1-847088f42a45" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_af40a30d-b47d-4c32-ba02-1e5f9ecf50df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_85eeb345-4065-4eb0-901c-4729d6ceeeb7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_af40a30d-b47d-4c32-ba02-1e5f9ecf50df" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_85eeb345-4065-4eb0-901c-4729d6ceeeb7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_8431df9b-21a2-423a-8f5f-1d1274275111" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_af40a30d-b47d-4c32-ba02-1e5f9ecf50df" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_8431df9b-21a2-423a-8f5f-1d1274275111" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_dc7460c4-2971-44ad-b74f-9bde89a7aaef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_lgnd_BasisOfPresentationTable_3e24e419-4002-4988-be23-31992016a302" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_dc7460c4-2971-44ad-b74f-9bde89a7aaef" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_dc7460c4-2971-44ad-b74f-9bde89a7aaef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_dc7460c4-2971-44ad-b74f-9bde89a7aaef" xlink:to="loc_us-gaap_EquityComponentDomain_dc7460c4-2971-44ad-b74f-9bde89a7aaef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9f0038c2-a727-4417-b192-5a270b757818" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_dc7460c4-2971-44ad-b74f-9bde89a7aaef" xlink:to="loc_us-gaap_EquityComponentDomain_9f0038c2-a727-4417-b192-5a270b757818" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_94fec6ab-0318-48e3-b680-1e2a7052e458" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9f0038c2-a727-4417-b192-5a270b757818" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_94fec6ab-0318-48e3-b680-1e2a7052e458" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_8cfae410-3ac5-401a-968c-dc006c74c33e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9f0038c2-a727-4417-b192-5a270b757818" xlink:to="loc_us-gaap_RetainedEarningsMember_8cfae410-3ac5-401a-968c-dc006c74c33e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuefromSignificantPartnersDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuefromSignificantPartnersDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuefromSignificantPartnersDetails" xlink:type="extended" id="i751f1c6bd3ac45abac58f842474f5b46_BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuefromSignificantPartnersDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_e7d456ef-ec75-48e9-ae20-0e6f5ad3cb29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_377a8bbe-82df-42e9-a2f4-8ec9d2cb5b25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_e7d456ef-ec75-48e9-ae20-0e6f5ad3cb29" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_377a8bbe-82df-42e9-a2f4-8ec9d2cb5b25" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_c8ef0db3-6652-482d-9529-0f3261bf3169" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_e7d456ef-ec75-48e9-ae20-0e6f5ad3cb29" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_c8ef0db3-6652-482d-9529-0f3261bf3169" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_897431dd-e8b6-40db-b21a-1086e51cc3e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_c8ef0db3-6652-482d-9529-0f3261bf3169" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_897431dd-e8b6-40db-b21a-1086e51cc3e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_897431dd-e8b6-40db-b21a-1086e51cc3e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_897431dd-e8b6-40db-b21a-1086e51cc3e3" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_897431dd-e8b6-40db-b21a-1086e51cc3e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_a56322b8-603f-405a-98de-b88da4e82c6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_897431dd-e8b6-40db-b21a-1086e51cc3e3" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_a56322b8-603f-405a-98de-b88da4e82c6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_1c693588-cef0-4887-8299-afac0aa55c0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_a56322b8-603f-405a-98de-b88da4e82c6b" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_1c693588-cef0-4887-8299-afac0aa55c0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ab65d6cc-4873-479d-8e77-bafb2dd215b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_c8ef0db3-6652-482d-9529-0f3261bf3169" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ab65d6cc-4873-479d-8e77-bafb2dd215b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ab65d6cc-4873-479d-8e77-bafb2dd215b6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ab65d6cc-4873-479d-8e77-bafb2dd215b6" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ab65d6cc-4873-479d-8e77-bafb2dd215b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b3d1549a-2670-4a20-a40f-20c56eca76af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ab65d6cc-4873-479d-8e77-bafb2dd215b6" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b3d1549a-2670-4a20-a40f-20c56eca76af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_16e71ea1-a66c-4db0-90b8-ea1ca173be52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b3d1549a-2670-4a20-a40f-20c56eca76af" xlink:to="loc_us-gaap_SalesRevenueNetMember_16e71ea1-a66c-4db0-90b8-ea1ca173be52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_61dd947e-d4fb-4bea-a72f-764e6ae0f5ef" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_c8ef0db3-6652-482d-9529-0f3261bf3169" xlink:to="loc_srt_MajorCustomersAxis_61dd947e-d4fb-4bea-a72f-764e6ae0f5ef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_61dd947e-d4fb-4bea-a72f-764e6ae0f5ef_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_61dd947e-d4fb-4bea-a72f-764e6ae0f5ef" xlink:to="loc_srt_NameOfMajorCustomerDomain_61dd947e-d4fb-4bea-a72f-764e6ae0f5ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_fd2a025d-2bcd-498c-9615-92cad3fb58c1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_61dd947e-d4fb-4bea-a72f-764e6ae0f5ef" xlink:to="loc_srt_NameOfMajorCustomerDomain_fd2a025d-2bcd-498c-9615-92cad3fb58c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PartnerAMember_4edd3ebe-6889-48e6-8682-41f3e2717fc7" xlink:href="lgnd-20221231.xsd#lgnd_PartnerAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_fd2a025d-2bcd-498c-9615-92cad3fb58c1" xlink:to="loc_lgnd_PartnerAMember_4edd3ebe-6889-48e6-8682-41f3e2717fc7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PartnerBMember_d2f928c9-7008-4b88-a57a-3d5afe2aac25" xlink:href="lgnd-20221231.xsd#lgnd_PartnerBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_fd2a025d-2bcd-498c-9615-92cad3fb58c1" xlink:to="loc_lgnd_PartnerBMember_d2f928c9-7008-4b88-a57a-3d5afe2aac25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PartnerCMember_3cc2e069-7314-488d-b23e-a14d849f015a" xlink:href="lgnd-20221231.xsd#lgnd_PartnerCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_fd2a025d-2bcd-498c-9615-92cad3fb58c1" xlink:to="loc_lgnd_PartnerCMember_3cc2e069-7314-488d-b23e-a14d849f015a" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" xlink:type="extended" id="ifc87cc0cd6284172ba8e3d8ec6022f77_BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_68fc3fd1-46b2-4faf-bd1c-d1bc5e5b48bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d4778c5e-d03e-49e0-8aee-0e89f5512736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_68fc3fd1-46b2-4faf-bd1c-d1bc5e5b48bb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d4778c5e-d03e-49e0-8aee-0e89f5512736" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments_73de94c7-57ea-4386-b5aa-965070f53437" xlink:href="lgnd-20221231.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_68fc3fd1-46b2-4faf-bd1c-d1bc5e5b48bb" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments_73de94c7-57ea-4386-b5aa-965070f53437" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_fb598d33-530a-4a43-9247-e7de6af44480" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_68fc3fd1-46b2-4faf-bd1c-d1bc5e5b48bb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_fb598d33-530a-4a43-9247-e7de6af44480" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f5d5b701-7955-42e0-9952-f715f5ccba8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_68fc3fd1-46b2-4faf-bd1c-d1bc5e5b48bb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f5d5b701-7955-42e0-9952-f715f5ccba8f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_8889e50d-4a6d-4d72-9543-6f39612bdfcb" xlink:href="lgnd-20221231.xsd#lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_68fc3fd1-46b2-4faf-bd1c-d1bc5e5b48bb" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_8889e50d-4a6d-4d72-9543-6f39612bdfcb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_81a5f7ec-5f46-4986-8b10-6dcb21cff73b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_68fc3fd1-46b2-4faf-bd1c-d1bc5e5b48bb" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_81a5f7ec-5f46-4986-8b10-6dcb21cff73b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ad636c8b-2dc6-4786-af66-778421a98c25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_81a5f7ec-5f46-4986-8b10-6dcb21cff73b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ad636c8b-2dc6-4786-af66-778421a98c25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ad636c8b-2dc6-4786-af66-778421a98c25_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ad636c8b-2dc6-4786-af66-778421a98c25" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ad636c8b-2dc6-4786-af66-778421a98c25_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79424ac4-9de6-4ab7-b9a2-af5235aee373" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ad636c8b-2dc6-4786-af66-778421a98c25" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79424ac4-9de6-4ab7-b9a2-af5235aee373" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_91bc5b7d-71dd-41b5-a40d-11f58a321fe3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79424ac4-9de6-4ab7-b9a2-af5235aee373" xlink:to="loc_us-gaap_LicensingAgreementsMember_91bc5b7d-71dd-41b5-a40d-11f58a321fe3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_1085f090-c0dc-41ac-8e06-51cb0af1052b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_81a5f7ec-5f46-4986-8b10-6dcb21cff73b" xlink:to="loc_srt_CounterpartyNameAxis_1085f090-c0dc-41ac-8e06-51cb0af1052b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1085f090-c0dc-41ac-8e06-51cb0af1052b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_1085f090-c0dc-41ac-8e06-51cb0af1052b" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1085f090-c0dc-41ac-8e06-51cb0af1052b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_28f10911-80b7-4c1a-8338-ab290afa4300" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_1085f090-c0dc-41ac-8e06-51cb0af1052b" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_28f10911-80b7-4c1a-8338-ab290afa4300" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoandCorMatrixMember_3704ac35-1222-4e7f-bd01-da22e133a997" xlink:href="lgnd-20221231.xsd#lgnd_AziyoandCorMatrixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_28f10911-80b7-4c1a-8338-ab290afa4300" xlink:to="loc_lgnd_AziyoandCorMatrixMember_3704ac35-1222-4e7f-bd01-da22e133a997" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisAndDianomiMember_da5a0772-98b2-4ab5-82f8-da98e1a78c26" xlink:href="lgnd-20221231.xsd#lgnd_SelexisAndDianomiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_28f10911-80b7-4c1a-8338-ab290afa4300" xlink:to="loc_lgnd_SelexisAndDianomiMember_da5a0772-98b2-4ab5-82f8-da98e1a78c26" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRoyaltyRevenueDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesRoyaltyRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRoyaltyRevenueDetails" xlink:type="extended" id="ie4c09de0a5c64619827c8a027ba04012_BasisofPresentationandSummaryofSignificantAccountingPoliciesRoyaltyRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_658b864b-eafc-445e-bf15-bea1227ab8a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_61ccc4fe-79ff-4019-b82e-5adfc63f1a16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_658b864b-eafc-445e-bf15-bea1227ab8a7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_61ccc4fe-79ff-4019-b82e-5adfc63f1a16" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_4ba39f10-680b-4c71-9113-9836f1b983b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_658b864b-eafc-445e-bf15-bea1227ab8a7" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_4ba39f10-680b-4c71-9113-9836f1b983b9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_efe4937a-b2d4-48bf-a717-a148355d5430" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_4ba39f10-680b-4c71-9113-9836f1b983b9" xlink:to="loc_srt_ProductOrServiceAxis_efe4937a-b2d4-48bf-a717-a148355d5430" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_efe4937a-b2d4-48bf-a717-a148355d5430_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_efe4937a-b2d4-48bf-a717-a148355d5430" xlink:to="loc_srt_ProductsAndServicesDomain_efe4937a-b2d4-48bf-a717-a148355d5430_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_51a4e708-e226-49aa-a59c-31cb6fdfc091" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_efe4937a-b2d4-48bf-a717-a148355d5430" xlink:to="loc_srt_ProductsAndServicesDomain_51a4e708-e226-49aa-a59c-31cb6fdfc091" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_8ebe69e2-96f8-472b-954b-31e4d1a9ada0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_51a4e708-e226-49aa-a59c-31cb6fdfc091" xlink:to="loc_us-gaap_RoyaltyMember_8ebe69e2-96f8-472b-954b-31e4d1a9ada0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyKyprolisMember_a6c5a91f-681a-4db3-aa24-a163042fa403" xlink:href="lgnd-20221231.xsd#lgnd_RoyaltyKyprolisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_8ebe69e2-96f8-472b-954b-31e4d1a9ada0" xlink:to="loc_lgnd_RoyaltyKyprolisMember_a6c5a91f-681a-4db3-aa24-a163042fa403" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyEvomelaMember_b13ee984-6824-4406-bda4-9ab95d5c500d" xlink:href="lgnd-20221231.xsd#lgnd_RoyaltyEvomelaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_8ebe69e2-96f8-472b-954b-31e4d1a9ada0" xlink:to="loc_lgnd_RoyaltyEvomelaMember_b13ee984-6824-4406-bda4-9ab95d5c500d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyTeriparatideInjectionMember_85ac8ade-b696-4015-8e6b-1cec52055ec9" xlink:href="lgnd-20221231.xsd#lgnd_RoyaltyTeriparatideInjectionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_8ebe69e2-96f8-472b-954b-31e4d1a9ada0" xlink:to="loc_lgnd_RoyaltyTeriparatideInjectionMember_85ac8ade-b696-4015-8e6b-1cec52055ec9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyRylazeMember_4530ecd6-9a34-4880-a4bc-b1ae0629e064" xlink:href="lgnd-20221231.xsd#lgnd_RoyaltyRylazeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_8ebe69e2-96f8-472b-954b-31e4d1a9ada0" xlink:to="loc_lgnd_RoyaltyRylazeMember_4530ecd6-9a34-4880-a4bc-b1ae0629e064" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyOtherMember_27c96d64-4521-4ebb-ab12-aa426303a626" xlink:href="lgnd-20221231.xsd#lgnd_RoyaltyOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_8ebe69e2-96f8-472b-954b-31e4d1a9ada0" xlink:to="loc_lgnd_RoyaltyOtherMember_27c96d64-4521-4ebb-ab12-aa426303a626" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_6eea9e5b-5e5e-4407-ba28-7abbdcd91d73" xlink:href="lgnd-20221231.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_51a4e708-e226-49aa-a59c-31cb6fdfc091" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_6eea9e5b-5e5e-4407-ba28-7abbdcd91d73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCoreMember_393c17dc-68ab-44f5-b444-ad4fe5ef7bae" xlink:href="lgnd-20221231.xsd#lgnd_MaterialSalesCaptisolCoreMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_MaterialSalesCaptisolMember_6eea9e5b-5e5e-4407-ba28-7abbdcd91d73" xlink:to="loc_lgnd_MaterialSalesCaptisolCoreMember_393c17dc-68ab-44f5-b444-ad4fe5ef7bae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCOVIDMember_110a55d8-051f-4210-a42f-96c6b234ea02" xlink:href="lgnd-20221231.xsd#lgnd_MaterialSalesCaptisolCOVIDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_MaterialSalesCaptisolMember_6eea9e5b-5e5e-4407-ba28-7abbdcd91d73" xlink:to="loc_lgnd_MaterialSalesCaptisolCOVIDMember_110a55d8-051f-4210-a42f-96c6b234ea02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_2137554e-4027-480d-b16c-d99077bd7533" xlink:href="lgnd-20221231.xsd#lgnd_ContractRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_51a4e708-e226-49aa-a59c-31cb6fdfc091" xlink:to="loc_lgnd_ContractRevenueMember_2137554e-4027-480d-b16c-d99077bd7533" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_5fb565ba-8395-410c-80ab-b3459e7ec054" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_2137554e-4027-480d-b16c-d99077bd7533" xlink:to="loc_us-gaap_ServiceMember_5fb565ba-8395-410c-80ab-b3459e7ec054" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMember_1215e607-6034-4c69-9f15-227d915754e3" xlink:href="lgnd-20221231.xsd#lgnd_LicenseFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_2137554e-4027-480d-b16c-d99077bd7533" xlink:to="loc_lgnd_LicenseFeesMember_1215e607-6034-4c69-9f15-227d915754e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestoneMember_f949ad95-496c-4e4c-b8be-85067cde27a4" xlink:href="lgnd-20221231.xsd#lgnd_MilestoneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_2137554e-4027-480d-b16c-d99077bd7533" xlink:to="loc_lgnd_MilestoneMember_f949ad95-496c-4e4c-b8be-85067cde27a4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMilestonesAndOtherProductOtherMember_5aca20d7-0651-4bc5-8e41-58f47efc3091" xlink:href="lgnd-20221231.xsd#lgnd_LicenseFeesMilestonesAndOtherProductOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_2137554e-4027-480d-b16c-d99077bd7533" xlink:to="loc_lgnd_LicenseFeesMilestonesAndOtherProductOtherMember_5aca20d7-0651-4bc5-8e41-58f47efc3091" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCalculationofEarningsperShareDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesCalculationofEarningsperShareDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCalculationofEarningsperShareDetails" xlink:type="extended" id="ic5cd4d928d40430d9052c2e3a5da5054_BasisofPresentationandSummaryofSignificantAccountingPoliciesCalculationofEarningsperShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems_f90b3ad4-8390-4d04-af57-530c702f3894" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_32cde136-b6d3-49c4-9abe-45afda308066" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_f90b3ad4-8390-4d04-af57-530c702f3894" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_32cde136-b6d3-49c4-9abe-45afda308066" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_65739bdc-c8a4-4883-854d-6975a15fb44e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_f90b3ad4-8390-4d04-af57-530c702f3894" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_65739bdc-c8a4-4883-854d-6975a15fb44e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5549ac34-6acd-4bee-9d7d-edb7a5becb2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_f90b3ad4-8390-4d04-af57-530c702f3894" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5549ac34-6acd-4bee-9d7d-edb7a5becb2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0fc239aa-57a2-4bbe-9e81-437001a3d109" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_f90b3ad4-8390-4d04-af57-530c702f3894" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0fc239aa-57a2-4bbe-9e81-437001a3d109" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_87634890-b36f-43d7-962f-a3ac27e36265" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_f90b3ad4-8390-4d04-af57-530c702f3894" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_87634890-b36f-43d7-962f-a3ac27e36265" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2f3b898e-eaff-4d64-8dd8-e1b4d4b4e0dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_87634890-b36f-43d7-962f-a3ac27e36265" xlink:to="loc_us-gaap_AwardTypeAxis_2f3b898e-eaff-4d64-8dd8-e1b4d4b4e0dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2f3b898e-eaff-4d64-8dd8-e1b4d4b4e0dc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_2f3b898e-eaff-4d64-8dd8-e1b4d4b4e0dc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2f3b898e-eaff-4d64-8dd8-e1b4d4b4e0dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dd058656-043e-4afe-9ce1-e9b30f113134" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_2f3b898e-eaff-4d64-8dd8-e1b4d4b4e0dc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dd058656-043e-4afe-9ce1-e9b30f113134" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_0fa8d94e-5ba8-493b-a86c-5646c078fb37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dd058656-043e-4afe-9ce1-e9b30f113134" xlink:to="loc_us-gaap_RestrictedStockMember_0fa8d94e-5ba8-493b-a86c-5646c078fb37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_faf99f83-d293-47a3-99dc-1c1e707b8c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dd058656-043e-4afe-9ce1-e9b30f113134" xlink:to="loc_us-gaap_EmployeeStockOptionMember_faf99f83-d293-47a3-99dc-1c1e707b8c8c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SpinoffofOmniAbNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#SpinoffofOmniAbNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/SpinoffofOmniAbNarrativeDetails" xlink:type="extended" id="i408243394dcd42d8b84c23ddf0facd9f_SpinoffofOmniAbNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_deae9e3e-2121-45b3-b9ed-690488eacc89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_46a64ef4-3345-4753-985f-d5e8fe956b91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_deae9e3e-2121-45b3-b9ed-690488eacc89" xlink:to="loc_us-gaap_NumberOfReportableSegments_46a64ef4-3345-4753-985f-d5e8fe956b91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed_03b29ebf-6b25-4362-98e8-3c93d23e104b" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_deae9e3e-2121-45b3-b9ed-690488eacc89" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed_03b29ebf-6b25-4362-98e8-3c93d23e104b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1e452118-1e4d-49fc-ac97-6feebdc8c574" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_deae9e3e-2121-45b3-b9ed-690488eacc89" xlink:to="loc_us-gaap_Goodwill_1e452118-1e4d-49fc-ac97-6feebdc8c574" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_f0da5154-290f-4a0c-8b4c-1860cc629e38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_deae9e3e-2121-45b3-b9ed-690488eacc89" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_f0da5154-290f-4a0c-8b4c-1860cc629e38" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b8df08c7-c638-4be8-97c6-08a748860725" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_deae9e3e-2121-45b3-b9ed-690488eacc89" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b8df08c7-c638-4be8-97c6-08a748860725" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_37a56faf-c6d4-4a39-a2e3-18091ab3690b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b8df08c7-c638-4be8-97c6-08a748860725" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_37a56faf-c6d4-4a39-a2e3-18091ab3690b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_37a56faf-c6d4-4a39-a2e3-18091ab3690b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_37a56faf-c6d4-4a39-a2e3-18091ab3690b" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_37a56faf-c6d4-4a39-a2e3-18091ab3690b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_3b2c965d-b179-4fc4-bab7-8a37de2b23ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_37a56faf-c6d4-4a39-a2e3-18091ab3690b" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_3b2c965d-b179-4fc4-bab7-8a37de2b23ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_3674fde7-32c0-4695-80ff-a335dce6fd45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_3b2c965d-b179-4fc4-bab7-8a37de2b23ab" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_3674fde7-32c0-4695-80ff-a335dce6fd45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3ccd7edc-05d2-4f8a-a4d3-7ec852492a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b8df08c7-c638-4be8-97c6-08a748860725" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3ccd7edc-05d2-4f8a-a4d3-7ec852492a6d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3ccd7edc-05d2-4f8a-a4d3-7ec852492a6d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3ccd7edc-05d2-4f8a-a4d3-7ec852492a6d" xlink:to="loc_us-gaap_SegmentDomain_3ccd7edc-05d2-4f8a-a4d3-7ec852492a6d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e0a01f2c-8a50-435c-9a28-5a197caf5dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3ccd7edc-05d2-4f8a-a4d3-7ec852492a6d" xlink:to="loc_us-gaap_SegmentDomain_e0a01f2c-8a50-435c-9a28-5a197caf5dd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LigandCoreBusinessMember_5c57a55f-92d5-4109-916c-496da68f8b47" xlink:href="lgnd-20221231.xsd#lgnd_LigandCoreBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e0a01f2c-8a50-435c-9a28-5a197caf5dd0" xlink:to="loc_lgnd_LigandCoreBusinessMember_5c57a55f-92d5-4109-916c-496da68f8b47" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails" xlink:type="extended" id="i0cf7517a855b45d5919f1ba88f118f53_SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cacf6624-fe4a-4396-bf35-b1f9ec182485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsAbstract_6dba820a-0bec-4e1a-b8d6-57b3c15d8dab" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cacf6624-fe4a-4396-bf35-b1f9ec182485" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsAbstract_6dba820a-0bec-4e1a-b8d6-57b3c15d8dab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_975d5a44-b022-4101-b39b-e00ab756ae63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsAbstract_6dba820a-0bec-4e1a-b8d6-57b3c15d8dab" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_975d5a44-b022-4101-b39b-e00ab756ae63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_2b76b4d9-e777-48a2-967d-740e7d055ec9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_975d5a44-b022-4101-b39b-e00ab756ae63" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_2b76b4d9-e777-48a2-967d-740e7d055ec9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_7e51c04a-41f8-4265-8b5f-778a8efdac0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_975d5a44-b022-4101-b39b-e00ab756ae63" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_7e51c04a-41f8-4265-8b5f-778a8efdac0b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_204f66c7-962c-4ca1-a1dc-afa6b26a7061" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_975d5a44-b022-4101-b39b-e00ab756ae63" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_204f66c7-962c-4ca1-a1dc-afa6b26a7061" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_673b77ad-38ab-4be7-aaaf-a2cca74ba266" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsAbstract_6dba820a-0bec-4e1a-b8d6-57b3c15d8dab" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_673b77ad-38ab-4be7-aaaf-a2cca74ba266" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_b29ab71d-8b29-4ce4-a634-a11e80518416" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsAbstract_6dba820a-0bec-4e1a-b8d6-57b3c15d8dab" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_b29ab71d-8b29-4ce4-a634-a11e80518416" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent_f287e50e-e691-463c-8ad8-5108d0d01369" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsAbstract_6dba820a-0bec-4e1a-b8d6-57b3c15d8dab" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent_f287e50e-e691-463c-8ad8-5108d0d01369" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsOperatingLeaseAssets_97555512-3fe9-4cad-b464-b8ae4c665c4d" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsOperatingLeaseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsAbstract_6dba820a-0bec-4e1a-b8d6-57b3c15d8dab" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsOperatingLeaseAssets_97555512-3fe9-4cad-b464-b8ae4c665c4d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsFinanceLeaseAssets_a725e4dc-4743-4d1e-a6df-51ce9c9e03c7" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsFinanceLeaseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsAbstract_6dba820a-0bec-4e1a-b8d6-57b3c15d8dab" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsFinanceLeaseAssets_a725e4dc-4743-4d1e-a6df-51ce9c9e03c7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_e62a68e9-d7fd-40d4-ac3a-578cc53053c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsAbstract_6dba820a-0bec-4e1a-b8d6-57b3c15d8dab" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_e62a68e9-d7fd-40d4-ac3a-578cc53053c4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_f119541e-36dd-48cb-9b97-70a842373bd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsAbstract_6dba820a-0bec-4e1a-b8d6-57b3c15d8dab" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_f119541e-36dd-48cb-9b97-70a842373bd7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndStockholdersEquityAbstract_4b6bc464-d65b-4f5e-baa1-bf03a605c82b" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cacf6624-fe4a-4396-bf35-b1f9ec182485" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndStockholdersEquityAbstract_4b6bc464-d65b-4f5e-baa1-bf03a605c82b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_214464d5-961e-4848-a589-782a01992064" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndStockholdersEquityAbstract_4b6bc464-d65b-4f5e-baa1-bf03a605c82b" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_214464d5-961e-4848-a589-782a01992064" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesCurrent_5ae866b9-0af7-4492-bcce-2cda9a212bc2" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_214464d5-961e-4848-a589-782a01992064" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesCurrent_5ae866b9-0af7-4492-bcce-2cda9a212bc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent_f3d815d3-048b-4625-839f-58ec986394c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_214464d5-961e-4848-a589-782a01992064" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent_f3d815d3-048b-4625-839f-58ec986394c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent_07435013-5e39-4b38-97a0-cf18aab18735" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_214464d5-961e-4848-a589-782a01992064" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent_07435013-5e39-4b38-97a0-cf18aab18735" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilitiesCurrent_31c891f8-23cc-443c-8a53-c58b84b5bf4d" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_214464d5-961e-4848-a589-782a01992064" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilitiesCurrent_31c891f8-23cc-443c-8a53-c58b84b5bf4d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_4823d18c-ca2d-445c-811d-2cab22b3f732" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_214464d5-961e-4848-a589-782a01992064" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_4823d18c-ca2d-445c-811d-2cab22b3f732" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesNoncurrent_4afdc03f-e6e9-4d77-9404-867a6f6fbdfe" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndStockholdersEquityAbstract_4b6bc464-d65b-4f5e-baa1-bf03a605c82b" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesNoncurrent_4afdc03f-e6e9-4d77-9404-867a6f6fbdfe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_9678af51-b1d5-47d0-b51a-6f6b1806fd6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndStockholdersEquityAbstract_4b6bc464-d65b-4f5e-baa1-bf03a605c82b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_9678af51-b1d5-47d0-b51a-6f6b1806fd6d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesOperatingLeaseNoncurrent_12a6e999-a198-4421-a68f-5a847756942f" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesOperatingLeaseNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndStockholdersEquityAbstract_4b6bc464-d65b-4f5e-baa1-bf03a605c82b" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesOperatingLeaseNoncurrent_12a6e999-a198-4421-a68f-5a847756942f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_8ffc2e46-a58e-427c-8abb-4d0b6ebc752c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndStockholdersEquityAbstract_4b6bc464-d65b-4f5e-baa1-bf03a605c82b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_8ffc2e46-a58e-427c-8abb-4d0b6ebc752c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_6a75ab78-6095-4d12-89c1-d6550141f0fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndStockholdersEquityAbstract_4b6bc464-d65b-4f5e-baa1-bf03a605c82b" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_6a75ab78-6095-4d12-89c1-d6550141f0fc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationNetAssetsTransferred_eebb531e-e41b-4a7b-97f4-64992c79f3ab" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationNetAssetsTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndStockholdersEquityAbstract_4b6bc464-d65b-4f5e-baa1-bf03a605c82b" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationNetAssetsTransferred_eebb531e-e41b-4a7b-97f4-64992c79f3ab" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_51c32efc-7109-4d13-8271-07bd3b3533f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cacf6624-fe4a-4396-bf35-b1f9ec182485" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_51c32efc-7109-4d13-8271-07bd3b3533f9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_89ddbaf2-acb9-43a7-98a5-0f012af9d3c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_51c32efc-7109-4d13-8271-07bd3b3533f9" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_89ddbaf2-acb9-43a7-98a5-0f012af9d3c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_89ddbaf2-acb9-43a7-98a5-0f012af9d3c2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_89ddbaf2-acb9-43a7-98a5-0f012af9d3c2" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_89ddbaf2-acb9-43a7-98a5-0f012af9d3c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_7b1fab52-112b-472c-be8e-260f8ea91b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_89ddbaf2-acb9-43a7-98a5-0f012af9d3c2" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_7b1fab52-112b-472c-be8e-260f8ea91b5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_21448bfb-2a4d-4386-bb58-03643398ece1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_7b1fab52-112b-472c-be8e-260f8ea91b5d" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_21448bfb-2a4d-4386-bb58-03643398ece1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails" xlink:type="extended" id="i7118b83303c94ac99bbb3ff155ecd13c_SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8b57c388-ec92-49d0-9127-7dba2699aebb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract_3dbf38ea-c876-4468-a6b8-5ea232b88fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8b57c388-ec92-49d0-9127-7dba2699aebb" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract_3dbf38ea-c876-4468-a6b8-5ea232b88fc3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_d8278641-209e-486a-9d81-0c3b0548f8fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract_3dbf38ea-c876-4468-a6b8-5ea232b88fc3" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_d8278641-209e-486a-9d81-0c3b0548f8fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract_65b4b3e4-47a6-40cf-b7ce-2a4360f8a8b1" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8b57c388-ec92-49d0-9127-7dba2699aebb" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract_65b4b3e4-47a6-40cf-b7ce-2a4360f8a8b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_bf34d107-97fc-4caa-b4d8-13af3db5845c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract_65b4b3e4-47a6-40cf-b7ce-2a4360f8a8b1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_bf34d107-97fc-4caa-b4d8-13af3db5845c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment_0fddef4b-74b1-431c-9a46-77bb82045e05" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract_65b4b3e4-47a6-40cf-b7ce-2a4360f8a8b1" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment_0fddef4b-74b1-431c-9a46-77bb82045e05" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_a4d1397e-300c-4609-9461-f10fcbe14e22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract_65b4b3e4-47a6-40cf-b7ce-2a4360f8a8b1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_a4d1397e-300c-4609-9461-f10fcbe14e22" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_d51ec999-5ff5-4383-af7b-55349131032b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract_65b4b3e4-47a6-40cf-b7ce-2a4360f8a8b1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_d51ec999-5ff5-4383-af7b-55349131032b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_d0f4238d-f41d-4a5d-ac05-20bd3f15a185" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8b57c388-ec92-49d0-9127-7dba2699aebb" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_d0f4238d-f41d-4a5d-ac05-20bd3f15a185" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_3d94829a-482a-44cf-900f-fb0c1400de56" xlink:href="lgnd-20221231.xsd#lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8b57c388-ec92-49d0-9127-7dba2699aebb" xlink:to="loc_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_3d94829a-482a-44cf-900f-fb0c1400de56" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments_ed800010-abe6-4e8d-853f-87a431f9f4d3" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_3d94829a-482a-44cf-900f-fb0c1400de56" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments_ed800010-abe6-4e8d-853f-87a431f9f4d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_d54c597b-3535-485f-9e73-5d7415ce4ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_3d94829a-482a-44cf-900f-fb0c1400de56" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_d54c597b-3535-485f-9e73-5d7415ce4ccb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_d57d1df4-1957-4163-9846-7828fcc8ac3d" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_3d94829a-482a-44cf-900f-fb0c1400de56" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_d57d1df4-1957-4163-9846-7828fcc8ac3d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_47b52734-99f7-4b72-ac6c-97fcba8411d6" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8b57c388-ec92-49d0-9127-7dba2699aebb" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_47b52734-99f7-4b72-ac6c-97fcba8411d6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_06adeffb-7e11-4e4f-b2e8-e9a66de0b97f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8b57c388-ec92-49d0-9127-7dba2699aebb" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_06adeffb-7e11-4e4f-b2e8-e9a66de0b97f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_073712f5-5aa1-491c-aa24-2a2b5933a2cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8b57c388-ec92-49d0-9127-7dba2699aebb" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_073712f5-5aa1-491c-aa24-2a2b5933a2cb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_1fd014cf-3c3c-4442-a8f6-1e31f10c9b92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8b57c388-ec92-49d0-9127-7dba2699aebb" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_1fd014cf-3c3c-4442-a8f6-1e31f10c9b92" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_2120aa3e-d7c5-4c96-966f-5605fabaa838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8b57c388-ec92-49d0-9127-7dba2699aebb" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_2120aa3e-d7c5-4c96-966f-5605fabaa838" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_08bf63e6-01ae-4fba-bc05-8981ea8126bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_2120aa3e-d7c5-4c96-966f-5605fabaa838" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_08bf63e6-01ae-4fba-bc05-8981ea8126bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_08bf63e6-01ae-4fba-bc05-8981ea8126bf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_08bf63e6-01ae-4fba-bc05-8981ea8126bf" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_08bf63e6-01ae-4fba-bc05-8981ea8126bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_de3fce08-4686-414a-913d-102dcfd15b90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_08bf63e6-01ae-4fba-bc05-8981ea8126bf" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_de3fce08-4686-414a-913d-102dcfd15b90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_15026d91-ef5c-4bdf-b3aa-39bf03d131aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_de3fce08-4686-414a-913d-102dcfd15b90" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_15026d91-ef5c-4bdf-b3aa-39bf03d131aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_995c22fa-71a4-43ca-a4c1-a2de13f2f935" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_2120aa3e-d7c5-4c96-966f-5605fabaa838" xlink:to="loc_srt_ProductOrServiceAxis_995c22fa-71a4-43ca-a4c1-a2de13f2f935" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_995c22fa-71a4-43ca-a4c1-a2de13f2f935_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_995c22fa-71a4-43ca-a4c1-a2de13f2f935" xlink:to="loc_srt_ProductsAndServicesDomain_995c22fa-71a4-43ca-a4c1-a2de13f2f935_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_07c6948a-627d-4dca-bc13-60d6b72fc4ae" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_995c22fa-71a4-43ca-a4c1-a2de13f2f935" xlink:to="loc_srt_ProductsAndServicesDomain_07c6948a-627d-4dca-bc13-60d6b72fc4ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_f686b0c4-8007-4d41-a2ab-40230b17c51d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_07c6948a-627d-4dca-bc13-60d6b72fc4ae" xlink:to="loc_us-gaap_RoyaltyMember_f686b0c4-8007-4d41-a2ab-40230b17c51d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_56e49311-ce8b-45e4-ae71-428a6c268751" xlink:href="lgnd-20221231.xsd#lgnd_ContractRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_07c6948a-627d-4dca-bc13-60d6b72fc4ae" xlink:to="loc_lgnd_ContractRevenueMember_56e49311-ce8b-45e4-ae71-428a6c268751" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails" xlink:type="extended" id="ibca144f3601f4a5d844bb5c5c9ba5a55_SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_64c71ad2-4054-4b55-b65f-4e79ecc7eaf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract_5ee067a5-f372-4f20-96cb-b1e6fd14879e" xlink:href="lgnd-20221231.xsd#lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_64c71ad2-4054-4b55-b65f-4e79ecc7eaf9" xlink:to="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract_5ee067a5-f372-4f20-96cb-b1e6fd14879e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration_30604fd0-c5c9-49f3-8673-1076baae1347" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract_5ee067a5-f372-4f20-96cb-b1e6fd14879e" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration_30604fd0-c5c9-49f3-8673-1076baae1347" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortizationDiscontinuedOperations_3a9bcd2a-d5ae-45bc-a3ff-999785779a06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortizationDiscontinuedOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract_5ee067a5-f372-4f20-96cb-b1e6fd14879e" xlink:to="loc_us-gaap_DepreciationAndAmortizationDiscontinuedOperations_3a9bcd2a-d5ae-45bc-a3ff-999785779a06" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense_659e5c5c-fabd-458b-9fde-06a44733c94b" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract_5ee067a5-f372-4f20-96cb-b1e6fd14879e" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense_659e5c5c-fabd-458b-9fde-06a44733c94b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivesAbstract_89d31410-ea4c-4e46-a659-27081e4a2352" xlink:href="lgnd-20221231.xsd#lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_64c71ad2-4054-4b55-b65f-4e79ecc7eaf9" xlink:to="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivesAbstract_89d31410-ea4c-4e46-a659-27081e4a2352" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireBusinessesNetOfCashAcquired_a8beb5db-cbf3-441a-92bf-dbc90feb0908" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivesAbstract_89d31410-ea4c-4e46-a659-27081e4a2352" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireBusinessesNetOfCashAcquired_a8beb5db-cbf3-441a-92bf-dbc90feb0908" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpenditureDiscontinuedOperations_eaea74ad-4dd7-498c-ba93-3a52fea15dea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpenditureDiscontinuedOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivesAbstract_89d31410-ea4c-4e46-a659-27081e4a2352" xlink:to="loc_us-gaap_CapitalExpenditureDiscontinuedOperations_eaea74ad-4dd7-498c-ba93-3a52fea15dea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersInvestingActivity_32a12e1d-bd36-43d2-838f-e8b06d0bd364" xlink:href="lgnd-20221231.xsd#lgnd_PaymentsToContingentValueRightHoldersInvestingActivity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivesAbstract_89d31410-ea4c-4e46-a659-27081e4a2352" xlink:to="loc_lgnd_PaymentsToContingentValueRightHoldersInvestingActivity_32a12e1d-bd36-43d2-838f-e8b06d0bd364" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract_65676d03-db0f-4888-9fce-9884055d6e6e" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_64c71ad2-4054-4b55-b65f-4e79ecc7eaf9" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract_65676d03-db0f-4888-9fce-9884055d6e6e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_9ea63c6d-52fd-42ac-9dcd-3992c91b25fe" xlink:href="lgnd-20221231.xsd#lgnd_PaymentsToContingentValueRightHoldersFinancingActivity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract_65676d03-db0f-4888-9fce-9884055d6e6e" xlink:to="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_9ea63c6d-52fd-42ac-9dcd-3992c91b25fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_0ecb4af8-77fe-4a1c-9b3a-eadcdfbd1f07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_64c71ad2-4054-4b55-b65f-4e79ecc7eaf9" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_0ecb4af8-77fe-4a1c-9b3a-eadcdfbd1f07" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid_f2cde32e-d033-43bb-b5dd-ebcb73d135a1" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_0ecb4af8-77fe-4a1c-9b3a-eadcdfbd1f07" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid_f2cde32e-d033-43bb-b5dd-ebcb73d135a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_293f0b2d-b5d6-4546-ba5b-723805c53858" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_64c71ad2-4054-4b55-b65f-4e79ecc7eaf9" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_293f0b2d-b5d6-4546-ba5b-723805c53858" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_45715310-550f-4a15-976f-a91c9173bb9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_293f0b2d-b5d6-4546-ba5b-723805c53858" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_45715310-550f-4a15-976f-a91c9173bb9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_45715310-550f-4a15-976f-a91c9173bb9e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_45715310-550f-4a15-976f-a91c9173bb9e" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_45715310-550f-4a15-976f-a91c9173bb9e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_4208be3c-5ff8-455c-bf39-06d27e689ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_45715310-550f-4a15-976f-a91c9173bb9e" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_4208be3c-5ff8-455c-bf39-06d27e689ac5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_6e0c4589-2579-4410-84ff-6a69d9cc2761" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_4208be3c-5ff8-455c-bf39-06d27e689ac5" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_6e0c4589-2579-4410-84ff-6a69d9cc2761" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ShorttermInvestmentsInvestmentinVikingNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#ShorttermInvestmentsInvestmentinVikingNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/ShorttermInvestmentsInvestmentinVikingNarrativeDetails" xlink:type="extended" id="i41392f188537413ea8ae966fae8fc373_ShorttermInvestmentsInvestmentinVikingNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_bc836bd3-f6e6-404c-b52d-2b45590cc0fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest_f67da8d7-d9d2-46e7-8916-69cbad8609e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_bc836bd3-f6e6-404c-b52d-2b45590cc0fb" xlink:to="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest_f67da8d7-d9d2-46e7-8916-69cbad8609e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_5a01924f-31fc-45fb-9df5-ac5b39ee7bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_bc836bd3-f6e6-404c-b52d-2b45590cc0fb" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_5a01924f-31fc-45fb-9df5-ac5b39ee7bc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_b27e608c-898a-49a1-8c2c-9f4fcb78749c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_bc836bd3-f6e6-404c-b52d-2b45590cc0fb" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_b27e608c-898a-49a1-8c2c-9f4fcb78749c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_6db6b48c-73b9-415b-a83d-113489275abd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_bc836bd3-f6e6-404c-b52d-2b45590cc0fb" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_6db6b48c-73b9-415b-a83d-113489275abd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfSharesSoldOfEquityMethodInvestee_2177fee4-4a55-483e-b408-3fb95ab6b2f3" xlink:href="lgnd-20221231.xsd#lgnd_NumberOfSharesSoldOfEquityMethodInvestee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_bc836bd3-f6e6-404c-b52d-2b45590cc0fb" xlink:to="loc_lgnd_NumberOfSharesSoldOfEquityMethodInvestee_2177fee4-4a55-483e-b408-3fb95ab6b2f3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_0e1df388-b8fa-43d9-aabf-d38651d76d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_bc836bd3-f6e6-404c-b52d-2b45590cc0fb" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_0e1df388-b8fa-43d9-aabf-d38651d76d3b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_92aa1bf2-7974-422f-9064-9a61ee5ab44f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_0e1df388-b8fa-43d9-aabf-d38651d76d3b" xlink:to="loc_srt_OwnershipAxis_92aa1bf2-7974-422f-9064-9a61ee5ab44f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_92aa1bf2-7974-422f-9064-9a61ee5ab44f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_92aa1bf2-7974-422f-9064-9a61ee5ab44f" xlink:to="loc_srt_OwnershipDomain_92aa1bf2-7974-422f-9064-9a61ee5ab44f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_89bd73c3-ad1f-426e-b5bc-8ed5ca02585d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_92aa1bf2-7974-422f-9064-9a61ee5ab44f" xlink:to="loc_srt_OwnershipDomain_89bd73c3-ad1f-426e-b5bc-8ed5ca02585d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_VikingTherapeuticsInc.Member_be3e3bdc-7e47-44d4-a338-18fff42f285a" xlink:href="lgnd-20221231.xsd#lgnd_VikingTherapeuticsInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_89bd73c3-ad1f-426e-b5bc-8ed5ca02585d" xlink:to="loc_lgnd_VikingTherapeuticsInc.Member_be3e3bdc-7e47-44d4-a338-18fff42f285a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#AcquisitionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/AcquisitionsNarrativeDetails" xlink:type="extended" id="ica1098e6f4d94459ac8f4e03ccb6a132_AcquisitionsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfAcquisitions_eaa87609-42aa-4749-b95c-572b98da4653" xlink:href="lgnd-20221231.xsd#lgnd_NumberOfAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:to="loc_lgnd_NumberOfAcquisitions_eaa87609-42aa-4749-b95c-572b98da4653" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_b7c25091-7a4b-45b0-b950-d6a6faf272cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_b7c25091-7a4b-45b0-b950-d6a6faf272cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_78ac6190-0920-4784-a893-d0a69ff3af4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_78ac6190-0920-4784-a893-d0a69ff3af4d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_58ab1f09-1805-4677-9cb2-f2b597ed7af0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_58ab1f09-1805-4677-9cb2-f2b597ed7af0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_9884124b-72e9-47f5-9395-b4b586085e7f" xlink:href="lgnd-20221231.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_9884124b-72e9-47f5-9395-b4b586085e7f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_ec70f951-de26-49d0-b959-2f9abd86ca55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_ec70f951-de26-49d0-b959-2f9abd86ca55" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_87aa3df5-c100-4da9-be0b-577c98109344" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_87aa3df5-c100-4da9-be0b-577c98109344" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_05ddec26-e430-4db2-91cc-b7b70697fa65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_05ddec26-e430-4db2-91cc-b7b70697fa65" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_cc8f53ed-b162-435b-b6b8-7b82c4dfb476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:to="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_cc8f53ed-b162-435b-b6b8-7b82c4dfb476" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions_ccd08933-7cde-43ff-9e38-5327fe281e66" xlink:href="lgnd-20221231.xsd#lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:to="loc_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions_ccd08933-7cde-43ff-9e38-5327fe281e66" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_2d802439-b883-44e1-bd0a-2b188489112f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_2d802439-b883-44e1-bd0a-2b188489112f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_78530266-7f16-4c59-bdf5-fa4e220cf706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_78530266-7f16-4c59-bdf5-fa4e220cf706" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_933913e8-6ca9-4b81-9829-e80a59a3a798" xlink:href="lgnd-20221231.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_933913e8-6ca9-4b81-9829-e80a59a3a798" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_4a875d0b-3286-4193-95f3-d2b729b1e8b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_4a875d0b-3286-4193-95f3-d2b729b1e8b8" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_5a6f6c0a-348c-4c77-93c1-b399256496ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_5a6f6c0a-348c-4c77-93c1-b399256496ee" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_eea60cf1-928b-4d09-a295-422fee35b4b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_eea60cf1-928b-4d09-a295-422fee35b4b3" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_85b16c48-2591-4148-be0a-a680c1c3dc72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_85b16c48-2591-4148-be0a-a680c1c3dc72" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_503754c2-4594-49dc-bddd-a260d4d32a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_85b16c48-2591-4148-be0a-a680c1c3dc72" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_503754c2-4594-49dc-bddd-a260d4d32a0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_503754c2-4594-49dc-bddd-a260d4d32a0c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_503754c2-4594-49dc-bddd-a260d4d32a0c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_503754c2-4594-49dc-bddd-a260d4d32a0c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bf636bf7-6b70-4f81-bd09-fd41c80fd69b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_503754c2-4594-49dc-bddd-a260d4d32a0c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bf636bf7-6b70-4f81-bd09-fd41c80fd69b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_dcfd2627-512a-445c-8ddb-df9bed80769e" xlink:href="lgnd-20221231.xsd#lgnd_PfenexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bf636bf7-6b70-4f81-bd09-fd41c80fd69b" xlink:to="loc_lgnd_PfenexMember_dcfd2627-512a-445c-8ddb-df9bed80769e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ef99d9cb-4d27-4873-b89f-9b4fdafbd522" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_85b16c48-2591-4148-be0a-a680c1c3dc72" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ef99d9cb-4d27-4873-b89f-9b4fdafbd522" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ef99d9cb-4d27-4873-b89f-9b4fdafbd522_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ef99d9cb-4d27-4873-b89f-9b4fdafbd522" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ef99d9cb-4d27-4873-b89f-9b4fdafbd522_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_43f5f831-1ecd-464a-82e9-a53f2d707a9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ef99d9cb-4d27-4873-b89f-9b4fdafbd522" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_43f5f831-1ecd-464a-82e9-a53f2d707a9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_2fe153e7-240b-4a3d-85d4-a0c3b925cc6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_43f5f831-1ecd-464a-82e9-a53f2d707a9e" xlink:to="loc_us-gaap_CustomerRelationshipsMember_2fe153e7-240b-4a3d-85d4-a0c3b925cc6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_53ae2b8d-158a-44c0-8cf7-a127021d8664" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_85b16c48-2591-4148-be0a-a680c1c3dc72" xlink:to="loc_srt_RangeAxis_53ae2b8d-158a-44c0-8cf7-a127021d8664" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_53ae2b8d-158a-44c0-8cf7-a127021d8664_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_53ae2b8d-158a-44c0-8cf7-a127021d8664" xlink:to="loc_srt_RangeMember_53ae2b8d-158a-44c0-8cf7-a127021d8664_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e8bece7a-fa0c-4e6a-9986-876000042621" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_53ae2b8d-158a-44c0-8cf7-a127021d8664" xlink:to="loc_srt_RangeMember_e8bece7a-fa0c-4e6a-9986-876000042621" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b15cac03-cbd0-4402-9342-427e045b4d31" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e8bece7a-fa0c-4e6a-9986-876000042621" xlink:to="loc_srt_MinimumMember_b15cac03-cbd0-4402-9342-427e045b4d31" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_26b13b91-50df-4f77-af96-97186388a61a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e8bece7a-fa0c-4e6a-9986-876000042621" xlink:to="loc_srt_MaximumMember_26b13b91-50df-4f77-af96-97186388a61a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_5d5aebf0-51cc-46c3-a672-2b16c8745fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_85b16c48-2591-4148-be0a-a680c1c3dc72" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_5d5aebf0-51cc-46c3-a672-2b16c8745fb7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_5d5aebf0-51cc-46c3-a672-2b16c8745fb7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_5d5aebf0-51cc-46c3-a672-2b16c8745fb7" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_5d5aebf0-51cc-46c3-a672-2b16c8745fb7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_7cd887cb-020e-4258-af21-607494c54740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_5d5aebf0-51cc-46c3-a672-2b16c8745fb7" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_7cd887cb-020e-4258-af21-607494c54740" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_b708e261-0bbc-415f-b17f-bc67e6c42387" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_7cd887cb-020e-4258-af21-607494c54740" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_b708e261-0bbc-415f-b17f-bc67e6c42387" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended" id="i6a147a9aff884ec69070e9a2ab943baa_AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_01ee6341-7209-452b-bb0e-d6a78beeeb7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_45d097fe-d345-4426-a096-a390e2584e88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01ee6341-7209-452b-bb0e-d6a78beeeb7a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_45d097fe-d345-4426-a096-a390e2584e88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_c1d9ee88-6138-4217-ba5c-066930616e47" xlink:href="lgnd-20221231.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01ee6341-7209-452b-bb0e-d6a78beeeb7a" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_c1d9ee88-6138-4217-ba5c-066930616e47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_cbec8e3b-1b2e-4a9b-8668-c3f837f740bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01ee6341-7209-452b-bb0e-d6a78beeeb7a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_cbec8e3b-1b2e-4a9b-8668-c3f837f740bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_8f7630c4-4e5c-4a93-9611-d97f1d3e2058" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01ee6341-7209-452b-bb0e-d6a78beeeb7a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_8f7630c4-4e5c-4a93-9611-d97f1d3e2058" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_533205a0-1517-42de-bfed-3f38a99c25ef" xlink:href="lgnd-20221231.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01ee6341-7209-452b-bb0e-d6a78beeeb7a" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_533205a0-1517-42de-bfed-3f38a99c25ef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_1c57c6f3-1c7d-4b63-b63a-3be6e9126259" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01ee6341-7209-452b-bb0e-d6a78beeeb7a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_1c57c6f3-1c7d-4b63-b63a-3be6e9126259" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_95c4f55b-c73d-4d79-b1fa-446ce4134edd" xlink:href="lgnd-20221231.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01ee6341-7209-452b-bb0e-d6a78beeeb7a" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_95c4f55b-c73d-4d79-b1fa-446ce4134edd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6476fc8e-95d7-441d-bea1-b96cb2f6e2df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01ee6341-7209-452b-bb0e-d6a78beeeb7a" xlink:to="loc_us-gaap_Goodwill_6476fc8e-95d7-441d-bea1-b96cb2f6e2df" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_0bc73f55-475d-4712-9bb1-011078dd8f38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01ee6341-7209-452b-bb0e-d6a78beeeb7a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_0bc73f55-475d-4712-9bb1-011078dd8f38" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_27c36011-1f71-4c04-8276-b2be17548a61" xlink:href="lgnd-20221231.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01ee6341-7209-452b-bb0e-d6a78beeeb7a" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_27c36011-1f71-4c04-8276-b2be17548a61" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_115de1b8-5ca6-4f50-ba26-a87cc8d383fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01ee6341-7209-452b-bb0e-d6a78beeeb7a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_115de1b8-5ca6-4f50-ba26-a87cc8d383fd" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_79764742-7fc9-456a-bd0f-30be80dd61c9" xlink:href="lgnd-20221231.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01ee6341-7209-452b-bb0e-d6a78beeeb7a" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_79764742-7fc9-456a-bd0f-30be80dd61c9" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_dada0c8f-7a85-4ff4-9723-fa88c251868f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01ee6341-7209-452b-bb0e-d6a78beeeb7a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_dada0c8f-7a85-4ff4-9723-fa88c251868f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_66369e0e-3502-4503-bafa-ab5d771bdec9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01ee6341-7209-452b-bb0e-d6a78beeeb7a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_66369e0e-3502-4503-bafa-ab5d771bdec9" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_08a23fb7-d535-4e5a-82c4-e3890467ec3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01ee6341-7209-452b-bb0e-d6a78beeeb7a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_08a23fb7-d535-4e5a-82c4-e3890467ec3b" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5a3830ff-a4eb-4f64-9a5a-33e053f56b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01ee6341-7209-452b-bb0e-d6a78beeeb7a" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5a3830ff-a4eb-4f64-9a5a-33e053f56b5f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_52551e59-50fe-4b84-841a-e61f8398d5bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5a3830ff-a4eb-4f64-9a5a-33e053f56b5f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_52551e59-50fe-4b84-841a-e61f8398d5bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_52551e59-50fe-4b84-841a-e61f8398d5bd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_52551e59-50fe-4b84-841a-e61f8398d5bd" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_52551e59-50fe-4b84-841a-e61f8398d5bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7320ba86-d666-4ef3-b59a-0eb310b0bfda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_52551e59-50fe-4b84-841a-e61f8398d5bd" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7320ba86-d666-4ef3-b59a-0eb310b0bfda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_d4cea8f7-599f-4957-b942-99b71184263a" xlink:href="lgnd-20221231.xsd#lgnd_PfenexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7320ba86-d666-4ef3-b59a-0eb310b0bfda" xlink:to="loc_lgnd_PfenexMember_d4cea8f7-599f-4957-b942-99b71184263a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsIntangiblesAcquiredandWeightedAverageUsefulLifeDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#AcquisitionsIntangiblesAcquiredandWeightedAverageUsefulLifeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/AcquisitionsIntangiblesAcquiredandWeightedAverageUsefulLifeDetails" xlink:type="extended" id="i682af7ec734f43a5b70bcd9d31907d2c_AcquisitionsIntangiblesAcquiredandWeightedAverageUsefulLifeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_52af3684-19e2-4265-9047-6c1249e93f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_5b31d46b-f841-41b4-b3db-768f6b152a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_52af3684-19e2-4265-9047-6c1249e93f9a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_5b31d46b-f841-41b4-b3db-768f6b152a7c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_85bd3ee7-0f76-4632-8635-617ff5335eac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_52af3684-19e2-4265-9047-6c1249e93f9a" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_85bd3ee7-0f76-4632-8635-617ff5335eac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4e39b724-224f-4e4e-b9c3-46c0116f0e03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_52af3684-19e2-4265-9047-6c1249e93f9a" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4e39b724-224f-4e4e-b9c3-46c0116f0e03" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ef1bbb13-da6e-4b82-936e-7b5e4ecb00c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4e39b724-224f-4e4e-b9c3-46c0116f0e03" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ef1bbb13-da6e-4b82-936e-7b5e4ecb00c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ef1bbb13-da6e-4b82-936e-7b5e4ecb00c5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ef1bbb13-da6e-4b82-936e-7b5e4ecb00c5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ef1bbb13-da6e-4b82-936e-7b5e4ecb00c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_838ad7a3-bdf7-41c8-8889-5f43dc4ae452" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ef1bbb13-da6e-4b82-936e-7b5e4ecb00c5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_838ad7a3-bdf7-41c8-8889-5f43dc4ae452" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_b9097038-1309-4393-93ed-1c1468ad9af4" xlink:href="lgnd-20221231.xsd#lgnd_PfenexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_838ad7a3-bdf7-41c8-8889-5f43dc4ae452" xlink:to="loc_lgnd_PfenexMember_b9097038-1309-4393-93ed-1c1468ad9af4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_986e25ca-7ad9-4bf4-b98b-8c01eb5a5bcc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4e39b724-224f-4e4e-b9c3-46c0116f0e03" xlink:to="loc_srt_RangeAxis_986e25ca-7ad9-4bf4-b98b-8c01eb5a5bcc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_986e25ca-7ad9-4bf4-b98b-8c01eb5a5bcc_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_986e25ca-7ad9-4bf4-b98b-8c01eb5a5bcc" xlink:to="loc_srt_RangeMember_986e25ca-7ad9-4bf4-b98b-8c01eb5a5bcc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b55d0bd2-203b-497b-a889-b3b061e2bac8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_986e25ca-7ad9-4bf4-b98b-8c01eb5a5bcc" xlink:to="loc_srt_RangeMember_b55d0bd2-203b-497b-a889-b3b061e2bac8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ff9bbc85-2898-4654-8c63-265e20142d8f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b55d0bd2-203b-497b-a889-b3b061e2bac8" xlink:to="loc_srt_MinimumMember_ff9bbc85-2898-4654-8c63-265e20142d8f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5932aba8-512e-4f2f-a7d1-f05a801651db" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b55d0bd2-203b-497b-a889-b3b061e2bac8" xlink:to="loc_srt_MaximumMember_5932aba8-512e-4f2f-a7d1-f05a801651db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_29412078-7aa8-4d50-b5ed-3505cc17b122" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4e39b724-224f-4e4e-b9c3-46c0116f0e03" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_29412078-7aa8-4d50-b5ed-3505cc17b122" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_29412078-7aa8-4d50-b5ed-3505cc17b122_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_29412078-7aa8-4d50-b5ed-3505cc17b122" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_29412078-7aa8-4d50-b5ed-3505cc17b122_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1e86cdb-2474-423a-b020-aad9ca1903cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_29412078-7aa8-4d50-b5ed-3505cc17b122" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1e86cdb-2474-423a-b020-aad9ca1903cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractualRelationshipsAlvogenMember_a9546e7c-a7e1-4b51-a808-980904747a5e" xlink:href="lgnd-20221231.xsd#lgnd_ContractualRelationshipsAlvogenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1e86cdb-2474-423a-b020-aad9ca1903cc" xlink:to="loc_lgnd_ContractualRelationshipsAlvogenMember_a9546e7c-a7e1-4b51-a808-980904747a5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractualRelationshipsMerckMember_99783993-cf7c-4972-b6f0-c01881d76595" xlink:href="lgnd-20221231.xsd#lgnd_ContractualRelationshipsMerckMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1e86cdb-2474-423a-b020-aad9ca1903cc" xlink:to="loc_lgnd_ContractualRelationshipsMerckMember_99783993-cf7c-4972-b6f0-c01881d76595" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractualRelationshipsJazzMember_34b48dce-e054-4ca2-af33-0b6080f112c6" xlink:href="lgnd-20221231.xsd#lgnd_ContractualRelationshipsJazzMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1e86cdb-2474-423a-b020-aad9ca1903cc" xlink:to="loc_lgnd_ContractualRelationshipsJazzMember_34b48dce-e054-4ca2-af33-0b6080f112c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractualRelationshipsSIIMember_209da249-9257-40e2-9090-dca7c3c0c1ec" xlink:href="lgnd-20221231.xsd#lgnd_ContractualRelationshipsSIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1e86cdb-2474-423a-b020-aad9ca1903cc" xlink:to="loc_lgnd_ContractualRelationshipsSIIMember_209da249-9257-40e2-9090-dca7c3c0c1ec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractualRelationshipsArcellxMember_c3537299-11e9-45d4-be91-4d8f4114ed85" xlink:href="lgnd-20221231.xsd#lgnd_ContractualRelationshipsArcellxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1e86cdb-2474-423a-b020-aad9ca1903cc" xlink:to="loc_lgnd_ContractualRelationshipsArcellxMember_c3537299-11e9-45d4-be91-4d8f4114ed85" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_97b7afce-d791-447c-8bff-330f46ed3842" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1e86cdb-2474-423a-b020-aad9ca1903cc" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_97b7afce-d791-447c-8bff-330f46ed3842" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#AcquisitionsProFormaFinancialInformationDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails" xlink:type="extended" id="iee17b69dce6747da8da00f68ee0a3e45_AcquisitionsProFormaFinancialInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_6776f679-e7f9-4864-bf00-e9252bed767d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_d26a454a-52c9-46e4-878f-ac4e3b11f896" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6776f679-e7f9-4864-bf00-e9252bed767d" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_d26a454a-52c9-46e4-878f-ac4e3b11f896" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_85c149d8-f735-43c2-b3c4-832dea91bc8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6776f679-e7f9-4864-bf00-e9252bed767d" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_85c149d8-f735-43c2-b3c4-832dea91bc8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareProFormaAbstract_0e310caf-347b-4366-9b77-0a7e529287b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareProFormaAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6776f679-e7f9-4864-bf00-e9252bed767d" xlink:to="loc_us-gaap_EarningsPerShareProFormaAbstract_0e310caf-347b-4366-9b77-0a7e529287b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_0a86431f-2505-4a7c-9a84-895658dbe6ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareProFormaAbstract_0e310caf-347b-4366-9b77-0a7e529287b3" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_0a86431f-2505-4a7c-9a84-895658dbe6ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_196266e0-ad39-44f3-bb76-0e2e9aa0b271" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareProFormaAbstract_0e310caf-347b-4366-9b77-0a7e529287b3" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_196266e0-ad39-44f3-bb76-0e2e9aa0b271" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_663a372e-9f92-4ae2-94c9-c5e80440ee77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6776f679-e7f9-4864-bf00-e9252bed767d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_663a372e-9f92-4ae2-94c9-c5e80440ee77" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_717451d3-5acd-47a8-92e6-6da05fe1f322" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_663a372e-9f92-4ae2-94c9-c5e80440ee77" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_717451d3-5acd-47a8-92e6-6da05fe1f322" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_717451d3-5acd-47a8-92e6-6da05fe1f322_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_717451d3-5acd-47a8-92e6-6da05fe1f322" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_717451d3-5acd-47a8-92e6-6da05fe1f322_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7c7a8b39-5e1d-4d13-8836-dcb554f9742a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_717451d3-5acd-47a8-92e6-6da05fe1f322" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7c7a8b39-5e1d-4d13-8836-dcb554f9742a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_6d962612-3bf9-473d-8b59-f0e341d5ddce" xlink:href="lgnd-20221231.xsd#lgnd_PfenexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7c7a8b39-5e1d-4d13-8836-dcb554f9742a" xlink:to="loc_lgnd_PfenexMember_6d962612-3bf9-473d-8b59-f0e341d5ddce" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended" id="i2921710385f24c2c8a885b10a7facf77_FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d382841f-dd1b-4de9-8caf-3b3b7b969568" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_f4d4ff35-0b7d-4ea7-b395-d690ab991121" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d382841f-dd1b-4de9-8caf-3b3b7b969568" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_f4d4ff35-0b7d-4ea7-b395-d690ab991121" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_233ca7f8-652b-4585-abc8-5262f73bddd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d382841f-dd1b-4de9-8caf-3b3b7b969568" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_233ca7f8-652b-4585-abc8-5262f73bddd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfContingentValueRightAgreements_f62fad0d-1a7f-48d8-8737-352299a6711c" xlink:href="lgnd-20221231.xsd#lgnd_NumberOfContingentValueRightAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d382841f-dd1b-4de9-8caf-3b3b7b969568" xlink:to="loc_lgnd_NumberOfContingentValueRightAgreements_f62fad0d-1a7f-48d8-8737-352299a6711c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_0242cf57-6db3-4db6-aca0-e3b636ddc7d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d382841f-dd1b-4de9-8caf-3b3b7b969568" xlink:to="loc_us-gaap_Investments_0242cf57-6db3-4db6-aca0-e3b636ddc7d0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross_be09bb0f-e7ca-442d-877f-0ebfd9500064" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d382841f-dd1b-4de9-8caf-3b3b7b969568" xlink:to="loc_us-gaap_ContractWithCustomerAssetGross_be09bb0f-e7ca-442d-877f-0ebfd9500064" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_05b3670d-e910-4557-bc82-1ed686d159cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d382841f-dd1b-4de9-8caf-3b3b7b969568" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_05b3670d-e910-4557-bc82-1ed686d159cd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f8ac6e1f-bb80-452b-ae10-872226de4877" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_05b3670d-e910-4557-bc82-1ed686d159cd" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f8ac6e1f-bb80-452b-ae10-872226de4877" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f8ac6e1f-bb80-452b-ae10-872226de4877_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f8ac6e1f-bb80-452b-ae10-872226de4877" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f8ac6e1f-bb80-452b-ae10-872226de4877_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_b4361f4c-81e2-47fc-819c-ae7179b066a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f8ac6e1f-bb80-452b-ae10-872226de4877" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_b4361f4c-81e2-47fc-819c-ae7179b066a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_a27b5cf9-b0a5-463f-8aea-ad3d3372d9f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_b4361f4c-81e2-47fc-819c-ae7179b066a6" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_a27b5cf9-b0a5-463f-8aea-ad3d3372d9f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4a97dbc2-2db3-4d8f-ab5a-f21cc835ece3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_05b3670d-e910-4557-bc82-1ed686d159cd" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4a97dbc2-2db3-4d8f-ab5a-f21cc835ece3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4a97dbc2-2db3-4d8f-ab5a-f21cc835ece3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4a97dbc2-2db3-4d8f-ab5a-f21cc835ece3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4a97dbc2-2db3-4d8f-ab5a-f21cc835ece3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ff970ccd-44ee-4900-ac18-79ff2bbc4c6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4a97dbc2-2db3-4d8f-ab5a-f21cc835ece3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ff970ccd-44ee-4900-ac18-79ff2bbc4c6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_e9118a9a-4d1a-47f7-a2b5-641e0f637fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ff970ccd-44ee-4900-ac18-79ff2bbc4c6f" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_e9118a9a-4d1a-47f7-a2b5-641e0f637fb5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_84631c73-58e1-46c5-a107-b714583e7b82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ff970ccd-44ee-4900-ac18-79ff2bbc4c6f" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_84631c73-58e1-46c5-a107-b714583e7b82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_e5efe54c-d66f-44c8-908e-f87f99f23b09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ff970ccd-44ee-4900-ac18-79ff2bbc4c6f" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_e5efe54c-d66f-44c8-908e-f87f99f23b09" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_19a4405b-9619-440b-ab6b-7646e0a0233c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_05b3670d-e910-4557-bc82-1ed686d159cd" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_19a4405b-9619-440b-ab6b-7646e0a0233c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_19a4405b-9619-440b-ab6b-7646e0a0233c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_19a4405b-9619-440b-ab6b-7646e0a0233c" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_19a4405b-9619-440b-ab6b-7646e0a0233c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e736a738-8d30-487b-b41c-847fab3cea21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_19a4405b-9619-440b-ab6b-7646e0a0233c" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e736a738-8d30-487b-b41c-847fab3cea21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_b3a282b0-0cf3-41c3-bbe4-90239bf5fa45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e736a738-8d30-487b-b41c-847fab3cea21" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_b3a282b0-0cf3-41c3-bbe4-90239bf5fa45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_a3b2996f-fe7b-4556-a37b-5d90465f4d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e736a738-8d30-487b-b41c-847fab3cea21" xlink:to="loc_us-gaap_EquitySecuritiesMember_a3b2996f-fe7b-4556-a37b-5d90465f4d6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_4317090d-a3cc-4a0c-9f56-cd9839558d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_05b3670d-e910-4557-bc82-1ed686d159cd" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_4317090d-a3cc-4a0c-9f56-cd9839558d4a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_4317090d-a3cc-4a0c-9f56-cd9839558d4a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_4317090d-a3cc-4a0c-9f56-cd9839558d4a" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_4317090d-a3cc-4a0c-9f56-cd9839558d4a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_844447b7-439e-4920-ba13-86e26b7cef86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_4317090d-a3cc-4a0c-9f56-cd9839558d4a" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_844447b7-439e-4920-ba13-86e26b7cef86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_7e2fb78e-b9ef-4a86-aea3-b6595fda0f92" xlink:href="lgnd-20221231.xsd#lgnd_LiabilityForContingentValueRightsCompanyCydexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_844447b7-439e-4920-ba13-86e26b7cef86" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_7e2fb78e-b9ef-4a86-aea3-b6595fda0f92" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_a4831363-b998-4c2b-ac0e-000a78125d2f" xlink:href="lgnd-20221231.xsd#lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_844447b7-439e-4920-ba13-86e26b7cef86" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_a4831363-b998-4c2b-ac0e-000a78125d2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_c38901cf-9a35-464a-b708-4d0cd1ef7699" xlink:href="lgnd-20221231.xsd#lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_844447b7-439e-4920-ba13-86e26b7cef86" xlink:to="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_c38901cf-9a35-464a-b708-4d0cd1ef7699" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_04b5ac43-d273-49a2-9805-586ff3d93dce" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_05b3670d-e910-4557-bc82-1ed686d159cd" xlink:to="loc_srt_RangeAxis_04b5ac43-d273-49a2-9805-586ff3d93dce" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_04b5ac43-d273-49a2-9805-586ff3d93dce_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_04b5ac43-d273-49a2-9805-586ff3d93dce" xlink:to="loc_srt_RangeMember_04b5ac43-d273-49a2-9805-586ff3d93dce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2c25aa0b-4c8e-4f57-b548-8f7f375e4d64" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_04b5ac43-d273-49a2-9805-586ff3d93dce" xlink:to="loc_srt_RangeMember_2c25aa0b-4c8e-4f57-b548-8f7f375e4d64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ed3d0097-6241-4e9f-be9c-39f22c434416" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2c25aa0b-4c8e-4f57-b548-8f7f375e4d64" xlink:to="loc_srt_MaximumMember_ed3d0097-6241-4e9f-be9c-39f22c434416" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_eba67d87-3758-4b01-8cb1-65d080eab78a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_05b3670d-e910-4557-bc82-1ed686d159cd" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_eba67d87-3758-4b01-8cb1-65d080eab78a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_eba67d87-3758-4b01-8cb1-65d080eab78a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_eba67d87-3758-4b01-8cb1-65d080eab78a" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_eba67d87-3758-4b01-8cb1-65d080eab78a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_b291ca7c-24be-463e-9a69-e117bece0c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_eba67d87-3758-4b01-8cb1-65d080eab78a" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_b291ca7c-24be-463e-9a69-e117bece0c0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_3e38e1ab-d0ce-44ef-b100-0c71095676c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_b291ca7c-24be-463e-9a69-e117bece0c0e" xlink:to="loc_us-gaap_TransferredOverTimeMember_3e38e1ab-d0ce-44ef-b100-0c71095676c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b3ab73f1-16f6-4e20-8ec4-c407bcc47d57" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_05b3670d-e910-4557-bc82-1ed686d159cd" xlink:to="loc_srt_ProductOrServiceAxis_b3ab73f1-16f6-4e20-8ec4-c407bcc47d57" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b3ab73f1-16f6-4e20-8ec4-c407bcc47d57_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_b3ab73f1-16f6-4e20-8ec4-c407bcc47d57" xlink:to="loc_srt_ProductsAndServicesDomain_b3ab73f1-16f6-4e20-8ec4-c407bcc47d57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b11a03a0-2bcd-4dcc-b1dc-5edc50172466" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_b3ab73f1-16f6-4e20-8ec4-c407bcc47d57" xlink:to="loc_srt_ProductsAndServicesDomain_b11a03a0-2bcd-4dcc-b1dc-5edc50172466" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_6cdf7ea7-b3f7-4c40-905d-868960b9a013" xlink:href="lgnd-20221231.xsd#lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b11a03a0-2bcd-4dcc-b1dc-5edc50172466" xlink:to="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_6cdf7ea7-b3f7-4c40-905d-868960b9a013" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_Phase3ClinicalTrialMember_f49af4c8-72fc-4400-b520-a294becb3f9b" xlink:href="lgnd-20221231.xsd#lgnd_Phase3ClinicalTrialMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b11a03a0-2bcd-4dcc-b1dc-5edc50172466" xlink:to="loc_lgnd_Phase3ClinicalTrialMember_f49af4c8-72fc-4400-b520-a294becb3f9b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementReconciliationofLevel3FinancialInstrumentsDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#FairValueMeasurementReconciliationofLevel3FinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/FairValueMeasurementReconciliationofLevel3FinancialInstrumentsDetails" xlink:type="extended" id="i65f009ba44ad4738818b94ab5b160a93_FairValueMeasurementReconciliationofLevel3FinancialInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8d48234e-32e3-44d5-96c2-b742ca4e89f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_37245fde-e426-4f3d-9df3-e5ef84d25eab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8d48234e-32e3-44d5-96c2-b742ca4e89f5" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_37245fde-e426-4f3d-9df3-e5ef84d25eab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3b03ef5a-05ce-45e0-9e8b-467ad59d33eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_37245fde-e426-4f3d-9df3-e5ef84d25eab" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3b03ef5a-05ce-45e0-9e8b-467ad59d33eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_6e7bac87-4b9f-430d-9a8d-828a672c3bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_37245fde-e426-4f3d-9df3-e5ef84d25eab" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_6e7bac87-4b9f-430d-9a8d-828a672c3bf0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHolders_810d3be4-c81c-4442-a6e9-c5de6bc34497" xlink:href="lgnd-20221231.xsd#lgnd_PaymentsToContingentValueRightHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_37245fde-e426-4f3d-9df3-e5ef84d25eab" xlink:to="loc_lgnd_PaymentsToContingentValueRightHolders_810d3be4-c81c-4442-a6e9-c5de6bc34497" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_065d0251-e571-4ce5-9bb0-6f06692bf670" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_453c2da0-f9e3-4c91-9b87-d2c318604fca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8d48234e-32e3-44d5-96c2-b742ca4e89f5" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_453c2da0-f9e3-4c91-9b87-d2c318604fca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0abbef77-00dd-490c-9b6d-4647dad42c96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_453c2da0-f9e3-4c91-9b87-d2c318604fca" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0abbef77-00dd-490c-9b6d-4647dad42c96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0abbef77-00dd-490c-9b6d-4647dad42c96_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0abbef77-00dd-490c-9b6d-4647dad42c96" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0abbef77-00dd-490c-9b6d-4647dad42c96_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b9d65b35-b951-42cc-9482-6934c99e8b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0abbef77-00dd-490c-9b6d-4647dad42c96" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b9d65b35-b951-42cc-9482-6934c99e8b9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a19439fc-7f05-44c5-9392-8eb7eb22b405" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b9d65b35-b951-42cc-9482-6934c99e8b9b" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a19439fc-7f05-44c5-9392-8eb7eb22b405" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/LeasesNarrativeDetails" xlink:type="extended" id="i6070f56ee93649699d609d5e4feebb86_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PurchaseCommitmentConsiderationPaidToDate_ba579f9d-9b22-4d83-b919-67f3eec2167f" xlink:href="lgnd-20221231.xsd#lgnd_PurchaseCommitmentConsiderationPaidToDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_lgnd_PurchaseCommitmentConsiderationPaidToDate_ba579f9d-9b22-4d83-b919-67f3eec2167f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PurchaseCommitmentConsiderationPaidAllocatedToInventory_c0519444-73d8-4d0b-8fb6-93d650d53b37" xlink:href="lgnd-20221231.xsd#lgnd_PurchaseCommitmentConsiderationPaidAllocatedToInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_lgnd_PurchaseCommitmentConsiderationPaidAllocatedToInventory_c0519444-73d8-4d0b-8fb6-93d650d53b37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_bce2647a-b7ed-4eb9-a7ed-1b4db6e7084a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_bce2647a-b7ed-4eb9-a7ed-1b4db6e7084a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseImpairmentLoss_461982c6-707e-4304-8ed7-011f5265f87f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_us-gaap_FinanceLeaseImpairmentLoss_461982c6-707e-4304-8ed7-011f5265f87f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_1dc0ed12-640e-411e-b232-62e7ffb93c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_1dc0ed12-640e-411e-b232-62e7ffb93c8e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm_480d0672-003e-4a73-b5cc-e4b79a6fc62f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm_480d0672-003e-4a73-b5cc-e4b79a6fc62f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_34f0cfc7-7c3b-41a3-8a9a-f7001693ec64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_34f0cfc7-7c3b-41a3-8a9a-f7001693ec64" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_37f0d5b3-6085-4c9a-aae9-ac46d9f2d232" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_37f0d5b3-6085-4c9a-aae9-ac46d9f2d232" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_c8e22fb7-cf69-4e39-8756-0ef7af04b513" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_c8e22fb7-cf69-4e39-8756-0ef7af04b513" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_aa4638d8-9a3e-4275-bfc6-c870524f317f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_aa4638d8-9a3e-4275-bfc6-c870524f317f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_0566960d-f185-47af-a6fc-d3e3d21e39a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_us-gaap_OperatingLeasePayments_0566960d-f185-47af-a6fc-d3e3d21e39a9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_8adb6f7d-3899-49ad-b7e6-8ed3a3e99cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_us-gaap_OperatingLeaseExpense_8adb6f7d-3899-49ad-b7e6-8ed3a3e99cf2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_ae20f31d-b036-41a8-ba7f-42b19ed46986" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_us-gaap_SubleaseIncome_ae20f31d-b036-41a8-ba7f-42b19ed46986" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_83db37fd-3303-42dc-94d6-c2d9acb91b42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_83db37fd-3303-42dc-94d6-c2d9acb91b42" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_ff9b3db0-d565-4b1a-84b7-f79f96e42c10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_ff9b3db0-d565-4b1a-84b7-f79f96e42c10" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_b382400f-f046-428d-bd80-4d3ec5bc9af0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_b382400f-f046-428d-bd80-4d3ec5bc9af0" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_c262ed11-ebdd-45da-88a8-87787067480f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_c262ed11-ebdd-45da-88a8-87787067480f" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_f1099bd2-7500-4333-9c81-2cc8de963614" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_f1099bd2-7500-4333-9c81-2cc8de963614" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_782d706f-c112-40ec-83f8-37482ed0b9d2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_f1099bd2-7500-4333-9c81-2cc8de963614" xlink:to="loc_srt_ProductOrServiceAxis_782d706f-c112-40ec-83f8-37482ed0b9d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_782d706f-c112-40ec-83f8-37482ed0b9d2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_782d706f-c112-40ec-83f8-37482ed0b9d2" xlink:to="loc_srt_ProductsAndServicesDomain_782d706f-c112-40ec-83f8-37482ed0b9d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8ca69da3-edf8-4804-a166-0628b1096543" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_782d706f-c112-40ec-83f8-37482ed0b9d2" xlink:to="loc_srt_ProductsAndServicesDomain_8ca69da3-edf8-4804-a166-0628b1096543" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_5bf7daeb-6318-4ae4-8da9-318c12cd9d22" xlink:href="lgnd-20221231.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8ca69da3-edf8-4804-a166-0628b1096543" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_5bf7daeb-6318-4ae4-8da9-318c12cd9d22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_87586390-21f5-416e-a81d-760ae942fe59" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_f1099bd2-7500-4333-9c81-2cc8de963614" xlink:to="loc_srt_RangeAxis_87586390-21f5-416e-a81d-760ae942fe59" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_87586390-21f5-416e-a81d-760ae942fe59_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_87586390-21f5-416e-a81d-760ae942fe59" xlink:to="loc_srt_RangeMember_87586390-21f5-416e-a81d-760ae942fe59_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ae549b31-fba6-4436-a592-06441db1abcd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_87586390-21f5-416e-a81d-760ae942fe59" xlink:to="loc_srt_RangeMember_ae549b31-fba6-4436-a592-06441db1abcd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_65159c6a-e660-4db2-8289-53faf3d14ca0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ae549b31-fba6-4436-a592-06441db1abcd" xlink:to="loc_srt_MaximumMember_65159c6a-e660-4db2-8289-53faf3d14ca0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#ConvertibleSeniorNotesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="extended" id="ia70afafc7697463b9b0775347499c533_ConvertibleSeniorNotesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_aa99765d-b9c1-42ec-aa2d-b08a8b4bc896" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_aa99765d-b9c1-42ec-aa2d-b08a8b4bc896" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c571e1c1-bfc9-46a7-8d79-c2d5434438d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c571e1c1-bfc9-46a7-8d79-c2d5434438d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_4f8a3598-4041-4f11-89a4-90f494e2063f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_4f8a3598-4041-4f11-89a4-90f494e2063f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_cd539a7e-0ae1-449e-9b04-c84dcf0f25dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_cd539a7e-0ae1-449e-9b04-c84dcf0f25dd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_93455951-dea3-418d-9879-43785a9e821c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_93455951-dea3-418d-9879-43785a9e821c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_aa60ec46-2dc7-4da4-88d8-048cd975ac1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_aa60ec46-2dc7-4da4-88d8-048cd975ac1f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_ed7b9886-ecd6-47bd-acfe-7649c808815f" xlink:href="lgnd-20221231.xsd#lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_ed7b9886-ecd6-47bd-acfe-7649c808815f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_1c423ddb-1949-4f58-a2f0-390422b868a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_1c423ddb-1949-4f58-a2f0-390422b868a7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_177f6838-4202-461b-825d-d19f4f7dff89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_177f6838-4202-461b-825d-d19f4f7dff89" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_199a6345-b14a-4ee7-9266-d7a3df44d125" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_199a6345-b14a-4ee7-9266-d7a3df44d125" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_06d3e893-e0ba-4695-8e09-5c1881ac7186" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_06d3e893-e0ba-4695-8e09-5c1881ac7186" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_5167a44e-496a-4ec4-8e36-96f93a2dbfc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_5167a44e-496a-4ec4-8e36-96f93a2dbfc8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_d4121478-bf53-4b0c-a3b5-57d5cd283a94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_d4121478-bf53-4b0c-a3b5-57d5cd283a94" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_7304ddb1-d599-4dbc-9cf8-f7e912894cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_InterestExpenseDebt_7304ddb1-d599-4dbc-9cf8-f7e912894cf4" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_3345b020-360c-4999-b7b9-aa53576f34f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_3345b020-360c-4999-b7b9-aa53576f34f7" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_974631f4-bbd5-4661-8124-b6a428ee7d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_974631f4-bbd5-4661-8124-b6a428ee7d7b" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_835249a5-ab89-4764-92bf-2a06fd2bc6d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_835249a5-ab89-4764-92bf-2a06fd2bc6d5" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_d881d10b-59e1-4cd5-9a1e-097ac983ac7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_d881d10b-59e1-4cd5-9a1e-097ac983ac7c" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RepaymentsOfNotesPayableInterestPortion_7066db25-1b01-423b-9db5-bbb4f757ca20" xlink:href="lgnd-20221231.xsd#lgnd_RepaymentsOfNotesPayableInterestPortion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_lgnd_RepaymentsOfNotesPayableInterestPortion_7066db25-1b01-423b-9db5-bbb4f757ca20" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_bd336b96-82a2-45fe-9b5d-7872310f03f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_bd336b96-82a2-45fe-9b5d-7872310f03f9" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IncreaseDecreaseInDebtDiscount_9494841c-01b1-449a-867f-d570225f8b3c" xlink:href="lgnd-20221231.xsd#lgnd_IncreaseDecreaseInDebtDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_lgnd_IncreaseDecreaseInDebtDiscount_9494841c-01b1-449a-867f-d570225f8b3c" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_f4ec11e8-3c88-47cb-bcc9-ae2b21d564be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_f4ec11e8-3c88-47cb-bcc9-ae2b21d564be" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_b729e647-dfeb-40ec-be09-476d67c9c007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_b729e647-dfeb-40ec-be09-476d67c9c007" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_342ec888-b789-4446-9d08-e7c5964cc43d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_342ec888-b789-4446-9d08-e7c5964cc43d" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsforConvertibleBondHedges_6ed1a42c-ce32-4ce4-8fbe-d4a5138ac25e" xlink:href="lgnd-20221231.xsd#lgnd_PaymentsforConvertibleBondHedges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_lgnd_PaymentsforConvertibleBondHedges_6ed1a42c-ce32-4ce4-8fbe-d4a5138ac25e" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_7bccd83a-a38a-4475-8685-6de771b80256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_7bccd83a-a38a-4475-8685-6de771b80256" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_752c9f8e-f817-42a4-978a-2cc410a68c52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_752c9f8e-f817-42a4-978a-2cc410a68c52" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToUnwindWarrants_6389a3f3-95d0-4e67-b0ee-59374d2cd729" xlink:href="lgnd-20221231.xsd#lgnd_PaymentsToUnwindWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_lgnd_PaymentsToUnwindWarrants_6389a3f3-95d0-4e67-b0ee-59374d2cd729" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges_f1c84c63-9376-4e96-968a-88cf78aa9a3a" xlink:href="lgnd-20221231.xsd#lgnd_ProceedsFromUnwindingConvertibleBondHedges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges_f1c84c63-9376-4e96-968a-88cf78aa9a3a" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges_b746439b-9db3-48c1-9dee-2576742e874d" xlink:href="lgnd-20221231.xsd#lgnd_NumberOfOptionsUnderConvertibleBondHedges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges_b746439b-9db3-48c1-9dee-2576742e874d" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod_e7dfa41c-e70f-44ad-8a64-73c0cb465265" xlink:href="lgnd-20221231.xsd#lgnd_DebtInstrumentRepurchasedAmountDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod_e7dfa41c-e70f-44ad-8a64-73c0cb465265" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a2b33c3c-b516-49bd-8d37-edb764b343c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_DebtInstrumentTable_a2b33c3c-b516-49bd-8d37-edb764b343c8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b8ea0f29-2357-4623-9e2f-9ebaafd373a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a2b33c3c-b516-49bd-8d37-edb764b343c8" xlink:to="loc_us-gaap_DebtInstrumentAxis_b8ea0f29-2357-4623-9e2f-9ebaafd373a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b8ea0f29-2357-4623-9e2f-9ebaafd373a9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_b8ea0f29-2357-4623-9e2f-9ebaafd373a9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b8ea0f29-2357-4623-9e2f-9ebaafd373a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e26a1e2f-b4f3-45db-85c6-f5eeb9ad5595" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_b8ea0f29-2357-4623-9e2f-9ebaafd373a9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e26a1e2f-b4f3-45db-85c6-f5eeb9ad5595" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_3cf56185-87fa-446f-b02b-70e408d24e6b" xlink:href="lgnd-20221231.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e26a1e2f-b4f3-45db-85c6-f5eeb9ad5595" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_3cf56185-87fa-446f-b02b-70e408d24e6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7c34a05b-2f7d-42b8-abb5-b67ada1ff095" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a2b33c3c-b516-49bd-8d37-edb764b343c8" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7c34a05b-2f7d-42b8-abb5-b67ada1ff095" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7c34a05b-2f7d-42b8-abb5-b67ada1ff095_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7c34a05b-2f7d-42b8-abb5-b67ada1ff095" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7c34a05b-2f7d-42b8-abb5-b67ada1ff095_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7d6a7940-44a1-4588-9a1d-1127d2faba8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7c34a05b-2f7d-42b8-abb5-b67ada1ff095" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7d6a7940-44a1-4588-9a1d-1127d2faba8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_da4bb743-5206-43db-a09e-14e4a07b097a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7d6a7940-44a1-4588-9a1d-1127d2faba8f" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_da4bb743-5206-43db-a09e-14e4a07b097a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_2bce5eab-f29c-468e-bc03-0beb4eae2820" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a2b33c3c-b516-49bd-8d37-edb764b343c8" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_2bce5eab-f29c-468e-bc03-0beb4eae2820" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_2bce5eab-f29c-468e-bc03-0beb4eae2820_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_2bce5eab-f29c-468e-bc03-0beb4eae2820" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_2bce5eab-f29c-468e-bc03-0beb4eae2820_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_1276d468-1984-446a-ac7b-99982d435dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_2bce5eab-f29c-468e-bc03-0beb4eae2820" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_1276d468-1984-446a-ac7b-99982d435dcc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_7d47a29b-4ae5-47d4-9203-493e1a9eefbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_1276d468-1984-446a-ac7b-99982d435dcc" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_7d47a29b-4ae5-47d4-9203-493e1a9eefbb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_0eb212b6-5102-44bd-a059-b1b8cd689e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_1276d468-1984-446a-ac7b-99982d435dcc" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_0eb212b6-5102-44bd-a059-b1b8cd689e1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ea4939b8-c13b-49cf-9861-d6f3a773d953" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a2b33c3c-b516-49bd-8d37-edb764b343c8" xlink:to="loc_srt_RangeAxis_ea4939b8-c13b-49cf-9861-d6f3a773d953" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ea4939b8-c13b-49cf-9861-d6f3a773d953_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_ea4939b8-c13b-49cf-9861-d6f3a773d953" xlink:to="loc_srt_RangeMember_ea4939b8-c13b-49cf-9861-d6f3a773d953_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ea4821fb-0bfa-4e2d-9135-725c24c77869" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_ea4939b8-c13b-49cf-9861-d6f3a773d953" xlink:to="loc_srt_RangeMember_ea4821fb-0bfa-4e2d-9135-725c24c77869" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7257b9ba-b4f8-4932-bff0-0fa13246c992" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ea4821fb-0bfa-4e2d-9135-725c24c77869" xlink:to="loc_srt_MaximumMember_7257b9ba-b4f8-4932-bff0-0fa13246c992" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis_856416bf-3d5a-4bf7-869f-3477cc50ac8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a2b33c3c-b516-49bd-8d37-edb764b343c8" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAxis_856416bf-3d5a-4bf7-869f-3477cc50ac8a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_856416bf-3d5a-4bf7-869f-3477cc50ac8a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_856416bf-3d5a-4bf7-869f-3477cc50ac8a" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_856416bf-3d5a-4bf7-869f-3477cc50ac8a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_cd689a73-b992-4726-a658-54c0ad0ae660" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_856416bf-3d5a-4bf7-869f-3477cc50ac8a" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_cd689a73-b992-4726-a658-54c0ad0ae660" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember_d55bb734-25f3-4e72-8261-30b0105f1996" xlink:href="lgnd-20221231.xsd#lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_cd689a73-b992-4726-a658-54c0ad0ae660" xlink:to="loc_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember_d55bb734-25f3-4e72-8261-30b0105f1996" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesEquityandLiabilityComponentsofFinancingArrangementsDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#ConvertibleSeniorNotesEquityandLiabilityComponentsofFinancingArrangementsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesEquityandLiabilityComponentsofFinancingArrangementsDetails" xlink:type="extended" id="iad738c80e9a74eaca5cc5c5394e84359_ConvertibleSeniorNotesEquityandLiabilityComponentsofFinancingArrangementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f3f83292-5834-49b2-98e8-507893aeb1d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_f44cbc7b-ab76-4676-a023-3d6c05183b75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f3f83292-5834-49b2-98e8-507893aeb1d4" xlink:to="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_f44cbc7b-ab76-4676-a023-3d6c05183b75" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_fdf84c53-1ebb-49ef-a4ad-c5028cd086fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_f44cbc7b-ab76-4676-a023-3d6c05183b75" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_fdf84c53-1ebb-49ef-a4ad-c5028cd086fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_17b826df-f1ec-453d-9b49-c89708f7ec28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_f44cbc7b-ab76-4676-a023-3d6c05183b75" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_17b826df-f1ec-453d-9b49-c89708f7ec28" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_47250a1c-07c3-4500-b556-bc3b495db665" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_f44cbc7b-ab76-4676-a023-3d6c05183b75" xlink:to="loc_us-gaap_LongTermNotesPayable_47250a1c-07c3-4500-b556-bc3b495db665" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_4daf9d23-4fe6-4e4c-bc66-ae99f67a9414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f3f83292-5834-49b2-98e8-507893aeb1d4" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_4daf9d23-4fe6-4e4c-bc66-ae99f67a9414" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_770b823f-9678-469b-9931-8cb62d7a0b09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f3f83292-5834-49b2-98e8-507893aeb1d4" xlink:to="loc_us-gaap_DebtInstrumentTable_770b823f-9678-469b-9931-8cb62d7a0b09" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8731e57d-01f4-49e4-81aa-8ac059e7d0f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_770b823f-9678-469b-9931-8cb62d7a0b09" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8731e57d-01f4-49e4-81aa-8ac059e7d0f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8731e57d-01f4-49e4-81aa-8ac059e7d0f2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8731e57d-01f4-49e4-81aa-8ac059e7d0f2" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8731e57d-01f4-49e4-81aa-8ac059e7d0f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_dd6b8ce1-4171-4fef-ae07-0fb872e8bd2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8731e57d-01f4-49e4-81aa-8ac059e7d0f2" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_dd6b8ce1-4171-4fef-ae07-0fb872e8bd2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_f8bd6936-acf3-45d0-b397-4de7ebec9d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_dd6b8ce1-4171-4fef-ae07-0fb872e8bd2b" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_f8bd6936-acf3-45d0-b397-4de7ebec9d3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8745a52c-04d9-468e-9cdb-c97ee563515f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_770b823f-9678-469b-9931-8cb62d7a0b09" xlink:to="loc_us-gaap_DebtInstrumentAxis_8745a52c-04d9-468e-9cdb-c97ee563515f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8745a52c-04d9-468e-9cdb-c97ee563515f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_8745a52c-04d9-468e-9cdb-c97ee563515f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8745a52c-04d9-468e-9cdb-c97ee563515f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_77012c16-80ab-4192-bdfe-726d96fa0270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_8745a52c-04d9-468e-9cdb-c97ee563515f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_77012c16-80ab-4192-bdfe-726d96fa0270" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_68659ae2-717c-4478-b768-95266e2a3ee6" xlink:href="lgnd-20221231.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_77012c16-80ab-4192-bdfe-726d96fa0270" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_68659ae2-717c-4478-b768-95266e2a3ee6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BalanceSheetAccountDetailsInvestmentCategoriesDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BalanceSheetAccountDetailsInvestmentCategoriesDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BalanceSheetAccountDetailsInvestmentCategoriesDetails" xlink:type="extended" id="i99f85141c9a844c0b9612b0090e952f6_BalanceSheetAccountDetailsInvestmentCategoriesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4190d53e-964e-46dc-b79a-8478e26a413b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b1af3877-2451-4f62-ba99-999da2a3e602" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4190d53e-964e-46dc-b79a-8478e26a413b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b1af3877-2451-4f62-ba99-999da2a3e602" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_051c1baf-75c4-4a22-83e2-ad7a25fa6fab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4190d53e-964e-46dc-b79a-8478e26a413b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_051c1baf-75c4-4a22-83e2-ad7a25fa6fab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_72cb73b9-6795-4773-93fa-0d8da4232c98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4190d53e-964e-46dc-b79a-8478e26a413b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_72cb73b9-6795-4773-93fa-0d8da4232c98" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_db3cd01d-f434-4664-bd53-04ec44cba513" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4190d53e-964e-46dc-b79a-8478e26a413b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_db3cd01d-f434-4664-bd53-04ec44cba513" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_120aab02-696f-4c28-8d85-bc8adb127c1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4190d53e-964e-46dc-b79a-8478e26a413b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_120aab02-696f-4c28-8d85-bc8adb127c1a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_391a308a-aa36-4cf6-9174-3e1b17a340fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_120aab02-696f-4c28-8d85-bc8adb127c1a" xlink:to="loc_us-gaap_FinancialInstrumentAxis_391a308a-aa36-4cf6-9174-3e1b17a340fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_391a308a-aa36-4cf6-9174-3e1b17a340fd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_391a308a-aa36-4cf6-9174-3e1b17a340fd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_391a308a-aa36-4cf6-9174-3e1b17a340fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0dc96836-3506-4574-82c2-be05342aad67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_391a308a-aa36-4cf6-9174-3e1b17a340fd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0dc96836-3506-4574-82c2-be05342aad67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_a93c2e55-2821-46ca-afcb-d1819d434399" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MutualFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0dc96836-3506-4574-82c2-be05342aad67" xlink:to="loc_us-gaap_MutualFundMember_a93c2e55-2821-46ca-afcb-d1819d434399" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositsMember_1139e5cd-1c75-48eb-ac21-cd94b5cca127" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DemandDepositsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0dc96836-3506-4574-82c2-be05342aad67" xlink:to="loc_us-gaap_DemandDepositsMember_1139e5cd-1c75-48eb-ac21-cd94b5cca127" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_8172d3f4-3afc-4b62-afba-aa23df041498" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0dc96836-3506-4574-82c2-be05342aad67" xlink:to="loc_us-gaap_CommercialPaperMember_8172d3f4-3afc-4b62-afba-aa23df041498" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_a35dc08a-d0f2-410b-a7c2-339f4b3f7f32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0dc96836-3506-4574-82c2-be05342aad67" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_a35dc08a-d0f2-410b-a7c2-339f4b3f7f32" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_194142b5-8cab-4505-8651-1c686be248f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0dc96836-3506-4574-82c2-be05342aad67" xlink:to="loc_us-gaap_EquitySecuritiesMember_194142b5-8cab-4505-8651-1c686be248f9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_2b3ddf8e-fdb2-4c06-b9c6-26322cd91d69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0dc96836-3506-4574-82c2-be05342aad67" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_2b3ddf8e-fdb2-4c06-b9c6-26322cd91d69" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_4bd08a7d-bcae-44cb-8cbf-31be743be5c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0dc96836-3506-4574-82c2-be05342aad67" xlink:to="loc_us-gaap_WarrantMember_4bd08a7d-bcae-44cb-8cbf-31be743be5c1" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BalanceSheetAccountDetailsNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BalanceSheetAccountDetailsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BalanceSheetAccountDetailsNarrativeDetails" xlink:type="extended" id="i10fd2757da7a4e8996ea7926e154ab8e_BalanceSheetAccountDetailsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_92af5e42-c5d4-435a-a060-dce336976c83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_6eb92ead-56fd-4762-9f06-1119bdecf656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92af5e42-c5d4-435a-a060-dce336976c83" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_6eb92ead-56fd-4762-9f06-1119bdecf656" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_04dc3ae8-79df-4b9b-96e8-4a5b995df05d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92af5e42-c5d4-435a-a060-dce336976c83" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_04dc3ae8-79df-4b9b-96e8-4a5b995df05d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_25450193-8077-47c0-98e9-76a3a6a72d60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92af5e42-c5d4-435a-a060-dce336976c83" xlink:to="loc_us-gaap_Depreciation_25450193-8077-47c0-98e9-76a3a6a72d60" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_3af3444c-9e68-496b-8899-d960cef0c95e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92af5e42-c5d4-435a-a060-dce336976c83" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_3af3444c-9e68-496b-8899-d960cef0c95e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_11041038-d733-4ad6-a08b-84d6a875ebb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92af5e42-c5d4-435a-a060-dce336976c83" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_11041038-d733-4ad6-a08b-84d6a875ebb1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c082031f-d554-4ee9-bb4a-3292bbf13685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92af5e42-c5d4-435a-a060-dce336976c83" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c082031f-d554-4ee9-bb4a-3292bbf13685" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_e9071cc9-c0b8-4df1-9364-ac5d460bb1c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92af5e42-c5d4-435a-a060-dce336976c83" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_e9071cc9-c0b8-4df1-9364-ac5d460bb1c2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_51c56679-61ac-49cc-b27e-2baa443dabeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92af5e42-c5d4-435a-a060-dce336976c83" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_51c56679-61ac-49cc-b27e-2baa443dabeb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c77c4900-5371-4cfc-b042-8b3d06f8f4da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92af5e42-c5d4-435a-a060-dce336976c83" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c77c4900-5371-4cfc-b042-8b3d06f8f4da" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_68152714-f886-40f4-a0f0-936451ac854f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92af5e42-c5d4-435a-a060-dce336976c83" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_68152714-f886-40f4-a0f0-936451ac854f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfContingentValueRightAgreements_19fc17a5-729e-4d9d-b847-c985a57997d1" xlink:href="lgnd-20221231.xsd#lgnd_NumberOfContingentValueRightAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92af5e42-c5d4-435a-a060-dce336976c83" xlink:to="loc_lgnd_NumberOfContingentValueRightAgreements_19fc17a5-729e-4d9d-b847-c985a57997d1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_47ca758d-34f2-46e8-a0ce-3b739bbad338" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92af5e42-c5d4-435a-a060-dce336976c83" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_47ca758d-34f2-46e8-a0ce-3b739bbad338" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cf45f0cd-53c1-46b8-8170-f3de5b9e5881" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_47ca758d-34f2-46e8-a0ce-3b739bbad338" xlink:to="loc_srt_RangeAxis_cf45f0cd-53c1-46b8-8170-f3de5b9e5881" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cf45f0cd-53c1-46b8-8170-f3de5b9e5881_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_cf45f0cd-53c1-46b8-8170-f3de5b9e5881" xlink:to="loc_srt_RangeMember_cf45f0cd-53c1-46b8-8170-f3de5b9e5881_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_76406a75-5b95-45d9-8ef4-97f0957a25b8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_cf45f0cd-53c1-46b8-8170-f3de5b9e5881" xlink:to="loc_srt_RangeMember_76406a75-5b95-45d9-8ef4-97f0957a25b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_9d951658-ce3e-4920-a40d-5c74d84ff482" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_76406a75-5b95-45d9-8ef4-97f0957a25b8" xlink:to="loc_srt_MinimumMember_9d951658-ce3e-4920-a40d-5c74d84ff482" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ba4168f4-e613-42ec-bec0-827364f67c6d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_76406a75-5b95-45d9-8ef4-97f0957a25b8" xlink:to="loc_srt_MaximumMember_ba4168f4-e613-42ec-bec0-827364f67c6d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails" xlink:type="extended" id="ib6228f0a5d3f42e59e688a558f2e199c_BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_32da8b80-8cd4-48ab-a8c2-629bd8d7e25b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_fbae8ab2-875e-4ae4-a09f-705122086594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_32da8b80-8cd4-48ab-a8c2-629bd8d7e25b" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_fbae8ab2-875e-4ae4-a09f-705122086594" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_cb5ecd99-9fae-408b-a8da-3832015bad97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_fbae8ab2-875e-4ae4-a09f-705122086594" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_cb5ecd99-9fae-408b-a8da-3832015bad97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_cf97d799-f2f5-4f7e-a37a-2d91af39b818" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_fbae8ab2-875e-4ae4-a09f-705122086594" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_cf97d799-f2f5-4f7e-a37a-2d91af39b818" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss_4e8b153b-18d1-446a-ac8d-b0d6001c634e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_fbae8ab2-875e-4ae4-a09f-705122086594" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss_4e8b153b-18d1-446a-ac8d-b0d6001c634e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_84547a30-ed2c-456b-90e3-b85a8bd8349f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_32da8b80-8cd4-48ab-a8c2-629bd8d7e25b" xlink:to="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_84547a30-ed2c-456b-90e3-b85a8bd8349f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_dcefe0c0-2c7d-40bb-be8a-971de236a9f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_84547a30-ed2c-456b-90e3-b85a8bd8349f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_dcefe0c0-2c7d-40bb-be8a-971de236a9f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_250883d4-2e55-49c8-a6b1-4c7c6746f26b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_84547a30-ed2c-456b-90e3-b85a8bd8349f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_250883d4-2e55-49c8-a6b1-4c7c6746f26b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_f52acbe9-b5db-4614-8bd3-1b52d4f1ca2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_84547a30-ed2c-456b-90e3-b85a8bd8349f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_f52acbe9-b5db-4614-8bd3-1b52d4f1ca2c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_208554c3-b35f-4239-ab10-b0000014a92c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_32da8b80-8cd4-48ab-a8c2-629bd8d7e25b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_208554c3-b35f-4239-ab10-b0000014a92c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_b92b66c0-22e1-40bd-b5bc-01e265a3d498" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_208554c3-b35f-4239-ab10-b0000014a92c" xlink:to="loc_us-gaap_FinancialInstrumentAxis_b92b66c0-22e1-40bd-b5bc-01e265a3d498" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b92b66c0-22e1-40bd-b5bc-01e265a3d498_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b92b66c0-22e1-40bd-b5bc-01e265a3d498" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b92b66c0-22e1-40bd-b5bc-01e265a3d498_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_22658037-3d2d-43b9-a42b-eeeea40b937e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b92b66c0-22e1-40bd-b5bc-01e265a3d498" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_22658037-3d2d-43b9-a42b-eeeea40b937e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositsMember_bedd7c1e-2627-459e-9306-359e2988e7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DemandDepositsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_22658037-3d2d-43b9-a42b-eeeea40b937e" xlink:to="loc_us-gaap_DemandDepositsMember_bedd7c1e-2627-459e-9306-359e2988e7c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_fda8189f-3a90-437b-895a-cb5558802233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_22658037-3d2d-43b9-a42b-eeeea40b937e" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_fda8189f-3a90-437b-895a-cb5558802233" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_fd5cc0b0-db7c-42c8-a655-c5f6cfe2a7ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_22658037-3d2d-43b9-a42b-eeeea40b937e" xlink:to="loc_us-gaap_CommercialPaperMember_fd5cc0b0-db7c-42c8-a655-c5f6cfe2a7ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_a126ebd5-2846-469e-b113-1178e14a5dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_22658037-3d2d-43b9-a42b-eeeea40b937e" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_a126ebd5-2846-469e-b113-1178e14a5dd4" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BalanceSheetAccountDetailsPropertyandEquipmentDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BalanceSheetAccountDetailsPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BalanceSheetAccountDetailsPropertyandEquipmentDetails" xlink:type="extended" id="i966ea5e339c845f7b15202a2beb2b490_BalanceSheetAccountDetailsPropertyandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1dfdc2ac-d88a-4ad6-ab88-aa18b7dd87a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_0a95b6cf-ec6b-4e23-a94c-6a62810ee1cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1dfdc2ac-d88a-4ad6-ab88-aa18b7dd87a5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_0a95b6cf-ec6b-4e23-a94c-6a62810ee1cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a65023e2-a815-4696-8c15-2b9a2a06cbb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1dfdc2ac-d88a-4ad6-ab88-aa18b7dd87a5" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a65023e2-a815-4696-8c15-2b9a2a06cbb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8f7cd299-12bf-4b34-93a9-3a7f7a17bdb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1dfdc2ac-d88a-4ad6-ab88-aa18b7dd87a5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_8f7cd299-12bf-4b34-93a9-3a7f7a17bdb8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a8e87831-959c-4aa2-a549-249c9c02e779" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1dfdc2ac-d88a-4ad6-ab88-aa18b7dd87a5" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a8e87831-959c-4aa2-a549-249c9c02e779" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7a2f73d4-5246-49e3-b371-5cbea3ab6ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a8e87831-959c-4aa2-a549-249c9c02e779" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7a2f73d4-5246-49e3-b371-5cbea3ab6ef2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7a2f73d4-5246-49e3-b371-5cbea3ab6ef2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7a2f73d4-5246-49e3-b371-5cbea3ab6ef2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7a2f73d4-5246-49e3-b371-5cbea3ab6ef2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3dcd9135-2ab0-4948-8d67-4df8789f1087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7a2f73d4-5246-49e3-b371-5cbea3ab6ef2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3dcd9135-2ab0-4948-8d67-4df8789f1087" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_1120f55e-e6b1-4328-8477-f7459878c1b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3dcd9135-2ab0-4948-8d67-4df8789f1087" xlink:to="loc_us-gaap_OfficeEquipmentMember_1120f55e-e6b1-4328-8477-f7459878c1b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_291f7bc6-b14e-438b-b9ba-4096f118c548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3dcd9135-2ab0-4948-8d67-4df8789f1087" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_291f7bc6-b14e-438b-b9ba-4096f118c548" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ComputerEquipmentAndSoftwareMember_18fd2322-0a70-463c-a265-007553e93685" xlink:href="lgnd-20221231.xsd#lgnd_ComputerEquipmentAndSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3dcd9135-2ab0-4948-8d67-4df8789f1087" xlink:to="loc_lgnd_ComputerEquipmentAndSoftwareMember_18fd2322-0a70-463c-a265-007553e93685" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BalanceSheetAccountDetailsGoodwillandOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BalanceSheetAccountDetailsGoodwillandOtherIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BalanceSheetAccountDetailsGoodwillandOtherIntangibleAssetsDetails" xlink:type="extended" id="i96f085465ce844ae86f680655d620f76_BalanceSheetAccountDetailsGoodwillandOtherIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cfb36937-f77b-4470-8c77-2f84d47f9586" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_37b954de-0440-4555-b14f-04654eb062b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cfb36937-f77b-4470-8c77-2f84d47f9586" xlink:to="loc_us-gaap_Goodwill_37b954de-0440-4555-b14f-04654eb062b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_48185d13-e2c6-450f-8804-21e058c59dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cfb36937-f77b-4470-8c77-2f84d47f9586" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_48185d13-e2c6-450f-8804-21e058c59dbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a099956e-d68a-4433-bcee-ad769be37c57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cfb36937-f77b-4470-8c77-2f84d47f9586" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a099956e-d68a-4433-bcee-ad769be37c57" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_27d27124-17c4-47cc-95e8-858772064a33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cfb36937-f77b-4470-8c77-2f84d47f9586" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_27d27124-17c4-47cc-95e8-858772064a33" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_af70f01b-34ba-4629-b164-db0c6dc91c64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cfb36937-f77b-4470-8c77-2f84d47f9586" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_af70f01b-34ba-4629-b164-db0c6dc91c64" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_64ea0efb-1641-40ce-a0c4-3f213d47c95d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_af70f01b-34ba-4629-b164-db0c6dc91c64" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_64ea0efb-1641-40ce-a0c4-3f213d47c95d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_64ea0efb-1641-40ce-a0c4-3f213d47c95d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_64ea0efb-1641-40ce-a0c4-3f213d47c95d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_64ea0efb-1641-40ce-a0c4-3f213d47c95d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0d175c01-05f9-4331-91d7-c782dc8e323d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_64ea0efb-1641-40ce-a0c4-3f213d47c95d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0d175c01-05f9-4331-91d7-c782dc8e323d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentedTechnologyMember_e2826b88-7b67-4653-99dd-258590779851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0d175c01-05f9-4331-91d7-c782dc8e323d" xlink:to="loc_us-gaap_PatentedTechnologyMember_e2826b88-7b67-4653-99dd-258590779851" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_1a10a31c-e485-445a-9b72-3ade95e31c41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0d175c01-05f9-4331-91d7-c782dc8e323d" xlink:to="loc_us-gaap_TradeNamesMember_1a10a31c-e485-445a-9b72-3ade95e31c41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_cbc005d2-053c-4468-b311-5919f17807e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0d175c01-05f9-4331-91d7-c782dc8e323d" xlink:to="loc_us-gaap_CustomerRelationshipsMember_cbc005d2-053c-4468-b311-5919f17807e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_a45e17f8-2303-4f70-8ef1-9709eb388e65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0d175c01-05f9-4331-91d7-c782dc8e323d" xlink:to="loc_us-gaap_ContractualRightsMember_a45e17f8-2303-4f70-8ef1-9709eb388e65" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BalanceSheetAccountDetailsContingentLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BalanceSheetAccountDetailsContingentLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BalanceSheetAccountDetailsContingentLiabilitiesDetails" xlink:type="extended" id="i85b37e6489e843378f2b2d0fbce865ee_BalanceSheetAccountDetailsContingentLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b71f4eec-06ab-4ec3-a798-dca0b2abb132" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentLiabilityRollForward_08603249-5dce-47fc-9a81-1a026856a7ff" xlink:href="lgnd-20221231.xsd#lgnd_ContingentLiabilityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b71f4eec-06ab-4ec3-a798-dca0b2abb132" xlink:to="loc_lgnd_ContingentLiabilityRollForward_08603249-5dce-47fc-9a81-1a026856a7ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod_de00a65b-1288-4bb5-b703-86ce92694d9d" xlink:href="lgnd-20221231.xsd#lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContingentLiabilityRollForward_08603249-5dce-47fc-9a81-1a026856a7ff" xlink:to="loc_lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod_de00a65b-1288-4bb5-b703-86ce92694d9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHolders_3224067c-0431-4843-b5ef-042cb601c82a" xlink:href="lgnd-20221231.xsd#lgnd_PaymentsToContingentValueRightHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContingentLiabilityRollForward_08603249-5dce-47fc-9a81-1a026856a7ff" xlink:to="loc_lgnd_PaymentsToContingentValueRightHolders_3224067c-0431-4843-b5ef-042cb601c82a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities_241a30b0-df5a-411c-aa86-4375a9c92ad8" xlink:href="lgnd-20221231.xsd#lgnd_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContingentLiabilityRollForward_08603249-5dce-47fc-9a81-1a026856a7ff" xlink:to="loc_lgnd_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities_241a30b0-df5a-411c-aa86-4375a9c92ad8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities_6d0cc6bd-5aff-4c6b-83ab-7f27b740716f" xlink:href="lgnd-20221231.xsd#lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContingentLiabilityRollForward_08603249-5dce-47fc-9a81-1a026856a7ff" xlink:to="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities_6d0cc6bd-5aff-4c6b-83ab-7f27b740716f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod_c0ed31f3-27c3-44ce-85e2-cf46a27cbdef" xlink:href="lgnd-20221231.xsd#lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_75156f3b-cf7a-4d13-81af-f9d6697bddd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b71f4eec-06ab-4ec3-a798-dca0b2abb132" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_75156f3b-cf7a-4d13-81af-f9d6697bddd2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_72b9244e-179b-4723-8296-caf05a0cc2e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_75156f3b-cf7a-4d13-81af-f9d6697bddd2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_72b9244e-179b-4723-8296-caf05a0cc2e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72b9244e-179b-4723-8296-caf05a0cc2e9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_72b9244e-179b-4723-8296-caf05a0cc2e9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72b9244e-179b-4723-8296-caf05a0cc2e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d376beee-e261-49d5-bd65-8629d7bdd51d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_72b9244e-179b-4723-8296-caf05a0cc2e9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d376beee-e261-49d5-bd65-8629d7bdd51d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CydexPharmaceuticalsIncMember_57645e60-a838-4638-8dfa-fcf03dc211d4" xlink:href="lgnd-20221231.xsd#lgnd_CydexPharmaceuticalsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d376beee-e261-49d5-bd65-8629d7bdd51d" xlink:to="loc_lgnd_CydexPharmaceuticalsIncMember_57645e60-a838-4638-8dfa-fcf03dc211d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MetabasisTherapeuticsMember_e64b840b-dcab-4436-88c9-8bc9ee4f5694" xlink:href="lgnd-20221231.xsd#lgnd_MetabasisTherapeuticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d376beee-e261-49d5-bd65-8629d7bdd51d" xlink:to="loc_lgnd_MetabasisTherapeuticsMember_e64b840b-dcab-4436-88c9-8bc9ee4f5694" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_4b705703-b822-427e-9117-e9faeec6740a" xlink:href="lgnd-20221231.xsd#lgnd_PfenexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d376beee-e261-49d5-bd65-8629d7bdd51d" xlink:to="loc_lgnd_PfenexMember_4b705703-b822-427e-9117-e9faeec6740a" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityShareBasedCompensationDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#StockholdersEquityShareBasedCompensationDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/StockholdersEquityShareBasedCompensationDetails" xlink:type="extended" id="ia84acf76a8fd415187ac8f33451078c8_StockholdersEquityShareBasedCompensationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8b61a1ca-8e68-4bc1-8c5c-3cac67726969" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_095577c4-818d-4696-9d85-eeff27510fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8b61a1ca-8e68-4bc1-8c5c-3cac67726969" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_095577c4-818d-4696-9d85-eeff27510fb8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a5305c9-88da-4db3-9316-8cba17699d10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8b61a1ca-8e68-4bc1-8c5c-3cac67726969" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a5305c9-88da-4db3-9316-8cba17699d10" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_339d8130-46c5-4779-8185-5042450bbfb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a5305c9-88da-4db3-9316-8cba17699d10" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_339d8130-46c5-4779-8185-5042450bbfb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_339d8130-46c5-4779-8185-5042450bbfb2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_339d8130-46c5-4779-8185-5042450bbfb2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_339d8130-46c5-4779-8185-5042450bbfb2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ee04b494-8804-47ae-9851-57d3b6047a35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_339d8130-46c5-4779-8185-5042450bbfb2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ee04b494-8804-47ae-9851-57d3b6047a35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_39d90a6f-4040-429d-b3a3-32dbfd0652ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ee04b494-8804-47ae-9851-57d3b6047a35" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_39d90a6f-4040-429d-b3a3-32dbfd0652ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_7c28b77a-652c-4b22-975c-6e772ad4e737" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ee04b494-8804-47ae-9851-57d3b6047a35" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_7c28b77a-652c-4b22-975c-6e772ad4e737" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#StockholdersEquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended" id="i2de65d35f8004d39993001819f834c7e_StockholdersEquityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44046b9f-53ac-4128-acd7-ebff878dd19a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_fa2a6686-08f9-4904-a5d6-85cd8f267b43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44046b9f-53ac-4128-acd7-ebff878dd19a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_fa2a6686-08f9-4904-a5d6-85cd8f267b43" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_8d11ff90-ed30-45fa-a79e-dd456a6f7f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44046b9f-53ac-4128-acd7-ebff878dd19a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_8d11ff90-ed30-45fa-a79e-dd456a6f7f9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7d5d56c3-45e4-4606-b189-76f4e70375e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44046b9f-53ac-4128-acd7-ebff878dd19a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7d5d56c3-45e4-4606-b189-76f4e70375e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_8ba1c8b0-2888-49f8-90d5-f9b785c6d288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44046b9f-53ac-4128-acd7-ebff878dd19a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_8ba1c8b0-2888-49f8-90d5-f9b785c6d288" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_5df1bda9-ede5-4261-a775-555006fb39e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44046b9f-53ac-4128-acd7-ebff878dd19a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_5df1bda9-ede5-4261-a775-555006fb39e6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_69594d0e-875c-4dd1-8307-6d00df31f05f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44046b9f-53ac-4128-acd7-ebff878dd19a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_69594d0e-875c-4dd1-8307-6d00df31f05f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_7dfb75ca-26de-41ff-841a-07c54d44f7d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44046b9f-53ac-4128-acd7-ebff878dd19a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_7dfb75ca-26de-41ff-841a-07c54d44f7d7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_3756cdc0-f087-41e5-99cf-a587da074bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44046b9f-53ac-4128-acd7-ebff878dd19a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_3756cdc0-f087-41e5-99cf-a587da074bd2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SaleOfStockAuthorizedOfferingAmount_ddf11226-6915-47f5-a465-fb7e348dede3" xlink:href="lgnd-20221231.xsd#lgnd_SaleOfStockAuthorizedOfferingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44046b9f-53ac-4128-acd7-ebff878dd19a" xlink:to="loc_lgnd_SaleOfStockAuthorizedOfferingAmount_ddf11226-6915-47f5-a465-fb7e348dede3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanAbstract_5735823d-a180-4032-aced-118ea9943242" xlink:href="lgnd-20221231.xsd#lgnd_EmployeeStockPurchasePlanAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44046b9f-53ac-4128-acd7-ebff878dd19a" xlink:to="loc_lgnd_EmployeeStockPurchasePlanAbstract_5735823d-a180-4032-aced-118ea9943242" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_0567fe61-d7c9-43f1-bd73-dcfdcf34486d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_5735823d-a180-4032-aced-118ea9943242" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_0567fe61-d7c9-43f1-bd73-dcfdcf34486d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_cdf382f2-70a6-4989-80b9-eca3c906afe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_5735823d-a180-4032-aced-118ea9943242" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_cdf382f2-70a6-4989-80b9-eca3c906afe7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_e343d4c1-885c-4274-8951-841da161d8a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_5735823d-a180-4032-aced-118ea9943242" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_e343d4c1-885c-4274-8951-841da161d8a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CorporateShareRepurchaseAbstract_4ffbd7a2-f838-4121-86ac-cb5727f515b0" xlink:href="lgnd-20221231.xsd#lgnd_CorporateShareRepurchaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44046b9f-53ac-4128-acd7-ebff878dd19a" xlink:to="loc_lgnd_CorporateShareRepurchaseAbstract_4ffbd7a2-f838-4121-86ac-cb5727f515b0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ce0fd9b2-d448-4cd6-9a44-ab1cd3697af7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CorporateShareRepurchaseAbstract_4ffbd7a2-f838-4121-86ac-cb5727f515b0" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ce0fd9b2-d448-4cd6-9a44-ab1cd3697af7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_7537d3bf-fb39-4f47-9ec4-b2611a773a88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CorporateShareRepurchaseAbstract_4ffbd7a2-f838-4121-86ac-cb5727f515b0" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_7537d3bf-fb39-4f47-9ec4-b2611a773a88" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_8717bb9f-5dc6-465c-b018-b9bd5d726b12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CorporateShareRepurchaseAbstract_4ffbd7a2-f838-4121-86ac-cb5727f515b0" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_8717bb9f-5dc6-465c-b018-b9bd5d726b12" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_cebd584b-c6f2-4953-b8e1-cbe94d77a4e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CorporateShareRepurchaseAbstract_4ffbd7a2-f838-4121-86ac-cb5727f515b0" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_cebd584b-c6f2-4953-b8e1-cbe94d77a4e3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1768f400-10ea-426e-9f3e-7ef6bbdcff40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44046b9f-53ac-4128-acd7-ebff878dd19a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1768f400-10ea-426e-9f3e-7ef6bbdcff40" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_d0ef33ba-8681-45f9-8c30-088228700256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1768f400-10ea-426e-9f3e-7ef6bbdcff40" xlink:to="loc_us-gaap_PlanNameAxis_d0ef33ba-8681-45f9-8c30-088228700256" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d0ef33ba-8681-45f9-8c30-088228700256_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_d0ef33ba-8681-45f9-8c30-088228700256" xlink:to="loc_us-gaap_PlanNameDomain_d0ef33ba-8681-45f9-8c30-088228700256_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_99c46180-0674-4055-80b7-5b794df6f41e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_d0ef33ba-8681-45f9-8c30-088228700256" xlink:to="loc_us-gaap_PlanNameDomain_99c46180-0674-4055-80b7-5b794df6f41e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_TwoThousandTwoStockIncentivePlanMember_c059fad7-9cf1-41f9-b8ed-ddcf20692d0d" xlink:href="lgnd-20221231.xsd#lgnd_TwoThousandTwoStockIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_99c46180-0674-4055-80b7-5b794df6f41e" xlink:to="loc_lgnd_TwoThousandTwoStockIncentivePlanMember_c059fad7-9cf1-41f9-b8ed-ddcf20692d0d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmendedESPPMember_7a03ceb1-622f-4b7e-8cb4-87643860453c" xlink:href="lgnd-20221231.xsd#lgnd_AmendedESPPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_99c46180-0674-4055-80b7-5b794df6f41e" xlink:to="loc_lgnd_AmendedESPPMember_7a03ceb1-622f-4b7e-8cb4-87643860453c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OmniabSeparationMember_c26f9d73-cf5c-4a43-8ac0-d4384b73dd0d" xlink:href="lgnd-20221231.xsd#lgnd_OmniabSeparationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_99c46180-0674-4055-80b7-5b794df6f41e" xlink:to="loc_lgnd_OmniabSeparationMember_c26f9d73-cf5c-4a43-8ac0-d4384b73dd0d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_310760fc-dfcd-4b17-a617-94343767d873" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1768f400-10ea-426e-9f3e-7ef6bbdcff40" xlink:to="loc_us-gaap_AwardTypeAxis_310760fc-dfcd-4b17-a617-94343767d873" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_310760fc-dfcd-4b17-a617-94343767d873_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_310760fc-dfcd-4b17-a617-94343767d873" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_310760fc-dfcd-4b17-a617-94343767d873_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_93d39d22-318b-4d37-8072-b2514765d189" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_310760fc-dfcd-4b17-a617-94343767d873" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_93d39d22-318b-4d37-8072-b2514765d189" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_aec94ac3-5bba-47b8-af67-cfff5a75783e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_93d39d22-318b-4d37-8072-b2514765d189" xlink:to="loc_us-gaap_EmployeeStockOptionMember_aec94ac3-5bba-47b8-af67-cfff5a75783e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_fe0da702-8bcf-4d39-9b05-3f6ac6c7cb1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_93d39d22-318b-4d37-8072-b2514765d189" xlink:to="loc_us-gaap_RestrictedStockMember_fe0da702-8bcf-4d39-9b05-3f6ac6c7cb1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_973862f3-ead0-44d2-8a8e-a004a7400217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1768f400-10ea-426e-9f3e-7ef6bbdcff40" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_973862f3-ead0-44d2-8a8e-a004a7400217" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_973862f3-ead0-44d2-8a8e-a004a7400217_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_973862f3-ead0-44d2-8a8e-a004a7400217" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_973862f3-ead0-44d2-8a8e-a004a7400217_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_68f503be-e208-4697-ac45-63d8747ed3a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_973862f3-ead0-44d2-8a8e-a004a7400217" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_68f503be-e208-4697-ac45-63d8747ed3a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AtTheMarketEquityOfferingMember_f5f8d5cc-b973-4c89-8539-a664b488d37d" xlink:href="lgnd-20221231.xsd#lgnd_AtTheMarketEquityOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_68f503be-e208-4697-ac45-63d8747ed3a5" xlink:to="loc_lgnd_AtTheMarketEquityOfferingMember_f5f8d5cc-b973-4c89-8539-a664b488d37d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityBreakdownofOptionsOutstandingDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#StockholdersEquityBreakdownofOptionsOutstandingDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/StockholdersEquityBreakdownofOptionsOutstandingDetails" xlink:type="extended" id="i658a566528414b9a9b3c458874ed9c37_StockholdersEquityBreakdownofOptionsOutstandingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffbd0e0-f1ae-49ea-a34f-1b5e00077129" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_cbbe8029-16a2-42c3-b6b7-747e84c427cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffbd0e0-f1ae-49ea-a34f-1b5e00077129" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_cbbe8029-16a2-42c3-b6b7-747e84c427cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_e20efbc1-f1f9-4d6b-9866-9a6dcd1749cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffbd0e0-f1ae-49ea-a34f-1b5e00077129" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_e20efbc1-f1f9-4d6b-9866-9a6dcd1749cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_44d38a3d-62ac-40dd-add2-115393f94a94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffbd0e0-f1ae-49ea-a34f-1b5e00077129" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_44d38a3d-62ac-40dd-add2-115393f94a94" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_064dea71-4dac-4cd8-b308-94f91304f728" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffbd0e0-f1ae-49ea-a34f-1b5e00077129" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_064dea71-4dac-4cd8-b308-94f91304f728" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_db9af6b8-092a-446c-807c-773a8256c5bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffbd0e0-f1ae-49ea-a34f-1b5e00077129" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_db9af6b8-092a-446c-807c-773a8256c5bd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_721e9404-a463-48b4-9d01-b8556c087209" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffbd0e0-f1ae-49ea-a34f-1b5e00077129" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_721e9404-a463-48b4-9d01-b8556c087209" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_99f5a029-7cc4-4b96-a740-bc75b2187d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffbd0e0-f1ae-49ea-a34f-1b5e00077129" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_99f5a029-7cc4-4b96-a740-bc75b2187d6b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7e049b06-a989-4fa0-a5b9-32ef96693874" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffbd0e0-f1ae-49ea-a34f-1b5e00077129" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7e049b06-a989-4fa0-a5b9-32ef96693874" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_2a477b94-1e9c-4554-9445-4a02ad8efb33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7e049b06-a989-4fa0-a5b9-32ef96693874" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_2a477b94-1e9c-4554-9445-4a02ad8efb33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2a477b94-1e9c-4554-9445-4a02ad8efb33_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_2a477b94-1e9c-4554-9445-4a02ad8efb33" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2a477b94-1e9c-4554-9445-4a02ad8efb33_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_596025af-e787-4bd0-b45b-d8871352e599" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_2a477b94-1e9c-4554-9445-4a02ad8efb33" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_596025af-e787-4bd0-b45b-d8871352e599" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ExercisePriceRangeOneMember_7bfe1917-76c5-4f83-bf81-5083aeeb89ae" xlink:href="lgnd-20221231.xsd#lgnd_ExercisePriceRangeOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_596025af-e787-4bd0-b45b-d8871352e599" xlink:to="loc_lgnd_ExercisePriceRangeOneMember_7bfe1917-76c5-4f83-bf81-5083aeeb89ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ExercisePriceRangeTwoMember_dbdbe251-cd69-416a-81c6-8c0af776407a" xlink:href="lgnd-20221231.xsd#lgnd_ExercisePriceRangeTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_596025af-e787-4bd0-b45b-d8871352e599" xlink:to="loc_lgnd_ExercisePriceRangeTwoMember_dbdbe251-cd69-416a-81c6-8c0af776407a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ExercisePriceRangeThreeMember_c7c6f0a8-408a-4a95-90b0-ffdca1bf687f" xlink:href="lgnd-20221231.xsd#lgnd_ExercisePriceRangeThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_596025af-e787-4bd0-b45b-d8871352e599" xlink:to="loc_lgnd_ExercisePriceRangeThreeMember_c7c6f0a8-408a-4a95-90b0-ffdca1bf687f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ExercisePriceRangeFourMember_179013f1-ad87-4afc-ac9c-f163341c06f2" xlink:href="lgnd-20221231.xsd#lgnd_ExercisePriceRangeFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_596025af-e787-4bd0-b45b-d8871352e599" xlink:to="loc_lgnd_ExercisePriceRangeFourMember_179013f1-ad87-4afc-ac9c-f163341c06f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ExercisePriceRangeFiveMember_f86cda8e-9ef1-4d1c-972f-879b41b81378" xlink:href="lgnd-20221231.xsd#lgnd_ExercisePriceRangeFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_596025af-e787-4bd0-b45b-d8871352e599" xlink:to="loc_lgnd_ExercisePriceRangeFiveMember_f86cda8e-9ef1-4d1c-972f-879b41b81378" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ExercisePriceRangeSixMember_b921dd9c-91f6-4b83-8240-eba32a001cf9" xlink:href="lgnd-20221231.xsd#lgnd_ExercisePriceRangeSixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_596025af-e787-4bd0-b45b-d8871352e599" xlink:to="loc_lgnd_ExercisePriceRangeSixMember_b921dd9c-91f6-4b83-8240-eba32a001cf9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ExercisePriceRangeSevenMember_ca158459-e58f-44c3-8ea6-ad6657f067b3" xlink:href="lgnd-20221231.xsd#lgnd_ExercisePriceRangeSevenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_596025af-e787-4bd0-b45b-d8871352e599" xlink:to="loc_lgnd_ExercisePriceRangeSevenMember_ca158459-e58f-44c3-8ea6-ad6657f067b3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ExercisePriceRangeEightMember_004732fc-2fed-483c-b61b-f76eb7e23653" xlink:href="lgnd-20221231.xsd#lgnd_ExercisePriceRangeEightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_596025af-e787-4bd0-b45b-d8871352e599" xlink:to="loc_lgnd_ExercisePriceRangeEightMember_004732fc-2fed-483c-b61b-f76eb7e23653" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ExercisePriceRangeNineMember_abdc86d5-0e97-49fa-bc30-1ba94b7f46ae" xlink:href="lgnd-20221231.xsd#lgnd_ExercisePriceRangeNineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_596025af-e787-4bd0-b45b-d8871352e599" xlink:to="loc_lgnd_ExercisePriceRangeNineMember_abdc86d5-0e97-49fa-bc30-1ba94b7f46ae" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ExercisePriceRangeTenMember_fb4954a1-c7b4-47d4-a529-d121994f1204" xlink:href="lgnd-20221231.xsd#lgnd_ExercisePriceRangeTenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_596025af-e787-4bd0-b45b-d8871352e599" xlink:to="loc_lgnd_ExercisePriceRangeTenMember_fb4954a1-c7b4-47d4-a529-d121994f1204" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityAssumptionsDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#StockholdersEquityAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/StockholdersEquityAssumptionsDetails" xlink:type="extended" id="i1f12d867e35a41b99ea3961eb5a323b2_StockholdersEquityAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c4d2fe9-6356-46c1-bd0a-47a0d9a2d5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_36c8936e-d821-46de-8fc3-5cfd2d7f1ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c4d2fe9-6356-46c1-bd0a-47a0d9a2d5ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_36c8936e-d821-46de-8fc3-5cfd2d7f1ec0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_8174100a-6b9c-4ae2-8c00-08540186fa23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c4d2fe9-6356-46c1-bd0a-47a0d9a2d5ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_8174100a-6b9c-4ae2-8c00-08540186fa23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ed8c3f3f-c64a-4460-9b72-5becad982dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c4d2fe9-6356-46c1-bd0a-47a0d9a2d5ef" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ed8c3f3f-c64a-4460-9b72-5becad982dc9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9d52a532-f950-4d80-9101-4b3a7d88338b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c4d2fe9-6356-46c1-bd0a-47a0d9a2d5ef" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9d52a532-f950-4d80-9101-4b3a7d88338b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7555bdd4-2606-4d99-95e5-ce6de20f37a2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9d52a532-f950-4d80-9101-4b3a7d88338b" xlink:to="loc_srt_RangeAxis_7555bdd4-2606-4d99-95e5-ce6de20f37a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7555bdd4-2606-4d99-95e5-ce6de20f37a2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7555bdd4-2606-4d99-95e5-ce6de20f37a2" xlink:to="loc_srt_RangeMember_7555bdd4-2606-4d99-95e5-ce6de20f37a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a9471dd6-c400-4df2-966b-2dfecf64aa14" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7555bdd4-2606-4d99-95e5-ce6de20f37a2" xlink:to="loc_srt_RangeMember_a9471dd6-c400-4df2-966b-2dfecf64aa14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2bc92c03-3e7f-4cc8-a9b7-2df7225df970" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a9471dd6-c400-4df2-966b-2dfecf64aa14" xlink:to="loc_srt_MinimumMember_2bc92c03-3e7f-4cc8-a9b7-2df7225df970" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_86612c55-897c-4bf1-93e7-518443aec255" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a9471dd6-c400-4df2-966b-2dfecf64aa14" xlink:to="loc_srt_MaximumMember_86612c55-897c-4bf1-93e7-518443aec255" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityRestrictedStockActivityDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#StockholdersEquityRestrictedStockActivityDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/StockholdersEquityRestrictedStockActivityDetails" xlink:type="extended" id="i74e3898857d249249b35d23d6bc58d95_StockholdersEquityRestrictedStockActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a8e3f72-3937-449b-b267-2d4dbc6a3a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9a183f4c-debb-4d4e-bd41-d1f32b57875b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a8e3f72-3937-449b-b267-2d4dbc6a3a7d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9a183f4c-debb-4d4e-bd41-d1f32b57875b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2f8dbbe5-6b3a-4cc9-bfee-e2f185174a16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9a183f4c-debb-4d4e-bd41-d1f32b57875b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2f8dbbe5-6b3a-4cc9-bfee-e2f185174a16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ad466b90-3dbc-4f1f-af1b-ff33a981936c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9a183f4c-debb-4d4e-bd41-d1f32b57875b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ad466b90-3dbc-4f1f-af1b-ff33a981936c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_870ecf3b-4633-4ae3-a71f-41fc8592652b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9a183f4c-debb-4d4e-bd41-d1f32b57875b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_870ecf3b-4633-4ae3-a71f-41fc8592652b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c8c6f8f6-ee49-4540-a88a-19ea77a71d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9a183f4c-debb-4d4e-bd41-d1f32b57875b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c8c6f8f6-ee49-4540-a88a-19ea77a71d1a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c819a8af-6ce0-49e1-8427-439c17c70207" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cbfe8e26-d744-4575-a96f-e53acf5101e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a8e3f72-3937-449b-b267-2d4dbc6a3a7d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cbfe8e26-d744-4575-a96f-e53acf5101e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6856fd4a-4944-4bb2-8508-4a74f2e8bd89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cbfe8e26-d744-4575-a96f-e53acf5101e3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6856fd4a-4944-4bb2-8508-4a74f2e8bd89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_403bceb5-0701-4a37-9978-6a55c92d9f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cbfe8e26-d744-4575-a96f-e53acf5101e3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_403bceb5-0701-4a37-9978-6a55c92d9f1e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_5eec652b-764e-44e6-a784-36cf3ac3d2da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cbfe8e26-d744-4575-a96f-e53acf5101e3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_5eec652b-764e-44e6-a784-36cf3ac3d2da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2e4bfb9d-6fda-45ba-9ffc-2641e4a43d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cbfe8e26-d744-4575-a96f-e53acf5101e3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2e4bfb9d-6fda-45ba-9ffc-2641e4a43d7d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_941fee24-e0c5-46b4-bf39-cdf165d84b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_64f47225-0526-48ba-be08-f347babaad44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a8e3f72-3937-449b-b267-2d4dbc6a3a7d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_64f47225-0526-48ba-be08-f347babaad44" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_258ab4b8-5d3d-4e21-bbe9-69bfed138c50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_64f47225-0526-48ba-be08-f347babaad44" xlink:to="loc_us-gaap_AwardTypeAxis_258ab4b8-5d3d-4e21-bbe9-69bfed138c50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_258ab4b8-5d3d-4e21-bbe9-69bfed138c50_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_258ab4b8-5d3d-4e21-bbe9-69bfed138c50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_258ab4b8-5d3d-4e21-bbe9-69bfed138c50_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_770909dd-59c1-4115-82fd-a2adc0a9560d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_258ab4b8-5d3d-4e21-bbe9-69bfed138c50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_770909dd-59c1-4115-82fd-a2adc0a9560d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_b6b162b7-0c40-45e5-a44e-8b6207bb9a20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_770909dd-59c1-4115-82fd-a2adc0a9560d" xlink:to="loc_us-gaap_RestrictedStockMember_b6b162b7-0c40-45e5-a44e-8b6207bb9a20" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="i354496379c0c47248812ae09747cefe2_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_0494adf2-5a70-425c-a649-5a164f9cdbdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_30541bbb-934d-4e05-996d-bbb5e3ed004e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0494adf2-5a70-425c-a649-5a164f9cdbdb" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_30541bbb-934d-4e05-996d-bbb5e3ed004e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_cbf58be4-ac6c-4677-8405-6a1237f8e87b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0494adf2-5a70-425c-a649-5a164f9cdbdb" xlink:to="loc_us-gaap_OperatingLossCarryforwards_cbf58be4-ac6c-4677-8405-6a1237f8e87b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_f1fcdd59-e8a7-43a6-92e5-c1b644edb9e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0494adf2-5a70-425c-a649-5a164f9cdbdb" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_f1fcdd59-e8a7-43a6-92e5-c1b644edb9e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_203fd423-4806-454c-a570-37b0db95f338" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0494adf2-5a70-425c-a649-5a164f9cdbdb" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_203fd423-4806-454c-a570-37b0db95f338" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount_8f2f13e5-ae6e-4acd-b4fd-bc050acc13ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0494adf2-5a70-425c-a649-5a164f9cdbdb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount_8f2f13e5-ae6e-4acd-b4fd-bc050acc13ec" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_c35fd5db-d442-4310-bdb4-dfbcb6ba89c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0494adf2-5a70-425c-a649-5a164f9cdbdb" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_c35fd5db-d442-4310-bdb4-dfbcb6ba89c7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_03d79305-cfac-42a0-a85a-58c7150fd010" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_c35fd5db-d442-4310-bdb4-dfbcb6ba89c7" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_03d79305-cfac-42a0-a85a-58c7150fd010" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_03d79305-cfac-42a0-a85a-58c7150fd010_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_03d79305-cfac-42a0-a85a-58c7150fd010" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_03d79305-cfac-42a0-a85a-58c7150fd010_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_17b7c64d-5dab-46d9-bc08-c3a9de60774c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_03d79305-cfac-42a0-a85a-58c7150fd010" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_17b7c64d-5dab-46d9-bc08-c3a9de60774c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_854accd6-a431-446e-8db1-0388d78968ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_17b7c64d-5dab-46d9-bc08-c3a9de60774c" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_854accd6-a431-446e-8db1-0388d78968ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_e49ebda2-f33d-4421-aab2-5a8a5a6dd8f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_17b7c64d-5dab-46d9-bc08-c3a9de60774c" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_e49ebda2-f33d-4421-aab2-5a8a5a6dd8f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_73782c52-98bd-4e64-86c3-d2419a001a88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_17b7c64d-5dab-46d9-bc08-c3a9de60774c" xlink:to="loc_us-gaap_ForeignCountryMember_73782c52-98bd-4e64-86c3-d2419a001a88" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_0b325684-fd6f-44d5-8ab8-fe072496d2e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_17b7c64d-5dab-46d9-bc08-c3a9de60774c" xlink:to="loc_us-gaap_DomesticCountryMember_0b325684-fd6f-44d5-8ab8-fe072496d2e9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_5ac247e4-9776-4c6a-b0e2-14e9f5f01303" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_c35fd5db-d442-4310-bdb4-dfbcb6ba89c7" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_5ac247e4-9776-4c6a-b0e2-14e9f5f01303" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_5ac247e4-9776-4c6a-b0e2-14e9f5f01303_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_5ac247e4-9776-4c6a-b0e2-14e9f5f01303" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_5ac247e4-9776-4c6a-b0e2-14e9f5f01303_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_f0bb86b0-4bfd-4949-8d79-733ec47a0665" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_5ac247e4-9776-4c6a-b0e2-14e9f5f01303" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_f0bb86b0-4bfd-4949-8d79-733ec47a0665" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_63c1d412-78dd-40ed-a3a8-481a9374ef3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_f0bb86b0-4bfd-4949-8d79-733ec47a0665" xlink:to="loc_us-gaap_ResearchMember_63c1d412-78dd-40ed-a3a8-481a9374ef3e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CaliforniaAndNewJerseyResearchTaxCreditCarryforwardMember_300cf89a-57b2-40e2-b0b8-1e3b654f8dd9" xlink:href="lgnd-20221231.xsd#lgnd_CaliforniaAndNewJerseyResearchTaxCreditCarryforwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_f0bb86b0-4bfd-4949-8d79-733ec47a0665" xlink:to="loc_lgnd_CaliforniaAndNewJerseyResearchTaxCreditCarryforwardMember_300cf89a-57b2-40e2-b0b8-1e3b654f8dd9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLossCarryforwardMember_427126a3-dc38-4980-8bf1-3dc49523cf5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalLossCarryforwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_f0bb86b0-4bfd-4949-8d79-733ec47a0665" xlink:to="loc_us-gaap_CapitalLossCarryforwardMember_427126a3-dc38-4980-8bf1-3dc49523cf5a" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>14
<FILENAME>lgnd-20221231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:c0902eea-a24e-41c4-9f5a-301d659aee15,g:8404f1f2-95a1-4d6b-a993-1c430637111f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_e5381a9d-c883-4f20-b21a-8d752aa3556a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_49a5cdcf-419f-4a24-88ed-c5e4a70a80ad_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_60f5de9e-6d0c-497e-a5bf-8c66dd52e2b6_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ExercisePriceRangeTenMember_b3472f60-9062-4c1c-83b0-550cac6cc67a_terseLabel_en-US" xlink:label="lab_lgnd_ExercisePriceRangeTenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$114.15-$114.15</link:label>
    <link:label id="lab_lgnd_ExercisePriceRangeTenMember_label_en-US" xlink:label="lab_lgnd_ExercisePriceRangeTenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range Ten [Member]</link:label>
    <link:label id="lab_lgnd_ExercisePriceRangeTenMember_documentation_en-US" xlink:label="lab_lgnd_ExercisePriceRangeTenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range Ten [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ExercisePriceRangeTenMember" xlink:href="lgnd-20221231.xsd#lgnd_ExercisePriceRangeTenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ExercisePriceRangeTenMember" xlink:to="lab_lgnd_ExercisePriceRangeTenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_a41acac7-0e73-47d9-bcf4-d9663d3e6817_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_0bfb4417-9671-4499-9e80-b946e396f73b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding principal amount of debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_cb25e339-b352-49c1-a685-d6ffeb52a1de_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-Sale Debt Securities in an Unrealized Loss Position</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_11e6620c-cff1-4021-819c-9b05b7a4c78a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_7c8e2b07-c11e-4176-8c98-060d3f1c0497_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ROU asset</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_55fec3cb-b0db-4db7-bbd7-36879a9cac4b_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_ffd8a426-b2c5-4e22-86ae-35a5b5ae1df3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred expense (benefit):</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_e387d6f5-7623-4eca-a933-a6e73b3099db_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestments_a6c72daa-5e0f-4095-9757-9067f68a49a3_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) from short-term investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod_c1423780-d276-46c4-8598-470adc984cae_periodStartLabel_en-US" xlink:label="lab_lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial rights, beginning of period</link:label>
    <link:label id="lab_lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod_b8672403-7a4e-4abf-a637-b8c7824feaaa_periodEndLabel_en-US" xlink:label="lab_lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial rights, end of period</link:label>
    <link:label id="lab_lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod_label_en-US" xlink:label="lab_lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition Contingent Consideration Potential Cash Payment at End of Period</link:label>
    <link:label id="lab_lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod_documentation_en-US" xlink:label="lab_lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition Contingent Consideration Potential Cash Payment at End of Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod" xlink:href="lgnd-20221231.xsd#lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod" xlink:to="lab_lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_661883f3-f531-41c7-b0c1-32e8b8411222_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of consecutive trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_d1ad0fe6-6ebf-430b-a8b8-1a08351b134b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ContractualRelationshipsAlvogenMember_2f70f935-9621-40d6-bd91-20ff51d914ee_terseLabel_en-US" xlink:label="lab_lgnd_ContractualRelationshipsAlvogenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Relationships - Alvogen</link:label>
    <link:label id="lab_lgnd_ContractualRelationshipsAlvogenMember_label_en-US" xlink:label="lab_lgnd_ContractualRelationshipsAlvogenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Relationships - Alvogen [Member]</link:label>
    <link:label id="lab_lgnd_ContractualRelationshipsAlvogenMember_documentation_en-US" xlink:label="lab_lgnd_ContractualRelationshipsAlvogenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Relationships - Alvogen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractualRelationshipsAlvogenMember" xlink:href="lgnd-20221231.xsd#lgnd_ContractualRelationshipsAlvogenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ContractualRelationshipsAlvogenMember" xlink:to="lab_lgnd_ContractualRelationshipsAlvogenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_f897a189-fdc5-4b4f-a30f-82fab0d05365_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment , gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_41099035-e9dc-4ae2-b7f2-11ab04b39861_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_f0791eee-79df-43aa-a2c0-9d327ec08ad8_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NovanMolluscumProductsMember_713bfd17-2ce3-44f7-8e32-8a5afb10da28_terseLabel_en-US" xlink:label="lab_lgnd_NovanMolluscumProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Novan</link:label>
    <link:label id="lab_lgnd_NovanMolluscumProductsMember_label_en-US" xlink:label="lab_lgnd_NovanMolluscumProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Novan Molluscum Products [Member]</link:label>
    <link:label id="lab_lgnd_NovanMolluscumProductsMember_documentation_en-US" xlink:label="lab_lgnd_NovanMolluscumProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Novan Molluscum Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NovanMolluscumProductsMember" xlink:href="lgnd-20221231.xsd#lgnd_NovanMolluscumProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NovanMolluscumProductsMember" xlink:to="lab_lgnd_NovanMolluscumProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_59d7f75b-fdd3-4b6d-bb7a-786714921390_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions_cb1c88a7-0de2-4ddf-80bd-20f41daac434_terseLabel_en-US" xlink:label="lab_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross payments to acquire business attributable to vested portion of stock options</link:label>
    <link:label id="lab_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions_label_en-US" xlink:label="lab_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross, Attributable to Vested Portion of Stock Options</link:label>
    <link:label id="lab_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions_documentation_en-US" xlink:label="lab_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross, Attributable to Vested Portion of Stock Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" xlink:href="lgnd-20221231.xsd#lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" xlink:to="lab_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_f8b00334-7f01-478d-83f3-6f519c1793d2_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EffectiveIncomeTaxRateReconciliationExpiredTaxCreditsResearch_25f614f8-a197-43a7-ae91-c474fa2d2b0b_terseLabel_en-US" xlink:label="lab_lgnd_EffectiveIncomeTaxRateReconciliationExpiredTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development credits</link:label>
    <link:label id="lab_lgnd_EffectiveIncomeTaxRateReconciliationExpiredTaxCreditsResearch_label_en-US" xlink:label="lab_lgnd_EffectiveIncomeTaxRateReconciliationExpiredTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Expired Tax Credits, Research</link:label>
    <link:label id="lab_lgnd_EffectiveIncomeTaxRateReconciliationExpiredTaxCreditsResearch_documentation_en-US" xlink:label="lab_lgnd_EffectiveIncomeTaxRateReconciliationExpiredTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Expired Tax Credits, Research</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EffectiveIncomeTaxRateReconciliationExpiredTaxCreditsResearch" xlink:href="lgnd-20221231.xsd#lgnd_EffectiveIncomeTaxRateReconciliationExpiredTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EffectiveIncomeTaxRateReconciliationExpiredTaxCreditsResearch" xlink:to="lab_lgnd_EffectiveIncomeTaxRateReconciliationExpiredTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6866812d-09ce-4277-8a62-3ed5e14be138_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid_949dc9d1-b34f-470e-b901-e7baee2d16ca_verboseLabel_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, plant and equipment included in accounts payable and accrued expenses</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid_documentation_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_afb99164-0d6e-448e-bfb7-6a6d49d5a5e7_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_28825974-30ce-4654-b271-5c1434f673b4_verboseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3d61bb4f-4ba8-4fe9-8a68-dc68dc21d545_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_2dd32033-9393-48d1-8995-7db4f944a7aa_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes, net</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_6d0cfe81-155a-46e6-8232-dfc878bc2ef2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on debt instrument (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_156eb04e-8b8a-4a25-8e46-2a8742bc30fc_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate of operating leases (as a percent)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AdditionalRoyaltiesReceivableUnderSalesbasedMilestones_d45ffed1-f467-47dc-bf49-385d46e2fed1_terseLabel_en-US" xlink:label="lab_lgnd_AdditionalRoyaltiesReceivableUnderSalesbasedMilestones" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional royalties receivable under sales-based milestones</link:label>
    <link:label id="lab_lgnd_AdditionalRoyaltiesReceivableUnderSalesbasedMilestones_label_en-US" xlink:label="lab_lgnd_AdditionalRoyaltiesReceivableUnderSalesbasedMilestones" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Royalties Receivable Under Sales-based Milestones</link:label>
    <link:label id="lab_lgnd_AdditionalRoyaltiesReceivableUnderSalesbasedMilestones_documentation_en-US" xlink:label="lab_lgnd_AdditionalRoyaltiesReceivableUnderSalesbasedMilestones" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Royalties Receivable Under Sales-based Milestones</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdditionalRoyaltiesReceivableUnderSalesbasedMilestones" xlink:href="lgnd-20221231.xsd#lgnd_AdditionalRoyaltiesReceivableUnderSalesbasedMilestones"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AdditionalRoyaltiesReceivableUnderSalesbasedMilestones" xlink:to="lab_lgnd_AdditionalRoyaltiesReceivableUnderSalesbasedMilestones" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_745937e3-b2c4-44a6-8925-f207fd0ad916_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_8bc92f92-7f92-4f98-a599-57dd8dd9934c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_1d701ea8-de1a-4a87-9886-65729fc066fe_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_c104f2f5-e1e1-4d56-a708-aa83a8a01fba_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_29f37cba-d2ec-4b93-9587-2e6abcab22df_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_34d49132-e96a-4d9d-baa7-4e5e60bb2ffe_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_78fb71e1-900d-4fef-8f78-77cbb34544ef_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potentially dilutive shares excluded from calculation due to anti-dilutive effect (shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_79dbb65d-5482-4da2-894e-505818957e2d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_002f8c36-2dcf-4ee6-937c-12c78661941e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (USD per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_8a82dc8c-6495-438f-b229-85f8ce353bce_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_0caebf90-e2f9-4628-887c-eff5e073aa70_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Option Plan Activity by Exercise Price Range</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_fb5d2ea9-180c-45e9-85af-287cdd57d230_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_23e9f6f7-88be-4d85-8aa0-0f6eb3effe7f_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_ebcb53ef-3972-4f51-aa33-820bf61be3c3_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_08272af0-253b-48ae-b4e8-961130cdb1a3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_82c51b92-ce60-47c6-b538-db59d1e784d1_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions based on tax positions related to the current year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent_37192362-53bf-46c6-a4ff-ec1adf0031c4_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_56cbf156-bfef-4256-b195-3a5d6f0c14a2_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price (USD per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ScheduleofContingentLiabilitiesTableTextBlock_17b86329-544f-4714-a16b-f9480a54b9ea_terseLabel_en-US" xlink:label="lab_lgnd_ScheduleofContingentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Contingent Liabilities</link:label>
    <link:label id="lab_lgnd_ScheduleofContingentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_lgnd_ScheduleofContingentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Contingent Liabilities [Table Text Block]</link:label>
    <link:label id="lab_lgnd_ScheduleofContingentLiabilitiesTableTextBlock_documentation_en-US" xlink:label="lab_lgnd_ScheduleofContingentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Contingent Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleofContingentLiabilitiesTableTextBlock" xlink:href="lgnd-20221231.xsd#lgnd_ScheduleofContingentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ScheduleofContingentLiabilitiesTableTextBlock" xlink:to="lab_lgnd_ScheduleofContingentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_5c97e0ea-ff91-477b-a462-b659f68b2134_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b89102c4-b374-4cdd-a6df-6133a58768a7_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_d44e2591-f6ea-4da7-ae5a-562168349618_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAxis_cff96b6f-8d08-40a7-9287-0dbe1d26652d_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt [Axis]</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAxis_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ExercisePriceRangeEightMember_57552804-b993-4a5e-974f-94839c9993a8_terseLabel_en-US" xlink:label="lab_lgnd_ExercisePriceRangeEightMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$99.80-$99.80</link:label>
    <link:label id="lab_lgnd_ExercisePriceRangeEightMember_label_en-US" xlink:label="lab_lgnd_ExercisePriceRangeEightMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range Eight [Member]</link:label>
    <link:label id="lab_lgnd_ExercisePriceRangeEightMember_documentation_en-US" xlink:label="lab_lgnd_ExercisePriceRangeEightMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range Eight [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ExercisePriceRangeEightMember" xlink:href="lgnd-20221231.xsd#lgnd_ExercisePriceRangeEightMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ExercisePriceRangeEightMember" xlink:to="lab_lgnd_ExercisePriceRangeEightMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputExpectedDividendRateMember_90202ff7-8875-49ef-9f6f-cfc0a5eee5af_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_MeasurementInputExpectedDividendRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Expected Dividend Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_d706a5f5-b4c0-4b7b-9383-7c955799bff5_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of cash flow information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c9a1f94e-180a-47b4-adbf-753321b21ae4_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_1cb5c5d1-83d8-4f0c-8438-a06c173f8417_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost, restricted stock</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_70e10ba2-b807-4bb6-86bb-19caee62c0b9_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_a2c1b314-4260-4b9c-888f-ab1f6ae2776c_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reacquisition of equity due to 2023 debt extinguishment, net of tax</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_e270361d-e45a-4f0a-8010-205c1592b070_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction to additional paid in capital</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_9b5baa59-1892-4b58-ab75-6b138ce99946_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ExercisePriceRangeTwoMember_5b058e65-fc7b-4e97-ae70-17933aca8839_terseLabel_en-US" xlink:label="lab_lgnd_ExercisePriceRangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$46.20-$52.78</link:label>
    <link:label id="lab_lgnd_ExercisePriceRangeTwoMember_label_en-US" xlink:label="lab_lgnd_ExercisePriceRangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range Two [Member]</link:label>
    <link:label id="lab_lgnd_ExercisePriceRangeTwoMember_documentation_en-US" xlink:label="lab_lgnd_ExercisePriceRangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ExercisePriceRangeTwoMember" xlink:href="lgnd-20221231.xsd#lgnd_ExercisePriceRangeTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ExercisePriceRangeTwoMember" xlink:to="lab_lgnd_ExercisePriceRangeTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_0743bf1b-1d3b-42d8-a74b-dab75bd58e8b_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Term in Years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_4d8074a4-0b7c-4626-b884-a0829bae5ec7_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PartnerBMember_1de190cf-04a4-4293-b7e6-5898b0f49056_terseLabel_en-US" xlink:label="lab_lgnd_PartnerBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partner B</link:label>
    <link:label id="lab_lgnd_PartnerBMember_label_en-US" xlink:label="lab_lgnd_PartnerBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partner B [Member]</link:label>
    <link:label id="lab_lgnd_PartnerBMember_documentation_en-US" xlink:label="lab_lgnd_PartnerBMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partner B [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PartnerBMember" xlink:href="lgnd-20221231.xsd#lgnd_PartnerBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PartnerBMember" xlink:to="lab_lgnd_PartnerBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_357b2de2-85d4-49c7-b7c6-fa666043fa8a_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts owed to former licensees</link:label>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Sales Commission</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalesCommissionCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_fe5f6854-08ba-4d5a-8826-eb6906c3b913_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_62c04715-6682-4be1-b1db-2338e504d15e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds on sale of Vernalis R&amp;D, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions_258ee27b-b013-49fa-888e-0af6aaf26b0e_negatedTerseLabel_en-US" xlink:label="lab_lgnd_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in uncertain tax positions</link:label>
    <link:label id="lab_lgnd_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions_label_en-US" xlink:label="lab_lgnd_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Uncertain Tax Positions</link:label>
    <link:label id="lab_lgnd_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions_documentation_en-US" xlink:label="lab_lgnd_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Uncertain Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions" xlink:href="lgnd-20221231.xsd#lgnd_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions" xlink:to="lab_lgnd_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_543cce18-1968-4d84-ae33-0f1eb05c56e0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts and unbilled receivables</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_555c20de-0a25-4264-bf3b-acc62ee49774_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_94ffbc66-a44d-45f4-a0c7-eefa6d56c0c6_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_77015782-083c-43a2-9e94-883707f8459a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term of operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_db79a871-8f7a-4788-811f-ac0eef87cd59_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0be47400-9ebf-4081-83d9-7ed0296b406c_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_db01bbb4-4788-41de-a60a-a79b6d9a3bcf_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4dcfe8ee-08d7-488c-95c9-a2b929ace3ee_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_d72780c3-8ffa-41b2-ba85-64e1871f1174_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_label_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:to="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_175d435c-778f-49f8-8eab-efd639acc3b5_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_3f66e100-5b50-425b-b0ba-f3b2841d553e_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current expense (benefit):</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_d6894c8d-9b9b-4367-9c6d-d356c0a7d9d5_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_991756a7-9a4c-415c-87b9-7f9a0346d3ea_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_ed75027c-6474-4ee6-836c-eaf622135618_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_336b9787-46de-48df-9c8b-614467657bed_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3037b4e0-0ff9-42e6-b147-609905ffee93_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2285b0a8-ef90-4128-9fe8-3dc6cc73ee2f_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_b821f31a-86bd-4aa5-9551-ace3c3c0e50b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_VestingPeriodOneMember_90b21c7c-8772-4e6d-b609-4d59cfc3dc8f_terseLabel_en-US" xlink:label="lab_lgnd_VestingPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vest 1/8 on the six month anniversary of the date of grant</link:label>
    <link:label id="lab_lgnd_VestingPeriodOneMember_label_en-US" xlink:label="lab_lgnd_VestingPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting Period One [Member]</link:label>
    <link:label id="lab_lgnd_VestingPeriodOneMember_documentation_en-US" xlink:label="lab_lgnd_VestingPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_VestingPeriodOneMember" xlink:href="lgnd-20221231.xsd#lgnd_VestingPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_VestingPeriodOneMember" xlink:to="lab_lgnd_VestingPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_e7869b81-0d2f-4be6-9706-47d031cf46af_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred expense (benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_d26f28f6-88f1-4ccf-bca9-233989852ab2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_ea132475-68d7-45af-bb26-2bb637561fff_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use asset</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_label_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-of-Use Assets</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:href="lgnd-20221231.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:to="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ExercisePriceRangeSixMember_e754195b-94db-46d7-8e9c-5637afbfc5d1_terseLabel_en-US" xlink:label="lab_lgnd_ExercisePriceRangeSixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$67.24-$69.70</link:label>
    <link:label id="lab_lgnd_ExercisePriceRangeSixMember_label_en-US" xlink:label="lab_lgnd_ExercisePriceRangeSixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range Six [Member]</link:label>
    <link:label id="lab_lgnd_ExercisePriceRangeSixMember_documentation_en-US" xlink:label="lab_lgnd_ExercisePriceRangeSixMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range Six [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ExercisePriceRangeSixMember" xlink:href="lgnd-20221231.xsd#lgnd_ExercisePriceRangeSixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ExercisePriceRangeSixMember" xlink:to="lab_lgnd_ExercisePriceRangeSixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_SelexisAndDianomiMember_15d2280d-b456-41aa-b126-87fb8c934222_terseLabel_en-US" xlink:label="lab_lgnd_SelexisAndDianomiMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis and Dianomi</link:label>
    <link:label id="lab_lgnd_SelexisAndDianomiMember_label_en-US" xlink:label="lab_lgnd_SelexisAndDianomiMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis and Dianomi [Member]</link:label>
    <link:label id="lab_lgnd_SelexisAndDianomiMember_documentation_en-US" xlink:label="lab_lgnd_SelexisAndDianomiMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis and Dianomi</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisAndDianomiMember" xlink:href="lgnd-20221231.xsd#lgnd_SelexisAndDianomiMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_SelexisAndDianomiMember" xlink:to="lab_lgnd_SelexisAndDianomiMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount_0e27c922-d4c4-461f-9999-091e93579e79_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase to current federal income tax expense due to Tax Cuts and Jobs Act</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_71eabb6c-ae4f-4255-85ba-202920d2b2b5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_d7a72c7f-4f24-4d58-b74c-be7f49fd6db2_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006Member_6dc5e688-0167-4893-92fd-81ebffdced87_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DeferredTaxLiabilitiesFiniteLivedIntangibleAssets_10144e17-f67b-4467-b5f2-b8bf3964e877_negatedTerseLabel_en-US" xlink:label="lab_lgnd_DeferredTaxLiabilitiesFiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identified intangibles</link:label>
    <link:label id="lab_lgnd_DeferredTaxLiabilitiesFiniteLivedIntangibleAssets_label_en-US" xlink:label="lab_lgnd_DeferredTaxLiabilitiesFiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_lgnd_DeferredTaxLiabilitiesFiniteLivedIntangibleAssets_documentation_en-US" xlink:label="lab_lgnd_DeferredTaxLiabilitiesFiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Finite-Lived Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DeferredTaxLiabilitiesFiniteLivedIntangibleAssets" xlink:href="lgnd-20221231.xsd#lgnd_DeferredTaxLiabilitiesFiniteLivedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DeferredTaxLiabilitiesFiniteLivedIntangibleAssets" xlink:to="lab_lgnd_DeferredTaxLiabilitiesFiniteLivedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_4bafc346-6e04-4f2e-bab2-200b477c28fe_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ComputerEquipmentAndSoftwareMember_9c36e15d-554f-4b44-b2b1-b8e8623143a7_verboseLabel_en-US" xlink:label="lab_lgnd_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer equipment and software</link:label>
    <link:label id="lab_lgnd_ComputerEquipmentAndSoftwareMember_label_en-US" xlink:label="lab_lgnd_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment And Software [Member]</link:label>
    <link:label id="lab_lgnd_ComputerEquipmentAndSoftwareMember_documentation_en-US" xlink:label="lab_lgnd_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer equipment and software.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ComputerEquipmentAndSoftwareMember" xlink:href="lgnd-20221231.xsd#lgnd_ComputerEquipmentAndSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ComputerEquipmentAndSoftwareMember" xlink:to="lab_lgnd_ComputerEquipmentAndSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_1db685a5-0afc-404c-afeb-fe574863dcdd_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (USD per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_3c09ab6d-236e-4b3d-b390-16e329cab842_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_cd18da87-3dbb-48dd-9f11-c71ac4a3cf31_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_eaf4851d-cb54-4125-a08d-a39a1a76502e_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_007c643f-8fad-4aa0-b149-f95a4efff632_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleNotesPayable_b34208c9-fc9c-45da-ac92-a3cc49f9bac0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in carrying amount of notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleNotesPayable_label_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleNotesPayable" xlink:to="lab_us-gaap_ConvertibleNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ProceedsFromCommercialLicenseRights_74b4bfe6-1566-4aa0-8d11-63a110a95563_terseLabel_en-US" xlink:label="lab_lgnd_ProceedsFromCommercialLicenseRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from commercial license rights</link:label>
    <link:label id="lab_lgnd_ProceedsFromCommercialLicenseRights_label_en-US" xlink:label="lab_lgnd_ProceedsFromCommercialLicenseRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Commercial License Rights</link:label>
    <link:label id="lab_lgnd_ProceedsFromCommercialLicenseRights_documentation_en-US" xlink:label="lab_lgnd_ProceedsFromCommercialLicenseRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Commercial License Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ProceedsFromCommercialLicenseRights" xlink:href="lgnd-20221231.xsd#lgnd_ProceedsFromCommercialLicenseRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ProceedsFromCommercialLicenseRights" xlink:to="lab_lgnd_ProceedsFromCommercialLicenseRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseImpairmentLoss_3d944698-08aa-49ce-bca9-e07b9b3788ec_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease, impairment charges</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseImpairmentLoss" xlink:to="lab_us-gaap_FinanceLeaseImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_95c34580-94dd-4e18-bd6a-041d594a344e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from sale of Vernalis R&amp;D</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_c4b85df7-73a8-4bc9-8d9d-5082fcad0d4c_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_e5819b57-49d0-4d7e-9dc1-db5f17673fc0_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract_40a91555-f9db-4780-87ac-9d69f37acda5_terseLabel_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities:</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract_label_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Financing Activities [Abstract]</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract_documentation_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract" xlink:to="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_ad0bf610-354d-4c48-a0a8-62f6856da397_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_4969d787-80b3-404a-950e-674345a56973_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_dbf2dc9f-a3da-459e-85c7-cbc5eb104c43_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_7aec002c-23f5-4117-be69-3140e1f45030_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Option Weighted-Average Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_624fa9ac-321c-4e71-9b86-4632ef67b2b6_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_96d5a85b-a8c6-4f6b-bb1c-c56086252262_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Account Details</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_7d3ff08d-cb47-42ba-a179-623da30d3756_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Benefit</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_b357c019-cd48-48c3-822f-d6dda5319641_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants issued in public offering (shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_3dc6464d-23a9-4bac-bf0d-0ee60dcf5a10_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average period in which cost is expected to be recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesCurrent_c4e0b476-880a-48bb-b42b-4d55788c545a_terseLabel_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current contingent liabilities</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesCurrent_label_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Contingent Liabilities, Current</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesCurrent_documentation_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Contingent Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesCurrent" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesCurrent" xlink:to="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2fe5b2ac-4fce-48dc-9c20-289151540e51_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual term, exercisable (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_aae805f2-d05e-4fb4-af0b-0290ed34f87d_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash consideration</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_2ba3351a-9f0a-454e-8f21-4045a5a9c506_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments_8ed73aa2-ff11-46f5-b997-505942f4159c_negatedLabel_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments_label_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization, Research &amp; Development Expense, and Credit Loss Adjustments</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments_documentation_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization, Research &amp; Development Expense, and Credit Loss Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments" xlink:href="lgnd-20221231.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments" xlink:to="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_a316e29b-5079-4d65-a1ca-7bd204e17821_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangibles acquired</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_label_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" xlink:href="lgnd-20221231.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" xlink:to="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesOperatingLeaseNoncurrent_e4086db3-c260-41a9-a3c3-5b39768bba24_terseLabel_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesOperatingLeaseNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesOperatingLeaseNoncurrent_label_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesOperatingLeaseNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Operating Lease, Noncurrent</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesOperatingLeaseNoncurrent_documentation_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesOperatingLeaseNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Operating Lease, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesOperatingLeaseNoncurrent" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesOperatingLeaseNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesOperatingLeaseNoncurrent" xlink:to="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesOperatingLeaseNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_21f08b49-8139-4351-be2f-82efd7627470_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upper range of exercise prices (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MutualFundMember_b69490fa-2be1-476d-952e-1c0358e91089_terseLabel_en-US" xlink:label="lab_us-gaap_MutualFundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual fund</link:label>
    <link:label id="lab_us-gaap_MutualFundMember_label_en-US" xlink:label="lab_us-gaap_MutualFundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual Fund [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MutualFundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MutualFundMember" xlink:to="lab_us-gaap_MutualFundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_ae3594f6-fb6f-43d6-baee-0bc32169999b_terseLabel_en-US" xlink:label="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of commercial license and other economic rights</link:label>
    <link:label id="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_label_en-US" xlink:label="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Commercial License and Other Economic Rights</link:label>
    <link:label id="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_documentation_en-US" xlink:label="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Commercial License and Other Economic Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" xlink:href="lgnd-20221231.xsd#lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" xlink:to="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_d84431ff-c81c-4041-9490-99a3c36821ac_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsAbstract_aaa74770-f65c-49bb-9431-199c4ca32174_terseLabel_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsAbstract_label_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets [Abstract]</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsAbstract_documentation_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsAbstract" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsAbstract" xlink:to="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_db548bc4-dda1-4a26-873d-12f3db1eda29_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsFinanceLeaseAssets_443ce5f8-27e6-4cc8-ae8b-5ae255d1426f_terseLabel_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsFinanceLeaseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease assets</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsFinanceLeaseAssets_label_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsFinanceLeaseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Finance Lease Assets</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsFinanceLeaseAssets_documentation_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsFinanceLeaseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Finance Lease Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsFinanceLeaseAssets" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsFinanceLeaseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsFinanceLeaseAssets" xlink:to="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsFinanceLeaseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_0141d616-0f5a-44f9-844b-4819bf79b3f6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from debt issuance</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Debt, Net of Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_8444568e-2b51-4f0a-a2fd-dcc47cc9beff_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_690310af-9d16-4c49-b13c-56335761c6dc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible debt conversion ratio</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_91c7a2b9-e4d1-45df-b15e-2ec67b7cf385_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_1a2d36ad-ad60-4a49-b73f-2b2c85932393_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_c5f7544d-3b4b-449f-a94e-aad062054159_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWriteDown_cd65bede-b0a0-4bf2-9181-3eb4cc76b448_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-downs related to obsolete inventory</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_5ca0b160-cbb6-488b-b1b2-5bbd30a1d3fe_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Approximate Fair Value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_e6441455-a37c-4a2a-aca1-d8217dbb52c9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_f9401835-f4e7-4ec7-9fa5-bfdaee3f5278_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_c97d7726-85f7-40aa-9040-36d33ec3809c_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_1a26a1d5-fbe0-4af5-bd51-61b40123b449_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated amortization expense for 2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_45e4fc74-e1a6-4467-a13c-e97838f8bfe0_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining life in years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ec9eab72-bde3-45bc-9656-19dabee44f89_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e152fea4-8722-4294-9cf9-79465cc632cd_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_8597a2b1-80bf-4581-b368-f48ffbdca75c_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract_7bd1c1a1-f84f-4ca8-9744-4e99731b3c6f_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_0a2b758d-fc2d-450c-b652-b76819a82baf_verboseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_17ab7ae4-503c-43df-ab40-615b05a7287b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_eb42a6c4-081a-4d4f-a539-63e1366ecf95_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_671b189e-5ad7-4faa-8a0b-74a32a078e96_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of level 3 financial instruments at beginning of period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_e98a2a0e-18b3-4f73-9d04-abee0855b1fc_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of level 3 financial instruments at end of period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_5df5f9e3-55c9-4141-a9dd-d9c8f2eb1402_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_dd16ed93-180e-415b-8648-27ea5fec1b0c_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues (as a percent)</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_dd77dd9d-fb5e-44f4-b104-856ac5c4fcc9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_608e5c7a-f6a7-4f07-9f9e-03086b3a8bd9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (loss)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_70ff81a4-489c-4cf6-9119-4b79eeeec310_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_895e07ee-41d1-4e43-8f53-1db5b92aa494_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_ceabe4c9-efa9-47a6-be6c-60c95ffb2d8f_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current liabilities of discontinued operations</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_e9e5ca7a-476d-49dc-a404-8d12a6c358a6_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs and expenses</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_da01e38e-1fa8-4fec-80a6-609bb8cd82ff_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs and expenses</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpenses" xlink:to="lab_us-gaap_OperatingCostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_489b0f4f-2fc6-47c9-bf04-1448448b05c3_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income (loss) per share (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtCurrent_0ce7e710-51dd-49f5-b14c-4e8d91bf227b_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 convertible senior notes, net</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtCurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtCurrent" xlink:to="lab_us-gaap_ConvertibleDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_d2b15a39-d1b6-4147-b6b9-ee5824449670_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_8718c300-d038-4c0e-b546-8d7003a77b04_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_fde6858e-c9c2-4471-864e-ac523c00a8d3_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_02e9cce4-d075-4893-b4fb-bd38e565f15e_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_87e66715-466d-4829-bcf5-c08c2c8a755e_terseLabel_en-US" xlink:label="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for restricted investments owed to former licensees</link:label>
    <link:label id="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_label_en-US" xlink:label="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Restricted Investments Owed to Former Licensees [Member]</link:label>
    <link:label id="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_documentation_en-US" xlink:label="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Restricted Investments Owed to Former Licensees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:href="lgnd-20221231.xsd#lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:to="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5ca0cc4b-321d-4c57-a280-823832d78f47_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_88419681-042f-4ea9-a57e-72d8941f81a8_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, net of acquisitions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_VernalisMember_6cd5befb-efaa-4d89-a853-2487981019cf_terseLabel_en-US" xlink:label="lab_lgnd_VernalisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vernalis</link:label>
    <link:label id="lab_lgnd_VernalisMember_label_en-US" xlink:label="lab_lgnd_VernalisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vernalis [Member]</link:label>
    <link:label id="lab_lgnd_VernalisMember_documentation_en-US" xlink:label="lab_lgnd_VernalisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vernalis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_VernalisMember" xlink:href="lgnd-20221231.xsd#lgnd_VernalisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_VernalisMember" xlink:to="lab_lgnd_VernalisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_96abfb73-0e7d-461e-99ed-0741583a3b97_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_3e4ee9c3-72df-40d6-b0dc-7209c304c42a_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of short-term investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_759186b8-e139-4058-83c9-6477018f05d7_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_66fe13ab-2de6-4817-95b3-49ad1aa9cead_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_RoyaltyAgreementExpirationPeriod_d7bf9701-b77b-4b0d-8122-cc5ed6023b92_terseLabel_en-US" xlink:label="lab_lgnd_RoyaltyAgreementExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration period of royalty agreement</link:label>
    <link:label id="lab_lgnd_RoyaltyAgreementExpirationPeriod_label_en-US" xlink:label="lab_lgnd_RoyaltyAgreementExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Agreement, Expiration Period</link:label>
    <link:label id="lab_lgnd_RoyaltyAgreementExpirationPeriod_documentation_en-US" xlink:label="lab_lgnd_RoyaltyAgreementExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Agreement, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyAgreementExpirationPeriod" xlink:href="lgnd-20221231.xsd#lgnd_RoyaltyAgreementExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_RoyaltyAgreementExpirationPeriod" xlink:to="lab_lgnd_RoyaltyAgreementExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_RestrictedStockUnitsAndPerformanceSharesMember_ab52fb53-ca5a-4e87-a22b-28b9fd18f364_terseLabel_en-US" xlink:label="lab_lgnd_RestrictedStockUnitsAndPerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs and PSUs</link:label>
    <link:label id="lab_lgnd_RestrictedStockUnitsAndPerformanceSharesMember_label_en-US" xlink:label="lab_lgnd_RestrictedStockUnitsAndPerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units and Performance Shares [Member]</link:label>
    <link:label id="lab_lgnd_RestrictedStockUnitsAndPerformanceSharesMember_documentation_en-US" xlink:label="lab_lgnd_RestrictedStockUnitsAndPerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units and Performance Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RestrictedStockUnitsAndPerformanceSharesMember" xlink:href="lgnd-20221231.xsd#lgnd_RestrictedStockUnitsAndPerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_RestrictedStockUnitsAndPerformanceSharesMember" xlink:to="lab_lgnd_RestrictedStockUnitsAndPerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock_2dc9d7ea-6b56-41f1-b3eb-0bc40da0c235_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:to="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_ebf53897-d7f7-45ea-8c0e-a42b953883d0_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock compensation plans, net</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_3a75dd14-bfe1-42f7-beca-bbe6d2706472_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchases</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AuditInformationAbstract_label_en-US" xlink:label="lab_lgnd_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_lgnd_AuditInformationAbstract_documentation_en-US" xlink:label="lab_lgnd_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AuditInformationAbstract" xlink:href="lgnd-20221231.xsd#lgnd_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AuditInformationAbstract" xlink:to="lab_lgnd_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_TwoThousandTwoStockIncentivePlanMember_e3e75e66-3108-4286-8a31-f9971ffbd89e_terseLabel_en-US" xlink:label="lab_lgnd_TwoThousandTwoStockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2002 Stock Incentive Plan</link:label>
    <link:label id="lab_lgnd_TwoThousandTwoStockIncentivePlanMember_label_en-US" xlink:label="lab_lgnd_TwoThousandTwoStockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two thousand Two Stock Incentive Plan [Member]</link:label>
    <link:label id="lab_lgnd_TwoThousandTwoStockIncentivePlanMember_documentation_en-US" xlink:label="lab_lgnd_TwoThousandTwoStockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two thousand two Stock Incentive Plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_TwoThousandTwoStockIncentivePlanMember" xlink:href="lgnd-20221231.xsd#lgnd_TwoThousandTwoStockIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_TwoThousandTwoStockIncentivePlanMember" xlink:to="lab_lgnd_TwoThousandTwoStockIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_0b4e4979-cbb8-4b84-902b-0c4f21a4821d_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_68b17f47-671f-48ff-9bb5-9358f1831d7b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent_389c5047-d1dd-4ef3-84ec-2ba3cd0f9339_terseLabel_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current operating lease liabilities</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent_label_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease Liabilities, Current</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent_documentation_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent" xlink:to="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_IncreaseDecreaseInDebtDiscount_7906140f-8539-4016-86bd-0eb9caeb2fe2_negatedTerseLabel_en-US" xlink:label="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction in debt discount</link:label>
    <link:label id="lab_lgnd_IncreaseDecreaseInDebtDiscount_label_en-US" xlink:label="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Debt Discount</link:label>
    <link:label id="lab_lgnd_IncreaseDecreaseInDebtDiscount_documentation_en-US" xlink:label="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Debt Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IncreaseDecreaseInDebtDiscount" xlink:href="lgnd-20221231.xsd#lgnd_IncreaseDecreaseInDebtDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_IncreaseDecreaseInDebtDiscount" xlink:to="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_0371cec1-cb27-4c0c-9a1d-c26fe66f5db1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renewal term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_7b9f748c-6e9d-440e-a45b-17ccbfbc65c4_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_298adfd0-17d1-4641-b22d-8810b4440856_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e68bab81-b7f5-4aa5-8bb3-cf88bf078441_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_f72c2487-4d8c-4dab-8fa1-a43ac6db110c_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_47137461-80bc-458b-a4f2-108c8d303256_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of contingent earn-out payment</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_label_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Fair Value Disclosure</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:href="lgnd-20221231.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:to="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_f5ae5f9b-411e-489f-9bf7-ef6edcbe7cdf_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at end of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_e89fdfb3-5065-45e4-a0d8-795bf370b8bd_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pro Forma Information</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights_fdec80b9-52bc-41ee-b2d1-f9dd9778acfc_terseLabel_en-US" xlink:label="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current contingent liabilities</link:label>
    <link:label id="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights_label_en-US" xlink:label="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Portion of Liability for Contingent Value Rights</link:label>
    <link:label id="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights_documentation_en-US" xlink:label="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of liability for contingent value rights.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:href="lgnd-20221231.xsd#lgnd_CurrentPortionOfLiabilityForContingentValueRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:to="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_767d9b14-04af-4fd0-bd83-b33fce6632c0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_91f5018e-e6a5-45a4-a799-3c0e30cc860a_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_29932827-854e-4bc2-bdc3-a10cf0ab35ae_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_25e7e3ba-1d5c-4d2c-a706-df4765483b09_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments under finance lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_4ab8b12c-a248-4dec-86b7-60305e361971_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_0fc4f63b-a4c7-40a2-aed2-4c25ed407813_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current expense (benefit)</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDiscontinuedOperationsMember_d7e14f3a-cefb-4ff2-b1a4-e4a3eb0626f7_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_SegmentDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_SegmentDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDiscontinuedOperationsMember" xlink:to="lab_us-gaap_SegmentDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_aa1bf92f-654a-4c6f-bcd1-0f2e17e4221a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsAmount_7fef767e-dcae-4f59-85fc-cebe97abe91f_negatedTerseLabel_en-US" xlink:label="lab_lgnd_EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision to return adjustments</link:label>
    <link:label id="lab_lgnd_EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsAmount_label_en-US" xlink:label="lab_lgnd_EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Provision to Return Adjustments, Amount</link:label>
    <link:label id="lab_lgnd_EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsAmount_documentation_en-US" xlink:label="lab_lgnd_EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Provision to Return Adjustments, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsAmount" xlink:href="lgnd-20221231.xsd#lgnd_EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsAmount" xlink:to="lab_lgnd_EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_39d1de10-c9e1-4be2-9cdd-ab2442700200_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options vested and expected to vest at end of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_1d93dc77-232d-4f54-a2d6-0178b78cd215_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AssetsAndLiabilitiesLesseeTableTextBlock_0f84f9a3-84c0-4e03-aad2-fa15d333b73f_terseLabel_en-US" xlink:label="lab_lgnd_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating and Finance Lease Assets and Liabilities</link:label>
    <link:label id="lab_lgnd_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_lgnd_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_lgnd_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_lgnd_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities, Lessee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="lgnd-20221231.xsd#lgnd_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_lgnd_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentedTechnologyMember_e11b6344-e85f-4222-859d-3bc38ceadf2a_verboseLabel_en-US" xlink:label="lab_us-gaap_PatentedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Complete technology</link:label>
    <link:label id="lab_us-gaap_PatentedTechnologyMember_label_en-US" xlink:label="lab_us-gaap_PatentedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patented Technology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentedTechnologyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentedTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentedTechnologyMember" xlink:to="lab_us-gaap_PatentedTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_cd48a6e9-6fff-4a88-bdae-8ee7b7870941_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_52993ee7-3034-4485-a430-560da61328e4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_08905a05-65fa-44c4-b46a-9764fa3284c1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_49a255d6-9d44-47ef-b25f-8ad717ee3a86_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ExercisePriceRangeFourMember_3a096b85-8db9-4f07-b504-4ee3e7e505ee_terseLabel_en-US" xlink:label="lab_lgnd_ExercisePriceRangeFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$54.81-$57.22</link:label>
    <link:label id="lab_lgnd_ExercisePriceRangeFourMember_label_en-US" xlink:label="lab_lgnd_ExercisePriceRangeFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range Four [Member]</link:label>
    <link:label id="lab_lgnd_ExercisePriceRangeFourMember_documentation_en-US" xlink:label="lab_lgnd_ExercisePriceRangeFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range Four [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ExercisePriceRangeFourMember" xlink:href="lgnd-20221231.xsd#lgnd_ExercisePriceRangeFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ExercisePriceRangeFourMember" xlink:to="lab_lgnd_ExercisePriceRangeFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock_d180c910-82be-4a02-9212-572aab16d84b_terseLabel_en-US" xlink:label="lab_lgnd_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Principles of Consolidation</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_lgnd_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis Of Presentation And Principles Of Consolidation [Policy Text Block]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock_documentation_en-US" xlink:label="lab_lgnd_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis Of Presentation And Principles Of Consolidation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" xlink:href="lgnd-20221231.xsd#lgnd_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" xlink:to="lab_lgnd_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_db4c632b-f40e-4e27-9551-53d2445d575c_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_ba827216-45a7-43d9-8f1f-e8501937caae_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1fa78b83-7c2d-4842-a87a-c32358b8eec2_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ConvertibleSeniorNotesDue2023Member_627b046e-76ab-4876-b1ab-007fa14fd656_terseLabel_en-US" xlink:label="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Convertible Senior Notes</link:label>
    <link:label id="lab_lgnd_ConvertibleSeniorNotesDue2023Member_label_en-US" xlink:label="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes due 2023 [Member]</link:label>
    <link:label id="lab_lgnd_ConvertibleSeniorNotesDue2023Member_documentation_en-US" xlink:label="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes due 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:href="lgnd-20221231.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:to="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_d15fa7d9-b276-480c-a622-0076621e00b8_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit (expense)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_f34a8182-8f43-48c6-8720-8745346e9308_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_13aed051-8abd-45e7-9fa2-5a8ab7eb61ee_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance for deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_754f8118-21a0-4e69-a175-bbcab3fa9344_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_7cf976f6-83e2-46c2-a46f-a420ec4e210c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease of deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_18e37c27-92db-4178-bf55-ec22297da0be_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_f670e0d9-f458-4b5b-950e-84eed384b761_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash to settle unvested stock options recognized as share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Cash Used to Settle Award</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8d883f47-2643-4e40-8dbb-70447d94da90_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_b5ee9287-ba0f-4d4f-8659-811a10e04a17_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares allowed to purchase in employee stock purchase plan per employee (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_8ad37ec7-2e16-4902-9169-ffc76450d34c_verboseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 convertible senior notes, net</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:to="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_f811f0f3-2639-4c24-8bdf-acb5b4005db1_terseLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_abe34879-6c92-41bb-88d6-0b12936c0ce8_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.001 par value; 60,000 shares authorized; 16,951 and 16,767 shares issued and outstanding at December&#160;31, 2022 and 2021, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_68f61539-a6c9-4752-aac3-f28a87f616fd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income (loss) from discontinued operations (USD per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_2f6dcab3-53c1-4f80-aec0-82b6076a2401_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_bc9a75cb-5745-4c11-9c3a-c02d5241dd58_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilitiesCurrent_7f180c57-fcaa-4301-8a4b-190083c303c8_terseLabel_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current finance lease liabilities</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilitiesCurrent_label_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Finance Lease Liabilities, Current</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilitiesCurrent_documentation_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Finance Lease Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilitiesCurrent" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilitiesCurrent" xlink:to="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_9c6118a4-7d81-4ec9-8d38-3977a3a72bb7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integration related costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Integration Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGrossAbstract_ab49bd9e-61b4-42bd-8d86-fe33964fad53_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGrossAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_44cadb74-f268-4b40-bf04-9c59671ad901_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating (income) expense</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_0796d0a3-3fea-454a-99c6-ea48258a1d99_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt conversion price per share (USD per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireBusinessesNetOfCashAcquired_f7ea3fcd-c1d1-4d14-8358-8029e1134589_negatedTerseLabel_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for acquisition, net of cash acquired</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireBusinessesNetOfCashAcquired_documentation_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ContractualRelationshipsMerckMember_7ce0ef46-6932-4abb-93fe-78b7301170ce_terseLabel_en-US" xlink:label="lab_lgnd_ContractualRelationshipsMerckMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Relationships - Merck</link:label>
    <link:label id="lab_lgnd_ContractualRelationshipsMerckMember_label_en-US" xlink:label="lab_lgnd_ContractualRelationshipsMerckMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Relationships - Merck [Member]</link:label>
    <link:label id="lab_lgnd_ContractualRelationshipsMerckMember_documentation_en-US" xlink:label="lab_lgnd_ContractualRelationshipsMerckMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Relationships - Merck</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractualRelationshipsMerckMember" xlink:href="lgnd-20221231.xsd#lgnd_ContractualRelationshipsMerckMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ContractualRelationshipsMerckMember" xlink:to="lab_lgnd_ContractualRelationshipsMerckMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_8fb4e1fc-36b0-442d-883e-bd2e25cd4308_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b50afe64-a6d3-4a48-89e8-cc6b0c4d27f7_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4d088817-6f53-4de8-845e-2971065eed58_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_72cf64f3-9c09-4055-aa75-7a9a107993ae_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CashPaidDuringTheYearAbstract_ea18c422-6e4c-4230-81c2-08856a6b057f_terseLabel_en-US" xlink:label="lab_lgnd_CashPaidDuringTheYearAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during the year:</link:label>
    <link:label id="lab_lgnd_CashPaidDuringTheYearAbstract_label_en-US" xlink:label="lab_lgnd_CashPaidDuringTheYearAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid During the Year [Abstract]</link:label>
    <link:label id="lab_lgnd_CashPaidDuringTheYearAbstract_documentation_en-US" xlink:label="lab_lgnd_CashPaidDuringTheYearAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid During the Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CashPaidDuringTheYearAbstract" xlink:href="lgnd-20221231.xsd#lgnd_CashPaidDuringTheYearAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CashPaidDuringTheYearAbstract" xlink:to="lab_lgnd_CashPaidDuringTheYearAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_1445d3a7-9171-41aa-b441-68992703389a_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_4e9020d5-1cd3-4021-99c5-d9b6cfecfa92_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_6ae102e1-5e31-464a-85e1-7003848823ae_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from stock option exercises and ESPP</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRoyaltiesReceived_63707082-18fb-408f-b1f7-f150089ed3f8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRoyaltiesReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from royalties received</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRoyaltiesReceived_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRoyaltiesReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Royalties Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRoyaltiesReceived" xlink:to="lab_us-gaap_ProceedsFromRoyaltiesReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_b81e1e56-9414-4de9-8f09-8a6ee6ebc746_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_eb4d7349-7055-41df-b712-d5dd1e3979fa_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual term, vested and expected to vest (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_0ce20218-7f1e-4b23-8234-897dccbf336b_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessSpinOffAndMigrationPolicyTextBlock_0195e454-bf9b-45b8-96ee-44e408e1f845_terseLabel_en-US" xlink:label="lab_lgnd_BusinessSpinOffAndMigrationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business</link:label>
    <link:label id="lab_lgnd_BusinessSpinOffAndMigrationPolicyTextBlock_label_en-US" xlink:label="lab_lgnd_BusinessSpinOffAndMigrationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Spin-Off And Migration [Policy Text Block]</link:label>
    <link:label id="lab_lgnd_BusinessSpinOffAndMigrationPolicyTextBlock_documentation_en-US" xlink:label="lab_lgnd_BusinessSpinOffAndMigrationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Spin-Off And Migration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessSpinOffAndMigrationPolicyTextBlock" xlink:href="lgnd-20221231.xsd#lgnd_BusinessSpinOffAndMigrationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessSpinOffAndMigrationPolicyTextBlock" xlink:to="lab_lgnd_BusinessSpinOffAndMigrationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_4d2a2594-81f2-4de8-9a1c-bd18c1f390f1_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease expense</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PartnerCMember_ac6c93fe-1222-4e48-9f4c-e8d96d5d6da9_terseLabel_en-US" xlink:label="lab_lgnd_PartnerCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partner C</link:label>
    <link:label id="lab_lgnd_PartnerCMember_label_en-US" xlink:label="lab_lgnd_PartnerCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partner C [Member]</link:label>
    <link:label id="lab_lgnd_PartnerCMember_documentation_en-US" xlink:label="lab_lgnd_PartnerCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partner C [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PartnerCMember" xlink:href="lgnd-20221231.xsd#lgnd_PartnerCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PartnerCMember" xlink:to="lab_lgnd_PartnerCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstanding_67c855f9-9a76-4da6-9c1d-6b27149c43ce_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstanding_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and Rights Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstanding" xlink:to="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_df7108fd-f2d9-4bb5-8afd-089b63226b0c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_a7174955-9990-40bc-bb88-86806c581184_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of positions in an unrealized loss position</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_cc283b80-72ae-4550-b1f3-27f4a978c75e_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesNoncurrent_c9d04cd6-6461-48d7-93f4-5aee3e9ae6d8_terseLabel_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term contingent liabilities</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesNoncurrent_label_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">"Disposal Group, Including Discontinued Operation, Contingent Liabilities, Noncurrent</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesNoncurrent_documentation_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">"Disposal Group, Including Discontinued Operation, Contingent Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesNoncurrent" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesNoncurrent" xlink:to="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_804d62b6-1fda-4039-996d-46928ca54d3b_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_e25379b8-3784-45c6-86a5-21d6fa8d630c_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible asset, useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_9d16329d-3913-4191-9e4e-6b1b018c6221_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease term of operating leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpenditureDiscontinuedOperations_093ea135-8223-47d0-84e6-7c2d31d9c847_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpenditureDiscontinuedOperations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_CapitalExpenditureDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CapitalExpenditureDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditure, Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpenditureDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpenditureDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpenditureDiscontinuedOperations" xlink:to="lab_us-gaap_CapitalExpenditureDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ExercisePriceRangeNineMember_3b7b83c0-e1ef-4f58-ae5c-2e6fa40c7790_terseLabel_en-US" xlink:label="lab_lgnd_ExercisePriceRangeNineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$103.42-$103.42</link:label>
    <link:label id="lab_lgnd_ExercisePriceRangeNineMember_label_en-US" xlink:label="lab_lgnd_ExercisePriceRangeNineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range Nine [Member]</link:label>
    <link:label id="lab_lgnd_ExercisePriceRangeNineMember_documentation_en-US" xlink:label="lab_lgnd_ExercisePriceRangeNineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range Nine [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ExercisePriceRangeNineMember" xlink:href="lgnd-20221231.xsd#lgnd_ExercisePriceRangeNineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ExercisePriceRangeNineMember" xlink:to="lab_lgnd_ExercisePriceRangeNineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_VestingPeriodTwoMember_038e3ea4-95ed-455f-b7e7-2fdd4fed7c0b_terseLabel_en-US" xlink:label="lab_lgnd_VestingPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vest 1/48 each month for forty-two months</link:label>
    <link:label id="lab_lgnd_VestingPeriodTwoMember_label_en-US" xlink:label="lab_lgnd_VestingPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting Period Two [Member]</link:label>
    <link:label id="lab_lgnd_VestingPeriodTwoMember_documentation_en-US" xlink:label="lab_lgnd_VestingPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_VestingPeriodTwoMember" xlink:href="lgnd-20221231.xsd#lgnd_VestingPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_VestingPeriodTwoMember" xlink:to="lab_lgnd_VestingPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_02ced171-d209-4ef9-89b9-9675fa2b1923_negatedLabel_en-US" xlink:label="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in estimated fair value of contingent liabilities</link:label>
    <link:label id="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_label_en-US" xlink:label="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Cash Change In Estimated Fair Value Of Contingent Value Rights</link:label>
    <link:label id="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_documentation_en-US" xlink:label="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Cash Change In Estimated Fair Value Of Contingent Value Rights.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:href="lgnd-20221231.xsd#lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:to="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_d0d427c8-eb24-4557-a136-2b4ec0d8e4d5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_77523339-909f-4864-919f-47877d71aa13_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_59c6a27c-c236-4546-816d-961e64b742ca_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for OmniAb transaction costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Merger Related Costs, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:to="lab_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_4a30a00f-7fec-4510-af61-9863e0a0ea74_terseLabel_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant and bond hedge unwind transactions</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_label_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_documentation_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:href="lgnd-20221231.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:to="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_8f033ebc-169b-40d4-8976-4ef1468010b5_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_a129fb4f-9bde-4099-b31a-457d4a0f4a05_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_IncomeTaxReconciliationContingentValueRights_068ff084-cc98-421f-b05b-8fe781f5ed2b_terseLabel_en-US" xlink:label="lab_lgnd_IncomeTaxReconciliationContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities</link:label>
    <link:label id="lab_lgnd_IncomeTaxReconciliationContingentValueRights_label_en-US" xlink:label="lab_lgnd_IncomeTaxReconciliationContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Reconciliation, Contingent Value Rights</link:label>
    <link:label id="lab_lgnd_IncomeTaxReconciliationContingentValueRights_documentation_en-US" xlink:label="lab_lgnd_IncomeTaxReconciliationContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Reconciliation, Contingent Value Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IncomeTaxReconciliationContingentValueRights" xlink:href="lgnd-20221231.xsd#lgnd_IncomeTaxReconciliationContingentValueRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_IncomeTaxReconciliationContingentValueRights" xlink:to="lab_lgnd_IncomeTaxReconciliationContingentValueRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_898e23ec-dc88-4ce8-8330-bef73741a73f_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at end of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_6d1f51a8-0396-4afb-8e11-0ac390c847e1_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation of fixed assets and amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_f9dee79d-4baa-46b6-8b89-503f64d359b8_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proportion of fair market value of common stock at which stock is purchased under ESPP (as a percent)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_17b9f7fb-43a4-4315-afe6-922b9e47938f_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Unrealized Loss Position, Accumulated Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_c6aa1a32-8544-4047-9162-88ecda486fcf_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs and expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_a2b8a8e5-1af9-49d5-8f29-91d0ce00479e_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_10a83886-3b91-46cb-b1e3-1035aa86d58e_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total goodwill and other identifiable intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Including Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_dd1cd9b0-76fb-4065-a410-a4b49b363b4e_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_eecbfa72-fe2f-4a64-a4e8-0b376b6cb945_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_ea5e83e6-1733-4871-b47d-5a3c330df2e6_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_a3252be8-df02-4a45-9ff5-722d3b01cf6c_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_cd6ec568-6a21-47b6-b1ab-f01c4e509836_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_abbcdc3d-c87a-4f2a-87b9-ccea8deb0ea2_totalLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs and expenses</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm_5bd730c9-6b07-44d6-a2ea-3daca059d322_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease term of finance leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeaseRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm" xlink:to="lab_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0b5a71e7-f53e-4a73-ab42-ed7429aea824_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized net gain (loss) on available-for-sale securities, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_de6b363a-87ab-4c63-89c5-e6135097f109_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock authorized (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_282fad5b-78b6-4d7d-a061-921327b4f874_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_bbb1d75c-b59b-4d48-ab8c-f0c9e1e8b9e8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AtTheMarketEquityOfferingMember_b00f8565-8ce0-45ec-89a5-a4eb83fc37cf_terseLabel_en-US" xlink:label="lab_lgnd_AtTheMarketEquityOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At-The Market Equity Offering</link:label>
    <link:label id="lab_lgnd_AtTheMarketEquityOfferingMember_label_en-US" xlink:label="lab_lgnd_AtTheMarketEquityOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At-The Market Equity Offering [Member]</link:label>
    <link:label id="lab_lgnd_AtTheMarketEquityOfferingMember_documentation_en-US" xlink:label="lab_lgnd_AtTheMarketEquityOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At-The Market Equity Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AtTheMarketEquityOfferingMember" xlink:href="lgnd-20221231.xsd#lgnd_AtTheMarketEquityOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AtTheMarketEquityOfferingMember" xlink:to="lab_lgnd_AtTheMarketEquityOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f840ff28-c584-4355-b7f2-65780f3b159c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_12f70ff6-cf80-47eb-b518-728570041fa1_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_08747095-457e-40cc-807f-8621aae49a1e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationNetAssetsTransferred_d3d9c3d2-efff-4b65-bdd1-22a2250dba47_totalLabel_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationNetAssetsTransferred" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets transferred to OmniAb</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationNetAssetsTransferred_label_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationNetAssetsTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Net Assets Transferred</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationNetAssetsTransferred_documentation_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationNetAssetsTransferred" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Net Assets Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationNetAssetsTransferred" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationNetAssetsTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationNetAssetsTransferred" xlink:to="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationNetAssetsTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_b14fa219-0bbe-4885-ac2e-0fca29750030_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_f36c053e-6531-4d05-a8f8-73fb830fb490_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_43604bbf-9ea1-4943-9af4-77519e365932_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_42f967cc-d020-4743-b2f3-7808deb1500d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_2f4d32cd-4cc1-41a1-9867-42b57be63f83_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss_ba1cc57d-e53e-4861-94ab-582f33e4e734_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Unrealized Loss Position, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CommercialLicenseRightsPolicyTextBlock_f0d510f8-9736-456c-afe5-401c723e185c_terseLabel_en-US" xlink:label="lab_lgnd_CommercialLicenseRightsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial license and other economic rights</link:label>
    <link:label id="lab_lgnd_CommercialLicenseRightsPolicyTextBlock_label_en-US" xlink:label="lab_lgnd_CommercialLicenseRightsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License Rights [Policy Text Block]</link:label>
    <link:label id="lab_lgnd_CommercialLicenseRightsPolicyTextBlock_documentation_en-US" xlink:label="lab_lgnd_CommercialLicenseRightsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License Rights [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRightsPolicyTextBlock" xlink:href="lgnd-20221231.xsd#lgnd_CommercialLicenseRightsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CommercialLicenseRightsPolicyTextBlock" xlink:to="lab_lgnd_CommercialLicenseRightsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_1b8570b6-bd5b-4b6a-83a9-27f08714a76e_totalLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before income tax</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubleaseIncome_1cbe65c8-8d89-4e4a-9cb7-b3389d710b56_terseLabel_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease income</link:label>
    <link:label id="lab_us-gaap_SubleaseIncome_label_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubleaseIncome" xlink:to="lab_us-gaap_SubleaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_b526a89a-9cb7-4913-8c60-6996218e1186_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_53adb355-30b4-4014-a33b-44905fa427d5_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_fe456b7f-aa1e-4850-a65d-43707b5450bf_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_6fdc1151-5ffe-4be7-8573-8178078b0030_terseLabel_en-US" xlink:label="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate of forecasted cash flows (as a percent)</link:label>
    <link:label id="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_label_en-US" xlink:label="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecasted Cash Flows, Effective Interest Rate, Percent</link:label>
    <link:label id="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_documentation_en-US" xlink:label="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecasted Cash Flows, Effective Interest Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" xlink:href="lgnd-20221231.xsd#lgnd_ForecastedCashFlowsEffectiveInterestRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" xlink:to="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_2e7689fe-ca4c-45e9-84b1-0a61d22db4e5_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_RoyaltyKyprolisMember_a401c7ed-fbdf-4dd5-8167-0e57eb561092_terseLabel_en-US" xlink:label="lab_lgnd_RoyaltyKyprolisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kyprolis</link:label>
    <link:label id="lab_lgnd_RoyaltyKyprolisMember_label_en-US" xlink:label="lab_lgnd_RoyaltyKyprolisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty, Kyprolis [Member]</link:label>
    <link:label id="lab_lgnd_RoyaltyKyprolisMember_documentation_en-US" xlink:label="lab_lgnd_RoyaltyKyprolisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty, Kyprolis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyKyprolisMember" xlink:href="lgnd-20221231.xsd#lgnd_RoyaltyKyprolisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_RoyaltyKyprolisMember" xlink:to="lab_lgnd_RoyaltyKyprolisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_1402babc-bdfe-48f2-9f5e-35825983d4b0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_3ff68e84-4f1e-4c1e-bfd5-7b1dd4753ee6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization/accretion of premium (discount) on investments, net</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_89062623-9a4b-4ff8-817c-cf820ac4e3b9_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill and Other Identifiable Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_91fc993c-2a12-458b-99d2-96decce4d35e_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other tax adjustments</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_c60797be-92dc-490f-9346-82ef5e36b639_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes, net</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_95ac984f-d38e-42b1-ba05-bae821aa6801_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_603b5d80-7596-4ebb-bf9d-70e86ba1e3bc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PartnerAMember_68783033-e0d3-49ed-b802-dd625bb5765b_terseLabel_en-US" xlink:label="lab_lgnd_PartnerAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partner A</link:label>
    <link:label id="lab_lgnd_PartnerAMember_label_en-US" xlink:label="lab_lgnd_PartnerAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partner A [Member]</link:label>
    <link:label id="lab_lgnd_PartnerAMember_documentation_en-US" xlink:label="lab_lgnd_PartnerAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partner A [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PartnerAMember" xlink:href="lgnd-20221231.xsd#lgnd_PartnerAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PartnerAMember" xlink:to="lab_lgnd_PartnerAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualRightsMember_3a1ca32b-96d3-4f41-b8da-a55366b7afca_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual relationships</link:label>
    <link:label id="lab_us-gaap_ContractualRightsMember_label_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualRightsMember" xlink:to="lab_us-gaap_ContractualRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_50d3518f-cac7-4c2b-bb31-90429c4e3c0e_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_28b8f2be-51cb-4794-b559-9a0ddf8c6e02_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_10343ccf-2588-4028-9bbc-a6c4a1e972f3_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_b405d2df-bb2a-49ef-b58f-88eb9c214db2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_b08dcbd0-7127-4ad7-846c-9827445be2e5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized discount (including unamortized debt issuance cost)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_44783235-ff50-4410-a64d-b245f334bb50_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value, vested and expected to vest</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_afc1c26b-4896-436e-bb73-29c58fbed8fc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock price trigger to classify convertible debt as current (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_3d57f53c-11ab-47b0-94f7-3715a24da1e0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income (loss) from continuing operations (USD per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableMember_1034a059-0b40-40d4-8ec2-407a790c142c_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleNotesPayableMember" xlink:to="lab_us-gaap_ConvertibleNotesPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AccountsReceivableCreditLossExpenseReversalCOVID19_d0648331-67ef-4d59-bae1-4a6854e9b029_negatedTerseLabel_en-US" xlink:label="lab_lgnd_AccountsReceivableCreditLossExpenseReversalCOVID19" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional reserve for credit losses due to COVID-19</link:label>
    <link:label id="lab_lgnd_AccountsReceivableCreditLossExpenseReversalCOVID19_label_en-US" xlink:label="lab_lgnd_AccountsReceivableCreditLossExpenseReversalCOVID19" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal), COVID-19</link:label>
    <link:label id="lab_lgnd_AccountsReceivableCreditLossExpenseReversalCOVID19_documentation_en-US" xlink:label="lab_lgnd_AccountsReceivableCreditLossExpenseReversalCOVID19" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal), COVID-19</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccountsReceivableCreditLossExpenseReversalCOVID19" xlink:href="lgnd-20221231.xsd#lgnd_AccountsReceivableCreditLossExpenseReversalCOVID19"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AccountsReceivableCreditLossExpenseReversalCOVID19" xlink:to="lab_lgnd_AccountsReceivableCreditLossExpenseReversalCOVID19" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EffectiveIncomeTaxRateReconciliationDebtRepurchasesAmount_cfd4ae9e-6dd5-4171-b83a-e2d26bbfa6d8_terseLabel_en-US" xlink:label="lab_lgnd_EffectiveIncomeTaxRateReconciliationDebtRepurchasesAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt repurchases</link:label>
    <link:label id="lab_lgnd_EffectiveIncomeTaxRateReconciliationDebtRepurchasesAmount_label_en-US" xlink:label="lab_lgnd_EffectiveIncomeTaxRateReconciliationDebtRepurchasesAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Debt Repurchases, Amount</link:label>
    <link:label id="lab_lgnd_EffectiveIncomeTaxRateReconciliationDebtRepurchasesAmount_documentation_en-US" xlink:label="lab_lgnd_EffectiveIncomeTaxRateReconciliationDebtRepurchasesAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Debt Repurchases, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EffectiveIncomeTaxRateReconciliationDebtRepurchasesAmount" xlink:href="lgnd-20221231.xsd#lgnd_EffectiveIncomeTaxRateReconciliationDebtRepurchasesAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EffectiveIncomeTaxRateReconciliationDebtRepurchasesAmount" xlink:to="lab_lgnd_EffectiveIncomeTaxRateReconciliationDebtRepurchasesAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiMeasurementInput_24bbf00f-6b91-4592-9943-52e3c5cf490b_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement input (as a percent)</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiMeasurementInput_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiMeasurementInput" xlink:to="lab_us-gaap_EquitySecuritiesFvNiMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cf1360d2-31b3-4424-8741-cfbddaa8667a_netLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in basic per share calculation (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_052f8874-8e2e-4e19-8e41-d4456f5fa72a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding - basic (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f7fdbd18-2f91-4c52-a8ce-6535b1e43515_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in the computation of basic net income (loss) per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_99b238c7-f079-4f26-943f-9d50929e44a9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ContractualRelationshipsSIIMember_13bdf097-b17b-4f13-8922-da88d930ca92_terseLabel_en-US" xlink:label="lab_lgnd_ContractualRelationshipsSIIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Relationships - SII</link:label>
    <link:label id="lab_lgnd_ContractualRelationshipsSIIMember_label_en-US" xlink:label="lab_lgnd_ContractualRelationshipsSIIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Relationships - SII [Member]</link:label>
    <link:label id="lab_lgnd_ContractualRelationshipsSIIMember_documentation_en-US" xlink:label="lab_lgnd_ContractualRelationshipsSIIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Relationships - SII</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractualRelationshipsSIIMember" xlink:href="lgnd-20221231.xsd#lgnd_ContractualRelationshipsSIIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ContractualRelationshipsSIIMember" xlink:to="lab_lgnd_ContractualRelationshipsSIIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_ae2c126b-37d3-4cd0-a572-b01070855e70_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Intangible Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_OtherBalanceSheetDetailsAbstract_label_en-US" xlink:label="lab_lgnd_OtherBalanceSheetDetailsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Balance Sheet Details [Abstract]</link:label>
    <link:label id="lab_lgnd_OtherBalanceSheetDetailsAbstract_documentation_en-US" xlink:label="lab_lgnd_OtherBalanceSheetDetailsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Balance Sheet Details [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OtherBalanceSheetDetailsAbstract" xlink:href="lgnd-20221231.xsd#lgnd_OtherBalanceSheetDetailsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_OtherBalanceSheetDetailsAbstract" xlink:to="lab_lgnd_OtherBalanceSheetDetailsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_30499353-f674-407b-953c-4c750486339c_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.001 par value; 5,000 shares authorized; zero issued and outstanding at December 31, 2022 and 2021</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_9a022726-a042-4e33-8c01-b00a7aafe91a_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash in other current assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_9f895fca-85ba-496b-ac06-df97c1a2b82a_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_56f43feb-da8e-4dca-81ca-c918af497b2d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_01d708a0-cc19-434f-a4b7-fcaa463531d9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity and Liability Components of the Convertible Senior Notes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_e90f252e-bedf-428d-a28d-a4cf4d7d9dd2_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative expenses</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_667912e3-af37-49dd-90e3-c462ecc670f8_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-Known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_a22fd869-7da1-4bf8-8f36-db3ca9b0b90a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_49816a0f-5a82-4057-ac7b-560618b6b194_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Unobservable Inputs (Level 3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_77aa750b-9b9d-4533-b085-62f458bc8c4e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_f43e0d79-9dd8-44b5-bfae-91fe7e46ebcd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityAmountPerShare_f7069900-da45-4ef9-a081-58dd5f569878_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration liability per share (USD per share)</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityAmountPerShare_label_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Amount per Share</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityAmountPerShare_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Amount per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityAmountPerShare" xlink:href="lgnd-20221231.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityAmountPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityAmountPerShare" xlink:to="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityAmountPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_59e90329-535d-4424-9713-f139d86ae14c_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_0efdc01d-128c-4043-865c-8f4cf05d2412_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, period in force</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Period in Force</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:to="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed_d6ab7fd6-a121-4dcc-9bb2-70ac6628f91f_terseLabel_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed_label_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Percentage Of Voting Interests Disposed</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed_documentation_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Percentage Of Voting Interests Disposed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed" xlink:to="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortizationDiscontinuedOperations_8065c9ed-c026-4fa3-9c78-4fc93e698215_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortizationDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortizationDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortizationDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and Amortization, Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortizationDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortizationDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortizationDiscontinuedOperations" xlink:to="lab_us-gaap_DepreciationAndAmortizationDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostDirectMaterial_fb96c67f-361c-47c3-a164-5a84a01d02c5_terseLabel_en-US" xlink:label="lab_us-gaap_CostDirectMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Captisol</link:label>
    <link:label id="lab_us-gaap_CostDirectMaterial_label_en-US" xlink:label="lab_us-gaap_CostDirectMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Direct Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostDirectMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostDirectMaterial" xlink:to="lab_us-gaap_CostDirectMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_6297a188-d18c-4bf8-885d-c7786524af3f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ScheduleofCommercialLicenseRightsTableTextBlock_051c298b-0c0e-4d05-a203-504231d47407_terseLabel_en-US" xlink:label="lab_lgnd_ScheduleofCommercialLicenseRightsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Commercial License Rights</link:label>
    <link:label id="lab_lgnd_ScheduleofCommercialLicenseRightsTableTextBlock_label_en-US" xlink:label="lab_lgnd_ScheduleofCommercialLicenseRightsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Commercial License Rights [Table Text Block]</link:label>
    <link:label id="lab_lgnd_ScheduleofCommercialLicenseRightsTableTextBlock_documentation_en-US" xlink:label="lab_lgnd_ScheduleofCommercialLicenseRightsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Commercial License Rights [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleofCommercialLicenseRightsTableTextBlock" xlink:href="lgnd-20221231.xsd#lgnd_ScheduleofCommercialLicenseRightsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ScheduleofCommercialLicenseRightsTableTextBlock" xlink:to="lab_lgnd_ScheduleofCommercialLicenseRightsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_889fc329-491d-492e-951b-8df9c89fea3b_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0a9ec1d3-e266-4520-84bc-d5cfe9d39c30_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_fcc0f729-0511-4c3a-b728-fe8ab82aa469_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for acquisition, net of cash and restricted cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_8b96e51c-e5b3-4c9d-8eb5-a96d062ff3c3_terseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities - Metabasis</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Metabasis [Member]</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_documentation_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Metabasis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:href="lgnd-20221231.xsd#lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:to="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_67473e3d-53d5-4873-9f5b-fa4e8f5da240_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Other Observable Inputs (Level 2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DemandDepositsMember_caf913ea-4b56-4a1c-9795-290ceaf5637e_terseLabel_en-US" xlink:label="lab_us-gaap_DemandDepositsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank deposits</link:label>
    <link:label id="lab_us-gaap_DemandDepositsMember_label_en-US" xlink:label="lab_us-gaap_DemandDepositsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Demand Deposits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DemandDepositsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DemandDepositsMember" xlink:to="lab_us-gaap_DemandDepositsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_7944050b-c710-4ce9-ae5a-0b781a02d1e1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption Period One</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_ec713151-2363-4554-b6ea-df0210492802_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_8b7fe5f6-84a0-45df-ad05-e3d768c7b04b_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_ca1146c9-9520-45df-a17b-2bb19354535f_verboseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Goodwill, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_1d016263-c74e-4b1a-bb5f-81ed661d2d61_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_33c7e06b-bb68-4fde-a064-6fc0cf98eb7b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_SelexisMember_7e90faba-a39c-4f3e-ab14-25ac6891e7ec_terseLabel_en-US" xlink:label="lab_lgnd_SelexisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis</link:label>
    <link:label id="lab_lgnd_SelexisMember_label_en-US" xlink:label="lab_lgnd_SelexisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis [Member]</link:label>
    <link:label id="lab_lgnd_SelexisMember_documentation_en-US" xlink:label="lab_lgnd_SelexisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisMember" xlink:href="lgnd-20221231.xsd#lgnd_SelexisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_SelexisMember" xlink:to="lab_lgnd_SelexisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_b5018df9-68a1-465c-8ba8-f51b07da58ac_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_fcae07a8-c749-4ce4-931e-6a4b79725a40_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromHedgeFinancingActivities_a1ff799b-3f31-403d-8a07-630d9003aadc_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from bond hedge settlement</link:label>
    <link:label id="lab_us-gaap_ProceedsFromHedgeFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Hedge, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromHedgeFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_b5d41861-8118-432c-a5bb-567153bfeb05_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_39eab57d-88e1-42d8-a4ed-9413a108ead5_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_RoyaltyTeriparatideInjectionMember_81b90499-f380-4c83-8843-db77af322613_terseLabel_en-US" xlink:label="lab_lgnd_RoyaltyTeriparatideInjectionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Teriparatide injection</link:label>
    <link:label id="lab_lgnd_RoyaltyTeriparatideInjectionMember_label_en-US" xlink:label="lab_lgnd_RoyaltyTeriparatideInjectionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty, Teriparatide Injection [Member]</link:label>
    <link:label id="lab_lgnd_RoyaltyTeriparatideInjectionMember_documentation_en-US" xlink:label="lab_lgnd_RoyaltyTeriparatideInjectionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty, Teriparatide Injection</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyTeriparatideInjectionMember" xlink:href="lgnd-20221231.xsd#lgnd_RoyaltyTeriparatideInjectionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_RoyaltyTeriparatideInjectionMember" xlink:to="lab_lgnd_RoyaltyTeriparatideInjectionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CorporateShareRepurchaseAbstract_9222d53e-5577-4339-8267-15c76d46d97d_terseLabel_en-US" xlink:label="lab_lgnd_CorporateShareRepurchaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Share Repurchase</link:label>
    <link:label id="lab_lgnd_CorporateShareRepurchaseAbstract_label_en-US" xlink:label="lab_lgnd_CorporateShareRepurchaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Share Repurchase [Abstract]</link:label>
    <link:label id="lab_lgnd_CorporateShareRepurchaseAbstract_documentation_en-US" xlink:label="lab_lgnd_CorporateShareRepurchaseAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Share Repurchase [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CorporateShareRepurchaseAbstract" xlink:href="lgnd-20221231.xsd#lgnd_CorporateShareRepurchaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CorporateShareRepurchaseAbstract" xlink:to="lab_lgnd_CorporateShareRepurchaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_42c3e065-394f-461a-b7a9-6ba10810af0c_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermNotesPayable_ac814237-d837-4065-8e83-ea95328dd2c5_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term portion of notes payable</link:label>
    <link:label id="lab_us-gaap_LongTermNotesPayable_label_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermNotesPayable" xlink:to="lab_us-gaap_LongTermNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_b5d2f16a-f3c6-40ad-b768-17fa614f293f_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BasisOfPresentationTable_9f5c01a1-2702-49e8-a8ee-f38f5878e9cd_terseLabel_en-US" xlink:label="lab_lgnd_BasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Table]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationTable_label_en-US" xlink:label="lab_lgnd_BasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Table]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationTable_documentation_en-US" xlink:label="lab_lgnd_BasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationTable" xlink:href="lgnd-20221231.xsd#lgnd_BasisOfPresentationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BasisOfPresentationTable" xlink:to="lab_lgnd_BasisOfPresentationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_e6482602-0277-4795-a7b4-5e2ccd204ef7_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spin-off of OmniAb</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_46fe5f6e-0c13-4ee9-98d0-ca043f67d3ff_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would impact effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CommercialLicenseRights_8aca6d45-099d-49b8-b3e1-1182cc2ff594_terseLabel_en-US" xlink:label="lab_lgnd_CommercialLicenseRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial license and other economic rights</link:label>
    <link:label id="lab_lgnd_CommercialLicenseRights_label_en-US" xlink:label="lab_lgnd_CommercialLicenseRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License Rights</link:label>
    <link:label id="lab_lgnd_CommercialLicenseRights_documentation_en-US" xlink:label="lab_lgnd_CommercialLicenseRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRights" xlink:href="lgnd-20221231.xsd#lgnd_CommercialLicenseRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CommercialLicenseRights" xlink:to="lab_lgnd_CommercialLicenseRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_95abe3ca-d51e-40a0-9f83-cddcd3075369_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EffectiveIncomeTaxRateReconciliationOtherIncome_8cff17ea-1f56-4716-b418-05403f483257_terseLabel_en-US" xlink:label="lab_lgnd_EffectiveIncomeTaxRateReconciliationOtherIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subpart F income</link:label>
    <link:label id="lab_lgnd_EffectiveIncomeTaxRateReconciliationOtherIncome_label_en-US" xlink:label="lab_lgnd_EffectiveIncomeTaxRateReconciliationOtherIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Income</link:label>
    <link:label id="lab_lgnd_EffectiveIncomeTaxRateReconciliationOtherIncome_documentation_en-US" xlink:label="lab_lgnd_EffectiveIncomeTaxRateReconciliationOtherIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EffectiveIncomeTaxRateReconciliationOtherIncome" xlink:href="lgnd-20221231.xsd#lgnd_EffectiveIncomeTaxRateReconciliationOtherIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EffectiveIncomeTaxRateReconciliationOtherIncome" xlink:to="lab_lgnd_EffectiveIncomeTaxRateReconciliationOtherIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount_e3431bb8-b7cd-4fdf-b678-80eed1e3eb1d_negatedLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FDII</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, FDII, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_c6caefb9-338d-4095-abb6-8c6573677201_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate change for changes in federal, foreign or state law</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_8a24928c-8098-40d1-9f57-9641ffdd76f3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lower range of exercise prices (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGross_293a71cd-6266-465b-8db1-24f794447c1a_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross contract asset</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGross_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetGross" xlink:to="lab_us-gaap_ContractWithCustomerAssetGross" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsOperatingLeaseAssets_f26486a7-999f-47e1-b68c-7e36b6829b3b_terseLabel_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsOperatingLeaseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease assets</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsOperatingLeaseAssets_label_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsOperatingLeaseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Operating Lease Assets</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsOperatingLeaseAssets_documentation_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsOperatingLeaseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Operating Lease Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsOperatingLeaseAssets" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsOperatingLeaseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsOperatingLeaseAssets" xlink:to="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsOperatingLeaseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_d1cb51f6-8ebf-4ec9-9411-837b5645587d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHolders_7fc4c298-d773-4205-8976-54997d482f3a_negatedLabel_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to CVR holders and other contingency payments</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHolders_274bdf0d-6a53-4dcb-a079-a8b02cb987ff_negatedTerseLabel_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHolders_label_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Contingent Value Right Holders</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHolders_documentation_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to contingent value right holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHolders" xlink:href="lgnd-20221231.xsd#lgnd_PaymentsToContingentValueRightHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsToContingentValueRightHolders" xlink:to="lab_lgnd_PaymentsToContingentValueRightHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_131798ff-d767-4a64-a942-881699423c93_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized loss on available-for-sale investments</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_ab9d5d47-d10d-4100-98e1-f3d31106093f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance, change in amount</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_f6e46518-2d68-42e8-8fe1-b11a7362d2f7_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term of finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ContingentLiabilityRollForward_bbc95ffc-5287-4468-9777-a4efb0e11748_terseLabel_en-US" xlink:label="lab_lgnd_ContingentLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Liability [Roll Forward]</link:label>
    <link:label id="lab_lgnd_ContingentLiabilityRollForward_label_en-US" xlink:label="lab_lgnd_ContingentLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Liability [Roll Forward]</link:label>
    <link:label id="lab_lgnd_ContingentLiabilityRollForward_documentation_en-US" xlink:label="lab_lgnd_ContingentLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Liability [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentLiabilityRollForward" xlink:href="lgnd-20221231.xsd#lgnd_ContingentLiabilityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ContingentLiabilityRollForward" xlink:to="lab_lgnd_ContingentLiabilityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsForSeparation_84b09d5f-fcdf-4fce-bc9c-edc5afffd338_negatedTerseLabel_en-US" xlink:label="lab_lgnd_PaymentsForSeparation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash transferred to OmniAb at separation</link:label>
    <link:label id="lab_lgnd_PaymentsForSeparation_label_en-US" xlink:label="lab_lgnd_PaymentsForSeparation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Separation</link:label>
    <link:label id="lab_lgnd_PaymentsForSeparation_documentation_en-US" xlink:label="lab_lgnd_PaymentsForSeparation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Separation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsForSeparation" xlink:href="lgnd-20221231.xsd#lgnd_PaymentsForSeparation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsForSeparation" xlink:to="lab_lgnd_PaymentsForSeparation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2119dafc-1276-4155-8400-c8eabc6b1d1b_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_60090629-a883-492f-a4e0-43c6376a296d_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_bf0aee02-682f-44ec-91e7-2a148d5dedbf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_GainLossOnShortTermInvestments_d08b8c3d-9e10-4828-a880-3e0e68122a0e_negatedTerseLabel_en-US" xlink:label="lab_lgnd_GainLossOnShortTermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) short-term investments</link:label>
    <link:label id="lab_lgnd_GainLossOnShortTermInvestments_label_en-US" xlink:label="lab_lgnd_GainLossOnShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Short-Term Investments</link:label>
    <link:label id="lab_lgnd_GainLossOnShortTermInvestments_documentation_en-US" xlink:label="lab_lgnd_GainLossOnShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_GainLossOnShortTermInvestments" xlink:href="lgnd-20221231.xsd#lgnd_GainLossOnShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_GainLossOnShortTermInvestments" xlink:to="lab_lgnd_GainLossOnShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_dbe47019-6f32-47f7-837c-656d1bbb766f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_label_en-US" xlink:label="lab_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:to="lab_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_c0f917fb-370d-4f36-8a69-a9cc5d2fa505_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_9a20cc82-13b1-4a42-8c34-00964fe1725b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_0eacf478-9586-482e-8c66-4779effb6a4c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration liability, measurement input (as a percent)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_325c0699-a1a2-4496-898c-d44207cce12c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization period</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Remaining Discount Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_e5a663f2-0191-46c6-b42b-34e33205a7a1_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_25b591dd-249b-437f-aeff-bacaf4ede2a0_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8845f0c0-ad81-4985-bd4e-43eee08baad8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ec7bb581-c00e-4aa9-9185-c65ecbbf0db6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_77518d14-a098-4d97-a72f-1b79bd844369_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_ff3723ec-898a-4ddb-b35d-5971df3fec23_verboseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentrations of Business Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_a37d589e-0d13-4936-9cd4-ab245833df3e_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Number of Positions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:to="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_fef46fdc-86bf-45d6-a3a0-5d41fde974a0_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_984004fc-fb17-450a-aff5-b3329345642b_terseLabel_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_label_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Income (Expense)</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_documentation_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" xlink:to="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_fee0dc2a-e737-443e-b5a2-c2c7ac980a7e_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_2aad136e-ec52-4149-a0c8-4d68baf96777_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_db8ef73d-cc55-4c6b-a0dd-1511b9809adf_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_ed572a3b-1ddc-48a7-98dd-c05afc7060c8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_41699127-4b70-40f8-ba9d-c773f76760bb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets and liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_544b3c9d-04ca-4a13-870e-afce5847124e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_6ca53edc-e5cc-438f-8c07-768968b0c797_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_11e3f60f-a2e0-40a2-bead-16f149c4d058_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_3c2f5943-53ba-49f1-b4cb-c24a0f322915_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_68dcfc9c-0b49-40b1-9743-56bef940c6c5_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental schedule of non-cash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_2e8c9f1a-c96e-4b74-aa69-0fe792a85d5d_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_c937af0b-925f-4781-bbed-04eb0e20bc53_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for equity method investment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b1a7c054-5f1d-42ca-86bf-d1a3f44f5694_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average grant date fair value per share of stock options (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_3652268d-1816-434f-a014-c383b9b959c9_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LeaseLiability_9141a81a-bdd4-4145-8b19-b2dbf981896f_totalLabel_en-US" xlink:label="lab_lgnd_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_lgnd_LeaseLiability_label_en-US" xlink:label="lab_lgnd_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability</link:label>
    <link:label id="lab_lgnd_LeaseLiability_documentation_en-US" xlink:label="lab_lgnd_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiability" xlink:href="lgnd-20221231.xsd#lgnd_LeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LeaseLiability" xlink:to="lab_lgnd_LeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_da12605a-e2a7-4747-aadf-8299fcd75b21_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_ee0470a0-94ec-4cde-ae0a-77081f0dc052_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated amortization expense for 2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_df6b619e-c0f6-47b9-9f1f-9b198fe8a2c6_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_774883cd-4407-426b-ac1e-9c6ca570b8b9_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Computation of Basic and Diluted Net Income (Loss) per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_f0158fd8-8ecb-4ff1-a93e-a3d6a938dc97_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit), Continuing Operations, Income Tax Reconciliation [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_a22f3b15-490a-4622-b53b-181434bfd654_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_fd43b1d7-e733-46b7-a97c-0ab6a4cdaf17_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8906b884-04ea-4b82-8b54-18e1be018e5a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_afa9c4aa-9e1a-4e76-8e5f-cae068f90b04_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_82f2c2a2-958b-47c8-8a5d-946c2ac2e581_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ContractualRelationshipsJazzMember_86341ced-e212-43b3-b7e6-d15aaa2d0cf2_terseLabel_en-US" xlink:label="lab_lgnd_ContractualRelationshipsJazzMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Relationships - Jazz</link:label>
    <link:label id="lab_lgnd_ContractualRelationshipsJazzMember_label_en-US" xlink:label="lab_lgnd_ContractualRelationshipsJazzMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Relationships - Jazz [Member]</link:label>
    <link:label id="lab_lgnd_ContractualRelationshipsJazzMember_documentation_en-US" xlink:label="lab_lgnd_ContractualRelationshipsJazzMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Relationships - Jazz</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractualRelationshipsJazzMember" xlink:href="lgnd-20221231.xsd#lgnd_ContractualRelationshipsJazzMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ContractualRelationshipsJazzMember" xlink:to="lab_lgnd_ContractualRelationshipsJazzMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_404bb956-1c15-4a6f-8d33-a99f46ab0331_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturity of short-term investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_cce2f136-a27a-4ced-b814-14ac6fd2e7fc_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_198509ff-774b-4568-a5b6-10d402b80ccc_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MaturityPeriodOfHighlyLiquidSecuritiesMaximum_4c98cf20-b515-4762-aa6e-abe889931f35_terseLabel_en-US" xlink:label="lab_lgnd_MaturityPeriodOfHighlyLiquidSecuritiesMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity period of cash and cash equivalents, maximum</link:label>
    <link:label id="lab_lgnd_MaturityPeriodOfHighlyLiquidSecuritiesMaximum_label_en-US" xlink:label="lab_lgnd_MaturityPeriodOfHighlyLiquidSecuritiesMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity Period Of Highly Liquid Securities Maximum</link:label>
    <link:label id="lab_lgnd_MaturityPeriodOfHighlyLiquidSecuritiesMaximum_documentation_en-US" xlink:label="lab_lgnd_MaturityPeriodOfHighlyLiquidSecuritiesMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity period of highly liquid securities maximum.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaturityPeriodOfHighlyLiquidSecuritiesMaximum" xlink:href="lgnd-20221231.xsd#lgnd_MaturityPeriodOfHighlyLiquidSecuritiesMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MaturityPeriodOfHighlyLiquidSecuritiesMaximum" xlink:to="lab_lgnd_MaturityPeriodOfHighlyLiquidSecuritiesMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_9ce7799b-c61d-4951-9486-dcafe9f6ce6c_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_d787311c-279a-45ef-9a6c-41fc8caa2f33_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NumberOfAcquisitions_0a329626-b8c7-4e21-91f3-60ec13281806_terseLabel_en-US" xlink:label="lab_lgnd_NumberOfAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of acquisitions</link:label>
    <link:label id="lab_lgnd_NumberOfAcquisitions_label_en-US" xlink:label="lab_lgnd_NumberOfAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Acquisitions</link:label>
    <link:label id="lab_lgnd_NumberOfAcquisitions_documentation_en-US" xlink:label="lab_lgnd_NumberOfAcquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfAcquisitions" xlink:href="lgnd-20221231.xsd#lgnd_NumberOfAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NumberOfAcquisitions" xlink:to="lab_lgnd_NumberOfAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_c4048289-4946-4fb6-ae10-7ba08753ec79_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_8ec2472d-3637-4621-bc13-1396cd1e7bef_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_f5c973a8-99fc-481d-bb59-fbd6e91c3c04_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_a3bfa51a-4b3e-4d2a-b4c8-de3fb8a0a305_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt, Excluding Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:to="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_32873388-dcb1-4a7f-b4da-4a3d89e65882_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_d37a1cb9-a91b-421c-b479-aae2e9d6d264_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss):</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_25ea86d2-9a69-43ce-bab2-6adab620170f_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_RoyaltyRylazeMember_2a8f44ed-07a3-4db8-a0c2-805f3a322d71_terseLabel_en-US" xlink:label="lab_lgnd_RoyaltyRylazeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rylaze</link:label>
    <link:label id="lab_lgnd_RoyaltyRylazeMember_label_en-US" xlink:label="lab_lgnd_RoyaltyRylazeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty, Rylaze [Member]</link:label>
    <link:label id="lab_lgnd_RoyaltyRylazeMember_documentation_en-US" xlink:label="lab_lgnd_RoyaltyRylazeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty, Rylaze</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyRylazeMember" xlink:href="lgnd-20221231.xsd#lgnd_RoyaltyRylazeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_RoyaltyRylazeMember" xlink:to="lab_lgnd_RoyaltyRylazeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_8e06c84a-c90e-4044-8462-85497d587141_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_427303db-aa65-4f62-a10d-a4a72e9fc6dc_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_6ae67296-87ff-4a4a-88f3-7b8a9138581e_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_1c7bcafa-0ea4-4bf1-908c-009e3f8e39ac_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_fd25798e-27e1-4034-acd7-4b61ed955fff_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, fair value</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_a71f9934-8dce-4c7b-99ad-80eb0157617a_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting right (as a percent)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_dffdab68-a77a-4d3c-9927-284521a94900_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_1ac72860-7318-46a0-b3e0-4f81b0e27189_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties owed to third parties</link:label>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Royalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRoyaltiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_490809fa-0e4b-415d-b88b-2411b1871156_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_eec4704d-b229-4ff2-b053-c77e7af620e9_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NumberOfContingentValueRightsIssued_0950ffe6-3fc6-4970-9a87-cfc2b3a9131d_terseLabel_en-US" xlink:label="lab_lgnd_NumberOfContingentValueRightsIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of contingent value rights</link:label>
    <link:label id="lab_lgnd_NumberOfContingentValueRightsIssued_label_en-US" xlink:label="lab_lgnd_NumberOfContingentValueRightsIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Contingent Value Rights Issued</link:label>
    <link:label id="lab_lgnd_NumberOfContingentValueRightsIssued_documentation_en-US" xlink:label="lab_lgnd_NumberOfContingentValueRightsIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Contingent Value Rights Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfContingentValueRightsIssued" xlink:href="lgnd-20221231.xsd#lgnd_NumberOfContingentValueRightsIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NumberOfContingentValueRightsIssued" xlink:to="lab_lgnd_NumberOfContingentValueRightsIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LeaseRightOfUseAsset_4ca69c01-6298-4326-942c-9154f1cc4dfd_totalLabel_en-US" xlink:label="lab_lgnd_LeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease assets</link:label>
    <link:label id="lab_lgnd_LeaseRightOfUseAsset_label_en-US" xlink:label="lab_lgnd_LeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_lgnd_LeaseRightOfUseAsset_documentation_en-US" xlink:label="lab_lgnd_LeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseRightOfUseAsset" xlink:href="lgnd-20221231.xsd#lgnd_LeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LeaseRightOfUseAsset" xlink:to="lab_lgnd_LeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AccruedAssetAcquisitionsCurrent_a0ce22df-cd37-4591-9713-b7154f3f8cc3_terseLabel_en-US" xlink:label="lab_lgnd_AccruedAssetAcquisitionsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition related liabilities</link:label>
    <link:label id="lab_lgnd_AccruedAssetAcquisitionsCurrent_label_en-US" xlink:label="lab_lgnd_AccruedAssetAcquisitionsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Asset Acquisitions, Current</link:label>
    <link:label id="lab_lgnd_AccruedAssetAcquisitionsCurrent_documentation_en-US" xlink:label="lab_lgnd_AccruedAssetAcquisitionsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Asset Acquisitions, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedAssetAcquisitionsCurrent" xlink:href="lgnd-20221231.xsd#lgnd_AccruedAssetAcquisitionsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AccruedAssetAcquisitionsCurrent" xlink:to="lab_lgnd_AccruedAssetAcquisitionsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_502f89cf-43c5-4536-aa37-6ae756a43cb1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income (loss) from continuing operations (USD per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_44985890-da91-474d-953b-370291cd4c64_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of business segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges_9275cc8b-c02c-4c32-af7f-78117072ddec_terseLabel_en-US" xlink:label="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from unwinding convertible bond hedges</link:label>
    <link:label id="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges_label_en-US" xlink:label="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Unwinding Convertible Bond Hedges</link:label>
    <link:label id="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges_documentation_en-US" xlink:label="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Unwinding Convertible Bond Hedges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:href="lgnd-20221231.xsd#lgnd_ProceedsFromUnwindingConvertibleBondHedges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:to="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_7a90c6f2-1c6e-4d84-969c-50aa52b3bac1_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted Prices in Active Markets for Identical Assets (Level 1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_dfcf561c-b0d9-4c00-adb6-8aad7459da68_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_59e8f510-80c4-4bfe-bbd7-1a8636f5e0f4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue of acquiree since acquisition date included in comprehensive income</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:to="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_eee289eb-44c8-4461-a4c8-5d00217cd3a5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-Sale Debt Securities by Contractual Maturity</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_01d76248-1356-4d4b-bd2c-8844d115c9ec_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate used to value intangible assets acquired (as a percent)</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_label_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Discount Rate</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" xlink:href="lgnd-20221231.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" xlink:to="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_8c560cd5-910d-4258-9498-dab4e8201283_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Vernalis R&amp;D</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Disposition of Business, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationDispositionOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:to="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AccruedSupplierExpensesCurrent_89b9c26d-8c09-45a2-b39b-8f6d72aa7b86_terseLabel_en-US" xlink:label="lab_lgnd_AccruedSupplierExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier</link:label>
    <link:label id="lab_lgnd_AccruedSupplierExpensesCurrent_label_en-US" xlink:label="lab_lgnd_AccruedSupplierExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Supplier Expenses, Current</link:label>
    <link:label id="lab_lgnd_AccruedSupplierExpensesCurrent_documentation_en-US" xlink:label="lab_lgnd_AccruedSupplierExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Supplier Expenses, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSupplierExpensesCurrent" xlink:href="lgnd-20221231.xsd#lgnd_AccruedSupplierExpensesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AccruedSupplierExpensesCurrent" xlink:to="lab_lgnd_AccruedSupplierExpensesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BasisOfPresentationLineItems_b856ea05-3591-4607-859b-93a2caf96211_terseLabel_en-US" xlink:label="lab_lgnd_BasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Line Items]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationLineItems_label_en-US" xlink:label="lab_lgnd_BasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Line Items]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationLineItems_documentation_en-US" xlink:label="lab_lgnd_BasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of presentation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationLineItems" xlink:href="lgnd-20221231.xsd#lgnd_BasisOfPresentationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BasisOfPresentationLineItems" xlink:to="lab_lgnd_BasisOfPresentationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_a5240f3f-11a8-4224-8fa4-6dde672a3019_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_d39e7b45-396c-43b8-b9d6-24d52745a68a_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_993818ab-8806-43b2-b2e9-29981a4e7baa_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_8981e172-40fd-43af-b8bb-1816647667d8_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_25b7d321-f5c4-4fa1-8e2a-e230935722d5_verboseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Technologies</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_c21d47d2-4a83-4b1a-a6f8-821cf8dbe670_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_793e8edf-f5ba-4de9-8f39-8e72e53d284a_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock issued (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2509f5ec-0c5e-47ba-b1d2-c3625ba1edc1_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_71a1ce62-c3cf-4503-9999-27d2c7b52e4f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_efe5bc7f-d631-4d6b-ad00-1908465fbb11_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current assets of discontinued operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CorMatrixMember_b6615e3c-679d-4217-8331-c2eb59502cf4_terseLabel_en-US" xlink:label="lab_lgnd_CorMatrixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CorMatrix</link:label>
    <link:label id="lab_lgnd_CorMatrixMember_label_en-US" xlink:label="lab_lgnd_CorMatrixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CorMatrix [Member]</link:label>
    <link:label id="lab_lgnd_CorMatrixMember_documentation_en-US" xlink:label="lab_lgnd_CorMatrixMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CorMatrix [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CorMatrixMember" xlink:href="lgnd-20221231.xsd#lgnd_CorMatrixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CorMatrixMember" xlink:to="lab_lgnd_CorMatrixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_VikingTherapeuticsInc.Member_858a17ef-18bb-4f2e-b58f-5728d04d5dc1_terseLabel_en-US" xlink:label="lab_lgnd_VikingTherapeuticsInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Viking Therapeutics, Inc.</link:label>
    <link:label id="lab_lgnd_VikingTherapeuticsInc.Member_label_en-US" xlink:label="lab_lgnd_VikingTherapeuticsInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Viking Therapeutics, Inc. [Member]</link:label>
    <link:label id="lab_lgnd_VikingTherapeuticsInc.Member_documentation_en-US" xlink:label="lab_lgnd_VikingTherapeuticsInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Viking Therapeutics, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_VikingTherapeuticsInc.Member" xlink:href="lgnd-20221231.xsd#lgnd_VikingTherapeuticsInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_VikingTherapeuticsInc.Member" xlink:to="lab_lgnd_VikingTherapeuticsInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_588cb703-192b-4e82-bef4-a038779dc7ca_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_e03986ae-80f4-45ed-963c-f4cd74971929_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_55d90140-8f5d-42f3-8753-34b59bda531c_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_fa2c6288-0b84-4982-84af-270755552ccb_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_d12692c5-dd5f-40cf-9f34-7e5c6769a925_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions for tax positions of prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2c3a9e81-8257-4a3c-bcfd-88520fd87522_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_ca1ac46e-b153-447e-994e-d71cec362b7a_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_ea5c2983-1ed3-4588-8102-3bc9829ad72b_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:to="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_c77142c8-d80c-44ec-9db8-83fe2431a820_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_0a0d63c4-d248-4051-b671-03559c46e515_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_RepaymentsOfNotesPayableInterestPortion_33f86b5a-6014-4eee-9090-554fcf5d6c96_terseLabel_en-US" xlink:label="lab_lgnd_RepaymentsOfNotesPayableInterestPortion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest portion of repurchased amount of debt instrument</link:label>
    <link:label id="lab_lgnd_RepaymentsOfNotesPayableInterestPortion_label_en-US" xlink:label="lab_lgnd_RepaymentsOfNotesPayableInterestPortion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments Of Notes Payable, Interest Portion</link:label>
    <link:label id="lab_lgnd_RepaymentsOfNotesPayableInterestPortion_documentation_en-US" xlink:label="lab_lgnd_RepaymentsOfNotesPayableInterestPortion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments Of Notes Payable, Interest Portion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RepaymentsOfNotesPayableInterestPortion" xlink:href="lgnd-20221231.xsd#lgnd_RepaymentsOfNotesPayableInterestPortion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_RepaymentsOfNotesPayableInterestPortion" xlink:to="lab_lgnd_RepaymentsOfNotesPayableInterestPortion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_7ef8c2b7-b092-47de-93af-68c99bb7ce19_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AccruedInventoryPurchases_eff86e82-b041-4eb4-be67-db766f1ee329_terseLabel_en-US" xlink:label="lab_lgnd_AccruedInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued inventory purchases</link:label>
    <link:label id="lab_lgnd_AccruedInventoryPurchases_label_en-US" xlink:label="lab_lgnd_AccruedInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Inventory Purchases</link:label>
    <link:label id="lab_lgnd_AccruedInventoryPurchases_documentation_en-US" xlink:label="lab_lgnd_AccruedInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Inventory Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedInventoryPurchases" xlink:href="lgnd-20221231.xsd#lgnd_AccruedInventoryPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AccruedInventoryPurchases" xlink:to="lab_lgnd_AccruedInventoryPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivesAbstract_804b4407-75e2-4068-872b-1b8eb88c9880_terseLabel_en-US" xlink:label="lab_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities:</link:label>
    <link:label id="lab_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivesAbstract_label_en-US" xlink:label="lab_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Discontinued Operations, Investing Actives [Abstract]</link:label>
    <link:label id="lab_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivesAbstract_documentation_en-US" xlink:label="lab_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Discontinued Operations, Investing Actives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivesAbstract" xlink:href="lgnd-20221231.xsd#lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivesAbstract" xlink:to="lab_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_664fdb48-8511-4d92-ace2-a0892706c9db_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_7788f092-977d-4101-bc01-80c87f3dd902_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs related to the liability component of convertible debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LigandCoreBusinessMember_245493a6-b19c-4ec6-8f34-1e0611c17234_terseLabel_en-US" xlink:label="lab_lgnd_LigandCoreBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ligand Core Business</link:label>
    <link:label id="lab_lgnd_LigandCoreBusinessMember_label_en-US" xlink:label="lab_lgnd_LigandCoreBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ligand Core Business [Member]</link:label>
    <link:label id="lab_lgnd_LigandCoreBusinessMember_documentation_en-US" xlink:label="lab_lgnd_LigandCoreBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ligand Core Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LigandCoreBusinessMember" xlink:href="lgnd-20221231.xsd#lgnd_LigandCoreBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LigandCoreBusinessMember" xlink:to="lab_lgnd_LigandCoreBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_e1fa1915-f15c-4082-86f9-b4dbfeb0d1a0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets and Liabilities Measured at Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_cff3be52-cf56-47b6-a587-4ec184a77ed5_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in Viking common stock</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_01e152d8-cb78-4b19-a582-295934fb3179_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PSUs</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_7d8c1243-3076-4a2d-8a8b-bd534c311ce6_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_7165e2b0-ed28-4c79-bd8d-77b826a24ab1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_e813b856-0c4a-4bb0-8754-2007ea90d27a_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PalvellaTherapeuticsIncMember_b0fe5a8c-57ca-4589-8f33-f902738de76e_terseLabel_en-US" xlink:label="lab_lgnd_PalvellaTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Palvella</link:label>
    <link:label id="lab_lgnd_PalvellaTherapeuticsIncMember_label_en-US" xlink:label="lab_lgnd_PalvellaTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Palvella Therapeutics, Inc. [Member]</link:label>
    <link:label id="lab_lgnd_PalvellaTherapeuticsIncMember_documentation_en-US" xlink:label="lab_lgnd_PalvellaTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Palvella Therapeutics, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PalvellaTherapeuticsIncMember" xlink:href="lgnd-20221231.xsd#lgnd_PalvellaTherapeuticsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PalvellaTherapeuticsIncMember" xlink:to="lab_lgnd_PalvellaTherapeuticsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_e6ad7ac3-5ab6-46fc-ba67-bcf7db6430c3_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8e7c0aad-ed9d-42fe-8fad-db94762fc5b3_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income tax from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_3747ca36-a53d-436b-8b5a-3abf94d6a4bb_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_3011da9e-cfb4-4f9c-8ebb-47112ca94d1e_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt discount and issuance fees</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_7a8e6b13-4a4b-46b5-8e03-4a1e72f523a1_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfIntangibleAssets_577995c7-65ca-4c63-a4c4-76f4d9f787b4_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from sale of Vernalis R&amp;D</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:to="lab_us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_4e5c4628-9eb5-425c-9d35-584492da34c1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_4277851b-d44c-41bc-87b7-c135e4df3090_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestmentsMember" xlink:to="lab_us-gaap_ShortTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_074ef8bc-f393-4d18-a8d1-9b33e05c35fc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_9de6182e-0e3f-4b4b-9179-b904edc4794a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on debt extinguishment</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_bd77944d-e352-4773-bda6-deea807d58d6_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangibles</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_84ddaf67-7bb6-423a-8cbc-8db8b651add9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ExercisePriceRangeFiveMember_1740fc9b-03f7-4ff4-aac3-ad7097b5a0c4_terseLabel_en-US" xlink:label="lab_lgnd_ExercisePriceRangeFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$58.28-$67.03</link:label>
    <link:label id="lab_lgnd_ExercisePriceRangeFiveMember_label_en-US" xlink:label="lab_lgnd_ExercisePriceRangeFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range Five [Member]</link:label>
    <link:label id="lab_lgnd_ExercisePriceRangeFiveMember_documentation_en-US" xlink:label="lab_lgnd_ExercisePriceRangeFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range Five [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ExercisePriceRangeFiveMember" xlink:href="lgnd-20221231.xsd#lgnd_ExercisePriceRangeFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ExercisePriceRangeFiveMember" xlink:to="lab_lgnd_ExercisePriceRangeFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_4272cf63-5c06-43cf-9577-6b27cd966cab_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investment Categories</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_63ff6d6e-7fd2-445f-898b-9ab12ac0f325_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income (loss) from discontinued operations (USD per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_56f3647f-67d8-4db7-85da-44b68f643246_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Intangible Assets and Other Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ContractRevenueMember_957478e6-fe16-49d2-bf26-cf2e7e38e653_terseLabel_en-US" xlink:label="lab_lgnd_ContractRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract revenue</link:label>
    <link:label id="lab_lgnd_ContractRevenueMember_label_en-US" xlink:label="lab_lgnd_ContractRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue [Member]</link:label>
    <link:label id="lab_lgnd_ContractRevenueMember_documentation_en-US" xlink:label="lab_lgnd_ContractRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember" xlink:href="lgnd-20221231.xsd#lgnd_ContractRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ContractRevenueMember" xlink:to="lab_lgnd_ContractRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_6d264c11-1a57-4721-94a8-0c6d247c5cd0_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_a2f52eb2-802c-4830-8718-84c95832ef89_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_OmniabSeparationMember_36d60674-f8ff-452f-af16-32ceee20163a_terseLabel_en-US" xlink:label="lab_lgnd_OmniabSeparationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Omniab Separation</link:label>
    <link:label id="lab_lgnd_OmniabSeparationMember_label_en-US" xlink:label="lab_lgnd_OmniabSeparationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Omniab Separation [Member]</link:label>
    <link:label id="lab_lgnd_OmniabSeparationMember_documentation_en-US" xlink:label="lab_lgnd_OmniabSeparationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Omniab Separation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OmniabSeparationMember" xlink:href="lgnd-20221231.xsd#lgnd_OmniabSeparationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_OmniabSeparationMember" xlink:to="lab_lgnd_OmniabSeparationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_1e51c828-462b-4b2f-a91f-3f83d3499f64_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_86d11350-99c4-4e3f-990c-eae82e238c24_terseLabel_en-US" xlink:label="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum threshold of debt trading price trigger (as a percent)</link:label>
    <link:label id="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_label_en-US" xlink:label="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Maximum Threshold Percentage of Debt Trading Price Trigger</link:label>
    <link:label id="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_documentation_en-US" xlink:label="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Maximum Threshold Percentage of Debt Trading Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:href="lgnd-20221231.xsd#lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:to="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AccruedSalesReturns_080887b1-27d2-4b45-8f22-0bcd3c32764e_terseLabel_en-US" xlink:label="lab_lgnd_AccruedSalesReturns" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return reserve and customer refunds</link:label>
    <link:label id="lab_lgnd_AccruedSalesReturns_label_en-US" xlink:label="lab_lgnd_AccruedSalesReturns" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Sales Returns</link:label>
    <link:label id="lab_lgnd_AccruedSalesReturns_documentation_en-US" xlink:label="lab_lgnd_AccruedSalesReturns" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Sales Returns</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSalesReturns" xlink:href="lgnd-20221231.xsd#lgnd_AccruedSalesReturns"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AccruedSalesReturns" xlink:to="lab_lgnd_AccruedSalesReturns" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_70aa0c59-2a4f-4886-b401-539b98042710_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Balance Sheet:</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyMember_aacfeff8-5c54-41cd-8285-900cf0df402d_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties</link:label>
    <link:label id="lab_us-gaap_RoyaltyMember_label_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyMember" xlink:to="lab_us-gaap_RoyaltyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AmendedESPPMember_0eb86b74-0232-4b6a-a8a3-8a59bfdf0190_terseLabel_en-US" xlink:label="lab_lgnd_AmendedESPPMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended ESPP</link:label>
    <link:label id="lab_lgnd_AmendedESPPMember_label_en-US" xlink:label="lab_lgnd_AmendedESPPMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended ESPP [Member]</link:label>
    <link:label id="lab_lgnd_AmendedESPPMember_documentation_en-US" xlink:label="lab_lgnd_AmendedESPPMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended ESPP [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmendedESPPMember" xlink:href="lgnd-20221231.xsd#lgnd_AmendedESPPMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AmendedESPPMember" xlink:to="lab_lgnd_AmendedESPPMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_3a2cb408-55c7-4782-adfb-bd938315c726_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_82deb6fe-9e28-4a76-9da7-f2da8a836aa6_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtTypeDomain_e1d3225b-1907-42c1-9f05-b1e8a226eff4_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:to="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_e3cb9979-756d-42f8-8c58-15894118f936_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforward</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_3d3b7c33-257d-4173-adbc-265f4589bf98_negatedTerseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_label_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Lease Liabilities</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" xlink:href="lgnd-20221231.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" xlink:to="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_0ecba775-97c0-453e-a673-a9950f4cb077_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post-combination expense</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_0a343b51-73c5-43c3-bd20-004662b99425_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_8c29f10d-fecf-44e3-97e0-4335b90b41a2_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_5dab7714-8756-4d83-863f-0bdc18e24717_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of short-term investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_67c60838-44b5-4d00-abf2-eb4f00c472cb_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions for tax positions of prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_6ecb0656-c529-4315-8c3e-7af3e2a2b99e_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersInvestingActivity_1cf72990-c2e1-414c-8b2f-e9f7cbc64d69_negatedTerseLabel_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersInvestingActivity" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to CVR Holders</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersInvestingActivity_label_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersInvestingActivity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Contingent Value Right Holders, Investing Activity</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersInvestingActivity_documentation_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersInvestingActivity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Contingent Value Right Holders, Investing Activity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersInvestingActivity" xlink:href="lgnd-20221231.xsd#lgnd_PaymentsToContingentValueRightHoldersInvestingActivity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsToContingentValueRightHoldersInvestingActivity" xlink:to="lab_lgnd_PaymentsToContingentValueRightHoldersInvestingActivity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_b799907c-3b29-4d0f-9b07-21e3d8a00ee5_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments: Investment in Viking</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:to="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchMember_09528913-49a1-4dc1-99a6-5b57ee3ec8e3_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Tax Credit Carryforward</link:label>
    <link:label id="lab_us-gaap_ResearchMember_label_en-US" xlink:label="lab_us-gaap_ResearchMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Tax Credit Carryforward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchMember" xlink:to="lab_us-gaap_ResearchMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_a6748e32-479c-4491-a8ee-fcb63d64fccf_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options vested and expected to vest at end of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_645604a3-ad48-41a6-9e26-78efa479cef5_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_40e8bbfe-da52-438e-b207-0302831ff7e7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase the number of shares under the 2002 Stock Incentive Plan (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments_533d3d51-3bf2-4621-a2f1-4c440614773e_terseLabel_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from short-term investments</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments_label_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Gain (Loss) On Short-Term Investments</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments_documentation_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Gain (Loss) On Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments" xlink:to="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_d5ca612b-b7f2-45b7-9db8-191545c8b0f6_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_47364a7c-821e-493e-afad-1030b49687e8_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2a21a5a1-3a32-4b55-b2eb-ebf81c4c7f57_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_15b7ed9a-dce7-4282-9b89-6895ff6c7527_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">12 months or greater</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_5b94554a-ffca-4e55-b074-9c0ace37a4b3_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_78066f54-51b9-4aa2-899b-8bfe8ab0686b_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price of warrants (USD per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_8777dda6-89de-428d-8155-9e9309db0354_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent_f2c7d730-a673-42d7-b4bf-d887b1369efe_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_5e6a5819-d9da-4dcb-910b-1f3d5fb7bb3f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_0db82ed3-cfe1-448b-abb1-a26cc4600041_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_28bb5b5e-011e-4dcc-9463-2d48ba27fab6_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_b6896138-1051-4c3b-98c9-30de57175d83_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_18a7a9fd-d361-47bc-9d5e-95b026fe0bc2_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_30a4e553-2b8e-41a0-b096-8be38fca90bc_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_0034ff6e-16e7-4be5-8742-6dba4c7aa60f_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_65d4b11c-443d-4ae4-97f5-49b85fd37f00_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease (increase) in stockholder's equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_6901e609-86c8-41fe-830c-2b3cd9e2800d_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carryforward</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_d817dcc8-f62e-4d6a-a946-7f7c5ee64b7c_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use asset recognized</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_3ca4c449-4d5b-4ccc-ba09-0b858e0d4af1_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_c303dcc7-4225-47af-bd80-cb1467c78fe0_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_4e9edce5-b4a4-487b-a6b4-d93b6d303896_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research credit carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_6a3625b6-89dc-40b5-a6a8-bc21041dc56c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5d50d71b-e04e-4ee8-a998-f86535382d2c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization on finite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_9f7a3b19-3945-45bf-8fa8-c2b79fff2088_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c033ed87-2a42-46d5-8103-b38c6a22b0e3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated amortization expense for 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_1ca4a74b-5114-4f8e-9c58-176cb99bcc8c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Level 3 Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock_7755c082-9eba-4591-8ec3-2b1dc0d7bb48_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment_f18bd8da-c0d1-452e-aa8b-c33f2cf43a3c_terseLabel_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment_label_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Research and Development</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment_documentation_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" xlink:to="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_d5a95684-e090-4d6b-b8be-3ba91437bd10_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retain earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_e06620a3-d450-44b6-9a98-0a0694a46ae2_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLossCarryforwardMember_3e15d856-22ff-4ef7-8e66-79394c5ca572_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLossCarryforwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Loss Carryforward</link:label>
    <link:label id="lab_us-gaap_CapitalLossCarryforwardMember_label_en-US" xlink:label="lab_us-gaap_CapitalLossCarryforwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Loss Carryforward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLossCarryforwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalLossCarryforwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLossCarryforwardMember" xlink:to="lab_us-gaap_CapitalLossCarryforwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_a0ff104f-d390-4f9d-8150-6b744f819553_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyAgreementsMember_0f546840-0b6f-470a-8123-61439d74da27_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Agreements</link:label>
    <link:label id="lab_us-gaap_RoyaltyAgreementsMember_label_en-US" xlink:label="lab_us-gaap_RoyaltyAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyAgreementsMember" xlink:to="lab_us-gaap_RoyaltyAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_09c67559-9135-422d-a7f7-d1aa5cd75677_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_aed7f827-a575-4a8c-994f-63565c495672_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for future option grants (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_b090fe10-df4a-452d-b3ce-e5d68cd75fad_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_d98ce0f2-6754-4ac7-8839-9f5894e9fe01_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restricted Stock Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_9ba14eea-7daf-45c3-9d57-6b0520afba90_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_0ee1c5d3-4f0d-42d9-8e1a-859d8bd54d84_negatedTerseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities, Current</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" xlink:href="lgnd-20221231.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" xlink:to="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_4ca08790-7899-436d-9c47-a55f6c81e515_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of transfers of assets and liabilities to OmniAb</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_d04b7a3a-2f5d-482a-a23c-71af9a2c4ad7_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of discontinued operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_3e8bee98-abed-4d8d-9bcf-dcd90404ece2_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AccruedSubcontractorExpensesCurrent_f1045449-be99-4e39-8062-3b7121957b1b_terseLabel_en-US" xlink:label="lab_lgnd_AccruedSubcontractorExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subcontractor</link:label>
    <link:label id="lab_lgnd_AccruedSubcontractorExpensesCurrent_label_en-US" xlink:label="lab_lgnd_AccruedSubcontractorExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Subcontractor Expenses, Current</link:label>
    <link:label id="lab_lgnd_AccruedSubcontractorExpensesCurrent_documentation_en-US" xlink:label="lab_lgnd_AccruedSubcontractorExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Subcontractor Expenses, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSubcontractorExpensesCurrent" xlink:href="lgnd-20221231.xsd#lgnd_AccruedSubcontractorExpensesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AccruedSubcontractorExpensesCurrent" xlink:to="lab_lgnd_AccruedSubcontractorExpensesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_0ae524f4-92f6-4f3f-80b3-ddf2e1d07563_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_7b5d8e40-582f-4c48-81f8-424604a166bc_verboseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities - CyDex</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Cydex [Member]</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_documentation_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Cydex</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:href="lgnd-20221231.xsd#lgnd_LiabilityForContingentValueRightsCompanyCydexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:to="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_b5528051-f8f0-4243-9cd6-5cf6d31bcd85_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_6c25ae1c-c75d-44e7-a35d-480593670c8b_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_8f703742-4069-484b-9163-7ad87b98bd55_verboseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_RoyaltyOtherMember_23a8d8db-2368-4799-a0fa-4221ad5b350e_terseLabel_en-US" xlink:label="lab_lgnd_RoyaltyOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_lgnd_RoyaltyOtherMember_label_en-US" xlink:label="lab_lgnd_RoyaltyOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty, Other [Member]</link:label>
    <link:label id="lab_lgnd_RoyaltyOtherMember_documentation_en-US" xlink:label="lab_lgnd_RoyaltyOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyOtherMember" xlink:href="lgnd-20221231.xsd#lgnd_RoyaltyOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_RoyaltyOtherMember" xlink:to="lab_lgnd_RoyaltyOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_f7869793-5347-4313-a989-5d0d132eeb42_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_6ecc1d48-8c3a-4aab-8032-9c1be5a39e3c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_ce3918b0-96ee-40d6-aea1-84f1d61c73aa_verboseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of convertible senior notes outstanding (Level 2)</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Fair Value Disclosures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:to="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_fc315cc3-bf95-4a12-9563-7010569fafba_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_3242a055-f29c-40d2-a6c7-f05402fe59d2_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_label_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restricted Cash</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:href="lgnd-20221231.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:to="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_506a4d1d-893c-4ad5-9c67-0020601b4c03_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_6d9a0a9f-d6b4-4b0a-b98c-b2d3859aceb7_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ExercisePriceRangeThreeMember_7c109d9f-acf7-41d2-b681-95529a2606ab_terseLabel_en-US" xlink:label="lab_lgnd_ExercisePriceRangeThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$52.84-$52.84</link:label>
    <link:label id="lab_lgnd_ExercisePriceRangeThreeMember_label_en-US" xlink:label="lab_lgnd_ExercisePriceRangeThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range Three [Member]</link:label>
    <link:label id="lab_lgnd_ExercisePriceRangeThreeMember_documentation_en-US" xlink:label="lab_lgnd_ExercisePriceRangeThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ExercisePriceRangeThreeMember" xlink:href="lgnd-20221231.xsd#lgnd_ExercisePriceRangeThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ExercisePriceRangeThreeMember" xlink:to="lab_lgnd_ExercisePriceRangeThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_0ea1f54c-ef8b-4c8c-b135-21154c6f317c_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:to="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_048f37f7-dd8a-4312-9cab-67b81bf55241_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_75b0c46a-848f-4fa3-b919-2f2686cfdc24_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c41411c3-b49d-4a25-bb65-0b856c1e85d1_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_3f2ffc22-f929-40b9-ae7e-b27ba2b91824_terseLabel_en-US" xlink:label="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties</link:label>
    <link:label id="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_label_en-US" xlink:label="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties [Member]</link:label>
    <link:label id="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_documentation_en-US" xlink:label="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:href="lgnd-20221231.xsd#lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:to="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_d8e07eaf-9985-4f57-b0db-1bf1b4755f38_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_cdbcf958-5994-42e0-889a-eb4aadbc5dca_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_1d224f69-27d8-4132-9844-202da428946f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1df8fdea-ef4e-467a-b693-9aae10b4d910_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction in contingent liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_492cc9f6-6684-4840-b235-d9c6f17f2c08_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_f7e854d9-bb8d-40af-a989-43c955f9591e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_08fc2c8f-c1df-47d8-bf90-4604475e23a3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_386b2687-8b71-40a3-9e6d-2a34f341f8a8_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased in period</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b162fbe9-31f4-4d6d-a71f-77b3ac63f262_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_4743da22-6091-4b91-9f70-47285d014b9a_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndStockholdersEquityAbstract_75542d18-f49c-4580-b4f3-8372ad902d27_terseLabel_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities And Stockholder's Equity [Abstract]</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndStockholdersEquityAbstract_documentation_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities And Stockholder's Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndStockholdersEquityAbstract" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_f814380c-04b6-4623-94b8-b6ebc57d1ce5_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_4dd7451c-f185-4dcf-807d-7d2442ad40a7_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_2e857062-28da-4932-b4a5-bc921b4a17f8_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NumberOfSharesSoldOfEquityMethodInvestee_7141b031-3a78-40f9-80a3-f906f553cd4c_terseLabel_en-US" xlink:label="lab_lgnd_NumberOfSharesSoldOfEquityMethodInvestee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock sold of equity method investee (in shares)</link:label>
    <link:label id="lab_lgnd_NumberOfSharesSoldOfEquityMethodInvestee_label_en-US" xlink:label="lab_lgnd_NumberOfSharesSoldOfEquityMethodInvestee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Shares Sold Of Equity Method Investee</link:label>
    <link:label id="lab_lgnd_NumberOfSharesSoldOfEquityMethodInvestee_documentation_en-US" xlink:label="lab_lgnd_NumberOfSharesSoldOfEquityMethodInvestee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Shares Sold Of Equity Method Investee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfSharesSoldOfEquityMethodInvestee" xlink:href="lgnd-20221231.xsd#lgnd_NumberOfSharesSoldOfEquityMethodInvestee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NumberOfSharesSoldOfEquityMethodInvestee" xlink:to="lab_lgnd_NumberOfSharesSoldOfEquityMethodInvestee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_ee0c354a-4bb1-482d-a371-f07475480106_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Option Plan Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_12d932ba-dac2-4384-a171-a230722b65d2_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_524e1123-7d46-48bc-a64c-9b961284b9d9_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Updates, Recently Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_2939070e-429e-4c72-ae01-e3d013b84d20_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_972df2ba-4a50-437f-81f2-f28e19d46cbb_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Revenue</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_37a5866b-dacb-4746-aaac-b457eb3253ac_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Tax Effect of Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:to="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_8b42fc32-84c6-408e-b8a2-8d87b14a89d3_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, fair value</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_9dda5a21-6c08-4042-8b3c-e50d9eba76f3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_f538f41c-86c6-444e-acee-9b50caa210b0_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased in period (shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_1cfd99de-6c93-48f7-af65-1c567f5559bc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign tax differential on income/loss of foreign subsidiaries</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod_a010b4b3-e19b-404e-95fa-a3c734264813_terseLabel_en-US" xlink:label="lab_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchased amount</link:label>
    <link:label id="lab_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod_label_en-US" xlink:label="lab_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchased Amount During Period</link:label>
    <link:label id="lab_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod_documentation_en-US" xlink:label="lab_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchased Amount During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod" xlink:href="lgnd-20221231.xsd#lgnd_DebtInstrumentRepurchasedAmountDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod" xlink:to="lab_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0db40689-7a13-4b62-b6f9-ffa72bf1f5dd_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_a59de527-a795-4827-83a5-521647e7e985_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_b871d952-e01f-4133-b027-4c0864f514ea_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (USD per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_33eaf0e9-0241-4b77-ba26-ad85f58d352c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_8cf75548-014a-4eed-bbe3-882979a81997_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Statement of Operations:</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_04c5ccbd-9949-4603-823d-bd75ecd6b2f8_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_3bc53212-c1d8-4bd7-869c-1d848f123bd8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_bb79ee07-6c99-4003-a902-641d7bba32c5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_14662904-2cda-4ce9-be93-3f359b213e27_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ProductRoyaltyPercentage_965b06d5-9d0a-429d-9c53-b70902a60424_terseLabel_en-US" xlink:label="lab_lgnd_ProductRoyaltyPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product royalty (as a percent)</link:label>
    <link:label id="lab_lgnd_ProductRoyaltyPercentage_label_en-US" xlink:label="lab_lgnd_ProductRoyaltyPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Royalty Percentage</link:label>
    <link:label id="lab_lgnd_ProductRoyaltyPercentage_documentation_en-US" xlink:label="lab_lgnd_ProductRoyaltyPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Royalty Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ProductRoyaltyPercentage" xlink:href="lgnd-20221231.xsd#lgnd_ProductRoyaltyPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ProductRoyaltyPercentage" xlink:to="lab_lgnd_ProductRoyaltyPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_a58f243b-8943-4466-9de6-aea127c36433_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_01859f86-4760-48a4-aded-9a0a04899193_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_4fc25424-3e6d-436c-b06e-97b74b6b55e4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">12 months or greater</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_9a52e680-51dc-49c2-866c-66658b755c29_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjusted Balance</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjusted Balance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3928905b-42d1-4904-9d00-38ea3c2e9a0b_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrinsic value of options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_b15d16d4-f227-4934-8d47-23c65095a3c3_terseLabel_en-US" xlink:label="lab_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_label_en-US" xlink:label="lab_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Browse Taxonomy Disposal Group, Including Discontinued Operation, Other Income (Expense) [Abstract]</link:label>
    <link:label id="lab_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_documentation_en-US" xlink:label="lab_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Browse Taxonomy Disposal Group, Including Discontinued Operation, Other Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" xlink:href="lgnd-20221231.xsd#lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" xlink:to="lab_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cac65926-7587-44c9-ada9-a8fd1ad776c6_netLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in diluted per share calculation (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a9fcf164-eea2-4e5e-bf20-ad177a10ac44_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used to compute diluted income per share</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cf6cd7bb-7c4d-42dd-906f-5f8822bf35ff_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in the computation of diluted net income (loss) per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ExercisePriceRangeOneMember_3dbd899a-ee77-48d5-88cc-fd0b116acc32_terseLabel_en-US" xlink:label="lab_lgnd_ExercisePriceRangeOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$12.78-$43.36</link:label>
    <link:label id="lab_lgnd_ExercisePriceRangeOneMember_label_en-US" xlink:label="lab_lgnd_ExercisePriceRangeOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range One [Member]</link:label>
    <link:label id="lab_lgnd_ExercisePriceRangeOneMember_documentation_en-US" xlink:label="lab_lgnd_ExercisePriceRangeOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ExercisePriceRangeOneMember" xlink:href="lgnd-20221231.xsd#lgnd_ExercisePriceRangeOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ExercisePriceRangeOneMember" xlink:to="lab_lgnd_ExercisePriceRangeOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_f5e3c5b3-c980-4c0b-8349-7f49f013d49e_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalBondHedgeTransaction_46683d81-ac0a-4f2c-ba78-ef125f7e338b_terseLabel_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalBondHedgeTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bond hedge transaction</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalBondHedgeTransaction_label_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalBondHedgeTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid In Capital, Bond Hedge Transaction</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalBondHedgeTransaction_documentation_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalBondHedgeTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid In Capital, Bond Hedge Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalBondHedgeTransaction" xlink:href="lgnd-20221231.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalBondHedgeTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalBondHedgeTransaction" xlink:to="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalBondHedgeTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_644fb93d-2011-4b6f-af5f-5b73fee225f7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_7044d0cc-8375-4e01-b1c5-814e262de752_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_d2d1990f-60c8-406f-b5e0-7ee1fe4ec048_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_120ec7bc-5873-4ee8-94b9-4fb2fae53991_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_8eaf0e74-e6b5-479d-95a1-a7d67a744ef7_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value, exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_10c65b9e-7f9e-45bb-8b47-ab90eaad277c_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock authorized (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_291b598f-789e-45db-92b3-a22434351806_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets with finite lives</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Finite-Lived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_874231b2-2abc-4d84-8ae6-1f776814f59f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant derivative</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_ea091440-9b2d-4f2e-9c1a-4ea3daf49db9_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment and Contingencies: Legal Proceedings</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization_ac02aee8-ca3b-4115-9251-8c3c5311ff96_terseLabel_en-US" xlink:label="lab_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease amortization expense</link:label>
    <link:label id="lab_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease And Operating Lease, Right-of-Use Asset, Amortization</link:label>
    <link:label id="lab_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization_documentation_en-US" xlink:label="lab_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease And Operating Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" xlink:href="lgnd-20221231.xsd#lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" xlink:to="lab_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_177c2f0d-4c9d-4936-8454-32096dbc2366_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities_d15ef557-8ca4-4b75-a623-739df7691cb4_negatedTerseLabel_en-US" xlink:label="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchases</link:label>
    <link:label id="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities_label_en-US" xlink:label="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Repurchases, Contingent Liabilities</link:label>
    <link:label id="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities_documentation_en-US" xlink:label="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Repurchases, Contingent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities" xlink:href="lgnd-20221231.xsd#lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities" xlink:to="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_28db3027-101c-40b2-9733-84bc1ceb9d44_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities of discontinued operations</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_b324dbf7-3ad3-4bed-8784-55f6f2515527_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities of discontinued operations</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AziyoMember_53e1bda2-aab9-460e-a5b6-3d1f5cd76eb5_terseLabel_en-US" xlink:label="lab_lgnd_AziyoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aziyo</link:label>
    <link:label id="lab_lgnd_AziyoMember_label_en-US" xlink:label="lab_lgnd_AziyoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aziyo [Member]</link:label>
    <link:label id="lab_lgnd_AziyoMember_documentation_en-US" xlink:label="lab_lgnd_AziyoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aziyo [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoMember" xlink:href="lgnd-20221231.xsd#lgnd_AziyoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AziyoMember" xlink:to="lab_lgnd_AziyoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_0814efa2-f6c8-46e0-8f5c-865c0bcc667f_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of fixed assets recorded in accounts payable</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_6b05491f-bc35-4b01-8dda-8b7aa5121dec_terseLabel_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred over Time</link:label>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_label_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred over Time [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferredOverTimeMember" xlink:to="lab_us-gaap_TransferredOverTimeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_8f977002-d3e0-47a2-a7f5-59c3fde537a2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_36655f3b-15a7-4331-8f4d-62fb1c16ff30_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6bc67827-b8a1-445d-a4eb-a8752387ce87_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_7da5673f-e916-494b-8855-f6988817f3a6_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_1cdf4e06-f84b-49e4-912e-76a5e5f50fbd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal amount of 2023 Notes outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_c83ebe5a-175e-480c-a8bd-870b115bb514_terseLabel_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Revenue Service (IRS)</link:label>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_label_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Revenue Service (IRS) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:to="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_70b155d1-8c4d-49f4-a460-8cd00b17bf8c_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_ad95d33a-66ef-4f0f-9dd8-078f25ee2959_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash received from options exercised</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_619fc654-7d9d-43c3-b130-55bb5d2ba333_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PurchaseCommitmentConsiderationPaidAllocatedToInventory_7df86cb4-b913-4d3c-9e0b-6e7b5b12cd4c_terseLabel_en-US" xlink:label="lab_lgnd_PurchaseCommitmentConsiderationPaidAllocatedToInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion of consideration allocated to inventory</link:label>
    <link:label id="lab_lgnd_PurchaseCommitmentConsiderationPaidAllocatedToInventory_label_en-US" xlink:label="lab_lgnd_PurchaseCommitmentConsiderationPaidAllocatedToInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Commitment, Consideration Paid, Allocated to Inventory</link:label>
    <link:label id="lab_lgnd_PurchaseCommitmentConsiderationPaidAllocatedToInventory_documentation_en-US" xlink:label="lab_lgnd_PurchaseCommitmentConsiderationPaidAllocatedToInventory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Commitment, Consideration Paid, Allocated to Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PurchaseCommitmentConsiderationPaidAllocatedToInventory" xlink:href="lgnd-20221231.xsd#lgnd_PurchaseCommitmentConsiderationPaidAllocatedToInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PurchaseCommitmentConsiderationPaidAllocatedToInventory" xlink:to="lab_lgnd_PurchaseCommitmentConsiderationPaidAllocatedToInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_37831d81-c39c-4619-80e1-cddb893ccdff_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss from discontinued operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_fe435249-f95e-42ed-8826-ed74087fa06e_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss from discontinued operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MaterialSalesCaptisolCOVIDMember_db6504f8-162e-4525-bbaf-dc26992ed15e_terseLabel_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolCOVIDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Captisol - COVID</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolCOVIDMember_label_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolCOVIDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol, COVID [Member]</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolCOVIDMember_documentation_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolCOVIDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol, COVID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCOVIDMember" xlink:href="lgnd-20221231.xsd#lgnd_MaterialSalesCaptisolCOVIDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MaterialSalesCaptisolCOVIDMember" xlink:to="lab_lgnd_MaterialSalesCaptisolCOVIDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_732a0d75-9b5d-4cef-8565-964602464b39_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_514ecc49-4d67-4700-beac-fdd0df08eb89_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_9190db88-d9bd-4f52-af3e-9e66492f0dd1_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfNotesPayable" xlink:to="lab_us-gaap_RepaymentsOfNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_2af5f5c0-35b2-4f57-9a75-3ba4179afe17_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRights_db0d6ca4-cfe9-40e4-a987-dc54cc721da8_verboseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term contingent liabilities</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRights_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Contingent Value Rights</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRights_documentation_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for contingent value rights.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRights" xlink:href="lgnd-20221231.xsd#lgnd_LiabilityForContingentValueRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRights" xlink:to="lab_lgnd_LiabilityForContingentValueRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_ae8a5c3b-9837-4c67-b048-9f3442bd8b2c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Consideration / Recognized Identified Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6ef86dde-a16b-4642-b57d-8bd3539ef9cd_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_46d851b8-6756-4bce-9078-84b4b7c3547d_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LeaseLiabilityCurrent_6432445a-c8fc-4d75-b15f-a4e978b44e72_totalLabel_en-US" xlink:label="lab_lgnd_LeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current lease liabilities</link:label>
    <link:label id="lab_lgnd_LeaseLiabilityCurrent_label_en-US" xlink:label="lab_lgnd_LeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Current</link:label>
    <link:label id="lab_lgnd_LeaseLiabilityCurrent_documentation_en-US" xlink:label="lab_lgnd_LeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiabilityCurrent" xlink:href="lgnd-20221231.xsd#lgnd_LeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LeaseLiabilityCurrent" xlink:to="lab_lgnd_LeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_eac4425d-9346-4cda-977c-a6b9e3462f9b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_4c32aa44-35cc-4186-a579-c4c801423127_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_8f874456-ddb8-4069-84ad-53a6db3a94be_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_6d054fe2-6a2a-41a6-86ce-68dee942e1b1_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_a5d3900b-2a4e-4037-a56e-91a6b98b09ed_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangibles Acquired</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_c9decace-b136-4ea8-9cd9-4e80ab43e8ac_terseLabel_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selected Quarterly Financial Data (Unaudited)</link:label>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:to="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OfficeEquipmentMember_ac7d4f61-3344-4c0d-a021-173e12d4e1f5_verboseLabel_en-US" xlink:label="lab_us-gaap_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lab and office equipment</link:label>
    <link:label id="lab_us-gaap_OfficeEquipmentMember_label_en-US" xlink:label="lab_us-gaap_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OfficeEquipmentMember" xlink:to="lab_us-gaap_OfficeEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_dfb3b039-5879-40a0-bacb-7a8ef3c2d9f1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value adjustments to contingent liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_a387b1ba-bd09-4bfd-a0b5-36af88b4b4e7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_d44d796b-b5f5-461f-8f99-81b9d01dc42c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2754e102-a06c-4d57-855d-8889787cad6e_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_b72aed3f-b0c5-4682-a7a2-e4139839c983_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_Phase3ClinicalTrialMember_010dbf2a-2aa5-4265-add9-f554701b7726_terseLabel_en-US" xlink:label="lab_lgnd_Phase3ClinicalTrialMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Phase 3 Clinical Trial</link:label>
    <link:label id="lab_lgnd_Phase3ClinicalTrialMember_label_en-US" xlink:label="lab_lgnd_Phase3ClinicalTrialMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Phase 3 Clinical Trial [Member]</link:label>
    <link:label id="lab_lgnd_Phase3ClinicalTrialMember_documentation_en-US" xlink:label="lab_lgnd_Phase3ClinicalTrialMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Phase 3 Clinical Trial</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_Phase3ClinicalTrialMember" xlink:href="lgnd-20221231.xsd#lgnd_Phase3ClinicalTrialMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_Phase3ClinicalTrialMember" xlink:to="lab_lgnd_Phase3ClinicalTrialMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_89691d7b-a067-41bc-9f42-5dbcd80b4f0e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MaterialSalesCaptisolCoreMember_d1154b82-fb3f-4659-9d33-047062537ddf_terseLabel_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolCoreMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Captisol - Core</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolCoreMember_label_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolCoreMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol, Core [Member]</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolCoreMember_documentation_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolCoreMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol, Core</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCoreMember" xlink:href="lgnd-20221231.xsd#lgnd_MaterialSalesCaptisolCoreMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MaterialSalesCaptisolCoreMember" xlink:to="lab_lgnd_MaterialSalesCaptisolCoreMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_3f9a3eb2-99bd-4b67-877d-88ad5b9b1bbe_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_dc8ed86a-d5f7-45ed-95d7-464bfb3bc7b7_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_199808d0-c95d-4026-adf1-2152064c9cfc_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_46a3e29d-cc70-44c4-adf3-f52c087afccb_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_0a09d573-bd53-4b64-9624-2741f525d324_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_843819d4-e61d-46f7-ab06-376aac8d3e53_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under amended ESSP (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_970cc788-69fa-49ae-a1b6-12cbcca27133_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend declared (USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_cb8b0f88-0ff8-4df8-afa9-e48cbc1fdd01_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_05407aaf-e21a-4ce8-bf07-b7bc8a353104_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_540f141e-5113-4f4c-be43-8e5e8861cfb6_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember_47abc316-ff32-4669-8fc8-63f245481979_terseLabel_en-US" xlink:label="lab_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Repurchased During Current Period, Two</link:label>
    <link:label id="lab_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember_label_en-US" xlink:label="lab_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Repurchased During Current Period, Two [Member]</link:label>
    <link:label id="lab_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember_documentation_en-US" xlink:label="lab_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Repurchased During Current Period, Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember" xlink:href="lgnd-20221231.xsd#lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember" xlink:to="lab_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_01760570-953f-40b3-94be-7718f413c270_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_0690da20-c44f-4955-a366-e078be22eb02_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_181aef7c-2ee8-43cc-abf3-a7ee9f0557bf_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_053b6b71-7118-45fb-b680-a280fbd04727_terseLabel_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from Significant Partners</link:label>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_label_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedules of Concentration of Risk, by Risk Factor [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:to="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_444dc8b3-3549-49d4-a651-d7acd073b67b_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value (In thousands)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_10dacd59-d0ee-4abf-b921-deef9b689332_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LicenseFeesMilestonesAndOtherProductOtherMember_d5f84a4a-7c09-494c-895a-c05c5135c443_terseLabel_en-US" xlink:label="lab_lgnd_LicenseFeesMilestonesAndOtherProductOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_lgnd_LicenseFeesMilestonesAndOtherProductOtherMember_label_en-US" xlink:label="lab_lgnd_LicenseFeesMilestonesAndOtherProductOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees, Milestones, and Other Product, Other [Member]</link:label>
    <link:label id="lab_lgnd_LicenseFeesMilestonesAndOtherProductOtherMember_documentation_en-US" xlink:label="lab_lgnd_LicenseFeesMilestonesAndOtherProductOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees, Milestones, and Other Product, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMilestonesAndOtherProductOtherMember" xlink:href="lgnd-20221231.xsd#lgnd_LicenseFeesMilestonesAndOtherProductOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LicenseFeesMilestonesAndOtherProductOtherMember" xlink:to="lab_lgnd_LicenseFeesMilestonesAndOtherProductOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MaterialSalesCaptisolMember_c0a47636-b4d7-4287-89db-6a1af0750625_terseLabel_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Captisol</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolMember_label_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol [Member]</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolMember_documentation_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember" xlink:href="lgnd-20221231.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MaterialSalesCaptisolMember" xlink:to="lab_lgnd_MaterialSalesCaptisolMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_c349b697-4d4b-4f35-8463-fdae5ae2ebe7_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Current and Noncurrent</link:label>
    <link:label id="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_label_en-US" xlink:label="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Current and Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:to="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchaseAmount_abfb8b37-ac7d-4792-868e-d971d5d39e7d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchased amount of debt instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchaseAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchaseAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CydexPharmaceuticalsIncMember_e10a871f-0172-4812-b5d4-1364d33e25a7_verboseLabel_en-US" xlink:label="lab_lgnd_CydexPharmaceuticalsIncMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cydex</link:label>
    <link:label id="lab_lgnd_CydexPharmaceuticalsIncMember_label_en-US" xlink:label="lab_lgnd_CydexPharmaceuticalsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cydex Pharmaceuticals, Inc [Member]</link:label>
    <link:label id="lab_lgnd_CydexPharmaceuticalsIncMember_documentation_en-US" xlink:label="lab_lgnd_CydexPharmaceuticalsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cydex Pharmaceuticals, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CydexPharmaceuticalsIncMember" xlink:href="lgnd-20221231.xsd#lgnd_CydexPharmaceuticalsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CydexPharmaceuticalsIncMember" xlink:to="lab_lgnd_CydexPharmaceuticalsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_940e92fd-f0b0-4ce7-96cc-2b0c5cfc19b1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ContractualRelationshipsArcellxMember_fc7220dc-16d4-45df-b9ca-83cf29cb0390_terseLabel_en-US" xlink:label="lab_lgnd_ContractualRelationshipsArcellxMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Relationships - Arcellx</link:label>
    <link:label id="lab_lgnd_ContractualRelationshipsArcellxMember_label_en-US" xlink:label="lab_lgnd_ContractualRelationshipsArcellxMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Relationships - Arcellx [Member]</link:label>
    <link:label id="lab_lgnd_ContractualRelationshipsArcellxMember_documentation_en-US" xlink:label="lab_lgnd_ContractualRelationshipsArcellxMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Relationships - Arcellx</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractualRelationshipsArcellxMember" xlink:href="lgnd-20221231.xsd#lgnd_ContractualRelationshipsArcellxMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ContractualRelationshipsArcellxMember" xlink:to="lab_lgnd_ContractualRelationshipsArcellxMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_0052f1e2-5e55-408d-8c43-2330a44588f0_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock compensation plans, net (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_c894ce0e-8102-4f42-ad65-c3c62b4e4539_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MetabasisTherapeuticsMember_c6f69786-4ed1-4857-bb67-9c6a6c767fc9_terseLabel_en-US" xlink:label="lab_lgnd_MetabasisTherapeuticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Metabasis Therapeutics</link:label>
    <link:label id="lab_lgnd_MetabasisTherapeuticsMember_6482d94c-23c4-4b56-8f09-662aae40c4c3_verboseLabel_en-US" xlink:label="lab_lgnd_MetabasisTherapeuticsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Metabasis</link:label>
    <link:label id="lab_lgnd_MetabasisTherapeuticsMember_label_en-US" xlink:label="lab_lgnd_MetabasisTherapeuticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Metabasis Therapeutics [Member]</link:label>
    <link:label id="lab_lgnd_MetabasisTherapeuticsMember_documentation_en-US" xlink:label="lab_lgnd_MetabasisTherapeuticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Metabasis Therapeutics [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MetabasisTherapeuticsMember" xlink:href="lgnd-20221231.xsd#lgnd_MetabasisTherapeuticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MetabasisTherapeuticsMember" xlink:to="lab_lgnd_MetabasisTherapeuticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_a212e1d2-7a79-4650-88e8-3f1c67dbdc6d_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_82d174ed-301f-42f7-8333-bd9daed57293_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_be5ce577-844c-4ff1-b009-eedc98decbd3_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturity of Finance Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfWarrants_13ea3b11-b94c-4c3d-ac26-c5e610721411_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfWarrants" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of warrants</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfWarrants_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfWarrants" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_56879684-ccbd-4f8e-83bf-ff4cf760ef79_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated amortization expense for 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_b20e035f-075d-47e3-9be3-456ce2b44529_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f7e6ea55-6e34-4375-9c28-c4f639b90f92_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AziyoandCorMatrixMember_c886942f-9f00-44c0-971c-586f5d855303_terseLabel_en-US" xlink:label="lab_lgnd_AziyoandCorMatrixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aziyo and CorMatrix</link:label>
    <link:label id="lab_lgnd_AziyoandCorMatrixMember_label_en-US" xlink:label="lab_lgnd_AziyoandCorMatrixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aziyo and CorMatrix [Member]</link:label>
    <link:label id="lab_lgnd_AziyoandCorMatrixMember_documentation_en-US" xlink:label="lab_lgnd_AziyoandCorMatrixMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aziyo and CorMatrix [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoandCorMatrixMember" xlink:href="lgnd-20221231.xsd#lgnd_AziyoandCorMatrixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AziyoandCorMatrixMember" xlink:to="lab_lgnd_AziyoandCorMatrixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanAbstract_0072929e-642c-42f1-ac58-a1b401eff29f_terseLabel_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanAbstract_label_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Abstract]</link:label>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanAbstract_documentation_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanAbstract" xlink:href="lgnd-20221231.xsd#lgnd_EmployeeStockPurchasePlanAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract" xlink:to="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_9346250c-1b7c-48f5-a941-c9aa90cfe98c_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_0d953a65-c28a-4fef-867b-a5654faab3e9_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_8aff1d24-3061-487c-89ec-f5703dacb8f2_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_52458f09-5e6a-4a82-a103-dfa3482e80e1_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_192d4914-6847-4045-aafd-cf4473658bc4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes of acquiree since acquisition date included in comprehensive income</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:to="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_f9ca5946-ae95-4028-a0e8-18b9dc369517_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow disclosures:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_3ed21616-8e37-41ea-b5d5-2b8116288468_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_1141d475-53fe-4f45-9456-46f9030cf7c7_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9e8af6a2-5f6a-400d-8585-894a951aa693_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_de4d610e-66f9-452c-8d81-2d3820623926_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_b5751b67-3318-4e14-9f34-676bdef58134_verboseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated useful life (in years)</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_5701f876-9192-45a5-ae7c-444cd67b542c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Quarterly Financial Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_789dff91-1e6b-46e6-bd12-819aea316057_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets of discontinued operations</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_7df52c86-858e-4549-8a3b-0e380d2fc151_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_8f1169f9-36fb-4923-bcd2-b9a0f65d9fe4_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_985c32be-8c0a-4551-91dc-e94bc97bdab9_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_7f40dffa-ff84-42c6-8344-d9743d3a6f24_totalLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_b4e547c2-17ee-4039-98b0-414dfe4b0283_negatedLabel_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to CVR Holders</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_af2307fc-7300-40a7-b428-2f9f63210f50_negatedTerseLabel_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to CVR Holders</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_label_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Contingent Value Right Holders, Financing Activity</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_documentation_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Contingent Value Right Holders, Financing Activity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:href="lgnd-20221231.xsd#lgnd_PaymentsToContingentValueRightHoldersFinancingActivity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:to="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_a341f3a4-ea59-4674-a96c-244f3c5f9a21_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_688ca728-aa13-497a-bafb-c6aca17f79b4_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_3f641fbc-ea79-4b4a-81cb-3760bd5a599c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ExercisePriceRangeSevenMember_33bf4605-b4b7-421d-bcf1-aefadcfc6112_terseLabel_en-US" xlink:label="lab_lgnd_ExercisePriceRangeSevenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">70.04</link:label>
    <link:label id="lab_lgnd_ExercisePriceRangeSevenMember_label_en-US" xlink:label="lab_lgnd_ExercisePriceRangeSevenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range Seven [Member]</link:label>
    <link:label id="lab_lgnd_ExercisePriceRangeSevenMember_documentation_en-US" xlink:label="lab_lgnd_ExercisePriceRangeSevenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range Seven [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ExercisePriceRangeSevenMember" xlink:href="lgnd-20221231.xsd#lgnd_ExercisePriceRangeSevenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ExercisePriceRangeSevenMember" xlink:to="lab_lgnd_ExercisePriceRangeSevenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_b5707c45-8211-42ac-b5d0-3983603d97d9_totalLabel_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other expense, net</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_label_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Nonoperating Income (Expense)</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_documentation_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" xlink:to="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_2b6b92c9-6c54-479f-ba25-e4039ce64175_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate of finance leases (as a percent)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentDebtSecuritiesMember_32981185-4702-4d14-b224-97fd17d812c4_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_e2dafaa0-9f36-4947-aee5-71b2c659687b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption Period Two</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7982cb9b-0817-4953-9c08-3c7329b970d5_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_55247872-1b1a-4ba8-b11d-289738655951_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract_32216948-0d1d-4b01-8b76-953a8fcf16f5_terseLabel_en-US" xlink:label="lab_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating activities:</link:label>
    <link:label id="lab_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract_label_en-US" xlink:label="lab_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Discontinued Operations, Operating Activities [Abstract]</link:label>
    <link:label id="lab_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract_documentation_en-US" xlink:label="lab_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Discontinued Operations, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract" xlink:href="lgnd-20221231.xsd#lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract" xlink:to="lab_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_563b2cab-f36b-4481-8ccc-2c68119cccf0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_94003f66-deff-42a7-86e9-c3bbf0ca93ed_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_b86ddf74-1e57-4233-87d1-89af19552eab_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_48738d21-0be2-4bf1-8a6b-cef355e72669_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LicenseFeesMember_b36b6578-b352-44a5-8fef-0010b91f3a75_terseLabel_en-US" xlink:label="lab_lgnd_LicenseFeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees</link:label>
    <link:label id="lab_lgnd_LicenseFeesMember_label_en-US" xlink:label="lab_lgnd_LicenseFeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees [Member]</link:label>
    <link:label id="lab_lgnd_LicenseFeesMember_documentation_en-US" xlink:label="lab_lgnd_LicenseFeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMember" xlink:href="lgnd-20221231.xsd#lgnd_LicenseFeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LicenseFeesMember" xlink:to="lab_lgnd_LicenseFeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_6073ab5e-6204-4155-9a99-b21c872cc5a5_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareProFormaAbstract_b80948c2-9e86-4b51-8349-74ef46a496ae_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareProFormaAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per common share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareProFormaAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareProFormaAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Pro Forma [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareProFormaAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareProFormaAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareProFormaAbstract" xlink:to="lab_us-gaap_EarningsPerShareProFormaAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense_2c42a710-cd45-4d03-873b-cf826941d9bb_terseLabel_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense_label_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Share-Based Payment Arrangement, Expense</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense_documentation_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense" xlink:to="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_80389c5e-cbe6-4567-919c-d69d33369a9b_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedLineItems_db597fe8-02e3-4140-acb2-d3e70ad5ffec_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedLineItems_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems" xlink:to="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_5ed1db20-f947-4e64-beb3-860613a39641_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_3f3ab670-33bd-4515-b23a-cfe1c9942f72_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income (loss) per share (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_dfe81c5c-9ae8-41fa-8880-a6fcebbcd7ba_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_d7d97bd2-bafc-409a-b545-e221fdc1110e_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CaliforniaAndNewJerseyResearchTaxCreditCarryforwardMember_fea7f6ba-c7a3-418e-9bc8-84f10bf84545_terseLabel_en-US" xlink:label="lab_lgnd_CaliforniaAndNewJerseyResearchTaxCreditCarryforwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">California and New Jersey Research Tax Credit Carryforward</link:label>
    <link:label id="lab_lgnd_CaliforniaAndNewJerseyResearchTaxCreditCarryforwardMember_label_en-US" xlink:label="lab_lgnd_CaliforniaAndNewJerseyResearchTaxCreditCarryforwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">California and New Jersey Research Tax Credit Carryforward [Member]</link:label>
    <link:label id="lab_lgnd_CaliforniaAndNewJerseyResearchTaxCreditCarryforwardMember_documentation_en-US" xlink:label="lab_lgnd_CaliforniaAndNewJerseyResearchTaxCreditCarryforwardMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">California and New Jersey Research Tax Credit Carryforward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CaliforniaAndNewJerseyResearchTaxCreditCarryforwardMember" xlink:href="lgnd-20221231.xsd#lgnd_CaliforniaAndNewJerseyResearchTaxCreditCarryforwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CaliforniaAndNewJerseyResearchTaxCreditCarryforwardMember" xlink:to="lab_lgnd_CaliforniaAndNewJerseyResearchTaxCreditCarryforwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_ac9ac470-2ea9-474a-a435-b0d8480c1788_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_29b8f1fb-6c44-4d09-a5dc-fb08415a1428_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_SaleOfStockAuthorizedOfferingAmount_39ce8dc1-d4c2-4788-bb3b-6f7836511090_terseLabel_en-US" xlink:label="lab_lgnd_SaleOfStockAuthorizedOfferingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, authorized offering amount</link:label>
    <link:label id="lab_lgnd_SaleOfStockAuthorizedOfferingAmount_label_en-US" xlink:label="lab_lgnd_SaleOfStockAuthorizedOfferingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Authorized Offering Amount</link:label>
    <link:label id="lab_lgnd_SaleOfStockAuthorizedOfferingAmount_documentation_en-US" xlink:label="lab_lgnd_SaleOfStockAuthorizedOfferingAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Authorized Offering Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SaleOfStockAuthorizedOfferingAmount" xlink:href="lgnd-20221231.xsd#lgnd_SaleOfStockAuthorizedOfferingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_SaleOfStockAuthorizedOfferingAmount" xlink:to="lab_lgnd_SaleOfStockAuthorizedOfferingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_eb252e28-6f06-40b1-af93-f0ce6661d4b0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_4c1f52c0-ffb2-43d6-a2b8-9fcfda6fed35_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangibles</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_1427e304-5278-46bc-8fa7-f8dc06027e9c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_156f9a54-dbac-412d-bd6f-948ee53aaef9_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_46265f0b-3971-4fc3-813b-7a6e014cd707_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_676ff05e-3c89-40e8-a309-63a81931a0c4_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_81fce67c-b53e-49c3-9cf9-3d58ab7084bb_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges_c021fe50-a860-4435-9378-0a22be883bcc_terseLabel_en-US" xlink:label="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options under convertible bond hedges</link:label>
    <link:label id="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges_label_en-US" xlink:label="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Options under Convertible Bond Hedges</link:label>
    <link:label id="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges_documentation_en-US" xlink:label="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Options under Convertible Bond Hedges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:href="lgnd-20221231.xsd#lgnd_NumberOfOptionsUnderConvertibleBondHedges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:to="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_bca6c09d-032a-4339-a59c-2ccf6c6fe0d5_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in Viking common stock (2)</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_6c9d8d37-4dcb-4118-89f7-8e75597f7dc7_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_1355efc5-e9f7-47aa-bf5e-6b059d010da5_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate bonds</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_4350811a-30e1-41bd-b707-319acd4cbb89_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_b9238d3f-6706-4305-b8fe-0b3cb6211cb2_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_0621e3c8-3d31-4a19-afd9-319419193f60_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturity of Operating Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_1dea6ebf-7d2a-475e-865f-18fd22d5b4b3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MilestoneMember_603ff8bb-037f-4145-b4be-d00166b83a61_terseLabel_en-US" xlink:label="lab_lgnd_MilestoneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone</link:label>
    <link:label id="lab_lgnd_MilestoneMember_label_en-US" xlink:label="lab_lgnd_MilestoneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone [Member]</link:label>
    <link:label id="lab_lgnd_MilestoneMember_documentation_en-US" xlink:label="lab_lgnd_MilestoneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestoneMember" xlink:href="lgnd-20221231.xsd#lgnd_MilestoneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MilestoneMember" xlink:to="lab_lgnd_MilestoneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_802b88b2-8050-476d-83e7-ab904d6ec232_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_6d2bbd47-f215-426a-bf12-468cb0b478e8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PfenexMember_b1399935-fe34-4b62-8a3c-98b8c30a98e8_terseLabel_en-US" xlink:label="lab_lgnd_PfenexMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfenex</link:label>
    <link:label id="lab_lgnd_PfenexMember_label_en-US" xlink:label="lab_lgnd_PfenexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfenex [Member]</link:label>
    <link:label id="lab_lgnd_PfenexMember_documentation_en-US" xlink:label="lab_lgnd_PfenexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfenex</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember" xlink:href="lgnd-20221231.xsd#lgnd_PfenexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PfenexMember" xlink:to="lab_lgnd_PfenexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_3662afd3-c397-437d-ab6a-7dbc74a8d91b_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_e7e33168-586b-49b0-bd82-32b829093d6b_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade name</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities_ec19c71c-43d6-48bd-bd99-5fa870dd318d_verboseLabel_en-US" xlink:label="lab_lgnd_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Adjustment</link:label>
    <link:label id="lab_lgnd_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities_label_en-US" xlink:label="lab_lgnd_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Fair Value Adjustment, Contingent Liabilities</link:label>
    <link:label id="lab_lgnd_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities_documentation_en-US" xlink:label="lab_lgnd_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Fair Value Adjustment, Contingent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities" xlink:href="lgnd-20221231.xsd#lgnd_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities" xlink:to="lab_lgnd_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalDecreaseDueToSeparation_b2da56da-537a-4590-a1bc-d33ccc7b7202_negatedTerseLabel_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalDecreaseDueToSeparation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution of OmniAb</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalDecreaseDueToSeparation_label_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalDecreaseDueToSeparation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Decrease Due To Separation</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalDecreaseDueToSeparation_documentation_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalDecreaseDueToSeparation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Decrease Due To Separation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalDecreaseDueToSeparation" xlink:href="lgnd-20221231.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalDecreaseDueToSeparation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalDecreaseDueToSeparation" xlink:to="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalDecreaseDueToSeparation" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsToUnwindWarrants_d8ee3d45-c210-4789-a9c4-b2b7fd47685c_terseLabel_en-US" xlink:label="lab_lgnd_PaymentsToUnwindWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to unwind warrants</link:label>
    <link:label id="lab_lgnd_PaymentsToUnwindWarrants_label_en-US" xlink:label="lab_lgnd_PaymentsToUnwindWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Unwind Warrants</link:label>
    <link:label id="lab_lgnd_PaymentsToUnwindWarrants_documentation_en-US" xlink:label="lab_lgnd_PaymentsToUnwindWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Unwind Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToUnwindWarrants" xlink:href="lgnd-20221231.xsd#lgnd_PaymentsToUnwindWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsToUnwindWarrants" xlink:to="lab_lgnd_PaymentsToUnwindWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_266280aa-7cee-46ff-97e5-f0d6be718e09_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration_98ffef2a-9db4-4ec1-9247-bcb1d5bdac0c_terseLabel_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration_label_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Change in Amount of Contingent Consideration</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration_documentation_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Change in Amount of Contingent Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration" xlink:to="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_d181752f-4115-4638-b0d9-37cf6f14e56a_negatedLabel_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit loss adjustments on finite-lived intangible assets</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_639a5ed4-a5a2-4b51-87a4-421abfd9eade_terseLabel_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit loss adjustments on finite-lived intangible assets</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_label_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Credit Loss Adjustments</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_documentation_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Credit Loss Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:href="lgnd-20221231.xsd#lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:to="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CashCashEquivalentsandShorttermInvestmentsPolicyTextBlock_4e898150-fde3-4366-8164-be977e9ba12b_verboseLabel_en-US" xlink:label="lab_lgnd_CashCashEquivalentsandShorttermInvestmentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents &amp; Short-term Investments</link:label>
    <link:label id="lab_lgnd_CashCashEquivalentsandShorttermInvestmentsPolicyTextBlock_label_en-US" xlink:label="lab_lgnd_CashCashEquivalentsandShorttermInvestmentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Short-term Investments [Policy Text Block]</link:label>
    <link:label id="lab_lgnd_CashCashEquivalentsandShorttermInvestmentsPolicyTextBlock_documentation_en-US" xlink:label="lab_lgnd_CashCashEquivalentsandShorttermInvestmentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Short-term Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CashCashEquivalentsandShorttermInvestmentsPolicyTextBlock" xlink:href="lgnd-20221231.xsd#lgnd_CashCashEquivalentsandShorttermInvestmentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CashCashEquivalentsandShorttermInvestmentsPolicyTextBlock" xlink:to="lab_lgnd_CashCashEquivalentsandShorttermInvestmentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest_2157f864-39f2-4f59-8755-51dcbdb23365_terseLabel_en-US" xlink:label="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership interest (as a percent)</link:label>
    <link:label id="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest_label_en-US" xlink:label="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited Liability Company or Limited Partnership, Members or Limited Partners, Ownership Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest" xlink:to="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NumberOfContingentValueRightAgreements_03808619-ff49-4ad4-830a-2d49351974f5_terseLabel_en-US" xlink:label="lab_lgnd_NumberOfContingentValueRightAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of CVR agreements</link:label>
    <link:label id="lab_lgnd_NumberOfContingentValueRightAgreements_label_en-US" xlink:label="lab_lgnd_NumberOfContingentValueRightAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Contingent Value Right Agreements</link:label>
    <link:label id="lab_lgnd_NumberOfContingentValueRightAgreements_documentation_en-US" xlink:label="lab_lgnd_NumberOfContingentValueRightAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Contingent Value Right Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfContingentValueRightAgreements" xlink:href="lgnd-20221231.xsd#lgnd_NumberOfContingentValueRightAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NumberOfContingentValueRightAgreements" xlink:to="lab_lgnd_NumberOfContingentValueRightAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_f849e791-2000-4977-93a1-0061fbcc4777_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_RoyaltyEvomelaMember_9b4c949d-5dac-461b-a1a4-ed2998cad190_terseLabel_en-US" xlink:label="lab_lgnd_RoyaltyEvomelaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evomela</link:label>
    <link:label id="lab_lgnd_RoyaltyEvomelaMember_label_en-US" xlink:label="lab_lgnd_RoyaltyEvomelaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty, Evomela [Member]</link:label>
    <link:label id="lab_lgnd_RoyaltyEvomelaMember_documentation_en-US" xlink:label="lab_lgnd_RoyaltyEvomelaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty, Evomela</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyEvomelaMember" xlink:href="lgnd-20221231.xsd#lgnd_RoyaltyEvomelaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_RoyaltyEvomelaMember" xlink:to="lab_lgnd_RoyaltyEvomelaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_345f6fa7-a763-4f2d-8eac-8fa3cfbb6583_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_b2000ea0-c341-47be-9b5d-297eb9214c64_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract_456569e6-0cdc-4054-9be8-b35ffd9c67ce_verboseLabel_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs and expenses:</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract_label_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Costs and Expenses [Abstract]</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract_documentation_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract" xlink:to="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_7749f55a-e25c-459f-8ea8-20836d261f19_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_bcbe534d-e142-4edf-99ed-83a07459c1e7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_7f9f0da8-4fff-48a5-a833-969e49432ffe_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive potential common shares (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_88fa6da8-e21b-4bd4-bb65-d514749b68e3_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsforConvertibleBondHedges_1343f842-aaec-4c2d-9e07-85b5a7a3edbd_terseLabel_en-US" xlink:label="lab_lgnd_PaymentsforConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for convertible bond hedges</link:label>
    <link:label id="lab_lgnd_PaymentsforConvertibleBondHedges_label_en-US" xlink:label="lab_lgnd_PaymentsforConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Convertible Bond Hedges</link:label>
    <link:label id="lab_lgnd_PaymentsforConvertibleBondHedges_documentation_en-US" xlink:label="lab_lgnd_PaymentsforConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Convertible Bond Hedges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsforConvertibleBondHedges" xlink:href="lgnd-20221231.xsd#lgnd_PaymentsforConvertibleBondHedges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsforConvertibleBondHedges" xlink:to="lab_lgnd_PaymentsforConvertibleBondHedges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_c800b4a3-2c06-459a-a01a-c7a0f351873c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_9df26196-5163-442c-9dd0-4212dd61bb68_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_87a4390d-e727-4e1c-982c-0f13fb6931e1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant&#160;Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_0d845cb5-7a91-439f-804e-10ef327f8688_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_360e6429-f53b-4a3f-a4f5-59d4fdd44749_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_2061b34a-8a15-4b80-920d-6398f915cd36_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_a0076359-ccbf-411c-a2d0-16fd84ae2e0e_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price (USD per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_c3b4aac1-7a45-496c-a51f-08417bfc1679_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_5ad1bd7e-9fb3-411e-b9de-670da6aafddb_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_1c8888b8-e450-408b-aabe-5008ce8c0479_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems_56b71ab5-574b-4bc1-b3f5-d197560d8c67_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Major Customer</link:label>
    <link:label id="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Major Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:to="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_d9b8bc0a-b67e-4670-974a-4a783ca4f678_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax at federal statutory rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_96b72d5d-6ef4-467a-a55e-edcbc2089cf0_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EffectiveIncomeTaxRateReconciliationOfficerCompensationAmount_9df5a6af-de8f-4f87-a6b3-326f7846a192_terseLabel_en-US" xlink:label="lab_lgnd_EffectiveIncomeTaxRateReconciliationOfficerCompensationAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Officer compensation</link:label>
    <link:label id="lab_lgnd_EffectiveIncomeTaxRateReconciliationOfficerCompensationAmount_label_en-US" xlink:label="lab_lgnd_EffectiveIncomeTaxRateReconciliationOfficerCompensationAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Officer Compensation, Amount</link:label>
    <link:label id="lab_lgnd_EffectiveIncomeTaxRateReconciliationOfficerCompensationAmount_documentation_en-US" xlink:label="lab_lgnd_EffectiveIncomeTaxRateReconciliationOfficerCompensationAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Officer Compensation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EffectiveIncomeTaxRateReconciliationOfficerCompensationAmount" xlink:href="lgnd-20221231.xsd#lgnd_EffectiveIncomeTaxRateReconciliationOfficerCompensationAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EffectiveIncomeTaxRateReconciliationOfficerCompensationAmount" xlink:to="lab_lgnd_EffectiveIncomeTaxRateReconciliationOfficerCompensationAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LicenseUpfrontPayment_350db9b1-e344-4c01-b419-7bff0d60da02_terseLabel_en-US" xlink:label="lab_lgnd_LicenseUpfrontPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront payment for license</link:label>
    <link:label id="lab_lgnd_LicenseUpfrontPayment_label_en-US" xlink:label="lab_lgnd_LicenseUpfrontPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Upfront Payment</link:label>
    <link:label id="lab_lgnd_LicenseUpfrontPayment_documentation_en-US" xlink:label="lab_lgnd_LicenseUpfrontPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Upfront Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseUpfrontPayment" xlink:href="lgnd-20221231.xsd#lgnd_LicenseUpfrontPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LicenseUpfrontPayment" xlink:to="lab_lgnd_LicenseUpfrontPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_77fa52fb-0cb1-4fea-b001-e7f07796f528_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_45ed5afb-ae8b-43ba-81f0-aab44f5ebfd9_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_5c896f25-51c8-483a-be82-96fa953c2be0_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_bdcb0fab-f63f-4a05-a5e8-d2ebd86b01a3_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset impairment charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_ea96a73c-936c-4677-9e62-b89b41547464_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_d9189d43-eb50-4640-9273-796090243f35_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_e1ad95e5-a117-4013-901d-ab2a68738bfd_totalLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PurchaseCommitmentConsiderationPaidToDate_806be32b-79b9-45a7-92e0-8789a0968acb_terseLabel_en-US" xlink:label="lab_lgnd_PurchaseCommitmentConsiderationPaidToDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration paid to date</link:label>
    <link:label id="lab_lgnd_PurchaseCommitmentConsiderationPaidToDate_label_en-US" xlink:label="lab_lgnd_PurchaseCommitmentConsiderationPaidToDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Commitment, Consideration Paid to Date</link:label>
    <link:label id="lab_lgnd_PurchaseCommitmentConsiderationPaidToDate_documentation_en-US" xlink:label="lab_lgnd_PurchaseCommitmentConsiderationPaidToDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Commitment, Consideration Paid to Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PurchaseCommitmentConsiderationPaidToDate" xlink:href="lgnd-20221231.xsd#lgnd_PurchaseCommitmentConsiderationPaidToDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PurchaseCommitmentConsiderationPaidToDate" xlink:to="lab_lgnd_PurchaseCommitmentConsiderationPaidToDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_4d1bbe9a-190f-4668-b3d7-e19aa3ee1b98_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>15
<FILENAME>lgnd-20221231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:c0902eea-a24e-41c4-9f5a-301d659aee15,g:8404f1f2-95a1-4d6b-a993-1c430637111f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ligand.com/role/Cover" xlink:type="simple" xlink:href="lgnd-20221231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_8742eed4-37cc-4fe9-8469-45e7e29f5fe4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:to="loc_dei_DocumentType_8742eed4-37cc-4fe9-8469-45e7e29f5fe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_97f77d3e-6bce-4ab1-bba4-00debc482fde" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:to="loc_dei_DocumentAnnualReport_97f77d3e-6bce-4ab1-bba4-00debc482fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_a52471f2-2ed4-45a0-a528-01f360ab311f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:to="loc_dei_DocumentPeriodEndDate_a52471f2-2ed4-45a0-a528-01f360ab311f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_91ea86ca-61ca-42f1-a9c5-5b9d7931b8ad" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:to="loc_dei_CurrentFiscalYearEndDate_91ea86ca-61ca-42f1-a9c5-5b9d7931b8ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_a7fb01e9-6283-49e2-88c0-f27092f1b523" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:to="loc_dei_DocumentTransitionReport_a7fb01e9-6283-49e2-88c0-f27092f1b523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_e6cea87d-67e4-43de-ab8d-476e0b95eca6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:to="loc_dei_EntityFileNumber_e6cea87d-67e4-43de-ab8d-476e0b95eca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_5bb01e9b-5f3d-49a2-a895-b740b635a3fb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:to="loc_dei_EntityRegistrantName_5bb01e9b-5f3d-49a2-a895-b740b635a3fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_d4ac8520-c747-4e43-a7d5-acf5568ffbd6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:to="loc_dei_EntityIncorporationStateCountryCode_d4ac8520-c747-4e43-a7d5-acf5568ffbd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_4bf74cc1-345b-4f2a-8eb1-095dd70cea9c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:to="loc_dei_EntityTaxIdentificationNumber_4bf74cc1-345b-4f2a-8eb1-095dd70cea9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_f53da948-ff50-4d37-85b7-728d2181e55e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:to="loc_dei_EntityAddressAddressLine1_f53da948-ff50-4d37-85b7-728d2181e55e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_0a4e8d13-c610-4df8-a5cf-633241fee67d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:to="loc_dei_EntityAddressCityOrTown_0a4e8d13-c610-4df8-a5cf-633241fee67d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_59113c38-fa26-48ac-a23a-a2bfac77924e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:to="loc_dei_EntityAddressStateOrProvince_59113c38-fa26-48ac-a23a-a2bfac77924e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_7c132159-29aa-4ecc-a540-af9ee4dec132" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:to="loc_dei_EntityAddressPostalZipCode_7c132159-29aa-4ecc-a540-af9ee4dec132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_81657428-31aa-4761-8273-12ce39956b60" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:to="loc_dei_CityAreaCode_81657428-31aa-4761-8273-12ce39956b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_39703349-9f18-4c47-a3ae-2d2a7544a1c3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:to="loc_dei_LocalPhoneNumber_39703349-9f18-4c47-a3ae-2d2a7544a1c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_54bdd8a1-715b-4059-97b6-473a32eb283e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:to="loc_dei_Security12bTitle_54bdd8a1-715b-4059-97b6-473a32eb283e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_cc4b755b-d182-46f7-a4ca-7ba4f5939d90" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:to="loc_dei_TradingSymbol_cc4b755b-d182-46f7-a4ca-7ba4f5939d90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_de4bffe2-9fa8-4e70-8eac-6c44d0b6d19b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:to="loc_dei_SecurityExchangeName_de4bffe2-9fa8-4e70-8eac-6c44d0b6d19b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_35bbbfed-5e21-45f5-8a5a-b2406dfe7485" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_35bbbfed-5e21-45f5-8a5a-b2406dfe7485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_65eab9c4-779b-45e6-a4ac-90544b502123" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:to="loc_dei_EntityVoluntaryFilers_65eab9c4-779b-45e6-a4ac-90544b502123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_d9c928bc-5b4e-4a09-878d-632e034328fd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:to="loc_dei_EntityCurrentReportingStatus_d9c928bc-5b4e-4a09-878d-632e034328fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_b4433370-e19b-49aa-8d89-4d487b38723a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:to="loc_dei_EntityInteractiveDataCurrent_b4433370-e19b-49aa-8d89-4d487b38723a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_24f9fafd-d05a-423a-ae48-e3d9c8f0ee17" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:to="loc_dei_EntityFilerCategory_24f9fafd-d05a-423a-ae48-e3d9c8f0ee17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_097c0d71-c4ff-4a66-97c1-e00c7e951874" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:to="loc_dei_EntitySmallBusiness_097c0d71-c4ff-4a66-97c1-e00c7e951874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_1a17e856-302f-46df-99e1-1fac2c1a7eab" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:to="loc_dei_EntityEmergingGrowthCompany_1a17e856-302f-46df-99e1-1fac2c1a7eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_4bf0fa94-e4f5-4333-abaf-83989a3c2490" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:to="loc_dei_IcfrAuditorAttestationFlag_4bf0fa94-e4f5-4333-abaf-83989a3c2490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_b916a481-86ea-488d-93f4-7ef29d576238" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:to="loc_dei_EntityShellCompany_b916a481-86ea-488d-93f4-7ef29d576238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_c1e95c11-4961-4682-9953-e8707a6ee12d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:to="loc_dei_EntityPublicFloat_c1e95c11-4961-4682-9953-e8707a6ee12d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_433f7547-6e91-4cee-bdac-9ec18dc4a988" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_433f7547-6e91-4cee-bdac-9ec18dc4a988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_df7390b3-f0ae-4085-a139-3b75fba97b1b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_df7390b3-f0ae-4085-a139-3b75fba97b1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_9927bef9-1a42-4478-9378-27697189c04f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:to="loc_dei_AmendmentFlag_9927bef9-1a42-4478-9378-27697189c04f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_905f10b9-7410-47ca-93f7-166b5b3e2ff4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:to="loc_dei_DocumentFiscalYearFocus_905f10b9-7410-47ca-93f7-166b5b3e2ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_5c0b19ba-4240-4c95-abab-e270e01471de" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:to="loc_dei_DocumentFiscalPeriodFocus_5c0b19ba-4240-4c95-abab-e270e01471de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_d543ab40-75cb-41f8-aea6-6e2d7c7fc04b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f036135e-7a43-4b54-b3a0-1617b988c789" xlink:to="loc_dei_EntityCentralIndexKey_d543ab40-75cb-41f8-aea6-6e2d7c7fc04b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AuditInformation" xlink:type="simple" xlink:href="lgnd-20221231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AuditInformationAbstract_86f2999b-3344-4c1e-ae6e-3163de4e2288" xlink:href="lgnd-20221231.xsd#lgnd_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_e3ec37c2-157e-447d-ac34-2dce51cc4674" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_AuditInformationAbstract_86f2999b-3344-4c1e-ae6e-3163de4e2288" xlink:to="loc_dei_AuditorName_e3ec37c2-157e-447d-ac34-2dce51cc4674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_ff8f3bb2-d24a-47a0-b4e5-bcbfcf3d6974" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_AuditInformationAbstract_86f2999b-3344-4c1e-ae6e-3163de4e2288" xlink:to="loc_dei_AuditorLocation_ff8f3bb2-d24a-47a0-b4e5-bcbfcf3d6974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_6482ffb3-b70a-4a4a-af51-1dab7e1bc103" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_AuditInformationAbstract_86f2999b-3344-4c1e-ae6e-3163de4e2288" xlink:to="loc_dei_AuditorFirmId_6482ffb3-b70a-4a4a-af51-1dab7e1bc103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="lgnd-20221231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_ccc28bab-8298-433b-8fd7-0ad8ee77c25a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_d0292950-310a-45a4-b5be-51877c3e1281" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ccc28bab-8298-433b-8fd7-0ad8ee77c25a" xlink:to="loc_us-gaap_AssetsAbstract_d0292950-310a-45a4-b5be-51877c3e1281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_1a6728c0-1387-459c-8d93-3f351c613ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d0292950-310a-45a4-b5be-51877c3e1281" xlink:to="loc_us-gaap_AssetsCurrentAbstract_1a6728c0-1387-459c-8d93-3f351c613ef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ed0efca1-3b9e-4b44-9c9b-8432d19740ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1a6728c0-1387-459c-8d93-3f351c613ef1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ed0efca1-3b9e-4b44-9c9b-8432d19740ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_ff8ca168-26f2-4372-8a96-cf41579b36e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1a6728c0-1387-459c-8d93-3f351c613ef1" xlink:to="loc_us-gaap_ShortTermInvestments_ff8ca168-26f2-4372-8a96-cf41579b36e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_bd0c5e32-61cf-4acd-80f8-af4aa638870a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1a6728c0-1387-459c-8d93-3f351c613ef1" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_bd0c5e32-61cf-4acd-80f8-af4aa638870a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_4df49a9c-1368-4daa-b2fe-6b7bed3de704" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1a6728c0-1387-459c-8d93-3f351c613ef1" xlink:to="loc_us-gaap_InventoryNet_4df49a9c-1368-4daa-b2fe-6b7bed3de704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_d861f95b-9145-4888-ad98-210006fa3532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1a6728c0-1387-459c-8d93-3f351c613ef1" xlink:to="loc_us-gaap_IncomeTaxesReceivable_d861f95b-9145-4888-ad98-210006fa3532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_5d00e06b-3e5c-4a33-81a4-c3af7e844d22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1a6728c0-1387-459c-8d93-3f351c613ef1" xlink:to="loc_us-gaap_OtherAssetsCurrent_5d00e06b-3e5c-4a33-81a4-c3af7e844d22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_ef8f8bfb-5b0c-464f-9278-d905b02510e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1a6728c0-1387-459c-8d93-3f351c613ef1" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_ef8f8bfb-5b0c-464f-9278-d905b02510e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_6bb94f6b-c78b-4867-825d-f74f59eecd69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1a6728c0-1387-459c-8d93-3f351c613ef1" xlink:to="loc_us-gaap_AssetsCurrent_6bb94f6b-c78b-4867-825d-f74f59eecd69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_15abf087-14f3-476f-b0ee-4b6dfd02b8e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d0292950-310a-45a4-b5be-51877c3e1281" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_15abf087-14f3-476f-b0ee-4b6dfd02b8e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c3914db6-c1ad-48f4-b63b-b39e517c48ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d0292950-310a-45a4-b5be-51877c3e1281" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c3914db6-c1ad-48f4-b63b-b39e517c48ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0f1e2c20-8272-4902-8dbe-09451a0f45d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d0292950-310a-45a4-b5be-51877c3e1281" xlink:to="loc_us-gaap_Goodwill_0f1e2c20-8272-4902-8dbe-09451a0f45d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRights_4e4c542a-7201-45ae-aa11-ddca8ec503db" xlink:href="lgnd-20221231.xsd#lgnd_CommercialLicenseRights"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d0292950-310a-45a4-b5be-51877c3e1281" xlink:to="loc_lgnd_CommercialLicenseRights_4e4c542a-7201-45ae-aa11-ddca8ec503db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_03dec6d5-db4b-4889-a5d7-618cec75984e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d0292950-310a-45a4-b5be-51877c3e1281" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_03dec6d5-db4b-4889-a5d7-618cec75984e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_a6de2657-cd82-43f4-a5a8-e4eb473ee482" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d0292950-310a-45a4-b5be-51877c3e1281" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_a6de2657-cd82-43f4-a5a8-e4eb473ee482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_d12e670c-6030-4aad-8064-a2ccfbd4a465" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d0292950-310a-45a4-b5be-51877c3e1281" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_d12e670c-6030-4aad-8064-a2ccfbd4a465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_ad4240e2-0e74-4a2a-81ea-967220c27004" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d0292950-310a-45a4-b5be-51877c3e1281" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_ad4240e2-0e74-4a2a-81ea-967220c27004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_80dd5990-5234-4343-ac52-d41bad77f869" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d0292950-310a-45a4-b5be-51877c3e1281" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_80dd5990-5234-4343-ac52-d41bad77f869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_bf564652-9ccb-412b-be5b-aec471c628f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d0292950-310a-45a4-b5be-51877c3e1281" xlink:to="loc_us-gaap_Assets_bf564652-9ccb-412b-be5b-aec471c628f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_94c37c13-4039-4bdb-b309-1e47993dfc0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ccc28bab-8298-433b-8fd7-0ad8ee77c25a" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_94c37c13-4039-4bdb-b309-1e47993dfc0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_83895ce7-30d2-47c4-8d7b-cfa75418e3aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_94c37c13-4039-4bdb-b309-1e47993dfc0f" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_83895ce7-30d2-47c4-8d7b-cfa75418e3aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_453ca8b3-1bed-4ba8-b730-8a0ca38b74d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_83895ce7-30d2-47c4-8d7b-cfa75418e3aa" xlink:to="loc_us-gaap_AccountsPayableCurrent_453ca8b3-1bed-4ba8-b730-8a0ca38b74d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_6232560c-f536-4cbf-94d2-6d93e490e78a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_83895ce7-30d2-47c4-8d7b-cfa75418e3aa" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_6232560c-f536-4cbf-94d2-6d93e490e78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_170a894e-4a32-48cc-90da-d6f45f941c85" xlink:href="lgnd-20221231.xsd#lgnd_CurrentPortionOfLiabilityForContingentValueRights"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_83895ce7-30d2-47c4-8d7b-cfa75418e3aa" xlink:to="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_170a894e-4a32-48cc-90da-d6f45f941c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_cb137e79-151c-48d2-94ee-5de0d790cc0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_83895ce7-30d2-47c4-8d7b-cfa75418e3aa" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_cb137e79-151c-48d2-94ee-5de0d790cc0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_da52b736-ab4c-4692-946e-04212d915fe3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_83895ce7-30d2-47c4-8d7b-cfa75418e3aa" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_da52b736-ab4c-4692-946e-04212d915fe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_024af866-6604-43a7-b4e5-597c60027ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_83895ce7-30d2-47c4-8d7b-cfa75418e3aa" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_024af866-6604-43a7-b4e5-597c60027ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtCurrent_018f2d88-12ee-426e-8f1d-872fba03be5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_83895ce7-30d2-47c4-8d7b-cfa75418e3aa" xlink:to="loc_us-gaap_ConvertibleDebtCurrent_018f2d88-12ee-426e-8f1d-872fba03be5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_82221554-da05-4efc-81b9-5a5da5d66582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_83895ce7-30d2-47c4-8d7b-cfa75418e3aa" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_82221554-da05-4efc-81b9-5a5da5d66582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_880f307b-4322-4ce5-bfcc-eea2390ec267" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_83895ce7-30d2-47c4-8d7b-cfa75418e3aa" xlink:to="loc_us-gaap_LiabilitiesCurrent_880f307b-4322-4ce5-bfcc-eea2390ec267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_d608d1b5-5bca-4184-8371-524f045c8531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_94c37c13-4039-4bdb-b309-1e47993dfc0f" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_d608d1b5-5bca-4184-8371-524f045c8531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRights_af69946a-fb46-4fc9-8367-f569fdced42e" xlink:href="lgnd-20221231.xsd#lgnd_LiabilityForContingentValueRights"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_94c37c13-4039-4bdb-b309-1e47993dfc0f" xlink:to="loc_lgnd_LiabilityForContingentValueRights_af69946a-fb46-4fc9-8367-f569fdced42e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_904bd99e-e4da-4ec1-aaf3-5857c34dd13a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_94c37c13-4039-4bdb-b309-1e47993dfc0f" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_904bd99e-e4da-4ec1-aaf3-5857c34dd13a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_a18a0086-5a05-4e96-ba7b-816999bc8eee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_94c37c13-4039-4bdb-b309-1e47993dfc0f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_a18a0086-5a05-4e96-ba7b-816999bc8eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_161c6b21-d19c-45bf-a271-ff3cbf8ff2d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_94c37c13-4039-4bdb-b309-1e47993dfc0f" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_161c6b21-d19c-45bf-a271-ff3cbf8ff2d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_47e28d98-df33-4fab-9dd2-3f94b49af441" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_94c37c13-4039-4bdb-b309-1e47993dfc0f" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_47e28d98-df33-4fab-9dd2-3f94b49af441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_dfa4df61-ea87-459b-a0f6-e6751544b011" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_94c37c13-4039-4bdb-b309-1e47993dfc0f" xlink:to="loc_us-gaap_Liabilities_dfa4df61-ea87-459b-a0f6-e6751544b011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_35a5db7b-fa7b-4b85-b054-5a794c38ebda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_94c37c13-4039-4bdb-b309-1e47993dfc0f" xlink:to="loc_us-gaap_CommitmentsAndContingencies_35a5db7b-fa7b-4b85-b054-5a794c38ebda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_3a86f115-aa84-432b-a32a-93b315c7ec41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_94c37c13-4039-4bdb-b309-1e47993dfc0f" xlink:to="loc_us-gaap_StockholdersEquityAbstract_3a86f115-aa84-432b-a32a-93b315c7ec41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_eb4ff7f3-4ab8-476b-a5c8-dd74d1ec11c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3a86f115-aa84-432b-a32a-93b315c7ec41" xlink:to="loc_us-gaap_PreferredStockValue_eb4ff7f3-4ab8-476b-a5c8-dd74d1ec11c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_22eb509a-da6a-4ee0-a3fe-4baaf218035f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3a86f115-aa84-432b-a32a-93b315c7ec41" xlink:to="loc_us-gaap_CommonStockValue_22eb509a-da6a-4ee0-a3fe-4baaf218035f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_c652fb47-7074-4f92-aa23-4022085c2a94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3a86f115-aa84-432b-a32a-93b315c7ec41" xlink:to="loc_us-gaap_AdditionalPaidInCapital_c652fb47-7074-4f92-aa23-4022085c2a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c66cd663-05e2-488e-a883-01d2cbdd27da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3a86f115-aa84-432b-a32a-93b315c7ec41" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c66cd663-05e2-488e-a883-01d2cbdd27da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_289efd93-93d1-4143-a53b-6167cc05bd5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3a86f115-aa84-432b-a32a-93b315c7ec41" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_289efd93-93d1-4143-a53b-6167cc05bd5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e3857a0a-da31-4d1d-9fe4-bccb88107d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3a86f115-aa84-432b-a32a-93b315c7ec41" xlink:to="loc_us-gaap_StockholdersEquity_e3857a0a-da31-4d1d-9fe4-bccb88107d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_5c3d4472-9fc6-4939-97b6-379b89ac1d50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_94c37c13-4039-4bdb-b309-1e47993dfc0f" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_5c3d4472-9fc6-4939-97b6-379b89ac1d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="lgnd-20221231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_db33b67e-ea3b-458c-a544-7a2f2cd7cf42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_ea1b75a9-64c5-4caf-85ad-c2fa6ebfc534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_db33b67e-ea3b-458c-a544-7a2f2cd7cf42" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_ea1b75a9-64c5-4caf-85ad-c2fa6ebfc534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_7cda5068-b7dd-4034-bdd7-6b71994f5620" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_db33b67e-ea3b-458c-a544-7a2f2cd7cf42" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_7cda5068-b7dd-4034-bdd7-6b71994f5620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_02b254d6-82cc-43b2-8fda-f9d3ba4b0e92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_db33b67e-ea3b-458c-a544-7a2f2cd7cf42" xlink:to="loc_us-gaap_PreferredStockSharesIssued_02b254d6-82cc-43b2-8fda-f9d3ba4b0e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_8838331c-3593-4a0a-b10b-964978b8b991" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_db33b67e-ea3b-458c-a544-7a2f2cd7cf42" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_8838331c-3593-4a0a-b10b-964978b8b991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_1e9fa73d-3a57-4265-a115-710e38ef6f73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_db33b67e-ea3b-458c-a544-7a2f2cd7cf42" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_1e9fa73d-3a57-4265-a115-710e38ef6f73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_748a93b7-9dbb-45db-83f8-0cb7c06dea31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_db33b67e-ea3b-458c-a544-7a2f2cd7cf42" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_748a93b7-9dbb-45db-83f8-0cb7c06dea31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_71bc03dd-b861-434b-9bdd-f85ec227d0e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_db33b67e-ea3b-458c-a544-7a2f2cd7cf42" xlink:to="loc_us-gaap_CommonStockSharesIssued_71bc03dd-b861-434b-9bdd-f85ec227d0e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_32751f96-5b42-4e9b-b8e7-3aa81b948aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_db33b67e-ea3b-458c-a544-7a2f2cd7cf42" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_32751f96-5b42-4e9b-b8e7-3aa81b948aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="lgnd-20221231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_6ee0ccd3-ac10-4c44-a5e2-e3b72dc54cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_603d4b6c-0f0e-4368-b4ef-7eae2c6e5945" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6ee0ccd3-ac10-4c44-a5e2-e3b72dc54cf9" xlink:to="loc_us-gaap_StatementTable_603d4b6c-0f0e-4368-b4ef-7eae2c6e5945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_03024c06-9ca0-4b7a-a9c3-b5709abc3354" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_603d4b6c-0f0e-4368-b4ef-7eae2c6e5945" xlink:to="loc_srt_ProductOrServiceAxis_03024c06-9ca0-4b7a-a9c3-b5709abc3354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ce70a3ae-c9ee-403d-9b56-aafe43d5dfb2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_03024c06-9ca0-4b7a-a9c3-b5709abc3354" xlink:to="loc_srt_ProductsAndServicesDomain_ce70a3ae-c9ee-403d-9b56-aafe43d5dfb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_a553e6d3-2334-4100-b8b3-6ca977f3cc11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ce70a3ae-c9ee-403d-9b56-aafe43d5dfb2" xlink:to="loc_us-gaap_RoyaltyMember_a553e6d3-2334-4100-b8b3-6ca977f3cc11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_db5e043b-8eab-4e96-a5e6-75f280f9897e" xlink:href="lgnd-20221231.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ce70a3ae-c9ee-403d-9b56-aafe43d5dfb2" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_db5e043b-8eab-4e96-a5e6-75f280f9897e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_19e632e6-89ad-467c-834c-cc906d88cf76" xlink:href="lgnd-20221231.xsd#lgnd_ContractRevenueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ce70a3ae-c9ee-403d-9b56-aafe43d5dfb2" xlink:to="loc_lgnd_ContractRevenueMember_19e632e6-89ad-467c-834c-cc906d88cf76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_VernalisMember_14da9509-a831-4570-a94c-796eb663dad0" xlink:href="lgnd-20221231.xsd#lgnd_VernalisMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ce70a3ae-c9ee-403d-9b56-aafe43d5dfb2" xlink:to="loc_lgnd_VernalisMember_14da9509-a831-4570-a94c-796eb663dad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f9216a69-882f-4d73-a2a5-654d82db66b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_603d4b6c-0f0e-4368-b4ef-7eae2c6e5945" xlink:to="loc_us-gaap_StatementLineItems_f9216a69-882f-4d73-a2a5-654d82db66b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_224774d3-9ffb-41cb-bca4-1be460ac43c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f9216a69-882f-4d73-a2a5-654d82db66b5" xlink:to="loc_us-gaap_RevenuesAbstract_224774d3-9ffb-41cb-bca4-1be460ac43c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_61b51a73-93af-443d-a40d-a518701774f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_224774d3-9ffb-41cb-bca4-1be460ac43c9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_61b51a73-93af-443d-a40d-a518701774f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_911641b7-1763-4b0a-ba4d-06dab93dd4cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f9216a69-882f-4d73-a2a5-654d82db66b5" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_911641b7-1763-4b0a-ba4d-06dab93dd4cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial_274f2c10-d388-4386-b913-cfea234b5e60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostDirectMaterial"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_911641b7-1763-4b0a-ba4d-06dab93dd4cf" xlink:to="loc_us-gaap_CostDirectMaterial_274f2c10-d388-4386-b913-cfea234b5e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_3460d243-1db2-474d-a3ab-681c375b920a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_911641b7-1763-4b0a-ba4d-06dab93dd4cf" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_3460d243-1db2-474d-a3ab-681c375b920a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_affe2908-aaef-46c1-bbaa-eb0a706ba60b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_911641b7-1763-4b0a-ba4d-06dab93dd4cf" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_affe2908-aaef-46c1-bbaa-eb0a706ba60b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_1a58f99e-acae-4d68-94e9-6aff64cc12a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_911641b7-1763-4b0a-ba4d-06dab93dd4cf" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_1a58f99e-acae-4d68-94e9-6aff64cc12a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_c4032b79-829c-49f4-8bf4-5dbb04556663" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_911641b7-1763-4b0a-ba4d-06dab93dd4cf" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_c4032b79-829c-49f4-8bf4-5dbb04556663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_50ccde9f-04a8-4ebe-8950-5c4dfc8a9f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_911641b7-1763-4b0a-ba4d-06dab93dd4cf" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_50ccde9f-04a8-4ebe-8950-5c4dfc8a9f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets_d04372c8-709b-4145-89a5-ad18be008b46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f9216a69-882f-4d73-a2a5-654d82db66b5" xlink:to="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets_d04372c8-709b-4145-89a5-ad18be008b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5dbd1bdc-e47d-469f-a379-9cfd28f03861" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f9216a69-882f-4d73-a2a5-654d82db66b5" xlink:to="loc_us-gaap_OperatingIncomeLoss_5dbd1bdc-e47d-469f-a379-9cfd28f03861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_add9a2a1-7f20-4769-af15-a6a49abe1431" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f9216a69-882f-4d73-a2a5-654d82db66b5" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_add9a2a1-7f20-4769-af15-a6a49abe1431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_dc62d477-2acc-43c4-9626-fe83d071322e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_add9a2a1-7f20-4769-af15-a6a49abe1431" xlink:to="loc_us-gaap_GainLossOnInvestments_dc62d477-2acc-43c4-9626-fe83d071322e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_1c6bf68c-df30-430d-b9ca-21aed029fc8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_add9a2a1-7f20-4769-af15-a6a49abe1431" xlink:to="loc_us-gaap_InvestmentIncomeInterest_1c6bf68c-df30-430d-b9ca-21aed029fc8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_563ee41d-c175-4d45-9c4c-6ad744a4b75e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_add9a2a1-7f20-4769-af15-a6a49abe1431" xlink:to="loc_us-gaap_InterestExpense_563ee41d-c175-4d45-9c4c-6ad744a4b75e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_4610eb17-0250-4e94-9c8d-8d22e3cbd72e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_add9a2a1-7f20-4769-af15-a6a49abe1431" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_4610eb17-0250-4e94-9c8d-8d22e3cbd72e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_1f20b7a9-14e6-4cd5-8702-8c19e5873f87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_add9a2a1-7f20-4769-af15-a6a49abe1431" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_1f20b7a9-14e6-4cd5-8702-8c19e5873f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3e7b6c3b-b0cd-4cca-8819-6053196191a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f9216a69-882f-4d73-a2a5-654d82db66b5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3e7b6c3b-b0cd-4cca-8819-6053196191a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9635ea7e-7402-474b-9632-f2bfbfa28a09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f9216a69-882f-4d73-a2a5-654d82db66b5" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9635ea7e-7402-474b-9632-f2bfbfa28a09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_ce7c3cc3-9720-4802-ac27-d59695c1f2cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f9216a69-882f-4d73-a2a5-654d82db66b5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_ce7c3cc3-9720-4802-ac27-d59695c1f2cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_31d4dcd2-f236-4cae-b1a2-be006e5e56bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f9216a69-882f-4d73-a2a5-654d82db66b5" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_31d4dcd2-f236-4cae-b1a2-be006e5e56bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_111250e4-baac-4e06-b6d0-bedfe14a1396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f9216a69-882f-4d73-a2a5-654d82db66b5" xlink:to="loc_us-gaap_NetIncomeLoss_111250e4-baac-4e06-b6d0-bedfe14a1396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_75299772-74c4-4d2a-8518-48e1ca9109c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f9216a69-882f-4d73-a2a5-654d82db66b5" xlink:to="loc_us-gaap_EarningsPerShareAbstract_75299772-74c4-4d2a-8518-48e1ca9109c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_c402bc00-6b4c-491b-8e36-3ef722429111" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_75299772-74c4-4d2a-8518-48e1ca9109c0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_c402bc00-6b4c-491b-8e36-3ef722429111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_f0b30650-c8aa-4086-b646-c65988a9dbf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_75299772-74c4-4d2a-8518-48e1ca9109c0" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_f0b30650-c8aa-4086-b646-c65988a9dbf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_96a81bb5-dd44-4ce3-a7df-29c2352ed983" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_75299772-74c4-4d2a-8518-48e1ca9109c0" xlink:to="loc_us-gaap_EarningsPerShareBasic_96a81bb5-dd44-4ce3-a7df-29c2352ed983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_64904732-8fab-4b85-bab7-cac066d63320" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_75299772-74c4-4d2a-8518-48e1ca9109c0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_64904732-8fab-4b85-bab7-cac066d63320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_c0bcdb73-f7fc-4896-907d-7ab8da38b984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_75299772-74c4-4d2a-8518-48e1ca9109c0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_c0bcdb73-f7fc-4896-907d-7ab8da38b984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_2b93d109-ec5f-4c27-bc16-fe5d556a7ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_75299772-74c4-4d2a-8518-48e1ca9109c0" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_2b93d109-ec5f-4c27-bc16-fe5d556a7ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_80661e75-3d89-4ac1-b6fa-ec9114ca9f76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_75299772-74c4-4d2a-8518-48e1ca9109c0" xlink:to="loc_us-gaap_EarningsPerShareDiluted_80661e75-3d89-4ac1-b6fa-ec9114ca9f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_989268e1-892f-43ff-8e02-f441f91d43f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_75299772-74c4-4d2a-8518-48e1ca9109c0" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_989268e1-892f-43ff-8e02-f441f91d43f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="lgnd-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_66b4bc28-d84b-4efb-b7c7-7f3fc3a2a069" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c618bfb6-9bc3-4b53-bb67-7b666cd42060" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_66b4bc28-d84b-4efb-b7c7-7f3fc3a2a069" xlink:to="loc_us-gaap_NetIncomeLoss_c618bfb6-9bc3-4b53-bb67-7b666cd42060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_dd01c925-0c47-401a-8eba-bffac82290e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_66b4bc28-d84b-4efb-b7c7-7f3fc3a2a069" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_dd01c925-0c47-401a-8eba-bffac82290e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_edd54b82-4bc9-4d01-b639-7ab738a05d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_66b4bc28-d84b-4efb-b7c7-7f3fc3a2a069" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_edd54b82-4bc9-4d01-b639-7ab738a05d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_4ac2f841-47c4-4643-9ea5-37ca0fa4ec74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_66b4bc28-d84b-4efb-b7c7-7f3fc3a2a069" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_4ac2f841-47c4-4643-9ea5-37ca0fa4ec74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="lgnd-20221231.xsd#CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_6bbeac6a-2ffb-4642-b385-5654eeef1a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f694b28d-047c-418b-b8e1-9e643b1dfb05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_6bbeac6a-2ffb-4642-b385-5654eeef1a7c" xlink:to="loc_us-gaap_StatementTable_f694b28d-047c-418b-b8e1-9e643b1dfb05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_714fc0f4-6b9a-4ff0-9bc2-e431aff1968b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f694b28d-047c-418b-b8e1-9e643b1dfb05" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_714fc0f4-6b9a-4ff0-9bc2-e431aff1968b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c59d16ef-ae86-40eb-a0ca-35890d9aa95b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_714fc0f4-6b9a-4ff0-9bc2-e431aff1968b" xlink:to="loc_us-gaap_EquityComponentDomain_c59d16ef-ae86-40eb-a0ca-35890d9aa95b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_38c09d7e-3dad-43c3-b63a-c5813c7f3214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c59d16ef-ae86-40eb-a0ca-35890d9aa95b" xlink:to="loc_us-gaap_CommonStockMember_38c09d7e-3dad-43c3-b63a-c5813c7f3214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_241d63f1-1a84-41b4-b91e-0de42407164d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c59d16ef-ae86-40eb-a0ca-35890d9aa95b" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_241d63f1-1a84-41b4-b91e-0de42407164d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4e987748-7e56-451d-8aea-5ccebc4bb47c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c59d16ef-ae86-40eb-a0ca-35890d9aa95b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4e987748-7e56-451d-8aea-5ccebc4bb47c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_8005f8c8-7f36-4106-af41-833b0b7ba223" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c59d16ef-ae86-40eb-a0ca-35890d9aa95b" xlink:to="loc_us-gaap_RetainedEarningsMember_8005f8c8-7f36-4106-af41-833b0b7ba223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8edb1346-1d89-49e0-9992-8dd4db6a5bbb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f694b28d-047c-418b-b8e1-9e643b1dfb05" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8edb1346-1d89-49e0-9992-8dd4db6a5bbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0cd52b82-4a16-4aa0-ad72-1bd1f83381c7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8edb1346-1d89-49e0-9992-8dd4db6a5bbb" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0cd52b82-4a16-4aa0-ad72-1bd1f83381c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_0fe533b0-4448-4578-962a-e493002cf860" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0cd52b82-4a16-4aa0-ad72-1bd1f83381c7" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_0fe533b0-4448-4578-962a-e493002cf860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c14696ee-6034-408b-ba47-3089470b02f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f694b28d-047c-418b-b8e1-9e643b1dfb05" xlink:to="loc_us-gaap_StatementLineItems_c14696ee-6034-408b-ba47-3089470b02f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c14696ee-6034-408b-ba47-3089470b02f0" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_ee5dc7f8-1ac6-47d8-ab6a-061a30342cd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:to="loc_us-gaap_SharesOutstanding_ee5dc7f8-1ac6-47d8-ab6a-061a30342cd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0444e584-b6ef-4a5f-ad17-7b81c61c53d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:to="loc_us-gaap_StockholdersEquity_0444e584-b6ef-4a5f-ad17-7b81c61c53d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_50272452-2dfc-405f-ac65-72e60829d26a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_50272452-2dfc-405f-ac65-72e60829d26a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_5bb65204-0ccc-4f02-a5df-61e91077aa4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_5bb65204-0ccc-4f02-a5df-61e91077aa4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c2ca4fa1-e251-4f4c-b1ba-44f8d7eeb7e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c2ca4fa1-e251-4f4c-b1ba-44f8d7eeb7e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_f11a5f66-7fa2-48d8-bb4c-c84579e26532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_f11a5f66-7fa2-48d8-bb4c-c84579e26532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_3ec2b401-4b6c-4172-a337-fb6fe3962a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_3ec2b401-4b6c-4172-a337-fb6fe3962a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_fa0e4c14-7882-4800-bd08-4a9f4cee46f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_fa0e4c14-7882-4800-bd08-4a9f4cee46f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_67100666-48cb-4b35-8ef7-fc90b1149eec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_67100666-48cb-4b35-8ef7-fc90b1149eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_be1d9838-8bbd-4392-9b0b-62ffebc4b4c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_be1d9838-8bbd-4392-9b0b-62ffebc4b4c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_c9265c36-943b-44c9-8f79-bedf028c6be0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_c9265c36-943b-44c9-8f79-bedf028c6be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_a4aca484-8c1c-4c52-86f8-28b453b16587" xlink:href="lgnd-20221231.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_a4aca484-8c1c-4c52-86f8-28b453b16587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalBondHedgeTransaction_e4179a9e-4089-4081-a4f6-7c7bfb1544f6" xlink:href="lgnd-20221231.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalBondHedgeTransaction"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalBondHedgeTransaction_e4179a9e-4089-4081-a4f6-7c7bfb1544f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalDecreaseDueToSeparation_3872078d-f5fc-4141-a13e-2ad9b465e3dc" xlink:href="lgnd-20221231.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalDecreaseDueToSeparation"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalDecreaseDueToSeparation_3872078d-f5fc-4141-a13e-2ad9b465e3dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_3e9d6427-362a-4f0e-9cb9-6943878b22d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_3e9d6427-362a-4f0e-9cb9-6943878b22d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1d4c237a-4826-4550-aea6-8a3cb3c8b7bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:to="loc_us-gaap_NetIncomeLoss_1d4c237a-4826-4550-aea6-8a3cb3c8b7bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_66e4aa7a-f293-4c6f-acad-7bc2f0b1f50c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:to="loc_us-gaap_SharesOutstanding_66e4aa7a-f293-4c6f-acad-7bc2f0b1f50c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7ae52778-e459-40f6-916f-2acb62138b78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e3e35c75-b730-420c-9218-5e158f2c849c" xlink:to="loc_us-gaap_StockholdersEquity_7ae52778-e459-40f6-916f-2acb62138b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="lgnd-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_73a90471-0755-488f-acf1-f4d8123c28be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_094733be-ee0a-4151-a1e1-a1f76651efb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_73a90471-0755-488f-acf1-f4d8123c28be" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_094733be-ee0a-4151-a1e1-a1f76651efb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6854c0c3-a7ee-4874-9ead-040cc925188b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_094733be-ee0a-4151-a1e1-a1f76651efb5" xlink:to="loc_us-gaap_ProfitLoss_6854c0c3-a7ee-4874-9ead-040cc925188b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c81dccaa-256c-4023-ad16-aa5d9d0a6101" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_094733be-ee0a-4151-a1e1-a1f76651efb5" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c81dccaa-256c-4023-ad16-aa5d9d0a6101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_10147823-87c6-4b70-bfcb-8baa25fff156" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c81dccaa-256c-4023-ad16-aa5d9d0a6101" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_10147823-87c6-4b70-bfcb-8baa25fff156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_31d5bccd-0201-4a48-8eca-934893824884" xlink:href="lgnd-20221231.xsd#lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c81dccaa-256c-4023-ad16-aa5d9d0a6101" xlink:to="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_31d5bccd-0201-4a48-8eca-934893824884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_88555c78-e238-430c-b98e-9ce6b5e6d9c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c81dccaa-256c-4023-ad16-aa5d9d0a6101" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_88555c78-e238-430c-b98e-9ce6b5e6d9c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_GainLossOnShortTermInvestments_22e70f7c-13ab-44d8-903c-d236e1808d51" xlink:href="lgnd-20221231.xsd#lgnd_GainLossOnShortTermInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c81dccaa-256c-4023-ad16-aa5d9d0a6101" xlink:to="loc_lgnd_GainLossOnShortTermInvestments_22e70f7c-13ab-44d8-903c-d236e1808d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_7b55fe04-6c46-4d2f-9d26-2c8f05ae5f6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c81dccaa-256c-4023-ad16-aa5d9d0a6101" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_7b55fe04-6c46-4d2f-9d26-2c8f05ae5f6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_9f8a7072-18a9-4c14-8afa-32e597f0eecf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c81dccaa-256c-4023-ad16-aa5d9d0a6101" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_9f8a7072-18a9-4c14-8afa-32e597f0eecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_5512839c-ea75-4722-a5cf-6a58bef6a0b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c81dccaa-256c-4023-ad16-aa5d9d0a6101" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_5512839c-ea75-4722-a5cf-6a58bef6a0b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_5037a1e1-e222-4440-abc9-962bec6a3fcf" xlink:href="lgnd-20221231.xsd#lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c81dccaa-256c-4023-ad16-aa5d9d0a6101" xlink:to="loc_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_5037a1e1-e222-4440-abc9-962bec6a3fcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization_8e15f59a-04b0-4391-b853-d65b2f71d4b3" xlink:href="lgnd-20221231.xsd#lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c81dccaa-256c-4023-ad16-aa5d9d0a6101" xlink:to="loc_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization_8e15f59a-04b0-4391-b853-d65b2f71d4b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_68e61ae9-8246-4b63-a25d-0b4a7c9f7c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c81dccaa-256c-4023-ad16-aa5d9d0a6101" xlink:to="loc_us-gaap_ShareBasedCompensation_68e61ae9-8246-4b63-a25d-0b4a7c9f7c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_466a7a3e-ec16-4057-b337-77ef2eb44957" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c81dccaa-256c-4023-ad16-aa5d9d0a6101" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_466a7a3e-ec16-4057-b337-77ef2eb44957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_11f2feba-ab62-4dec-b008-1a858623746f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c81dccaa-256c-4023-ad16-aa5d9d0a6101" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_11f2feba-ab62-4dec-b008-1a858623746f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ccd3f4a9-9b51-4fff-a9ab-3ed24e69ed22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c81dccaa-256c-4023-ad16-aa5d9d0a6101" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ccd3f4a9-9b51-4fff-a9ab-3ed24e69ed22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_52b9330a-ff45-48ac-b9ec-9f4151547a33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ccd3f4a9-9b51-4fff-a9ab-3ed24e69ed22" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_52b9330a-ff45-48ac-b9ec-9f4151547a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_1a9bf4f1-7520-48d3-9714-2494721715dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ccd3f4a9-9b51-4fff-a9ab-3ed24e69ed22" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_1a9bf4f1-7520-48d3-9714-2494721715dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_009b2ede-4cd0-4c66-b217-184749eac47c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ccd3f4a9-9b51-4fff-a9ab-3ed24e69ed22" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_009b2ede-4cd0-4c66-b217-184749eac47c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_52805391-0d3a-4d1e-8a9e-c9e8f35522b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ccd3f4a9-9b51-4fff-a9ab-3ed24e69ed22" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_52805391-0d3a-4d1e-8a9e-c9e8f35522b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_e94f1bd3-4f41-4014-b09d-66f007a99f22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ccd3f4a9-9b51-4fff-a9ab-3ed24e69ed22" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_e94f1bd3-4f41-4014-b09d-66f007a99f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_18670236-c7ad-490f-9462-20fdd898b8bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ccd3f4a9-9b51-4fff-a9ab-3ed24e69ed22" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_18670236-c7ad-490f-9462-20fdd898b8bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f05f3e6a-9d28-4d29-b156-4a79dfa99e27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_094733be-ee0a-4151-a1e1-a1f76651efb5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f05f3e6a-9d28-4d29-b156-4a79dfa99e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d2ae1f4c-1597-4b97-a0ea-c28968137538" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_73a90471-0755-488f-acf1-f4d8123c28be" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d2ae1f4c-1597-4b97-a0ea-c28968137538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_9c2b0b0b-0afd-4330-a6b4-f4181340df8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d2ae1f4c-1597-4b97-a0ea-c28968137538" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_9c2b0b0b-0afd-4330-a6b4-f4181340df8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4b9cda1f-625e-459d-b9ea-ae2b5333f08d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d2ae1f4c-1597-4b97-a0ea-c28968137538" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4b9cda1f-625e-459d-b9ea-ae2b5333f08d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_cbe1a6a2-3062-419a-af79-4734b946b3cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d2ae1f4c-1597-4b97-a0ea-c28968137538" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_cbe1a6a2-3062-419a-af79-4734b946b3cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ProceedsFromCommercialLicenseRights_512854b9-2682-43ff-855b-8c7e6f197f95" xlink:href="lgnd-20221231.xsd#lgnd_ProceedsFromCommercialLicenseRights"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d2ae1f4c-1597-4b97-a0ea-c28968137538" xlink:to="loc_lgnd_ProceedsFromCommercialLicenseRights_512854b9-2682-43ff-855b-8c7e6f197f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_7920bfa0-b059-4640-bbe0-5782e6e8506d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d2ae1f4c-1597-4b97-a0ea-c28968137538" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_7920bfa0-b059-4640-bbe0-5782e6e8506d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_c80f4abe-4ac5-4df3-8108-420e9860e1f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d2ae1f4c-1597-4b97-a0ea-c28968137538" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_c80f4abe-4ac5-4df3-8108-420e9860e1f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_bc8de6ef-7518-454e-a303-ee7997abc1d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d2ae1f4c-1597-4b97-a0ea-c28968137538" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_bc8de6ef-7518-454e-a303-ee7997abc1d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_5d1466f1-e061-4641-b06d-a00530972d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d2ae1f4c-1597-4b97-a0ea-c28968137538" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_5d1466f1-e061-4641-b06d-a00530972d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_f3df21c0-2be1-446e-b850-a03990bec233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d2ae1f4c-1597-4b97-a0ea-c28968137538" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_f3df21c0-2be1-446e-b850-a03990bec233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6b801dd1-fafa-4922-b09e-3b9ac3501928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d2ae1f4c-1597-4b97-a0ea-c28968137538" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6b801dd1-fafa-4922-b09e-3b9ac3501928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1ddfff5-9e56-4812-8fbb-9a1d05ae0488" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_73a90471-0755-488f-acf1-f4d8123c28be" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1ddfff5-9e56-4812-8fbb-9a1d05ae0488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsForSeparation_f10e7c3d-0816-4349-b38f-a15fc520e4f6" xlink:href="lgnd-20221231.xsd#lgnd_PaymentsForSeparation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1ddfff5-9e56-4812-8fbb-9a1d05ae0488" xlink:to="loc_lgnd_PaymentsForSeparation_f10e7c3d-0816-4349-b38f-a15fc520e4f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_a8ec7c4e-0891-4c62-9b1d-7280713db9f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1ddfff5-9e56-4812-8fbb-9a1d05ae0488" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_a8ec7c4e-0891-4c62-9b1d-7280713db9f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_64eea66a-36d0-4285-8a29-5f734e4a3be8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1ddfff5-9e56-4812-8fbb-9a1d05ae0488" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_64eea66a-36d0-4285-8a29-5f734e4a3be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_e58964df-bd3a-445a-9f34-cfa556b3719f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1ddfff5-9e56-4812-8fbb-9a1d05ae0488" xlink:to="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_e58964df-bd3a-445a-9f34-cfa556b3719f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeFinancingActivities_4ff7eb66-e877-4268-9cac-8bb809fd8a88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromHedgeFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1ddfff5-9e56-4812-8fbb-9a1d05ae0488" xlink:to="loc_us-gaap_ProceedsFromHedgeFinancingActivities_4ff7eb66-e877-4268-9cac-8bb809fd8a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_98c69257-2ee5-4b85-8c41-474714a13bd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1ddfff5-9e56-4812-8fbb-9a1d05ae0488" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_98c69257-2ee5-4b85-8c41-474714a13bd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_190bf623-a64c-47dc-a4f5-92e043915154" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1ddfff5-9e56-4812-8fbb-9a1d05ae0488" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_190bf623-a64c-47dc-a4f5-92e043915154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_1154272c-1a2d-4286-8378-55de6437502f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1ddfff5-9e56-4812-8fbb-9a1d05ae0488" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_1154272c-1a2d-4286-8378-55de6437502f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfWarrants_7906fd25-f57c-40cc-8b8b-06b05d54f129" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfWarrants"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1ddfff5-9e56-4812-8fbb-9a1d05ae0488" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfWarrants_7906fd25-f57c-40cc-8b8b-06b05d54f129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_620bf5c7-e400-479b-ae95-2313f8c3c590" xlink:href="lgnd-20221231.xsd#lgnd_PaymentsToContingentValueRightHoldersFinancingActivity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1ddfff5-9e56-4812-8fbb-9a1d05ae0488" xlink:to="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_620bf5c7-e400-479b-ae95-2313f8c3c590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5e1dc4be-0de4-426d-871a-dfe8e0d179e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1ddfff5-9e56-4812-8fbb-9a1d05ae0488" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5e1dc4be-0de4-426d-871a-dfe8e0d179e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_e155c9a7-ad7e-432d-965f-e8c998a8cb72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_73a90471-0755-488f-acf1-f4d8123c28be" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_e155c9a7-ad7e-432d-965f-e8c998a8cb72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_327d9a4f-4a1a-42aa-9506-07a7c8cd8ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_73a90471-0755-488f-acf1-f4d8123c28be" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_327d9a4f-4a1a-42aa-9506-07a7c8cd8ccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_06316884-af4a-454c-abff-1ae66db985a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_73a90471-0755-488f-acf1-f4d8123c28be" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_06316884-af4a-454c-abff-1ae66db985a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_c7152274-39da-41ed-8e6b-ff00d5295fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_73a90471-0755-488f-acf1-f4d8123c28be" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_c7152274-39da-41ed-8e6b-ff00d5295fb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CashPaidDuringTheYearAbstract_109aaee6-e5b1-47d2-bf4a-0be8bb360fc3" xlink:href="lgnd-20221231.xsd#lgnd_CashPaidDuringTheYearAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_c7152274-39da-41ed-8e6b-ff00d5295fb1" xlink:to="loc_lgnd_CashPaidDuringTheYearAbstract_109aaee6-e5b1-47d2-bf4a-0be8bb360fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_614c412f-109e-4209-9e3b-b71e5f45d3ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CashPaidDuringTheYearAbstract_109aaee6-e5b1-47d2-bf4a-0be8bb360fc3" xlink:to="loc_us-gaap_InterestPaidNet_614c412f-109e-4209-9e3b-b71e5f45d3ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_7ac812aa-d118-4250-a9db-be5be4041bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CashPaidDuringTheYearAbstract_109aaee6-e5b1-47d2-bf4a-0be8bb360fc3" xlink:to="loc_us-gaap_IncomeTaxesPaid_7ac812aa-d118-4250-a9db-be5be4041bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_5cb6ab1a-d8d5-4452-93c1-4f70209044a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CashPaidDuringTheYearAbstract_109aaee6-e5b1-47d2-bf4a-0be8bb360fc3" xlink:to="loc_us-gaap_RestrictedCashCurrent_5cb6ab1a-d8d5-4452-93c1-4f70209044a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_46a00a97-f79d-4cc4-b061-bdfef03a9a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_73a90471-0755-488f-acf1-f4d8123c28be" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_46a00a97-f79d-4cc4-b061-bdfef03a9a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedInventoryPurchases_21991a7e-9725-4a7a-bf6e-993ac6313960" xlink:href="lgnd-20221231.xsd#lgnd_AccruedInventoryPurchases"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_46a00a97-f79d-4cc4-b061-bdfef03a9a0d" xlink:to="loc_lgnd_AccruedInventoryPurchases_21991a7e-9725-4a7a-bf6e-993ac6313960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_7c4025a8-0e5c-42fb-9987-a46a1741f192" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_46a00a97-f79d-4cc4-b061-bdfef03a9a0d" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_7c4025a8-0e5c-42fb-9987-a46a1741f192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_3c148026-3d22-4032-b751-83079a1cd6d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_46a00a97-f79d-4cc4-b061-bdfef03a9a0d" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_3c148026-3d22-4032-b751-83079a1cd6d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BasisofPresentationandSummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_42a87183-7c6b-4fe7-afff-aa8973855d85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_16a23c51-a140-4a35-bf93-198548f02247" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_42a87183-7c6b-4fe7-afff-aa8973855d85" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_16a23c51-a140-4a35-bf93-198548f02247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SpinoffofOmniAb" xlink:type="simple" xlink:href="lgnd-20221231.xsd#SpinoffofOmniAb"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/SpinoffofOmniAb" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_f595524d-9ef7-425c-b33a-89905bd88924" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_5618d0a6-126e-4da9-a018-da15ade3657b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_f595524d-9ef7-425c-b33a-89905bd88924" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_5618d0a6-126e-4da9-a018-da15ade3657b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ShorttermInvestmentsInvestmentinViking" xlink:type="simple" xlink:href="lgnd-20221231.xsd#ShorttermInvestmentsInvestmentinViking"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ShorttermInvestmentsInvestmentinViking" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8e139c98-172b-49b1-95d1-09996db0fcaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_6e7f9203-218b-425a-8f2d-e94b9c118229" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8e139c98-172b-49b1-95d1-09996db0fcaa" xlink:to="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_6e7f9203-218b-425a-8f2d-e94b9c118229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/Acquisitions" xlink:type="simple" xlink:href="lgnd-20221231.xsd#Acquisitions"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/Acquisitions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_7c32ed9c-a504-4fb8-b1d1-fc101576fd94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_feab2753-baf4-4090-ad68-e3fe97449ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_7c32ed9c-a504-4fb8-b1d1-fc101576fd94" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_feab2753-baf4-4090-ad68-e3fe97449ad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurement" xlink:type="simple" xlink:href="lgnd-20221231.xsd#FairValueMeasurement"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_263fd7de-7bb1-494b-9331-2214eaa2d190" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_0e61fcb8-38f5-406d-85bb-d1485df346b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_263fd7de-7bb1-494b-9331-2214eaa2d190" xlink:to="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_0e61fcb8-38f5-406d-85bb-d1485df346b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/Leases" xlink:type="simple" xlink:href="lgnd-20221231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_3089da7a-9c9a-4eba-a647-071929fba165" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_3e5f4b36-3f8e-430b-8631-3f76ec2221c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3089da7a-9c9a-4eba-a647-071929fba165" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_3e5f4b36-3f8e-430b-8631-3f76ec2221c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_3de74611-7f10-4c41-92a3-87000e4c3be4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3089da7a-9c9a-4eba-a647-071929fba165" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_3de74611-7f10-4c41-92a3-87000e4c3be4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotes" xlink:type="simple" xlink:href="lgnd-20221231.xsd#ConvertibleSeniorNotes"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_bb4cdef4-5c34-4160-bf79-407930872790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_e9dc912c-3c2e-4d9f-b2d1-2df83328eaef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bb4cdef4-5c34-4160-bf79-407930872790" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_e9dc912c-3c2e-4d9f-b2d1-2df83328eaef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BalanceSheetAccountDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BalanceSheetAccountDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BalanceSheetAccountDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OtherBalanceSheetDetailsAbstract_8eae1411-944d-4240-8ef0-a23847f0d8ff" xlink:href="lgnd-20221231.xsd#lgnd_OtherBalanceSheetDetailsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_67e731aa-15fa-499c-8995-bc8eb49b0269" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_OtherBalanceSheetDetailsAbstract_8eae1411-944d-4240-8ef0-a23847f0d8ff" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_67e731aa-15fa-499c-8995-bc8eb49b0269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquity" xlink:type="simple" xlink:href="lgnd-20221231.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_4ef73689-db5c-4906-98ab-968cd48043bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1c7c0ad8-dff3-46e8-9ba1-3feccaa22862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4ef73689-db5c-4906-98ab-968cd48043bc" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1c7c0ad8-dff3-46e8-9ba1-3feccaa22862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_27ea0fa0-ed62-4ee3-93b4-aa787efcedfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4ef73689-db5c-4906-98ab-968cd48043bc" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_27ea0fa0-ed62-4ee3-93b4-aa787efcedfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings" xlink:type="simple" xlink:href="lgnd-20221231.xsd#CommitmentandContingenciesLegalProceedings"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3a975d3e-998c-40e9-977d-4f5444450ff5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_a6ef7c87-0e08-4f23-868c-087d5aa74cad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3a975d3e-998c-40e9-977d-4f5444450ff5" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_a6ef7c87-0e08-4f23-868c-087d5aa74cad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTaxes" xlink:type="simple" xlink:href="lgnd-20221231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_c52295ea-c68c-41ed-a29d-221730f2d243" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_f8a852f8-375a-498b-9fc2-de10194f6daa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c52295ea-c68c-41ed-a29d-221730f2d243" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_f8a852f8-375a-498b-9fc2-de10194f6daa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SelectedQuarterlyFinancialDataUnaudited" xlink:type="simple" xlink:href="lgnd-20221231.xsd#SelectedQuarterlyFinancialDataUnaudited"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/SelectedQuarterlyFinancialDataUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_5c62e19f-dd12-4de2-b3e9-ac5c63034f03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock_1e603666-71f2-4a50-80c9-b9ae8c892ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_5c62e19f-dd12-4de2-b3e9-ac5c63034f03" xlink:to="loc_us-gaap_QuarterlyFinancialInformationTextBlock_1e603666-71f2-4a50-80c9-b9ae8c892ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b1841287-5be7-472e-9d9f-c1f9ce40baa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessSpinOffAndMigrationPolicyTextBlock_fb850e2b-a554-454a-acf7-76aba098fdd2" xlink:href="lgnd-20221231.xsd#lgnd_BusinessSpinOffAndMigrationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b1841287-5be7-472e-9d9f-c1f9ce40baa5" xlink:to="loc_lgnd_BusinessSpinOffAndMigrationPolicyTextBlock_fb850e2b-a554-454a-acf7-76aba098fdd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock_2dc89a8a-d230-4bd7-93b6-8dfa794fec7e" xlink:href="lgnd-20221231.xsd#lgnd_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b1841287-5be7-472e-9d9f-c1f9ce40baa5" xlink:to="loc_lgnd_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock_2dc89a8a-d230-4bd7-93b6-8dfa794fec7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock_c2fc3e07-ff02-424c-8976-770bd5caa741" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b1841287-5be7-472e-9d9f-c1f9ce40baa5" xlink:to="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock_c2fc3e07-ff02-424c-8976-770bd5caa741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_6881a42a-d2b9-44e4-95c1-c8e5dd21afd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b1841287-5be7-472e-9d9f-c1f9ce40baa5" xlink:to="loc_us-gaap_UseOfEstimates_6881a42a-d2b9-44e4-95c1-c8e5dd21afd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_56ac7d74-fcd4-4e8f-bf9e-736f08b323e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b1841287-5be7-472e-9d9f-c1f9ce40baa5" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_56ac7d74-fcd4-4e8f-bf9e-736f08b323e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CashCashEquivalentsandShorttermInvestmentsPolicyTextBlock_1d762289-052f-4b37-b50b-60fc531f87db" xlink:href="lgnd-20221231.xsd#lgnd_CashCashEquivalentsandShorttermInvestmentsPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b1841287-5be7-472e-9d9f-c1f9ce40baa5" xlink:to="loc_lgnd_CashCashEquivalentsandShorttermInvestmentsPolicyTextBlock_1d762289-052f-4b37-b50b-60fc531f87db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_7a096bba-3af1-4c95-8fc6-89a19e898606" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b1841287-5be7-472e-9d9f-c1f9ce40baa5" xlink:to="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_7a096bba-3af1-4c95-8fc6-89a19e898606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_7bad4034-ccb5-4a29-aa94-3adc24c1b3a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b1841287-5be7-472e-9d9f-c1f9ce40baa5" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_7bad4034-ccb5-4a29-aa94-3adc24c1b3a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_8fde2496-0b62-40e5-89e9-98ac6a03fa75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b1841287-5be7-472e-9d9f-c1f9ce40baa5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_8fde2496-0b62-40e5-89e9-98ac6a03fa75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_c31e9a3b-58d8-463e-82d4-49a565d7e5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b1841287-5be7-472e-9d9f-c1f9ce40baa5" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_c31e9a3b-58d8-463e-82d4-49a565d7e5f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_16a8bb2b-7d2c-49ea-a3d9-144c89c10629" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b1841287-5be7-472e-9d9f-c1f9ce40baa5" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_16a8bb2b-7d2c-49ea-a3d9-144c89c10629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRightsPolicyTextBlock_2e90899b-ce04-4c7a-bb07-e465e9a71895" xlink:href="lgnd-20221231.xsd#lgnd_CommercialLicenseRightsPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b1841287-5be7-472e-9d9f-c1f9ce40baa5" xlink:to="loc_lgnd_CommercialLicenseRightsPolicyTextBlock_2e90899b-ce04-4c7a-bb07-e465e9a71895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_05f6447e-20a8-421f-b82d-5d034417d7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b1841287-5be7-472e-9d9f-c1f9ce40baa5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_05f6447e-20a8-421f-b82d-5d034417d7f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_7c2276c8-2b67-4cb8-918b-87e7b469d6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b1841287-5be7-472e-9d9f-c1f9ce40baa5" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_7c2276c8-2b67-4cb8-918b-87e7b469d6f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_10ad9f5e-1581-42f7-8b53-9346c312c7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b1841287-5be7-472e-9d9f-c1f9ce40baa5" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_10ad9f5e-1581-42f7-8b53-9346c312c7a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_93e4e274-80f0-4a00-bf51-7136d1f85946" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b1841287-5be7-472e-9d9f-c1f9ce40baa5" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_93e4e274-80f0-4a00-bf51-7136d1f85946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_3b01539b-8a06-44a7-86d5-8a393eed9d68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b1841287-5be7-472e-9d9f-c1f9ce40baa5" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_3b01539b-8a06-44a7-86d5-8a393eed9d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_c27be1ab-81f0-4d00-88f9-fddd9cd1dd95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b1841287-5be7-472e-9d9f-c1f9ce40baa5" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_c27be1ab-81f0-4d00-88f9-fddd9cd1dd95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_d91f8655-a28d-4a87-9dc3-15771ddc0bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b1841287-5be7-472e-9d9f-c1f9ce40baa5" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_d91f8655-a28d-4a87-9dc3-15771ddc0bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_398c7e99-10a4-4447-94e5-9d9b1f39d0d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b1841287-5be7-472e-9d9f-c1f9ce40baa5" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_398c7e99-10a4-4447-94e5-9d9b1f39d0d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_279f92c0-c7e8-436d-809b-27e72ea32f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_f0bcc832-e213-49fa-a810-a7b724df8372" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_279f92c0-c7e8-436d-809b-27e72ea32f0f" xlink:to="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_f0bcc832-e213-49fa-a810-a7b724df8372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleofCommercialLicenseRightsTableTextBlock_36b7d7c3-bd49-491d-aa0b-a3b29029d1a9" xlink:href="lgnd-20221231.xsd#lgnd_ScheduleofCommercialLicenseRightsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_279f92c0-c7e8-436d-809b-27e72ea32f0f" xlink:to="loc_lgnd_ScheduleofCommercialLicenseRightsTableTextBlock_36b7d7c3-bd49-491d-aa0b-a3b29029d1a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_c46f2975-02b3-47a8-b0ba-3f4565ffd2e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_279f92c0-c7e8-436d-809b-27e72ea32f0f" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_c46f2975-02b3-47a8-b0ba-3f4565ffd2e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_d7f18e42-3e35-410e-8508-6bb87a20aba3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_279f92c0-c7e8-436d-809b-27e72ea32f0f" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_d7f18e42-3e35-410e-8508-6bb87a20aba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SpinoffofOmniAbTables" xlink:type="simple" xlink:href="lgnd-20221231.xsd#SpinoffofOmniAbTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/SpinoffofOmniAbTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_bb79e0f8-e2fc-42d7-b2e0-c7ddba36e684" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_86667403-628e-4b6e-89df-8541e2199a70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_bb79e0f8-e2fc-42d7-b2e0-c7ddba36e684" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_86667403-628e-4b6e-89df-8541e2199a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_82682da6-611a-4b88-928a-be4ab5988ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_bb79e0f8-e2fc-42d7-b2e0-c7ddba36e684" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_82682da6-611a-4b88-928a-be4ab5988ba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsTables" xlink:type="simple" xlink:href="lgnd-20221231.xsd#AcquisitionsTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/AcquisitionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_a4e6fe51-1796-4776-abbf-dc1b9a2fcd84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_5b401b73-5701-4633-a1f5-1d2756d74896" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_a4e6fe51-1796-4776-abbf-dc1b9a2fcd84" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_5b401b73-5701-4633-a1f5-1d2756d74896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_7a786288-d89c-411f-8f3d-3a77d21d0ac4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_a4e6fe51-1796-4776-abbf-dc1b9a2fcd84" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_7a786288-d89c-411f-8f3d-3a77d21d0ac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_ab526cf1-0524-42c8-9b01-cdad6f3e28f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_a4e6fe51-1796-4776-abbf-dc1b9a2fcd84" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_ab526cf1-0524-42c8-9b01-cdad6f3e28f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementTables" xlink:type="simple" xlink:href="lgnd-20221231.xsd#FairValueMeasurementTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_eed011bd-0267-494a-9338-8f05b6399cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_da3459f3-3f82-42ad-8838-79dad21007ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_eed011bd-0267-494a-9338-8f05b6399cd9" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_da3459f3-3f82-42ad-8838-79dad21007ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_67faea16-8de4-46f4-a312-9f42b5b9d574" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_eed011bd-0267-494a-9338-8f05b6399cd9" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_67faea16-8de4-46f4-a312-9f42b5b9d574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesTables" xlink:type="simple" xlink:href="lgnd-20221231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_76539c80-5650-474f-985f-304b2f18ef66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AssetsAndLiabilitiesLesseeTableTextBlock_7ea64663-0b21-4aea-91f4-b3ad8f9ecb6f" xlink:href="lgnd-20221231.xsd#lgnd_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_76539c80-5650-474f-985f-304b2f18ef66" xlink:to="loc_lgnd_AssetsAndLiabilitiesLesseeTableTextBlock_7ea64663-0b21-4aea-91f4-b3ad8f9ecb6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_90aebeae-31ca-4778-b538-c349e4657c81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_76539c80-5650-474f-985f-304b2f18ef66" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_90aebeae-31ca-4778-b538-c349e4657c81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_80a5dd0a-9ae3-47fe-a558-1c98d7a7c2fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_76539c80-5650-474f-985f-304b2f18ef66" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_80a5dd0a-9ae3-47fe-a558-1c98d7a7c2fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesTables" xlink:type="simple" xlink:href="lgnd-20221231.xsd#ConvertibleSeniorNotesTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_62a88878-9a3c-4ed7-be96-81837ff8b815" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_79413b78-e9f4-4c5c-a11c-c51635bc869b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_62a88878-9a3c-4ed7-be96-81837ff8b815" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_79413b78-e9f4-4c5c-a11c-c51635bc869b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BalanceSheetAccountDetailsTables" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BalanceSheetAccountDetailsTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BalanceSheetAccountDetailsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OtherBalanceSheetDetailsAbstract_ede071a0-2cab-440c-9a04-1d588a9f6bab" xlink:href="lgnd-20221231.xsd#lgnd_OtherBalanceSheetDetailsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock_88470336-e02c-41f0-845e-0be7a55b59e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_OtherBalanceSheetDetailsAbstract_ede071a0-2cab-440c-9a04-1d588a9f6bab" xlink:to="loc_us-gaap_MarketableSecuritiesTextBlock_88470336-e02c-41f0-845e-0be7a55b59e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_d723d397-5245-4602-84fd-e1286c1fdf42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_OtherBalanceSheetDetailsAbstract_ede071a0-2cab-440c-9a04-1d588a9f6bab" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_d723d397-5245-4602-84fd-e1286c1fdf42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_00ea3dc0-8eca-4e64-9f1d-15030f767656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_OtherBalanceSheetDetailsAbstract_ede071a0-2cab-440c-9a04-1d588a9f6bab" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_00ea3dc0-8eca-4e64-9f1d-15030f767656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_3c7537b6-34cf-4963-bd4a-3f7b3fece53a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_OtherBalanceSheetDetailsAbstract_ede071a0-2cab-440c-9a04-1d588a9f6bab" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_3c7537b6-34cf-4963-bd4a-3f7b3fece53a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_90957206-d46e-4069-a9ce-a74789d20c80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_OtherBalanceSheetDetailsAbstract_ede071a0-2cab-440c-9a04-1d588a9f6bab" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_90957206-d46e-4069-a9ce-a74789d20c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_0baff480-a751-48a4-bfbe-3175808ebd0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_OtherBalanceSheetDetailsAbstract_ede071a0-2cab-440c-9a04-1d588a9f6bab" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_0baff480-a751-48a4-bfbe-3175808ebd0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleofContingentLiabilitiesTableTextBlock_bf324187-260f-4e66-ba55-64dcaf9c52db" xlink:href="lgnd-20221231.xsd#lgnd_ScheduleofContingentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_OtherBalanceSheetDetailsAbstract_ede071a0-2cab-440c-9a04-1d588a9f6bab" xlink:to="loc_lgnd_ScheduleofContingentLiabilitiesTableTextBlock_bf324187-260f-4e66-ba55-64dcaf9c52db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="lgnd-20221231.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_0ced76e0-b666-4cbd-83f4-8919aa04fb35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_5199aa54-79fd-4a07-8ae8-6dbee7e0382c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0ced76e0-b666-4cbd-83f4-8919aa04fb35" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_5199aa54-79fd-4a07-8ae8-6dbee7e0382c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_8c20eaa1-7bcd-4c30-91b1-045ae71d6679" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0ced76e0-b666-4cbd-83f4-8919aa04fb35" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_8c20eaa1-7bcd-4c30-91b1-045ae71d6679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_a82e8ff9-ef1a-4759-a079-c4aafcf44d8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0ced76e0-b666-4cbd-83f4-8919aa04fb35" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_a82e8ff9-ef1a-4759-a079-c4aafcf44d8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_3c48a19e-e536-402d-874e-749a0ce21f72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0ced76e0-b666-4cbd-83f4-8919aa04fb35" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_3c48a19e-e536-402d-874e-749a0ce21f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_febbf459-6c4c-42b7-beec-5ee30777223b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0ced76e0-b666-4cbd-83f4-8919aa04fb35" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_febbf459-6c4c-42b7-beec-5ee30777223b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleofContingentLiabilitiesTableTextBlock_464dcce6-09ef-4a44-9dc1-b7d0393f809d" xlink:href="lgnd-20221231.xsd#lgnd_ScheduleofContingentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0ced76e0-b666-4cbd-83f4-8919aa04fb35" xlink:to="loc_lgnd_ScheduleofContingentLiabilitiesTableTextBlock_464dcce6-09ef-4a44-9dc1-b7d0393f809d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="lgnd-20221231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_7af012f8-3986-489e-88c3-58fd79261e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_78a05274-6abe-4f44-92e2-a6fc6a67d9e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7af012f8-3986-489e-88c3-58fd79261e5d" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_78a05274-6abe-4f44-92e2-a6fc6a67d9e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_9f35467e-e5de-4c4e-8c8a-e74ec5ce9f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7af012f8-3986-489e-88c3-58fd79261e5d" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_9f35467e-e5de-4c4e-8c8a-e74ec5ce9f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_b86a5161-41ab-49aa-96cd-2a2a4f13793e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7af012f8-3986-489e-88c3-58fd79261e5d" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_b86a5161-41ab-49aa-96cd-2a2a4f13793e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock_d7b00e8b-1055-4bb4-a97c-8e2b73f6b75a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7af012f8-3986-489e-88c3-58fd79261e5d" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock_d7b00e8b-1055-4bb4-a97c-8e2b73f6b75a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SelectedQuarterlyFinancialDataUnauditedTables" xlink:type="simple" xlink:href="lgnd-20221231.xsd#SelectedQuarterlyFinancialDataUnauditedTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/SelectedQuarterlyFinancialDataUnauditedTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_c77099d8-35b4-4674-a2c5-21238202cc4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_ff52c5c8-3d8c-41ca-b188-a32a87733eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_c77099d8-35b4-4674-a2c5-21238202cc4c" xlink:to="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_ff52c5c8-3d8c-41ca-b188-a32a87733eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3ac54cd9-3170-42cd-88c4-6d8baf51f852" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationTable_3e24e419-4002-4988-be23-31992016a302" xlink:href="lgnd-20221231.xsd#lgnd_BasisOfPresentationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3ac54cd9-3170-42cd-88c4-6d8baf51f852" xlink:to="loc_lgnd_BasisOfPresentationTable_3e24e419-4002-4988-be23-31992016a302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_3690d44d-c7f2-46f8-b998-299a16670c54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationTable_3e24e419-4002-4988-be23-31992016a302" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_3690d44d-c7f2-46f8-b998-299a16670c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_b941c633-ba00-4404-ab66-775ba9fbd59b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_3690d44d-c7f2-46f8-b998-299a16670c54" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_b941c633-ba00-4404-ab66-775ba9fbd59b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_11a8c842-2792-4fa9-ab09-e6e2e95cca04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_b941c633-ba00-4404-ab66-775ba9fbd59b" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_11a8c842-2792-4fa9-ab09-e6e2e95cca04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_a58b472d-bc1f-401a-b624-676f1850c517" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationTable_3e24e419-4002-4988-be23-31992016a302" xlink:to="loc_srt_CounterpartyNameAxis_a58b472d-bc1f-401a-b624-676f1850c517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a57cf8d3-ac34-4d02-b01e-262b69f8c4a8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_a58b472d-bc1f-401a-b624-676f1850c517" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a57cf8d3-ac34-4d02-b01e-262b69f8c4a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NovanMolluscumProductsMember_f027c7c0-e3a6-41ea-8a9c-93a3524abcf9" xlink:href="lgnd-20221231.xsd#lgnd_NovanMolluscumProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a57cf8d3-ac34-4d02-b01e-262b69f8c4a8" xlink:to="loc_lgnd_NovanMolluscumProductsMember_f027c7c0-e3a6-41ea-8a9c-93a3524abcf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PalvellaTherapeuticsIncMember_cc2a6c49-0372-4dc3-b4f4-c7f144252076" xlink:href="lgnd-20221231.xsd#lgnd_PalvellaTherapeuticsIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a57cf8d3-ac34-4d02-b01e-262b69f8c4a8" xlink:to="loc_lgnd_PalvellaTherapeuticsIncMember_cc2a6c49-0372-4dc3-b4f4-c7f144252076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoMember_6de583af-c57f-4964-a1ce-a1549db984a8" xlink:href="lgnd-20221231.xsd#lgnd_AziyoMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a57cf8d3-ac34-4d02-b01e-262b69f8c4a8" xlink:to="loc_lgnd_AziyoMember_6de583af-c57f-4964-a1ce-a1549db984a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CorMatrixMember_bf6ba029-73f3-4a82-93e7-f871a409685f" xlink:href="lgnd-20221231.xsd#lgnd_CorMatrixMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a57cf8d3-ac34-4d02-b01e-262b69f8c4a8" xlink:to="loc_lgnd_CorMatrixMember_bf6ba029-73f3-4a82-93e7-f871a409685f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisMember_cd4ce613-b4fd-4cde-9630-f78603735d30" xlink:href="lgnd-20221231.xsd#lgnd_SelexisMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a57cf8d3-ac34-4d02-b01e-262b69f8c4a8" xlink:to="loc_lgnd_SelexisMember_cd4ce613-b4fd-4cde-9630-f78603735d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7891aa68-1a44-4656-b070-4920663d55d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationTable_3e24e419-4002-4988-be23-31992016a302" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7891aa68-1a44-4656-b070-4920663d55d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_57ace918-a9f3-421a-bf12-fc5dc45a07b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7891aa68-1a44-4656-b070-4920663d55d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_57ace918-a9f3-421a-bf12-fc5dc45a07b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyAgreementsMember_68afae2b-943a-499c-aa22-762d201ce3a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_57ace918-a9f3-421a-bf12-fc5dc45a07b8" xlink:to="loc_us-gaap_RoyaltyAgreementsMember_68afae2b-943a-499c-aa22-762d201ce3a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_f43bf9ad-35ad-4028-8b9a-b3c98baf4357" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_57ace918-a9f3-421a-bf12-fc5dc45a07b8" xlink:to="loc_us-gaap_LicensingAgreementsMember_f43bf9ad-35ad-4028-8b9a-b3c98baf4357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3e3fcbe8-d970-42c9-8415-c90741d18161" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationTable_3e24e419-4002-4988-be23-31992016a302" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3e3fcbe8-d970-42c9-8415-c90741d18161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dfde5c4e-90c2-460d-b1c7-d487e1c92233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3e3fcbe8-d970-42c9-8415-c90741d18161" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dfde5c4e-90c2-460d-b1c7-d487e1c92233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_3b2b1e19-41e3-441b-bc57-1f38cbc6bd24" xlink:href="lgnd-20221231.xsd#lgnd_PfenexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dfde5c4e-90c2-460d-b1c7-d487e1c92233" xlink:to="loc_lgnd_PfenexMember_3b2b1e19-41e3-441b-bc57-1f38cbc6bd24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MetabasisTherapeuticsMember_a25b5252-74e6-4bcd-833f-037d346b7ce2" xlink:href="lgnd-20221231.xsd#lgnd_MetabasisTherapeuticsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dfde5c4e-90c2-460d-b1c7-d487e1c92233" xlink:to="loc_lgnd_MetabasisTherapeuticsMember_a25b5252-74e6-4bcd-833f-037d346b7ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2a38c760-9f36-4abc-9cef-c62cb62e3d58" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationTable_3e24e419-4002-4988-be23-31992016a302" xlink:to="loc_srt_RangeAxis_2a38c760-9f36-4abc-9cef-c62cb62e3d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_99c2f395-c038-4884-87a1-81a6d993cf9d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_2a38c760-9f36-4abc-9cef-c62cb62e3d58" xlink:to="loc_srt_RangeMember_99c2f395-c038-4884-87a1-81a6d993cf9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d4b19c01-e65f-4c39-b1a4-5f204832cc65" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_99c2f395-c038-4884-87a1-81a6d993cf9d" xlink:to="loc_srt_MinimumMember_d4b19c01-e65f-4c39-b1a4-5f204832cc65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_be4234f3-00b3-467a-9615-74a8a1cbb90d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_99c2f395-c038-4884-87a1-81a6d993cf9d" xlink:to="loc_srt_MaximumMember_be4234f3-00b3-467a-9615-74a8a1cbb90d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d845814b-2055-4cb5-840c-a55b85013986" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationTable_3e24e419-4002-4988-be23-31992016a302" xlink:to="loc_us-gaap_AwardTypeAxis_d845814b-2055-4cb5-840c-a55b85013986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8655ee89-1f52-4b85-b794-ea5062cf15db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_d845814b-2055-4cb5-840c-a55b85013986" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8655ee89-1f52-4b85-b794-ea5062cf15db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e9139c73-823c-4963-b841-6f4114d8d27c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8655ee89-1f52-4b85-b794-ea5062cf15db" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e9139c73-823c-4963-b841-6f4114d8d27c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RestrictedStockUnitsAndPerformanceSharesMember_949745ca-9620-45f3-9402-95d1302ad43e" xlink:href="lgnd-20221231.xsd#lgnd_RestrictedStockUnitsAndPerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8655ee89-1f52-4b85-b794-ea5062cf15db" xlink:to="loc_lgnd_RestrictedStockUnitsAndPerformanceSharesMember_949745ca-9620-45f3-9402-95d1302ad43e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_58d1068f-371f-4015-af39-4efba9321511" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_RestrictedStockUnitsAndPerformanceSharesMember_949745ca-9620-45f3-9402-95d1302ad43e" xlink:to="loc_us-gaap_PerformanceSharesMember_58d1068f-371f-4015-af39-4efba9321511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_662db579-5412-46a0-8344-392261ad910e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationTable_3e24e419-4002-4988-be23-31992016a302" xlink:to="loc_us-gaap_VestingAxis_662db579-5412-46a0-8344-392261ad910e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_0aa13c38-44f1-494e-852e-42c4e79e98c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_662db579-5412-46a0-8344-392261ad910e" xlink:to="loc_us-gaap_VestingDomain_0aa13c38-44f1-494e-852e-42c4e79e98c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_VestingPeriodOneMember_8d1b419e-e5a6-48c8-b04e-2cc664b92359" xlink:href="lgnd-20221231.xsd#lgnd_VestingPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_0aa13c38-44f1-494e-852e-42c4e79e98c5" xlink:to="loc_lgnd_VestingPeriodOneMember_8d1b419e-e5a6-48c8-b04e-2cc664b92359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_VestingPeriodTwoMember_f321fb79-4894-48dc-83e1-98cf567a14b9" xlink:href="lgnd-20221231.xsd#lgnd_VestingPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_0aa13c38-44f1-494e-852e-42c4e79e98c5" xlink:to="loc_lgnd_VestingPeriodTwoMember_f321fb79-4894-48dc-83e1-98cf567a14b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_4da96513-7b3d-4c78-bcc3-2e3fef195136" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationTable_3e24e419-4002-4988-be23-31992016a302" xlink:to="loc_us-gaap_PlanNameAxis_4da96513-7b3d-4c78-bcc3-2e3fef195136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_9cddc78e-82b6-486c-8a13-1e5b388a5f33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_4da96513-7b3d-4c78-bcc3-2e3fef195136" xlink:to="loc_us-gaap_PlanNameDomain_9cddc78e-82b6-486c-8a13-1e5b388a5f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_TwoThousandTwoStockIncentivePlanMember_bd9964e6-a340-44d2-9fd2-41eba7baa555" xlink:href="lgnd-20221231.xsd#lgnd_TwoThousandTwoStockIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_9cddc78e-82b6-486c-8a13-1e5b388a5f33" xlink:to="loc_lgnd_TwoThousandTwoStockIncentivePlanMember_bd9964e6-a340-44d2-9fd2-41eba7baa555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_29cfdf1d-c6bd-461a-8a09-f3ec01077cdd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationTable_3e24e419-4002-4988-be23-31992016a302" xlink:to="loc_srt_ProductOrServiceAxis_29cfdf1d-c6bd-461a-8a09-f3ec01077cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_530ffbce-ee1f-45ae-986e-b2b939a3c56b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_29cfdf1d-c6bd-461a-8a09-f3ec01077cdd" xlink:to="loc_srt_ProductsAndServicesDomain_530ffbce-ee1f-45ae-986e-b2b939a3c56b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_eceb8091-1dcb-4ff3-bff1-79a3e121828f" xlink:href="lgnd-20221231.xsd#lgnd_ContractRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_530ffbce-ee1f-45ae-986e-b2b939a3c56b" xlink:to="loc_lgnd_ContractRevenueMember_eceb8091-1dcb-4ff3-bff1-79a3e121828f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_39452a78-d1b0-4e9e-9a39-600782cb9f32" xlink:href="lgnd-20221231.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_530ffbce-ee1f-45ae-986e-b2b939a3c56b" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_39452a78-d1b0-4e9e-9a39-600782cb9f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_172fc8d9-459f-4ffc-9e53-6bd812b77d34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationTable_3e24e419-4002-4988-be23-31992016a302" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_172fc8d9-459f-4ffc-9e53-6bd812b77d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_2770afe8-cefe-463b-a725-a0c7d1002920" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_172fc8d9-459f-4ffc-9e53-6bd812b77d34" xlink:to="loc_us-gaap_TypeOfAdoptionMember_2770afe8-cefe-463b-a725-a0c7d1002920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_efe03acc-43c1-4a19-b540-aaee31a492d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_2770afe8-cefe-463b-a725-a0c7d1002920" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_efe03acc-43c1-4a19-b540-aaee31a492d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_d6fd4263-c976-42ce-8e6e-0c89557c4fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_2770afe8-cefe-463b-a725-a0c7d1002920" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_d6fd4263-c976-42ce-8e6e-0c89557c4fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_9f87b940-4ea7-40f0-a2f1-847088f42a45" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationTable_3e24e419-4002-4988-be23-31992016a302" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_9f87b940-4ea7-40f0-a2f1-847088f42a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_af40a30d-b47d-4c32-ba02-1e5f9ecf50df" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_9f87b940-4ea7-40f0-a2f1-847088f42a45" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_af40a30d-b47d-4c32-ba02-1e5f9ecf50df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_85eeb345-4065-4eb0-901c-4729d6ceeeb7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_af40a30d-b47d-4c32-ba02-1e5f9ecf50df" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_85eeb345-4065-4eb0-901c-4729d6ceeeb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_8431df9b-21a2-423a-8f5f-1d1274275111" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_af40a30d-b47d-4c32-ba02-1e5f9ecf50df" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_8431df9b-21a2-423a-8f5f-1d1274275111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_dc7460c4-2971-44ad-b74f-9bde89a7aaef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationTable_3e24e419-4002-4988-be23-31992016a302" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_dc7460c4-2971-44ad-b74f-9bde89a7aaef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9f0038c2-a727-4417-b192-5a270b757818" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_dc7460c4-2971-44ad-b74f-9bde89a7aaef" xlink:to="loc_us-gaap_EquityComponentDomain_9f0038c2-a727-4417-b192-5a270b757818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_94fec6ab-0318-48e3-b680-1e2a7052e458" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9f0038c2-a727-4417-b192-5a270b757818" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_94fec6ab-0318-48e3-b680-1e2a7052e458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_8cfae410-3ac5-401a-968c-dc006c74c33e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9f0038c2-a727-4417-b192-5a270b757818" xlink:to="loc_us-gaap_RetainedEarningsMember_8cfae410-3ac5-401a-968c-dc006c74c33e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:href="lgnd-20221231.xsd#lgnd_BasisOfPresentationLineItems"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationTable_3e24e419-4002-4988-be23-31992016a302" xlink:to="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_94ba85f0-63e4-448f-b997-3ba94bb5c8bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_NumberOfOperatingSegments_94ba85f0-63e4-448f-b997-3ba94bb5c8bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaturityPeriodOfHighlyLiquidSecuritiesMaximum_b519c0bd-2378-4e8e-a6e2-ea32e0c968ef" xlink:href="lgnd-20221231.xsd#lgnd_MaturityPeriodOfHighlyLiquidSecuritiesMaximum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_lgnd_MaturityPeriodOfHighlyLiquidSecuritiesMaximum_b519c0bd-2378-4e8e-a6e2-ea32e0c968ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_276aec50-d205-4ba6-a373-bf4099364aca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_InventoryWriteDown_276aec50-d205-4ba6-a373-bf4099364aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_ccc725ba-0254-40ea-b211-0c87745ba6ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_InventoryNet_ccc725ba-0254-40ea-b211-0c87745ba6ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_e4577a6f-f53c-487d-b62f-67fdba3de82e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_e4577a6f-f53c-487d-b62f-67fdba3de82e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityAmountPerShare_c9551ab5-2f9b-491e-a652-fd9b27f39216" xlink:href="lgnd-20221231.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityAmountPerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityAmountPerShare_c9551ab5-2f9b-491e-a652-fd9b27f39216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_99cc97ac-f17c-4e8d-8d94-fc893cc75137" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_99cc97ac-f17c-4e8d-8d94-fc893cc75137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfContingentValueRightsIssued_ebe97c01-352f-4b45-9eae-9bcdea8aad82" xlink:href="lgnd-20221231.xsd#lgnd_NumberOfContingentValueRightsIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_lgnd_NumberOfContingentValueRightsIssued_ebe97c01-352f-4b45-9eae-9bcdea8aad82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseUpfrontPayment_d7efad4b-a706-446c-b605-6bda6118615f" xlink:href="lgnd-20221231.xsd#lgnd_LicenseUpfrontPayment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_lgnd_LicenseUpfrontPayment_d7efad4b-a706-446c-b605-6bda6118615f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdditionalRoyaltiesReceivableUnderSalesbasedMilestones_296e8678-d3d0-4d83-8675-6bddd25c6a79" xlink:href="lgnd-20221231.xsd#lgnd_AdditionalRoyaltiesReceivableUnderSalesbasedMilestones"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_lgnd_AdditionalRoyaltiesReceivableUnderSalesbasedMilestones_296e8678-d3d0-4d83-8675-6bddd25c6a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ProductRoyaltyPercentage_8d9ec38e-e1af-47ac-8cee-f91b30020b4a" xlink:href="lgnd-20221231.xsd#lgnd_ProductRoyaltyPercentage"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_lgnd_ProductRoyaltyPercentage_8d9ec38e-e1af-47ac-8cee-f91b30020b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_07e15e5e-2e67-4a01-939f-3ece90e1238a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_07e15e5e-2e67-4a01-939f-3ece90e1238a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3948cb39-4446-4155-8b73-94b3f627531b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3948cb39-4446-4155-8b73-94b3f627531b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived_0c75a31a-b721-42f8-88b5-eb3a8c844ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_ProceedsFromRoyaltiesReceived_0c75a31a-b721-42f8-88b5-eb3a8c844ffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyAgreementExpirationPeriod_9cde90bf-2c1d-4adc-979e-3095322692a3" xlink:href="lgnd-20221231.xsd#lgnd_RoyaltyAgreementExpirationPeriod"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_lgnd_RoyaltyAgreementExpirationPeriod_9cde90bf-2c1d-4adc-979e-3095322692a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_5bd6b198-28ac-4da3-9179-f4d95d3fa2b6" xlink:href="lgnd-20221231.xsd#lgnd_ForecastedCashFlowsEffectiveInterestRatePercent"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_5bd6b198-28ac-4da3-9179-f4d95d3fa2b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_0b97a369-ce86-498a-b4dc-7f3a61acb891" xlink:href="lgnd-20221231.xsd#lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_0b97a369-ce86-498a-b4dc-7f3a61acb891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccountsReceivableCreditLossExpenseReversalCOVID19_18ee074b-ad38-4af8-88c0-617ab4ab5ca3" xlink:href="lgnd-20221231.xsd#lgnd_AccountsReceivableCreditLossExpenseReversalCOVID19"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_lgnd_AccountsReceivableCreditLossExpenseReversalCOVID19_18ee074b-ad38-4af8-88c0-617ab4ab5ca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_c0ae5486-1309-42e9-8ecf-09f6c37dab3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_c0ae5486-1309-42e9-8ecf-09f6c37dab3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_52587af7-1d49-4a0e-afc8-9057d21bc740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_52587af7-1d49-4a0e-afc8-9057d21bc740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_37851f70-66b0-4ac4-9f6e-0624d1972047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_37851f70-66b0-4ac4-9f6e-0624d1972047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiMeasurementInput_7aa510ad-3359-41cd-8e5b-9271b1ed85bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiMeasurementInput"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_EquitySecuritiesFvNiMeasurementInput_7aa510ad-3359-41cd-8e5b-9271b1ed85bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_54eef744-83f5-4933-91e2-1a2c81e3d9b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_54eef744-83f5-4933-91e2-1a2c81e3d9b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dafce638-8907-48b4-91ad-3d875fbb77f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dafce638-8907-48b4-91ad-3d875fbb77f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable_49c2a2c6-8781-4496-bd2b-ee4f40eddcbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_ConvertibleNotesPayable_49c2a2c6-8781-4496-bd2b-ee4f40eddcbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_b41accbe-d511-4314-a928-3e9cc2c51671" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_b41accbe-d511-4314-a928-3e9cc2c51671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_eb820841-2674-410d-92c7-f9689e1c3a14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_StockholdersEquity_eb820841-2674-410d-92c7-f9689e1c3a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_58d0bd2f-59a4-49b3-a384-6c99093fa832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_439e0b71-a9d1-4022-a715-897cff2f43af" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_58d0bd2f-59a4-49b3-a384-6c99093fa832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuefromSignificantPartnersDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuefromSignificantPartnersDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuefromSignificantPartnersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e33e789c-91a2-4e2a-8518-64677b1f308d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_c8ef0db3-6652-482d-9529-0f3261bf3169" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e33e789c-91a2-4e2a-8518-64677b1f308d" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_c8ef0db3-6652-482d-9529-0f3261bf3169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_897431dd-e8b6-40db-b21a-1086e51cc3e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_c8ef0db3-6652-482d-9529-0f3261bf3169" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_897431dd-e8b6-40db-b21a-1086e51cc3e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_a56322b8-603f-405a-98de-b88da4e82c6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_897431dd-e8b6-40db-b21a-1086e51cc3e3" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_a56322b8-603f-405a-98de-b88da4e82c6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_1c693588-cef0-4887-8299-afac0aa55c0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_a56322b8-603f-405a-98de-b88da4e82c6b" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_1c693588-cef0-4887-8299-afac0aa55c0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ab65d6cc-4873-479d-8e77-bafb2dd215b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_c8ef0db3-6652-482d-9529-0f3261bf3169" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ab65d6cc-4873-479d-8e77-bafb2dd215b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b3d1549a-2670-4a20-a40f-20c56eca76af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ab65d6cc-4873-479d-8e77-bafb2dd215b6" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b3d1549a-2670-4a20-a40f-20c56eca76af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_16e71ea1-a66c-4db0-90b8-ea1ca173be52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b3d1549a-2670-4a20-a40f-20c56eca76af" xlink:to="loc_us-gaap_SalesRevenueNetMember_16e71ea1-a66c-4db0-90b8-ea1ca173be52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_61dd947e-d4fb-4bea-a72f-764e6ae0f5ef" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_c8ef0db3-6652-482d-9529-0f3261bf3169" xlink:to="loc_srt_MajorCustomersAxis_61dd947e-d4fb-4bea-a72f-764e6ae0f5ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_fd2a025d-2bcd-498c-9615-92cad3fb58c1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_61dd947e-d4fb-4bea-a72f-764e6ae0f5ef" xlink:to="loc_srt_NameOfMajorCustomerDomain_fd2a025d-2bcd-498c-9615-92cad3fb58c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PartnerAMember_4edd3ebe-6889-48e6-8682-41f3e2717fc7" xlink:href="lgnd-20221231.xsd#lgnd_PartnerAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_fd2a025d-2bcd-498c-9615-92cad3fb58c1" xlink:to="loc_lgnd_PartnerAMember_4edd3ebe-6889-48e6-8682-41f3e2717fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PartnerBMember_d2f928c9-7008-4b88-a57a-3d5afe2aac25" xlink:href="lgnd-20221231.xsd#lgnd_PartnerBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_fd2a025d-2bcd-498c-9615-92cad3fb58c1" xlink:to="loc_lgnd_PartnerBMember_d2f928c9-7008-4b88-a57a-3d5afe2aac25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PartnerCMember_3cc2e069-7314-488d-b23e-a14d849f015a" xlink:href="lgnd-20221231.xsd#lgnd_PartnerCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_fd2a025d-2bcd-498c-9615-92cad3fb58c1" xlink:to="loc_lgnd_PartnerCMember_3cc2e069-7314-488d-b23e-a14d849f015a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_e7d456ef-ec75-48e9-ae20-0e6f5ad3cb29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_c8ef0db3-6652-482d-9529-0f3261bf3169" xlink:to="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_e7d456ef-ec75-48e9-ae20-0e6f5ad3cb29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_377a8bbe-82df-42e9-a2f4-8ec9d2cb5b25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_e7d456ef-ec75-48e9-ae20-0e6f5ad3cb29" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_377a8bbe-82df-42e9-a2f4-8ec9d2cb5b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c3a9539b-5e7b-47a3-9e83-cb67ddf36fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_81a5f7ec-5f46-4986-8b10-6dcb21cff73b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c3a9539b-5e7b-47a3-9e83-cb67ddf36fe5" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_81a5f7ec-5f46-4986-8b10-6dcb21cff73b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ad636c8b-2dc6-4786-af66-778421a98c25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_81a5f7ec-5f46-4986-8b10-6dcb21cff73b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ad636c8b-2dc6-4786-af66-778421a98c25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79424ac4-9de6-4ab7-b9a2-af5235aee373" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ad636c8b-2dc6-4786-af66-778421a98c25" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79424ac4-9de6-4ab7-b9a2-af5235aee373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_91bc5b7d-71dd-41b5-a40d-11f58a321fe3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79424ac4-9de6-4ab7-b9a2-af5235aee373" xlink:to="loc_us-gaap_LicensingAgreementsMember_91bc5b7d-71dd-41b5-a40d-11f58a321fe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_1085f090-c0dc-41ac-8e06-51cb0af1052b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_81a5f7ec-5f46-4986-8b10-6dcb21cff73b" xlink:to="loc_srt_CounterpartyNameAxis_1085f090-c0dc-41ac-8e06-51cb0af1052b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_28f10911-80b7-4c1a-8338-ab290afa4300" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_1085f090-c0dc-41ac-8e06-51cb0af1052b" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_28f10911-80b7-4c1a-8338-ab290afa4300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoandCorMatrixMember_3704ac35-1222-4e7f-bd01-da22e133a997" xlink:href="lgnd-20221231.xsd#lgnd_AziyoandCorMatrixMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_28f10911-80b7-4c1a-8338-ab290afa4300" xlink:to="loc_lgnd_AziyoandCorMatrixMember_3704ac35-1222-4e7f-bd01-da22e133a997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisAndDianomiMember_da5a0772-98b2-4ab5-82f8-da98e1a78c26" xlink:href="lgnd-20221231.xsd#lgnd_SelexisAndDianomiMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_28f10911-80b7-4c1a-8338-ab290afa4300" xlink:to="loc_lgnd_SelexisAndDianomiMember_da5a0772-98b2-4ab5-82f8-da98e1a78c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_68fc3fd1-46b2-4faf-bd1c-d1bc5e5b48bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_81a5f7ec-5f46-4986-8b10-6dcb21cff73b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_68fc3fd1-46b2-4faf-bd1c-d1bc5e5b48bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d4778c5e-d03e-49e0-8aee-0e89f5512736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_68fc3fd1-46b2-4faf-bd1c-d1bc5e5b48bb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d4778c5e-d03e-49e0-8aee-0e89f5512736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments_73de94c7-57ea-4386-b5aa-965070f53437" xlink:href="lgnd-20221231.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_68fc3fd1-46b2-4faf-bd1c-d1bc5e5b48bb" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments_73de94c7-57ea-4386-b5aa-965070f53437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_fb598d33-530a-4a43-9247-e7de6af44480" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_68fc3fd1-46b2-4faf-bd1c-d1bc5e5b48bb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_fb598d33-530a-4a43-9247-e7de6af44480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f5d5b701-7955-42e0-9952-f715f5ccba8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_68fc3fd1-46b2-4faf-bd1c-d1bc5e5b48bb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f5d5b701-7955-42e0-9952-f715f5ccba8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_8889e50d-4a6d-4d72-9543-6f39612bdfcb" xlink:href="lgnd-20221231.xsd#lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_68fc3fd1-46b2-4faf-bd1c-d1bc5e5b48bb" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_8889e50d-4a6d-4d72-9543-6f39612bdfcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRoyaltyRevenueDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesRoyaltyRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRoyaltyRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_aa8debd2-4f2f-4751-9c96-f84499a5b252" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_4ba39f10-680b-4c71-9113-9836f1b983b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_aa8debd2-4f2f-4751-9c96-f84499a5b252" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_4ba39f10-680b-4c71-9113-9836f1b983b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_efe4937a-b2d4-48bf-a717-a148355d5430" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_4ba39f10-680b-4c71-9113-9836f1b983b9" xlink:to="loc_srt_ProductOrServiceAxis_efe4937a-b2d4-48bf-a717-a148355d5430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_51a4e708-e226-49aa-a59c-31cb6fdfc091" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_efe4937a-b2d4-48bf-a717-a148355d5430" xlink:to="loc_srt_ProductsAndServicesDomain_51a4e708-e226-49aa-a59c-31cb6fdfc091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_8ebe69e2-96f8-472b-954b-31e4d1a9ada0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_51a4e708-e226-49aa-a59c-31cb6fdfc091" xlink:to="loc_us-gaap_RoyaltyMember_8ebe69e2-96f8-472b-954b-31e4d1a9ada0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyKyprolisMember_a6c5a91f-681a-4db3-aa24-a163042fa403" xlink:href="lgnd-20221231.xsd#lgnd_RoyaltyKyprolisMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_8ebe69e2-96f8-472b-954b-31e4d1a9ada0" xlink:to="loc_lgnd_RoyaltyKyprolisMember_a6c5a91f-681a-4db3-aa24-a163042fa403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyEvomelaMember_b13ee984-6824-4406-bda4-9ab95d5c500d" xlink:href="lgnd-20221231.xsd#lgnd_RoyaltyEvomelaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_8ebe69e2-96f8-472b-954b-31e4d1a9ada0" xlink:to="loc_lgnd_RoyaltyEvomelaMember_b13ee984-6824-4406-bda4-9ab95d5c500d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyTeriparatideInjectionMember_85ac8ade-b696-4015-8e6b-1cec52055ec9" xlink:href="lgnd-20221231.xsd#lgnd_RoyaltyTeriparatideInjectionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_8ebe69e2-96f8-472b-954b-31e4d1a9ada0" xlink:to="loc_lgnd_RoyaltyTeriparatideInjectionMember_85ac8ade-b696-4015-8e6b-1cec52055ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyRylazeMember_4530ecd6-9a34-4880-a4bc-b1ae0629e064" xlink:href="lgnd-20221231.xsd#lgnd_RoyaltyRylazeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_8ebe69e2-96f8-472b-954b-31e4d1a9ada0" xlink:to="loc_lgnd_RoyaltyRylazeMember_4530ecd6-9a34-4880-a4bc-b1ae0629e064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyOtherMember_27c96d64-4521-4ebb-ab12-aa426303a626" xlink:href="lgnd-20221231.xsd#lgnd_RoyaltyOtherMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_8ebe69e2-96f8-472b-954b-31e4d1a9ada0" xlink:to="loc_lgnd_RoyaltyOtherMember_27c96d64-4521-4ebb-ab12-aa426303a626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_6eea9e5b-5e5e-4407-ba28-7abbdcd91d73" xlink:href="lgnd-20221231.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_51a4e708-e226-49aa-a59c-31cb6fdfc091" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_6eea9e5b-5e5e-4407-ba28-7abbdcd91d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCoreMember_393c17dc-68ab-44f5-b444-ad4fe5ef7bae" xlink:href="lgnd-20221231.xsd#lgnd_MaterialSalesCaptisolCoreMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_MaterialSalesCaptisolMember_6eea9e5b-5e5e-4407-ba28-7abbdcd91d73" xlink:to="loc_lgnd_MaterialSalesCaptisolCoreMember_393c17dc-68ab-44f5-b444-ad4fe5ef7bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCOVIDMember_110a55d8-051f-4210-a42f-96c6b234ea02" xlink:href="lgnd-20221231.xsd#lgnd_MaterialSalesCaptisolCOVIDMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_MaterialSalesCaptisolMember_6eea9e5b-5e5e-4407-ba28-7abbdcd91d73" xlink:to="loc_lgnd_MaterialSalesCaptisolCOVIDMember_110a55d8-051f-4210-a42f-96c6b234ea02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_2137554e-4027-480d-b16c-d99077bd7533" xlink:href="lgnd-20221231.xsd#lgnd_ContractRevenueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_51a4e708-e226-49aa-a59c-31cb6fdfc091" xlink:to="loc_lgnd_ContractRevenueMember_2137554e-4027-480d-b16c-d99077bd7533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_5fb565ba-8395-410c-80ab-b3459e7ec054" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_2137554e-4027-480d-b16c-d99077bd7533" xlink:to="loc_us-gaap_ServiceMember_5fb565ba-8395-410c-80ab-b3459e7ec054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMember_1215e607-6034-4c69-9f15-227d915754e3" xlink:href="lgnd-20221231.xsd#lgnd_LicenseFeesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_2137554e-4027-480d-b16c-d99077bd7533" xlink:to="loc_lgnd_LicenseFeesMember_1215e607-6034-4c69-9f15-227d915754e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestoneMember_f949ad95-496c-4e4c-b8be-85067cde27a4" xlink:href="lgnd-20221231.xsd#lgnd_MilestoneMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_2137554e-4027-480d-b16c-d99077bd7533" xlink:to="loc_lgnd_MilestoneMember_f949ad95-496c-4e4c-b8be-85067cde27a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMilestonesAndOtherProductOtherMember_5aca20d7-0651-4bc5-8e41-58f47efc3091" xlink:href="lgnd-20221231.xsd#lgnd_LicenseFeesMilestonesAndOtherProductOtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_2137554e-4027-480d-b16c-d99077bd7533" xlink:to="loc_lgnd_LicenseFeesMilestonesAndOtherProductOtherMember_5aca20d7-0651-4bc5-8e41-58f47efc3091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_658b864b-eafc-445e-bf15-bea1227ab8a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_4ba39f10-680b-4c71-9113-9836f1b983b9" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_658b864b-eafc-445e-bf15-bea1227ab8a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_61ccc4fe-79ff-4019-b82e-5adfc63f1a16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_658b864b-eafc-445e-bf15-bea1227ab8a7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_61ccc4fe-79ff-4019-b82e-5adfc63f1a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCalculationofEarningsperShareDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesCalculationofEarningsperShareDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCalculationofEarningsperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_90b639a8-4146-4f89-bd7a-b5605ad32c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_87634890-b36f-43d7-962f-a3ac27e36265" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_90b639a8-4146-4f89-bd7a-b5605ad32c0b" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_87634890-b36f-43d7-962f-a3ac27e36265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2f3b898e-eaff-4d64-8dd8-e1b4d4b4e0dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_87634890-b36f-43d7-962f-a3ac27e36265" xlink:to="loc_us-gaap_AwardTypeAxis_2f3b898e-eaff-4d64-8dd8-e1b4d4b4e0dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dd058656-043e-4afe-9ce1-e9b30f113134" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2f3b898e-eaff-4d64-8dd8-e1b4d4b4e0dc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dd058656-043e-4afe-9ce1-e9b30f113134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_0fa8d94e-5ba8-493b-a86c-5646c078fb37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dd058656-043e-4afe-9ce1-e9b30f113134" xlink:to="loc_us-gaap_RestrictedStockMember_0fa8d94e-5ba8-493b-a86c-5646c078fb37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_faf99f83-d293-47a3-99dc-1c1e707b8c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dd058656-043e-4afe-9ce1-e9b30f113134" xlink:to="loc_us-gaap_EmployeeStockOptionMember_faf99f83-d293-47a3-99dc-1c1e707b8c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems_f90b3ad4-8390-4d04-af57-530c702f3894" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_87634890-b36f-43d7-962f-a3ac27e36265" xlink:to="loc_us-gaap_EarningsPerShareDilutedLineItems_f90b3ad4-8390-4d04-af57-530c702f3894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_32cde136-b6d3-49c4-9abe-45afda308066" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_f90b3ad4-8390-4d04-af57-530c702f3894" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_32cde136-b6d3-49c4-9abe-45afda308066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_65739bdc-c8a4-4883-854d-6975a15fb44e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_f90b3ad4-8390-4d04-af57-530c702f3894" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_65739bdc-c8a4-4883-854d-6975a15fb44e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5549ac34-6acd-4bee-9d7d-edb7a5becb2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_f90b3ad4-8390-4d04-af57-530c702f3894" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5549ac34-6acd-4bee-9d7d-edb7a5becb2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0fc239aa-57a2-4bbe-9e81-437001a3d109" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_f90b3ad4-8390-4d04-af57-530c702f3894" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0fc239aa-57a2-4bbe-9e81-437001a3d109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SpinoffofOmniAbNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#SpinoffofOmniAbNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/SpinoffofOmniAbNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_fa89ddd3-f856-423d-b35c-8b59b054e777" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b8df08c7-c638-4be8-97c6-08a748860725" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_fa89ddd3-f856-423d-b35c-8b59b054e777" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b8df08c7-c638-4be8-97c6-08a748860725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_37a56faf-c6d4-4a39-a2e3-18091ab3690b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b8df08c7-c638-4be8-97c6-08a748860725" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_37a56faf-c6d4-4a39-a2e3-18091ab3690b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_3b2c965d-b179-4fc4-bab7-8a37de2b23ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_37a56faf-c6d4-4a39-a2e3-18091ab3690b" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_3b2c965d-b179-4fc4-bab7-8a37de2b23ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_3674fde7-32c0-4695-80ff-a335dce6fd45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_3b2c965d-b179-4fc4-bab7-8a37de2b23ab" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_3674fde7-32c0-4695-80ff-a335dce6fd45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3ccd7edc-05d2-4f8a-a4d3-7ec852492a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b8df08c7-c638-4be8-97c6-08a748860725" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3ccd7edc-05d2-4f8a-a4d3-7ec852492a6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e0a01f2c-8a50-435c-9a28-5a197caf5dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3ccd7edc-05d2-4f8a-a4d3-7ec852492a6d" xlink:to="loc_us-gaap_SegmentDomain_e0a01f2c-8a50-435c-9a28-5a197caf5dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LigandCoreBusinessMember_5c57a55f-92d5-4109-916c-496da68f8b47" xlink:href="lgnd-20221231.xsd#lgnd_LigandCoreBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e0a01f2c-8a50-435c-9a28-5a197caf5dd0" xlink:to="loc_lgnd_LigandCoreBusinessMember_5c57a55f-92d5-4109-916c-496da68f8b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_deae9e3e-2121-45b3-b9ed-690488eacc89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b8df08c7-c638-4be8-97c6-08a748860725" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_deae9e3e-2121-45b3-b9ed-690488eacc89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_46a64ef4-3345-4753-985f-d5e8fe956b91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_deae9e3e-2121-45b3-b9ed-690488eacc89" xlink:to="loc_us-gaap_NumberOfReportableSegments_46a64ef4-3345-4753-985f-d5e8fe956b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed_03b29ebf-6b25-4362-98e8-3c93d23e104b" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_deae9e3e-2121-45b3-b9ed-690488eacc89" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed_03b29ebf-6b25-4362-98e8-3c93d23e104b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1e452118-1e4d-49fc-ac97-6feebdc8c574" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_deae9e3e-2121-45b3-b9ed-690488eacc89" xlink:to="loc_us-gaap_Goodwill_1e452118-1e4d-49fc-ac97-6feebdc8c574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_f0da5154-290f-4a0c-8b4c-1860cc629e38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_deae9e3e-2121-45b3-b9ed-690488eacc89" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_f0da5154-290f-4a0c-8b4c-1860cc629e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_3bb49a57-3558-49c4-9c35-c09d8c2cd01d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_51c32efc-7109-4d13-8271-07bd3b3533f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_3bb49a57-3558-49c4-9c35-c09d8c2cd01d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_51c32efc-7109-4d13-8271-07bd3b3533f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_89ddbaf2-acb9-43a7-98a5-0f012af9d3c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_51c32efc-7109-4d13-8271-07bd3b3533f9" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_89ddbaf2-acb9-43a7-98a5-0f012af9d3c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_7b1fab52-112b-472c-be8e-260f8ea91b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_89ddbaf2-acb9-43a7-98a5-0f012af9d3c2" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_7b1fab52-112b-472c-be8e-260f8ea91b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_21448bfb-2a4d-4386-bb58-03643398ece1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_7b1fab52-112b-472c-be8e-260f8ea91b5d" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_21448bfb-2a4d-4386-bb58-03643398ece1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cacf6624-fe4a-4396-bf35-b1f9ec182485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_51c32efc-7109-4d13-8271-07bd3b3533f9" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cacf6624-fe4a-4396-bf35-b1f9ec182485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsAbstract_6dba820a-0bec-4e1a-b8d6-57b3c15d8dab" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cacf6624-fe4a-4396-bf35-b1f9ec182485" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsAbstract_6dba820a-0bec-4e1a-b8d6-57b3c15d8dab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_975d5a44-b022-4101-b39b-e00ab756ae63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsAbstract_6dba820a-0bec-4e1a-b8d6-57b3c15d8dab" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_975d5a44-b022-4101-b39b-e00ab756ae63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_2b76b4d9-e777-48a2-967d-740e7d055ec9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_975d5a44-b022-4101-b39b-e00ab756ae63" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_2b76b4d9-e777-48a2-967d-740e7d055ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_7e51c04a-41f8-4265-8b5f-778a8efdac0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_975d5a44-b022-4101-b39b-e00ab756ae63" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_7e51c04a-41f8-4265-8b5f-778a8efdac0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_204f66c7-962c-4ca1-a1dc-afa6b26a7061" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_975d5a44-b022-4101-b39b-e00ab756ae63" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_204f66c7-962c-4ca1-a1dc-afa6b26a7061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_673b77ad-38ab-4be7-aaaf-a2cca74ba266" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsAbstract_6dba820a-0bec-4e1a-b8d6-57b3c15d8dab" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_673b77ad-38ab-4be7-aaaf-a2cca74ba266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_b29ab71d-8b29-4ce4-a634-a11e80518416" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsAbstract_6dba820a-0bec-4e1a-b8d6-57b3c15d8dab" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_b29ab71d-8b29-4ce4-a634-a11e80518416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent_f287e50e-e691-463c-8ad8-5108d0d01369" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsAbstract_6dba820a-0bec-4e1a-b8d6-57b3c15d8dab" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent_f287e50e-e691-463c-8ad8-5108d0d01369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsOperatingLeaseAssets_97555512-3fe9-4cad-b464-b8ae4c665c4d" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsOperatingLeaseAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsAbstract_6dba820a-0bec-4e1a-b8d6-57b3c15d8dab" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsOperatingLeaseAssets_97555512-3fe9-4cad-b464-b8ae4c665c4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsFinanceLeaseAssets_a725e4dc-4743-4d1e-a6df-51ce9c9e03c7" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsFinanceLeaseAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsAbstract_6dba820a-0bec-4e1a-b8d6-57b3c15d8dab" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsFinanceLeaseAssets_a725e4dc-4743-4d1e-a6df-51ce9c9e03c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_e62a68e9-d7fd-40d4-ac3a-578cc53053c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsAbstract_6dba820a-0bec-4e1a-b8d6-57b3c15d8dab" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_e62a68e9-d7fd-40d4-ac3a-578cc53053c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_f119541e-36dd-48cb-9b97-70a842373bd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsAbstract_6dba820a-0bec-4e1a-b8d6-57b3c15d8dab" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_f119541e-36dd-48cb-9b97-70a842373bd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndStockholdersEquityAbstract_4b6bc464-d65b-4f5e-baa1-bf03a605c82b" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cacf6624-fe4a-4396-bf35-b1f9ec182485" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndStockholdersEquityAbstract_4b6bc464-d65b-4f5e-baa1-bf03a605c82b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_214464d5-961e-4848-a589-782a01992064" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndStockholdersEquityAbstract_4b6bc464-d65b-4f5e-baa1-bf03a605c82b" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_214464d5-961e-4848-a589-782a01992064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesCurrent_5ae866b9-0af7-4492-bcce-2cda9a212bc2" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_214464d5-961e-4848-a589-782a01992064" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesCurrent_5ae866b9-0af7-4492-bcce-2cda9a212bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent_f3d815d3-048b-4625-839f-58ec986394c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_214464d5-961e-4848-a589-782a01992064" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent_f3d815d3-048b-4625-839f-58ec986394c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent_07435013-5e39-4b38-97a0-cf18aab18735" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_214464d5-961e-4848-a589-782a01992064" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent_07435013-5e39-4b38-97a0-cf18aab18735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilitiesCurrent_31c891f8-23cc-443c-8a53-c58b84b5bf4d" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_214464d5-961e-4848-a589-782a01992064" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilitiesCurrent_31c891f8-23cc-443c-8a53-c58b84b5bf4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_4823d18c-ca2d-445c-811d-2cab22b3f732" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_214464d5-961e-4848-a589-782a01992064" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_4823d18c-ca2d-445c-811d-2cab22b3f732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesNoncurrent_4afdc03f-e6e9-4d77-9404-867a6f6fbdfe" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndStockholdersEquityAbstract_4b6bc464-d65b-4f5e-baa1-bf03a605c82b" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesNoncurrent_4afdc03f-e6e9-4d77-9404-867a6f6fbdfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_9678af51-b1d5-47d0-b51a-6f6b1806fd6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndStockholdersEquityAbstract_4b6bc464-d65b-4f5e-baa1-bf03a605c82b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_9678af51-b1d5-47d0-b51a-6f6b1806fd6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesOperatingLeaseNoncurrent_12a6e999-a198-4421-a68f-5a847756942f" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesOperatingLeaseNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndStockholdersEquityAbstract_4b6bc464-d65b-4f5e-baa1-bf03a605c82b" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesOperatingLeaseNoncurrent_12a6e999-a198-4421-a68f-5a847756942f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_8ffc2e46-a58e-427c-8abb-4d0b6ebc752c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndStockholdersEquityAbstract_4b6bc464-d65b-4f5e-baa1-bf03a605c82b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_8ffc2e46-a58e-427c-8abb-4d0b6ebc752c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_6a75ab78-6095-4d12-89c1-d6550141f0fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndStockholdersEquityAbstract_4b6bc464-d65b-4f5e-baa1-bf03a605c82b" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_6a75ab78-6095-4d12-89c1-d6550141f0fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationNetAssetsTransferred_eebb531e-e41b-4a7b-97f4-64992c79f3ab" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationNetAssetsTransferred"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndStockholdersEquityAbstract_4b6bc464-d65b-4f5e-baa1-bf03a605c82b" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationNetAssetsTransferred_eebb531e-e41b-4a7b-97f4-64992c79f3ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_d1f12349-0317-4dd5-86ca-31091e6b44e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_2120aa3e-d7c5-4c96-966f-5605fabaa838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_d1f12349-0317-4dd5-86ca-31091e6b44e7" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_2120aa3e-d7c5-4c96-966f-5605fabaa838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_08bf63e6-01ae-4fba-bc05-8981ea8126bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_2120aa3e-d7c5-4c96-966f-5605fabaa838" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_08bf63e6-01ae-4fba-bc05-8981ea8126bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_de3fce08-4686-414a-913d-102dcfd15b90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_08bf63e6-01ae-4fba-bc05-8981ea8126bf" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_de3fce08-4686-414a-913d-102dcfd15b90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_15026d91-ef5c-4bdf-b3aa-39bf03d131aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_de3fce08-4686-414a-913d-102dcfd15b90" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_15026d91-ef5c-4bdf-b3aa-39bf03d131aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_995c22fa-71a4-43ca-a4c1-a2de13f2f935" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_2120aa3e-d7c5-4c96-966f-5605fabaa838" xlink:to="loc_srt_ProductOrServiceAxis_995c22fa-71a4-43ca-a4c1-a2de13f2f935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_07c6948a-627d-4dca-bc13-60d6b72fc4ae" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_995c22fa-71a4-43ca-a4c1-a2de13f2f935" xlink:to="loc_srt_ProductsAndServicesDomain_07c6948a-627d-4dca-bc13-60d6b72fc4ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_f686b0c4-8007-4d41-a2ab-40230b17c51d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_07c6948a-627d-4dca-bc13-60d6b72fc4ae" xlink:to="loc_us-gaap_RoyaltyMember_f686b0c4-8007-4d41-a2ab-40230b17c51d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_56e49311-ce8b-45e4-ae71-428a6c268751" xlink:href="lgnd-20221231.xsd#lgnd_ContractRevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_07c6948a-627d-4dca-bc13-60d6b72fc4ae" xlink:to="loc_lgnd_ContractRevenueMember_56e49311-ce8b-45e4-ae71-428a6c268751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8b57c388-ec92-49d0-9127-7dba2699aebb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_2120aa3e-d7c5-4c96-966f-5605fabaa838" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8b57c388-ec92-49d0-9127-7dba2699aebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract_3dbf38ea-c876-4468-a6b8-5ea232b88fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8b57c388-ec92-49d0-9127-7dba2699aebb" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract_3dbf38ea-c876-4468-a6b8-5ea232b88fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_d8278641-209e-486a-9d81-0c3b0548f8fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract_3dbf38ea-c876-4468-a6b8-5ea232b88fc3" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_d8278641-209e-486a-9d81-0c3b0548f8fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract_65b4b3e4-47a6-40cf-b7ce-2a4360f8a8b1" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8b57c388-ec92-49d0-9127-7dba2699aebb" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract_65b4b3e4-47a6-40cf-b7ce-2a4360f8a8b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_bf34d107-97fc-4caa-b4d8-13af3db5845c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract_65b4b3e4-47a6-40cf-b7ce-2a4360f8a8b1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_bf34d107-97fc-4caa-b4d8-13af3db5845c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment_0fddef4b-74b1-431c-9a46-77bb82045e05" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract_65b4b3e4-47a6-40cf-b7ce-2a4360f8a8b1" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment_0fddef4b-74b1-431c-9a46-77bb82045e05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_a4d1397e-300c-4609-9461-f10fcbe14e22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract_65b4b3e4-47a6-40cf-b7ce-2a4360f8a8b1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_a4d1397e-300c-4609-9461-f10fcbe14e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_d51ec999-5ff5-4383-af7b-55349131032b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract_65b4b3e4-47a6-40cf-b7ce-2a4360f8a8b1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_d51ec999-5ff5-4383-af7b-55349131032b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_d0f4238d-f41d-4a5d-ac05-20bd3f15a185" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8b57c388-ec92-49d0-9127-7dba2699aebb" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_d0f4238d-f41d-4a5d-ac05-20bd3f15a185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_3d94829a-482a-44cf-900f-fb0c1400de56" xlink:href="lgnd-20221231.xsd#lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8b57c388-ec92-49d0-9127-7dba2699aebb" xlink:to="loc_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_3d94829a-482a-44cf-900f-fb0c1400de56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments_ed800010-abe6-4e8d-853f-87a431f9f4d3" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_3d94829a-482a-44cf-900f-fb0c1400de56" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments_ed800010-abe6-4e8d-853f-87a431f9f4d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_d54c597b-3535-485f-9e73-5d7415ce4ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_3d94829a-482a-44cf-900f-fb0c1400de56" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_d54c597b-3535-485f-9e73-5d7415ce4ccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_d57d1df4-1957-4163-9846-7828fcc8ac3d" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_3d94829a-482a-44cf-900f-fb0c1400de56" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_d57d1df4-1957-4163-9846-7828fcc8ac3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_47b52734-99f7-4b72-ac6c-97fcba8411d6" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8b57c388-ec92-49d0-9127-7dba2699aebb" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_47b52734-99f7-4b72-ac6c-97fcba8411d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_06adeffb-7e11-4e4f-b2e8-e9a66de0b97f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8b57c388-ec92-49d0-9127-7dba2699aebb" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_06adeffb-7e11-4e4f-b2e8-e9a66de0b97f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_073712f5-5aa1-491c-aa24-2a2b5933a2cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8b57c388-ec92-49d0-9127-7dba2699aebb" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_073712f5-5aa1-491c-aa24-2a2b5933a2cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_1fd014cf-3c3c-4442-a8f6-1e31f10c9b92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8b57c388-ec92-49d0-9127-7dba2699aebb" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_1fd014cf-3c3c-4442-a8f6-1e31f10c9b92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_91d2cdf0-27e7-461c-b92c-3681633211a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_293f0b2d-b5d6-4546-ba5b-723805c53858" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_91d2cdf0-27e7-461c-b92c-3681633211a6" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_293f0b2d-b5d6-4546-ba5b-723805c53858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_45715310-550f-4a15-976f-a91c9173bb9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_293f0b2d-b5d6-4546-ba5b-723805c53858" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_45715310-550f-4a15-976f-a91c9173bb9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_4208be3c-5ff8-455c-bf39-06d27e689ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_45715310-550f-4a15-976f-a91c9173bb9e" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_4208be3c-5ff8-455c-bf39-06d27e689ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_6e0c4589-2579-4410-84ff-6a69d9cc2761" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_4208be3c-5ff8-455c-bf39-06d27e689ac5" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_6e0c4589-2579-4410-84ff-6a69d9cc2761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_64c71ad2-4054-4b55-b65f-4e79ecc7eaf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_293f0b2d-b5d6-4546-ba5b-723805c53858" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_64c71ad2-4054-4b55-b65f-4e79ecc7eaf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract_5ee067a5-f372-4f20-96cb-b1e6fd14879e" xlink:href="lgnd-20221231.xsd#lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_64c71ad2-4054-4b55-b65f-4e79ecc7eaf9" xlink:to="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract_5ee067a5-f372-4f20-96cb-b1e6fd14879e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration_30604fd0-c5c9-49f3-8673-1076baae1347" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract_5ee067a5-f372-4f20-96cb-b1e6fd14879e" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration_30604fd0-c5c9-49f3-8673-1076baae1347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortizationDiscontinuedOperations_3a9bcd2a-d5ae-45bc-a3ff-999785779a06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortizationDiscontinuedOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract_5ee067a5-f372-4f20-96cb-b1e6fd14879e" xlink:to="loc_us-gaap_DepreciationAndAmortizationDiscontinuedOperations_3a9bcd2a-d5ae-45bc-a3ff-999785779a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense_659e5c5c-fabd-458b-9fde-06a44733c94b" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract_5ee067a5-f372-4f20-96cb-b1e6fd14879e" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense_659e5c5c-fabd-458b-9fde-06a44733c94b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivesAbstract_89d31410-ea4c-4e46-a659-27081e4a2352" xlink:href="lgnd-20221231.xsd#lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_64c71ad2-4054-4b55-b65f-4e79ecc7eaf9" xlink:to="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivesAbstract_89d31410-ea4c-4e46-a659-27081e4a2352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireBusinessesNetOfCashAcquired_a8beb5db-cbf3-441a-92bf-dbc90feb0908" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivesAbstract_89d31410-ea4c-4e46-a659-27081e4a2352" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireBusinessesNetOfCashAcquired_a8beb5db-cbf3-441a-92bf-dbc90feb0908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpenditureDiscontinuedOperations_eaea74ad-4dd7-498c-ba93-3a52fea15dea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpenditureDiscontinuedOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivesAbstract_89d31410-ea4c-4e46-a659-27081e4a2352" xlink:to="loc_us-gaap_CapitalExpenditureDiscontinuedOperations_eaea74ad-4dd7-498c-ba93-3a52fea15dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersInvestingActivity_32a12e1d-bd36-43d2-838f-e8b06d0bd364" xlink:href="lgnd-20221231.xsd#lgnd_PaymentsToContingentValueRightHoldersInvestingActivity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivesAbstract_89d31410-ea4c-4e46-a659-27081e4a2352" xlink:to="loc_lgnd_PaymentsToContingentValueRightHoldersInvestingActivity_32a12e1d-bd36-43d2-838f-e8b06d0bd364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract_65676d03-db0f-4888-9fce-9884055d6e6e" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_64c71ad2-4054-4b55-b65f-4e79ecc7eaf9" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract_65676d03-db0f-4888-9fce-9884055d6e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_9ea63c6d-52fd-42ac-9dcd-3992c91b25fe" xlink:href="lgnd-20221231.xsd#lgnd_PaymentsToContingentValueRightHoldersFinancingActivity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract_65676d03-db0f-4888-9fce-9884055d6e6e" xlink:to="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_9ea63c6d-52fd-42ac-9dcd-3992c91b25fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_0ecb4af8-77fe-4a1c-9b3a-eadcdfbd1f07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_64c71ad2-4054-4b55-b65f-4e79ecc7eaf9" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_0ecb4af8-77fe-4a1c-9b3a-eadcdfbd1f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid_f2cde32e-d033-43bb-b5dd-ebcb73d135a1" xlink:href="lgnd-20221231.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_0ecb4af8-77fe-4a1c-9b3a-eadcdfbd1f07" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid_f2cde32e-d033-43bb-b5dd-ebcb73d135a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ShorttermInvestmentsInvestmentinVikingNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#ShorttermInvestmentsInvestmentinVikingNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ShorttermInvestmentsInvestmentinVikingNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_092cd10b-bc69-4284-bf80-d74cf78d1147" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_0e1df388-b8fa-43d9-aabf-d38651d76d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_092cd10b-bc69-4284-bf80-d74cf78d1147" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_0e1df388-b8fa-43d9-aabf-d38651d76d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_92aa1bf2-7974-422f-9064-9a61ee5ab44f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_0e1df388-b8fa-43d9-aabf-d38651d76d3b" xlink:to="loc_srt_OwnershipAxis_92aa1bf2-7974-422f-9064-9a61ee5ab44f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_89bd73c3-ad1f-426e-b5bc-8ed5ca02585d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_92aa1bf2-7974-422f-9064-9a61ee5ab44f" xlink:to="loc_srt_OwnershipDomain_89bd73c3-ad1f-426e-b5bc-8ed5ca02585d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_VikingTherapeuticsInc.Member_be3e3bdc-7e47-44d4-a338-18fff42f285a" xlink:href="lgnd-20221231.xsd#lgnd_VikingTherapeuticsInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_89bd73c3-ad1f-426e-b5bc-8ed5ca02585d" xlink:to="loc_lgnd_VikingTherapeuticsInc.Member_be3e3bdc-7e47-44d4-a338-18fff42f285a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_bc836bd3-f6e6-404c-b52d-2b45590cc0fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_0e1df388-b8fa-43d9-aabf-d38651d76d3b" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_bc836bd3-f6e6-404c-b52d-2b45590cc0fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest_f67da8d7-d9d2-46e7-8916-69cbad8609e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_bc836bd3-f6e6-404c-b52d-2b45590cc0fb" xlink:to="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest_f67da8d7-d9d2-46e7-8916-69cbad8609e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_5a01924f-31fc-45fb-9df5-ac5b39ee7bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_bc836bd3-f6e6-404c-b52d-2b45590cc0fb" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_5a01924f-31fc-45fb-9df5-ac5b39ee7bc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_b27e608c-898a-49a1-8c2c-9f4fcb78749c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_bc836bd3-f6e6-404c-b52d-2b45590cc0fb" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_b27e608c-898a-49a1-8c2c-9f4fcb78749c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_6db6b48c-73b9-415b-a83d-113489275abd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_bc836bd3-f6e6-404c-b52d-2b45590cc0fb" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_6db6b48c-73b9-415b-a83d-113489275abd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfSharesSoldOfEquityMethodInvestee_2177fee4-4a55-483e-b408-3fb95ab6b2f3" xlink:href="lgnd-20221231.xsd#lgnd_NumberOfSharesSoldOfEquityMethodInvestee"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_bc836bd3-f6e6-404c-b52d-2b45590cc0fb" xlink:to="loc_lgnd_NumberOfSharesSoldOfEquityMethodInvestee_2177fee4-4a55-483e-b408-3fb95ab6b2f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#AcquisitionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/AcquisitionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_b6e36dd9-c7ef-4816-873e-3bb353604c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_85b16c48-2591-4148-be0a-a680c1c3dc72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_b6e36dd9-c7ef-4816-873e-3bb353604c3a" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_85b16c48-2591-4148-be0a-a680c1c3dc72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_503754c2-4594-49dc-bddd-a260d4d32a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_85b16c48-2591-4148-be0a-a680c1c3dc72" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_503754c2-4594-49dc-bddd-a260d4d32a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bf636bf7-6b70-4f81-bd09-fd41c80fd69b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_503754c2-4594-49dc-bddd-a260d4d32a0c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bf636bf7-6b70-4f81-bd09-fd41c80fd69b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_dcfd2627-512a-445c-8ddb-df9bed80769e" xlink:href="lgnd-20221231.xsd#lgnd_PfenexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bf636bf7-6b70-4f81-bd09-fd41c80fd69b" xlink:to="loc_lgnd_PfenexMember_dcfd2627-512a-445c-8ddb-df9bed80769e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ef99d9cb-4d27-4873-b89f-9b4fdafbd522" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_85b16c48-2591-4148-be0a-a680c1c3dc72" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ef99d9cb-4d27-4873-b89f-9b4fdafbd522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_43f5f831-1ecd-464a-82e9-a53f2d707a9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ef99d9cb-4d27-4873-b89f-9b4fdafbd522" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_43f5f831-1ecd-464a-82e9-a53f2d707a9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_2fe153e7-240b-4a3d-85d4-a0c3b925cc6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_43f5f831-1ecd-464a-82e9-a53f2d707a9e" xlink:to="loc_us-gaap_CustomerRelationshipsMember_2fe153e7-240b-4a3d-85d4-a0c3b925cc6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_53ae2b8d-158a-44c0-8cf7-a127021d8664" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_85b16c48-2591-4148-be0a-a680c1c3dc72" xlink:to="loc_srt_RangeAxis_53ae2b8d-158a-44c0-8cf7-a127021d8664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e8bece7a-fa0c-4e6a-9986-876000042621" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_53ae2b8d-158a-44c0-8cf7-a127021d8664" xlink:to="loc_srt_RangeMember_e8bece7a-fa0c-4e6a-9986-876000042621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b15cac03-cbd0-4402-9342-427e045b4d31" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e8bece7a-fa0c-4e6a-9986-876000042621" xlink:to="loc_srt_MinimumMember_b15cac03-cbd0-4402-9342-427e045b4d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_26b13b91-50df-4f77-af96-97186388a61a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e8bece7a-fa0c-4e6a-9986-876000042621" xlink:to="loc_srt_MaximumMember_26b13b91-50df-4f77-af96-97186388a61a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_5d5aebf0-51cc-46c3-a672-2b16c8745fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_85b16c48-2591-4148-be0a-a680c1c3dc72" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_5d5aebf0-51cc-46c3-a672-2b16c8745fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_7cd887cb-020e-4258-af21-607494c54740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_5d5aebf0-51cc-46c3-a672-2b16c8745fb7" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_7cd887cb-020e-4258-af21-607494c54740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_b708e261-0bbc-415f-b17f-bc67e6c42387" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_7cd887cb-020e-4258-af21-607494c54740" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_b708e261-0bbc-415f-b17f-bc67e6c42387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_85b16c48-2591-4148-be0a-a680c1c3dc72" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfAcquisitions_eaa87609-42aa-4749-b95c-572b98da4653" xlink:href="lgnd-20221231.xsd#lgnd_NumberOfAcquisitions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:to="loc_lgnd_NumberOfAcquisitions_eaa87609-42aa-4749-b95c-572b98da4653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_b7c25091-7a4b-45b0-b950-d6a6faf272cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_b7c25091-7a4b-45b0-b950-d6a6faf272cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_78ac6190-0920-4784-a893-d0a69ff3af4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_78ac6190-0920-4784-a893-d0a69ff3af4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_58ab1f09-1805-4677-9cb2-f2b597ed7af0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_58ab1f09-1805-4677-9cb2-f2b597ed7af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_9884124b-72e9-47f5-9395-b4b586085e7f" xlink:href="lgnd-20221231.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_9884124b-72e9-47f5-9395-b4b586085e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_ec70f951-de26-49d0-b959-2f9abd86ca55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_ec70f951-de26-49d0-b959-2f9abd86ca55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_87aa3df5-c100-4da9-be0b-577c98109344" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_87aa3df5-c100-4da9-be0b-577c98109344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_05ddec26-e430-4db2-91cc-b7b70697fa65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_05ddec26-e430-4db2-91cc-b7b70697fa65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_cc8f53ed-b162-435b-b6b8-7b82c4dfb476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:to="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_cc8f53ed-b162-435b-b6b8-7b82c4dfb476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions_ccd08933-7cde-43ff-9e38-5327fe281e66" xlink:href="lgnd-20221231.xsd#lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:to="loc_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions_ccd08933-7cde-43ff-9e38-5327fe281e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_2d802439-b883-44e1-bd0a-2b188489112f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_2d802439-b883-44e1-bd0a-2b188489112f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_78530266-7f16-4c59-bdf5-fa4e220cf706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_78530266-7f16-4c59-bdf5-fa4e220cf706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_933913e8-6ca9-4b81-9829-e80a59a3a798" xlink:href="lgnd-20221231.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_933913e8-6ca9-4b81-9829-e80a59a3a798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_4a875d0b-3286-4193-95f3-d2b729b1e8b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_4a875d0b-3286-4193-95f3-d2b729b1e8b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_5a6f6c0a-348c-4c77-93c1-b399256496ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_5a6f6c0a-348c-4c77-93c1-b399256496ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_eea60cf1-928b-4d09-a295-422fee35b4b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45ad9ce3-7e79-426b-a1b1-d9e3ee069b2b" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_eea60cf1-928b-4d09-a295-422fee35b4b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_1fcc9fb8-48a3-4802-92d3-bf2ee35d8efc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5a3830ff-a4eb-4f64-9a5a-33e053f56b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_1fcc9fb8-48a3-4802-92d3-bf2ee35d8efc" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5a3830ff-a4eb-4f64-9a5a-33e053f56b5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_52551e59-50fe-4b84-841a-e61f8398d5bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5a3830ff-a4eb-4f64-9a5a-33e053f56b5f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_52551e59-50fe-4b84-841a-e61f8398d5bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7320ba86-d666-4ef3-b59a-0eb310b0bfda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_52551e59-50fe-4b84-841a-e61f8398d5bd" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7320ba86-d666-4ef3-b59a-0eb310b0bfda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_d4cea8f7-599f-4957-b942-99b71184263a" xlink:href="lgnd-20221231.xsd#lgnd_PfenexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7320ba86-d666-4ef3-b59a-0eb310b0bfda" xlink:to="loc_lgnd_PfenexMember_d4cea8f7-599f-4957-b942-99b71184263a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_01ee6341-7209-452b-bb0e-d6a78beeeb7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5a3830ff-a4eb-4f64-9a5a-33e053f56b5f" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_01ee6341-7209-452b-bb0e-d6a78beeeb7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_45d097fe-d345-4426-a096-a390e2584e88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01ee6341-7209-452b-bb0e-d6a78beeeb7a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_45d097fe-d345-4426-a096-a390e2584e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_c1d9ee88-6138-4217-ba5c-066930616e47" xlink:href="lgnd-20221231.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01ee6341-7209-452b-bb0e-d6a78beeeb7a" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_c1d9ee88-6138-4217-ba5c-066930616e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_cbec8e3b-1b2e-4a9b-8668-c3f837f740bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01ee6341-7209-452b-bb0e-d6a78beeeb7a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_cbec8e3b-1b2e-4a9b-8668-c3f837f740bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_8f7630c4-4e5c-4a93-9611-d97f1d3e2058" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01ee6341-7209-452b-bb0e-d6a78beeeb7a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_8f7630c4-4e5c-4a93-9611-d97f1d3e2058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_533205a0-1517-42de-bfed-3f38a99c25ef" xlink:href="lgnd-20221231.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01ee6341-7209-452b-bb0e-d6a78beeeb7a" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_533205a0-1517-42de-bfed-3f38a99c25ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_1c57c6f3-1c7d-4b63-b63a-3be6e9126259" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01ee6341-7209-452b-bb0e-d6a78beeeb7a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_1c57c6f3-1c7d-4b63-b63a-3be6e9126259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_95c4f55b-c73d-4d79-b1fa-446ce4134edd" xlink:href="lgnd-20221231.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01ee6341-7209-452b-bb0e-d6a78beeeb7a" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_95c4f55b-c73d-4d79-b1fa-446ce4134edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6476fc8e-95d7-441d-bea1-b96cb2f6e2df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01ee6341-7209-452b-bb0e-d6a78beeeb7a" xlink:to="loc_us-gaap_Goodwill_6476fc8e-95d7-441d-bea1-b96cb2f6e2df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_0bc73f55-475d-4712-9bb1-011078dd8f38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01ee6341-7209-452b-bb0e-d6a78beeeb7a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_0bc73f55-475d-4712-9bb1-011078dd8f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_27c36011-1f71-4c04-8276-b2be17548a61" xlink:href="lgnd-20221231.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01ee6341-7209-452b-bb0e-d6a78beeeb7a" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_27c36011-1f71-4c04-8276-b2be17548a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_115de1b8-5ca6-4f50-ba26-a87cc8d383fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01ee6341-7209-452b-bb0e-d6a78beeeb7a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_115de1b8-5ca6-4f50-ba26-a87cc8d383fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_79764742-7fc9-456a-bd0f-30be80dd61c9" xlink:href="lgnd-20221231.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01ee6341-7209-452b-bb0e-d6a78beeeb7a" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_79764742-7fc9-456a-bd0f-30be80dd61c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_dada0c8f-7a85-4ff4-9723-fa88c251868f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01ee6341-7209-452b-bb0e-d6a78beeeb7a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_dada0c8f-7a85-4ff4-9723-fa88c251868f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_66369e0e-3502-4503-bafa-ab5d771bdec9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01ee6341-7209-452b-bb0e-d6a78beeeb7a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_66369e0e-3502-4503-bafa-ab5d771bdec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_08a23fb7-d535-4e5a-82c4-e3890467ec3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01ee6341-7209-452b-bb0e-d6a78beeeb7a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_08a23fb7-d535-4e5a-82c4-e3890467ec3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsIntangiblesAcquiredandWeightedAverageUsefulLifeDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#AcquisitionsIntangiblesAcquiredandWeightedAverageUsefulLifeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/AcquisitionsIntangiblesAcquiredandWeightedAverageUsefulLifeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_75b6fb20-2fb1-473b-8251-26d91f821212" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4e39b724-224f-4e4e-b9c3-46c0116f0e03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_75b6fb20-2fb1-473b-8251-26d91f821212" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4e39b724-224f-4e4e-b9c3-46c0116f0e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ef1bbb13-da6e-4b82-936e-7b5e4ecb00c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4e39b724-224f-4e4e-b9c3-46c0116f0e03" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ef1bbb13-da6e-4b82-936e-7b5e4ecb00c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_838ad7a3-bdf7-41c8-8889-5f43dc4ae452" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ef1bbb13-da6e-4b82-936e-7b5e4ecb00c5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_838ad7a3-bdf7-41c8-8889-5f43dc4ae452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_b9097038-1309-4393-93ed-1c1468ad9af4" xlink:href="lgnd-20221231.xsd#lgnd_PfenexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_838ad7a3-bdf7-41c8-8889-5f43dc4ae452" xlink:to="loc_lgnd_PfenexMember_b9097038-1309-4393-93ed-1c1468ad9af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_986e25ca-7ad9-4bf4-b98b-8c01eb5a5bcc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4e39b724-224f-4e4e-b9c3-46c0116f0e03" xlink:to="loc_srt_RangeAxis_986e25ca-7ad9-4bf4-b98b-8c01eb5a5bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b55d0bd2-203b-497b-a889-b3b061e2bac8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_986e25ca-7ad9-4bf4-b98b-8c01eb5a5bcc" xlink:to="loc_srt_RangeMember_b55d0bd2-203b-497b-a889-b3b061e2bac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ff9bbc85-2898-4654-8c63-265e20142d8f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b55d0bd2-203b-497b-a889-b3b061e2bac8" xlink:to="loc_srt_MinimumMember_ff9bbc85-2898-4654-8c63-265e20142d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5932aba8-512e-4f2f-a7d1-f05a801651db" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b55d0bd2-203b-497b-a889-b3b061e2bac8" xlink:to="loc_srt_MaximumMember_5932aba8-512e-4f2f-a7d1-f05a801651db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_29412078-7aa8-4d50-b5ed-3505cc17b122" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4e39b724-224f-4e4e-b9c3-46c0116f0e03" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_29412078-7aa8-4d50-b5ed-3505cc17b122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1e86cdb-2474-423a-b020-aad9ca1903cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_29412078-7aa8-4d50-b5ed-3505cc17b122" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1e86cdb-2474-423a-b020-aad9ca1903cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractualRelationshipsAlvogenMember_a9546e7c-a7e1-4b51-a808-980904747a5e" xlink:href="lgnd-20221231.xsd#lgnd_ContractualRelationshipsAlvogenMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1e86cdb-2474-423a-b020-aad9ca1903cc" xlink:to="loc_lgnd_ContractualRelationshipsAlvogenMember_a9546e7c-a7e1-4b51-a808-980904747a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractualRelationshipsMerckMember_99783993-cf7c-4972-b6f0-c01881d76595" xlink:href="lgnd-20221231.xsd#lgnd_ContractualRelationshipsMerckMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1e86cdb-2474-423a-b020-aad9ca1903cc" xlink:to="loc_lgnd_ContractualRelationshipsMerckMember_99783993-cf7c-4972-b6f0-c01881d76595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractualRelationshipsJazzMember_34b48dce-e054-4ca2-af33-0b6080f112c6" xlink:href="lgnd-20221231.xsd#lgnd_ContractualRelationshipsJazzMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1e86cdb-2474-423a-b020-aad9ca1903cc" xlink:to="loc_lgnd_ContractualRelationshipsJazzMember_34b48dce-e054-4ca2-af33-0b6080f112c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractualRelationshipsSIIMember_209da249-9257-40e2-9090-dca7c3c0c1ec" xlink:href="lgnd-20221231.xsd#lgnd_ContractualRelationshipsSIIMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1e86cdb-2474-423a-b020-aad9ca1903cc" xlink:to="loc_lgnd_ContractualRelationshipsSIIMember_209da249-9257-40e2-9090-dca7c3c0c1ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractualRelationshipsArcellxMember_c3537299-11e9-45d4-be91-4d8f4114ed85" xlink:href="lgnd-20221231.xsd#lgnd_ContractualRelationshipsArcellxMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1e86cdb-2474-423a-b020-aad9ca1903cc" xlink:to="loc_lgnd_ContractualRelationshipsArcellxMember_c3537299-11e9-45d4-be91-4d8f4114ed85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_97b7afce-d791-447c-8bff-330f46ed3842" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1e86cdb-2474-423a-b020-aad9ca1903cc" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_97b7afce-d791-447c-8bff-330f46ed3842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_52af3684-19e2-4265-9047-6c1249e93f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4e39b724-224f-4e4e-b9c3-46c0116f0e03" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_52af3684-19e2-4265-9047-6c1249e93f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_5b31d46b-f841-41b4-b3db-768f6b152a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_52af3684-19e2-4265-9047-6c1249e93f9a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_5b31d46b-f841-41b4-b3db-768f6b152a7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_85bd3ee7-0f76-4632-8635-617ff5335eac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_52af3684-19e2-4265-9047-6c1249e93f9a" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_85bd3ee7-0f76-4632-8635-617ff5335eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#AcquisitionsProFormaFinancialInformationDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_c2cd74f8-1cd1-4da8-bf40-2ce942172d08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_663a372e-9f92-4ae2-94c9-c5e80440ee77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_c2cd74f8-1cd1-4da8-bf40-2ce942172d08" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_663a372e-9f92-4ae2-94c9-c5e80440ee77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_717451d3-5acd-47a8-92e6-6da05fe1f322" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_663a372e-9f92-4ae2-94c9-c5e80440ee77" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_717451d3-5acd-47a8-92e6-6da05fe1f322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7c7a8b39-5e1d-4d13-8836-dcb554f9742a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_717451d3-5acd-47a8-92e6-6da05fe1f322" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7c7a8b39-5e1d-4d13-8836-dcb554f9742a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_6d962612-3bf9-473d-8b59-f0e341d5ddce" xlink:href="lgnd-20221231.xsd#lgnd_PfenexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7c7a8b39-5e1d-4d13-8836-dcb554f9742a" xlink:to="loc_lgnd_PfenexMember_6d962612-3bf9-473d-8b59-f0e341d5ddce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_6776f679-e7f9-4864-bf00-e9252bed767d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_663a372e-9f92-4ae2-94c9-c5e80440ee77" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_6776f679-e7f9-4864-bf00-e9252bed767d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_d26a454a-52c9-46e4-878f-ac4e3b11f896" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6776f679-e7f9-4864-bf00-e9252bed767d" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_d26a454a-52c9-46e4-878f-ac4e3b11f896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_85c149d8-f735-43c2-b3c4-832dea91bc8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6776f679-e7f9-4864-bf00-e9252bed767d" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_85c149d8-f735-43c2-b3c4-832dea91bc8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareProFormaAbstract_0e310caf-347b-4366-9b77-0a7e529287b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareProFormaAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6776f679-e7f9-4864-bf00-e9252bed767d" xlink:to="loc_us-gaap_EarningsPerShareProFormaAbstract_0e310caf-347b-4366-9b77-0a7e529287b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_0a86431f-2505-4a7c-9a84-895658dbe6ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareProFormaAbstract_0e310caf-347b-4366-9b77-0a7e529287b3" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_0a86431f-2505-4a7c-9a84-895658dbe6ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_196266e0-ad39-44f3-bb76-0e2e9aa0b271" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareProFormaAbstract_0e310caf-347b-4366-9b77-0a7e529287b3" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_196266e0-ad39-44f3-bb76-0e2e9aa0b271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_79dadb63-9748-46f3-b40e-4f4cce37ad9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_05b3670d-e910-4557-bc82-1ed686d159cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_79dadb63-9748-46f3-b40e-4f4cce37ad9d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_05b3670d-e910-4557-bc82-1ed686d159cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f8ac6e1f-bb80-452b-ae10-872226de4877" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_05b3670d-e910-4557-bc82-1ed686d159cd" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f8ac6e1f-bb80-452b-ae10-872226de4877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_b4361f4c-81e2-47fc-819c-ae7179b066a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f8ac6e1f-bb80-452b-ae10-872226de4877" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_b4361f4c-81e2-47fc-819c-ae7179b066a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_a27b5cf9-b0a5-463f-8aea-ad3d3372d9f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_b4361f4c-81e2-47fc-819c-ae7179b066a6" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_a27b5cf9-b0a5-463f-8aea-ad3d3372d9f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4a97dbc2-2db3-4d8f-ab5a-f21cc835ece3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_05b3670d-e910-4557-bc82-1ed686d159cd" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4a97dbc2-2db3-4d8f-ab5a-f21cc835ece3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ff970ccd-44ee-4900-ac18-79ff2bbc4c6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4a97dbc2-2db3-4d8f-ab5a-f21cc835ece3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ff970ccd-44ee-4900-ac18-79ff2bbc4c6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_e9118a9a-4d1a-47f7-a2b5-641e0f637fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ff970ccd-44ee-4900-ac18-79ff2bbc4c6f" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_e9118a9a-4d1a-47f7-a2b5-641e0f637fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_84631c73-58e1-46c5-a107-b714583e7b82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ff970ccd-44ee-4900-ac18-79ff2bbc4c6f" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_84631c73-58e1-46c5-a107-b714583e7b82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_e5efe54c-d66f-44c8-908e-f87f99f23b09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ff970ccd-44ee-4900-ac18-79ff2bbc4c6f" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_e5efe54c-d66f-44c8-908e-f87f99f23b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_19a4405b-9619-440b-ab6b-7646e0a0233c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_05b3670d-e910-4557-bc82-1ed686d159cd" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_19a4405b-9619-440b-ab6b-7646e0a0233c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e736a738-8d30-487b-b41c-847fab3cea21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_19a4405b-9619-440b-ab6b-7646e0a0233c" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e736a738-8d30-487b-b41c-847fab3cea21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_b3a282b0-0cf3-41c3-bbe4-90239bf5fa45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e736a738-8d30-487b-b41c-847fab3cea21" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_b3a282b0-0cf3-41c3-bbe4-90239bf5fa45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_a3b2996f-fe7b-4556-a37b-5d90465f4d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e736a738-8d30-487b-b41c-847fab3cea21" xlink:to="loc_us-gaap_EquitySecuritiesMember_a3b2996f-fe7b-4556-a37b-5d90465f4d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_4317090d-a3cc-4a0c-9f56-cd9839558d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_05b3670d-e910-4557-bc82-1ed686d159cd" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_4317090d-a3cc-4a0c-9f56-cd9839558d4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_844447b7-439e-4920-ba13-86e26b7cef86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_4317090d-a3cc-4a0c-9f56-cd9839558d4a" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_844447b7-439e-4920-ba13-86e26b7cef86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_7e2fb78e-b9ef-4a86-aea3-b6595fda0f92" xlink:href="lgnd-20221231.xsd#lgnd_LiabilityForContingentValueRightsCompanyCydexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_844447b7-439e-4920-ba13-86e26b7cef86" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_7e2fb78e-b9ef-4a86-aea3-b6595fda0f92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_a4831363-b998-4c2b-ac0e-000a78125d2f" xlink:href="lgnd-20221231.xsd#lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_844447b7-439e-4920-ba13-86e26b7cef86" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_a4831363-b998-4c2b-ac0e-000a78125d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_c38901cf-9a35-464a-b708-4d0cd1ef7699" xlink:href="lgnd-20221231.xsd#lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_844447b7-439e-4920-ba13-86e26b7cef86" xlink:to="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_c38901cf-9a35-464a-b708-4d0cd1ef7699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_04b5ac43-d273-49a2-9805-586ff3d93dce" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_05b3670d-e910-4557-bc82-1ed686d159cd" xlink:to="loc_srt_RangeAxis_04b5ac43-d273-49a2-9805-586ff3d93dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2c25aa0b-4c8e-4f57-b548-8f7f375e4d64" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_04b5ac43-d273-49a2-9805-586ff3d93dce" xlink:to="loc_srt_RangeMember_2c25aa0b-4c8e-4f57-b548-8f7f375e4d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ed3d0097-6241-4e9f-be9c-39f22c434416" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2c25aa0b-4c8e-4f57-b548-8f7f375e4d64" xlink:to="loc_srt_MaximumMember_ed3d0097-6241-4e9f-be9c-39f22c434416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_eba67d87-3758-4b01-8cb1-65d080eab78a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_05b3670d-e910-4557-bc82-1ed686d159cd" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_eba67d87-3758-4b01-8cb1-65d080eab78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_b291ca7c-24be-463e-9a69-e117bece0c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_eba67d87-3758-4b01-8cb1-65d080eab78a" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_b291ca7c-24be-463e-9a69-e117bece0c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_3e38e1ab-d0ce-44ef-b100-0c71095676c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_b291ca7c-24be-463e-9a69-e117bece0c0e" xlink:to="loc_us-gaap_TransferredOverTimeMember_3e38e1ab-d0ce-44ef-b100-0c71095676c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b3ab73f1-16f6-4e20-8ec4-c407bcc47d57" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_05b3670d-e910-4557-bc82-1ed686d159cd" xlink:to="loc_srt_ProductOrServiceAxis_b3ab73f1-16f6-4e20-8ec4-c407bcc47d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b11a03a0-2bcd-4dcc-b1dc-5edc50172466" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_b3ab73f1-16f6-4e20-8ec4-c407bcc47d57" xlink:to="loc_srt_ProductsAndServicesDomain_b11a03a0-2bcd-4dcc-b1dc-5edc50172466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_6cdf7ea7-b3f7-4c40-905d-868960b9a013" xlink:href="lgnd-20221231.xsd#lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b11a03a0-2bcd-4dcc-b1dc-5edc50172466" xlink:to="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_6cdf7ea7-b3f7-4c40-905d-868960b9a013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_Phase3ClinicalTrialMember_f49af4c8-72fc-4400-b520-a294becb3f9b" xlink:href="lgnd-20221231.xsd#lgnd_Phase3ClinicalTrialMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b11a03a0-2bcd-4dcc-b1dc-5edc50172466" xlink:to="loc_lgnd_Phase3ClinicalTrialMember_f49af4c8-72fc-4400-b520-a294becb3f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d382841f-dd1b-4de9-8caf-3b3b7b969568" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_05b3670d-e910-4557-bc82-1ed686d159cd" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d382841f-dd1b-4de9-8caf-3b3b7b969568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_f4d4ff35-0b7d-4ea7-b395-d690ab991121" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d382841f-dd1b-4de9-8caf-3b3b7b969568" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_f4d4ff35-0b7d-4ea7-b395-d690ab991121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_233ca7f8-652b-4585-abc8-5262f73bddd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d382841f-dd1b-4de9-8caf-3b3b7b969568" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_233ca7f8-652b-4585-abc8-5262f73bddd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfContingentValueRightAgreements_f62fad0d-1a7f-48d8-8737-352299a6711c" xlink:href="lgnd-20221231.xsd#lgnd_NumberOfContingentValueRightAgreements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d382841f-dd1b-4de9-8caf-3b3b7b969568" xlink:to="loc_lgnd_NumberOfContingentValueRightAgreements_f62fad0d-1a7f-48d8-8737-352299a6711c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_0242cf57-6db3-4db6-aca0-e3b636ddc7d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d382841f-dd1b-4de9-8caf-3b3b7b969568" xlink:to="loc_us-gaap_Investments_0242cf57-6db3-4db6-aca0-e3b636ddc7d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross_be09bb0f-e7ca-442d-877f-0ebfd9500064" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d382841f-dd1b-4de9-8caf-3b3b7b969568" xlink:to="loc_us-gaap_ContractWithCustomerAssetGross_be09bb0f-e7ca-442d-877f-0ebfd9500064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementReconciliationofLevel3FinancialInstrumentsDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#FairValueMeasurementReconciliationofLevel3FinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementReconciliationofLevel3FinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_84e73f7c-5c4e-4c95-af43-73ac841816a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_453c2da0-f9e3-4c91-9b87-d2c318604fca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_84e73f7c-5c4e-4c95-af43-73ac841816a0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_453c2da0-f9e3-4c91-9b87-d2c318604fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0abbef77-00dd-490c-9b6d-4647dad42c96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_453c2da0-f9e3-4c91-9b87-d2c318604fca" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0abbef77-00dd-490c-9b6d-4647dad42c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b9d65b35-b951-42cc-9482-6934c99e8b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0abbef77-00dd-490c-9b6d-4647dad42c96" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b9d65b35-b951-42cc-9482-6934c99e8b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a19439fc-7f05-44c5-9392-8eb7eb22b405" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b9d65b35-b951-42cc-9482-6934c99e8b9b" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a19439fc-7f05-44c5-9392-8eb7eb22b405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8d48234e-32e3-44d5-96c2-b742ca4e89f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_453c2da0-f9e3-4c91-9b87-d2c318604fca" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8d48234e-32e3-44d5-96c2-b742ca4e89f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_37245fde-e426-4f3d-9df3-e5ef84d25eab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8d48234e-32e3-44d5-96c2-b742ca4e89f5" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_37245fde-e426-4f3d-9df3-e5ef84d25eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3b03ef5a-05ce-45e0-9e8b-467ad59d33eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_37245fde-e426-4f3d-9df3-e5ef84d25eab" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3b03ef5a-05ce-45e0-9e8b-467ad59d33eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_6e7bac87-4b9f-430d-9a8d-828a672c3bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_37245fde-e426-4f3d-9df3-e5ef84d25eab" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_6e7bac87-4b9f-430d-9a8d-828a672c3bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHolders_810d3be4-c81c-4442-a6e9-c5de6bc34497" xlink:href="lgnd-20221231.xsd#lgnd_PaymentsToContingentValueRightHolders"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_37245fde-e426-4f3d-9df3-e5ef84d25eab" xlink:to="loc_lgnd_PaymentsToContingentValueRightHolders_810d3be4-c81c-4442-a6e9-c5de6bc34497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_065d0251-e571-4ce5-9bb0-6f06692bf670" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_37245fde-e426-4f3d-9df3-e5ef84d25eab" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_065d0251-e571-4ce5-9bb0-6f06692bf670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a999bf70-8911-4adc-8445-6cf7821198c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_bfe8b7a2-b167-47b6-8587-2d0a5e67a848" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a999bf70-8911-4adc-8445-6cf7821198c2" xlink:to="loc_us-gaap_AssetImpairmentCharges_bfe8b7a2-b167-47b6-8587-2d0a5e67a848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_c4248439-62db-44d6-b3d5-66a654e4477b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_f1099bd2-7500-4333-9c81-2cc8de963614" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c4248439-62db-44d6-b3d5-66a654e4477b" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_f1099bd2-7500-4333-9c81-2cc8de963614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_782d706f-c112-40ec-83f8-37482ed0b9d2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_f1099bd2-7500-4333-9c81-2cc8de963614" xlink:to="loc_srt_ProductOrServiceAxis_782d706f-c112-40ec-83f8-37482ed0b9d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8ca69da3-edf8-4804-a166-0628b1096543" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_782d706f-c112-40ec-83f8-37482ed0b9d2" xlink:to="loc_srt_ProductsAndServicesDomain_8ca69da3-edf8-4804-a166-0628b1096543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_5bf7daeb-6318-4ae4-8da9-318c12cd9d22" xlink:href="lgnd-20221231.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8ca69da3-edf8-4804-a166-0628b1096543" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_5bf7daeb-6318-4ae4-8da9-318c12cd9d22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_87586390-21f5-416e-a81d-760ae942fe59" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_f1099bd2-7500-4333-9c81-2cc8de963614" xlink:to="loc_srt_RangeAxis_87586390-21f5-416e-a81d-760ae942fe59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ae549b31-fba6-4436-a592-06441db1abcd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_87586390-21f5-416e-a81d-760ae942fe59" xlink:to="loc_srt_RangeMember_ae549b31-fba6-4436-a592-06441db1abcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_65159c6a-e660-4db2-8289-53faf3d14ca0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ae549b31-fba6-4436-a592-06441db1abcd" xlink:to="loc_srt_MaximumMember_65159c6a-e660-4db2-8289-53faf3d14ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_f1099bd2-7500-4333-9c81-2cc8de963614" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PurchaseCommitmentConsiderationPaidToDate_ba579f9d-9b22-4d83-b919-67f3eec2167f" xlink:href="lgnd-20221231.xsd#lgnd_PurchaseCommitmentConsiderationPaidToDate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_lgnd_PurchaseCommitmentConsiderationPaidToDate_ba579f9d-9b22-4d83-b919-67f3eec2167f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PurchaseCommitmentConsiderationPaidAllocatedToInventory_c0519444-73d8-4d0b-8fb6-93d650d53b37" xlink:href="lgnd-20221231.xsd#lgnd_PurchaseCommitmentConsiderationPaidAllocatedToInventory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_lgnd_PurchaseCommitmentConsiderationPaidAllocatedToInventory_c0519444-73d8-4d0b-8fb6-93d650d53b37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_bce2647a-b7ed-4eb9-a7ed-1b4db6e7084a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_bce2647a-b7ed-4eb9-a7ed-1b4db6e7084a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseImpairmentLoss_461982c6-707e-4304-8ed7-011f5265f87f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_us-gaap_FinanceLeaseImpairmentLoss_461982c6-707e-4304-8ed7-011f5265f87f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_1dc0ed12-640e-411e-b232-62e7ffb93c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_1dc0ed12-640e-411e-b232-62e7ffb93c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm_480d0672-003e-4a73-b5cc-e4b79a6fc62f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeaseRemainingLeaseTerm"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm_480d0672-003e-4a73-b5cc-e4b79a6fc62f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_34f0cfc7-7c3b-41a3-8a9a-f7001693ec64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_34f0cfc7-7c3b-41a3-8a9a-f7001693ec64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_37f0d5b3-6085-4c9a-aae9-ac46d9f2d232" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_37f0d5b3-6085-4c9a-aae9-ac46d9f2d232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_c8e22fb7-cf69-4e39-8756-0ef7af04b513" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_c8e22fb7-cf69-4e39-8756-0ef7af04b513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_aa4638d8-9a3e-4275-bfc6-c870524f317f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_aa4638d8-9a3e-4275-bfc6-c870524f317f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_0566960d-f185-47af-a6fc-d3e3d21e39a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_us-gaap_OperatingLeasePayments_0566960d-f185-47af-a6fc-d3e3d21e39a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_8adb6f7d-3899-49ad-b7e6-8ed3a3e99cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_us-gaap_OperatingLeaseExpense_8adb6f7d-3899-49ad-b7e6-8ed3a3e99cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_ae20f31d-b036-41a8-ba7f-42b19ed46986" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_us-gaap_SubleaseIncome_ae20f31d-b036-41a8-ba7f-42b19ed46986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_83db37fd-3303-42dc-94d6-c2d9acb91b42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_83db37fd-3303-42dc-94d6-c2d9acb91b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_ff9b3db0-d565-4b1a-84b7-f79f96e42c10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_ff9b3db0-d565-4b1a-84b7-f79f96e42c10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_b382400f-f046-428d-bd80-4d3ec5bc9af0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_b382400f-f046-428d-bd80-4d3ec5bc9af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_c262ed11-ebdd-45da-88a8-87787067480f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b67c00e-95a4-404b-a477-712ab718490f" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_c262ed11-ebdd-45da-88a8-87787067480f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_cb27b93f-2bb8-4e17-9688-8a18b862dac1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_03e35ef7-3ef0-496d-ad54-d87a3c995380" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cb27b93f-2bb8-4e17-9688-8a18b862dac1" xlink:to="loc_us-gaap_AssetsAbstract_03e35ef7-3ef0-496d-ad54-d87a3c995380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_be315764-9abc-4d7c-b446-61020fc47dae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_03e35ef7-3ef0-496d-ad54-d87a3c995380" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_be315764-9abc-4d7c-b446-61020fc47dae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_e24767fe-879b-4fc7-b18f-6d64435fbf8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_03e35ef7-3ef0-496d-ad54-d87a3c995380" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_e24767fe-879b-4fc7-b18f-6d64435fbf8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseRightOfUseAsset_b4592a26-d589-4e3f-9714-5770c35c209a" xlink:href="lgnd-20221231.xsd#lgnd_LeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_03e35ef7-3ef0-496d-ad54-d87a3c995380" xlink:to="loc_lgnd_LeaseRightOfUseAsset_b4592a26-d589-4e3f-9714-5770c35c209a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_a11c5c17-6b4a-41b9-babb-3b8441a63a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cb27b93f-2bb8-4e17-9688-8a18b862dac1" xlink:to="loc_us-gaap_LiabilitiesAbstract_a11c5c17-6b4a-41b9-babb-3b8441a63a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_04d66260-a570-4f6c-8e14-77d203bfcab0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_a11c5c17-6b4a-41b9-babb-3b8441a63a6a" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_04d66260-a570-4f6c-8e14-77d203bfcab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_cbbd9a3a-243b-4a2b-82ed-631bc36affd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_04d66260-a570-4f6c-8e14-77d203bfcab0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_cbbd9a3a-243b-4a2b-82ed-631bc36affd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_9276c625-6f93-4d62-8b2f-12938f86147d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_04d66260-a570-4f6c-8e14-77d203bfcab0" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_9276c625-6f93-4d62-8b2f-12938f86147d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiabilityCurrent_53fad676-5d72-4479-81b1-53646339cbf0" xlink:href="lgnd-20221231.xsd#lgnd_LeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_04d66260-a570-4f6c-8e14-77d203bfcab0" xlink:to="loc_lgnd_LeaseLiabilityCurrent_53fad676-5d72-4479-81b1-53646339cbf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_6c9fd994-d91e-44c9-99be-bc4ed3a6256c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_a11c5c17-6b4a-41b9-babb-3b8441a63a6a" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_6c9fd994-d91e-44c9-99be-bc4ed3a6256c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8dcaebeb-e8a1-48df-9fa1-c8d81e140d18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_6c9fd994-d91e-44c9-99be-bc4ed3a6256c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8dcaebeb-e8a1-48df-9fa1-c8d81e140d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_c7cd49ea-47c5-437d-9743-881ff6410a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_6c9fd994-d91e-44c9-99be-bc4ed3a6256c" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_c7cd49ea-47c5-437d-9743-881ff6410a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiability_1884d424-f60a-4574-a457-13098f4a8425" xlink:href="lgnd-20221231.xsd#lgnd_LeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_a11c5c17-6b4a-41b9-babb-3b8441a63a6a" xlink:to="loc_lgnd_LeaseLiability_1884d424-f60a-4574-a457-13098f4a8425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_c1d5a482-d5cc-496f-9fe5-c44c5b3b6d99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cb27b93f-2bb8-4e17-9688-8a18b862dac1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_c1d5a482-d5cc-496f-9fe5-c44c5b3b6d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_ab2869fb-0364-495c-8523-eff221fbec91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_c8ab407d-78d0-45de-8313-c6f4b9756791" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ab2869fb-0364-495c-8523-eff221fbec91" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_c8ab407d-78d0-45de-8313-c6f4b9756791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_496ed179-d666-4b2e-9365-2829b0ec4608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_c8ab407d-78d0-45de-8313-c6f4b9756791" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_496ed179-d666-4b2e-9365-2829b0ec4608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_4851bcc4-6f3f-46cc-bf25-65768e07f7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_c8ab407d-78d0-45de-8313-c6f4b9756791" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_4851bcc4-6f3f-46cc-bf25-65768e07f7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_337dd81c-f151-42bb-99a6-8d82cfb8f81a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_c8ab407d-78d0-45de-8313-c6f4b9756791" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_337dd81c-f151-42bb-99a6-8d82cfb8f81a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_e0365828-2be1-4522-bb3a-a1582088af57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_c8ab407d-78d0-45de-8313-c6f4b9756791" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_e0365828-2be1-4522-bb3a-a1582088af57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c2de4503-3d12-4779-9199-ea7fe87b4f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_c8ab407d-78d0-45de-8313-c6f4b9756791" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c2de4503-3d12-4779-9199-ea7fe87b4f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_1d51cefa-a8ad-4017-9826-91a632599adc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_c8ab407d-78d0-45de-8313-c6f4b9756791" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_1d51cefa-a8ad-4017-9826-91a632599adc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5eeb3ef7-b081-4d49-9bd6-6afd07ac97ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_c8ab407d-78d0-45de-8313-c6f4b9756791" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5eeb3ef7-b081-4d49-9bd6-6afd07ac97ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_ca4c4588-8ec2-4848-9c9d-dec2897c6d89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_c8ab407d-78d0-45de-8313-c6f4b9756791" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_ca4c4588-8ec2-4848-9c9d-dec2897c6d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_b0f031d6-e4b8-473a-8ab8-36a3886f6725" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_c8ab407d-78d0-45de-8313-c6f4b9756791" xlink:to="loc_us-gaap_OperatingLeaseLiability_b0f031d6-e4b8-473a-8ab8-36a3886f6725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_48eecafb-4c77-4ca3-b479-de32bd0e2c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ab2869fb-0364-495c-8523-eff221fbec91" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_48eecafb-4c77-4ca3-b479-de32bd0e2c0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_ffb8f50c-59d1-426e-b5e3-8b2a3ed40a97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_48eecafb-4c77-4ca3-b479-de32bd0e2c0b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_ffb8f50c-59d1-426e-b5e3-8b2a3ed40a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_54d8c0b2-627a-40e9-a8b7-59e43a1a0b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_48eecafb-4c77-4ca3-b479-de32bd0e2c0b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_54d8c0b2-627a-40e9-a8b7-59e43a1a0b5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_c2570344-7041-4a2e-885f-775bfd9828fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_48eecafb-4c77-4ca3-b479-de32bd0e2c0b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_c2570344-7041-4a2e-885f-775bfd9828fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_92bb939a-2d80-4664-8378-1b526c4cffa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_48eecafb-4c77-4ca3-b479-de32bd0e2c0b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_92bb939a-2d80-4664-8378-1b526c4cffa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_53df1473-9c64-4d4a-af49-3adfb9e0be50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_48eecafb-4c77-4ca3-b479-de32bd0e2c0b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_53df1473-9c64-4d4a-af49-3adfb9e0be50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_04b2a168-0d69-48a8-bfbc-cba5247bb9f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_48eecafb-4c77-4ca3-b479-de32bd0e2c0b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_04b2a168-0d69-48a8-bfbc-cba5247bb9f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_acb6e5d5-bea7-4f39-a3f3-23085fcdc379" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_48eecafb-4c77-4ca3-b479-de32bd0e2c0b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_acb6e5d5-bea7-4f39-a3f3-23085fcdc379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_2ae00f7b-b798-4023-b724-a9fb6b0f5c89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_48eecafb-4c77-4ca3-b479-de32bd0e2c0b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_2ae00f7b-b798-4023-b724-a9fb6b0f5c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_1f71993e-f7af-40eb-9ac5-9da50a0e580d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_48eecafb-4c77-4ca3-b479-de32bd0e2c0b" xlink:to="loc_us-gaap_FinanceLeaseLiability_1f71993e-f7af-40eb-9ac5-9da50a0e580d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="lgnd-20221231.xsd#LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#ConvertibleSeniorNotesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_fe1a67dc-e7e9-43ed-90fb-7230b9c2ab30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a2b33c3c-b516-49bd-8d37-edb764b343c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_fe1a67dc-e7e9-43ed-90fb-7230b9c2ab30" xlink:to="loc_us-gaap_DebtInstrumentTable_a2b33c3c-b516-49bd-8d37-edb764b343c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b8ea0f29-2357-4623-9e2f-9ebaafd373a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a2b33c3c-b516-49bd-8d37-edb764b343c8" xlink:to="loc_us-gaap_DebtInstrumentAxis_b8ea0f29-2357-4623-9e2f-9ebaafd373a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e26a1e2f-b4f3-45db-85c6-f5eeb9ad5595" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_b8ea0f29-2357-4623-9e2f-9ebaafd373a9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e26a1e2f-b4f3-45db-85c6-f5eeb9ad5595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_3cf56185-87fa-446f-b02b-70e408d24e6b" xlink:href="lgnd-20221231.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e26a1e2f-b4f3-45db-85c6-f5eeb9ad5595" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_3cf56185-87fa-446f-b02b-70e408d24e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7c34a05b-2f7d-42b8-abb5-b67ada1ff095" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a2b33c3c-b516-49bd-8d37-edb764b343c8" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7c34a05b-2f7d-42b8-abb5-b67ada1ff095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7d6a7940-44a1-4588-9a1d-1127d2faba8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7c34a05b-2f7d-42b8-abb5-b67ada1ff095" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7d6a7940-44a1-4588-9a1d-1127d2faba8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_da4bb743-5206-43db-a09e-14e4a07b097a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7d6a7940-44a1-4588-9a1d-1127d2faba8f" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_da4bb743-5206-43db-a09e-14e4a07b097a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_2bce5eab-f29c-468e-bc03-0beb4eae2820" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a2b33c3c-b516-49bd-8d37-edb764b343c8" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_2bce5eab-f29c-468e-bc03-0beb4eae2820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_1276d468-1984-446a-ac7b-99982d435dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_2bce5eab-f29c-468e-bc03-0beb4eae2820" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_1276d468-1984-446a-ac7b-99982d435dcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_7d47a29b-4ae5-47d4-9203-493e1a9eefbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_1276d468-1984-446a-ac7b-99982d435dcc" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_7d47a29b-4ae5-47d4-9203-493e1a9eefbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_0eb212b6-5102-44bd-a059-b1b8cd689e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_1276d468-1984-446a-ac7b-99982d435dcc" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_0eb212b6-5102-44bd-a059-b1b8cd689e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ea4939b8-c13b-49cf-9861-d6f3a773d953" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a2b33c3c-b516-49bd-8d37-edb764b343c8" xlink:to="loc_srt_RangeAxis_ea4939b8-c13b-49cf-9861-d6f3a773d953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ea4821fb-0bfa-4e2d-9135-725c24c77869" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_ea4939b8-c13b-49cf-9861-d6f3a773d953" xlink:to="loc_srt_RangeMember_ea4821fb-0bfa-4e2d-9135-725c24c77869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7257b9ba-b4f8-4932-bff0-0fa13246c992" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ea4821fb-0bfa-4e2d-9135-725c24c77869" xlink:to="loc_srt_MaximumMember_7257b9ba-b4f8-4932-bff0-0fa13246c992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis_856416bf-3d5a-4bf7-869f-3477cc50ac8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a2b33c3c-b516-49bd-8d37-edb764b343c8" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAxis_856416bf-3d5a-4bf7-869f-3477cc50ac8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_cd689a73-b992-4726-a658-54c0ad0ae660" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_856416bf-3d5a-4bf7-869f-3477cc50ac8a" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_cd689a73-b992-4726-a658-54c0ad0ae660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember_d55bb734-25f3-4e72-8261-30b0105f1996" xlink:href="lgnd-20221231.xsd#lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_cd689a73-b992-4726-a658-54c0ad0ae660" xlink:to="loc_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember_d55bb734-25f3-4e72-8261-30b0105f1996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a2b33c3c-b516-49bd-8d37-edb764b343c8" xlink:to="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_aa99765d-b9c1-42ec-aa2d-b08a8b4bc896" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_aa99765d-b9c1-42ec-aa2d-b08a8b4bc896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c571e1c1-bfc9-46a7-8d79-c2d5434438d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c571e1c1-bfc9-46a7-8d79-c2d5434438d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_4f8a3598-4041-4f11-89a4-90f494e2063f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_4f8a3598-4041-4f11-89a4-90f494e2063f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_cd539a7e-0ae1-449e-9b04-c84dcf0f25dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_cd539a7e-0ae1-449e-9b04-c84dcf0f25dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_93455951-dea3-418d-9879-43785a9e821c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_93455951-dea3-418d-9879-43785a9e821c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_aa60ec46-2dc7-4da4-88d8-048cd975ac1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_aa60ec46-2dc7-4da4-88d8-048cd975ac1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_ed7b9886-ecd6-47bd-acfe-7649c808815f" xlink:href="lgnd-20221231.xsd#lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_ed7b9886-ecd6-47bd-acfe-7649c808815f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_1c423ddb-1949-4f58-a2f0-390422b868a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_1c423ddb-1949-4f58-a2f0-390422b868a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_177f6838-4202-461b-825d-d19f4f7dff89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_177f6838-4202-461b-825d-d19f4f7dff89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_199a6345-b14a-4ee7-9266-d7a3df44d125" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_199a6345-b14a-4ee7-9266-d7a3df44d125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_06d3e893-e0ba-4695-8e09-5c1881ac7186" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_06d3e893-e0ba-4695-8e09-5c1881ac7186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_5167a44e-496a-4ec4-8e36-96f93a2dbfc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_5167a44e-496a-4ec4-8e36-96f93a2dbfc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_d4121478-bf53-4b0c-a3b5-57d5cd283a94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_d4121478-bf53-4b0c-a3b5-57d5cd283a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_7304ddb1-d599-4dbc-9cf8-f7e912894cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_InterestExpenseDebt_7304ddb1-d599-4dbc-9cf8-f7e912894cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_3345b020-360c-4999-b7b9-aa53576f34f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_3345b020-360c-4999-b7b9-aa53576f34f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_974631f4-bbd5-4661-8124-b6a428ee7d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_974631f4-bbd5-4661-8124-b6a428ee7d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_835249a5-ab89-4764-92bf-2a06fd2bc6d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_835249a5-ab89-4764-92bf-2a06fd2bc6d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_d881d10b-59e1-4cd5-9a1e-097ac983ac7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_d881d10b-59e1-4cd5-9a1e-097ac983ac7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RepaymentsOfNotesPayableInterestPortion_7066db25-1b01-423b-9db5-bbb4f757ca20" xlink:href="lgnd-20221231.xsd#lgnd_RepaymentsOfNotesPayableInterestPortion"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_lgnd_RepaymentsOfNotesPayableInterestPortion_7066db25-1b01-423b-9db5-bbb4f757ca20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_bd336b96-82a2-45fe-9b5d-7872310f03f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_bd336b96-82a2-45fe-9b5d-7872310f03f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IncreaseDecreaseInDebtDiscount_9494841c-01b1-449a-867f-d570225f8b3c" xlink:href="lgnd-20221231.xsd#lgnd_IncreaseDecreaseInDebtDiscount"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_lgnd_IncreaseDecreaseInDebtDiscount_9494841c-01b1-449a-867f-d570225f8b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_f4ec11e8-3c88-47cb-bcc9-ae2b21d564be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_f4ec11e8-3c88-47cb-bcc9-ae2b21d564be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_b729e647-dfeb-40ec-be09-476d67c9c007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_b729e647-dfeb-40ec-be09-476d67c9c007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_342ec888-b789-4446-9d08-e7c5964cc43d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_342ec888-b789-4446-9d08-e7c5964cc43d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsforConvertibleBondHedges_6ed1a42c-ce32-4ce4-8fbe-d4a5138ac25e" xlink:href="lgnd-20221231.xsd#lgnd_PaymentsforConvertibleBondHedges"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_lgnd_PaymentsforConvertibleBondHedges_6ed1a42c-ce32-4ce4-8fbe-d4a5138ac25e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_7bccd83a-a38a-4475-8685-6de771b80256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_7bccd83a-a38a-4475-8685-6de771b80256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_752c9f8e-f817-42a4-978a-2cc410a68c52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_752c9f8e-f817-42a4-978a-2cc410a68c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToUnwindWarrants_6389a3f3-95d0-4e67-b0ee-59374d2cd729" xlink:href="lgnd-20221231.xsd#lgnd_PaymentsToUnwindWarrants"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_lgnd_PaymentsToUnwindWarrants_6389a3f3-95d0-4e67-b0ee-59374d2cd729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges_f1c84c63-9376-4e96-968a-88cf78aa9a3a" xlink:href="lgnd-20221231.xsd#lgnd_ProceedsFromUnwindingConvertibleBondHedges"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges_f1c84c63-9376-4e96-968a-88cf78aa9a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges_b746439b-9db3-48c1-9dee-2576742e874d" xlink:href="lgnd-20221231.xsd#lgnd_NumberOfOptionsUnderConvertibleBondHedges"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges_b746439b-9db3-48c1-9dee-2576742e874d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod_e7dfa41c-e70f-44ad-8a64-73c0cb465265" xlink:href="lgnd-20221231.xsd#lgnd_DebtInstrumentRepurchasedAmountDuringPeriod"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ebbbf1f-76c4-47b2-81c4-c49f45f81cf9" xlink:to="loc_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod_e7dfa41c-e70f-44ad-8a64-73c0cb465265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesEquityandLiabilityComponentsofFinancingArrangementsDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#ConvertibleSeniorNotesEquityandLiabilityComponentsofFinancingArrangementsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesEquityandLiabilityComponentsofFinancingArrangementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_9390bf5d-7b14-4c50-8b94-c96b8d93a03a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_770b823f-9678-469b-9931-8cb62d7a0b09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9390bf5d-7b14-4c50-8b94-c96b8d93a03a" xlink:to="loc_us-gaap_DebtInstrumentTable_770b823f-9678-469b-9931-8cb62d7a0b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8731e57d-01f4-49e4-81aa-8ac059e7d0f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_770b823f-9678-469b-9931-8cb62d7a0b09" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8731e57d-01f4-49e4-81aa-8ac059e7d0f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_dd6b8ce1-4171-4fef-ae07-0fb872e8bd2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8731e57d-01f4-49e4-81aa-8ac059e7d0f2" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_dd6b8ce1-4171-4fef-ae07-0fb872e8bd2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_f8bd6936-acf3-45d0-b397-4de7ebec9d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_dd6b8ce1-4171-4fef-ae07-0fb872e8bd2b" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_f8bd6936-acf3-45d0-b397-4de7ebec9d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8745a52c-04d9-468e-9cdb-c97ee563515f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_770b823f-9678-469b-9931-8cb62d7a0b09" xlink:to="loc_us-gaap_DebtInstrumentAxis_8745a52c-04d9-468e-9cdb-c97ee563515f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_77012c16-80ab-4192-bdfe-726d96fa0270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_8745a52c-04d9-468e-9cdb-c97ee563515f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_77012c16-80ab-4192-bdfe-726d96fa0270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_68659ae2-717c-4478-b768-95266e2a3ee6" xlink:href="lgnd-20221231.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_77012c16-80ab-4192-bdfe-726d96fa0270" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_68659ae2-717c-4478-b768-95266e2a3ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f3f83292-5834-49b2-98e8-507893aeb1d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_770b823f-9678-469b-9931-8cb62d7a0b09" xlink:to="loc_us-gaap_DebtInstrumentLineItems_f3f83292-5834-49b2-98e8-507893aeb1d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_f44cbc7b-ab76-4676-a023-3d6c05183b75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f3f83292-5834-49b2-98e8-507893aeb1d4" xlink:to="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_f44cbc7b-ab76-4676-a023-3d6c05183b75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_fdf84c53-1ebb-49ef-a4ad-c5028cd086fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_f44cbc7b-ab76-4676-a023-3d6c05183b75" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_fdf84c53-1ebb-49ef-a4ad-c5028cd086fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_17b826df-f1ec-453d-9b49-c89708f7ec28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_f44cbc7b-ab76-4676-a023-3d6c05183b75" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_17b826df-f1ec-453d-9b49-c89708f7ec28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_47250a1c-07c3-4500-b556-bc3b495db665" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_f44cbc7b-ab76-4676-a023-3d6c05183b75" xlink:to="loc_us-gaap_LongTermNotesPayable_47250a1c-07c3-4500-b556-bc3b495db665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_4daf9d23-4fe6-4e4c-bc66-ae99f67a9414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f3f83292-5834-49b2-98e8-507893aeb1d4" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_4daf9d23-4fe6-4e4c-bc66-ae99f67a9414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BalanceSheetAccountDetailsInvestmentCategoriesDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BalanceSheetAccountDetailsInvestmentCategoriesDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BalanceSheetAccountDetailsInvestmentCategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OtherBalanceSheetDetailsAbstract_230fa65b-ceb3-449d-82f2-5f95ed13aa14" xlink:href="lgnd-20221231.xsd#lgnd_OtherBalanceSheetDetailsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_120aab02-696f-4c28-8d85-bc8adb127c1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_OtherBalanceSheetDetailsAbstract_230fa65b-ceb3-449d-82f2-5f95ed13aa14" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_120aab02-696f-4c28-8d85-bc8adb127c1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_391a308a-aa36-4cf6-9174-3e1b17a340fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_120aab02-696f-4c28-8d85-bc8adb127c1a" xlink:to="loc_us-gaap_FinancialInstrumentAxis_391a308a-aa36-4cf6-9174-3e1b17a340fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0dc96836-3506-4574-82c2-be05342aad67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_391a308a-aa36-4cf6-9174-3e1b17a340fd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0dc96836-3506-4574-82c2-be05342aad67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_a93c2e55-2821-46ca-afcb-d1819d434399" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MutualFundMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0dc96836-3506-4574-82c2-be05342aad67" xlink:to="loc_us-gaap_MutualFundMember_a93c2e55-2821-46ca-afcb-d1819d434399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositsMember_1139e5cd-1c75-48eb-ac21-cd94b5cca127" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DemandDepositsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0dc96836-3506-4574-82c2-be05342aad67" xlink:to="loc_us-gaap_DemandDepositsMember_1139e5cd-1c75-48eb-ac21-cd94b5cca127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_8172d3f4-3afc-4b62-afba-aa23df041498" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0dc96836-3506-4574-82c2-be05342aad67" xlink:to="loc_us-gaap_CommercialPaperMember_8172d3f4-3afc-4b62-afba-aa23df041498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_a35dc08a-d0f2-410b-a7c2-339f4b3f7f32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0dc96836-3506-4574-82c2-be05342aad67" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_a35dc08a-d0f2-410b-a7c2-339f4b3f7f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_194142b5-8cab-4505-8651-1c686be248f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0dc96836-3506-4574-82c2-be05342aad67" xlink:to="loc_us-gaap_EquitySecuritiesMember_194142b5-8cab-4505-8651-1c686be248f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_2b3ddf8e-fdb2-4c06-b9c6-26322cd91d69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0dc96836-3506-4574-82c2-be05342aad67" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_2b3ddf8e-fdb2-4c06-b9c6-26322cd91d69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_4bd08a7d-bcae-44cb-8cbf-31be743be5c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0dc96836-3506-4574-82c2-be05342aad67" xlink:to="loc_us-gaap_WarrantMember_4bd08a7d-bcae-44cb-8cbf-31be743be5c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4190d53e-964e-46dc-b79a-8478e26a413b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_120aab02-696f-4c28-8d85-bc8adb127c1a" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4190d53e-964e-46dc-b79a-8478e26a413b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b1af3877-2451-4f62-ba99-999da2a3e602" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4190d53e-964e-46dc-b79a-8478e26a413b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b1af3877-2451-4f62-ba99-999da2a3e602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_051c1baf-75c4-4a22-83e2-ad7a25fa6fab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4190d53e-964e-46dc-b79a-8478e26a413b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_051c1baf-75c4-4a22-83e2-ad7a25fa6fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_72cb73b9-6795-4773-93fa-0d8da4232c98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4190d53e-964e-46dc-b79a-8478e26a413b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_72cb73b9-6795-4773-93fa-0d8da4232c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_db3cd01d-f434-4664-bd53-04ec44cba513" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4190d53e-964e-46dc-b79a-8478e26a413b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_db3cd01d-f434-4664-bd53-04ec44cba513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BalanceSheetAccountDetailsNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BalanceSheetAccountDetailsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BalanceSheetAccountDetailsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OtherBalanceSheetDetailsAbstract_683d883c-1051-4939-a911-40c00097c21b" xlink:href="lgnd-20221231.xsd#lgnd_OtherBalanceSheetDetailsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_47ca758d-34f2-46e8-a0ce-3b739bbad338" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_OtherBalanceSheetDetailsAbstract_683d883c-1051-4939-a911-40c00097c21b" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_47ca758d-34f2-46e8-a0ce-3b739bbad338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cf45f0cd-53c1-46b8-8170-f3de5b9e5881" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_47ca758d-34f2-46e8-a0ce-3b739bbad338" xlink:to="loc_srt_RangeAxis_cf45f0cd-53c1-46b8-8170-f3de5b9e5881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_76406a75-5b95-45d9-8ef4-97f0957a25b8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_cf45f0cd-53c1-46b8-8170-f3de5b9e5881" xlink:to="loc_srt_RangeMember_76406a75-5b95-45d9-8ef4-97f0957a25b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_9d951658-ce3e-4920-a40d-5c74d84ff482" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_76406a75-5b95-45d9-8ef4-97f0957a25b8" xlink:to="loc_srt_MinimumMember_9d951658-ce3e-4920-a40d-5c74d84ff482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ba4168f4-e613-42ec-bec0-827364f67c6d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_76406a75-5b95-45d9-8ef4-97f0957a25b8" xlink:to="loc_srt_MaximumMember_ba4168f4-e613-42ec-bec0-827364f67c6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_92af5e42-c5d4-435a-a060-dce336976c83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_47ca758d-34f2-46e8-a0ce-3b739bbad338" xlink:to="loc_us-gaap_ScheduleOfInvestmentsLineItems_92af5e42-c5d4-435a-a060-dce336976c83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_6eb92ead-56fd-4762-9f06-1119bdecf656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92af5e42-c5d4-435a-a060-dce336976c83" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_6eb92ead-56fd-4762-9f06-1119bdecf656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_04dc3ae8-79df-4b9b-96e8-4a5b995df05d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92af5e42-c5d4-435a-a060-dce336976c83" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_04dc3ae8-79df-4b9b-96e8-4a5b995df05d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_25450193-8077-47c0-98e9-76a3a6a72d60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92af5e42-c5d4-435a-a060-dce336976c83" xlink:to="loc_us-gaap_Depreciation_25450193-8077-47c0-98e9-76a3a6a72d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_3af3444c-9e68-496b-8899-d960cef0c95e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92af5e42-c5d4-435a-a060-dce336976c83" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_3af3444c-9e68-496b-8899-d960cef0c95e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_11041038-d733-4ad6-a08b-84d6a875ebb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92af5e42-c5d4-435a-a060-dce336976c83" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_11041038-d733-4ad6-a08b-84d6a875ebb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c082031f-d554-4ee9-bb4a-3292bbf13685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92af5e42-c5d4-435a-a060-dce336976c83" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c082031f-d554-4ee9-bb4a-3292bbf13685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_e9071cc9-c0b8-4df1-9364-ac5d460bb1c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92af5e42-c5d4-435a-a060-dce336976c83" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_e9071cc9-c0b8-4df1-9364-ac5d460bb1c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_51c56679-61ac-49cc-b27e-2baa443dabeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92af5e42-c5d4-435a-a060-dce336976c83" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_51c56679-61ac-49cc-b27e-2baa443dabeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c77c4900-5371-4cfc-b042-8b3d06f8f4da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92af5e42-c5d4-435a-a060-dce336976c83" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c77c4900-5371-4cfc-b042-8b3d06f8f4da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_68152714-f886-40f4-a0f0-936451ac854f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92af5e42-c5d4-435a-a060-dce336976c83" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_68152714-f886-40f4-a0f0-936451ac854f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfContingentValueRightAgreements_19fc17a5-729e-4d9d-b847-c985a57997d1" xlink:href="lgnd-20221231.xsd#lgnd_NumberOfContingentValueRightAgreements"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92af5e42-c5d4-435a-a060-dce336976c83" xlink:to="loc_lgnd_NumberOfContingentValueRightAgreements_19fc17a5-729e-4d9d-b847-c985a57997d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OtherBalanceSheetDetailsAbstract_2e5dc737-9a17-4b3a-88b1-4e1c25079050" xlink:href="lgnd-20221231.xsd#lgnd_OtherBalanceSheetDetailsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_b6de0b23-f6bc-488a-ab59-20ea0b5ad527" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_OtherBalanceSheetDetailsAbstract_2e5dc737-9a17-4b3a-88b1-4e1c25079050" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_b6de0b23-f6bc-488a-ab59-20ea0b5ad527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_5bc4645a-5551-4ec6-a67a-c5ba0ae803a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_b6de0b23-f6bc-488a-ab59-20ea0b5ad527" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_5bc4645a-5551-4ec6-a67a-c5ba0ae803a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_c279f073-c6fd-41e0-a838-aa1e4d26e0de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_b6de0b23-f6bc-488a-ab59-20ea0b5ad527" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_c279f073-c6fd-41e0-a838-aa1e4d26e0de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_5b26f7ee-5c94-42ee-bd23-bf211110e2a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_b6de0b23-f6bc-488a-ab59-20ea0b5ad527" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_5b26f7ee-5c94-42ee-bd23-bf211110e2a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_e6cdbb14-71a5-40bd-b945-ff33e954ee77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_OtherBalanceSheetDetailsAbstract_2e5dc737-9a17-4b3a-88b1-4e1c25079050" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_e6cdbb14-71a5-40bd-b945-ff33e954ee77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_399ab594-1920-4207-8275-674a446662e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_e6cdbb14-71a5-40bd-b945-ff33e954ee77" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_399ab594-1920-4207-8275-674a446662e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_937362ec-2ccf-4d9e-b61e-4d8eada52e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_e6cdbb14-71a5-40bd-b945-ff33e954ee77" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_937362ec-2ccf-4d9e-b61e-4d8eada52e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_b6eadefa-ed09-457c-b161-69d7cc9ad17d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_e6cdbb14-71a5-40bd-b945-ff33e954ee77" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_b6eadefa-ed09-457c-b161-69d7cc9ad17d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OtherBalanceSheetDetailsAbstract_0dfbfb3d-d9e2-44f5-862c-f295acb587b0" xlink:href="lgnd-20221231.xsd#lgnd_OtherBalanceSheetDetailsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_208554c3-b35f-4239-ab10-b0000014a92c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_OtherBalanceSheetDetailsAbstract_0dfbfb3d-d9e2-44f5-862c-f295acb587b0" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_208554c3-b35f-4239-ab10-b0000014a92c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_b92b66c0-22e1-40bd-b5bc-01e265a3d498" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_208554c3-b35f-4239-ab10-b0000014a92c" xlink:to="loc_us-gaap_FinancialInstrumentAxis_b92b66c0-22e1-40bd-b5bc-01e265a3d498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_22658037-3d2d-43b9-a42b-eeeea40b937e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b92b66c0-22e1-40bd-b5bc-01e265a3d498" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_22658037-3d2d-43b9-a42b-eeeea40b937e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositsMember_bedd7c1e-2627-459e-9306-359e2988e7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DemandDepositsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_22658037-3d2d-43b9-a42b-eeeea40b937e" xlink:to="loc_us-gaap_DemandDepositsMember_bedd7c1e-2627-459e-9306-359e2988e7c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_fda8189f-3a90-437b-895a-cb5558802233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_22658037-3d2d-43b9-a42b-eeeea40b937e" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_fda8189f-3a90-437b-895a-cb5558802233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_fd5cc0b0-db7c-42c8-a655-c5f6cfe2a7ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_22658037-3d2d-43b9-a42b-eeeea40b937e" xlink:to="loc_us-gaap_CommercialPaperMember_fd5cc0b0-db7c-42c8-a655-c5f6cfe2a7ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_a126ebd5-2846-469e-b113-1178e14a5dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_22658037-3d2d-43b9-a42b-eeeea40b937e" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_a126ebd5-2846-469e-b113-1178e14a5dd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_32da8b80-8cd4-48ab-a8c2-629bd8d7e25b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_208554c3-b35f-4239-ab10-b0000014a92c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_32da8b80-8cd4-48ab-a8c2-629bd8d7e25b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_fbae8ab2-875e-4ae4-a09f-705122086594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_32da8b80-8cd4-48ab-a8c2-629bd8d7e25b" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_fbae8ab2-875e-4ae4-a09f-705122086594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_cb5ecd99-9fae-408b-a8da-3832015bad97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_fbae8ab2-875e-4ae4-a09f-705122086594" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_cb5ecd99-9fae-408b-a8da-3832015bad97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_cf97d799-f2f5-4f7e-a37a-2d91af39b818" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_fbae8ab2-875e-4ae4-a09f-705122086594" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_cf97d799-f2f5-4f7e-a37a-2d91af39b818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss_4e8b153b-18d1-446a-ac8d-b0d6001c634e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_fbae8ab2-875e-4ae4-a09f-705122086594" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss_4e8b153b-18d1-446a-ac8d-b0d6001c634e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_84547a30-ed2c-456b-90e3-b85a8bd8349f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_32da8b80-8cd4-48ab-a8c2-629bd8d7e25b" xlink:to="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_84547a30-ed2c-456b-90e3-b85a8bd8349f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_dcefe0c0-2c7d-40bb-be8a-971de236a9f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_84547a30-ed2c-456b-90e3-b85a8bd8349f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_dcefe0c0-2c7d-40bb-be8a-971de236a9f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_250883d4-2e55-49c8-a6b1-4c7c6746f26b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_84547a30-ed2c-456b-90e3-b85a8bd8349f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_250883d4-2e55-49c8-a6b1-4c7c6746f26b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_f52acbe9-b5db-4614-8bd3-1b52d4f1ca2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_84547a30-ed2c-456b-90e3-b85a8bd8349f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_f52acbe9-b5db-4614-8bd3-1b52d4f1ca2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BalanceSheetAccountDetailsPropertyandEquipmentDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BalanceSheetAccountDetailsPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BalanceSheetAccountDetailsPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OtherBalanceSheetDetailsAbstract_8a7e2b74-c14f-4812-81dd-3838cebca964" xlink:href="lgnd-20221231.xsd#lgnd_OtherBalanceSheetDetailsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a8e87831-959c-4aa2-a549-249c9c02e779" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_OtherBalanceSheetDetailsAbstract_8a7e2b74-c14f-4812-81dd-3838cebca964" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a8e87831-959c-4aa2-a549-249c9c02e779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7a2f73d4-5246-49e3-b371-5cbea3ab6ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a8e87831-959c-4aa2-a549-249c9c02e779" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7a2f73d4-5246-49e3-b371-5cbea3ab6ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3dcd9135-2ab0-4948-8d67-4df8789f1087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7a2f73d4-5246-49e3-b371-5cbea3ab6ef2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3dcd9135-2ab0-4948-8d67-4df8789f1087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_1120f55e-e6b1-4328-8477-f7459878c1b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3dcd9135-2ab0-4948-8d67-4df8789f1087" xlink:to="loc_us-gaap_OfficeEquipmentMember_1120f55e-e6b1-4328-8477-f7459878c1b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_291f7bc6-b14e-438b-b9ba-4096f118c548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3dcd9135-2ab0-4948-8d67-4df8789f1087" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_291f7bc6-b14e-438b-b9ba-4096f118c548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ComputerEquipmentAndSoftwareMember_18fd2322-0a70-463c-a265-007553e93685" xlink:href="lgnd-20221231.xsd#lgnd_ComputerEquipmentAndSoftwareMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3dcd9135-2ab0-4948-8d67-4df8789f1087" xlink:to="loc_lgnd_ComputerEquipmentAndSoftwareMember_18fd2322-0a70-463c-a265-007553e93685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1dfdc2ac-d88a-4ad6-ab88-aa18b7dd87a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a8e87831-959c-4aa2-a549-249c9c02e779" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1dfdc2ac-d88a-4ad6-ab88-aa18b7dd87a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_0a95b6cf-ec6b-4e23-a94c-6a62810ee1cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1dfdc2ac-d88a-4ad6-ab88-aa18b7dd87a5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_0a95b6cf-ec6b-4e23-a94c-6a62810ee1cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a65023e2-a815-4696-8c15-2b9a2a06cbb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1dfdc2ac-d88a-4ad6-ab88-aa18b7dd87a5" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a65023e2-a815-4696-8c15-2b9a2a06cbb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8f7cd299-12bf-4b34-93a9-3a7f7a17bdb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1dfdc2ac-d88a-4ad6-ab88-aa18b7dd87a5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_8f7cd299-12bf-4b34-93a9-3a7f7a17bdb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BalanceSheetAccountDetailsGoodwillandOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BalanceSheetAccountDetailsGoodwillandOtherIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BalanceSheetAccountDetailsGoodwillandOtherIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OtherBalanceSheetDetailsAbstract_6aa27c99-a7d9-4231-8e3b-20f1284f34c5" xlink:href="lgnd-20221231.xsd#lgnd_OtherBalanceSheetDetailsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_af70f01b-34ba-4629-b164-db0c6dc91c64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_OtherBalanceSheetDetailsAbstract_6aa27c99-a7d9-4231-8e3b-20f1284f34c5" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_af70f01b-34ba-4629-b164-db0c6dc91c64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_64ea0efb-1641-40ce-a0c4-3f213d47c95d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_af70f01b-34ba-4629-b164-db0c6dc91c64" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_64ea0efb-1641-40ce-a0c4-3f213d47c95d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0d175c01-05f9-4331-91d7-c782dc8e323d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_64ea0efb-1641-40ce-a0c4-3f213d47c95d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0d175c01-05f9-4331-91d7-c782dc8e323d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentedTechnologyMember_e2826b88-7b67-4653-99dd-258590779851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentedTechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0d175c01-05f9-4331-91d7-c782dc8e323d" xlink:to="loc_us-gaap_PatentedTechnologyMember_e2826b88-7b67-4653-99dd-258590779851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_1a10a31c-e485-445a-9b72-3ade95e31c41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0d175c01-05f9-4331-91d7-c782dc8e323d" xlink:to="loc_us-gaap_TradeNamesMember_1a10a31c-e485-445a-9b72-3ade95e31c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_cbc005d2-053c-4468-b311-5919f17807e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0d175c01-05f9-4331-91d7-c782dc8e323d" xlink:to="loc_us-gaap_CustomerRelationshipsMember_cbc005d2-053c-4468-b311-5919f17807e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_a45e17f8-2303-4f70-8ef1-9709eb388e65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualRightsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0d175c01-05f9-4331-91d7-c782dc8e323d" xlink:to="loc_us-gaap_ContractualRightsMember_a45e17f8-2303-4f70-8ef1-9709eb388e65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cfb36937-f77b-4470-8c77-2f84d47f9586" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_af70f01b-34ba-4629-b164-db0c6dc91c64" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cfb36937-f77b-4470-8c77-2f84d47f9586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_37b954de-0440-4555-b14f-04654eb062b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cfb36937-f77b-4470-8c77-2f84d47f9586" xlink:to="loc_us-gaap_Goodwill_37b954de-0440-4555-b14f-04654eb062b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_48185d13-e2c6-450f-8804-21e058c59dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cfb36937-f77b-4470-8c77-2f84d47f9586" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_48185d13-e2c6-450f-8804-21e058c59dbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a099956e-d68a-4433-bcee-ad769be37c57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cfb36937-f77b-4470-8c77-2f84d47f9586" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a099956e-d68a-4433-bcee-ad769be37c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_27d27124-17c4-47cc-95e8-858772064a33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_cfb36937-f77b-4470-8c77-2f84d47f9586" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_27d27124-17c4-47cc-95e8-858772064a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BalanceSheetAccountDetailsAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BalanceSheetAccountDetailsAccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BalanceSheetAccountDetailsAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OtherBalanceSheetDetailsAbstract_6f97401d-f236-47ba-8060-1609e9e52b63" xlink:href="lgnd-20221231.xsd#lgnd_OtherBalanceSheetDetailsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_3ec935d1-21b0-4ee3-8d2c-b121c6b857c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_OtherBalanceSheetDetailsAbstract_6f97401d-f236-47ba-8060-1609e9e52b63" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_3ec935d1-21b0-4ee3-8d2c-b121c6b857c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_7e0ef58e-f43e-48fc-b60b-1c3833e95c02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_OtherBalanceSheetDetailsAbstract_6f97401d-f236-47ba-8060-1609e9e52b63" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_7e0ef58e-f43e-48fc-b60b-1c3833e95c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_28a4c62a-8596-4087-8fcb-acb14c50ba8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalesCommissionCurrentAndNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_OtherBalanceSheetDetailsAbstract_6f97401d-f236-47ba-8060-1609e9e52b63" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_28a4c62a-8596-4087-8fcb-acb14c50ba8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_03063caa-3f47-445c-8740-5697da793d49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRoyaltiesCurrentAndNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_OtherBalanceSheetDetailsAbstract_6f97401d-f236-47ba-8060-1609e9e52b63" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_03063caa-3f47-445c-8740-5697da793d49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSalesReturns_2ec28986-af9e-47fb-b51e-2c0be8cb1f18" xlink:href="lgnd-20221231.xsd#lgnd_AccruedSalesReturns"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_OtherBalanceSheetDetailsAbstract_6f97401d-f236-47ba-8060-1609e9e52b63" xlink:to="loc_lgnd_AccruedSalesReturns_2ec28986-af9e-47fb-b51e-2c0be8cb1f18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedAssetAcquisitionsCurrent_7896d936-0cb7-4706-812e-bf18643bbdaf" xlink:href="lgnd-20221231.xsd#lgnd_AccruedAssetAcquisitionsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_OtherBalanceSheetDetailsAbstract_6f97401d-f236-47ba-8060-1609e9e52b63" xlink:to="loc_lgnd_AccruedAssetAcquisitionsCurrent_7896d936-0cb7-4706-812e-bf18643bbdaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSubcontractorExpensesCurrent_ad4a5cea-07a8-4f83-923d-e39fd7c9155e" xlink:href="lgnd-20221231.xsd#lgnd_AccruedSubcontractorExpensesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_OtherBalanceSheetDetailsAbstract_6f97401d-f236-47ba-8060-1609e9e52b63" xlink:to="loc_lgnd_AccruedSubcontractorExpensesCurrent_ad4a5cea-07a8-4f83-923d-e39fd7c9155e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSupplierExpensesCurrent_ec871ef7-02d7-4f47-aaf2-0a0be2c9e655" xlink:href="lgnd-20221231.xsd#lgnd_AccruedSupplierExpensesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_OtherBalanceSheetDetailsAbstract_6f97401d-f236-47ba-8060-1609e9e52b63" xlink:to="loc_lgnd_AccruedSupplierExpensesCurrent_ec871ef7-02d7-4f47-aaf2-0a0be2c9e655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_7a780ecc-236b-4316-ba16-d9cb7801c45a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_OtherBalanceSheetDetailsAbstract_6f97401d-f236-47ba-8060-1609e9e52b63" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_7a780ecc-236b-4316-ba16-d9cb7801c45a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_f18b2440-1a31-466e-9e99-f7fad865c4aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_OtherBalanceSheetDetailsAbstract_6f97401d-f236-47ba-8060-1609e9e52b63" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_f18b2440-1a31-466e-9e99-f7fad865c4aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BalanceSheetAccountDetailsContingentLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#BalanceSheetAccountDetailsContingentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BalanceSheetAccountDetailsContingentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OtherBalanceSheetDetailsAbstract_49bef099-104f-49da-8715-72f119845df2" xlink:href="lgnd-20221231.xsd#lgnd_OtherBalanceSheetDetailsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_75156f3b-cf7a-4d13-81af-f9d6697bddd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_OtherBalanceSheetDetailsAbstract_49bef099-104f-49da-8715-72f119845df2" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_75156f3b-cf7a-4d13-81af-f9d6697bddd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_72b9244e-179b-4723-8296-caf05a0cc2e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_75156f3b-cf7a-4d13-81af-f9d6697bddd2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_72b9244e-179b-4723-8296-caf05a0cc2e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d376beee-e261-49d5-bd65-8629d7bdd51d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_72b9244e-179b-4723-8296-caf05a0cc2e9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d376beee-e261-49d5-bd65-8629d7bdd51d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CydexPharmaceuticalsIncMember_57645e60-a838-4638-8dfa-fcf03dc211d4" xlink:href="lgnd-20221231.xsd#lgnd_CydexPharmaceuticalsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d376beee-e261-49d5-bd65-8629d7bdd51d" xlink:to="loc_lgnd_CydexPharmaceuticalsIncMember_57645e60-a838-4638-8dfa-fcf03dc211d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MetabasisTherapeuticsMember_e64b840b-dcab-4436-88c9-8bc9ee4f5694" xlink:href="lgnd-20221231.xsd#lgnd_MetabasisTherapeuticsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d376beee-e261-49d5-bd65-8629d7bdd51d" xlink:to="loc_lgnd_MetabasisTherapeuticsMember_e64b840b-dcab-4436-88c9-8bc9ee4f5694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_4b705703-b822-427e-9117-e9faeec6740a" xlink:href="lgnd-20221231.xsd#lgnd_PfenexMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d376beee-e261-49d5-bd65-8629d7bdd51d" xlink:to="loc_lgnd_PfenexMember_4b705703-b822-427e-9117-e9faeec6740a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b71f4eec-06ab-4ec3-a798-dca0b2abb132" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_75156f3b-cf7a-4d13-81af-f9d6697bddd2" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_b71f4eec-06ab-4ec3-a798-dca0b2abb132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentLiabilityRollForward_08603249-5dce-47fc-9a81-1a026856a7ff" xlink:href="lgnd-20221231.xsd#lgnd_ContingentLiabilityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b71f4eec-06ab-4ec3-a798-dca0b2abb132" xlink:to="loc_lgnd_ContingentLiabilityRollForward_08603249-5dce-47fc-9a81-1a026856a7ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod_de00a65b-1288-4bb5-b703-86ce92694d9d" xlink:href="lgnd-20221231.xsd#lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContingentLiabilityRollForward_08603249-5dce-47fc-9a81-1a026856a7ff" xlink:to="loc_lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod_de00a65b-1288-4bb5-b703-86ce92694d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHolders_3224067c-0431-4843-b5ef-042cb601c82a" xlink:href="lgnd-20221231.xsd#lgnd_PaymentsToContingentValueRightHolders"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContingentLiabilityRollForward_08603249-5dce-47fc-9a81-1a026856a7ff" xlink:to="loc_lgnd_PaymentsToContingentValueRightHolders_3224067c-0431-4843-b5ef-042cb601c82a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities_241a30b0-df5a-411c-aa86-4375a9c92ad8" xlink:href="lgnd-20221231.xsd#lgnd_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContingentLiabilityRollForward_08603249-5dce-47fc-9a81-1a026856a7ff" xlink:to="loc_lgnd_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities_241a30b0-df5a-411c-aa86-4375a9c92ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities_6d0cc6bd-5aff-4c6b-83ab-7f27b740716f" xlink:href="lgnd-20221231.xsd#lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContingentLiabilityRollForward_08603249-5dce-47fc-9a81-1a026856a7ff" xlink:to="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities_6d0cc6bd-5aff-4c6b-83ab-7f27b740716f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod_c0ed31f3-27c3-44ce-85e2-cf46a27cbdef" xlink:href="lgnd-20221231.xsd#lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContingentLiabilityRollForward_08603249-5dce-47fc-9a81-1a026856a7ff" xlink:to="loc_lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod_c0ed31f3-27c3-44ce-85e2-cf46a27cbdef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityShareBasedCompensationDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#StockholdersEquityShareBasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquityShareBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_255e18a0-98a1-4049-97a0-51b7991a8803" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a5305c9-88da-4db3-9316-8cba17699d10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_255e18a0-98a1-4049-97a0-51b7991a8803" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a5305c9-88da-4db3-9316-8cba17699d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_339d8130-46c5-4779-8185-5042450bbfb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a5305c9-88da-4db3-9316-8cba17699d10" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_339d8130-46c5-4779-8185-5042450bbfb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ee04b494-8804-47ae-9851-57d3b6047a35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_339d8130-46c5-4779-8185-5042450bbfb2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ee04b494-8804-47ae-9851-57d3b6047a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_39d90a6f-4040-429d-b3a3-32dbfd0652ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ee04b494-8804-47ae-9851-57d3b6047a35" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_39d90a6f-4040-429d-b3a3-32dbfd0652ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_7c28b77a-652c-4b22-975c-6e772ad4e737" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ee04b494-8804-47ae-9851-57d3b6047a35" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_7c28b77a-652c-4b22-975c-6e772ad4e737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8b61a1ca-8e68-4bc1-8c5c-3cac67726969" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a5305c9-88da-4db3-9316-8cba17699d10" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8b61a1ca-8e68-4bc1-8c5c-3cac67726969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_095577c4-818d-4696-9d85-eeff27510fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8b61a1ca-8e68-4bc1-8c5c-3cac67726969" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_095577c4-818d-4696-9d85-eeff27510fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#StockholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_31a59571-2da5-47f8-81c7-114d0d04cc24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1768f400-10ea-426e-9f3e-7ef6bbdcff40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_31a59571-2da5-47f8-81c7-114d0d04cc24" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1768f400-10ea-426e-9f3e-7ef6bbdcff40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_d0ef33ba-8681-45f9-8c30-088228700256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1768f400-10ea-426e-9f3e-7ef6bbdcff40" xlink:to="loc_us-gaap_PlanNameAxis_d0ef33ba-8681-45f9-8c30-088228700256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_99c46180-0674-4055-80b7-5b794df6f41e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_d0ef33ba-8681-45f9-8c30-088228700256" xlink:to="loc_us-gaap_PlanNameDomain_99c46180-0674-4055-80b7-5b794df6f41e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_TwoThousandTwoStockIncentivePlanMember_c059fad7-9cf1-41f9-b8ed-ddcf20692d0d" xlink:href="lgnd-20221231.xsd#lgnd_TwoThousandTwoStockIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_99c46180-0674-4055-80b7-5b794df6f41e" xlink:to="loc_lgnd_TwoThousandTwoStockIncentivePlanMember_c059fad7-9cf1-41f9-b8ed-ddcf20692d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmendedESPPMember_7a03ceb1-622f-4b7e-8cb4-87643860453c" xlink:href="lgnd-20221231.xsd#lgnd_AmendedESPPMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_99c46180-0674-4055-80b7-5b794df6f41e" xlink:to="loc_lgnd_AmendedESPPMember_7a03ceb1-622f-4b7e-8cb4-87643860453c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OmniabSeparationMember_c26f9d73-cf5c-4a43-8ac0-d4384b73dd0d" xlink:href="lgnd-20221231.xsd#lgnd_OmniabSeparationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_99c46180-0674-4055-80b7-5b794df6f41e" xlink:to="loc_lgnd_OmniabSeparationMember_c26f9d73-cf5c-4a43-8ac0-d4384b73dd0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_310760fc-dfcd-4b17-a617-94343767d873" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1768f400-10ea-426e-9f3e-7ef6bbdcff40" xlink:to="loc_us-gaap_AwardTypeAxis_310760fc-dfcd-4b17-a617-94343767d873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_93d39d22-318b-4d37-8072-b2514765d189" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_310760fc-dfcd-4b17-a617-94343767d873" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_93d39d22-318b-4d37-8072-b2514765d189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_aec94ac3-5bba-47b8-af67-cfff5a75783e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_93d39d22-318b-4d37-8072-b2514765d189" xlink:to="loc_us-gaap_EmployeeStockOptionMember_aec94ac3-5bba-47b8-af67-cfff5a75783e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_fe0da702-8bcf-4d39-9b05-3f6ac6c7cb1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_93d39d22-318b-4d37-8072-b2514765d189" xlink:to="loc_us-gaap_RestrictedStockMember_fe0da702-8bcf-4d39-9b05-3f6ac6c7cb1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_973862f3-ead0-44d2-8a8e-a004a7400217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1768f400-10ea-426e-9f3e-7ef6bbdcff40" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_973862f3-ead0-44d2-8a8e-a004a7400217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_68f503be-e208-4697-ac45-63d8747ed3a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_973862f3-ead0-44d2-8a8e-a004a7400217" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_68f503be-e208-4697-ac45-63d8747ed3a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AtTheMarketEquityOfferingMember_f5f8d5cc-b973-4c89-8539-a664b488d37d" xlink:href="lgnd-20221231.xsd#lgnd_AtTheMarketEquityOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_68f503be-e208-4697-ac45-63d8747ed3a5" xlink:to="loc_lgnd_AtTheMarketEquityOfferingMember_f5f8d5cc-b973-4c89-8539-a664b488d37d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44046b9f-53ac-4128-acd7-ebff878dd19a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1768f400-10ea-426e-9f3e-7ef6bbdcff40" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44046b9f-53ac-4128-acd7-ebff878dd19a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_fa2a6686-08f9-4904-a5d6-85cd8f267b43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44046b9f-53ac-4128-acd7-ebff878dd19a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_fa2a6686-08f9-4904-a5d6-85cd8f267b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_8d11ff90-ed30-45fa-a79e-dd456a6f7f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44046b9f-53ac-4128-acd7-ebff878dd19a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_8d11ff90-ed30-45fa-a79e-dd456a6f7f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7d5d56c3-45e4-4606-b189-76f4e70375e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44046b9f-53ac-4128-acd7-ebff878dd19a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7d5d56c3-45e4-4606-b189-76f4e70375e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_8ba1c8b0-2888-49f8-90d5-f9b785c6d288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44046b9f-53ac-4128-acd7-ebff878dd19a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_8ba1c8b0-2888-49f8-90d5-f9b785c6d288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_5df1bda9-ede5-4261-a775-555006fb39e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44046b9f-53ac-4128-acd7-ebff878dd19a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_5df1bda9-ede5-4261-a775-555006fb39e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_69594d0e-875c-4dd1-8307-6d00df31f05f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44046b9f-53ac-4128-acd7-ebff878dd19a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_69594d0e-875c-4dd1-8307-6d00df31f05f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_7dfb75ca-26de-41ff-841a-07c54d44f7d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44046b9f-53ac-4128-acd7-ebff878dd19a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_7dfb75ca-26de-41ff-841a-07c54d44f7d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_3756cdc0-f087-41e5-99cf-a587da074bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44046b9f-53ac-4128-acd7-ebff878dd19a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_3756cdc0-f087-41e5-99cf-a587da074bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SaleOfStockAuthorizedOfferingAmount_ddf11226-6915-47f5-a465-fb7e348dede3" xlink:href="lgnd-20221231.xsd#lgnd_SaleOfStockAuthorizedOfferingAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44046b9f-53ac-4128-acd7-ebff878dd19a" xlink:to="loc_lgnd_SaleOfStockAuthorizedOfferingAmount_ddf11226-6915-47f5-a465-fb7e348dede3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanAbstract_5735823d-a180-4032-aced-118ea9943242" xlink:href="lgnd-20221231.xsd#lgnd_EmployeeStockPurchasePlanAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44046b9f-53ac-4128-acd7-ebff878dd19a" xlink:to="loc_lgnd_EmployeeStockPurchasePlanAbstract_5735823d-a180-4032-aced-118ea9943242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_0567fe61-d7c9-43f1-bd73-dcfdcf34486d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_5735823d-a180-4032-aced-118ea9943242" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_0567fe61-d7c9-43f1-bd73-dcfdcf34486d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_cdf382f2-70a6-4989-80b9-eca3c906afe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_5735823d-a180-4032-aced-118ea9943242" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_cdf382f2-70a6-4989-80b9-eca3c906afe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_e343d4c1-885c-4274-8951-841da161d8a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_5735823d-a180-4032-aced-118ea9943242" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_e343d4c1-885c-4274-8951-841da161d8a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CorporateShareRepurchaseAbstract_4ffbd7a2-f838-4121-86ac-cb5727f515b0" xlink:href="lgnd-20221231.xsd#lgnd_CorporateShareRepurchaseAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44046b9f-53ac-4128-acd7-ebff878dd19a" xlink:to="loc_lgnd_CorporateShareRepurchaseAbstract_4ffbd7a2-f838-4121-86ac-cb5727f515b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ce0fd9b2-d448-4cd6-9a44-ab1cd3697af7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CorporateShareRepurchaseAbstract_4ffbd7a2-f838-4121-86ac-cb5727f515b0" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ce0fd9b2-d448-4cd6-9a44-ab1cd3697af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_7537d3bf-fb39-4f47-9ec4-b2611a773a88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CorporateShareRepurchaseAbstract_4ffbd7a2-f838-4121-86ac-cb5727f515b0" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_7537d3bf-fb39-4f47-9ec4-b2611a773a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_8717bb9f-5dc6-465c-b018-b9bd5d726b12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CorporateShareRepurchaseAbstract_4ffbd7a2-f838-4121-86ac-cb5727f515b0" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_8717bb9f-5dc6-465c-b018-b9bd5d726b12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_cebd584b-c6f2-4953-b8e1-cbe94d77a4e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CorporateShareRepurchaseAbstract_4ffbd7a2-f838-4121-86ac-cb5727f515b0" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_cebd584b-c6f2-4953-b8e1-cbe94d77a4e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityStockOptionPlanActivityDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#StockholdersEquityStockOptionPlanActivityDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquityStockOptionPlanActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_71ce5880-3979-4ec9-a511-0b273941291c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b147a774-975a-41cd-b408-851a08e013c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_71ce5880-3979-4ec9-a511-0b273941291c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b147a774-975a-41cd-b408-851a08e013c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_efb4a780-d312-4a30-970f-ee121c8791c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b147a774-975a-41cd-b408-851a08e013c8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_efb4a780-d312-4a30-970f-ee121c8791c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c5377ee3-939b-46f2-bb57-034331a27680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b147a774-975a-41cd-b408-851a08e013c8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c5377ee3-939b-46f2-bb57-034331a27680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d55621d9-13c1-4b4f-acfc-6966283762dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b147a774-975a-41cd-b408-851a08e013c8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d55621d9-13c1-4b4f-acfc-6966283762dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4e6ef9b4-bf1b-4420-b190-c6c6e1ac2543" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b147a774-975a-41cd-b408-851a08e013c8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4e6ef9b4-bf1b-4420-b190-c6c6e1ac2543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5af92cb8-299b-4fcb-b14c-758b2c927802" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b147a774-975a-41cd-b408-851a08e013c8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5af92cb8-299b-4fcb-b14c-758b2c927802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c00adf96-81f0-4d59-927e-7f93669d8674" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_71ce5880-3979-4ec9-a511-0b273941291c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c00adf96-81f0-4d59-927e-7f93669d8674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_fc390d0b-b839-4263-853f-da43f1e657f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_71ce5880-3979-4ec9-a511-0b273941291c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_fc390d0b-b839-4263-853f-da43f1e657f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_059ac542-564a-4e41-a186-d7b0240b41b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_71ce5880-3979-4ec9-a511-0b273941291c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_059ac542-564a-4e41-a186-d7b0240b41b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_dabf0152-b40a-4855-bbe5-eaa9d4b8cc7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_059ac542-564a-4e41-a186-d7b0240b41b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_dabf0152-b40a-4855-bbe5-eaa9d4b8cc7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_251cf3ca-a262-48ee-be22-c00375027c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_059ac542-564a-4e41-a186-d7b0240b41b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_251cf3ca-a262-48ee-be22-c00375027c9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1006f4e6-450f-4929-b1c8-beaa00e73925" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_059ac542-564a-4e41-a186-d7b0240b41b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1006f4e6-450f-4929-b1c8-beaa00e73925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_b50ef339-f57d-4cc9-9834-3aeb6fa38826" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_059ac542-564a-4e41-a186-d7b0240b41b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_b50ef339-f57d-4cc9-9834-3aeb6fa38826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_609912b3-7af8-4428-b1af-f4ccfa99d969" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_059ac542-564a-4e41-a186-d7b0240b41b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_609912b3-7af8-4428-b1af-f4ccfa99d969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_d401a7f0-1c62-4328-b087-733e07e1bba1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_71ce5880-3979-4ec9-a511-0b273941291c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_d401a7f0-1c62-4328-b087-733e07e1bba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_44c1cff7-464f-472a-81db-32877c64f4e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_71ce5880-3979-4ec9-a511-0b273941291c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_44c1cff7-464f-472a-81db-32877c64f4e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_a11a27b4-0ea4-477a-8c9e-0de2efb6980e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_71ce5880-3979-4ec9-a511-0b273941291c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_a11a27b4-0ea4-477a-8c9e-0de2efb6980e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_9b4cb528-cece-46e4-8305-69eb644f13b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_71ce5880-3979-4ec9-a511-0b273941291c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_9b4cb528-cece-46e4-8305-69eb644f13b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_f8e88f1e-895c-4177-9a23-4069bcc00060" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_71ce5880-3979-4ec9-a511-0b273941291c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_f8e88f1e-895c-4177-9a23-4069bcc00060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_82b06df9-5fbe-4999-a087-d446b7d05ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_71ce5880-3979-4ec9-a511-0b273941291c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_82b06df9-5fbe-4999-a087-d446b7d05ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_1a8dc7ba-b2a2-4d99-8960-28efbcf69b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_71ce5880-3979-4ec9-a511-0b273941291c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_1a8dc7ba-b2a2-4d99-8960-28efbcf69b4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_1492d5c9-e70e-4883-b78f-22dfda35c9c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_71ce5880-3979-4ec9-a511-0b273941291c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_1492d5c9-e70e-4883-b78f-22dfda35c9c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityBreakdownofOptionsOutstandingDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#StockholdersEquityBreakdownofOptionsOutstandingDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquityBreakdownofOptionsOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_3af5305f-a4db-44ba-846c-a0692d32738c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7e049b06-a989-4fa0-a5b9-32ef96693874" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_3af5305f-a4db-44ba-846c-a0692d32738c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7e049b06-a989-4fa0-a5b9-32ef96693874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_2a477b94-1e9c-4554-9445-4a02ad8efb33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7e049b06-a989-4fa0-a5b9-32ef96693874" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_2a477b94-1e9c-4554-9445-4a02ad8efb33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_596025af-e787-4bd0-b45b-d8871352e599" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_2a477b94-1e9c-4554-9445-4a02ad8efb33" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_596025af-e787-4bd0-b45b-d8871352e599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ExercisePriceRangeOneMember_7bfe1917-76c5-4f83-bf81-5083aeeb89ae" xlink:href="lgnd-20221231.xsd#lgnd_ExercisePriceRangeOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_596025af-e787-4bd0-b45b-d8871352e599" xlink:to="loc_lgnd_ExercisePriceRangeOneMember_7bfe1917-76c5-4f83-bf81-5083aeeb89ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ExercisePriceRangeTwoMember_dbdbe251-cd69-416a-81c6-8c0af776407a" xlink:href="lgnd-20221231.xsd#lgnd_ExercisePriceRangeTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_596025af-e787-4bd0-b45b-d8871352e599" xlink:to="loc_lgnd_ExercisePriceRangeTwoMember_dbdbe251-cd69-416a-81c6-8c0af776407a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ExercisePriceRangeThreeMember_c7c6f0a8-408a-4a95-90b0-ffdca1bf687f" xlink:href="lgnd-20221231.xsd#lgnd_ExercisePriceRangeThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_596025af-e787-4bd0-b45b-d8871352e599" xlink:to="loc_lgnd_ExercisePriceRangeThreeMember_c7c6f0a8-408a-4a95-90b0-ffdca1bf687f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ExercisePriceRangeFourMember_179013f1-ad87-4afc-ac9c-f163341c06f2" xlink:href="lgnd-20221231.xsd#lgnd_ExercisePriceRangeFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_596025af-e787-4bd0-b45b-d8871352e599" xlink:to="loc_lgnd_ExercisePriceRangeFourMember_179013f1-ad87-4afc-ac9c-f163341c06f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ExercisePriceRangeFiveMember_f86cda8e-9ef1-4d1c-972f-879b41b81378" xlink:href="lgnd-20221231.xsd#lgnd_ExercisePriceRangeFiveMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_596025af-e787-4bd0-b45b-d8871352e599" xlink:to="loc_lgnd_ExercisePriceRangeFiveMember_f86cda8e-9ef1-4d1c-972f-879b41b81378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ExercisePriceRangeSixMember_b921dd9c-91f6-4b83-8240-eba32a001cf9" xlink:href="lgnd-20221231.xsd#lgnd_ExercisePriceRangeSixMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_596025af-e787-4bd0-b45b-d8871352e599" xlink:to="loc_lgnd_ExercisePriceRangeSixMember_b921dd9c-91f6-4b83-8240-eba32a001cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ExercisePriceRangeSevenMember_ca158459-e58f-44c3-8ea6-ad6657f067b3" xlink:href="lgnd-20221231.xsd#lgnd_ExercisePriceRangeSevenMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_596025af-e787-4bd0-b45b-d8871352e599" xlink:to="loc_lgnd_ExercisePriceRangeSevenMember_ca158459-e58f-44c3-8ea6-ad6657f067b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ExercisePriceRangeEightMember_004732fc-2fed-483c-b61b-f76eb7e23653" xlink:href="lgnd-20221231.xsd#lgnd_ExercisePriceRangeEightMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_596025af-e787-4bd0-b45b-d8871352e599" xlink:to="loc_lgnd_ExercisePriceRangeEightMember_004732fc-2fed-483c-b61b-f76eb7e23653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ExercisePriceRangeNineMember_abdc86d5-0e97-49fa-bc30-1ba94b7f46ae" xlink:href="lgnd-20221231.xsd#lgnd_ExercisePriceRangeNineMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_596025af-e787-4bd0-b45b-d8871352e599" xlink:to="loc_lgnd_ExercisePriceRangeNineMember_abdc86d5-0e97-49fa-bc30-1ba94b7f46ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ExercisePriceRangeTenMember_fb4954a1-c7b4-47d4-a529-d121994f1204" xlink:href="lgnd-20221231.xsd#lgnd_ExercisePriceRangeTenMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_596025af-e787-4bd0-b45b-d8871352e599" xlink:to="loc_lgnd_ExercisePriceRangeTenMember_fb4954a1-c7b4-47d4-a529-d121994f1204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffbd0e0-f1ae-49ea-a34f-1b5e00077129" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7e049b06-a989-4fa0-a5b9-32ef96693874" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffbd0e0-f1ae-49ea-a34f-1b5e00077129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_cbbe8029-16a2-42c3-b6b7-747e84c427cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffbd0e0-f1ae-49ea-a34f-1b5e00077129" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_cbbe8029-16a2-42c3-b6b7-747e84c427cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_e20efbc1-f1f9-4d6b-9866-9a6dcd1749cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffbd0e0-f1ae-49ea-a34f-1b5e00077129" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_e20efbc1-f1f9-4d6b-9866-9a6dcd1749cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_44d38a3d-62ac-40dd-add2-115393f94a94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffbd0e0-f1ae-49ea-a34f-1b5e00077129" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_44d38a3d-62ac-40dd-add2-115393f94a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_064dea71-4dac-4cd8-b308-94f91304f728" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffbd0e0-f1ae-49ea-a34f-1b5e00077129" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_064dea71-4dac-4cd8-b308-94f91304f728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_db9af6b8-092a-446c-807c-773a8256c5bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffbd0e0-f1ae-49ea-a34f-1b5e00077129" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_db9af6b8-092a-446c-807c-773a8256c5bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_721e9404-a463-48b4-9d01-b8556c087209" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffbd0e0-f1ae-49ea-a34f-1b5e00077129" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_721e9404-a463-48b4-9d01-b8556c087209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_99f5a029-7cc4-4b96-a740-bc75b2187d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffbd0e0-f1ae-49ea-a34f-1b5e00077129" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_99f5a029-7cc4-4b96-a740-bc75b2187d6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityAssumptionsDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#StockholdersEquityAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquityAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_8ba7f971-6abd-4eb1-87d8-bb545b1f1f81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9d52a532-f950-4d80-9101-4b3a7d88338b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8ba7f971-6abd-4eb1-87d8-bb545b1f1f81" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9d52a532-f950-4d80-9101-4b3a7d88338b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7555bdd4-2606-4d99-95e5-ce6de20f37a2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9d52a532-f950-4d80-9101-4b3a7d88338b" xlink:to="loc_srt_RangeAxis_7555bdd4-2606-4d99-95e5-ce6de20f37a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a9471dd6-c400-4df2-966b-2dfecf64aa14" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7555bdd4-2606-4d99-95e5-ce6de20f37a2" xlink:to="loc_srt_RangeMember_a9471dd6-c400-4df2-966b-2dfecf64aa14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2bc92c03-3e7f-4cc8-a9b7-2df7225df970" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a9471dd6-c400-4df2-966b-2dfecf64aa14" xlink:to="loc_srt_MinimumMember_2bc92c03-3e7f-4cc8-a9b7-2df7225df970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_86612c55-897c-4bf1-93e7-518443aec255" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a9471dd6-c400-4df2-966b-2dfecf64aa14" xlink:to="loc_srt_MaximumMember_86612c55-897c-4bf1-93e7-518443aec255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c4d2fe9-6356-46c1-bd0a-47a0d9a2d5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9d52a532-f950-4d80-9101-4b3a7d88338b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c4d2fe9-6356-46c1-bd0a-47a0d9a2d5ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_36c8936e-d821-46de-8fc3-5cfd2d7f1ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c4d2fe9-6356-46c1-bd0a-47a0d9a2d5ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_36c8936e-d821-46de-8fc3-5cfd2d7f1ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_8174100a-6b9c-4ae2-8c00-08540186fa23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c4d2fe9-6356-46c1-bd0a-47a0d9a2d5ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_8174100a-6b9c-4ae2-8c00-08540186fa23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ed8c3f3f-c64a-4460-9b72-5becad982dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c4d2fe9-6356-46c1-bd0a-47a0d9a2d5ef" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ed8c3f3f-c64a-4460-9b72-5becad982dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityRestrictedStockActivityDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#StockholdersEquityRestrictedStockActivityDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquityRestrictedStockActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_18987c81-ce96-4e93-9727-cc80ecc7c3ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_64f47225-0526-48ba-be08-f347babaad44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_18987c81-ce96-4e93-9727-cc80ecc7c3ba" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_64f47225-0526-48ba-be08-f347babaad44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_258ab4b8-5d3d-4e21-bbe9-69bfed138c50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_64f47225-0526-48ba-be08-f347babaad44" xlink:to="loc_us-gaap_AwardTypeAxis_258ab4b8-5d3d-4e21-bbe9-69bfed138c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_770909dd-59c1-4115-82fd-a2adc0a9560d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_258ab4b8-5d3d-4e21-bbe9-69bfed138c50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_770909dd-59c1-4115-82fd-a2adc0a9560d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_b6b162b7-0c40-45e5-a44e-8b6207bb9a20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_770909dd-59c1-4115-82fd-a2adc0a9560d" xlink:to="loc_us-gaap_RestrictedStockMember_b6b162b7-0c40-45e5-a44e-8b6207bb9a20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a8e3f72-3937-449b-b267-2d4dbc6a3a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_64f47225-0526-48ba-be08-f347babaad44" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a8e3f72-3937-449b-b267-2d4dbc6a3a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9a183f4c-debb-4d4e-bd41-d1f32b57875b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a8e3f72-3937-449b-b267-2d4dbc6a3a7d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9a183f4c-debb-4d4e-bd41-d1f32b57875b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2f8dbbe5-6b3a-4cc9-bfee-e2f185174a16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9a183f4c-debb-4d4e-bd41-d1f32b57875b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2f8dbbe5-6b3a-4cc9-bfee-e2f185174a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ad466b90-3dbc-4f1f-af1b-ff33a981936c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9a183f4c-debb-4d4e-bd41-d1f32b57875b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ad466b90-3dbc-4f1f-af1b-ff33a981936c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_870ecf3b-4633-4ae3-a71f-41fc8592652b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9a183f4c-debb-4d4e-bd41-d1f32b57875b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_870ecf3b-4633-4ae3-a71f-41fc8592652b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c8c6f8f6-ee49-4540-a88a-19ea77a71d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9a183f4c-debb-4d4e-bd41-d1f32b57875b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c8c6f8f6-ee49-4540-a88a-19ea77a71d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c819a8af-6ce0-49e1-8427-439c17c70207" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9a183f4c-debb-4d4e-bd41-d1f32b57875b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c819a8af-6ce0-49e1-8427-439c17c70207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cbfe8e26-d744-4575-a96f-e53acf5101e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a8e3f72-3937-449b-b267-2d4dbc6a3a7d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cbfe8e26-d744-4575-a96f-e53acf5101e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6856fd4a-4944-4bb2-8508-4a74f2e8bd89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cbfe8e26-d744-4575-a96f-e53acf5101e3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6856fd4a-4944-4bb2-8508-4a74f2e8bd89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_403bceb5-0701-4a37-9978-6a55c92d9f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cbfe8e26-d744-4575-a96f-e53acf5101e3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_403bceb5-0701-4a37-9978-6a55c92d9f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_5eec652b-764e-44e6-a784-36cf3ac3d2da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cbfe8e26-d744-4575-a96f-e53acf5101e3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_5eec652b-764e-44e6-a784-36cf3ac3d2da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2e4bfb9d-6fda-45ba-9ffc-2641e4a43d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cbfe8e26-d744-4575-a96f-e53acf5101e3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2e4bfb9d-6fda-45ba-9ffc-2641e4a43d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_941fee24-e0c5-46b4-bf39-cdf165d84b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cbfe8e26-d744-4575-a96f-e53acf5101e3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_941fee24-e0c5-46b4-bf39-cdf165d84b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_97720ef9-f6ec-4d7d-9acb-667aa3d201f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_c35fd5db-d442-4310-bdb4-dfbcb6ba89c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_97720ef9-f6ec-4d7d-9acb-667aa3d201f8" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_c35fd5db-d442-4310-bdb4-dfbcb6ba89c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_03d79305-cfac-42a0-a85a-58c7150fd010" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_c35fd5db-d442-4310-bdb4-dfbcb6ba89c7" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_03d79305-cfac-42a0-a85a-58c7150fd010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_17b7c64d-5dab-46d9-bc08-c3a9de60774c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_03d79305-cfac-42a0-a85a-58c7150fd010" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_17b7c64d-5dab-46d9-bc08-c3a9de60774c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_854accd6-a431-446e-8db1-0388d78968ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_17b7c64d-5dab-46d9-bc08-c3a9de60774c" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_854accd6-a431-446e-8db1-0388d78968ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_e49ebda2-f33d-4421-aab2-5a8a5a6dd8f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_17b7c64d-5dab-46d9-bc08-c3a9de60774c" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_e49ebda2-f33d-4421-aab2-5a8a5a6dd8f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_73782c52-98bd-4e64-86c3-d2419a001a88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_17b7c64d-5dab-46d9-bc08-c3a9de60774c" xlink:to="loc_us-gaap_ForeignCountryMember_73782c52-98bd-4e64-86c3-d2419a001a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_0b325684-fd6f-44d5-8ab8-fe072496d2e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_17b7c64d-5dab-46d9-bc08-c3a9de60774c" xlink:to="loc_us-gaap_DomesticCountryMember_0b325684-fd6f-44d5-8ab8-fe072496d2e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_5ac247e4-9776-4c6a-b0e2-14e9f5f01303" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_c35fd5db-d442-4310-bdb4-dfbcb6ba89c7" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_5ac247e4-9776-4c6a-b0e2-14e9f5f01303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_f0bb86b0-4bfd-4949-8d79-733ec47a0665" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_5ac247e4-9776-4c6a-b0e2-14e9f5f01303" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_f0bb86b0-4bfd-4949-8d79-733ec47a0665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_63c1d412-78dd-40ed-a3a8-481a9374ef3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_f0bb86b0-4bfd-4949-8d79-733ec47a0665" xlink:to="loc_us-gaap_ResearchMember_63c1d412-78dd-40ed-a3a8-481a9374ef3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CaliforniaAndNewJerseyResearchTaxCreditCarryforwardMember_300cf89a-57b2-40e2-b0b8-1e3b654f8dd9" xlink:href="lgnd-20221231.xsd#lgnd_CaliforniaAndNewJerseyResearchTaxCreditCarryforwardMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_f0bb86b0-4bfd-4949-8d79-733ec47a0665" xlink:to="loc_lgnd_CaliforniaAndNewJerseyResearchTaxCreditCarryforwardMember_300cf89a-57b2-40e2-b0b8-1e3b654f8dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLossCarryforwardMember_427126a3-dc38-4980-8bf1-3dc49523cf5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalLossCarryforwardMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_f0bb86b0-4bfd-4949-8d79-733ec47a0665" xlink:to="loc_us-gaap_CapitalLossCarryforwardMember_427126a3-dc38-4980-8bf1-3dc49523cf5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_0494adf2-5a70-425c-a649-5a164f9cdbdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_c35fd5db-d442-4310-bdb4-dfbcb6ba89c7" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_0494adf2-5a70-425c-a649-5a164f9cdbdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_30541bbb-934d-4e05-996d-bbb5e3ed004e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0494adf2-5a70-425c-a649-5a164f9cdbdb" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_30541bbb-934d-4e05-996d-bbb5e3ed004e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_cbf58be4-ac6c-4677-8405-6a1237f8e87b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0494adf2-5a70-425c-a649-5a164f9cdbdb" xlink:to="loc_us-gaap_OperatingLossCarryforwards_cbf58be4-ac6c-4677-8405-6a1237f8e87b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_f1fcdd59-e8a7-43a6-92e5-c1b644edb9e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0494adf2-5a70-425c-a649-5a164f9cdbdb" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_f1fcdd59-e8a7-43a6-92e5-c1b644edb9e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_203fd423-4806-454c-a570-37b0db95f338" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0494adf2-5a70-425c-a649-5a164f9cdbdb" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_203fd423-4806-454c-a570-37b0db95f338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount_8f2f13e5-ae6e-4acd-b4fd-bc050acc13ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0494adf2-5a70-425c-a649-5a164f9cdbdb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount_8f2f13e5-ae6e-4acd-b4fd-bc050acc13ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_35b969f9-479d-442e-a2d0-e26153013701" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_156e04ce-23de-48b8-a7ab-e396ecd9736f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_35b969f9-479d-442e-a2d0-e26153013701" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_156e04ce-23de-48b8-a7ab-e396ecd9736f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_aefa96b9-80d0-47c6-a835-e83c5a1f3654" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_156e04ce-23de-48b8-a7ab-e396ecd9736f" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_aefa96b9-80d0-47c6-a835-e83c5a1f3654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_0c4c4ab9-7af7-4cc5-a01f-2eb576d72d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_156e04ce-23de-48b8-a7ab-e396ecd9736f" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_0c4c4ab9-7af7-4cc5-a01f-2eb576d72d4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_4dab69c0-db9e-44d1-b204-0b06aced9dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_156e04ce-23de-48b8-a7ab-e396ecd9736f" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_4dab69c0-db9e-44d1-b204-0b06aced9dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_96ac5940-1627-48a3-917f-f9d875a565e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_156e04ce-23de-48b8-a7ab-e396ecd9736f" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_96ac5940-1627-48a3-917f-f9d875a565e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_67ad997f-0333-4f2f-9892-c7e53b8c6942" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_35b969f9-479d-442e-a2d0-e26153013701" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_67ad997f-0333-4f2f-9892-c7e53b8c6942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_fea23add-3ca9-49f4-b8e6-3392831ea6c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_67ad997f-0333-4f2f-9892-c7e53b8c6942" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_fea23add-3ca9-49f4-b8e6-3392831ea6c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_9af83a79-54ef-44c4-92b6-a8b18e447e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_67ad997f-0333-4f2f-9892-c7e53b8c6942" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_9af83a79-54ef-44c4-92b6-a8b18e447e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_5457551d-db5e-4cf0-ac3a-85dbeae90141" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_67ad997f-0333-4f2f-9892-c7e53b8c6942" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_5457551d-db5e-4cf0-ac3a-85dbeae90141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_18dfea51-b900-4a06-be85-e7689bc57199" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_35b969f9-479d-442e-a2d0-e26153013701" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_18dfea51-b900-4a06-be85-e7689bc57199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4292868e-d9b5-4b76-8239-2f5b06723de1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5afc4e2f-45a8-4b6a-8e47-e1967e6f5480" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4292868e-d9b5-4b76-8239-2f5b06723de1" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5afc4e2f-45a8-4b6a-8e47-e1967e6f5480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_bbd065d3-a1bb-4a0e-bda6-f33a08d7dafc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5afc4e2f-45a8-4b6a-8e47-e1967e6f5480" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_bbd065d3-a1bb-4a0e-bda6-f33a08d7dafc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_93a4f0dd-393e-4ae2-ba68-c8bb93691a60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5afc4e2f-45a8-4b6a-8e47-e1967e6f5480" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_93a4f0dd-393e-4ae2-ba68-c8bb93691a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IncomeTaxReconciliationContingentValueRights_9c77d609-e01c-4cf1-af6e-6f35c4d497c9" xlink:href="lgnd-20221231.xsd#lgnd_IncomeTaxReconciliationContingentValueRights"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5afc4e2f-45a8-4b6a-8e47-e1967e6f5480" xlink:to="loc_lgnd_IncomeTaxReconciliationContingentValueRights_9c77d609-e01c-4cf1-af6e-6f35c4d497c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_754a31da-6836-48df-9136-4c44d8514f54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5afc4e2f-45a8-4b6a-8e47-e1967e6f5480" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_754a31da-6836-48df-9136-4c44d8514f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount_8cddb27f-731d-4231-82fe-f5fa227d4bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5afc4e2f-45a8-4b6a-8e47-e1967e6f5480" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount_8cddb27f-731d-4231-82fe-f5fa227d4bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EffectiveIncomeTaxRateReconciliationExpiredTaxCreditsResearch_81ee5df0-6935-4a39-b4b4-f0d7da8aef32" xlink:href="lgnd-20221231.xsd#lgnd_EffectiveIncomeTaxRateReconciliationExpiredTaxCreditsResearch"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5afc4e2f-45a8-4b6a-8e47-e1967e6f5480" xlink:to="loc_lgnd_EffectiveIncomeTaxRateReconciliationExpiredTaxCreditsResearch_81ee5df0-6935-4a39-b4b4-f0d7da8aef32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions_f66b05d4-6d3a-46a3-8f2c-20f123ace9f3" xlink:href="lgnd-20221231.xsd#lgnd_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5afc4e2f-45a8-4b6a-8e47-e1967e6f5480" xlink:to="loc_lgnd_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions_f66b05d4-6d3a-46a3-8f2c-20f123ace9f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_495c313c-0070-416a-bf2e-b1795882a974" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5afc4e2f-45a8-4b6a-8e47-e1967e6f5480" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_495c313c-0070-416a-bf2e-b1795882a974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsAmount_6c85d86f-98b2-4586-bb7f-96757330878e" xlink:href="lgnd-20221231.xsd#lgnd_EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5afc4e2f-45a8-4b6a-8e47-e1967e6f5480" xlink:to="loc_lgnd_EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsAmount_6c85d86f-98b2-4586-bb7f-96757330878e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_6016976b-d9f5-4fd5-a36d-0922f93c3f61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5afc4e2f-45a8-4b6a-8e47-e1967e6f5480" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_6016976b-d9f5-4fd5-a36d-0922f93c3f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_4d376670-2be5-46cb-8dea-5e70b7766ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5afc4e2f-45a8-4b6a-8e47-e1967e6f5480" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_4d376670-2be5-46cb-8dea-5e70b7766ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_20f83a51-af68-4d8c-9a79-93621ee10791" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationDispositionOfBusiness"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5afc4e2f-45a8-4b6a-8e47-e1967e6f5480" xlink:to="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_20f83a51-af68-4d8c-9a79-93621ee10791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EffectiveIncomeTaxRateReconciliationDebtRepurchasesAmount_711b74f9-035e-4771-9bda-f036ec4c6583" xlink:href="lgnd-20221231.xsd#lgnd_EffectiveIncomeTaxRateReconciliationDebtRepurchasesAmount"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5afc4e2f-45a8-4b6a-8e47-e1967e6f5480" xlink:to="loc_lgnd_EffectiveIncomeTaxRateReconciliationDebtRepurchasesAmount_711b74f9-035e-4771-9bda-f036ec4c6583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EffectiveIncomeTaxRateReconciliationOtherIncome_bfd63590-b3d8-4365-ba09-ed9699c0c114" xlink:href="lgnd-20221231.xsd#lgnd_EffectiveIncomeTaxRateReconciliationOtherIncome"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5afc4e2f-45a8-4b6a-8e47-e1967e6f5480" xlink:to="loc_lgnd_EffectiveIncomeTaxRateReconciliationOtherIncome_bfd63590-b3d8-4365-ba09-ed9699c0c114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EffectiveIncomeTaxRateReconciliationOfficerCompensationAmount_477dfa3d-b005-4448-b707-756de470999b" xlink:href="lgnd-20221231.xsd#lgnd_EffectiveIncomeTaxRateReconciliationOfficerCompensationAmount"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5afc4e2f-45a8-4b6a-8e47-e1967e6f5480" xlink:to="loc_lgnd_EffectiveIncomeTaxRateReconciliationOfficerCompensationAmount_477dfa3d-b005-4448-b707-756de470999b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_9f8da9e0-57f4-4d04-be7e-41d2a344aee8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5afc4e2f-45a8-4b6a-8e47-e1967e6f5480" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_9f8da9e0-57f4-4d04-be7e-41d2a344aee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c3173e39-1662-415f-a65e-d85f606e7ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5afc4e2f-45a8-4b6a-8e47-e1967e6f5480" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c3173e39-1662-415f-a65e-d85f606e7ea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTaxesDeferredTaxesDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#IncomeTaxesDeferredTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/IncomeTaxesDeferredTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_43348ad0-40dc-4c4a-9f3c-ae936fe7c978" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract_77576e6c-a796-4792-9224-95891c0453b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_43348ad0-40dc-4c4a-9f3c-ae936fe7c978" xlink:to="loc_us-gaap_DeferredTaxAssetsGrossAbstract_77576e6c-a796-4792-9224-95891c0453b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_cea4b9c3-3152-42c7-b8c1-ef1931f4bd6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_77576e6c-a796-4792-9224-95891c0453b0" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_cea4b9c3-3152-42c7-b8c1-ef1931f4bd6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_8f034aa1-027a-450a-a6ae-6ce06cf776cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_77576e6c-a796-4792-9224-95891c0453b0" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_8f034aa1-027a-450a-a6ae-6ce06cf776cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_929af5b2-f28d-4ca8-a576-4aada519d15f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_77576e6c-a796-4792-9224-95891c0453b0" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_929af5b2-f28d-4ca8-a576-4aada519d15f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_954aee11-295c-4c98-be16-f2338e867a45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_77576e6c-a796-4792-9224-95891c0453b0" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_954aee11-295c-4c98-be16-f2338e867a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_a86936d6-b308-4536-94ba-846b952a3367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_77576e6c-a796-4792-9224-95891c0453b0" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_a86936d6-b308-4536-94ba-846b952a3367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_662a01a7-b1ff-4cf5-bf49-9c375f0669fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_77576e6c-a796-4792-9224-95891c0453b0" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_662a01a7-b1ff-4cf5-bf49-9c375f0669fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_d4ef773d-e229-437c-9911-846d09deb704" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_77576e6c-a796-4792-9224-95891c0453b0" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_d4ef773d-e229-437c-9911-846d09deb704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_b77978da-7a0d-4587-a8c1-de169eb99efb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_43348ad0-40dc-4c4a-9f3c-ae936fe7c978" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_b77978da-7a0d-4587-a8c1-de169eb99efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DeferredTaxLiabilitiesFiniteLivedIntangibleAssets_8e8ba33d-cab0-4853-a5f4-e23fee85e6ba" xlink:href="lgnd-20221231.xsd#lgnd_DeferredTaxLiabilitiesFiniteLivedIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_b77978da-7a0d-4587-a8c1-de169eb99efb" xlink:to="loc_lgnd_DeferredTaxLiabilitiesFiniteLivedIntangibleAssets_8e8ba33d-cab0-4853-a5f4-e23fee85e6ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_5458309d-d7d4-411c-9605-195261b23ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_b77978da-7a0d-4587-a8c1-de169eb99efb" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_5458309d-d7d4-411c-9605-195261b23ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_574d40a7-15d0-45cf-9e7c-cc346dd56e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_b77978da-7a0d-4587-a8c1-de169eb99efb" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_574d40a7-15d0-45cf-9e7c-cc346dd56e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_a83c157d-0c3f-44d9-8b54-4df65f5791fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_b77978da-7a0d-4587-a8c1-de169eb99efb" xlink:to="loc_us-gaap_DeferredTaxLiabilities_a83c157d-0c3f-44d9-8b54-4df65f5791fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_a6be1e88-cbb4-49c9-b709-9cef360f026b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_b77978da-7a0d-4587-a8c1-de169eb99efb" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_a6be1e88-cbb4-49c9-b709-9cef360f026b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0ca82de8-2a6e-4371-be1c-2e65dfdcbd1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a094ee80-5681-4fc8-a4e3-e514f0b523dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0ca82de8-2a6e-4371-be1c-2e65dfdcbd1f" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a094ee80-5681-4fc8-a4e3-e514f0b523dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_e895e14b-1904-47ae-a072-980fb3dba182" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a094ee80-5681-4fc8-a4e3-e514f0b523dc" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_e895e14b-1904-47ae-a072-980fb3dba182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_589bff30-5ab1-4968-ac29-15b87482b1d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a094ee80-5681-4fc8-a4e3-e514f0b523dc" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_589bff30-5ab1-4968-ac29-15b87482b1d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_41cff1bf-02ab-4936-ba1b-6820ab90d788" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a094ee80-5681-4fc8-a4e3-e514f0b523dc" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_41cff1bf-02ab-4936-ba1b-6820ab90d788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_ffc60f4e-5abd-4a73-8885-6ba0d33b94a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a094ee80-5681-4fc8-a4e3-e514f0b523dc" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_ffc60f4e-5abd-4a73-8885-6ba0d33b94a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_50777d03-950d-48e3-8def-4fbcdd119d75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a094ee80-5681-4fc8-a4e3-e514f0b523dc" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_50777d03-950d-48e3-8def-4fbcdd119d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SelectedQuarterlyFinancialDataUnauditedSummaryDetails" xlink:type="simple" xlink:href="lgnd-20221231.xsd#SelectedQuarterlyFinancialDataUnauditedSummaryDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/SelectedQuarterlyFinancialDataUnauditedSummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_0ab496ba-0d46-41a1-bc9e-babf597a85b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0fc24398-1956-4c02-a399-d2ecf3ef3d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_0ab496ba-0d46-41a1-bc9e-babf597a85b7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0fc24398-1956-4c02-a399-d2ecf3ef3d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_8a0176ec-9935-4a14-b57a-317ec1d136fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_0ab496ba-0d46-41a1-bc9e-babf597a85b7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_8a0176ec-9935-4a14-b57a-317ec1d136fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_995b7ff6-e56e-4c48-99ee-c3ee9621b79c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_0ab496ba-0d46-41a1-bc9e-babf597a85b7" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_995b7ff6-e56e-4c48-99ee-c3ee9621b79c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_2fab12b5-bc5a-49dc-a59e-22b3aa4bc705" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_0ab496ba-0d46-41a1-bc9e-babf597a85b7" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_2fab12b5-bc5a-49dc-a59e-22b3aa4bc705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_23b74679-93fa-4a23-bd6b-2a530067a442" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_0ab496ba-0d46-41a1-bc9e-babf597a85b7" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_23b74679-93fa-4a23-bd6b-2a530067a442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_9d108eeb-91fa-4079-a80f-fad755a2e678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_0ab496ba-0d46-41a1-bc9e-babf597a85b7" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_9d108eeb-91fa-4079-a80f-fad755a2e678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ceed4771-a49a-4e80-94d7-58d92a8b4ba4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_0ab496ba-0d46-41a1-bc9e-babf597a85b7" xlink:to="loc_us-gaap_NetIncomeLoss_ceed4771-a49a-4e80-94d7-58d92a8b4ba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_d43695d5-7fc6-4575-b50f-8d9ba6b084d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_0ab496ba-0d46-41a1-bc9e-babf597a85b7" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_d43695d5-7fc6-4575-b50f-8d9ba6b084d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_ebacab59-9779-4ea0-bbf1-b9ee96f29815" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_0ab496ba-0d46-41a1-bc9e-babf597a85b7" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_ebacab59-9779-4ea0-bbf1-b9ee96f29815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_0bf0cd14-b9e9-42d1-a862-2e6616b68227" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_0ab496ba-0d46-41a1-bc9e-babf597a85b7" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_0bf0cd14-b9e9-42d1-a862-2e6616b68227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_4035d886-9801-401b-a133-bb1e14458e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_0ab496ba-0d46-41a1-bc9e-babf597a85b7" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_4035d886-9801-401b-a133-bb1e14458e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_fdabe428-2c85-4bd5-83f8-1c8fcf3fa6f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_0ab496ba-0d46-41a1-bc9e-babf597a85b7" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_fdabe428-2c85-4bd5-83f8-1c8fcf3fa6f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6b062f44-fc5b-4da5-85d9-cfe45f84958a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_0ab496ba-0d46-41a1-bc9e-babf597a85b7" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6b062f44-fc5b-4da5-85d9-cfe45f84958a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>lgnd-20221231_g1.jpg
<DESCRIPTION>LIGAND LOGO
<TEXT>
begin 644 lgnd-20221231_g1.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1#R17AI9@  34T *@    @ ! $[  (
M   -   (2H=I  0    !   (6)R=  $    :   0T.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $)O8F)Y+E9I
M9V%R<P    60 P "    %   $*:0!  "    %   $+J2D0 "     S$S  "2
MD@ "     S$S  #J'  '   (#   ")H     '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "O#/BA_R/ES_P!<H_\ T$5[G7AGQ0_Y'RY_ZY1_^@B@#D*FL_\
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M0#+P/\LB?4?U&10!L5X9\4/^1\N?^N4?_H(KW.O#/BA_R/ES_P!<H_\ T$4
M<A4UG_Q_V_\ UU7^=0U-9_\ '_;_ /75?YTQGTY1112$%%%% !1110 4444
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M0!\P45[KJ?PS\.:BQ=+:2R<]6M7VC_ODY'Y"L"?X-6[-_HVLRQCTDMP_\F%
M'E-%>I)\&5##?KI*]P+3!_\ 0ZT[/X1:)"P:[N;NY(_AW!%/Y#/ZT >-HC2.
M$12S,<  9)KO/"_PPO\ 4W2YUP/8VG7RB,2R#Z?P_CS[5ZEI7AO1]$_Y!FGP
MP/C'F;=SG_@1R?UK3H$06-C;:;91VEC"L$$8PJ(.!4]%%( J.XN(K2UEN+AP
MD4*%W8]%4#)-25R/Q-OVL?!%PJ-M:ZD2 $>AY(_)2* /'_$6N3^(=<GU"XR
MYQ$A/^K0?=7_ #W)K+HHIC);:VFO+J.WM8FEFE8*B(,EC7KOACX6V%C$EQKX
M%Y=$9\G/[N/V_P!H_I[5F?"#18Y&O-9F4,T;?9X2?X3C+'ZX*C\Z]3H C@@A
MMH5BMHDBC7[J1J% _ 5)112$%%%% '.^/O\ D0]4_P"N0_\ 0A7S_7T!X^_Y
M$/5/^N0_]"%?/],85Z[\'?\ D"ZC_P!?"_\ H->15Z[\'?\ D"ZC_P!?"_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "@@$$$9!Z@T44 >"^.?"<OAK67>*,G3[ABT
M#@<+WV'W'ZC\:Y>OIF_T^UU2QDM-0@2>"089''Z^Q]Z\I\1_"F]M':?P^_VR
M#KY#D"1?H>C?H?8TQGGE6++4+S39Q-874UM)_>B<J3^76FW5I<6-PT%Y!)!*
MO5)4*D?@:AH [&R^*7B6T4"6:WNP/^>\/_Q.*UHOC'?C'G:5;/SSLD9?\:\X
MHH ]+;XRW!7Y-&B!]3<$_P#LM4KGXO:U(,6UG9P#U*LY_GC]*X&B@#9U7Q;K
MFM*R:AJ,SQ-UB0[$/U5< _C6-14D%O-=3+#;1232M]U(U+,?P% $=:.A:%>^
M(=32RT^/<S<NY^[&O]XGTKJO#_PKU34&2;6&_L^VZE.LK#Z=!^/Y5ZOHVAZ?
MH%B+72[=8DZLW5G/JQ[F@"/P[H%KX;T>.PLQG'S22$8,CGJQ_P ]*U***0@H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** (+NQM+^'RKZUAN8_P"[+&&'ZUS5[\-/#-X2RV;V
MS'O!*1^AR/TKK** /.YO@[I;9^SZE=Q^GF!6_D!51_@RI8^7KI5>P:TR?SWB
MO3Z* /+O^%,>NO?^2?\ ]G5N'X.:<I_?ZI=./]A%7^>:]&HH X^S^%_AFTP9
M+>:[([SS'^2X%=-8Z98Z9%Y>G6<%LG<11A<_7'6K5% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
$4 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>lgnd-20221231_g2.jpg
<DESCRIPTION>CHART1
<TEXT>
begin 644 lgnd-20221231_g2.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1#R17AI9@  34T *@    @ ! $[  (
M   -   (2H=I  0    !   (6)R=  $    :   0T.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 %EE+"!8:6%O
M<6EN9P    60 P "    %   $*:0!  "    %   $+J2D0 "     S<P  "2
MD@ "     S<P  #J'  '   (#   ")H     '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MX_\ C=5R3[$^TAW1WU%<#_PN_P"'G_0P?^25Q_\ &Z/^%W_#S_H8/_)*X_\
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M6BJ]_?6^F:;<W]])Y5M:Q/--)M+;44%F.!R< 'I7$_\ "[_AY_T,'_DE<?\
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M?(W^J?WCR+]F[_DG%_\ ]A:3_P!$PU6_:5_Y$W2?^O\ _P#:;5[-7C/[2O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *\9_:5_Y$W2?^O_\ ]IM7LU>,_M*_\B;I/_7_ /\
MM-JTI?&C&M_#9\VU]P>$SCP3HA/ _LZ#_P!%K7P_17;4I\_4X*57V;>A]7?%
MGXCZ+H?@_4=-M;^"YU6]@:WC@A<.8PXVEVQPN 3C/4U\HT=>E>D> /@SKOBZ
MZCN=3AETK2 0SSS)MDE'I&IZY_O'CZ]*48QI1U82E*M+1'I'[-NBS6GA?5=7
ME0JFH7"1Q9_B6(-R/;<[#\#6U\>_$G]B?#I["%]MSJT@MUP>1&/F<_3 "_\
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M^'?%7_(Y:U_U_P __HQJ^XJ^'?%7_(Y:U_U_S_\ HQJZ,/NSDQ>R/1_V;O\
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M)Q]_<****S-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!,G_ *.AKZ;J*_QFF&_AA7SU^TU_R%?#_P#UQF_]"2OH6OGK]IK_ )"OA_\
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M_P#1C5]Q5\.^*O\ D<M:_P"O^?\ ]&-6.'W9T8O9'I_[-?\ R.NJ_P#8/_\
M:B5])U\1^%?&.L^#+^:\\/W"03S1>4[/$KY7(.,,#W KJO\ A?'C[_H*0?\
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M_P#7K#_*OH3X<:U?>(OAYI.JZK();NYC9I75 H)#L.@X' %?/?[0'_)5I_\
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M5?)OQX_Y*[J/_7*#_P!%+7/A_C.O%? 'P'_Y*[IW_7*?_P!%-7UE7R;\!_\
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M<44@%I&,JS@'G'H:^HJQG3<-SIIU(U-@HHHK,T"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MAO(9+CQ1Y\*2*TD0T_;O4'E<^:<9'&<&O=Z*T56:5DS%T:;=VA  J@*  !@
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M2;R_[.W;=S%L9\WG&:]QHJ8SE'8J=.,_B/ _^&8O^IN_\IG_ -MH_P"&8O\
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M/;/FG!S@@X/2O5Z*U=6;5FS%4::=TC@?B?\ ##_A8_\ 9?\ Q-_[-_L_S?\
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MF7C*^U[_ (2+[%]K\O\ <?8?,V;8U3[WF#.=N>G>O7:*J,G%W1$H1FK2/(O
M_P "?^$-\96.O?\ "1?;?LGF?N/L/E[]T;)][S#C&[/3M7KM%%$I.3NPC",%
M:)Y-X\^!W_";>+KG7/\ A(?L/GHB^1]B\S;M4+][S!Z>E5_!_P  _P#A$_%U
MAKG_  DGVO[&Y?R?L&S?E2/O>8<=?2O8:*KVL[6N3[&'-S6U"BBBLS4****
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MYC_O#&1D$=L]0#VKKJ*2;3NAR2DK,\#_ .&8O^IN_P#*9_\ ;:]2^'?@G_A
M?##:/_:']H;KAY_.\GROO!1C&YO[O7-=515RJ2DK-F<:4(.\44->TO\ MOPW
MJ6E>=Y'VZTEMO-V[MF]"N[&1G&<XR*\2_P"&8O\ J;O_ "F?_;:]\HI1J2CL
M.=.$_B1X'_PS%_U-W_E,_P#MM'_#,7_4W?\ E,_^VU[Y15>VJ=R/J]/L>':5
M^SA_9FLV5_\ \)5YOV6XCF\O^SMN[:P;&?-XSBO<:**B4Y2W-(4XP^$****D
ML**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHKQKXPZOK%GXRTNSTG5KRQ6>V4%8+AXU+&1ADA3]*3T ]EHKQY_AU\1TC+1
M^,Y'8<A3J%P,_I4'A?QYXE\-^,(_#?C9FF2618O,E(+QEN%8,/O*3CK_ $Q1
M<#VBBBOGS3/^$N\6^.-6TK2_$]]:FW>:4>9>RA JR!=H"D_WA^5#=@/H.BO&
MKKP+\3=/A-S:>*9KUT&?)6_E);Z!QM/XUL?#+XBWNN:A)H'B10-1B5C'+LVM
M)M^\K+V8<GMT/XEP/3:*1W6-&>1@JJ,LS'  ]:\7U[Q]XA\:^(&T/P#YD-NI
M(-Q&=KR =7+?P+Z=_P \4-V ]IHKQR+X%7=W'YNL>)"URPYV0&0 _P"\S G\
MA6=J.@^-_A@HU'3-4:_TR,CS0,E%'^W&2<#W!X]11=@>Z45SO@KQ?:^,M"%[
M;KY,\9V7$&<F-OZ@]0?\*Z*F 45P'Q?\33Z!X4BM]/N)+>]OY0B21.5=$7!8
M@CD?PC_@58_PB\2:F^KZMX=\17=Q<7L+&2,W4K.RE3M=<L<_W3CZFE?6P'J]
M%%<Q\1[NXL?AYJMS97$MM/&B%)87*,O[Q1P1R*8'3T5X-X4\/>._%NB#4['Q
MA=0Q&1H]LU_/NR/IGUK5F\'?%/25\ZQ\1O?D<A!>NQ/X2C'ZU-P/9**\@\,_
M%O4++6!HWCRU\B3?L-SY?EM&?]M>F/<8^E>O AE!4@@C(([TT[@+1113 **^
M>=!7QAXP\4:EI^F>*+ZV-N7D_>WTP7:'VX&"?6N@NO!?Q0TF,W5EXEFU!D&?
M*6]D9CCT60;34W ]FHKSCX9_$>?Q)-)HVO($U6%2RR!=HF Z@KV8>@_3%=YJ
MNJ6FBZ5<:CJ,GE6UNF]V_D!ZDG  ]33N!;HKPPZWXT^*FJS6^@R/INDQMABK
ME%53_?8<LQ_NCC^=:)^ TC1^8_B5C=8R6^RY&?KOS^/Z47[ >Q45X7+J'C7X
M3ZA"NI3MJFD2-M7<Y>-O8$\HW?'3ZU[-HNL6>OZ/;ZGITF^WN%W+ZJ>A4^X.
M10F!>HKRSXW:OJ6DVFCG2]0NK(R/*'-M.T>[ 7&=I&>M9MIX!^(5Y8P7,?C2
M8+-&LBAK^XR 1GG\Z+@>RT5X7+XD\=_#36((O$D[:G8RGK))YBR@==LA&X,/
M0^V17J&OP7OBSP6C>%M2-E+=B.:&Y$C1D)P<97D<<8HN!TE%>0?\*X^(G_0[
M2_\ @?<?X5R?@V'QIXUN+J+3_%=] ULJLQGOIN<DCC!/I2N!]%T5YCH'@7QQ
MIWB"RN]3\627=I#*&E@-Y.WF+Z8/!_&CXV:MJ.E:3I3Z7?W5DTD[AVMIFC+#
M:.#M(S3OH!Z=17C%AX$^(.H:;;7L7C294N84E56O[C(# $ _G6MHG@/QU8:]
M976H^+I+FUAG5YH3>SMYB@\K@\'/O1<#U&BJVHZA;:3IL]_?RB*WMT+R.>P'
M]:\6F\1>,?BCK$UIX::33M*C.&97*!5/0R..23C[H_\ KT-@>Y45X[_PH>62
M/S9_$K&Z/.[[*2 ?J7S^-9EQ<>-_A/>0O=W)U/1W;:-SEXS_ +//,;8!]OK1
M<#W6BL[0-<L_$>B6^IZ<^Z&9<X/5&[J?<&N"^-FK:CI6DZ4^EW]U9-).X=K:
M9HRPVC@[2,T7T ].HK.\/2R3^%]+EF=I))+.%G=SDL2@))/<UHTP"BO,?C9J
MVHZ5I.E/I=_=6323N':VF:,L-HX.TC-=[X>EDG\+Z7+,[2226<+.[G)8E 22
M>YI7U T:*X;XC?$.+P?:+:6*K/JUPNZ-&Y6)>F]O7O@?Y/%Z?\._&/C:-=0\
M5:W-9Q3#<D4N7;!_Z9@A5'M^E%P/;:*\9N?@MK.D+]J\,>(F-RG(0JT#$^S*
MQY^N*T/ /Q(U'^VQX8\:*T=\'\J&=UVL7[(X'&3V;O[YS1?N!ZM1113 **\E
M^--YK6C7FE:EI.J7MI!(K0R1P7#HA93N!*@X)()_*O3M(U!-6T6RU"+&VZ@2
M48[;E!Q2N!<HJCK>I)HVA7NHRXVVL#RX/<@9 _$\5XM\)_&6K7'CM+/6-4N[
MN&]B=$6YG9U5Q\P(!.!]TC\:+@>[T45Y)\9_$FI6.I:3I.B7MU:3R*TLGV:9
MHV?<=J#@CN&H;L!ZW16!K*7.E?#C4$%W,UU:Z5*/M/F,9"ZQ'Y]W7.1G/6N5
M^"NJ:AJOA[49-4OKF]D2Z"JUQ,TA4;!P"Q-%P/2:*\HO_A]X_N-2N9K;QC)%
M#),[QQB^G&Q220,#@8%<7XBA\:>&_$UEHEWXKOI9[Q8V22*^FVKO<H,Y(/5:
M5P/HNBO(/^%<?$3_ *':7_P/N/\ "O0+6UU#2/ +V^HWK7-_;V<F^Y$C,S,
M2&W'G/3FF!OT5Y9\$=7U+5K36#JFH75Z8WB"&YG:3;D-G&XG'2O4Z%J 45R?
MQ/O+K3_AQJES87,UM<)Y6R6%RCKF9 <$<C@D5!\*+Z[U'X?VUQJ%U-=3M+*#
M+/(78@,<<GFB^M@.SHHHI@%%<-\1OB'%X/M%M+%5GU:X7=&C<K$O3>WKWP/\
MGB]/^'?C'QM&NH>*M;FLXIAN2*7+M@_],P0JCV_2E<#VVBO&;GX+:SI"_:O#
M'B)C<IR$*M Q/LRL>?KBM#P#\2-1_ML>&/&BM'?!_*AG==K%^R.!QD]F[^^<
MT7[@>K45R/Q.M]1?P-=76C7EU:75D1<;K65HV9!PP)4],$G_ (#53X2>(Y?$
M'@P+?7#W%[92M%+)*Y9W!^96)/7@X_X#1?6P'<T45QGQ3\12>'O \[VDS0WE
MTZP0/&^UE)Y9@1SPH//8D4P.SHKC?A;#J0\#P7FLWUU>7-\QG5KF9I"B=% W
M$X&!N_X%7EVF?\)=XM\<:MI6E^)[ZU-N\TH\R]E"!5D"[0%)_O#\J5P/H.BO
M(/\ A7'Q$_Z':7_P/N/\*[[P5HVL:'H+6OB'4VU*Z,[.)FE>3"D#"Y?GL?SH
M Z&BO%/B7J6NM\4+/1]'UF\L5NT@B18KEXT#.Y7<0I]Q5M_AU\1U0M'XSD=A
MR%.H7 S^E%P/8**\5\/^/_$OA+Q4F@^.6::&1U4S2X+Q@G <,/O+ZYS^F*]J
MH3N 4455U/4(=*TJZU"Z.(;6%I7]PHS@>],"U17A>D:=XC^,&H75[J6I26.C
MPR%%CC!*@\'8JY )QC+'U%.\0>"]>^&=LNN>&M;FFM8F43QE=NW)_B7)5E)P
M/Q'UJ;@>Y45B>$/$4?BKPO::JB"-Y5*RQCHC@X8?3N/8BN3^*'C6^TF:T\/>
M&RW]K7V,N@RR*QVJ%_VB?RQ[T[Z >CT5X_'\#[JZM!=:EXBE.J,NXML+JK>F
MXMD_7BG> /%&LZ!XRD\%^*YFF^8I;RR-N*MC( 8\E6'3/3BBX'KU%%%, HK@
MOC%J-[IG@B.?3;RXLYC>(IDMY6C;&UN,@YQQ7&Z%X/\ 'VOZ':ZI;>,KB.*Z
M3>J27\^X#..<?2E<#V^BO&+CPU\5]!'GV6MOJ83G:MR93C_=E'/T&:UO _Q9
M?4M331?%=NMI?,WEQSA2BL_]UE/W6_3/I1<#U&BBO']%UO59?C]=:=+J=X]D
MLTX%LUPQC $9(^7..*+@>P45D^*YI;?P;K4]O(\4L=A.Z2(Q5D81L001T(/>
MO%/!VE>./&EA<7>G^+KR!()?*83W\^2< \8SZT-@?0-%>0?\*X^(G_0[2_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6 _(BO+_ (?:7I_CWQ ]_P"+-7GO]2M_F^P3+M5E!ZYZ%0?X0![\5[H!@8'
MH6NH!7B7P#_Y"FL_]<8O_0FKVVO$O@'_ ,A36?\ KC%_Z$U#W0'MM>2_'O\
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M,%N)(_,)!Q]SKC!Z^M=E_P *X^(G_0[2_P#@?<?X5*>@SK?BU_R2[5_^V/\
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MEX(O7CD0[UMGD*NI_P!B3^A_.CPC\5-2TO5ET'QW$Z.&$8NI%VO&>WF#N/\
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MIV0'AWPVN)/!WQ2U'PS>.?*N&:%2>A=?FC;\5)_[Z%>B?%'_ ))GK'_7-/\
MT8M8GCGX=:KK?C"S\0>';JTMKB$(9/M#LN70Y5AM4]L#\*ZKQ?HMWXC\%WNE
M6S0Q75S&@!D8[ 0RD\@9QP>U+I8#G/@K_P D[3_KZE_I7H#NL:,\C!5499F.
M !ZUXOI_PP^(>DVOV;3/$EK:0;BWEPWDRKD]3@)4[?"7Q?K#!/$GBSS8<\J)
M99\?16VBC4"M\3?%X\7WMKX4\*YO0TP,LD7(D<=%!_NCDD]/RKU3PKH,?AKP
MQ9:5&0QMX_WCC^-R<L?S)_"J/A/P%HO@^(G3XFENW7$EU-@N1Z#LH]A^.:Z6
MFEU ****8'B7P<_Y*-KO_7&3_P!&K7MM>=^ ?A_JOA7Q9J6IZA<6<D-W&ZHL
M#L6!+AN<J!T'K7HE); %>7?&_P .RZAH-KK%JF]]/9EF '/EMCG\"!^9KU&F
MR1I-$T<J*\;J59&&0P/4$=Q0]0.1^&_C"W\4^&8$:4?VC:1K'<Q$_,<<!_<'
M^>1785Y%KOPAU#3]6;5? >H_8WR6%NTA0IGLKCJ/8_F:CV?&@Q_9_D QM\[=
M:YQ]>OZ9I78':_$3Q=;^%?#$Y\T"_N8VCM8P?FW$8W?09SGZ"N>^"7AV33?#
MEQJUTA23467R@1SY2YP?Q)/X 52T+X0WU_JHU7Q[J)O9,Y-NLC.7]F<]![#\
MZ]8C1(HUCB541 %55&  .@ I];@>1?'W_CST/_KI-_)*]1T/_D7M._Z]8O\
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M"@#  'I7%?$WP5J/C2PL(-+FM8FMI6=S<NR@@@#C:IHMI8#I/#/_ "*6D?\
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M/QKUK5M/CU;1KS3YL;+J!XCD=-P(S7.?#CP=/X,\/2VE])!+=SSF61X&)7&
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M#_5?$GCS2];L;BSCMK..)9$F=@Y*2LYP I'1AWH>P'HE4=<_Y%[4?^O67_T
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MW4_$5U<6;VEW)<,B1NQD D?<,@J!TZ\TV!Z)1113 *\2^/G_ "%-&_ZXR_\
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M>SJ/SQZFN\^!/_(BWG_82?\ ]%1UH?$GX=MXSAMKG39((-2@^3?,2%DCZX)
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<2:Q.G9?J;OAS4[]_%.E*][<,K7D((,K8(WCWKZ?KY6\,_\ (V:3_P!?L/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MGL/85$L1!+34Z:&45YR7M%RHTM$TN/1="L]-A.5MHECW?WCW/XG)KR?XZ?\
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M:N/.U&X:0Y^5.BK]!5"BO9HX>G2VW[G@U\54K/WGIV"BBBN@Y0HHHH ****
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M]-G_ +3,<5N@QF-( 0&8^K8'!/-=5H?A36[3XP:9K-S8LFGP^&XK*2<NI"S
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M\\;K_O\ FGQ?"+PE&^6M)Y?9[AL?IBE]9@']BXGNOO\ ^ > V-C=:E>QVEA
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M5"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;U?!=\\+W<#?;K>!<K!GT/;U_P!G\:[BS\/>+/#?A&:VTR\;4]7O7+/+-/\
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M[^@KYSN+B:ZN)+BZE>::1BSR.V68GN35K6M7NM>UNZU2_8M/=2%R,_='91[
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M1E\J:YH.YYQ!-);SQS0.T<L;!T=3@J1T(KZL^'_B4^*O!EGJ,N/M(!BN,?\
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M2W&GV=U*DMS:P321\H\D88K]"1Q5D#%:2J75D91I6=V%%%%9&P4444 %%%%
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M:1M1KRHR<HCY6#S.Z+L5F)"C^$9Z4RBBMC **L6=C=:C<K;V,#SRMT5!G_\
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MNDZL]C#ILT=S-"6,DT?("GHN>_K7GM*E-S@I-6*K4U3J.,7=!1116AD%%%%
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M@ J2WN)K2X2XM96BFC.Y'0X*FHZ* 3:=T>AV>N:3XZM(]-\4[+35%&VWU!0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4BHKRY*4I=D>M0CSU8Q[GTRJA5"J, # 'I2T#I17R!]@%%%% !1110 4444
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M/FSWW9KPYMN]MF=N3C/I6%&M[5M6M8Z:]#V*B[WN)1116YS!1110 444H&2
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MG7-UV?@[Q+;&U?PWXD_>:5=<1NQ_X]V/0@]AG\C64DXOFC\SOHU(UH*A5?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-+VE&48K4^4:ZGP9KYT.T\1*'VM=Z7)%'ZE\C'Z$UZ'_ ,,\>OB4_P#@%_\
M9T?\,\#_ *&4_P#@%_\ 9U[=3&8:I'E<OP/#A@\3"7,HGB8&!@=JO:)8'5-?
ML+!1DW-PD7YL!7KW_#/ _P"AE_\ )+_[.M?PK\%$\.>)[/5Y=:^UBU8N(?LV
MS)P0.=QZ=>E$\?0Y7RO4(8"OSKF6AZC&BI&$0851@#V%/H%%?.'TH4444 %!
MHI",B@#Y^^/FI>?XLL+!6RMK:EV&>C.W^"_K7E5?0OBWX-R>*_%%UK$NO&#S
M]H6+[+NV!0!C.\?7\:QO^&>!_P!#*?\ P"_^SKW\-B\/2I1@V?/8C"8BK5<E
M$A_9]TW==:QJ;=$1+=#]3N/\A7N(KE_ ?@M/!&A2:>EW]L:2<RM-Y>S.0 !C
M)Z8]:Z@5Y&)J*K6<UL>QA:;I45%[@:^<?CEJ/VSQ^MJ#E;*U5,>C,2Q_3%?1
MK#->4>)/@I)XC\27NK3>(3$;J3?Y?V3=L&  ,[_:M<%4ITZO--F6.IU*M+DI
MH\ KW/\ 9^T[9IVKZDR_ZR5(%/\ NC)_]"%0?\,\#_H93_X!?_9UZ3X)\*)X
M-\-II27/VHB1I'FV;-Q8^F3VP*[<9C*52ERTWN<."P=6G5YYHY'XQ> YO$>G
MQZOI$7F:A9*0\2CYIHNN!ZD=1^-?/+ JQ5@00<$$8(-?:N.*XGQ7\*O#_BJ1
M[F2-K&^;K<VV!N/^TO1OKU]ZPP>.]DN2>QOC,"ZKYX;GS!2;1Z"O6+_X :Y"
M[?V;JEE<IV\X-$WZ BJ ^!7B[/W].'O]H;_XFO76,P\E\1Y+P>(B_A9YO0!N
M8 #))P .]>O:=^S]J4C@ZKK-M G=;>-I&_,X%>C>%_A=X<\+2)<6]L;N\7I<
MW1WLI_V1T7\!FL*F848+W=6;TLOK3?O:'(_"#X<3Z5*OB'7H3%<NA%I;N/FB
M!ZNP[$C@#M7I7B'0X/$&CRV,YVEAN1\<HPZ&M845X=2O.=3VG4]N.&IQI>RM
MH]SYTU72KO1M0>SOXC'*IX..''J#W%4J^A]7T.PURU\C4K99E_A/1E/J#U%<
M'J/PD.XMI6HX7/$=PN<?\"'^%?1X?-J<XVK:/\#XO&</UZ<G*A[R_$\UQ]#1
MT[8KLV^%GB ,0K6;#L?-/_Q-36WPHUF1A]JNK2$?[)9S_(5VO'X5:\Z/-658
MYOE]FSAL5T/A;PA>^)+E656ALE/[R=AC/LOJ:[_2/A?I-BRR7[R7\@YVO\J?
M]\CK^)KLX8D@B6*)%1%&%51@ 5Y>*S=6Y:'WGN8'A^7,IXIZ=E^IG^3:>'/#
ML@MD$5M9P,V/8 DD^]?($\[W5Q)<2$EYG:1B?4G/]:^O_$FD2:]X<O=+AN?L
MC7<1B\[9OV@\'C(SQ7E'_#/'_4R?^27_ -G7#@<13I<TJCU9[F-P]2IRQIK1
M'B=%>V?\,\#_ *&4_P#@%_\ 9T?\,\#_ *&4_P#@%_\ 9UZ7]H8?^;\&>;_9
M^(_E_(\3HKVS_AG@?]#*?_ +_P"SH_X9X_ZF7_R2_P#LZ/K^'_F_!A_9^(_E
M/,/!6F_VOXXTBR8;EDND+C'\(.3^@KZY!]*\T\%_!Y/"/B:+6'U?[:T2,J1_
M9_+P6&,YW'MFO2P,5X^.KQK5$X/1(]G 4)4:;4UJV+1117 >@%%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***1F"J6/
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M'_"%>)?^@)>?]^Z]ZLM3L-2\S^SKZUN_*;;)]GF638?0[2<&LOQ5XAO?#]K
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(_X6#X=_Y^I?^_#?X4?\+!\._P#/U+_WX;_"E["K_*_N']9H_P Z^\\G\9^
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M_P!1TC4-(G\K4[.:V?MYBX!^AZ&J==GIOQ)U".#[)K]O#K%FW#+.HWX^O?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MRKJ4****]L^?"BBB@ KLO!RKI&B:GXBF'S1)Y-OGNQ_^N0/SKCE4NP51EF.
M/4UV/C)AI&B:7X>A/,<8FGQW8_\ U\_I7/7]ZU/O^2W.G#^[S5>WYO8XYF9W
M9W.68Y)/<TE%%=!S!1110 5VF@8\-^#;O7' %W>?N+7/4#U_,$_A7*Z982:I
MJEO90_?F<+GT'<_@*Z#QW?QMJ4&DV?%KIL8C '0MCG\N!^=<]7WY*G\WZ'51
M]R,JO;1>K_R1RQ)))8Y).23WI***Z#E.F\(^"KKQ89WCN$MK> A6D9=Q+'G
M%9WB/P_<^&M7:PNV60[0Z2)T=3W]JO\ A/QI>>%&G6"&.Y@G(+1.2N&'<&L_
MQ%K]UXDU=[^\"HQ4(D:=$4=JP7M?:N_PG3+V/L5;XS+HHHK<YA\,,EQ.D,"%
MY)&"JHZDFNRU^:/POX=B\/63@W=P!)>RK[_P_P">WUJ/P?:0Z7I]UXGU!<QV
MX*6RG^-SQD?R_.N4O+N:_O9;JY;?+,Q9C[US/][4MTC^?_ .I?N:5_M2_!?\
M$AHHHKI.4**** "M30-"N-?U);:#Y8U^:64CB-?7ZU4L+"XU.^BL[--\LK8
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV\0F]CM5CTW4GM;=K8'$D8SAB23D\=1@4?6)A_8V%\_O.-_X5-XC_OV/_?\
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M_4"LCN/=**9 ^^%6Z\<T^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_?X?X5A>+O$NC>--)AT_5=/OXX8;A+A3;W"*VY>@Y4\<T?5*_P#+^0?7</\
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M?\*ZN@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1UHHKH.8].T3XKV]CH4-KJ%C/+<P1B-6B*[7 &!G)R/R->>:IJ,NK:M<W]P
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MI_@;6+$\M 1.@_7_ -E_6N4H **** "BBB@ KJ_%1^V>'-#U'JQB,3GW _\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@)_^RH Y2BBB@ HI\L,L! FB>,L,C>I&1^-,H ZGP%(&U:ZLV^[=6S+S[?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M10 4444 %;7A X\6V'O(1_XZ:Q:V?"(SXMT__KH?_030!7\0#;XDU$>EP_\
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MP_6OI.]&;<_6OG#4%V:I=J?X9W'_ (\:]3+]Y?(\?--H_,K4445ZQXH4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MYSS_ (5I"I3DW&+V,ZE*I!*4UN=3=+_:_P ,+:9?FETN8H_J%/'\B*XVNM\
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MJX:M75/$NKZS;1V^I7KS11G(7:!D^IP.3]:RJ  ]*ZKQU^[ETJW_ .>=FO\
MA_2N9MH_.NX8NN^15_,UT7CZ3=XF\H=(8$3^O]: .9HHHH **** "O=?"$7E
M>'K-/[MNG\J\*QGCUKZ!T./RM+A3&-D:+^0H T:*** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH 1QNC8>HQ7AGQ(A\OQ89,?ZZ!&_$9']*]TKQ_XKV^S4
MK&8# *.GY'_Z]=N"=JR\S@S"-Z#?:QY_1117NGS@4444 '3IUKL/'^)FT>]'
M2>R'/KCG_P!FKCZ[#7?]-^'6AWG5K=C Q]!T_P#916%32I!^J^]'32UISCY)
M_<SCZ***W.8**** .P\#_P"EZ=KNFGK-:[U'J1D?U%<?73?#^Y^S^+X$)PL\
M;Q'\LC]0*P]4MOL>KW=L1CRIF4#VSQ^E80TK27>S_0Z9^]0@^UU^I5KT7X9^
M*-'T6SN[75)EM99)!(LK X<8QC(]/ZUYU15U::JPY69T:LJ,^>)T7CK6++7/
M%<]YIHS!L5-^W'F$=6_I^%<[1150BH145T(G-SDY/J%=CH8_M#X<:U9#E[9Q
M.H]N#_[*:XZNM^'<ZG6[FPD/R7MLR$'U'_ULUEB/X?-VU^XWPO\ $Y7UNOO.
M2HJ2X@:VNI8'&&B<H<^QQ4=;G-L%%%% $]E<M9W]O<KUAD5_R.:Z3XA6RIXB
M2\BYBO8%E5AW.,'^GYURE=EJ0_MGX;6%Z/FFTV3R9/7;T_\ B:YZGNU(S^7W
MG32]ZE.'S^[_ (!QM%%%=!S!1110!UO@"YCDO[S2+D_N=0@*8/\ > /]":Y>
M[M9+.\FM9AAX7*-]0<4ZRNY+"_@NX3B2&0.OX&NF\=V<<MS:ZY9\VVHQAB1V
M<#_#^1KG^"MY2_-?\ ZOXE#SC^3_ .#^9V&B_%/2(]#A34TGCNX8PC)''N#D
M#&0??WKS/7]6;7->N]1:/R_/?*IG.T 8 _(5G5KZ+X9U/79!]C@VPY^:>3A!
M^/?\*4:-*@W/8)UJV(2I[V,VVN)+2ZBN(&VR1.'4^A%>A:OX7_X2N>RUFVD2
MRBN8 UT91@J1W [^GX572V\-^$.92-6U->W&U#_(?J:FTKQ4VNZA/INMB-;6
M]3RXPHP(V[<^_P#/%<%?%IR3I].IZ>'P+4&JNSZ$0U/P_P"%%,>AP"_O@,-=
M2'(!]C_0?G7-:GK%]J\WF7\[28^ZG15^@INJZ;-I.I2V=R/FC/#8X9>Q%5*\
M^4I3=Y.YZ<81@N6*L@KV?X<26C>#X%M2OF*S>>!UWY[_ (8KQBI;>[N+1R]K
M/+ Q&"8W*Y_*I*.V^*LEH^N6JP%3<K"1-M[#/R@^_6N$I7=I'+R,69CDLQR3
M24 %% !)P!DGH!005.&!!'4$4 =Q\,=6L=.U2[@O9$A>Y11%(YP,@G*Y]\C\
MJZ7XC:UIZ^&9;$3137-PR[$5@2H!!W'TZ?K7D5'2@ HHHH Z[P[\0KW0=-%C
M);)=PQY\K<Q4H/3W%8>NZY=^(-3:]O=H;&U$7[J+Z"LVB@ HK6\-:%)XBUJ.
MQCD\I=I>23&=JCKQZ\@?C78^(?AG;66C37>EW,S2VZ%V24@AP.N,=#0!YQ11
M10  X.1P:ZF/XB^((].%H)XB0NT3F/,@'UZ9]\5RU*JEF"J"6)P .YH U_#>
MEOK>O1I+EHE;S9W/IG)R?<TOBG5?[6UV62,_N(?W4('3:._XFMB](\)^%5L4
M.-3U ;IB.L:>G]/SKCJ "BBB@ KK;G_B2_#R&#[MQJ<F]AWV=?Y ?G6%H>F-
MJ^LV]FOW7;,A]%')J]XQU);_ %YXX#_H]HODQ@=..OZ_RH P:**]@L/AQH7]
MBQQW,337$D8+7 D(()'89QB@#Q^BK&H6OV'4KFTWA_(E:/<.^#C-5Z +.G6K
M7VIVUJO6655_#/-;/CFZ%QXE>&/_ %=K&L0 [<9/\_TJ3P-;*=7FU";B&QA:
M0D^I''Z9KGKNX:[O)KF3[TSES^)H BHHHH **** .K\+_P"A>&=<U$\'RA"A
M]R/_ *XKE!Q75WW_ !+_ (;V4'1[Z8R-[@<_T%<I0 4444 %%%% !75V?^A_
M#2^E/!N[@(/<#'_UZY2NKU__ $/P3HEET,F9F'Z_^S4 <I1110 4444 :7AR
M'[1XET^/&1YZD_0<_P!*F\63>?XJOVZ@2;1^  JYX$@$OB=)6^[;Q/(3Z<8_
MK6%?3FZU"XG/665G_,DT 04444 %%%% $]C#]HU&VAZ^9*J_F0*^@[$8M_J:
M\+\+0_:/%-@F,@2[C^ S7N]L,6Z8],T 2T444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 5YO\6;3?I$-P!S#<#\ P_QQ7I%<K\0;/[7X5O@!EEBWCZJ<
MUM0ERU8OS,,1'GHR7D>$T445](?*!1110 5V.E_Z=\+]4M^K6DXE4>@X/^-<
M=78?#YUN+G4M*D^[>VI 'J1Q_(UAB-(<W:S.G"ZU.7NFCCZ*<Z-%(T;_ 'D)
M4_44VMSF"BO4K?X9:5+X.6\:ZE^V/;>?YP;Y =N[&/3M7EM94ZT*M^7H;5:$
MZ5N;J6]*NS8:Q:78./)F5C],\_I6W\0+06WBR:11\ERBRCWXP?U%<S79>+/^
M)EX3T+5EY(C^SR'W _Q4U$_=JQEWNOU+I^]1G'M9_HSC:***Z#F"BBB@ J]H
ME\=-URSO <"*52W^[T/Z$U1HI-*2LQQ;BTT='X[L19>*YW0?N[I1.I'?/7]0
M:YRNSU__ (G7@/2]6'S36A^SSGVZ9/X@?G7&5C0;=-)[K3[C?$Q2J-K9Z_>%
M%%%;G.%=?X#F2[_M'0K@XCOX#LSV<#_#G\*Y"K.G7TFFZE;WD/WX9 X]_4?E
M6=6'/!Q1K1J>SJ*3V_0BGADMKB2"8;9(V*,/0@XJ.NK\>6$:ZG#JUIS:ZC&)
M PZ;L<_I@_G7*4Z<^>"D*K3]G-Q"BBIK6TN+VX6"SA>:5NB(N35WMN9I-NR(
M:[;PJI\1>%[[0)U):']]:RD'"-Z9[<_S-+9>"K/2[=;WQ;>+"O5;6-OF;V)'
M7Z#\Z?=>-C;*EMX>M([*TC8$?*,N![=L_G7F8G%0:Y8:ON>OA,'43YIZ)]!T
M/AS0_#,:S^([A;V[QE;2/D ^X[_C@52U?QC?:A']GM +&T P(H>"1[G^@JSX
MKLXK^U@\1:>/W-R MPH_@?IS_+_]=<K7F5*LZCO)GK4Z,*2M!!0"000<$=".
MU%%9FIV<3)XTT'R7*C6;)?D8\><O^?U^M<=)&\4C1RJ4=3AE88(/I4EI=SV-
MU'<VLACEC.585UMY:6_C.P^WZ<$BU:)?](M\X\P>H_Q_"@#C**<Z-'(R2*4=
M3AE88(--H **** /2OA5I]E+;WEY)&DEVD@0%ADHN,\?7U]JL?%/3[)=)M[T
M(D=WYP0$#!=2#D'UQ7G.FZM?:/<_:--N7MY",$KT8>A!X-.U36=0UJ=9=3NG
MG91A0> OT X% %&BBB@ KO=&^&$VH:3'=WM]]FDF0.D2Q[L ]-QR/RK@J]6T
M/XDZ4NBPQZIYL-S#&$8+&6#X&,C'K0!YOK.DW&B:M-87>#)$>&7HP/0BJ-:W
MB;6_^$@UZ:_"&.-@%C0]0HZ9]ZR: -7PWKLOAW6H[^)/-4 I)'G&Y3U&?R/X
M5V'B'XF07^C2V>EVLR27"%'DEP-BGKC!.37G5% !1110 5UGAW3H=(L&\1:P
MN%0?Z)"W61NQ_P /SJ'0/#\*VW]L:^?)L(_F1&ZS'MQZ?SK.U_79]<OO,<>7
M;Q\0PCH@_P : *>H7\^IW\MW=-NDD.?91V ]A5:BB@ HHK6\-Z,=:U=(6XMX
M_GG?T4=OQH V=('_  CGA.XU>08N[T>5:@]0OK_7\!7($DG).3W-;?BG61JV
MJ;;?Y;.V'EP*.F!W_'^6*Q* "NDM/'NOV>EK8PW*;%7:DC("ZCT!KFZ* %9F
M=BSDLS'))/)-)15S2-.?5=6M[./_ ):/\Q]%[G\J .A/_$E^'>#\MQJDGX[/
M_P!0_6N2KH?&FH)=:W]EM_\ CWLD$* =,CK_ (?A7/4 %%%% !4EO US=101
M\M*X0?4G%1UT?@BR6XU_[3-_J;-#,Q/8]O\ '\* )/'4ZKJEMIT/^JL8%0 >
MI_\ K 5S%6M2O&U#5+F[;K-(6'L.WZ8JK0 4444 %%%% $MM US=PP)]Z614
M'XG%=%X\G5M=BM(_N6D"Q@>A//\ +%5O!=I]K\4VQ(^2 &5O; X_4BL[6;O[
M?K=Y<YR))6*_3.!^E %*BBB@ HHHH ZOPC_HFBZYJ!X\NW\M3[D$_P"%<H.E
M=8W_ !+OAFHZ/J%QGZJ#_P#8UR= !112D%6PP((Z@C% "4444 =5\/+;SO$I
MEQGR(68?4X']37LZKM0+Z#%>8_"ZTS]LN#_$Z1CWQR?YUZ?0 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 51U>V%UI\D3<K(K(WT(Q5ZH[A=T#CKQ
MF@#YGGA:WN)(9/O1N4/U!Q4=;_C:R^P^+KU0,+*PE7_@0S_/-8%?40ES14NY
M\A4CR3<>P44451 5L>%+W[!XJL)B<*90C?1N/ZUCTJL48,APRG(/H:F4>:+B
M^I4).$E)=#9\767V'Q9?Q 85I/,7Z-S_ %-8M=CXY5;ZTTC6XQQ=6X20_P"T
M.?ZD?A7'5G0ES4U?^K&N(BHU7;;?[]3077M572SIJZA<"S(QY(?Y<>GT]JSZ
M**U22V,7)O<*[+0/^)MX!U?2S\TEJ1<Q#]3_ "/YUQM='X%U 6/BB&.4_NKM
M3 X/3GI^H_6LJZ;IW6ZU^XWPTDJB3V>GWG.45?US3SI6N7=D1@12$+[J>1^A
MJA6L6I*Z,)1<6TPHHHIB"BBB@#L?!$B:C8:IX?G.!=Q&2'/9Q_D'\*Y"2-X9
M7CD&UT8JP/8CK5K2-0?2M7MKV/K#(&(]1W'Y9K<\=Z<EMK:W]M@VNH()D8=,
M]_Z'\:YU[E9KI+\T=3_>4$^L?R?_  3EZ***Z#E"BBB@#M-!QXD\&W>AN<W=
MG^_M<]2/3]2/QKC5C=I!&J,7)P% R<^F*Z_P9X>U>/4X-6P+*UB.6>?C>O<
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^)O$-MX4\.W.LZA%<S6]L 62VCWN<D#@9 []2:T+.Y%[90W4*R!)HUD4.I#
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MI7OEE$(K8 #&>GTH L4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4?#'Q\AT;^W=2U.TU+2&NIUOIM_[T$\J!@*/EX ' .*[OQW_ ,BE/_UTC_\
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M/Z?SKU@ *H Z 8KGO!VDC2]#MX6&'5=S_P"^W)_PKHJ "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*R#\V %;L4L<T:R0NLB,,JR'(/XT .HJMJ&H6NE6$E[?R^5;Q8WOM+8R0!P
M3U(K$_X6%X8_Z"?_ )+R_P#Q- '245S?_"PO#'_03_\ )>7_ .)J_8>)]%U.
M41V6I022$X"$[6/T!P30!JT451U76;#1+5;G5)_(A9Q&&V,V6()QA0>P- %Z
MBL&S\;>'K^\BM;34/,FF8*B^3(,GZE<5O4 %%<W_ ,+"\,?]!/\ \EY?_B:/
M^%A>&/\ H)_^2\O_ ,30!TE%<W_PL+PQ_P!!/_R7E_\ B:T-4\2:3HT=O)J5
MUY*W(+1'RW;<!C/0''4=: -2BN;_ .%A>&/^@G_Y+R__ !-'_"PO#'_03_\
M)>7_ .)H Z2BN;_X6%X8_P"@G_Y+R_\ Q-6M-\7:'J]ZMIIU[YT[ D)Y3KD#
MKR5 H VJ**I:KJ]CHMH+G4Y_(A+A VTMEB"<8 )[&@"[17-_\+"\,?\ 03_\
MEY?_ (FMZTNH+ZTBNK202PS*'1QW!H FHHJCJNLV&B6JW.J3^1"SB,-L9LL0
M3C"@]@: +U%<W_PL+PQ_T$__ "7E_P#B:!\0?#!./[3_ /($G_Q- '245G:=
MX@TG5FVZ=?PSO_<#8;_OD\U?=Q'&SMG:H). 2<?0=: '45S?_"P?#'_03_\
M)>7_ .)K8TO5K+6;/[5IDXGAW%-VTKR.V" >] %RBBL"[\;^'K&\EM;K40DT
M+%'40R-@CJ,A<4 ;]%4-)UO3]<A>;2YS/'&VUF\ME /7'S 9J_0 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"MKXEB6WN@,1WL8Q^?I_+Z4 <A16SK7AB]T?][Q<VC<K<1<C'OZ5C4 %%%%
M!1110 45Z)X4^'VGZOX=CO\ 4)YO,N 3&(F " ''/')XKAM5L3IFK75B7$AM
MY6CWC^+!ZT 5**** "@'!!':BB@#TVS\?:3):1M>-+#/CYU$989]B*F_X3O0
M?^?B7_OPU>644 >I_P#"=Z#_ ,_$O_?AJ/\ A.]!_P"?B7_ORU>644 >I_\
M"=Z#_P _$O\ WY:E_P"$[T'_ )^)?^_+5Y710!ZI_P )WH/_ #\R_P#?EJ/^
M$[T'_GYE_P"_+5Y710!ZI_PG>@_\_,O_ 'Y:C_A.]!_Y^)?^_+5Y710!ZI_P
MG>@_\_$O_?EJ3_A.]!_Y^)?^_#5Y910!ZG_PG>@_\_$O_?AJP?%WBVQU32A8
MZ=ODWN&=V7: !S@9KBJ* "BBB@ HHHH **** "BBB@ HHJYINDWNKW AL(&D
M/\3=%7ZGM0!3KI-)\*;[;^T=>E^PV"C.&X>3Z#M_.KPAT3P@ UR5U/51TC'W
M(C_G\?I7.:MK5[K5SYM]+N ^Y&O"I]!_6@#5UCQ2)+7^S="B^Q:>O!V\-)]?
M3^=<W110 5J>'-:;P_KD.H+$)0F59,XRI&#@^M9=% '5^-/&2>)TMX+:V:"&
M%BY,A!9F(QVZ"N4HHH *OZ1H]UK5\MM:+[NY^Z@]33M%T2ZUR]$%J,(.9)2/
ME0?Y[5MZOK=KH]BVB^'#A>EQ=C[TA[X/]?RH -;U>VT>P.A: W XNKD=7;N,
M_P"?2N3HHH *<R.F-ZLN1D;AC-3Z=/%;:G;3W,7FPQRJSQ_W@#R*[;Q]XIT;
M6]'MK?33YTZR!]^PKY:X.1SZ\<>U ' 4444 %7M'TJ?6=2CM+8<MR[XX1>Y-
M5;>"6ZN$@MT,DLC;54=2:]C\'>%X]&T\"0!IWPTS^I_NCV% &OH6D0:5I\4$
M";4C&%]3ZD^YK4HHH **** "BBB@ HHHH **** *FK?\@6^_Z]Y/_037SQ7T
M/JW_ "!;[_KWD_\ 037SQ0!U-K\/-=O+"&[@2W,<\:RH#+@D,,C^=8.I:7>:
M1>&UU&!H)0,X;N/4$<$5[KX;_P"15TG_ *\H?_0!7#?%N2 S:9&-OV@+(S<<
M[3C'Z@_K0!'\,_$MQ]N_L2[D:2*12UON.2A R5^F 3^'O5WXM?\ 'AIO_75_
MY"N/\"QO)XVTX1C)5RQ]@%.:[#XM?\>&F_\ 75_Y"@#SW1M*GUO5H=/M'C2:
M;=M:4D*,*6.< ]A6_??#;7[*!I56WN@HW$02$G\B!FJWP]_Y'O3_ /MK_P"B
MFKVFYN8;*UDN+J58H8UW.['  H ^=H9I;:=)H)'BEC.5=#@J?8U[EX.UM]>\
M-074_P#KU)BF(&,L._XC!_&O#[V59[^XFC&$DE9E'H"<U[!\-K26U\'HTPV_
M:)FE0?[/ '_H- $WC7Q4/#>F!;?:U]<9$0/.P=W(_E[UXS--<ZA>-),\EQ<3
M-R3EF8FMWQ[J#:AXQO,D[+<^0@)Z!>OZY/XUN_"S1XKF^N=4G4,;;"0@CHQZ
MM]0./QH R;;X<>(KB%9#;Q0[AD++* WY#I6+J^A:CH5P(=3MFB+<HV05;Z$<
M5]!5C^*M(BUGPY=6TB@R*ADA..5<#(_P_&@#S;P-XPFT>^CL+Z4MI\S;1N/^
MI)[CV]1^->PU\VU[UX2OGU'PEIUS(<N8MC'U*DKG]* /%_$G_(U:M_U^S?\
MH9J]HW@O5M>T_P"V6 A,6\I\\F#D?A5'Q)_R-6K?]?LW_H9KU#X8_P#(G_\
M;P_]* /,-9\.ZGH,B+J=L8P_W'!#*WXBM7P/XEGT76H;>25C8W#A)(R>%)X#
M#TP>OJ*[GXGR0KX1V2E?,:=/+!ZY&<X_#->1VJ-)>0I&"7:10H'<YH ]I^(7
M_(B:A_VR_P#1JUXG%&99DC7 +L%&?>O;/B%_R(FH?]LO_1JUXQ9?\?\ ;_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#3L_#6L7]NL]K82/$W*L2%S],D5/_P (=K__ $#G_P"_B?XUZRB+&BH@PJC
M ["G4#/)/^$.U_\ Z!S_ /?Q/\:/^$.U_P#Z!S_]_$_QKUNO.?$WQ*UK2O'L
MOA?P]X2_MRXBLUNV9;X0G8>O!4YQ[')]* ,K_A#M?_Z!S_\ ?Q/\:/\ A#M?
M_P"@<_\ W\3_ !I[_&@WNF>&;[2M/C@75-5_LZ^BO"2UN1MR5(('1LY/Y5Z+
M9^)-#U"QN;RPU>QN;6U)$\T5PK)%CKN(.!^- 'F__"':_P#] YO^_B?XT?\
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M!NEA2U3NTS@8_ 5;_L'P[IG_ "%]:^T2#K#:C].,_P!*!')CD@#DGH*V-/\
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MH_[J?^AK7BMC"MQJ%O#)G9)*J-CT) KVKQY_R(^H_P"ZG_H:UXSI7_(8LO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MLM],,2R#HH_NK[?SK:U;_D"WW_7O)_Z": /GBO>-4TP:QX,>RQEI+93'_O@
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M; ?1F(Q^BFN1TS2+[6+H6^G6SS.>I4?*ON3T KVOPMX=B\-Z,MJK"29SOFD
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M 8%%.='C<I(K(PZJPP13: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !5*?1=+NI#)=:;9S.3DM)
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
*4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>lgnd-20221231_g3.jpg
<DESCRIPTION>CHART2
<TEXT>
begin 644 lgnd-20221231_g3.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_X1#H17AI9@  34T *@    @ ! $[  (
M   *   (2H=I  0    !   (5)R=  $    4   0S.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $QI+"!*96YN
M>0  !9 #  (    4   0HI $  (    4   0MI*1  (    #,C(  )*2  (
M   #,C(  .H<  <   @,   (E@     <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0
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MV9R>@ #9)IV9K[&HOLO[C8HHHI&04444 %%-DD2*-I)75$499F. !]:Y:_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%C>:]>20O<"26-'\M61 78$+@8(7&/>O,J]7_9^TS[3XTO;]QE;.T(4^CNP
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M+% ]J[=6AZ%??:2/P/M7/5I)+FB?/9IE,*,/;4-ENO\ (]=HHHKF/F@HHHH
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M9]+/):%"C*I4DW9-]CZEHHHKD/E HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH 1F"*68A5 R23TKG-5^(7A/12PU#7K-74<QQ/YK#
M_@*9->,?'W69KCQK#ID<SB"UM$WQACM+L2V2/IMKRFNF%%-7;/I<'DL:U*-6
MI+?HO\_^ ?7'A+X@:1XUO;R#0X[IDLU5I)Y8PBDL3@#G/\)Z@=*ZFO*/V?=-
M^S>"[Z_88:[O"H]U10!^I:O5ZQFDI-(\;&TJ='$2IT]D%%%%0<84444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% ',^/_%D?@WPA=:D2IN6'E6J
M'^*5AQ^ Y8^PKY'FFDN)WFG=I))&+N[')8DY)-=_\8_&7_"3^+VL[23=I^F$
MPQ8/#R?QO^8P/8>]>>UWT8<L3[S*<']7H<TOBEJ_T1Z#\&/"Y\0>.X;J=-UI
MI>+F0GH7_P"6:_\ ?0S_ ,!-<-?J4U*Y5AAEE<$>AR:^H/A'X6_X1GP);F=-
MMYJ&+J?(Y&1\JGZ+CCU)KYG\01^5XEU.,'(2[E7/KAS1"7--A@\5]8Q=6VRL
ME\KDOA:[-CXPT>Z!QY-]"_X!P:^S*^($=HY%=#AE((/H:^VK2X6[LH+A!A9H
MUD SV(S66(Z,\OB"/O4Y>OZ"W,Z6MK+<2_<B0NV/0#)KY;;XS>/"Q(US:">
M+.#C_P <KZ"^(^I?V3\.-;N00&-JT*D^LGR#_P!"KY$HH133;09'A:=2G.=2
M*>MM5?\ K<]!T[XN>/;S5+6U_MS/G3)'C['!SE@/[GO77_$+XWSPWLVE^#61
M1$Q234&4/N(X/E@\8_VCG/;UKQ!&9'5HR593E2IP0:[J/X.^+7\,MK1MX(T6
M(R_99)")R@&<[<8Z=B<^U:RA!--GJU\)@85(SJ**[+17?ZF*_C_Q=)/YS>)=
M4#9SA;MPO_?(./TKUKX4?%N\UG4X_#_BB19;B48M;O:%+L!]Q\<$D#@_@<YK
MP2K&GWLNG:E;7MN2LMM*LJ$'&&4@C^55*G&2L;XK 4:])PY4GT?8^V:^;?%G
MQ=\7VGC#5K72M8\JSM[N2*%!:PMA58J.2A)Z=S7T7?W::?IUS>3?ZNWB:5N<
M<*"3_*OBFXG>YN99Y3EY7+L?<G)KGH13NV?/9'AZ=64Y5(II6W5SM/\ A<OC
MW_H._P#DG!_\17H7BOXSSZ%H6GZ;IICO-=:SA:]NG4;(I"@+?*."V3G'0?H/
M!:[CP[\)_%7BO2&U>UCABADRT9NY2K3^Z\'\S@&MI0@M6>WB<'@HN,ZJ44O)
M*YEW?Q#\7WLYEF\2:DK$YQ#<-$O_ 'RI KN?AS\9=4M=7M],\5W)O+&X<1K=
M2_ZR!CT);^)?7/(ZYXQ7DUS;RVEU+;7*&.:%S'(AZJP."/SJ.K<(M6L=-7!8
M>M3Y'%6\E^1]PUX!\2OBEXHT7X@:CIN@ZM]GL[8HBI]GB?YMBEN60GJ37L?@
MJ^DU+P+HMW/S++91%R3G<VT G\<9KY/\4:E_;'BS5=0#;EN;N213_LECM_3%
M<M&*<G<^9R?"QGB)JHDU'3776_\ P#H_^%R^/?\ H._^2<'_ ,17;7?QBU32
M/AOI?F7*7OB/44DE:5HD"V\?F,JDJH )(7@8]S[^(U;M+'4=8N!%86ES?3!0
M D$32, !@< 'TKI=.+Z'T57+\+*S<$DG?9+^D=7X?\7^,->\9Z;:GQ'J>^[N
MXXV"W+*@!89.P';@#)Z5],>(?$6F^%]'DU+6;@0P)P.,L[=E4=S7@7P=\*ZC
M#\3X'U;3KJS-C;R7&VYA:,Y(V#A@/[^?PK!^)_C.7QAXMF>.0G3K1C#:)GC:
M#R_U8C/TP.U92@ISLMCR\5@X8S%QI0LHQ5W;SZ'1^)?CUKVH3/'X=BCTJVY"
MNRB29AZDGY1] ./4UQ5QX_\ %UR^^3Q+JBG_ *9W3QC\E(%<]7<^'?A#XI\2
MZ*-4M(K>WMY%W0BZD*-,/50 >#V)P#6O+""/4]A@L)"[22\S/T_XF>,M-E5X
M?$-[+M/W;F3S@?J'S7L?PX^,D?B:\CTCQ#%%::C)\L,T?$<Y_NX/W6_0^W K
MYYO+2>PO9K2\B:&X@<QRQMU5@<$5'%*\,R2Q,4D1@RLIP5(Z$4I4XR0L3E^'
MQ,+<J3Z-?UJ?;]?./B_XB_$'POXMU#29-=;;;RGRF-E!\\9Y0_<]"/QKW;PC
MK#>(/!^EZI)CS;FV1Y,# WXPWZ@UY9^T%X9\RVL?$ENGS1G[+<D#^$Y*'\#D
M?B*Y:5E.TCY;*_9PQ3HUHIWTU5]4<#_PN7Q[_P!!W_R3@_\ B*]K^$'C"^\7
M>$YY=9N/M%_:W)CD?8J;E(!4X4 =R.G:OERO0?A5XXB\%MKLMR=RR60>&(G_
M %DRL B_^/G/L#714IIQT1]!F.7TYX=JC!*6EK)(]%^+_P 3[WPS=V^C>&KE
M8=0&);F;RU?RU(^5,,",GKTZ8]:\Q_X7+X]_Z#O_ ))P?_$5R&HZA<ZKJ5Q?
MWTIEN;B0R2.>Y)S6WX'\%WWC;Q EC: QVZ8:ZN<9$*9_5CV'?Z9IJG",=36E
M@<+A</\ O8IVW;2_KT/2_AIXC^(GCC6=UQKCQ:3;,#<S"S@!<_\ /-3Y?4]_
M0<^F8OBI\3_$FA>/+C2_#VIBUMK:*-7001/ER-Q.64GHP'X5[1H>B6'AW1X-
M,TJ$0VT"X4=V/=B>Y/4FOD7Q=JG]M>,M6U'.5N+N1DYS\NXA?T K*G:<V[:'
MEX!4<;BY3]FE"*T5E][\SH/^%R^/?^@[_P"2<'_Q%>X_"36=;\0^"?[4\17A
MNYI[EQ"WE)&!&N%QA0,_,&YKY6K[ \!:9_8_@#1;(C#):([CT9AO;]6-.LHJ
M.B+SJE0HT$H02;?1(\U^,'Q&\0^&O%\&F^'=1^RQ+:+),OD1OEV9O[RD] OY
MUP/_  N7Q[_T'?\ R3@_^(J#XKZC_:?Q0UF0-E891;J/3RU"G]0:XZM80CRJ
MZ/2P>"H+#PYX)NRW2/>_!GQ;FLO MYK'C74#>W+7;0V4$<2(\NU%) "@#&6Y
M8_\ UJX/Q%\9O%FN3M]DN_[)ML_+#:<,![O]XGZ8'M6)X1\":[XWN)(]'B00
MP<27$[%8D)[9P23[ &LWQ!H5YX9UZYTC4P@NK8@/Y;;E.5# @^X(-)0@I/N3
M1P>"C7E9)RWMV7H:VF_$GQAIETL\/B"_F*G)2ZF:9&]B')KZ T[XIZ._P[MO
M$^K.+8R9B>VC^9FF7JJ#OGK[ C)KY7K<\-^'-<\8WD>E:-$\XARYWOB* '&6
M)Z#.![G'>B=.+U8\;E^&K14IVC;=[:'6>)_C=XFUJ=TTF4:/9Y^5(,&0CW<\
MY^F*YFW^(/B^UN!-'XEU-G!SB6Y:1?\ OEB1^E1^+_!^I^"M833M8,+221"6
M.2!RR.I)'!(!Z@]16#51C"VB.FAA\+[->RBN5^1]5?"SQS+XW\-22WZHNH6<
MGE7&P85\C*N!VSSQZ@UVS,J*6<A549))P *\2_9QB80^(I2/D9K90?<>9G^8
MI/CKX\EBD_X1/2Y=@9 ]^ZGD@\K'^6"?J/>N25.]3E1\E6P'M,PEAZ.B_)63
M9H^,OCQ8Z9-)9>%;=-1G7(:ZE)$*G_9 Y?\ ,#ZUY=J7Q8\::G(6?6YK=>R6
MJK$!^*C/YFN-KN?A[\,-0\=/)<M-]BTR%MCW)7<7;^Z@[GU/0>]=/)""NSZ.
M.#P6!I\\TM.KU_KY&'_PF_BO.?\ A)M8_P# ^7_XJKMM\3?&=JV8O$5ZQSG]
MZXD_]"!KHOBG\.=$\!Z7IKZ=>7L]W=RLK"X="NU0,D *".67N:\SJH\LE=(Z
M:/U;$TU4C!-/NCV;X??%OQ=K?B_3M&OFM;R.ZDVR.T&UU4 LQ&W R #VI?B?
M\4_$FC>/+O3/#NIBVM;5$1E%O$^7*[F.64GOC\*RO@#IOVOQY<7K#Y;*T8@_
M[3D*/TW5#\1/AGX@TO\ M7Q5K%]IKQ371D,<4LA<EWX4 H!QGUZ"LK052QY;
MI8../Y)125DK6W;?;T/.+FXEN[J6YN7WS3.9)'(^\Q.2?SJ*BM?PQX;O?%GB
M"#1],:)+B8,0\S$(H52Q)(!/;T[UT:)'ORE&G%R>B1N6GQ;\;6-E!:6FM>7!
M;QK%$@M(#M51@#E/05]-^&FOW\+Z;)K$QGOI+:-[AR@7+E02,  <$XZ=J\-L
M/V?O$4>HVSWU]I+6RRJ9@DLA8ID;L Q@$XSWKL_C;XXE\/:)%HVF3&._U%29
M'4X:*'H2/0L<@'V:N2IRS:4#Y3'1P^+J4Z.$2N[W:7Y_B,\=?&ZPT"XET[P[
M"FI7T9*R3,?W,3>G'+GZ8'O7D>I_%;QIJDI>37)[=>R6F(0/^^<$_B37'UZQ
M\)OA79^*K&36O$/FFQ$ACM[>-]OG$?>9B.<#IQCG//'.O+"FKL]3ZK@LNH\\
MXW\WJWZ'#1>//%L,@=/$VK$C^_>R,/R)(KN_!WQUU>QO(K;Q45U"R9@K7 0+
M+$/7C 8>V,^]<K\4=$T?P]XZN-.\/?+;1QH6B\POY3D<KDDGT/)[UQ]7RQFM
MCJ^KX;%T5)PT:[69]M_:X#8_;!*IM_+\WS!R"F,Y^F*^+]5OGU36+R_ER7NI
MWF;/7+,3_6OH*WU:;2_V9UNYF*RG3C A)Y^=S&N/P8&OG*LJ,;7/,R7#^R=5
M]G;[A54LP5022<  =:^A?B/J?B#X>^ _#:>';TV2P*MG<8ACD#,(P1]Y3S\C
M].N:\9\!Z9_;'C[1;(KN5[M&<>J*=S?HIKZ'^,NF_P!H_"_42HR]JR7"_P#
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M#7_CCXJU:5UTV2+2;8\*D"!GQ[NPZ_0"N6E\=^+9I"[^)M6!/]R]D4?D#BL
M DX R37?Q_!?QA)X?.J_9H%/E^8+-I")RN,_=QC..Q.?;-=5H1/IW3P6%234
M8W[E#2OBMXSTF8/'K<]TO>.\_?!O^^N?R(KW3X<_%&S\<1M:7,:V6K1+N: -
ME95[LA/ZCJ/>OENM#0=8N- U^RU6S8K+:S+(,=QW'T(R/QJ9THR1CC,LH8BF
M^6*4NC7ZGTO\7=<UKPYX,34_#MZ;2:*Z196\I'#1L".C*?XMM>(?\+E\>_\
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MJ6UB$LX47HBQH%Q^>:XVM8ZJYZF'DYTHSEUU^_4]T_9UTS$&M:HPY9H[9#]
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MANW"YNY9%/\ LECC],5SP493=EH>%A*>'Q.-J2A%."22T5O7\SI/^%R^/?\
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MX]_Z#O\ Y)P?_$5QU[>3ZA?W%[>/YEQ<RM+*^T+N9CDG X')Z"M7_A"/%?\
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MJTL8O]7:P)"OT50!_*JQ#T2.G/ZSC2C375_D?._Q\U/[9\0(K-?NV-HB,/\
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M*^EOR/C&OI+X W0G^'<T.1NM[^1<9YP51L_J?RKL_P#A"/"G_0L:-_X+XO\
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M,#U!'<5E.LY*R/)QV;SQ,?9P7+'KW9\]?&'XFG7+B3P]H,W_ !+86Q<S(?\
MCX<'H#W0'\R/0"O):^Q?^$(\*?\ 0L:-_P""^+_XFC_A"/"G_0L:-_X+XO\
MXFKC6C%62.O#9OA\-35.%-_@> _!WP)_PE/B'^TM0BW:7ISAG!'$TO54]P.I
M]L#O77?M$:-NM=(UJ-3E&:UE;'8_,G\G_.O8[#3K'2[46VF6=O9P EA%;Q+&
MN3U.  *+_3;'5;7[-JEG;WL&X-Y5Q$LBY'0X8$9K-U6Y\QQ3S64L9'$-:+IY
M'Q/7H?P6\2_V%X^AM9GVVNJ+]F?/0/UC/Y\?\"-?07_"$>%/^A8T;_P7Q?\
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M96'H0>M<\9\LKGSV%Q<L/B/;)7_X)\0T5]7W7PD\#7<QDET")6/:*:2(?DK
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M3HI\]RLEIU'BU**T5[GG=:&A:-=>(==M-*T]=T]U($7T4=V/L!DGZ5GU] ?
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MN:L:%X(\-^&I/,T71[>VEQCS2"\@'LS$D?G73]85MCZ)\04>2Z@[_*WW_P#
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MEB[.Y\Q0J^RJQJ=FF?$=%?8O_"$>%/\ H6-&_P#!?%_\31_PA'A3_H6-&_\
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M@M3^S>"[+3U.&O+L,>>JHI)_4K7INGZ7I^D6[0:38VUC"S[VCMH5C4M@#.%
M&< <^U1ZEHFE:SY?]KZ99W_E9\O[5;I+LSC.-P.,X'Y"L_:)SYCSY8Z,\=]9
MDM.WHCXLKT[X"Z9]L^(3WC#Y;&T>0'_:;"#]&:O=_P#A"/"G_0L:-_X+XO\
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M,\=G490=/#]>O^0X# P.!1117*?+!1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !17):W\1M(T'6)]-O+>]>:#;N:)$*G
M*AAC+ ]#Z50_X6]H/_/IJ7_?J/\ ^+K=8>JU=1.=XJC%V<CO**X/_A;V@_\
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M\+(\*?\ 05_\EY?_ (FCV-7^5_<'MZ/\R^]'445R_P#PLCPI_P!!7_R7E_\
MB:/^%D>%/^@K_P"2\O\ \31[&K_*_N#ZQ1_G7WHZBBN7_P"%D>%/^@K_ .2\
MO_Q-'_"R/"G_ $%?_)>7_P")H]C5_E?W!]8H_P Z^]'445R__"R/"G_05_\
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M>QJ_RO[@^L4?YU]Z.HHKE_\ A9'A3_H*_P#DO+_\31_PLCPI_P!!7_R7E_\
MB:/8U?Y7]P?6*/\ .OO1U%%<O_PLCPI_T%?_ "7E_P#B:/\ A9'A3_H*_P#D
MO+_\31[&K_*_N#ZQ1_G7WHZBBN7_ .%D>%/^@K_Y+R__ !-'_"R/"G_05_\
M)>7_ .)H]C5_E?W!]8H_SK[T=117+_\ "R/"G_05_P#)>7_XFC_A9'A3_H*_
M^2\O_P 31[&K_*_N#ZQ1_G7WHZBBN7_X61X4_P"@K_Y+R_\ Q-'_  LCPI_T
M%?\ R7E_^)H]C5_E?W!]8H_SK[T=117+_P#"R/"G_05_\EY?_B:/^%D>%/\
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M%D>%/^@K_P"2\O\ \31_PLCPI_T%?_)>7_XFCV-7^5_<'UBC_.OO1U%%<O\
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M>QJ_RO[@^L4?YU]Z.HHKE_\ A9'A3_H*_P#DO+_\31_PLCPI_P!!7_R7E_\
MB:/8U?Y7]P?6*/\ .OO1U%%<O_PLCPI_T%?_ "7E_P#B:/\ A9'A3_H*_P#D
MO+_\31[&K_*_N#ZQ1_G7WHZBBN7_ .%D>%/^@K_Y+R__ !-'_"R/"G_05_\
M)>7_ .)H]C5_E?W!]8H_SK[T=117+_\ "R/"G_05_P#)>7_XFC_A9'A3_H*_
M^2\O_P 31[&K_*_N#ZQ1_G7WHZBBN7_X61X4_P"@K_Y+R_\ Q-'_  LCPI_T
M%?\ R7E_^)H]C5_E?W!]8H_SK[T=117+_P#"R/"G_05_\EY?_B:/^%D>%/\
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M*?\ 05_\EY?_ (FC_A9'A3_H*_\ DO+_ /$T>QJ_RO[@^L4?YU]Z.HHKE_\
MA9'A3_H*_P#DO+_\31_PLCPI_P!!7_R7E_\ B:/8U?Y7]P?6*/\ .OO1U%%<
MO_PLCPI_T%?_ "7E_P#B:/\ A9'A3_H*_P#DO+_\31[&K_*_N#ZQ1_G7WHZB
MBN7_ .%D>%/^@K_Y+R__ !-'_"R/"G_05_\ )>7_ .)H]C5_E?W!]8H_SK[T
M=117+_\ "R/"G_05_P#)>7_XFC_A9'A3_H*_^2\O_P 31[&K_*_N#ZQ1_G7W
MHZBBN7_X61X4_P"@K_Y+R_\ Q-6(O'7AR>UEN8M1W10XWMY$@Q^&VCV-1?9?
MW J])[27WHZ"BN7_ .%D>%/^@K_Y+R__ !-'_"R/"G_05_\ )>7_ .)H]C5_
ME?W!]8H_SK[T=117+_\ "R/"G_05_P#)>7_XFC_A9'A3_H*_^2\O_P 31[&K
M_*_N#ZQ1_G7WHZBBN7_X61X4_P"@K_Y+R_\ Q-'_  LCPI_T%?\ R7E_^)H]
MC5_E?W!]8H_SK[T=117+_P#"R/"G_05_\EY?_B:/^%D>%/\ H*_^2\O_ ,31
M[&K_ "O[@^L4?YU]Z.HHKE_^%D>%/^@K_P"2\O\ \31_PLCPI_T%?_)>7_XF
MCV-7^5_<'UBC_.OO1U%%<O\ \+(\*?\ 05_\EY?_ (FC_A9'A3_H*_\ DO+_
M /$T>QJ_RO[@^L4?YU]Z.HHKE_\ A9'A3_H*_P#DO+_\31_PLCPI_P!!7_R7
ME_\ B:/8U?Y7]P?6*/\ .OO1U%%<O_PLCPI_T%?_ "7E_P#B:/\ A9'A3_H*
M_P#DO+_\31[&K_*_N#ZQ1_G7WHZBBN7_ .%D>%/^@K_Y+R__ !-'_"R/"G_0
M5_\ )>7_ .)H]C5_E?W!]8H_SK[T=117+_\ "R/"G_05_P#)>7_XFC_A9'A3
M_H*_^2\O_P 31[&K_*_N#ZQ1_G7WHZBBN7_X61X4_P"@K_Y+R_\ Q-'_  LC
MPI_T%?\ R7E_^)H]C5_E?W!]8H_SK[T=117/VOCKPY>^9]FU'?Y:[W_<2# _
M%:K_ /"R/"G_ $%?_)>7_P")H]C4_E?W![>E_,OO.HHKE_\ A9'A3_H*_P#D
MO+_\31_PLCPI_P!!7_R7E_\ B:/8U?Y7]P?6*/\ .OO1U%%<O_PLCPI_T%?_
M "7E_P#B:/\ A9'A3_H*_P#DO+_\31[&K_*_N#ZQ1_G7WHZBBN7_ .%D>%/^
M@K_Y+R__ !-'_"R/"G_05_\ )>7_ .)H]C5_E?W!]8H_SK[T=117+_\ "R/"
MG_05_P#)>7_XFC_A9'A3_H*_^2\O_P 31[&K_*_N#ZQ1_G7WHZBBN7_X61X4
M_P"@K_Y+R_\ Q-'_  LCPI_T%?\ R7E_^)H]C5_E?W!]8H_SK[T=117+_P#"
MR/"G_05_\EY?_B:/^%D>%/\ H*_^2\O_ ,31[&K_ "O[@^L4?YU]Z.HHKE_^
M%D>%/^@K_P"2\O\ \31_PLCPI_T%?_)>7_XFCV-7^5_<'UBC_.OO1U%%<O\
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M7_XFC_A9'A3_ *"O_DO+_P#$T>QJ_P K^X/K%'^=?>CJ**Y?_A9'A3_H*_\
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M_P!!7_R7E_\ B:/8U?Y7]P?6*/\ .OO1U%%<O_PLCPI_T%?_ "7E_P#B:/\
MA9'A3_H*_P#DO+_\31[&K_*_N#ZQ1_G7WHZBBN7_ .%D>%/^@K_Y+R__ !-'
M_"R/"G_05_\ )>7_ .)H]C5_E?W!]8H_SK[T=117+_\ "R/"G_05_P#)>7_X
MFC_A9'A3_H*_^2\O_P 31[&K_*_N#ZQ1_G7WHZBBN7_X61X4_P"@K_Y+R_\
MQ-'_  LCPI_T%?\ R7E_^)H]C5_E?W!]8H_SK[T=117+_P#"R/"G_05_\EY?
M_B:/^%D>%/\ H*_^2\O_ ,31[&K_ "O[@^L4?YU]Z.HHKE_^%D>%/^@K_P"2
M\O\ \31_PLCPI_T%?_)>7_XFCV-7^5_<'UBC_.OO1U%%<O\ \+(\*?\ 05_\
MEY?_ (FC_A9'A3_H*_\ DO+_ /$T>QJ_RO[@^L4?YU]Z.HHKE_\ A9'A3_H*
M_P#DO+_\36OH^O:;KT,DVDW/VA(VVL?+9<'_ ($!2E3J15Y1:*C6IR=HR3^9
MHT445F:!1110 4444 %%%% '@_Q(_P"2@ZE_VR_]%)7+UU'Q(_Y*#J7_ &R_
M]%)7+U]+1_A1]$?)XC^-/U?YA1116IB%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110![3X5"GX-XDD,2?9+K=(.J#=)S^%>+M]XX.1GK7M/A,X^#H
M(B\X_9;K]T?X_FD^7\>E>+-]X\8YZ>E<.%^.IZGH8S^'2]!****[CSPHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JQ8A#>Q"6=H$W<RKU
M7WJO5G3R5U"$BW%R=W^I(^_[4GL..Z&7807DHBE,R;SMD;JP]:AJ>].;Z8F#
M[.=Y_=#^#VJ"A; ]PHHHIB"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MIUZ=1VBS:IAJM)<TUH95%=WH7PMOM4TU+W4+U-/250T:&/>VT]"1D8K.\6>
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MCJL7P]M(]6>.340T0#CJT@'SD>W7]*\>KNP;7LM#S\<G[;4****ZSA"BBB@
MJWI@G;4X!:.L<V[Y&?H#[U4J:T\C[7']LW>1GY]O7%)[#CNA^H"8:C.+EE>7
MS#O9>A/M5:I;GR?M4GV7=Y.X[-W7':HJ%L#W"BBBF(**** "K27][_9_]G13
MRBV>0R&!#PSD 9('7H*JUZO\+_#%NFE_V_=0B>XD9A;*<'8JD@D9XW$@C/\
MB:QK5(TH<TC?#TI5I\D6:?@&RN?#'@VXN->;[-&7,XC<\QI@=1V)(Z?3O5#X
M4Q)<2:UJ@0*9[@*J_P!T<L1_X\/RK/\ %6E^._$]P5DTPP62MF.V2YBQ]6.[
MD_IZ5-\);S[)>:IHUUA)PPD5,YY7*N/3TKSIQO2G.Z;=KVZ'J0E:M3A9J*O:
M_5F5X<U.Y/QADD>5C]HN9HI!G.5PVT?0;5_*NTO-+BE^+EC=L 2NGM)C_:#%
M<_D_Z5C:)X'U.R^)DVI7$8%A'-+-'+N!\S<#@8SD$;O3M4USXFMA\8X(Q*#
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M-5\1>(WM;YHDMX;)BL428&X.@!).3G!/>LSXO:I%/J5CIT3[FMD:24 ]"V,
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M^GB3Q-%:7!/V>-#-, <$J"!C\20*]0\4KXDALX]+\&Z8L5N(P&N$DC3:/[J
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MG8K<R!]L6WG)R>.O%<DI*S?3FVZG;&+O%6UY?BZ'A]%%%>V?/A1110 4444
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MQ%Q%&L !\EU^\WUYK,J[<BW&GVQANI)93GS(FSB/Z5+W14=F4J***HD****
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MO:1K5_H5X;K2I_(F9"A;8K?*2#C# CL*BU'4;K5=0EO;^7S;B4@N^T+G  '
M '0"JU%'*K\UM0YI<O+?0****9(4444 %%%% &GHS7@-U]ABBDS$?,\SLOJ.
M>M9E7=.%L3-]JNI+?]V=FS/SGT-4JE;LI_"@HHHJB0HHHH **** .G'Q&\5*
MH U7@# _T>+_ .)J*[\>^);ZSFM;K4O,AF0I(OD1C<I&",A<USM%9>QIK[*^
MXV]O5:MS/[V7-,U>_P!&NOM&F74EM+C!*'AAZ$'@_C5_4_&6OZQ:FVU#4I)(
M6^\BHJ!OKM S^-8E%6X1;YFM2%4FH\J;L%;=EXOUS3M)_LRSOO+L]K+Y?DH>
M&SGDKGN>]8E%.48RTDKBC*47>+L3V=Y<6%Y'=6<K0SQ'*.O4&M]OB)XJ:/8=
M6;&,<0Q@_GMS7,T5,J<).\E<<:DX*T6T/FFEN)FEN)'ED<Y9W8LS'U)-,HHJ
MR HHHH **** "M#1#=+JB&PCCDFVG"R=",<]Q6?5O31 ;Y1=7#VT>#F1,Y''
MM2ELRH_$BO-N\^3> &W'('0'-,ITF/-;:Q9=QP3WIM,D**** "BBB@ KHK3Q
M[XEL;.&UM=2\N&% D:^1&=J@8 R5S7.T5,H1E\2N5&<X:Q=CIS\1O%3*0=5X
M(P?]'B_^)K LKZZTV[2ZL)W@G3[KH<$?Y]*KT4HTX15DD.52<FG)MV.@O/'7
MB2_M&MKG59#$XPP1$0D>F5 -<_113C&,=(JPI3E-WD[FQH_BS6M!M7M])O?L
M\3OO9?*1LM@#.6![ 5DR2-+*\DAR[L68XZDTVBFHQ3ND#E)I)O1&WIGC'7]'
MM1;:?J4D<(^ZC*KA?IN!Q^%4=3UC4-9N1/JEW)<R 8!<\+] .!^%4J*2A%/F
M2U&ZDW'E;=@HHHJB HHHH **** +.G&8:E ;55>;>-BMT)]Z74S,=2G-TBI-
MN^=4Z ^U1VGEF\B\Z5H8]PW2+U4>M+>B,7LOD2M-'N^61NK#UJ?M%?9(****
MHD**** "BBB@#=TSQKK^CZ?'9:=?^3;QDE4\F-L9.3R5)ZFK?_"R/%?_ $%?
M_)>+_P")KEZ*S=&FW=Q7W&JKU4K*3^\L-?W3:BU^)W6Z:0RF5#M.\G)(QTY]
M*VY/B!XHEMS"VK2!",96-%;_ +Z"Y_6N<HING"6Z)C4G'X6T*S%F+,223DDG
MK6EHWB/5?#[3'2+K[.9@!)^[5]V,X^\#ZFLRBJ<5)6:)C*47>+LR>]O;C4;Z
M6[O)/,GF;<[[0,GZ#BM+1_%FM:#:O;:3>_9XG?S&7R4;+8 SE@3T K&HI.,6
MK-:#4Y1?,GJ*S%F+,223DDGK24451(4444 %%%% !3DSYB[>N1BFTJXW#)P,
M\GTH T-<-VVI$ZA%'%-M&5CZ8_,UG5<U,0"\(M+E[F/:/WDF<Y].:IU,?A14
M_B844451(4444 %;&C^+-:T&U>WTF]^SQ.^]E\I&RV ,Y8'L!6/12E&,E:2N
M5&4HN\78ZC_A9'BO_H*_^2\7_P 36#?ZE=ZGJ4E_>S&2ZD(+2!0N2  .!@#H
M*JT5,:<(N\4D5*K4FK2DW\SHX_B!XHBMQ"NK2% ,9:-&;_OHKG]:P)YY;F=Y
MKB1Y99#N=W;)8^I-1T4XPC'X584JDYZ2=R]I&M7^A7ANM*G\B9D*%MBM\I(.
M,,".PINJ:M>ZU?->:G-Y\[*%+[%7@=.  *IT4^6-^:VHN:7+RWT-32/$NL:$
MK+I5]);HQR4P&4GUVL",U+JOBW7=:M_(U+49)8>\:JJ*?J% S^-8U%3[.%^:
MVH_:3Y>6[L%%%%60%%%% !1110 5IZNUX8K/[;%'&/)'E%/XEXY//6LRKNH"
MW$=O]FNI+@^7\X?/R'T%2]T4OA92HHHJB0HHHH **** -/1O$>J^'VF.D77V
M<S "3]VK[L9Q]X'U-:O_  LCQ7_T%?\ R7B_^)KEZ*SE2IR=W%?<:1K5(JT9
M-+U+VKZU?Z[>"ZU6?SYE0(&V*OR@DXPH [FM*S\=>)+"T6VMM5D$2#"AT1R!
MZ98$US]%-TX-6:T$JDT^9-W+%[?76I7;W5_.\\[_ 'G<Y)_SZ4MA?W.EW\5Y
M8R>5<0G*/M#8.,=#D=ZK455E:Q/,[WZFGK/B'5/$$D3ZO=?:&A!"'RU7 /7[
MH'I4FD>*M:T&W>#2;YK>)WWLGEJP+8 S\P/8"LBBER0Y>6VA7M)\W-=W[FIJ
M_B76-=55U6^DN$0Y5,!5!]=J@#-9=%%.,5%62)E*4G>3N%%%%,04444 %%%%
M &G=F\.A68FBC%L&/E.OWF/.<\UF5=G%N-+MS'=2/-D[X3G:G7I5*ICL5+<*
M***HD**** "KVD:U?Z%>&ZTJ?R)F0H6V*WRD@XPP(["J-%)I-68TW%W1U'_"
MR/%?_05_\EXO_B:RM9\1ZKX@:$ZO=?:#""(_W:IMSC/W0/05F45$:5.+NHK[
MBY5JDE:4FUZFUI7B_7M%M?LVFZC)%"#D1LJN%^@8''X53U36=1UJY$^J7<ES
M(HPN[HH]@.!^%4:*I0BGS):B=2;CRMNQT=KX_P#$UG9PVMMJ6R&"-8XU\B,[
M5 P!DKGH*D?XB^*9(V1]4RK#!'V>+D?]\US%%1[&G_*ON*]O5M;F?WLLV&HW
M>EWBW6GW$EO,O1T../3W'M6M?>./$>I6;VMWJDC0N-K*B(FX>A*@'%8%%6X1
M;NT2JDXJR;L%%%%40%%%% !1110 5ZQ\'C+_ &?J095$7F1[&'4G#9S^GYUY
M/7JOP<$?V35=LC&3?%N3LH^;!_'G\JY,9_ 9VX#_ 'A?/\CTNBBBO /I0HHH
MH **** "BBB@#P?XD?\ )0=2_P"V7_HI*Y>NH^)'_)0=2_[9?^BDKEZ^EH_P
MH^B/D\1_&GZO\PHHHK4Q"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH ]J\)DCX/#;$)C]ENL1GH_SR<?C7BS?>/&.>GI7M?@Z*2X^$<<,#,LLEO<
MJC*,D$O( 0.YKRAO#&O[C_Q)=1//7[))S^E<&&DE.I=]3TL5&3ITK+H95%:G
M_",:]_T!-2_\!)/\*/\ A&->_P"@)J7_ ("2?X5V\\>YP>SGV9ET5J?\(QKW
M_0$U+_P$D_PH_P"$8U[_ * FI?\ @))_A1SQ[A[.?9F716I_PC&O?] 34O\
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M&O?] 34O_ 23_"CGCW#V<^S,NBM3_A&->_Z FI?^ DG^%'_",:]_T!-2_P#
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M%:G_  C&O?\ 0$U+_P !)/\ "C_A&->_Z FI?^ DG^%5SQ[D^SGV9ET5J?\
M",:]_P! 34O_  $D_P */^$8U[_H":E_X"2?X4<\>X>SGV9ET5J?\(QKW_0$
MU+_P$D_PH_X1C7O^@)J7_@))_A1SQ[A[.?9F716I_P (QKW_ $!-2_\  23_
M  H_X1C7O^@)J7_@))_A1SQ[A[.?9F716I_PC&O?] 34O_ 23_"C_A&->_Z
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M[_H":E_X"2?X4<\>X>SGV9ET5J?\(QKW_0$U+_P$D_PH_P"$8U[_ * FI?\
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M^ DG^%'_  C&O?\ 0$U+_P !)/\ "CGCW#V<^S,NBM3_ (1C7O\ H":E_P"
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M>X>SGV97U@N=0)DLULFVC]TH 'UJC71:OX7U];\@V.HWWRC]\+1^?;H:H_\
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M_0$U+_P$D_PH_P"$8U[_ * FI?\ @))_A1SQ[A[.?9F716I_PC&O?] 34O\
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M7_XJNHHH]M5_F?WA]7H_R+[D<O\ \*W\*?\ 0*_\F)?_ (JC_A6_A3_H%?\
MDQ+_ /%5U%%'MJO\S^\/J]'^1?<BKINFVFD:?%8Z=%Y-M%G8FXMC))/))/4F
MK5%%9MMN[-4DE9!1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M7(>./'"^%XTM;2-9[^9=P#'Y8EZ!CZ\]![?G<(2J2Y8F=2I&G'FEL=?17BUG
M\5M?AO!)=BWN8<_-%Y>SCV(Z?CFO7-'U6VUO28-0LSF*9<X/53W4^X-:UL/4
MHZR,J.*IUW:.Y=HHHKG.D**** "BBB@ HHHH **** "BBB@ HHHH **0LH8
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M6Z\EIK<]I-/8****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH Q_$GB6R\,:;]JO=SLYVQ1)]Z1OZ#U->?Q_&*\^T@RZ5 8
M,\JLAW8^O3]*/C%'-_:6FR$'R/)95.. V>?TQ7F]>QAL-2E24I*]SP\7BZL*
MKC%V2/I'1-9M-?TJ*_L&)BDX*MPR,.JD>M7Z\Z^#R3C1M0=\^0TZ^7D?Q!?F
M_P#9:]%KS:T%3J.*/5P]1U*2F^H4445B;A1110 4444 %%%% !1110 4444
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MXXPTP0X\QFY /L!CCW^E;4:3JSY485ZRH0YV>HPZA9W,IBM[N"61>J)*&(_
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M!!(_/'X5Z%7EUX1A4<8['KX><JE*,I;L****Q-PHHHH **** "BBB@ HHHH
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M^GF5M,M3<P+;S&%#)"G2-MHRH]@>*L5->M*K*\B\/0A1A:/4****P.@****
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M^A/YXZ5JT45,I.3NQQBHJR"BBBD4%%%% !1110 4444 %%%% !1110 4444
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M=%%%9FH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!E
MPIK0\33O-);G1S$/)11^\#X7KQT^]W]*U*Y^VTVP3QU=WZ0WXOI( CR/$1;E
M<)PK8P3P._8UT%7.VGH9T[Z^K"BBBH- HHHH **** "BBB@ HHHH **** "B
MBB@ K*N'UD>*+5+>VMFT@Q$SS-_K5?#8 YZ?=[=S6K7-WJ::?B%I[3:G/'J
MMSY5BH/ERKB3YCQC/WN_\(K2"NWZ,RJ.R7JCI****S-0HHHH **** .=\:R6
M,>BPG4])FU6+[0H$,.<JVUOFX[8R/QKHJR/$D>KR:;&- OK:RN?-!:2Y VE,
M'(Y4\YQ^5:]:2^!?,SC\<OD%%%%9F@4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %96K-K8U#3O['6W-J9?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^O[6V;KB:94/ZFGVFH65^I:PNX+E1U,,JOC\C3Y7:]B>97M<L4444B@HHHH
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MY:HR-V^Z "#TZ5ZI6=6C*E+ED:T:\*\>:(4445B;A1110 4444 %95NVM_\
M"3W0N%MQH_E#R&7_ %A?"YS[??\ TK5KF[)-('Q#U%H+ZY?5#;#SK5L^4B8C
MP1QU^[W/4UI!73]#*H[./K_7J=)11169J%%%% !1110 4444 %%%% !1110
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MC9G2U@@HHHK,U"BBB@ HHHH *PO"4;1Z3*'UY==/GD_:58';\J_)P3TZ_P#
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MJ!C($WVYMA?& =WRYSQCIUKK-1TKXE:MI\MEJ&R:WEQO3-NN<$$<C!Z@5?\
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M@7,JL?(MQ;S<?=?:O4^^#^5;FB:#I&@W*W,7A[4YKB([3+,HD,<O95 P"/\
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M^%QU_ ]1]:\=\&?\E!T__KX/\C7H/AO2K?PK<RRV5CKK"11%/%($=/-_A
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M70\BC1Q5&[44V^KW.YAF2X@CFA;='(H=3C&01D4^HK:!;6TAMXR2D2*BENI
M&.:EKS'OH>NKVU"BBBD,**** "N9OGT4?$?35N(;@ZN;8^1(O^K"8DR#SU^_
MV[BNFK*N&UL>)[5;>.W.CF(^>[?ZP/AL8YZ?<_6M*;LWZ,RJ*Z7JNE_Z]35H
MHHK,U/&/BQ8R6_BQ+I@?+N8%*MCC*\$?R/XUW?P]\0VNK>&;6T$JB[LXA#)$
M>#M7A2/48 _&M'Q'HNF>)M/6PO9D61F;[/(K#>KKG./7'<>W:O*+CX>ZW;7,
M?]F36MZLI;R9(+I5+XZX#$<COC.*]*,Z5>BJ<Y6:/+G2KX>NZL(N2?\ 7Z'M
M\T\5M$9;B5(HUZN[!0/Q->0?%[=_PE5IG.S[$N/3.]\_TJE:>"?$FI75M]LG
MA"2.?+>:]63=MZ[=I;.,'I7H?C#PY8>+[&W$%[!'> M]EEW B3'WEXY(X[=*
MBG[+#U8OFN75C7Q-&2Y'&W?Y_P"1I>#A /!>D_9=NS[*F=O]_'S_ /CV:\;\
M5!3\0K\6O7[9QL_O9&?QSFM.U\.>--/C6TTJ[/V>=F$?V;4$"2$?>*C<#VYP
M,UN>"O :VFI6VJ:W>6\DN\O;01RA][KU8L.I4C.!GWK:$J5"4JG.G<QJ4Z]>
M,:?LVK;MK^O,K?&+_D)Z9_UQ?^8KKOAO;16_@6R>) K3%Y)&_O-O(S^0 _"L
M'XCZ)?>)+[3)-$2&[7RY%!6XC7<0>0,L,XP<XZ5TW@J/^SO".F65W)"EQB0!
M%E5MQ#L3@@D' ZXZ5A4J1>%C%/7_ (<Z*=&HL9.3B[6[?UV?XG(_&7_F#?\
M;?\ ]IU7O])%_P#!73KI%!EL2T@/?:9&##]0?PK6^).D7GB7^Q_[#6&[P9Q\
MMQ&N[[G3+#/W3G&<8K<\*6<<7@:RTG4GB$DT4L31K,K;P6;< 02#P>W2J5:,
M*$+/5/\ S(EAJD\143B[-;V]/\OP/()-?D?P3#H>3A+MICS_  [1@?\ ?18U
MU_B72O['^#^F6[+B5[A)9?\ >96//T! _"L;2? &IOX@LENXX38/<']ZMU$?
M-13\VT!LG@>G'>N^^(%E+XA\-6]KHQANII+D/&JSH-X56#8)(!QWQ6]2M3]I
M!1:M>[.:EAJ_LYRG%WM9:?UV_,P_A).EKHNLW$QQ'$RNY] %)-9\/BWQ7XSU
MQ[+09TL8L%PHP-B @99\$]QT]>E;?P[T.;3]'U"SU@11+J)V1!+B-_-4*0^W
M:3TKEHO!OB71]827P]<PRB4LD%S!=1KYJCJ,%N<8Y'.,5*E1E5FVU?I?8MT\
M1&C37+*VM[;[O_@F9XTTW5M,U:&+7M1%_<M"'#"1FV+N/'('<&O6H>?A9'G_
M * P_P#1%>;ZOX)\07MQ:W/VB/5;F[C)>07<?W@2"B[F!; '..!^%>I:3%;R
M>$=/TR[FBW2V*VS*DJDL1'M<*02#C!Z9Z5&(JP<(6DG;L:86A552=XM774\M
M^%?_ ".R_P#7O)_2NP^+W_(HVO\ U_)_Z+DKC!X)\1Z9JD<NAS13%F86]Q;7
MB(7 ZXRP)XSD#/>NI\0Z5JNM?#O1[!)$O=3-QO<&Z0E]JR!L,6PV,C.":NI*
MFZ\:BDK&=*G6CAYTG!WUZ?UV9)\'[2)=!OKP*/.DN?*+8_A55('YL:;\8?\
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M:$]&'OW^HQ2?$F:.Y\8/<0.)(9K>)XW'1E*\&O1?B)X7_M_1/M-K'F^LP63
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MK_5CIZ***S-3*\3+&_AVZ6;4WTI#LS>(2#'\X[@CKT_&K>E!5T>S"7)NU$"
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=%')'L'UBM_._O9F/X<TB3S<V$(\T -M&W&.FW'W>G;&>]#^'-(D\W-A"/-
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M:3:;#97D";S-*]S(KC>0H 1E W#"YSCCI].FHI*53EY>;0)>Q;<U32EWN_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *R+A]8'BJT6"SM7THQ'S[EO]:CX; 'S=/N]CU-:]<[>I8'Q_I[2ZM/%?
M"W/EV"Y\N5<2?,>,9Z_]\BM(;OT,ZFR]4=%11169H%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!11169J%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ K&N8]0/BZS>+588K$0D26#8WRMA_
MF'&<?=_[Y-;-<U?2:./B+IR7%G<OJQMB8+A?]4B8DR#\W7[W8]16E/=^C,JC
MLEZHZ6BBBLS4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MFA(0'N1R!^.,5C6DX.$9*UGWN=%""FJDXRYKKM8\R^$UK;W6M7RW4$<RBW!
MD0, =P]:[/QOK>@Z)#9QZIIZ7TR'?;6N %4#C)[ =AP:\MT'7=3\&:O,T=H!
M,Z&*2&X1AW].#G(K>^(^GZA>MINO-"[0W%E&)-@)$3X+$8Z@<]_>M:E+FQ"<
MGHS&E6Y,,XQ7O+?0=K/BC5=<\.SI%X5CATXJ2)_)8B(>H; &>!S4_P '97&K
M:C$&.QH%8KZD-@']35*;QAKFN>$9-,MM/CCMK>V N+E0<;%'3T!.,5;^#W_(
M=U#_ *]A_P"A"B<>6A-6M^(J<N;$PE>_RL<UK\ NOB#?0,2%EU!D)'8%\5ZS
MKOA+0QX2N[>+3[>$06[O'*J .K*I(.[J>G.>M>2>(TED\>ZBEN<2M?N$.<8;
M?Q^M;.N^/?$=WITFBW]JEK*P\N9EB99''0C&<#/? JJE.I/DY'L32JTZ?M.=
M7N,^%DSQ^-HT1B%E@D5QZC&?Y@5T6M^-]%LO$=RND:''J>H2.$DN6YW,HVX7
M@DC QQC\:=\+_"=U822:SJ4+0M)'Y=O&XPV#R6([=,#\:XJ$ZEX%\7">>UWS
M6[L%$H.V4,",@CU!J6H5:TK:V7WE1E4HT(7T3>]KV)?&FH:IJ=Q;7.KZ(NEN
MP8*WDLC3=,YW=<9_6NLN-)OO$'P:TN.R5IIX'\SRQU=5+K@?@1Q[5ROC/5]8
MUU;#4-5M!:6SB1+6(9YQMW-SSSE>?:NOM=:U+0?A1HM[I,0E<3E94:,L"F9,
MYQR.0.:=3F5.'*E>_P NHJ?*ZM3F;:M\^AR'ACQ;-X2:>TNM+AGCD?,JRILE
M7C!&2.G'0C^=>GZ=K>E:YX/U&XT>)8!Y,GG0A I1RAZXZYQUKSKQ#XZD\4Z;
M]ADT. 7/'[]27=<'/R\9'IU-=/X(\.WVB>#]:N-2B:![R [(7X90J-R1VSNZ
M>U9XB$7'GDK2OWW-,-.2G[.#YHV?38Y7X7_\CU;_ /7*3_T&D\=:'J.D^*[K
M49+=I+6:?SXYMNY.3G:?ITP:7X7_ /(]6_\ URD_]!KHM4^(VK:'KM_97^FQ
MW-JD[K$7!C)3)P,X((Q[5M-S6(]Q7T,::IO#)3=M=_D.T'XDZ7?W-O;Z[I5O
M;.K*(IXT#(C \<'E<'G()Q7IE>!QZ;?^-O$;2Z;I:6<<S#>8D(BB&.6)Z>_O
M7O4:"*)(P20JA06.2<>M<&+IP@UR[]4>C@JE2:?-JNC[CJ***XCT HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *Q;E[T>,+-8](AELS"?,U XWQ-A_E'
M?'3_ +Z-;58%XB'QU8.=>>!Q <:4"=L_#_/C./T_@K2&[]#*ILO5&_11169J
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML/\ ,.,XZ?\ ?)K2&[]#*ILO5&U11169J%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %8UR^HCQ=9K%I<$M@83YM\V/,B;#_*.<X^[V_B-;-<_>) ?'=@S:Y+#
M,(#MTP,=DPP_SD9QZ]OX:TAN_0RJ;+U1T%%%%9FH4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !61K,FK)J6F#2["WNK=IL7<DI&Z%,KRN2.<;CWZ"M>N=\1QV;Z
MUH9N]7FL)5N,PP1DXNCN3Y6QVZ#G^]6E/XC*KI#^NYT5%%%9FH4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ KFKY]''Q$TY+BSN7U8VQ\BY7_ %2)B3(/
MS=?O=CU%=+65<?VW_P )/:_9S;_V/Y1\_=_K-^&QCV^Y^M:4W9OT9E45TO5>
M9JT445F:A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\G)/3K^-=!6!X/>-]'E,6A/H8\\_Z,ZD%OE7Y^0.O3\*TC\#^1E+^)'Y]_\
MAC?HHHK,U,7Q>--/A6\_MLS"Q^3S3#][[ZXQ^.*NZ-]F_L&P^P;S:_9H_)W_
M 'MFT;<^^,4W6VOTT>=M'MH;F\&WRXI_N-\PSGD=LGK5BP-P=.MC>QI%<F)?
M-CC^ZCX&0/8'-:7_ '=O/^M#*W[V_E_6I/11169J%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MX2@[25CKA4C47-!W"BBBH+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#_KVC_\ 015RJ>C_ /("L/\ KVC_ /015RN*6[/0C\*"BBBI*"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ JLFGV\>HR7R^;Y\J[6S,Y3''1"=HZ#D#^9JS13NT)I/<****0PHHH
MH **** "BBB@ HHHH Y_P;)#)H\IM]#DT1?/(-O(I!8[5^?D#Z?A705C>%TU
M"/3)!JNJP:I-YQ*S08PJ[1\O '.<G\:V:TJ?&S*E\"_K\@HHHK,U"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MG&3U1ZQ17 ^)_'>IZ+H>@WMI!:/)J5MYLPD1B%.U#\N&''SGKGM65+\6KO\
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MFM<],HHHKE.P**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ]#$TJ?LW*FMG9GFX2M5]HHU7NKHN_$G7]2T#2[.;2;G[/)),5<^6K9&W/\
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M!;77(B\H,H++]Y2"3SQ^AK1X>:YO[NYDL33?+TYMCO****P.D**** "BBB@
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M ./ 5[/_ ,(_HW_0)L?_  &3_"O(O&/A/4K3Q=<OH^F74EL[":)K:W8JA/)
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH IZQ_P @*_\ ^O:3_P!!->-_"_\ Y'JW_P"N4G_H->X45T4Z_LX2A;<Y
M:N']I4C._P (4445SG4%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_&7C:#PK'%"D/VF]F7<D9.%5>FXGZ]O8]*Y"/XE^*I(A<KHD#VQ/#K;RX/\
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MR2>_/Z5XU\0K"2P\;7WF [+AA/&Q'W@P_H<C\*]E\.:Y;Z_H=O>P2*SL@$R
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M5AI>I,?NF9 /KM/^(KT>N/$I*M)([L))RH1;"BBBN<Z@HHHH **** "BBB@
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M3_A%=+/^LCEESQ+YLS/YR]DDR?G4<8!_J<[-%'LX=@^MXC^=_>8W_"*Z6?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M191INKSZM%]H;,\Y.5;:OR\]L8/XUT587A)Y'TF4RZ$FAGSS_HR* &^5?GX
MZ]/PK2/P/Y&4OXD?F;M%%%9FH4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110!D>&GU5]-D.N:=;Z?<><=L5N05*X
M&&X)YSD?A6O7.^"DM$T646&L3:O']H;,\Q.5.U?EY[=#^-=%6E3XV94M8+^O
MR"BBBLS4**** "BBB@ K#\)I(FDRB;78]<;SS_I,; A?E7Y.">G7\:W*YSP2
M]@^BS'2])FTJ+[0V89LY9MJ_-SVQ@?A6D?@?R,I?Q(_,Z.BBBLS4**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% %'2=&L-#M&MM*MQ;PNYD90S-EB ,\D]@
M*O444VVW=B2459!1112&%%%% !1110 4@4*,* !["EHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y/\
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M\?JTE?6_^1V>SE]:A*VEOT8OQ:_Y$Z+_ *^T_P#06JE\'F']CZBN>1<*2/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MRIU%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>lgnd-20221231_g4.jpg
<DESCRIPTION>STOCK CHART
<TEXT>
begin 644 lgnd-20221231_g4.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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M_LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-(_\ D>OH"B@#Y_\
M^'3O[+/_ $;3^S__ .&\TC_Y'H_X=._LL_\ 1M/[/_\ X;S2/_D>OH"B@#Y_
M_P"'3O[+/_1M/[/_ /X;S2/_ )'H_P"'3O[+/_1M/[/_ /X;S2/_ )'KZ HH
M ^?_ /AT[^RS_P!&T_L__P#AO-(_^1Z/^'3O[+/_ $;3^S__ .&\TC_Y'KZ
MHH ^?_\ AT[^RS_T;3^S_P#^&\TC_P"1Z/\ AT[^RS_T;3^S_P#^&\TC_P"1
MZ^@** /G_P#X=._LL_\ 1M/[/_\ X;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_
M^1Z^@** /G__ (=._LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-
M(_\ D>OH"B@#Y_\ ^'3O[+/_ $;3^S__ .&\TC_Y'H_X=._LL_\ 1M/[/_\
MX;S2/_D>OH"B@#Y__P"'3O[+/_1M/[/_ /X;S2/_ )'H_P"'3O[+/_1M/[/_
M /X;S2/_ )'KZ HH ^?_ /AT[^RS_P!&T_L__P#AO-(_^1Z/^'3O[+/_ $;3
M^S__ .&\TC_Y'KZ HH ^?_\ AT[^RS_T;3^S_P#^&\TC_P"1Z/\ AT[^RS_T
M;3^S_P#^&\TC_P"1Z^@** /G_P#X=._LL_\ 1M/[/_\ X;S2/_D>C_AT[^RS
M_P!&T_L__P#AO-(_^1Z^@** /G__ (=._LL_]&T_L_\ _AO-(_\ D>C_ (=.
M_LL_]&T_L_\ _AO-(_\ D>OH"B@#Y_\ ^'3O[+/_ $;3^S__ .&\TC_Y'H_X
M=._LL_\ 1M/[/_\ X;S2/_D>OH"B@#Y__P"'3O[+/_1M/[/_ /X;S2/_ )'H
M_P"'3O[+/_1M/[/_ /X;S2/_ )'KZ HH ^?_ /AT[^RS_P!&T_L__P#AO-(_
M^1Z/^'3O[+/_ $;3^S__ .&\TC_Y'KZ HH ^?_\ AT[^RS_T;3^S_P#^&\TC
M_P"1Z/\ AT[^RS_T;3^S_P#^&\TC_P"1Z^@** /G_P#X=._LL_\ 1M/[/_\
MX;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_^1Z^@** /G__ (=._LL_]&T_L_\
M_AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-(_\ D>OH"B@#Y_\ ^'3O[+/_ $;3
M^S__ .&\TC_Y'H_X=._LL_\ 1M/[/_\ X;S2/_D>OH"B@#Y__P"'3O[+/_1M
M/[/_ /X;S2/_ )'H_P"'3O[+/_1M/[/_ /X;S2/_ )'KZ HH ^?_ /AT[^RS
M_P!&T_L__P#AO-(_^1Z/^'3O[+/_ $;3^S__ .&\TC_Y'KZ HH ^?_\ AT[^
MRS_T;3^S_P#^&\TC_P"1Z/\ AT[^RS_T;3^S_P#^&\TC_P"1Z^@** /G_P#X
M=._LL_\ 1M/[/_\ X;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_^1Z^@** /G__
M (=._LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-(_\ D>OH"B@#
MY_\ ^'3O[+/_ $;3^S__ .&\TC_Y'H_X=._LL_\ 1M/[/_\ X;S2/_D>OH"B
M@#Y__P"'3O[+/_1M/[/_ /X;S2/_ )'H_P"'3O[+/_1M/[/_ /X;S2/_ )'K
MZ HH ^?_ /AT[^RS_P!&T_L__P#AO-(_^1Z/^'3O[+/_ $;3^S__ .&\TC_Y
M'KZ HH ^?_\ AT[^RS_T;3^S_P#^&\TC_P"1Z/\ AT[^RS_T;3^S_P#^&\TC
M_P"1Z^@** /G_P#X=._LL_\ 1M/[/_\ X;S2/_D>C_AT[^RS_P!&T_L__P#A
MO-(_^1Z^@** /G__ (=._LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_L_\
M_AO-(_\ D>OH"B@#Y_\ ^'3O[+/_ $;3^S__ .&\TC_Y'H_X=._LL_\ 1M/[
M/_\ X;S2/_D>OH"B@#Y__P"'3O[+/_1M/[/_ /X;S2/_ )'H_P"'3O[+/_1M
M/[/_ /X;S2/_ )'KZ HH ^?_ /AT[^RS_P!&T_L__P#AO-(_^1Z/^'3O[+/_
M $;3^S__ .&\TC_Y'KZ HH ^?_\ AT[^RS_T;3^S_P#^&\TC_P"1Z/\ AT[^
MRS_T;3^S_P#^&\TC_P"1Z^@** /G_P#X=._LL_\ 1M/[/_\ X;S2/_D>C_AT
M[^RS_P!&T_L__P#AO-(_^1Z^@** /G__ (=._LL_]&T_L_\ _AO-(_\ D>C_
M (=._LL_]&T_L_\ _AO-(_\ D>OH"B@#Y_\ ^'3O[+/_ $;3^S__ .&\TC_Y
M'H_X=._LL_\ 1M/[/_\ X;S2/_D>OH"B@#Y__P"'3O[+/_1M/[/_ /X;S2/_
M )'H_P"'3O[+/_1M/[/_ /X;S2/_ )'KZ HH ^?_ /AT[^RS_P!&T_L__P#A
MO-(_^1Z/^'3O[+/_ $;3^S__ .&\TC_Y'KZ HH ^?_\ AT[^RS_T;3^S_P#^
M&\TC_P"1Z/\ AT[^RS_T;3^S_P#^&\TC_P"1Z^@** /G_P#X=._LL_\ 1M/[
M/_\ X;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_^1Z^@** /G__ (=._LL_]&T_
ML_\ _AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-(_\ D>OH"B@#Y_\ ^'3O[+/_
M $;3^S__ .&\TC_Y'H_X=._LL_\ 1M/[/_\ X;S2/_D>OH"B@#Y__P"'3O[+
M/_1M/[/_ /X;S2/_ )'H_P"'3O[+/_1M/[/_ /X;S2/_ )'KZ HH ^?_ /AT
M[^RS_P!&T_L__P#AO-(_^1Z/^'3O[+/_ $;3^S__ .&\TC_Y'KZ HH ^?_\
MAT[^RS_T;3^S_P#^&\TC_P"1Z/\ AT[^RS_T;3^S_P#^&\TC_P"1Z^@** /G
M_P#X=._LL_\ 1M/[/_\ X;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_^1Z^@**
M/G__ (=._LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-(_\ D>OH
M"B@#Y_\ ^'3O[+/_ $;3^S__ .&\TC_Y'H_X=._LL_\ 1M/[/_\ X;S2/_D>
MOH"B@#Y__P"'3O[+/_1M/[/_ /X;S2/_ )'H_P"'3O[+/_1M/[/_ /X;S2/_
M )'KZ HH ^?_ /AT[^RS_P!&T_L__P#AO-(_^1Z/^'3O[+/_ $;3^S__ .&\
MTC_Y'KZ HH ^?_\ AT[^RS_T;3^S_P#^&\TC_P"1Z/\ AT[^RS_T;3^S_P#^
M&\TC_P"1Z^@** /G_P#X=._LL_\ 1M/[/_\ X;S2/_D>C_AT[^RS_P!&T_L_
M_P#AO-(_^1Z^@** /G__ (=._LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_
ML_\ _AO-(_\ D>OH"B@#Y_\ ^'3O[+/_ $;3^S__ .&\TC_Y'H_X=._LL_\
M1M/[/_\ X;S2/_D>OH"B@#Y__P"'3O[+/_1M/[/_ /X;S2/_ )'H_P"'3O[+
M/_1M/[/_ /X;S2/_ )'KZ HH ^?_ /AT[^RS_P!&T_L__P#AO-(_^1Z/^'3O
M[+/_ $;3^S__ .&\TC_Y'KZ HH ^?_\ AT[^RS_T;3^S_P#^&\TC_P"1Z/\
MAT[^RS_T;3^S_P#^&\TC_P"1Z^@** /G_P#X=._LL_\ 1M/[/_\ X;S2/_D>
MC_AT[^RS_P!&T_L__P#AO-(_^1Z^@** /G__ (=._LL_]&T_L_\ _AO-(_\
MD>C_ (=._LL_]&T_L_\ _AO-(_\ D>OH"B@#Y_\ ^'3O[+/_ $;3^S__ .&\
MTC_Y'H_X=._LL_\ 1M/[/_\ X;S2/_D>OH"B@#Y__P"'3O[+/_1M/[/_ /X;
MS2/_ )'H_P"'3O[+/_1M/[/_ /X;S2/_ )'KZ HH ^?_ /AT[^RS_P!&T_L_
M_P#AO-(_^1Z/^'3O[+/_ $;3^S__ .&\TC_Y'KZ HH ^?_\ AT[^RS_T;3^S
M_P#^&\TC_P"1Z/\ AT[^RS_T;3^S_P#^&\TC_P"1Z^@** /G_P#X=._LL_\
M1M/[/_\ X;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_^1Z^@** /G__ (=._LL_
M]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-(_\ D>OH"B@#Y_\ ^'3O
M[+/_ $;3^S__ .&\TC_Y'H_X=._LL_\ 1M/[/_\ X;S2/_D>OH"B@#Y__P"'
M3O[+/_1M/[/_ /X;S2/_ )'H_P"'3O[+/_1M/[/_ /X;S2/_ )'KZ HH ^?_
M /AT[^RS_P!&T_L__P#AO-(_^1Z/^'3O[+/_ $;3^S__ .&\TC_Y'KZ HH ^
M?_\ AT[^RS_T;3^S_P#^&\TC_P"1Z/\ AT[^RS_T;3^S_P#^&\TC_P"1Z^@*
M* /G_P#X=._LL_\ 1M/[/_\ X;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_^1Z^
M@** /G__ (=._LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-(_\
MD>OH"B@#Y_\ ^'3O[+/_ $;3^S__ .&\TC_Y'H_X=._LL_\ 1M/[/_\ X;S2
M/_D>OH"B@#Y__P"'3O[+/_1M/[/_ /X;S2/_ )'H_P"'3O[+/_1M/[/_ /X;
MS2/_ )'KZ HH ^?_ /AT[^RS_P!&T_L__P#AO-(_^1Z/^'3O[+/_ $;3^S__
M .&\TC_Y'KZ HH ^?_\ AT[^RS_T;3^S_P#^&\TC_P"1Z/\ AT[^RS_T;3^S
M_P#^&\TC_P"1Z^@** /G_P#X=._LL_\ 1M/[/_\ X;S2/_D>C_AT[^RS_P!&
MT_L__P#AO-(_^1Z^@** /G__ (=._LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_
M]&T_L_\ _AO-(_\ D>OH"B@#Y_\ ^'3O[+/_ $;3^S__ .&\TC_Y'H_X=._L
ML_\ 1M/[/_\ X;S2/_D>OH"B@#Y__P"'3O[+/_1M/[/_ /X;S2/_ )'H_P"'
M3O[+/_1M/[/_ /X;S2/_ )'KZ HH ^?_ /AT[^RS_P!&T_L__P#AO-(_^1Z/
M^'3O[+/_ $;3^S__ .&\TC_Y'KZ HH ^?_\ AT[^RS_T;3^S_P#^&\TC_P"1
MZ_GA_P"#M?X2>%/V3_\ @HYX*\._"SPSX>^&OA^]^&]CJ5QIGA73H=&LY[IM
M4U6-IWAME1&E*11*7(W%8T&<* /ZGJ_F!_X/5O\ E*;X!_[)5IW_ *=]8H _
M?[_@D[_RBR_9I_[)5X7_ /31:U] 5\__ /!)W_E%E^S3_P!DJ\+_ /IHM:^@
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6D[B1+2!V,CSK'&&G9(<L IS5\%?M5>,_ W_  3S^/W@?XM?M.S?#74/@/\
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MZ78VPFFATJ%BL:7#[T'F$DQ1)*ZJ2O'B_P#P2C_:$^+7@C]N_P -^!=-\/\
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MAH6JVMPT6JZBLBLLBNEE;R7/F*P*F=#D&@#]5J*_&G_@IC^U_P"-_&'_  4
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MOXIZM\.+V#3]:U'P%X$BUS3(9IK:.Y1?-2Z5E)CE7AT4Y!P".3Z]_P $E/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !7\P/_!ZM_RE-\ _]DJT[_T[
MZQ7]/U?S _\ !ZM_RE-\ _\ 9*M._P#3OK% '[_?\$G?^467[-/_ &2KPO\
M^FBUKZ KY_\ ^"3O_*++]FG_ +)5X7_]-%K7T!0 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M3+#X+?"?Q/XQU2&\N-,\)Z3=:Q=Q6J*T\D-O"TKK&&95+E4( + 9QDCK6?\
ML[_&_2?VF/@'X+^(N@V^H6FB>.]#L]?L(+^-([J&"ZA2:-951G42!7 8*S '
M."1S0!V$T*W$31R*LD<@*LK#(8'J"*_/W_AS'\4_V?O$&LV7[,?[6'BSX#_#
M?7KZ;4Y?!5UX-T[Q7I^DS3.SS+IKW3*UE"S,6$:!@&).3P!]8?"7]KSPW\9/
MVE?BQ\*]+L=<M_$'P=;2DUFXNH8EL[DZC:FZ@^SLLC.VU!A]Z)AN!N'->J4
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M7EEM$UMF,^PM(X/[L!E8J5P3GN==_P""+.O/_P $Z?@=\&/#_P ;KSPSXV^
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M[/+\H8QG>>E>X444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX+._M,>%K[Q!KEYX9T'PAX0N=,TB>^EDL-.EG2],TD,!8QQM)L7>R@%MHSG
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %?S _\ !ZM_RE-\ _\ 9*M._P#3OK%?T_5_,#_P>K?\I3? /_9*
MM._].^L4 ?O]_P $G?\ E%E^S3_V2KPO_P"FBUKZ KY__P""3O\ RBR_9I_[
M)5X7_P#31:U] 4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MV[6]Y\6+FRN%E@LM.A;#QZ8)HU>2Y<!I2@6/;M8G]'J "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *_F!_X/5O^4IO@'_LE6G?^G?6*_I^K^8'_@]6
M_P"4IO@'_LE6G?\ IWUB@#]_O^"3O_*++]FG_LE7A?\ ]-%K7T!7S_\ \$G?
M^467[-/_ &2KPO\ ^FBUKZ H **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MP!_PX+_ZO4_;_P#_  [W_P!R4?\ #@O_ *O4_;__ /#O?_<E??\ 10!\ ?\
M#@O_ *O4_;__ /#O?_<E'_#@O_J]3]O_ /\ #O?_ ')7W_10!\ ?\."_^KU/
MV_\ _P .]_\ <E'_  X+_P"KU/V__P#P[W_W)7W_ $4 ? '_  X+_P"KU/V_
M_P#P[W_W)1_PX+_ZO4_;_P#_  [W_P!R5]_T4 ? '_#@O_J]3]O_ /\ #O?_
M ')1_P ."_\ J]3]O_\ \.]_]R5]_P!% 'P!_P ."_\ J]3]O_\ \.]_]R4?
M\."_^KU/V_\ _P .]_\ <E??]% 'P!_PX+_ZO4_;_P#_  [W_P!R4?\ #@O_
M *O4_;__ /#O?_<E??\ 10!\ ?\ #@O_ *O4_;__ /#O?_<E'_#@O_J]3]O_
M /\ #O?_ ')7W_10!\ ?\."_^KU/V_\ _P .]_\ <E'_  X+_P"KU/V__P#P
M[W_W)7W_ $4 ? '_  X+_P"KU/V__P#P[W_W)1_PX+_ZO4_;_P#_  [W_P!R
M5]_T4 ? '_#@O_J]3]O_ /\ #O?_ ')1_P ."_\ J]3]O_\ \.]_]R5]_P!%
M 'P!_P ."_\ J]3]O_\ \.]_]R4?\."_^KU/V_\ _P .]_\ <E??]% 'P!_P
MX+_ZO4_;_P#_  [W_P!R4?\ #@O_ *O4_;__ /#O?_<E??\ 10!\ ?\ #@O_
M *O4_;__ /#O?_<E'_#@O_J]3]O_ /\ #O?_ ')7W_10!\ ?\."_^KU/V_\
M_P .]_\ <E'_  X+_P"KU/V__P#P[W_W)7W_ $4 ? '_  X+_P"KU/V__P#P
M[W_W)1_PX+_ZO4_;_P#_  [W_P!R5]_T4 ? '_#@O_J]3]O_ /\ #O?_ ')1
M_P ."_\ J]3]O_\ \.]_]R5]_P!% 'P!_P ."_\ J]3]O_\ \.]_]R4?\."_
M^KU/V_\ _P .]_\ <E??]% 'P!_PX+_ZO4_;_P#_  [W_P!R4?\ #@O_ *O4
M_;__ /#O?_<E??\ 10!\ ?\ #@O_ *O4_;__ /#O?_<E'_#@O_J]3]O_ /\
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M $4 ? '_  X+_P"KU/V__P#P[W_W)1_PX+_ZO4_;_P#_  [W_P!R5]_T4 ?
M'_#@O_J]3]O_ /\ #O?_ ')1_P ."_\ J]3]O_\ \.]_]R5]_P!% 'P!_P .
M"_\ J]3]O_\ \.]_]R4?\."_^KU/V_\ _P .]_\ <E??]% 'P!_PX+_ZO4_;
M_P#_  [W_P!R4?\ #@O_ *O4_;__ /#O?_<E??\ 10!\ ?\ #@O_ *O4_;__
M /#O?_<E'_#@O_J]3]O_ /\ #O?_ ')7W_10!\ ?\."_^KU/V_\ _P .]_\
M<E'_  X+_P"KU/V__P#P[W_W)7W_ $4 ? '_  X+_P"KU/V__P#P[W_W)1_P
MX+_ZO4_;_P#_  [W_P!R5]_T4 ? '_#@O_J]3]O_ /\ #O?_ ')1_P ."_\
MJ]3]O_\ \.]_]R5]_P!% 'P!_P ."_\ J]3]O_\ \.]_]R4?\."_^KU/V_\
M_P .]_\ <E??]% 'P!_PX+_ZO4_;_P#_  [W_P!R4?\ #@O_ *O4_;__ /#O
M?_<E??\ 10!\ ?\ #@O_ *O4_;__ /#O?_<E'_#@O_J]3]O_ /\ #O?_ ')7
MW_10!\ ?\."_^KU/V_\ _P .]_\ <E'_  X+_P"KU/V__P#P[W_W)7W_ $4
M? '_  X+_P"KU/V__P#P[W_W)1_PX+_ZO4_;_P#_  [W_P!R5]_T4 ? '_#@
MO_J]3]O_ /\ #O?_ ')1_P ."_\ J]3]O_\ \.]_]R5]_P!% 'P!_P ."_\
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M_P#_  [W_P!R5]_T4 ? '_#@O_J]3]O_ /\ #O?_ ')1_P ."_\ J]3]O_\
M\.]_]R5]_P!% 'P!_P ."_\ J]3]O_\ \.]_]R4?\."_^KU/V_\ _P .]_\
M<E??]% 'P!_PX+_ZO4_;_P#_  [W_P!R4?\ #@O_ *O4_;__ /#O?_<E??\
M10!\ ?\ #@O_ *O4_;__ /#O?_<E'_#@O_J]3]O_ /\ #O?_ ')7W_10!\ ?
M\."_^KU/V_\ _P .]_\ <E'_  X+_P"KU/V__P#P[W_W)7W_ $4 ? '_  X+
M_P"KU/V__P#P[W_W)1_PX+_ZO4_;_P#_  [W_P!R5]_T4 ? '_#@O_J]3]O_
M /\ #O?_ ')1_P ."_\ J]3]O_\ \.]_]R5]_P!% 'P!_P ."_\ J]3]O_\
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **^:/^"CO_  4=L_\
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M*<GY;'[1E/@?F$<.LQXHQ$,OP_>HTZC\HPNM?)M2_NLZK_@O)^VW\-_VH)O
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<+YGD&.EE^:TG3J+[I+I*+VDGW7H[--!1116A\^%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% 'P!_P4/_ .4Z_P#P3J_[J5_ZC]O7W_7P!_P4/_Y3K_\ !.K_ +J5_P"H
M_;U]_P! !7\P/_!ZM_RE-\ _]DJT[_T[ZQ7]/U?S _\ !ZM_RE-\ _\ 9*M.
M_P#3OK% '[_?\$G?^467[-/_ &2KPO\ ^FBUKZ KY_\ ^"3O_*++]FG_ +)5
MX7_]-%K7T!0 4444 %%%% !1110 4444 %?(O_!=#_E&WXB_[&[P7_ZENCU]
M=5\B_P#!=#_E&WXB_P"QN\%_^I;H] 'UU1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 445D^./'^A_#+PW<:SXDUC2]!TFU&9KW4+
MI+:WB^KN0!^=&VYI3ISJ35.FFV]$EJV^R1K4V218D9F9551DDG  K\]_VJ?^
M#A/X<_#'[1IOPUTN[^(&K)E!?2[K'2XFZ9!8>;+@]E55(Z/S7Q_<>*_VO/\
M@KS>R0V::P/!UPY1X[4'1_#L2YY5G)'VC;Z,TKCTK@J9A33Y:?O/R/V/(?!'
M.L30_M#.YPP&&ZSK/E=O*#:=^RDXWZ7/T:_:J_X+,_!/]F$W-C'KA\<>(H,K
M_9OA\K<K&X[2W&?)3!X(#,Z\_)VKX!^)O_!6+]I3]OWQ1/X5^$^AZEX<L;CY
M39>%X7N-0$9. T]Z0#&/]M/)7UKZ._96_P"#=KP7X&^SZE\5M?N/&>H+AVTK
M36>STU#W5I.)I1Z$&+W4U^@'PS^$_AGX,^%H=$\)Z!I'AS2;?[EKIUJEO'G^
M\0H&YCW8Y)[DUG[+$UOXCY5V6_\ 7]6/=_UB\/N%/=R3#/,<2O\ E[6TI)]X
MPMK9[>[?M-GY6_LT?\&\7BOQ[J"Z]\:?%K:/]JD\^XTS2YEO=1G).6\VZ;,2
M,3GE1+G/45^C7[-?[#_PM_9(TQ8? O@_2]*N]FR74I%^T:A< ]=UQ)F3!Z[0
M0HSP!7K%%=-'!TJ7PK7OU/SSBWQ0XCXCO#,,0U2_Y]P]RFEVY5\5NG,Y/S"B
MBBNH_/@HHHH **** "BBB@ HHHH **** "BBB@ HHHH *;/"ES"\<B+)'(I5
ME895@>""/2G44 ?F'_P4K_X(80^(I;[QY\#K6+3]44FYO?"L;"*&X(Y+V1X$
M;YY\HD*?X"N K<=_P3J_X+<:Q\)M7A^&WQ\.I-;6,OV&'Q!=0O\ ;]*=3M\F
M^0C>ZJ1@R8\Q2/F#YROZVU\G_P#!17_@E!X+_;GTF;6+,6_A?XB01;;;6HHO
MW=]M&%CNT7_6+@8#CYT&,;E&P^;5PDH2]KAM'U71G[UPSXF8#-L#'ASCN+JT
M-J==:U:3VNWJY1\]7;22FK)?4N@Z_8^*=%M=2TR\M=1TZ^B6>VNK:59H;B-A
ME71U)#*1R"#@U;K\-_V>?VP?C1_P1I^,LO@#Q[H]]J'A'S?,FT6XEW0M$S'_
M $O3I^5 )R2!\C'(8*XRO[$?LV_M/>"OVL_AK;>*O ^LPZKILV$FC^Y<V,N,
MF&>/K&X]#P1RI92"=\-C(U?=>DENCY#C[PSQ_#CCBZ<E7P=36G6AK%I[*5K\
MLOFT_LMV:7H%%%%=9^:!1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% 'P!_P4/\ ^4Z__!.K_NI7
M_J/V]??]? '_  4/_P"4Z_\ P3J_[J5_ZC]O7W_0 5_,#_P>K?\ *4WP#_V2
MK3O_ $[ZQ7]/U?S _P#!ZM_RE-\ _P#9*M._].^L4 ?O]_P2=_Y19?LT_P#9
M*O"__IHM:^@*^?\ _@D[_P HLOV:?^R5>%__ $T6M?0% !17F=E^VG\'-2^+
MY^'MO\6?AG<>/A,;<^&H_%%BVL"4#)3[()?.W <XVYKK/B?\6?"OP2\&W7B+
MQIXF\/\ A'P_8X^T:IK6HPZ?9V^>!OFE947/N: .@HKG?A9\7_"?QS\&V_B/
MP3XH\.^,?#UX66#5-#U*'4+.8J<,%FA9D;!X.#Q7/^!?VM_A3\4?B7J'@OPS
M\3OA[XB\8Z3O^W:%IGB.SO-3L]G#^;;QR&5-IZ[E&.] 'H5%%>>_$+]K?X4_
M"3XAZ;X1\5_$[X>^&?%FL;/L&BZMXCL[+4;[><+Y5O)(LC[CP-JG)H ]"HKG
M_B?\6?"OP2\&W7B+QIXF\/\ A'P_8X^T:IK6HPZ?9V^>!OFE947/N:;\+/B_
MX3^.?@VW\1^"?%'AWQCX>O"RP:IH>I0ZA9S%3A@LT+,C8/!P>* .BKY%_P""
MZ'_*-OQ%_P!C=X+_ /4MT>OKJOD7_@NA_P HV_$7_8W>"_\ U+='H ^NJ***
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJR_O.Z7E%;17DDD%%%%:'AA1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 >:_M2_LE^!_VQ/AK-X8\<:3'?VOS/:7<>$O--E(
MQYL$F"4;ID<JV,,&'%?CY\:?V:OCA_P10^-T?C3P?JEQJ'A&YF$,.L0PEK&_
MB+9%IJ$&<(Q[9.#]Z-PP.W]S:S_%/A73?''AR\T?6=/L]4TK48F@NK2[A6:&
MXC;@JZ,""#Z&N/$X.-7WEI);,_3N ?$[&\/*6!Q$%B,%4TJ49ZQ:>[C>_*_E
M9]5>S7SA_P $]/\ @J1X)_;P\/QV,;1^'/'UK#OOM!N)03* /FEMF./-C[D8
MW)_$,89OI^OR!_X*%?\ !%SQ)^SGX@D^)WP%EUB?2]-E^WR:1:3/_:FA.IW>
M;:NIWRQKZ ^8G'WQDKZM_P $T?\ @N9I_P 2CI_@;XT75KH_B)MMO8^)6 AL
M]1/0+<CA893_ '^(V[[#C=E1QDH2]EB-'WZ,^HXH\,<%F6!EQ)P--UL-O.CO
M5HO=JVKDE\W;5.:O)?I110K!U!'(/(([T5Z)^$A1110 4444 %%%% !1110
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M\1^)O"'P;\5:IX+\._\ "7>,-/TJYN-$T4W45JNJWJQ,8(&EE9(XU>3:I9F
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MX(6>O/I6BJ;.RTC6#K]MH;75K!'MCMB]M?<F(#YDW;21S[1_P52_X)E?!O\
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M7X?_ .@?X[_\(C6O_D6N[HH X3_AHOP__P! _P =_P#A$:U_\BT?\-%^'_\
MH'^._P#PB-:_^1:[NB@#A/\ AHOP_P#] _QW_P"$1K7_ ,BT?\-%^'_^@?X[
M_P#"(UK_ .1:[NB@#A/^&B_#_P#T#_'?_A$:U_\ (M'_  T7X?\ ^@?X[_\
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M^'_^@?X[_P#"(UK_ .1:[NB@#A/^&B_#_P#T#_'?_A$:U_\ (M'_  T7X?\
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M'^.__"(UK_Y%KNZ* .$_X:+\/_\ 0/\ '?\ X1&M?_(M'_#1?A__ *!_CO\
M\(C6O_D6N[HH X3_ (:+\/\ _0/\=_\ A$:U_P#(M'_#1?A__H'^._\ PB-:
M_P#D6N[HH X3_AHOP_\ ] _QW_X1&M?_ "+1_P -%^'_ /H'^.__  B-:_\
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MQP2C7DX62X(ZK%&,O*W^RBL?:OSN_:J_X.--.TW[3I?P?\+/J4V"@US7U,4
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M *!_CO\ \(C6O_D6C_AHOP__ - _QW_X1&M?_(M=W10!PG_#1?A__H'^._\
MPB-:_P#D6C_AHOP__P! _P =_P#A$:U_\BUW=% '"?\ #1?A_P#Z!_CO_P (
MC6O_ )%H_P"&B_#_ /T#_'?_ (1&M?\ R+7=T4 <)_PT7X?_ .@?X[_\(C6O
M_D6C_AHOP_\ ] _QW_X1&M?_ "+7=T4 <)_PT7X?_P"@?X[_ /"(UK_Y%H_X
M:+\/_P#0/\=_^$1K7_R+7=T4 <)_PT7X?_Z!_CO_ ,(C6O\ Y%H_X:+\/_\
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M1K7_ ,BT?\-%^'_^@?X[_P#"(UK_ .1:[NB@#A/^&B_#_P#T#_'?_A$:U_\
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MO=-W;O#\.-GVF*/?]TYV9QQG&1G]'*^ /^"A_P#RG7_X)U?]U*_]1^WK[_H
M*_F!_P"#U;_E*;X!_P"R5:=_Z=]8K^GZOY@?^#U;_E*;X!_[)5IW_IWUB@#]
M_O\ @D[_ ,HLOV:?^R5>%_\ TT6M?0%?/_\ P2=_Y19?LT_]DJ\+_P#IHM:^
M@* "BBB@ HHHH **** "BBB@ KY%_P""Z'_*-OQ%_P!C=X+_ /4MT>OKJOD7
M_@NA_P HV_$7_8W>"_\ U+='H ^NJ*** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR_/T,^./"UX#"K/^'JOUK+IZJ:UE3\JB6UMG*RL])*+LG].T445W'X^%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'P!_P4/_ .4Z
M_P#P3J_[J5_ZC]O7W_7P!_P4/_Y3K_\ !.K_ +J5_P"H_;U]_P! !7\P/_!Z
MM_RE-\ _]DJT[_T[ZQ7]/U?S _\ !ZM_RE-\ _\ 9*M._P#3OK% '[_?\$G?
M^467[-/_ &2KPO\ ^FBUKZ KY_\ ^"3O_*++]FG_ +)5X7_]-%K7T!0 4444
M %%%% !1110 4444 %?(O_!=#_E&WXB_[&[P7_ZENCU]=5\B_P#!=#_E&WXB
M_P"QN\%_^I;H] 'UU1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0>01WKX)_P""E_\ P15T']IP7_C3X;QV/ACX@-NFN;/ BT_7FY)+ #$4[?\
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MC]S<!<<X#IQN5T(#?K=^Q?\ MW> OVY?A^-7\(ZAY>I6J+_:FBW+!;[3'/\
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M\$G?^467[-/_ &2KPO\ ^FBUKZ KY_\ ^"3O_*++]FG_ +)5X7_]-%K7T!0
M4444 %%%% !1110 4444 %?(O_!=#_E&WXB_[&[P7_ZENCU]=5\B_P#!=#_E
M&WXB_P"QN\%_^I;H] 'UU1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!X*.BI4]+K^_))<U^J5HOJF]0HHHKM/R0**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *9<6\=Y;R0S1I+%*I1T==RNIX((/4'TI]% ;:H_+[_@I3_P
M0QCU:>]\?? NUCL=1C)NKWPK$WEQS,#N,ED<@1MW\G(4_P !4@(>8_X)S?\
M!;W5/AKJ=O\ #CX^2:@T-G+]A@\1W43_ &W3G4[?*OD(WN 1CS,;U(^<-RR_
MK17R7_P49_X)->#?VY=+GUO3_L_A;XC0Q8M]8CB_<ZAM&%BNU7EUX $@^=!C
M[P&P^;5PDH2]KAM'U71G[UPWXF9?G&!CPYQW%U:*TIUU_%I/:[>KE'SU>EI*
M:LE]5:+K=GXDT>UU#3KNVO["^B6>WN;>42PSQL,JZ,I(92"""#@BK5?AS^S?
M^V;\9O\ @CA\89?A[\0-%U"_\(K-YDVBW$FY%C9CF[TZ8_+ACD[0=C'<&"OE
ME_8K]G+]ICP7^U=\-;7Q5X'UJWU;2[CY)4!VW%E+C)AFCZQR#/0]1@@E2">C
M#8N-73:2W1\?Q]X9X_AMQQ4)*O@ZFM.M#6,D]D[7Y96\VG]EO6W>4445U'YJ
M%%%% !1110 4444 %%%% !1110 4444 ? '_  4/_P"4Z_\ P3J_[J5_ZC]O
M7W_7P!_P4/\ ^4Z__!.K_NI7_J/V]??] !7\P/\ P>K?\I3? /\ V2K3O_3O
MK%?T_5_,#_P>K?\ *4WP#_V2K3O_ $[ZQ0!^_P!_P2=_Y19?LT_]DJ\+_P#I
MHM:^@*^?_P#@D[_RBR_9I_[)5X7_ /31:U] 4 %%%% !1110 4444 %%%% !
M7R+_ ,%T/^4;?B+_ +&[P7_ZENCU]=5\B_\ !=#_ )1M^(O^QN\%_P#J6Z/0
M!]=4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_?):3KA@#MKZVK*.#J57SXE_);?U_5SZ3'>*&3<-4)99P!0Y6U:6)J).I/\
MPIK1=KI+M!/4\W_9I_9*^'_[(O@I=#\!^';31[=P#<W./,O+]A_%-,WSN>N
M3M7.% '%>D445Z,8J*M'8_!\=CL1C*\L3BYNI4D[N4FVV^[;U844451RA111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MXCLM,9I[/_C\&FZ?,IFU$189<QE=S*0.Q/W[81R)HD*-N$RP*ISUW;:^&?\
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M_"1N_P#Y94?\(_\ $W_H;O G_A(W?_RRH [NBN$_X1_XF_\ 0W>!/_"1N_\
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M G_A(W?_ ,LJ/^$?^)O_ $-W@3_PD;O_ .65 '=T5PG_  C_ ,3?^AN\"?\
MA(W?_P LJ/\ A'_B;_T-W@3_ ,)&[_\ EE0!W=%<)_PC_P 3?^AN\"?^$C=_
M_+*C_A'_ (F_]#=X$_\ "1N__EE0!W=%<)_PC_Q-_P"AN\"?^$C=_P#RRH_X
M1_XF_P#0W>!/_"1N_P#Y94 =W17"?\(_\3?^AN\"?^$C=_\ RRH_X1_XF_\
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M(_\ $W_H;O G_A(W?_RRH_X1_P")O_0W>!/_  D;O_Y94 =W17"?\(_\3?\
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M/_"1N_\ Y94 =W17"?\ "/\ Q-_Z&[P)_P"$C=__ "RH_P"$?^)O_0W>!/\
MPD;O_P"65 '=T5PG_"/_ !-_Z&[P)_X2-W_\LJ/^$?\ B;_T-W@3_P )&[_^
M65 '=T5PG_"/_$W_ *&[P)_X2-W_ /+*C_A'_B;_ -#=X$_\)&[_ /EE0!W=
M%<)_PC_Q-_Z&[P)_X2-W_P#+*C_A'_B;_P!#=X$_\)&[_P#EE0!W=%<)_P (
M_P#$W_H;O G_ (2-W_\ +*C_ (1_XF_]#=X$_P#"1N__ )94 =W17"?\(_\
M$W_H;O G_A(W?_RRH_X1_P")O_0W>!/_  D;O_Y94 =W7(^+O@!X#\?ZW)J6
MO>"?".MZE*JJ]W?Z/;W,[A1A07="Q ' YXJE_P (_P#$W_H;O G_ (2-W_\
M+*C_ (1_XF_]#=X$_P#"1N__ )94FD]S;#XFM0EST9.+[IM/\"+_ (9,^%?_
M $3/X?\ _A.V?_QNNJ\&^!-#^'6C_P!G^']%TG0=/\PR_9M.M([6'><9;8@
MR<#)QGBN:_X1_P")O_0W>!/_  D;O_Y94?\ "/\ Q-_Z&[P)_P"$C=__ "RI
M**6R-J^8XNO'DK59279R;7XL[NBN$_X1_P")O_0W>!/_  D;O_Y94?\ "/\
MQ-_Z&[P)_P"$C=__ "RJCC.[HKA/^$?^)O\ T-W@3_PD;O\ ^65'_"/_ !-_
MZ&[P)_X2-W_\LJ .[HKA/^$?^)O_ $-W@3_PD;O_ .65'_"/_$W_ *&[P)_X
M2-W_ /+*@#NZ*X3_ (1_XF_]#=X$_P#"1N__ )94?\(_\3?^AN\"?^$C=_\
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M(O\ L;O!?_J6Z/7UU7R+_P %T/\ E&WXB_[&[P7_ .I;H] 'UU1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 445P_Q^_:1\$?LO>!9?$7CKQ%I_A_3$R(S.V9KIP,^7#$N7E?_90$
MXY.!DTI225V=&%PE?%5HX?#0<YR=E&*;;?9):MG<5\Q?MQ_\%7?AC^Q);7&G
M7EY_PE'C54/E>'],E4RQ-CC[3+RMNO3KE\$$(PKX)_:X_P""V/Q+_:U\4_\
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M3]#T;3T\NVLK*!8881[*H R>I/4GDY-;%:4<#&,O:5'S2[L\'BSQ@QN.PO\
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M-%NHU_*M/O=E;S5SXG,/$C**#<:#E6DND%I][LK>:N??_P"W'_P5VMOV8O\
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ML?[9XM_Z%\?_  9'_P"2/T._X;Z^!/\ T6KX2_\ A7Z?_P#'J/\ AOKX$_\
M1:OA+_X5^G__ !ZOSQ_XA<_^JY?^69_]W4?\0N?_ %7+_P LS_[NH_M3B/\
MZ X_^!Q_^2#^V>+?^A?'_P &1_\ DC]#O^&^O@3_ -%J^$O_ (5^G_\ QZC_
M (;Z^!/_ $6KX2_^%?I__P >K\\?^(7/_JN7_EF?_=U'_$+G_P!5R_\ +,_^
M[J/[4XC_ .@./_@<?_D@_MGBW_H7Q_\ !D?_ )(_0[_AOKX$_P#1:OA+_P"%
M?I__ ,>H_P"&^O@3_P!%J^$O_A7Z?_\ 'J_/'_B%S_ZKE_Y9G_W=1_Q"Y_\
M5<O_ "S/_NZC^U.(_P#H#C_X''_Y(/[9XM_Z%\?_  9'_P"2/T._X;Z^!/\
MT6KX2_\ A7Z?_P#'J/\ AOKX$_\ 1:OA+_X5^G__ !ZOSQ_XA<_^JY?^69_]
MW4?\0N?_ %7+_P LS_[NH_M3B/\ Z X_^!Q_^2#^V>+?^A?'_P &1_\ DC]#
MO^&^O@3_ -%J^$O_ (5^G_\ QZC_ (;Z^!/_ $6KX2_^%?I__P >K\\?^(7/
M_JN7_EF?_=U'_$+G_P!5R_\ +,_^[J/[4XC_ .@./_@<?_D@_MGBW_H7Q_\
M!D?_ )(_0[_AOKX$_P#1:OA+_P"%?I__ ,>H_P"&^O@3_P!%J^$O_A7Z?_\
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M(ZP/X?[4L+C3<]>OE^?CMZ]3Z<\>/^"5O[<'[/ W>#M:UR:&W^8#PWXW-LA
MY_U<DL)8=?EVG.>AS7[C45Y4^!<LOS4>>F_[LG^MSQ*GAKD]^;#\])_W9O\
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MKPO_ .FBUKZ H **** "BBB@ HHHH **** "OD7_ (+H?\HV_$7_ &-W@O\
M]2W1Z^NJ^1?^"Z'_ "C;\1?]C=X+_P#4MT>@#ZZHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKY^_:-_X*A_!#]F 3P>(/&^
MGWVKP9!TG1C_ &A>;AGY&6/*Q-Q_RU9.WJ*F=2,%>3L>EE>38_,ZRPV74959
M]H1<G^"=EYO0^@:KZKJMKH6FS7E]<V]G9VR&2:>>01QQ*.K,QP !ZFOR3_:
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^)\CF7'F2X-\KJ\\NT/>?WK3[V?M%?ZA;Z592W-U-#;6\"EY)97")&HZDD\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P"*K8M[B.[@26)UDCD4.CH=RN#R"#W!I.+6Z)E&2W0ZBBBI)"BBB@ HHHH
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ME#]<_9W[.7_! SX+?!T6]YXJ&J?$?5H\,6U)_LU@&'=;:(\C_9E>05]F>"_
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%?IE^R)_P1+_ &?/V/EM;S3?!\/BWQ);X;^V_$^W4+E7'(:.,J((B#T:.-6
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MF%HA]:^@_MC)\QTS*C[.;^W3_-K_ ($F?4_ZP9!FVF;X?V-1_P#+REMZN/\
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MJ_@F+38=0DTTVVI7UQ!=-)&L;,0%@=-N)%Y+@\'CIG]<Q_P0^_9;'_-+8?\
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M_6:?;MCU13_2OZGO$GP0\%^,E8:QX0\+ZJ&&&%YI4$^X9SSN4]^?K7 ^)O\
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MI>(&(EI#,8_-07YH]BC]*#P^K;Y;37_<=+\XH_%#_A<?Q>_Z+5\4/_"BO?\
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M   X<=!Z5\O?ME?\$Z/^"=_AA+M[?XIW/@74XP2MIX7UMO$"+)_=>$I<N/\
M=\Q,<<@5][EL.%*>&C+-93A-I7DY1Y=NB[>J;\S^0^-O'?!X;%8K)JM66 A3
MJ5(\U+DC?EDTY.3]Y-M7?*D_,^Y_V2?A=^RWK&F-#\$_$>BLETN^>W\+>.[U
M)V[_ +V.&[$F1_MC(KVS_AG3P_\ ]!#QW_X6^M?_ "57\NWQH^"?@7PCXP:/
MX>>.O$GB;3X7#1WFH^'4TIEQR-NVZE9L>I5#["O8?V8OVSOVC_A=J4&G^ ?B
M7\3-4DA ,6F><^L6Z ?W;:994 ^BXKR,ZXCX4PD?]@QKJOI&-.5__ K*)_)_
M%G''!].;KX;-)8JK+6WLYRDWYS=DW\S^BC_AG3P__P!!#QW_ .%OK7_R57F_
MQ>\<? OX">:OC+XI7GA^XAX:UNOB5JBW7X0B\,A_!37X%_M&?\%"/C7X[U:Z
MTSXA?$;QZT_2?2I;B:QA'^];1A(Q^*UR/[.>J_!OQEXE2#XE>-?&/@NQW<S:
M=X9CU.-AW!<7*NGKD0R?2O+HU.)<=#VF6Y74<>DIKE3]$[7^39\YAZO%^94_
M:Y/DU5QZ2J+D37=)VO\ *3/U]^+_ /P64_9?^'HDCT'5/C-XYN%R$.F>(];M
MK?/^T]S>1,![JC?3'-?+?Q9_X+N:QK\CV_@/P-K6A^8=D<VK_$+7]3F;/ (2
M.ZA4-Z [AGUKV[]CG]D#_@GCXX:U;3_B;8>/M2D*F.V\3>(6TB:1_1;7;:NW
M^Z0WOFOT?^#O[,7PS^"%E"_@?P/X0\.J4#)<Z9ID,4LH(X8RJN]\CN6/%>;7
MRCBF<N7&5%A_)1=_QU^Z1Y6)R'C2I+DS"M'"W^S&#YO_ "97^Z1^)GA/4OV[
MOVJ+II/#DOQMAT^]/[HQZE>:58;3V6XN)4#+[M(W7DUZ%X#_ .#=OXZ?%_51
MJGQ"\:>'-!DN,>=)<WLVL:C^( "-U_Y[5^V%%9QX)P]1\V.K3JOSEI_G^)A#
MPYPE5\^95ZE=_P!Z3M]V_P")^<WP?_X-KOA)X1\N;QAXL\8>,;F/&Z* Q:79
MR>N44/+^4H_&OH'P9_P1Y_9Q^']U#<:3\-;>UN[?!CN?[7U!YT/J':<L#]"*
M^F**]W"9!EV&_@T8I][7?WN[_$^EP/"^4X/_ '?#Q3[VN_O=W^)P-O\ LV^&
M[2".**]\<1Q1J$1$\:ZRJH!P !]JX I__#.GA_\ Z"'CO_PM]:_^2J[NBO7/
M>.$_X9T\/_\ 00\=_P#A;ZU_\E4?\,Z>'_\ H(>._P#PM]:_^2J[NB@#A/\
MAG3P_P#]!#QW_P"%OK7_ ,E4?\,Z>'_^@AX[_P#"WUK_ .2J[NB@#A/^&=/#
M_P#T$/'?_A;ZU_\ )5'_  SIX?\ ^@AX[_\ "WUK_P"2J[NB@#A/^&=/#_\
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M .$_X9T\/_\ 00\=_P#A;ZU_\E4?\,Z>'_\ H(>._P#PM]:_^2J[NB@#A/\
MAG3P_P#]!#QW_P"%OK7_ ,E4?\,Z>'_^@AX[_P#"WUK_ .2J[NB@#A/^&=/#
M_P#T$/'?_A;ZU_\ )5'_  SIX?\ ^@AX[_\ "WUK_P"2J[NB@#A/^&=/#_\
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M .$_X9T\/_\ 00\=_P#A;ZU_\E4?\,Z>'_\ H(>._P#PM]:_^2J[NB@#A/\
MAG3P_P#]!#QW_P"%OK7_ ,E4?\,Z>'_^@AX[_P#"WUK_ .2J[NB@#A/^&=/#
M_P#T$/'?_A;ZU_\ )5'_  SIX?\ ^@AX[_\ "WUK_P"2J[NB@#A/^&=/#_\
MT$/'?_A;ZU_\E4?\,Z>'_P#H(>.__"WUK_Y*KNZ* .$_X9T\/_\ 00\=_P#A
M;ZU_\E4?\,Z>'_\ H(>._P#PM]:_^2J[NOFG]KO_ (*Y_ 7]BP75KXL\;V>H
M>(;7*G0-#QJ.I;Q_ Z(=D+?]=GC'OR*Z,-A:V(G[.A!R?9*YU8/ XC%5/98:
M#G+LDV_P/6_^&=/#_P#T$/'?_A;ZU_\ )5<M\7M%^%OP \)2:]XW\<:]X3T>
M/(-WJGQ$U:UC9O[JE[L;F/95R3V!K\D_VE?^#EWXN_'_ %Y?"_P*\%KX2;4)
M/(M+AK?^VM=NV.<>5$$,2,1GY0DIXR&KE?@__P $+OVIO^"@?C"/QA\:?$6H
M>$K>\ +W_BR[DU#6&C/.V.T#9C Z>7*\.WL,5]91X/=""K9M6C1CVO>3]$OT
MOZ'W5#@)X:"KYYB(X>/:_--^B7Z7?D>Y_M>?\%_?@Q\.UNM,^$.E_$SX@:HN
M535=2\:ZYIVDH?[RHUS]HEZ?=*Q=1AJ^2O"L?[:O_!7"[N;709/'\_@C4WV2
MQMK%[9^&(4SRIENIF\\+U*EY7]CQ7ZR?LA_\$"OV>_V5UM;Z]\.M\1O$MOAC
MJ7B<+=0HXYS': "!1GD;E=UP/G[U]J6MK'8VT<,,<<,,*A(XT4*J*!@  <
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M._\ *++]FG_LE7A?_P!-%K7T!7S_ /\ !)W_ )19?LT_]DJ\+_\ IHM:^@*
M"BBB@ HHHH **** "BBB@ KY%_X+H?\ *-OQ%_V-W@O_ -2W1Z^NJ^1?^"Z'
M_*-OQ%_V-W@O_P!2W1Z /KJBBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5%%?)5JU2K-SJR<F^K=W]Y\-7Q%6M-U:TG*3W;;;?S84445F8A1110 4444
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MF([F%I /6O0_VE/V,_A;^U_X<_LOXD>"="\4PJACAN+F#9>6@/7R;A-LT7_
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MTWR_]Z9U^S_E*?Y5X^+X8S3#:U*,K=U[R_"YX..X-SK":UL/*W>*YE_Y+?\
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MB%4>Y.*_'7]KG_@Z>GNGN-)^!_@;R]Q,::YXH&YR<XS%9Q-CW5GD/49CZBO
MO#7[!W[;7_!7[7K?7O'U]X@L/#<SB:*]\73-I>FP*?XK6P10>5Z-'"%;C+C.
M:^NP_!M>,/;YE4C0A_>=Y/T7_!OY'W6$\/\ $PIK$YO5CAJ?]YIR?HK[^5[^
M1^A_[7O_  <?? G]GE;K3_!LMY\6/$,.4$>CMY&EHX_OWCJ58?[4*2@^M?GS
MXW_X*B_MF_\ !5GQ3=>&?A9IFN:+H\A\N73_  5;O;K"C<#[5J+'='D'!)DB
MC;/W:^[OV0O^#:/X+? X6FI?$.[U+XJ:]#AVBNLV.D1N.1BWC8O)CH?-D96
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M7(<(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'P!_P4/_Y3K_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX@U+XC:M'AVTVTW:;I"-UVMM/GRX/??&".J<XK?^P\IR_7-*_/-?8IZ_)O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_: U%-+T?4O^%9ZM+YF@:E+/]K780"89) B;9%.1M89QCYF^\?Z;JX7]HO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MCO\ \(C6O_D6N[HH X3_ (:+\/\ _0/\=_\ A$:U_P#(M'_#1?A__H'^._\
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M1K7_ ,BT?\-%^'_^@?X[_P#"(UK_ .1:[NB@#A/^&B_#_P#T#_'?_A$:U_\
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M:+\/_P#0/\=_^$1K7_R+1_PT7X?_ .@?X[_\(C6O_D6N[HH X3_AHOP__P!
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MZ* .$_X:+\/_ /0/\=_^$1K7_P BT?\ #1?A_P#Z!_CO_P (C6O_ )%KNZ*
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MUK_Y%KNZ* .$_P"&B_#_ /T#_'?_ (1&M?\ R+1_PT7X?_Z!_CO_ ,(C6O\
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M%^'_ /H'^.__  B-:_\ D6N[HH X3_AHOP__ - _QW_X1&M?_(M'_#1?A_\
MZ!_CO_PB-:_^1:[NB@#A/^&B_#__ $#_ !W_ .$1K7_R+1_PT7X?_P"@?X[_
M /"(UK_Y%KNZ* .$_P"&B_#_ /T#_'?_ (1&M?\ R+1_PT7X?_Z!_CO_ ,(C
M6O\ Y%KNZ* .$_X:+\/_ /0/\=_^$1K7_P BT?\ #1?A_P#Z!_CO_P (C6O_
M )%KNZ* .$_X:+\/_P#0/\=_^$1K7_R+1_PT7X?_ .@?X[_\(C6O_D6N[HH
MX3_AHOP__P! _P =_P#A$:U_\BT?\-%^'_\ H'^._P#PB-:_^1:[NB@#A/\
MAHOP_P#] _QW_P"$1K7_ ,BT?\-%^'_^@?X[_P#"(UK_ .1:[NB@#A/^&B_#
M_P#T#_'?_A$:U_\ (M'_  T7X?\ ^@?X[_\ "(UK_P"1:[NB@#A/^&B_#_\
MT#_'?_A$:U_\BT?\-%^'_P#H'^.__"(UK_Y%KNZ* .$_X:+\/_\ 0/\ '?\
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M#_\ T#_'?_A$:U_\BT?\-%^'_P#H'^.__"(UK_Y%KNZ* .$_X:+\/_\ 0/\
M'?\ X1&M?_(M'_#1?A__ *!_CO\ \(C6O_D6N[HH X3_ (:+\/\ _0/\=_\
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M_P#TT6M?0%?/_P#P2=_Y19?LT_\ 9*O"_P#Z:+6OH"@ HHHH **** "BBB@
MHHHH *^1?^"Z'_*-OQ%_V-W@O_U+='KZZKY%_P""Z'_*-OQ%_P!C=X+_ /4M
MT>@#ZZHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /@#_ (*'_P#*=?\
MX)U?]U*_]1^WK[_KX _X*'_\IU_^"=7_ '4K_P!1^WK[_H *_F!_X/5O^4IO
M@'_LE6G?^G?6*_I^K^8'_@]6_P"4IO@'_LE6G?\ IWUB@#]_O^"3O_*++]FG
M_LE7A?\ ]-%K7T!7S_\ \$G?^467[-/_ &2KPO\ ^FBUKZ H **** "BBB@
MHHHH **** "OD7_@NA_RC;\1?]C=X+_]2W1Z^NJ^1?\ @NA_RC;\1?\ 8W>"
M_P#U+='H ^NJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#X _P""A_\
MRG7_ ."=7_=2O_4?MZ^_Z^ /^"A__*=?_@G5_P!U*_\ 4?MZ^_Z "OY@?^#U
M;_E*;X!_[)5IW_IWUBOZ?J_F!_X/5O\ E*;X!_[)5IW_ *=]8H _?[_@D[_R
MBR_9I_[)5X7_ /31:U] 5\__ /!)W_E%E^S3_P!DJ\+_ /IHM:^@* "BBB@
MHHHH **** "BBB@ KY%_X+H?\HV_$7_8W>"__4MT>OKJOD7_ (+H?\HV_$7_
M &-W@O\ ]2W1Z /KJBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^ /\
M@H?_ ,IU_P#@G5_W4K_U'[>OO^O@#_@H?_RG7_X)U?\ =2O_ %'[>OO^@ K^
M8'_@]6_Y2F^ ?^R5:=_Z=]8K^GZOY@?^#U;_ )2F^ ?^R5:=_P"G?6* /W^_
MX)._\HLOV:?^R5>%_P#TT6M?0%?/_P#P2=_Y19?LT_\ 9*O"_P#Z:+6OH"@
MHHHH **** "BBB@ HHHH *^1?^"Z'_*-OQ%_V-W@O_U+='KZZKY%_P""Z'_*
M-OQ%_P!C=X+_ /4MT>@#ZZHHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M/@#_ (*'_P#*=?\ X)U?]U*_]1^WK[_KX _X*'_\IU_^"=7_ '4K_P!1^WK[
M_H *_F!_X/5O^4IO@'_LE6G?^G?6*_I^K^8'_@]6_P"4IO@'_LE6G?\ IWUB
M@#]_O^"3O_*++]FG_LE7A?\ ]-%K7T!7S_\ \$G?^467[-/_ &2KPO\ ^FBU
MKZ H **** "BBB@ HHHH **** "OD7_@NA_RC;\1?]C=X+_]2W1Z^NJ^1?\
M@NA_RC;\1?\ 8W>"_P#U+='H ^NJ*** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#X _P""A_\ RG7_ ."=7_=2O_4?MZ^_Z^ /^"A__*=?_@G5_P!U*_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH ^ /\ @H?_ ,IU_P#@G5_W4K_U'[>OO^O@#_@H?_RG7_X)U?\
M=2O_ %'[>OO^@ K^8'_@]6_Y2F^ ?^R5:=_Z=]8K^GZOY@?^#U;_ )2F^ ?^
MR5:=_P"G?6* /W^_X)._\HLOV:?^R5>%_P#TT6M?0%?/_P#P2=_Y19?LT_\
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MX=T*-(R+^\%OF>02/*D:)%R3NY.,'4_8!_;E^*?C[]H?QS\!?VA/"?@SPO\
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M@#ZZHKY%_P"&%OVDO^CX/B)_X;GPE_\ (%'_  PM^TE_T?!\1/\ PW/A+_Y
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M_H^#XB?^&Y\)?_(% 'UU17R+_P ,+?M)?]'P?$3_ ,-SX2_^0*/^&%OVDO\
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M'P?$3_PW/A+_ .0* /KJBOD7_AA;]I+_ */@^(G_ (;GPE_\@4?\,+?M)?\
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M@4?\,+?M)?\ 1\'Q$_\ #<^$O_D"@#ZZHKY%_P"&%OVDO^CX/B)_X;GPE_\
M(%'_  PM^TE_T?!\1/\ PW/A+_Y H ^NJ*^1?^&%OVDO^CX/B)_X;GPE_P#(
M%'_#"W[27_1\'Q$_\-SX2_\ D"@#ZZHKY%_X86_:2_Z/@^(G_AN?"7_R!1_P
MPM^TE_T?!\1/_#<^$O\ Y H ^NJ*^1?^&%OVDO\ H^#XB?\ AN?"7_R!1_PP
MM^TE_P!'P?$3_P -SX2_^0* /KJBOD7_ (86_:2_Z/@^(G_AN?"7_P @4?\
M#"W[27_1\'Q$_P##<^$O_D"@#ZZHKY%_X86_:2_Z/@^(G_AN?"7_ ,@4?\,+
M?M)?]'P?$3_PW/A+_P"0* /KJBOD7_AA;]I+_H^#XB?^&Y\)?_(%'_#"W[27
M_1\'Q$_\-SX2_P#D"@#ZNT/7[/Q+927%C<)<0QW$]JSKG EAE>&5>>ZR(ZGW
M6KE?']A_P3^_: T*!H=)_;-\>:3:R2/</!!\/O#$BO/*YEGF)ELW;=+,\DK
M$(K2$(J(%19O^&%OVDO^CX/B)_X;GPE_\@4 ?75%?(O_  PM^TE_T?!\1/\
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M:&\5?%J^\ Z=JNF:58:GX5T?2H;>+44@%P0UA#"2Q:UMSF3> (R !N)KZRH
M*_F!_P"#U;_E*;X!_P"R5:=_Z=]8K^GZOY@?^#U;_E*;X!_[)5IW_IWUB@#]
M_O\ @D[_ ,HLOV:?^R5>%_\ TT6M?0%?/_\ P2=_Y19?LT_]DJ\+_P#IHM:^
M@* "BBB@"'4=.M]8T^>TN[>&ZM;J-H9H9D#QS(PPRLIX*D$@@\$&OEOX#?\
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MX@:3\)_A]KOBGQ!>1Z=H/AO3Y]4U&ZD^[;6T$;2RR'V5%8_A0!LT5^;&H?\
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MQ/\ LS_#/Q5\,_AKXX^(?Q(^+6IWV@Z#\.08M+U:VU'3PW]H17TDI*6L=L5
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MJ>O_ !,^,GP]O/AG=7&H:++X#UVWTF1+J943[2TCVTK^:B(51D92HDD'\1H
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M@ K^8'_@]6_Y2F^ ?^R5:=_Z=]8K^GZOY@?^#U;_ )2F^ ?^R5:=_P"G?6*
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M]$;_ &?_ /P\FK__ #,4?\+'_:F_Z(W^S_\ ^'DU?_YF* /H"BOG_P#X6/\
MM3?]$;_9_P#_  \FK_\ S,4?\+'_ &IO^B-_L_\ _AY-7_\ F8H ^@**^?\
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M^?\ _A8_[4W_ $1O]G__ ,/)J_\ \S%'_"Q_VIO^B-_L_P#_ (>35_\ YF*
M/H"BOG__ (6/^U-_T1O]G_\ \/)J_P#\S%'_  L?]J;_ *(W^S__ .'DU?\
M^9B@#Z HKY__ .%C_M3?]$;_ &?_ /P\FK__ #,4?\+'_:F_Z(W^S_\ ^'DU
M?_YF* /H"BOG_P#X6/\ M3?]$;_9_P#_  \FK_\ S,4?\+'_ &IO^B-_L_\
M_AY-7_\ F8H ^@**^?\ _A8_[4W_ $1O]G__ ,/)J_\ \S%'_"Q_VIO^B-_L
M_P#_ (>35_\ YF* /H"BOG__ (6/^U-_T1O]G_\ \/)J_P#\S%'_  L?]J;_
M *(W^S__ .'DU?\ ^9B@#Z HKY__ .%C_M3?]$;_ &?_ /P\FK__ #,4?\+'
M_:F_Z(W^S_\ ^'DU?_YF* /H"BOG_P#X6/\ M3?]$;_9_P#_  \FK_\ S,4?
M\+'_ &IO^B-_L_\ _AY-7_\ F8H ^@**^?\ _A8_[4W_ $1O]G__ ,/)J_\
M\S%'_"Q_VIO^B-_L_P#_ (>35_\ YF* /H"BOG__ (6/^U-_T1O]G_\ \/)J
M_P#\S%'_  L?]J;_ *(W^S__ .'DU?\ ^9B@#Z HKY__ .%C_M3?]$;_ &?_
M /P\FK__ #,4?\+'_:F_Z(W^S_\ ^'DU?_YF* /H"BOG_P#X6/\ M3?]$;_9
M_P#_  \FK_\ S,4?\+'_ &IO^B-_L_\ _AY-7_\ F8H ^@**^?\ _A8_[4W_
M $1O]G__ ,/)J_\ \S%'_"Q_VIO^B-_L_P#_ (>35_\ YF* /H"BOG__ (6/
M^U-_T1O]G_\ \/)J_P#\S%'_  L?]J;_ *(W^S__ .'DU?\ ^9B@#Z HKY__
M .%C_M3?]$;_ &?_ /P\FK__ #,4?\+'_:F_Z(W^S_\ ^'DU?_YF* /H"BOG
M_P#X6/\ M3?]$;_9_P#_  \FK_\ S,4?\+'_ &IO^B-_L_\ _AY-7_\ F8H
M^@**^?\ _A8_[4W_ $1O]G__ ,/)J_\ \S%'_"Q_VIO^B-_L_P#_ (>35_\
MYF* /H"BOG__ (6/^U-_T1O]G_\ \/)J_P#\S%'_  L?]J;_ *(W^S__ .'D
MU?\ ^9B@#Z HKY__ .%C_M3?]$;_ &?_ /P\FK__ #,4?\+'_:F_Z(W^S_\
M^'DU?_YF* /H"BOG_P#X6/\ M3?]$;_9_P#_  \FK_\ S,4?\+'_ &IO^B-_
ML_\ _AY-7_\ F8H ^@**^?\ _A8_[4W_ $1O]G__ ,/)J_\ \S%'_"Q_VIO^
MB-_L_P#_ (>35_\ YF* /H"BOG__ (6/^U-_T1O]G_\ \/)J_P#\S%'_  L?
M]J;_ *(W^S__ .'DU?\ ^9B@#Z HKY__ .%C_M3?]$;_ &?_ /P\FK__ #,4
M?\+'_:F_Z(W^S_\ ^'DU?_YF* /H"BOG_P#X6/\ M3?]$;_9_P#_  \FK_\
MS,4?\+'_ &IO^B-_L_\ _AY-7_\ F8H ^@**^?\ _A8_[4W_ $1O]G__ ,/)
MJ_\ \S%'_"Q_VIO^B-_L_P#_ (>35_\ YF* /H"BOG__ (6/^U-_T1O]G_\
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M"BOG_P#X6/\ M3?]$;_9_P#_  \FK_\ S,4?\+'_ &IO^B-_L_\ _AY-7_\
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M]$;_ &?_ /P\FK__ #,4?\+'_:F_Z(W^S_\ ^'DU?_YF* /H"BOG_P#X6/\
MM3?]$;_9_P#_  \FK_\ S,4?\+'_ &IO^B-_L_\ _AY-7_\ F8H ^@**^?\
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M^?\ _A8_[4W_ $1O]G__ ,/)J_\ \S%'_"Q_VIO^B-_L_P#_ (>35_\ YF*
M/H"BOG__ (6/^U-_T1O]G_\ \/)J_P#\S%2?"W]I7XH?\-/Z'\-?B9\._ ?A
M>7Q/X7U?Q-I>H>&/'-WX@4KIMWI5M-#-'<:58^66_M:%D96DSY3@A>"0#WRB
MBB@ HHHH **** "BBB@ HHHH *_F!_X/5O\ E*;X!_[)5IW_ *=]8K^GZOY@
M?^#U;_E*;X!_[)5IW_IWUB@#]_O^"3O_ "BR_9I_[)5X7_\ 31:U] 5\_P#_
M  2=_P"467[-/_9*O"__ *:+6OH"@ HHHH **** "BBB@ HHHH *^?\ _@K%
M_P HLOVEO^R5>*/_ $T75?0%?/\ _P %8O\ E%E^TM_V2KQ1_P"FBZH ^@**
M** "BBB@ HHHH ***_.O_@I-_P '!&D_L ?M)7WPTL_ACJ'C34M)MK>>_NY=
M;&E0(T\2S(L?^CS&0!'3+?* 21SBN[+\MQ..J^QPL>:5KVNEIZMI'I95D^,S
M*M]7P4.:5KVNEHNMVTNJZGZ*45^-?_$6Y_U;_P#^7S_][Z\A_;;_ .#E_P <
M?M,_ Z^\&^!_!/\ PJR;6,P:CJ\/B ZC>/;$$-%"1;P^2S=#("S;<A=I.X?0
MT>!LWG449T^5/=N47;SLFW]Q]5A_#7/JE6,*E)0BWJW*#27>RDV_DC]\J*_
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MGWQE\2?L[_\ !.WXU>.O!VI?V/XJ\(^#M2U72;[[/%<?9+F*!GCD\N56C?#
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MT:2*3?=Q!<SR1,B!)"<J" <@*!\1? WQY^W!_P %,_A;J'Q[^%_QO^'?P?\
M!=]J%^O@;P#<>"H=8BU^SM;F6"-]5U"4^?;23-$P;[,I"J00%.5 !^HE%?D%
M\)/^"F'[3'_!2?X^_!_PC\*_&7AGX0_\+ ^$VIZOXLFF\/P:Y#X6U?3]:?3[
MF\LXI,/,YDA$4<4T_DK'<%V$CHNZAI?[2_[='Q._9'^.NN6OQM\!>$]6_9#U
MG7]'UC5H_!5K?77Q5FTR,WA,T;8@TV%K5X% MXV<NS9* 4 ?L917YV_MW_\
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MH\=W.(Y-3OIB1%;PKUDD;#'"@X568X521^;_ ,#?'G[<'_!3/X6ZA\>_A?\
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MQ2T?P#??&+X-R>*?$7B.^\-6>JMIMW$-.E>_@M615DF;S'A$)=(0MR[[2T:
M9^I:U^V=\:?^"B'Q _9_\$_M(:'X1T'X<^!?#.I:MXSOOA]INI:E/J4\,@E>
MWL_W<*K=NDKR+(SK"(T6+;D[@#]0J*^3?^"-W[4GQ&_:A_9;\0?\+:FT>^^(
M'PY\;:SX$U?5-,A%O;ZS+I\XC^UB( +&7##*K@97("YVK]94 %%%% !1110
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M&W; C[=H9C7RC_P6Y_;2_9U^*_\ P4AU#X,_'KQ_'X2\#_#7X::I%;[M)O\
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MF)$C;S3Y;LV,K7;_  <_X+6?%K]OO]GKX/\ @'X1Z_X%TGXR_$WQIKO@^_\
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ME4XW9. "1VJ.)$5EY5AD5\2_\'%?_*'[XJ?]?.@_^GW3ZY+]O?XO_M*^*O\
M@IM\,?@7\#/B5X?^&^B^,/ASJ.NZYJFJ>&[;6FT@P7<<:WEM%)M,EP"T<2QO
M)Y.V5V9"54@ _0BN'_:)_:/\%_LG_"J\\;?$#6?[ \,6%Q;6L][]DGNO+DN)
MX[>%?+A1Y#NEE1<A2!NR< $CX@_97_X*#_%K]G3X2?MA:3\>M:TKXI^(?V3R
M+^#Q)IVF1:+)XJLYM,:^@66VA!B@D^4*2F0-^/FV;G^5O^"B?AW]L37?^"7-
MO\4OBQ\6_!/C+P?\2[WPQJ6I^ K+PC%I(\#1W&J65Q;&SOE8SW;(QBBDCN!D
M"1B'8IE@#]P**_)'_@K9_P %J9OA)^W3K'P+L/VC/#W[*^E^"]'LM1U+Q9/\
M/KGQSJFMWUTOFI9P6B1/!!#' 49Y)2'9IE"# 8UU?_!._P#X*+?$[_@J-^R3
M\>/ _P -OC/X9UCXO?"F>U7PS\2]*\+G3K#Q5%/&T]JUWIFH0$VS.\$]M/LC
MVKG?$3@,0#]0Z*_./_@G)_P4=^,G_!5;]I;3KC2=(O\ X1_#7X+V+Z;\3;.X
MM+6YN/$OBYE\N328'D21HK2T*M*TL;+*Q>-3@-FOT<H **** "BBB@ KY_\
MB-_RE-^#?_9*O'G_ *=_!E?0%?/_ ,1O^4IOP;_[)5X\_P#3OX,H ^@****
M"BBB@ HHHH **** "BBB@ K^8'_@]6_Y2F^ ?^R5:=_Z=]8K^GZOY@?^#U;_
M )2F^ ?^R5:=_P"G?6* /W^_X)._\HLOV:?^R5>%_P#TT6M?0%?/_P#P2=_Y
M19?LT_\ 9*O"_P#Z:+6OH"@ HHHH **** "BBB@ HHHH *^?_P#@K%_RBR_:
M6_[)5XH_]-%U7T!7S_\ \%8O^467[2W_ &2KQ1_Z:+J@#Z HHHH **** "BB
MB@ K@/BG^RA\+?CEKT6J^-OAKX \8:I!"+>.\USP]::A<1Q DA \T;,%!).
M<9)KOZ*TIU)TWS0;3\M#2E6J4I<U.3B^Z=CQK_AW/^SW_P!$(^#7_A%:;_\
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M.]P"[']8J* "BBB@ HHHH **** "N5^)GP)\#_&G[)_PF7@WPKXL^P;OLO\
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ML?!]OX>U*^T6:1H[>[A :*[M))$1]\4RI*C,@^9!E<9!^;?AM_P1C^.FA_\
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M7'^*_P#P3&\>^.O^")O@7]FVSU?PA'XX\,Z5X9L;J^FNKA=)D?3;NTGG*2"
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M_,#_ ,'JW_*4WP#_ -DJT[_T[ZQ7]/U?S _\'JW_ "E-\ _]DJT[_P!.^L4
M?O\ ?\$G?^467[-/_9*O"_\ Z:+6OH"OYQ?V6?\ @\A_X95_9C^'/PO_ .&<
M_P"WO^%;^%],\+?VG_PG_P!E_M'[#:16WG^5_9K^7O\ *W;-[;=V-S8R>\_X
MCG/^K7?_ #)'_P!ZZ /W^HK\ ?\ B.<_ZM=_\R1_]ZZ/^(YS_JUW_P R1_\
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M_P!&T_L__P#AO-(_^1Z_('_B.<_ZM=_\R1_]ZZ/^(YS_ *M=_P#,D?\ WKH
M_7[_ (=._LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-(_\ D>OR
M!_XCG/\ JUW_ ,R1_P#>NC_B.<_ZM=_\R1_]ZZ /U^_X=._LL_\ 1M/[/_\
MX;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_^1Z_('_B.<_ZM=_\R1_]ZZ/^(YS_
M *M=_P#,D?\ WKH _7[_ (=._LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_
ML_\ _AO-(_\ D>OR!_XCG/\ JUW_ ,R1_P#>NC_B.<_ZM=_\R1_]ZZ /U^_X
M=._LL_\ 1M/[/_\ X;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_^1Z_('_B.<_Z
MM=_\R1_]ZZ/^(YS_ *M=_P#,D?\ WKH _7[_ (=._LL_]&T_L_\ _AO-(_\
MD>C_ (=._LL_]&T_L_\ _AO-(_\ D>OR!_XCG/\ JUW_ ,R1_P#>NC_B.<_Z
MM=_\R1_]ZZ /U^_X=._LL_\ 1M/[/_\ X;S2/_D>C_AT[^RS_P!&T_L__P#A
MO-(_^1Z_('_B.<_ZM=_\R1_]ZZ/^(YS_ *M=_P#,D?\ WKH _7[_ (=._LL_
M]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-(_\ D>OR!_XCG/\ JUW_
M ,R1_P#>NC_B.<_ZM=_\R1_]ZZ /U^_X=._LL_\ 1M/[/_\ X;S2/_D>C_AT
M[^RS_P!&T_L__P#AO-(_^1Z_('_B.<_ZM=_\R1_]ZZ/^(YS_ *M=_P#,D?\
MWKH _7[_ (=._LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-(_\
MD>OR!_XCG/\ JUW_ ,R1_P#>NC_B.<_ZM=_\R1_]ZZ /U^_X=._LL_\ 1M/[
M/_\ X;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_^1Z_('_B.<_ZM=_\R1_]ZZ/^
M(YS_ *M=_P#,D?\ WKH _7[_ (=._LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_
M]&T_L_\ _AO-(_\ D>OR!_XCG/\ JUW_ ,R1_P#>NC_B.<_ZM=_\R1_]ZZ /
MU^_X=._LL_\ 1M/[/_\ X;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_^1Z_('_B
M.<_ZM=_\R1_]ZZ/^(YS_ *M=_P#,D?\ WKH _7[_ (=._LL_]&T_L_\ _AO-
M(_\ D>C_ (=._LL_]&T_L_\ _AO-(_\ D>OR!_XCG/\ JUW_ ,R1_P#>NC_B
M.<_ZM=_\R1_]ZZ /U^_X=._LL_\ 1M/[/_\ X;S2/_D>C_AT[^RS_P!&T_L_
M_P#AO-(_^1Z_('_B.<_ZM=_\R1_]ZZ/^(YS_ *M=_P#,D?\ WKH _7[_ (=.
M_LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-(_\ D>OR!_XCG/\
MJUW_ ,R1_P#>NC_B.<_ZM=_\R1_]ZZ /U^_X=._LL_\ 1M/[/_\ X;S2/_D>
MC_AT[^RS_P!&T_L__P#AO-(_^1Z_('_B.<_ZM=_\R1_]ZZ/^(YS_ *M=_P#,
MD?\ WKH _7[_ (=._LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-
M(_\ D>OR!_XCG/\ JUW_ ,R1_P#>NC_B.<_ZM=_\R1_]ZZ /U^_X=._LL_\
M1M/[/_\ X;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_^1Z_('_B.<_ZM=_\R1_]
MZZ/^(YS_ *M=_P#,D?\ WKH _7[_ (=._LL_]&T_L_\ _AO-(_\ D>C_ (=.
M_LL_]&T_L_\ _AO-(_\ D>OR!_XCG/\ JUW_ ,R1_P#>NC_B.<_ZM=_\R1_]
MZZ /U^_X=._LL_\ 1M/[/_\ X;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_^1Z_
M('_B.<_ZM=_\R1_]ZZ/^(YS_ *M=_P#,D?\ WKH _7[_ (=._LL_]&T_L_\
M_AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-(_\ D>OR!_XCG/\ JUW_ ,R1_P#>
MNC_B.<_ZM=_\R1_]ZZ /U^_X=._LL_\ 1M/[/_\ X;S2/_D>C_AT[^RS_P!&
MT_L__P#AO-(_^1Z_('_B.<_ZM=_\R1_]ZZ/^(YS_ *M=_P#,D?\ WKH _7[_
M (=._LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-(_\ D>OR!_XC
MG/\ JUW_ ,R1_P#>NC_B.<_ZM=_\R1_]ZZ /U^_X=._LL_\ 1M/[/_\ X;S2
M/_D>C_AT[^RS_P!&T_L__P#AO-(_^1Z_('_B.<_ZM=_\R1_]ZZ/^(YS_ *M=
M_P#,D?\ WKH _7[_ (=._LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_L_\
M_AO-(_\ D>OR!_XCG/\ JUW_ ,R1_P#>NC_B.<_ZM=_\R1_]ZZ /U^_X=._L
ML_\ 1M/[/_\ X;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_^1Z_('_B.<_ZM=_\
MR1_]ZZ/^(YS_ *M=_P#,D?\ WKH _7[_ (=._LL_]&T_L_\ _AO-(_\ D>C_
M (=._LL_]&T_L_\ _AO-(_\ D>OR!_XCG/\ JUW_ ,R1_P#>NC_B.<_ZM=_\
MR1_]ZZ /U^_X=._LL_\ 1M/[/_\ X;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_
M^1Z_('_B.<_ZM=_\R1_]ZZ/^(YS_ *M=_P#,D?\ WKH _7[_ (=._LL_]&T_
ML_\ _AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-(_\ D>OR!_XCG/\ JUW_ ,R1
M_P#>NC_B.<_ZM=_\R1_]ZZ /U^_X=._LL_\ 1M/[/_\ X;S2/_D>C_AT[^RS
M_P!&T_L__P#AO-(_^1Z_('_B.<_ZM=_\R1_]ZZ/^(YS_ *M=_P#,D?\ WKH
M_7[_ (=._LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-(_\ D>OR
M!_XCG/\ JUW_ ,R1_P#>NC_B.<_ZM=_\R1_]ZZ /U^_X=._LL_\ 1M/[/_\
MX;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_^1Z_('_B.<_ZM=_\R1_]ZZ/^(YS_
M *M=_P#,D?\ WKH _7[_ (=._LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_
ML_\ _AO-(_\ D>OR!_XCG/\ JUW_ ,R1_P#>NC_B.<_ZM=_\R1_]ZZ /U^_X
M=._LL_\ 1M/[/_\ X;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_^1Z_('_B.<_Z
MM=_\R1_]ZZ/^(YS_ *M=_P#,D?\ WKH _7[_ (=._LL_]&T_L_\ _AO-(_\
MD>C_ (=._LL_]&T_L_\ _AO-(_\ D>OR!_XCG/\ JUW_ ,R1_P#>NC_B.<_Z
MM=_\R1_]ZZ /U^_X=._LL_\ 1M/[/_\ X;S2/_D>C_AT[^RS_P!&T_L__P#A
MO-(_^1Z_('_B.<_ZM=_\R1_]ZZ/^(YS_ *M=_P#,D?\ WKH _7[_ (=._LL_
M]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-(_\ D>OR!_XCG/\ JUW_
M ,R1_P#>NC_B.<_ZM=_\R1_]ZZ /U^_X=._LL_\ 1M/[/_\ X;S2/_D>C_AT
M[^RS_P!&T_L__P#AO-(_^1Z_('_B.<_ZM=_\R1_]ZZ/^(YS_ *M=_P#,D?\
MWKH _7[_ (=._LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-(_\
MD>OR!_XCG/\ JUW_ ,R1_P#>NC_B.<_ZM=_\R1_]ZZ /U^_X=._LL_\ 1M/[
M/_\ X;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_^1Z_('_B.<_ZM=_\R1_]ZZ/^
M(YS_ *M=_P#,D?\ WKH _7[_ (=._LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_
M]&T_L_\ _AO-(_\ D>OR!_XCG/\ JUW_ ,R1_P#>NC_B.<_ZM=_\R1_]ZZ /
MU^_X=._LL_\ 1M/[/_\ X;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_^1Z_('_B
M.<_ZM=_\R1_]ZZ/^(YS_ *M=_P#,D?\ WKH _7[_ (=._LL_]&T_L_\ _AO-
M(_\ D>C_ (=._LL_]&T_L_\ _AO-(_\ D>OR!_XCG/\ JUW_ ,R1_P#>NC_B
M.<_ZM=_\R1_]ZZ /U^_X=._LL_\ 1M/[/_\ X;S2/_D>C_AT[^RS_P!&T_L_
M_P#AO-(_^1Z_('_B.<_ZM=_\R1_]ZZ/^(YS_ *M=_P#,D?\ WKH _7[_ (=.
M_LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-(_\ D>OR!_XCG/\
MJUW_ ,R1_P#>NC_B.<_ZM=_\R1_]ZZ /U^_X=._LL_\ 1M/[/_\ X;S2/_D>
MC_AT[^RS_P!&T_L__P#AO-(_^1Z_('_B.<_ZM=_\R1_]ZZ/^(YS_ *M=_P#,
MD?\ WKH _7[_ (=._LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-
M(_\ D>OR!_XCG/\ JUW_ ,R1_P#>NC_B.<_ZM=_\R1_]ZZ /U^_X=._LL_\
M1M/[/_\ X;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_^1Z_('_B.<_ZM=_\R1_]
MZZ/^(YS_ *M=_P#,D?\ WKH _7[_ (=._LL_]&T_L_\ _AO-(_\ D>C_ (=.
M_LL_]&T_L_\ _AO-(_\ D>OR!_XCG/\ JUW_ ,R1_P#>NC_B.<_ZM=_\R1_]
MZZ /U^_X=._LL_\ 1M/[/_\ X;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_^1Z_
M('_B.<_ZM=_\R1_]ZZ/^(YS_ *M=_P#,D?\ WKH _7[_ (=._LL_]&T_L_\
M_AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-(_\ D>OR!_XCG/\ JUW_ ,R1_P#>
MNC_B.<_ZM=_\R1_]ZZ /U^_X=._LL_\ 1M/[/_\ X;S2/_D>C_AT[^RS_P!&
MT_L__P#AO-(_^1Z_('_B.<_ZM=_\R1_]ZZ/^(YS_ *M=_P#,D?\ WKH _7[_
M (=._LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-(_\ D>OR!_XC
MG/\ JUW_ ,R1_P#>NC_B.<_ZM=_\R1_]ZZ /U^_X=._LL_\ 1M/[/_\ X;S2
M/_D>C_AT[^RS_P!&T_L__P#AO-(_^1Z_('_B.<_ZM=_\R1_]ZZ/^(YS_ *M=
M_P#,D?\ WKH _7[_ (=._LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_L_\
M_AO-(_\ D>OR!_XCG/\ JUW_ ,R1_P#>NC_B.<_ZM=_\R1_]ZZ /U^_X=._L
ML_\ 1M/[/_\ X;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_^1Z_('_B.<_ZM=_\
MR1_]ZZ/^(YS_ *M=_P#,D?\ WKH _7[_ (=._LL_]&T_L_\ _AO-(_\ D>C_
M (=._LL_]&T_L_\ _AO-(_\ D>OR!_XCG/\ JUW_ ,R1_P#>NC_B.<_ZM=_\
MR1_]ZZ /U^_X=._LL_\ 1M/[/_\ X;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_
M^1Z_('_B.<_ZM=_\R1_]ZZ/^(YS_ *M=_P#,D?\ WKH _7[_ (=._LL_]&T_
ML_\ _AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-(_\ D>OR!_XCG/\ JUW_ ,R1
M_P#>NC_B.<_ZM=_\R1_]ZZ /U^_X=._LL_\ 1M/[/_\ X;S2/_D>C_AT[^RS
M_P!&T_L__P#AO-(_^1Z_('_B.<_ZM=_\R1_]ZZ/^(YS_ *M=_P#,D?\ WKH
M_7[_ (=._LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-(_\ D>OR
M!_XCG/\ JUW_ ,R1_P#>NC_B.<_ZM=_\R1_]ZZ /U^_X=._LL_\ 1M/[/_\
MX;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_^1Z_('_B.<_ZM=_\R1_]ZZ/^(YS_
M *M=_P#,D?\ WKH _7[_ (=._LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_
ML_\ _AO-(_\ D>OR!_XCG/\ JUW_ ,R1_P#>NC_B.<_ZM=_\R1_]ZZ /U^_X
M=._LL_\ 1M/[/_\ X;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_^1Z_('_B.<_Z
MM=_\R1_]ZZ/^(YS_ *M=_P#,D?\ WKH _7[_ (=._LL_]&T_L_\ _AO-(_\
MD>C_ (=._LL_]&T_L_\ _AO-(_\ D>OR!_XCG/\ JUW_ ,R1_P#>NC_B.<_Z
MM=_\R1_]ZZ /U^_X=._LL_\ 1M/[/_\ X;S2/_D>C_AT[^RS_P!&T_L__P#A
MO-(_^1Z_('_B.<_ZM=_\R1_]ZZ/^(YS_ *M=_P#,D?\ WKH _7[_ (=._LL_
M]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-(_\ D>OR!_XCG/\ JUW_
M ,R1_P#>NC_B.<_ZM=_\R1_]ZZ /U^_X=._LL_\ 1M/[/_\ X;S2/_D>C_AT
M[^RS_P!&T_L__P#AO-(_^1Z_('_B.<_ZM=_\R1_]ZZ/^(YS_ *M=_P#,D?\
MWKH _7[_ (=._LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-(_\
MD>OR!_XCG/\ JUW_ ,R1_P#>NC_B.<_ZM=_\R1_]ZZ /U^_X=._LL_\ 1M/[
M/_\ X;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_^1Z_('_B.<_ZM=_\R1_]ZZ/^
M(YS_ *M=_P#,D?\ WKH _7[_ (=._LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_
M]&T_L_\ _AO-(_\ D>OR!_XCG/\ JUW_ ,R1_P#>NC_B.<_ZM=_\R1_]ZZ /
MU^_X=._LL_\ 1M/[/_\ X;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_^1Z_('_B
M.<_ZM=_\R1_]ZZ/^(YS_ *M=_P#,D?\ WKH _7[_ (=._LL_]&T_L_\ _AO-
M(_\ D>C_ (=._LL_]&T_L_\ _AO-(_\ D>OR!_XCG/\ JUW_ ,R1_P#>NC_B
M.<_ZM=_\R1_]ZZ /U^_X=._LL_\ 1M/[/_\ X;S2/_D>C_AT[^RS_P!&T_L_
M_P#AO-(_^1Z_('_B.<_ZM=_\R1_]ZZ/^(YS_ *M=_P#,D?\ WKH _7[_ (=.
M_LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-(_\ D>OR!_XCG/\
MJUW_ ,R1_P#>NC_B.<_ZM=_\R1_]ZZ /U^_X=._LL_\ 1M/[/_\ X;S2/_D>
MC_AT[^RS_P!&T_L__P#AO-(_^1Z_('_B.<_ZM=_\R1_]ZZ/^(YS_ *M=_P#,
MD?\ WKH _7[_ (=._LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-
M(_\ D>OR!_XCG/\ JUW_ ,R1_P#>NC_B.<_ZM=_\R1_]ZZ /U^_X=._LL_\
M1M/[/_\ X;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_^1Z_('_B.<_ZM=_\R1_]
MZZ/^(YS_ *M=_P#,D?\ WKH _7[_ (=._LL_]&T_L_\ _AO-(_\ D>NR^"G[
M$OP9_9J\3W&M_#GX1_#'P!K5Y:M8SW_AOPM8Z5=3V[.CF%I((D9HR\:,5)P2
MBG&0*_$__B.<_P"K7?\ S)'_ -ZZ/^(YS_JUW_S)'_WKH _?ZBOP!_XCG/\
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C7M_"W]F?VQ_;'G^3=W=SY_F^1!MS]LV[-AQY>=QW8 !__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625572440816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br> $ in Billions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Feb. 22, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LIGAND PHARMACEUTICALS INC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">77-0160744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3911 Sorrento Valley Boulevard, Suite 110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">550-7500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LGND<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-Known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,076,658<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Portions of the Proxy Statement for the Registrant&#8217;s 2023 Annual Meeting of Stockholders to be filed with the Commission within 120 days of December&#160;31, 2022 are incorporated by reference in Part&#160;III of this Annual Report on Form&#160;10-K.&#160;With the exception of those portions that are specifically incorporated by reference in this Annual Report on Form&#160;10-K, such Proxy Statement shall not be deemed filed as part of this Report or incorporated by reference herein.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000886163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625572438160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Ernst&#160;& Young&#160;LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">San Diego, California<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">42<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625571475456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 45,006<span></span>
</td>
<td class="nump">$ 19,522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">166,864<span></span>
</td>
<td class="nump">321,586<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">30,424<span></span>
</td>
<td class="nump">85,453<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">13,294<span></span>
</td>
<td class="nump">27,326<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income taxes receivable</a></td>
<td class="nump">4,614<span></span>
</td>
<td class="nump">6,193<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">3,399<span></span>
</td>
<td class="nump">3,571<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Current assets of discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">263,601<span></span>
</td>
<td class="nump">464,751<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income taxes, net</a></td>
<td class="nump">8,530<span></span>
</td>
<td class="nump">35,729<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">342,455<span></span>
</td>
<td class="nump">376,691<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">105,673<span></span>
</td>
<td class="nump">105,673<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_CommercialLicenseRights', window );">Commercial license and other economic rights</a></td>
<td class="nump">10,182<span></span>
</td>
<td class="nump">10,110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">12,482<span></span>
</td>
<td class="nump">13,191<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">10,914<span></span>
</td>
<td class="nump">3,210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance lease assets</a></td>
<td class="nump">4,095<span></span>
</td>
<td class="nump">16,201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">4,736<span></span>
</td>
<td class="nump">1,251<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent', window );">Non-current assets of discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">270,783<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">762,668<span></span>
</td>
<td class="nump">1,297,590<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">5,307<span></span>
</td>
<td class="nump">8,403<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">15,681<span></span>
</td>
<td class="nump">17,579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_CurrentPortionOfLiabilityForContingentValueRights', window );">Current contingent liabilities</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">355<span></span>
</td>
<td class="nump">654<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liabilities</a></td>
<td class="nump">670<span></span>
</td>
<td class="nump">1,368<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current finance lease liabilities</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">2023 convertible senior notes, net</a></td>
<td class="nump">76,695<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Current liabilities of discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,566<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">98,810<span></span>
</td>
<td class="nump">41,665<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">2023 convertible senior notes, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">320,717<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_LiabilityForContingentValueRights', window );">Long-term contingent liabilities</a></td>
<td class="nump">3,456<span></span>
</td>
<td class="nump">3,657<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes, net</a></td>
<td class="nump">30,615<span></span>
</td>
<td class="nump">30,856<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">10,336<span></span>
</td>
<td class="nump">2,256<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">21,966<span></span>
</td>
<td class="nump">21,752<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent', window );">Non-current liabilities of discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">55,528<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">165,183<span></span>
</td>
<td class="nump">476,431<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value; 5,000 shares authorized; zero issued and outstanding at December 31, 2022 and 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value; 60,000 shares authorized; 16,951 and 16,767 shares issued and outstanding at December&#160;31, 2022 and 2021, respectively</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">147,590<span></span>
</td>
<td class="nump">372,969<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(984)<span></span>
</td>
<td class="num">(917)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">450,862<span></span>
</td>
<td class="nump">449,090<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">597,485<span></span>
</td>
<td class="nump">821,159<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 762,668<span></span>
</td>
<td class="nump">$ 1,297,590<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CommercialLicenseRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commercial License Rights</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CommercialLicenseRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CurrentPortionOfLiabilityForContingentValueRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current portion of liability for contingent value rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CurrentPortionOfLiabilityForContingentValueRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LiabilityForContingentValueRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability for contingent value rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LiabilityForContingentValueRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2510-110228<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2510-110228<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625572386656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (USD per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock authorized (shares)</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock issued (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock outstanding (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (USD per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock authorized (shares)</a></td>
<td class="nump">60,000<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock issued (shares)</a></td>
<td class="nump">16,951<span></span>
</td>
<td class="nump">16,767<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock outstanding (shares)</a></td>
<td class="nump">16,951<span></span>
</td>
<td class="nump">16,767<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625571807232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 196,245<span></span>
</td>
<td class="nump">$ 241,544<span></span>
</td>
<td class="nump">$ 163,562<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Operating costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostDirectMaterial', window );">Cost of Captisol</a></td>
<td class="nump">52,827<span></span>
</td>
<td class="nump">62,176<span></span>
</td>
<td class="nump">30,419<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAmortization', window );">Amortization of intangibles</a></td>
<td class="nump">34,237<span></span>
</td>
<td class="nump">34,222<span></span>
</td>
<td class="nump">11,642<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">36,082<span></span>
</td>
<td class="nump">32,105<span></span>
</td>
<td class="nump">40,503<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">70,062<span></span>
</td>
<td class="nump">46,790<span></span>
</td>
<td class="nump">60,012<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other operating (income) expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(37,600)<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Total operating costs and expenses</a></td>
<td class="nump">193,208<span></span>
</td>
<td class="nump">137,693<span></span>
</td>
<td class="nump">143,176<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from continuing operations</a></td>
<td class="nump">3,037<span></span>
</td>
<td class="nump">103,851<span></span>
</td>
<td class="nump">37,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Gain (loss) from short-term investments</a></td>
<td class="nump">28,540<span></span>
</td>
<td class="num">(5,263)<span></span>
</td>
<td class="num">(16,933)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">2,046<span></span>
</td>
<td class="nump">886<span></span>
</td>
<td class="nump">8,078<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(1,799)<span></span>
</td>
<td class="num">(19,619)<span></span>
</td>
<td class="num">(27,415)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">4,187<span></span>
</td>
<td class="num">(7,650)<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense, net</a></td>
<td class="nump">32,974<span></span>
</td>
<td class="num">(31,646)<span></span>
</td>
<td class="num">(36,208)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income tax from continuing operations</a></td>
<td class="nump">36,011<span></span>
</td>
<td class="nump">72,205<span></span>
</td>
<td class="nump">1,292<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="num">(41,230)<span></span>
</td>
<td class="nump">4,148<span></span>
</td>
<td class="nump">5,306<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Net income (loss) from continuing operations</a></td>
<td class="num">(5,219)<span></span>
</td>
<td class="nump">76,353<span></span>
</td>
<td class="nump">6,598<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Net loss from discontinued operations</a></td>
<td class="num">(28,142)<span></span>
</td>
<td class="num">(19,215)<span></span>
</td>
<td class="num">(9,583)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss):</a></td>
<td class="num">$ (33,361)<span></span>
</td>
<td class="nump">$ 57,138<span></span>
</td>
<td class="num">$ (2,985)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic net income (loss) from continuing operations (USD per share)</a></td>
<td class="num">$ (0.31)<span></span>
</td>
<td class="nump">$ 4.59<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Basic net income (loss) from discontinued operations (USD per share)</a></td>
<td class="num">(1.67)<span></span>
</td>
<td class="num">(1.16)<span></span>
</td>
<td class="num">(0.59)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income (loss) per share (USD per share)</a></td>
<td class="num">$ (1.98)<span></span>
</td>
<td class="nump">$ 3.44<span></span>
</td>
<td class="num">$ (0.18)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Shares used in basic per share calculation (shares)</a></td>
<td class="nump">16,868,000<span></span>
</td>
<td class="nump">16,630,000<span></span>
</td>
<td class="nump">16,185,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Diluted net income (loss) from continuing operations (USD per share)</a></td>
<td class="num">$ (0.31)<span></span>
</td>
<td class="nump">$ 4.43<span></span>
</td>
<td class="nump">$ 0.39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Diluted net income (loss) from discontinued operations (USD per share)</a></td>
<td class="num">(1.67)<span></span>
</td>
<td class="num">(1.11)<span></span>
</td>
<td class="num">(0.57)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income (loss) per share (USD per share)</a></td>
<td class="num">$ (1.98)<span></span>
</td>
<td class="nump">$ 3.31<span></span>
</td>
<td class="num">$ (0.18)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used in diluted per share calculation (shares)</a></td>
<td class="nump">16,868,000<span></span>
</td>
<td class="nump">17,246,000<span></span>
</td>
<td class="nump">16,825,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 72,527<span></span>
</td>
<td class="nump">$ 48,927<span></span>
</td>
<td class="nump">$ 33,796<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember', window );">Captisol</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">104,495<span></span>
</td>
<td class="nump">164,250<span></span>
</td>
<td class="nump">109,959<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember', window );">Contract revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">19,223<span></span>
</td>
<td class="nump">28,367<span></span>
</td>
<td class="nump">19,807<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_VernalisMember', window );">Vernalis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Operating costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfIntangibleAssets', window );">Gain from sale of Vernalis R&amp;D</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 17,114<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostDirectMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of material used for good produced and service rendered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostDirectMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_ContractRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_VernalisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_VernalisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625577814992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (33,361)<span></span>
</td>
<td class="nump">$ 57,138<span></span>
</td>
<td class="num">$ (2,985)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized net gain (loss) on available-for-sale securities, net of tax</a></td>
<td class="num">(67)<span></span>
</td>
<td class="num">(116)<span></span>
</td>
<td class="num">(162)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(423)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss)</a></td>
<td class="num">$ (33,428)<span></span>
</td>
<td class="nump">$ 57,022<span></span>
</td>
<td class="num">$ (3,570)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625574759600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional paid-in capital</div></th>
<th class="th">
<div>Additional paid-in capital </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Accumulated other comprehensive income (loss)</div></th>
<th class="th"><div>Retain earnings</div></th>
<th class="th">
<div>Retain earnings </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at beginning of period (shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,824,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2019</a></td>
<td class="nump">$ 767,232<span></span>
</td>
<td class="num">$ (5,168)<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 367,326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (216)<span></span>
</td>
<td class="nump">$ 400,105<span></span>
</td>
<td class="num">$ (5,168)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">190,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net</a></td>
<td class="nump">1,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">$ 30,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (shares)</a></td>
<td class="num">(934,079)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(934,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">$ (77,998)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="num">(77,997)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss', window );">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</a></td>
<td class="num">(162)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(162)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(423)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(423)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Reacquisition of equity due to 2023 debt extinguishment, net of tax</a></td>
<td class="num">(3,236)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,236)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Other tax adjustments</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(2,985)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at end of period (shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,080,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Dec. 31, 2020</a></td>
<td class="nump">709,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">318,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(801)<span></span>
</td>
<td class="nump">391,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">687,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net</a></td>
<td class="nump">27,745<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">27,744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">38,783<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,783<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss', window );">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</a></td>
<td class="num">(116)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(116)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Reacquisition of equity due to 2023 debt extinguishment, net of tax</a></td>
<td class="num">$ (12,407)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,407)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="text">Accounting Standards Update 2020-06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions', window );">Warrant and bond hedge unwind transactions</a></td>
<td class="nump">$ 491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">57,138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at end of period (shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,767,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Dec. 31, 2021</a></td>
<td class="nump">821,159<span></span>
</td>
<td class="num">$ (15,997)<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">372,969<span></span>
</td>
<td class="num">$ (51,130)<span></span>
</td>
<td class="num">(917)<span></span>
</td>
<td class="nump">449,090<span></span>
</td>
<td class="nump">$ 35,133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">184,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net</a></td>
<td class="num">(5,004)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,004)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">60,285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss', window );">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</a></td>
<td class="num">(67)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(67)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalBondHedgeTransaction', window );">Bond hedge transaction</a></td>
<td class="nump">202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalDecreaseDueToSeparation', window );">Distribution of OmniAb</a></td>
<td class="num">(229,732)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(229,732)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(33,361)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at end of period (shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,951,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Dec. 31, 2022</a></td>
<td class="nump">$ 597,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 147,590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (984)<span></span>
</td>
<td class="nump">$ 450,862<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AdjustmentsToAdditionalPaidInCapitalBondHedgeTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid In Capital, Bond Hedge Transaction</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AdjustmentsToAdditionalPaidInCapitalBondHedgeTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AdjustmentsToAdditionalPaidInCapitalDecreaseDueToSeparation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Decrease Due To Separation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AdjustmentsToAdditionalPaidInCapitalDecreaseDueToSeparation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 32: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 66: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 67: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 68: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=123466103&amp;loc=SL6014347-161799<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other increase (decrease) in additional paid in capital (APIC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625571972400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">$ (33,361)<span></span>
</td>
<td class="nump">$ 57,138<span></span>
</td>
<td class="num">$ (2,985)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain from sale of Vernalis R&amp;D</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(17,114)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights', window );">Change in estimated fair value of contingent liabilities</a></td>
<td class="num">(748)<span></span>
</td>
<td class="num">(36,962)<span></span>
</td>
<td class="nump">963<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation of fixed assets and amortization of intangible assets</a></td>
<td class="nump">51,534<span></span>
</td>
<td class="nump">51,071<span></span>
</td>
<td class="nump">25,691<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_GainLossOnShortTermInvestments', window );">Loss (gain) short-term investments</a></td>
<td class="num">(28,540)<span></span>
</td>
<td class="nump">3,997<span></span>
</td>
<td class="nump">16,933<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization/accretion of premium (discount) on investments, net</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="nump">1,479<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and issuance fees</a></td>
<td class="nump">734<span></span>
</td>
<td class="nump">16,692<span></span>
</td>
<td class="nump">23,077<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss (gain) on debt extinguishment</a></td>
<td class="num">(4,192)<span></span>
</td>
<td class="nump">7,303<span></span>
</td>
<td class="nump">2,466<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights', window );">Amortization of commercial license and other economic rights</a></td>
<td class="num">(164)<span></span>
</td>
<td class="num">(125)<span></span>
</td>
<td class="nump">2,275<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization', window );">Lease amortization expense</a></td>
<td class="nump">5,521<span></span>
</td>
<td class="nump">4,840<span></span>
</td>
<td class="nump">1,609<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">60,285<span></span>
</td>
<td class="nump">38,783<span></span>
</td>
<td class="nump">30,727<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred income taxes, net</a></td>
<td class="nump">20,723<span></span>
</td>
<td class="num">(8,618)<span></span>
</td>
<td class="num">(19,053)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other</a></td>
<td class="nump">365<span></span>
</td>
<td class="nump">1,572<span></span>
</td>
<td class="nump">191<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, net of acquisitions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="nump">55,319<span></span>
</td>
<td class="num">(28,616)<span></span>
</td>
<td class="num">(26,061)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="nump">12,058<span></span>
</td>
<td class="num">(427)<span></span>
</td>
<td class="num">(17,799)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="num">(3,340)<span></span>
</td>
<td class="nump">2,810<span></span>
</td>
<td class="num">(1,245)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable', window );">Income taxes receivable</a></td>
<td class="nump">1,579<span></span>
</td>
<td class="num">(3,976)<span></span>
</td>
<td class="nump">9,144<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="num">(6,281)<span></span>
</td>
<td class="num">(17,870)<span></span>
</td>
<td class="nump">29,236<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other assets and liabilities</a></td>
<td class="nump">6,342<span></span>
</td>
<td class="num">(8,925)<span></span>
</td>
<td class="num">(4,948)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">137,850<span></span>
</td>
<td class="nump">78,798<span></span>
</td>
<td class="nump">54,586<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid for acquisition, net of cash and restricted cash acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(404,884)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(17,923)<span></span>
</td>
<td class="num">(8,761)<span></span>
</td>
<td class="num">(4,458)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchases of short-term investments</a></td>
<td class="num">(51,226)<span></span>
</td>
<td class="num">(181,325)<span></span>
</td>
<td class="num">(422,523)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_ProceedsFromCommercialLicenseRights', window );">Proceeds from commercial license rights</a></td>
<td class="nump">92<span></span>
</td>
<td class="nump">494<span></span>
</td>
<td class="nump">1,358<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfShortTermInvestments', window );">Proceeds from sale of short-term investments</a></td>
<td class="nump">209,561<span></span>
</td>
<td class="nump">154,230<span></span>
</td>
<td class="nump">394,539<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments', window );">Proceeds from maturity of short-term investments</a></td>
<td class="nump">24,830<span></span>
</td>
<td class="nump">67,105<span></span>
</td>
<td class="nump">644,155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Cash paid for equity method investment</a></td>
<td class="num">(750)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(500)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds on sale of Vernalis R&amp;D, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">22,061<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other, net</a></td>
<td class="num">(960)<span></span>
</td>
<td class="num">(1,220)<span></span>
</td>
<td class="nump">1,900<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">163,624<span></span>
</td>
<td class="nump">30,523<span></span>
</td>
<td class="nump">231,648<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_PaymentsForSeparation', window );">Net cash transferred to OmniAb at separation</a></td>
<td class="num">(1,840)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayment of debt</a></td>
<td class="num">(260,949)<span></span>
</td>
<td class="num">(155,760)<span></span>
</td>
<td class="num">(222,209)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Payments under finance lease obligations</a></td>
<td class="num">(54)<span></span>
</td>
<td class="num">(9,188)<span></span>
</td>
<td class="num">(9,549)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities', window );">Cash paid for OmniAb transaction costs</a></td>
<td class="num">(6,800)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromHedgeFinancingActivities', window );">Proceeds from bond hedge settlement</a></td>
<td class="nump">202<span></span>
</td>
<td class="nump">18,938<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Net proceeds from stock option exercises and ESPP</a></td>
<td class="nump">3,232<span></span>
</td>
<td class="nump">33,763<span></span>
</td>
<td class="nump">3,017<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid related to net share settlement of equity awards</a></td>
<td class="num">(8,236)<span></span>
</td>
<td class="num">(6,018)<span></span>
</td>
<td class="num">(1,481)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Share repurchases</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(77,998)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfWarrants', window );">Repurchase of warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(18,446)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity', window );">Payments to CVR Holders</a></td>
<td class="num">(1,545)<span></span>
</td>
<td class="num">(1,050)<span></span>
</td>
<td class="num">(2,325)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(275,990)<span></span>
</td>
<td class="num">(137,761)<span></span>
</td>
<td class="num">(310,545)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents, and restricted cash</a></td>
<td class="nump">25,484<span></span>
</td>
<td class="num">(28,440)<span></span>
</td>
<td class="num">(24,311)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of year</a></td>
<td class="nump">19,522<span></span>
</td>
<td class="nump">47,962<span></span>
</td>
<td class="nump">72,273<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of year</a></td>
<td class="nump">45,006<span></span>
</td>
<td class="nump">19,522<span></span>
</td>
<td class="nump">47,962<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_CashPaidDuringTheYearAbstract', window );"><strong>Cash paid during the year:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">1,428<span></span>
</td>
<td class="nump">3,028<span></span>
</td>
<td class="nump">4,463<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Taxes paid</a></td>
<td class="nump">11,642<span></span>
</td>
<td class="nump">3,722<span></span>
</td>
<td class="nump">2,130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash in other current assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">343<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental schedule of non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AccruedInventoryPurchases', window );">Accrued inventory purchases</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,974<span></span>
</td>
<td class="nump">1,562<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized loss on available-for-sale investments</a></td>
<td class="num">(85)<span></span>
</td>
<td class="num">(221)<span></span>
</td>
<td class="num">(212)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Purchase of fixed assets recorded in accounts payable</a></td>
<td class="nump">$ 2,333<span></span>
</td>
<td class="nump">$ 1,567<span></span>
</td>
<td class="nump">$ 249<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AccruedInventoryPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Inventory Purchases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AccruedInventoryPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization of Commercial License and Other Economic Rights</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CashPaidDuringTheYearAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Paid During the Year</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CashPaidDuringTheYearAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease And Operating Lease, Right-of-Use Asset, Amortization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_GainLossOnShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Short-Term Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_GainLossOnShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-Cash Change In Estimated Fair Value Of Contingent Value Rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsForSeparation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Separation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsForSeparation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments to Contingent Value Right Holders, Financing Activity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsToContingentValueRightHoldersFinancingActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ProceedsFromCommercialLicenseRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Commercial License Rights</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ProceedsFromCommercialLicenseRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126938201&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInIncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount paid by the entity to reacquire the right to purchase equity shares at a predetermined price, usually issued together with corporate debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for financing costs associated with business combinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromHedgeFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3581-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromHedgeFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625572307248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Summary of Significant Accounting Policies</a></td>
<td class="text">Basis of Presentation and Summary of Significant Accounting Policies<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, we completed the separation (the &#8220;Separation&#8221;) of our antibody discovery business and certain related assets and liabilities (the &#8220;OmniAb Business&#8221;) through a spin-off of OmniAb to Ligand&#8217;s shareholders of record as of October 26, 2022 on a pro rata basis (the &#8220;Distribution&#8221;) and merger (the &#8220;Merger&#8221;) of OmniAb with a wholly owned subsidiary of a separate public company, OmniAb, Inc. (formerly known as Avista Public Acquisition Corp. II (&#8220;New OmniAb&#8221;)), in a Reverse Morris Trust transaction pursuant to the Agreement and Plan of Merger, dated as of March 23, 2022 (the &#8220;Merger Agreement&#8221;), and the Separation and Distribution Agreement, dated as of March 23, 2022 (the &#8220;Separation Agreement&#8221;) (the Merger Agreement and Separation Agreement, collectively with the other related transaction documents, the &#8220;Transaction Agreements&#8221;). Pursuant to the Transaction Agreements, Ligand contributed to OmniAb cash and certain assets and liabilities constituting the OmniAb Business, including but not limited to the equity interests of Ab Initio Biotherapeutics, Inc., Crystal Bioscience, Inc., Icagen, LLC, Taurus Biosciences, LLC and xCella Biosciences, Inc.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the spin-off of our OmniAb antibody discovery business, Ligand is a revenue-generating biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. We operate in one business segment: development and licensing of biopharmaceutical assets.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements have been prepared in accordance with U.S. GAAP and include the accounts of our parent company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Discontinued operations</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined that the spin-off of the OmniAb Business in November 2022 met the criteria for classification as a discontinued operation in accordance with ASC Subtopic 205-20, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Discontinued Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 205-20&#8221;). Accordingly, the accompanying consolidated financial statements for all periods presented have been updated to present the assets and liabilities associated with the OmniAb Business separately as discontinued operations on the consolidated balance sheets and the results of all discontinued operations reported as a separate component of loss in the consolidated statements of operations and comprehensive loss (see Note 2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Spin-off of OmniAb</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). All disclosures have been adjusted to reflect continuing operations.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires the use of estimates and assumptions that affect the amounts reported in the consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Business Risk</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to significant concentrations of credit risk consist primarily of cash equivalents and investments. We invest excess cash principally in United States government debt securities, investment grade corporate debt securities, mutual funds and certificates of deposit. We maintain some cash and cash equivalents balances with financial institutions that are in excess of the Federal Deposit Insurance Corporation insurance limits. We have established guidelines relative to diversification and maturities that maintain safety and liquidity. These guidelines are periodically reviewed and modified to take advantage of trends in yields and interest rates.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from significant partners, which is defined as 10% or more of our total revenue, was as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Partner A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Partner B</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Partner C</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&lt;10%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&lt;10%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&lt;10%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtain Captisol primarily from two sites related to a single supplier, Hovione.&#160;If this supplier were not able to supply the requested amounts of Captisol from each site, and if our safety stocks of material were depleted, we would be unable to continue to derive revenues from the sale of Captisol until we obtained material from an alternative source, which could take a considerable length of time.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Equivalents </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents consist of highly liquid investments with maturities of three months or less from the date of acquisition. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Investments</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments primarily consist of investments in debt and equity securities. We classify our short-term investments as &#8220;available-for-sale&#8221;. Such investments are carried at fair value, with unrealized gains and losses on debt securities included in the statement of comprehensive income (loss), net of tax, and unrealized gains and losses on equity securities included the consolidated statement of operations. We determine the cost of investments based on the specific identification method. We determine the realized gains or losses on the sale of available-for-sale securities using the specific identification method and includes net realized gains and losses as a component of other income or expense within the consolidated statements of operations.  </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities consist of certificates of deposit, corporate debt securities, and securities of government-sponsored entities have effective maturities greater than&#160;three&#160;months and less than twenty-five months from the date of acquisition. Debt securities available-for-sale in an unrealized loss position are assessed for the current expected credit losses methodology. We start by assessing whether we intend to sell the security, or whether it is more likely than not that we will be required to sell the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security&#8217;s amortized cost basis is written down to fair value through earnings. For debt securities available-for-sale that do not meet the aforementioned criteria, we evaluate whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, we consider the extent to which fair value is less than amortized cost, any changes in interest rates, and any changes to the rating of the security by a rating agency, among other factors. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security is compared to the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded, limited by the amount that the fair value is less than the amortized cost basis. Any impairment that has not been recorded through an allowance for credit losses is recognized in other comprehensive income or loss, as applicable.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities are mutual funds, investments in privately held companies (non-marketable equity securities), and companies that have completed initial public offerings (marketable equity securities). Mutual funds are valued at their publicly quoted net asset value (NAV) price on the last day of the period. Our non-marketable equity securities without readily determinable market values are initially measured at cost and adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment. Our marketable equity securities are measured at fair value. Equity investments are classified as short-term investments, or non-current other assets, based on the nature of the securities and their availability for use in current operations. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory, which consists of finished goods, is stated at the lower of cost or net realizable value. We determine cost using the specific identification method. We analyze our inventory levels periodically and write down inventory to net realizable value if it has become obsolete, has a cost basis in excess of its expected net realizable value or is in excess of expected requirements. During the year ended December 31, 2022, we recorded an obsolete inventory charge of $1.1&#160;million. There were no adjustments to inventory recorded for the years ended December&#160;31, 2021 and 2020. As of December 31, 2022 and 2021, inventory included prepayments of $5.9&#160;million and $24.6&#160;million, respectively, to our supplier for Captisol.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost, subject to review for impairment, and depreciated over the estimated useful lives of the assets, which generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNzU2MQ_9d23c4d7-711e-44c5-af62-13230621da18">three</span> to ten years, using the straight-line method. Amortization of leasehold improvements is recorded over the shorter of the lease term or estimated useful life of the related asset. Maintenance and repairs are charged to operations as incurred. When assets are sold, or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts and any gain or loss is included in operating income or expense.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We first determine whether a set of assets acquired constitute a business and should be accounted for as a business combination. If the assets acquired are not a business, we account for the transaction as an asset acquisition. Business combinations are accounted for by using the acquisition method of accounting which requires us to use significant estimates and assumptions, especially with respect to intangible assets. We record the excess consideration over the aggregate fair value of tangible and intangible assets, net of liabilities assumed, as goodwill.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the acquisition method of accounting, we recognize separately from goodwill the identifiable assets acquired, the liabilities assumed, including contingent consideration and all contractual contingencies, generally at the acquisition date fair value. Contingent purchase consideration to be settled in cash are remeasured to estimated fair value at each reporting period with the change in fair value recorded in statement of operations. Costs that we incur to complete the business combination such as investment banking, legal and other professional fees are not considered part of consideration and we charge them to general and administrative expense as they are incurred. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Should the initial accounting for a business combination be incomplete by the end of a reporting period that falls within the measurement period, we report provisional amounts in our financial statements. During the measurement period, we adjust the provisional amounts recognized at the acquisition date to reflect new information obtained about facts and circumstances that existed as of the acquisition date that, if known, would have affected the measurement of the amounts recognized as of that date and we record those adjustments to our financial statements in the period of change, if any.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the acquisition method of accounting for business combinations, if we identify changes to acquired deferred tax asset valuation allowances or liabilities related to uncertain tax positions during the measurement period and they relate to new information obtained about facts and circumstances that existed as of the acquisition date, those changes are considered a measurement period adjustment and we record the offset to goodwill. We record all other changes to deferred tax asset valuation allowances and liabilities related to uncertain tax positions in current period income tax expense. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Liabilities</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition of Pfenex in October 2020, we entered into a CVR agreement pursuant to which former equity holders of Pfenex received one nontransferable contractual right entitling such holder to receive $2.00 per share (or approximately $77.8&#160;million total) in the event that Pfenex&#8217;s teriparatide injection product received notice from the FDA that such product is therapeutically equivalent with respect to FORTEO&#174; (teriparatide injection) on or before December 31, 2021. The FDA did not provide notice of such event prior to the CVR expiration date and as a result, the Pfenex CVRs expired without payment.  </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition of CyDex in January 2011, we recorded a contingent liability for amounts potentially due to holders of the CyDex CVRs and former license holders. The liability is periodically assessed based on events and circumstances related to the underlying milestones, royalties and material sales. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs for each Metabasis share. The fair values of the CVRs are remeasured at each reporting date through the term of the related agreement. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any change in fair value is recorded in our consolidated statement of operations. For additional information, see &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note (5), Fair Value Measurement and Note (8), Balance Sheet Account Details</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;   </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill, Intangible Assets and Other Long-Lived Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill, which has an indefinite useful life, represents the excess of cost over fair value of net assets acquired. Goodwill is reviewed for impairment at least annually during the fourth quarter, or more frequently if an event occurs indicating the potential for impairment. During the goodwill impairment review, we assess qualitative factors to determine whether it is more </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">likely than not that the fair value of our reporting unit is less than the carrying amount, including goodwill. The qualitative factors include, but are not limited to, macroeconomic conditions, industry and market considerations, and the overall financial performance. If, after assessing the totality of these qualitative factors, we determine that it is not more likely than not that the fair value of our reporting unit is less than the carrying amount, then no additional assessment is deemed necessary. Otherwise, we proceed to perform the quantitative assessment. We will then evaluate goodwill for impairment by comparing the estimated fair value of the reporting unit to its carrying value, including the associated goodwill. To determine the fair value, we generally use a combination of market approach based on Ligand and comparable publicly traded companies in similar lines of businesses and the income approach based on estimated discounted future cash flows. Our cash flow assumptions consider historical and forecasted revenue, operating costs and other relevant factors. We may also elect to bypass the qualitative assessment in a period and elect to proceed to perform the quantitative assessment for the goodwill impairment test. We performed the annual assessment for goodwill impairment during the fourth quarter of 2022, noting no impairment. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our identifiable intangible assets are typically composed of acquired core technologies, licensed technologies, contractual relationships, customer relationships and trade names. The cost of identifiable intangible assets with finite lives is generally amortized on a straight-line basis over the assets&#8217; respective estimated useful lives. We regularly perform reviews to determine if any event has occurred that may indicate that intangible assets with finite useful lives and other long-lived assets are potentially impaired. If indicators of impairment exist, an impairment test is performed to assess the recoverability of the affected assets by determining whether the carrying amount of such assets exceeds the undiscounted expected future cash flows. If the affected assets are not recoverable, we estimate the fair value of the assets and record an impairment loss if the carrying value of the assets exceeds the fair value. Factors that may indicate potential impairment include market conditions, industry and economic trends, changes in regulations, clinical success, historical and forecasted financial results, market capitalization, significant changes in the ability of a particular asset to generate positive cash flows, and the pattern of utilization of a particular asset. We did not identify indicators of impairment for the finite-lived intangibles at December&#160;31, 2022.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commercial license and other economic rights</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022 and 2021, commercial license and other economic rights consist of the following (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.338%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.607%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo and CorMatrix</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,538)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,158&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,461)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,235&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis and Dianomi</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,578)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,024&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,727)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18,116)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18,188)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Amounts represent accumulated amortization to principal of $11.6 million and credit loss adjustments of $6.5 million as of December 31, 2022. </span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(2) Amounts represent accumulated amortization to principal of $11.7 million and credit loss adjustments of $6.5 million as of December 31, 2021. </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial license and other economic rights as of December&#160;31, 2022 represent a portfolio of future milestone and royalty payment rights acquired from Selexis in April 2013 and April 2015, CorMatrix in May 2016, and Dianomi in January 2019. Commercial license rights acquired are accounted for as financial assets, and other economic rights are accounted for as funded research and developments as further discussed below. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2019, we entered into a development funding and royalties agreement with Novan, pursuant to which we would receive certain payments at specified milestones, as well as royalties on any future net sales of SB206, a product candidate being developed to treat molluscum contagiosum, and any other Novan products used for the treatment of molluscum (&#8220;Novan Molluscum Products&#8221;). We paid Novan an upfront payment of $12.0 million, which Novan is required to use to fund the development of SB206. We are not obligated to provide additional funding to Novan for the development or commercialization of SB206. Pursuant to the agreement, we would receive up to $20.0 million of milestone payments upon the achievement by Novan of certain regulatory milestones for SB206 or any other Novan Molluscum Product and commercial milestones. In addition to the milestone payments, Novan will pay us tiered royalties from 7.0% to 10.0% based on aggregate annual net sales of SB206 or any other Novan Molluscum Product in North America. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2018, we entered into a development funding and royalties agreement with Palvella. Pursuant to the agreement, we will receive up to $8.0 million of milestone payments upon the achievement by Palvella of certain corporate, financing and regulatory milestones for PTX-022, a product candidate being developed to treat pachyonychia congenita. In addition to the milestone payments, Palvella will pay us tiered royalties from 5.0% to 9.8% based on aggregate annual worldwide net sales of any PTX-022 products, if approved, subject to Palvella&#8217;s right to reduce the royalty rates by making payments in certain circumstances. We made an upfront payment of $10.0 million, which Palvella is required to use to fund the development of PTX-022. We are not obligated to provide additional funding to Palvella for development or commercialization of PTX-022. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determined the economic rights related to Novan and Palvella should be characterized as a funded research and development arrangement, thus we account for them in accordance with ASC 730-20, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Arrangement, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and reduce our asset as the funds are expended by Novan and Palvella. As of December 31, 2019, Novan had used up the $12.0 million upfront payment provided by us. As such, our other economic rights related to Novan had been fully amortized as of December 31, 2019. As of December 31, 2020, the fund has been fully expended by Palvella and our cost basis for the asset has been reduced to zero, and therefore we will recognize milestones and royalties as revenue when earned. During 2020, we recorded a $3.0 million milestone from Palvella under contract revenue, which has been included in our consolidated statement of operations for the year ended December 31, 2020.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, we entered into a royalty agreement with Aziyo pursuant to which we will receive royalties from certain marketed products that Aziyo acquired from CorMatrix. Pursuant to the agreement, we received $10.0 million in 2017 from Aziyo to buydown the royalty rates on the products CorMatrix sold to Aziyo. The agreement closed on May 31, 2017, in connection with the closing of the asset sale from CorMatrix to Aziyo (the &#8220;CorMatrix Asset Sale&#8221;). Per the agreement, we will receive a 5% royalty on the products Aziyo acquired in the CorMatrix Asset Sale, reduced from the original 20% royalty from CorMatrix pursuant to the previously disclosed interest purchase agreement, dated May 3, 2016 (the &#8220;Original Interest Purchase Agreement&#8221;) between CorMatrix and us. In addition, Aziyo has agreed to pay us up to $10.0 million of additional milestones tied to cumulative net sales of the products Aziyo acquired in the CorMatrix Asset Sale and to extend the term on these royalties by one year. The royalty agreement will terminate on May 31, 2027. In addition, in May 2017, we entered into an amended and restated interest purchase agreement (the &#8220;Amended Interest Purchase Agreement&#8221;) with CorMatrix, which supersedes in its entirety the Original Interest Purchase Agreement. Other than removing the commercial products sold to Aziyo in the CorMatrix Sale, the terms of the Amended Interest Purchase Agreement remain unchanged with respect to the CorMatrix developmental pipeline products, including the royalty rate of 5% on such pipeline products. The Amended Interest Purchase Agreement will terminate 10 years from the date of the first commercial sale of such products. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for the Aziyo commercial license right as a financial asset in accordance with ASC 310, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Receivables</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and amortize the commercial license right using the effective interest method whereby we forecast expected cash flows over the term of the arrangement to arrive at an annualized effective interest. The annual effective interest associated with the forecasted cash flows from the royalty agreement with Aziyo as of December&#160;31, 2022 is 19.0%. Revenue is calculated by multiplying the carrying value of the commercial license right by the effective interest. The payments received in the year ended December&#160;31, 2022 and 2021 were allocated accordingly between revenue and the amortization of the commercial license rights.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to 2020, we accounted for commercial license rights related to developmental pipeline products such as Selexis and Dianomi on a non-accrual basis. These developmental pipeline products are non-commercialized, non-approved products that require FDA or other regulatory approval, and thus have uncertain cash flows. The developmental pipeline products are on a non-accrual basis as we are not yet able to forecast future cash flows given their pre-commercial stages of development. We will prospectively update the yield model under the effective interest method once the underlying products are commercialized and we can reliably forecast expected cash flows. Income will be calculated by multiplying the carrying value of the commercial license right by the effective interest rate. We regularly perform reviews to determine if any event has occurred that may indicate the carrying value of these commercial license rights are potentially impaired. If the affected commercial license rights are not recoverable, we estimate the fair value of the assets and record an impairment loss if the carrying value of the assets exceeds the fair value. During 2020, given the expected cash flow from the Selexis program, we started to account for the Selexis commercial license right as a financial asset in accordance with ASC 310, and amortize the commercial license right using the effective interest method whereby we forecast expected cash flows over the term of the arrangement to arrive at an annualized effective interest. The annual effective interest associated with the forecasted cash flows from the royalty agreement with Selexis as of December&#160;31, 2022 is 24.6%. Revenue is calculated by multiplying the carrying value of the commercial license right by the effective interest. The payments received in the year ended December&#160;31, 2022 and 2021 were allocated accordingly between revenue and the amortization of the commercial license rights. We still accounted for commercial license rights related to Dianomi on a non-accrual basis as of December&#160;31, 2022.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For commercial license rights, we have elected a prospective approach to account for changes in estimated cash flows and selected a method for determining when an impairment would be recognized and how to measure that impairment. In circumstances where our new estimate of expected cash flows is greater than previously expected, we will update our yield prospectively. In circumstances where our new estimate of expected cash flows is less than previously expected and below our original estimated yield we record an impairment. Impairment is recognized by reducing the financial asset to an amount that represents the present value of our most recent estimate of expected cash flows discounted by the original effective interest rate.&#160;In circumstances where our new estimate of expected cash flows is less than previously expected, but not below our original estimated yield, we update our yield prospectively.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of adopting ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments &#8211; Credit Losses: Measurement of Credit losses on Financial Instruments (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we now recognize an allowance for current expected credit losses on the commercial license rights subject to credit risk. We recorded a $5.5 million pre-tax reserve for credit losses upon adoption of the standard on January 1, </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020. We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the twelve months ended December 31, 2022 and 2021, we further considered the current and expected future economic and market conditions. We concluded a reduction of $0.3 million and  $0.5 million to the allowance for credit losses in other expense, net, in our consolidated statements of operations for the year ended 2022 and 2021, respectively.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply the following five-step model in accordance with ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in order to determine the revenue: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalties</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive royalty revenue on sales by our partners of products covered by patents that we or our partners own under contractual agreements. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a royalty to be recorded no sooner than the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues are adjusted in the period in which they become known, typically the following quarter. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Captisol Sales</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from Captisol sales is recognized when control of Captisol material or intellectual property license rights is transferred to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. For Captisol material, we consider our performance obligation is satisfied at a point in time, once we have transferred control of the product, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We have elected to recognize the cost of freight and shipping when control over Captisol material has transferred to the customer as an expense in Cost of Captisol. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Revenue</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contracts with customers often will include variable consideration in the form of contingent milestone-based payments. We include contingent milestone based payments in the estimated transaction price when it is probable a significant reversal in the amount of cumulative revenue recognized will not occur. These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone based payment is sales-based, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development based milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon the development milestone or regulatory approval. Depending on the terms of the arrangement, we may also defer a portion of the consideration received if we have to satisfy a future obligation, which typically occurs with our contracts for R&amp;D services.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For R&amp;D services we recognize revenue over time and we measure our progress using an input method. The input methods we use are based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time it will take us to complete the activities, or the costs we may incur in a given </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make numerous estimates and use significant judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We occasionally have sub-license obligations related to arrangements for which we receive license fees, milestones and royalties. We evaluate the determination of gross as a principal versus net as an agent reporting based on each individual agreement.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Revenue</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the terms of the arrangement, we may also defer a portion of the consideration received if we have to satisfy a future obligation.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry a contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue. During the twelve months ended December&#160;31, 2022, the amount recognized as revenue that was previously deferred at December 31, 2021 was $0.4 million. During the twelve months ended December&#160;31, 2021, the amount recognized as revenue that was previously deferred at December 31, 2020 was $23.3 million. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenue </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Royalty revenue for 2022, 2021 and 2020 for continuing operations are reported as below (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kyprolis</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Teriparatide injection </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rylaze </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,527&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,927&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,796&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents disaggregation of Captisol and contract revenue for continuing operations (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Captisol</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Captisol - Core</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Captisol - COVID</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,066&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,827&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,495&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,250&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,959&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Service Revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;License Fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Milestone</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,223&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,367&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,807&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(a) Captisol - COVID represents revenue on Captisol supplied for use in formulation with remdesivir, an antiviral treatment for COVID-19.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expenses</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense consists of labor, material, equipment, and allocated facilities costs of our scientific staff who are working pursuant to our collaborative agreements and other research and development projects. Also included in research and development expenses are third-party costs incurred for our research programs including in-licensing costs, contract research organization (CRO) costs and costs incurred by other research and development service vendors. We expense these costs as they are incurred. When we make payments for research and development services prior to the services being rendered, we record those amounts as prepaid assets on our consolidated balance sheet and we expense them as the services are provided. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incur share-based compensation expense related to restricted stock, ESPP, and stock options.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock unit (RSU) and performance stock unit (PSU) are all considered restricted stock. The fair value of restricted stock is determined by the closing market price of our common stock on the date of grant. We recognize share-based compensation expense based on the fair value on a straight-line basis over the requisite service periods of the awards, taking into consideration of forfeitures as they occur. PSU generally represents a right to receive a certain number of shares of common stock based on the achievement of corporate performance goals and continued employment during the vesting period. At each reporting period, we reassess the probability of the achievement of such corporate performance goals and any expense change resulting from an adjustment in the estimated shares to be released are treated as a cumulative catch-up in the period of adjustment. A limited amount of PSUs contain a market condition dependent upon the Company&#8217;s relative and absolute total stockholder return over a three-year period, with a range of 0% to 200% of the target amount granted to be issued under the award. Share-based compensation expense for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the market conditions.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes-Merton option-pricing model is used to estimate the fair value of stock purchases under our ESPP and stock options granted. The model assumptions include expected volatility, term, dividends, and the risk-free interest rate. We look to historical and implied volatility of our stock to determine the expected volatility. The expected term of an award is based on historical forfeiture experience, exercise activity, and on the terms and conditions of the stock awards. The expected dividend yield is determined to be 0% given that except for 2007, during which we declared a cash dividend on our common stock of $2.50 per share, we have not paid any dividends on our common stock in the past and currently do not expect to pay cash dividends or make any other distributions on common stock in the future. The risk-free interest rate is based upon U.S. Treasury securities with remaining terms similar to the expected term of the share-based awards.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We grant options, RSUs and PSUs to employees and non-employee directors. Non-employee directors are accounted for as employees. Options and RSUs granted to certain non-employee directors typically vest one year from the date of grant. Options granted to employees typically vest 1/8 on the six month anniversary of the date of grant, and 1/48 each month thereafter for forty-two months. RSUs and PSUs granted to employees vest over three years. All option awards generally expire ten years from the date of grant.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense for awards to employees and non-employee directors is recognized on a straight-line basis over the vesting period until the last tranche vests. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes is computed using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for the expected future tax benefit to be derived from tax loss and credit carryforwards. Deferred tax assets and liabilities are determined using the enacted tax rates in effect for the years in which those tax assets are expected to be realized. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the provision for income taxes in the period that includes the enactment date. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets are regularly assessed to determine the likelihood they will be recovered from future taxable income. A valuation allowance is established when we believe it is more likely than not the future realization of all or some of a deferred tax asset will not be achieved. In evaluating the ability to recover deferred tax assets within the jurisdiction which they arise we consider all available positive and negative evidence. Factors reviewed include the cumulative pre-tax book income for the past three years, scheduled reversals of deferred tax liabilities, history of earnings and reliable forecasting, projections of pre-tax book income over the foreseeable future, and the impact of any feasible and prudent tax planning strategies.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the impact of a tax position in our financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Tax authorities regularly examine our returns in the jurisdictions in which we do business and we regularly assess the tax risk of our return filing positions. Due to the complexity of some of the uncertainties, the ultimate resolution may result in payments that are materially </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">different from our current estimate of the tax liability. These differences, as well as any interest and penalties, will be reflected in the provision for income taxes in the period in which they are determined.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income (Loss) Per Share</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic income (loss) per share is calculated by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Diluted income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of the Company&#8217;s common stock exceeds the applicable conversion price of the respective notes. It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for stock options and restricted stock. In loss periods, basic net loss per share and diluted net loss per share are identical since the effect of otherwise dilutive potential common shares is anti-dilutive and therefore excluded.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 260, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, if a company had a discontinuing operation, the company uses income from continuing operations, adjusted for preferred dividends and similar adjustments, as its control number to determine whether potential common shares a dilutive. The following table presents the calculation of weighted average shares used to calculate basic and diluted income (loss) per share (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:62.189%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.649%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,868&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,630&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,185&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive potential common shares:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used to compute diluted income per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,868&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potentially dilutive shares excluded from calculation due to anti-dilutive effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Income (Loss)</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) represents net income (loss) adjusted for the change during the periods presented in unrealized gains and losses on available-for-sale debt securities, foreign currency translation adjustments, and reclassification adjustments for realized gains or losses included in net income (loss). The unrealized gains or losses are reported on the Consolidated Statements of Comprehensive Income (Loss).</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The British Pound Sterling was the functional currency of our subsidiary, Vernalis, which was sold in fourth quarter of the year ended December 31, 2020. For the year ended December 31, 2020, the corresponding financial statements have been translated into U.S. Dollars in accordance with ASC 830-30, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Translation of Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Assets and liabilities are translated at end-of-period rates while revenues and expenses are translated at average rates in effect during the period in which the activity took place. Equity is translated at historical rates and the resulting cumulative translation adjustments are included as a component of accumulated other comprehensive income (loss).</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Standards Updates, Recently Adopted</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2020-06&#8221;). The guidance simplifies the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#8217;s own equity. Consequently, a convertible debt instrument, such as the Company&#8217;s 2023 Notes, will be accounted for as a single liability measured at its amortized cost, if no other features require bifurcation and recognition as derivatives. The new guidance also requires the if-converted method to be applied for all convertible instruments and requires additional disclosures. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We adopted this guidance effective January 1, 2022 under the modified retrospective approach and the comparative information has not been restated and continues to be presented according to accounting standards in effect for those periods. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption and our 2023 Notes are no longer bifurcated into separate liability and equity components. The principal amount of the 2023 Notes is classified as a single liability measured at amortized cost in the consolidated balance sheet for the period ended December 31, 2022. Upon adoption of ASU 2020-06 on January 1, 2022, we recorded an adjustment to the 2023 Notes liability component, deferred tax liabilities, additional paid-in-capital and retained earnings. This adjustment was calculated based on the carrying amount of the 2023 Notes as if it had always been treated as a single liability measured at amortized cost. Furthermore, we recorded an adjustment to the debt issuance costs contra liability and equity (additional paid-in-capital) components under the same premise, as if debt issuance costs had always been treated as a contra liability only. Under this transition method, the cumulative effect of the accounting change increased the carrying amount of the 2023 Notes by $20.4 million, reduced deferred tax liabilities by $4.4 million, reduced additional paid-in capital by $51.1 million and increased retained earnings by $35.1 million. The net balance of the 2023 Notes at January 1, 2022 was $341.1 million which included an unamortized discount of $2.2 million.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Standards Not Yet Adopted</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on our consolidated financial statements or disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625577705104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Spin-off of OmniAb<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Spin-off of OmniAb</a></td>
<td class="text">Spin-off of OmniAb<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 23, 2022, we entered into the Separation Agreement to separate our OmniAb Business and the Merger Agreement, pursuant to which Avista Public Acquisition Corp. II (&#8220;APAC&#8221;) would combine with OmniAb, and acquire Ligand's OmniAb Business, in a Reverse Morris Trust transaction (collectively, the &#8220;Transactions&#8221;). In connection with the execution of the Merger Agreement, we made organizational changes to better align our organizational structure with our strategy and operations, and management reorganized the reportable segments to better reflect how the business is evaluated by the chief operating decision maker. Beginning in the first quarter of 2022, we operated the following two reportable segments: (1) OmniAb business and (2) Ligand core business. The OmniAb business segment is focused on enabling the discovery of therapeutic candidates for our partners by pairing antibody repertoires generated from our proprietary transgenic animals with our OmniAb business platform screening tools. The Ligand core business segment is a biopharmaceutical business focused on developing or acquiring technologies that help pharmaceutical companies deliver and develop medicines. We performed a fair value analysis utilizing a combination of income approach and market approach to determine the fair value of each segment in order to appropriately allocate the goodwill between the segments as of the announcement date. We reassigned goodwill using a relative fair value allocation method, which resulted in goodwill of a $105.7 million and $75.5 million being allocated to Ligand core business and OminAb business, respectively.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the closing date of the Transactions on November 1, 2022, the historical financial results of OmniAb have been reflected in our consolidated financial statements as discontinued operations under GAAP for all periods presented through the date of the Distribution. Pursuant to the Transaction Agreements, Ligand contributed to OmniAb cash and certain specific assets and liabilities constituting the OmniAb Business. Pursuant to the Distribution, Ligand distributed on a pro rata basis to its shareholders as of October 26, 2022 shares of the common stock of OmniAb representing 100% of Ligand&#8217;s interest in OmniAb. Immediately following the Distribution, Orwell Merger Sub Inc., a wholly-owned subsidiary of APAC, merged with and into OmniAb, with OmniAb continuing as the surviving company in the Merger and as a wholly owned subsidiary of New OmniAb. The entire transaction was completed on November 1, 2022, and following the Merger, New OmniAb is an independent, publicly traded company whose common stock trades on NASDAQ under the symbol &#8220;OABI.&#8221; After the Distribution, we do not beneficially own any shares of common stock in OmniAb and no longer consolidate OmniAb into our financial results for periods ending after November 1, 2022. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transfer of assets and liabilities to OmniAb was effected through a contribution in accordance with the Merger Agreement, as summarized below (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.860%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of November 1, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,842&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,861&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">165,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,921&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,290&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">294,476&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY </span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current contingent liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,569&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Deferred revenue   </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current finance lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,762&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,978&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,823&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64,744&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net assets transferred to OmniAb</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">229,732&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Discontinued operations</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger, the Company determined its antibody discovery business qualified for discontinued operations accounting treatment in accordance with ASC 205-20. The following table summarizes revenue and expenses of the discontinued operations for the years ended December 31, 2022, 2021 and 2020 (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:62.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.370%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.373%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Royalties</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,564&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,589&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,857&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating costs and expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38,466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36,907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">62,696&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60,545&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(36,132)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(24,956)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11,655)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain from short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,210)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,070)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other expense, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss before income tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(35,578)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(24,907)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11,830)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,692&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28,142)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19,215)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,583)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no assets and liabilities related to discontinued operations as of December&#160;31, 2022, as all balances were transferred to OmniAb upon Separation. The following table summarizes the assets and liabilities of the discontinued operations as of December&#160;31, 2021 (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.860%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current assets of discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">174,349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets of discontinued operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">271,883&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">LIABILITIES</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current contingent liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Deferred revenue   </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,342&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current finance lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current liabilities of discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,566&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total liabilities of discontinued operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69,094&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the significant non-cash items, capital expenditures of the discontinued operations, and financing activities that are included in the consolidated statements of cash flows for the years ended December 31, 2022, 2021 and 2020 (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:62.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.370%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.373%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(554)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,553&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,457&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for acquisition, net of cash acquired</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(27,127)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,572)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,070)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,753)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to CVR Holders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(960)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(720)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to CVR Holders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,545)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,050)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,325)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental cash flow disclosures:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment included in accounts payable and accrued expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625578753920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-term Investments: Investment in Viking<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityDisclosureTextBlock', window );">Short-term Investments: Investment in Viking</a></td>
<td class="text">Short-term Investments: Investment in VikingOur ownership in Viking was approximately 8.6% as of December&#160;31, 2022, and we account for it as an investment in available-for-sale equity securities, which is measured at fair value, with changes in fair value recognized in net income. Viking <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is considered a related party as we maintain a seat on Viking's board of directors and we do not exert significant influence over Viking. </span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022 and December&#160;31, 2021, we recorded our common stock in Viking in &#8220;short-term investments&#8221; at fair value of $63.1 million and $30.9 million, respectively. At December&#160;31, 2020, we owned warrants to purchase up to 1.5 million shares of Viking's common stock at an exercise price of  $1.50 per share, and during the year ended December&#160;31, 2021 we exercised all outstanding Viking warrants. As of December&#160;31, 2022 and December&#160;31, 2021, we have zero Viking warrants outstanding. During the year ended December&#160;31, 2021, we also sold 0.6&#160;million Viking shares. See further discussion in &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note (5), Fair Value Measurement.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625577837760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions</a></td>
<td class="text">Acquisitions<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding the impact of OmniAb, we completed one acquisition from January 1, 2020 through December 31, 2022, where we applied the acquisition method of accounting for business combinations. Accordingly, we recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the applicable date of acquisition. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pfenex Acquisition </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2020, we acquired Pfenex, which develops next-generation and novel protein therapeutics to improve existing therapies and create new therapies for biological targets linked to critical, unmet diseases using a protein expression technology platform.  </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purchase price of $465.1 million included $429.6 million cash consideration paid upon acquisition, and a contingent CVR payment of up to $77.8 million in cash based on a certain specified milestone with an estimated initial fair value of $37.0 million. The CVR will only be paid in full if the milestone is achieved by December 31, 2021. The amount of the CVR included in purchase price was reduced by $1.5&#160;million which was determined to be post-combination expense. The fair value of the CVR liability was determined using a probability adjusted income approach. These cash flows were then discounted to present value using a discount rate based on market participants' cost of debt reflective of the Company, which was 7.1%. The liability is periodically assessed based on events and circumstances related to the underlying milestone, and any change in fair value is recorded in our consolidated statements of operations. During the year ended December&#160;31, 2021, we wrote off the entire CVR liability of $37.6&#160;million to <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfMjc0ODc3OTA5MTQ4Mw_faecaf46-33bf-4086-b9d1-f6c39448988e">other operation income</span>, primarily due to not achieving the specific development and regulatory milestone by December 31, 2021 as defined by Pfenex CVR.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition, a portion of Pfenex's equity awards that were outstanding and unvested prior to the acquisition became fully vested per the terms of the merger agreement. The acceleration of vesting required us to allocate the fair value of the equity attributable to pre-combination service to the purchase price and the remaining amount was considered our post-combination expense. We paid $17.3 million in cash for equity compensation, which is attributable to pre-combination services and is reflected as a component of the total purchase price paid of $429.6 million. In addition, the fair value of equity compensation attributable to the post-combination service period was $8.7 million. These amounts were associated with the accelerated vesting of stock options previously granted to Pfenex employees and were fully paid in cash, which was recognized as general and administrative expenses during the fourth quarter of 2020. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded $20.7 million of acquisition-related costs for legal, severance and other costs in connection with the acquisition within operating expenses in our consolidated statement of operations for 2020. The following table sets forth an allocation of the purchase price to the identifiable tangible and intangible assets acquired and liabilities assumed, with the excess recorded to goodwill (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.449%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.351%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts and unbilled receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,814)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,606)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,908)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,070)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,382)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,622)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consideration</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465,098&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Goodwill represents the excess of the purchase price over the preliminary fair value of the underlying assets acquired and liabilities assumed. Goodwill is attributable to the assembled workforce of experienced personnel at Pfenex and expected synergies. None of the goodwill is deductible for tax purposes. </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intangibles acquired and their weighted average useful life are as follows (in thousands, except useful lives):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate<br/>Fair Value</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated useful life<br/>(in years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual Relationships:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alvogen</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merck</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jazz</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SII</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arcellx</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired Technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-19</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the contractual relationships were based on the discounted cash flow method that estimated the present value of the potential royalties, milestones and collaboration revenue streams derived from the licensing of the related technologies over the estimated contractual relationship period. The fair values of the acquired technologies were based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, collaboration and product revenue streams derived from the licensing of the related technologies over the estimated useful lives. These projected cash flows were discounted to present value using discount rate, which varies from 12% to 15%. The intangible assets acquired are being amortized on a straight-line basis over the estimated useful life. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately $2.0 million of revenue and $19.3 million of loss before income taxes of Pfenex were included in the consolidated statement of operations for the year ended December 31, 2020. The following summary presents our unaudited pro forma consolidated results of operations for the years ended December 31, 2020 and December 31, 2019 as if the Pfenex acquisition had occurred on January 1, 2019, which gives effect to certain transaction accounting adjustments, including amortization of acquired intangibles and stock based compensation expense for retained Pfenex employees. The transaction accounting adjustments do not include non-recurring adjustments related to Pfenex's executive salary, board of director compensation, and salary of Pfenex employees involved in the reduction of force as part of the acquisition, estimated to be $7.1 million in 2020 and $4.8&#160;million in 2019. The pro forma financial information is not necessarily indicative of the operating results that would have occurred had the acquisition been consummated as if the date indicated, nor is it necessarily indicative of future operating results (in thousands, except per share amounts):</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,608&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60,059)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594,941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) per common share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.71)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.71)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625573398000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsDisclosureTextBlock', window );">Fair Value Measurement</a></td>
<td class="text">Fair Value Measurement<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measure certain financial assets and liabilities at fair value on a recurring basis. Fair value is a market-based measurement that should be determined using assumptions that market participants would use in pricing an asset or liability. We establish a three-level hierarchy to prioritize the inputs used in measuring fair value. The levels are described in the below with level 1 having the highest priority and level 3 having the lowest:</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 - Observable inputs such as quoted prices in active markets </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 - Inputs other than the quoted prices in active markets that are observable either directly or indirectly </span></div><div style="margin-bottom:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 - Unobservable inputs in which there is little or no market data, which require the Company to develop its own assumptions</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the assets and liabilities that are measured at fair value on a recurring basis as of December&#160;31, 2022 and 2021 (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurements at Reporting Date Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Active Markets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">for Identical</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Observable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in Viking common stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,864&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,114&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,615&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent liabilities - Cydex</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent liabilities - Metabasis </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for amounts owed to a former licensor</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,557&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,429&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurements at Reporting Date Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Active Markets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">for Identical</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Observable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in Viking common stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321,586&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,624&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280,553&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent liabilities - Cydex</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent liabilities - Metabasis </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for amounts owed to a former licensor</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,793&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,358&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2) Investment in Viking warrants, which we received as a result of Viking&#8217;s partial repayment of the Viking note receivable and our purchase of Viking common stock and warrants in April 2016, is classified as level 1 as the fair value is determined using quoted market prices in active markets for the same securities. The change of the fair value is recorded in &#8220;gain (loss) from short-term investments&#8221; in our consolidated statement of operations. See further discussion in &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Note (3), Short-term Investments: Investment in Viking.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;  </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3) In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially differ than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#946; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375.0 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10.0 million payment upon initiation of a Phase 3 clinical trial.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the level 3 financial instruments as of December&#160;31, 2022 is as follows (in thousands):</span></div><div style="text-align:center;text-indent:45pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustments to contingent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(265)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of December&#160;31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the level 3 financial instruments as of December&#160;31, 2021 is as follows (in thousands):</span></div><div style="text-align:center;text-indent:45pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to CVR holders and other contingency payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustments to contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,708)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of December&#160;31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Measured on a Non-Recurring Basis</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to our goodwill, indefinite-lived intangible assets, and long-lived assets.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. We determine the fair value of our reporting unit based on a combination of inputs, including the market capitalization of Ligand, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. We determine the fair value of our indefinite-lived intangible assets using the income approach based on Level 3 inputs.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than the finance lease equipment discussed in &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note (6), Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;, there was no impairment of our goodwill, indefinite-lived assets, or long-lived assets recorded during the twelve months ended December&#160;31, 2022.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, we issued the 2023 Notes. We use quoted market rates in an inactive market, which are classified as a Level 2 input, to estimate the fair value of our 2023 Notes. The carrying value of the notes does not reflect the market rate. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note (7), Convertible Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for additional information related to the fair value.</span></div>In addition, our accounts receivable, accounts payable, accrued liabilities, current deferred revenue, current operating lease liabilities, current financing lease liabilities are financial instruments and are recorded at cost in the consolidated balance sheets. The estimated fair value of these financial instruments approximates their carrying value due to their short-term nature.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625573462256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Finance lease</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020 and January 2021, we entered into an agreement and the first amendment with Hovione, our third-party manufacturer, to increase our manufacturing of Captisol, respectively. The agreements are considered to include an embedded finance lease under ASC 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as it provides the Company the right to use the underlying equipment to exclusively manufacture Captisol. As of December&#160;31, 2021, we have fully paid consideration of $69.1 million for prepaid inventory and capacity ramp-up fee. We allocated consideration in the agreements between lease and non-lease components using relative standalone prices. Since the inception of the agreements, we have allocated $50.2 million of the consideration paid to the non-lease component which is accounted for as prepaid inventory and being amortized to cost of Captisol based on the usage.  The remaining balance of $18.9 million was recognized as a right of use asset. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the current COVID status, our forecast for COVID-related Captisol has been significantly reduced, which triggered an indicator of impairment of the right of use asset as of December 31, 2022. We performed a recoverability test at the asset group level by comparing the sum of the estimated undiscounted future cash flows attributable to the asset group to its carrying value and identified the asset was impaired. We recorded a $9.8&#160;million of impairment charge based on the fair value of the right of use asset which has been recognized in cost of Captisol in our consolidated statement of operations for the year ended December&#160;31, 2022. As of December&#160;31, 2022 the remaining right of use asset balance is $4.0&#160;million which will be amortized straight-line over the remaining 6 years lease term. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating lease </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease certain office facilities and equipment primarily under various operating leases. Our operating leases have remaining contractual terms up to ten years, some of which include options to extend the leases for up to five years. Our lease agreements do not contain any material residual value guarantees, material restrictive covenants, or material termination options. Our operating lease costs are primarily related to facility leases for administration offices and research and development facilities.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate generally applicable to the location of the lease asset, unless the implicit rate is readily determinable. Lease assets also include any upfront lease payments made and lease incentives. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to base rent, certain of our operating leases require variable payments, such as insurance and common area maintenance. These variable lease costs, other than those dependent upon an index or rate, are expensed when the obligation for those payments is incurred. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The depreciable life of lease assets and leasehold improvements is limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating and Finance Lease Assets and Liabilities (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,914&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total lease assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,009&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,411&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzExLTAtMS0xLTExMjY0MA_a1a5fccc-ae24-4f80-98b2-5c22c6e04753"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzExLTAtMS0xLTExMjY0MA_f02bfdd2-8ed4-4dd1-a881-ebd664bece19">Long-term finance lease liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total lease liabilities   </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,056&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,727&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Maturity of Operating and Finance Lease Liabilities as of December&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.391%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.499%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Dates</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,425&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,386&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,380)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,006&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, our operating leases have a weighted-average remaining lease term of 9.3 years and a weighted-average discount rate of 7.1%. As of December&#160;31, 2021, our operating leases have a weighted-average remaining lease term of 2.9 years and a weighted-average discount rate of 5.1%. Cash paid for amounts included in the measurement of operating lease liabilities was $1.7 million and $1.5 million for the twelve months ended December&#160;31, 2022 and 2021, respectively. Operating lease expense was $0.7 million (net of sublease income of $0.7 million) and $1.0 million (net of sublease income of $0.4 million) for the twelve months ended December&#160;31, 2022 and 2021, respectively.</span></div>As of December&#160;31, 2022, our finance leases have a weighted-average remaining lease term of 1.1 years and a weighted-average discount rate of 4.1%. As of December&#160;31, 2021, our finance leases have a weighted-average remaining lease term of 2.1 years and a weighted-average discount rate of 4.1%. We excluded the Hovione equipment lease in the calculation of weighted average remaining lease term and weighted average discount rate because the Hovione lease was fully paid off as of December&#160;31, 2021. Cash paid for amounts included in the measurement of these finance lease liabilities was $0.05&#160;million and $9.3&#160;million for the twelve months ended December&#160;31, 2022 and 2021, respectively. Finance lease expense was $2.3 million and $2.3 million for the twelve months ended December&#160;31, 2022 and 2021, respectively.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Finance lease</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020 and January 2021, we entered into an agreement and the first amendment with Hovione, our third-party manufacturer, to increase our manufacturing of Captisol, respectively. The agreements are considered to include an embedded finance lease under ASC 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as it provides the Company the right to use the underlying equipment to exclusively manufacture Captisol. As of December&#160;31, 2021, we have fully paid consideration of $69.1 million for prepaid inventory and capacity ramp-up fee. We allocated consideration in the agreements between lease and non-lease components using relative standalone prices. Since the inception of the agreements, we have allocated $50.2 million of the consideration paid to the non-lease component which is accounted for as prepaid inventory and being amortized to cost of Captisol based on the usage.  The remaining balance of $18.9 million was recognized as a right of use asset. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the current COVID status, our forecast for COVID-related Captisol has been significantly reduced, which triggered an indicator of impairment of the right of use asset as of December 31, 2022. We performed a recoverability test at the asset group level by comparing the sum of the estimated undiscounted future cash flows attributable to the asset group to its carrying value and identified the asset was impaired. We recorded a $9.8&#160;million of impairment charge based on the fair value of the right of use asset which has been recognized in cost of Captisol in our consolidated statement of operations for the year ended December&#160;31, 2022. As of December&#160;31, 2022 the remaining right of use asset balance is $4.0&#160;million which will be amortized straight-line over the remaining 6 years lease term. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating lease </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease certain office facilities and equipment primarily under various operating leases. Our operating leases have remaining contractual terms up to ten years, some of which include options to extend the leases for up to five years. Our lease agreements do not contain any material residual value guarantees, material restrictive covenants, or material termination options. Our operating lease costs are primarily related to facility leases for administration offices and research and development facilities.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate generally applicable to the location of the lease asset, unless the implicit rate is readily determinable. Lease assets also include any upfront lease payments made and lease incentives. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to base rent, certain of our operating leases require variable payments, such as insurance and common area maintenance. These variable lease costs, other than those dependent upon an index or rate, are expensed when the obligation for those payments is incurred. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The depreciable life of lease assets and leasehold improvements is limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating and Finance Lease Assets and Liabilities (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,914&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total lease assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,009&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,411&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzExLTAtMS0xLTExMjY0MA_a1a5fccc-ae24-4f80-98b2-5c22c6e04753"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzExLTAtMS0xLTExMjY0MA_f02bfdd2-8ed4-4dd1-a881-ebd664bece19">Long-term finance lease liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total lease liabilities   </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,056&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,727&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Maturity of Operating and Finance Lease Liabilities as of December&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.391%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.499%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Dates</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,425&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,386&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,380)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,006&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, our operating leases have a weighted-average remaining lease term of 9.3 years and a weighted-average discount rate of 7.1%. As of December&#160;31, 2021, our operating leases have a weighted-average remaining lease term of 2.9 years and a weighted-average discount rate of 5.1%. Cash paid for amounts included in the measurement of operating lease liabilities was $1.7 million and $1.5 million for the twelve months ended December&#160;31, 2022 and 2021, respectively. Operating lease expense was $0.7 million (net of sublease income of $0.7 million) and $1.0 million (net of sublease income of $0.4 million) for the twelve months ended December&#160;31, 2022 and 2021, respectively.</span></div>As of December&#160;31, 2022, our finance leases have a weighted-average remaining lease term of 1.1 years and a weighted-average discount rate of 4.1%. As of December&#160;31, 2021, our finance leases have a weighted-average remaining lease term of 2.1 years and a weighted-average discount rate of 4.1%. We excluded the Hovione equipment lease in the calculation of weighted average remaining lease term and weighted average discount rate because the Hovione lease was fully paid off as of December&#160;31, 2021. Cash paid for amounts included in the measurement of these finance lease liabilities was $0.05&#160;million and $9.3&#160;million for the twelve months ended December&#160;31, 2022 and 2021, respectively. Finance lease expense was $2.3 million and $2.3 million for the twelve months ended December&#160;31, 2022 and 2021, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625573459232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Senior Notes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Convertible Senior Notes</a></td>
<td class="text">Convertible Senior Notes<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">0.75% Convertible Senior Notes due 2023</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, we issued $750 million aggregate principal amount of 2023 Notes, bearing cash interest at a rate of 0.75% per year, payable semi-annually. The net proceeds from the offering, after deducting the initial purchasers' discount and offering expenses, were approximately $733.1 million. The 2023 Notes will be convertible into cash, shares of common stock, or a combination of cash and shares of common stock, at our election, based on a conversion rate as discussed below. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2023 Notes were entitled to convert the notes at any time prior to the close of business on the business day immediately preceding November 15, 2022, under any of the following circumstances:</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) during any fiscal quarter (and only during such fiscal quarter) commencing after September 30, 2018, if, for at least 20 trading days (whether or not consecutive) during the 30 consecutive trading day period ending on the last trading day of the immediately preceding fiscal quarter, the last reported sale price of our common stock on such trading day was greater than 130% of the conversion price on such trading day;</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) during the five business day period immediately following any 10 consecutive trading day period, in which the trading price per $1,000 principal amount of notes was less than 98% of the product of the last reported sale price of our common stock on such trading day and the conversion rate on each such trading day; or</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) upon the occurrence of certain specified corporate events as specified in the indenture governing the notes.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In advance of the Distribution of the shares of common stock of OmniAb to Ligand&#8217;s shareholders on November 1, 2022, a notice of convertibility was delivered to the holders of the 2023 Notes. No holders exercised their right to convert their 2023 Notes during the applicable period for conversion. After we completed the Separation of the OmniAb Business, on November&#160;15, 2022, the conversion rate was adjusted to 4.8390 shares of common stock per $1,000 principal amount of the 2023 Notes which represents a conversion price of approximately&#160;$206.65 per share. The maximum conversion rate of the 2023 Notes was adjusted to 6.2907 per $1,000 principal amount of the 2023 Notes which represents a conversion price of approximately $158.97.  The conversion rate for the 2023 Notes was adjusted in accordance with the requirements of the Indenture based on calculations determined with reference to a valuation period of the first 10 consecutive trading days after, and including, the ex-dividend date of the spin-off (as determined in the Indenture). The conversion rate and maximum conversion rate are subject to further adjustment under the circumstances and pursuant to the terms set forth in the Indenture.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notes will have a dilutive effect to the extent the average market price per share of common stock for a given reporting period exceeds the current conversion price of $206.65. In connection with the issuance of the 2023 Notes, we incurred $16.9 million of issuance costs, which primarily consisted of underwriting, legal and other professional fees. The portion of these costs allocated to the liability component totaling $13.7 million is amortized to interest expense using the effective interest method over the five years expected life of the 2023 Notes, and the effective interest rate as of December 31, 2022 is 0.5%. During the year ended December 31, 2022 we recognized a total of $1.8 million in interest expense which includes $1.1 million in contractual interest expense and $0.7 million in amortized issuance costs. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, we repurchased $152.0&#160;million in principal of the 2023 Notes for $156.0&#160;million in cash, including accrued interest of $0.3&#160;million. We accounted for the repurchase as a debt extinguishment, which resulted in (1) a loss of $7.3&#160;million reflected in other income (expense), net, in our consolidated statement of operations for the year ended December&#160;31, 2021, (2) a $13.7&#160;million reduction in debt discount, and (3) a $10.2&#160;million reduction to additional paid in capital, related to the reacquisition of the equity component in our consolidated balance sheet as of December&#160;31, 2021. After the repurchases, approximately $343.3 million in principal amount of the 2023 Notes remain outstanding. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, we repurchased $266.4 million in principal amount of the 2023 Notes for $261.4 million in cash, including accrued interest of $0.5 million We accounted for the repurchase as a debt extinguishment, which resulted in a gain of $4.2 million reflected in other income (expense), net, in our consolidated statement of operations for the year ended December 31, 2022, and a $1.3 million reduction in debt discount. After the repurchases, approximately $76.9 million in principal amount of the 2023 Notes remain outstanding. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Bond Hedge and Warrant Transactions</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the 2023 Notes, in May 2018, we entered into convertible bond hedges and sold warrants covering 3,018,327 shares of our common stock to minimize the impact of potential dilution to our common stock and/or offset the cash payments we are required to make in excess of the principal amount upon conversion of the 2023 Notes. The convertible bond hedges have an exercise price of $206.65 per share and are exercisable when and if the 2023 Notes are converted. We paid $140.3 million for these convertible bond hedges. If upon conversion of the 2023 Notes, the price of our common stock is above the exercise price of the convertible bond hedges, the counterparties will deliver shares of common stock and/or cash with an aggregate value approximately equal to the difference between the price of common stock at the conversion date and the exercise price, multiplied by the number of shares of common stock related to the convertible bond hedge transaction being exercised. The convertible bond hedges and warrants described below are separate transactions entered into by us and are not part of the terms of the 2023 Notes. Holders of the 2023 Notes and warrants will not have any rights with respect to the convertible bond hedges.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrently with the convertible bond hedge transactions, we entered into warrant transactions whereby we sold warrants covering 3,018,327 shares of common stock with an exercise price of $315.38 per share, subject to certain adjustments. We received $90.0 million for these warrants. The warrants have various expiration dates ranging from August 15, 2023 to February 6, 2024. The warrants will have a dilutive effect to the extent the market price per share of common stock exceeds the applicable exercise price of the warrants, as measured under the terms of the warrant transactions. The common stock issuable upon exercise of the warrants will be in unregistered shares, and we do not have the obligation and do not intend to file any registration statement with the SEC registering the issuance of the shares under the warrants.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, in connection with the repurchases of $234.4&#160;million in principal of the 2023 Notes for $203.8&#160;million in cash, including accrued interest of $0.6&#160;million, during the quarter ended March 31, 2020, we entered into amendments with Barclays Bank PLC, Deutsche Bank AG, London Branch, and Goldman Sachs &amp; Co. LLC to the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. The amendments provide that the options under the convertible note hedges corresponding to such repurchased 2023 Notes will remain outstanding notwithstanding such repurchase.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, in connection with the repurchases of approximately $20.3&#160;million in principal of the 2023 Notes for approximately $19.1&#160;million in cash, including accrued interest of $0.1&#160;million, during the quarter ended December 31, 2020, we entered into amendments with Barclays Bank PLC, Deutsche Bank AG, London Branch, and Goldman Sachs &amp; Co. LLC to the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. The amendments provide that the options under the convertible note hedges corresponding to such repurchased 2023 Notes will remain outstanding notwithstanding such repurchase.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, in connection with the repurchases of $152.0&#160;million in principal of the 2023 Notes for $156.0&#160;million in cash, including accrued interest of $0.3&#160;million, we entered into Warrant Early Unwind Agreements and Bond Hedge Unwind Agreements with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp; Co. LLC to unwind a portion of the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. We paid $18.4&#160;million as part of the Warrant Early Unwind Agreements reducing the number of shares covered by the warrants from 3,018,327 to 2,559,254. We received $18.9&#160;million as part of the Bond Hedge Early Unwind Agreements reducing the number of options under the convertible bond hedges to 598,021. These unwind transactions resulted in a $0.5&#160;million net increase in additional paid-in-capital in our consolidated balance sheet as of December&#160;31, 2021.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, in connection with the repurchases of $227.8&#160;million in principal of the 2023 Notes for $223.7&#160;million in cash, including accrued interest of $0.4&#160;million made during the six months ended June 30, 2022, we entered into Bond Hedge Unwind Agreements with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp; Co. LLC to unwind a portion of the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. We received $0.2&#160;million as part of these Bond Hedge Early Unwind Agreements reducing the number of options under the convertible bond hedges to 370,219 as of December&#160;31, 2022. This transaction resulted in a $0.2&#160;million net increase in additional paid-in-capital in our consolidated balance sheet as of December&#160;31, 2022.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the equity and liability components of the 2023 Notes (in thousands).</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.499%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount of 2023 Notes outstanding</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,854&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount (including unamortized debt issuance cost)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,584)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total long-term portion of notes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,695&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320,717&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of convertible senior notes outstanding (Level 2)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341,801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, there were no events of default or violation of any covenants under our financing obligations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625573281152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Account Details<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_OtherBalanceSheetDetailsAbstract', window );"><strong>Other Balance Sheet Details [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Balance Sheet Account Details</a></td>
<td class="text">Balance Sheet Account Details<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Investments</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding our investments in Viking, the following table summarizes the various investment categories at December&#160;31, 2022 and 2021 (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.321%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.501%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">gains</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">losses</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">fair value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mutual Funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1050)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,656&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,239)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,778&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,451)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,742&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Mutual fund</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(249)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper  </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,027)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292,225&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,370)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290,697&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain (loss) from short-term investments on our consolidated statements of operations includes both realized and unrealized gain (loss) from our short-term investments in public equity and warrant securities, and realized gain (loss) from available-for-sale debt securities. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,158&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,036&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,769&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,952&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,805&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities in an unrealized loss position (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.772%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12 months or greater</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">947&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,834&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Government Securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,354&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">947&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,301&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank deposits</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,689&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,814&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Government Securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,949&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,674&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,623&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment policy is capital preservation and we only invested in U.S.-dollar denominated investments. We held a total of 12 positions which were in an unrealized loss position as of December&#160;31, 2022. We believe that we will collect the principal and interest due on our debt securities that have an amortized cost in excess of fair value. The unrealized losses are largely due to changes in interest rates and not to unfavorable changes in the credit quality associated with these securities that impacted our assessment on collectability of principal and interest. We do not intend to sell these securities nor do we believe that we will be required to sell these securities before the recovery of the amortized cost basis. Accordingly, no credit losses were recognized for the twelve months ended December&#160;31, 2022.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and equipment are stated at cost and consists of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lab and office equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,172&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,417&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,607&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,606&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,482&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,191&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation of equipment is computed using the straight-line method over the estimated useful lives of the assets which ranges from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzE3MDc_277b8799-ffa7-4ac8-873b-e1ce3c67cce8">three</span> to ten years. Leasehold improvements are amortized using the straight-line method over their estimated useful lives or their related lease term, whichever is shorter. Depreciation expense of $3.8 million, $2.4 million, and $1.5 million was recognized for the twelve months ended December&#160;31, 2022, 2021, and 2020, respectively, and was included in operating expenses.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and identifiable intangible assets consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Complete technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,560)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,916)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,577)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,444)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,670)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,184)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Contractual relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,218)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total goodwill and other identifiable intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">448,128&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482,364&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of finite-lived intangible assets is computed using the straight-line method over the estimated useful life of the asset of up to 20 years. Amortization expense of $34.2 million, $34.2 million, and $11.6 million was recognized for the years ended December&#160;31, 2022, 2021, and 2020, respectively. Estimated amortization expense for the years ending December&#160;31, 2023 through 2027 is $34.1 million per year. For each of the years ended December&#160;31, 2022, 2021, and 2020, there was no material impairment of intangible assets with finite lives.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued liabilities consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,201&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,532&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts owed to former licensees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties owed to third parties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return reserve and customer refunds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subcontractor</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,759&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplier</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,681&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,579&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent liabilities:</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition of CyDex in January 2011, we issued a series of CVRs and also assumed certain contingent liabilities. We may be required to make additional payments upon achievement of certain clinical and regulatory milestones to the CyDex shareholders and former license holders.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition of Metabasis in January 2010, we entered into four CVR agreements with Metabasis shareholders. The CVRs entitle the holders to cash payments as frequently as every six months as proceeds are received by us upon the sale or licensing of any of the Metabasis drug development programs and upon the achievement of specified milestones.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For CVRs associated with the Pfenex, see &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note (4), Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for more information.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes roll-forward of contingent liabilities as of December 2022 and 2021 (in thousands):</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"><tr><td style="width:1.0%"/><td style="width:20.985%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.562%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.176%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.949%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.176%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.566%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Payments</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair Value Adjustment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Payments</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair Value Adjustment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Repurchases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cydex</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(265)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(464)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pfenex</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(37,600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">41,929</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(50)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(38,172)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,707</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(194)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,513</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_OtherBalanceSheetDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Balance Sheet Details [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_OtherBalanceSheetDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI https://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625573477648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">Stockholders&#8217; Equity<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-based Compensation Expense</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes share-based compensation expense from continuing operations (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.869%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense as a component of:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,612&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,881&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,326&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,125&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conversion and Modification of Equity Awards Outstanding at Separation Date</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the OmniAb Separation on November 1, 2022, under the provisions of the existing plans, we adjusted our outstanding equity awards in accordance with the Merger Agreement to preserve the intrinsic value of the awards immediately before and after the Distribution. Upon the Distribution, employees holding stock options, restricted stock units and performance restricted stock units denominated in pre-Distribution Ligand stock received a number of otherwise-similar awards either in post-Distribution Ligand stock or in a combination of post-Distribution Ligand stock and OmniAb stock based on conversion ratios outlined for each group of employees in the Merger Agreement that we entered into in connection with the Distribution. The equity awards that were granted prior to March 2, 2022 were converted under the shareholder method, wherein employees holding outstanding equity awards received equity awards in both Ligand and OmniAb. For equity awards granted after March 2, 2022, for Ligand employees, the number of awards that were outstanding at the Separation were proportionately adjusted into post-Distribution Ligand stock to maintain the aggregate intrinsic value of the awards at the date of the Separation; for OmniAb employees, the number of awards that were outstanding at the Separation were proportionately adjusted into post-Distribution OmniAb stock to maintain the aggregate intrinsic value of the awards at the date of the Separation. The conversion ratio was determined based on the relative values of Ligand common stock in the &#8220;regular way&#8221; and &#8220;ex-distribution&#8221; markets during the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">five-trading day period prior to the closing of the business combination.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These modified awards otherwise retained substantially the same terms and conditions, including term and vesting provisions. Additionally, we will not incur any future compensation cost related to equity awards held by OmniAb employees and directors. We will incur future compensation cost related to OmniAb equity awards held by our employees.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Plans</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, our stockholders approved the amendment and restatement of the Ligand Pharmaceuticals Incorporated 2002 Stock Incentive Plan (the &#8220;2002 Plan&#8221;). The amended and restated 2002 Plan, which is referred to herein as the &#8220;Restated Plan&#8221; was amended to increase the shares available for issuance by 1.0 million. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 29, 2022, our board of directors (the &#8220;Board&#8221;) approved the Ligand Pharmaceuticals Incorporated 2022 Employment Inducement Plan (the &#8220;2022 Inducement Plan&#8221;). The terms of the 2022 Inducement Plan are substantially similar to the terms of the Restated Plan with the exception that incentive stock options may not be issued under the 2022 Inducement Plan and awards under the 2022 Inducement Plan may only be issued to eligible recipients under the applicable Nasdaq Listing Rules. The 2022 Inducement Plan was adopted by the Board without stockholder approval pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules. The Board has initially reserved 300,000 shares of the Company&#8217;s common stock for issuance pursuant to awards granted under the 2022 Inducement Plan. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, there were 1.3 million shares available for future option grants or direct issuance under the Restated Plan and the 2022 Inducement Plan.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following is a summary of our stock option plan activity and related information:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:49.120%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.244%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Price</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Remaining</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contractual</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Term in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intrinsic</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January&#160;1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,956,379&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.45</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,002&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">806,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(156,845)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,012)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,561,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.09</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December&#160;31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,611,830&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.54</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest as of December&#160;31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,561,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.09</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">393,589&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(619,731)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136,082)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021 </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,199,598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.34</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December&#160;31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,391,952&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest as of December&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,199,598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.34</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863,245&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,941)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,069)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at October 31, 2022 </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,987,833&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at October 31, 2022 </span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,769,629&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,722&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest as of October 31, 2022, before Separation and Regrant</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,987,833&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation due to Separation, Before Regrant</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,987,833)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at November 1, 2022, Before Regrant</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,584,760&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50,449)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(542,838)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,991,473&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.07</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,559,662&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.51</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest as of December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,991,473&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.07</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(1) Options granted primarily relate to the modifications in connection with the Separation which resulted in new stock option grants at the modification date fair value. </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant-date fair value of all stock options granted during 2022, 2021 and 2020 was $28.90, $80.08, and $41.39 per share, respectively. The total intrinsic value of all options exercised during 2022, 2021 and 2020 was approximately $4.6 million, $77.3 million, and $11.9 million, respectively. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash received from options exercised, net of fees paid, in 2022, 2021 and 2020 was $2.6 million, $33.0 million and $2.5 million, respectively. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following is a further breakdown of the options outstanding as of December&#160;31, 2022:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.040%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.057%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.057%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.057%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.057%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.212%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Range of exercise prices</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">outstanding</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">remaining&#160; life</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">in&#160;years</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">exercise price</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">exercisable</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">exercise&#160;price</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$12.78-$43.36</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395,660&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.32</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.76&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366,426&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.44&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$46.20-$52.78</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.63</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,734&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$52.84-$52.84</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580,629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.59</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$54.81-$57.22</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391,280&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.47</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$58.28-$67.03</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.78</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274,719&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$67.24-$69.70</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403,187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.93</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$70.04-$93.12</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.56</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$99.80-$99.80</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.84</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$103.42-$103.42</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.26</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$114.15-$114.15</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.47</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,991,473&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.07</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,559,662&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assumptions used for the specified reporting periods and the resulting estimates of weighted-average grant date fair value per share of options granted:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.701%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.227%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.227%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4%-4.3%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4%-1.2%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2%-1.4%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49%-55%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47%-63%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47%-71%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 to 6.5 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7 to 6.3 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7 to 5.1 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, there was $32.7 million of total unrecognized compensation cost related to non-vested stock options under the 2002 Plan. That cost is expected to be recognized over a weighted average period of 2.7 years.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, there was $4.8&#160;million of total unrecognized compensation cost related to non-vested OmniAb stock options received upon aforementioned spin-off conversion. That cost is expected to be recognized over a weighted average period of 1.8 years. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Activity</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our restricted stock activity and related information:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:69.721%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.416%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.830%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Grant&#160;Date Fair</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52,363)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206,202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,292&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98,501)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,850)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260,577&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138,867)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,383)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at October 31, 2022, before Separation and Regrant</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366,470&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited due to Separation, Before Regrant</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(366,470)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at November 1, 2022, Before Regrant</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424,473&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73,385)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,635)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348,453&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, unrecognized compensation cost related to non-vested stock awards under the 2002 Plan amounted to $12.4&#160;million. That cost is expected to be recognized over a weighted average period of 1.7 years.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, there was $1.2&#160;million of total unrecognized compensation cost related to non-vested OmniAb stock awards received upon aforementioned spin-off conversion. That cost is expected to be recognized over a weighted average period of 1.0 years.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, 35,881 shares of our common stock are available for future issuance under the Amended Employee Stock Purchase Plan, or ESPP. The ESPP permits eligible employees to purchase up to 1,250 shares of Ligand common stock per calendar year at a discount through payroll deductions. The price at which stock is purchased under the ESPP is equal to 85% of the fair market value of the common stock on the first of a six month offering period or purchase date, whichever is lower. There were 8,479, 8,448 and 6,455 shares issued under the ESPP in 2022, 2021 and 2020, respectively. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2019, our Board of Directors approved a stock repurchase program authorizing the repurchase of up to $500.0 million of our common stock from time to time over a period of up to three years. This repurchase program expired in September 2022.   During the year ended December&#160;31, 2022 and 2021, we did not repurchase any common stock, respectively. During the year ended December&#160;31, 2020, we repurchased 934,079 shares for $78.0 million.  </span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">At-the Market Equity Offering Program</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2022, we filed a registration statement on Form S-3 (the &#8220;Shelf Registration Statement&#8221;), which became automatically effective upon filing, covering the offering of common stock, preferred stock, debt securities, warrants and units. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2022, we also entered into an At-The-Market Equity Offering Sales Agreement (the &#8220;Sales Agreement&#8221;) with Stifel, Nicolaus &amp; Company, Incorporated (the &#8220;Agent&#8221;), under which we may, from time to time, sell shares of our common stock having an aggregate offering price of up to $100.0&#160;million in &#8220;at the market&#8221; offerings through the Agent (the </span></div>&#8220;ATM Offering&#8221;). The Shelf Registration Statement included a prospectus covering the offering, issuance and sale of up to $100.0&#160;million of our common stock from time to time through the ATM Offering. The shares to be sold under the Sales Agreement may be issued and sold pursuant to the Shelf Registration Statement. To date, we have not issued any shares of common stock in the ATM Offering.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Balance Sheet Account Details</a></td>
<td class="text">Balance Sheet Account Details<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Investments</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding our investments in Viking, the following table summarizes the various investment categories at December&#160;31, 2022 and 2021 (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.321%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.501%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">gains</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">losses</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">fair value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mutual Funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1050)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,656&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,239)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,778&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,451)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,742&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Mutual fund</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(249)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper  </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,027)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292,225&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,370)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290,697&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain (loss) from short-term investments on our consolidated statements of operations includes both realized and unrealized gain (loss) from our short-term investments in public equity and warrant securities, and realized gain (loss) from available-for-sale debt securities. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,158&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,036&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,769&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,952&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,805&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities in an unrealized loss position (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.772%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12 months or greater</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">947&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,834&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Government Securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,354&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">947&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,301&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank deposits</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,689&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,814&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Government Securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,949&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,674&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,623&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment policy is capital preservation and we only invested in U.S.-dollar denominated investments. We held a total of 12 positions which were in an unrealized loss position as of December&#160;31, 2022. We believe that we will collect the principal and interest due on our debt securities that have an amortized cost in excess of fair value. The unrealized losses are largely due to changes in interest rates and not to unfavorable changes in the credit quality associated with these securities that impacted our assessment on collectability of principal and interest. We do not intend to sell these securities nor do we believe that we will be required to sell these securities before the recovery of the amortized cost basis. Accordingly, no credit losses were recognized for the twelve months ended December&#160;31, 2022.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and equipment are stated at cost and consists of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lab and office equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,172&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,417&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,607&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,606&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,482&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,191&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation of equipment is computed using the straight-line method over the estimated useful lives of the assets which ranges from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzE3MDc_277b8799-ffa7-4ac8-873b-e1ce3c67cce8">three</span> to ten years. Leasehold improvements are amortized using the straight-line method over their estimated useful lives or their related lease term, whichever is shorter. Depreciation expense of $3.8 million, $2.4 million, and $1.5 million was recognized for the twelve months ended December&#160;31, 2022, 2021, and 2020, respectively, and was included in operating expenses.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and identifiable intangible assets consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Complete technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,560)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,916)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,577)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,444)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,670)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,184)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Contractual relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,218)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total goodwill and other identifiable intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">448,128&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482,364&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of finite-lived intangible assets is computed using the straight-line method over the estimated useful life of the asset of up to 20 years. Amortization expense of $34.2 million, $34.2 million, and $11.6 million was recognized for the years ended December&#160;31, 2022, 2021, and 2020, respectively. Estimated amortization expense for the years ending December&#160;31, 2023 through 2027 is $34.1 million per year. For each of the years ended December&#160;31, 2022, 2021, and 2020, there was no material impairment of intangible assets with finite lives.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued liabilities consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,201&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,532&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts owed to former licensees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties owed to third parties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return reserve and customer refunds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subcontractor</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,759&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplier</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,681&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,579&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent liabilities:</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition of CyDex in January 2011, we issued a series of CVRs and also assumed certain contingent liabilities. We may be required to make additional payments upon achievement of certain clinical and regulatory milestones to the CyDex shareholders and former license holders.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition of Metabasis in January 2010, we entered into four CVR agreements with Metabasis shareholders. The CVRs entitle the holders to cash payments as frequently as every six months as proceeds are received by us upon the sale or licensing of any of the Metabasis drug development programs and upon the achievement of specified milestones.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For CVRs associated with the Pfenex, see &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note (4), Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for more information.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes roll-forward of contingent liabilities as of December 2022 and 2021 (in thousands):</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"><tr><td style="width:1.0%"/><td style="width:20.985%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.562%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.176%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.949%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.176%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.566%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Payments</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair Value Adjustment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Payments</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair Value Adjustment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Repurchases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cydex</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(265)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(464)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pfenex</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(37,600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">41,929</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(50)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(38,172)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,707</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(194)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,513</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI https://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625573331248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies: Legal Proceedings<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitment and Contingencies: Legal Proceedings</a></td>
<td class="text">Commitment and Contingencies: Legal Proceedings<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record an estimate of a loss when the loss is considered probable and estimable. Where a liability is probable and there is a range of estimated loss and no amount in the range is more likely than any other number in the range, we record the minimum estimated liability related to the claim in accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As additional information becomes available, we assess the potential liability related to our pending litigation and revises our estimates. Revisions in our estimates of potential liability could materially impact our results of operations. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 31, 2019, we received three civil complaints filed in the U.S. District Court for the Northern District of Ohio on behalf of several Indian tribes. The Northern District of Ohio is the Court that the Judicial Panel on Multi-District Litigation (&#8220;JPML&#8221;) has assigned more than one thousand civil cases which have been designated as a Multi-District Litigation (&#8220;MDL&#8221;) and captioned In Re: National Prescription Opiate Litigation. The allegations in these complaints focus on the activities of defendants other than the Company and no individualized factual allegations have been advanced against us in any of the three complaints. We reject all claims raised in the complaints and intend to vigorously defend these matters. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CyDex, a wholly owned subsidiary of Ligand, and Baxter Healthcare Corp. (&#8220;Baxter&#8221;) are parties to a license agreement relating to Ligand&#8217;s Captisol&#174; technology and, more specifically, relating to Captisol&#174;-enabled Nexterone&#174; (amiodarone HCl premixed injection). CyDex contended that Baxter has not paid all of the royalties due to CyDex under the terms of the license agreement and Baxter contends that it has overpaid royalties for several years. On April 6, 2021, Baxter initiated an arbitration with AAA pursuant to the arbitration provision of the license agreement. On April 21, 2021, CyDex filed an answering statement and counterdemand. On December 2, 2021, Baxter filed an Amended Notice of Arbitration Demand seeking a declaration limiting the &#8220;royalty term&#8221; of the license agreement to &#8220;the later of i) the expiration of the licensed [p]atent; or ii) when there are no longer any CyDex patents listed in the Orange Book for [Nexterone&#174;].&#8221; Baxter later clarified its position, and asserted that royalties should have ceased being due upon the May 4, 2022 expiry of CyDex&#8217;s U.S. Patent No. 6,869,939. The parties conducted a three-day arbitration hearing May 24-26, 2022. In a September 9, 2022 Final Award, the Tribunal ruled in CyDex&#8217;s favor by (1) denying Baxter&#8217;s request for a partial refund of previously paid royalties, (2) granting CyDex&#8217;s request for underpaid royalties, and (3) concluding that &#8220;[g]oing forward Baxter shall pay CyDex&#8221; a royalty consistent with CyDex&#8217;s construction of the license agreement until, at least, the March 13, 2029 expiry of CyDex&#8217;s U.S. Patent No. 7,635,773. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 22, 2022, Pfenex Inc. (&#8220;Pfenex&#8221;), a wholly owned subsidiary of Ligand, received a notice of alleged breach from Beijing Kangchen Biological Technology Co., Ltd. (&#8220;Kangchen&#8221;) with respect to a Development and License Agreement , dated April 18, 2018, between Pfenex and Kangchen (&#8220;License Agreement&#8221;) pertaining to the development and commercialization of teriparatide in certain Southeast Asian countries. The allegations in the notice focused on the activities of Pfenex and other parties. On June 16, 2022, we rejected all claims raised by Kangchen in the notice. On June 24, 2022, Kangchen served Pfenex a notice of termination of the License Agreement and demanded initiation of the dispute resolution process in accordance with the License Agreement. On June 29, 2022, we again rejected all claims raised by Kangchen in the notice of termination and agreed to engage in the applicable dispute resolution process, including good faith negotiations between the parties. On October 20, 2022, we agreed to make a single lump sum payment to Kangchen in connection with a termination agreement that, among other things, terminates the License Agreement and releases all claims between the parties arising from the License Agreement. The payment was recorded as general and administrative expense during the year ended December&#160;31, 2022. A termination agreement between Pfenex and Kangchen went into effect in December 2022. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may also become subject to other legal proceedings or claims arising in the ordinary course of our business. We currently believe that none of the claims or actions pending against us is likely to have, individually or in the aggregate, a material adverse effect on our business, financial condition or results of operations. Given the unpredictability inherent in litigation, however, we cannot predict the outcome of these matters.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625573276336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the income tax expense (benefit) for continuing operations are as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:66.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.092%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.833%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.092%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.686%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.094%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current expense (benefit):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,742&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">438&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,384&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred expense (benefit):</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,656)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,901)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,456)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,685)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,234)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,488&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,586)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,690)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax expense (benefit)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,230&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,148)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,306)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of income tax expense (benefit) from continuing operations to the amount computed by applying the statutory federal income tax rate to the net income (loss) from continuing operations is summarized as follows (in thousands):</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:66.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.047%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.047%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.048%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax at federal statutory rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,562&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,231)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FDII</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,395)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(637)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,652)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate change for changes in federal, foreign or state law</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(535)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,963)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(673)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale of Vernalis R&amp;D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,993)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(266)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax differential on income/loss of foreign subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,839)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,628)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subpart F income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,080)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(623)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision to return adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,347)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,920)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Officer compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,410&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,799&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121,864)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,823)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,230&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,148)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,306)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We remeasured certain deferred tax assets and liabilities based on the rates at which they are expected to reverse in the future, which is generally 21%. Significant components of our deferred tax assets and liabilities as of December&#160;31, 2022 and 2021 are shown below. We assess the positive and negative evidence to determine if sufficient future taxable income will be generated to use the existing deferred tax assets. Our evaluation of evidence resulted in management concluding that the majority of our deferred tax assets will be realized. However, we maintain a valuation allowance to offset certain net deferred tax assets as management believes realization of such assets are uncertain as of December&#160;31, 2022, 2021 and 2020. The valuation allowance increased $21.5 million in 2022, increased $11.4 million in 2021 and decreased $116.5 million in 2020.  </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offset all deferred tax assets and liabilities by jurisdiction, as well as any related valuation allowance, and present them on our consolidated balance sheet as a non-current deferred income tax asset or liability (as applicable). Deferred tax assets </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(liabilities) are comprised of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.807%"><tr><td style="width:1.0%"/><td style="width:76.478%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.662%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.813%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,908&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,969&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance for deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,472)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,931)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,497&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,180&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:13pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identified intangibles</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,696)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66,848)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,886)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,459)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75,582)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,307)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:13pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,085)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,873&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in 2022, the Tax Cuts and Jobs Act of 2017 requires taxpayers to capitalize and amortize R&amp;D expenditures over five years for domestic research and 15 years for foreign research pursuant to Section 174 of the Internal Revenue Code of 1986, as amended. We recorded an increase of $4.7&#160;million to our current federal income tax expense and deferred tax assets for continuing operations during 2022 due to the capitalization of R&amp;D under Section 174. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of December&#160;31, 2022, we had federal net operating loss carryforwards set to expire through 2037 of $81.1 million and $168.3 million of state net operating loss carryforwards that begin to expire in 2028. We also have $8.5 million of federal research and development credit carryforwards, which expire through 2040. We have $29.0 million of California research and development credit carryforwards that have no expiration date. In addition, we have approximately $96.1 million of non-U.S. net operating loss carryovers and approximately $15.6 million of non-U.S. capital loss carryovers that have no expiration date. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021 we had federal net operating loss carryforwards set to expire through 2037 of  $117.5&#160;million and $170.1&#160;million of state net operating loss carryforwards that begin to expire in 2028. We also had $9.3 million in federal research and development credit carryforwards, which expire through 2040, and $29.0 million of California research and development credit carryforwards that have no expiration date. In addition, we had approximately $101.6 million of non-U.S. capital loss carryovers and approximately $17.5 million of non-U.S. capital loss carryovers that have no expiration date. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Section 382 and 383 of the Internal Revenue Code of 1986, as amended, utilization of our net operating losses and credits may be subject to annual limitations in the event of any significant future changes in its ownership structure. These annual limitations may result in the expiration of net operating losses and credits prior to utilization. The deferred tax assets as of December&#160;31, 2022 are net of any previous limitations due to Section 382 and 383.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for income taxes by evaluating a probability threshold that a tax position must meet before a financial statement benefit is recognized. The minimum threshold is a tax position that is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. Our remaining liabilities for uncertain tax positions are presented net of the deferred tax asset balances on the accompanying consolidated balance sheet.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the amount of unrecognized tax benefits at December&#160;31, 2022, 2021 and 2020 is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,550&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,619&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,647&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Additions based on tax positions related to the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Additions for tax positions of prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Reductions for tax positions of prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(512)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,072)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(954)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,096&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,550&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,619&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in the balance of unrecognized tax benefits at December&#160;31, 2022 is $27.3 million of tax benefits that, if recognized would impact the effective rate. There are no positions for which it is reasonably possible that the uncertain tax benefit will significantly increase or decrease within twelve months.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We recognize interest and penalties related to uncertain tax positions in income tax expense. As of December&#160;31, 2022 and December&#160;31, 2021, we recognized an immaterial amount of interest and penalties. We file income tax returns in the United States, various state jurisdictions, United Kingdom, and Canada with varying statutes of limitations. The federal statute of limitation remains open for the 2019 tax year to the present.&#160;The state income tax returns generally remain open for the 2018 tax year through the present.&#160;Net operating loss and research credit carryforwards arising prior to these years are also open to examination if and when utilized. The Ligand California tax returns for 2019 and 2020 are currently under audit. We believe our reserve for unrecognized tax benefits and contingent tax issues is adequate with respect to all open years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625573471184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Selected Quarterly Financial Data (Unaudited)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">Selected Quarterly Financial Data (Unaudited)</a></td>
<td class="text">Selected Quarterly Financial Data (Unaudited)<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table contains quarterly financial information for 2022 and 2021. The Company believes that the following information reflects all normal recurring adjustments necessary for a fair presentation of the information for the periods presented. The operating results for any quarter are not necessarily indicative of results for any future period.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.832%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.313%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.313%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.313%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.313%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.316%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except per share data)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36,516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50,126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50,382&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">196,245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,086&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41,464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46,880&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">193,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12,929)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,645&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14,534)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,219)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss from discontinued operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,456)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13,494)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,241)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,951)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28,142)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(15,385)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(895)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17,485)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(33,361)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic net income (loss) from continuing operations per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.86)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic net loss from discontinued operations per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.80)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.67)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted net income (loss) from continuing operations per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.86)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted net loss from discontinued operations per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.79)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.67)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares used in the computation of basic  net income (loss) per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,888&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares used in the computation of diluted  net income (loss) per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,058&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.832%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.313%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.313%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.313%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.313%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.316%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except per share data)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">78,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59,694&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56,404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">241,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,482&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,967&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46,790&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41,280&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,767&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36,442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,194)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76,353&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss from discontinued operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,660)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,717)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,615)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,223)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19,215)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,725&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,417)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57,138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic net income (loss) from continuing operations per share </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic net loss from discontinued operations per share </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted net income (loss) from continuing operations per share </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted net loss from discontinued operations per share </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares used in the computation of basic net income (loss) per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares used in the computation of diluted net income (loss) per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -URI https://asc.fasb.org/topic&amp;trid=2126967<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=126900988&amp;loc=SL124452896-108306<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625571252640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessSpinOffAndMigrationPolicyTextBlock', window );">Business</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, we completed the separation (the &#8220;Separation&#8221;) of our antibody discovery business and certain related assets and liabilities (the &#8220;OmniAb Business&#8221;) through a spin-off of OmniAb to Ligand&#8217;s shareholders of record as of October 26, 2022 on a pro rata basis (the &#8220;Distribution&#8221;) and merger (the &#8220;Merger&#8221;) of OmniAb with a wholly owned subsidiary of a separate public company, OmniAb, Inc. (formerly known as Avista Public Acquisition Corp. II (&#8220;New OmniAb&#8221;)), in a Reverse Morris Trust transaction pursuant to the Agreement and Plan of Merger, dated as of March 23, 2022 (the &#8220;Merger Agreement&#8221;), and the Separation and Distribution Agreement, dated as of March 23, 2022 (the &#8220;Separation Agreement&#8221;) (the Merger Agreement and Separation Agreement, collectively with the other related transaction documents, the &#8220;Transaction Agreements&#8221;). Pursuant to the Transaction Agreements, Ligand contributed to OmniAb cash and certain assets and liabilities constituting the OmniAb Business, including but not limited to the equity interests of Ab Initio Biotherapeutics, Inc., Crystal Bioscience, Inc., Icagen, LLC, Taurus Biosciences, LLC and xCella Biosciences, Inc.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the spin-off of our OmniAb antibody discovery business, Ligand is a revenue-generating biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. We operate in one business segment: development and licensing of biopharmaceutical assets.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock', window );">Basis of Presentation and Principles of Consolidation</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements have been prepared in accordance with U.S. GAAP and include the accounts of our parent company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsPolicyTextBlock', window );">Discontinued Operations</a></td>
<td class="text">Discontinued operations<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined that the spin-off of the OmniAb Business in November 2022 met the criteria for classification as a discontinued operation in accordance with ASC Subtopic 205-20, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Discontinued Operations</span> (&#8220;ASC 205-20&#8221;). Accordingly, the accompanying consolidated financial statements for all periods presented have been updated to present the assets and liabilities associated with the OmniAb Business separately as discontinued operations on the consolidated balance sheets and the results of all discontinued operations reported as a separate component of loss in the consolidated statements of operations and comprehensive loss<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires the use of estimates and assumptions that affect the amounts reported in the consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Business Risk</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Business Risk</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to significant concentrations of credit risk consist primarily of cash equivalents and investments. We invest excess cash principally in United States government debt securities, investment grade corporate debt securities, mutual funds and certificates of deposit. We maintain some cash and cash equivalents balances with financial institutions that are in excess of the Federal Deposit Insurance Corporation insurance limits. We have established guidelines relative to diversification and maturities that maintain safety and liquidity. These guidelines are periodically reviewed and modified to take advantage of trends in yields and interest rates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_CashCashEquivalentsandShorttermInvestmentsPolicyTextBlock', window );">Cash Equivalents &amp; Short-term Investments</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Equivalents </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents consist of highly liquid investments with maturities of three months or less from the date of acquisition. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Investments</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments primarily consist of investments in debt and equity securities. We classify our short-term investments as &#8220;available-for-sale&#8221;. Such investments are carried at fair value, with unrealized gains and losses on debt securities included in the statement of comprehensive income (loss), net of tax, and unrealized gains and losses on equity securities included the consolidated statement of operations. We determine the cost of investments based on the specific identification method. We determine the realized gains or losses on the sale of available-for-sale securities using the specific identification method and includes net realized gains and losses as a component of other income or expense within the consolidated statements of operations.  </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities consist of certificates of deposit, corporate debt securities, and securities of government-sponsored entities have effective maturities greater than&#160;three&#160;months and less than twenty-five months from the date of acquisition. Debt securities available-for-sale in an unrealized loss position are assessed for the current expected credit losses methodology. We start by assessing whether we intend to sell the security, or whether it is more likely than not that we will be required to sell the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security&#8217;s amortized cost basis is written down to fair value through earnings. For debt securities available-for-sale that do not meet the aforementioned criteria, we evaluate whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, we consider the extent to which fair value is less than amortized cost, any changes in interest rates, and any changes to the rating of the security by a rating agency, among other factors. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security is compared to the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded, limited by the amount that the fair value is less than the amortized cost basis. Any impairment that has not been recorded through an allowance for credit losses is recognized in other comprehensive income or loss, as applicable.</span></div>Equity securities are mutual funds, investments in privately held companies (non-marketable equity securities), and companies that have completed initial public offerings (marketable equity securities). Mutual funds are valued at their publicly quoted net asset value (NAV) price on the last day of the period. Our non-marketable equity securities without readily determinable market values are initially measured at cost and adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment. Our marketable equity securities are measured at fair value. Equity investments are classified as short-term investments, or non-current other assets, based on the nature of the securities and their availability for use in current operations.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy', window );">Accounts Receivable</a></td>
<td class="text">Accounts Receivable Our accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text">InventoryInventory, which consists of finished goods, is stated at the lower of cost or net realizable value. We determine cost using the specific identification method. We analyze our inventory levels periodically and write down inventory to net realizable value if it has become obsolete, has a cost basis in excess of its expected net realizable value or is in excess of expected requirements.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost, subject to review for impairment, and depreciated over the estimated useful lives of the assets, which generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNzU2MQ_9d23c4d7-711e-44c5-af62-13230621da18">three</span> to ten years, using the straight-line method. Amortization of leasehold improvements is recorded over the shorter of the lease term or estimated useful life of the related asset. Maintenance and repairs are charged to operations as incurred. When assets are sold, or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts and any gain or loss is included in operating income or expense.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Acquisitions</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We first determine whether a set of assets acquired constitute a business and should be accounted for as a business combination. If the assets acquired are not a business, we account for the transaction as an asset acquisition. Business combinations are accounted for by using the acquisition method of accounting which requires us to use significant estimates and assumptions, especially with respect to intangible assets. We record the excess consideration over the aggregate fair value of tangible and intangible assets, net of liabilities assumed, as goodwill.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the acquisition method of accounting, we recognize separately from goodwill the identifiable assets acquired, the liabilities assumed, including contingent consideration and all contractual contingencies, generally at the acquisition date fair value. Contingent purchase consideration to be settled in cash are remeasured to estimated fair value at each reporting period with the change in fair value recorded in statement of operations. Costs that we incur to complete the business combination such as investment banking, legal and other professional fees are not considered part of consideration and we charge them to general and administrative expense as they are incurred. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Should the initial accounting for a business combination be incomplete by the end of a reporting period that falls within the measurement period, we report provisional amounts in our financial statements. During the measurement period, we adjust the provisional amounts recognized at the acquisition date to reflect new information obtained about facts and circumstances that existed as of the acquisition date that, if known, would have affected the measurement of the amounts recognized as of that date and we record those adjustments to our financial statements in the period of change, if any.</span></div>Under the acquisition method of accounting for business combinations, if we identify changes to acquired deferred tax asset valuation allowances or liabilities related to uncertain tax positions during the measurement period and they relate to new information obtained about facts and circumstances that existed as of the acquisition date, those changes are considered a measurement period adjustment and we record the offset to goodwill. We record all other changes to deferred tax asset valuation allowances and liabilities related to uncertain tax positions in current period income tax expense.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill, Intangible Assets and Other Long-Lived Assets</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill, Intangible Assets and Other Long-Lived Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill, which has an indefinite useful life, represents the excess of cost over fair value of net assets acquired. Goodwill is reviewed for impairment at least annually during the fourth quarter, or more frequently if an event occurs indicating the potential for impairment. During the goodwill impairment review, we assess qualitative factors to determine whether it is more </span></div>likely than not that the fair value of our reporting unit is less than the carrying amount, including goodwill. The qualitative factors include, but are not limited to, macroeconomic conditions, industry and market considerations, and the overall financial performance. If, after assessing the totality of these qualitative factors, we determine that it is not more likely than not that the fair value of our reporting unit is less than the carrying amount, then no additional assessment is deemed necessary. Otherwise, we proceed to perform the quantitative assessment. We will then evaluate goodwill for impairment by comparing the estimated fair value of the reporting unit to its carrying value, including the associated goodwill. To determine the fair value, we generally use a combination of market approach based on Ligand and comparable publicly traded companies in similar lines of businesses and the income approach based on estimated discounted future cash flows. Our cash flow assumptions consider historical and forecasted revenue, operating costs and other relevant factors. We may also elect to bypass the qualitative assessment in a period and elect to proceed to perform the quantitative assessment for the goodwill impairment test. We performed the annual assessment for goodwill impairment during the fourth quarter of 2022, noting no impairment. Our identifiable intangible assets are typically composed of acquired core technologies, licensed technologies, contractual relationships, customer relationships and trade names. The cost of identifiable intangible assets with finite lives is generally amortized on a straight-line basis over the assets&#8217; respective estimated useful lives. We regularly perform reviews to determine if any event has occurred that may indicate that intangible assets with finite useful lives and other long-lived assets are potentially impaired. If indicators of impairment exist, an impairment test is performed to assess the recoverability of the affected assets by determining whether the carrying amount of such assets exceeds the undiscounted expected future cash flows. If the affected assets are not recoverable, we estimate the fair value of the assets and record an impairment loss if the carrying value of the assets exceeds the fair value. Factors that may indicate potential impairment include market conditions, industry and economic trends, changes in regulations, clinical success, historical and forecasted financial results, market capitalization, significant changes in the ability of a particular asset to generate positive cash flows, and the pattern of utilization of a particular asset.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_CommercialLicenseRightsPolicyTextBlock', window );">Commercial license and other economic rights</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commercial license and other economic rights</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022 and 2021, commercial license and other economic rights consist of the following (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.338%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.607%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo and CorMatrix</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,538)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,158&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,461)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,235&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis and Dianomi</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,578)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,024&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,727)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18,116)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18,188)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Amounts represent accumulated amortization to principal of $11.6 million and credit loss adjustments of $6.5 million as of December 31, 2022. </span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(2) Amounts represent accumulated amortization to principal of $11.7 million and credit loss adjustments of $6.5 million as of December 31, 2021. </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial license and other economic rights as of December&#160;31, 2022 represent a portfolio of future milestone and royalty payment rights acquired from Selexis in April 2013 and April 2015, CorMatrix in May 2016, and Dianomi in January 2019. Commercial license rights acquired are accounted for as financial assets, and other economic rights are accounted for as funded research and developments as further discussed below. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2019, we entered into a development funding and royalties agreement with Novan, pursuant to which we would receive certain payments at specified milestones, as well as royalties on any future net sales of SB206, a product candidate being developed to treat molluscum contagiosum, and any other Novan products used for the treatment of molluscum (&#8220;Novan Molluscum Products&#8221;). We paid Novan an upfront payment of $12.0 million, which Novan is required to use to fund the development of SB206. We are not obligated to provide additional funding to Novan for the development or commercialization of SB206. Pursuant to the agreement, we would receive up to $20.0 million of milestone payments upon the achievement by Novan of certain regulatory milestones for SB206 or any other Novan Molluscum Product and commercial milestones. In addition to the milestone payments, Novan will pay us tiered royalties from 7.0% to 10.0% based on aggregate annual net sales of SB206 or any other Novan Molluscum Product in North America. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2018, we entered into a development funding and royalties agreement with Palvella. Pursuant to the agreement, we will receive up to $8.0 million of milestone payments upon the achievement by Palvella of certain corporate, financing and regulatory milestones for PTX-022, a product candidate being developed to treat pachyonychia congenita. In addition to the milestone payments, Palvella will pay us tiered royalties from 5.0% to 9.8% based on aggregate annual worldwide net sales of any PTX-022 products, if approved, subject to Palvella&#8217;s right to reduce the royalty rates by making payments in certain circumstances. We made an upfront payment of $10.0 million, which Palvella is required to use to fund the development of PTX-022. We are not obligated to provide additional funding to Palvella for development or commercialization of PTX-022. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determined the economic rights related to Novan and Palvella should be characterized as a funded research and development arrangement, thus we account for them in accordance with ASC 730-20, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Arrangement, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and reduce our asset as the funds are expended by Novan and Palvella. As of December 31, 2019, Novan had used up the $12.0 million upfront payment provided by us. As such, our other economic rights related to Novan had been fully amortized as of December 31, 2019. As of December 31, 2020, the fund has been fully expended by Palvella and our cost basis for the asset has been reduced to zero, and therefore we will recognize milestones and royalties as revenue when earned. During 2020, we recorded a $3.0 million milestone from Palvella under contract revenue, which has been included in our consolidated statement of operations for the year ended December 31, 2020.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, we entered into a royalty agreement with Aziyo pursuant to which we will receive royalties from certain marketed products that Aziyo acquired from CorMatrix. Pursuant to the agreement, we received $10.0 million in 2017 from Aziyo to buydown the royalty rates on the products CorMatrix sold to Aziyo. The agreement closed on May 31, 2017, in connection with the closing of the asset sale from CorMatrix to Aziyo (the &#8220;CorMatrix Asset Sale&#8221;). Per the agreement, we will receive a 5% royalty on the products Aziyo acquired in the CorMatrix Asset Sale, reduced from the original 20% royalty from CorMatrix pursuant to the previously disclosed interest purchase agreement, dated May 3, 2016 (the &#8220;Original Interest Purchase Agreement&#8221;) between CorMatrix and us. In addition, Aziyo has agreed to pay us up to $10.0 million of additional milestones tied to cumulative net sales of the products Aziyo acquired in the CorMatrix Asset Sale and to extend the term on these royalties by one year. The royalty agreement will terminate on May 31, 2027. In addition, in May 2017, we entered into an amended and restated interest purchase agreement (the &#8220;Amended Interest Purchase Agreement&#8221;) with CorMatrix, which supersedes in its entirety the Original Interest Purchase Agreement. Other than removing the commercial products sold to Aziyo in the CorMatrix Sale, the terms of the Amended Interest Purchase Agreement remain unchanged with respect to the CorMatrix developmental pipeline products, including the royalty rate of 5% on such pipeline products. The Amended Interest Purchase Agreement will terminate 10 years from the date of the first commercial sale of such products. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for the Aziyo commercial license right as a financial asset in accordance with ASC 310, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Receivables</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and amortize the commercial license right using the effective interest method whereby we forecast expected cash flows over the term of the arrangement to arrive at an annualized effective interest. The annual effective interest associated with the forecasted cash flows from the royalty agreement with Aziyo as of December&#160;31, 2022 is 19.0%. Revenue is calculated by multiplying the carrying value of the commercial license right by the effective interest. The payments received in the year ended December&#160;31, 2022 and 2021 were allocated accordingly between revenue and the amortization of the commercial license rights.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to 2020, we accounted for commercial license rights related to developmental pipeline products such as Selexis and Dianomi on a non-accrual basis. These developmental pipeline products are non-commercialized, non-approved products that require FDA or other regulatory approval, and thus have uncertain cash flows. The developmental pipeline products are on a non-accrual basis as we are not yet able to forecast future cash flows given their pre-commercial stages of development. We will prospectively update the yield model under the effective interest method once the underlying products are commercialized and we can reliably forecast expected cash flows. Income will be calculated by multiplying the carrying value of the commercial license right by the effective interest rate. We regularly perform reviews to determine if any event has occurred that may indicate the carrying value of these commercial license rights are potentially impaired. If the affected commercial license rights are not recoverable, we estimate the fair value of the assets and record an impairment loss if the carrying value of the assets exceeds the fair value. During 2020, given the expected cash flow from the Selexis program, we started to account for the Selexis commercial license right as a financial asset in accordance with ASC 310, and amortize the commercial license right using the effective interest method whereby we forecast expected cash flows over the term of the arrangement to arrive at an annualized effective interest. The annual effective interest associated with the forecasted cash flows from the royalty agreement with Selexis as of December&#160;31, 2022 is 24.6%. Revenue is calculated by multiplying the carrying value of the commercial license right by the effective interest. The payments received in the year ended December&#160;31, 2022 and 2021 were allocated accordingly between revenue and the amortization of the commercial license rights. We still accounted for commercial license rights related to Dianomi on a non-accrual basis as of December&#160;31, 2022.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For commercial license rights, we have elected a prospective approach to account for changes in estimated cash flows and selected a method for determining when an impairment would be recognized and how to measure that impairment. In circumstances where our new estimate of expected cash flows is greater than previously expected, we will update our yield prospectively. In circumstances where our new estimate of expected cash flows is less than previously expected and below our original estimated yield we record an impairment. Impairment is recognized by reducing the financial asset to an amount that represents the present value of our most recent estimate of expected cash flows discounted by the original effective interest rate.&#160;In circumstances where our new estimate of expected cash flows is less than previously expected, but not below our original estimated yield, we update our yield prospectively.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of adopting ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments &#8211; Credit Losses: Measurement of Credit losses on Financial Instruments (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we now recognize an allowance for current expected credit losses on the commercial license rights subject to credit risk. We recorded a $5.5 million pre-tax reserve for credit losses upon adoption of the standard on January 1, </span></div>2020. We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the twelve months ended December 31, 2022 and 2021, we further considered the current and expected future economic and market conditions. We concluded a reduction of $0.3 million and  $0.5 million to the allowance for credit losses in other expense, net, in our consolidated statements of operations for the year ended 2022 and 2021, respectively.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply the following five-step model in accordance with ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in order to determine the revenue: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalties</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive royalty revenue on sales by our partners of products covered by patents that we or our partners own under contractual agreements. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a royalty to be recorded no sooner than the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues are adjusted in the period in which they become known, typically the following quarter. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Captisol Sales</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from Captisol sales is recognized when control of Captisol material or intellectual property license rights is transferred to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. For Captisol material, we consider our performance obligation is satisfied at a point in time, once we have transferred control of the product, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We have elected to recognize the cost of freight and shipping when control over Captisol material has transferred to the customer as an expense in Cost of Captisol. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Revenue</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contracts with customers often will include variable consideration in the form of contingent milestone-based payments. We include contingent milestone based payments in the estimated transaction price when it is probable a significant reversal in the amount of cumulative revenue recognized will not occur. These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone based payment is sales-based, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development based milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon the development milestone or regulatory approval. Depending on the terms of the arrangement, we may also defer a portion of the consideration received if we have to satisfy a future obligation, which typically occurs with our contracts for R&amp;D services.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For R&amp;D services we recognize revenue over time and we measure our progress using an input method. The input methods we use are based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time it will take us to complete the activities, or the costs we may incur in a given </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make numerous estimates and use significant judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We occasionally have sub-license obligations related to arrangements for which we receive license fees, milestones and royalties. We evaluate the determination of gross as a principal versus net as an agent reporting based on each individual agreement.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Revenue</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the terms of the arrangement, we may also defer a portion of the consideration received if we have to satisfy a future obligation.</span></div>The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry a contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expenses</a></td>
<td class="text">Research and Development ExpensesResearch and development expense consists of labor, material, equipment, and allocated facilities costs of our scientific staff who are working pursuant to our collaborative agreements and other research and development projects. Also included in research and development expenses are third-party costs incurred for our research programs including in-licensing costs, contract research organization (CRO) costs and costs incurred by other research and development service vendors. We expense these costs as they are incurred. When we make payments for research and development services prior to the services being rendered, we record those amounts as prepaid assets on our consolidated balance sheet and we expense them as the services are provided.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incur share-based compensation expense related to restricted stock, ESPP, and stock options.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock unit (RSU) and performance stock unit (PSU) are all considered restricted stock. The fair value of restricted stock is determined by the closing market price of our common stock on the date of grant. We recognize share-based compensation expense based on the fair value on a straight-line basis over the requisite service periods of the awards, taking into consideration of forfeitures as they occur. PSU generally represents a right to receive a certain number of shares of common stock based on the achievement of corporate performance goals and continued employment during the vesting period. At each reporting period, we reassess the probability of the achievement of such corporate performance goals and any expense change resulting from an adjustment in the estimated shares to be released are treated as a cumulative catch-up in the period of adjustment. A limited amount of PSUs contain a market condition dependent upon the Company&#8217;s relative and absolute total stockholder return over a three-year period, with a range of 0% to 200% of the target amount granted to be issued under the award. Share-based compensation expense for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the market conditions.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes-Merton option-pricing model is used to estimate the fair value of stock purchases under our ESPP and stock options granted. The model assumptions include expected volatility, term, dividends, and the risk-free interest rate. We look to historical and implied volatility of our stock to determine the expected volatility. The expected term of an award is based on historical forfeiture experience, exercise activity, and on the terms and conditions of the stock awards. The expected dividend yield is determined to be 0% given that except for 2007, during which we declared a cash dividend on our common stock of $2.50 per share, we have not paid any dividends on our common stock in the past and currently do not expect to pay cash dividends or make any other distributions on common stock in the future. The risk-free interest rate is based upon U.S. Treasury securities with remaining terms similar to the expected term of the share-based awards.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We grant options, RSUs and PSUs to employees and non-employee directors. Non-employee directors are accounted for as employees. Options and RSUs granted to certain non-employee directors typically vest one year from the date of grant. Options granted to employees typically vest 1/8 on the six month anniversary of the date of grant, and 1/48 each month thereafter for forty-two months. RSUs and PSUs granted to employees vest over three years. All option awards generally expire ten years from the date of grant.</span></div>Share-based compensation expense for awards to employees and non-employee directors is recognized on a straight-line basis over the vesting period until the last tranche vests.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes is computed using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for the expected future tax benefit to be derived from tax loss and credit carryforwards. Deferred tax assets and liabilities are determined using the enacted tax rates in effect for the years in which those tax assets are expected to be realized. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the provision for income taxes in the period that includes the enactment date. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets are regularly assessed to determine the likelihood they will be recovered from future taxable income. A valuation allowance is established when we believe it is more likely than not the future realization of all or some of a deferred tax asset will not be achieved. In evaluating the ability to recover deferred tax assets within the jurisdiction which they arise we consider all available positive and negative evidence. Factors reviewed include the cumulative pre-tax book income for the past three years, scheduled reversals of deferred tax liabilities, history of earnings and reliable forecasting, projections of pre-tax book income over the foreseeable future, and the impact of any feasible and prudent tax planning strategies.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the impact of a tax position in our financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Tax authorities regularly examine our returns in the jurisdictions in which we do business and we regularly assess the tax risk of our return filing positions. Due to the complexity of some of the uncertainties, the ultimate resolution may result in payments that are materially </span></div>different from our current estimate of the tax liability. These differences, as well as any interest and penalties, will be reflected in the provision for income taxes in the period in which they are determined.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Income (Loss) Per Share</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income (Loss) Per Share</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic income (loss) per share is calculated by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Diluted income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of the Company&#8217;s common stock exceeds the applicable conversion price of the respective notes. It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for stock options and restricted stock. In loss periods, basic net loss per share and diluted net loss per share are identical since the effect of otherwise dilutive potential common shares is anti-dilutive and therefore excluded.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 260, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings per Share</span>, if a company had a discontinuing operation, the company uses income from continuing operations, adjusted for preferred dividends and similar adjustments, as its control number to determine whether potential common shares a dilutive.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Income (Loss)</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) represents net income (loss) adjusted for the change during the periods presented in unrealized gains and losses on available-for-sale debt securities, foreign currency translation adjustments, and reclassification adjustments for realized gains or losses included in net income (loss). The unrealized gains or losses are reported on the Consolidated Statements of Comprehensive Income (Loss).</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The British Pound Sterling was the functional currency of our subsidiary, Vernalis, which was sold in fourth quarter of the year ended December 31, 2020. For the year ended December 31, 2020, the corresponding financial statements have been translated into U.S. Dollars in accordance with ASC 830-30, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Translation of Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Assets and liabilities are translated at end-of-period rates while revenues and expenses are translated at average rates in effect during the period in which the activity took place. Equity is translated at historical rates and the resulting cumulative translation adjustments are included as a component of accumulated other comprehensive income (loss).</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Accounting Standards Updates, Recently Adopted</a></td>
<td class="text">Accounting Standards Updates, Recently Adopted<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2020-06&#8221;). The guidance simplifies the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#8217;s own equity. Consequently, a convertible debt instrument, such as the Company&#8217;s 2023 Notes, will be accounted for as a single liability measured at its amortized cost, if no other features require bifurcation and recognition as derivatives. The new guidance also requires the if-converted method to be applied for all convertible instruments and requires additional disclosures. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We adopted this guidance effective January 1, 2022 under the modified retrospective approach and the comparative information has not been restated and continues to be presented according to accounting standards in effect for those periods. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption and our 2023 Notes are no longer bifurcated into separate liability and equity components. The principal amount of the 2023 Notes is classified as a single liability measured at amortized cost in the consolidated balance sheet for the period ended December 31, 2022. Upon adoption of ASU 2020-06 on January 1, 2022, we recorded an adjustment to the 2023 Notes liability component, deferred tax liabilities, additional paid-in-capital and retained earnings. This adjustment was calculated based on the carrying amount of the 2023 Notes as if it had always been treated as a single liability measured at amortized cost. Furthermore, we recorded an adjustment to the debt issuance costs contra liability and equity (additional paid-in-capital) components under the same premise, as if debt issuance costs had always been treated as a contra liability only. Under this transition method, the cumulative effect of the accounting change increased the carrying amount of the 2023 Notes by $20.4 million, reduced deferred tax liabilities by $4.4 million, reduced additional paid-in capital by $51.1 million and increased retained earnings by $35.1 million. The net balance of the 2023 Notes at January 1, 2022 was $341.1 million which included an unamortized discount of $2.2 million.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Standards Not Yet Adopted</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on our consolidated financial statements or disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Basis Of Presentation And Principles Of Consolidation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessSpinOffAndMigrationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Spin-Off And Migration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessSpinOffAndMigrationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CashCashEquivalentsandShorttermInvestmentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents, and Short-term Investments [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CashCashEquivalentsandShorttermInvestmentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CommercialLicenseRightsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commercial License Rights [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CommercialLicenseRightsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for discontinued operations. Includes, but is not limited to, method of interest allocation to a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section S99<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=26872618&amp;loc=d3e7436-122677<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144439<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e543-108305<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5144-111524<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625568502336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">Schedule of Revenue from Significant Partners</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from significant partners, which is defined as 10% or more of our total revenue, was as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Partner A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Partner B</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Partner C</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&lt;10%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&lt;10%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&lt;10%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_ScheduleofCommercialLicenseRightsTableTextBlock', window );">Schedule of Commercial License Rights</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022 and 2021, commercial license and other economic rights consist of the following (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.338%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.607%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo and CorMatrix</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,538)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,158&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,461)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,235&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis and Dianomi</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,578)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,024&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,727)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18,116)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18,188)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Amounts represent accumulated amortization to principal of $11.6 million and credit loss adjustments of $6.5 million as of December 31, 2022. </span></div>(2) Amounts represent accumulated amortization to principal of $11.7 million and credit loss adjustments of $6.5 million as of December 31, 2021.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Royalty revenue for 2022, 2021 and 2020 for continuing operations are reported as below (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kyprolis</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Teriparatide injection </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rylaze </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,527&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,927&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,796&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents disaggregation of Captisol and contract revenue for continuing operations (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Captisol</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Captisol - Core</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Captisol - COVID</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,066&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,827&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,495&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,250&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,959&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Service Revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;License Fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Milestone</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,223&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,367&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,807&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(a) Captisol - COVID represents revenue on Captisol supplied for use in formulation with remdesivir, an antiviral treatment for COVID-19.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Basic and Diluted Net Income (Loss) per Share</a></td>
<td class="text">The following table presents the calculation of weighted average shares used to calculate basic and diluted income (loss) per share (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:62.189%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.649%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,868&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,630&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,185&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive potential common shares:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used to compute diluted income per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,868&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potentially dilutive shares excluded from calculation due to anti-dilutive effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ScheduleofCommercialLicenseRightsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Commercial License Rights [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ScheduleofCommercialLicenseRightsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6327-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6442-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625572645104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Spin-off of OmniAb (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Schedule of transfers of assets and liabilities to OmniAb</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transfer of assets and liabilities to OmniAb was effected through a contribution in accordance with the Merger Agreement, as summarized below (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.860%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of November 1, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,842&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,861&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">165,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,921&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,290&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">294,476&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY </span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current contingent liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,569&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Deferred revenue   </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current finance lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,762&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,978&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,823&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64,744&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net assets transferred to OmniAb</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">229,732&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The following table summarizes revenue and expenses of the discontinued operations for the years ended December 31, 2022, 2021 and 2020 (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:62.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.370%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.373%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Royalties</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,564&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,589&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,857&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating costs and expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38,466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36,907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">62,696&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60,545&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(36,132)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(24,956)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11,655)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain from short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,210)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,070)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other expense, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss before income tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(35,578)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(24,907)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11,830)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,692&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28,142)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19,215)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,583)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>The following table summarizes the assets and liabilities of the discontinued operations as of December&#160;31, 2021 (in thousands):<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.860%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current assets of discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">174,349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets of discontinued operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">271,883&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">LIABILITIES</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current contingent liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Deferred revenue   </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,342&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current finance lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current liabilities of discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,566&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total liabilities of discontinued operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69,094&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the significant non-cash items, capital expenditures of the discontinued operations, and financing activities that are included in the consolidated statements of cash flows for the years ended December 31, 2022, 2021 and 2020 (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:62.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.370%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.373%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(554)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,553&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,457&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for acquisition, net of cash acquired</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(27,127)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,572)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,070)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,753)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to CVR Holders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(960)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(720)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to CVR Holders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,545)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,050)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,325)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental cash flow disclosures:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment included in accounts payable and accrued expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Schedule of discontinued operations</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transfer of assets and liabilities to OmniAb was effected through a contribution in accordance with the Merger Agreement, as summarized below (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.860%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of November 1, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,842&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,861&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">165,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,921&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,290&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">294,476&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY </span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current contingent liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,569&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Deferred revenue   </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current finance lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,762&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,978&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,823&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64,744&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net assets transferred to OmniAb</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">229,732&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The following table summarizes revenue and expenses of the discontinued operations for the years ended December 31, 2022, 2021 and 2020 (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:62.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.370%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.373%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Royalties</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,564&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,589&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,857&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating costs and expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38,466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36,907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">62,696&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60,545&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(36,132)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(24,956)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11,655)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain from short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,210)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,070)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other expense, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss before income tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(35,578)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(24,907)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11,830)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,692&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28,142)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19,215)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,583)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>The following table summarizes the assets and liabilities of the discontinued operations as of December&#160;31, 2021 (in thousands):<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.860%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current assets of discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">174,349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets of discontinued operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">271,883&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">LIABILITIES</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current contingent liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Deferred revenue   </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,342&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current finance lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current liabilities of discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,566&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total liabilities of discontinued operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69,094&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the significant non-cash items, capital expenditures of the discontinued operations, and financing activities that are included in the consolidated statements of cash flows for the years ended December 31, 2022, 2021 and 2020 (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:62.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.370%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.373%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(554)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,553&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,457&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for acquisition, net of cash acquired</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(27,127)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,572)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,070)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,753)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to CVR Holders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(960)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(720)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to CVR Holders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,545)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,050)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,325)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental cash flow disclosures:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment included in accounts payable and accrued expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625573729104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Allocation of Consideration / Recognized Identified Assets Acquired and Liabilities Assumed</a></td>
<td class="text">The following table sets forth an allocation of the purchase price to the identifiable tangible and intangible assets acquired and liabilities assumed, with the excess recorded to goodwill (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.449%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.351%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts and unbilled receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,814)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,606)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,908)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,070)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,382)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,622)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consideration</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465,098&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>(1) Goodwill represents the excess of the purchase price over the preliminary fair value of the underlying assets acquired and liabilities assumed. Goodwill is attributable to the assembled workforce of experienced personnel at Pfenex and expected synergies. None of the goodwill is deductible for tax purposes.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock', window );">Schedule of Finite-Lived Intangibles Acquired</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intangibles acquired and their weighted average useful life are as follows (in thousands, except useful lives):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate<br/>Fair Value</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated useful life<br/>(in years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual Relationships:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alvogen</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merck</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jazz</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SII</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arcellx</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired Technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-19</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Schedule of Pro Forma Information</a></td>
<td class="text">The pro forma financial information is not necessarily indicative of the operating results that would have occurred had the acquisition been consummated as if the date indicated, nor is it necessarily indicative of future operating results (in thousands, except per share amounts):<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,608&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60,059)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594,941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) per common share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.71)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.71)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625572645104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Schedule of Assets and Liabilities Measured at Fair Value</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the assets and liabilities that are measured at fair value on a recurring basis as of December&#160;31, 2022 and 2021 (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurements at Reporting Date Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Active Markets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">for Identical</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Observable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in Viking common stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,864&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,114&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,615&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent liabilities - Cydex</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent liabilities - Metabasis </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for amounts owed to a former licensor</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,557&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,429&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurements at Reporting Date Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Active Markets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">for Identical</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Observable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in Viking common stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321,586&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,624&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280,553&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent liabilities - Cydex</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent liabilities - Metabasis </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for amounts owed to a former licensor</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,793&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,358&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2) Investment in Viking warrants, which we received as a result of Viking&#8217;s partial repayment of the Viking note receivable and our purchase of Viking common stock and warrants in April 2016, is classified as level 1 as the fair value is determined using quoted market prices in active markets for the same securities. The change of the fair value is recorded in &#8220;gain (loss) from short-term investments&#8221; in our consolidated statement of operations. See further discussion in &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Note (3), Short-term Investments: Investment in Viking.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;  </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3) In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially differ than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#946; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375.0 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10.0 million payment upon initiation of a Phase 3 clinical trial.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Reconciliation of Level 3 Financial Instruments</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the level 3 financial instruments as of December&#160;31, 2022 is as follows (in thousands):</span></div><div style="text-align:center;text-indent:45pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustments to contingent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(265)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of December&#160;31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the level 3 financial instruments as of December&#160;31, 2021 is as follows (in thousands):</span></div><div style="text-align:center;text-indent:45pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to CVR holders and other contingency payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustments to contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,708)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of December&#160;31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2C<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=SL7498348-110258<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625573730464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Schedule of Operating and Finance Lease Assets and Liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating and Finance Lease Assets and Liabilities (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,914&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total lease assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,009&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,411&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzExLTAtMS0xLTExMjY0MA_a1a5fccc-ae24-4f80-98b2-5c22c6e04753"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzExLTAtMS0xLTExMjY0MA_f02bfdd2-8ed4-4dd1-a881-ebd664bece19">Long-term finance lease liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total lease liabilities   </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,056&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,727&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturity of Operating Lease Liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Maturity of Operating and Finance Lease Liabilities as of December&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.391%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.499%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Dates</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,425&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,386&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,380)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,006&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturity of Finance Lease Liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Maturity of Operating and Finance Lease Liabilities as of December&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.391%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.499%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Dates</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,425&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,386&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,380)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,006&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets and Liabilities, Lessee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625573420432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Senior Notes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Equity and Liability Components of the Convertible Senior Notes</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the equity and liability components of the 2023 Notes (in thousands).</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.499%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount of 2023 Notes outstanding</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,854&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount (including unamortized debt issuance cost)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,584)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total long-term portion of notes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,695&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320,717&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of convertible senior notes outstanding (Level 2)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341,801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625569120976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Account Details (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_OtherBalanceSheetDetailsAbstract', window );"><strong>Other Balance Sheet Details [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">Schedule of Investment Categories</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding our investments in Viking, the following table summarizes the various investment categories at December&#160;31, 2022 and 2021 (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.321%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.501%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">gains</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">losses</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">fair value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mutual Funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1050)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,656&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,239)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,778&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,451)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,742&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Mutual fund</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(249)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper  </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,027)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292,225&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,370)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290,697&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Available-for-Sale Debt Securities by Contractual Maturity</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,158&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,036&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,769&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,952&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,805&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock', window );">Schedule of Available-for-Sale Debt Securities in an Unrealized Loss Position</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities in an unrealized loss position (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.772%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12 months or greater</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">947&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,834&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Government Securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,354&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">947&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,301&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank deposits</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,689&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,814&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Government Securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,949&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,674&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,623&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and equipment are stated at cost and consists of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lab and office equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,172&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,417&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,607&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,606&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,482&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,191&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Goodwill and Other Identifiable Intangible Assets</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and identifiable intangible assets consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Complete technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,560)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,916)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,577)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,444)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,670)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,184)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Contractual relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,218)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total goodwill and other identifiable intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">448,128&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482,364&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued liabilities consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,201&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,532&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts owed to former licensees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties owed to third parties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return reserve and customer refunds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subcontractor</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,759&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplier</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,681&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,579&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_ScheduleofContingentLiabilitiesTableTextBlock', window );">Schedule of Contingent Liabilities</a></td>
<td class="text">The following table summarizes roll-forward of contingent liabilities as of December 2022 and 2021 (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"><tr><td style="width:1.0%"/><td style="width:20.985%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.562%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.176%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.949%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.176%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.566%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Payments</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair Value Adjustment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Payments</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair Value Adjustment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Repurchases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cydex</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(265)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(464)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pfenex</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(37,600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">41,929</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(50)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(38,172)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,707</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(194)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,513</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_OtherBalanceSheetDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Balance Sheet Details [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_OtherBalanceSheetDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ScheduleofContingentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Contingent Liabilities [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ScheduleofContingentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625572163344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Schedule of Share-Based Compensation Expense</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes share-based compensation expense from continuing operations (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.869%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense as a component of:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,612&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,881&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,326&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,125&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Plan Activity</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following is a summary of our stock option plan activity and related information:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:49.120%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.244%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Price</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Remaining</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contractual</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Term in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intrinsic</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January&#160;1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,956,379&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.45</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,002&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">806,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(156,845)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,012)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,561,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.09</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December&#160;31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,611,830&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.54</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest as of December&#160;31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,561,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.09</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">393,589&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(619,731)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136,082)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021 </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,199,598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.34</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December&#160;31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,391,952&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest as of December&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,199,598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.34</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863,245&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,941)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,069)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at October 31, 2022 </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,987,833&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at October 31, 2022 </span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,769,629&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,722&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest as of October 31, 2022, before Separation and Regrant</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,987,833&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation due to Separation, Before Regrant</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,987,833)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at November 1, 2022, Before Regrant</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,584,760&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50,449)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(542,838)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,991,473&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.07</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,559,662&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.51</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest as of December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,991,473&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.07</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(1) Options granted primarily relate to the modifications in connection with the Separation which resulted in new stock option grants at the modification date fair value.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Schedule of Stock Option Plan Activity by Exercise Price Range</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following is a further breakdown of the options outstanding as of December&#160;31, 2022:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.040%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.057%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.057%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.057%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.057%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.212%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Range of exercise prices</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">outstanding</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">remaining&#160; life</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">in&#160;years</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">exercise price</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">exercisable</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">exercise&#160;price</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$12.78-$43.36</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395,660&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.32</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.76&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366,426&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.44&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$46.20-$52.78</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.63</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,734&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$52.84-$52.84</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580,629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.59</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$54.81-$57.22</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391,280&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.47</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$58.28-$67.03</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.78</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274,719&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$67.24-$69.70</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403,187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.93</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$70.04-$93.12</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.56</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$99.80-$99.80</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.84</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$103.42-$103.42</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.26</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$114.15-$114.15</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.47</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,991,473&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.07</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,559,662&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Stock Option Weighted-Average Assumptions</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assumptions used for the specified reporting periods and the resulting estimates of weighted-average grant date fair value per share of options granted:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.701%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.227%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.227%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4%-4.3%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4%-1.2%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2%-1.4%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49%-55%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47%-63%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47%-71%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 to 6.5 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7 to 6.3 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7 to 5.1 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Restricted Stock Activity</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our restricted stock activity and related information:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:69.721%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.416%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.830%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Grant&#160;Date Fair</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52,363)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206,202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,292&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98,501)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,850)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260,577&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138,867)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,383)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at October 31, 2022, before Separation and Regrant</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366,470&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited due to Separation, Before Regrant</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(366,470)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at November 1, 2022, Before Regrant</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424,473&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73,385)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,635)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348,453&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_ScheduleofContingentLiabilitiesTableTextBlock', window );">Schedule of Contingent Liabilities</a></td>
<td class="text">The following table summarizes roll-forward of contingent liabilities as of December 2022 and 2021 (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"><tr><td style="width:1.0%"/><td style="width:20.985%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.562%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.176%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.949%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.176%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.566%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Payments</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair Value Adjustment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Payments</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair Value Adjustment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Repurchases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cydex</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(265)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(464)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pfenex</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(37,600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">41,929</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(50)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(38,172)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,707</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(194)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,513</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ScheduleofContingentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Contingent Liabilities [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ScheduleofContingentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625572636624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Benefit</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the income tax expense (benefit) for continuing operations are as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:66.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.092%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.833%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.092%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.686%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.094%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current expense (benefit):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,742&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">438&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,384&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred expense (benefit):</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,656)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,901)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,456)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,685)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,234)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,488&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,586)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,690)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax expense (benefit)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,230&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,148)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,306)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of income tax expense (benefit) from continuing operations to the amount computed by applying the statutory federal income tax rate to the net income (loss) from continuing operations is summarized as follows (in thousands):</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:66.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.047%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.047%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.048%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax at federal statutory rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,562&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,231)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FDII</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,395)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(637)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,652)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate change for changes in federal, foreign or state law</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(535)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,963)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(673)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale of Vernalis R&amp;D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,993)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(266)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax differential on income/loss of foreign subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,839)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,628)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subpart F income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,080)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(623)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision to return adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,347)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,920)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Officer compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,410&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,799&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121,864)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,823)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,230&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,148)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,306)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text">Deferred tax assets <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(liabilities) are comprised of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.807%"><tr><td style="width:1.0%"/><td style="width:76.478%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.662%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.813%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,908&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,969&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance for deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,472)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,931)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,497&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,180&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:13pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identified intangibles</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,696)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66,848)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,886)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,459)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75,582)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,307)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:13pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,085)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,873&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock', window );">Schedule of Unrecognized Tax Benefits</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the amount of unrecognized tax benefits at December&#160;31, 2022, 2021 and 2020 is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,550&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,619&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,647&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Additions based on tax positions related to the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Additions for tax positions of prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Reductions for tax positions of prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(512)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,072)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(954)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,096&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,550&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,619&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits, excluding amounts pertaining to examined tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625573315312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Selected Quarterly Financial Data (Unaudited) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock', window );">Schedule of Quarterly Financial Information</a></td>
<td class="text">The operating results for any quarter are not necessarily indicative of results for any future period.<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.832%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.313%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.313%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.313%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.313%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.316%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except per share data)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36,516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50,126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50,382&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">196,245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,086&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41,464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46,880&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">193,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12,929)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,645&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14,534)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,219)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss from discontinued operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,456)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13,494)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,241)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,951)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28,142)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(15,385)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(895)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17,485)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(33,361)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic net income (loss) from continuing operations per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.86)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic net loss from discontinued operations per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.80)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.67)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted net income (loss) from continuing operations per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.86)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted net loss from discontinued operations per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.79)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.67)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares used in the computation of basic  net income (loss) per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,888&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares used in the computation of diluted  net income (loss) per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,058&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.832%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.313%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.313%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.313%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.313%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.316%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except per share data)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">78,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59,694&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56,404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">241,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,482&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,967&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46,790&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41,280&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,767&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36,442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,194)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76,353&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss from discontinued operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,660)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,717)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,615)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,223)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19,215)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,725&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,417)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57,138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic net income (loss) from continuing operations per share </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic net loss from discontinued operations per share </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted net income (loss) from continuing operations per share </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted net loss from discontinued operations per share </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares used in the computation of basic net income (loss) per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares used in the computation of diluted net income (loss) per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126900988&amp;loc=d3e1280-108306<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625556372960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2007 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Oct. 01, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2010 </div>
<div>right</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of business segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_MaturityPeriodOfHighlyLiquidSecuritiesMaximum', window );">Maturity period of cash and cash equivalents, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Write-downs related to obsolete inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,294,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,326,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,294,000<span></span>
</td>
<td class="nump">27,326,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,382,000<span></span>
</td>
<td class="nump">$ 59,221,000<span></span>
</td>
<td class="nump">$ 50,126,000<span></span>
</td>
<td class="nump">$ 36,516,000<span></span>
</td>
<td class="nump">56,404,000<span></span>
</td>
<td class="nump">$ 59,694,000<span></span>
</td>
<td class="nump">$ 78,854,000<span></span>
</td>
<td class="nump">$ 46,592,000<span></span>
</td>
<td class="nump">196,245,000<span></span>
</td>
<td class="nump">241,544,000<span></span>
</td>
<td class="nump">163,562,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments', window );">Credit loss adjustments on finite-lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,500,000)<span></span>
</td>
<td class="num">(6,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AccountsReceivableCreditLossExpenseReversalCOVID19', window );">Additional reserve for credit losses due to COVID-19</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="nump">23,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividend declared (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Decrease of deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30,615,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30,856,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30,615,000)<span></span>
</td>
<td class="num">(30,856,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Decrease (increase) in stockholder's equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(597,485,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(821,159,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(597,485,000)<span></span>
</td>
<td class="num">(821,159,000)<span></span>
</td>
<td class="num">(709,525,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (767,232,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Decrease (increase) in stockholder's equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(147,590,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(372,969,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(147,590,000)<span></span>
</td>
<td class="num">(372,969,000)<span></span>
</td>
<td class="num">(318,358,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(367,326,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retain earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Decrease (increase) in stockholder's equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(450,862,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(449,090,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(450,862,000)<span></span>
</td>
<td class="num">(449,090,000)<span></span>
</td>
<td class="num">(391,952,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(400,105,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Decrease (increase) in stockholder's equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,997,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,997,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,168,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Decrease (increase) in stockholder's equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,130,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,130,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Retain earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Decrease (increase) in stockholder's equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35,133,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35,133,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,168,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember', window );">Cumulative Effect, Period of Adoption, Adjusted Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Increase in carrying amount of notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(341,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(341,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Unamortized discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member', window );">Accounting Standards Update 2020-06 | Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Increase in carrying amount of notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Decrease of deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member', window );">Accounting Standards Update 2020-06 | Cumulative Effect, Period of Adoption, Adjustment | Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Decrease (increase) in stockholder's equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member', window );">Accounting Standards Update 2020-06 | Cumulative Effect, Period of Adoption, Adjustment | Retain earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Decrease (increase) in stockholder's equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember', window );">Contract revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,223,000<span></span>
</td>
<td class="nump">28,367,000<span></span>
</td>
<td class="nump">19,807,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember', window );">Captisol</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,900,000<span></span>
</td>
<td class="nump">24,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 104,495,000<span></span>
</td>
<td class="nump">164,250,000<span></span>
</td>
<td class="nump">109,959,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options | 2002 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Award expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options | Vest 1/8 on the six month anniversary of the date of grant | 2002 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting right (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options | Vest 1/48 each month for forty-two months | 2002 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">42 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting right (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.08%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=lgnd_RestrictedStockUnitsAndPerformanceSharesMember', window );">RSUs and PSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">PSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | PSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting right (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | PSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting right (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Pfenex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityAmountPerShare', window );">Contingent consideration liability per share (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 77,800,000<span></span>
</td>
<td class="nump">$ 77,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_MetabasisTherapeuticsMember', window );">Metabasis Therapeutics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_NumberOfContingentValueRightsIssued', window );">Number of contingent value rights | right</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_RoyaltyAgreementsMember', window );">Royalty Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_ProductRoyaltyPercentage', window );">Product royalty (as a percent)</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Licensing Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,182,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,182,000<span></span>
</td>
<td class="nump">$ 10,110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Licensing Agreements | Accounting Standards Update 2016-13</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments', window );">Credit loss adjustments on finite-lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (5,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=lgnd_NovanMolluscumProductsMember', window );">Novan | Royalty Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AdditionalRoyaltiesReceivableUnderSalesbasedMilestones', window );">Additional royalties receivable under sales-based milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=lgnd_NovanMolluscumProductsMember', window );">Novan | Royalty Agreements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_ProductRoyaltyPercentage', window );">Product royalty (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=lgnd_NovanMolluscumProductsMember', window );">Novan | Royalty Agreements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_ProductRoyaltyPercentage', window );">Product royalty (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=lgnd_NovanMolluscumProductsMember', window );">Novan | Licensing Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_LicenseUpfrontPayment', window );">Upfront payment for license</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=lgnd_PalvellaTherapeuticsIncMember', window );">Palvella | Contract revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=lgnd_PalvellaTherapeuticsIncMember', window );">Palvella | Royalty Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AdditionalRoyaltiesReceivableUnderSalesbasedMilestones', window );">Additional royalties receivable under sales-based milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=lgnd_PalvellaTherapeuticsIncMember', window );">Palvella | Royalty Agreements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_ProductRoyaltyPercentage', window );">Product royalty (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=lgnd_PalvellaTherapeuticsIncMember', window );">Palvella | Royalty Agreements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_ProductRoyaltyPercentage', window );">Product royalty (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=lgnd_PalvellaTherapeuticsIncMember', window );">Palvella | Licensing Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_LicenseUpfrontPayment', window );">Upfront payment for license</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=lgnd_AziyoMember', window );">Aziyo | Royalty Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_ProductRoyaltyPercentage', window );">Product royalty (as a percent)</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRoyaltiesReceived', window );">Proceeds from royalties received</a></td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent', window );">Effective interest rate of forecasted cash flows (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=lgnd_AziyoMember', window );">Aziyo | Royalty Agreements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AdditionalRoyaltiesReceivableUnderSalesbasedMilestones', window );">Additional royalties receivable under sales-based milestones</a></td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=lgnd_CorMatrixMember', window );">CorMatrix | Royalty Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_ProductRoyaltyPercentage', window );">Product royalty (as a percent)</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_RoyaltyAgreementExpirationPeriod', window );">Expiration period of royalty agreement</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=lgnd_SelexisMember', window );">Selexis | Royalty Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent', window );">Effective interest rate of forecasted cash flows (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiMeasurementInput', window );">Measurement input (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AccountsReceivableCreditLossExpenseReversalCOVID19">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Credit Loss Expense (Reversal), COVID-19</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AccountsReceivableCreditLossExpenseReversalCOVID19</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AdditionalRoyaltiesReceivableUnderSalesbasedMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional Royalties Receivable Under Sales-based Milestones</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AdditionalRoyaltiesReceivableUnderSalesbasedMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BasisOfPresentationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Basis of presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BasisOfPresentationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationContingentConsiderationLiabilityAmountPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability, Amount per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationContingentConsiderationLiabilityAmountPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite-lived Intangible Assets, Credit Loss Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Forecasted Cash Flows, Effective Interest Rate, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ForecastedCashFlowsEffectiveInterestRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LicenseUpfrontPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License Upfront Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LicenseUpfrontPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_MaturityPeriodOfHighlyLiquidSecuritiesMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maturity period of highly liquid securities maximum.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_MaturityPeriodOfHighlyLiquidSecuritiesMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NumberOfContingentValueRightsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Contingent Value Rights Issued</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NumberOfContingentValueRightsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ProductRoyaltyPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Product Royalty Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ProductRoyaltyPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_RoyaltyAgreementExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty Agreement, Expiration Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_RoyaltyAgreementExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount (premium).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28567-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRoyaltiesReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received for royalties during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRoyaltiesReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_ContractRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lgnd_TwoThousandTwoStockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lgnd_TwoThousandTwoStockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=lgnd_VestingPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=lgnd_VestingPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=lgnd_VestingPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=lgnd_VestingPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=lgnd_RestrictedStockUnitsAndPerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=lgnd_RestrictedStockUnitsAndPerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_MetabasisTherapeuticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_MetabasisTherapeuticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_RoyaltyAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_RoyaltyAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=lgnd_NovanMolluscumProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=lgnd_NovanMolluscumProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=lgnd_PalvellaTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=lgnd_PalvellaTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=lgnd_AziyoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=lgnd_AziyoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=lgnd_CorMatrixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=lgnd_CorMatrixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=lgnd_SelexisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=lgnd_SelexisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625571812768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Revenue from Significant Partners (Details) - Customer Concentration Risk - Revenue<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Partner A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Total revenues (as a percent)</a></td>
<td class="nump">45.00%<span></span>
</td>
<td class="nump">47.00%<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Partner B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Total revenues (as a percent)</a></td>
<td class="nump">16.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Partner C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Total revenues (as a percent)</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideRevenueMajorCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideRevenueMajorCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=lgnd_PartnerAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=lgnd_PartnerAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=lgnd_PartnerBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=lgnd_PartnerBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=lgnd_PartnerCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=lgnd_PartnerCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625569064464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Commercial License Rights (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization on finite-lived intangible assets</a></td>
<td class="num">$ (11,600)<span></span>
</td>
<td class="num">$ (11,700)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments', window );">Credit loss adjustments on finite-lived intangible assets</a></td>
<td class="nump">6,500<span></span>
</td>
<td class="nump">6,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Licensing Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross</a></td>
<td class="nump">28,298<span></span>
</td>
<td class="nump">28,298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments', window );">Adjustments</a></td>
<td class="num">(18,116)<span></span>
</td>
<td class="num">(18,188)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">10,182<span></span>
</td>
<td class="nump">10,110<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Licensing Agreements | Aziyo and CorMatrix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross</a></td>
<td class="nump">17,696<span></span>
</td>
<td class="nump">17,696<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments', window );">Adjustments</a></td>
<td class="num">(9,538)<span></span>
</td>
<td class="num">(9,461)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">8,158<span></span>
</td>
<td class="nump">8,235<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Licensing Agreements | Selexis and Dianomi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross</a></td>
<td class="nump">10,602<span></span>
</td>
<td class="nump">10,602<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments', window );">Adjustments</a></td>
<td class="num">(8,578)<span></span>
</td>
<td class="num">(8,727)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 2,024<span></span>
</td>
<td class="nump">$ 1,875<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Assets, Accumulated Amortization, Research &amp; Development Expense, and Credit Loss Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite-lived Intangible Assets, Credit Loss Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=lgnd_AziyoandCorMatrixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=lgnd_AziyoandCorMatrixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=lgnd_SelexisAndDianomiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=lgnd_SelexisAndDianomiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625575082976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Royalty Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 50,382<span></span>
</td>
<td class="nump">$ 59,221<span></span>
</td>
<td class="nump">$ 50,126<span></span>
</td>
<td class="nump">$ 36,516<span></span>
</td>
<td class="nump">$ 56,404<span></span>
</td>
<td class="nump">$ 59,694<span></span>
</td>
<td class="nump">$ 78,854<span></span>
</td>
<td class="nump">$ 46,592<span></span>
</td>
<td class="nump">$ 196,245<span></span>
</td>
<td class="nump">$ 241,544<span></span>
</td>
<td class="nump">$ 163,562<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,527<span></span>
</td>
<td class="nump">48,927<span></span>
</td>
<td class="nump">33,796<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_RoyaltyKyprolisMember', window );">Kyprolis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,116<span></span>
</td>
<td class="nump">27,472<span></span>
</td>
<td class="nump">25,164<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_RoyaltyEvomelaMember', window );">Evomela</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,197<span></span>
</td>
<td class="nump">10,079<span></span>
</td>
<td class="nump">6,377<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_RoyaltyTeriparatideInjectionMember', window );">Teriparatide injection</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,785<span></span>
</td>
<td class="nump">5,260<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_RoyaltyRylazeMember', window );">Rylaze</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,796<span></span>
</td>
<td class="nump">2,420<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_RoyaltyOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,633<span></span>
</td>
<td class="nump">3,696<span></span>
</td>
<td class="nump">2,255<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember', window );">Captisol</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104,495<span></span>
</td>
<td class="nump">164,250<span></span>
</td>
<td class="nump">109,959<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCoreMember', window );">Captisol - Core</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,429<span></span>
</td>
<td class="nump">23,423<span></span>
</td>
<td class="nump">24,566<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCOVIDMember', window );">Captisol - COVID</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88,066<span></span>
</td>
<td class="nump">140,827<span></span>
</td>
<td class="nump">85,393<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember', window );">Contract revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,223<span></span>
</td>
<td class="nump">28,367<span></span>
</td>
<td class="nump">19,807<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,117<span></span>
</td>
<td class="nump">3,737<span></span>
</td>
<td class="nump">9,330<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMember', window );">License Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,849<span></span>
</td>
<td class="nump">634<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MilestoneMember', window );">Milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,150<span></span>
</td>
<td class="nump">17,584<span></span>
</td>
<td class="nump">5,217<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMilestonesAndOtherProductOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,107<span></span>
</td>
<td class="nump">$ 6,412<span></span>
</td>
<td class="nump">$ 5,141<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_RoyaltyKyprolisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_RoyaltyKyprolisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_RoyaltyEvomelaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_RoyaltyEvomelaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_RoyaltyTeriparatideInjectionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_RoyaltyTeriparatideInjectionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_RoyaltyRylazeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_RoyaltyRylazeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_RoyaltyOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_RoyaltyOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCoreMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCoreMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCOVIDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCOVIDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_ContractRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_LicenseFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMilestonesAndOtherProductOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_LicenseFeesMilestonesAndOtherProductOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625568384864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Calculation of Earnings per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedLineItems', window );"><strong>Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares outstanding - basic (shares)</a></td>
<td class="nump">16,890,000<span></span>
</td>
<td class="nump">16,888,000<span></span>
</td>
<td class="nump">16,868,000<span></span>
</td>
<td class="nump">16,824,000<span></span>
</td>
<td class="nump">16,733,000<span></span>
</td>
<td class="nump">16,688,000<span></span>
</td>
<td class="nump">16,659,000<span></span>
</td>
<td class="nump">16,435,000<span></span>
</td>
<td class="nump">16,868,000<span></span>
</td>
<td class="nump">16,630,000<span></span>
</td>
<td class="nump">16,185,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used to compute diluted income per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,733,000<span></span>
</td>
<td class="nump">17,142,000<span></span>
</td>
<td class="nump">17,172,000<span></span>
</td>
<td class="nump">17,248,000<span></span>
</td>
<td class="nump">16,868,000<span></span>
</td>
<td class="nump">17,246,000<span></span>
</td>
<td class="nump">16,825,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive shares excluded from calculation due to anti-dilutive effect (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,241,000<span></span>
</td>
<td class="nump">4,793,000<span></span>
</td>
<td class="nump">8,458,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedLineItems', window );"><strong>Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Dilutive potential common shares (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">96,000<span></span>
</td>
<td class="nump">56,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedLineItems', window );"><strong>Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Dilutive potential common shares (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">520,000<span></span>
</td>
<td class="nump">584,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625568382400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Spin-off of OmniAb - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 01, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Oct. 26, 2022</div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 105,673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 105,673<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_LigandCoreBusinessMember', window );">Ligand Core Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 105,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember', window );">Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent', window );">Intangible assets, net</a></td>
<td class="nump">$ 75,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,533<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Percentage Of Voting Interests Disposed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as goodwill attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2510-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_LigandCoreBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lgnd_LigandCoreBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625575027056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Spin-off of OmniAb - Schedule of transfers of assets and liabilities to OmniAb (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Nov. 01, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Total current assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Current liabilities of discontinued operations</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,566<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember', window );">Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets', window );">Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Total current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent', window );">Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">165,422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">174,349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,533<span></span>
</td>
<td class="nump">$ 75,500<span></span>
</td>
<td class="nump">75,533<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,921<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,320<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsOperatingLeaseAssets', window );">Operating lease assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,332<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsFinanceLeaseAssets', window );">Finance lease assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">243<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">294,476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271,883<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesCurrent', window );">Current contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,538<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,342<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent', window );">Current operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">685<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilitiesCurrent', window );">Current finance lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Current liabilities of discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,762<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,566<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesNoncurrent', window );">Long-term contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,826<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities', window );">Deferred income taxes, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,239<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesOperatingLeaseNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,238<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities', window );">Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,225<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69,094<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DisposalGroupIncludingDiscontinuedOperationNetAssetsTransferred', window );">Net assets transferred to OmniAb</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 229,732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsFinanceLeaseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Assets, Finance Lease Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsFinanceLeaseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsOperatingLeaseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Assets, Operating Lease Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsOperatingLeaseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Contingent Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>"Disposal Group, Including Discontinued Operation, Contingent Liabilities, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Finance Lease Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesOperatingLeaseNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Liabilities, Operating Lease, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesOperatingLeaseNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DisposalGroupIncludingDiscontinuedOperationNetAssetsTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Net Assets Transferred</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DisposalGroupIncludingDiscontinuedOperationNetAssetsTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Operating Lease Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as deferred revenue attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as deferred tax liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as goodwill attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2510-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2510-110228<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2510-110228<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2510-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2510-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625569144304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Spin-off of OmniAb - Schedule of revenue and expenses of the discontinued operations (Details) - Discontinued Operations - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue', window );">Total revenues</a></td>
<td class="nump">$ 26,564<span></span>
</td>
<td class="nump">$ 35,589<span></span>
</td>
<td class="nump">$ 22,857<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract', window );"><strong>Operating costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization', window );">Amortization of intangibles</a></td>
<td class="nump">10,847<span></span>
</td>
<td class="nump">12,945<span></span>
</td>
<td class="nump">11,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment', window );">Research and development</a></td>
<td class="nump">38,466<span></span>
</td>
<td class="nump">36,907<span></span>
</td>
<td class="nump">18,889<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">13,383<span></span>
</td>
<td class="nump">10,693<span></span>
</td>
<td class="nump">3,823<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense', window );">Total operating costs and expenses</a></td>
<td class="nump">62,696<span></span>
</td>
<td class="nump">60,545<span></span>
</td>
<td class="nump">34,512<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(36,132)<span></span>
</td>
<td class="num">(24,956)<span></span>
</td>
<td class="num">(11,655)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments', window );">Gain from short-term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,266<span></span>
</td>
<td class="nump">1,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense', window );">Interest expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">554<span></span>
</td>
<td class="num">(1,210)<span></span>
</td>
<td class="num">(2,070)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense', window );">Total other expense, net</a></td>
<td class="nump">554<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="num">(175)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax', window );">Loss before income tax</a></td>
<td class="num">(35,578)<span></span>
</td>
<td class="num">(24,907)<span></span>
</td>
<td class="num">(11,830)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation', window );">Income tax benefit</a></td>
<td class="nump">7,436<span></span>
</td>
<td class="nump">5,692<span></span>
</td>
<td class="nump">2,247<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Net loss</a></td>
<td class="num">(28,142)<span></span>
</td>
<td class="num">(19,215)<span></span>
</td>
<td class="num">(9,583)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember', window );">Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue', window );">Total revenues</a></td>
<td class="nump">1,289<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember', window );">Contract revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue', window );">Total revenues</a></td>
<td class="nump">$ 25,275<span></span>
</td>
<td class="nump">$ 35,589<span></span>
</td>
<td class="nump">$ 22,857<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Browse Taxonomy Disposal Group, Including Discontinued Operation, Other Income (Expense)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Gain (Loss) On Short-Term Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Nonoperating Income (Expense)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Operating Costs and Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Other Income (Expense)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Research and Development</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of depreciation and amortization expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of general and administrative expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section S99<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=26872618&amp;loc=d3e7436-122677<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1063-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1060-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_ContractRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625577645520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Spin-off of OmniAb - Schedule of non-cash items and capital expenditures of the discontinued operations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity', window );">Payments to CVR Holders</a></td>
<td class="num">$ (1,545)<span></span>
</td>
<td class="num">$ (1,050)<span></span>
</td>
<td class="num">$ (2,325)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember', window );">Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract', window );"><strong>Operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration', window );">Change in fair value of contingent consideration</a></td>
<td class="num">(554)<span></span>
</td>
<td class="nump">1,210<span></span>
</td>
<td class="nump">2,070<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationDiscontinuedOperations', window );">Depreciation and amortization</a></td>
<td class="nump">13,218<span></span>
</td>
<td class="nump">14,553<span></span>
</td>
<td class="nump">12,503<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">9,404<span></span>
</td>
<td class="nump">9,457<span></span>
</td>
<td class="nump">5,602<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivesAbstract', window );"><strong>Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid for acquisition, net of cash acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(27,127)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpenditureDiscontinuedOperations', window );">Purchase of property, plant and equipment</a></td>
<td class="num">(5,572)<span></span>
</td>
<td class="num">(4,070)<span></span>
</td>
<td class="num">(1,753)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_PaymentsToContingentValueRightHoldersInvestingActivity', window );">Payments to CVR Holders</a></td>
<td class="num">(960)<span></span>
</td>
<td class="num">(720)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity', window );">Payments to CVR Holders</a></td>
<td class="num">(1,545)<span></span>
</td>
<td class="num">(1,050)<span></span>
</td>
<td class="num">(2,325)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental cash flow disclosures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid', window );">Purchases of property, plant and equipment included in accounts payable and accrued expenses</a></td>
<td class="nump">$ 2,310<span></span>
</td>
<td class="nump">$ 1,231<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Change in Amount of Contingent Consideration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Financing Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Payments to Acquire Businesses, Net of Cash Acquired</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Share-Based Payment Arrangement, Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operations, Capital Expenditures Incurred but Not yet Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Cash Provided by (Used in) Discontinued Operations, Investing Actives</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Cash Provided by (Used in) Discontinued Operations, Operating Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments to Contingent Value Right Holders, Financing Activity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsToContingentValueRightHoldersFinancingActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsToContingentValueRightHoldersInvestingActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments to Contingent Value Right Holders, Investing Activity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsToContingentValueRightHoldersInvestingActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpenditureDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of capital expenditure attributable to discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpenditureDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortizationDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deprecation and amortization expense attributable to property, plant and equipment and intangible assets of discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortizationDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625569032512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-term Investments: Investment in Viking - Narrative (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investment in Viking common stock</a></td>
<td class="nump">$ 63.1<span></span>
</td>
<td class="nump">$ 30.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=lgnd_VikingTherapeuticsInc.Member', window );">Viking Therapeutics, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest', window );">Ownership interest (as a percent)</a></td>
<td class="nump">8.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_NumberOfSharesSoldOfEquityMethodInvestee', window );">Stock sold of equity method investee (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NumberOfSharesSoldOfEquityMethodInvestee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Shares Sold Of Equity Method Investee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NumberOfSharesSoldOfEquityMethodInvestee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage investment held by members or limited partners of limited liability company (LLC) or limited partnership (LP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 272<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6373374&amp;loc=d3e70478-108055<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=lgnd_VikingTherapeuticsInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=lgnd_VikingTherapeuticsInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625575189168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1">36 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 01, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>acquisition</div>
</th>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_NumberOfAcquisitions', window );">Number of acquisitions | acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList', window );">Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Other Nonoperating Income (Expense)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Pfenex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="nump">$ 465.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash consideration</a></td>
<td class="nump">429.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability</a></td>
<td class="nump">77.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 77.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure', window );">Fair value of contingent earn-out payment</a></td>
<td class="nump">37.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Post-combination expense</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Reduction in contingent liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions', window );">Gross payments to acquire business attributable to vested portion of stock options</a></td>
<td class="nump">17.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards', window );">Cash to settle unvested stock options recognized as share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition-related costs</a></td>
<td class="nump">$ 20.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual', window );">Revenue of acquiree since acquisition date included in comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual', window );">Income before income taxes of acquiree since acquisition date included in comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Integration related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.1<span></span>
</td>
<td class="nump">$ 4.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Pfenex | Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration liability, measurement input (as a percent)</a></td>
<td class="nump">0.071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Pfenex | Customer Relationships | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate', window );">Discount rate used to value intangible assets acquired (as a percent)</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Pfenex | Customer Relationships | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate', window );">Discount rate used to value intangible assets acquired (as a percent)</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability, Fair Value Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Discount Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NumberOfAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NumberOfAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments to Acquire Businesses, Gross, Attributable to Vested Portion of Stock Options</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate cash paid by the entity during the period to settle equity instruments granted under equity-based payment arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (k)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement in which net income is reported that includes gain (loss) from liability measured at fair value using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625571237984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions - Assets Acquired and Liabilities Assumed (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Oct. 01, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 105,673<span></span>
</td>
<td class="nump">$ 105,673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Pfenex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,407<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash', window );">Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts and unbilled receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,359<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,823<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets', window );">Right-of-use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,070<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,338<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets', window );">Intangibles acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">385,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,814)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,606)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,908)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,070)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,382)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liabilities, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(42,622)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 465,098<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restricted Cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625571445936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions - Intangibles Acquired and Weighted Average Useful Life (Details) - Pfenex<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Oct. 01, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Approximate Fair Value</a></td>
<td class="nump">$ 385,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Contractual Relationships - Alvogen</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Approximate Fair Value</a></td>
<td class="nump">$ 114,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Estimated useful life (in years)</a></td>
<td class="text">12 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Contractual Relationships - Merck</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Approximate Fair Value</a></td>
<td class="nump">$ 117,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Estimated useful life (in years)</a></td>
<td class="text">12 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Contractual Relationships - Jazz</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Approximate Fair Value</a></td>
<td class="nump">$ 80,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Estimated useful life (in years)</a></td>
<td class="text">17 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Contractual Relationships - SII</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Approximate Fair Value</a></td>
<td class="nump">$ 49,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Estimated useful life (in years)</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Contractual Relationships - Arcellx</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Approximate Fair Value</a></td>
<td class="nump">$ 2,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Estimated useful life (in years)</a></td>
<td class="text">17 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Acquired Technologies</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Approximate Fair Value</a></td>
<td class="nump">$ 23,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Minimum | Acquired Technologies</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Estimated useful life (in years)</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Maximum | Acquired Technologies</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Estimated useful life (in years)</a></td>
<td class="text">19 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lgnd_ContractualRelationshipsAlvogenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lgnd_ContractualRelationshipsAlvogenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lgnd_ContractualRelationshipsMerckMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lgnd_ContractualRelationshipsMerckMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lgnd_ContractualRelationshipsJazzMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lgnd_ContractualRelationshipsJazzMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lgnd_ContractualRelationshipsSIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lgnd_ContractualRelationshipsSIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lgnd_ContractualRelationshipsArcellxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lgnd_ContractualRelationshipsArcellxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625575011152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Pro Forma Financial Information (Details) - Pfenex - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenue</a></td>
<td class="nump">$ 189,203<span></span>
</td>
<td class="nump">$ 170,608<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net Income (loss)</a></td>
<td class="num">$ (60,059)<span></span>
</td>
<td class="nump">$ 594,941<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareProFormaAbstract', window );"><strong>Net income (loss) per common share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic', window );">Basic (USD per share)</a></td>
<td class="num">$ (3.71)<span></span>
</td>
<td class="nump">$ 31.32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted', window );">Diluted (USD per share)</a></td>
<td class="num">$ (3.71)<span></span>
</td>
<td class="nump">$ 30.11<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareProFormaAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareProFormaAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625568831472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurement - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2010 </div>
<div>USD ($) </div>
<div>agreement</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_NumberOfContingentValueRightAgreements', window );">Number of CVR agreements | agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember', window );">Transferred over Time | Phase 3 Clinical Trial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetGross', window );">Gross contract asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Transferred over Time | Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 375,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="nump">$ 166,864,000<span></span>
</td>
<td class="nump">$ 321,586,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="nump">3,557,000<span></span>
</td>
<td class="nump">3,793,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Contingent liabilities - CyDex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="nump">84,000<span></span>
</td>
<td class="nump">349,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Contingent liabilities - Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="nump">3,429,000<span></span>
</td>
<td class="nump">3,358,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Liability for restricted investments owed to former licensees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="nump">44,000<span></span>
</td>
<td class="nump">86,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="nump">103,742,000<span></span>
</td>
<td class="nump">290,697,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Investment in Viking common stock (2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="nump">63,122,000<span></span>
</td>
<td class="nump">30,889,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="nump">67,114,000<span></span>
</td>
<td class="nump">40,624,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="nump">44,000<span></span>
</td>
<td class="nump">86,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Contingent liabilities - CyDex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Contingent liabilities - Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Liability for restricted investments owed to former licensees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="nump">44,000<span></span>
</td>
<td class="nump">86,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="nump">3,992,000<span></span>
</td>
<td class="nump">9,735,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Investment in Viking common stock (2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="nump">63,122,000<span></span>
</td>
<td class="nump">30,889,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Significant Other Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="nump">99,615,000<span></span>
</td>
<td class="nump">280,553,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="nump">3,429,000<span></span>
</td>
<td class="nump">3,358,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Significant Other Observable Inputs (Level 2) | Contingent liabilities - CyDex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Significant Other Observable Inputs (Level 2) | Contingent liabilities - Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="nump">3,429,000<span></span>
</td>
<td class="nump">3,358,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Significant Other Observable Inputs (Level 2) | Liability for restricted investments owed to former licensees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Significant Other Observable Inputs (Level 2) | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="nump">99,615,000<span></span>
</td>
<td class="nump">280,553,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Significant Other Observable Inputs (Level 2) | Investment in Viking common stock (2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Significant Unobservable Inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="nump">135,000<span></span>
</td>
<td class="nump">409,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="nump">84,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Significant Unobservable Inputs (Level 3) | Contingent liabilities - CyDex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="nump">84,000<span></span>
</td>
<td class="nump">349,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Significant Unobservable Inputs (Level 3) | Contingent liabilities - Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Significant Unobservable Inputs (Level 3) | Liability for restricted investments owed to former licensees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Significant Unobservable Inputs (Level 3) | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="nump">135,000<span></span>
</td>
<td class="nump">409,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Significant Unobservable Inputs (Level 3) | Investment in Viking common stock (2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NumberOfContingentValueRightAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Contingent Value Right Agreements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NumberOfContingentValueRightAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer, when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7A<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953401-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919253-210447<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_Phase3ClinicalTrialMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_Phase3ClinicalTrialMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyCydexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyCydexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625575106592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement - Reconciliation of Level 3 Financial Instruments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_PaymentsToContingentValueRightHolders', window );">Payments to CVR holders and other contingency payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (50)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value of level 3 financial instruments at beginning of period</a></td>
<td class="nump">$ 349<span></span>
</td>
<td class="nump">38,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Fair value adjustments to contingent liabilities</a></td>
<td class="num">(265)<span></span>
</td>
<td class="num">(37,708)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_PaymentsToContingentValueRightHolders', window );">Payments to CVR holders and other contingency payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(50)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value of level 3 financial instruments at end of period</a></td>
<td class="nump">$ 84<span></span>
</td>
<td class="nump">$ 349<span></span>
</td>
<td class="nump">$ 38,107<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsToContingentValueRightHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments to contingent value right holders</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsToContingentValueRightHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625658025856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset impairment charges</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625574935696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">ROU asset</a></td>
<td class="nump">$ 4,095<span></span>
</td>
<td class="nump">$ 16,201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term of operating leases</a></td>
<td class="text">9 years 3 months 18 days<span></span>
</td>
<td class="text">2 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate of operating leases (as a percent)</a></td>
<td class="nump">7.10%<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating lease payments</a></td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease expense</a></td>
<td class="nump">700<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease income</a></td>
<td class="nump">$ 700<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term of finance leases</a></td>
<td class="text">1 year 1 month 6 days<span></span>
</td>
<td class="text">2 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate of finance leases (as a percent)</a></td>
<td class="nump">4.10%<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Cash paid for amounts included in finance lease liabilities</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 9,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Finance lease expense</a></td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="nump">2,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining lease term of operating leases</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Renewal term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember', window );">Captisol</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_PurchaseCommitmentConsiderationPaidToDate', window );">Consideration paid to date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_PurchaseCommitmentConsiderationPaidAllocatedToInventory', window );">Portion of consideration allocated to inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-use asset recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseImpairmentLoss', window );">Finance lease, impairment charges</a></td>
<td class="nump">$ 9,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">ROU asset</a></td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm', window );">Remaining lease term of finance leases</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PurchaseCommitmentConsiderationPaidAllocatedToInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase Commitment, Consideration Paid, Allocated to Inventory</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PurchaseCommitmentConsiderationPaidAllocatedToInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PurchaseCommitmentConsiderationPaidToDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase Commitment, Consideration Paid to Date</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PurchaseCommitmentConsiderationPaidToDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss from right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 25<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123399704&amp;loc=SL77918425-209957<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625574931520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Operating and Finance Lease Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">$ 10,914<span></span>
</td>
<td class="nump">$ 3,210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance lease assets</a></td>
<td class="nump">4,095<span></span>
</td>
<td class="nump">16,201<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_LeaseRightOfUseAsset', window );">Total lease assets</a></td>
<td class="nump">15,009<span></span>
</td>
<td class="nump">19,411<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liabilities</a></td>
<td class="nump">670<span></span>
</td>
<td class="nump">1,368<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current finance lease liabilities</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_LeaseLiabilityCurrent', window );">Current lease liabilities</a></td>
<td class="nump">715<span></span>
</td>
<td class="nump">1,413<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Noncurrent liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">10,336<span></span>
</td>
<td class="nump">2,256<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Long-term finance lease liabilities</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_LeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 11,056<span></span>
</td>
<td class="nump">$ 3,727<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other Liabilities, Noncurrent<span></span>
</td>
<td class="text">Other Liabilities, Noncurrent<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Right-of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625575271024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Maturities of Operating and Finance Lease Liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 1,425<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">1,483<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">1,576<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">1,621<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">1,667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">7,614<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">15,386<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(4,380)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">11,006<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 50<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625555953680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Senior Notes - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 15, 2022</div></th>
<th class="th">
<div>Aug. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2018 </div>
<div>USD ($) </div>
<div>trading_day </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>option</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>option </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss (gain) on debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,192,000)<span></span>
</td>
<td class="nump">$ 7,303,000<span></span>
</td>
<td class="nump">$ 2,466,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Reduction to additional paid in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,407,000<span></span>
</td>
<td class="nump">$ 3,236,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Warrant derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(200,000)<span></span>
</td>
<td class="num">(500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_PaymentsToUnwindWarrants', window );">Payments to unwind warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_ProceedsFromUnwindingConvertibleBondHedges', window );">Proceeds from unwinding convertible bond hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 18,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_NumberOfOptionsUnderConvertibleBondHedges', window );">Number of options under convertible bond hedges | option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">370,219<span></span>
</td>
<td class="nump">598,021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member', window );">2023 Convertible Senior Notes | Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount of 2023 Notes outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 76,854,000<span></span>
</td>
<td class="nump">$ 343,301,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest on debt instrument (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Net proceeds from debt issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 733,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Debt conversion price per share (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 206.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Convertible debt conversion ratio</a></td>
<td class="nump">0.004893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt issuance costs related to the liability component of convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Contractual interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchaseAmount', window );">Repurchased amount of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,300,000<span></span>
</td>
<td class="nump">$ 234,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">266,400,000<span></span>
</td>
<td class="nump">152,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayments of notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,100,000<span></span>
</td>
<td class="nump">203,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">261,400,000<span></span>
</td>
<td class="nump">156,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_RepaymentsOfNotesPayableInterestPortion', window );">Accrued interest portion of repurchased amount of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss (gain) on debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,200,000)<span></span>
</td>
<td class="nump">7,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_IncreaseDecreaseInDebtDiscount', window );">Reduction in debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="nump">13,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Reduction to additional paid in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding principal amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 76,900,000<span></span>
</td>
<td class="nump">$ 343,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued in public offering (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,018,327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,559,254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_PaymentsforConvertibleBondHedges', window );">Payments for convertible bond hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 140,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 315.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Warrant derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (90,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member', window );">2023 Convertible Senior Notes | Convertible Notes | Notes Repurchased During Current Period, Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayments of notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 223,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod', window );">Repurchased amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 227,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member', window );">2023 Convertible Senior Notes | Convertible Notes | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Debt conversion price per share (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 158.97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Convertible debt conversion ratio</a></td>
<td class="nump">0.0062907<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member', window );">2023 Convertible Senior Notes | Convertible Notes | Redemption Period One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Number of trading days | trading_day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of consecutive trading days | trading_day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Stock price trigger to classify convertible debt as current (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member', window );">2023 Convertible Senior Notes | Convertible Notes | Redemption Period Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Number of trading days | trading_day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of consecutive trading days | trading_day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger', window );">Maximum threshold of debt trading price trigger (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Maximum Threshold Percentage of Debt Trading Price Trigger</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Repurchased Amount During Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DebtInstrumentRepurchasedAmountDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_IncreaseDecreaseInDebtDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Debt Discount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_IncreaseDecreaseInDebtDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NumberOfOptionsUnderConvertibleBondHedges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Options under Convertible Bond Hedges</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NumberOfOptionsUnderConvertibleBondHedges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsToUnwindWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments to Unwind Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsToUnwindWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsforConvertibleBondHedges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments for Convertible Bond Hedges</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsforConvertibleBondHedges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ProceedsFromUnwindingConvertibleBondHedges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Unwinding Convertible Bond Hedges</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ProceedsFromUnwindingConvertibleBondHedges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_RepaymentsOfNotesPayableInterestPortion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repayments Of Notes Payable, Interest Portion</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_RepaymentsOfNotesPayableInterestPortion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=123466103&amp;loc=SL6014347-161799<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123466302&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period for discount on the liability component of convertible debt which may be settled in cash upon conversion, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value amount of debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAxis=lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAxis=lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625571578720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Convertible Senior Notes - Equity and Liability Components of Financing Arrangements (Details) - Convertible Notes - 2023 Convertible Senior Notes - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>May 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract', window );"><strong>Notes Payable, Current and Noncurrent</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount of 2023 Notes outstanding</a></td>
<td class="nump">$ 76,854,000<span></span>
</td>
<td class="nump">$ 343,301,000<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount (including unamortized debt issuance cost)</a></td>
<td class="num">(159,000)<span></span>
</td>
<td class="num">(22,584,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Total long-term portion of notes payable</a></td>
<td class="nump">76,695,000<span></span>
</td>
<td class="nump">320,717,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Fair value of convertible senior notes outstanding (Level 2)</a></td>
<td class="nump">$ 74,789,000<span></span>
</td>
<td class="nump">$ 341,801,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625575329552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Account Details - Investment Categories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">$ 108,778<span></span>
</td>
<td class="nump">$ 292,225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">415<span></span>
</td>
<td class="nump">842<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(5,451)<span></span>
</td>
<td class="num">(2,370)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">103,742<span></span>
</td>
<td class="nump">290,697<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MutualFundMember', window );">Mutual fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">81,815<span></span>
</td>
<td class="nump">152,136<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(1,050)<span></span>
</td>
<td class="num">(249)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">80,765<span></span>
</td>
<td class="nump">151,887<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DemandDepositsMember', window );">Bank deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">5,012<span></span>
</td>
<td class="nump">63,389<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(34)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">4,980<span></span>
</td>
<td class="nump">63,381<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">7,211<span></span>
</td>
<td class="nump">36,008<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">7,214<span></span>
</td>
<td class="nump">35,998<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">6,701<span></span>
</td>
<td class="nump">29,308<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(58)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">6,656<span></span>
</td>
<td class="nump">29,287<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember', window );">Corporate equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">5,807<span></span>
</td>
<td class="nump">5,807<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">262<span></span>
</td>
<td class="nump">402<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(4,239)<span></span>
</td>
<td class="num">(2,027)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">1,830<span></span>
</td>
<td class="nump">4,182<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember', window );">U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">2,232<span></span>
</td>
<td class="nump">5,577<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(70)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">2,162<span></span>
</td>
<td class="nump">5,554<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">135<span></span>
</td>
<td class="nump">408<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">$ 135<span></span>
</td>
<td class="nump">$ 408<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MutualFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MutualFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DemandDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DemandDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625571519920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Account Details - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>position</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2010 </div>
<div>agreement</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of positions in an unrealized loss position | position</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 3,800,000<span></span>
</td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAmortization', window );">Amortization of intangibles</a></td>
<td class="nump">$ 34,237,000<span></span>
</td>
<td class="nump">34,222,000<span></span>
</td>
<td class="nump">11,642,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Estimated amortization expense for 2022</a></td>
<td class="nump">34,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Estimated amortization expense for 2023</a></td>
<td class="nump">34,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Estimated amortization expense for 2024</a></td>
<td class="nump">34,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Estimated amortization expense for 2025</a></td>
<td class="nump">34,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of intangible assets with finite lives</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_NumberOfContingentValueRightAgreements', window );">Number of CVR agreements | agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NumberOfContingentValueRightAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Contingent Value Right Agreements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NumberOfContingentValueRightAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625556362384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Account Details - Available-for-Sale Debt Securities by Contractual Maturity (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Within one year</a></td>
<td class="nump">$ 57,158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">After one year through five years</a></td>
<td class="nump">2,794<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis', window );">Total</a></td>
<td class="nump">59,952<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Within one year</a></td>
<td class="nump">57,036<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">After one year through five years</a></td>
<td class="nump">2,769<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate', window );">Total</a></td>
<td class="nump">$ 59,805<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=d3e62586-112803<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625571388160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Account Details - Available-for-Sale Debt Securities in an Unrealized Loss Position (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months</a></td>
<td class="num">$ (125)<span></span>
</td>
<td class="num">$ (34)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 months or greater</a></td>
<td class="num">(37)<span></span>
</td>
<td class="num">(60)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss', window );">Total</a></td>
<td class="num">(162)<span></span>
</td>
<td class="num">(94)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Estimated Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months</a></td>
<td class="nump">12,354<span></span>
</td>
<td class="nump">53,949<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 months or greater</a></td>
<td class="nump">947<span></span>
</td>
<td class="nump">18,674<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total</a></td>
<td class="nump">13,301<span></span>
</td>
<td class="nump">72,623<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DemandDepositsMember', window );">Bank deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months</a></td>
<td class="num">(34)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 months or greater</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss', window );">Total</a></td>
<td class="num">(34)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Estimated Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months</a></td>
<td class="nump">2,470<span></span>
</td>
<td class="nump">20,008<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 months or greater</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total</a></td>
<td class="nump">2,470<span></span>
</td>
<td class="nump">20,008<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 months or greater</a></td>
<td class="num">(37)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss', window );">Total</a></td>
<td class="num">(58)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Estimated Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months</a></td>
<td class="nump">3,887<span></span>
</td>
<td class="nump">27,252<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 months or greater</a></td>
<td class="nump">947<span></span>
</td>
<td class="nump">2,996<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total</a></td>
<td class="nump">4,834<span></span>
</td>
<td class="nump">30,248<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 months or greater</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Estimated Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months</a></td>
<td class="nump">3,836<span></span>
</td>
<td class="nump">6,689<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 months or greater</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,125<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total</a></td>
<td class="nump">3,836<span></span>
</td>
<td class="nump">16,814<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember', window );">U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months</a></td>
<td class="num">(70)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 months or greater</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss', window );">Total</a></td>
<td class="num">(70)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Estimated Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months</a></td>
<td class="nump">2,161<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 months or greater</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,553<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total</a></td>
<td class="nump">$ 2,161<span></span>
</td>
<td class="nump">$ 5,553<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at amortized cost (held-to-maturity), in continuous loss position for 12 months or longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at amortized cost (held-to-maturity), in unrealized loss position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DemandDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DemandDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625572143264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Account Details - Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment , gross</a></td>
<td class="nump">$ 22,607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,606<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation and amortization</a></td>
<td class="num">(10,125)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,415)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">12,482<span></span>
</td>
<td class="nump">$ 13,191<span></span>
</td>
<td class="nump">13,191<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Lab and office equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment , gross</a></td>
<td class="nump">14,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,417<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment , gross</a></td>
<td class="nump">7,446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,265<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=lgnd_ComputerEquipmentAndSoftwareMember', window );">Computer equipment and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment , gross</a></td>
<td class="nump">$ 989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 924<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=lgnd_ComputerEquipmentAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=lgnd_ComputerEquipmentAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625555742656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Account Details - Goodwill and Other Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 105,673<span></span>
</td>
<td class="nump">$ 105,673<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: Accumulated amortization</a></td>
<td class="num">(11,600)<span></span>
</td>
<td class="num">(11,700)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Total goodwill and other identifiable intangible assets, net</a></td>
<td class="nump">448,128<span></span>
</td>
<td class="nump">482,364<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentedTechnologyMember', window );">Complete technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite-lived intangible assets</a></td>
<td class="nump">55,211<span></span>
</td>
<td class="nump">55,211<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: Accumulated amortization</a></td>
<td class="num">(22,560)<span></span>
</td>
<td class="num">(18,916)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite-lived intangible assets</a></td>
<td class="nump">2,642<span></span>
</td>
<td class="nump">2,642<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: Accumulated amortization</a></td>
<td class="num">(1,577)<span></span>
</td>
<td class="num">(1,444)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite-lived intangible assets</a></td>
<td class="nump">29,600<span></span>
</td>
<td class="nump">29,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: Accumulated amortization</a></td>
<td class="num">(17,670)<span></span>
</td>
<td class="num">(16,184)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember', window );">Contractual relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite-lived intangible assets</a></td>
<td class="nump">362,000<span></span>
</td>
<td class="nump">362,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: Accumulated amortization</a></td>
<td class="num">$ (65,191)<span></span>
</td>
<td class="num">$ (36,218)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625568692608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Account Details - Accrued Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_OtherBalanceSheetDetailsAbstract', window );"><strong>Other Balance Sheet Details [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Compensation</a></td>
<td class="nump">$ 6,201<span></span>
</td>
<td class="nump">$ 6,532<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Professional fees</a></td>
<td class="nump">662<span></span>
</td>
<td class="nump">2,046<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent', window );">Amounts owed to former licensees</a></td>
<td class="nump">3,989<span></span>
</td>
<td class="nump">630<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent', window );">Royalties owed to third parties</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AccruedSalesReturns', window );">Return reserve and customer refunds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,420<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AccruedAssetAcquisitionsCurrent', window );">Acquisition related liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AccruedSubcontractorExpensesCurrent', window );">Subcontractor</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,759<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AccruedSupplierExpensesCurrent', window );">Supplier</a></td>
<td class="nump">634<span></span>
</td>
<td class="nump">848<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">4,183<span></span>
</td>
<td class="nump">2,195<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">$ 15,681<span></span>
</td>
<td class="nump">$ 17,579<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AccruedAssetAcquisitionsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Asset Acquisitions, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AccruedAssetAcquisitionsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AccruedSalesReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Sales Returns</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AccruedSalesReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AccruedSubcontractorExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Subcontractor Expenses, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AccruedSubcontractorExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AccruedSupplierExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Supplier Expenses, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AccruedSupplierExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_OtherBalanceSheetDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Balance Sheet Details [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_OtherBalanceSheetDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRoyaltiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalesCommissionCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625575083712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Account Details - Contingent Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_ContingentLiabilityRollForward', window );"><strong>Contingent Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod', window );">Commercial rights, beginning of period</a></td>
<td class="nump">$ 3,707<span></span>
</td>
<td class="nump">$ 41,929<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_PaymentsToContingentValueRightHolders', window );">Payments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(50)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities', window );">Fair Value Adjustment</a></td>
<td class="num">(194)<span></span>
</td>
<td class="num">(38,172)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities', window );">Repurchases</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod', window );">Commercial rights, end of period</a></td>
<td class="nump">3,513<span></span>
</td>
<td class="nump">3,707<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_CydexPharmaceuticalsIncMember', window );">Cydex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_ContingentLiabilityRollForward', window );"><strong>Contingent Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod', window );">Commercial rights, beginning of period</a></td>
<td class="nump">349<span></span>
</td>
<td class="nump">507<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_PaymentsToContingentValueRightHolders', window );">Payments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(50)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities', window );">Fair Value Adjustment</a></td>
<td class="num">(265)<span></span>
</td>
<td class="num">(108)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities', window );">Repurchases</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod', window );">Commercial rights, end of period</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">349<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_MetabasisTherapeuticsMember', window );">Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_ContingentLiabilityRollForward', window );"><strong>Contingent Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod', window );">Commercial rights, beginning of period</a></td>
<td class="nump">3,358<span></span>
</td>
<td class="nump">3,822<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_PaymentsToContingentValueRightHolders', window );">Payments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities', window );">Fair Value Adjustment</a></td>
<td class="nump">71<span></span>
</td>
<td class="num">(464)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities', window );">Repurchases</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod', window );">Commercial rights, end of period</a></td>
<td class="nump">3,429<span></span>
</td>
<td class="nump">3,358<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Pfenex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_ContingentLiabilityRollForward', window );"><strong>Contingent Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod', window );">Commercial rights, beginning of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">37,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_PaymentsToContingentValueRightHolders', window );">Payments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities', window );">Fair Value Adjustment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(37,600)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities', window );">Repurchases</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod', window );">Commercial rights, end of period</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition Contingent Consideration Potential Cash Payment at End of Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ContingentLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent Liability [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ContingentLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Repurchases, Contingent Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Fair Value Adjustment, Contingent Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsToContingentValueRightHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments to contingent value right holders</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsToContingentValueRightHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_CydexPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_CydexPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_MetabasisTherapeuticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_MetabasisTherapeuticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625577484976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Share-Based Compensation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense</a></td>
<td class="nump">$ 50,881<span></span>
</td>
<td class="nump">$ 29,326<span></span>
</td>
<td class="nump">$ 25,125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense</a></td>
<td class="nump">10,970<span></span>
</td>
<td class="nump">9,341<span></span>
</td>
<td class="nump">8,513<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense</a></td>
<td class="nump">$ 39,911<span></span>
</td>
<td class="nump">$ 19,985<span></span>
</td>
<td class="nump">$ 16,612<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of expense for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625556307920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_CorporateShareRepurchaseAbstract', window );"><strong>Corporate Share Repurchase</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramPeriodInForce1', window );">Stock repurchase program, period in force</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Shares repurchased in period (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">934,079<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Shares repurchased in period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 77,998,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=lgnd_AtTheMarketEquityOfferingMember', window );">At-The Market Equity Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_SaleOfStockAuthorizedOfferingAmount', window );">Sale of stock, authorized offering amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value per share of stock options (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28.90<span></span>
</td>
<td class="nump">$ 80.08<span></span>
</td>
<td class="nump">$ 41.39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value of options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,600,000<span></span>
</td>
<td class="nump">$ 77,300,000<span></span>
</td>
<td class="nump">$ 11,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Cash received from options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,600,000<span></span>
</td>
<td class="nump">$ 33,000,000<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lgnd_TwoThousandTwoStockIncentivePlanMember', window );">2002 Stock Incentive Plan | Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Increase the number of shares under the 2002 Stock Incentive Plan (shares)</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future option grants (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period in which cost is expected to be recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lgnd_TwoThousandTwoStockIncentivePlanMember', window );">2002 Stock Incentive Plan | Restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period in which cost is expected to be recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation cost, restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lgnd_AmendedESPPMember', window );">Amended ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future option grants (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,881<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_EmployeeStockPurchasePlanAbstract', window );"><strong>Employee Stock Purchase Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee', window );">Shares allowed to purchase in employee stock purchase plan per employee (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Proportion of fair market value of common stock at which stock is purchased under ESPP (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Common stock issued under amended ESSP (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,479<span></span>
</td>
<td class="nump">8,448<span></span>
</td>
<td class="nump">6,455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lgnd_OmniabSeparationMember', window );">Omniab Separation | Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period in which cost is expected to be recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lgnd_OmniabSeparationMember', window );">Omniab Separation | Restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period in which cost is expected to be recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation cost, restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CorporateShareRepurchaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Corporate Share Repurchase [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CorporateShareRepurchaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_EmployeeStockPurchasePlanAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee Stock Purchase Plan [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_EmployeeStockPurchasePlanAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_SaleOfStockAuthorizedOfferingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Authorized Offering Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_SaleOfStockAuthorizedOfferingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The highest quantity of shares an employee can purchase under the plan per period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramPeriodInForce1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramPeriodInForce1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=lgnd_AtTheMarketEquityOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=lgnd_AtTheMarketEquityOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lgnd_TwoThousandTwoStockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lgnd_TwoThousandTwoStockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lgnd_AmendedESPPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lgnd_AmendedESPPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lgnd_OmniabSeparationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lgnd_OmniabSeparationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625555921024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Stock Option Plan Activity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 01, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance at beginning of period (shares)</a></td>
<td class="nump">2,987,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,199,598<span></span>
</td>
<td class="nump">2,561,822<span></span>
</td>
<td class="nump">1,956,379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,584,760<span></span>
</td>
<td class="nump">863,245<span></span>
</td>
<td class="nump">393,589<span></span>
</td>
<td class="nump">806,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(50,449)<span></span>
</td>
<td class="num">(34,941)<span></span>
</td>
<td class="num">(619,731)<span></span>
</td>
<td class="num">(156,845)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (shares)</a></td>
<td class="num">(2,987,833)<span></span>
</td>
<td class="num">(542,838)<span></span>
</td>
<td class="num">(40,069)<span></span>
</td>
<td class="num">(136,082)<span></span>
</td>
<td class="num">(44,012)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance at end of period (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,991,473<span></span>
</td>
<td class="nump">2,987,833<span></span>
</td>
<td class="nump">2,199,598<span></span>
</td>
<td class="nump">2,561,822<span></span>
</td>
<td class="nump">1,956,379<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at end of period (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,559,662<span></span>
</td>
<td class="nump">1,769,629<span></span>
</td>
<td class="nump">1,391,952<span></span>
</td>
<td class="nump">1,611,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Options vested and expected to vest at end of period (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,991,473<span></span>
</td>
<td class="nump">2,987,833<span></span>
</td>
<td class="nump">2,199,598<span></span>
</td>
<td class="nump">2,561,822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at beginning of period (USD per share)</a></td>
<td class="nump">$ 102.92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 106.00<span></span>
</td>
<td class="nump">$ 85.59<span></span>
</td>
<td class="nump">$ 77.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60.10<span></span>
</td>
<td class="nump">91.34<span></span>
</td>
<td class="nump">159.12<span></span>
</td>
<td class="nump">92.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.24<span></span>
</td>
<td class="nump">38.56<span></span>
</td>
<td class="nump">54.28<span></span>
</td>
<td class="nump">21.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56.20<span></span>
</td>
<td class="nump">78.46<span></span>
</td>
<td class="nump">110.83<span></span>
</td>
<td class="nump">91.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at end of period (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61.31<span></span>
</td>
<td class="nump">102.92<span></span>
</td>
<td class="nump">106.00<span></span>
</td>
<td class="nump">85.59<span></span>
</td>
<td class="nump">$ 77.54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable at end of period (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.83<span></span>
</td>
<td class="nump">102.38<span></span>
</td>
<td class="nump">98.16<span></span>
</td>
<td class="nump">76.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Options vested and expected to vest at end of period (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 61.31<span></span>
</td>
<td class="nump">$ 102.92<span></span>
</td>
<td class="nump">$ 106.00<span></span>
</td>
<td class="nump">$ 85.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Term in Years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 25 days<span></span>
</td>
<td class="text">0 years<span></span>
</td>
<td class="text">6 years 4 months 2 days<span></span>
</td>
<td class="text">6 years 1 month 2 days<span></span>
</td>
<td class="text">5 years 5 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term, exercisable (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 6 months 3 days<span></span>
</td>
<td class="text">0 years<span></span>
</td>
<td class="text">5 years 1 month 13 days<span></span>
</td>
<td class="text">4 years 6 months 14 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term, vested and expected to vest (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 25 days<span></span>
</td>
<td class="text">0 years<span></span>
</td>
<td class="text">6 years 4 months 2 days<span></span>
</td>
<td class="text">6 years 1 month 2 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value (In thousands)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,477<span></span>
</td>
<td class="nump">$ 14,835<span></span>
</td>
<td class="nump">$ 113,302<span></span>
</td>
<td class="nump">$ 59,033<span></span>
</td>
<td class="nump">$ 72,002<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value, exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,951<span></span>
</td>
<td class="nump">13,722<span></span>
</td>
<td class="nump">80,849<span></span>
</td>
<td class="nump">53,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate intrinsic value, vested and expected to vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,477<span></span>
</td>
<td class="nump">$ 14,835<span></span>
</td>
<td class="nump">$ 113,302<span></span>
</td>
<td class="nump">$ 59,033<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625575195792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Breakdown of Options Outstanding (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options outstanding (shares) | shares</a></td>
<td class="nump">2,991,473<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining life in years</a></td>
<td class="text">6 years 25 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 61.31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options exercisable (shares) | shares</a></td>
<td class="nump">1,559,662<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 60.83<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lgnd_ExercisePriceRangeOneMember', window );">$12.78-$43.36</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Lower range of exercise prices (USD per share)</a></td>
<td class="nump">12.78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Upper range of exercise prices (USD per share)</a></td>
<td class="nump">$ 43.36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options outstanding (shares) | shares</a></td>
<td class="nump">395,660<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining life in years</a></td>
<td class="text">2 years 3 months 25 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 35.76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options exercisable (shares) | shares</a></td>
<td class="nump">366,426<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 35.44<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lgnd_ExercisePriceRangeTwoMember', window );">$46.20-$52.78</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Lower range of exercise prices (USD per share)</a></td>
<td class="nump">46.20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Upper range of exercise prices (USD per share)</a></td>
<td class="nump">$ 52.78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options outstanding (shares) | shares</a></td>
<td class="nump">279,405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining life in years</a></td>
<td class="text">6 years 7 months 17 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 50.24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options exercisable (shares) | shares</a></td>
<td class="nump">122,734<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 50.18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lgnd_ExercisePriceRangeThreeMember', window );">$52.84-$52.84</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Lower range of exercise prices (USD per share)</a></td>
<td class="nump">52.84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Upper range of exercise prices (USD per share)</a></td>
<td class="nump">$ 52.84<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options outstanding (shares) | shares</a></td>
<td class="nump">580,629<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining life in years</a></td>
<td class="text">7 years 7 months 2 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 52.84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options exercisable (shares) | shares</a></td>
<td class="nump">88,647<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 52.84<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lgnd_ExercisePriceRangeFourMember', window );">$54.81-$57.22</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Lower range of exercise prices (USD per share)</a></td>
<td class="nump">54.81<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Upper range of exercise prices (USD per share)</a></td>
<td class="nump">$ 57.22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options outstanding (shares) | shares</a></td>
<td class="nump">391,280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining life in years</a></td>
<td class="text">6 years 5 months 19 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 56.24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options exercisable (shares) | shares</a></td>
<td class="nump">198,283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 56.26<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lgnd_ExercisePriceRangeFiveMember', window );">$58.28-$67.03</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Lower range of exercise prices (USD per share)</a></td>
<td class="nump">58.28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Upper range of exercise prices (USD per share)</a></td>
<td class="nump">$ 67.03<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options outstanding (shares) | shares</a></td>
<td class="nump">477,042<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining life in years</a></td>
<td class="text">5 years 9 months 10 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 64.11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options exercisable (shares) | shares</a></td>
<td class="nump">274,719<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 62.90<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lgnd_ExercisePriceRangeSixMember', window );">$67.24-$69.70</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Lower range of exercise prices (USD per share)</a></td>
<td class="nump">67.24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Upper range of exercise prices (USD per share)</a></td>
<td class="nump">$ 69.70<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options outstanding (shares) | shares</a></td>
<td class="nump">403,187<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining life in years</a></td>
<td class="text">6 years 11 months 4 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 68.98<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options exercisable (shares) | shares</a></td>
<td class="nump">207,981<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 68.60<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lgnd_ExercisePriceRangeSevenMember', window );">70.04</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Lower range of exercise prices (USD per share)</a></td>
<td class="nump">70.04<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Upper range of exercise prices (USD per share)</a></td>
<td class="nump">$ 93.12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options outstanding (shares) | shares</a></td>
<td class="nump">254,738<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining life in years</a></td>
<td class="text">5 years 6 months 21 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 87.72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options exercisable (shares) | shares</a></td>
<td class="nump">204,332<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 89.21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lgnd_ExercisePriceRangeEightMember', window );">$99.80-$99.80</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Lower range of exercise prices (USD per share)</a></td>
<td class="nump">99.80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Upper range of exercise prices (USD per share)</a></td>
<td class="nump">$ 99.80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options outstanding (shares) | shares</a></td>
<td class="nump">3,389<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining life in years</a></td>
<td class="text">5 years 10 months 2 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 99.80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options exercisable (shares) | shares</a></td>
<td class="nump">3,389<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 99.80<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lgnd_ExercisePriceRangeNineMember', window );">$103.42-$103.42</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Lower range of exercise prices (USD per share)</a></td>
<td class="nump">103.42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Upper range of exercise prices (USD per share)</a></td>
<td class="nump">$ 103.42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options outstanding (shares) | shares</a></td>
<td class="nump">193,177<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining life in years</a></td>
<td class="text">7 years 3 months 3 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 103.42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options exercisable (shares) | shares</a></td>
<td class="nump">80,185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 103.42<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lgnd_ExercisePriceRangeTenMember', window );">$114.15-$114.15</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Lower range of exercise prices (USD per share)</a></td>
<td class="nump">114.15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Upper range of exercise prices (USD per share)</a></td>
<td class="nump">$ 114.15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options outstanding (shares) | shares</a></td>
<td class="nump">12,966<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining life in years</a></td>
<td class="text">5 years 5 months 19 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 114.15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options exercisable (shares) | shares</a></td>
<td class="nump">12,966<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 114.15<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lgnd_ExercisePriceRangeOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lgnd_ExercisePriceRangeOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lgnd_ExercisePriceRangeTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lgnd_ExercisePriceRangeTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lgnd_ExercisePriceRangeThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lgnd_ExercisePriceRangeThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lgnd_ExercisePriceRangeFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lgnd_ExercisePriceRangeFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lgnd_ExercisePriceRangeFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lgnd_ExercisePriceRangeFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lgnd_ExercisePriceRangeSixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lgnd_ExercisePriceRangeSixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lgnd_ExercisePriceRangeSevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lgnd_ExercisePriceRangeSevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lgnd_ExercisePriceRangeEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lgnd_ExercisePriceRangeEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lgnd_ExercisePriceRangeNineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lgnd_ExercisePriceRangeNineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lgnd_ExercisePriceRangeTenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lgnd_ExercisePriceRangeTenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625577252656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Assumptions (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate (as a percent)</a></td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility (as a percent)</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="nump">47.00%<span></span>
</td>
<td class="nump">47.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">4 years 8 months 12 days<span></span>
</td>
<td class="text">4 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate (as a percent)</a></td>
<td class="nump">4.30%<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility (as a percent)</a></td>
<td class="nump">55.00%<span></span>
</td>
<td class="nump">63.00%<span></span>
</td>
<td class="nump">71.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">6 years 6 months<span></span>
</td>
<td class="text">6 years 3 months 18 days<span></span>
</td>
<td class="text">5 years 1 month 6 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625571919536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Restricted Stock Activity (Details) - Restricted stock - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 01, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at beginning of period (shares)</a></td>
<td class="nump">366,470<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">264,143<span></span>
</td>
<td class="nump">206,202<span></span>
</td>
<td class="nump">147,259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">424,473<span></span>
</td>
<td class="nump">260,577<span></span>
</td>
<td class="nump">167,292<span></span>
</td>
<td class="nump">111,306<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(73,385)<span></span>
</td>
<td class="num">(138,867)<span></span>
</td>
<td class="num">(98,501)<span></span>
</td>
<td class="num">(52,363)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (shares)</a></td>
<td class="num">(366,470)<span></span>
</td>
<td class="num">(2,635)<span></span>
</td>
<td class="num">(19,383)<span></span>
</td>
<td class="num">(10,850)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at end of period (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">348,453<span></span>
</td>
<td class="nump">366,470<span></span>
</td>
<td class="nump">264,143<span></span>
</td>
<td class="nump">206,202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant&#160;Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at beginning of period (USD per share)</a></td>
<td class="nump">$ 114.83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 138.21<span></span>
</td>
<td class="nump">$ 106.88<span></span>
</td>
<td class="nump">$ 125.11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75.61<span></span>
</td>
<td class="nump">89.99<span></span>
</td>
<td class="nump">169.63<span></span>
</td>
<td class="nump">89.73<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.17<span></span>
</td>
<td class="nump">120.57<span></span>
</td>
<td class="nump">125.59<span></span>
</td>
<td class="nump">121.69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89.05<span></span>
</td>
<td class="nump">58.45<span></span>
</td>
<td class="nump">141.85<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at end of period (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75.60<span></span>
</td>
<td class="nump">$ 114.83<span></span>
</td>
<td class="nump">$ 138.21<span></span>
</td>
<td class="nump">$ 106.88<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625568472176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Valuation allowance, change in amount</a></td>
<td class="num">$ (21.5)<span></span>
</td>
<td class="num">$ (11.4)<span></span>
</td>
<td class="nump">$ 116.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="nump">27.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount', window );">Increase to current federal income tax expense due to Tax Cuts and Jobs Act</a></td>
<td class="nump">4.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember', window );">Research Tax Credit Carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward</a></td>
<td class="nump">8.5<span></span>
</td>
<td class="nump">9.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember', window );">Internal Revenue Service (IRS)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforward</a></td>
<td class="nump">81.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforward</a></td>
<td class="nump">168.3<span></span>
</td>
<td class="nump">170.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction | California and New Jersey Research Tax Credit Carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward</a></td>
<td class="nump">29.0<span></span>
</td>
<td class="nump">29.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforward</a></td>
<td class="nump">96.1<span></span>
</td>
<td class="nump">101.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Non-US | Capital Loss Carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward</a></td>
<td class="nump">$ 15.6<span></span>
</td>
<td class="nump">17.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 117.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to Tax Cuts and Jobs Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=lgnd_CaliforniaAndNewJerseyResearchTaxCreditCarryforwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=lgnd_CaliforniaAndNewJerseyResearchTaxCreditCarryforwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_CapitalLossCarryforwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_CapitalLossCarryforwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625571863872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Components of Income Tax Expense (Benefit) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current expense (benefit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 10,097<span></span>
</td>
<td class="nump">$ 460<span></span>
</td>
<td class="nump">$ 10,820<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">193<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="nump">541<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">452<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current expense (benefit)</a></td>
<td class="nump">10,742<span></span>
</td>
<td class="nump">438<span></span>
</td>
<td class="nump">11,384<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred expense (benefit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(3,656)<span></span>
</td>
<td class="num">(2,901)<span></span>
</td>
<td class="num">(13,456)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="nump">34,144<span></span>
</td>
<td class="num">(1,685)<span></span>
</td>
<td class="num">(3,234)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred expense (benefit)</a></td>
<td class="nump">30,488<span></span>
</td>
<td class="num">(4,586)<span></span>
</td>
<td class="num">(16,690)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax expense (benefit)</a></td>
<td class="nump">$ 41,230<span></span>
</td>
<td class="num">$ (4,148)<span></span>
</td>
<td class="num">$ (5,306)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625577453296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of Income Tax Expense (Benefit) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract', window );"><strong>Income Tax Expense (Benefit), Continuing Operations, Income Tax Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Tax at federal statutory rate</a></td>
<td class="nump">$ 7,562<span></span>
</td>
<td class="nump">$ 15,163<span></span>
</td>
<td class="nump">$ 272<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State, net of federal benefit</a></td>
<td class="nump">264<span></span>
</td>
<td class="num">(82)<span></span>
</td>
<td class="num">(1,231)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_IncomeTaxReconciliationContingentValueRights', window );">Contingent liabilities</a></td>
<td class="nump">15<span></span>
</td>
<td class="num">(7,993)<span></span>
</td>
<td class="num">(266)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Share-based compensation</a></td>
<td class="nump">1,279<span></span>
</td>
<td class="num">(12,080)<span></span>
</td>
<td class="num">(623)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount', window );">FDII</a></td>
<td class="num">(2,395)<span></span>
</td>
<td class="num">(637)<span></span>
</td>
<td class="num">(1,652)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_EffectiveIncomeTaxRateReconciliationExpiredTaxCreditsResearch', window );">Research and development credits</a></td>
<td class="nump">256<span></span>
</td>
<td class="num">(1,628)<span></span>
</td>
<td class="num">(168)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions', window );">Change in uncertain tax positions</a></td>
<td class="num">(158)<span></span>
</td>
<td class="nump">480<span></span>
</td>
<td class="num">(673)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Rate change for changes in federal, foreign or state law</a></td>
<td class="num">(535)<span></span>
</td>
<td class="num">(7,963)<span></span>
</td>
<td class="num">(164)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsAmount', window );">Provision to return adjustments</a></td>
<td class="nump">2,232<span></span>
</td>
<td class="num">(1,347)<span></span>
</td>
<td class="num">(5,920)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Foreign tax differential on income/loss of foreign subsidiaries</a></td>
<td class="nump">103<span></span>
</td>
<td class="num">(114)<span></span>
</td>
<td class="num">(3,839)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="nump">24,799<span></span>
</td>
<td class="nump">11,245<span></span>
</td>
<td class="num">(121,864)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationDispositionOfBusiness', window );">Sale of Vernalis R&amp;D</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">127,372<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_EffectiveIncomeTaxRateReconciliationDebtRepurchasesAmount', window );">Debt repurchases</a></td>
<td class="nump">626<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_EffectiveIncomeTaxRateReconciliationOtherIncome', window );">Subpart F income</a></td>
<td class="nump">853<span></span>
</td>
<td class="nump">1,392<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_EffectiveIncomeTaxRateReconciliationOfficerCompensationAmount', window );">Officer compensation</a></td>
<td class="nump">5,869<span></span>
</td>
<td class="nump">3,239<span></span>
</td>
<td class="nump">2,410<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">460<span></span>
</td>
<td class="num">(3,823)<span></span>
</td>
<td class="nump">1,015<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax expense (benefit)</a></td>
<td class="nump">$ 41,230<span></span>
</td>
<td class="num">$ (4,148)<span></span>
</td>
<td class="num">$ (5,306)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Change in Uncertain Tax Positions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_EffectiveIncomeTaxRateReconciliationDebtRepurchasesAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Debt Repurchases, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_EffectiveIncomeTaxRateReconciliationDebtRepurchasesAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_EffectiveIncomeTaxRateReconciliationExpiredTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Expired Tax Credits, Research</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_EffectiveIncomeTaxRateReconciliationExpiredTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_EffectiveIncomeTaxRateReconciliationOfficerCompensationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Officer Compensation, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_EffectiveIncomeTaxRateReconciliationOfficerCompensationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_EffectiveIncomeTaxRateReconciliationOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Other Income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_EffectiveIncomeTaxRateReconciliationOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Provision to Return Adjustments, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_IncomeTaxReconciliationContingentValueRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax Reconciliation, Contingent Value Rights</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_IncomeTaxReconciliationContingentValueRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax benefit from difference to expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to foreign-derived intangible income (FDII).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32059-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationDispositionOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the disposition of a business not qualifying as a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationDispositionOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625572219984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Deferred Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGrossAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 53,960<span></span>
</td>
<td class="nump">$ 63,471<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Research credit carryforwards</a></td>
<td class="nump">26,309<span></span>
</td>
<td class="nump">26,908<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock compensation</a></td>
<td class="nump">11,158<span></span>
</td>
<td class="nump">9,743<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">19,542<span></span>
</td>
<td class="nump">12,989<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred tax assets</a></td>
<td class="nump">110,969<span></span>
</td>
<td class="nump">113,111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance for deferred tax assets</a></td>
<td class="num">(57,472)<span></span>
</td>
<td class="num">(35,931)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets</a></td>
<td class="nump">53,497<span></span>
</td>
<td class="nump">77,180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DeferredTaxLiabilitiesFiniteLivedIntangibleAssets', window );">Identified intangibles</a></td>
<td class="num">(64,696)<span></span>
</td>
<td class="num">(66,848)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="num">(10,886)<span></span>
</td>
<td class="num">(5,459)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Net deferred tax liabilities</a></td>
<td class="num">(75,582)<span></span>
</td>
<td class="num">(72,307)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Deferred income taxes, net</a></td>
<td class="num">$ (22,085)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Deferred income taxes, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,873<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DeferredTaxLiabilitiesFiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Finite-Lived Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DeferredTaxLiabilitiesFiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGrossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGrossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625569077056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at beginning of period</a></td>
<td class="nump">$ 29,550<span></span>
</td>
<td class="nump">$ 31,619<span></span>
</td>
<td class="nump">$ 28,647<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Additions based on tax positions related to the current year</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">252<span></span>
</td>
<td class="nump">3,911<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Additions for tax positions of prior years</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">751<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Reductions for tax positions of prior years</a></td>
<td class="num">(512)<span></span>
</td>
<td class="num">(3,072)<span></span>
</td>
<td class="num">(954)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at end of period</a></td>
<td class="nump">$ 29,096<span></span>
</td>
<td class="nump">$ 29,550<span></span>
</td>
<td class="nump">$ 31,619<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625568336992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Selected Quarterly Financial Data (Unaudited) - Summary (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 50,382<span></span>
</td>
<td class="nump">$ 59,221<span></span>
</td>
<td class="nump">$ 50,126<span></span>
</td>
<td class="nump">$ 36,516<span></span>
</td>
<td class="nump">$ 56,404<span></span>
</td>
<td class="nump">$ 59,694<span></span>
</td>
<td class="nump">$ 78,854<span></span>
</td>
<td class="nump">$ 46,592<span></span>
</td>
<td class="nump">$ 196,245<span></span>
</td>
<td class="nump">$ 241,544<span></span>
</td>
<td class="nump">$ 163,562<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">9,197<span></span>
</td>
<td class="nump">9,239<span></span>
</td>
<td class="nump">8,467<span></span>
</td>
<td class="nump">9,179<span></span>
</td>
<td class="nump">8,147<span></span>
</td>
<td class="nump">7,430<span></span>
</td>
<td class="nump">7,482<span></span>
</td>
<td class="nump">9,046<span></span>
</td>
<td class="nump">36,082<span></span>
</td>
<td class="nump">32,105<span></span>
</td>
<td class="nump">40,503<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">31,131<span></span>
</td>
<td class="nump">14,920<span></span>
</td>
<td class="nump">12,086<span></span>
</td>
<td class="nump">11,925<span></span>
</td>
<td class="nump">12,596<span></span>
</td>
<td class="nump">10,967<span></span>
</td>
<td class="nump">12,412<span></span>
</td>
<td class="nump">10,815<span></span>
</td>
<td class="nump">70,062<span></span>
</td>
<td class="nump">46,790<span></span>
</td>
<td class="nump">60,012<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Total operating costs and expenses</a></td>
<td class="nump">70,481<span></span>
</td>
<td class="nump">46,880<span></span>
</td>
<td class="nump">41,464<span></span>
</td>
<td class="nump">34,383<span></span>
</td>
<td class="nump">41,280<span></span>
</td>
<td class="nump">34,597<span></span>
</td>
<td class="nump">24,941<span></span>
</td>
<td class="nump">36,875<span></span>
</td>
<td class="nump">193,208<span></span>
</td>
<td class="nump">137,693<span></span>
</td>
<td class="nump">143,176<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Net income (loss) from continuing operations</a></td>
<td class="num">(14,534)<span></span>
</td>
<td class="nump">9,645<span></span>
</td>
<td class="nump">12,599<span></span>
</td>
<td class="num">(12,929)<span></span>
</td>
<td class="num">(3,194)<span></span>
</td>
<td class="nump">20,338<span></span>
</td>
<td class="nump">36,442<span></span>
</td>
<td class="nump">22,767<span></span>
</td>
<td class="num">(5,219)<span></span>
</td>
<td class="nump">76,353<span></span>
</td>
<td class="nump">6,598<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Net loss from discontinued operations</a></td>
<td class="num">(2,951)<span></span>
</td>
<td class="num">(9,241)<span></span>
</td>
<td class="num">(13,494)<span></span>
</td>
<td class="num">(2,456)<span></span>
</td>
<td class="num">(2,223)<span></span>
</td>
<td class="num">(6,615)<span></span>
</td>
<td class="num">(5,717)<span></span>
</td>
<td class="num">(4,660)<span></span>
</td>
<td class="num">(28,142)<span></span>
</td>
<td class="num">(19,215)<span></span>
</td>
<td class="num">(9,583)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (17,485)<span></span>
</td>
<td class="nump">$ 404<span></span>
</td>
<td class="num">$ (895)<span></span>
</td>
<td class="num">$ (15,385)<span></span>
</td>
<td class="num">$ (5,417)<span></span>
</td>
<td class="nump">$ 13,723<span></span>
</td>
<td class="nump">$ 30,725<span></span>
</td>
<td class="nump">$ 18,107<span></span>
</td>
<td class="num">$ (33,361)<span></span>
</td>
<td class="nump">$ 57,138<span></span>
</td>
<td class="num">$ (2,985)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic net income (loss) from continuing operations (USD per share)</a></td>
<td class="num">$ (0.86)<span></span>
</td>
<td class="nump">$ 0.57<span></span>
</td>
<td class="nump">$ 0.75<span></span>
</td>
<td class="num">$ (0.77)<span></span>
</td>
<td class="num">$ (0.19)<span></span>
</td>
<td class="nump">$ 1.22<span></span>
</td>
<td class="nump">$ 2.19<span></span>
</td>
<td class="nump">$ 1.39<span></span>
</td>
<td class="num">$ (0.31)<span></span>
</td>
<td class="nump">$ 4.59<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Basic net income (loss) from discontinued operations (USD per share)</a></td>
<td class="num">(0.17)<span></span>
</td>
<td class="num">(0.55)<span></span>
</td>
<td class="num">(0.80)<span></span>
</td>
<td class="num">(0.15)<span></span>
</td>
<td class="num">(0.13)<span></span>
</td>
<td class="num">(0.40)<span></span>
</td>
<td class="num">(0.34)<span></span>
</td>
<td class="num">(0.28)<span></span>
</td>
<td class="num">(1.67)<span></span>
</td>
<td class="num">(1.16)<span></span>
</td>
<td class="num">(0.59)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Diluted net income (loss) from continuing operations (USD per share)</a></td>
<td class="num">(0.86)<span></span>
</td>
<td class="nump">0.57<span></span>
</td>
<td class="nump">0.75<span></span>
</td>
<td class="num">(0.77)<span></span>
</td>
<td class="num">(0.19)<span></span>
</td>
<td class="nump">1.19<span></span>
</td>
<td class="nump">2.12<span></span>
</td>
<td class="nump">1.32<span></span>
</td>
<td class="num">(0.31)<span></span>
</td>
<td class="nump">4.43<span></span>
</td>
<td class="nump">0.39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Diluted net income (loss) from discontinued operations (USD per share)</a></td>
<td class="num">$ (0.17)<span></span>
</td>
<td class="num">$ (0.55)<span></span>
</td>
<td class="num">$ (0.80)<span></span>
</td>
<td class="num">$ (0.15)<span></span>
</td>
<td class="num">$ (0.13)<span></span>
</td>
<td class="num">$ (0.39)<span></span>
</td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="num">$ (0.27)<span></span>
</td>
<td class="num">$ (1.67)<span></span>
</td>
<td class="num">$ (1.11)<span></span>
</td>
<td class="num">$ (0.57)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Shares used in the computation of basic net income (loss) per share (in shares)</a></td>
<td class="nump">16,890,000<span></span>
</td>
<td class="nump">16,888,000<span></span>
</td>
<td class="nump">16,868,000<span></span>
</td>
<td class="nump">16,824,000<span></span>
</td>
<td class="nump">16,733,000<span></span>
</td>
<td class="nump">16,688,000<span></span>
</td>
<td class="nump">16,659,000<span></span>
</td>
<td class="nump">16,435,000<span></span>
</td>
<td class="nump">16,868,000<span></span>
</td>
<td class="nump">16,630,000<span></span>
</td>
<td class="nump">16,185,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used in the computation of diluted net income (loss) per share (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,733,000<span></span>
</td>
<td class="nump">17,142,000<span></span>
</td>
<td class="nump">17,172,000<span></span>
</td>
<td class="nump">17,248,000<span></span>
</td>
<td class="nump">16,868,000<span></span>
</td>
<td class="nump">17,246,000<span></span>
</td>
<td class="nump">16,825,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R9999.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140625568377808">
<tr>
<th class="tl" colspan="1">Label</th>
<th class="tl"><strong>Element</strong></th>
<th class="th" colspan="1">Value</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible Enumeration]</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
<td class="text">Accounting Standards Update 2016-13 [Member]<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 32: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 66: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 67: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 68: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>lgnd-20221231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:lgnd="http://www.ligand.com/20221231"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="lgnd-20221231.xsd" xlink:type="simple"/>
    <context id="if45af0da2212401f917e14836fcf8e57_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia41df9d4ed2a449d9d3a0d5079eee8d8_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i60e7b5cfa61b4bd3ba008a679e0b0390_I20230222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2023-02-22</instant>
        </period>
    </context>
    <context id="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i91e01e3752fa4607875a52688c787ed4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7acccfdc49ae41ec9d81e2a77aaeab89_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8303bd1e530e4c06b3bb8c3093343f43_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if07332e474464098b61af13fe5a470f2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6747a650dc714496a27ce80ca1fde353_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i065c2ca723f44ed7b4161976d58b5fe9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7a2c832b6c46461c9fa690319f44159f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if6041ab2411645599b1e142a09232af6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibbbf2bd60ac64c15aa70a568639f50ab_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i722c9276c7584a49823e2aa504120dab_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6b86bff9b54f4d76bce0d4e8b7a8fb96_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:VernalisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9b297d5d47f94315a7c2461666a1e657_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:VernalisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iccc4fa061bfd4f28acff3954baafb1a4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:VernalisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i357eff174d874e71a3e0da8d3f8ba240_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie900f916c5ce4b118f337c7cd5784087_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i55fd66c34dcf459fa6f35389d1c92e7d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0b902bcb600d40ed842e738be013d24e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i859e9607437a43d8adb4d3dc08e60773_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie94bcf078bda4c3095feb1fef072c734_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia0325d2944844148b93606f4579a387f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifb599d49cd844079adbdcf3fbcea1bf6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic67831c921904253a87bb44165f263ef_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib307560c9d0a46168d9fc559bfdf76db_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iadc71aaacd92446fa2fa49e3a0be8871_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8b2e2abd1a8f48cbb470a39e45b33d50_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8d465be99a3842c397fabfc41d61594f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6ea688d541394c9693a42fb9c6332aea_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id1632e4f73e14852bc153b6b86f8ac63_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id7184134d4134a439ed750ceb1bd33ec_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0fe34795168e4efab32422048060cbb7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie20afe7ce80947c68d760e57a457a87d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iaafb881f4e07495d854952edabcc137a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i948695d093514268aa5ad004f473dbda_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7d56363a509d4e11b592758da0456ba3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i93f039f3e3c5453fbe65524dc44ad87a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ica032a6f26e9432b8884add2372c3753_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i23836cb1b26e4183bcbd3dcfe2a97c57_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ief52e61130d8499e8c4dbc42893dc5b6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i65b0d907ef504ee2b3d109652685018c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1ba90afbe5994d2387d3257ea4ba047e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i155fa2cc21e744f28351005564253c83_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2a1cc21146284996b1a957be45c91abd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i33d7a741bf9e4e2d90927adfa7ef78e5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2f6875eb2c49451e827356ab2addb68a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4e38dd10e28e4af0b6ff937e3289a628_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i72f4dbdc77184f48bcecf231e8e2ca80_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lgnd:PartnerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i14ad94cabb1447e9a5f01458bd06ae4c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lgnd:PartnerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia3ecad76cf15478e978cd158a1acc62b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lgnd:PartnerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i032f9a1963654916a1d87cdbf84a1c8c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lgnd:PartnerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i84da35f51bc941fb9605c4e27d374dc2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lgnd:PartnerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie756c741eed64e91bbd573fd37cc5dc5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lgnd:PartnerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i320b82dcca2f4f7c9916c6e2f9c91339_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lgnd:PartnerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib51bff40a74549a49092eaf3d331dfb2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lgnd:PartnerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i53db40ae7eaa43a29ee0d41f7837b347_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lgnd:PartnerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0d685acb7be943ae8d15dc5799a4444a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic202f70f62e8428d9c78a4978a746eee_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idbafb024b44d43f0b4a9e4440b3833cb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5a1083da45f7446987097262ce780281_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id219523c2b3d4296bdc72fa8f030e324_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="ied0c882ba4784643aa73cead8f57f992_I20100131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisTherapeuticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2010-01-31</instant>
        </period>
    </context>
    <context id="i708cef8824df4406829b45bafcb19aec_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoandCorMatrixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i51a7db08b41d4559b10e461df7cae951_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoandCorMatrixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6f4284fcd53e4be492bf1abd42007aa6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisAndDianomiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icafaf42275b04638a6eb47f7e4f9d5ae_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisAndDianomiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i753bf04acd14417f84584d364adb5bb8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2fdc31d97ec44363932ea54316ee86c1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie4ed1fc049264324b4138e54a53f1363_D20190501-20190531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:NovanMolluscumProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-01</startDate>
            <endDate>2019-05-31</endDate>
        </period>
    </context>
    <context id="i7e227d79f69e4aea8a7ba69a8fb5790c_I20190531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:NovanMolluscumProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-31</instant>
        </period>
    </context>
    <context id="if79b3620292a470e909e7af19aa0f62a_I20190531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:NovanMolluscumProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-31</instant>
        </period>
    </context>
    <context id="i41a81ed9d20a45a39c1cfa8bf254af62_I20190531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:NovanMolluscumProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-31</instant>
        </period>
    </context>
    <context id="i4ed660187f8a4347b6987765f4320888_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:PalvellaTherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="id02e516cbca146e2836770e595c232e1_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:PalvellaTherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i91f484a16cb744a5b11a95592c952710_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:PalvellaTherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i1454c0a0b9464c84aec81eed615b63f1_D20181201-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:PalvellaTherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i457b511b1d08453b8802d9e74dbddb90_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:PalvellaTherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifa528f43c78d4e52915523cdd982ac81_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:PalvellaTherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id2cce7f20f9b4fb296a7526469510cff_D20170531-20170531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-31</startDate>
            <endDate>2017-05-31</endDate>
        </period>
    </context>
    <context id="i60474bf54aa94e98b1b7827f2c4e28ec_I20170531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-05-31</instant>
        </period>
    </context>
    <context id="i9a7a01e9b3e44e6d9b9d6af540a8e364_I20170531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-05-31</instant>
        </period>
    </context>
    <context id="i362045e8eca24e9b94ed9065fd915555_I20170531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-05-31</instant>
        </period>
    </context>
    <context id="iad947c25f57e49ecb7709c07507fa8f5_I20170531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:CorMatrixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-05-31</instant>
        </period>
    </context>
    <context id="ia0566a97a54e4f9ab7c582ae4caada22_D20170531-20170531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:CorMatrixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-31</startDate>
            <endDate>2017-05-31</endDate>
        </period>
    </context>
    <context id="iacff0d31a3c2457a9ee720c8fbcc8054_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i670101d682ab4040a9ecb714406fabd0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if715884926d24da68b91903ae544927e_I20200101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-01</instant>
        </period>
    </context>
    <context id="i9ec9717cd1d246078b4b569036ffdc49_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyKyprolisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i54dbd99694aa4daab7990f243b799c03_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyKyprolisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8afb2b3d7d6642b4a6bf2a125abec1e1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyKyprolisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0c92061ff9b94c6eb2d8a4a23c829de0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyEvomelaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifd8f3bf9de1f4fd7beedb580d9c6cdee_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyEvomelaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i33e6496921c848a79e380a93f9d05bc4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyEvomelaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4b7d6c7b066c452794362e3368d3f7e3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyTeriparatideInjectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iea65617bbc2b47b48426079a24526cbe_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyTeriparatideInjectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5493b3bc3d6c4726aa3bd80b40ca081f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyTeriparatideInjectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8fbfab2afcba47db8cd01d943434d7c7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyRylazeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4ece9d53186c440cbe209564d6285e78_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyRylazeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i49757f616a7c43cf861c739d9acb2ab5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyRylazeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idac514c491cc4a208f76c94595c132f5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i73902d56a64240c0bf0d410617877557_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i03cd5d2142d44bf7a2bcaa6d8f29b13a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i65647a80fbc847cb96058a3c631b002b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i43de1a804883437584799c38ec4bbfba_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie02c8b74a58c4e0da8c4a0da3e2af0ab_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id131b624b01b400987332697abc2b43d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCOVIDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ief5aa8a800b746d481cd0985dd7ec3d3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCOVIDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i11e9985562a84328a97129345abae661_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCOVIDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i08870b2004dd43bdaece251ed3f21347_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i68260ef8bbec41adbf8a2108d95376f8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if88162f99d40461a9310c0ae816fd224_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie1de672c0b42480eb2b6b143b340f6a5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0ffe37b6e1e44b3a84fe52fd8879a67d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if42c010475e14a4099a8428492cce1cb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic38b9e57dd5b4eccb6ea203b21533a2b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0e8ef293cc81451599d632430c78f16d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i91b0803652084754984846b312275eec_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibf61891c2afc4735abc2848c436bdd90_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndOtherProductOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2e3529f39eae4d9e9e67e1b00baf464b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndOtherProductOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0132672fab9842058c3e5d0239853868_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndOtherProductOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2323eac91b2548d9bb0aa30d38e34f63_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i842018ac4595423692c11f2da85cf3eb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i489ca56af41b4556bad1bd319b7b8c4d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icc63108210a948b5865cfb7ad3c24f5b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0e24dfa538c74d94916136c2c583e53b_D20070101-20071231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2007-01-01</startDate>
            <endDate>2007-12-31</endDate>
        </period>
    </context>
    <context id="i0ea94c0a78a84acbbb4c6b276629f850_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:TwoThousandTwoStockIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">lgnd:VestingPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0c3c548b83e74abda3686b765b62aafc_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:TwoThousandTwoStockIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">lgnd:VestingPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1a7d01a48d59487f83e3391779612e31_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">lgnd:RestrictedStockUnitsAndPerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7c0d366af0a24bf3b783d1043d41aeac_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:TwoThousandTwoStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icd7c9aa2ea5a470e8fbd4d80fce77775_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i70fc66a3f20848b5bb0f70e3f866d45d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i18c9bf22eb2e40bdb955de4a851b78c5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if66ef91cf250497180df8bdafb040c04_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i67a5c3e26a4a41c5965dfa8c1722d00f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i76c8d1f51aad42668b7908e89daf66dd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i46c8bfd47e7444e6a01496cd453532d1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i710339a456f64bc8bad5a607120931a7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie30007c66bb747999bd003d8277ab95c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib6f656a779984d2e9b0f895f98e24654_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6992767e8dd8406c922375c93b5376c2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib1f6b297465e41fc91ec81b76fb00d45_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i38815b046b134f4e89a040e922235cd3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic0c506012de345dda2926c4191966e7a_I20221026">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-26</instant>
        </period>
    </context>
    <context id="i71db46073a8c4e54a85cdb15a16cda65_I20221101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="id5d258c544454d8287d67c0885d9f073_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i180d8ced9233474d9767fa54ba805af7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ida2ce874ab0f45d1a868ff9dc946ad7a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id10d2e678e034d80baef68bce5e0f4dd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if084a5c5e7a04c2ab6433cfecec6c5ea_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i76065f9fe2324b1eab8ade930477eaf4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic19bd9bd07214754968a75ae83faf30f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">lgnd:VikingTherapeuticsInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i78dcb59101a846b19a565ed0e098ef09_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">lgnd:VikingTherapeuticsInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifeea5a6633434f93bbe3e33fea893ad4_D20200101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4ed842cd826a473aa27b3be44b9dff45_D20201001-20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-01</endDate>
        </period>
    </context>
    <context id="if6722b1819674d1ca58d43ab78f42fee_I20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-01</instant>
        </period>
    </context>
    <context id="i0031e41cbf7c45bbb25efe78bbbcea4a_I20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-01</instant>
        </period>
    </context>
    <context id="i36cbb3f817354f04b57d665248187943_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0787b2990c934b468deda9c36c3f0273_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4c6f37320d134abeb77221e2c28f7476_I20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lgnd:ContractualRelationshipsAlvogenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-01</instant>
        </period>
    </context>
    <context id="ie17cc4f187524c6ab5d90741e0260c93_D20201001-20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lgnd:ContractualRelationshipsAlvogenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-01</endDate>
        </period>
    </context>
    <context id="i3c16dd0f6ad94561a190f6fb614d008c_I20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lgnd:ContractualRelationshipsMerckMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-01</instant>
        </period>
    </context>
    <context id="i0879712cff614a0b90c548a17d56dc6e_D20201001-20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lgnd:ContractualRelationshipsMerckMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-01</endDate>
        </period>
    </context>
    <context id="i0183c839f90a44d78e84690651518be4_I20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lgnd:ContractualRelationshipsJazzMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-01</instant>
        </period>
    </context>
    <context id="ifac692c703d348d388432995b6f0fa8a_D20201001-20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lgnd:ContractualRelationshipsJazzMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-01</endDate>
        </period>
    </context>
    <context id="i646b177827484736a084009b96add04f_I20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lgnd:ContractualRelationshipsSIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-01</instant>
        </period>
    </context>
    <context id="iada43374af48485cb39ed70b764ce849_D20201001-20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lgnd:ContractualRelationshipsSIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-01</endDate>
        </period>
    </context>
    <context id="i29179647d1e74e45a16db04ef1607aa3_I20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lgnd:ContractualRelationshipsArcellxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-01</instant>
        </period>
    </context>
    <context id="i0793bd25b06b4adb80e8bcf79ba4daae_D20201001-20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lgnd:ContractualRelationshipsArcellxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-01</endDate>
        </period>
    </context>
    <context id="i56ebc06b13944fc8bae568b634e1b508_I20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-01</instant>
        </period>
    </context>
    <context id="i8104cc1e7e204b4f9867e0af251d6d20_D20201001-20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-01</endDate>
        </period>
    </context>
    <context id="ifdcdcd7c135242418722134cac4afc56_D20201001-20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-01</endDate>
        </period>
    </context>
    <context id="id589112d140b42ffa4f049057293f7a7_D20201001-20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-01</endDate>
        </period>
    </context>
    <context id="i7eada68668c8443ba5abbd0bcde52836_D20201001-20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-01</endDate>
        </period>
    </context>
    <context id="i67ed4423d4894d809c0e43396ff89fb7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5cbea891771f402ba63e1011224d9594_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic56146394448409b96d33c1403f18303_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3b6118bd78b042f680823946386c507b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib96a633a4e0742be9fe13b947aa7bbf8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icb1ec84b065e4c5ca2b74a1668e4e379_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia4aee961123f4b77b2f7f7b245ce72b5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9dc44c4cfaf6498b9f6dc3d014f4bdf8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie4de80e6e30c4350bd4abd2929927cf1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1b0be75d14a440b5bcdb6664f17060fc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icd4315ab1b654686b5cdda294406fe38_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2dd090c573e94ca6a2ef574f8aca0f84_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaf74ed3f29894bbe89f67ce3f1638368_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id273e2ab6d4d4d30bf4734bdb2617f06_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia295c8d89c994fc1bfcfee13cdca48ce_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if0f397fe74994049bf8a93a1ab577e34_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id5dcb4186e044e5882d93180a92f8279_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4dcc4622d787496ea953a0a254ba9e7c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5bab37c9b6cc4977ba02a28e26ed9ca5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id71f5699fd5b463690456b9be5c3a966_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0b5b0d44ecc94db89ec934970defe064_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8e56f08463f24218a5dd7f6e8d12a3dc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i849c3dacc5614e158a39923417210219_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i289ae7096dd54d348dbd227aaa42f5e8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id323f390108741218d29588c00e4c8a0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1f8fb2e550b84e4faf3a5b2a433bea1a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idb86b09115894c9fbb794f501b2d2dcf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5c67973b49304b2cbbb84811600c1663_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4fc3ae0a79b44517bb99fc381adc9058_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i70302a79a5c24d0e881d281ae6cbe66b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia7bd44fb046a40d79acd8b5094a6af2f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i057df6feb256427ebd16d5cfd07edad1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8224f6e8d10e45e78c84ba1c9a2f97a2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5e70582ec04b46de89b0fe1f65dbc1e1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if16a34f8456e47dc9f5b67e39d4c9548_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i358f804697e94a7f8d741b250dbff084_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i89b5b12d4524461fb990aac54d517487_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7421ded7a02748e5bd60df47f2093b9b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib1fb2de098654192b5935f2063f1a97a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i61cb7f2d12cc441e9bd457c78d89b1aa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7678c8eb61e14518b6fb8be69a443a07_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icc472a6bccfc444c92220855618d517b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i85fd2713598b4a62a7669055f5df86b4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic4eab6a2ac394d7aba45f348a01f8201_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i08c9b0174a48479ea68f212652608932_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia5237f56ef074e7eb32dbcc66c6db515_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i379ebe35361f4afc805f81c76a89b0c4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0a30b0e8302e45e3b5d48f2a7758a37e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idd920ac870274bd29c5d3815db9bc027_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if01f6df650ee4787be25d17587903c8a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i430a03cc0e9c405e9df59a233c9bd258_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iefe06608d69a4810b5ef7844034e3616_I20100131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2010-01-31</instant>
        </period>
    </context>
    <context id="i800dff6c80e4444f9003b3ac53dd8573_I20100131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2010-01-31</instant>
        </period>
    </context>
    <context id="i21d27e0d975f4344a297876b55e27170_I20100131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:Phase3ClinicalTrialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2010-01-31</instant>
        </period>
    </context>
    <context id="i80eaf9a4b47f4c988d4ed66997f6cdfc_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i33228b6719394b3784c1b537e298a756_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib390d2fa586a4871b184b3ae93ef7a46_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i749ac5b664db4f20af265ce3e3d5b538_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1566abca593746beacdf6a287d3c798c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic8ae4ee0f64a46979ca5a2c15da782e7_I20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-31</instant>
        </period>
    </context>
    <context id="i8ae5acdc120c4e40981302a07b8d28a6_D20180501-20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="i11b50fd2d77b498e82f14c8ee21dcc5c_D20180501-20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="i2a146d0761cc415ba2c40a2459586b06_D20180501-20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="ic965f5b4e009491284f786378035d4e1_I20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-31</instant>
        </period>
    </context>
    <context id="ia361a8f8b6774d9f9e3b2a48a102ecb8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3316b5508b924ffc8fd7ec36b3aa455e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id1dd1d35129f4cd39fb80e6800cfe252_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia99cec91b0284a4090f6d9399292f293_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibbe666f5347841329bf2326c9232e329_I20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="ibf823eb4d59c42a0a2bc0d1990fa4bc0_D20200401-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="i0c628cd07ad342459335204c06df1ef0_I20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="i111b05d5f55a49a8811a99582e5b230b_D20210101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i58d85fd3024241a592f18e215570d51a_D20220801-20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">lgnd:NotesRepurchasedDuringCurrentPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="i54f5a452c3934a41b9d24ab5e96cffaf_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6a379c1b7d334bdcada538a9c12cb207_D20221115-20221115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-15</startDate>
            <endDate>2022-11-15</endDate>
        </period>
    </context>
    <context id="i1129e67c6bf84ef883ea9a80f1135ee7_D20221115-20221115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-15</startDate>
            <endDate>2022-11-15</endDate>
        </period>
    </context>
    <context id="i548f60b85719418dac5410346d1603e7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1471709cc0844e7fa518a8ce9a1cd2bb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7463bea47b82478d8f5459d601f865f3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibd0bbb0bb1ab4703911061427590d10b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id5437e7ad7374bbba38f616727645f32_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0615fa1d1c0f4ab3a4d0ed6cab329254_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i71e35599919c4fce950d103cf2cb9a03_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i04cf813834a54b609f2d0c0a39769017_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2f92fad18c07418281242e26ae88ac27_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if12b1ab4a6244599831e9df4b3d630d5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie313cb8f8e784d82b8ae991a863ca12c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6696160e9f0146f7bee8c94a11813846_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic790b5e0a22343c88149b3aa20638bbe_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3d6d432e3de740d2b05ca748ea45be9a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaad9f14d4ad04902a0ea102d27e11be4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5b3cf5a61a1e4ab181aaf966a0f14569_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1ce0655576844f1290eb9958550ec9af_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic2f48884d4a143de8f95a4b3a211788e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3ca7d470a3274ceaa4b0cd0f4f1c8bad_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">lgnd:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2ad7defd94a44484b2144c9440eb26ff_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">lgnd:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i25d3b1f41ab6459bbb46a5beb92b4ef3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i67a7f28b4edc41f8a4828a6e2caa478f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i07e4bdb069784c6995843f555b7fc3df_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2701c5cf7228445c8f19ae56602a97cf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i181eff0de1144e58b256d8ec0c77ad61_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ide40dc66b4694626bfa8f046840911c4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i744575df31604eb09f525875d978efa1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie8c9e47632c8468988399e7e93608f12_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib9073dde9293463fa30e092e8acddc86_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CydexPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie069fdb21c2e4a7f9f6faafc2d873eaf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CydexPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic917cc56cbc14ef49457a08f97faabb2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CydexPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i419fb6a0c6af4050bccc7d5632925f3b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CydexPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1a5eaef79f744090a57acf2dd9bc3f41_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CydexPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i36ae892ec43144929bf8462e64709b35_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisTherapeuticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie9a291d0bcd642c590a67f6bf07d86c7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisTherapeuticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i32c3e35d3cae415a91aa7ff9a8a97fc1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisTherapeuticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if67f5d0a5e884fae8966a608bcecbc8e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisTherapeuticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iaf9732e8831a435d9e39b39f45cb491b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisTherapeuticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i36459dab15864e27a999bdcd2e68206a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i45f91b32714d4d798c728a94c1d3c363_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1e5c28dda3f24c618a0e97fdb4db6a82_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i58c8e37938964262a8d9fbb812dc0595_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i06d744f80dd94f3190aafa087db24d87_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if7ee9d97264e44b99c988c2bc5b6d24f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4c0071327d664b04b5121faf1e1aafbb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0496dc8b573246759849c58cf2ee5081_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifb4f9e0d157846e39f3e696539899f72_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iae45ac44b4cf4613953eedfe31c7f341_D20220601-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:TwoThousandTwoStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i14ec222f5248466398774a2561f84042_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:TwoThousandTwoStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i59fa0ea34268498a977d54122e7473c5_D20220101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i1e08d73fd52941c8b0a838aeb83cbe3b_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="ifb8d1e2f9bc24fa4a2bc478bc667577c_D20221101-20221101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-01</endDate>
        </period>
    </context>
    <context id="ie06ebd7de19543a9be2b5f0c195a8849_I20221101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="ieaaf4e1776ca4ee3b882116a392a5b8c_D20221102-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2022-11-02</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3ea9d8dc84e843c18bf275e4e37eca43_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic08afe60b35d4e72a651be2308becc85_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ief7b0c06377d406cb4005ea8273c1cc1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3e7d98d1709e4fe5b08bdc5dac823ced_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibd1f4da528084577aee7dcabc5455e87_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8df448bf131f436d8340558685040924_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id70a7d71b0a14b0abc0db27c646a2a71_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic75d320692e9481bb881a28239201125_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if0206a09bd2447e0b7a819f3e88399b0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if244aca373d34599b957dd0229b16240_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i53aac02f675646bc9f345ded193cb397_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ida99b6789c3a4f50b772bdb7b47fa5cd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6b63563893e044e48841c92b5fe75d81_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeSevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i832e5c7bccde4123b022c8bab92e41a3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeSevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6b74c7e45f8c4749a8ef280613702146_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3a0d0b5e84d344cfbc5b391903f924fc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia1c885f91b7f4f689c7b8a8c9df23e98_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeNineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia739273d90a041b18ac1f97de8da164c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeNineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9e0dbd02e5924340b2b6ef89413e73fd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeTenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2768e2bc60244b69915cbe3b77507013_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lgnd:ExercisePriceRangeTenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i542a16c3353248bc8dd8336f95ea2022_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id13b17e9fe134b41b5c293358c0d8d1e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i70799954d0214652bfaf7cd03d05d0e7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6721b383c78a462dad20bcc6ce92e012_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1830acfcfe9d479fa705570392f59958_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:OmniabSeparationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ice33364cbd56406b88429f2aa093f6cd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:OmniabSeparationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic7e2f70f54f74635b9da899358a0eb40_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifc03504c5b21431cb85fbddc8d239a0b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id7b81ae076014d259846e22ddab69ac4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i34a7906b62e04f2a93fcbf8c96e0b8c5_D20220101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i0b64d9bdb1cd4eceb9508d306b942d87_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i2ffc7c8d47654559a26bf1224c8dac2c_D20221101-20221101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-01</endDate>
        </period>
    </context>
    <context id="i82b4fc5c5a994b2db38284c45930d10d_I20221101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="i6bbc8a04f4fe422fbc818ec598c0b7f1_D20221102-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-02</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i47a751f245b748f0843958f32f5f80c0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0687f0c421e14290af9f6cd6184a6b5e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:TwoThousandTwoStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5e816eb25c2e46aa9b39c605fe0b678f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:TwoThousandTwoStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i955aaff5ae7f47659be272a78642d979_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:OmniabSeparationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i041cfa14d0e74eefad61ffd3960940a4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:OmniabSeparationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2739bb11c12f4306b4cbdc98a749e080_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:AmendedESPPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i747d4f67a97149e1a99e9c59c6e2de2d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:AmendedESPPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icf5e0295a2234a42822346d8b0a38103_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:AmendedESPPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2298a5c46c60467d9749217af84898cd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:AmendedESPPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iac54b9d00e76487d9a441f663e698e18_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i8364d475253b452d820d30294b040699_D20190901-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i73ee438cb9984aaa8e59bf39f453f651_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lgnd:AtTheMarketEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i4e9e56a3dff444f1b28980b0d2c80207_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7793ca8a70014fca9041f46a2bcbbb00_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4d2fbdca41684dfa9a100d455115d767_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iff27bbd909ef454a889168bc2e1dc2ab_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">lgnd:CaliforniaAndNewJerseyResearchTaxCreditCarryforwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia1547d40c4f44431b0ac46de39c392f7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i761a3b7f76b64061bb3f971fa489c7c9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:CapitalLossCarryforwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i52ab528f20684598afd7cd8e8d6192f8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1e13a6f6bcd64e4eba32eae14ed422df_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9181deee2e7d45b3a86be0f8af806dcc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib4dfcde4db4a4453ae87a69ae3dc6bb1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">lgnd:CaliforniaAndNewJerseyResearchTaxCreditCarryforwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8e5c23045c2d4ab0af6422e7ac56c5dd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6f417214d42c4bd5a425fd3e6b350310_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:CapitalLossCarryforwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2b403a13d95c4618a2a1ecf0b72f5ec3_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i897d788652aa45e480cac84774ce09ff_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9f4b841dc87a45f4876ae68269b5ee3f_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1be8c52ea4fa41c8b69ccfc9a0092bb8_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i290c867cc3064c3584ca75424dac7e37_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i85bfaefbe85344cbbe2d82fd78da0834_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic08f18c873f549b8b87bea293a4ae096_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>lgnd:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="right">
        <measure>lgnd:right</measure>
    </unit>
    <unit id="acquisition">
        <measure>lgnd:acquisition</measure>
    </unit>
    <unit id="agreement">
        <measure>lgnd:agreement</measure>
    </unit>
    <unit id="trading_day">
        <measure>lgnd:trading_day</measure>
    </unit>
    <unit id="option">
        <measure>lgnd:option</measure>
    </unit>
    <unit id="position">
        <measure>lgnd:position</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV80L2ZyYWc6MGQ1MDYyOGMzMzUyNDdmZmJhNDQwNTNmZTBlMTNiNzYvdGFibGU6MGVmOTcwMmU5MjkxNDU4ZmJhOGJmOGMyMDE1MDZmYmQvdGFibGVyYW5nZTowZWY5NzAyZTkyOTE0NThmYmE4YmY4YzIwMTUwNmZiZF8xLTEtMS0xLTExMjY0MA_05a89076-0442-45d1-8845-32bebc8a9b2b">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV80L2ZyYWc6MGQ1MDYyOGMzMzUyNDdmZmJhNDQwNTNmZTBlMTNiNzYvdGFibGU6MGVmOTcwMmU5MjkxNDU4ZmJhOGJmOGMyMDE1MDZmYmQvdGFibGVyYW5nZTowZWY5NzAyZTkyOTE0NThmYmE4YmY4YzIwMTUwNmZiZF8yLTEtMS0xLTExMjY0MA_4b6d00e2-84dd-43dd-ac76-47ad8ecb3999">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV80L2ZyYWc6MGQ1MDYyOGMzMzUyNDdmZmJhNDQwNTNmZTBlMTNiNzYvdGFibGU6MGVmOTcwMmU5MjkxNDU4ZmJhOGJmOGMyMDE1MDZmYmQvdGFibGVyYW5nZTowZWY5NzAyZTkyOTE0NThmYmE4YmY4YzIwMTUwNmZiZF8zLTEtMS0xLTExMjY0MA_1aabcf18-f422-49f3-a1cd-2e1a8587a7cd">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV80L2ZyYWc6MGQ1MDYyOGMzMzUyNDdmZmJhNDQwNTNmZTBlMTNiNzYvdGFibGU6MGVmOTcwMmU5MjkxNDU4ZmJhOGJmOGMyMDE1MDZmYmQvdGFibGVyYW5nZTowZWY5NzAyZTkyOTE0NThmYmE4YmY4YzIwMTUwNmZiZF80LTEtMS0xLTExMjY0MA_721d6096-4606-4012-be7f-ddcc66896f27">0000886163</dei:EntityCentralIndexKey>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="ic67831c921904253a87bb44165f263ef_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTctMC0xLTEtMTEyNjQw_3be36137-77b0-489a-9749-cfb3e877f98b">http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201613Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjAtMC0xLTEtMTM1NjU0_ead01d8d-25b8-4804-af03-812067b2c1eb">http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="idbafb024b44d43f0b4a9e4440b3833cb_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNzU2MQ_9d23c4d7-711e-44c5-af62-13230621da18">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i0ea94c0a78a84acbbb4c6b276629f850_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84NS9mcmFnOmYxYmE3MWM4ZGVmZDRjZGQ4NDVkMjQyZjYyYWZiZTFmL3RhYmxlOjE1ZWExNDA5YTQzZjQzN2I4ZjUwODY4YzA2MGEzM2ZhL3RhYmxlcmFuZ2U6MTVlYTE0MDlhNDNmNDM3YjhmNTA4NjhjMDYwYTMzZmFfMS0xLTEtMS0xMTI2NDA_5f2a2bf8-16e0-42b9-8c4e-0d20a1705d87"
      unitRef="number">0.1250</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i0c3c548b83e74abda3686b765b62aafc_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84NS9mcmFnOmYxYmE3MWM4ZGVmZDRjZGQ4NDVkMjQyZjYyYWZiZTFmL3RhYmxlOjE1ZWExNDA5YTQzZjQzN2I4ZjUwODY4YzA2MGEzM2ZhL3RhYmxlcmFuZ2U6MTVlYTE0MDlhNDNmNDM3YjhmNTA4NjhjMDYwYTMzZmFfMi0xLTEtMS0xMTI2NDA_5d587b9a-0f6b-4260-ad27-2cf8ed0ccf75"
      unitRef="number">0.0208</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfMjc0ODc3OTA5MTQ4Mw_faecaf46-33bf-4086-b9d1-f6c39448988e">http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense</us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzExLTAtMS0xLTExMjY0MA_a1a5fccc-ae24-4f80-98b2-5c22c6e04753">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzExLTAtMS0xLTExMjY0MA_f02bfdd2-8ed4-4dd1-a881-ebd664bece19">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i6a379c1b7d334bdcada538a9c12cb207_D20221115-20221115"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDYvZnJhZzpkZmNmMTA2NjYxYjU0YmQxYjEwZmJiM2I1YjAxNTRkNC90YWJsZTpjZjZiMmQ5NzkyNDg0YmNlYmY4NmQyYmI1OTFlOTRkMS90YWJsZXJhbmdlOmNmNmIyZDk3OTI0ODRiY2ViZjg2ZDJiYjU5MWU5NGQxXzItMy0xLTEtMTIyMDQ4_3b59526d-b59c-44a4-b205-4033965a1849"
      unitRef="number">0.004893</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i1129e67c6bf84ef883ea9a80f1135ee7_D20221115-20221115"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDYvZnJhZzpkZmNmMTA2NjYxYjU0YmQxYjEwZmJiM2I1YjAxNTRkNC90YWJsZTpjZjZiMmQ5NzkyNDg0YmNlYmY4NmQyYmI1OTFlOTRkMS90YWJsZXJhbmdlOmNmNmIyZDk3OTI0ODRiY2ViZjg2ZDJiYjU5MWU5NGQxXzItNC0xLTEtMTIyMDQ4_a00fbf93-721c-46ca-b618-dead5c8a8fe6"
      unitRef="number">0.0062907</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="idbafb024b44d43f0b4a9e4440b3833cb_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzE3MDc_277b8799-ffa7-4ac8-873b-e1ce3c67cce8">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <dei:DocumentType
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGV4dHJlZ2lvbjoyOGY3MDk2NGZhYTg0YjQ2ODE1MjdkYjcwNGUzZGI4N180MDQ5_70af6b6e-71a3-4744-b875-61943131ffce">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGFibGU6MzY4ZjQ4ZDU2MTFlNDE0Yjk3NDkyZGQyZDcwMDRiMTUvdGFibGVyYW5nZTozNjhmNDhkNTYxMWU0MTRiOTc0OTJkZDJkNzAwNGIxNV8wLTAtMS0xLTExMjY0MA_9b920909-1775-4bcf-b781-9b9d949ff88f">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGV4dHJlZ2lvbjoyOGY3MDk2NGZhYTg0YjQ2ODE1MjdkYjcwNGUzZGI4N18zMDM_3bdb6b11-0a4f-4e0c-a429-6e9a0836c18b">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGV4dHJlZ2lvbjoyOGY3MDk2NGZhYTg0YjQ2ODE1MjdkYjcwNGUzZGI4N18zMDM_976ef479-d7bd-4052-86d3-e58ae2c5ef1c">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGFibGU6M2JjYzNlMDA5ZWM1NDY1Mzg2OGQ5NDA1ZDlhODVhMjUvdGFibGVyYW5nZTozYmNjM2UwMDllYzU0NjUzODY4ZDk0MDVkOWE4NWEyNV8wLTAtMS0xLTExMjY0MA_e4a8478d-51e1-42df-8da4-0a6f403fdc01">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGV4dHJlZ2lvbjoyOGY3MDk2NGZhYTg0YjQ2ODE1MjdkYjcwNGUzZGI4N180MDQz_4a76d553-5af5-43a3-8571-87235a6fa4bb">001-33093</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGV4dHJlZ2lvbjoyOGY3MDk2NGZhYTg0YjQ2ODE1MjdkYjcwNGUzZGI4N180MDQ0_69734c33-576e-4fe0-bb1f-c13212dd0498">LIGAND PHARMACEUTICALS INC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGFibGU6MWRiODE4NGNiYjliNGM4MDlkYTY3NDhhMDU1MzJhYTEvdGFibGVyYW5nZToxZGI4MTg0Y2JiOWI0YzgwOWRhNjc0OGEwNTUzMmFhMV8wLTAtMS0xLTExMjY0MA_162dcf73-b845-4cea-aaed-b83b3fb736f3">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGFibGU6MWRiODE4NGNiYjliNGM4MDlkYTY3NDhhMDU1MzJhYTEvdGFibGVyYW5nZToxZGI4MTg0Y2JiOWI0YzgwOWRhNjc0OGEwNTUzMmFhMV8wLTItMS0xLTExMjY0MA_d8606948-89eb-4dd1-bef7-ebba94da5e01">77-0160744</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGFibGU6MWRiODE4NGNiYjliNGM4MDlkYTY3NDhhMDU1MzJhYTEvdGFibGVyYW5nZToxZGI4MTg0Y2JiOWI0YzgwOWRhNjc0OGEwNTUzMmFhMV8zLTAtMS0xLTExMjY0MA_461f5be1-7dba-43e3-a1e3-702afe123b46">3911 Sorrento Valley Boulevard, Suite 110</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGFibGU6MWRiODE4NGNiYjliNGM4MDlkYTY3NDhhMDU1MzJhYTEvdGFibGVyYW5nZToxZGI4MTg0Y2JiOWI0YzgwOWRhNjc0OGEwNTUzMmFhMV80LTAtMS0xLTExMjY0MA_3dc0f92d-7dbf-4181-ad14-ffdefc31ffac">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGFibGU6MWRiODE4NGNiYjliNGM4MDlkYTY3NDhhMDU1MzJhYTEvdGFibGVyYW5nZToxZGI4MTg0Y2JiOWI0YzgwOWRhNjc0OGEwNTUzMmFhMV81LTAtMS0xLTExMjY0MA_5c32b032-eb34-40cb-aafc-bd5d03a45aac">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGFibGU6MWRiODE4NGNiYjliNGM4MDlkYTY3NDhhMDU1MzJhYTEvdGFibGVyYW5nZToxZGI4MTg0Y2JiOWI0YzgwOWRhNjc0OGEwNTUzMmFhMV81LTItMS0xLTExMjY0MA_474a5061-085c-437d-8dd6-9d65c5699dbd">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGV4dHJlZ2lvbjoyOGY3MDk2NGZhYTg0YjQ2ODE1MjdkYjcwNGUzZGI4N180MDQ1_6397fcff-1e7d-4f11-8d87-0ca73c9e32e0">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGV4dHJlZ2lvbjoyOGY3MDk2NGZhYTg0YjQ2ODE1MjdkYjcwNGUzZGI4N180MDM4_6076db34-dbc8-4a9a-a045-c75f7d60531a">550-7500</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGFibGU6NjIwMzkzODk5N2UwNDY4ODg4NzQzYWI0YTUzY2VhODgvdGFibGVyYW5nZTo2MjAzOTM4OTk3ZTA0Njg4ODg3NDNhYjRhNTNjZWE4OF8xLTAtMS0xLTExMjY0MA_7e9b0b4e-e331-4107-ac52-f51c3b774126">Common Stock, par value $.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGFibGU6NjIwMzkzODk5N2UwNDY4ODg4NzQzYWI0YTUzY2VhODgvdGFibGVyYW5nZTo2MjAzOTM4OTk3ZTA0Njg4ODg3NDNhYjRhNTNjZWE4OF8xLTEtMS0xLTExMjY0MA_70497721-73be-406b-9500-24fe24a514f6">LGND</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGFibGU6NjIwMzkzODk5N2UwNDY4ODg4NzQzYWI0YTUzY2VhODgvdGFibGVyYW5nZTo2MjAzOTM4OTk3ZTA0Njg4ODg3NDNhYjRhNTNjZWE4OF8xLTItMS0xLTExMjY0MA_bd2604a1-bc47-48ef-abdb-c6e87cb1b43f">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGV4dHJlZ2lvbjoyOGY3MDk2NGZhYTg0YjQ2ODE1MjdkYjcwNGUzZGI4N180MDUw_da2a447d-1c76-44a3-a5b3-e4a8b685a254">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGV4dHJlZ2lvbjoyOGY3MDk2NGZhYTg0YjQ2ODE1MjdkYjcwNGUzZGI4N180MDM5_f2b886e9-e0d6-46c8-b3f4-e033ea0fc3b2">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGV4dHJlZ2lvbjoyOGY3MDk2NGZhYTg0YjQ2ODE1MjdkYjcwNGUzZGI4N180MDQw_cfa1a62b-defc-4d94-bb31-1bb2c35e54f6">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGV4dHJlZ2lvbjoyOGY3MDk2NGZhYTg0YjQ2ODE1MjdkYjcwNGUzZGI4N180MDQx_b522d9a7-61bc-4a00-ac80-20e906e1ffd7">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGFibGU6Mjg2NzAwYWI0YjU0NDQ1YWIyMjdiNTYwNWRmOThmN2UvdGFibGVyYW5nZToyODY3MDBhYjRiNTQ0NDVhYjIyN2I1NjA1ZGY5OGY3ZV8wLTAtMS0xLTExMjY0MA_1dd655e6-643f-44fb-9310-99c00ae678e5">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGFibGU6Mjg2NzAwYWI0YjU0NDQ1YWIyMjdiNTYwNWRmOThmN2UvdGFibGVyYW5nZToyODY3MDBhYjRiNTQ0NDVhYjIyN2I1NjA1ZGY5OGY3ZV8wLTgtMS0xLTExMjY0MA_6f19cd9c-e56a-4e16-8b25-41a22f785ec3">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGFibGU6Mjg2NzAwYWI0YjU0NDQ1YWIyMjdiNTYwNWRmOThmN2UvdGFibGVyYW5nZToyODY3MDBhYjRiNTQ0NDVhYjIyN2I1NjA1ZGY5OGY3ZV8wLTEwLTEtMS0xMTI2NDA_daaf5d74-b7ee-4797-afb4-cc4d46be3763">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGV4dHJlZ2lvbjoyOGY3MDk2NGZhYTg0YjQ2ODE1MjdkYjcwNGUzZGI4N180MDQ3_0c8a82b4-9696-4a55-b657-415d33b50035">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGV4dHJlZ2lvbjoyOGY3MDk2NGZhYTg0YjQ2ODE1MjdkYjcwNGUzZGI4N180MDQy_38ae7d20-ab86-45db-a5f6-68cc6666c952">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="ia41df9d4ed2a449d9d3a0d5079eee8d8_I20220630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGV4dHJlZ2lvbjoyOGY3MDk2NGZhYTg0YjQ2ODE1MjdkYjcwNGUzZGI4N18yODk5_6ee2b9b6-7595-4ed7-9c93-659e42d545fa"
      unitRef="usd">1000000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i60e7b5cfa61b4bd3ba008a679e0b0390_I20230222"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGV4dHJlZ2lvbjoyOGY3MDk2NGZhYTg0YjQ2ODE1MjdkYjcwNGUzZGI4N18zNTEy_da1c55b4-cbd0-4490-8dfd-fb2a1843a4ad"
      unitRef="shares">17076658</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xL2ZyYWc6MjhmNzA5NjRmYWE4NGI0NjgxNTI3ZGI3MDRlM2RiODcvdGV4dHJlZ2lvbjoyOGY3MDk2NGZhYTg0YjQ2ODE1MjdkYjcwNGUzZGI4N180MDQ2_94331132-7e40-4a5b-93d5-55c1a6bd595b">Portions of the Proxy Statement for the Registrant&#x2019;s 2023 Annual Meeting of Stockholders to be filed with the Commission within 120 days of December&#160;31, 2022 are incorporated by reference in Part&#160;III of this Annual Report on Form&#160;10-K.&#160;With the exception of those portions that are specifically incorporated by reference in this Annual Report on Form&#160;10-K, such Proxy Statement shall not be deemed filed as part of this Report or incorporated by reference herein.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorFirmId
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV81OC9mcmFnOjFjNDE1NjZmMWJhYTRlODg4ZWIxMTE5OTkxNmQ3NGZlL3RhYmxlOmJjZTBkODY0NGM4YzQxMjI5NDdhZGZmZWY0NzMzNzYxL3RhYmxlcmFuZ2U6YmNlMGQ4NjQ0YzhjNDEyMjk0N2FkZmZlZjQ3MzM3NjFfMS0wLTEtMS0xMTI2NDAvdGV4dHJlZ2lvbjplYWJiMGE3YjgxMTk0ZTc1YjdmMjNiZThmOGE2Njg2ZV83Mg_67b74a41-13bf-4e51-8abf-2a49ac6aeff6">42</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82MS9mcmFnOjYzYjliNDM5NTU4NDQ4MjM5NGZhMmQ4NzVjMjdiMjdiL3RleHRyZWdpb246NjNiOWI0Mzk1NTg0NDgyMzk0ZmEyZDg3NWMyN2IyN2JfMzU2MQ_3c3d4c32-3136-4f2f-97c1-2beb9363ed19">Ernst&#160;&amp; Young&#160;LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82MS9mcmFnOjYzYjliNDM5NTU4NDQ4MjM5NGZhMmQ4NzVjMjdiMjdiL3RleHRyZWdpb246NjNiOWI0Mzk1NTg0NDgyMzk0ZmEyZDg3NWMyN2IyN2JfMzU2Mw_9bc92b44-7800-46ec-8f1e-3ab7a2ae79dc">San Diego, California</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfNC0xLTEtMS0xMTI2NDA_0ba6f04e-d6e5-4c48-b0f9-7c456478341a"
      unitRef="usd">45006000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfNC0zLTEtMS0xMTI2NDA_623472f1-1e8a-41e3-86c4-4de1af4f5cc6"
      unitRef="usd">19522000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfNS0xLTEtMS0xMTI2NDA_4ac9f862-5fb4-499e-8814-34081f84e689"
      unitRef="usd">166864000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfNS0zLTEtMS0xMTI2NDA_244219af-50a5-4f66-89c6-2adae2cdc8ff"
      unitRef="usd">321586000</us-gaap:ShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfNi0xLTEtMS0xMTI2NDA_9b0bd8cd-d185-4fa4-88f8-281777c87a57"
      unitRef="usd">30424000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfNi0zLTEtMS0xMTI2NDA_f1be9f7b-6d2e-4014-ac5f-bfbd3495e248"
      unitRef="usd">85453000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfNy0xLTEtMS0xMTI2NDA_d42453db-3165-48ec-be04-0c8b0f41d38d"
      unitRef="usd">13294000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfNy0zLTEtMS0xMTI2NDA_c1d4bc0c-5648-4797-a2d5-6f62d77bbe5d"
      unitRef="usd">27326000</us-gaap:InventoryNet>
    <us-gaap:IncomeTaxesReceivable
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfOC0xLTEtMS0xMTI2NDA_029ad174-4be4-481e-b139-09b6e9979dde"
      unitRef="usd">4614000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfOC0zLTEtMS0xMTI2NDA_fbf0a3e5-eaf6-4ab6-83d0-274d685f4e2a"
      unitRef="usd">6193000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:OtherAssetsCurrent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfOS0xLTEtMS0xMTI2NDA_11c39aaa-0452-41ad-9fe4-9d3b24e3cf42"
      unitRef="usd">3399000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfOS0zLTEtMS0xMTI2NDA_e8074175-a335-481b-be46-2e72d5c8e581"
      unitRef="usd">3571000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTAtMS0xLTEtMTE2Mzcx_42b0e1e9-31fd-4976-9bd1-87e4277d8507"
      unitRef="usd">0</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTAtMy0xLTEtMTE2Mzc0_922db2a4-ed47-4287-9a65-e72001859f63"
      unitRef="usd">1100000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTAtMS0xLTEtMTEyNjQw_e1bdd2c2-7aaa-4402-8f5d-f198e308102b"
      unitRef="usd">263601000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTAtMy0xLTEtMTEyNjQw_220de77a-e8c6-40fb-bd63-c70a617bf8e9"
      unitRef="usd">464751000</us-gaap:AssetsCurrent>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTEtMS0xLTEtMTEyNjQw_4e1c5da5-c1b4-4465-b53d-b91a7e97ae55"
      unitRef="usd">8530000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTEtMy0xLTEtMTEyNjQw_93cb6b22-8d72-445d-9d39-6c9b8c512b37"
      unitRef="usd">35729000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTItMS0xLTEtMTEyNjQw_b58c5282-7c64-4d09-91a2-4d02c4170afb"
      unitRef="usd">342455000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTItMy0xLTEtMTEyNjQw_e3c439d4-e2b6-4dca-bbd9-97e5170286e8"
      unitRef="usd">376691000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTMtMS0xLTEtMTEyNjQw_214f38af-8913-4314-804e-7f58f16452e7"
      unitRef="usd">105673000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTMtMy0xLTEtMTEyNjQw_8be9cb60-24ac-4541-a904-2928d06d217d"
      unitRef="usd">105673000</us-gaap:Goodwill>
    <lgnd:CommercialLicenseRights
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTQtMS0xLTEtMTEyNjQw_1d01c7cc-d48e-4988-ade2-21b020ceed85"
      unitRef="usd">10182000</lgnd:CommercialLicenseRights>
    <lgnd:CommercialLicenseRights
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTQtMy0xLTEtMTEyNjQw_b0dd51b9-e82f-4d2b-b1f8-338d69421c82"
      unitRef="usd">10110000</lgnd:CommercialLicenseRights>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTUtMS0xLTEtMTEyNjQw_1752cf54-9e65-4fed-b648-d1b3708efaea"
      unitRef="usd">12482000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTUtMy0xLTEtMTEyNjQw_950e22b9-a3e6-4270-a326-4ed4d1864075"
      unitRef="usd">13191000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTYtMS0xLTEtMTEyNjQw_ed2f4cc5-1bf2-4564-ab69-ab098933ade0"
      unitRef="usd">10914000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTYtMy0xLTEtMTEyNjQw_09fefe12-65dd-4c0c-8969-ec337b201edb"
      unitRef="usd">3210000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTctMS0xLTEtMTEyNjQw_337d761c-718f-41b0-97c6-25d11ea3d137"
      unitRef="usd">4095000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTctMy0xLTEtMTEyNjQw_205a7bb4-8b7c-44b2-8e9c-0b3a5a59c7e2"
      unitRef="usd">16201000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTgtMS0xLTEtMTEyNjQw_bc7f8ef5-e1e1-4487-867c-9568d1f94f83"
      unitRef="usd">4736000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTgtMy0xLTEtMTEyNjQw_d8a070dd-01ce-4905-9887-f994924d22ee"
      unitRef="usd">1251000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjAtMS0xLTEtMTE2Mzc2_d0aa78d7-c6a9-4d25-9b83-8578df10b2cf"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjAtMy0xLTEtMTE2Mzc4_21a122b3-9bae-49e1-989b-e8a18e8c8607"
      unitRef="usd">270783000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTktMS0xLTEtMTEyNjQw_d1d63ae0-d7c7-4ff1-a67c-73f895609635"
      unitRef="usd">762668000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMTktMy0xLTEtMTEyNjQw_54eb1e0a-2b2c-49ef-80cc-860cdc03f549"
      unitRef="usd">1297590000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjItMS0xLTEtMTEyNjQw_9ab477df-922b-4df3-9972-622af04e65d2"
      unitRef="usd">5307000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjItMy0xLTEtMTEyNjQw_b5e24296-f828-48fc-8bdc-98534ee19f66"
      unitRef="usd">8403000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjMtMS0xLTEtMTEyNjQw_8cea5c21-0438-4b16-ab4f-b2712bfcaedf"
      unitRef="usd">15681000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjMtMy0xLTEtMTEyNjQw_ca21393b-3a52-4ed3-aa36-47594bdf8bef"
      unitRef="usd">17579000</us-gaap:AccruedLiabilitiesCurrent>
    <lgnd:CurrentPortionOfLiabilityForContingentValueRights
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjQtMS0xLTEtMTEyNjQw_f7912f66-63cf-4a74-8597-ce8c32c4e2cc"
      unitRef="usd">57000</lgnd:CurrentPortionOfLiabilityForContingentValueRights>
    <lgnd:CurrentPortionOfLiabilityForContingentValueRights
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjQtMy0xLTEtMTEyNjQw_1794fbe8-488e-43e4-a2dc-6510d3bb7a2b"
      unitRef="usd">50000</lgnd:CurrentPortionOfLiabilityForContingentValueRights>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjUtMS0xLTEtMTEyNjQw_b064a6e2-4423-435b-9325-6d5db6e1f3fe"
      unitRef="usd">355000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjUtMy0xLTEtMTEyNjQw_1abf7827-e76e-4d13-871f-683787ad8066"
      unitRef="usd">654000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjYtMS0xLTEtMTEyNjQw_64e9501b-f5e9-4879-94e7-467d8b73e497"
      unitRef="usd">670000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjYtMy0xLTEtMTEyNjQw_cd92ea14-83f9-41af-ae5d-b60933b6d5c0"
      unitRef="usd">1368000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjctMS0xLTEtMTEyNjQw_e088b548-4dc6-42c0-9cef-9fc9c325f7cd"
      unitRef="usd">45000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjctMy0xLTEtMTEyNjQw_3e7b7987-de4f-40d5-aea0-50f2a2a98ac2"
      unitRef="usd">45000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzEtMS0xLTEtMTE3NzIw_d753737c-e40b-4cd6-ac7b-ad0114aff87e"
      unitRef="usd">76695000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzEtMy0xLTEtMTE3NzMw_4628a2f5-c6a1-46b1-90e4-ca57d0cb1eb9"
      unitRef="usd">0</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzAtMS0xLTEtMTE2Mzgw_bacfcb4d-b85f-4835-9438-a4dc0b824b24"
      unitRef="usd">0</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzAtMy0xLTEtMTE2Mzgy_a9058820-67c2-468e-bfc1-067955dd1989"
      unitRef="usd">13566000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjgtMS0xLTEtMTEyNjQw_259610f6-c916-45e5-9ff8-46e7de2aef86"
      unitRef="usd">98810000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjgtMy0xLTEtMTEyNjQw_77a60440-b131-492f-abb0-6b3be2647aab"
      unitRef="usd">41665000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjktMS0xLTEtMTEyNjQw_566da830-d7ed-45c6-b5f9-e05024363b9b"
      unitRef="usd">0</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMjktMy0xLTEtMTEyNjQw_02c16771-88cf-4298-916e-db0e730e8b21"
      unitRef="usd">320717000</us-gaap:ConvertibleDebtNoncurrent>
    <lgnd:LiabilityForContingentValueRights
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzAtMS0xLTEtMTEyNjQw_bba470e1-ba13-4d81-9080-b70e77bd0d04"
      unitRef="usd">3456000</lgnd:LiabilityForContingentValueRights>
    <lgnd:LiabilityForContingentValueRights
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzAtMy0xLTEtMTEyNjQw_00e18046-4cb4-4fab-99c5-e0fa1ad5b2f5"
      unitRef="usd">3657000</lgnd:LiabilityForContingentValueRights>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzEtMS0xLTEtMTEyNjQw_6117fd88-698a-4f4d-b616-862cce0210a3"
      unitRef="usd">30615000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzEtMy0xLTEtMTEyNjQw_f16ac74b-5458-42b5-896b-fc1395e48fe6"
      unitRef="usd">30856000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzItMS0xLTEtMTEyNjQw_40991ea0-ff98-4653-ab6e-da653e49f042"
      unitRef="usd">10336000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzItMy0xLTEtMTEyNjQw_0a7c524c-1751-45c4-bef0-a1c5b77e8c53"
      unitRef="usd">2256000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzMtMS0xLTEtMTEyNjQw_67e91ed4-6910-4881-bf36-a8e35b2e6c20"
      unitRef="usd">21966000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzMtMy0xLTEtMTEyNjQw_6be51cd7-c7a9-4e69-91b4-3c51c852e2bf"
      unitRef="usd">21752000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzctMS0xLTEtMTE2Mzg0_2c9b5649-2699-461d-a84d-5cc72c9b1a55"
      unitRef="usd">0</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzctMy0xLTEtMTE2Mzg2_98281c5e-8c96-4477-a1ca-cd4cbe22001e"
      unitRef="usd">55528000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent>
    <us-gaap:Liabilities
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzQtMS0xLTEtMTEyNjQw_b4a59116-1510-4bb1-b728-a2ae5da1f75a"
      unitRef="usd">165183000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzQtMy0xLTEtMTEyNjQw_18aba139-1d90-4717-87ff-616ae4f57e89"
      unitRef="usd">476431000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzUtMS0xLTEtMTEyNjQw_91a6225b-1dc5-4a80-86f7-0f2592a6bb3f"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzUtMy0xLTEtMTEyNjQw_83112bf7-e34f-49ea-81bd-cbec49453a0d"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzctMC0xLTEtMTEyNjQwL3RleHRyZWdpb246MmMyYWRjNTg1M2UwNDZjMGI2MzMxNDQ0Nzk3MWUyYmJfMjc_2929aa6b-20a2-40ca-b29c-5cdae4581b38"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzctMC0xLTEtMTEyNjQwL3RleHRyZWdpb246MmMyYWRjNTg1M2UwNDZjMGI2MzMxNDQ0Nzk3MWUyYmJfMjc_e3f5105d-9965-424e-bb01-3cd73690e612"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzctMC0xLTEtMTEyNjQwL3RleHRyZWdpb246MmMyYWRjNTg1M2UwNDZjMGI2MzMxNDQ0Nzk3MWUyYmJfNDE_1922bf50-7070-414a-85d3-e54f3d7fd2be"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzctMC0xLTEtMTEyNjQwL3RleHRyZWdpb246MmMyYWRjNTg1M2UwNDZjMGI2MzMxNDQ0Nzk3MWUyYmJfNDE_bf5f61ab-85f9-4599-b545-2de9cc82e3a3"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzctMC0xLTEtMTEyNjQwL3RleHRyZWdpb246MmMyYWRjNTg1M2UwNDZjMGI2MzMxNDQ0Nzk3MWUyYmJfNjM_429dc88b-813b-469e-85f2-c76638820e07"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzctMC0xLTEtMTEyNjQwL3RleHRyZWdpb246MmMyYWRjNTg1M2UwNDZjMGI2MzMxNDQ0Nzk3MWUyYmJfNjM_a2e8ef2e-0b43-4030-b311-2a66a69174a3"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzctMC0xLTEtMTEyNjQwL3RleHRyZWdpb246MmMyYWRjNTg1M2UwNDZjMGI2MzMxNDQ0Nzk3MWUyYmJfNjM_b47f5d71-6376-43dd-813c-bec606210e84"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzctMC0xLTEtMTEyNjQwL3RleHRyZWdpb246MmMyYWRjNTg1M2UwNDZjMGI2MzMxNDQ0Nzk3MWUyYmJfNjM_de970e5f-22fb-4ff2-89af-d6910b501abb"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzctMS0xLTEtMTEyNjQw_5a0e59f8-58ac-4de8-a458-363cec6332d4"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzctMy0xLTEtMTEyNjQw_947a3660-19ec-497a-91f6-d0a3e761cfda"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzgtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246ZDViOGFlNjQ2MjA0NGU3NWEwMDA1ZTkzNDMzYjBmNGFfMTk_5bf8f9f9-93b9-4341-ac07-b0fee75a20f2"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzgtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246ZDViOGFlNjQ2MjA0NGU3NWEwMDA1ZTkzNDMzYjBmNGFfMTk_fb0ec03b-bbb2-46ec-9e2d-80894424a468"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzgtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246ZDViOGFlNjQ2MjA0NGU3NWEwMDA1ZTkzNDMzYjBmNGFfMzM_d4948ec8-e48a-4382-9f6e-b4562582d3a5"
      unitRef="shares">60000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzgtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246ZDViOGFlNjQ2MjA0NGU3NWEwMDA1ZTkzNDMzYjBmNGFfMzM_e14a602b-786b-490d-bb04-b05fee285366"
      unitRef="shares">60000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzgtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246ZDViOGFlNjQ2MjA0NGU3NWEwMDA1ZTkzNDMzYjBmNGFfNTU_017f959d-eede-4bbb-9efa-2ebfb7d750ba"
      unitRef="shares">16951000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzgtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246ZDViOGFlNjQ2MjA0NGU3NWEwMDA1ZTkzNDMzYjBmNGFfNTU_285f5ac9-5c8c-4373-86dd-611d36607895"
      unitRef="shares">16951000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzgtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246ZDViOGFlNjQ2MjA0NGU3NWEwMDA1ZTkzNDMzYjBmNGFfNjI_77fcb6f4-fe8d-4255-a0b5-5dc00b926592"
      unitRef="shares">16767000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzgtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246ZDViOGFlNjQ2MjA0NGU3NWEwMDA1ZTkzNDMzYjBmNGFfNjI_ab67b6aa-a5ca-4c5b-adac-772596a8c46c"
      unitRef="shares">16767000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzgtMS0xLTEtMTEyNjQw_c9b2cc39-45ea-49a7-a856-a6adb16b42cf"
      unitRef="usd">17000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzgtMy0xLTEtMTEyNjQw_0e0ee862-5620-48fd-9399-454ed8f18b2f"
      unitRef="usd">17000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzktMS0xLTEtMTEyNjQw_ffda42fb-3142-497e-a954-4f3e6ae5b64d"
      unitRef="usd">147590000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfMzktMy0xLTEtMTEyNjQw_244bf965-94ec-44de-b998-95991709c7f1"
      unitRef="usd">372969000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfNDAtMS0xLTEtMTEyNjQw_13c6139f-a3d9-4ab2-bde6-bdf73adcd983"
      unitRef="usd">-984000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfNDAtMy0xLTEtMTEyNjQw_2a63ccb1-6bd6-464b-a4c1-12cfefab9762"
      unitRef="usd">-917000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfNDEtMS0xLTEtMTEyNjQw_110d1e10-9e8b-4073-9e1b-5a9a7e17ffc4"
      unitRef="usd">450862000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfNDEtMy0xLTEtMTEyNjQw_0f081060-7693-461c-88c5-99336980099c"
      unitRef="usd">449090000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfNDItMS0xLTEtMTEyNjQw_8097b87b-7e7e-4e92-b16a-0654f8a42c47"
      unitRef="usd">597485000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfNDItMy0xLTEtMTEyNjQw_5a1eaf47-75d7-4dd2-870a-982c65e18477"
      unitRef="usd">821159000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfNDMtMS0xLTEtMTEyNjQw_43eddb34-c3c6-46e0-8c3d-54469b3e513c"
      unitRef="usd">762668000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82NC9mcmFnOjU1YWU1NjBhM2Y4ZTQ4NDBiMDE5ZmVjMGQyN2YwOWUzL3RhYmxlOmRkY2YyZjllOGUyZDRhMGE5MTYyOWQ1MjY4YTlhM2E0L3RhYmxlcmFuZ2U6ZGRjZjJmOWU4ZTJkNGEwYTkxNjI5ZDUyNjhhOWEzYTRfNDMtMy0xLTEtMTEyNjQw_a49ab76a-cf7a-4451-90bd-7d9fa24e0720"
      unitRef="usd">1297590000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i91e01e3752fa4607875a52688c787ed4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMy0xLTEtMS0xMTI2NDA_9136db05-d6fe-433a-868a-698f154643bd"
      unitRef="usd">72527000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7acccfdc49ae41ec9d81e2a77aaeab89_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMy0zLTEtMS0xMTI2NDA_b399f0e4-032c-4e2d-9bc9-56df934ba1a7"
      unitRef="usd">48927000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8303bd1e530e4c06b3bb8c3093343f43_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMy01LTEtMS0xMTI2NDA_27a82ce6-40e9-4c80-bad8-82e932c35ae2"
      unitRef="usd">33796000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if07332e474464098b61af13fe5a470f2_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfNC0xLTEtMS0xMTI2NDA_2968564b-fdaa-47b4-a930-0e4af76ed839"
      unitRef="usd">104495000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6747a650dc714496a27ce80ca1fde353_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfNC0zLTEtMS0xMTI2NDA_4de27445-2d71-4207-8058-f51d94a24bf5"
      unitRef="usd">164250000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i065c2ca723f44ed7b4161976d58b5fe9_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfNC01LTEtMS0xMTI2NDA_86b11669-80b4-4efc-be7a-678e4d3a4910"
      unitRef="usd">109959000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7a2c832b6c46461c9fa690319f44159f_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfNS0xLTEtMS0xMTI2NDA_75fb1545-b874-45b0-bb6d-9ff4270f442b"
      unitRef="usd">19223000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if6041ab2411645599b1e142a09232af6_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfNS0zLTEtMS0xMTI2NDA_d44e76f9-e2d2-4bad-995f-075789cddf35"
      unitRef="usd">28367000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibbbf2bd60ac64c15aa70a568639f50ab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfNS01LTEtMS0xMTI2NDA_3c468781-341f-4236-a3e8-538ad4d721de"
      unitRef="usd">19807000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfNi0xLTEtMS0xMTI2NDA_795801c6-eeef-4a0a-887c-d68f08d456dd"
      unitRef="usd">196245000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfNi0zLTEtMS0xMTI2NDA_1f429421-fbcb-4f44-b9c9-327f791a7a6e"
      unitRef="usd">241544000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfNi01LTEtMS0xMTI2NDA_6b104122-f148-4cc2-9007-508d9db8a971"
      unitRef="usd">163562000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostDirectMaterial
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfOC0xLTEtMS0xMTI2NDA_12692914-00b1-4d0c-9996-52d5bf3ccb3c"
      unitRef="usd">52827000</us-gaap:CostDirectMaterial>
    <us-gaap:CostDirectMaterial
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfOC0zLTEtMS0xMTI2NDA_f83f46cf-7b3d-46e9-b911-c522fce88f8f"
      unitRef="usd">62176000</us-gaap:CostDirectMaterial>
    <us-gaap:CostDirectMaterial
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfOC01LTEtMS0xMTI2NDA_c54874e4-2151-438e-bfe1-328a861ff386"
      unitRef="usd">30419000</us-gaap:CostDirectMaterial>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfOS0xLTEtMS0xMTI2NDA_d6a3e768-2b8f-4551-a474-e71368061f8f"
      unitRef="usd">34237000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfOS0zLTEtMS0xMTI2NDA_dccdafb9-245e-4c65-b412-5e23fd5bdfbe"
      unitRef="usd">34222000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfOS01LTEtMS0xMTI2NDA_08c7fbac-eaa5-4910-bacf-02e6ba22ab1d"
      unitRef="usd">11642000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTAtMS0xLTEtMTEyNjQw_9083861c-b153-477f-b1d8-9b91cdab36f7"
      unitRef="usd">36082000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTAtMy0xLTEtMTEyNjQw_a76eb6e9-a494-4f70-b927-7ec33d0f5dcc"
      unitRef="usd">32105000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTAtNS0xLTEtMTEyNjQw_6ad6d67a-ccf9-4d68-b0ad-8e9e9635a090"
      unitRef="usd">40503000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTEtMS0xLTEtMTEyNjQw_5c95e674-2662-4ab9-a836-c88337c25f18"
      unitRef="usd">70062000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTEtMy0xLTEtMTEyNjQw_034a343b-671d-48c5-806f-2fe07a3d5409"
      unitRef="usd">46790000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTEtNS0xLTEtMTEyNjQw_868668ee-c1af-4c5d-a8c7-36ad20e1139f"
      unitRef="usd">60012000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTItMS0xLTEtMTEyNjQw_f048dc48-6f73-4673-961a-e70824c13830"
      unitRef="usd">0</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTItMy0xLTEtMTEyNjQw_93db6c2d-caa7-4f0a-b39e-723c36d90f98"
      unitRef="usd">37600000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTItNS0xLTEtMTEyNjQw_75fa9fec-510e-4842-b1d4-f9550a384cf2"
      unitRef="usd">-600000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTMtMS0xLTEtMTEyNjQw_2b8e9296-69bf-4a56-9a80-a852159919e1"
      unitRef="usd">193208000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTMtMy0xLTEtMTEyNjQw_7e76eff5-2f25-48ea-abcb-9104eb5a8006"
      unitRef="usd">137693000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTMtNS0xLTEtMTEyNjQw_afa20dc3-85a4-4b59-8c52-527ae2ac8e1c"
      unitRef="usd">143176000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:GainLossOnDispositionOfIntangibleAssets
      contextRef="i6b86bff9b54f4d76bce0d4e8b7a8fb96_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTQtMS0xLTEtMTEyNjQw_5b135cfa-bbc6-4653-ba3c-62b220a91f33"
      unitRef="usd">0</us-gaap:GainLossOnDispositionOfIntangibleAssets>
    <us-gaap:GainLossOnDispositionOfIntangibleAssets
      contextRef="i9b297d5d47f94315a7c2461666a1e657_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTQtMy0xLTEtMTEyNjQw_6e582e2e-710c-418a-9206-818a681409b5"
      unitRef="usd">0</us-gaap:GainLossOnDispositionOfIntangibleAssets>
    <us-gaap:GainLossOnDispositionOfIntangibleAssets
      contextRef="iccc4fa061bfd4f28acff3954baafb1a4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTQtNS0xLTEtMTEyNjQw_a6040ee5-a047-42c3-8892-c890d4c3f561"
      unitRef="usd">17114000</us-gaap:GainLossOnDispositionOfIntangibleAssets>
    <us-gaap:OperatingIncomeLoss
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTYtMS0xLTEtMTEyNjQw_4951fddf-973c-4ee3-8f91-0f24a736914a"
      unitRef="usd">3037000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTYtMy0xLTEtMTEyNjQw_84afe9df-422a-4667-857d-b40ec1f3d13b"
      unitRef="usd">103851000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTYtNS0xLTEtMTEyNjQw_0256f173-c849-48e8-a92e-28bc35d0b0b8"
      unitRef="usd">37500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:GainLossOnInvestments
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTgtMS0xLTEtMTEyNjQw_29e784e7-eda8-40db-8e46-e26374412f3e"
      unitRef="usd">28540000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTgtMy0xLTEtMTEyNjQw_1edc0740-1442-44d3-bbbc-29d6fc9285a5"
      unitRef="usd">-5263000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTgtNS0xLTEtMTEyNjQw_e9492b1e-675e-476a-a6df-c261060b4ed4"
      unitRef="usd">-16933000</us-gaap:GainLossOnInvestments>
    <us-gaap:InvestmentIncomeInterest
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTktMS0xLTEtMTEyNjQw_60b996ae-ad3b-44cc-bd49-24634e70166f"
      unitRef="usd">2046000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTktMy0xLTEtMTEyNjQw_b3c371df-306b-4113-ab8a-ea0785901eae"
      unitRef="usd">886000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMTktNS0xLTEtMTEyNjQw_c3999307-efbc-4ac2-8c68-0bd2f8d1a1be"
      unitRef="usd">8078000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjAtMS0xLTEtMTEyNjQw_a74fc40d-14c8-479a-ac2a-c25d41f5d7cd"
      unitRef="usd">1799000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjAtMy0xLTEtMTEyNjQw_3c0cd6b3-e407-4e62-a7a1-9d81a1074fe8"
      unitRef="usd">19619000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjAtNS0xLTEtMTEyNjQw_4ce60ef8-93a6-4fe6-a199-22181456eac1"
      unitRef="usd">27415000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjEtMS0xLTEtMTEyNjQw_6725094d-f492-4885-b35d-853be892a8ef"
      unitRef="usd">4187000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjEtMy0xLTEtMTEyNjQw_885e8416-05fb-4100-afe6-c2df17cb7ffb"
      unitRef="usd">-7650000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjEtNS0xLTEtMTEyNjQw_949e728d-7a0b-4b52-95e4-4a26665b8b7f"
      unitRef="usd">62000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjItMS0xLTEtMTEyNjQw_f378a89b-3f32-4bc6-8ada-e147ceda49a6"
      unitRef="usd">32974000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjItMy0xLTEtMTEyNjQw_506317bb-e413-42e5-b30c-940a14e276ef"
      unitRef="usd">-31646000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjItNS0xLTEtMTEyNjQw_b489cc50-9beb-44a9-9b0b-100331bfdd2c"
      unitRef="usd">-36208000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjMtMS0xLTEtMTEyNjQw_ffbe9279-1ce5-4375-b684-3728ab08a089"
      unitRef="usd">36011000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjMtMy0xLTEtMTEyNjQw_ea5c5fe8-e8bc-4dff-8394-e1875511e156"
      unitRef="usd">72205000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjMtNS0xLTEtMTEyNjQw_1e0b7c77-d306-427f-a86e-cdb5db906d30"
      unitRef="usd">1292000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjQtMS0xLTEtMTEyNjQw_8e6edaf3-cd82-43bb-9403-e0d75d7fe65c"
      unitRef="usd">41230000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjQtMy0xLTEtMTEyNjQw_be3d2fdd-6bf1-48c6-9cdc-bda91e9e4ce7"
      unitRef="usd">-4148000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjQtNS0xLTEtMTEyNjQw_0707fae0-12ec-476e-a828-82d31603f223"
      unitRef="usd">-5306000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjUtMS0xLTEtMTE2NDA4_640fce1e-7ae8-40fe-a3d1-08b6cc75d4f4"
      unitRef="usd">-5219000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjUtMy0xLTEtMTE0NjY2_cd6b69cc-8aa9-4a73-9f87-517c8d90cad2"
      unitRef="usd">76353000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjUtNS0xLTEtMTE0NjY3_57f8da30-a609-4efe-bf25-93006d1fd9e4"
      unitRef="usd">6598000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjYtMS0xLTEtMTE2NDA4_7f0da51b-f7e5-49d0-9e54-87865cc6d66e"
      unitRef="usd">-28142000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjYtMy0xLTEtMTE0NDY4_7891a66d-7cd2-48b3-83e4-ba295824b630"
      unitRef="usd">-19215000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjYtNS0xLTEtMTE0Njc2_7d3959e4-58d3-450b-b291-827bc41ba761"
      unitRef="usd">-9583000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:NetIncomeLoss
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjUtMS0xLTEtMTEyNjQw_70098963-ea30-4b9c-a1ac-784f4adff177"
      unitRef="usd">-33361000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjUtMy0xLTEtMTEyNjQw_7feb0c63-e093-4cf2-be85-964e49f35626"
      unitRef="usd">57138000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjUtNS0xLTEtMTEyNjQw_060a35ae-e38f-40b4-90ac-d8159b45a2fb"
      unitRef="usd">-2985000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjgtMS0xLTEtMTE2NDEw_2f19cc7d-b7d4-4506-be70-1672ac6a5c92"
      unitRef="usdPerShare">-0.31</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjgtMy0xLTEtMTE0Njk4_3d85e797-a1ab-41b4-bc06-f5b3005526f2"
      unitRef="usdPerShare">4.59</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjgtNS0xLTEtMTE0Njk5_dcf6f404-7752-44aa-a33b-a13b8f146fc0"
      unitRef="usdPerShare">0.41</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjktMS0xLTEtMTE2NDEw_e482bc17-58e0-4fa4-9115-87fef9a286f3"
      unitRef="usdPerShare">-1.67</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjktMy0xLTEtMTE0Njk4_b65f96ca-acdd-4bfa-ad20-2f953075e45e"
      unitRef="usdPerShare">-1.16</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjktNS0xLTEtMTE0Njk5_f60af717-674c-4daa-8412-fd73180fc338"
      unitRef="usdPerShare">-0.59</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjctMS0xLTEtMTEyNjQw_40937e9f-03ac-4b35-bbbf-bde99174c621"
      unitRef="usdPerShare">-1.98</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjctMy0xLTEtMTEyNjQw_3312272f-3be5-4f7b-87cd-2b63e7419f4a"
      unitRef="usdPerShare">3.44</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjctNS0xLTEtMTEyNjQw_c2517511-d574-42fb-9e94-0c2d5b480d20"
      unitRef="usdPerShare">-0.18</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjgtMS0xLTEtMTEyNjQw_d84f4b79-d4ec-48a8-a992-94f04dc1659e"
      unitRef="shares">16868000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjgtMy0xLTEtMTEyNjQw_5186eaaa-80e1-4f08-a8a5-ca70ededd5c6"
      unitRef="shares">16630000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMjgtNS0xLTEtMTEyNjQw_11b5457d-499c-47a1-b958-2abe7baceac7"
      unitRef="shares">16185000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMzMtMS0xLTEtMTE2NDEy_0ef7d14e-aece-4765-8ebf-3f80f5802a5e"
      unitRef="usdPerShare">-0.31</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMzMtMy0xLTEtMTE0NzI2_d5a801c0-bf8f-4694-8eb2-d43254182f81"
      unitRef="usdPerShare">4.43</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMzMtNS0xLTEtMTE0NzI3_7a1479ce-60e5-4aad-bb3c-3c2f8f01bd14"
      unitRef="usdPerShare">0.39</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMzQtMS0xLTEtMTE2NDEy_6e9badc7-3489-4a05-9b45-e837eb9b29da"
      unitRef="usdPerShare">-1.67</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMzQtMy0xLTEtMTE0NzI2_20fd674a-305b-494f-b4cd-d0cab34d2809"
      unitRef="usdPerShare">-1.11</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMzQtNS0xLTEtMTE0NzI3_b9727723-f7ab-4c21-80be-1231bb841687"
      unitRef="usdPerShare">-0.57</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMzAtMS0xLTEtMTEyNjQw_e641e773-a6e3-48d4-92c7-faec9ef9fd57"
      unitRef="usdPerShare">-1.98</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMzAtMy0xLTEtMTEyNjQw_51e2c2ee-4cd5-47a9-b046-f27e236a79cb"
      unitRef="usdPerShare">3.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMzAtNS0xLTEtMTEyNjQw_3d86e432-1192-44eb-9a4b-889f103d62db"
      unitRef="usdPerShare">-0.18</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMzgtMS0xLTEtMTIwNDM1_34042a6a-1763-4f6f-beea-7fcc0fac02d1"
      unitRef="shares">16868000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMzgtMy0xLTEtMTIwNDM3_4da3fd83-78c6-449b-931b-87bd7767c56f"
      unitRef="shares">17246000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV82Ny9mcmFnOjFlYzg0MWJiNTE5NTRmZTliZTY0ZjU5ZDA3ODlmOGQ4L3RhYmxlOjQ3NDcxYzdmMjdkMTQ5Njg4ZWVkMmFmOGQzOTExYjc3L3RhYmxlcmFuZ2U6NDc0NzFjN2YyN2QxNDk2ODhlZWQyYWY4ZDM5MTFiNzdfMzgtNS0xLTEtMTIwNDQw_6843a985-8bef-465d-914a-a9ccde1f49d1"
      unitRef="shares">16825000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83MC9mcmFnOjg2Y2RmZTczZTc3ODQ5MmM5OWZmYjg1ODM3ODA2ZjIxL3RhYmxlOjhlYmQyOGMxMzA1ZjQxOTE4MjgzZWI0ZTA4NmZmNzI1L3RhYmxlcmFuZ2U6OGViZDI4YzEzMDVmNDE5MTgyODNlYjRlMDg2ZmY3MjVfMi0xLTEtMS0xMTI2NDA_c2beb80c-5c80-40ec-a3b8-d80a066e6c94"
      unitRef="usd">-33361000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83MC9mcmFnOjg2Y2RmZTczZTc3ODQ5MmM5OWZmYjg1ODM3ODA2ZjIxL3RhYmxlOjhlYmQyOGMxMzA1ZjQxOTE4MjgzZWI0ZTA4NmZmNzI1L3RhYmxlcmFuZ2U6OGViZDI4YzEzMDVmNDE5MTgyODNlYjRlMDg2ZmY3MjVfMi0zLTEtMS0xMTI2NDA_5748b1c5-5dbe-45c8-851b-6a3d31f083c9"
      unitRef="usd">57138000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83MC9mcmFnOjg2Y2RmZTczZTc3ODQ5MmM5OWZmYjg1ODM3ODA2ZjIxL3RhYmxlOjhlYmQyOGMxMzA1ZjQxOTE4MjgzZWI0ZTA4NmZmNzI1L3RhYmxlcmFuZ2U6OGViZDI4YzEzMDVmNDE5MTgyODNlYjRlMDg2ZmY3MjVfMi01LTEtMS0xMTI2NDA_429c6b04-6379-4b0c-88a6-802075591af1"
      unitRef="usd">-2985000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83MC9mcmFnOjg2Y2RmZTczZTc3ODQ5MmM5OWZmYjg1ODM3ODA2ZjIxL3RhYmxlOjhlYmQyOGMxMzA1ZjQxOTE4MjgzZWI0ZTA4NmZmNzI1L3RhYmxlcmFuZ2U6OGViZDI4YzEzMDVmNDE5MTgyODNlYjRlMDg2ZmY3MjVfMy0xLTEtMS0xMTI2NDA_133b5354-87c6-4d5e-a9ec-307081261dee"
      unitRef="usd">-67000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83MC9mcmFnOjg2Y2RmZTczZTc3ODQ5MmM5OWZmYjg1ODM3ODA2ZjIxL3RhYmxlOjhlYmQyOGMxMzA1ZjQxOTE4MjgzZWI0ZTA4NmZmNzI1L3RhYmxlcmFuZ2U6OGViZDI4YzEzMDVmNDE5MTgyODNlYjRlMDg2ZmY3MjVfMy0zLTEtMS0xMTI2NDA_d3820c47-39b8-4073-83be-601cc4cacdc4"
      unitRef="usd">-116000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83MC9mcmFnOjg2Y2RmZTczZTc3ODQ5MmM5OWZmYjg1ODM3ODA2ZjIxL3RhYmxlOjhlYmQyOGMxMzA1ZjQxOTE4MjgzZWI0ZTA4NmZmNzI1L3RhYmxlcmFuZ2U6OGViZDI4YzEzMDVmNDE5MTgyODNlYjRlMDg2ZmY3MjVfMy01LTEtMS0xMTI2NDA_0c7f3666-d6dd-40c4-ae63-92bad7260c8d"
      unitRef="usd">-162000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83MC9mcmFnOjg2Y2RmZTczZTc3ODQ5MmM5OWZmYjg1ODM3ODA2ZjIxL3RhYmxlOjhlYmQyOGMxMzA1ZjQxOTE4MjgzZWI0ZTA4NmZmNzI1L3RhYmxlcmFuZ2U6OGViZDI4YzEzMDVmNDE5MTgyODNlYjRlMDg2ZmY3MjVfNC0xLTEtMS0xMTI2NDA_2339c26c-f908-4f40-8fb7-e8edcc15d927"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83MC9mcmFnOjg2Y2RmZTczZTc3ODQ5MmM5OWZmYjg1ODM3ODA2ZjIxL3RhYmxlOjhlYmQyOGMxMzA1ZjQxOTE4MjgzZWI0ZTA4NmZmNzI1L3RhYmxlcmFuZ2U6OGViZDI4YzEzMDVmNDE5MTgyODNlYjRlMDg2ZmY3MjVfNC0zLTEtMS0xMTI2NDA_01b69bac-2f55-4677-9f0e-3f4acf17eef3"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83MC9mcmFnOjg2Y2RmZTczZTc3ODQ5MmM5OWZmYjg1ODM3ODA2ZjIxL3RhYmxlOjhlYmQyOGMxMzA1ZjQxOTE4MjgzZWI0ZTA4NmZmNzI1L3RhYmxlcmFuZ2U6OGViZDI4YzEzMDVmNDE5MTgyODNlYjRlMDg2ZmY3MjVfNC01LTEtMS0xMTI2NDA_ba704259-78ed-4cb0-b018-97861642905c"
      unitRef="usd">-423000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83MC9mcmFnOjg2Y2RmZTczZTc3ODQ5MmM5OWZmYjg1ODM3ODA2ZjIxL3RhYmxlOjhlYmQyOGMxMzA1ZjQxOTE4MjgzZWI0ZTA4NmZmNzI1L3RhYmxlcmFuZ2U6OGViZDI4YzEzMDVmNDE5MTgyODNlYjRlMDg2ZmY3MjVfNS0xLTEtMS0xMTI2NDA_bd6b1cb7-a98b-44f3-8c42-21d01ad89f09"
      unitRef="usd">-33428000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83MC9mcmFnOjg2Y2RmZTczZTc3ODQ5MmM5OWZmYjg1ODM3ODA2ZjIxL3RhYmxlOjhlYmQyOGMxMzA1ZjQxOTE4MjgzZWI0ZTA4NmZmNzI1L3RhYmxlcmFuZ2U6OGViZDI4YzEzMDVmNDE5MTgyODNlYjRlMDg2ZmY3MjVfNS0zLTEtMS0xMTI2NDA_0ef577a2-6187-492c-a3c3-60e0fac63a94"
      unitRef="usd">57022000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83MC9mcmFnOjg2Y2RmZTczZTc3ODQ5MmM5OWZmYjg1ODM3ODA2ZjIxL3RhYmxlOjhlYmQyOGMxMzA1ZjQxOTE4MjgzZWI0ZTA4NmZmNzI1L3RhYmxlcmFuZ2U6OGViZDI4YzEzMDVmNDE5MTgyODNlYjRlMDg2ZmY3MjVfNS01LTEtMS0xMTI2NDA_8b2f6ad1-2981-45b1-8b20-b05f00b04bf4"
      unitRef="usd">-3570000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="i357eff174d874e71a3e0da8d3f8ba240_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTAtMS0xLTEtMTEyNjQw_05b61c2d-a321-4a08-a236-8b62cb480f90"
      unitRef="shares">16824000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i357eff174d874e71a3e0da8d3f8ba240_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTAtMy0xLTEtMTEyNjQw_5fc60741-ac9a-46d1-b652-2fbdb194fb62"
      unitRef="usd">17000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie900f916c5ce4b118f337c7cd5784087_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTAtNS0xLTEtMTEyNjQw_16d655ac-d0c0-483a-b160-923bd82cb760"
      unitRef="usd">367326000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i55fd66c34dcf459fa6f35389d1c92e7d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTAtNy0xLTEtMTEyNjQw_2f712b9b-7ec5-48fe-8692-161290a7e719"
      unitRef="usd">-216000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0b902bcb600d40ed842e738be013d24e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTAtOS0xLTEtMTEyNjQw_19f0f239-ce45-4106-a2c0-903542fba632"
      unitRef="usd">400105000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i859e9607437a43d8adb4d3dc08e60773_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTAtMTEtMS0xLTExMjY0MA_0324a173-4fbd-4cde-9223-e22b0f9b266c"
      unitRef="usd">767232000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ie94bcf078bda4c3095feb1fef072c734_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTEtMS0xLTEtMTEyNjQw_8e4abb10-5106-43a8-b156-169e902ffbc7"
      unitRef="shares">190000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ia0325d2944844148b93606f4579a387f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTEtNS0xLTEtMTEyNjQw_45e37ad0-f995-4956-9bd4-0460baceb6a8"
      unitRef="usd">1535000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTEtMTEtMS0xLTExMjY0MA_af3189e5-c772-440a-ac11-a61e76f3d41a"
      unitRef="usd">1535000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia0325d2944844148b93606f4579a387f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTItNS0xLTEtMTEyNjQw_6f86643e-edde-4b49-a220-9c3965a472b0"
      unitRef="usd">30727000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTItMTEtMS0xLTExMjY0MA_5e033a9a-603d-4f96-b922-f0952da86cff"
      unitRef="usd">30727000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ie94bcf078bda4c3095feb1fef072c734_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTMtMS0xLTEtMTEyNjQw_9ab58eb1-1232-4858-9402-e021898385f9"
      unitRef="shares">934000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ie94bcf078bda4c3095feb1fef072c734_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTMtMy0xLTEtMTEyNjQw_e8107821-1b54-4f27-92fe-d148df154e97"
      unitRef="usd">1000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ia0325d2944844148b93606f4579a387f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTMtNS0xLTEtMTEyNjQw_eaddce50-e154-4c07-911c-b8d630c7585a"
      unitRef="usd">77997000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTMtMTEtMS0xLTExMjY0MA_4dfe5509-8f9d-4d57-b594-7dbff0f321a3"
      unitRef="usd">77998000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="ifb599d49cd844079adbdcf3fbcea1bf6_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTQtNy0xLTEtMTEyNjQw_f2a2ed2a-85ac-4725-a81a-d1b7832a47f3"
      unitRef="usd">-162000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTQtMTEtMS0xLTExMjY0MA_ed7f2217-294e-427e-b1fd-9b7b6a04da38"
      unitRef="usd">-162000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ifb599d49cd844079adbdcf3fbcea1bf6_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTUtNy0xLTEtMTEyNjQw_69ab91a2-2de6-4b74-9ebf-e93242b44911"
      unitRef="usd">-423000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTUtMTEtMS0xLTExMjY0MA_a8bbae45-c37a-4de6-a188-29d7a2a430d4"
      unitRef="usd">-423000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="ia0325d2944844148b93606f4579a387f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTYtNS0xLTEtMTEyNjQw_428d374a-6ca5-4432-92ac-491689fd0af2"
      unitRef="usd">-3236000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTYtMTEtMS0xLTExMjY0MA_8d936c10-4ffb-4e97-b839-fa8aa9fd83e6"
      unitRef="usd">-3236000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:StockholdersEquity
      contextRef="ib307560c9d0a46168d9fc559bfdf76db_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTctOS0xLTEtMTEyNjQw_84670c3c-0dd3-45a8-b65b-47b2c8b88b72"
      unitRef="usd">-5168000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iadc71aaacd92446fa2fa49e3a0be8871_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTctMTEtMS0xLTExMjY0MA_417e3d01-8201-4e39-be75-ca3d0675809b"
      unitRef="usd">-5168000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="ia0325d2944844148b93606f4579a387f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTgtNS0xLTEtMTEyNjQw_1850fc86-edbe-4dd3-8d16-69348ffcf312"
      unitRef="usd">3000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTgtMTEtMS0xLTExMjY0MA_4463d6e2-82bf-46cd-a2f7-8d0ca49fb3dc"
      unitRef="usd">3000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:NetIncomeLoss
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTktOS0xLTEtMTEyNjQw_25687bcd-709b-4158-abb4-0ebbe817da27"
      unitRef="usd">-2985000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMTktMTEtMS0xLTExMjY0MA_12b5c522-4782-4499-aab3-6434177077c1"
      unitRef="usd">-2985000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i8b2e2abd1a8f48cbb470a39e45b33d50_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjAtMS0xLTEtMTEyNjQw_22d733c7-86f4-4baa-90eb-bd8240cb7a1a"
      unitRef="shares">16080000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i8b2e2abd1a8f48cbb470a39e45b33d50_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjAtMy0xLTEtMTEyNjQw_a62789d6-b974-42a1-add1-fd789d0ffe79"
      unitRef="usd">16000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8d465be99a3842c397fabfc41d61594f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjAtNS0xLTEtMTEyNjQw_a3ee104d-bf57-43ec-a8d6-8ea1bfd7cda9"
      unitRef="usd">318358000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6ea688d541394c9693a42fb9c6332aea_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjAtNy0xLTEtMTEyNjQw_d41da730-3fb3-4417-b875-bcf7db45f842"
      unitRef="usd">-801000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id1632e4f73e14852bc153b6b86f8ac63_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjAtOS0xLTEtMTEyNjQw_c820edeb-6acf-490c-a0c7-3c741e795c43"
      unitRef="usd">391952000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjAtMTEtMS0xLTExMjY0MA_6ac43e0d-d45c-46d4-9e20-241122d0d094"
      unitRef="usd">709525000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="id7184134d4134a439ed750ceb1bd33ec_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjEtMS0xLTEtMTEyNjQw_0171728d-41a6-4747-8ff0-172991e5c2e2"
      unitRef="shares">687000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="id7184134d4134a439ed750ceb1bd33ec_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjEtMy0xLTEtMTEyNjQw_0a3e1d2e-1f73-4034-b087-74096ccc49c9"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i0fe34795168e4efab32422048060cbb7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjEtNS0xLTEtMTEyNjQw_33314f87-0acc-4cb2-be44-9e02be0d4ed7"
      unitRef="usd">27744000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjEtMTEtMS0xLTExMjY0MA_e587f9f0-821e-4a8a-a4c6-d43e686e6c5e"
      unitRef="usd">27745000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0fe34795168e4efab32422048060cbb7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjItNS0xLTEtMTEyNjQw_e802d730-3118-426e-bf9b-2ec3ed966c4f"
      unitRef="usd">38783000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjItMTEtMS0xLTExMjY0MA_4d90edf3-ca69-463f-95d8-b93edfae759f"
      unitRef="usd">38783000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="ie20afe7ce80947c68d760e57a457a87d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjQtNy0xLTEtMTEyNjQw_96999636-b970-468c-93dc-7238cc2c1b0e"
      unitRef="usd">-116000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjQtMTEtMS0xLTExMjY0MA_d14c3666-f8c3-4015-8858-fff9a1e6b9f6"
      unitRef="usd">-116000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i0fe34795168e4efab32422048060cbb7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjUtNS0xLTEtMTEyNjQw_d3386399-b6cd-4c24-b275-cadf7dfbadfa"
      unitRef="usd">-12407000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjUtMTEtMS0xLTExMjY0MA_97d8f573-7007-476b-a894-a7234d2ba738"
      unitRef="usd">-12407000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions
      contextRef="i0fe34795168e4efab32422048060cbb7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjYtNS0xLTEtMTEyNjQw_3d594dc0-a39e-42f5-bb5d-93204e58c76c"
      unitRef="usd">491000</lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjYtMTEtMS0xLTExMjY0MA_88458b4c-dcaa-4dca-a08b-588fc90cdf99"
      unitRef="usd">491000</lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions>
    <us-gaap:NetIncomeLoss
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjctOS0xLTEtMTEyNjQw_7feb0c63-e093-4cf2-be85-964e49f35626"
      unitRef="usd">57138000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjctMTEtMS0xLTExMjY0MA_15c85166-677a-4487-9a9d-a3b0f1c69019"
      unitRef="usd">57138000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="iaafb881f4e07495d854952edabcc137a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjgtMS0xLTEtMTEyNjQw_b101fa76-4fcb-475b-8f0d-2b505eb89812"
      unitRef="shares">16767000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="iaafb881f4e07495d854952edabcc137a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjgtMy0xLTEtMTEyNjQw_90361a9b-a035-4e8c-9096-4dd0890e3a0d"
      unitRef="usd">17000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i948695d093514268aa5ad004f473dbda_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjgtNS0xLTEtMTEyNjQw_b3310e22-94b2-4b9d-8d95-a3d3d9f05c40"
      unitRef="usd">372969000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7d56363a509d4e11b592758da0456ba3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjgtNy0xLTEtMTEyNjQw_04a8060a-5b33-45b4-bc7a-454822ec7f7b"
      unitRef="usd">-917000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i93f039f3e3c5453fbe65524dc44ad87a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjgtOS0xLTEtMTEyNjQw_b1c1369d-6413-4cb9-a8b8-89fb713ba585"
      unitRef="usd">449090000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjgtMTEtMS0xLTExMjY0MA_415f395f-738b-46ca-8488-6135f6ae0758"
      unitRef="usd">821159000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ica032a6f26e9432b8884add2372c3753_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjAtNS0xLTEtMTMwNjA2_3e6d6563-a9bb-4116-9998-8e20cbd33ba6"
      unitRef="usd">-51130000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i23836cb1b26e4183bcbd3dcfe2a97c57_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjAtOS0xLTEtMTMwNjcw_4d5697b2-6209-408d-9e1a-d837b6745d14"
      unitRef="usd">35133000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ief52e61130d8499e8c4dbc42893dc5b6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjAtMTEtMS0xLTEzNTYzNg_984ae54a-52f3-4717-8f37-bb7eea252991"
      unitRef="usd">-15997000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i65b0d907ef504ee2b3d109652685018c_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjEtMS0xLTEtMTMwNjc4_5115a16a-57e2-4ac9-94e2-cdf8f257f1ae"
      unitRef="shares">184000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i1ba90afbe5994d2387d3257ea4ba047e_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjEtNS0xLTEtMTMwNjA2_7b5dcc72-313e-4175-a827-0d31cdc5de2c"
      unitRef="usd">-5004000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjEtMTEtMS0xLTEzNTYzNg_c95d72f5-21d3-47fc-8ecc-ac28294b3f85"
      unitRef="usd">-5004000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i1ba90afbe5994d2387d3257ea4ba047e_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjItNS0xLTEtMTMwNjA2_ff80555f-727c-4f54-80e3-95478ea690ae"
      unitRef="usd">60285000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjItMTEtMS0xLTEzNTYzNg_818c4eec-d882-4f5a-b62b-a646821e49e3"
      unitRef="usd">60285000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="i155fa2cc21e744f28351005564253c83_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjMtNy0xLTEtMTMwNjIy_004ccd9d-e853-4458-abce-64b355f2514b"
      unitRef="usd">-67000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjMtMTEtMS0xLTEzNTYzNg_161d9ee6-9362-4fc1-95b1-51f2c78e79c1"
      unitRef="usd">-67000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalBondHedgeTransaction
      contextRef="i1ba90afbe5994d2387d3257ea4ba047e_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjQtNS0xLTEtMTMwNjA2_fe6dcc9d-675a-4919-83a0-bf89a51530a3"
      unitRef="usd">202000</lgnd:AdjustmentsToAdditionalPaidInCapitalBondHedgeTransaction>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalBondHedgeTransaction
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjQtMTEtMS0xLTEzNTYzNg_653e6e7c-0e17-47fa-adfb-063941c3ec8a"
      unitRef="usd">202000</lgnd:AdjustmentsToAdditionalPaidInCapitalBondHedgeTransaction>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalDecreaseDueToSeparation
      contextRef="i1ba90afbe5994d2387d3257ea4ba047e_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjUtNS0xLTEtMTMwNjA2_2aeaccc5-07c4-402c-907b-6ee6fea8ed5e"
      unitRef="usd">229732000</lgnd:AdjustmentsToAdditionalPaidInCapitalDecreaseDueToSeparation>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalDecreaseDueToSeparation
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjUtMTEtMS0xLTEzNTYzNg_a2d46484-0cb5-4fbe-beed-84edfa356fd6"
      unitRef="usd">229732000</lgnd:AdjustmentsToAdditionalPaidInCapitalDecreaseDueToSeparation>
    <us-gaap:NetIncomeLoss
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjYtOS0xLTEtMTMwNjQx_63817890-02d4-4156-901c-ff761430465d"
      unitRef="usd">-33361000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjYtMTEtMS0xLTEzNTYzNg_c674b186-4605-4a62-bc48-a5054ae0b1b0"
      unitRef="usd">-33361000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i2a1cc21146284996b1a957be45c91abd_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjctMS0xLTEtMTM1NjQ0_e988b75b-d809-403f-81a5-22dbd44dceb2"
      unitRef="shares">16951000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i2a1cc21146284996b1a957be45c91abd_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjctMy0xLTEtMTM1NjQ4_7b1f9fa2-627d-4d4d-a6f7-38e629299238"
      unitRef="usd">17000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i33d7a741bf9e4e2d90927adfa7ef78e5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjctNS0xLTEtMTM1NjUw_1ba92502-640b-4153-a5f8-27a7f27cb90c"
      unitRef="usd">147590000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2f6875eb2c49451e827356ab2addb68a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjctNy0xLTEtMTM1NjUy_a8ffe90d-d68b-4337-a536-5920445a218c"
      unitRef="usd">-984000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4e38dd10e28e4af0b6ff937e3289a628_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjctOS0xLTEtMTM1NjQx_94d8142e-bb7b-45ac-a1e8-89dbe56e346c"
      unitRef="usd">450862000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83My9mcmFnOjcwZDRkNjlhMmVhMzQwMTE5M2Q4MmU2NmM2OWQwZGEyL3RhYmxlOjJiZWI4NTk2YTZkYzQ0NjRiZGM2ZGNkOWYxMTNiZTQ0L3RhYmxlcmFuZ2U6MmJlYjg1OTZhNmRjNDQ2NGJkYzZkY2Q5ZjExM2JlNDRfMjctMTEtMS0xLTEzNTYzNg_68b29974-089b-4ab0-8f5c-91c6c0d830c4"
      unitRef="usd">597485000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMy0xLTEtMS0xMTI2NDA_a0a809f8-7cc1-4325-924d-3f3c71a798af"
      unitRef="usd">-33361000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMy0zLTEtMS0xMTI2NDA_90875934-82dc-4203-a04b-5bbb06157577"
      unitRef="usd">57138000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMy01LTEtMS0xMTI2NDA_36f2a782-d0bc-40a9-a1be-b7762fad4786"
      unitRef="usd">-2985000</us-gaap:ProfitLoss>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNi0xLTEtMS0xMTI2NDA_308c26b2-d476-4a25-86ae-6a1479d0397b"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNi0zLTEtMS0xMTI2NDA_5211f4aa-ec63-4085-a264-92fc829d10c5"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNi01LTEtMS0xMTI2NDA_a976ef89-7cec-4f6d-9136-6c1aefb4f07c"
      unitRef="usd">17114000</us-gaap:GainLossOnSaleOfBusiness>
    <lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNy0xLTEtMS0xMTI2NDA_4f490ee2-ff08-483c-9313-5df77c975058"
      unitRef="usd">748000</lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights>
    <lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNy0zLTEtMS0xMTI2NDA_8d989c4c-5e42-4ed0-957c-bc51a7c8b3a3"
      unitRef="usd">36962000</lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights>
    <lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNy01LTEtMS0xMTI2NDA_85367350-3972-4144-8b50-9f3a7b62902c"
      unitRef="usd">-963000</lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfOC0xLTEtMS0xMTI2NDA_e005ba1a-003d-4090-b3e8-31236850a02e"
      unitRef="usd">51534000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfOC0zLTEtMS0xMTI2NDA_4939c479-7915-4fa1-8df9-1c93ca738e28"
      unitRef="usd">51071000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfOC01LTEtMS0xMTI2NDA_5de231ec-bdb4-4d2e-a597-4d8d97577654"
      unitRef="usd">25691000</us-gaap:DepreciationDepletionAndAmortization>
    <lgnd:GainLossOnShortTermInvestments
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfOS0xLTEtMS0xMTI2NDA_676e3c17-c588-4a9e-a792-31ec781515e3"
      unitRef="usd">28540000</lgnd:GainLossOnShortTermInvestments>
    <lgnd:GainLossOnShortTermInvestments
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfOS0zLTEtMS0xMTI2NDA_91add643-149a-4dea-937d-a013d89e58b3"
      unitRef="usd">-3997000</lgnd:GainLossOnShortTermInvestments>
    <lgnd:GainLossOnShortTermInvestments
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfOS01LTEtMS0xMTI2NDA_7640d606-bd4d-44b3-931d-6ee26a760e21"
      unitRef="usd">-16933000</lgnd:GainLossOnShortTermInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTAtMS0xLTEtMTEyNjQw_31eaf841-87fc-4356-a09d-999faedb289c"
      unitRef="usd">-16000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTAtMy0xLTEtMTEyNjQw_de2ce1c0-d35f-4599-9100-6dac5baea1de"
      unitRef="usd">-111000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTAtNS0xLTEtMTEyNjQw_b02197d2-daa0-4661-9796-2afe68bccc89"
      unitRef="usd">-1479000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTEtMS0xLTEtMTEyNjQw_242dfd20-9a9a-4162-be2b-5c172ac76829"
      unitRef="usd">734000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTEtMy0xLTEtMTEyNjQw_08928021-4cb3-417a-b4a7-c27c53cc4ab3"
      unitRef="usd">16692000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTEtNS0xLTEtMTEyNjQw_e26b2cb8-8f56-428a-b8f3-afea8a221c6f"
      unitRef="usd">23077000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTItMS0xLTEtMTEyNjQw_d60ab63e-fb72-48e4-832d-d2993a439bd2"
      unitRef="usd">4192000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTItMy0xLTEtMTEyNjQw_e15fcb0d-a679-41f1-bc41-0d31e8137de1"
      unitRef="usd">-7303000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTItNS0xLTEtMTEyNjQw_1cd7f404-4187-4fa6-aecd-ac316b6d3062"
      unitRef="usd">-2466000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <lgnd:AmortizationOfCommercialLicenseAndOtherEconomicRights
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTMtMS0xLTEtMTEyNjQw_a1609f86-3d27-41aa-bdd2-8afc70733630"
      unitRef="usd">-164000</lgnd:AmortizationOfCommercialLicenseAndOtherEconomicRights>
    <lgnd:AmortizationOfCommercialLicenseAndOtherEconomicRights
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTMtMy0xLTEtMTEyNjQw_14108e0d-ddb2-419c-a4c6-31098e4a76e3"
      unitRef="usd">-125000</lgnd:AmortizationOfCommercialLicenseAndOtherEconomicRights>
    <lgnd:AmortizationOfCommercialLicenseAndOtherEconomicRights
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTMtNS0xLTEtMTEyNjQw_aedde1b5-1f18-4b00-aca2-44b79258fdc9"
      unitRef="usd">2275000</lgnd:AmortizationOfCommercialLicenseAndOtherEconomicRights>
    <lgnd:FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTMtMS0xLTEtMTMwNDIw_c5cb690f-6c6e-4aac-a3d3-12cde4271978"
      unitRef="usd">5521000</lgnd:FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization>
    <lgnd:FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTMtMy0xLTEtMTMwMzg3_3822ecb1-2a76-4555-b1d8-9d6872d97d1e"
      unitRef="usd">4840000</lgnd:FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization>
    <lgnd:FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTMtNS0xLTEtMTMwMzc4_887400f3-dce0-47a3-adb0-b632639d1377"
      unitRef="usd">1609000</lgnd:FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTQtMS0xLTEtMTEyNjQw_b02cb193-421e-45c6-8884-c0e05e92e888"
      unitRef="usd">60285000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTQtMy0xLTEtMTEyNjQw_996d6b7b-7b49-4eac-9ce2-dafb0c1ea4ed"
      unitRef="usd">38783000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTQtNS0xLTEtMTEyNjQw_33c413e4-ad6c-4202-b5f9-104dab4dc1bc"
      unitRef="usd">30727000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTUtMS0xLTEtMTEyNjQw_9423294b-1690-4c87-8461-d35cdd9eee6a"
      unitRef="usd">-20723000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTUtMy0xLTEtMTEyNjQw_dd07ade1-6cef-4ea1-a1c7-6db544859319"
      unitRef="usd">8618000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTUtNS0xLTEtMTEyNjQw_4945fc44-d9d6-4236-a27b-1aff1ae78471"
      unitRef="usd">19053000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTYtMS0xLTEtMTEyNjQw_67c0456f-5aca-4dce-8270-f9557053b840"
      unitRef="usd">365000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTYtMy0xLTEtMTEyNjQw_f15a108c-a9c6-4066-be13-77f79d2c1c49"
      unitRef="usd">1572000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTYtNS0xLTEtMTEyNjQw_9a8d4e1a-4fd6-4d99-a465-827363dacc76"
      unitRef="usd">191000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTgtMS0xLTEtMTEyNjQw_758f1cf8-790e-4108-b621-c1712e831eec"
      unitRef="usd">-55319000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTgtMy0xLTEtMTEyNjQw_d3da8a4b-6d9d-4013-af1f-3a73a5ba0ab7"
      unitRef="usd">28616000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTgtNS0xLTEtMTEyNjQw_bf3fa4a7-9d2b-4232-8720-f49b9b489c4d"
      unitRef="usd">26061000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTktMS0xLTEtMTEyNjQw_a4b2727f-5970-4f83-aac5-f6a580c4eeea"
      unitRef="usd">-12058000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTktMy0xLTEtMTEyNjQw_d164bb7d-918a-40fd-a5cd-fd28d674d8ae"
      unitRef="usd">427000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMTktNS0xLTEtMTEyNjQw_ed4833b0-8968-4df0-bebe-89b05a7cbc6a"
      unitRef="usd">17799000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjAtMS0xLTEtMTEyNjQw_995f894b-cef1-4c2a-8e5b-9f9b17dfe019"
      unitRef="usd">-3340000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjAtMy0xLTEtMTEyNjQw_8d394d4c-a434-4910-9675-2b36f7d83c1e"
      unitRef="usd">2810000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjAtNS0xLTEtMTEyNjQw_bcf51d96-a099-4b60-b776-57f49c6f665e"
      unitRef="usd">-1245000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjEtMS0xLTEtMTEyNjQw_70e92ea9-17bc-4e51-8646-66efba0bee18"
      unitRef="usd">-1579000</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjEtMy0xLTEtMTEyNjQw_ebcc68a7-cea4-4e24-9997-619c5e84d8be"
      unitRef="usd">3976000</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjEtNS0xLTEtMTEyNjQw_0302bd2e-7d65-4b9c-b5c7-29ec2d6a407f"
      unitRef="usd">-9144000</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjMtMS0xLTEtMTEyNjQw_9a584055-3e67-4519-a52e-12e33e34a98f"
      unitRef="usd">-6281000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjMtMy0xLTEtMTEyNjQw_46dc7410-4139-42b8-9958-b691d0b6515b"
      unitRef="usd">-17870000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjMtNS0xLTEtMTEyNjQw_41651d20-5579-4b96-ab4f-83007cf0c0e4"
      unitRef="usd">29236000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjQtMS0xLTEtMTEyNjQw_c0895610-13cf-4232-bb8e-1b614578b1e8"
      unitRef="usd">-6342000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjQtMy0xLTEtMTEyNjQw_9178c18e-f2cc-4160-9c3f-483f5a988a70"
      unitRef="usd">8925000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjQtNS0xLTEtMTEyNjQw_9c8e2e00-ce79-4afd-9c00-e3ddcd8f7f3f"
      unitRef="usd">4948000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjUtMS0xLTEtMTEyNjQw_c502ee27-a603-4174-9e24-e174652018f8"
      unitRef="usd">137850000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjUtMy0xLTEtMTEyNjQw_79938a16-3e20-4330-9541-272b1b60b75d"
      unitRef="usd">78798000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjUtNS0xLTEtMTEyNjQw_fadcd62a-35f2-4fae-b6b3-512757687377"
      unitRef="usd">54586000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjktMS0xLTEtMTEyNjQw_02533dae-8c28-4b9b-b71a-0702508c9d49"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjktMy0xLTEtMTEyNjQw_53c37894-480a-4284-964e-09c60c840fb2"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMjktNS0xLTEtMTEyNjQw_36011f21-d841-435a-b118-8031cf63da27"
      unitRef="usd">404884000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzAtMS0xLTEtMTEyNjQw_bc68165e-599a-4970-a553-c6b10324fdd4"
      unitRef="usd">17923000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzAtMy0xLTEtMTEyNjQw_02c6b184-f26b-405c-80e4-5de96ddb850e"
      unitRef="usd">8761000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzAtNS0xLTEtMTEyNjQw_8e332afe-5ac5-4537-a577-0e8562ed1cd6"
      unitRef="usd">4458000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzEtMS0xLTEtMTEyNjQw_4216ca4b-d4f5-4634-9dfa-4acaea6c06e7"
      unitRef="usd">51226000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzEtMy0xLTEtMTEyNjQw_0358421a-8840-404f-9cc0-b67f4a90fba6"
      unitRef="usd">181325000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzEtNS0xLTEtMTEyNjQw_3233c00a-1dfd-4ca7-aebb-46bc92ac96b2"
      unitRef="usd">422523000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <lgnd:ProceedsFromCommercialLicenseRights
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzItMS0xLTEtMTEyNjQw_5f5f18f0-fc48-460c-a74b-3c6da30cc94b"
      unitRef="usd">92000</lgnd:ProceedsFromCommercialLicenseRights>
    <lgnd:ProceedsFromCommercialLicenseRights
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzItMy0xLTEtMTEyNjQw_a9519000-98ba-4ffa-ad73-fc88a486fa66"
      unitRef="usd">494000</lgnd:ProceedsFromCommercialLicenseRights>
    <lgnd:ProceedsFromCommercialLicenseRights
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzItNS0xLTEtMTEyNjQw_b39aa775-36a5-4bfa-a446-0cc3d9388fc6"
      unitRef="usd">1358000</lgnd:ProceedsFromCommercialLicenseRights>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzMtMS0xLTEtMTEyNjQw_6d4ea866-9392-4268-a8c6-48ca26990c98"
      unitRef="usd">209561000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzMtMy0xLTEtMTEyNjQw_fd0ea3d8-65ff-46cf-80e6-42f053876625"
      unitRef="usd">154230000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzMtNS0xLTEtMTEyNjQw_b7e43dd4-c73a-47f1-b6b4-46ef1480830c"
      unitRef="usd">394539000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzQtMS0xLTEtMTEyNjQw_30e388fb-8166-4264-a3e0-6a9f21fd2b50"
      unitRef="usd">24830000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzQtMy0xLTEtMTEyNjQw_313e2f10-deab-4e87-af3a-5b35506ba276"
      unitRef="usd">67105000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzQtNS0xLTEtMTEyNjQw_d02d121d-1820-40c7-b1f9-5b11a237d016"
      unitRef="usd">644155000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzYtMS0xLTEtMTEyNjQw_a6d34600-cf00-4043-b405-df9b3e4629b1"
      unitRef="usd">750000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzYtMy0xLTEtMTEyNjQw_0aabebf0-0f66-4aa0-9e52-e1b38e2b4c89"
      unitRef="usd">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzYtNS0xLTEtMTEyNjQw_85ae34a0-6a8e-46b8-ab8e-fc9d4591d4c6"
      unitRef="usd">500000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzctMS0xLTEtMTEyNjQw_0d3e3d69-a76d-46a4-a1d6-d7fd5d9b9f11"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzctMy0xLTEtMTEyNjQw_e022436a-ac25-4054-83c8-8a259050b3d2"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzctNS0xLTEtMTEyNjQw_01fc91d8-e70c-47a7-a729-0fa23a6279bb"
      unitRef="usd">22061000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzgtMS0xLTEtMTEyNjQw_e2685f60-3a40-40e3-9706-374ab827cf85"
      unitRef="usd">960000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzgtMy0xLTEtMTEyNjQw_95c77923-0845-4cfa-b792-79fd0668da4e"
      unitRef="usd">1220000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzgtNS0xLTEtMTEyNjQw_72f0869b-df63-43a8-b473-06d7ea0f5c65"
      unitRef="usd">-1900000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzktMS0xLTEtMTEyNjQw_6678cc8a-5fa1-456f-8dc2-bb5fb91f4cd6"
      unitRef="usd">163624000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzktMy0xLTEtMTEyNjQw_65a227f6-57dc-4a69-bd5b-87db194abc75"
      unitRef="usd">30523000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfMzktNS0xLTEtMTEyNjQw_cfe8aac1-8a76-4380-b80c-6fbb2fffc9f7"
      unitRef="usd">231648000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <lgnd:PaymentsForSeparation
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDEtMS0xLTEtMTI5NDE2_f3330155-d99f-4c52-807d-86bf6bc2aef0"
      unitRef="usd">1840000</lgnd:PaymentsForSeparation>
    <lgnd:PaymentsForSeparation
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDAtMy0xLTEtMTM1NjY4_287044ac-5022-4414-bf75-950febaa4e0c"
      unitRef="usd">0</lgnd:PaymentsForSeparation>
    <lgnd:PaymentsForSeparation
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDAtNS0xLTEtMTM1NjY4_4a78c8a5-0645-459d-a05f-f42bec39eee9"
      unitRef="usd">0</lgnd:PaymentsForSeparation>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDEtMS0xLTEtMTEyNjQw_948d4169-39c1-4e1f-b4ed-f08faf98790f"
      unitRef="usd">260949000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDEtMy0xLTEtMTEyNjQw_4e8ae48b-c60c-4568-af56-b6e380f4ce77"
      unitRef="usd">155760000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDEtNS0xLTEtMTEyNjQw_665c7930-3696-4ac3-876a-182f58b5b6b7"
      unitRef="usd">222209000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDItMS0xLTEtMTEyNjQw_deb916e5-5195-4653-aadd-ff3940039cb0"
      unitRef="usd">54000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDItMy0xLTEtMTEyNjQw_725185ea-023d-4eb7-8a84-e259d26e58b7"
      unitRef="usd">9188000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDItNS0xLTEtMTEyNjQw_1f0e1158-b96d-42b6-8db1-d9638cc0c7cf"
      unitRef="usd">9549000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDYtMS0xLTEtMTEyNjQw_7edc0859-c0b3-4764-bfe9-433f39146827"
      unitRef="usd">6800000</us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities>
    <us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDYtMy0xLTEtMTEyNjQw_2c7fc6df-d15b-43c2-a974-e6dae880bd17"
      unitRef="usd">0</us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities>
    <us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDYtNS0xLTEtMTEyNjQw_4e536d46-72d3-4a39-8ad6-246b8971fc6b"
      unitRef="usd">0</us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities>
    <us-gaap:ProceedsFromHedgeFinancingActivities
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDctMS0xLTEtMTEyNjQw_70111c03-c068-4c83-9947-d92923152f08"
      unitRef="usd">202000</us-gaap:ProceedsFromHedgeFinancingActivities>
    <us-gaap:ProceedsFromHedgeFinancingActivities
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDctMy0xLTEtMTEyNjQw_c1435230-9a1a-4432-b4e2-405ace9e9447"
      unitRef="usd">18938000</us-gaap:ProceedsFromHedgeFinancingActivities>
    <us-gaap:ProceedsFromHedgeFinancingActivities
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDctNS0xLTEtMTEyNjQw_4d28e9f1-0d08-4301-a2d4-2b42b68fc065"
      unitRef="usd">0</us-gaap:ProceedsFromHedgeFinancingActivities>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDktMS0xLTEtMTEyNjQw_236ce907-bac8-42d9-bac4-ec939e6fba2f"
      unitRef="usd">3232000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDktMy0xLTEtMTEyNjQw_e023a434-086c-433d-af0c-40387d8100de"
      unitRef="usd">33763000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNDktNS0xLTEtMTEyNjQw_00c7f9c3-fe4a-41cd-ae6b-683dad7c8e67"
      unitRef="usd">3017000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTAtMS0xLTEtMTEyNjQw_b40081dc-d31b-431a-b811-af21c1781dd2"
      unitRef="usd">8236000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTAtMy0xLTEtMTEyNjQw_113db21b-8e74-44af-8b65-2f39b835ceb0"
      unitRef="usd">6018000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTAtNS0xLTEtMTEyNjQw_8f157eab-7948-4eeb-a73e-782bd8b29236"
      unitRef="usd">1481000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTEtMS0xLTEtMTEyNjQw_8970f45e-1e4e-4fff-8c05-425aa358fc25"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTEtMy0xLTEtMTEyNjQw_d57a6591-af42-43a2-89b4-8d2950a72901"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTEtNS0xLTEtMTEyNjQw_4b5a2207-20be-44ac-856e-23571a591cfd"
      unitRef="usd">77998000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfWarrants
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTItMS0xLTEtMTEyNjQw_c42a0041-2d60-476b-b2b2-23f91b59becf"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfWarrants>
    <us-gaap:PaymentsForRepurchaseOfWarrants
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTItMy0xLTEtMTEyNjQw_9a3271d6-8e8a-41a3-b394-8a089478fa6b"
      unitRef="usd">18446000</us-gaap:PaymentsForRepurchaseOfWarrants>
    <us-gaap:PaymentsForRepurchaseOfWarrants
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTItNS0xLTEtMTEyNjQw_407043b3-7924-4ded-9256-4ac70e65cd0a"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfWarrants>
    <lgnd:PaymentsToContingentValueRightHoldersFinancingActivity
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTMtMS0xLTEtMTEyNjQw_0728ccb8-41a1-4d87-9a22-7786f1eb01e1"
      unitRef="usd">1545000</lgnd:PaymentsToContingentValueRightHoldersFinancingActivity>
    <lgnd:PaymentsToContingentValueRightHoldersFinancingActivity
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTMtMy0xLTEtMTEyNjQw_ee6924e3-e259-4bf6-b3e0-f230144290d0"
      unitRef="usd">1050000</lgnd:PaymentsToContingentValueRightHoldersFinancingActivity>
    <lgnd:PaymentsToContingentValueRightHoldersFinancingActivity
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTMtNS0xLTEtMTEyNjQw_e6a7b323-184f-4e95-b525-465a792c38c5"
      unitRef="usd">2325000</lgnd:PaymentsToContingentValueRightHoldersFinancingActivity>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTQtMS0xLTEtMTEyNjQw_9b58658c-a513-4107-99dc-d5e69cf6e248"
      unitRef="usd">-275990000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTQtMy0xLTEtMTEyNjQw_b5edb76c-3d7e-4893-bf37-bfbf52602f70"
      unitRef="usd">-137761000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTQtNS0xLTEtMTEyNjQw_f434e2a1-296d-4f99-9e0c-1392ee360660"
      unitRef="usd">-310545000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTUtMS0xLTEtMTEyNjQw_56b84fe1-cc43-428c-9c26-6cbb6f8911cf"
      unitRef="usd">25484000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTUtMy0xLTEtMTEyNjQw_f93f1799-d5e3-4324-8a20-eed5ded9b63a"
      unitRef="usd">-28440000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTUtNS0xLTEtMTEyNjQw_44b6d200-452f-417c-a650-25a8369fef2f"
      unitRef="usd">-24311000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTctMS0xLTEtMTEyNjQw_94327c4a-760f-4ffd-8c76-ec14a7c4885c"
      unitRef="usd">19522000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTctMy0xLTEtMTEyNjQw_604d905c-d296-4575-b755-b1abe5a739c9"
      unitRef="usd">47962000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i859e9607437a43d8adb4d3dc08e60773_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTctNS0xLTEtMTEyNjQw_43637298-57ca-4a8b-af5b-3bd9be255bbb"
      unitRef="usd">72273000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTgtMS0xLTEtMTEyNjQw_9b6909c7-e03f-438c-ba49-fe72c4ef24ac"
      unitRef="usd">45006000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTgtMy0xLTEtMTEyNjQw_ba43ae8d-5283-49c7-8415-7c221ad26d04"
      unitRef="usd">19522000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNTgtNS0xLTEtMTEyNjQw_04da5a75-00f0-48ac-81b9-db6ba42ebfe2"
      unitRef="usd">47962000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjEtMS0xLTEtMTEyNjQw_83f9ada2-82f4-434b-82e3-fda4cc6c946a"
      unitRef="usd">1428000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjEtMy0xLTEtMTEyNjQw_cfacb14c-2912-48b1-b200-b9f50627ec8b"
      unitRef="usd">3028000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjEtNS0xLTEtMTEyNjQw_19974508-5f86-4493-8773-22b4b550e1cc"
      unitRef="usd">4463000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjItMS0xLTEtMTEyNjQw_e033e316-4fd6-4957-8ae5-8f621cecccb5"
      unitRef="usd">11642000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjItMy0xLTEtMTEyNjQw_c5a81bd8-81cb-496c-867b-5e57b46a05af"
      unitRef="usd">3722000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjItNS0xLTEtMTEyNjQw_af76c532-ce32-4ef3-a321-db029482625a"
      unitRef="usd">2130000</us-gaap:IncomeTaxesPaid>
    <us-gaap:RestrictedCashCurrent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjMtMS0xLTEtMTEyNjQw_f6eef0c2-8dc0-4152-871c-c7032a389b5c"
      unitRef="usd">0</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjMtMy0xLTEtMTEyNjQw_ae2a5162-e1f2-4992-8863-0c6e8b9aec15"
      unitRef="usd">0</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjMtNS0xLTEtMTEyNjQw_76b72452-d50a-49a1-9d4a-0b3dc6e49f09"
      unitRef="usd">343000</us-gaap:RestrictedCashCurrent>
    <lgnd:AccruedInventoryPurchases
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjUtMS0xLTEtMTEyNjQw_791e92df-9909-4e78-a7b4-38cdbe171c8e"
      unitRef="usd">0</lgnd:AccruedInventoryPurchases>
    <lgnd:AccruedInventoryPurchases
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjUtMy0xLTEtMTEyNjQw_376054f1-280b-4721-9724-1e59a143b02b"
      unitRef="usd">1974000</lgnd:AccruedInventoryPurchases>
    <lgnd:AccruedInventoryPurchases
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjUtNS0xLTEtMTEyNjQw_fd093cc4-2e8d-4cc5-9c55-988f01375bd1"
      unitRef="usd">1562000</lgnd:AccruedInventoryPurchases>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjYtMS0xLTEtMTEyNjQw_17e4dc21-d029-436b-94bf-c6881d9b7894"
      unitRef="usd">-85000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjYtMy0xLTEtMTEyNjQw_a3c9feca-f209-4b09-a321-e1bd99258951"
      unitRef="usd">-221000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjYtNS0xLTEtMTEyNjQw_a873229c-a751-4aa1-9882-4ed7d88f19d9"
      unitRef="usd">-212000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjctMS0xLTEtMTEyNjQw_efbb6d27-998d-4b86-b827-a4febebf2193"
      unitRef="usd">2333000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjctMy0xLTEtMTEyNjQw_fb3f71db-2834-4105-a79e-10bceb5344d4"
      unitRef="usd">1567000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83Ni9mcmFnOjQ3ZWI1ZmNlODQ4OTRhNjg4MzYwMmEwOTE2M2UyMWUwL3RhYmxlOjdlMTMxNzI2Y2JkNjRhM2M5NDliMjc5OTRiNDQ5NWZiL3RhYmxlcmFuZ2U6N2UxMzE3MjZjYmQ2NGEzYzk0OWIyNzk5NGI0NDk1ZmJfNjctNS0xLTEtMTEyNjQw_2737d7a4-58bf-438a-a422-1864c820580f"
      unitRef="usd">249000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2ODc_26141f76-ca8a-4ba3-a0b3-5e8c7bdce9c1">Basis of Presentation and Summary of Significant Accounting Policies&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Business&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 1, 2022, we completed the separation (the &#x201c;Separation&#x201d;) of our antibody discovery business and certain related assets and liabilities (the &#x201c;OmniAb Business&#x201d;) through a spin-off of OmniAb to Ligand&#x2019;s shareholders of record as of October 26, 2022 on a pro rata basis (the &#x201c;Distribution&#x201d;) and merger (the &#x201c;Merger&#x201d;) of OmniAb with a wholly owned subsidiary of a separate public company, OmniAb, Inc. (formerly known as Avista Public Acquisition Corp. II (&#x201c;New OmniAb&#x201d;)), in a Reverse Morris Trust transaction pursuant to the Agreement and Plan of Merger, dated as of March 23, 2022 (the &#x201c;Merger Agreement&#x201d;), and the Separation and Distribution Agreement, dated as of March 23, 2022 (the &#x201c;Separation Agreement&#x201d;) (the Merger Agreement and Separation Agreement, collectively with the other related transaction documents, the &#x201c;Transaction Agreements&#x201d;). Pursuant to the Transaction Agreements, Ligand contributed to OmniAb cash and certain assets and liabilities constituting the OmniAb Business, including but not limited to the equity interests of Ab Initio Biotherapeutics, Inc., Crystal Bioscience, Inc., Icagen, LLC, Taurus Biosciences, LLC and xCella Biosciences, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After the spin-off of our OmniAb antibody discovery business, Ligand is a revenue-generating biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. We operate in one business segment: development and licensing of biopharmaceutical assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our consolidated financial statements have been prepared in accordance with U.S. GAAP and include the accounts of our parent company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Discontinued operations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined that the spin-off of the OmniAb Business in November 2022 met the criteria for classification as a discontinued operation in accordance with ASC Subtopic 205-20, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Discontinued Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 205-20&#x201d;). Accordingly, the accompanying consolidated financial statements for all periods presented have been updated to present the assets and liabilities associated with the OmniAb Business separately as discontinued operations on the consolidated balance sheets and the results of all discontinued operations reported as a separate component of loss in the consolidated statements of operations and comprehensive loss (see Note 2, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Spin-off of OmniAb&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). All disclosures have been adjusted to reflect continuing operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in conformity with U.S. GAAP requires the use of estimates and assumptions that affect the amounts reported in the consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentrations of Business Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject us to significant concentrations of credit risk consist primarily of cash equivalents and investments. We invest excess cash principally in United States government debt securities, investment grade corporate debt securities, mutual funds and certificates of deposit. We maintain some cash and cash equivalents balances with financial institutions that are in excess of the Federal Deposit Insurance Corporation insurance limits. We have established guidelines relative to diversification and maturities that maintain safety and liquidity. These guidelines are periodically reviewed and modified to take advantage of trends in yields and interest rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from significant partners, which is defined as 10% or more of our total revenue, was as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Partner A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Partner B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Partner C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;lt;10%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;lt;10%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;lt;10%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We obtain Captisol primarily from two sites related to a single supplier, Hovione.&#160;If this supplier were not able to supply the requested amounts of Captisol from each site, and if our safety stocks of material were depleted, we would be unable to continue to derive revenues from the sale of Captisol until we obtained material from an alternative source, which could take a considerable length of time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash Equivalents &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents consist of highly liquid investments with maturities of three months or less from the date of acquisition. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Short-term Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments primarily consist of investments in debt and equity securities. We classify our short-term investments as &#x201c;available-for-sale&#x201d;. Such investments are carried at fair value, with unrealized gains and losses on debt securities included in the statement of comprehensive income (loss), net of tax, and unrealized gains and losses on equity securities included the consolidated statement of operations. We determine the cost of investments based on the specific identification method. We determine the realized gains or losses on the sale of available-for-sale securities using the specific identification method and includes net realized gains and losses as a component of other income or expense within the consolidated statements of operations.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities consist of certificates of deposit, corporate debt securities, and securities of government-sponsored entities have effective maturities greater than&#160;three&#160;months and less than twenty-five months from the date of acquisition. Debt securities available-for-sale in an unrealized loss position are assessed for the current expected credit losses methodology. We start by assessing whether we intend to sell the security, or whether it is more likely than not that we will be required to sell the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security&#x2019;s amortized cost basis is written down to fair value through earnings. For debt securities available-for-sale that do not meet the aforementioned criteria, we evaluate whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, we consider the extent to which fair value is less than amortized cost, any changes in interest rates, and any changes to the rating of the security by a rating agency, among other factors. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security is compared to the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded, limited by the amount that the fair value is less than the amortized cost basis. Any impairment that has not been recorded through an allowance for credit losses is recognized in other comprehensive income or loss, as applicable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity securities are mutual funds, investments in privately held companies (non-marketable equity securities), and companies that have completed initial public offerings (marketable equity securities). Mutual funds are valued at their publicly quoted net asset value (NAV) price on the last day of the period. Our non-marketable equity securities without readily determinable market values are initially measured at cost and adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment. Our marketable equity securities are measured at fair value. Equity investments are classified as short-term investments, or non-current other assets, based on the nature of the securities and their availability for use in current operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory, which consists of finished goods, is stated at the lower of cost or net realizable value. We determine cost using the specific identification method. We analyze our inventory levels periodically and write down inventory to net realizable value if it has become obsolete, has a cost basis in excess of its expected net realizable value or is in excess of expected requirements. During the year ended December 31, 2022, we recorded an obsolete inventory charge of $1.1&#160;million. There were no adjustments to inventory recorded for the years ended December&#160;31, 2021 and 2020. As of December 31, 2022 and 2021, inventory included prepayments of $5.9&#160;million and $24.6&#160;million, respectively, to our supplier for Captisol.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are stated at cost, subject to review for impairment, and depreciated over the estimated useful lives of the assets, which generally range from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNzU2MQ_9d23c4d7-711e-44c5-af62-13230621da18"&gt;three&lt;/span&gt; to ten years, using the straight-line method. Amortization of leasehold improvements is recorded over the shorter of the lease term or estimated useful life of the related asset. Maintenance and repairs are charged to operations as incurred. When assets are sold, or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts and any gain or loss is included in operating income or expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We first determine whether a set of assets acquired constitute a business and should be accounted for as a business combination. If the assets acquired are not a business, we account for the transaction as an asset acquisition. Business combinations are accounted for by using the acquisition method of accounting which requires us to use significant estimates and assumptions, especially with respect to intangible assets. We record the excess consideration over the aggregate fair value of tangible and intangible assets, net of liabilities assumed, as goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the acquisition method of accounting, we recognize separately from goodwill the identifiable assets acquired, the liabilities assumed, including contingent consideration and all contractual contingencies, generally at the acquisition date fair value. Contingent purchase consideration to be settled in cash are remeasured to estimated fair value at each reporting period with the change in fair value recorded in statement of operations. Costs that we incur to complete the business combination such as investment banking, legal and other professional fees are not considered part of consideration and we charge them to general and administrative expense as they are incurred. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Should the initial accounting for a business combination be incomplete by the end of a reporting period that falls within the measurement period, we report provisional amounts in our financial statements. During the measurement period, we adjust the provisional amounts recognized at the acquisition date to reflect new information obtained about facts and circumstances that existed as of the acquisition date that, if known, would have affected the measurement of the amounts recognized as of that date and we record those adjustments to our financial statements in the period of change, if any.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the acquisition method of accounting for business combinations, if we identify changes to acquired deferred tax asset valuation allowances or liabilities related to uncertain tax positions during the measurement period and they relate to new information obtained about facts and circumstances that existed as of the acquisition date, those changes are considered a measurement period adjustment and we record the offset to goodwill. We record all other changes to deferred tax asset valuation allowances and liabilities related to uncertain tax positions in current period income tax expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingent Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the acquisition of Pfenex in October 2020, we entered into a CVR agreement pursuant to which former equity holders of Pfenex received one nontransferable contractual right entitling such holder to receive $2.00 per share (or approximately $77.8&#160;million total) in the event that Pfenex&#x2019;s teriparatide injection product received notice from the FDA that such product is therapeutically equivalent with respect to FORTEO&#xae; (teriparatide injection) on or before December 31, 2021. The FDA did not provide notice of such event prior to the CVR expiration date and as a result, the Pfenex CVRs expired without payment.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the acquisition of CyDex in January 2011, we recorded a contingent liability for amounts potentially due to holders of the CyDex CVRs and former license holders. The liability is periodically assessed based on events and circumstances related to the underlying milestones, royalties and material sales. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs for each Metabasis share. The fair values of the CVRs are remeasured at each reporting date through the term of the related agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any change in fair value is recorded in our consolidated statement of operations. For additional information, see &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note (5), Fair Value Measurement and Note (8), Balance Sheet Account Details&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&#x201d;   &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill, Intangible Assets and Other Long-Lived Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill, which has an indefinite useful life, represents the excess of cost over fair value of net assets acquired. Goodwill is reviewed for impairment at least annually during the fourth quarter, or more frequently if an event occurs indicating the potential for impairment. During the goodwill impairment review, we assess qualitative factors to determine whether it is more &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;likely than not that the fair value of our reporting unit is less than the carrying amount, including goodwill. The qualitative factors include, but are not limited to, macroeconomic conditions, industry and market considerations, and the overall financial performance. If, after assessing the totality of these qualitative factors, we determine that it is not more likely than not that the fair value of our reporting unit is less than the carrying amount, then no additional assessment is deemed necessary. Otherwise, we proceed to perform the quantitative assessment. We will then evaluate goodwill for impairment by comparing the estimated fair value of the reporting unit to its carrying value, including the associated goodwill. To determine the fair value, we generally use a combination of market approach based on Ligand and comparable publicly traded companies in similar lines of businesses and the income approach based on estimated discounted future cash flows. Our cash flow assumptions consider historical and forecasted revenue, operating costs and other relevant factors. We may also elect to bypass the qualitative assessment in a period and elect to proceed to perform the quantitative assessment for the goodwill impairment test. We performed the annual assessment for goodwill impairment during the fourth quarter of 2022, noting no impairment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our identifiable intangible assets are typically composed of acquired core technologies, licensed technologies, contractual relationships, customer relationships and trade names. The cost of identifiable intangible assets with finite lives is generally amortized on a straight-line basis over the assets&#x2019; respective estimated useful lives. We regularly perform reviews to determine if any event has occurred that may indicate that intangible assets with finite useful lives and other long-lived assets are potentially impaired. If indicators of impairment exist, an impairment test is performed to assess the recoverability of the affected assets by determining whether the carrying amount of such assets exceeds the undiscounted expected future cash flows. If the affected assets are not recoverable, we estimate the fair value of the assets and record an impairment loss if the carrying value of the assets exceeds the fair value. Factors that may indicate potential impairment include market conditions, industry and economic trends, changes in regulations, clinical success, historical and forecasted financial results, market capitalization, significant changes in the ability of a particular asset to generate positive cash flows, and the pattern of utilization of a particular asset. We did not identify indicators of impairment for the finite-lived intangibles at December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Commercial license and other economic rights&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022 and 2021, commercial license and other economic rights consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.338%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Aziyo and CorMatrix&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,538)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Selexis and Dianomi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,578)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18,116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18,188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(1) Amounts represent accumulated amortization to principal of $11.6 million and credit loss adjustments of $6.5 million as of December 31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(2) Amounts represent accumulated amortization to principal of $11.7 million and credit loss adjustments of $6.5 million as of December 31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial license and other economic rights as of December&#160;31, 2022 represent a portfolio of future milestone and royalty payment rights acquired from Selexis in April 2013 and April 2015, CorMatrix in May 2016, and Dianomi in January 2019. Commercial license rights acquired are accounted for as financial assets, and other economic rights are accounted for as funded research and developments as further discussed below. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2019, we entered into a development funding and royalties agreement with Novan, pursuant to which we would receive certain payments at specified milestones, as well as royalties on any future net sales of SB206, a product candidate being developed to treat molluscum contagiosum, and any other Novan products used for the treatment of molluscum (&#x201c;Novan Molluscum Products&#x201d;). We paid Novan an upfront payment of $12.0 million, which Novan is required to use to fund the development of SB206. We are not obligated to provide additional funding to Novan for the development or commercialization of SB206. Pursuant to the agreement, we would receive up to $20.0 million of milestone payments upon the achievement by Novan of certain regulatory milestones for SB206 or any other Novan Molluscum Product and commercial milestones. In addition to the milestone payments, Novan will pay us tiered royalties from 7.0% to 10.0% based on aggregate annual net sales of SB206 or any other Novan Molluscum Product in North America. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2018, we entered into a development funding and royalties agreement with Palvella. Pursuant to the agreement, we will receive up to $8.0 million of milestone payments upon the achievement by Palvella of certain corporate, financing and regulatory milestones for PTX-022, a product candidate being developed to treat pachyonychia congenita. In addition to the milestone payments, Palvella will pay us tiered royalties from 5.0% to 9.8% based on aggregate annual worldwide net sales of any PTX-022 products, if approved, subject to Palvella&#x2019;s right to reduce the royalty rates by making payments in certain circumstances. We made an upfront payment of $10.0 million, which Palvella is required to use to fund the development of PTX-022. We are not obligated to provide additional funding to Palvella for development or commercialization of PTX-022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determined the economic rights related to Novan and Palvella should be characterized as a funded research and development arrangement, thus we account for them in accordance with ASC 730-20, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Research and Development Arrangement, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and reduce our asset as the funds are expended by Novan and Palvella. As of December 31, 2019, Novan had used up the $12.0 million upfront payment provided by us. As such, our other economic rights related to Novan had been fully amortized as of December 31, 2019. As of December 31, 2020, the fund has been fully expended by Palvella and our cost basis for the asset has been reduced to zero, and therefore we will recognize milestones and royalties as revenue when earned. During 2020, we recorded a $3.0 million milestone from Palvella under contract revenue, which has been included in our consolidated statement of operations for the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2017, we entered into a royalty agreement with Aziyo pursuant to which we will receive royalties from certain marketed products that Aziyo acquired from CorMatrix. Pursuant to the agreement, we received $10.0 million in 2017 from Aziyo to buydown the royalty rates on the products CorMatrix sold to Aziyo. The agreement closed on May 31, 2017, in connection with the closing of the asset sale from CorMatrix to Aziyo (the &#x201c;CorMatrix Asset Sale&#x201d;). Per the agreement, we will receive a 5% royalty on the products Aziyo acquired in the CorMatrix Asset Sale, reduced from the original 20% royalty from CorMatrix pursuant to the previously disclosed interest purchase agreement, dated May 3, 2016 (the &#x201c;Original Interest Purchase Agreement&#x201d;) between CorMatrix and us. In addition, Aziyo has agreed to pay us up to $10.0 million of additional milestones tied to cumulative net sales of the products Aziyo acquired in the CorMatrix Asset Sale and to extend the term on these royalties by one year. The royalty agreement will terminate on May 31, 2027. In addition, in May 2017, we entered into an amended and restated interest purchase agreement (the &#x201c;Amended Interest Purchase Agreement&#x201d;) with CorMatrix, which supersedes in its entirety the Original Interest Purchase Agreement. Other than removing the commercial products sold to Aziyo in the CorMatrix Sale, the terms of the Amended Interest Purchase Agreement remain unchanged with respect to the CorMatrix developmental pipeline products, including the royalty rate of 5% on such pipeline products. The Amended Interest Purchase Agreement will terminate 10 years from the date of the first commercial sale of such products. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for the Aziyo commercial license right as a financial asset in accordance with ASC 310, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Receivables&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and amortize the commercial license right using the effective interest method whereby we forecast expected cash flows over the term of the arrangement to arrive at an annualized effective interest. The annual effective interest associated with the forecasted cash flows from the royalty agreement with Aziyo as of December&#160;31, 2022 is 19.0%. Revenue is calculated by multiplying the carrying value of the commercial license right by the effective interest. The payments received in the year ended December&#160;31, 2022 and 2021 were allocated accordingly between revenue and the amortization of the commercial license rights.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to 2020, we accounted for commercial license rights related to developmental pipeline products such as Selexis and Dianomi on a non-accrual basis. These developmental pipeline products are non-commercialized, non-approved products that require FDA or other regulatory approval, and thus have uncertain cash flows. The developmental pipeline products are on a non-accrual basis as we are not yet able to forecast future cash flows given their pre-commercial stages of development. We will prospectively update the yield model under the effective interest method once the underlying products are commercialized and we can reliably forecast expected cash flows. Income will be calculated by multiplying the carrying value of the commercial license right by the effective interest rate. We regularly perform reviews to determine if any event has occurred that may indicate the carrying value of these commercial license rights are potentially impaired. If the affected commercial license rights are not recoverable, we estimate the fair value of the assets and record an impairment loss if the carrying value of the assets exceeds the fair value. During 2020, given the expected cash flow from the Selexis program, we started to account for the Selexis commercial license right as a financial asset in accordance with ASC 310, and amortize the commercial license right using the effective interest method whereby we forecast expected cash flows over the term of the arrangement to arrive at an annualized effective interest. The annual effective interest associated with the forecasted cash flows from the royalty agreement with Selexis as of December&#160;31, 2022 is 24.6%. Revenue is calculated by multiplying the carrying value of the commercial license right by the effective interest. The payments received in the year ended December&#160;31, 2022 and 2021 were allocated accordingly between revenue and the amortization of the commercial license rights. We still accounted for commercial license rights related to Dianomi on a non-accrual basis as of December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For commercial license rights, we have elected a prospective approach to account for changes in estimated cash flows and selected a method for determining when an impairment would be recognized and how to measure that impairment. In circumstances where our new estimate of expected cash flows is greater than previously expected, we will update our yield prospectively. In circumstances where our new estimate of expected cash flows is less than previously expected and below our original estimated yield we record an impairment. Impairment is recognized by reducing the financial asset to an amount that represents the present value of our most recent estimate of expected cash flows discounted by the original effective interest rate.&#160;In circumstances where our new estimate of expected cash flows is less than previously expected, but not below our original estimated yield, we update our yield prospectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of adopting ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments &#x2013; Credit Losses: Measurement of Credit losses on Financial Instruments (Topic 326)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we now recognize an allowance for current expected credit losses on the commercial license rights subject to credit risk. We recorded a $5.5 million pre-tax reserve for credit losses upon adoption of the standard on January 1, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2020. We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the twelve months ended December 31, 2022 and 2021, we further considered the current and expected future economic and market conditions. We concluded a reduction of $0.3 million and  $0.5 million to the allowance for credit losses in other expense, net, in our consolidated statements of operations for the year ended 2022 and 2021, respectively.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We apply the following five-step model in accordance with ASC 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in order to determine the revenue: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Royalties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We receive royalty revenue on sales by our partners of products covered by patents that we or our partners own under contractual agreements. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a royalty to be recorded no sooner than the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues are adjusted in the period in which they become known, typically the following quarter. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Captisol Sales&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from Captisol sales is recognized when control of Captisol material or intellectual property license rights is transferred to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. For Captisol material, we consider our performance obligation is satisfied at a point in time, once we have transferred control of the product, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We have elected to recognize the cost of freight and shipping when control over Captisol material has transferred to the customer as an expense in Cost of Captisol. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our contracts with customers often will include variable consideration in the form of contingent milestone-based payments. We include contingent milestone based payments in the estimated transaction price when it is probable a significant reversal in the amount of cumulative revenue recognized will not occur. These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone based payment is sales-based, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development based milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon the development milestone or regulatory approval. Depending on the terms of the arrangement, we may also defer a portion of the consideration received if we have to satisfy a future obligation, which typically occurs with our contracts for R&amp;amp;D services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For R&amp;amp;D services we recognize revenue over time and we measure our progress using an input method. The input methods we use are based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time it will take us to complete the activities, or the costs we may incur in a given &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make numerous estimates and use significant judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We occasionally have sub-license obligations related to arrangements for which we receive license fees, milestones and royalties. We evaluate the determination of gross as a principal versus net as an agent reporting based on each individual agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depending on the terms of the arrangement, we may also defer a portion of the consideration received if we have to satisfy a future obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry a contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue. During the twelve months ended December&#160;31, 2022, the amount recognized as revenue that was previously deferred at December 31, 2021 was $0.4 million. During the twelve months ended December&#160;31, 2021, the amount recognized as revenue that was previously deferred at December 31, 2020 was $23.3 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disaggregation of Revenue &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Royalty revenue for 2022, 2021 and 2020 for continuing operations are reported as below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Kyprolis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Evomela&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Teriparatide injection &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rylaze &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents disaggregation of Captisol and contract revenue for continuing operations (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Captisol&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Captisol - Core&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Captisol - COVID&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Service Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;License Fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Milestone&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Captisol - COVID represents revenue on Captisol supplied for use in formulation with remdesivir, an antiviral treatment for COVID-19.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development Expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development expense consists of labor, material, equipment, and allocated facilities costs of our scientific staff who are working pursuant to our collaborative agreements and other research and development projects. Also included in research and development expenses are third-party costs incurred for our research programs including in-licensing costs, contract research organization (CRO) costs and costs incurred by other research and development service vendors. We expense these costs as they are incurred. When we make payments for research and development services prior to the services being rendered, we record those amounts as prepaid assets on our consolidated balance sheet and we expense them as the services are provided. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We incur share-based compensation expense related to restricted stock, ESPP, and stock options.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted stock unit (RSU) and performance stock unit (PSU) are all considered restricted stock. The fair value of restricted stock is determined by the closing market price of our common stock on the date of grant. We recognize share-based compensation expense based on the fair value on a straight-line basis over the requisite service periods of the awards, taking into consideration of forfeitures as they occur. PSU generally represents a right to receive a certain number of shares of common stock based on the achievement of corporate performance goals and continued employment during the vesting period. At each reporting period, we reassess the probability of the achievement of such corporate performance goals and any expense change resulting from an adjustment in the estimated shares to be released are treated as a cumulative catch-up in the period of adjustment. A limited amount of PSUs contain a market condition dependent upon the Company&#x2019;s relative and absolute total stockholder return over a three-year period, with a range of 0% to 200% of the target amount granted to be issued under the award. Share-based compensation expense for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the market conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Black-Scholes-Merton option-pricing model is used to estimate the fair value of stock purchases under our ESPP and stock options granted. The model assumptions include expected volatility, term, dividends, and the risk-free interest rate. We look to historical and implied volatility of our stock to determine the expected volatility. The expected term of an award is based on historical forfeiture experience, exercise activity, and on the terms and conditions of the stock awards. The expected dividend yield is determined to be 0% given that except for 2007, during which we declared a cash dividend on our common stock of $2.50 per share, we have not paid any dividends on our common stock in the past and currently do not expect to pay cash dividends or make any other distributions on common stock in the future. The risk-free interest rate is based upon U.S. Treasury securities with remaining terms similar to the expected term of the share-based awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We grant options, RSUs and PSUs to employees and non-employee directors. Non-employee directors are accounted for as employees. Options and RSUs granted to certain non-employee directors typically vest one year from the date of grant. Options granted to employees typically vest 1/8 on the six month anniversary of the date of grant, and 1/48 each month thereafter for forty-two months. RSUs and PSUs granted to employees vest over three years. All option awards generally expire ten years from the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense for awards to employees and non-employee directors is recognized on a straight-line basis over the vesting period until the last tranche vests. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes is computed using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for the expected future tax benefit to be derived from tax loss and credit carryforwards. Deferred tax assets and liabilities are determined using the enacted tax rates in effect for the years in which those tax assets are expected to be realized. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the provision for income taxes in the period that includes the enactment date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets are regularly assessed to determine the likelihood they will be recovered from future taxable income. A valuation allowance is established when we believe it is more likely than not the future realization of all or some of a deferred tax asset will not be achieved. In evaluating the ability to recover deferred tax assets within the jurisdiction which they arise we consider all available positive and negative evidence. Factors reviewed include the cumulative pre-tax book income for the past three years, scheduled reversals of deferred tax liabilities, history of earnings and reliable forecasting, projections of pre-tax book income over the foreseeable future, and the impact of any feasible and prudent tax planning strategies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize the impact of a tax position in our financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Tax authorities regularly examine our returns in the jurisdictions in which we do business and we regularly assess the tax risk of our return filing positions. Due to the complexity of some of the uncertainties, the ultimate resolution may result in payments that are materially &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;different from our current estimate of the tax liability. These differences, as well as any interest and penalties, will be reflected in the provision for income taxes in the period in which they are determined.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income (Loss) Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic income (loss) per share is calculated by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Diluted income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of the Company&#x2019;s common stock exceeds the applicable conversion price of the respective notes. It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for stock options and restricted stock. In loss periods, basic net loss per share and diluted net loss per share are identical since the effect of otherwise dilutive potential common shares is anti-dilutive and therefore excluded.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with ASC 260, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Earnings per Share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, if a company had a discontinuing operation, the company uses income from continuing operations, adjusted for preferred dividends and similar adjustments, as its control number to determine whether potential common shares a dilutive. The following table presents the calculation of weighted average shares used to calculate basic and diluted income (loss) per share (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.189%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive potential common shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares used to compute diluted income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Potentially dilutive shares excluded from calculation due to anti-dilutive effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Comprehensive Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive income (loss) represents net income (loss) adjusted for the change during the periods presented in unrealized gains and losses on available-for-sale debt securities, foreign currency translation adjustments, and reclassification adjustments for realized gains or losses included in net income (loss). The unrealized gains or losses are reported on the Consolidated Statements of Comprehensive Income (Loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The British Pound Sterling was the functional currency of our subsidiary, Vernalis, which was sold in fourth quarter of the year ended December 31, 2020. For the year ended December 31, 2020, the corresponding financial statements have been translated into U.S. Dollars in accordance with ASC 830-30, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Translation of Financial Statements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Assets and liabilities are translated at end-of-period rates while revenues and expenses are translated at average rates in effect during the period in which the activity took place. Equity is translated at historical rates and the resulting cumulative translation adjustments are included as a component of accumulated other comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Standards Updates, Recently Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU 2020-06&#x201d;). The guidance simplifies the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#x2019;s own equity. Consequently, a convertible debt instrument, such as the Company&#x2019;s 2023 Notes, will be accounted for as a single liability measured at its amortized cost, if no other features require bifurcation and recognition as derivatives. The new guidance also requires the if-converted method to be applied for all convertible instruments and requires additional disclosures. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We adopted this guidance effective January 1, 2022 under the modified retrospective approach and the comparative information has not been restated and continues to be presented according to accounting standards in effect for those periods. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption and our 2023 Notes are no longer bifurcated into separate liability and equity components. The principal amount of the 2023 Notes is classified as a single liability measured at amortized cost in the consolidated balance sheet for the period ended December 31, 2022. Upon adoption of ASU 2020-06 on January 1, 2022, we recorded an adjustment to the 2023 Notes liability component, deferred tax liabilities, additional paid-in-capital and retained earnings. This adjustment was calculated based on the carrying amount of the 2023 Notes as if it had always been treated as a single liability measured at amortized cost. Furthermore, we recorded an adjustment to the debt issuance costs contra liability and equity (additional paid-in-capital) components under the same premise, as if debt issuance costs had always been treated as a contra liability only. Under this transition method, the cumulative effect of the accounting change increased the carrying amount of the 2023 Notes by $20.4 million, reduced deferred tax liabilities by $4.4 million, reduced additional paid-in capital by $51.1 million and increased retained earnings by $35.1 million. The net balance of the 2023 Notes at January 1, 2022 was $341.1 million which included an unamortized discount of $2.2 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on our consolidated financial statements or disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <lgnd:BusinessSpinOffAndMigrationPolicyTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMjc0ODc3OTE1MTc4Nw_aad64683-9bb8-4a4f-920d-1762cdd2f172">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Business&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 1, 2022, we completed the separation (the &#x201c;Separation&#x201d;) of our antibody discovery business and certain related assets and liabilities (the &#x201c;OmniAb Business&#x201d;) through a spin-off of OmniAb to Ligand&#x2019;s shareholders of record as of October 26, 2022 on a pro rata basis (the &#x201c;Distribution&#x201d;) and merger (the &#x201c;Merger&#x201d;) of OmniAb with a wholly owned subsidiary of a separate public company, OmniAb, Inc. (formerly known as Avista Public Acquisition Corp. II (&#x201c;New OmniAb&#x201d;)), in a Reverse Morris Trust transaction pursuant to the Agreement and Plan of Merger, dated as of March 23, 2022 (the &#x201c;Merger Agreement&#x201d;), and the Separation and Distribution Agreement, dated as of March 23, 2022 (the &#x201c;Separation Agreement&#x201d;) (the Merger Agreement and Separation Agreement, collectively with the other related transaction documents, the &#x201c;Transaction Agreements&#x201d;). Pursuant to the Transaction Agreements, Ligand contributed to OmniAb cash and certain assets and liabilities constituting the OmniAb Business, including but not limited to the equity interests of Ab Initio Biotherapeutics, Inc., Crystal Bioscience, Inc., Icagen, LLC, Taurus Biosciences, LLC and xCella Biosciences, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After the spin-off of our OmniAb antibody discovery business, Ligand is a revenue-generating biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. We operate in one business segment: development and licensing of biopharmaceutical assets.&lt;/span&gt;&lt;/div&gt;</lgnd:BusinessSpinOffAndMigrationPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDQ5_1f30967b-9444-4443-8ac3-5998c95de976"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <lgnd:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2NTE_1cc4ca10-ce7b-4e40-b227-d461a414948b">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our consolidated financial statements have been prepared in accordance with U.S. GAAP and include the accounts of our parent company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;</lgnd:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock>
    <us-gaap:DiscontinuedOperationsPolicyTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMjc0ODc3OTEzMzk2OQ_af8a3856-9970-4645-b1d6-f7f6ec87acb1">Discontinued operations&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined that the spin-off of the OmniAb Business in November 2022 met the criteria for classification as a discontinued operation in accordance with ASC Subtopic 205-20, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Discontinued Operations&lt;/span&gt; (&#x201c;ASC 205-20&#x201d;). Accordingly, the accompanying consolidated financial statements for all periods presented have been updated to present the assets and liabilities associated with the OmniAb Business separately as discontinued operations on the consolidated balance sheets and the results of all discontinued operations reported as a separate component of loss in the consolidated statements of operations and comprehensive loss</us-gaap:DiscontinuedOperationsPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2NTI_596df23d-ed52-48ad-aa2d-9a1f66fe6923">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in conformity with U.S. GAAP requires the use of estimates and assumptions that affect the amounts reported in the consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2Nzg_17bd73c1-478a-4adb-b23d-82157cb7e615">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentrations of Business Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject us to significant concentrations of credit risk consist primarily of cash equivalents and investments. We invest excess cash principally in United States government debt securities, investment grade corporate debt securities, mutual funds and certificates of deposit. We maintain some cash and cash equivalents balances with financial institutions that are in excess of the Federal Deposit Insurance Corporation insurance limits. We have established guidelines relative to diversification and maturities that maintain safety and liquidity. These guidelines are periodically reviewed and modified to take advantage of trends in yields and interest rates.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2Njk_e1677363-b341-4225-99ee-b874a2327c24">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from significant partners, which is defined as 10% or more of our total revenue, was as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Partner A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Partner B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Partner C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;lt;10%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;lt;10%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;lt;10%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.&lt;/span&gt;&lt;/div&gt;</us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i72f4dbdc77184f48bcecf231e8e2ca80_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjY0NTRlMmI1YzYyZTQ2NmRhNjMyNmRhMGI2OTA1ZGFjL3RhYmxlcmFuZ2U6NjQ1NGUyYjVjNjJlNDY2ZGE2MzI2ZGEwYjY5MDVkYWNfMi0xLTEtMS0xMTI2NDA_6a09a20f-09a8-48ce-9a3e-cccac372ed53"
      unitRef="number">0.45</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i14ad94cabb1447e9a5f01458bd06ae4c_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjY0NTRlMmI1YzYyZTQ2NmRhNjMyNmRhMGI2OTA1ZGFjL3RhYmxlcmFuZ2U6NjQ1NGUyYjVjNjJlNDY2ZGE2MzI2ZGEwYjY5MDVkYWNfMi0zLTEtMS0xMTI2NDA_dbae888f-8d8b-4f67-b290-00889221d5d2"
      unitRef="number">0.47</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia3ecad76cf15478e978cd158a1acc62b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjY0NTRlMmI1YzYyZTQ2NmRhNjMyNmRhMGI2OTA1ZGFjL3RhYmxlcmFuZ2U6NjQ1NGUyYjVjNjJlNDY2ZGE2MzI2ZGEwYjY5MDVkYWNfMi01LTEtMS0xMTY2MzY_9c5a5ac6-4449-410d-8b34-86b970fdf24f"
      unitRef="number">0.51</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i032f9a1963654916a1d87cdbf84a1c8c_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjY0NTRlMmI1YzYyZTQ2NmRhNjMyNmRhMGI2OTA1ZGFjL3RhYmxlcmFuZ2U6NjQ1NGUyYjVjNjJlNDY2ZGE2MzI2ZGEwYjY5MDVkYWNfMy0xLTEtMS0xMTI2NDA_6707665b-4363-4a71-ba53-143fd4a5a79e"
      unitRef="number">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i84da35f51bc941fb9605c4e27d374dc2_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjY0NTRlMmI1YzYyZTQ2NmRhNjMyNmRhMGI2OTA1ZGFjL3RhYmxlcmFuZ2U6NjQ1NGUyYjVjNjJlNDY2ZGE2MzI2ZGEwYjY5MDVkYWNfMy0zLTEtMS0xMTI2NDA_69ae4369-d6bd-405e-ab8f-21f46173d025"
      unitRef="number">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie756c741eed64e91bbd573fd37cc5dc5_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjY0NTRlMmI1YzYyZTQ2NmRhNjMyNmRhMGI2OTA1ZGFjL3RhYmxlcmFuZ2U6NjQ1NGUyYjVjNjJlNDY2ZGE2MzI2ZGEwYjY5MDVkYWNfMy01LTEtMS0xMTI2NDA_609fb8e3-e490-43e6-8bb3-bf12b4a3478b"
      unitRef="number">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i320b82dcca2f4f7c9916c6e2f9c91339_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjY0NTRlMmI1YzYyZTQ2NmRhNjMyNmRhMGI2OTA1ZGFjL3RhYmxlcmFuZ2U6NjQ1NGUyYjVjNjJlNDY2ZGE2MzI2ZGEwYjY5MDVkYWNfNC0xLTEtMS0xMTY2NDA_e5210e3a-8aa7-4711-b47b-5c0a33637a94"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib51bff40a74549a49092eaf3d331dfb2_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjY0NTRlMmI1YzYyZTQ2NmRhNjMyNmRhMGI2OTA1ZGFjL3RhYmxlcmFuZ2U6NjQ1NGUyYjVjNjJlNDY2ZGE2MzI2ZGEwYjY5MDVkYWNfNC0zLTEtMS0xMTY2Mzg_4f1b0f02-6d16-4599-8865-58eca9a0d6cc"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i53db40ae7eaa43a29ee0d41f7837b347_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjY0NTRlMmI1YzYyZTQ2NmRhNjMyNmRhMGI2OTA1ZGFjL3RhYmxlcmFuZ2U6NjQ1NGUyYjVjNjJlNDY2ZGE2MzI2ZGEwYjY5MDVkYWNfNC01LTEtMS0xMTI2NDA_43f64ec7-6ff7-4368-9d38-8fb3d59efebb"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <lgnd:CashCashEquivalentsandShorttermInvestmentsPolicyTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2NTk_079d0bb3-e661-45e7-acd3-376659277e20">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash Equivalents &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents consist of highly liquid investments with maturities of three months or less from the date of acquisition. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Short-term Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments primarily consist of investments in debt and equity securities. We classify our short-term investments as &#x201c;available-for-sale&#x201d;. Such investments are carried at fair value, with unrealized gains and losses on debt securities included in the statement of comprehensive income (loss), net of tax, and unrealized gains and losses on equity securities included the consolidated statement of operations. We determine the cost of investments based on the specific identification method. We determine the realized gains or losses on the sale of available-for-sale securities using the specific identification method and includes net realized gains and losses as a component of other income or expense within the consolidated statements of operations.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities consist of certificates of deposit, corporate debt securities, and securities of government-sponsored entities have effective maturities greater than&#160;three&#160;months and less than twenty-five months from the date of acquisition. Debt securities available-for-sale in an unrealized loss position are assessed for the current expected credit losses methodology. We start by assessing whether we intend to sell the security, or whether it is more likely than not that we will be required to sell the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security&#x2019;s amortized cost basis is written down to fair value through earnings. For debt securities available-for-sale that do not meet the aforementioned criteria, we evaluate whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, we consider the extent to which fair value is less than amortized cost, any changes in interest rates, and any changes to the rating of the security by a rating agency, among other factors. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security is compared to the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded, limited by the amount that the fair value is less than the amortized cost basis. Any impairment that has not been recorded through an allowance for credit losses is recognized in other comprehensive income or loss, as applicable.&lt;/span&gt;&lt;/div&gt;Equity securities are mutual funds, investments in privately held companies (non-marketable equity securities), and companies that have completed initial public offerings (marketable equity securities). Mutual funds are valued at their publicly quoted net asset value (NAV) price on the last day of the period. Our non-marketable equity securities without readily determinable market values are initially measured at cost and adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment. Our marketable equity securities are measured at fair value. Equity investments are classified as short-term investments, or non-current other assets, based on the nature of the securities and their availability for use in current operations.</lgnd:CashCashEquivalentsandShorttermInvestmentsPolicyTextBlock>
    <lgnd:MaturityPeriodOfHighlyLiquidSecuritiesMaximum
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMjY2NQ_ce22e824-f123-4ccc-aeb1-d18a25e77351">P3M</lgnd:MaturityPeriodOfHighlyLiquidSecuritiesMaximum>
    <us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2NjA_32b2f27c-e9a3-4066-815a-efe5226aa323">Accounts Receivable Our accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers.</us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2ODQ_35ae2f75-a297-4ded-a1a9-a82c3425319b">InventoryInventory, which consists of finished goods, is stated at the lower of cost or net realizable value. We determine cost using the specific identification method. We analyze our inventory levels periodically and write down inventory to net realizable value if it has become obsolete, has a cost basis in excess of its expected net realizable value or is in excess of expected requirements.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:InventoryWriteDown
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNTQ5NzU1ODgxOTIy_38dfac5e-28c5-491a-85df-f2a4495a8b61"
      unitRef="usd">1100000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNzE3Mw_1bb4e5f1-cdbc-48c2-87d4-41535bc01fbd"
      unitRef="usd">0</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNzE3Mw_fb525606-e868-459a-8220-f6f15e3ad1ec"
      unitRef="usd">0</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryNet
      contextRef="i0d685acb7be943ae8d15dc5799a4444a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNzM0NA_82a192ce-b8a7-42e3-9005-f71b11670789"
      unitRef="usd">5900000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ic202f70f62e8428d9c78a4978a746eee_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNzM1MQ_6212e0eb-896b-4e4b-a44c-377e6d1305aa"
      unitRef="usd">24600000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2NTM_2b0e4059-58da-4407-a906-c8175d765f69">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are stated at cost, subject to review for impairment, and depreciated over the estimated useful lives of the assets, which generally range from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNzU2MQ_9d23c4d7-711e-44c5-af62-13230621da18"&gt;three&lt;/span&gt; to ten years, using the straight-line method. Amortization of leasehold improvements is recorded over the shorter of the lease term or estimated useful life of the related asset. Maintenance and repairs are charged to operations as incurred. When assets are sold, or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts and any gain or loss is included in operating income or expense.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i5a1083da45f7446987097262ce780281_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2NTQ_e4bb9b02-006a-41ca-b467-292dce2e9875">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:BusinessCombinationsPolicy
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2NjU_08716a71-22cb-4f5b-ba54-59bc09b811ae">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We first determine whether a set of assets acquired constitute a business and should be accounted for as a business combination. If the assets acquired are not a business, we account for the transaction as an asset acquisition. Business combinations are accounted for by using the acquisition method of accounting which requires us to use significant estimates and assumptions, especially with respect to intangible assets. We record the excess consideration over the aggregate fair value of tangible and intangible assets, net of liabilities assumed, as goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the acquisition method of accounting, we recognize separately from goodwill the identifiable assets acquired, the liabilities assumed, including contingent consideration and all contractual contingencies, generally at the acquisition date fair value. Contingent purchase consideration to be settled in cash are remeasured to estimated fair value at each reporting period with the change in fair value recorded in statement of operations. Costs that we incur to complete the business combination such as investment banking, legal and other professional fees are not considered part of consideration and we charge them to general and administrative expense as they are incurred. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Should the initial accounting for a business combination be incomplete by the end of a reporting period that falls within the measurement period, we report provisional amounts in our financial statements. During the measurement period, we adjust the provisional amounts recognized at the acquisition date to reflect new information obtained about facts and circumstances that existed as of the acquisition date that, if known, would have affected the measurement of the amounts recognized as of that date and we record those adjustments to our financial statements in the period of change, if any.&lt;/span&gt;&lt;/div&gt;Under the acquisition method of accounting for business combinations, if we identify changes to acquired deferred tax asset valuation allowances or liabilities related to uncertain tax positions during the measurement period and they relate to new information obtained about facts and circumstances that existed as of the acquisition date, those changes are considered a measurement period adjustment and we record the offset to goodwill. We record all other changes to deferred tax asset valuation allowances and liabilities related to uncertain tax positions in current period income tax expense.</us-gaap:BusinessCombinationsPolicy>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityAmountPerShare
      contextRef="id219523c2b3d4296bdc72fa8f030e324_I20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTA3MDc_1d242e55-42fd-4bc2-ba5f-8a91d5953a77"
      unitRef="usdPerShare">2.00</lgnd:BusinessCombinationContingentConsiderationLiabilityAmountPerShare>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="id219523c2b3d4296bdc72fa8f030e324_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTA3Mzg_0a67c573-3a86-4f72-8314-5e8a5ccb1917"
      unitRef="usd">77800000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <lgnd:NumberOfContingentValueRightsIssued
      contextRef="ied0c882ba4784643aa73cead8f57f992_I20100131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTE3MDE_7539fa26-fc0b-4072-a814-14fd60cfb7e1"
      unitRef="right">4</lgnd:NumberOfContingentValueRightsIssued>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2ODM_47de061a-7429-4891-bd50-1d4e468e765e">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill, Intangible Assets and Other Long-Lived Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill, which has an indefinite useful life, represents the excess of cost over fair value of net assets acquired. Goodwill is reviewed for impairment at least annually during the fourth quarter, or more frequently if an event occurs indicating the potential for impairment. During the goodwill impairment review, we assess qualitative factors to determine whether it is more &lt;/span&gt;&lt;/div&gt;likely than not that the fair value of our reporting unit is less than the carrying amount, including goodwill. The qualitative factors include, but are not limited to, macroeconomic conditions, industry and market considerations, and the overall financial performance. If, after assessing the totality of these qualitative factors, we determine that it is not more likely than not that the fair value of our reporting unit is less than the carrying amount, then no additional assessment is deemed necessary. Otherwise, we proceed to perform the quantitative assessment. We will then evaluate goodwill for impairment by comparing the estimated fair value of the reporting unit to its carrying value, including the associated goodwill. To determine the fair value, we generally use a combination of market approach based on Ligand and comparable publicly traded companies in similar lines of businesses and the income approach based on estimated discounted future cash flows. Our cash flow assumptions consider historical and forecasted revenue, operating costs and other relevant factors. We may also elect to bypass the qualitative assessment in a period and elect to proceed to perform the quantitative assessment for the goodwill impairment test. We performed the annual assessment for goodwill impairment during the fourth quarter of 2022, noting no impairment. Our identifiable intangible assets are typically composed of acquired core technologies, licensed technologies, contractual relationships, customer relationships and trade names. The cost of identifiable intangible assets with finite lives is generally amortized on a straight-line basis over the assets&#x2019; respective estimated useful lives. We regularly perform reviews to determine if any event has occurred that may indicate that intangible assets with finite useful lives and other long-lived assets are potentially impaired. If indicators of impairment exist, an impairment test is performed to assess the recoverability of the affected assets by determining whether the carrying amount of such assets exceeds the undiscounted expected future cash flows. If the affected assets are not recoverable, we estimate the fair value of the assets and record an impairment loss if the carrying value of the assets exceeds the fair value. Factors that may indicate potential impairment include market conditions, industry and economic trends, changes in regulations, clinical success, historical and forecasted financial results, market capitalization, significant changes in the ability of a particular asset to generate positive cash flows, and the pattern of utilization of a particular asset.</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <lgnd:CommercialLicenseRightsPolicyTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2NjE_a8a42335-bcfa-4b0e-8e34-4bf55c56ddcd">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Commercial license and other economic rights&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022 and 2021, commercial license and other economic rights consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.338%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Aziyo and CorMatrix&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,538)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Selexis and Dianomi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,578)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18,116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18,188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(1) Amounts represent accumulated amortization to principal of $11.6 million and credit loss adjustments of $6.5 million as of December 31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(2) Amounts represent accumulated amortization to principal of $11.7 million and credit loss adjustments of $6.5 million as of December 31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial license and other economic rights as of December&#160;31, 2022 represent a portfolio of future milestone and royalty payment rights acquired from Selexis in April 2013 and April 2015, CorMatrix in May 2016, and Dianomi in January 2019. Commercial license rights acquired are accounted for as financial assets, and other economic rights are accounted for as funded research and developments as further discussed below. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2019, we entered into a development funding and royalties agreement with Novan, pursuant to which we would receive certain payments at specified milestones, as well as royalties on any future net sales of SB206, a product candidate being developed to treat molluscum contagiosum, and any other Novan products used for the treatment of molluscum (&#x201c;Novan Molluscum Products&#x201d;). We paid Novan an upfront payment of $12.0 million, which Novan is required to use to fund the development of SB206. We are not obligated to provide additional funding to Novan for the development or commercialization of SB206. Pursuant to the agreement, we would receive up to $20.0 million of milestone payments upon the achievement by Novan of certain regulatory milestones for SB206 or any other Novan Molluscum Product and commercial milestones. In addition to the milestone payments, Novan will pay us tiered royalties from 7.0% to 10.0% based on aggregate annual net sales of SB206 or any other Novan Molluscum Product in North America. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2018, we entered into a development funding and royalties agreement with Palvella. Pursuant to the agreement, we will receive up to $8.0 million of milestone payments upon the achievement by Palvella of certain corporate, financing and regulatory milestones for PTX-022, a product candidate being developed to treat pachyonychia congenita. In addition to the milestone payments, Palvella will pay us tiered royalties from 5.0% to 9.8% based on aggregate annual worldwide net sales of any PTX-022 products, if approved, subject to Palvella&#x2019;s right to reduce the royalty rates by making payments in certain circumstances. We made an upfront payment of $10.0 million, which Palvella is required to use to fund the development of PTX-022. We are not obligated to provide additional funding to Palvella for development or commercialization of PTX-022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determined the economic rights related to Novan and Palvella should be characterized as a funded research and development arrangement, thus we account for them in accordance with ASC 730-20, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Research and Development Arrangement, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and reduce our asset as the funds are expended by Novan and Palvella. As of December 31, 2019, Novan had used up the $12.0 million upfront payment provided by us. As such, our other economic rights related to Novan had been fully amortized as of December 31, 2019. As of December 31, 2020, the fund has been fully expended by Palvella and our cost basis for the asset has been reduced to zero, and therefore we will recognize milestones and royalties as revenue when earned. During 2020, we recorded a $3.0 million milestone from Palvella under contract revenue, which has been included in our consolidated statement of operations for the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2017, we entered into a royalty agreement with Aziyo pursuant to which we will receive royalties from certain marketed products that Aziyo acquired from CorMatrix. Pursuant to the agreement, we received $10.0 million in 2017 from Aziyo to buydown the royalty rates on the products CorMatrix sold to Aziyo. The agreement closed on May 31, 2017, in connection with the closing of the asset sale from CorMatrix to Aziyo (the &#x201c;CorMatrix Asset Sale&#x201d;). Per the agreement, we will receive a 5% royalty on the products Aziyo acquired in the CorMatrix Asset Sale, reduced from the original 20% royalty from CorMatrix pursuant to the previously disclosed interest purchase agreement, dated May 3, 2016 (the &#x201c;Original Interest Purchase Agreement&#x201d;) between CorMatrix and us. In addition, Aziyo has agreed to pay us up to $10.0 million of additional milestones tied to cumulative net sales of the products Aziyo acquired in the CorMatrix Asset Sale and to extend the term on these royalties by one year. The royalty agreement will terminate on May 31, 2027. In addition, in May 2017, we entered into an amended and restated interest purchase agreement (the &#x201c;Amended Interest Purchase Agreement&#x201d;) with CorMatrix, which supersedes in its entirety the Original Interest Purchase Agreement. Other than removing the commercial products sold to Aziyo in the CorMatrix Sale, the terms of the Amended Interest Purchase Agreement remain unchanged with respect to the CorMatrix developmental pipeline products, including the royalty rate of 5% on such pipeline products. The Amended Interest Purchase Agreement will terminate 10 years from the date of the first commercial sale of such products. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for the Aziyo commercial license right as a financial asset in accordance with ASC 310, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Receivables&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and amortize the commercial license right using the effective interest method whereby we forecast expected cash flows over the term of the arrangement to arrive at an annualized effective interest. The annual effective interest associated with the forecasted cash flows from the royalty agreement with Aziyo as of December&#160;31, 2022 is 19.0%. Revenue is calculated by multiplying the carrying value of the commercial license right by the effective interest. The payments received in the year ended December&#160;31, 2022 and 2021 were allocated accordingly between revenue and the amortization of the commercial license rights.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to 2020, we accounted for commercial license rights related to developmental pipeline products such as Selexis and Dianomi on a non-accrual basis. These developmental pipeline products are non-commercialized, non-approved products that require FDA or other regulatory approval, and thus have uncertain cash flows. The developmental pipeline products are on a non-accrual basis as we are not yet able to forecast future cash flows given their pre-commercial stages of development. We will prospectively update the yield model under the effective interest method once the underlying products are commercialized and we can reliably forecast expected cash flows. Income will be calculated by multiplying the carrying value of the commercial license right by the effective interest rate. We regularly perform reviews to determine if any event has occurred that may indicate the carrying value of these commercial license rights are potentially impaired. If the affected commercial license rights are not recoverable, we estimate the fair value of the assets and record an impairment loss if the carrying value of the assets exceeds the fair value. During 2020, given the expected cash flow from the Selexis program, we started to account for the Selexis commercial license right as a financial asset in accordance with ASC 310, and amortize the commercial license right using the effective interest method whereby we forecast expected cash flows over the term of the arrangement to arrive at an annualized effective interest. The annual effective interest associated with the forecasted cash flows from the royalty agreement with Selexis as of December&#160;31, 2022 is 24.6%. Revenue is calculated by multiplying the carrying value of the commercial license right by the effective interest. The payments received in the year ended December&#160;31, 2022 and 2021 were allocated accordingly between revenue and the amortization of the commercial license rights. We still accounted for commercial license rights related to Dianomi on a non-accrual basis as of December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For commercial license rights, we have elected a prospective approach to account for changes in estimated cash flows and selected a method for determining when an impairment would be recognized and how to measure that impairment. In circumstances where our new estimate of expected cash flows is greater than previously expected, we will update our yield prospectively. In circumstances where our new estimate of expected cash flows is less than previously expected and below our original estimated yield we record an impairment. Impairment is recognized by reducing the financial asset to an amount that represents the present value of our most recent estimate of expected cash flows discounted by the original effective interest rate.&#160;In circumstances where our new estimate of expected cash flows is less than previously expected, but not below our original estimated yield, we update our yield prospectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of adopting ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments &#x2013; Credit Losses: Measurement of Credit losses on Financial Instruments (Topic 326)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we now recognize an allowance for current expected credit losses on the commercial license rights subject to credit risk. We recorded a $5.5 million pre-tax reserve for credit losses upon adoption of the standard on January 1, &lt;/span&gt;&lt;/div&gt;2020. We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the twelve months ended December 31, 2022 and 2021, we further considered the current and expected future economic and market conditions. We concluded a reduction of $0.3 million and  $0.5 million to the allowance for credit losses in other expense, net, in our consolidated statements of operations for the year ended 2022 and 2021, respectively.</lgnd:CommercialLicenseRightsPolicyTextBlock>
    <lgnd:ScheduleofCommercialLicenseRightsTableTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2NzI_cd589d2d-e666-4c6e-a2e5-e5eb680f3879">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022 and 2021, commercial license and other economic rights consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.338%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Aziyo and CorMatrix&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,538)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Selexis and Dianomi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,578)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18,116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18,188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(1) Amounts represent accumulated amortization to principal of $11.6 million and credit loss adjustments of $6.5 million as of December 31, 2022. &lt;/span&gt;&lt;/div&gt;(2) Amounts represent accumulated amortization to principal of $11.7 million and credit loss adjustments of $6.5 million as of December 31, 2021.</lgnd:ScheduleofCommercialLicenseRightsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i708cef8824df4406829b45bafcb19aec_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfMi0yLTEtMS0xMTI2NDA_b303165c-7a58-4267-b3dc-8f1be187a0e6"
      unitRef="usd">17696000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments
      contextRef="i708cef8824df4406829b45bafcb19aec_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfMi00LTEtMS0xMTI2NDA_184ae151-604b-495c-a16a-45ea29d372a0"
      unitRef="usd">9538000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i708cef8824df4406829b45bafcb19aec_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfMi02LTEtMS0xMTI2NDA_3fffa725-6a37-4d98-9f16-bf87f75e70f8"
      unitRef="usd">8158000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i51a7db08b41d4559b10e461df7cae951_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfMi04LTEtMS0xMTI2NDA_6c903e5c-dd90-4e45-90fa-0b099bcbfdf8"
      unitRef="usd">17696000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments
      contextRef="i51a7db08b41d4559b10e461df7cae951_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfMi0xMC0xLTEtMTEyNjQw_0ccaae86-4830-4051-91e9-57c038d51ecb"
      unitRef="usd">9461000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i51a7db08b41d4559b10e461df7cae951_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfMi0xMi0xLTEtMTEyNjQw_d799b719-a635-4962-a32d-c39e0426e983"
      unitRef="usd">8235000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6f4284fcd53e4be492bf1abd42007aa6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfMy0yLTEtMS0xMTI2NDA_bf440871-7974-4205-ad16-13dac5c7a42d"
      unitRef="usd">10602000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments
      contextRef="i6f4284fcd53e4be492bf1abd42007aa6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfMy00LTEtMS0xMTI2NDA_8dad2ae0-80a1-4237-abad-88addcb8fd71"
      unitRef="usd">8578000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i6f4284fcd53e4be492bf1abd42007aa6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfMy02LTEtMS0xMTI2NDA_ea096cfb-9667-4a8e-8077-a9a7509e72c7"
      unitRef="usd">2024000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="icafaf42275b04638a6eb47f7e4f9d5ae_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfMy04LTEtMS0xMTI2NDA_5d757dd8-de38-4247-b69d-03198a5dbc9f"
      unitRef="usd">10602000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments
      contextRef="icafaf42275b04638a6eb47f7e4f9d5ae_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfMy0xMC0xLTEtMTEyNjQw_7bc5a3fd-4f42-45c2-ab77-1d306f92867b"
      unitRef="usd">8727000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="icafaf42275b04638a6eb47f7e4f9d5ae_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfMy0xMi0xLTEtMTEyNjQw_c9a3bc66-6190-4769-90c4-bea9c4079a9b"
      unitRef="usd">1875000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i753bf04acd14417f84584d364adb5bb8_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfNC0yLTEtMS0xMTI2NDA_da9fe0c8-321e-495c-974d-0b2bcd6f37cb"
      unitRef="usd">28298000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments
      contextRef="i753bf04acd14417f84584d364adb5bb8_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfNC00LTEtMS0xMTI2NDA_0fb4444b-0ea1-412e-adb5-73f0cbed89a5"
      unitRef="usd">18116000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i753bf04acd14417f84584d364adb5bb8_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfNC02LTEtMS0xMTI2NDA_d634e317-0168-4b90-bd32-347fd95b99eb"
      unitRef="usd">10182000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2fdc31d97ec44363932ea54316ee86c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfNC04LTEtMS0xMTI2NDA_63130f0f-f9b5-444d-8b36-9294728b8614"
      unitRef="usd">28298000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments
      contextRef="i2fdc31d97ec44363932ea54316ee86c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfNC0xMC0xLTEtMTEyNjQw_1f92ee51-7c21-4442-abb8-0d6f8d26e4cc"
      unitRef="usd">18188000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i2fdc31d97ec44363932ea54316ee86c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmI3MWI4MjM4MTdiODRhNThiNjU5NzVlNGY1NzU5ZjU2L3RhYmxlcmFuZ2U6YjcxYjgyMzgxN2I4NGE1OGI2NTk3NWU0ZjU3NTlmNTZfNC0xMi0xLTEtMTEyNjQw_02467d91-2407-40f7-8221-8f99fb67bdac"
      unitRef="usd">10110000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTY0OTI2NzUwNjgwMQ_4329d5be-5379-40e8-be45-a803892e92fd"
      unitRef="usd">11600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTY0OTI2NzUwNjgyMA_34a2bd63-93cc-4695-9ad0-41e8f6071cac"
      unitRef="usd">6500000</lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTY0OTI2NzUwNjg0Mg_42895083-d2ae-4337-8543-a8459979de73"
      unitRef="usd">11700000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTY0OTI2NzUwNjg1Ng_0070f537-907d-40b4-b0f8-280040652f6f"
      unitRef="usd">6500000</lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments>
    <lgnd:LicenseUpfrontPayment
      contextRef="ie4ed1fc049264324b4138e54a53f1363_D20190501-20190531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTY1MDU_bd723695-ebcb-419f-889b-2f5988f3657f"
      unitRef="usd">12000000</lgnd:LicenseUpfrontPayment>
    <lgnd:AdditionalRoyaltiesReceivableUnderSalesbasedMilestones
      contextRef="i7e227d79f69e4aea8a7ba69a8fb5790c_I20190531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTY3MzU_78e55737-2a99-4435-ad1c-d3e698389617"
      unitRef="usd">20000000</lgnd:AdditionalRoyaltiesReceivableUnderSalesbasedMilestones>
    <lgnd:ProductRoyaltyPercentage
      contextRef="if79b3620292a470e909e7af19aa0f62a_I20190531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTY5NzY_cebc6118-f58f-4f89-831c-5a05a3938b62"
      unitRef="number">0.070</lgnd:ProductRoyaltyPercentage>
    <lgnd:ProductRoyaltyPercentage
      contextRef="i41a81ed9d20a45a39c1cfa8bf254af62_I20190531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTY5ODI_699c63ff-2aed-419d-bc41-f9c9c0359647"
      unitRef="number">0.100</lgnd:ProductRoyaltyPercentage>
    <lgnd:AdditionalRoyaltiesReceivableUnderSalesbasedMilestones
      contextRef="i4ed660187f8a4347b6987765f4320888_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTcyMzE_18e0cf41-1893-4858-b90e-cc06ef58e594"
      unitRef="usd">8000000</lgnd:AdditionalRoyaltiesReceivableUnderSalesbasedMilestones>
    <lgnd:ProductRoyaltyPercentage
      contextRef="id02e516cbca146e2836770e595c232e1_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTc1MTE_5c3171db-f34d-4781-9faa-edcbee37100d"
      unitRef="number">0.050</lgnd:ProductRoyaltyPercentage>
    <lgnd:ProductRoyaltyPercentage
      contextRef="i91f484a16cb744a5b11a95592c952710_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTc1MTc_393a92b4-769d-4a58-8a23-1cb4124da370"
      unitRef="number">0.098</lgnd:ProductRoyaltyPercentage>
    <lgnd:LicenseUpfrontPayment
      contextRef="i1454c0a0b9464c84aec81eed615b63f1_D20181201-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTc3MzU_9241cfea-391b-49e0-ba7b-4dec979ba4e3"
      unitRef="usd">10000000</lgnd:LicenseUpfrontPayment>
    <lgnd:LicenseUpfrontPayment
      contextRef="ie4ed1fc049264324b4138e54a53f1363_D20190501-20190531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTgyNzI_bd723695-ebcb-419f-889b-2f5988f3657f"
      unitRef="usd">12000000</lgnd:LicenseUpfrontPayment>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i457b511b1d08453b8802d9e74dbddb90_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTg1MzI_aad20ff8-bdc8-4ca6-ae80-df9ed45d8d60"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifa528f43c78d4e52915523cdd982ac81_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTg2NDQ_022597d9-20c3-443f-94c1-19a8b327d374"
      unitRef="usd">3000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ProceedsFromRoyaltiesReceived
      contextRef="id2cce7f20f9b4fb296a7526469510cff_D20170531-20170531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTg5OTc_c24d1288-e306-42f8-967a-6e17af15e8a6"
      unitRef="usd">10000000</us-gaap:ProceedsFromRoyaltiesReceived>
    <lgnd:ProductRoyaltyPercentage
      contextRef="i60474bf54aa94e98b1b7827f2c4e28ec_I20170531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTkyNjc_701e7c8a-4b7f-4546-b856-3df1ff45131f"
      unitRef="number">0.05</lgnd:ProductRoyaltyPercentage>
    <lgnd:ProductRoyaltyPercentage
      contextRef="i9a7a01e9b3e44e6d9b9d6af540a8e364_I20170531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTkzNjQ_0759a1a5-2ef2-450a-85f6-92eca71a5cde"
      unitRef="number">0.20</lgnd:ProductRoyaltyPercentage>
    <lgnd:AdditionalRoyaltiesReceivableUnderSalesbasedMilestones
      contextRef="i362045e8eca24e9b94ed9065fd915555_I20170531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTk1OTE_dc6d88bc-e952-4a91-852b-bf7cb89a6aca"
      unitRef="usd">10000000</lgnd:AdditionalRoyaltiesReceivableUnderSalesbasedMilestones>
    <lgnd:ProductRoyaltyPercentage
      contextRef="iad947c25f57e49ecb7709c07507fa8f5_I20170531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMjAyODk_aeddb724-c008-481f-b0b9-2c51c8ff70c6"
      unitRef="number">0.05</lgnd:ProductRoyaltyPercentage>
    <lgnd:RoyaltyAgreementExpirationPeriod
      contextRef="ia0566a97a54e4f9ab7c582ae4caada22_D20170531-20170531"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMjAzNzQ_434188dd-3824-47bd-b839-3e50698dadb6">P10Y</lgnd:RoyaltyAgreementExpirationPeriod>
    <lgnd:ForecastedCashFlowsEffectiveInterestRatePercent
      contextRef="iacff0d31a3c2457a9ee720c8fbcc8054_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMjA4NzI_686128fe-684a-4cc0-94cc-379e9fb3abb7"
      unitRef="number">0.190</lgnd:ForecastedCashFlowsEffectiveInterestRatePercent>
    <lgnd:ForecastedCashFlowsEffectiveInterestRatePercent
      contextRef="i670101d682ab4040a9ecb714406fabd0_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMjI3NzE_eb0158f4-c349-4cc0-b5ef-a0cb80ef7b98"
      unitRef="number">0.246</lgnd:ForecastedCashFlowsEffectiveInterestRatePercent>
    <lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments
      contextRef="if715884926d24da68b91903ae544927e_I20200101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMjQzMzQ_250e86cf-b9ba-439e-a382-4e6fbadd8981"
      unitRef="usd">5500000</lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments>
    <lgnd:AccountsReceivableCreditLossExpenseReversalCOVID19
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNTQ5NzU1ODgxOTcx_e2913a71-be55-4b01-9a8e-454797437417"
      unitRef="usd">-300000</lgnd:AccountsReceivableCreditLossExpenseReversalCOVID19>
    <lgnd:AccountsReceivableCreditLossExpenseReversalCOVID19
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTY0OTI2NzUwNjg5Nw_dded8f80-bc39-46c3-9fd1-54c501aa34fd"
      unitRef="usd">-500000</lgnd:AccountsReceivableCreditLossExpenseReversalCOVID19>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2NzM_2971fe71-47ba-4513-ac5c-432d2615e26b">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We apply the following five-step model in accordance with ASC 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in order to determine the revenue: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Royalties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We receive royalty revenue on sales by our partners of products covered by patents that we or our partners own under contractual agreements. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a royalty to be recorded no sooner than the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues are adjusted in the period in which they become known, typically the following quarter. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Captisol Sales&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from Captisol sales is recognized when control of Captisol material or intellectual property license rights is transferred to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. For Captisol material, we consider our performance obligation is satisfied at a point in time, once we have transferred control of the product, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We have elected to recognize the cost of freight and shipping when control over Captisol material has transferred to the customer as an expense in Cost of Captisol. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our contracts with customers often will include variable consideration in the form of contingent milestone-based payments. We include contingent milestone based payments in the estimated transaction price when it is probable a significant reversal in the amount of cumulative revenue recognized will not occur. These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone based payment is sales-based, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development based milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon the development milestone or regulatory approval. Depending on the terms of the arrangement, we may also defer a portion of the consideration received if we have to satisfy a future obligation, which typically occurs with our contracts for R&amp;amp;D services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For R&amp;amp;D services we recognize revenue over time and we measure our progress using an input method. The input methods we use are based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time it will take us to complete the activities, or the costs we may incur in a given &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make numerous estimates and use significant judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We occasionally have sub-license obligations related to arrangements for which we receive license fees, milestones and royalties. We evaluate the determination of gross as a principal versus net as an agent reporting based on each individual agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depending on the terms of the arrangement, we may also defer a portion of the consideration received if we have to satisfy a future obligation.&lt;/span&gt;&lt;/div&gt;The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry a contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMzE4NDY_3c45aba2-2b78-4bb7-9c23-6d0c66628553"
      unitRef="usd">400000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMzE5NTU_e95d9614-84ea-4e75-a11f-7d50f0ee291c"
      unitRef="usd">23300000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2NTY_78affdb8-b0c0-4533-ad7a-b0ce1ac57d55">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Royalty revenue for 2022, 2021 and 2020 for continuing operations are reported as below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Kyprolis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Evomela&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Teriparatide injection &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rylaze &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents disaggregation of Captisol and contract revenue for continuing operations (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Captisol&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Captisol - Core&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Captisol - COVID&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Service Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;License Fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Milestone&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Captisol - COVID represents revenue on Captisol supplied for use in formulation with remdesivir, an antiviral treatment for COVID-19.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9ec9717cd1d246078b4b569036ffdc49_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfMy0yLTEtMS0xMTI2NDA_cd7a2006-5e11-4705-bdc5-eeaba3a696a1"
      unitRef="usd">30116000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i54dbd99694aa4daab7990f243b799c03_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfMy00LTEtMS0xMTI2NDA_ae262c89-3d62-4c4b-924d-d51c05d3464b"
      unitRef="usd">27472000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8afb2b3d7d6642b4a6bf2a125abec1e1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfMy02LTEtMS0xMTI2NDA_7d53bea2-7550-4137-8f86-19d058215231"
      unitRef="usd">25164000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0c92061ff9b94c6eb2d8a4a23c829de0_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfNC0yLTEtMS0xMTI2NDA_b6ceefce-8db9-4146-9a6a-18643abae07c"
      unitRef="usd">10197000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifd8f3bf9de1f4fd7beedb580d9c6cdee_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfNC00LTEtMS0xMTI2NDA_77332419-8d73-40ee-8a2f-b8f04d52647e"
      unitRef="usd">10079000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i33e6496921c848a79e380a93f9d05bc4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfNC02LTEtMS0xMTI2NDA_286c6d89-e163-4ce6-89f6-b69e067fd158"
      unitRef="usd">6377000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4b7d6c7b066c452794362e3368d3f7e3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfNS0yLTEtMS0xMjU2NDg_341e4325-14fc-4603-8aa9-7001abd153ac"
      unitRef="usd">15785000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iea65617bbc2b47b48426079a24526cbe_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfNS00LTEtMS0xMjU5MDU_e0a0eadb-3901-4a18-bcb8-7bcab8ee40b0"
      unitRef="usd">5260000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5493b3bc3d6c4726aa3bd80b40ca081f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfNS02LTEtMS0xMjU5NzI_7854633b-db8f-47eb-a54a-8bf6fe289812"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8fbfab2afcba47db8cd01d943434d7c7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfNi0yLTEtMS0xMjU2NDg_68b419c7-55ac-4b06-8e23-afd7c8d6ab91"
      unitRef="usd">8796000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4ece9d53186c440cbe209564d6285e78_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfNi00LTEtMS0xMjU5MDU_145aa668-792a-4bc0-b635-6e804a34083f"
      unitRef="usd">2420000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i49757f616a7c43cf861c739d9acb2ab5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfNi02LTEtMS0xMjU5NzI_53c9dcae-b5b8-444c-a003-fd49e4277e64"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idac514c491cc4a208f76c94595c132f5_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfNS0yLTEtMS0xMTI2NDA_7cc3eaca-1f66-4826-a2e4-c657f635f78e"
      unitRef="usd">7633000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i73902d56a64240c0bf0d410617877557_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfNS00LTEtMS0xMTI2NDA_8317ddcd-9798-4a8e-afda-89d1530d4c59"
      unitRef="usd">3696000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i03cd5d2142d44bf7a2bcaa6d8f29b13a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfNS02LTEtMS0xMTI2NDA_b4557738-7340-46c6-9385-02aa78672fb4"
      unitRef="usd">2255000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i91e01e3752fa4607875a52688c787ed4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfNy0yLTEtMS0xMTI2NDA_bd690be7-26f4-4f6f-8285-28038f513b75"
      unitRef="usd">72527000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7acccfdc49ae41ec9d81e2a77aaeab89_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfNy00LTEtMS0xMTI2NDA_c1e723ba-c4b4-47bc-996c-517925c53e80"
      unitRef="usd">48927000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8303bd1e530e4c06b3bb8c3093343f43_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjdlMDE1YTFiNTMzMDQ2MTY5MTFlMDU4YzI3MGNlMTkzL3RhYmxlcmFuZ2U6N2UwMTVhMWI1MzMwNDYxNjkxMWUwNThjMjcwY2UxOTNfNy02LTEtMS0xMTI2NDA_f27f048d-c06d-41ab-ba75-edd7ce7e7a7a"
      unitRef="usd">33796000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i65647a80fbc847cb96058a3c631b002b_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfMy0yLTEtMS0xMjU3ODM_7dbc9648-f6f9-4f39-93cf-407629a53e53"
      unitRef="usd">16429000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i43de1a804883437584799c38ec4bbfba_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfMy00LTEtMS0xMjU5MTk_bed67803-634d-4d9b-a72a-3f8d1acdcdcb"
      unitRef="usd">23423000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie02c8b74a58c4e0da8c4a0da3e2af0ab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfMy02LTEtMS0xMjYwNDk_3710ab3e-b0a8-4339-8b27-de9b30b57d8c"
      unitRef="usd">24566000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id131b624b01b400987332697abc2b43d_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfNC0yLTEtMS0xMjU3ODk_fd9b0430-29f0-408b-b491-7ebd3885d212"
      unitRef="usd">88066000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ief5aa8a800b746d481cd0985dd7ec3d3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfNC00LTEtMS0xMjU5MTk_7ca26503-52f1-4203-9232-690be87ef091"
      unitRef="usd">140827000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i11e9985562a84328a97129345abae661_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfNC02LTEtMS0xMjYwNDk_d54ca929-fe73-47ff-959e-03e018ac7cf0"
      unitRef="usd">85393000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if07332e474464098b61af13fe5a470f2_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfNS0yLTEtMS0xMzU4MDQ_f01887e1-ce94-4a36-b454-80480b8c3ad3"
      unitRef="usd">104495000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6747a650dc714496a27ce80ca1fde353_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfNS00LTEtMS0xMzU4MDc_b275ad37-50ee-4bff-bbdc-e4988587aa27"
      unitRef="usd">164250000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i065c2ca723f44ed7b4161976d58b5fe9_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfNS02LTEtMS0xMzU4MTA_d0d51756-8917-4824-b7e5-bfc2338b1712"
      unitRef="usd">109959000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i08870b2004dd43bdaece251ed3f21347_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfNS0yLTEtMS0xMTI2NDA_89a598d8-2869-4be0-a4fd-1d747d82630a"
      unitRef="usd">1117000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i68260ef8bbec41adbf8a2108d95376f8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfNS00LTEtMS0xMTI2NDA_946020e5-781e-402b-ab60-94c46dd1d8d5"
      unitRef="usd">3737000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if88162f99d40461a9310c0ae816fd224_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfNS02LTEtMS0xMTI2NDA_cf79e818-89e6-4738-ae44-d30b9759d6d0"
      unitRef="usd">9330000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie1de672c0b42480eb2b6b143b340f6a5_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfNi0yLTEtMS0xMTI2NDA_e51697d2-1457-4ab1-9f83-5f0e946e51b9"
      unitRef="usd">2849000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0ffe37b6e1e44b3a84fe52fd8879a67d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfNi00LTEtMS0xMTI2NDA_1aa10a15-f74b-43ec-a3a0-ec7b74e176c5"
      unitRef="usd">634000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if42c010475e14a4099a8428492cce1cb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfNi02LTEtMS0xMTI2NDA_49c4d630-2bb6-434a-a10b-9d26ed50efd0"
      unitRef="usd">119000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic38b9e57dd5b4eccb6ea203b21533a2b_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfNy0yLTEtMS0xMTI2NDA_34021eaa-347b-40b1-af7f-0ff7db8f316a"
      unitRef="usd">9150000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0e8ef293cc81451599d632430c78f16d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfNy00LTEtMS0xMTI2NDA_946209f7-1e7f-4706-a7e7-f9a56eeb07ea"
      unitRef="usd">17584000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i91b0803652084754984846b312275eec_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfNy02LTEtMS0xMTI2NDA_d2eac504-89b3-4c78-80c5-e344025466de"
      unitRef="usd">5217000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibf61891c2afc4735abc2848c436bdd90_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfOC0yLTEtMS0xMTI2NDA_25ade74c-d6e0-4369-af12-eae3a236c04e"
      unitRef="usd">6107000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2e3529f39eae4d9e9e67e1b00baf464b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfOC00LTEtMS0xMTI2NDA_bd9299a4-3d57-4612-8e14-e28aafb73703"
      unitRef="usd">6412000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0132672fab9842058c3e5d0239853868_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfOC02LTEtMS0xMTI2NDA_ea5f3ce0-86a4-4e5a-9b55-39dbd06d0ca7"
      unitRef="usd">5141000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7a2c832b6c46461c9fa690319f44159f_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfOS0yLTEtMS0xMTI2NDA_2f525de3-0c4f-4d67-88fa-91d5b2dd55da"
      unitRef="usd">19223000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if6041ab2411645599b1e142a09232af6_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfOS00LTEtMS0xMTI2NDA_110c793e-f246-4433-b088-5b815b1d546e"
      unitRef="usd">28367000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibbbf2bd60ac64c15aa70a568639f50ab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOjE2ZWMxOGY1ZDVhNzRmOTdhZjAwMzE5NDEwOGE4NTgwL3RhYmxlcmFuZ2U6MTZlYzE4ZjVkNWE3NGY5N2FmMDAzMTk0MTA4YTg1ODBfOS02LTEtMS0xMTI2NDA_7dab7020-d004-46cf-af39-4258cdb2c05c"
      unitRef="usd">19807000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2ODU_cebc3275-6aac-444b-ba44-92d11298a584">Research and Development ExpensesResearch and development expense consists of labor, material, equipment, and allocated facilities costs of our scientific staff who are working pursuant to our collaborative agreements and other research and development projects. Also included in research and development expenses are third-party costs incurred for our research programs including in-licensing costs, contract research organization (CRO) costs and costs incurred by other research and development service vendors. We expense these costs as they are incurred. When we make payments for research and development services prior to the services being rendered, we record those amounts as prepaid assets on our consolidated balance sheet and we expense them as the services are provided.</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2NjY_7e8dd424-9002-4dca-adce-627a1a15f0de">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We incur share-based compensation expense related to restricted stock, ESPP, and stock options.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted stock unit (RSU) and performance stock unit (PSU) are all considered restricted stock. The fair value of restricted stock is determined by the closing market price of our common stock on the date of grant. We recognize share-based compensation expense based on the fair value on a straight-line basis over the requisite service periods of the awards, taking into consideration of forfeitures as they occur. PSU generally represents a right to receive a certain number of shares of common stock based on the achievement of corporate performance goals and continued employment during the vesting period. At each reporting period, we reassess the probability of the achievement of such corporate performance goals and any expense change resulting from an adjustment in the estimated shares to be released are treated as a cumulative catch-up in the period of adjustment. A limited amount of PSUs contain a market condition dependent upon the Company&#x2019;s relative and absolute total stockholder return over a three-year period, with a range of 0% to 200% of the target amount granted to be issued under the award. Share-based compensation expense for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the market conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Black-Scholes-Merton option-pricing model is used to estimate the fair value of stock purchases under our ESPP and stock options granted. The model assumptions include expected volatility, term, dividends, and the risk-free interest rate. We look to historical and implied volatility of our stock to determine the expected volatility. The expected term of an award is based on historical forfeiture experience, exercise activity, and on the terms and conditions of the stock awards. The expected dividend yield is determined to be 0% given that except for 2007, during which we declared a cash dividend on our common stock of $2.50 per share, we have not paid any dividends on our common stock in the past and currently do not expect to pay cash dividends or make any other distributions on common stock in the future. The risk-free interest rate is based upon U.S. Treasury securities with remaining terms similar to the expected term of the share-based awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We grant options, RSUs and PSUs to employees and non-employee directors. Non-employee directors are accounted for as employees. Options and RSUs granted to certain non-employee directors typically vest one year from the date of grant. Options granted to employees typically vest 1/8 on the six month anniversary of the date of grant, and 1/48 each month thereafter for forty-two months. RSUs and PSUs granted to employees vest over three years. All option awards generally expire ten years from the date of grant.&lt;/span&gt;&lt;/div&gt;Share-based compensation expense for awards to employees and non-employee directors is recognized on a straight-line basis over the vesting period until the last tranche vests.</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i2323eac91b2548d9bb0aa30d38e34f63_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2ODg_f1a3c611-b62b-4131-91f7-14279e42ad83">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i842018ac4595423692c11f2da85cf3eb_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMzQwOTA_ec161f9b-2c14-4472-a4ea-5be8b84749a5"
      unitRef="number">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i489ca56af41b4556bad1bd319b7b8c4d_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMzQwOTY_aa71b043-ca4b-47bb-9c45-b95af354e978"
      unitRef="number">2</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:EquitySecuritiesFvNiMeasurementInput
      contextRef="icc63108210a948b5865cfb7ad3c24f5b_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMzQ4ODk_b7df06d2-3eb6-49fc-baca-8710edc232fe"
      unitRef="number">0</us-gaap:EquitySecuritiesFvNiMeasurementInput>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i0e24dfa538c74d94916136c2c583e53b_D20070101-20071231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMzQ5ODQ_359b00b1-0707-4d59-be5c-08890c39f276"
      unitRef="usdPerShare">2.50</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i0ea94c0a78a84acbbb4c6b276629f850_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2NzU_47e0ca34-c23d-45cb-9e1a-dd47a60474df">P6M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i0c3c548b83e74abda3686b765b62aafc_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2ODA_b122f46f-69d1-4494-a81b-dcc69d7f79fa">P42M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i1a7d01a48d59487f83e3391779612e31_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMzU3NDM_9fa98211-127a-4679-84b6-b66ebbc7ec63">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i7c0d366af0a24bf3b783d1043d41aeac_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMzU3ODI_90aba991-1035-4af8-b1f6-bbf5f4d5e4b1">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2NjI_7d652817-a618-487a-a06c-73614a40d608">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes is computed using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for the expected future tax benefit to be derived from tax loss and credit carryforwards. Deferred tax assets and liabilities are determined using the enacted tax rates in effect for the years in which those tax assets are expected to be realized. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the provision for income taxes in the period that includes the enactment date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets are regularly assessed to determine the likelihood they will be recovered from future taxable income. A valuation allowance is established when we believe it is more likely than not the future realization of all or some of a deferred tax asset will not be achieved. In evaluating the ability to recover deferred tax assets within the jurisdiction which they arise we consider all available positive and negative evidence. Factors reviewed include the cumulative pre-tax book income for the past three years, scheduled reversals of deferred tax liabilities, history of earnings and reliable forecasting, projections of pre-tax book income over the foreseeable future, and the impact of any feasible and prudent tax planning strategies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize the impact of a tax position in our financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Tax authorities regularly examine our returns in the jurisdictions in which we do business and we regularly assess the tax risk of our return filing positions. Due to the complexity of some of the uncertainties, the ultimate resolution may result in payments that are materially &lt;/span&gt;&lt;/div&gt;different from our current estimate of the tax liability. These differences, as well as any interest and penalties, will be reflected in the provision for income taxes in the period in which they are determined.</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2NzY_ef4d9cb1-96eb-4b58-8a33-56dc2313a4de">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income (Loss) Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic income (loss) per share is calculated by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Diluted income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of the Company&#x2019;s common stock exceeds the applicable conversion price of the respective notes. It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for stock options and restricted stock. In loss periods, basic net loss per share and diluted net loss per share are identical since the effect of otherwise dilutive potential common shares is anti-dilutive and therefore excluded.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with ASC 260, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Earnings per Share&lt;/span&gt;, if a company had a discontinuing operation, the company uses income from continuing operations, adjusted for preferred dividends and similar adjustments, as its control number to determine whether potential common shares a dilutive.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2NzA_eed3067c-348c-42bf-ac5a-c16409413505">The following table presents the calculation of weighted average shares used to calculate basic and diluted income (loss) per share (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.189%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive potential common shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares used to compute diluted income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Potentially dilutive shares excluded from calculation due to anti-dilutive effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmFiZGE2NmQ1MjFmYzQ0ZDJiMzEwMGVkMzUxOTQ0YjAwL3RhYmxlcmFuZ2U6YWJkYTY2ZDUyMWZjNDRkMmIzMTAwZWQzNTE5NDRiMDBfMi0xLTEtMS0xMTI2NDA_d84f4b79-d4ec-48a8-a992-94f04dc1659e"
      unitRef="shares">16868000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmFiZGE2NmQ1MjFmYzQ0ZDJiMzEwMGVkMzUxOTQ0YjAwL3RhYmxlcmFuZ2U6YWJkYTY2ZDUyMWZjNDRkMmIzMTAwZWQzNTE5NDRiMDBfMi0zLTEtMS0xMTI2NDA_5186eaaa-80e1-4f08-a8a5-ca70ededd5c6"
      unitRef="shares">16630000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmFiZGE2NmQ1MjFmYzQ0ZDJiMzEwMGVkMzUxOTQ0YjAwL3RhYmxlcmFuZ2U6YWJkYTY2ZDUyMWZjNDRkMmIzMTAwZWQzNTE5NDRiMDBfMi01LTEtMS0xMTI2NDA_11b5457d-499c-47a1-b958-2abe7baceac7"
      unitRef="shares">16185000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="icd7c9aa2ea5a470e8fbd4d80fce77775_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmFiZGE2NmQ1MjFmYzQ0ZDJiMzEwMGVkMzUxOTQ0YjAwL3RhYmxlcmFuZ2U6YWJkYTY2ZDUyMWZjNDRkMmIzMTAwZWQzNTE5NDRiMDBfNC0xLTEtMS0xMTI2NDA_ba2c9985-1718-4dbd-9ec7-0a6ddabaad42"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i70fc66a3f20848b5bb0f70e3f866d45d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmFiZGE2NmQ1MjFmYzQ0ZDJiMzEwMGVkMzUxOTQ0YjAwL3RhYmxlcmFuZ2U6YWJkYTY2ZDUyMWZjNDRkMmIzMTAwZWQzNTE5NDRiMDBfNC0zLTEtMS0xMTI2NDA_49942c52-6cff-4b3c-94f5-75e7da7cab2d"
      unitRef="shares">96000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i18c9bf22eb2e40bdb955de4a851b78c5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmFiZGE2NmQ1MjFmYzQ0ZDJiMzEwMGVkMzUxOTQ0YjAwL3RhYmxlcmFuZ2U6YWJkYTY2ZDUyMWZjNDRkMmIzMTAwZWQzNTE5NDRiMDBfNC01LTEtMS0xMTI2NDA_69b7a2fc-eac6-40cd-925e-0f6edfdf3097"
      unitRef="shares">56000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="if66ef91cf250497180df8bdafb040c04_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmFiZGE2NmQ1MjFmYzQ0ZDJiMzEwMGVkMzUxOTQ0YjAwL3RhYmxlcmFuZ2U6YWJkYTY2ZDUyMWZjNDRkMmIzMTAwZWQzNTE5NDRiMDBfNS0xLTEtMS0xMTI2NDA_791220ee-a2e1-481a-a708-e4e942cf6292"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i67a5c3e26a4a41c5965dfa8c1722d00f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmFiZGE2NmQ1MjFmYzQ0ZDJiMzEwMGVkMzUxOTQ0YjAwL3RhYmxlcmFuZ2U6YWJkYTY2ZDUyMWZjNDRkMmIzMTAwZWQzNTE5NDRiMDBfNS0zLTEtMS0xMTI2NDA_d61e435c-26d4-4437-b2e0-3f83369f141b"
      unitRef="shares">520000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i76c8d1f51aad42668b7908e89daf66dd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmFiZGE2NmQ1MjFmYzQ0ZDJiMzEwMGVkMzUxOTQ0YjAwL3RhYmxlcmFuZ2U6YWJkYTY2ZDUyMWZjNDRkMmIzMTAwZWQzNTE5NDRiMDBfNS01LTEtMS0xMTI2NDA_031f9fc0-8dbf-4174-b746-c293d91fa07f"
      unitRef="shares">584000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmFiZGE2NmQ1MjFmYzQ0ZDJiMzEwMGVkMzUxOTQ0YjAwL3RhYmxlcmFuZ2U6YWJkYTY2ZDUyMWZjNDRkMmIzMTAwZWQzNTE5NDRiMDBfOC0xLTEtMS0xMTI2NDA_2b1591b7-4cf4-4531-984e-4646da32611d"
      unitRef="shares">16868000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmFiZGE2NmQ1MjFmYzQ0ZDJiMzEwMGVkMzUxOTQ0YjAwL3RhYmxlcmFuZ2U6YWJkYTY2ZDUyMWZjNDRkMmIzMTAwZWQzNTE5NDRiMDBfOC0zLTEtMS0xMTI2NDA_29178ffd-d04e-480f-84c3-d3fde454786c"
      unitRef="shares">17246000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmFiZGE2NmQ1MjFmYzQ0ZDJiMzEwMGVkMzUxOTQ0YjAwL3RhYmxlcmFuZ2U6YWJkYTY2ZDUyMWZjNDRkMmIzMTAwZWQzNTE5NDRiMDBfOC01LTEtMS0xMTI2NDA_07438b4b-2295-4b51-a7a3-35cb5f78dbee"
      unitRef="shares">16825000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmFiZGE2NmQ1MjFmYzQ0ZDJiMzEwMGVkMzUxOTQ0YjAwL3RhYmxlcmFuZ2U6YWJkYTY2ZDUyMWZjNDRkMmIzMTAwZWQzNTE5NDRiMDBfOS0xLTEtMS0xMTI2NDA_649c6ec6-45cb-4707-a738-c8c938f4d35b"
      unitRef="shares">6241000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmFiZGE2NmQ1MjFmYzQ0ZDJiMzEwMGVkMzUxOTQ0YjAwL3RhYmxlcmFuZ2U6YWJkYTY2ZDUyMWZjNDRkMmIzMTAwZWQzNTE5NDRiMDBfOS0zLTEtMS0xMTI2NDA_276eabd1-b407-4c96-8ef2-d668ae2c0ae2"
      unitRef="shares">4793000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RhYmxlOmFiZGE2NmQ1MjFmYzQ0ZDJiMzEwMGVkMzUxOTQ0YjAwL3RhYmxlcmFuZ2U6YWJkYTY2ZDUyMWZjNDRkMmIzMTAwZWQzNTE5NDRiMDBfOS01LTEtMS0xMTI2NDA_55794c8c-f2ac-4187-a552-0f9ae114384f"
      unitRef="shares">8458000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2NzE_9a0a3186-f092-4682-9fd8-9152a739011c">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Comprehensive Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive income (loss) represents net income (loss) adjusted for the change during the periods presented in unrealized gains and losses on available-for-sale debt securities, foreign currency translation adjustments, and reclassification adjustments for realized gains or losses included in net income (loss). The unrealized gains or losses are reported on the Consolidated Statements of Comprehensive Income (Loss).&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2Nzc_22baffd5-22e7-450e-b574-4b6fd8a8f5aa">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The British Pound Sterling was the functional currency of our subsidiary, Vernalis, which was sold in fourth quarter of the year ended December 31, 2020. For the year ended December 31, 2020, the corresponding financial statements have been translated into U.S. Dollars in accordance with ASC 830-30, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Translation of Financial Statements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Assets and liabilities are translated at end-of-period rates while revenues and expenses are translated at average rates in effect during the period in which the activity took place. Equity is translated at historical rates and the resulting cumulative translation adjustments are included as a component of accumulated other comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfNDc2ODI_7feae187-b5b7-48a0-bfb4-1da42d14c507">Accounting Standards Updates, Recently Adopted&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU 2020-06&#x201d;). The guidance simplifies the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#x2019;s own equity. Consequently, a convertible debt instrument, such as the Company&#x2019;s 2023 Notes, will be accounted for as a single liability measured at its amortized cost, if no other features require bifurcation and recognition as derivatives. The new guidance also requires the if-converted method to be applied for all convertible instruments and requires additional disclosures. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We adopted this guidance effective January 1, 2022 under the modified retrospective approach and the comparative information has not been restated and continues to be presented according to accounting standards in effect for those periods. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption and our 2023 Notes are no longer bifurcated into separate liability and equity components. The principal amount of the 2023 Notes is classified as a single liability measured at amortized cost in the consolidated balance sheet for the period ended December 31, 2022. Upon adoption of ASU 2020-06 on January 1, 2022, we recorded an adjustment to the 2023 Notes liability component, deferred tax liabilities, additional paid-in-capital and retained earnings. This adjustment was calculated based on the carrying amount of the 2023 Notes as if it had always been treated as a single liability measured at amortized cost. Furthermore, we recorded an adjustment to the debt issuance costs contra liability and equity (additional paid-in-capital) components under the same premise, as if debt issuance costs had always been treated as a contra liability only. Under this transition method, the cumulative effect of the accounting change increased the carrying amount of the 2023 Notes by $20.4 million, reduced deferred tax liabilities by $4.4 million, reduced additional paid-in capital by $51.1 million and increased retained earnings by $35.1 million. The net balance of the 2023 Notes at January 1, 2022 was $341.1 million which included an unamortized discount of $2.2 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on our consolidated financial statements or disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ConvertibleNotesPayable
      contextRef="i46c8bfd47e7444e6a01496cd453532d1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTY0OTI2NzUwNjIxNA_27b4583e-6c5b-47c8-8906-f5878e095b7f"
      unitRef="usd">20400000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i46c8bfd47e7444e6a01496cd453532d1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTY0OTI2NzUwNjIzNg_cfaccadb-60eb-4d44-b009-93d38e9f1951"
      unitRef="usd">-4400000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:StockholdersEquity
      contextRef="i710339a456f64bc8bad5a607120931a7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTY0OTI2NzUwNjI1Nw_5331e7a0-d695-43dc-b0f2-c461541a4006"
      unitRef="usd">-51100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie30007c66bb747999bd003d8277ab95c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTY0OTI2NzUwNjI3OA_e8dc2f6f-2c5f-46d8-a512-d754c0c24d26"
      unitRef="usd">35100000</us-gaap:StockholdersEquity>
    <us-gaap:ConvertibleNotesPayable
      contextRef="ib6f656a779984d2e9b0f895f98e24654_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTY0OTI2NzUwNjMwMA_c1756a22-55e3-43f4-a12b-7ca13677bc94"
      unitRef="usd">341100000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="ib6f656a779984d2e9b0f895f98e24654_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84Mi9mcmFnOjVhNGMwMjFkZTk5ZjQ1N2Q4NDRiODk1ZWI4ZjE3YjA2L3RleHRyZWdpb246NWE0YzAyMWRlOTlmNDU3ZDg0NGI4OTVlYjhmMTdiMDZfMTY0OTI2NzUwNjMyMA_990243d1-71a4-416a-8b5b-a8c36cd7f9bc"
      unitRef="usd">2200000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RleHRyZWdpb246YTY5ZWNiMDEyMTk5NDkxZTg3NmMwYjhiNjM3ZjY5NjFfMjgxMw_0ca76ed5-1a86-4858-98dd-6f005b643679">Spin-off of OmniAb&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 23, 2022, we entered into the Separation Agreement to separate our OmniAb Business and the Merger Agreement, pursuant to which Avista Public Acquisition Corp. II (&#x201c;APAC&#x201d;) would combine with OmniAb, and acquire Ligand's OmniAb Business, in a Reverse Morris Trust transaction (collectively, the &#x201c;Transactions&#x201d;). In connection with the execution of the Merger Agreement, we made organizational changes to better align our organizational structure with our strategy and operations, and management reorganized the reportable segments to better reflect how the business is evaluated by the chief operating decision maker. Beginning in the first quarter of 2022, we operated the following two reportable segments: (1) OmniAb business and (2) Ligand core business. The OmniAb business segment is focused on enabling the discovery of therapeutic candidates for our partners by pairing antibody repertoires generated from our proprietary transgenic animals with our OmniAb business platform screening tools. The Ligand core business segment is a biopharmaceutical business focused on developing or acquiring technologies that help pharmaceutical companies deliver and develop medicines. We performed a fair value analysis utilizing a combination of income approach and market approach to determine the fair value of each segment in order to appropriately allocate the goodwill between the segments as of the announcement date. We reassigned goodwill using a relative fair value allocation method, which resulted in goodwill of a $105.7 million and $75.5 million being allocated to Ligand core business and OminAb business, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After the closing date of the Transactions on November 1, 2022, the historical financial results of OmniAb have been reflected in our consolidated financial statements as discontinued operations under GAAP for all periods presented through the date of the Distribution. Pursuant to the Transaction Agreements, Ligand contributed to OmniAb cash and certain specific assets and liabilities constituting the OmniAb Business. Pursuant to the Distribution, Ligand distributed on a pro rata basis to its shareholders as of October 26, 2022 shares of the common stock of OmniAb representing 100% of Ligand&#x2019;s interest in OmniAb. Immediately following the Distribution, Orwell Merger Sub Inc., a wholly-owned subsidiary of APAC, merged with and into OmniAb, with OmniAb continuing as the surviving company in the Merger and as a wholly owned subsidiary of New OmniAb. The entire transaction was completed on November 1, 2022, and following the Merger, New OmniAb is an independent, publicly traded company whose common stock trades on NASDAQ under the symbol &#x201c;OABI.&#x201d; After the Distribution, we do not beneficially own any shares of common stock in OmniAb and no longer consolidate OmniAb into our financial results for periods ending after November 1, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The transfer of assets and liabilities to OmniAb was effected through a contribution in accordance with the Merger Agreement, as summarized below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of November 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;165,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;294,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;LIABILITIES AND STOCKHOLDERS&#x2019; EQUITY &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Deferred revenue   &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Long-term contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;64,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net assets transferred to OmniAb&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;229,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Discontinued operations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Merger, the Company determined its antibody discovery business qualified for discontinued operations accounting treatment in accordance with ASC 205-20. The following table summarizes revenue and expenses of the discontinued operations for the years ended December 31, 2022, 2021 and 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.370%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Contract revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;25,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating costs and expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amortization of intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;38,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;36,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total operating costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;62,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(36,132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(24,956)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(11,655)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other income (expense):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain from short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,210)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,070)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Loss before income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(35,578)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(24,907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(11,830)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(28,142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(19,215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,583)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no assets and liabilities related to discontinued operations as of December&#160;31, 2022, as all balances were transferred to OmniAb upon Separation. The following table summarizes the assets and liabilities of the discontinued operations as of December&#160;31, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total current assets of discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;174,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total assets of discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;271,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;LIABILITIES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Deferred revenue   &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total current liabilities of discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Long-term contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total liabilities of discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;69,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the significant non-cash items, capital expenditures of the discontinued operations, and financing activities that are included in the consolidated statements of cash flows for the years ended December 31, 2022, 2021 and 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.370%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Change in fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(554)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Investing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash paid for acquisition, net of cash acquired&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(27,127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Purchase of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,572)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,070)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,753)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Payments to CVR Holders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(960)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(720)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Payments to CVR Holders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,545)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,050)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,325)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Supplemental cash flow disclosures:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Purchases of property, plant and equipment included in accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i6992767e8dd8406c922375c93b5376c2_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RleHRyZWdpb246YTY5ZWNiMDEyMTk5NDkxZTg3NmMwYjhiNjM3ZjY5NjFfMjc0ODc3OTExMzI3OA_3c820760-14ef-4843-a566-2b2580cb5683"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:Goodwill
      contextRef="ib1f6b297465e41fc91ec81b76fb00d45_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RleHRyZWdpb246YTY5ZWNiMDEyMTk5NDkxZTg3NmMwYjhiNjM3ZjY5NjFfMTY0OTI2NzQ4NTUwNQ_a743c972-cdd0-4451-ad94-8d2ddd91a446"
      unitRef="usd">105700000</us-gaap:Goodwill>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent
      contextRef="i38815b046b134f4e89a040e922235cd3_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RleHRyZWdpb246YTY5ZWNiMDEyMTk5NDkxZTg3NmMwYjhiNjM3ZjY5NjFfMTY0OTI2NzQ4NTUxMw_c74b8dc9-e5cb-43da-aca3-f3b4e41a1586"
      unitRef="usd">75500000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed
      contextRef="ic0c506012de345dda2926c4191966e7a_I20221026"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RleHRyZWdpb246YTY5ZWNiMDEyMTk5NDkxZTg3NmMwYjhiNjM3ZjY5NjFfNTQ5NzU1ODU0NDI5_a9e01a50-c024-48ee-9b97-7447029b8bc0"
      unitRef="number">1</lgnd:DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RleHRyZWdpb246YTY5ZWNiMDEyMTk5NDkxZTg3NmMwYjhiNjM3ZjY5NjFfMjc0ODc3OTA4MTQ4MQ_1f085e76-3cd8-4def-8c9b-cfe5d73e978d">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The transfer of assets and liabilities to OmniAb was effected through a contribution in accordance with the Merger Agreement, as summarized below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of November 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;165,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;294,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;LIABILITIES AND STOCKHOLDERS&#x2019; EQUITY &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Deferred revenue   &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Long-term contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;64,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net assets transferred to OmniAb&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;229,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The following table summarizes revenue and expenses of the discontinued operations for the years ended December 31, 2022, 2021 and 2020 (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.370%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Contract revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;25,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating costs and expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amortization of intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;38,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;36,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total operating costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;62,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(36,132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(24,956)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(11,655)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other income (expense):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain from short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,210)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,070)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Loss before income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(35,578)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(24,907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(11,830)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(28,142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(19,215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,583)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;The following table summarizes the assets and liabilities of the discontinued operations as of December&#160;31, 2021 (in thousands):&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total current assets of discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;174,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total assets of discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;271,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;LIABILITIES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Deferred revenue   &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total current liabilities of discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Long-term contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total liabilities of discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;69,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the significant non-cash items, capital expenditures of the discontinued operations, and financing activities that are included in the consolidated statements of cash flows for the years ended December 31, 2022, 2021 and 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.370%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Change in fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(554)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Investing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash paid for acquisition, net of cash acquired&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(27,127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Purchase of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,572)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,070)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,753)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Payments to CVR Holders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(960)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(720)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Payments to CVR Holders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,545)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,050)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,325)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Supplemental cash flow disclosures:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Purchases of property, plant and equipment included in accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMy0xLTEtMS0xMTY2NTk_028e9350-4933-47c9-ab70-138e0d6cbc8a"
      unitRef="usd">1842000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets
      contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfOC0xLTEtMS0xMTY2NTk_71e093ef-2c2d-463e-a48e-77e682dccdfa"
      unitRef="usd">9019000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMTAtMS0xLTEtMTE2NjU5_27f48204-1f73-47df-bf57-4df3fb8dae9e"
      unitRef="usd">10861000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent
      contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMTItMS0xLTEtMTE2NjU5_b09b6cb2-1620-4b86-b764-7693f321638b"
      unitRef="usd">165422000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent
      contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMTMtMS0xLTEtMTE2NjU5_217769c1-0d66-462b-8265-4d2fa2cefd13"
      unitRef="usd">75533000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent
      contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMTUtMS0xLTEtMTE2NjU5_07aeb6f2-90af-4665-94a4-6057811f4895"
      unitRef="usd">19921000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationAssetsOperatingLeaseAssets
      contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMTYtMS0xLTEtMTE2NjU5_0aab8d52-234c-41db-9d32-139e10849dce"
      unitRef="usd">21290000</lgnd:DisposalGroupIncludingDiscontinuedOperationAssetsOperatingLeaseAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets
      contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMTgtMS0xLTEtMTE2NjU5_29e3ea4b-503d-4139-bab2-8f2572b90d0a"
      unitRef="usd">1449000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMjAtMS0xLTEtMTE2NjU5_19661b54-8128-4107-bfa9-89b627b2fe23"
      unitRef="usd">294476000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesCurrent
      contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMjUtMS0xLTEtMTE2NjYx_8c4e4976-1269-4bd9-bbdb-0e5334493d98"
      unitRef="usd">1569000</lgnd:DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent
      contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMjYtMS0xLTEtMTE2NjYx_e1c110e1-8631-491c-bd2c-12e15c966bc7"
      unitRef="usd">8582000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent
      contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMjctMS0xLTEtMTE2NjYx_19a9a716-3c4b-4aab-a34d-5255f3d2fd36"
      unitRef="usd">1610000</lgnd:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilitiesCurrent
      contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMjgtMS0xLTEtMTE2NjYx_7ec0225d-8256-4ad4-bd20-efc8e3a2519a"
      unitRef="usd">1000</lgnd:DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilitiesCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMzAtMS0xLTEtMTE2NjYx_89ac5af9-73a6-4f0d-abb3-5fb3a8b20f40"
      unitRef="usd">11762000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesNoncurrent
      contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMzItMS0xLTEtMTE2NjYx_33430722-fb9d-4866-ac5f-df1b4075ebfb"
      unitRef="usd">4175000</lgnd:DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesNoncurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities
      contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMzMtMS0xLTEtMTE2NjYx_de0331b3-0e85-4cd1-a018-87126abedc17"
      unitRef="usd">18978000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationLiabilitiesOperatingLeaseNoncurrent
      contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMzQtMS0xLTEtMTE2NjYx_cb0d911b-2d50-4219-897b-9d44845a67a6"
      unitRef="usd">24823000</lgnd:DisposalGroupIncludingDiscontinuedOperationLiabilitiesOperatingLeaseNoncurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities
      contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMzUtMS0xLTEtMTE2NjYx_bf1b4358-4a8a-4ec7-bf5b-278216a8e18c"
      unitRef="usd">5006000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMzctMS0xLTEtMTE2NjYx_4fd2aae5-9373-48e8-85d6-92df3c26b88a"
      unitRef="usd">64744000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationNetAssetsTransferred
      contextRef="i71db46073a8c4e54a85cdb15a16cda65_I20221101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjk5YTIxNDE5ZTg2YzRjMjI4MWIzY2E2YzhjNjNhMTcyL3RhYmxlcmFuZ2U6OTlhMjE0MTllODZjNGMyMjgxYjNjYTZjOGM2M2ExNzJfMzgtMS0xLTEtMTE2NjYx_b62c9153-559e-4d46-843c-106555d48684"
      unitRef="usd">229732000</lgnd:DisposalGroupIncludingDiscontinuedOperationNetAssetsTransferred>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="id5d258c544454d8287d67c0885d9f073_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMy0xLTEtMS0xMTYyOTY_39344994-90b6-4e59-81d7-e43ceeb9f2cd"
      unitRef="usd">1289000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="i180d8ced9233474d9767fa54ba805af7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMy0zLTEtMS0xMTYxNzI_5c3ed9ae-3078-40d5-af3e-072ba030f07c"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="ida2ce874ab0f45d1a868ff9dc946ad7a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMy01LTEtMS0xMTYwNDk_4ce03c32-07d2-4120-9679-aee0b4632b9c"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="id10d2e678e034d80baef68bce5e0f4dd_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfNC0xLTEtMS0xMTYyOTY_9c3c3647-eb04-4a86-bc73-72946820895d"
      unitRef="usd">25275000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="if084a5c5e7a04c2ab6433cfecec6c5ea_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfNC0zLTEtMS0xMTYxNzI_ba519298-2bc5-4150-a2f8-c158135219df"
      unitRef="usd">35589000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="i76065f9fe2324b1eab8ade930477eaf4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfNC01LTEtMS0xMTYwNDk_080c2688-d368-443d-ae41-2fd81745709f"
      unitRef="usd">22857000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfNS0xLTEtMS0xMTY4Mzc_c3c9f284-b2fd-4e7d-853b-b4dd6451a317"
      unitRef="usd">26564000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfNS0zLTEtMS0xMTY4OTI_24fa7533-7700-4155-bb08-30fa05850226"
      unitRef="usd">35589000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfNS01LTEtMS0xMTY4OTU_4ccc2495-d055-4d11-9533-9facaccafe1d"
      unitRef="usd">22857000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization
      contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfNy0xLTEtMS0xMTYzMDY_77798860-baee-4b11-a84b-b7b4d8b146cc"
      unitRef="usd">10847000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization
      contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfNy0zLTEtMS0xMTYxODI_92ba0904-6603-4930-bdae-2d4e53757787"
      unitRef="usd">12945000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization
      contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfNy01LTEtMS0xMTYwNTY_cf67e3b1-69c1-466b-adb4-4c2e86fa4bab"
      unitRef="usd">11800000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment
      contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfOC0xLTEtMS0xMTYzMDY_67351267-27ab-4b30-b7be-dc0944886e4f"
      unitRef="usd">38466000</lgnd:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment
      contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfOC0zLTEtMS0xMTYxODI_ccb2ac30-e7da-4d25-906b-faa1d0fa2177"
      unitRef="usd">36907000</lgnd:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment
      contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfOC01LTEtMS0xMTYwNTY_86312c10-502a-45a3-9463-de25f500395c"
      unitRef="usd">18889000</lgnd:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
      contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfOS0xLTEtMS0xMTYzMDY_eaa51f5a-af83-4c07-832b-2df4b3b21878"
      unitRef="usd">13383000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
      contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfOS0zLTEtMS0xMTYxODI_c1ef714d-9483-4c8e-9f77-480bb2e7461f"
      unitRef="usd">10693000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
      contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfOS01LTEtMS0xMTYwNTY_1834e323-7dbe-4f31-bfd7-7c80caaf79c8"
      unitRef="usd">3823000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTAtMS0xLTEtMTE2ODQw_534fd5b7-4428-418d-93e9-605ba6f10389"
      unitRef="usd">62696000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTAtMy0xLTEtMTE2ODky_069b7c56-6613-44c5-947d-43088554bfdc"
      unitRef="usd">60545000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTAtNS0xLTEtMTE2ODk1_174d605f-e9c5-459a-95ce-d4252fbfd7e3"
      unitRef="usd">34512000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
      contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTEtMS0xLTEtMTE2ODQw_61451091-c4ce-4693-a2c4-a6dbe3716833"
      unitRef="usd">-36132000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
      contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTEtMy0xLTEtMTE2ODky_c9cbf2f7-7d1c-4794-8cb6-fa73df190ffe"
      unitRef="usd">-24956000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
      contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTEtNS0xLTEtMTE2ODk1_e0eaf8c2-e1b8-4a1d-bdaf-af119eb11393"
      unitRef="usd">-11655000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments
      contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTMtMS0xLTEtMTE2MzIx_25a50fb7-779b-4ba8-8778-42eae742106d"
      unitRef="usd">0</lgnd:DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments
      contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTUtMy0xLTEtMTE2MTkz_eca17283-d029-474b-afa8-8a47817cff63"
      unitRef="usd">1266000</lgnd:DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments
      contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTUtNS0xLTEtMTE2MDY4_e9166fcd-f9fa-44ff-8e07-7e6994e6ecbf"
      unitRef="usd">1900000</lgnd:DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense
      contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTQtMS0xLTEtMTE2MzMx_80993c3d-cf83-4799-bc34-bed92b675846"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense
      contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTYtMy0xLTEtMTE2MjA2_7183d9e9-47e7-41c7-997a-410d3a7799bd"
      unitRef="usd">7000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense
      contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTctNS0xLTEtMTE2MDgw_c2264358-83fa-4b43-adf8-4755cf099d16"
      unitRef="usd">5000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense
      contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTUtMS0xLTEtMTE2MzQx_1060b18f-0017-4411-8d8f-82f95fb54eb1"
      unitRef="usd">554000</lgnd:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense
      contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTctMy0xLTEtMTE2MjE2_7157fbf5-bf18-4817-a3e7-102ad6898533"
      unitRef="usd">-1210000</lgnd:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense
      contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTgtNS0xLTEtMTE2MDkw_3ffe0cc8-b1bf-4bf6-a323-abca0938f2c6"
      unitRef="usd">-2070000</lgnd:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense
      contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTYtMS0xLTEtMTE2ODQz_800b152c-4bfe-4105-b80a-8e15a1dbbd53"
      unitRef="usd">554000</lgnd:DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense
      contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTYtMy0xLTEtMTE2ODky_eafc17d9-35d7-4d8d-990f-eb9cd9d0bad7"
      unitRef="usd">49000</lgnd:DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense
      contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTYtNS0xLTEtMTE2ODk1_e06dfddf-14f1-4cb2-aac3-09c8003e2834"
      unitRef="usd">-175000</lgnd:DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
      contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTctMS0xLTEtMTE2ODQz_ae0ac7b4-d548-4b6f-9f66-14ea2196b06c"
      unitRef="usd">-35578000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
      contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTctMy0xLTEtMTE2ODky_903abb52-5b96-41ed-ab12-496d5bd1d9a5"
      unitRef="usd">-24907000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
      contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTctNS0xLTEtMTE2ODk1_01a21855-d139-489c-a2b1-3dfbf1bb4632"
      unitRef="usd">-11830000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation
      contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTgtMS0xLTEtMTE2MzUy_0fa8eaec-24c4-400d-b56b-af99d9d37d19"
      unitRef="usd">-7436000</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation
      contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMjAtMy0xLTEtMTE2MjMw_9663881e-7831-4a23-944b-d751be9675cc"
      unitRef="usd">-5692000</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation
      contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMjEtNS0xLTEtMTE2MTAy_c3f9543f-7f50-4ca0-b8e8-9a2d98542dc3"
      unitRef="usd">-2247000</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTktMS0xLTEtMTE2ODQz_498a4885-ec26-4ec4-8460-b75b88600f31"
      unitRef="usd">-28142000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTktMy0xLTEtMTE2ODky_cf3d8ed0-d8b4-4cac-b92b-91b63b504f30"
      unitRef="usd">-19215000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmI5NTg1NWRmNTIzYTRjZDhiMTI1MDgwZTQ1NmVkY2ZiL3RhYmxlcmFuZ2U6Yjk1ODU1ZGY1MjNhNGNkOGIxMjUwODBlNDU2ZWRjZmJfMTktNS0xLTEtMTE2ODk1_143bf8c9-d6a0-46a7-a9ef-a375949c5695"
      unitRef="usd">-9583000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets
      contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfNC0xLTEtMS0xMTk4NDk_bf147763-fdc6-43ac-9ca7-807385f9fe9e"
      unitRef="usd">1100000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfNC0xLTEtMS0xMjA4MzE_aa54ae4d-847e-4d6a-bf18-6237edb491a9"
      unitRef="usd">1100000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent
      contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfNi0xLTEtMS0xMTk4Njc_752b943f-4c8d-497b-bf41-d9fec6e1eed4"
      unitRef="usd">174349000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent
      contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfNy0xLTEtMS0xMTk4Njc_9784e031-201d-4818-89bf-87818946352b"
      unitRef="usd">75533000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent
      contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfOC0xLTEtMS0xMTk4Njc_95c390d0-c15e-4528-b75f-b416bec94a5a"
      unitRef="usd">7320000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationAssetsOperatingLeaseAssets
      contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfOS0xLTEtMS0xMTk4Njc_fd483444-2cc1-4bfd-a45c-3dc2aded4cb3"
      unitRef="usd">13332000</lgnd:DisposalGroupIncludingDiscontinuedOperationAssetsOperatingLeaseAssets>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationAssetsFinanceLeaseAssets
      contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfOS0xLTEtMS0xMjA3ODA_01ef69ef-87d8-493a-9d0e-8c373d16c023"
      unitRef="usd">6000</lgnd:DisposalGroupIncludingDiscontinuedOperationAssetsFinanceLeaseAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets
      contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfMTAtMS0xLTEtMTE5ODY3_7b9fbfcf-90b0-4b8b-a733-da18569719b1"
      unitRef="usd">243000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfMTEtMS0xLTEtMTIwODMx_c096b5ba-e6bf-4c00-a8d4-e4197f2ba89d"
      unitRef="usd">271883000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesCurrent
      contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfMTQtMS0xLTEtMTE5ODg1_0669f0cb-e2ca-4680-a091-e5f2c94a90fb"
      unitRef="usd">2538000</lgnd:DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent
      contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfMTUtMS0xLTEtMTE5ODg1_a0c94399-f2f5-439c-abb9-b04d46bd8d38"
      unitRef="usd">10342000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent
      contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfMTYtMS0xLTEtMTE5ODg1_10c2f4e4-029b-476a-a1f8-e1bcd5d9cdf2"
      unitRef="usd">685000</lgnd:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilitiesCurrent
      contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfMTctMS0xLTEtMTE5ODg1_b88272e0-24e6-4f39-8af5-453bbfc2dfbd"
      unitRef="usd">1000</lgnd:DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilitiesCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfMTgtMS0xLTEtMTIwODM0_1838cefd-1185-466a-8913-0df973299d4e"
      unitRef="usd">13566000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesNoncurrent
      contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfMTktMS0xLTEtMTE5OTAw_42006840-4398-4631-88d5-393b5d686cd0"
      unitRef="usd">4826000</lgnd:DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesNoncurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities
      contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfMjAtMS0xLTEtMTE5OTAw_335a36c8-e5fb-41c1-8408-56161ad68af8"
      unitRef="usd">28239000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationLiabilitiesOperatingLeaseNoncurrent
      contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfMjEtMS0xLTEtMTE5OTAw_1508ff93-d916-4a3b-b2c8-b43223f7e2c8"
      unitRef="usd">13238000</lgnd:DisposalGroupIncludingDiscontinuedOperationLiabilitiesOperatingLeaseNoncurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities
      contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfMjItMS0xLTEtMTE5OTAw_03aaaaf5-fb25-4482-81f3-e550107913c6"
      unitRef="usd">9225000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i4b1f069cf76c405e9d9f40dbc3f6db10_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOmVhNjM3MmFlMTg3YzQ5OWE5NmNlZWEyMzgyMjc0YzA2L3RhYmxlcmFuZ2U6ZWE2MzcyYWUxODdjNDk5YTk2Y2VlYTIzODIyNzRjMDZfMjMtMS0xLTEtMTIwODM0_681805ba-b74a-4ff1-b53c-cf0e99c672cb"
      unitRef="usd">69094000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration
      contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfMy0xLTEtMS0xMTk5OTQ_04c83faa-0fa3-4469-83ac-ed1d7f4cac7d"
      unitRef="usd">-554000</lgnd:DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration
      contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfMy0zLTEtMS0xMjAwMDY_1105963d-cb6e-4b80-a8b4-101065a5d22d"
      unitRef="usd">1210000</lgnd:DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration
      contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfMy01LTEtMS0xMjAwMDY_b26c6b07-a567-469c-a965-18c9a314793a"
      unitRef="usd">2070000</lgnd:DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration>
    <us-gaap:DepreciationAndAmortizationDiscontinuedOperations
      contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfNC0xLTEtMS0xMTk5OTQ_76b31bd0-17f5-482e-bcb9-111fdccd807d"
      unitRef="usd">13218000</us-gaap:DepreciationAndAmortizationDiscontinuedOperations>
    <us-gaap:DepreciationAndAmortizationDiscontinuedOperations
      contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfNC0zLTEtMS0xMjAwMDY_f60cf54b-8da3-412b-9331-23bdc56dc57b"
      unitRef="usd">14553000</us-gaap:DepreciationAndAmortizationDiscontinuedOperations>
    <us-gaap:DepreciationAndAmortizationDiscontinuedOperations
      contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfNC01LTEtMS0xMjAwMDY_365e292e-d13a-44d5-8911-f8c662d75c2f"
      unitRef="usd">12503000</us-gaap:DepreciationAndAmortizationDiscontinuedOperations>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense
      contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfNS0xLTEtMS0xMTk5OTQ_889fa3b0-e81f-48e5-b317-aab06233b9bd"
      unitRef="usd">9404000</lgnd:DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense
      contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfNS0zLTEtMS0xMjAwMDY_421c8d78-1e54-4f16-bd21-4ba507d08dce"
      unitRef="usd">9457000</lgnd:DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense
      contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfNS01LTEtMS0xMjAwMDY_39722631-6110-4916-8e17-5facca5d4cda"
      unitRef="usd">5602000</lgnd:DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfOC0xLTEtMS0xMjA0OTE_4beaf1aa-20d3-489c-9fae-72e6206b9ccd"
      unitRef="usd">0</lgnd:DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireBusinessesNetOfCashAcquired>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfOC0zLTEtMS0xMjA0OTE_d30d5eb1-5c07-4086-895c-fc129fd08fab"
      unitRef="usd">0</lgnd:DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireBusinessesNetOfCashAcquired>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfOC01LTEtMS0xMjAyMDI_9372b01c-eb17-4b77-891b-bb33f58ae89a"
      unitRef="usd">27127000</lgnd:DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:CapitalExpenditureDiscontinuedOperations
      contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfOC0xLTEtMS0xMTk5OTQ_9453e2b5-75ea-4e56-b5e1-b2e782749e0e"
      unitRef="usd">5572000</us-gaap:CapitalExpenditureDiscontinuedOperations>
    <us-gaap:CapitalExpenditureDiscontinuedOperations
      contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfOC0zLTEtMS0xMjAwMDY_1353c8a5-ae38-41df-9a42-7d45aec08ed1"
      unitRef="usd">4070000</us-gaap:CapitalExpenditureDiscontinuedOperations>
    <us-gaap:CapitalExpenditureDiscontinuedOperations
      contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfOC01LTEtMS0xMjAwMDY_7fd15aa5-fe66-4b4e-a4aa-026148c4c5f0"
      unitRef="usd">1753000</us-gaap:CapitalExpenditureDiscontinuedOperations>
    <lgnd:PaymentsToContingentValueRightHoldersInvestingActivity
      contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfOS0xLTEtMS0xMTk5OTQ_b7324cc6-6f18-4656-af36-d66cdcfb4de8"
      unitRef="usd">960000</lgnd:PaymentsToContingentValueRightHoldersInvestingActivity>
    <lgnd:PaymentsToContingentValueRightHoldersInvestingActivity
      contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfOS0zLTEtMS0xMjAwMDY_f93cfd6f-b51c-43cc-a1e5-0ba7f4cbca0a"
      unitRef="usd">720000</lgnd:PaymentsToContingentValueRightHoldersInvestingActivity>
    <lgnd:PaymentsToContingentValueRightHoldersInvestingActivity
      contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfOS01LTEtMS0xMjAwMDY_c3d9826b-435a-4323-944f-d2223e2960ee"
      unitRef="usd">0</lgnd:PaymentsToContingentValueRightHoldersInvestingActivity>
    <lgnd:PaymentsToContingentValueRightHoldersFinancingActivity
      contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfMTMtMS0xLTEtMTIxMDk4_9f878e65-ac25-4834-9d45-598e9f914e91"
      unitRef="usd">1545000</lgnd:PaymentsToContingentValueRightHoldersFinancingActivity>
    <lgnd:PaymentsToContingentValueRightHoldersFinancingActivity
      contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfMTMtMy0xLTEtMTIwNTU3_2f756645-ca8b-4160-9feb-5506ce491e68"
      unitRef="usd">1050000</lgnd:PaymentsToContingentValueRightHoldersFinancingActivity>
    <lgnd:PaymentsToContingentValueRightHoldersFinancingActivity
      contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfMTMtNS0xLTEtMTIwMjUx_2a0cd272-10df-4b08-933b-3ec637b3e2ab"
      unitRef="usd">2325000</lgnd:PaymentsToContingentValueRightHoldersFinancingActivity>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid
      contextRef="i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfMTItMS0xLTEtMTE5OTk0_b99729f4-ab2d-4c98-87f5-0036fd0c9ed8"
      unitRef="usd">2310000</lgnd:DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid
      contextRef="i718ffe5f65d249bf919b34a8f3559060_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfMTItMy0xLTEtMTIwMDA2_d8b0fab6-34c0-4afa-900d-b3132f00dea2"
      unitRef="usd">1231000</lgnd:DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid
      contextRef="ief8ce2e37bce444ba8550b785fc0a1d1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV84OC9mcmFnOmE2OWVjYjAxMjE5OTQ5MWU4NzZjMGI4YjYzN2Y2OTYxL3RhYmxlOjFiNDlmMWNlODQ4NTQwNmM4ZGZlYmQzMDgxOTVmNmVjL3RhYmxlcmFuZ2U6MWI0OWYxY2U4NDg1NDA2YzhkZmViZDMwODE5NWY2ZWNfMTItNS0xLTEtMTIwMDA2_eceb389a-0331-408a-8776-acf07a8886d1"
      unitRef="usd">0</lgnd:DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:VariableInterestEntityDisclosureTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85MS9mcmFnOjUwNDI1ZTQwYmIwYTQzNTBiMTM2NGVmMGVkZjRiNWMyL3RleHRyZWdpb246NTA0MjVlNDBiYjBhNDM1MGIxMzY0ZWYwZWRmNGI1YzJfMTA3Ng_c124bcda-8f21-44a7-ac6f-e97f81de2d94">Short-term Investments: Investment in VikingOur ownership in Viking was approximately 8.6% as of December&#160;31, 2022, and we account for it as an investment in available-for-sale equity securities, which is measured at fair value, with changes in fair value recognized in net income. Viking &lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;is considered a related party as we maintain a seat on Viking's board of directors and we do not exert significant influence over Viking. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022 and December&#160;31, 2021, we recorded our common stock in Viking in &#x201c;short-term investments&#x201d; at fair value of $63.1 million and $30.9 million, respectively. At December&#160;31, 2020, we owned warrants to purchase up to 1.5 million shares of Viking's common stock at an exercise price of  $1.50 per share, and during the year ended December&#160;31, 2021 we exercised all outstanding Viking warrants. As of December&#160;31, 2022 and December&#160;31, 2021, we have zero Viking warrants outstanding. During the year ended December&#160;31, 2021, we also sold 0.6&#160;million Viking shares. See further discussion in &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note (5), Fair Value Measurement.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;/div&gt;</us-gaap:VariableInterestEntityDisclosureTextBlock>
    <us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest
      contextRef="ic19bd9bd07214754968a75ae83faf30f_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85MS9mcmFnOjUwNDI1ZTQwYmIwYTQzNTBiMTM2NGVmMGVkZjRiNWMyL3RleHRyZWdpb246NTA0MjVlNDBiYjBhNDM1MGIxMzY0ZWYwZWRmNGI1YzJfOTc_a1aea048-8742-4a73-8b94-ce7c31ecf1e7"
      unitRef="number">0.086</us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85MS9mcmFnOjUwNDI1ZTQwYmIwYTQzNTBiMTM2NGVmMGVkZjRiNWMyL3RleHRyZWdpb246NTA0MjVlNDBiYjBhNDM1MGIxMzY0ZWYwZWRmNGI1YzJfNTc0_6bab4695-4d3d-4273-8e12-a288750dd3eb"
      unitRef="usd">63100000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85MS9mcmFnOjUwNDI1ZTQwYmIwYTQzNTBiMTM2NGVmMGVkZjRiNWMyL3RleHRyZWdpb246NTA0MjVlNDBiYjBhNDM1MGIxMzY0ZWYwZWRmNGI1YzJfNTgx_d9154f03-b86a-4641-9ddf-c8a0cb91d9a8"
      unitRef="usd">30900000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85MS9mcmFnOjUwNDI1ZTQwYmIwYTQzNTBiMTM2NGVmMGVkZjRiNWMyL3RleHRyZWdpb246NTA0MjVlNDBiYjBhNDM1MGIxMzY0ZWYwZWRmNGI1YzJfNjQy_49c87c57-45be-45cf-81d4-738830ac289d"
      unitRef="usd">1500000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85MS9mcmFnOjUwNDI1ZTQwYmIwYTQzNTBiMTM2NGVmMGVkZjRiNWMyL3RleHRyZWdpb246NTA0MjVlNDBiYjBhNDM1MGIxMzY0ZWYwZWRmNGI1YzJfNzAy_f67ecb82-6c04-431e-9e5e-c5fcd04d011b"
      unitRef="usdPerShare">1.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85MS9mcmFnOjUwNDI1ZTQwYmIwYTQzNTBiMTM2NGVmMGVkZjRiNWMyL3RleHRyZWdpb246NTA0MjVlNDBiYjBhNDM1MGIxMzY0ZWYwZWRmNGI1YzJfODA5_7919faef-b5ea-4979-b74b-3d49f4e0d4b7"
      unitRef="usd">0</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85MS9mcmFnOjUwNDI1ZTQwYmIwYTQzNTBiMTM2NGVmMGVkZjRiNWMyL3RleHRyZWdpb246NTA0MjVlNDBiYjBhNDM1MGIxMzY0ZWYwZWRmNGI1YzJfODA5_ac56ba0c-0a1b-460b-9cf9-c7a208e37f05"
      unitRef="usd">0</us-gaap:WarrantsAndRightsOutstanding>
    <lgnd:NumberOfSharesSoldOfEquityMethodInvestee
      contextRef="i78dcb59101a846b19a565ed0e098ef09_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85MS9mcmFnOjUwNDI1ZTQwYmIwYTQzNTBiMTM2NGVmMGVkZjRiNWMyL3RleHRyZWdpb246NTA0MjVlNDBiYjBhNDM1MGIxMzY0ZWYwZWRmNGI1YzJfODgw_978519f6-8788-4f06-beff-4b8facf74a8d"
      unitRef="shares">600000</lgnd:NumberOfSharesSoldOfEquityMethodInvestee>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfMTMyNDE_1c0a8b3a-7872-41bf-ab24-7eb2c984afff">Acquisitions&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Excluding the impact of OmniAb, we completed one acquisition from January 1, 2020 through December 31, 2022, where we applied the acquisition method of accounting for business combinations. Accordingly, we recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the applicable date of acquisition. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Pfenex Acquisition &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 1, 2020, we acquired Pfenex, which develops next-generation and novel protein therapeutics to improve existing therapies and create new therapies for biological targets linked to critical, unmet diseases using a protein expression technology platform.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The purchase price of $465.1 million included $429.6 million cash consideration paid upon acquisition, and a contingent CVR payment of up to $77.8 million in cash based on a certain specified milestone with an estimated initial fair value of $37.0 million. The CVR will only be paid in full if the milestone is achieved by December 31, 2021. The amount of the CVR included in purchase price was reduced by $1.5&#160;million which was determined to be post-combination expense. The fair value of the CVR liability was determined using a probability adjusted income approach. These cash flows were then discounted to present value using a discount rate based on market participants' cost of debt reflective of the Company, which was 7.1%. The liability is periodically assessed based on events and circumstances related to the underlying milestone, and any change in fair value is recorded in our consolidated statements of operations. During the year ended December&#160;31, 2021, we wrote off the entire CVR liability of $37.6&#160;million to &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfMjc0ODc3OTA5MTQ4Mw_faecaf46-33bf-4086-b9d1-f6c39448988e"&gt;other operation income&lt;/span&gt;, primarily due to not achieving the specific development and regulatory milestone by December 31, 2021 as defined by Pfenex CVR.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the acquisition, a portion of Pfenex's equity awards that were outstanding and unvested prior to the acquisition became fully vested per the terms of the merger agreement. The acceleration of vesting required us to allocate the fair value of the equity attributable to pre-combination service to the purchase price and the remaining amount was considered our post-combination expense. We paid $17.3 million in cash for equity compensation, which is attributable to pre-combination services and is reflected as a component of the total purchase price paid of $429.6 million. In addition, the fair value of equity compensation attributable to the post-combination service period was $8.7 million. These amounts were associated with the accelerated vesting of stock options previously granted to Pfenex employees and were fully paid in cash, which was recognized as general and administrative expenses during the fourth quarter of 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded $20.7 million of acquisition-related costs for legal, severance and other costs in connection with the acquisition within operating expenses in our consolidated statement of operations for 2020. The following table sets forth an allocation of the purchase price to the identifiable tangible and intangible assets acquired and liabilities assumed, with the excess recorded to goodwill (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.351%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts and unbilled receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangibles acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,814)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,606)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,908)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,070)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42,622)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(1) Goodwill represents the excess of the purchase price over the preliminary fair value of the underlying assets acquired and liabilities assumed. Goodwill is attributable to the assembled workforce of experienced personnel at Pfenex and expected synergies. None of the goodwill is deductible for tax purposes. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The intangibles acquired and their weighted average useful life are as follows (in thousands, except useful lives):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.707%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Approximate&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Estimated useful life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contractual Relationships:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Alvogen&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Merck&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Jazz&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SII&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Arcellx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10-19&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of the contractual relationships were based on the discounted cash flow method that estimated the present value of the potential royalties, milestones and collaboration revenue streams derived from the licensing of the related technologies over the estimated contractual relationship period. The fair values of the acquired technologies were based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, collaboration and product revenue streams derived from the licensing of the related technologies over the estimated useful lives. These projected cash flows were discounted to present value using discount rate, which varies from 12% to 15%. The intangible assets acquired are being amortized on a straight-line basis over the estimated useful life. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Approximately $2.0 million of revenue and $19.3 million of loss before income taxes of Pfenex were included in the consolidated statement of operations for the year ended December 31, 2020. The following summary presents our unaudited pro forma consolidated results of operations for the years ended December 31, 2020 and December 31, 2019 as if the Pfenex acquisition had occurred on January 1, 2019, which gives effect to certain transaction accounting adjustments, including amortization of acquired intangibles and stock based compensation expense for retained Pfenex employees. The transaction accounting adjustments do not include non-recurring adjustments related to Pfenex's executive salary, board of director compensation, and salary of Pfenex employees involved in the reduction of force as part of the acquisition, estimated to be $7.1 million in 2020 and $4.8&#160;million in 2019. The pro forma financial information is not necessarily indicative of the operating results that would have occurred had the acquisition been consummated as if the date indicated, nor is it necessarily indicative of future operating results (in thousands, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.707%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60,059)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income (loss) per common share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <lgnd:NumberOfAcquisitions
      contextRef="ifeea5a6633434f93bbe3e33fea893ad4_D20200101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfNTY_e6e8c1cd-9f36-4a5c-9a85-9fa1b5ca76d9"
      unitRef="acquisition">1</lgnd:NumberOfAcquisitions>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i4ed842cd826a473aa27b3be44b9dff45_D20201001-20201001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfOTQ4_45beecdc-637e-4867-89ee-e18eed97de30"
      unitRef="usd">465100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i4ed842cd826a473aa27b3be44b9dff45_D20201001-20201001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfOTYw_7b378def-fb1f-4ffd-ab19-a0f2f0114cee"
      unitRef="usd">429600000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfMTA0Mw_e7a48212-cff9-40e7-9045-9838f3515d5e"
      unitRef="usd">77800000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfMTEzMw_b53f8655-3cb8-482c-a50b-5f93cf21a50e"
      unitRef="usd">37000000</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfMTI4Ng_f5886066-c521-4dbf-bc29-b5337385b8c2"
      unitRef="usd">1500000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i0031e41cbf7c45bbb25efe78bbbcea4a_I20201001"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfMTU5Ng_92dbb026-8cbf-4720-99ba-3f5814b34b7c"
      unitRef="number">0.071</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i36cbb3f817354f04b57d665248187943_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfMTg2NA_703da142-1309-4efd-bb7b-1e7bd2e23c7c"
      unitRef="usd">-37600000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <lgnd:PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions
      contextRef="i4ed842cd826a473aa27b3be44b9dff45_D20201001-20201001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfMjQzNQ_7af98d81-d39d-418f-89df-f95e770c0b9b"
      unitRef="usd">17300000</lgnd:PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i4ed842cd826a473aa27b3be44b9dff45_D20201001-20201001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfMjU4OQ_7b378def-fb1f-4ffd-ab19-a0f2f0114cee"
      unitRef="usd">429600000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards
      contextRef="i0787b2990c934b468deda9c36c3f0273_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfMjcwMA_81e2d66c-b797-4969-9b09-f1d51235ee92"
      unitRef="usd">8700000</us-gaap:EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i4ed842cd826a473aa27b3be44b9dff45_D20201001-20201001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfMjk1Nw_d4777a72-814f-47e6-8889-8f6ac5b2c110"
      unitRef="usd">20700000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfMTMyNDU_32d82888-aa1d-4fa2-bcf5-395ccd25740c">The following table sets forth an allocation of the purchase price to the identifiable tangible and intangible assets acquired and liabilities assumed, with the excess recorded to goodwill (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.351%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts and unbilled receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangibles acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,814)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,606)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,908)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,070)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42,622)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;(1) Goodwill represents the excess of the purchase price over the preliminary fair value of the underlying assets acquired and liabilities assumed. Goodwill is attributable to the assembled workforce of experienced personnel at Pfenex and expected synergies. None of the goodwill is deductible for tax purposes.</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOjE0MmZmMjFmNDcwZjQ4MWQ5ZTNkYzM5NTM4YTBkYWUwL3RhYmxlcmFuZ2U6MTQyZmYyMWY0NzBmNDgxZDllM2RjMzk1MzhhMGRhZTBfMC0xLTEtMS0xMTI2NDA_c5743171-709d-4898-b1ff-8b9852cd2413"
      unitRef="usd">51407000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash
      contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOjE0MmZmMjFmNDcwZjQ4MWQ5ZTNkYzM5NTM4YTBkYWUwL3RhYmxlcmFuZ2U6MTQyZmYyMWY0NzBmNDgxZDllM2RjMzk1MzhhMGRhZTBfMS0xLTEtMS0xMTI2NDA_091496e4-2997-4d62-b8e7-e66cacb1fc87"
      unitRef="usd">200000</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOjE0MmZmMjFmNDcwZjQ4MWQ5ZTNkYzM5NTM4YTBkYWUwL3RhYmxlcmFuZ2U6MTQyZmYyMWY0NzBmNDgxZDllM2RjMzk1MzhhMGRhZTBfMi0xLTEtMS0xMTI2NDA_1bc86517-e184-4226-9aed-ea06f02a4ac0"
      unitRef="usd">1359000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOjE0MmZmMjFmNDcwZjQ4MWQ5ZTNkYzM5NTM4YTBkYWUwL3RhYmxlcmFuZ2U6MTQyZmYyMWY0NzBmNDgxZDllM2RjMzk1MzhhMGRhZTBfMy0xLTEtMS0xMTI2NDA_1f25629b-4824-4ef5-ac79-3d09ea63a4fa"
      unitRef="usd">7823000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets
      contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOjE0MmZmMjFmNDcwZjQ4MWQ5ZTNkYzM5NTM4YTBkYWUwL3RhYmxlcmFuZ2U6MTQyZmYyMWY0NzBmNDgxZDllM2RjMzk1MzhhMGRhZTBfNC0xLTEtMS0xMTI2NDA_7689ba61-4bda-4ecd-8570-e798b42dbe1f"
      unitRef="usd">3070000</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOjE0MmZmMjFmNDcwZjQ4MWQ5ZTNkYzM5NTM4YTBkYWUwL3RhYmxlcmFuZ2U6MTQyZmYyMWY0NzBmNDgxZDllM2RjMzk1MzhhMGRhZTBfNS0xLTEtMS0xMTI2NDA_165ec9f0-c7e2-43dc-80dd-aa6441c8100f"
      unitRef="usd">1338000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets
      contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOjE0MmZmMjFmNDcwZjQ4MWQ5ZTNkYzM5NTM4YTBkYWUwL3RhYmxlcmFuZ2U6MTQyZmYyMWY0NzBmNDgxZDllM2RjMzk1MzhhMGRhZTBfNi0xLTEtMS0xMTI2NDA_5dc29416-b788-4193-8ca1-893694c0229f"
      unitRef="usd">385000000</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets>
    <us-gaap:Goodwill
      contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOjE0MmZmMjFmNDcwZjQ4MWQ5ZTNkYzM5NTM4YTBkYWUwL3RhYmxlcmFuZ2U6MTQyZmYyMWY0NzBmNDgxZDllM2RjMzk1MzhhMGRhZTBfNy0xLTEtMS0xMTI2NDA_2cb0d189-a9ae-4beb-8f93-abfbefa14aa7"
      unitRef="usd">82303000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOjE0MmZmMjFmNDcwZjQ4MWQ5ZTNkYzM5NTM4YTBkYWUwL3RhYmxlcmFuZ2U6MTQyZmYyMWY0NzBmNDgxZDllM2RjMzk1MzhhMGRhZTBfOC0xLTEtMS0xMTI2NDA_103be432-d255-4166-9df9-d662c1c29208"
      unitRef="usd">6814000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent
      contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOjE0MmZmMjFmNDcwZjQ4MWQ5ZTNkYzM5NTM4YTBkYWUwL3RhYmxlcmFuZ2U6MTQyZmYyMWY0NzBmNDgxZDllM2RjMzk1MzhhMGRhZTBfOS0xLTEtMS0xMTI2NDA_1530792a-a1f2-4c63-a4fe-6ec0195f0115"
      unitRef="usd">9606000</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOjE0MmZmMjFmNDcwZjQ4MWQ5ZTNkYzM5NTM4YTBkYWUwL3RhYmxlcmFuZ2U6MTQyZmYyMWY0NzBmNDgxZDllM2RjMzk1MzhhMGRhZTBfMTAtMS0xLTEtMTEyNjQw_fb166224-ad59-4886-a064-b7e2357ce0c2"
      unitRef="usd">3908000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities
      contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOjE0MmZmMjFmNDcwZjQ4MWQ5ZTNkYzM5NTM4YTBkYWUwL3RhYmxlcmFuZ2U6MTQyZmYyMWY0NzBmNDgxZDllM2RjMzk1MzhhMGRhZTBfMTEtMS0xLTEtMTEyNjQw_9ea0ef81-c0ed-4f4a-a41f-4015ec145e43"
      unitRef="usd">3070000</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOjE0MmZmMjFmNDcwZjQ4MWQ5ZTNkYzM5NTM4YTBkYWUwL3RhYmxlcmFuZ2U6MTQyZmYyMWY0NzBmNDgxZDllM2RjMzk1MzhhMGRhZTBfMTItMS0xLTEtMTEyNjQw_471e8add-94e3-4cb0-8ec8-e570e3b49e38"
      unitRef="usd">1382000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOjE0MmZmMjFmNDcwZjQ4MWQ5ZTNkYzM5NTM4YTBkYWUwL3RhYmxlcmFuZ2U6MTQyZmYyMWY0NzBmNDgxZDllM2RjMzk1MzhhMGRhZTBfMTMtMS0xLTEtMTEyNjQw_bf9beee1-149c-41b0-8dec-3836f0153ab1"
      unitRef="usd">42622000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOjE0MmZmMjFmNDcwZjQ4MWQ5ZTNkYzM5NTM4YTBkYWUwL3RhYmxlcmFuZ2U6MTQyZmYyMWY0NzBmNDgxZDllM2RjMzk1MzhhMGRhZTBfMTQtMS0xLTEtMTEyNjQw_10efcb0f-58f3-4eb6-8162-45a1d384d4fa"
      unitRef="usd">465098000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfMTMyNDY_eff8b2af-48c5-411b-8486-9b7f7365a7e4">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The intangibles acquired and their weighted average useful life are as follows (in thousands, except useful lives):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.707%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Approximate&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Estimated useful life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contractual Relationships:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Alvogen&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Merck&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Jazz&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SII&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Arcellx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10-19&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i4c6f37320d134abeb77221e2c28f7476_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmYyMzI3ODc2MDMxYjRjMjQ4YTMzMWM4NjdkY2E3N2QzL3RhYmxlcmFuZ2U6ZjIzMjc4NzYwMzFiNGMyNDhhMzMxYzg2N2RjYTc3ZDNfMi0xLTEtMS0xMTI2NDA_72b5fb57-d4b1-421a-8f61-43c62cc281d4"
      unitRef="usd">114000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ie17cc4f187524c6ab5d90741e0260c93_D20201001-20201001"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmYyMzI3ODc2MDMxYjRjMjQ4YTMzMWM4NjdkY2E3N2QzL3RhYmxlcmFuZ2U6ZjIzMjc4NzYwMzFiNGMyNDhhMzMxYzg2N2RjYTc3ZDNfMi0yLTEtMS0xMTI2NDA_b4291319-4f18-4250-ad55-7ec04ee01dfe">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i3c16dd0f6ad94561a190f6fb614d008c_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmYyMzI3ODc2MDMxYjRjMjQ4YTMzMWM4NjdkY2E3N2QzL3RhYmxlcmFuZ2U6ZjIzMjc4NzYwMzFiNGMyNDhhMzMxYzg2N2RjYTc3ZDNfMy0xLTEtMS0xMTI2NDA_5e7a127f-d0de-4ed1-9595-73e627fb1258"
      unitRef="usd">117000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i0879712cff614a0b90c548a17d56dc6e_D20201001-20201001"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmYyMzI3ODc2MDMxYjRjMjQ4YTMzMWM4NjdkY2E3N2QzL3RhYmxlcmFuZ2U6ZjIzMjc4NzYwMzFiNGMyNDhhMzMxYzg2N2RjYTc3ZDNfMy0yLTEtMS0xMTI2NDA_8d20f7b0-9311-4b82-bc0b-3591d284f0a0">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i0183c839f90a44d78e84690651518be4_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmYyMzI3ODc2MDMxYjRjMjQ4YTMzMWM4NjdkY2E3N2QzL3RhYmxlcmFuZ2U6ZjIzMjc4NzYwMzFiNGMyNDhhMzMxYzg2N2RjYTc3ZDNfNC0xLTEtMS0xMTI2NDA_7c449bab-b857-4bb7-9878-e7af8378495a"
      unitRef="usd">80000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ifac692c703d348d388432995b6f0fa8a_D20201001-20201001"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmYyMzI3ODc2MDMxYjRjMjQ4YTMzMWM4NjdkY2E3N2QzL3RhYmxlcmFuZ2U6ZjIzMjc4NzYwMzFiNGMyNDhhMzMxYzg2N2RjYTc3ZDNfNC0yLTEtMS0xMTI2NDA_d14be5d8-e320-40d7-9c51-4de26cb2dbe2">P17Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i646b177827484736a084009b96add04f_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmYyMzI3ODc2MDMxYjRjMjQ4YTMzMWM4NjdkY2E3N2QzL3RhYmxlcmFuZ2U6ZjIzMjc4NzYwMzFiNGMyNDhhMzMxYzg2N2RjYTc3ZDNfNS0xLTEtMS0xMTI2NDA_e28c7253-8360-4efb-9bc2-a9fba3f25c74"
      unitRef="usd">49000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="iada43374af48485cb39ed70b764ce849_D20201001-20201001"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmYyMzI3ODc2MDMxYjRjMjQ4YTMzMWM4NjdkY2E3N2QzL3RhYmxlcmFuZ2U6ZjIzMjc4NzYwMzFiNGMyNDhhMzMxYzg2N2RjYTc3ZDNfNS0yLTEtMS0xMTI2NDA_757dcbe8-2e0c-40b1-866f-4fb9634daa81">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i29179647d1e74e45a16db04ef1607aa3_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmYyMzI3ODc2MDMxYjRjMjQ4YTMzMWM4NjdkY2E3N2QzL3RhYmxlcmFuZ2U6ZjIzMjc4NzYwMzFiNGMyNDhhMzMxYzg2N2RjYTc3ZDNfNi0xLTEtMS0xMTI2NDA_bfa43fff-cd0b-40b2-97c9-995b4a3eeb93"
      unitRef="usd">2000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i0793bd25b06b4adb80e8bcf79ba4daae_D20201001-20201001"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmYyMzI3ODc2MDMxYjRjMjQ4YTMzMWM4NjdkY2E3N2QzL3RhYmxlcmFuZ2U6ZjIzMjc4NzYwMzFiNGMyNDhhMzMxYzg2N2RjYTc3ZDNfNi0yLTEtMS0xMTI2NDA_29afb9e7-3f21-4357-b8e1-4d546d730dc8">P17Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i56ebc06b13944fc8bae568b634e1b508_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmYyMzI3ODc2MDMxYjRjMjQ4YTMzMWM4NjdkY2E3N2QzL3RhYmxlcmFuZ2U6ZjIzMjc4NzYwMzFiNGMyNDhhMzMxYzg2N2RjYTc3ZDNfNy0xLTEtMS0xMTI2NDA_2ee74908-ae9c-4437-bb14-5afd753b339b"
      unitRef="usd">23000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i8104cc1e7e204b4f9867e0af251d6d20_D20201001-20201001"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmYyMzI3ODc2MDMxYjRjMjQ4YTMzMWM4NjdkY2E3N2QzL3RhYmxlcmFuZ2U6ZjIzMjc4NzYwMzFiNGMyNDhhMzMxYzg2N2RjYTc3ZDNfNy0yLTEtMS0xMTI2NDAvdGV4dHJlZ2lvbjo1Y2EzZDllN2MyMDQ0Mzg4OWZiNTNkMDY0M2Y3YWZiNF80_7e6ae8bb-c090-446e-a47e-11cb82062a6e">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ifdcdcd7c135242418722134cac4afc56_D20201001-20201001"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmYyMzI3ODc2MDMxYjRjMjQ4YTMzMWM4NjdkY2E3N2QzL3RhYmxlcmFuZ2U6ZjIzMjc4NzYwMzFiNGMyNDhhMzMxYzg2N2RjYTc3ZDNfNy0yLTEtMS0xMTI2NDAvdGV4dHJlZ2lvbjo1Y2EzZDllN2MyMDQ0Mzg4OWZiNTNkMDY0M2Y3YWZiNF83_07b51734-220b-4e50-8884-111d27cd7f45">P19Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="if6722b1819674d1ca58d43ab78f42fee_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmYyMzI3ODc2MDMxYjRjMjQ4YTMzMWM4NjdkY2E3N2QzL3RhYmxlcmFuZ2U6ZjIzMjc4NzYwMzFiNGMyNDhhMzMxYzg2N2RjYTc3ZDNfOC0xLTEtMS0xMTI2NDA_07823ee3-b02b-42cd-ac06-96afd0213d43"
      unitRef="usd">385000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate
      contextRef="id589112d140b42ffa4f049057293f7a7_D20201001-20201001"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfNDQ4Mw_c3082701-a042-4ca0-aa7e-549c5491deed"
      unitRef="number">0.12</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate
      contextRef="i7eada68668c8443ba5abbd0bcde52836_D20201001-20201001"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfNDQ4OQ_1c70f903-0390-4667-bb19-dfbbbe609269"
      unitRef="number">0.15</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate>
    <us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual
      contextRef="i67ed4423d4894d809c0e43396ff89fb7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfNDYxNw_22575b21-99e4-4e24-a23a-f33ea9ece32a"
      unitRef="usd">2000000</us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual
      contextRef="i67ed4423d4894d809c0e43396ff89fb7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfNDYzNQ_518d70f5-ddb7-461f-8d1e-16f2fe462244"
      unitRef="usd">-19300000</us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i67ed4423d4894d809c0e43396ff89fb7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfNTQyNQ_c4a11f76-a9c7-438b-af45-9eaa6f276099"
      unitRef="usd">7100000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i5cbea891771f402ba63e1011224d9594_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfNTQ0MA_ddc2a723-ec21-48e7-b45b-9ef0350bebbb"
      unitRef="usd">4800000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RleHRyZWdpb246MTI0MWFiZDBhZTI4NGZhMWIyZDU3YzljZjEyMDczZmVfMTMyNDc_bef30867-bf26-4f72-abc4-171056f17ffd">The pro forma financial information is not necessarily indicative of the operating results that would have occurred had the acquisition been consummated as if the date indicated, nor is it necessarily indicative of future operating results (in thousands, except per share amounts):&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.707%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60,059)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income (loss) per common share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i67ed4423d4894d809c0e43396ff89fb7_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmUxNjUzNjhjYmNiNzQyMzM5ODI1MTZjZWFhMDVmYzMzL3RhYmxlcmFuZ2U6ZTE2NTM2OGNiY2I3NDIzMzk4MjUxNmNlYWEwNWZjMzNfMi0xLTEtMS0xMTI2NDA_bb8338b2-9d1f-49ee-bcbb-66808f3117e9"
      unitRef="usd">189203000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i5cbea891771f402ba63e1011224d9594_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmUxNjUzNjhjYmNiNzQyMzM5ODI1MTZjZWFhMDVmYzMzL3RhYmxlcmFuZ2U6ZTE2NTM2OGNiY2I3NDIzMzk4MjUxNmNlYWEwNWZjMzNfMi0yLTEtMS0xMTI2NDA_15c509d3-06fd-43b9-a61d-0a84a5b19239"
      unitRef="usd">170608000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i67ed4423d4894d809c0e43396ff89fb7_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmUxNjUzNjhjYmNiNzQyMzM5ODI1MTZjZWFhMDVmYzMzL3RhYmxlcmFuZ2U6ZTE2NTM2OGNiY2I3NDIzMzk4MjUxNmNlYWEwNWZjMzNfMy0xLTEtMS0xMTI2NDA_28da4bd8-4319-457b-8165-3828d6b5f4da"
      unitRef="usd">-60059000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i5cbea891771f402ba63e1011224d9594_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmUxNjUzNjhjYmNiNzQyMzM5ODI1MTZjZWFhMDVmYzMzL3RhYmxlcmFuZ2U6ZTE2NTM2OGNiY2I3NDIzMzk4MjUxNmNlYWEwNWZjMzNfMy0yLTEtMS0xMTI2NDA_d35d97e3-74be-4328-a93e-6095e9a1445b"
      unitRef="usd">594941000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic
      contextRef="i67ed4423d4894d809c0e43396ff89fb7_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmUxNjUzNjhjYmNiNzQyMzM5ODI1MTZjZWFhMDVmYzMzL3RhYmxlcmFuZ2U6ZTE2NTM2OGNiY2I3NDIzMzk4MjUxNmNlYWEwNWZjMzNfNS0xLTEtMS0xMTI2NDA_c2e1c8b6-c5cd-48aa-984e-6f53486de9a2"
      unitRef="usdPerShare">-3.71</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic
      contextRef="i5cbea891771f402ba63e1011224d9594_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmUxNjUzNjhjYmNiNzQyMzM5ODI1MTZjZWFhMDVmYzMzL3RhYmxlcmFuZ2U6ZTE2NTM2OGNiY2I3NDIzMzk4MjUxNmNlYWEwNWZjMzNfNS0yLTEtMS0xMTI2NDA_7aaf3162-2727-4dc3-af82-56e77572081c"
      unitRef="usdPerShare">31.32</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted
      contextRef="i67ed4423d4894d809c0e43396ff89fb7_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmUxNjUzNjhjYmNiNzQyMzM5ODI1MTZjZWFhMDVmYzMzL3RhYmxlcmFuZ2U6ZTE2NTM2OGNiY2I3NDIzMzk4MjUxNmNlYWEwNWZjMzNfNi0xLTEtMS0xMTI2NDA_cbf405fb-cb9d-454c-a580-83813765078c"
      unitRef="usdPerShare">-3.71</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted
      contextRef="i5cbea891771f402ba63e1011224d9594_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85NC9mcmFnOjEyNDFhYmQwYWUyODRmYTFiMmQ1N2M5Y2YxMjA3M2ZlL3RhYmxlOmUxNjUzNjhjYmNiNzQyMzM5ODI1MTZjZWFhMDVmYzMzL3RhYmxlcmFuZ2U6ZTE2NTM2OGNiY2I3NDIzMzk4MjUxNmNlYWEwNWZjMzNfNi0yLTEtMS0xMTI2NDA_36ef058f-71da-40cd-9bf6-4d5732b3bab9"
      unitRef="usdPerShare">30.11</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:FinancialInstrumentsDisclosureTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RleHRyZWdpb246MmQxYTM0MTYwZjNlNGU1ZTliNmNiODZkZTcxZDFkMzlfNzQ3Nw_cc4d76c0-bf4d-4450-a222-678675ebfbe4">Fair Value Measurement&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We measure certain financial assets and liabilities at fair value on a recurring basis. Fair value is a market-based measurement that should be determined using assumptions that market participants would use in pricing an asset or liability. We establish a three-level hierarchy to prioritize the inputs used in measuring fair value. The levels are described in the below with level 1 having the highest priority and level 3 having the lowest:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 - Observable inputs such as quoted prices in active markets &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2 - Inputs other than the quoted prices in active markets that are observable either directly or indirectly &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 - Unobservable inputs in which there is little or no market data, which require the Company to develop its own assumptions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a summary of the assets and liabilities that are measured at fair value on a recurring basis as of December&#160;31, 2022 and 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements at Reporting Date Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted Prices in&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Active Markets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;for Identical&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Observable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Inputs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Inputs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in Viking common stock &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent liabilities - Cydex&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent liabilities - Metabasis &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for amounts owed to a former licensor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements at Reporting Date Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted Prices in&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Active Markets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;for Identical&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Observable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Inputs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Inputs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in Viking common stock &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent liabilities - Cydex&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent liabilities - Metabasis &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for amounts owed to a former licensor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2) Investment in Viking warrants, which we received as a result of Viking&#x2019;s partial repayment of the Viking note receivable and our purchase of Viking common stock and warrants in April 2016, is classified as level 1 as the fair value is determined using quoted market prices in active markets for the same securities. The change of the fair value is recorded in &#x201c;gain (loss) from short-term investments&#x201d; in our consolidated statement of operations. See further discussion in &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note (3), Short-term Investments: Investment in Viking.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x201d;  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3) In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially differ than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#x3b2; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375.0 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10.0 million payment upon initiation of a Phase 3 clinical trial.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the level 3 financial instruments as of December&#160;31, 2022 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:45pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustments to contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(265)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the level 3 financial instruments as of December&#160;31, 2021 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:45pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to CVR holders and other contingency payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustments to contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,708)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets Measured on a Non-Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We apply fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to our goodwill, indefinite-lived intangible assets, and long-lived assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. We determine the fair value of our reporting unit based on a combination of inputs, including the market capitalization of Ligand, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. We determine the fair value of our indefinite-lived intangible assets using the income approach based on Level 3 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other than the finance lease equipment discussed in &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note (6), Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;, there was no impairment of our goodwill, indefinite-lived assets, or long-lived assets recorded during the twelve months ended December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2018, we issued the 2023 Notes. We use quoted market rates in an inactive market, which are classified as a Level 2 input, to estimate the fair value of our 2023 Notes. The carrying value of the notes does not reflect the market rate. See &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note (7), Convertible Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; for additional information related to the fair value.&lt;/span&gt;&lt;/div&gt;In addition, our accounts receivable, accounts payable, accrued liabilities, current deferred revenue, current operating lease liabilities, current financing lease liabilities are financial instruments and are recorded at cost in the consolidated balance sheets. The estimated fair value of these financial instruments approximates their carrying value due to their short-term nature.</us-gaap:FinancialInstrumentsDisclosureTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RleHRyZWdpb246MmQxYTM0MTYwZjNlNGU1ZTliNmNiODZkZTcxZDFkMzlfNzQ4MQ_b444c8ba-9beb-4d5b-bbda-3f3e430fd2a3">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a summary of the assets and liabilities that are measured at fair value on a recurring basis as of December&#160;31, 2022 and 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements at Reporting Date Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted Prices in&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Active Markets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;for Identical&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Observable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Inputs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Inputs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in Viking common stock &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent liabilities - Cydex&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent liabilities - Metabasis &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for amounts owed to a former licensor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements at Reporting Date Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted Prices in&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Active Markets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;for Identical&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Observable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Inputs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Inputs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in Viking common stock &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent liabilities - Cydex&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent liabilities - Metabasis &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for amounts owed to a former licensor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2) Investment in Viking warrants, which we received as a result of Viking&#x2019;s partial repayment of the Viking note receivable and our purchase of Viking common stock and warrants in April 2016, is classified as level 1 as the fair value is determined using quoted market prices in active markets for the same securities. The change of the fair value is recorded in &#x201c;gain (loss) from short-term investments&#x201d; in our consolidated statement of operations. See further discussion in &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note (3), Short-term Investments: Investment in Viking.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x201d;  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3) In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially differ than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#x3b2; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375.0 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10.0 million payment upon initiation of a Phase 3 clinical trial.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic56146394448409b96d33c1403f18303_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfNC0xLTEtMS0xMTI2NDA_674f7826-93f2-412b-af9f-090b48a290d0"
      unitRef="usd">103742000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i3b6118bd78b042f680823946386c507b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfNC0zLTEtMS0xMTI2NDA_c454a0c5-6ca9-4d27-91e7-6e0ab6e08a9b"
      unitRef="usd">3992000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib96a633a4e0742be9fe13b947aa7bbf8_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfNC01LTEtMS0xMTI2NDA_1392a855-2176-4ce3-b5e0-5b598b0f0e25"
      unitRef="usd">99615000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="icb1ec84b065e4c5ca2b74a1668e4e379_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfNC03LTEtMS0xMTI2NDA_4a66d786-d1ee-486d-b3c1-5ac75418314e"
      unitRef="usd">135000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia4aee961123f4b77b2f7f7b245ce72b5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfNS0xLTEtMS0xMTI2NDA_76e222ad-2c1a-4086-b0be-d0eef6f344ba"
      unitRef="usd">63122000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9dc44c4cfaf6498b9f6dc3d014f4bdf8_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfNS0zLTEtMS0xMTI2NDA_b29a9dd1-6e13-46fa-a201-69d7e8fc925b"
      unitRef="usd">63122000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ie4de80e6e30c4350bd4abd2929927cf1_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfNS01LTEtMS0xMTI2NDA_45bab4d6-39c0-4213-83c1-df63b269bed9"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i1b0be75d14a440b5bcdb6664f17060fc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfNS03LTEtMS0xMTI2NDA_f812044e-ec3b-436b-9c5f-c5c2f1541a5a"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="icd4315ab1b654686b5cdda294406fe38_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfNi0xLTEtMS0xMTI2NDA_f416e5d3-77e6-4f41-bf83-a09467a2feca"
      unitRef="usd">166864000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i2dd090c573e94ca6a2ef574f8aca0f84_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfNi0zLTEtMS0xMTI2NDA_785d6c87-85b9-4c7b-a36a-b1e36f545dbf"
      unitRef="usd">67114000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="iaf74ed3f29894bbe89f67ce3f1638368_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfNi01LTEtMS0xMTI2NDA_9af74725-f311-42ba-ad09-3687ebd7a1a2"
      unitRef="usd">99615000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id273e2ab6d4d4d30bf4734bdb2617f06_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfNi03LTEtMS0xMTI2NDA_89a50ec2-5e80-4637-a816-f6c861746eec"
      unitRef="usd">135000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ia295c8d89c994fc1bfcfee13cdca48ce_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfOS0xLTEtMS0xMTI2NDA_2ea8d3a0-0ebd-4be8-bd65-41584323c700"
      unitRef="usd">84000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="if0f397fe74994049bf8a93a1ab577e34_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfOS0zLTEtMS0xMTI2NDA_f46f6aac-e5fd-47e7-a342-c8d9cd338434"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id5dcb4186e044e5882d93180a92f8279_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfOS01LTEtMS0xMTI2NDA_63a9bc4f-cfa2-42b0-a927-a895cff24d11"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i4dcc4622d787496ea953a0a254ba9e7c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfOS03LTEtMS0xMTI2NDA_14fa17f6-f817-4b19-869a-674e677c2721"
      unitRef="usd">84000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i5bab37c9b6cc4977ba02a28e26ed9ca5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfMTAtMS0xLTEtMTEyNjQw_9c043fe4-5af8-4028-856f-f26c8a99d098"
      unitRef="usd">3429000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id71f5699fd5b463690456b9be5c3a966_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfMTAtMy0xLTEtMTEyNjQw_159037c3-b758-4601-a7eb-ea27a6eb61c9"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i0b5b0d44ecc94db89ec934970defe064_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfMTAtNS0xLTEtMTEyNjQw_1f43c7d9-51e0-4221-b77e-abce562374d9"
      unitRef="usd">3429000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i8e56f08463f24218a5dd7f6e8d12a3dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfMTAtNy0xLTEtMTEyNjQw_3404dd36-2fd6-4d7a-91b8-b0ef8ababd88"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i849c3dacc5614e158a39923417210219_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfMTMtMS0xLTEtMTEyNjQw_6c9e9ebd-b53d-4ca9-b0eb-6143db5dd521"
      unitRef="usd">44000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i289ae7096dd54d348dbd227aaa42f5e8_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfMTMtMy0xLTEtMTEyNjQw_926c6acb-e368-4f8a-afc0-b8487d5f8022"
      unitRef="usd">44000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id323f390108741218d29588c00e4c8a0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfMTMtNS0xLTEtMTEyNjQw_709b560e-a9bf-4852-be91-2a931a7ade10"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i1f8fb2e550b84e4faf3a5b2a433bea1a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfMTMtNy0xLTEtMTEyNjQw_58a489f2-eaeb-449c-924d-f8e8830b27d6"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="icd4315ab1b654686b5cdda294406fe38_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfMTQtMS0xLTEtMTEyNjQw_892cff10-e5e8-43ac-82c7-d26e3d385589"
      unitRef="usd">3557000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i2dd090c573e94ca6a2ef574f8aca0f84_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfMTQtMy0xLTEtMTEyNjQw_c5f1daf8-24fc-4b0b-b0b3-3fe727ea557c"
      unitRef="usd">44000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="iaf74ed3f29894bbe89f67ce3f1638368_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfMTQtNS0xLTEtMTEyNjQw_19d87aba-d8fd-487c-8c7b-2212cf64a574"
      unitRef="usd">3429000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id273e2ab6d4d4d30bf4734bdb2617f06_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOmViYmQ4MDk1MTUyZjRjNDQ4ZThiNjFkODI5ZjQwODBmL3RhYmxlcmFuZ2U6ZWJiZDgwOTUxNTJmNGM0NDhlOGI2MWQ4MjlmNDA4MGZfMTQtNy0xLTEtMTEyNjQw_fbe9579f-cb13-43e7-bb1d-f85748c9ec6d"
      unitRef="usd">84000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="idb86b09115894c9fbb794f501b2d2dcf_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfNC0xLTEtMS0xMTI2NDA_fcf127d3-1284-44d1-893f-900d1a11cd69"
      unitRef="usd">290697000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5c67973b49304b2cbbb84811600c1663_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfNC0zLTEtMS0xMTI2NDA_f219e046-abea-4f0a-9ea6-980c85fb5ed5"
      unitRef="usd">9735000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i4fc3ae0a79b44517bb99fc381adc9058_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfNC01LTEtMS0xMTI2NDA_3a069c66-5ae9-42ea-a925-6ab3cff56cb6"
      unitRef="usd">280553000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i70302a79a5c24d0e881d281ae6cbe66b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfNC03LTEtMS0xMTI2NDA_fc065f67-5288-45b5-89f0-2de7a98afabf"
      unitRef="usd">409000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia7bd44fb046a40d79acd8b5094a6af2f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfNS0xLTEtMS0xMTI2NDA_2041d7bf-1860-43e6-9ec7-78dbdc5230fd"
      unitRef="usd">30889000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i057df6feb256427ebd16d5cfd07edad1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfNS0zLTEtMS0xMTI2NDA_8aef2933-418f-4aac-8f83-a33902b1c1ff"
      unitRef="usd">30889000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i8224f6e8d10e45e78c84ba1c9a2f97a2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfNS01LTEtMS0xMTI2NDA_00b033d6-0934-4c68-b7d8-b9c533463065"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5e70582ec04b46de89b0fe1f65dbc1e1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfNS03LTEtMS0xMTI2NDA_29d36b0b-e32c-44c0-9f8b-f62c24679631"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if16a34f8456e47dc9f5b67e39d4c9548_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfNy0xLTEtMS0xMTI2NDA_9a31d2c4-fa84-42c6-8421-f11607ad1509"
      unitRef="usd">321586000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i358f804697e94a7f8d741b250dbff084_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfNy0zLTEtMS0xMTI2NDA_753da735-d413-4a22-992d-dafa33edb94c"
      unitRef="usd">40624000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i89b5b12d4524461fb990aac54d517487_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfNy01LTEtMS0xMTI2NDA_c8ee5042-2118-4dfb-8100-71734ea6347f"
      unitRef="usd">280553000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i7421ded7a02748e5bd60df47f2093b9b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfNy03LTEtMS0xMTI2NDA_7603051a-4f49-4133-9e17-5a22d04bbc15"
      unitRef="usd">409000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ib1fb2de098654192b5935f2063f1a97a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfMTAtMS0xLTEtMTEyNjQw_05ee30a3-6f22-44d0-bba2-53bf009485b4"
      unitRef="usd">349000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i61cb7f2d12cc441e9bd457c78d89b1aa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfMTAtMy0xLTEtMTEyNjQw_7edab1e6-9eb4-49f7-bfb7-bb70685fc5b7"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i7678c8eb61e14518b6fb8be69a443a07_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfMTAtNS0xLTEtMTEyNjQw_e7010eaa-92d2-4f50-8941-11dbc4fc1201"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="icc472a6bccfc444c92220855618d517b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfMTAtNy0xLTEtMTEyNjQw_2852df41-397b-4302-9124-1701a4a6ec7d"
      unitRef="usd">349000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i85fd2713598b4a62a7669055f5df86b4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfMTEtMS0xLTEtMTEyNjQw_47855d0b-466b-4bd7-862a-f0f42d2d9443"
      unitRef="usd">3358000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ic4eab6a2ac394d7aba45f348a01f8201_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfMTEtMy0xLTEtMTEyNjQw_0a16d435-6efd-4b32-a2de-f41036dfeab8"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i08c9b0174a48479ea68f212652608932_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfMTEtNS0xLTEtMTEyNjQw_de5f6bdd-0eb8-4d19-8b7e-182f5ce199a8"
      unitRef="usd">3358000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ia5237f56ef074e7eb32dbcc66c6db515_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfMTEtNy0xLTEtMTEyNjQw_03b25624-ed61-4daa-8bad-75181bc4d3de"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i379ebe35361f4afc805f81c76a89b0c4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfMTQtMS0xLTEtMTEyNjQw_41dface8-3d66-436d-a6e1-50107b48c764"
      unitRef="usd">86000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i0a30b0e8302e45e3b5d48f2a7758a37e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfMTQtMy0xLTEtMTEyNjQw_88e9324e-f85a-4438-8f92-3b05a8bc9406"
      unitRef="usd">86000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="idd920ac870274bd29c5d3815db9bc027_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfMTQtNS0xLTEtMTEyNjQw_64cf69ba-fc11-486b-b4bc-4293807dd7a4"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="if01f6df650ee4787be25d17587903c8a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfMTQtNy0xLTEtMTEyNjQw_e132aba8-ceb8-4db1-852b-3ed9821ec107"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="if16a34f8456e47dc9f5b67e39d4c9548_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfMTUtMS0xLTEtMTEyNjQw_1186cc05-23f7-4281-a6c3-99102dfa8e24"
      unitRef="usd">3793000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i358f804697e94a7f8d741b250dbff084_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfMTUtMy0xLTEtMTEyNjQw_84f1770e-c958-42e0-991e-f5aa69326606"
      unitRef="usd">86000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i89b5b12d4524461fb990aac54d517487_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfMTUtNS0xLTEtMTEyNjQw_8eab5961-bf15-49f1-b3bb-3e1547538b5e"
      unitRef="usd">3358000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i430a03cc0e9c405e9df59a233c9bd258_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjU4ZGRlM2QzMTI3NDQ1NGQ4MzUxZDljNzczMTY2ZTc0L3RhYmxlcmFuZ2U6NThkZGUzZDMxMjc0NDU0ZDgzNTFkOWM3NzMxNjZlNzRfMTUtNy0xLTEtMTEyNjQw_8a27a413-640f-427a-8fae-73009f2d76dd"
      unitRef="usd">349000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <lgnd:NumberOfContingentValueRightAgreements
      contextRef="iefe06608d69a4810b5ef7844034e3616_I20100131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RleHRyZWdpb246MmQxYTM0MTYwZjNlNGU1ZTliNmNiODZkZTcxZDFkMzlfMzMyMQ_d7ffcdc3-350b-44b5-897e-bfab0ae85d4e"
      unitRef="agreement">4</lgnd:NumberOfContingentValueRightAgreements>
    <us-gaap:Investments
      contextRef="i800dff6c80e4444f9003b3ac53dd8573_I20100131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RleHRyZWdpb246MmQxYTM0MTYwZjNlNGU1ZTliNmNiODZkZTcxZDFkMzlfNDMwNA_2f5dd221-fc26-45c0-ada8-0f983efa5ffc"
      unitRef="usd">375000000</us-gaap:Investments>
    <us-gaap:ContractWithCustomerAssetGross
      contextRef="i21d27e0d975f4344a297876b55e27170_I20100131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RleHRyZWdpb246MmQxYTM0MTYwZjNlNGU1ZTliNmNiODZkZTcxZDFkMzlfNDQxOQ_f9eeff35-a029-4204-a615-35e504041e86"
      unitRef="usd">10000000</us-gaap:ContractWithCustomerAssetGross>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RleHRyZWdpb246MmQxYTM0MTYwZjNlNGU1ZTliNmNiODZkZTcxZDFkMzlfNzQ3Ng_156270e2-85a7-4731-81dd-b397172048e9">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the level 3 financial instruments as of December&#160;31, 2022 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:45pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustments to contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(265)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the level 3 financial instruments as of December&#160;31, 2021 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:45pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to CVR holders and other contingency payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustments to contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,708)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i430a03cc0e9c405e9df59a233c9bd258_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjc3ZmNmYTkwNGE5NzQ3MDM4NmYxZDBmNjM3NmVkNjljL3RhYmxlcmFuZ2U6NzdmY2ZhOTA0YTk3NDcwMzg2ZjFkMGY2Mzc2ZWQ2OWNfMS0xLTEtMS0xMjM3NjA_8a27a413-640f-427a-8fae-73009f2d76dd"
      unitRef="usd">349000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i80eaf9a4b47f4c988d4ed66997f6cdfc_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjc3ZmNmYTkwNGE5NzQ3MDM4NmYxZDBmNjM3NmVkNjljL3RhYmxlcmFuZ2U6NzdmY2ZhOTA0YTk3NDcwMzg2ZjFkMGY2Mzc2ZWQ2OWNfMy0xLTEtMS0xMjM3NjA_a7791ab1-8503-4cfd-b561-50bee6a53ff0"
      unitRef="usd">265000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i33228b6719394b3784c1b537e298a756_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjc3ZmNmYTkwNGE5NzQ3MDM4NmYxZDBmNjM3NmVkNjljL3RhYmxlcmFuZ2U6NzdmY2ZhOTA0YTk3NDcwMzg2ZjFkMGY2Mzc2ZWQ2OWNfMy0xLTEtMS0xMzU4MjI_0665a36b-e5a5-4a0b-9fb1-c5c472e8e5fc"
      unitRef="usd">84000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ib390d2fa586a4871b184b3ae93ef7a46_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjY2YjIyYjdhODZlNjQ5NTk4M2QzZWEwZjFmMzg1ZTk1L3RhYmxlcmFuZ2U6NjZiMjJiN2E4NmU2NDk1OTgzZDNlYTBmMWYzODVlOTVfMS0xLTEtMS0xMTI2NDA_c7b7687c-7f5b-4f68-b401-47b7815cbc44"
      unitRef="usd">38107000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <lgnd:PaymentsToContingentValueRightHolders
      contextRef="i749ac5b664db4f20af265ce3e3d5b538_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjY2YjIyYjdhODZlNjQ5NTk4M2QzZWEwZjFmMzg1ZTk1L3RhYmxlcmFuZ2U6NjZiMjJiN2E4NmU2NDk1OTgzZDNlYTBmMWYzODVlOTVfMi0xLTEtMS0xMTI2NDA_4fc663d8-ff82-4951-a92d-cf4fcb5039cd"
      unitRef="usd">50000</lgnd:PaymentsToContingentValueRightHolders>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i749ac5b664db4f20af265ce3e3d5b538_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjY2YjIyYjdhODZlNjQ5NTk4M2QzZWEwZjFmMzg1ZTk1L3RhYmxlcmFuZ2U6NjZiMjJiN2E4NmU2NDk1OTgzZDNlYTBmMWYzODVlOTVfMy0xLTEtMS0xMTI2NDA_97d16891-aa10-4ad1-8ca0-a217c6664c66"
      unitRef="usd">37708000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i430a03cc0e9c405e9df59a233c9bd258_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RhYmxlOjY2YjIyYjdhODZlNjQ5NTk4M2QzZWEwZjFmMzg1ZTk1L3RhYmxlcmFuZ2U6NjZiMjJiN2E4NmU2NDk1OTgzZDNlYTBmMWYzODVlOTVfNS0xLTEtMS0xMTI2NDA_98daec7b-0625-4d92-8c38-118b9f331c65"
      unitRef="usd">349000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:AssetImpairmentCharges
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV85Ny9mcmFnOjJkMWEzNDE2MGYzZTRlNWU5YjZjYjg2ZGU3MWQxZDM5L3RleHRyZWdpb246MmQxYTM0MTYwZjNlNGU1ZTliNmNiODZkZTcxZDFkMzlfNjU1OA_9dcde7ee-8ede-4ea6-bf9b-c4c981abb60b"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzQ1ODQ_b055d43a-7930-4edb-9761-01bc00310816">Leases&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Finance lease&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2020 and January 2021, we entered into an agreement and the first amendment with Hovione, our third-party manufacturer, to increase our manufacturing of Captisol, respectively. The agreements are considered to include an embedded finance lease under ASC 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as it provides the Company the right to use the underlying equipment to exclusively manufacture Captisol. As of December&#160;31, 2021, we have fully paid consideration of $69.1 million for prepaid inventory and capacity ramp-up fee. We allocated consideration in the agreements between lease and non-lease components using relative standalone prices. Since the inception of the agreements, we have allocated $50.2 million of the consideration paid to the non-lease component which is accounted for as prepaid inventory and being amortized to cost of Captisol based on the usage.  The remaining balance of $18.9 million was recognized as a right of use asset. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Given the current COVID status, our forecast for COVID-related Captisol has been significantly reduced, which triggered an indicator of impairment of the right of use asset as of December 31, 2022. We performed a recoverability test at the asset group level by comparing the sum of the estimated undiscounted future cash flows attributable to the asset group to its carrying value and identified the asset was impaired. We recorded a $9.8&#160;million of impairment charge based on the fair value of the right of use asset which has been recognized in cost of Captisol in our consolidated statement of operations for the year ended December&#160;31, 2022. As of December&#160;31, 2022 the remaining right of use asset balance is $4.0&#160;million which will be amortized straight-line over the remaining 6 years lease term. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Operating lease &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We lease certain office facilities and equipment primarily under various operating leases. Our operating leases have remaining contractual terms up to ten years, some of which include options to extend the leases for up to five years. Our lease agreements do not contain any material residual value guarantees, material restrictive covenants, or material termination options. Our operating lease costs are primarily related to facility leases for administration offices and research and development facilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate generally applicable to the location of the lease asset, unless the implicit rate is readily determinable. Lease assets also include any upfront lease payments made and lease incentives. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to base rent, certain of our operating leases require variable payments, such as insurance and common area maintenance. These variable lease costs, other than those dependent upon an index or rate, are expensed when the obligation for those payments is incurred. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The depreciable life of lease assets and leasehold improvements is limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Operating and Finance Lease Assets and Liabilities (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total lease assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzExLTAtMS0xLTExMjY0MA_a1a5fccc-ae24-4f80-98b2-5c22c6e04753"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzExLTAtMS0xLTExMjY0MA_f02bfdd2-8ed4-4dd1-a881-ebd664bece19"&gt;Long-term finance lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total lease liabilities   &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Maturity of Operating and Finance Lease Liabilities as of December&#160;31, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity Dates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,380)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, our operating leases have a weighted-average remaining lease term of 9.3 years and a weighted-average discount rate of 7.1%. As of December&#160;31, 2021, our operating leases have a weighted-average remaining lease term of 2.9 years and a weighted-average discount rate of 5.1%. Cash paid for amounts included in the measurement of operating lease liabilities was $1.7 million and $1.5 million for the twelve months ended December&#160;31, 2022 and 2021, respectively. Operating lease expense was $0.7 million (net of sublease income of $0.7 million) and $1.0 million (net of sublease income of $0.4 million) for the twelve months ended December&#160;31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;As of December&#160;31, 2022, our finance leases have a weighted-average remaining lease term of 1.1 years and a weighted-average discount rate of 4.1%. As of December&#160;31, 2021, our finance leases have a weighted-average remaining lease term of 2.1 years and a weighted-average discount rate of 4.1%. We excluded the Hovione equipment lease in the calculation of weighted average remaining lease term and weighted average discount rate because the Hovione lease was fully paid off as of December&#160;31, 2021. Cash paid for amounts included in the measurement of these finance lease liabilities was $0.05&#160;million and $9.3&#160;million for the twelve months ended December&#160;31, 2022 and 2021, respectively. Finance lease expense was $2.3 million and $2.3 million for the twelve months ended December&#160;31, 2022 and 2021, respectively.</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzQ1ODQ_f99bdfc1-2e89-472d-8476-2e8ac5ff19b2">Leases&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Finance lease&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2020 and January 2021, we entered into an agreement and the first amendment with Hovione, our third-party manufacturer, to increase our manufacturing of Captisol, respectively. The agreements are considered to include an embedded finance lease under ASC 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as it provides the Company the right to use the underlying equipment to exclusively manufacture Captisol. As of December&#160;31, 2021, we have fully paid consideration of $69.1 million for prepaid inventory and capacity ramp-up fee. We allocated consideration in the agreements between lease and non-lease components using relative standalone prices. Since the inception of the agreements, we have allocated $50.2 million of the consideration paid to the non-lease component which is accounted for as prepaid inventory and being amortized to cost of Captisol based on the usage.  The remaining balance of $18.9 million was recognized as a right of use asset. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Given the current COVID status, our forecast for COVID-related Captisol has been significantly reduced, which triggered an indicator of impairment of the right of use asset as of December 31, 2022. We performed a recoverability test at the asset group level by comparing the sum of the estimated undiscounted future cash flows attributable to the asset group to its carrying value and identified the asset was impaired. We recorded a $9.8&#160;million of impairment charge based on the fair value of the right of use asset which has been recognized in cost of Captisol in our consolidated statement of operations for the year ended December&#160;31, 2022. As of December&#160;31, 2022 the remaining right of use asset balance is $4.0&#160;million which will be amortized straight-line over the remaining 6 years lease term. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Operating lease &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We lease certain office facilities and equipment primarily under various operating leases. Our operating leases have remaining contractual terms up to ten years, some of which include options to extend the leases for up to five years. Our lease agreements do not contain any material residual value guarantees, material restrictive covenants, or material termination options. Our operating lease costs are primarily related to facility leases for administration offices and research and development facilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate generally applicable to the location of the lease asset, unless the implicit rate is readily determinable. Lease assets also include any upfront lease payments made and lease incentives. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to base rent, certain of our operating leases require variable payments, such as insurance and common area maintenance. These variable lease costs, other than those dependent upon an index or rate, are expensed when the obligation for those payments is incurred. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The depreciable life of lease assets and leasehold improvements is limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Operating and Finance Lease Assets and Liabilities (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total lease assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzExLTAtMS0xLTExMjY0MA_a1a5fccc-ae24-4f80-98b2-5c22c6e04753"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzExLTAtMS0xLTExMjY0MA_f02bfdd2-8ed4-4dd1-a881-ebd664bece19"&gt;Long-term finance lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total lease liabilities   &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Maturity of Operating and Finance Lease Liabilities as of December&#160;31, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity Dates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,380)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, our operating leases have a weighted-average remaining lease term of 9.3 years and a weighted-average discount rate of 7.1%. As of December&#160;31, 2021, our operating leases have a weighted-average remaining lease term of 2.9 years and a weighted-average discount rate of 5.1%. Cash paid for amounts included in the measurement of operating lease liabilities was $1.7 million and $1.5 million for the twelve months ended December&#160;31, 2022 and 2021, respectively. Operating lease expense was $0.7 million (net of sublease income of $0.7 million) and $1.0 million (net of sublease income of $0.4 million) for the twelve months ended December&#160;31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;As of December&#160;31, 2022, our finance leases have a weighted-average remaining lease term of 1.1 years and a weighted-average discount rate of 4.1%. As of December&#160;31, 2021, our finance leases have a weighted-average remaining lease term of 2.1 years and a weighted-average discount rate of 4.1%. We excluded the Hovione equipment lease in the calculation of weighted average remaining lease term and weighted average discount rate because the Hovione lease was fully paid off as of December&#160;31, 2021. Cash paid for amounts included in the measurement of these finance lease liabilities was $0.05&#160;million and $9.3&#160;million for the twelve months ended December&#160;31, 2022 and 2021, respectively. Finance lease expense was $2.3 million and $2.3 million for the twelve months ended December&#160;31, 2022 and 2021, respectively.</us-gaap:LesseeFinanceLeasesTextBlock>
    <lgnd:PurchaseCommitmentConsiderationPaidToDate
      contextRef="ic202f70f62e8428d9c78a4978a746eee_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzE2NDkyNjc0NjE0Mjk_f0726ffb-ec04-457d-9fcd-db897f80d9d9"
      unitRef="usd">69100000</lgnd:PurchaseCommitmentConsiderationPaidToDate>
    <lgnd:PurchaseCommitmentConsiderationPaidAllocatedToInventory
      contextRef="ic202f70f62e8428d9c78a4978a746eee_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzE2NDkyNjc0NjE0Mzc_6db8c0c8-02c4-49de-aa26-9b8832d21c46"
      unitRef="usd">50200000</lgnd:PurchaseCommitmentConsiderationPaidAllocatedToInventory>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i6747a650dc714496a27ce80ca1fde353_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzE2NDkyNjc0NjE0NDU_3c64ac78-f4df-470e-92ab-ba8fef9afb42"
      unitRef="usd">18900000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:FinanceLeaseImpairmentLoss
      contextRef="if07332e474464098b61af13fe5a470f2_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzU0OTc1NTgzMTIxNQ_22ae5aea-dc96-4586-bed1-e3afdba1236e"
      unitRef="usd">9800000</us-gaap:FinanceLeaseImpairmentLoss>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i0d685acb7be943ae8d15dc5799a4444a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzE2NDkyNjc0NDY1MTM_1467e055-18d3-4049-8d89-7cd573b7eebb"
      unitRef="usd">4000000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:LesseeFinanceLeaseRemainingLeaseTerm
      contextRef="i0d685acb7be943ae8d15dc5799a4444a_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzQ1ODU_d7dc61aa-e1ca-4ae0-babd-eeb285eb7abc">P6Y</us-gaap:LesseeFinanceLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm
      contextRef="i1566abca593746beacdf6a287d3c798c_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzEyMjE_d06eb8b0-7b57-4e29-bab8-e3b61e177491">P10Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i1566abca593746beacdf6a287d3c798c_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzEyODY_8003b402-f9f0-4896-9014-2002568a262d">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <lgnd:AssetsAndLiabilitiesLesseeTableTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzQ1ODY_df0d0770-8637-4586-b9c5-7164c5242204">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Operating and Finance Lease Assets and Liabilities (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total lease assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzExLTAtMS0xLTExMjY0MA_a1a5fccc-ae24-4f80-98b2-5c22c6e04753"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzExLTAtMS0xLTExMjY0MA_f02bfdd2-8ed4-4dd1-a881-ebd664bece19"&gt;Long-term finance lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total lease liabilities   &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.&lt;/span&gt;&lt;/div&gt;</lgnd:AssetsAndLiabilitiesLesseeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzItMS0xLTEtMTEyNjQw_ed2f4cc5-1bf2-4564-ab69-ab098933ade0"
      unitRef="usd">10914000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzItMy0xLTEtMTEyNjQw_09fefe12-65dd-4c0c-8969-ec337b201edb"
      unitRef="usd">3210000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzMtMS0xLTEtMTEyNjQw_ee31ba1d-a63a-4f9f-bb03-6bec80d75432"
      unitRef="usd">4095000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzMtMy0xLTEtMTEyNjQw_5511a4ba-3e2d-49cc-be20-6ae3d0cb95ac"
      unitRef="usd">16201000</us-gaap:FinanceLeaseRightOfUseAsset>
    <lgnd:LeaseRightOfUseAsset
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzQtMS0xLTEtMTEyNjQw_fb3ea923-be37-4806-a4ce-7146f31f8b85"
      unitRef="usd">15009000</lgnd:LeaseRightOfUseAsset>
    <lgnd:LeaseRightOfUseAsset
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzQtMy0xLTEtMTEyNjQw_ab2abf69-e356-406c-bce8-f52aaf22eef0"
      unitRef="usd">19411000</lgnd:LeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzctMS0xLTEtMTEyNjQw_64e9501b-f5e9-4879-94e7-467d8b73e497"
      unitRef="usd">670000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzctMy0xLTEtMTEyNjQw_cd92ea14-83f9-41af-ae5d-b60933b6d5c0"
      unitRef="usd">1368000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzgtMS0xLTEtMTEyNjQw_e088b548-4dc6-42c0-9cef-9fc9c325f7cd"
      unitRef="usd">45000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzgtMy0xLTEtMTEyNjQw_3e7b7987-de4f-40d5-aea0-50f2a2a98ac2"
      unitRef="usd">45000</us-gaap:FinanceLeaseLiabilityCurrent>
    <lgnd:LeaseLiabilityCurrent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzktMS0xLTEtMTEyNjQw_45cead86-2f96-4b6c-a816-6877cca290c7"
      unitRef="usd">715000</lgnd:LeaseLiabilityCurrent>
    <lgnd:LeaseLiabilityCurrent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzktMy0xLTEtMTEyNjQw_696f00a9-823b-4a70-a423-4dc40e503b4c"
      unitRef="usd">1413000</lgnd:LeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzEwLTEtMS0xLTExMjY0MA_40991ea0-ff98-4653-ab6e-da653e49f042"
      unitRef="usd">10336000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzEwLTMtMS0xLTExMjY0MA_0a7c524c-1751-45c4-bef0-a1c5b77e8c53"
      unitRef="usd">2256000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzExLTEtMS0xLTExMjY0MA_d93f0f68-86b3-4e86-96c6-35b25ae7e2b3"
      unitRef="usd">5000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzExLTMtMS0xLTExMjY0MA_6fcc7bdf-c4d2-4f98-9ff6-051ee28ddbc5"
      unitRef="usd">58000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <lgnd:LeaseLiability
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzEyLTEtMS0xLTExMjY0MA_696cb15f-1107-4060-982e-014a73b1164d"
      unitRef="usd">11056000</lgnd:LeaseLiability>
    <lgnd:LeaseLiability
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTowZjU0YzEzODJlMTU0Mzg3OTk2ZTlhOWFjNmRmOTAyZi90YWJsZXJhbmdlOjBmNTRjMTM4MmUxNTQzODc5OTZlOWE5YWM2ZGY5MDJmXzEyLTMtMS0xLTExMjY0MA_511e8427-b48f-4c70-a55b-6f9dad628664"
      unitRef="usd">3727000</lgnd:LeaseLiability>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzQ1ODc_9c1ea644-9793-41c1-9d35-6e71e2d2c5fe">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Maturity of Operating and Finance Lease Liabilities as of December&#160;31, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity Dates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,380)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzQ1ODc_c5f3a32f-2a0e-4b66-8a2c-57c01566ab6c">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Maturity of Operating and Finance Lease Liabilities as of December&#160;31, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity Dates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,380)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzEtMi0xLTEtMTEyNjQw_19e40ca6-5b15-47c7-92d5-fe32905df8b6"
      unitRef="usd">1425000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzEtNC0xLTEtMTEyNjQw_50eac388-4e46-4bb9-a2b4-277e90b66752"
      unitRef="usd">49000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzItMi0xLTEtMTEyNjQw_e4ea925a-d4c7-4180-8ae1-48132461fd1f"
      unitRef="usd">1483000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzItNC0xLTEtMTEyNjQw_8bccf52b-d683-4b06-aba6-4fde656aebd2"
      unitRef="usd">2000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzMtMi0xLTEtMTEyNjQw_affe4a93-b28a-4145-8aa2-828a77f8305f"
      unitRef="usd">1576000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzMtNC0xLTEtMTEyNjQw_f840e9fd-792b-4ebb-af29-7e6493aa0553"
      unitRef="usd">0</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzQtMi0xLTEtMTEyNjQw_69462e8d-267d-4f38-a13c-c3d6c76b5904"
      unitRef="usd">1621000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzQtNC0xLTEtMTEyNjQw_bf435384-3386-4ac5-b1db-59404d15f527"
      unitRef="usd">0</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzUtMi0xLTEtMTEyNjQw_f64c1324-4935-4f5d-9198-74a8d759f7ca"
      unitRef="usd">1667000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzUtNC0xLTEtMTEyNjQw_8d90a37c-3785-4771-a882-5f2020cadd97"
      unitRef="usd">0</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzYtMi0xLTEtMTEyNjQw_8b7a4c67-1c75-425c-a569-6b107199c6e6"
      unitRef="usd">7614000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzYtNC0xLTEtMTEyNjQw_58813d12-0961-4932-91e6-b7e882a8632f"
      unitRef="usd">0</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzctMi0xLTEtMTEyNjQw_dc584939-b9f9-4d94-90bd-19c1aa86c203"
      unitRef="usd">15386000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzctNC0xLTEtMTEyNjQw_2e82ee79-9da6-420a-b6ad-f6ad6c486547"
      unitRef="usd">51000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzktMi0xLTEtMTEyNjQw_2c49527f-df50-469c-9826-ff8fbeb4c5e0"
      unitRef="usd">4380000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzktNC0xLTEtMTEyNjQw_a1e4845a-e3c6-47b4-b5bc-aad7515b1b58"
      unitRef="usd">1000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzEwLTItMS0xLTExMjY0MA_f07f8db7-7b51-47ad-8d34-ddbdec00806e"
      unitRef="usd">11006000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90YWJsZTo3ZDkwMTkxMTc2ZGY0MDkxOGUyNzZjOGEwZDM1YjlmYy90YWJsZXJhbmdlOjdkOTAxOTExNzZkZjQwOTE4ZTI3NmM4YTBkMzViOWZjXzEwLTQtMS0xLTExMjY0MA_95a81cde-a77d-4d21-967a-538c09094689"
      unitRef="usd">50000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzE2NDkyNjc0NDcwNDM_ef935a25-882d-4610-8a8d-a05860d2ea8a">P9Y3M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzM3MjQ_3f87ce8b-2af5-4d16-b022-9e44d5ecbb04"
      unitRef="number">0.071</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzM4MDc_2840368d-d70e-40f7-b3dc-0141e191d6d7">P2Y10M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzM4NTA_d3755863-78f4-4726-b975-37eb742d43a0"
      unitRef="number">0.051</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeasePayments
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzM5Mzk_4c06c8bc-a9df-41b0-b045-3696329de706"
      unitRef="usd">1700000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzE2NDkyNjc0NTkxNDQ_dab98211-c84c-4114-b821-334428f9e526"
      unitRef="usd">1500000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseExpense
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzQwMTU_179285df-9956-48bd-b37a-94082d7e11f8"
      unitRef="usd">700000</us-gaap:OperatingLeaseExpense>
    <us-gaap:SubleaseIncome
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzQwNDU_228fa617-d043-4f6b-bf12-ea369530daa4"
      unitRef="usd">700000</us-gaap:SubleaseIncome>
    <us-gaap:OperatingLeaseExpense
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzQwNTM_0f280dfa-005d-4a87-96d7-10e05b3f4ab1"
      unitRef="usd">1000000</us-gaap:OperatingLeaseExpense>
    <us-gaap:SubleaseIncome
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzQwODM_0b37ef42-aacc-42ca-9c7c-5e29de7eca23"
      unitRef="usd">400000</us-gaap:SubleaseIncome>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzQyMDM_d9d10e9c-ee18-4798-ac14-1044751a680b">P1Y1M6D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzQyNDY_cd978f6b-f3b7-490a-b2ac-65cd1b2d05cb"
      unitRef="number">0.041</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzQzMjc_a30d6103-cdb2-4356-b63b-91490fe19071">P2Y1M6D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzQzNzA_c6effec0-fdcc-4099-81b1-2ba11928aa8e"
      unitRef="number">0.041</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzQ0NjM_b265d684-9bdf-46d0-9578-9949fe49c0e2"
      unitRef="usd">50000.00</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzE2NDkyNjc0NTk1NjQ_380315c3-c0c2-4ecc-9267-5bbd648068a6"
      unitRef="usd">9300000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzQ1Mzc_f417e119-f88c-4267-91eb-4be4982b463e"
      unitRef="usd">2300000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDAvZnJhZzpiMGIwMTZmY2RlMTk0OGIzOGJhYzc2MGRmZGZmNDZjMy90ZXh0cmVnaW9uOmIwYjAxNmZjZGUxOTQ4YjM4YmFjNzYwZGZkZmY0NmMzXzE2NDkyNjc0NTk1NzQ_5be4042d-a458-498a-a50c-ff5b5c48ed25"
      unitRef="usd">2300000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzE1ODYw_934f6bc8-b728-4ba7-867d-28c520c0b5d8">Convertible Senior Notes&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;0.75% Convertible Senior Notes due 2023&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2018, we issued $750 million aggregate principal amount of 2023 Notes, bearing cash interest at a rate of 0.75% per year, payable semi-annually. The net proceeds from the offering, after deducting the initial purchasers' discount and offering expenses, were approximately $733.1 million. The 2023 Notes will be convertible into cash, shares of common stock, or a combination of cash and shares of common stock, at our election, based on a conversion rate as discussed below. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of the 2023 Notes were entitled to convert the notes at any time prior to the close of business on the business day immediately preceding November 15, 2022, under any of the following circumstances:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) during any fiscal quarter (and only during such fiscal quarter) commencing after September 30, 2018, if, for at least 20 trading days (whether or not consecutive) during the 30 consecutive trading day period ending on the last trading day of the immediately preceding fiscal quarter, the last reported sale price of our common stock on such trading day was greater than 130% of the conversion price on such trading day;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2) during the five business day period immediately following any 10 consecutive trading day period, in which the trading price per $1,000 principal amount of notes was less than 98% of the product of the last reported sale price of our common stock on such trading day and the conversion rate on each such trading day; or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3) upon the occurrence of certain specified corporate events as specified in the indenture governing the notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In advance of the Distribution of the shares of common stock of OmniAb to Ligand&#x2019;s shareholders on November 1, 2022, a notice of convertibility was delivered to the holders of the 2023 Notes. No holders exercised their right to convert their 2023 Notes during the applicable period for conversion. After we completed the Separation of the OmniAb Business, on November&#160;15, 2022, the conversion rate was adjusted to 4.8390 shares of common stock per $1,000 principal amount of the 2023 Notes which represents a conversion price of approximately&#160;$206.65 per share. The maximum conversion rate of the 2023 Notes was adjusted to 6.2907 per $1,000 principal amount of the 2023 Notes which represents a conversion price of approximately $158.97.  The conversion rate for the 2023 Notes was adjusted in accordance with the requirements of the Indenture based on calculations determined with reference to a valuation period of the first 10 consecutive trading days after, and including, the ex-dividend date of the spin-off (as determined in the Indenture). The conversion rate and maximum conversion rate are subject to further adjustment under the circumstances and pursuant to the terms set forth in the Indenture.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The notes will have a dilutive effect to the extent the average market price per share of common stock for a given reporting period exceeds the current conversion price of $206.65. In connection with the issuance of the 2023 Notes, we incurred $16.9 million of issuance costs, which primarily consisted of underwriting, legal and other professional fees. The portion of these costs allocated to the liability component totaling $13.7 million is amortized to interest expense using the effective interest method over the five years expected life of the 2023 Notes, and the effective interest rate as of December 31, 2022 is 0.5%. During the year ended December 31, 2022 we recognized a total of $1.8 million in interest expense which includes $1.1 million in contractual interest expense and $0.7 million in amortized issuance costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2021, we repurchased $152.0&#160;million in principal of the 2023 Notes for $156.0&#160;million in cash, including accrued interest of $0.3&#160;million. We accounted for the repurchase as a debt extinguishment, which resulted in (1) a loss of $7.3&#160;million reflected in other income (expense), net, in our consolidated statement of operations for the year ended December&#160;31, 2021, (2) a $13.7&#160;million reduction in debt discount, and (3) a $10.2&#160;million reduction to additional paid in capital, related to the reacquisition of the equity component in our consolidated balance sheet as of December&#160;31, 2021. After the repurchases, approximately $343.3 million in principal amount of the 2023 Notes remain outstanding. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2022, we repurchased $266.4 million in principal amount of the 2023 Notes for $261.4 million in cash, including accrued interest of $0.5 million We accounted for the repurchase as a debt extinguishment, which resulted in a gain of $4.2 million reflected in other income (expense), net, in our consolidated statement of operations for the year ended December 31, 2022, and a $1.3 million reduction in debt discount. After the repurchases, approximately $76.9 million in principal amount of the 2023 Notes remain outstanding. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Convertible Bond Hedge and Warrant Transactions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In conjunction with the 2023 Notes, in May 2018, we entered into convertible bond hedges and sold warrants covering 3,018,327 shares of our common stock to minimize the impact of potential dilution to our common stock and/or offset the cash payments we are required to make in excess of the principal amount upon conversion of the 2023 Notes. The convertible bond hedges have an exercise price of $206.65 per share and are exercisable when and if the 2023 Notes are converted. We paid $140.3 million for these convertible bond hedges. If upon conversion of the 2023 Notes, the price of our common stock is above the exercise price of the convertible bond hedges, the counterparties will deliver shares of common stock and/or cash with an aggregate value approximately equal to the difference between the price of common stock at the conversion date and the exercise price, multiplied by the number of shares of common stock related to the convertible bond hedge transaction being exercised. The convertible bond hedges and warrants described below are separate transactions entered into by us and are not part of the terms of the 2023 Notes. Holders of the 2023 Notes and warrants will not have any rights with respect to the convertible bond hedges.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Concurrently with the convertible bond hedge transactions, we entered into warrant transactions whereby we sold warrants covering 3,018,327 shares of common stock with an exercise price of $315.38 per share, subject to certain adjustments. We received $90.0 million for these warrants. The warrants have various expiration dates ranging from August 15, 2023 to February 6, 2024. The warrants will have a dilutive effect to the extent the market price per share of common stock exceeds the applicable exercise price of the warrants, as measured under the terms of the warrant transactions. The common stock issuable upon exercise of the warrants will be in unregistered shares, and we do not have the obligation and do not intend to file any registration statement with the SEC registering the issuance of the shares under the warrants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2020, in connection with the repurchases of $234.4&#160;million in principal of the 2023 Notes for $203.8&#160;million in cash, including accrued interest of $0.6&#160;million, during the quarter ended March 31, 2020, we entered into amendments with Barclays Bank PLC, Deutsche Bank AG, London Branch, and Goldman Sachs &amp;amp; Co. LLC to the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. The amendments provide that the options under the convertible note hedges corresponding to such repurchased 2023 Notes will remain outstanding notwithstanding such repurchase.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, in connection with the repurchases of approximately $20.3&#160;million in principal of the 2023 Notes for approximately $19.1&#160;million in cash, including accrued interest of $0.1&#160;million, during the quarter ended December 31, 2020, we entered into amendments with Barclays Bank PLC, Deutsche Bank AG, London Branch, and Goldman Sachs &amp;amp; Co. LLC to the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. The amendments provide that the options under the convertible note hedges corresponding to such repurchased 2023 Notes will remain outstanding notwithstanding such repurchase.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2021, in connection with the repurchases of $152.0&#160;million in principal of the 2023 Notes for $156.0&#160;million in cash, including accrued interest of $0.3&#160;million, we entered into Warrant Early Unwind Agreements and Bond Hedge Unwind Agreements with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp;amp; Co. LLC to unwind a portion of the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. We paid $18.4&#160;million as part of the Warrant Early Unwind Agreements reducing the number of shares covered by the warrants from 3,018,327 to 2,559,254. We received $18.9&#160;million as part of the Bond Hedge Early Unwind Agreements reducing the number of options under the convertible bond hedges to 598,021. These unwind transactions resulted in a $0.5&#160;million net increase in additional paid-in-capital in our consolidated balance sheet as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2022, in connection with the repurchases of $227.8&#160;million in principal of the 2023 Notes for $223.7&#160;million in cash, including accrued interest of $0.4&#160;million made during the six months ended June 30, 2022, we entered into Bond Hedge Unwind Agreements with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp;amp; Co. LLC to unwind a portion of the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. We received $0.2&#160;million as part of these Bond Hedge Early Unwind Agreements reducing the number of options under the convertible bond hedges to 370,219 as of December&#160;31, 2022. This transaction resulted in a $0.2&#160;million net increase in additional paid-in-capital in our consolidated balance sheet as of December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes information about the equity and liability components of the 2023 Notes (in thousands).&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal amount of 2023 Notes outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized discount (including unamortized debt issuance cost)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total long-term portion of notes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of convertible senior notes outstanding (Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, there were no events of default or violation of any covenants under our financing obligations.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic8ae4ee0f64a46979ca5a2c15da782e7_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzU0OTc1NTg1MjUwOA_fadfe2bd-2b94-4c98-85f0-a993a795fc4c"
      unitRef="number">0.0075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ic8ae4ee0f64a46979ca5a2c15da782e7_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4Xzc3MDE_e20e13e5-57a7-4a49-8d1e-8c57d7421b9a"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic8ae4ee0f64a46979ca5a2c15da782e7_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4Xzc3ODE_fadfe2bd-2b94-4c98-85f0-a993a795fc4c"
      unitRef="number">0.0075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="i8ae5acdc120c4e40981302a07b8d28a6_D20180501-20180531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4Xzc5NDQ_9fb12907-bfc8-48de-a163-ef4737135684"
      unitRef="usd">733100000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i11b50fd2d77b498e82f14c8ee21dcc5c_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4Xzg1OTc_109b2442-ffc7-45da-97a4-f008b6537274"
      unitRef="trading_day">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i11b50fd2d77b498e82f14c8ee21dcc5c_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4Xzg2NTM_7599b168-a84e-4213-ba18-6682d1a73a3a"
      unitRef="trading_day">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i11b50fd2d77b498e82f14c8ee21dcc5c_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4Xzg4NDg_817b7747-7be1-4f21-a010-6a7d3a6e6425"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i2a146d0761cc415ba2c40a2459586b06_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4Xzg5MTI_5de19ef7-21eb-49d0-856e-64bb24785127"
      unitRef="trading_day">5</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i2a146d0761cc415ba2c40a2459586b06_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4Xzg5NjE_699dea30-513d-48af-80d7-88d627d872f0"
      unitRef="trading_day">10</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <lgnd:DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger
      contextRef="i2a146d0761cc415ba2c40a2459586b06_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzkwNzQ_3ad7180e-f47c-4a30-abff-15daacb2da26"
      unitRef="number">0.98</lgnd:DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="ic8ae4ee0f64a46979ca5a2c15da782e7_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzEwOTk1MTE2NTk0NTM_9403ba6b-231b-4e7b-a5be-9470d92498bb"
      unitRef="usdPerShare">206.65</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="ic965f5b4e009491284f786378035d4e1_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzU0OTc1NTg1MjQyMA_936b8314-2a4a-476f-aeb3-9ca6107a7232"
      unitRef="usdPerShare">158.97</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i2a146d0761cc415ba2c40a2459586b06_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzU0OTc1NTgzMjI0MQ_740031ff-548f-44d0-b6b3-13fc1f5c747d"
      unitRef="trading_day">10</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="ic8ae4ee0f64a46979ca5a2c15da782e7_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4Xzk0OTY_9403ba6b-231b-4e7b-a5be-9470d92498bb"
      unitRef="usdPerShare">206.65</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="ic8ae4ee0f64a46979ca5a2c15da782e7_I20180531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4Xzk2NTQ_d2ec8951-34c6-4d9d-99c2-f451f9a5d985"
      unitRef="usd">16900000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="ic8ae4ee0f64a46979ca5a2c15da782e7_I20180531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4Xzk4Mjc_7b8e6619-d3e5-46c6-b3c2-a1b9fa436697"
      unitRef="usd">13700000</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1
      contextRef="ia361a8f8b6774d9f9e3b2a48a102ecb8_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzE2NDkyNjc0ODE2MzU_494d61a5-aeff-4b35-9ea8-32baf860c274">P5Y</us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i3316b5508b924ffc8fd7ec36b3aa455e_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzE2NDkyNjc0ODE1Nzg_dd6a4582-7c4e-4d31-83b9-ff60f495eed3"
      unitRef="number">0.005</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:InterestExpenseDebt
      contextRef="ia361a8f8b6774d9f9e3b2a48a102ecb8_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzU0OTc1NTg1MjMyMw_858aa7bb-98f4-4d44-8f81-796de4fe493f"
      unitRef="usd">1800000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="ia361a8f8b6774d9f9e3b2a48a102ecb8_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzU0OTc1NTg1MjM1OA_21da1c25-fa07-4d9a-a43d-6fe6815fd968"
      unitRef="usd">1100000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="ia361a8f8b6774d9f9e3b2a48a102ecb8_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzU0OTc1NTg1MjM2Nw_3c715847-9917-4c31-8ffa-edc11dc7b502"
      unitRef="usd">700000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="id1dd1d35129f4cd39fb80e6800cfe252_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzEwNzU3_0ce97b15-3028-42b4-86a6-139f607a0889"
      unitRef="usd">152000000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="ia99cec91b0284a4090f6d9399292f293_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzEwNzk1_6dbeaee5-790f-4bfe-b700-2075e944c29a"
      unitRef="usd">156000000</us-gaap:RepaymentsOfNotesPayable>
    <lgnd:RepaymentsOfNotesPayableInterestPortion
      contextRef="ia99cec91b0284a4090f6d9399292f293_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzEwODM3_2c1e8a61-9c45-4e88-a8c3-e08fec1c4fb9"
      unitRef="usd">300000</lgnd:RepaymentsOfNotesPayableInterestPortion>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ia99cec91b0284a4090f6d9399292f293_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzEwOTMx_465ef6c4-6b39-4ce4-b438-51b74e3b35d3"
      unitRef="usd">-7300000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <lgnd:IncreaseDecreaseInDebtDiscount
      contextRef="ia99cec91b0284a4090f6d9399292f293_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzExMDUw_78d3351e-f469-44f3-a7cc-8ce921db8b03"
      unitRef="usd">-13700000</lgnd:IncreaseDecreaseInDebtDiscount>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="ia99cec91b0284a4090f6d9399292f293_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzExMDkx_814f80fc-39d4-43cf-9b01-d75559753452"
      unitRef="usd">-10200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id1dd1d35129f4cd39fb80e6800cfe252_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzExMjkx_65697dc1-a901-4b93-8f4b-9895182f173e"
      unitRef="usd">343300000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="i3316b5508b924ffc8fd7ec36b3aa455e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzU0OTc1NTg0ODgyOA_e55ed531-9f24-4682-a4b9-5e4579a4d5a1"
      unitRef="usd">266400000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="ia361a8f8b6774d9f9e3b2a48a102ecb8_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzU0OTc1NTg0ODc1OQ_2e49609d-4ccf-4b49-8d79-abd64cf61f9d"
      unitRef="usd">261400000</us-gaap:RepaymentsOfNotesPayable>
    <lgnd:RepaymentsOfNotesPayableInterestPortion
      contextRef="ia361a8f8b6774d9f9e3b2a48a102ecb8_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzU0OTc1NTg0ODc0MQ_d08f2062-fc06-40b8-9a4b-c87afd5a29c6"
      unitRef="usd">500000</lgnd:RepaymentsOfNotesPayableInterestPortion>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ia361a8f8b6774d9f9e3b2a48a102ecb8_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzU0OTc1NTg0ODc3OA_b74da5c0-475d-4101-891f-e3e4963ded8c"
      unitRef="usd">4200000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <lgnd:IncreaseDecreaseInDebtDiscount
      contextRef="ia361a8f8b6774d9f9e3b2a48a102ecb8_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzU0OTc1NTg0ODc5Mw_5e064d78-7ad5-4fc2-ae7f-b19e84b9f2f3"
      unitRef="usd">-1300000</lgnd:IncreaseDecreaseInDebtDiscount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3316b5508b924ffc8fd7ec36b3aa455e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzE2NDkyNjc0ODU1NzA_f94b99bf-7840-4aaf-8aa1-116e7882b778"
      unitRef="usd">76900000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="ic8ae4ee0f64a46979ca5a2c15da782e7_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzExNjQy_a4e40323-1ac4-4b81-9a47-b0a8ca361628"
      unitRef="shares">3018327</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="ic8ae4ee0f64a46979ca5a2c15da782e7_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzExOTE2_6708e02a-0eef-4c94-95a3-30b5ba4154e2"
      unitRef="usdPerShare">206.65</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <lgnd:PaymentsforConvertibleBondHedges
      contextRef="i8ae5acdc120c4e40981302a07b8d28a6_D20180501-20180531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzExOTk5_b7cfed6b-248d-4549-92d7-f7e8ff069490"
      unitRef="usd">140300000</lgnd:PaymentsforConvertibleBondHedges>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="ic8ae4ee0f64a46979ca5a2c15da782e7_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzEyODg0_dea8e3a2-fd34-4bd0-8950-a2c2f74ea5c2"
      unitRef="shares">3018327</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="ic8ae4ee0f64a46979ca5a2c15da782e7_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzEyOTM2_8af40687-9a6a-448f-917e-c166d718b710"
      unitRef="usdPerShare">315.38</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="i8ae5acdc120c4e40981302a07b8d28a6_D20180501-20180531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzEyOTk0_88dfd941-5869-4714-a574-18d4f0162e0a"
      unitRef="usd">90000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="ibbe666f5347841329bf2326c9232e329_I20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzEzNjIx_cbb7a820-e180-44ac-86ee-3560c0551ea9"
      unitRef="usd">234400000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="ibf823eb4d59c42a0a2bc0d1990fa4bc0_D20200401-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzEzNjU5_485c4fc5-aff6-4c3c-8c90-714071074594"
      unitRef="usd">203800000</us-gaap:RepaymentsOfNotesPayable>
    <lgnd:RepaymentsOfNotesPayableInterestPortion
      contextRef="ibf823eb4d59c42a0a2bc0d1990fa4bc0_D20200401-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzEzNzAx_79f9126b-c7cb-4f5e-a7c5-9e19e011af6c"
      unitRef="usd">600000</lgnd:RepaymentsOfNotesPayableInterestPortion>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="i0c628cd07ad342459335204c06df1ef0_I20210131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzE0MjI1_8e873dd8-c66b-49b8-95a1-1515213d7eeb"
      unitRef="usd">20300000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="i111b05d5f55a49a8811a99582e5b230b_D20210101-20210131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzE0Mjc3_458470b4-b4ac-41ff-977d-0d2916485986"
      unitRef="usd">19100000</us-gaap:RepaymentsOfNotesPayable>
    <lgnd:RepaymentsOfNotesPayableInterestPortion
      contextRef="i111b05d5f55a49a8811a99582e5b230b_D20210101-20210131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzE0MzE5_51318282-cf46-4b9f-872a-7e3d3787fc43"
      unitRef="usd">100000</lgnd:RepaymentsOfNotesPayableInterestPortion>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="id1dd1d35129f4cd39fb80e6800cfe252_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzE0ODU2_0ce97b15-3028-42b4-86a6-139f607a0889"
      unitRef="usd">152000000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="ia99cec91b0284a4090f6d9399292f293_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzE0ODk0_6dbeaee5-790f-4bfe-b700-2075e944c29a"
      unitRef="usd">156000000</us-gaap:RepaymentsOfNotesPayable>
    <lgnd:RepaymentsOfNotesPayableInterestPortion
      contextRef="ia99cec91b0284a4090f6d9399292f293_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzE0OTM2_2c1e8a61-9c45-4e88-a8c3-e08fec1c4fb9"
      unitRef="usd">300000</lgnd:RepaymentsOfNotesPayableInterestPortion>
    <lgnd:PaymentsToUnwindWarrants
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzE1MjQw_5a93e3b2-f33f-446a-af4d-b45433df467e"
      unitRef="usd">18400000</lgnd:PaymentsToUnwindWarrants>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="ic8ae4ee0f64a46979ca5a2c15da782e7_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzE1MzQ5_dea8e3a2-fd34-4bd0-8950-a2c2f74ea5c2"
      unitRef="shares">3018327</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="id1dd1d35129f4cd39fb80e6800cfe252_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzE1MzU1_a75510d4-520f-4b12-a3fb-aad55a904f1b"
      unitRef="shares">2559254</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <lgnd:ProceedsFromUnwindingConvertibleBondHedges
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzE1Mzcx_eba60ae5-2a2e-41d7-a16a-60d5a1cc55b8"
      unitRef="usd">18900000</lgnd:ProceedsFromUnwindingConvertibleBondHedges>
    <lgnd:NumberOfOptionsUnderConvertibleBondHedges
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzE1NDky_22a05259-90d0-4130-911e-15c3d7cca8b2"
      unitRef="option">598021</lgnd:NumberOfOptionsUnderConvertibleBondHedges>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzE1NTM2_d1f680d9-cf4c-4093-a0a3-81f05a1ef72a"
      unitRef="usd">500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <lgnd:DebtInstrumentRepurchasedAmountDuringPeriod
      contextRef="i58d85fd3024241a592f18e215570d51a_D20220801-20220831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzU0OTc1NTg1MjEzMA_f034b74b-f218-4b18-af4d-5531bd2a38d0"
      unitRef="usd">227800000</lgnd:DebtInstrumentRepurchasedAmountDuringPeriod>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="i58d85fd3024241a592f18e215570d51a_D20220801-20220831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzU0OTc1NTg1MjE0MA_041356c1-f09f-4ece-9c2d-ec1fd5590325"
      unitRef="usd">223700000</us-gaap:RepaymentsOfNotesPayable>
    <lgnd:RepaymentsOfNotesPayableInterestPortion
      contextRef="i54f5a452c3934a41b9d24ab5e96cffaf_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzU0OTc1NTg1MjE2NA_db109e4b-f510-4d5b-a346-9bd3c3696f40"
      unitRef="usd">400000</lgnd:RepaymentsOfNotesPayableInterestPortion>
    <lgnd:ProceedsFromUnwindingConvertibleBondHedges
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzU0OTc1NTg1MjE4MA_acea1611-a0ea-4084-b95c-4bcc89b17ac8"
      unitRef="usd">200000</lgnd:ProceedsFromUnwindingConvertibleBondHedges>
    <lgnd:NumberOfOptionsUnderConvertibleBondHedges
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzU0OTc1NTg1MjE5Mw_6e6db05c-8929-42ad-8723-95163480c65a"
      unitRef="option">370219</lgnd:NumberOfOptionsUnderConvertibleBondHedges>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzU0OTc1NTg1MjIzNg_4e9433f7-148b-494b-b715-50bc7c51d2c6"
      unitRef="usd">200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90ZXh0cmVnaW9uOmI2M2U3Zjk5YTM3ODQxOTBhM2NjM2Y0NzFkNzFlZGU4XzE1ODYz_93846cef-6dc5-4f1e-bb40-d63fd996c378">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes information about the equity and liability components of the 2023 Notes (in thousands).&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal amount of 2023 Notes outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized discount (including unamortized debt issuance cost)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total long-term portion of notes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of convertible senior notes outstanding (Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i3316b5508b924ffc8fd7ec36b3aa455e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90YWJsZToxZGUwMTBiYTliNTM0ODlmYTJlMGI0YWE0YjNjOTIyNC90YWJsZXJhbmdlOjFkZTAxMGJhOWI1MzQ4OWZhMmUwYjRhYTRiM2M5MjI0XzEtMS0xLTEtMTEyNjQw_afa79b0d-1817-4b30-b189-99231477433a"
      unitRef="usd">76854000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id1dd1d35129f4cd39fb80e6800cfe252_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90YWJsZToxZGUwMTBiYTliNTM0ODlmYTJlMGI0YWE0YjNjOTIyNC90YWJsZXJhbmdlOjFkZTAxMGJhOWI1MzQ4OWZhMmUwYjRhYTRiM2M5MjI0XzEtMy0xLTEtMTEyNjQw_b4397df8-7c96-465e-b9bd-169ed0f14ea6"
      unitRef="usd">343301000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i3316b5508b924ffc8fd7ec36b3aa455e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90YWJsZToxZGUwMTBiYTliNTM0ODlmYTJlMGI0YWE0YjNjOTIyNC90YWJsZXJhbmdlOjFkZTAxMGJhOWI1MzQ4OWZhMmUwYjRhYTRiM2M5MjI0XzItMS0xLTEtMTEyNjQw_6f612d2f-0e5c-47c4-8e4c-7634a68b0081"
      unitRef="usd">159000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="id1dd1d35129f4cd39fb80e6800cfe252_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90YWJsZToxZGUwMTBiYTliNTM0ODlmYTJlMGI0YWE0YjNjOTIyNC90YWJsZXJhbmdlOjFkZTAxMGJhOWI1MzQ4OWZhMmUwYjRhYTRiM2M5MjI0XzItMy0xLTEtMTEyNjQw_8f2f7638-4e41-47bc-b806-81e2823d4f43"
      unitRef="usd">22584000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermNotesPayable
      contextRef="i3316b5508b924ffc8fd7ec36b3aa455e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90YWJsZToxZGUwMTBiYTliNTM0ODlmYTJlMGI0YWE0YjNjOTIyNC90YWJsZXJhbmdlOjFkZTAxMGJhOWI1MzQ4OWZhMmUwYjRhYTRiM2M5MjI0XzMtMS0xLTEtMTEyNjQw_d2b65d89-c528-4563-9fe5-a49b8f702974"
      unitRef="usd">76695000</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermNotesPayable
      contextRef="id1dd1d35129f4cd39fb80e6800cfe252_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90YWJsZToxZGUwMTBiYTliNTM0ODlmYTJlMGI0YWE0YjNjOTIyNC90YWJsZXJhbmdlOjFkZTAxMGJhOWI1MzQ4OWZhMmUwYjRhYTRiM2M5MjI0XzMtMy0xLTEtMTEyNjQw_d75d3961-fdc4-46b3-ad89-3f455931f713"
      unitRef="usd">320717000</us-gaap:LongTermNotesPayable>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="i3316b5508b924ffc8fd7ec36b3aa455e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90YWJsZToxZGUwMTBiYTliNTM0ODlmYTJlMGI0YWE0YjNjOTIyNC90YWJsZXJhbmdlOjFkZTAxMGJhOWI1MzQ4OWZhMmUwYjRhYTRiM2M5MjI0XzUtMS0xLTEtMTEyNjQw_0bcadc67-3f69-4dca-8969-62026f77dc29"
      unitRef="usd">74789000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="id1dd1d35129f4cd39fb80e6800cfe252_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDMvZnJhZzpiNjNlN2Y5OWEzNzg0MTkwYTNjYzNmNDcxZDcxZWRlOC90YWJsZToxZGUwMTBiYTliNTM0ODlmYTJlMGI0YWE0YjNjOTIyNC90YWJsZXJhbmdlOjFkZTAxMGJhOWI1MzQ4OWZhMmUwYjRhYTRiM2M5MjI0XzUtMy0xLTEtMTEyNjQw_a9218bd7-45b6-450f-bb23-27d8228428a2"
      unitRef="usd">341801000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzM3NjI_638abb43-8804-4929-a92a-ada1abe3938f">Balance Sheet Account Details&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Short-term Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Excluding our investments in Viking, the following table summarizes the various investment categories at December&#160;31, 2022 and 2021 (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;gains&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;losses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;fair value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mutual Funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1050)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,239)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,451)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Mutual fund&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Commercial paper  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,027)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,370)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gain (loss) from short-term investments on our consolidated statements of operations includes both realized and unrealized gain (loss) from our short-term investments in public equity and warrant securities, and realized gain (loss) from available-for-sale debt securities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our available-for-sale debt securities in an unrealized loss position (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12 months or greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Government Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Government Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our investment policy is capital preservation and we only invested in U.S.-dollar denominated investments. We held a total of 12 positions which were in an unrealized loss position as of December&#160;31, 2022. We believe that we will collect the principal and interest due on our debt securities that have an amortized cost in excess of fair value. The unrealized losses are largely due to changes in interest rates and not to unfavorable changes in the credit quality associated with these securities that impacted our assessment on collectability of principal and interest. We do not intend to sell these securities nor do we believe that we will be required to sell these securities before the recovery of the amortized cost basis. Accordingly, no credit losses were recognized for the twelve months ended December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and equipment are stated at cost and consists of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lab and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation of equipment is computed using the straight-line method over the estimated useful lives of the assets which ranges from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzE3MDc_277b8799-ffa7-4ac8-873b-e1ce3c67cce8"&gt;three&lt;/span&gt; to ten years. Leasehold improvements are amortized using the straight-line method over their estimated useful lives or their related lease term, whichever is shorter. Depreciation expense of $3.8 million, $2.4 million, and $1.5 million was recognized for the twelve months ended December&#160;31, 2022, 2021, and 2020, respectively, and was included in operating expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill and identifiable intangible assets consist of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Definite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Complete technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,560)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,916)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,577)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,444)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,670)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Contractual relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65,191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total goodwill and other identifiable intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;448,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;482,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of finite-lived intangible assets is computed using the straight-line method over the estimated useful life of the asset of up to 20 years. Amortization expense of $34.2 million, $34.2 million, and $11.6 million was recognized for the years ended December&#160;31, 2022, 2021, and 2020, respectively. Estimated amortization expense for the years ending December&#160;31, 2023 through 2027 is $34.1 million per year. For each of the years ended December&#160;31, 2022, 2021, and 2020, there was no material impairment of intangible assets with finite lives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accrued liabilities consist of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts owed to former licensees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalties owed to third parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return reserve and customer refunds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subcontractor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplier&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingent liabilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the acquisition of CyDex in January 2011, we issued a series of CVRs and also assumed certain contingent liabilities. We may be required to make additional payments upon achievement of certain clinical and regulatory milestones to the CyDex shareholders and former license holders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the acquisition of Metabasis in January 2010, we entered into four CVR agreements with Metabasis shareholders. The CVRs entitle the holders to cash payments as frequently as every six months as proceeds are received by us upon the sale or licensing of any of the Metabasis drug development programs and upon the achievement of specified milestones.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For CVRs associated with the Pfenex, see &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note (4), Acquisitions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes roll-forward of contingent liabilities as of December 2022 and 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.176%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.949%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.176%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair Value Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair Value Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Repurchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cydex&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(265)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Metabasis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(464)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pfenex&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(37,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;41,929&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(38,172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,707&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,513&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:MarketableSecuritiesTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzM3NTI_c3ce5de6-b805-4511-9102-d573e50a82a3">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Excluding our investments in Viking, the following table summarizes the various investment categories at December&#160;31, 2022 and 2021 (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;gains&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;losses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;fair value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mutual Funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1050)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,239)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,451)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Mutual fund&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Commercial paper  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,027)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,370)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:MarketableSecuritiesTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i548f60b85719418dac5410346d1603e7_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzMtMS0xLTEtMTEyNjQw_e447deb0-14c9-4524-ac39-d03ee52d92e4"
      unitRef="usd">81815000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i548f60b85719418dac5410346d1603e7_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzMtMy0xLTEtMTEyNjQw_9cbd6ee9-62cc-4302-802a-5e9305403fd2"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i548f60b85719418dac5410346d1603e7_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzMtNS0xLTEtMTEyNjQw_229766ec-4d57-46ef-a771-55b5b3869666"
      unitRef="usd">1050000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i548f60b85719418dac5410346d1603e7_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzMtNy0xLTEtMTEyNjQw_7dc6d62b-9cb8-4cb4-858d-06b5920fa458"
      unitRef="usd">80765000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i1471709cc0844e7fa518a8ce9a1cd2bb_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzQtMS0xLTEtMTEyNjQw_8076725e-9732-405f-be9d-0c56ed75967c"
      unitRef="usd">5012000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i1471709cc0844e7fa518a8ce9a1cd2bb_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzQtMy0xLTEtMTEyNjQw_5020707e-9cee-473d-86a7-3b491c682b23"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i1471709cc0844e7fa518a8ce9a1cd2bb_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzQtNS0xLTEtMTEyNjQw_b132e850-a34b-4c51-93e0-ea8b82d5732e"
      unitRef="usd">34000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1471709cc0844e7fa518a8ce9a1cd2bb_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzQtNy0xLTEtMTEyNjQw_13d1380c-c9ce-4508-9f88-a05a9dbc2dd5"
      unitRef="usd">4980000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i7463bea47b82478d8f5459d601f865f3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzUtMS0xLTEtMTEyNjQw_7d269f9c-1fc3-4db5-9fdf-2a216163616f"
      unitRef="usd">7211000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i7463bea47b82478d8f5459d601f865f3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzUtMy0xLTEtMTEyNjQw_6df7a07f-6eb8-4ae3-963b-9b76aaeb4ac0"
      unitRef="usd">3000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7463bea47b82478d8f5459d601f865f3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzUtNS0xLTEtMTEyNjQw_c9bc567c-32f2-44dd-8caa-c327550f0e94"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7463bea47b82478d8f5459d601f865f3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzUtNy0xLTEtMTEyNjQw_bc4e8340-40e1-4d6e-963e-2d59aea34d56"
      unitRef="usd">7214000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ibd0bbb0bb1ab4703911061427590d10b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzYtMS0xLTEtMTEyNjQw_d234497f-acaa-4ec4-93a6-aab7c1dabb55"
      unitRef="usd">6701000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ibd0bbb0bb1ab4703911061427590d10b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzYtMy0xLTEtMTEyNjQw_43ebc4a8-742d-4000-891c-4fd514a21ae6"
      unitRef="usd">13000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ibd0bbb0bb1ab4703911061427590d10b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzYtNS0xLTEtMTEyNjQw_92981c2c-6d2e-41fe-82be-18f54dc83b24"
      unitRef="usd">58000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibd0bbb0bb1ab4703911061427590d10b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzYtNy0xLTEtMTEyNjQw_0a179f60-d2c7-45ad-b53c-db2fa375e501"
      unitRef="usd">6656000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="id5437e7ad7374bbba38f616727645f32_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzctMS0xLTEtMTEyNjQw_e81eca37-dcd9-4421-86da-ca16b4cce3cb"
      unitRef="usd">5807000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="id5437e7ad7374bbba38f616727645f32_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzctMy0xLTEtMTEyNjQw_28e2acbf-a374-4cc8-b75e-c6090a14f758"
      unitRef="usd">262000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="id5437e7ad7374bbba38f616727645f32_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzctNS0xLTEtMTEyNjQw_1230c666-19df-488a-ae02-272276c4ab14"
      unitRef="usd">4239000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id5437e7ad7374bbba38f616727645f32_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzctNy0xLTEtMTEyNjQw_08006420-e1c6-43a1-9acd-87b695d70190"
      unitRef="usd">1830000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i0615fa1d1c0f4ab3a4d0ed6cab329254_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzgtMS0xLTEtMTEyNjQw_8b60d146-0ff7-4b83-8551-01269cf11c1b"
      unitRef="usd">2232000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i0615fa1d1c0f4ab3a4d0ed6cab329254_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzgtMy0xLTEtMTEyNjQw_8d0186a8-7e97-4b17-a8b2-630f1c4f8904"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i0615fa1d1c0f4ab3a4d0ed6cab329254_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzgtNS0xLTEtMTEyNjQw_8f4186ae-2b44-4f7d-a350-ebe7c3899ee6"
      unitRef="usd">70000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0615fa1d1c0f4ab3a4d0ed6cab329254_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzgtNy0xLTEtMTEyNjQw_fbcfd3be-af97-4966-9052-9126980f3169"
      unitRef="usd">2162000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i71e35599919c4fce950d103cf2cb9a03_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzktMS0xLTEtMTEyNjQw_9a4548cf-dddf-4516-b014-f7e5bb0699c3"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i71e35599919c4fce950d103cf2cb9a03_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzktMy0xLTEtMTEyNjQw_439e431f-5f52-4bbd-adef-c2d33b323ccf"
      unitRef="usd">135000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i71e35599919c4fce950d103cf2cb9a03_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzktNS0xLTEtMTEyNjQw_74489445-09ea-4fb4-bed1-23e5eb14bca2"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i71e35599919c4fce950d103cf2cb9a03_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzktNy0xLTEtMTEyNjQw_258ba0c2-3b59-4078-bc94-a663e0df362f"
      unitRef="usd">135000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzEwLTEtMS0xLTExMjY0MA_4180af5b-2b9d-4aef-8f53-cf5dce7a49af"
      unitRef="usd">108778000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzEwLTMtMS0xLTExMjY0MA_5dfb5542-2466-40d3-8c4b-8fb9738d587a"
      unitRef="usd">415000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzEwLTUtMS0xLTExMjY0MA_ef3e4ce8-e2e0-4854-900b-3828ff6fb785"
      unitRef="usd">5451000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzEwLTctMS0xLTExMjY0MA_54e97d66-2339-4d9b-9825-de606b94a490"
      unitRef="usd">103742000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i04cf813834a54b609f2d0c0a39769017_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzEzLTEtMS0xLTExMjY0MA_3d504a12-7d96-461c-89bc-985f5d124e69"
      unitRef="usd">152136000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i04cf813834a54b609f2d0c0a39769017_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzEzLTMtMS0xLTExMjY0MA_797b272b-43f9-4863-b830-31c914636e0b"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i04cf813834a54b609f2d0c0a39769017_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzEzLTUtMS0xLTExMjY0MA_dd261882-8242-48f3-a5f3-809fe6eabde0"
      unitRef="usd">249000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i04cf813834a54b609f2d0c0a39769017_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzEzLTctMS0xLTExMjY0MA_6b22649c-33ae-44ed-8b74-4861bcb553ae"
      unitRef="usd">151887000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i2f92fad18c07418281242e26ae88ac27_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE0LTEtMS0xLTExMjY0MA_8c82b1b7-5348-4c5c-b806-9068f89fb38b"
      unitRef="usd">63389000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i2f92fad18c07418281242e26ae88ac27_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE0LTMtMS0xLTExMjY0MA_1cac3c27-5bd8-456c-adc8-1104419744c9"
      unitRef="usd">13000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2f92fad18c07418281242e26ae88ac27_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE0LTUtMS0xLTExMjY0MA_ca47a96c-c854-4262-8175-68546e4ed9fd"
      unitRef="usd">21000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2f92fad18c07418281242e26ae88ac27_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE0LTctMS0xLTExMjY0MA_1d0413c7-ab20-4bca-8dbb-3f17251a92d0"
      unitRef="usd">63381000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="if12b1ab4a6244599831e9df4b3d630d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE1LTEtMS0xLTExMjY0MA_1ee37a8a-cd13-4cc8-b793-84c5f7471734"
      unitRef="usd">36008000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if12b1ab4a6244599831e9df4b3d630d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE1LTMtMS0xLTExMjY0MA_c872b616-878f-4d6a-9eb3-75b35f0333cc"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if12b1ab4a6244599831e9df4b3d630d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE1LTUtMS0xLTExMjY0MA_ef397c40-2e55-4a93-aae3-e82b803ec2f2"
      unitRef="usd">12000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if12b1ab4a6244599831e9df4b3d630d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE1LTctMS0xLTExMjY0MA_b6d77af3-b20b-4931-837d-8b71e049657c"
      unitRef="usd">35998000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ie313cb8f8e784d82b8ae991a863ca12c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE2LTEtMS0xLTExMjY0MA_c94438d8-d66a-4c7c-bc58-d008355d2f04"
      unitRef="usd">29308000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie313cb8f8e784d82b8ae991a863ca12c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE2LTMtMS0xLTExMjY0MA_3825f473-cd10-46db-aae0-19f722562a38"
      unitRef="usd">17000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie313cb8f8e784d82b8ae991a863ca12c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE2LTUtMS0xLTExMjY0MA_9cf7f745-f503-41f5-bb84-ab07e6718501"
      unitRef="usd">38000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie313cb8f8e784d82b8ae991a863ca12c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE2LTctMS0xLTExMjY0MA_2759d54a-3e73-4a88-86b8-a07fa2dcd80c"
      unitRef="usd">29287000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i6696160e9f0146f7bee8c94a11813846_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE4LTEtMS0xLTExMjY0MA_e0711992-3bd8-4fe4-a7eb-edaeb0ca79ce"
      unitRef="usd">5807000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i6696160e9f0146f7bee8c94a11813846_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE4LTMtMS0xLTExMjY0MA_1fe48495-c643-46f6-b668-bea9b3a1241b"
      unitRef="usd">402000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i6696160e9f0146f7bee8c94a11813846_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE4LTUtMS0xLTExMjY0MA_1f528536-63ab-45d7-ba77-68057a05ee75"
      unitRef="usd">2027000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6696160e9f0146f7bee8c94a11813846_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE4LTctMS0xLTExMjY0MA_6955112d-3e26-4f67-a6e4-c9f5a46b4539"
      unitRef="usd">4182000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ic790b5e0a22343c88149b3aa20638bbe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE5LTEtMS0xLTExMjY0MA_c562639c-1148-49ed-9de2-916ebab45b49"
      unitRef="usd">5577000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic790b5e0a22343c88149b3aa20638bbe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE5LTMtMS0xLTExMjY0MA_193ce297-a278-46fe-abb4-f5b9ea39f53d"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic790b5e0a22343c88149b3aa20638bbe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE5LTUtMS0xLTExMjY0MA_4829ba7e-3cc3-49c8-a9fb-6335f2d3dc23"
      unitRef="usd">23000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic790b5e0a22343c88149b3aa20638bbe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzE5LTctMS0xLTExMjY0MA_27fb8f2d-fb41-469a-be8f-d589d1c22e34"
      unitRef="usd">5554000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i3d6d432e3de740d2b05ca748ea45be9a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzIwLTEtMS0xLTExMjY0MA_11cb418c-1627-4683-89f8-934ee0048847"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i3d6d432e3de740d2b05ca748ea45be9a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzIwLTMtMS0xLTExMjY0MA_323699c0-d12b-4614-9bee-a1adf3aa9e49"
      unitRef="usd">408000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i3d6d432e3de740d2b05ca748ea45be9a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzIwLTUtMS0xLTExMjY0MA_8b64a535-b719-49d6-ad02-8316b9794af9"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3d6d432e3de740d2b05ca748ea45be9a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzIwLTctMS0xLTExMjY0MA_74248354-ada6-47a0-b947-bf411c1d9126"
      unitRef="usd">408000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzIxLTEtMS0xLTExMjY0MA_2c27a69b-2b4c-472a-851a-a3e1940e3598"
      unitRef="usd">292225000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzIxLTMtMS0xLTExMjY0MA_bc970dc4-a0fc-433a-9247-0f16fb8ee4fc"
      unitRef="usd">842000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzIxLTUtMS0xLTExMjY0MA_e8c76e24-9c2d-4890-903f-f27b193ee03a"
      unitRef="usd">2370000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo2YzQxZDViNmY1MzQ0MjYzYmY1ZmY4MTNkOGI4M2ZkZC90YWJsZXJhbmdlOjZjNDFkNWI2ZjUzNDQyNjNiZjVmZjgxM2Q4YjgzZmRkXzIxLTctMS0xLTExMjY0MA_f652bd92-0b6f-46b1-895c-446b7f881bfb"
      unitRef="usd">290697000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzM3NjM_60ce17cb-1d2e-406b-a77c-fd93254cc53d">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyMTVlZjQyYTI4ZTA0NTQzODZkYjYzNTgwYmNlOTQwNy90YWJsZXJhbmdlOjIxNWVmNDJhMjhlMDQ1NDM4NmRiNjM1ODBiY2U5NDA3XzItMS0xLTEtMTEyNjQw_5d712024-417a-405b-ba03-a00af8e9815e"
      unitRef="usd">57158000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyMTVlZjQyYTI4ZTA0NTQzODZkYjYzNTgwYmNlOTQwNy90YWJsZXJhbmdlOjIxNWVmNDJhMjhlMDQ1NDM4NmRiNjM1ODBiY2U5NDA3XzItMy0xLTEtMTEyNjQw_072aa2d6-85e1-4a53-80f7-3531c51b03a2"
      unitRef="usd">57036000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyMTVlZjQyYTI4ZTA0NTQzODZkYjYzNTgwYmNlOTQwNy90YWJsZXJhbmdlOjIxNWVmNDJhMjhlMDQ1NDM4NmRiNjM1ODBiY2U5NDA3XzMtMS0xLTEtMTEyNjQw_dffd9bfb-5e8f-4d8e-8413-b38bde0b4bb8"
      unitRef="usd">2794000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyMTVlZjQyYTI4ZTA0NTQzODZkYjYzNTgwYmNlOTQwNy90YWJsZXJhbmdlOjIxNWVmNDJhMjhlMDQ1NDM4NmRiNjM1ODBiY2U5NDA3XzMtMy0xLTEtMTEyNjQw_914160da-b754-4f20-bb19-6ce369dd2b10"
      unitRef="usd">2769000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyMTVlZjQyYTI4ZTA0NTQzODZkYjYzNTgwYmNlOTQwNy90YWJsZXJhbmdlOjIxNWVmNDJhMjhlMDQ1NDM4NmRiNjM1ODBiY2U5NDA3XzUtMS0xLTEtMTEyNjQw_c5823a90-e63a-47d4-89d8-1abe8a7acac8"
      unitRef="usd">59952000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyMTVlZjQyYTI4ZTA0NTQzODZkYjYzNTgwYmNlOTQwNy90YWJsZXJhbmdlOjIxNWVmNDJhMjhlMDQ1NDM4NmRiNjM1ODBiY2U5NDA3XzUtMy0xLTEtMTEyNjQw_471890d0-bf6e-4ff1-9d51-dbd70fe5b982"
      unitRef="usd">59805000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzM3NTc_51b73f8f-40be-4980-9269-7025a96de90a">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our available-for-sale debt securities in an unrealized loss position (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12 months or greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Government Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Government Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i1471709cc0844e7fa518a8ce9a1cd2bb_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzMtMS0xLTEtMTEyNjQw_b68390a0-c230-406e-ac70-75a945463f08"
      unitRef="usd">34000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i1471709cc0844e7fa518a8ce9a1cd2bb_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzMtMy0xLTEtMTEyNjQw_5ad150d0-f78b-4d35-affc-6040d9057da8"
      unitRef="usd">2470000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i1471709cc0844e7fa518a8ce9a1cd2bb_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzMtNS0xLTEtMTEyNjQw_52d05b11-3004-46fb-be76-c1e6c1b3de95"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i1471709cc0844e7fa518a8ce9a1cd2bb_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzMtNy0xLTEtMTEyNjQw_89afa2c8-877c-4255-aee3-d1539fadebe3"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
      contextRef="i1471709cc0844e7fa518a8ce9a1cd2bb_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzMtOS0xLTEtMTEyNjQw_25050f1e-08b4-449b-9451-78d360e426dd"
      unitRef="usd">34000</us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i1471709cc0844e7fa518a8ce9a1cd2bb_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzMtMTEtMS0xLTExMjY0MA_835a2ca0-f28f-429f-b1e8-27be5a2d4bae"
      unitRef="usd">2470000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ibd0bbb0bb1ab4703911061427590d10b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzQtMS0xLTEtMTEyNjQw_daca8a13-84cf-49dc-85be-da05a8bca8db"
      unitRef="usd">21000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ibd0bbb0bb1ab4703911061427590d10b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzQtMy0xLTEtMTEyNjQw_12cdcdca-df59-421a-93f6-5332f5e680fd"
      unitRef="usd">3887000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ibd0bbb0bb1ab4703911061427590d10b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzQtNS0xLTEtMTEyNjQw_bf2bca1f-e231-4fde-a05e-993aa5916ed8"
      unitRef="usd">37000</us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ibd0bbb0bb1ab4703911061427590d10b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzQtNy0xLTEtMTEyNjQw_4aec8678-ab85-4ae3-8d88-c720a962e2c1"
      unitRef="usd">947000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
      contextRef="ibd0bbb0bb1ab4703911061427590d10b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzQtOS0xLTEtMTEyNjQw_ec331a1e-7e03-4ea5-9f28-1905e690fb5b"
      unitRef="usd">58000</us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ibd0bbb0bb1ab4703911061427590d10b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzQtMTEtMS0xLTExMjY0MA_ba772596-bdab-4755-bc23-f3a7d227093b"
      unitRef="usd">4834000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i7463bea47b82478d8f5459d601f865f3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzUtMS0xLTEtMTEyNjQw_3709a52a-4d41-4d9d-865b-8bd91eb789ad"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i7463bea47b82478d8f5459d601f865f3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzUtMy0xLTEtMTEyNjQw_ee22483c-2d35-4b29-adc6-fe39c4dcbcbe"
      unitRef="usd">3836000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i7463bea47b82478d8f5459d601f865f3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzUtNS0xLTEtMTEyNjQw_e54be6c2-6c68-4008-9025-39cfac989f5c"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i7463bea47b82478d8f5459d601f865f3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzUtNy0xLTEtMTEyNjQw_d47518a9-a2a6-4932-be39-771b4a4910f3"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
      contextRef="i7463bea47b82478d8f5459d601f865f3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzUtOS0xLTEtMTEyNjQw_d1cc0137-d7f4-4b42-a8b0-db13bccfc563"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i7463bea47b82478d8f5459d601f865f3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzUtMTEtMS0xLTExMjY0MA_78c7e2f2-a6ca-4a97-81fe-bd0d929c5418"
      unitRef="usd">3836000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i0615fa1d1c0f4ab3a4d0ed6cab329254_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzYtMS0xLTEtMTEyNjQw_b63ac614-b147-415a-ad26-94c3235f5160"
      unitRef="usd">70000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i0615fa1d1c0f4ab3a4d0ed6cab329254_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzYtMy0xLTEtMTEyNjQw_7eb176ea-f42b-49fe-9e26-db37f2ede84d"
      unitRef="usd">2161000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i0615fa1d1c0f4ab3a4d0ed6cab329254_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzYtNS0xLTEtMTEyNjQw_edebee35-d99b-4cdf-80e1-a1fb7b4082bd"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i0615fa1d1c0f4ab3a4d0ed6cab329254_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzYtNy0xLTEtMTEyNjQw_d31c9b84-f989-4cff-99c9-bd9fd0ee164c"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
      contextRef="i0615fa1d1c0f4ab3a4d0ed6cab329254_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzYtOS0xLTEtMTEyNjQw_97e9d09d-2844-4bae-bc3b-4d564829a801"
      unitRef="usd">70000</us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i0615fa1d1c0f4ab3a4d0ed6cab329254_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzYtMTEtMS0xLTExMjY0MA_05503fff-7a75-482a-91b0-697eba936da0"
      unitRef="usd">2161000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzctMS0xLTEtMTEyNjQw_84fd5387-9aa5-463f-a13b-2824560e6db1"
      unitRef="usd">125000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzctMy0xLTEtMTEyNjQw_cffeb7f2-0503-4eaa-96e2-ac6464018cd3"
      unitRef="usd">12354000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzctNS0xLTEtMTEyNjQw_c36fb070-a758-4e62-9552-3d6684541dec"
      unitRef="usd">37000</us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzctNy0xLTEtMTEyNjQw_bc8fcdb6-1e12-4911-a490-a9b8c7382c34"
      unitRef="usd">947000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzctOS0xLTEtMTEyNjQw_7d08bf37-03a1-453b-8c41-ab8d5a104424"
      unitRef="usd">162000</us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzctMTEtMS0xLTExMjY0MA_593484fd-fb71-4612-b0a0-45eef9828737"
      unitRef="usd">13301000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i2f92fad18c07418281242e26ae88ac27_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEwLTEtMS0xLTExMjY0MA_b9051ba0-2451-4983-9e27-77556a6c7ecb"
      unitRef="usd">13000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i2f92fad18c07418281242e26ae88ac27_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEwLTMtMS0xLTExMjY0MA_b5229ae0-25a0-4652-9211-136ea1f31163"
      unitRef="usd">20008000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i2f92fad18c07418281242e26ae88ac27_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEwLTUtMS0xLTExMjY0MA_88aaabef-c031-4ea8-83c0-54b731e3cac8"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i2f92fad18c07418281242e26ae88ac27_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEwLTctMS0xLTExMjY0MA_e91122fa-dcd0-4868-84df-10ae2d3ea7d9"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
      contextRef="i2f92fad18c07418281242e26ae88ac27_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEwLTktMS0xLTExMjY0MA_430f895e-ecac-4076-8d1a-88c28ce07454"
      unitRef="usd">13000</us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i2f92fad18c07418281242e26ae88ac27_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEwLTExLTEtMS0xMTI2NDA_9fd4c14f-90ca-4f24-af30-4824aaa1c8be"
      unitRef="usd">20008000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ie313cb8f8e784d82b8ae991a863ca12c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzExLTEtMS0xLTExMjY0MA_9b5bd5e7-3ee9-4984-a84a-671257f01fc5"
      unitRef="usd">15000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ie313cb8f8e784d82b8ae991a863ca12c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzExLTMtMS0xLTExMjY0MA_05d3c6e7-b357-4ecd-acab-b2715ba0423b"
      unitRef="usd">27252000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ie313cb8f8e784d82b8ae991a863ca12c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzExLTUtMS0xLTExMjY0MA_269c065d-1103-4856-a2c3-887621df8dc5"
      unitRef="usd">5000</us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ie313cb8f8e784d82b8ae991a863ca12c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzExLTctMS0xLTExMjY0MA_c68fd5be-5969-4e8d-a75b-4bd663878000"
      unitRef="usd">2996000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
      contextRef="ie313cb8f8e784d82b8ae991a863ca12c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzExLTktMS0xLTExMjY0MA_e56f839d-8298-4bbf-ad2a-aed8266e569f"
      unitRef="usd">20000</us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ie313cb8f8e784d82b8ae991a863ca12c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzExLTExLTEtMS0xMTI2NDA_c7abe8ad-3bd4-4378-8848-06abdfa3623b"
      unitRef="usd">30248000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="if12b1ab4a6244599831e9df4b3d630d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEyLTEtMS0xLTExMjY0MA_7b901e8e-1357-4061-80b9-91fb949f0557"
      unitRef="usd">6000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="if12b1ab4a6244599831e9df4b3d630d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEyLTMtMS0xLTExMjY0MA_b8dac2e5-81a0-41aa-9d9a-c0e4c08019c0"
      unitRef="usd">6689000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="if12b1ab4a6244599831e9df4b3d630d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEyLTUtMS0xLTExMjY0MA_8aa42f19-4736-4a48-806c-323e7f4cad2a"
      unitRef="usd">32000</us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="if12b1ab4a6244599831e9df4b3d630d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEyLTctMS0xLTExMjY0MA_1b85163a-8002-45ed-a9bd-83f7fd6d853a"
      unitRef="usd">10125000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
      contextRef="if12b1ab4a6244599831e9df4b3d630d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEyLTktMS0xLTExMjY0MA_45fd61d9-fb5b-4360-9fc6-84c503ab9803"
      unitRef="usd">38000</us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="if12b1ab4a6244599831e9df4b3d630d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEyLTExLTEtMS0xMTI2NDA_19fe9edb-aaac-46c1-ac96-f015b1078455"
      unitRef="usd">16814000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ic790b5e0a22343c88149b3aa20638bbe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEzLTEtMS0xLTEyMTc1Mg_a2b40bdc-e19e-4456-b581-5e040e3ab334"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ic790b5e0a22343c88149b3aa20638bbe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEzLTMtMS0xLTEyMTc2MA_8a0c37e7-9f7a-4cbc-9d6a-f1b526079274"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ic790b5e0a22343c88149b3aa20638bbe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEzLTUtMS0xLTEyMTc2Nw_93f12fb0-2e41-4550-8458-353bbf96b88f"
      unitRef="usd">23000</us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ic790b5e0a22343c88149b3aa20638bbe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEzLTctMS0xLTEyMTc4Ng_d3f1517a-08dd-47ce-8afb-41e593a6e56f"
      unitRef="usd">5553000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
      contextRef="ic790b5e0a22343c88149b3aa20638bbe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEzLTktMS0xLTEyMjU4Mw_2eebf83e-dbe9-432a-b0db-d84956a7f153"
      unitRef="usd">23000</us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ic790b5e0a22343c88149b3aa20638bbe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEzLTExLTEtMS0xMjI1ODM_76338f69-526d-42be-a1d9-02fa5ded004b"
      unitRef="usd">5553000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEzLTEtMS0xLTExMjY0MA_f6750da4-1dd5-4fd5-a451-c62abbe44a7c"
      unitRef="usd">34000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEzLTMtMS0xLTExMjY0MA_0329c750-ab87-476f-9445-d9031b9d0bb8"
      unitRef="usd">53949000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEzLTUtMS0xLTExMjY0MA_f3c49226-1a6c-4e4f-8218-5a57718cbdd2"
      unitRef="usd">60000</us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEzLTctMS0xLTExMjY0MA_f8b56c83-bd25-4bb1-9459-6851923b342e"
      unitRef="usd">18674000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEzLTktMS0xLTExMjY0MA_04f54d0a-5785-465a-bca0-5a48744a1664"
      unitRef="usd">94000</us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTpkMWNmMjAyMjdlOGQ0MTAzYTA2YmZmMGM0OGUwNTY4OS90YWJsZXJhbmdlOmQxY2YyMDIyN2U4ZDQxMDNhMDZiZmYwYzQ4ZTA1Njg5XzEzLTExLTEtMS0xMTI2NDA_dd473c9d-7435-4df2-93b2-9e58f133127f"
      unitRef="usd">72623000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzgzMw_a731bae6-e640-4a32-8c99-23f3679874aa"
      unitRef="position">12</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzM3NTg_8a2f93d9-85fc-49ec-b754-844ffaa0126f">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and equipment are stated at cost and consists of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lab and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iaad9f14d4ad04902a0ea102d27e11be4_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo5MGVjYWI5MzVhMzU0Njc4OGM5ODlhZWZiOTkzYWNmNS90YWJsZXJhbmdlOjkwZWNhYjkzNWEzNTQ2Nzg4Yzk4OWFlZmI5OTNhY2Y1XzItMS0xLTEtMTEyNjQw_98c79f9b-80a0-4b3d-af1a-cd450df70de6"
      unitRef="usd">14172000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i5b3cf5a61a1e4ab181aaf966a0f14569_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo5MGVjYWI5MzVhMzU0Njc4OGM5ODlhZWZiOTkzYWNmNS90YWJsZXJhbmdlOjkwZWNhYjkzNWEzNTQ2Nzg4Yzk4OWFlZmI5OTNhY2Y1XzItMy0xLTEtMTEyNjQw_16f12484-b906-4869-8971-2e3b2618cc2f"
      unitRef="usd">13417000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i1ce0655576844f1290eb9958550ec9af_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo5MGVjYWI5MzVhMzU0Njc4OGM5ODlhZWZiOTkzYWNmNS90YWJsZXJhbmdlOjkwZWNhYjkzNWEzNTQ2Nzg4Yzk4OWFlZmI5OTNhY2Y1XzMtMS0xLTEtMTEyNjQw_abf4869a-4940-4e79-8a55-65aefaf8758d"
      unitRef="usd">7446000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic2f48884d4a143de8f95a4b3a211788e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo5MGVjYWI5MzVhMzU0Njc4OGM5ODlhZWZiOTkzYWNmNS90YWJsZXJhbmdlOjkwZWNhYjkzNWEzNTQ2Nzg4Yzk4OWFlZmI5OTNhY2Y1XzMtMy0xLTEtMTEyNjQw_039fb9de-c1a2-48df-a67d-3cf77171b8cb"
      unitRef="usd">5265000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i3ca7d470a3274ceaa4b0cd0f4f1c8bad_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo5MGVjYWI5MzVhMzU0Njc4OGM5ODlhZWZiOTkzYWNmNS90YWJsZXJhbmdlOjkwZWNhYjkzNWEzNTQ2Nzg4Yzk4OWFlZmI5OTNhY2Y1XzQtMS0xLTEtMTEyNjQw_712402a7-e381-451d-a98f-d1cdd0e6b1c4"
      unitRef="usd">989000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i2ad7defd94a44484b2144c9440eb26ff_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo5MGVjYWI5MzVhMzU0Njc4OGM5ODlhZWZiOTkzYWNmNS90YWJsZXJhbmdlOjkwZWNhYjkzNWEzNTQ2Nzg4Yzk4OWFlZmI5OTNhY2Y1XzQtMy0xLTEtMTEyNjQw_65e55938-9c85-4a3f-bc71-6ef49d0399a1"
      unitRef="usd">924000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo5MGVjYWI5MzVhMzU0Njc4OGM5ODlhZWZiOTkzYWNmNS90YWJsZXJhbmdlOjkwZWNhYjkzNWEzNTQ2Nzg4Yzk4OWFlZmI5OTNhY2Y1XzUtMS0xLTEtMTEyNjQw_dc2514a8-ed14-4191-9c46-602a54b6ad0c"
      unitRef="usd">22607000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo5MGVjYWI5MzVhMzU0Njc4OGM5ODlhZWZiOTkzYWNmNS90YWJsZXJhbmdlOjkwZWNhYjkzNWEzNTQ2Nzg4Yzk4OWFlZmI5OTNhY2Y1XzUtMy0xLTEtMTEyNjQw_c83e6346-0dc0-406f-b9f2-b32d9383c982"
      unitRef="usd">19606000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo5MGVjYWI5MzVhMzU0Njc4OGM5ODlhZWZiOTkzYWNmNS90YWJsZXJhbmdlOjkwZWNhYjkzNWEzNTQ2Nzg4Yzk4OWFlZmI5OTNhY2Y1XzYtMS0xLTEtMTEyNjQw_c57a19ba-63d9-411c-b8f5-fce1dbf229cf"
      unitRef="usd">10125000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo5MGVjYWI5MzVhMzU0Njc4OGM5ODlhZWZiOTkzYWNmNS90YWJsZXJhbmdlOjkwZWNhYjkzNWEzNTQ2Nzg4Yzk4OWFlZmI5OTNhY2Y1XzYtMy0xLTEtMTEyNjQw_79efd756-59ff-42d5-8b3b-4f75a34fd0e3"
      unitRef="usd">6415000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo5MGVjYWI5MzVhMzU0Njc4OGM5ODlhZWZiOTkzYWNmNS90YWJsZXJhbmdlOjkwZWNhYjkzNWEzNTQ2Nzg4Yzk4OWFlZmI5OTNhY2Y1XzctMS0xLTEtMTEyNjQw_8d613c16-eede-49e5-84b6-59bd302bd371"
      unitRef="usd">12482000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo5MGVjYWI5MzVhMzU0Njc4OGM5ODlhZWZiOTkzYWNmNS90YWJsZXJhbmdlOjkwZWNhYjkzNWEzNTQ2Nzg4Yzk4OWFlZmI5OTNhY2Y1XzctMy0xLTEtMTEyNjQw_13200476-5ebb-4ddd-8aa6-10bb6401404e"
      unitRef="usd">13191000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i5a1083da45f7446987097262ce780281_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzE3MTM_90a59c9f-3c64-4d14-bc7c-df0d22b832fa">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:Depreciation
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzE4OTQ_feb06c77-89e1-4eb2-a8ca-ba24a157638b"
      unitRef="usd">3800000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzE4OTg_e2068cc6-8fb1-411a-ba2e-198a9582ad80"
      unitRef="usd">2400000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzE5MDY_74e7f74d-2be0-4c2f-939f-d9c40a628e60"
      unitRef="usd">1500000</us-gaap:Depreciation>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzM3NTA_009c4015-c758-44b2-adaa-079792c75c78">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill and identifiable intangible assets consist of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Definite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Complete technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,560)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,916)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,577)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,444)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,670)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Contractual relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65,191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total goodwill and other identifiable intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;448,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;482,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:Goodwill
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzMtMS0xLTEtMTEyNjQw_a2adf4da-4e4e-45ec-8fc9-41acc0ed1f09"
      unitRef="usd">105673000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzMtMy0xLTEtMTEyNjQw_707713d2-f206-4e20-a229-0a592b510204"
      unitRef="usd">105673000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i25d3b1f41ab6459bbb46a5beb92b4ef3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzUtMS0xLTEtMTEyNjQw_ce92a02e-015e-4bec-a3da-1a02899adf64"
      unitRef="usd">55211000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i67a7f28b4edc41f8a4828a6e2caa478f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzUtMy0xLTEtMTEyNjQw_cb9e90b2-9449-466d-b2ac-2d13d52edc7d"
      unitRef="usd">55211000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i25d3b1f41ab6459bbb46a5beb92b4ef3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzYtMS0xLTEtMTEyNjQw_a6c6d8c5-6a9f-4832-9b70-2821470dfe67"
      unitRef="usd">22560000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i67a7f28b4edc41f8a4828a6e2caa478f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzYtMy0xLTEtMTEyNjQw_a8d82a9f-c4e2-4b76-afe6-94e2d0e70430"
      unitRef="usd">18916000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i07e4bdb069784c6995843f555b7fc3df_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzctMS0xLTEtMTEyNjQw_2ab1a418-b641-46b4-9dff-db0b98537f44"
      unitRef="usd">2642000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2701c5cf7228445c8f19ae56602a97cf_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzctMy0xLTEtMTEyNjQw_34b375e1-8b05-4420-9de4-a9043e7ef10d"
      unitRef="usd">2642000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i07e4bdb069784c6995843f555b7fc3df_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzgtMS0xLTEtMTEyNjQw_1ff68646-f442-4a5e-9963-be513961197f"
      unitRef="usd">1577000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2701c5cf7228445c8f19ae56602a97cf_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzgtMy0xLTEtMTEyNjQw_7c0dae30-ad80-40e5-9918-98927021eec1"
      unitRef="usd">1444000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i181eff0de1144e58b256d8ec0c77ad61_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzktMS0xLTEtMTEyNjQw_38006b28-96bd-427d-a344-0b4ec16ac97d"
      unitRef="usd">29600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ide40dc66b4694626bfa8f046840911c4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzktMy0xLTEtMTEyNjQw_fbf23d97-b1ff-41f5-90ee-24cffab9b11b"
      unitRef="usd">29600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i181eff0de1144e58b256d8ec0c77ad61_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzEwLTEtMS0xLTExMjY0MA_5d43e4e5-1a17-4c2a-9d58-3672e4721b00"
      unitRef="usd">17670000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ide40dc66b4694626bfa8f046840911c4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzEwLTMtMS0xLTExMjY0MA_b2a79757-c36a-4abe-9203-5f76b27d78a6"
      unitRef="usd">16184000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i744575df31604eb09f525875d978efa1_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzExLTEtMS0xLTExMjY0MA_72b3ee8e-b760-4dc8-9cfc-82f8888c25a2"
      unitRef="usd">362000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie8c9e47632c8468988399e7e93608f12_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzExLTMtMS0xLTExMjY0MA_1bcb0dff-1133-428f-a5b7-71aecdae22d0"
      unitRef="usd">362000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i744575df31604eb09f525875d978efa1_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzEyLTEtMS0xLTExMjY0MA_0a9cb2f4-d2a1-45e4-b283-99a5f1722ac1"
      unitRef="usd">65191000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie8c9e47632c8468988399e7e93608f12_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzEyLTMtMS0xLTExMjY0MA_abf25cec-d626-4233-a0ff-6ff8d15ff166"
      unitRef="usd">36218000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzEzLTEtMS0xLTExMjY0MA_c6fc88ed-c31c-47c1-af1b-7a171e1dd914"
      unitRef="usd">448128000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTphYzAwMDBmNzE1M2Y0M2NiYTNjM2NhNGJhYjE3Yzk1Yi90YWJsZXJhbmdlOmFjMDAwMGY3MTUzZjQzY2JhM2MzY2E0YmFiMTdjOTViXzEzLTMtMS0xLTExMjY0MA_ce13535d-3647-4910-a63f-81d476e86604"
      unitRef="usd">482364000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzIyMzY_e5d458f4-35ca-46cf-8309-fbbeb41bc72c">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzE2NDkyNjc0NDc5NDE_8cf97075-842e-4e56-9f01-e260238f1fda"
      unitRef="usd">34200000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzE2NDkyNjc0NDc5NDg_53dd465d-8423-438f-8e27-0bc98bd0e647"
      unitRef="usd">34200000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzE2NDkyNjc0NDc5NTU_8e24ea8c-02ce-4f67-a366-1243fc289579"
      unitRef="usd">11600000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzI0MzA_000ca473-bff6-423c-a1fe-c53b572a1c50"
      unitRef="usd">34100000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzI0MzA_45ff51f8-9d9f-425d-bf9c-0a5436043a8b"
      unitRef="usd">34100000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzI0MzA_741259b9-3a6c-4fd7-9512-202b5c89a905"
      unitRef="usd">34100000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzI0MzA_c7e20c8d-83bc-469a-b5c6-50f9e9ccd794"
      unitRef="usd">34100000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzI0OTc_645439c4-c614-4b30-9648-76ceb003ce00"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzI0OTc_688bf3ff-fb13-4075-adbb-183bfedffc31"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzI0OTc_c17ed5be-f48e-4b41-807e-d34da8e8d111"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzM3NTQ_e25ffc30-6899-4c25-9b43-89fc333033f6">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accrued liabilities consist of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts owed to former licensees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalties owed to third parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return reserve and customer refunds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subcontractor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplier&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzItMS0xLTEtMTEyNjQw_193b2747-f742-49c9-bc28-19d3938d6d98"
      unitRef="usd">6201000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzItMy0xLTEtMTEyNjQw_0a9004fb-7c37-4500-8287-ee64aac44029"
      unitRef="usd">6532000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzMtMS0xLTEtMTEyNjQw_7de11a29-6e2b-4d17-8bba-8b50b1a1fc32"
      unitRef="usd">662000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzMtMy0xLTEtMTEyNjQw_cddd605c-5e63-4ec1-afb3-78267c2a2ebb"
      unitRef="usd">2046000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedSalesCommissionCurrentAndNoncurrent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzQtMS0xLTEtMTEyNjQw_ba94dfed-b664-4bc7-9a4a-d80d9dcf5c5f"
      unitRef="usd">3989000</us-gaap:AccruedSalesCommissionCurrentAndNoncurrent>
    <us-gaap:AccruedSalesCommissionCurrentAndNoncurrent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzQtMy0xLTEtMTEyNjQw_6b97c6a1-e30e-4a09-a69b-1f10c06e96c1"
      unitRef="usd">630000</us-gaap:AccruedSalesCommissionCurrentAndNoncurrent>
    <us-gaap:AccruedRoyaltiesCurrentAndNoncurrent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzUtMS0xLTEtMTEyNjQw_f6e476fe-8926-43a2-b03d-04c330623890"
      unitRef="usd">12000</us-gaap:AccruedRoyaltiesCurrentAndNoncurrent>
    <us-gaap:AccruedRoyaltiesCurrentAndNoncurrent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzUtMy0xLTEtMTEyNjQw_a1828849-c8c9-4a65-9ac3-a5ae2ce4852e"
      unitRef="usd">149000</us-gaap:AccruedRoyaltiesCurrentAndNoncurrent>
    <lgnd:AccruedSalesReturns
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzYtMS0xLTEtMTEyNjQw_d3c109db-4943-4269-9be8-56fa06aed351"
      unitRef="usd">0</lgnd:AccruedSalesReturns>
    <lgnd:AccruedSalesReturns
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzYtMy0xLTEtMTEyNjQw_d87e524c-46f9-4587-94cc-c5670dd2435d"
      unitRef="usd">2420000</lgnd:AccruedSalesReturns>
    <lgnd:AccruedAssetAcquisitionsCurrent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzctMS0xLTEtMTEyNjQw_2a7408ec-ac0e-40b2-827c-6e90146e762e"
      unitRef="usd">0</lgnd:AccruedAssetAcquisitionsCurrent>
    <lgnd:AccruedAssetAcquisitionsCurrent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzctMy0xLTEtMTEyNjQw_13d4b7dd-6e7a-4e08-a5ec-586b419d8780"
      unitRef="usd">1000000</lgnd:AccruedAssetAcquisitionsCurrent>
    <lgnd:AccruedSubcontractorExpensesCurrent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzgtMS0xLTEtMTEyNjQw_9bc4cb6d-a001-403b-8d9e-45b4da3f0b86"
      unitRef="usd">0</lgnd:AccruedSubcontractorExpensesCurrent>
    <lgnd:AccruedSubcontractorExpensesCurrent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzgtMy0xLTEtMTEyNjQw_47f7e64d-c909-4b3f-8099-d7e4d4013d8c"
      unitRef="usd">1759000</lgnd:AccruedSubcontractorExpensesCurrent>
    <lgnd:AccruedSupplierExpensesCurrent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzktMS0xLTEtMTEyNjQw_0c22d952-9119-483e-a2fa-8574a4c81d5c"
      unitRef="usd">634000</lgnd:AccruedSupplierExpensesCurrent>
    <lgnd:AccruedSupplierExpensesCurrent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzktMy0xLTEtMTEyNjQw_e9ee7ae4-1089-41d4-9289-a1b80e752315"
      unitRef="usd">848000</lgnd:AccruedSupplierExpensesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzEwLTEtMS0xLTExMjY0MA_9cc66309-544e-47fc-9fb8-76f25b19b3fe"
      unitRef="usd">4183000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzEwLTMtMS0xLTExMjY0MA_38eadd6b-f424-4517-a90c-061efc35a8bf"
      unitRef="usd">2195000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzExLTEtMS0xLTExMjY0MA_5d973962-6980-45c3-8ef8-0db784d54f3d"
      unitRef="usd">15681000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZToyZWU5MDU2Mjk5ZmQ0MTJlODVkNmZjMjAzMDY2YWEzZS90YWJsZXJhbmdlOjJlZTkwNTYyOTlmZDQxMmU4NWQ2ZmMyMDMwNjZhYTNlXzExLTMtMS0xLTExMjY0MA_043e6336-f09e-4202-b834-5e1d45e0bd1f"
      unitRef="usd">17579000</us-gaap:AccruedLiabilitiesCurrent>
    <lgnd:NumberOfContingentValueRightAgreements
      contextRef="iefe06608d69a4810b5ef7844034e3616_I20100131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzMyMzY_18e8ee7f-babb-4927-9600-c60411fcf91c"
      unitRef="agreement">4</lgnd:NumberOfContingentValueRightAgreements>
    <lgnd:ScheduleofContingentLiabilitiesTableTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90ZXh0cmVnaW9uOjJmNTIzNzNkZTU1ZTQ0MTM5MGRmNjUwNjAyNjNkMGMzXzM3NTE_884124dd-89ef-496d-a7ab-bc3de5671c2d">The following table summarizes roll-forward of contingent liabilities as of December 2022 and 2021 (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.176%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.949%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.176%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair Value Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair Value Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Repurchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cydex&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(265)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Metabasis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(464)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pfenex&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(37,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;41,929&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(38,172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,707&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,513&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</lgnd:ScheduleofContingentLiabilitiesTableTextBlock>
    <lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod
      contextRef="ib9073dde9293463fa30e092e8acddc86_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzEtMS0xLTEtMTEyNjQw_b87e45bf-0f75-4824-8c40-4fbe364c52df"
      unitRef="usd">507000</lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod>
    <lgnd:PaymentsToContingentValueRightHolders
      contextRef="ie069fdb21c2e4a7f9f6faafc2d873eaf_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzEtMy0xLTEtMTEyNjQw_d84456f1-9a57-424a-99ab-9ddb98db4317"
      unitRef="usd">50000</lgnd:PaymentsToContingentValueRightHolders>
    <lgnd:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities
      contextRef="ie069fdb21c2e4a7f9f6faafc2d873eaf_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzEtNC0xLTEtMTEyNjQw_452d5154-00bd-4cd1-922e-d01d3c4eef9f"
      unitRef="usd">-108000</lgnd:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities>
    <lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod
      contextRef="ic917cc56cbc14ef49457a08f97faabb2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzEtNi0xLTEtMTEyNjQw_4415e817-dd46-439d-ac2a-c6f23c58eba3"
      unitRef="usd">349000</lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod>
    <lgnd:PaymentsToContingentValueRightHolders
      contextRef="i419fb6a0c6af4050bccc7d5632925f3b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzEtOS0xLTEtMTEyNjQw_54f979d9-8814-45c6-b666-002f244d6d80"
      unitRef="usd">0</lgnd:PaymentsToContingentValueRightHolders>
    <lgnd:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities
      contextRef="i419fb6a0c6af4050bccc7d5632925f3b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzEtMTAtMS0xLTExMjY0MA_2d625fd8-9c7a-45e1-8bb7-a52ba25b7d1a"
      unitRef="usd">-265000</lgnd:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities>
    <lgnd:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities
      contextRef="i419fb6a0c6af4050bccc7d5632925f3b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzEtMTEtMS0xLTExMjY0MA_1f6c1c96-620c-4548-acb2-8378af9635e7"
      unitRef="usd">0</lgnd:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities>
    <lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod
      contextRef="i1a5eaef79f744090a57acf2dd9bc3f41_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzEtMTItMS0xLTExMjY0MA_002a9dc4-66ca-4478-bfaf-2b3765e600ea"
      unitRef="usd">84000</lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod>
    <lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod
      contextRef="i36ae892ec43144929bf8462e64709b35_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzItMS0xLTEtMTEyNjQw_0a18e48a-f1a0-4523-8ac3-4c14a60ae689"
      unitRef="usd">3822000</lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod>
    <lgnd:PaymentsToContingentValueRightHolders
      contextRef="ie9a291d0bcd642c590a67f6bf07d86c7_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzItMy0xLTEtMTEyNjQw_23b3cb38-5819-4a77-8ab0-85366f768947"
      unitRef="usd">0</lgnd:PaymentsToContingentValueRightHolders>
    <lgnd:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities
      contextRef="ie9a291d0bcd642c590a67f6bf07d86c7_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzItNC0xLTEtMTEyNjQw_294b857a-6d1a-4197-a5de-1e8212954261"
      unitRef="usd">-464000</lgnd:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities>
    <lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod
      contextRef="i32c3e35d3cae415a91aa7ff9a8a97fc1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzItNi0xLTEtMTEyNjQw_252e6f6c-f6fb-4969-9a5f-6fba8acb21ca"
      unitRef="usd">3358000</lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod>
    <lgnd:PaymentsToContingentValueRightHolders
      contextRef="if67f5d0a5e884fae8966a608bcecbc8e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzItOS0xLTEtMTEyNjQw_0f93d79c-f38f-4352-8087-a8cf7f21f7d2"
      unitRef="usd">0</lgnd:PaymentsToContingentValueRightHolders>
    <lgnd:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities
      contextRef="if67f5d0a5e884fae8966a608bcecbc8e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzItMTAtMS0xLTExMjY0MA_cfd4de11-9e3c-481a-bb18-cdf2d24d58bb"
      unitRef="usd">71000</lgnd:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities>
    <lgnd:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities
      contextRef="if67f5d0a5e884fae8966a608bcecbc8e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzItMTEtMS0xLTExMjY0MA_5c914ae3-cc31-4a13-a05f-2dd83ed3839f"
      unitRef="usd">0</lgnd:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities>
    <lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod
      contextRef="iaf9732e8831a435d9e39b39f45cb491b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzItMTItMS0xLTExMjY0MA_64271445-a36b-49fe-9027-d1ea6cee84e4"
      unitRef="usd">3429000</lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod>
    <lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod
      contextRef="i36459dab15864e27a999bdcd2e68206a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzUtMS0xLTEtMTEyNjQw_2f10a5bb-6e88-4ebe-a836-7af00492be35"
      unitRef="usd">37600000</lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod>
    <lgnd:PaymentsToContingentValueRightHolders
      contextRef="i67ed4423d4894d809c0e43396ff89fb7_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzUtMy0xLTEtMTEyNjQw_c0418e0d-4838-430a-8485-9d097f108cb4"
      unitRef="usd">0</lgnd:PaymentsToContingentValueRightHolders>
    <lgnd:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities
      contextRef="i67ed4423d4894d809c0e43396ff89fb7_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzUtNC0xLTEtMTEyNjQw_c715cda2-7df6-435c-9df0-ae14d517f4e9"
      unitRef="usd">-37600000</lgnd:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities>
    <lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod
      contextRef="i45f91b32714d4d798c728a94c1d3c363_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzUtNi0xLTEtMTEyNjQw_e36be3d4-1314-4614-9703-ed16c5e72474"
      unitRef="usd">0</lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod>
    <lgnd:PaymentsToContingentValueRightHolders
      contextRef="i36cbb3f817354f04b57d665248187943_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzUtOS0xLTEtMTEyNjQw_c8db2809-4650-4bcb-b8f3-856cc6e45e8f"
      unitRef="usd">0</lgnd:PaymentsToContingentValueRightHolders>
    <lgnd:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities
      contextRef="i36cbb3f817354f04b57d665248187943_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzUtMTAtMS0xLTExMjY0MA_90aceaab-ebb7-47fb-b8f2-2731d82bea12"
      unitRef="usd">0</lgnd:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities>
    <lgnd:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities
      contextRef="i36cbb3f817354f04b57d665248187943_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzUtMTEtMS0xLTExMjY0MA_bd710ab6-f1ab-47b2-b905-5a367b7d48a7"
      unitRef="usd">0</lgnd:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities>
    <lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod
      contextRef="i1e5c28dda3f24c618a0e97fdb4db6a82_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzUtMTItMS0xLTExMjY0MA_c68dbd2e-c0dd-47fd-8e97-8058adcda4cb"
      unitRef="usd">0</lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod>
    <lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod
      contextRef="i859e9607437a43d8adb4d3dc08e60773_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzctMS0xLTEtMTEyNjQw_269389a7-2393-47b9-9348-888db1f55f7b"
      unitRef="usd">41929000</lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod>
    <lgnd:PaymentsToContingentValueRightHolders
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzctMy0xLTEtMTEyNjQw_d05708d7-0a27-4fba-ae88-f811c9e38279"
      unitRef="usd">50000</lgnd:PaymentsToContingentValueRightHolders>
    <lgnd:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzctNC0xLTEtMTEyNjQw_bdc7733a-8a0d-4250-a257-8ebfc315338a"
      unitRef="usd">-38172000</lgnd:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities>
    <lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod
      contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzctNi0xLTEtMTEyNjQw_b55ea5e2-10e1-4a3b-a051-8571c6d68406"
      unitRef="usd">3707000</lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod>
    <lgnd:PaymentsToContingentValueRightHolders
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzctOS0xLTEtMTEyNjQw_0f7c010b-d85a-4200-b0ea-9f60fc37af46"
      unitRef="usd">0</lgnd:PaymentsToContingentValueRightHolders>
    <lgnd:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzctMTAtMS0xLTExMjY0MA_ff34c611-5c23-4dda-a853-8d2c3359aa20"
      unitRef="usd">-194000</lgnd:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities>
    <lgnd:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzctMTEtMS0xLTExMjY0MA_853c1571-4a62-4bef-bce3-eb13f26006c6"
      unitRef="usd">0</lgnd:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities>
    <lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMDkvZnJhZzoyZjUyMzczZGU1NWU0NDEzOTBkZjY1MDYwMjYzZDBjMy90YWJsZTo0ZmFjMGE3MjY0NWI0NWM3OWY3NWY4NzdhOTQ0OGI2Mi90YWJsZXJhbmdlOjRmYWMwYTcyNjQ1YjQ1Yzc5Zjc1Zjg3N2E5NDQ4YjYyXzctMTItMS0xLTExMjY0MA_74c6287b-b730-467c-a172-a8bd6b64a8a4"
      unitRef="usd">3513000</lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzMxMTE_24d19e90-cc40-4f29-ac9b-0a9108f96c9e">Stockholders&#x2019; Equity&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-based Compensation Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes share-based compensation expense from continuing operations (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense as a component of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Conversion and Modification of Equity Awards Outstanding at Separation Date&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the OmniAb Separation on November 1, 2022, under the provisions of the existing plans, we adjusted our outstanding equity awards in accordance with the Merger Agreement to preserve the intrinsic value of the awards immediately before and after the Distribution. Upon the Distribution, employees holding stock options, restricted stock units and performance restricted stock units denominated in pre-Distribution Ligand stock received a number of otherwise-similar awards either in post-Distribution Ligand stock or in a combination of post-Distribution Ligand stock and OmniAb stock based on conversion ratios outlined for each group of employees in the Merger Agreement that we entered into in connection with the Distribution. The equity awards that were granted prior to March 2, 2022 were converted under the shareholder method, wherein employees holding outstanding equity awards received equity awards in both Ligand and OmniAb. For equity awards granted after March 2, 2022, for Ligand employees, the number of awards that were outstanding at the Separation were proportionately adjusted into post-Distribution Ligand stock to maintain the aggregate intrinsic value of the awards at the date of the Separation; for OmniAb employees, the number of awards that were outstanding at the Separation were proportionately adjusted into post-Distribution OmniAb stock to maintain the aggregate intrinsic value of the awards at the date of the Separation. The conversion ratio was determined based on the relative values of Ligand common stock in the &#x201c;regular way&#x201d; and &#x201c;ex-distribution&#x201d; markets during the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;five-trading day period prior to the closing of the business combination.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These modified awards otherwise retained substantially the same terms and conditions, including term and vesting provisions. Additionally, we will not incur any future compensation cost related to equity awards held by OmniAb employees and directors. We will incur future compensation cost related to OmniAb equity awards held by our employees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, our stockholders approved the amendment and restatement of the Ligand Pharmaceuticals Incorporated 2002 Stock Incentive Plan (the &#x201c;2002 Plan&#x201d;). The amended and restated 2002 Plan, which is referred to herein as the &#x201c;Restated Plan&#x201d; was amended to increase the shares available for issuance by 1.0 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 29, 2022, our board of directors (the &#x201c;Board&#x201d;) approved the Ligand Pharmaceuticals Incorporated 2022 Employment Inducement Plan (the &#x201c;2022 Inducement Plan&#x201d;). The terms of the 2022 Inducement Plan are substantially similar to the terms of the Restated Plan with the exception that incentive stock options may not be issued under the 2022 Inducement Plan and awards under the 2022 Inducement Plan may only be issued to eligible recipients under the applicable Nasdaq Listing Rules. The 2022 Inducement Plan was adopted by the Board without stockholder approval pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules. The Board has initially reserved 300,000 shares of the Company&#x2019;s common stock for issuance pursuant to awards granted under the 2022 Inducement Plan. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, there were 1.3 million shares available for future option grants or direct issuance under the Restated Plan and the 2022 Inducement Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following is a summary of our stock option plan activity and related information:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.244%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Exercise&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Remaining&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contractual&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Term in&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Intrinsic&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January&#160;1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,956,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.45&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;806,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(156,845)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44,012)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,561,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.09&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,611,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.54&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options vested and expected to vest as of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,561,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.09&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;393,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(619,731)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(136,082)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,199,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.34&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,391,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options vested and expected to vest as of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,199,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.34&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,941)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,069)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2022 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,987,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at October 31, 2022 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,769,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options vested and expected to vest as of October 31, 2022, before Separation and Regrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,987,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancellation due to Separation, Before Regrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,987,833)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at November 1, 2022, Before Regrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,584,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50,449)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(542,838)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,991,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.07&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,559,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.51&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options vested and expected to vest as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,991,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.07&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;(1) Options granted primarily relate to the modifications in connection with the Separation which resulted in new stock option grants at the modification date fair value. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average grant-date fair value of all stock options granted during 2022, 2021 and 2020 was $28.90, $80.08, and $41.39 per share, respectively. The total intrinsic value of all options exercised during 2022, 2021 and 2020 was approximately $4.6 million, $77.3 million, and $11.9 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash received from options exercised, net of fees paid, in 2022, 2021 and 2020 was $2.6 million, $33.0 million and $2.5 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following is a further breakdown of the options outstanding as of December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.212%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Range of exercise prices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;remaining&#160; life&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;in&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&#160;average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;exercise price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;exercisable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&#160;average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;exercise&#160;price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$12.78-$43.36&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.32&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$46.20-$52.78&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.63&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$52.84-$52.84&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;580,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.59&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$54.81-$57.22&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.47&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$58.28-$67.03&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.78&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$67.24-$69.70&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.93&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$70.04-$93.12&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.56&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$99.80-$99.80&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.84&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$103.42-$103.42&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$114.15-$114.15&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.47&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,991,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.07&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,559,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assumptions used for the specified reporting periods and the resulting estimates of weighted-average grant date fair value per share of options granted:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4%-4.3%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4%-1.2%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2%-1.4%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49%-55%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47%-63%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47%-71%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0 to 6.5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7 to 6.3 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7 to 5.1 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, there was $32.7 million of total unrecognized compensation cost related to non-vested stock options under the 2002 Plan. That cost is expected to be recognized over a weighted average period of 2.7 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, there was $4.8&#160;million of total unrecognized compensation cost related to non-vested OmniAb stock options received upon aforementioned spin-off conversion. That cost is expected to be recognized over a weighted average period of 1.8 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Activity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our restricted stock activity and related information:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.721%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Grant&#160;Date Fair&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52,363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98,501)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,850)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(138,867)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,383)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at October 31, 2022, before Separation and Regrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited due to Separation, Before Regrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(366,470)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at November 1, 2022, Before Regrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;424,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73,385)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,635)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, unrecognized compensation cost related to non-vested stock awards under the 2002 Plan amounted to $12.4&#160;million. That cost is expected to be recognized over a weighted average period of 1.7 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, there was $1.2&#160;million of total unrecognized compensation cost related to non-vested OmniAb stock awards received upon aforementioned spin-off conversion. That cost is expected to be recognized over a weighted average period of 1.0 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, 35,881 shares of our common stock are available for future issuance under the Amended Employee Stock Purchase Plan, or ESPP. The ESPP permits eligible employees to purchase up to 1,250 shares of Ligand common stock per calendar year at a discount through payroll deductions. The price at which stock is purchased under the ESPP is equal to 85% of the fair market value of the common stock on the first of a six month offering period or purchase date, whichever is lower. There were 8,479, 8,448 and 6,455 shares issued under the ESPP in 2022, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share Repurchases &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2019, our Board of Directors approved a stock repurchase program authorizing the repurchase of up to $500.0 million of our common stock from time to time over a period of up to three years. This repurchase program expired in September 2022.   During the year ended December&#160;31, 2022 and 2021, we did not repurchase any common stock, respectively. During the year ended December&#160;31, 2020, we repurchased 934,079 shares for $78.0 million.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;At-the Market Equity Offering Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 30, 2022, we filed a registration statement on Form S-3 (the &#x201c;Shelf Registration Statement&#x201d;), which became automatically effective upon filing, covering the offering of common stock, preferred stock, debt securities, warrants and units. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 30, 2022, we also entered into an At-The-Market Equity Offering Sales Agreement (the &#x201c;Sales Agreement&#x201d;) with Stifel, Nicolaus &amp;amp; Company, Incorporated (the &#x201c;Agent&#x201d;), under which we may, from time to time, sell shares of our common stock having an aggregate offering price of up to $100.0&#160;million in &#x201c;at the market&#x201d; offerings through the Agent (the &lt;/span&gt;&lt;/div&gt;&#x201c;ATM Offering&#x201d;). The Shelf Registration Statement included a prospectus covering the offering, issuance and sale of up to $100.0&#160;million of our common stock from time to time through the ATM Offering. The shares to be sold under the Sales Agreement may be issued and sold pursuant to the Shelf Registration Statement. To date, we have not issued any shares of common stock in the ATM Offering.</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzMxMTI_be4b0835-dd22-4fcb-bb41-e759d842c934">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes share-based compensation expense from continuing operations (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense as a component of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Prior period amounts have been retrospectively adjusted to reflect the effects of the Separation.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i58c8e37938964262a8d9fbb812dc0595_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3MzEyNDRlOTViMTY0ZjFjYWU1MGYxZTY2ZmE0ODIzNS90YWJsZXJhbmdlOjczMTI0NGU5NWIxNjRmMWNhZTUwZjFlNjZmYTQ4MjM1XzMtMS0xLTEtMTI0MTUz_e237f7d7-2141-4722-8c15-a3b82ce0a801"
      unitRef="usd">10970000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i06d744f80dd94f3190aafa087db24d87_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3MzEyNDRlOTViMTY0ZjFjYWU1MGYxZTY2ZmE0ODIzNS90YWJsZXJhbmdlOjczMTI0NGU5NWIxNjRmMWNhZTUwZjFlNjZmYTQ4MjM1XzMtMS0xLTEtMTEyNjQw_7f965e17-c576-4e4a-b957-3d834a29e399"
      unitRef="usd">9341000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="if7ee9d97264e44b99c988c2bc5b6d24f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3MzEyNDRlOTViMTY0ZjFjYWU1MGYxZTY2ZmE0ODIzNS90YWJsZXJhbmdlOjczMTI0NGU5NWIxNjRmMWNhZTUwZjFlNjZmYTQ4MjM1XzMtMy0xLTEtMTEyNjQw_d4bb062b-81e4-4cab-b953-6cf498a6dd45"
      unitRef="usd">8513000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i4c0071327d664b04b5121faf1e1aafbb_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3MzEyNDRlOTViMTY0ZjFjYWU1MGYxZTY2ZmE0ODIzNS90YWJsZXJhbmdlOjczMTI0NGU5NWIxNjRmMWNhZTUwZjFlNjZmYTQ4MjM1XzQtMS0xLTEtMTI0MTUz_d691039e-dfed-460a-a559-80300f602623"
      unitRef="usd">39911000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i0496dc8b573246759849c58cf2ee5081_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3MzEyNDRlOTViMTY0ZjFjYWU1MGYxZTY2ZmE0ODIzNS90YWJsZXJhbmdlOjczMTI0NGU5NWIxNjRmMWNhZTUwZjFlNjZmYTQ4MjM1XzQtMS0xLTEtMTEyNjQw_3565d97b-3ef8-4f42-97be-cf95db817512"
      unitRef="usd">19985000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ifb4f9e0d157846e39f3e696539899f72_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3MzEyNDRlOTViMTY0ZjFjYWU1MGYxZTY2ZmE0ODIzNS90YWJsZXJhbmdlOjczMTI0NGU5NWIxNjRmMWNhZTUwZjFlNjZmYTQ4MjM1XzQtMy0xLTEtMTEyNjQw_b18d1998-9fbf-47b2-a94f-880f96ff6711"
      unitRef="usd">16612000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3MzEyNDRlOTViMTY0ZjFjYWU1MGYxZTY2ZmE0ODIzNS90YWJsZXJhbmdlOjczMTI0NGU5NWIxNjRmMWNhZTUwZjFlNjZmYTQ4MjM1XzUtMS0xLTEtMTI0MTYz_f1a6728f-e25c-4c50-8fe5-0269bc7a0b6a"
      unitRef="usd">50881000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3MzEyNDRlOTViMTY0ZjFjYWU1MGYxZTY2ZmE0ODIzNS90YWJsZXJhbmdlOjczMTI0NGU5NWIxNjRmMWNhZTUwZjFlNjZmYTQ4MjM1XzUtMS0xLTEtMTEyNjQw_ea50ea40-aca9-4a19-a97a-c72f6db760ef"
      unitRef="usd">29326000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3MzEyNDRlOTViMTY0ZjFjYWU1MGYxZTY2ZmE0ODIzNS90YWJsZXJhbmdlOjczMTI0NGU5NWIxNjRmMWNhZTUwZjFlNjZmYTQ4MjM1XzUtMy0xLTEtMTEyNjQw_9ea2b0e6-b150-4c72-9e6a-ca4ed7d69b15"
      unitRef="usd">25125000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="iae45ac44b4cf4613953eedfe31c7f341_D20220601-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzE2NDkyNjc0NDg3MTU_25080fca-73be-488b-a4ee-35253c9fd0f5"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i14ec222f5248466398774a2561f84042_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzM4NDgyOTA3MTI0NTE_5358c1e8-db3d-48ab-b593-ee63f4301d75"
      unitRef="shares">1300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzMxMTQ_561dba41-6670-4ec8-9c41-82dfe07c0cc4">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following is a summary of our stock option plan activity and related information:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.244%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Exercise&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Remaining&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contractual&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Term in&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Intrinsic&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January&#160;1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,956,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.45&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;806,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(156,845)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44,012)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,561,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.09&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,611,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.54&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options vested and expected to vest as of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,561,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.09&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;393,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(619,731)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(136,082)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,199,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.34&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,391,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options vested and expected to vest as of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,199,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.34&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,941)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,069)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2022 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,987,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at October 31, 2022 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,769,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options vested and expected to vest as of October 31, 2022, before Separation and Regrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,987,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancellation due to Separation, Before Regrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,987,833)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at November 1, 2022, Before Regrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,584,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50,449)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(542,838)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,991,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.07&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,559,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.51&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options vested and expected to vest as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,991,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.07&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1) Options granted primarily relate to the modifications in connection with the Separation which resulted in new stock option grants at the modification date fair value.</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i859e9607437a43d8adb4d3dc08e60773_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzctMS0xLTEtMTEyNjQw_50e74837-89c1-4c40-8c21-7f74ffa662b9"
      unitRef="shares">1956379</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i859e9607437a43d8adb4d3dc08e60773_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzctMy0xLTEtMTEyNjQw_19e0ceee-629a-4b3d-87d3-7d9fdf467709"
      unitRef="usdPerShare">77.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ic67831c921904253a87bb44165f263ef_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzctNS0xLTEtMTEyNjQw_dd1816ab-c3e3-4f0f-9730-28a747dfc2f8">P5Y5M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i859e9607437a43d8adb4d3dc08e60773_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzctNy0xLTEtMTEyNjQw_d11ff704-a6c9-4259-88d0-139211d86895"
      unitRef="usd">72002000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzgtMS0xLTEtMTEyNjQw_2569f7c7-970e-4c8c-8b85-3850b0473c57"
      unitRef="shares">806300</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzgtMy0xLTEtMTEyNjQw_65d1413d-6086-41c1-91cd-51089080bc2e"
      unitRef="usdPerShare">92.93</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzktMS0xLTEtMTEyNjQw_5307bccf-03bc-46ec-8f93-f9ca7b506d65"
      unitRef="shares">156845</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzktMy0xLTEtMTEyNjQw_b90ed4f3-54b6-4d92-9e0e-fd1caf2ef18a"
      unitRef="usdPerShare">21.26</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzEwLTEtMS0xLTExMjY0MA_5d2aea25-7d98-473c-9c5b-c94ad9239adf"
      unitRef="shares">44012</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzEwLTMtMS0xLTExMjY0MA_55ce430b-f0d6-49e9-b883-c1810944a3a3"
      unitRef="usdPerShare">91.30</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzExLTEtMS0xLTExMjY0MA_b6087154-ea0a-4521-863b-4fa455ec51ba"
      unitRef="shares">2561822</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzExLTMtMS0xLTExMjY0MA_e00494bc-2553-4467-b4cd-fe406f67dfdf"
      unitRef="usdPerShare">85.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzExLTUtMS0xLTExMjY0MA_53dfabd5-65ff-4f04-a692-762ce68ff032">P6Y1M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzExLTctMS0xLTExMjY0MA_920e1e72-a5d4-4754-a94c-cc00d6076950"
      unitRef="usd">59033000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzEyLTEtMS0xLTExMjY0MA_5a7f528e-89bb-4202-9e20-52f5c88f2bb0"
      unitRef="shares">1611830</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzEyLTMtMS0xLTExMjY0MA_630d7e50-8fab-464d-9c0a-71927430c4f8"
      unitRef="usdPerShare">76.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzEyLTUtMS0xLTExMjY0MA_4ccb5a24-ab4e-4e85-8f6d-40963258f6b2">P4Y6M14D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzEyLTctMS0xLTExMjY0MA_bdfbe237-1811-4e8b-ad08-c4ff740f2662"
      unitRef="usd">53286000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzEzLTEtMS0xLTExMjY0MA_58adc081-26ee-42b1-a45d-76884d9e4c32"
      unitRef="shares">2561822</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzEzLTMtMS0xLTExMjY0MA_cca51fbb-7983-4f84-b744-c4e23c3f9a38"
      unitRef="usdPerShare">85.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzEzLTUtMS0xLTExMjY0MA_97dfc029-9193-4950-b990-c645f24b2866">P6Y1M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzEzLTctMS0xLTExMjY0MA_d6a9aee9-33ff-4aaa-8f0c-438ca30dae03"
      unitRef="usd">59033000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE0LTEtMS0xLTExMjY0MA_553e7c68-481f-42c4-884a-3f62898797ac"
      unitRef="shares">393589</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE0LTMtMS0xLTExMjY0MA_348e371e-3e78-404e-879b-9930ee801c8f"
      unitRef="usdPerShare">159.12</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE1LTEtMS0xLTExMjY0MA_d052b649-844c-4a9c-af1d-318d16d37439"
      unitRef="shares">619731</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE1LTMtMS0xLTExMjY0MA_8e686eb2-b82f-4e1f-a9fc-da0338dd34e9"
      unitRef="usdPerShare">54.28</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE2LTEtMS0xLTExMjY0MA_48f4dbe7-4441-482f-bdf4-8b9ad22a762b"
      unitRef="shares">136082</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE2LTMtMS0xLTExMjY0MA_e2042277-e36a-4cbc-9954-b4ce8aefead1"
      unitRef="usdPerShare">110.83</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE3LTEtMS0xLTExMjY0MA_cbec92e6-8868-4242-a246-6f508900621a"
      unitRef="shares">2199598</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE3LTMtMS0xLTExMjY0MA_12c29e7e-2f79-4b94-bf3c-7cb2db163fba"
      unitRef="usdPerShare">106.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE3LTUtMS0xLTExMjY0MA_e085f382-4a96-4545-8ab5-9e614c897ee4">P6Y4M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE3LTctMS0xLTExMjY0MA_9e0335ff-3b98-47e3-8e6d-b400dcea0b85"
      unitRef="usd">113302000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE4LTEtMS0xLTExMjY0MA_f7d42ca4-fd85-4eaf-aad5-1f249d312822"
      unitRef="shares">1391952</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE4LTMtMS0xLTExMjY0MA_d63244d8-a35d-40f2-bbb1-04946ea630da"
      unitRef="usdPerShare">98.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE4LTUtMS0xLTExMjY0MA_04e021dd-5180-411f-96fa-db9ae09b8338">P5Y1M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE4LTctMS0xLTExMjY0MA_58a86fee-4eaa-4c0c-b77c-3bc4f77514fa"
      unitRef="usd">80849000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE5LTEtMS0xLTExMjY0MA_06a6b8bf-88a9-4d7c-99f1-c206d1c62cef"
      unitRef="shares">2199598</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE5LTMtMS0xLTExMjY0MA_70502e31-4202-458f-b65b-ea2205576c91"
      unitRef="usdPerShare">106.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE5LTUtMS0xLTExMjY0MA_e38c0287-0720-4c00-aafa-7c8c08e07857">P6Y4M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE5LTctMS0xLTExMjY0MA_6e1272fe-1bee-4e7e-9918-eb686cf9779a"
      unitRef="usd">113302000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i59fa0ea34268498a977d54122e7473c5_D20220101-20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE0LTEtMS0xLTEyMTQ5OQ_81456e2f-edbe-4b9e-bf59-1a951bf4b322"
      unitRef="shares">863245</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i59fa0ea34268498a977d54122e7473c5_D20220101-20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE0LTMtMS0xLTEyMTQ5OQ_33b16cf8-24b7-4722-956d-0945be7a2740"
      unitRef="usdPerShare">91.34</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i59fa0ea34268498a977d54122e7473c5_D20220101-20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE1LTEtMS0xLTEyMTQ5OQ_db7b8387-7960-4e7d-8d76-5530401469d8"
      unitRef="shares">34941</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i59fa0ea34268498a977d54122e7473c5_D20220101-20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE1LTMtMS0xLTEyMTQ5OQ_fefe898d-1e9e-43da-9e47-8269f4ebf54f"
      unitRef="usdPerShare">38.56</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i59fa0ea34268498a977d54122e7473c5_D20220101-20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE2LTEtMS0xLTEyMTQ5OQ_7c751a96-f108-401e-8776-360097ab8149"
      unitRef="shares">40069</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i59fa0ea34268498a977d54122e7473c5_D20220101-20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE2LTMtMS0xLTEyMTQ5OQ_d2f6736d-4407-4568-88d6-c54911a6e766"
      unitRef="usdPerShare">78.46</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i1e08d73fd52941c8b0a838aeb83cbe3b_I20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE3LTEtMS0xLTEyMTY4Mg_6b81cfe7-76aa-4dee-9d3d-ea1d57a58864"
      unitRef="shares">2987833</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i1e08d73fd52941c8b0a838aeb83cbe3b_I20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE3LTMtMS0xLTEyMTUxMQ_3edeb388-df48-478c-9cdc-8f9aa0e8ca4c"
      unitRef="usdPerShare">102.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i59fa0ea34268498a977d54122e7473c5_D20220101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE3LTUtMS0xLTEyMTU5Nw_c326ddf1-20dd-4faf-b0f3-6a30375edd1a">P0Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i1e08d73fd52941c8b0a838aeb83cbe3b_I20221031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE3LTctMS0xLTEyMTU5Nw_3ee1c124-f8df-4b28-9db4-8ac078373d2f"
      unitRef="usd">14835000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i1e08d73fd52941c8b0a838aeb83cbe3b_I20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE4LTEtMS0xLTEyMTUxOA_aefbe20e-b756-4e9c-bd94-814525843d5a"
      unitRef="shares">1769629</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i1e08d73fd52941c8b0a838aeb83cbe3b_I20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE4LTMtMS0xLTEyMTUxMQ_daacd09b-910a-4be2-81da-5b6f4b209c1b"
      unitRef="usdPerShare">102.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i59fa0ea34268498a977d54122e7473c5_D20220101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE4LTUtMS0xLTEyMTU5Nw_b95bd79e-2b49-4396-9ce5-dacbcc562844">P0Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i1e08d73fd52941c8b0a838aeb83cbe3b_I20221031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE4LTctMS0xLTEyMTU5Nw_faf70ebc-660b-4092-8cb7-d3cf5f2dc3bc"
      unitRef="usd">13722000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="i1e08d73fd52941c8b0a838aeb83cbe3b_I20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE5LTEtMS0xLTEyMTY4NA_6160733d-e9c3-4d02-9923-cea495fae090"
      unitRef="shares">2987833</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="i1e08d73fd52941c8b0a838aeb83cbe3b_I20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE5LTMtMS0xLTEyMTY4OQ_e1d0e79c-ee52-43ff-84a2-339d50c85099"
      unitRef="usdPerShare">102.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i59fa0ea34268498a977d54122e7473c5_D20220101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE5LTUtMS0xLTEyMTY5NA_a40ca74d-5d6b-42b7-a01e-70ec2797d0f4">P0Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i1e08d73fd52941c8b0a838aeb83cbe3b_I20221031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzE5LTctMS0xLTEyMTY5Ng_203be641-66de-482a-b6b5-c6746a5dc28c"
      unitRef="usd">14835000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="ifb8d1e2f9bc24fa4a2bc478bc667577c_D20221101-20221101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzIwLTEtMS0xLTEyNzA0NQ_0d1efb63-d4b8-4ae5-b675-285b9bfbfb02"
      unitRef="shares">2987833</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="ie06ebd7de19543a9be2b5f0c195a8849_I20221101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzIxLTEtMS0xLTEyNzA0OA_ee269a64-0f98-43fc-bc94-65008a649806"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ieaaf4e1776ca4ee3b882116a392a5b8c_D20221102-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzIwLTEtMS0xLTEyMTU1Mg_e0ccdd37-c173-4339-8043-bd599c4bc4e9"
      unitRef="shares">3584760</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="ieaaf4e1776ca4ee3b882116a392a5b8c_D20221102-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzIwLTMtMS0xLTEyMTU0MQ_190c25d2-cef0-4c47-9fd9-7b1466129b83"
      unitRef="usdPerShare">60.10</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ieaaf4e1776ca4ee3b882116a392a5b8c_D20221102-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzIxLTEtMS0xLTEyMTU1Mg_898d01f1-22a3-421f-b92e-62e2e0ab55ea"
      unitRef="shares">50449</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ieaaf4e1776ca4ee3b882116a392a5b8c_D20221102-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzIxLTMtMS0xLTEyMTU0MQ_dbf4e010-c08f-4f24-9b69-9a756bc62511"
      unitRef="usdPerShare">30.24</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="ieaaf4e1776ca4ee3b882116a392a5b8c_D20221102-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzIyLTEtMS0xLTEyMTU1Mg_cb9bd89c-39da-4319-9d35-1b7b31b0d1b2"
      unitRef="shares">542838</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="ieaaf4e1776ca4ee3b882116a392a5b8c_D20221102-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzIyLTMtMS0xLTEyMTU0MQ_6ea41632-f932-4198-9f02-905df8501faf"
      unitRef="usdPerShare">56.20</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzIzLTEtMS0xLTEyMTY4Ng_1d763b70-5350-4ead-af57-c99ed74a4ec3"
      unitRef="shares">2991473</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzIzLTMtMS0xLTEyMTU0MQ_fe5effba-3a4c-43a5-ab7e-4e87fe417d3f"
      unitRef="usdPerShare">61.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ieaaf4e1776ca4ee3b882116a392a5b8c_D20221102-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzIzLTUtMS0xLTEyMTYxMQ_6d7ae13c-56d1-466e-a1b4-7be04419ff7e">P6Y25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzIzLTctMS0xLTEyMTYxMQ_415b942d-ad8e-45f3-844d-0abab32b0dd5"
      unitRef="usd">30477000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzI0LTEtMS0xLTEyMTU2OA_a3c9f731-58fa-4236-9fca-ac369f7a9cac"
      unitRef="shares">1559662</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzI0LTMtMS0xLTEyMTU2OA_6a489d1d-2127-467b-8e5a-4c97fc743d1c"
      unitRef="usdPerShare">60.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="ieaaf4e1776ca4ee3b882116a392a5b8c_D20221102-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzI0LTUtMS0xLTEyMTU4MQ_2e7e80c7-f9ef-43d3-88e0-6ac46ae322d3">P4Y6M3D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzI0LTctMS0xLTEyMTU4MQ_c5934bb2-a77a-40ee-a5d7-5e2091945d47"
      unitRef="usd">17951000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzI1LTEtMS0xLTEyMTY4Ng_a3f539fc-a0e5-4391-9854-60253a107ebe"
      unitRef="shares">2991473</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzI1LTMtMS0xLTEyMTY5MQ_7086c301-712f-4408-b4f5-ebe0592022da"
      unitRef="usdPerShare">61.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="ieaaf4e1776ca4ee3b882116a392a5b8c_D20221102-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzI1LTUtMS0xLTEyMTU4MQ_06fd6641-e70e-42bf-9e66-c26b9cb8c2cc">P6Y25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo3NGY2NzVhNDI3ZDI0Y2U1YjFkM2FlYzNhZmJhMmExNy90YWJsZXJhbmdlOjc0ZjY3NWE0MjdkMjRjZTViMWQzYWVjM2FmYmEyYTE3XzI1LTctMS0xLTEyMTU4MQ_cb045d8d-2e88-415d-8cdd-21da95fcdad4"
      unitRef="usd">30477000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="if66ef91cf250497180df8bdafb040c04_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzU0OTc1NTgxNzIxNA_656b2bd7-f99b-4f7c-929d-289818ab7cd0"
      unitRef="usdPerShare">28.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i67a5c3e26a4a41c5965dfa8c1722d00f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzU5Ng_e7a6109b-b021-45fa-a4aa-d12ffad60589"
      unitRef="usdPerShare">80.08</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i76c8d1f51aad42668b7908e89daf66dd_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzYwMA_0f9795da-599f-4db6-a875-183f7a413b73"
      unitRef="usdPerShare">41.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="if66ef91cf250497180df8bdafb040c04_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzU0OTc1NTgxNzQ1Ng_e44fe5d0-1ad6-450b-a275-ea65d6beb51c"
      unitRef="usd">4600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i67a5c3e26a4a41c5965dfa8c1722d00f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzcyNQ_bfeb5aed-5a53-43e5-bd55-f900d693e778"
      unitRef="usd">77300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i76c8d1f51aad42668b7908e89daf66dd_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzcyOQ_f2e18485-356f-4e98-9f78-cd436431fb35"
      unitRef="usd">11900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="if66ef91cf250497180df8bdafb040c04_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzU0OTc1NTgxNzQ2Nw_f727bb45-8709-4f8e-a0d2-f3ba9a20ebf5"
      unitRef="usd">2600000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i67a5c3e26a4a41c5965dfa8c1722d00f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzgzMg_25e69397-f991-4262-a818-1c38662ce328"
      unitRef="usd">33000000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i76c8d1f51aad42668b7908e89daf66dd_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzgzNg_e52ec8ae-7665-4d95-aaf4-6a0ab1341f79"
      unitRef="usd">2500000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzMxMTU_bc33442c-99ef-4a10-8001-913f197d2733">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following is a further breakdown of the options outstanding as of December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.212%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Range of exercise prices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;remaining&#160; life&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;in&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&#160;average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;exercise price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;exercisable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&#160;average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;exercise&#160;price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$12.78-$43.36&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.32&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$46.20-$52.78&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.63&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$52.84-$52.84&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;580,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.59&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$54.81-$57.22&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.47&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$58.28-$67.03&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.78&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$67.24-$69.70&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.93&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$70.04-$93.12&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.56&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$99.80-$99.80&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.84&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$103.42-$103.42&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$114.15-$114.15&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.47&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,991,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.07&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,559,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i3ea9d8dc84e843c18bf275e4e37eca43_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzEtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246OWU2MGFhMzc2YmM1NGE1MWE5MDIxYmM5YjkzZjQ2NmZfNA_9663a72b-6a07-4f32-a683-335068370daa"
      unitRef="usdPerShare">12.78</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i3ea9d8dc84e843c18bf275e4e37eca43_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzEtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246OWU2MGFhMzc2YmM1NGE1MWE5MDIxYmM5YjkzZjQ2NmZfNw_caf25dee-2c6b-45d5-9d47-2823fa40f73a"
      unitRef="usdPerShare">43.36</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="ic08afe60b35d4e72a651be2308becc85_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzEtMS0xLTEtMTEyNjQw_c0e35443-8b47-4d3e-9fcf-696b657a7edb"
      unitRef="shares">395660</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i3ea9d8dc84e843c18bf275e4e37eca43_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzEtMy0xLTEtMTEyNjQw_e739888f-f5e7-4705-b20d-7fe17691b08f">P2Y3M25D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="ic08afe60b35d4e72a651be2308becc85_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzEtNS0xLTEtMTEyNjQw_9e76de47-fe42-4b7d-9b71-d019344c3992"
      unitRef="usdPerShare">35.76</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="ic08afe60b35d4e72a651be2308becc85_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzEtNy0xLTEtMTEyNjQw_ecd0ea67-e016-45d6-a1a5-876589cdca72"
      unitRef="shares">366426</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="ic08afe60b35d4e72a651be2308becc85_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzEtOS0xLTEtMTEyNjQw_0da126f6-e4bd-4964-8ef9-75deaadc3fa5"
      unitRef="usdPerShare">35.44</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="ief7b0c06377d406cb4005ea8273c1cc1_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzItMC0xLTEtMTEyNjQwL3RleHRyZWdpb246Y2MyZDI4YzRiZWMzNGViMDgyMjVhYmZhMDc3Y2UyZjhfNA_d9b20596-5edf-417b-81dc-131607d3c6ca"
      unitRef="usdPerShare">46.20</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="ief7b0c06377d406cb4005ea8273c1cc1_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzItMC0xLTEtMTEyNjQwL3RleHRyZWdpb246Y2MyZDI4YzRiZWMzNGViMDgyMjVhYmZhMDc3Y2UyZjhfNw_ccd1cba8-15c4-4c48-b944-9e462d985d49"
      unitRef="usdPerShare">52.78</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i3e7d98d1709e4fe5b08bdc5dac823ced_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzItMS0xLTEtMTEyNjQw_be530aef-23de-459b-843f-558bca744055"
      unitRef="shares">279405</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="ief7b0c06377d406cb4005ea8273c1cc1_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzItMy0xLTEtMTEyNjQw_ad539628-4060-4829-8c30-73add1a6e4a2">P6Y7M17D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="i3e7d98d1709e4fe5b08bdc5dac823ced_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzItNS0xLTEtMTEyNjQw_3791ad90-6e30-4776-87ed-bde31f8f4819"
      unitRef="usdPerShare">50.24</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i3e7d98d1709e4fe5b08bdc5dac823ced_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzItNy0xLTEtMTEyNjQw_b18584ee-f858-41da-bdc4-e1a6b178ded4"
      unitRef="shares">122734</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="i3e7d98d1709e4fe5b08bdc5dac823ced_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzItOS0xLTEtMTEyNjQw_fc12fbe1-f57c-48a7-aff6-4ec0014e8bee"
      unitRef="usdPerShare">50.18</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="ibd1f4da528084577aee7dcabc5455e87_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzMtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246NWMxNDhlMTE4MjQ5NGI0MmIwMzJmNTU0MDZmNmFlYTNfNA_d6cc7264-b944-4135-98c0-944b3d5bb37b"
      unitRef="usdPerShare">52.84</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="ibd1f4da528084577aee7dcabc5455e87_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzMtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246NWMxNDhlMTE4MjQ5NGI0MmIwMzJmNTU0MDZmNmFlYTNfNw_96c9df10-2b39-4330-89e9-750b896b5628"
      unitRef="usdPerShare">52.84</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i8df448bf131f436d8340558685040924_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzMtMS0xLTEtMTEyNjQw_78d509a4-f5fa-478a-a791-8ba6ddb81324"
      unitRef="shares">580629</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="ibd1f4da528084577aee7dcabc5455e87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzMtMy0xLTEtMTEyNjQw_1a1c622a-e573-40df-bfdd-d89289785e9d">P7Y7M2D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="i8df448bf131f436d8340558685040924_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzMtNS0xLTEtMTEyNjQw_83cff767-82bd-4a9a-83b2-a5f1303084be"
      unitRef="usdPerShare">52.84</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i8df448bf131f436d8340558685040924_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzMtNy0xLTEtMTEyNjQw_7aa9a72a-d0d9-4e5d-b36a-22c9ac011e1a"
      unitRef="shares">88647</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="i8df448bf131f436d8340558685040924_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzMtOS0xLTEtMTEyNjQw_4d550723-498c-4585-b8e7-717a5006c4f9"
      unitRef="usdPerShare">52.84</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="id70a7d71b0a14b0abc0db27c646a2a71_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzQtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246YzAyMDJhMDZlNzI3NGEwMDlkNjFiZDE2MjI3NWI5NGVfNTQ5NzU1ODEzOTAy_755db3e0-98d6-4862-bc55-d1b3f726dd51"
      unitRef="usdPerShare">54.81</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="id70a7d71b0a14b0abc0db27c646a2a71_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzQtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246YzAyMDJhMDZlNzI3NGEwMDlkNjFiZDE2MjI3NWI5NGVfNTQ5NzU1ODEzODk4_963801cd-017b-41bc-9c7a-87bb32502256"
      unitRef="usdPerShare">57.22</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="ic75d320692e9481bb881a28239201125_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzQtMS0xLTEtMTEyNjQw_634127f9-a8ab-473f-b319-63cd06641c5e"
      unitRef="shares">391280</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="id70a7d71b0a14b0abc0db27c646a2a71_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzQtMy0xLTEtMTEyNjQw_f23062f7-5ebe-496f-94eb-332e7d20aac7">P6Y5M19D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="ic75d320692e9481bb881a28239201125_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzQtNS0xLTEtMTEyNjQw_89d9f650-0b5b-4893-a4b8-9bce30653d6a"
      unitRef="usdPerShare">56.24</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="ic75d320692e9481bb881a28239201125_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzQtNy0xLTEtMTEyNjQw_b801e37f-9c2d-4062-907f-234411afd8e6"
      unitRef="shares">198283</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="ic75d320692e9481bb881a28239201125_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzQtOS0xLTEtMTEyNjQw_6ec51a1d-2716-443e-931a-cdfa13a83452"
      unitRef="usdPerShare">56.26</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="if0206a09bd2447e0b7a819f3e88399b0_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzUtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246YjEzYWMzMTEyOTU5NDc0N2I0ZjhmMmY4NzI0MzI0N2JfNA_51c41bfa-5dac-4aa1-9949-010857d4c79e"
      unitRef="usdPerShare">58.28</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="if0206a09bd2447e0b7a819f3e88399b0_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzUtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246YjEzYWMzMTEyOTU5NDc0N2I0ZjhmMmY4NzI0MzI0N2JfNw_1c13aa3e-c6e1-495b-82d8-fa4d8d978db8"
      unitRef="usdPerShare">67.03</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="if244aca373d34599b957dd0229b16240_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzUtMS0xLTEtMTEyNjQw_8c188c33-d27c-486c-b0e5-51aed520337b"
      unitRef="shares">477042</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="if0206a09bd2447e0b7a819f3e88399b0_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzUtMy0xLTEtMTEyNjQw_777493c8-9207-49d9-95d5-56abbdd540a2">P5Y9M10D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="if244aca373d34599b957dd0229b16240_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzUtNS0xLTEtMTEyNjQw_6f04ca67-8fcc-4d95-a79b-054dfd71dd9c"
      unitRef="usdPerShare">64.11</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="if244aca373d34599b957dd0229b16240_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzUtNy0xLTEtMTEyNjQw_65bb09e2-943c-4fc7-9f57-7758ca935bc9"
      unitRef="shares">274719</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="if244aca373d34599b957dd0229b16240_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzUtOS0xLTEtMTEyNjQw_84850e5d-dd7b-4d19-85b8-8db0d71754f1"
      unitRef="usdPerShare">62.90</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i53aac02f675646bc9f345ded193cb397_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzYtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246MDgwNDczMmFiNTVlNDFjMzkyOWE0YmMyMjk2NTBlYWRfNA_ecf7d1fa-ba54-4e4b-8647-9f9d40e183e1"
      unitRef="usdPerShare">67.24</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i53aac02f675646bc9f345ded193cb397_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzYtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246MDgwNDczMmFiNTVlNDFjMzkyOWE0YmMyMjk2NTBlYWRfNw_78808955-56e3-4da3-9091-c5fc2036105e"
      unitRef="usdPerShare">69.70</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="ida99b6789c3a4f50b772bdb7b47fa5cd_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzYtMS0xLTEtMTEyNjQw_afc23f75-ff5e-4027-b65b-3f7266482e13"
      unitRef="shares">403187</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i53aac02f675646bc9f345ded193cb397_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzYtMy0xLTEtMTEyNjQw_2eff08eb-5be2-438a-bf38-9878f3f87cb7">P6Y11M4D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="ida99b6789c3a4f50b772bdb7b47fa5cd_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzYtNS0xLTEtMTEyNjQw_85940fa8-60bc-4c37-a1d3-13d001731d9f"
      unitRef="usdPerShare">68.98</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="ida99b6789c3a4f50b772bdb7b47fa5cd_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzYtNy0xLTEtMTEyNjQw_74a0a745-5127-4d39-9f72-61769221efb1"
      unitRef="shares">207981</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="ida99b6789c3a4f50b772bdb7b47fa5cd_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzYtOS0xLTEtMTEyNjQw_f9341407-f25b-41a5-98ba-0f027b82ceec"
      unitRef="usdPerShare">68.60</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i6b63563893e044e48841c92b5fe75d81_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzctMC0xLTEtMTEyNjQwL3RleHRyZWdpb246OGE5MDVlZTIwMTM1NGRkNGExMzE3MDk4M2Y1Y2JjYzFfNTQ5NzU1ODEzODk4_119f76f8-88e2-40a2-a345-895ec636caeb"
      unitRef="usdPerShare">70.04</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i6b63563893e044e48841c92b5fe75d81_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzctMC0xLTEtMTEyNjQwL3RleHRyZWdpb246OGE5MDVlZTIwMTM1NGRkNGExMzE3MDk4M2Y1Y2JjYzFfNTQ5NzU1ODEzOTAy_75d6586f-6e84-4413-87fe-92c0f8c7a5ef"
      unitRef="usdPerShare">93.12</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i832e5c7bccde4123b022c8bab92e41a3_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzctMS0xLTEtMTEyNjQw_45dcaba9-ebd8-4c4d-b6d3-3f96ce430c38"
      unitRef="shares">254738</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i6b63563893e044e48841c92b5fe75d81_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzctMy0xLTEtMTEyNjQw_3fef2bab-332c-4a56-aba4-91f023cd7581">P5Y6M21D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="i832e5c7bccde4123b022c8bab92e41a3_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzctNS0xLTEtMTEyNjQw_454bfae6-69f1-4f52-9d07-5ff7e932b825"
      unitRef="usdPerShare">87.72</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i832e5c7bccde4123b022c8bab92e41a3_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzctNy0xLTEtMTEyNjQw_a5a9b5bf-ebd5-4ad8-b3e2-37bf03fc011b"
      unitRef="shares">204332</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="i832e5c7bccde4123b022c8bab92e41a3_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzctOS0xLTEtMTEyNjQw_bb109aa5-bdb8-4158-a378-001db43b3f6b"
      unitRef="usdPerShare">89.21</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i6b74c7e45f8c4749a8ef280613702146_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzgtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246ZDg5MGRmY2U5ZTlkNDBlNmE3ZDk3ODM4MGQwN2I1NzJfNA_94e531b7-3fef-4ab9-affc-2856186f5125"
      unitRef="usdPerShare">99.80</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i6b74c7e45f8c4749a8ef280613702146_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzgtMC0xLTEtMTEyNjQwL3RleHRyZWdpb246ZDg5MGRmY2U5ZTlkNDBlNmE3ZDk3ODM4MGQwN2I1NzJfNw_17185860-0664-43a6-b6c0-5b29c808f5a4"
      unitRef="usdPerShare">99.80</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i3a0d0b5e84d344cfbc5b391903f924fc_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzgtMS0xLTEtMTEyNjQw_f61215e7-b681-40d4-b2e7-e1bd72025a53"
      unitRef="shares">3389</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i6b74c7e45f8c4749a8ef280613702146_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzgtMy0xLTEtMTEyNjQw_4b445f36-a709-4b3c-aec1-e0b38c22c7d4">P5Y10M2D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="i3a0d0b5e84d344cfbc5b391903f924fc_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzgtNS0xLTEtMTEyNjQw_210e1ab3-4d2f-461f-bbbf-dbe6dd0e7bfb"
      unitRef="usdPerShare">99.80</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i3a0d0b5e84d344cfbc5b391903f924fc_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzgtNy0xLTEtMTEyNjQw_40a9fda8-ce14-4daf-bf32-9aea8d430f27"
      unitRef="shares">3389</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="i3a0d0b5e84d344cfbc5b391903f924fc_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzgtOS0xLTEtMTEyNjQw_4cc9b916-9db9-47ba-af96-c0c58e652f02"
      unitRef="usdPerShare">99.80</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="ia1c885f91b7f4f689c7b8a8c9df23e98_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzktMC0xLTEtMTEyNjQwL3RleHRyZWdpb246ZjgwNzA3Zjc5M2ZkNGZjYTg4NjAyYWY1YzhlMGRhNjJfNA_d000edc0-6558-4ae8-b043-de1282d5a826"
      unitRef="usdPerShare">103.42</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="ia1c885f91b7f4f689c7b8a8c9df23e98_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzktMC0xLTEtMTEyNjQwL3RleHRyZWdpb246ZjgwNzA3Zjc5M2ZkNGZjYTg4NjAyYWY1YzhlMGRhNjJfNw_80e61160-37e3-4590-a3bc-23a896f0fd10"
      unitRef="usdPerShare">103.42</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="ia739273d90a041b18ac1f97de8da164c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzktMS0xLTEtMTEyNjQw_d261f46e-2af3-4626-9013-9cf98b708761"
      unitRef="shares">193177</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="ia1c885f91b7f4f689c7b8a8c9df23e98_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzktMy0xLTEtMTEyNjQw_08f050d9-9332-4a9f-9218-0d738e218550">P7Y3M3D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="ia739273d90a041b18ac1f97de8da164c_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzktNS0xLTEtMTEyNjQw_114a0c71-a558-40c3-ad1c-1f2c39da2da4"
      unitRef="usdPerShare">103.42</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="ia739273d90a041b18ac1f97de8da164c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzktNy0xLTEtMTEyNjQw_7cdba969-8c83-4d52-a2ef-0a1812cce9aa"
      unitRef="shares">80185</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="ia739273d90a041b18ac1f97de8da164c_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzktOS0xLTEtMTEyNjQw_942b938b-0393-4bb0-b245-d9e532db7ca9"
      unitRef="usdPerShare">103.42</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i9e0dbd02e5924340b2b6ef89413e73fd_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzEwLTAtMS0xLTExMjY0MC90ZXh0cmVnaW9uOjNkODgyYmE1YTc4OTRlNDRiNzZjMjRjNmUzZjJhNWE5XzQ_746f1083-d087-4246-a4de-73179112e51b"
      unitRef="usdPerShare">114.15</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i9e0dbd02e5924340b2b6ef89413e73fd_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzEwLTAtMS0xLTExMjY0MC90ZXh0cmVnaW9uOjNkODgyYmE1YTc4OTRlNDRiNzZjMjRjNmUzZjJhNWE5Xzc_8a9ca1ea-7afa-4145-bc93-1a38ac5a717a"
      unitRef="usdPerShare">114.15</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i2768e2bc60244b69915cbe3b77507013_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzEwLTEtMS0xLTExMjY0MA_74b8d33b-e5fc-4690-821e-0ca9a8723e2e"
      unitRef="shares">12966</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i9e0dbd02e5924340b2b6ef89413e73fd_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzEwLTMtMS0xLTExMjY0MA_88ee96cb-62c7-4967-bdba-642b65adc623">P5Y5M19D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="i2768e2bc60244b69915cbe3b77507013_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzEwLTUtMS0xLTExMjY0MA_d3b790d7-88ed-48f4-a16c-22300441ab4d"
      unitRef="usdPerShare">114.15</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i2768e2bc60244b69915cbe3b77507013_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzEwLTctMS0xLTExMjY0MA_d48f79fb-f36b-4a3b-ad11-5b00667a1370"
      unitRef="shares">12966</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="i2768e2bc60244b69915cbe3b77507013_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzEwLTktMS0xLTExMjY0MA_5fbc96e5-f04e-43e5-a4fb-1b21b3adb4d8"
      unitRef="usdPerShare">114.15</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzExLTEtMS0xLTExMjY0MA_745d112a-6f2e-45b6-8a68-8cc3d4f9a1d4"
      unitRef="shares">2991473</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzExLTMtMS0xLTExMjY0MA_7f69754b-5a8f-4c70-ae6d-1d44b07cb50b">P6Y25D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzExLTUtMS0xLTExMjY0MA_08ff5f41-68f3-4e7e-a1d4-32fca349785c"
      unitRef="usdPerShare">61.31</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzExLTctMS0xLTExMjY0MA_ee6649fd-55b6-4d02-9e47-4fad709e6595"
      unitRef="shares">1559662</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo4NjU1YTEzZTA5ZDI0Y2EyOTZmMmY5MTNkZTAxZGJmMS90YWJsZXJhbmdlOjg2NTVhMTNlMDlkMjRjYTI5NmYyZjkxM2RlMDFkYmYxXzExLTktMS0xLTExMjY0MA_bb41496a-ebf0-4b87-859e-4c4dc1248d3b"
      unitRef="usdPerShare">60.83</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzMxMjA_0f5a03ff-f740-4b4c-b032-cf73fd01c559">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assumptions used for the specified reporting periods and the resulting estimates of weighted-average grant date fair value per share of options granted:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4%-4.3%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4%-1.2%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2%-1.4%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49%-55%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47%-63%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47%-71%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0 to 6.5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7 to 6.3 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7 to 5.1 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="idbafb024b44d43f0b4a9e4440b3833cb_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzItMS0xLTEtMTIyOTgzL3RleHRyZWdpb246ZTFjYzFkZTEyOTgzNGNhMDhlNjg2MDA0ZTkxNmNhMDJfNTQ5NzU1ODEzOTI0_270caf86-8b05-4e92-a27d-818f0bb8257d"
      unitRef="number">0.014</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i5a1083da45f7446987097262ce780281_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzItMS0xLTEtMTIyOTgzL3RleHRyZWdpb246ZTFjYzFkZTEyOTgzNGNhMDhlNjg2MDA0ZTkxNmNhMDJfNTQ5NzU1ODEzOTM1_ae5851eb-3356-4c7c-b720-08634a766fbc"
      unitRef="number">0.043</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i542a16c3353248bc8dd8336f95ea2022_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzItMS0xLTEtMTEyNjQwL3RleHRyZWdpb246Y2UzOTM4NDA0YjVmNGFmNWEwNWNmMDA0ZDJlYWEzNzFfNA_7f752006-72b8-4c49-97d2-d773f70f0781"
      unitRef="number">0.004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="id13b17e9fe134b41b5c293358c0d8d1e_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzItMS0xLTEtMTEyNjQwL3RleHRyZWdpb246Y2UzOTM4NDA0YjVmNGFmNWEwNWNmMDA0ZDJlYWEzNzFfNw_c6180f75-27b9-4b64-8565-5c0cbe73bfeb"
      unitRef="number">0.012</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i70799954d0214652bfaf7cd03d05d0e7_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzItMy0xLTEtMTEyNjQwL3RleHRyZWdpb246ZGM2MTlkZWIwMWZlNDFjMjk1Y2UwNzg0Y2ZlMzQ1NzFfNA_b2868c5f-e6ea-44ec-9126-ff4014cf2f49"
      unitRef="number">0.002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i6721b383c78a462dad20bcc6ce92e012_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzItMy0xLTEtMTEyNjQwL3RleHRyZWdpb246ZGM2MTlkZWIwMWZlNDFjMjk1Y2UwNzg0Y2ZlMzQ1NzFfNw_5c3ddf55-0569-401a-9a9e-4737732ff026"
      unitRef="number">0.014</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="idbafb024b44d43f0b4a9e4440b3833cb_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzMtMS0xLTEtMTIzMDUyL3RleHRyZWdpb246YWIyNjdkNjVhNjI3NGM4Zjk1NWNiNThjOWUyNDAwZTZfNTQ5NzU1ODEzODky_448d385e-351c-4c19-9895-fdf12584d960"
      unitRef="number">0.49</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i5a1083da45f7446987097262ce780281_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzMtMS0xLTEtMTIzMDUyL3RleHRyZWdpb246YWIyNjdkNjVhNjI3NGM4Zjk1NWNiNThjOWUyNDAwZTZfNTQ5NzU1ODEzODk4_1558865e-58de-4954-bb0a-184e345a0bd8"
      unitRef="number">0.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i542a16c3353248bc8dd8336f95ea2022_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzMtMS0xLTEtMTEyNjQwL3RleHRyZWdpb246Y2E2ZWVkN2RmYmNkNDJkMWE4MmU5OGI3NTlmZTM0ODdfNA_4b32d4f6-5ba4-45b4-893c-afe597946827"
      unitRef="number">0.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="id13b17e9fe134b41b5c293358c0d8d1e_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzMtMS0xLTEtMTEyNjQwL3RleHRyZWdpb246Y2E2ZWVkN2RmYmNkNDJkMWE4MmU5OGI3NTlmZTM0ODdfNw_03830ff9-8b74-4a98-8923-627fa8a9f186"
      unitRef="number">0.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i70799954d0214652bfaf7cd03d05d0e7_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzMtMy0xLTEtMTEyNjQwL3RleHRyZWdpb246Y2ZmODdlNzk5ZTgxNGU0Y2ExNDkzNTM1ZWU0ODg4MzBfNA_216be01b-37aa-49de-a41e-9f86dc11cd36"
      unitRef="number">0.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i6721b383c78a462dad20bcc6ce92e012_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzMtMy0xLTEtMTEyNjQwL3RleHRyZWdpb246Y2ZmODdlNzk5ZTgxNGU0Y2ExNDkzNTM1ZWU0ODg4MzBfNw_aac52ca3-bffc-4949-91db-ce16822a4863"
      unitRef="number">0.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="idbafb024b44d43f0b4a9e4440b3833cb_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzQtMS0xLTEtMTIzMDY1L3RleHRyZWdpb246MDJkYTVmYTRiMzQwNDQwYWJkMDQ2YTIzZmZiYTkzMjVfNTQ5NzU1ODEzOTA3_a5ae4de1-2326-44bc-8e77-dbb8125d4f01">P2Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i5a1083da45f7446987097262ce780281_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzQtMS0xLTEtMTIzMDY1L3RleHRyZWdpb246MDJkYTVmYTRiMzQwNDQwYWJkMDQ2YTIzZmZiYTkzMjVfNTQ5NzU1ODEzOTAw_bc3e3d9a-c52b-4f64-bf70-85264c100b92">P6Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i542a16c3353248bc8dd8336f95ea2022_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzQtMS0xLTEtMTEyNjQwL3RleHRyZWdpb246NjFlZTJiODE3MzFlNGM5ZTgwZTIxMGY2ZWVmYTFiMTdfNA_9c14b843-9f95-4243-9d80-e15151a8b429">P4Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="id13b17e9fe134b41b5c293358c0d8d1e_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzQtMS0xLTEtMTEyNjQwL3RleHRyZWdpb246NjFlZTJiODE3MzFlNGM5ZTgwZTIxMGY2ZWVmYTFiMTdfMTA_77188983-6bff-46f1-82e7-698d24486bd2">P6Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i70799954d0214652bfaf7cd03d05d0e7_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzQtMy0xLTEtMTEyNjQwL3RleHRyZWdpb246YWJkZTc2Zjc3YzQ0NGRhNWFkN2IwODNjNjM0MTlkZjZfNA_ca0fb31b-d604-48bf-a2b0-7d446a9156ae">P4Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i6721b383c78a462dad20bcc6ce92e012_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTpjZjllZTE2MzUzYmY0OTJkYjkyNzM1NTRkYTAzMzQyNS90YWJsZXJhbmdlOmNmOWVlMTYzNTNiZjQ5MmRiOTI3MzU1NGRhMDMzNDI1XzQtMy0xLTEtMTEyNjQwL3RleHRyZWdpb246YWJkZTc2Zjc3YzQ0NGRhNWFkN2IwODNjNjM0MTlkZjZfMTA_39f74fde-0d5f-4046-bd83-847b31dfc4e1">P5Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i14ec222f5248466398774a2561f84042_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzExMTY_1d42255c-a763-4fbe-a359-1b06bd733b04"
      unitRef="usd">32700000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i7c0d366af0a24bf3b783d1043d41aeac_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzEyNzA_d63e78ef-b5a3-4d7b-bd75-267ecada3a54">P2Y8M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i1830acfcfe9d479fa705570392f59958_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzU0OTc1NTgyODA1MA_4b721945-8b55-4ce6-b109-d24512aacbe8"
      unitRef="usd">4800000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ice33364cbd56406b88429f2aa093f6cd_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzM4NDgyOTA3MTE0NTc_f167adb0-bdfb-4cc4-ae7f-763424ecd29a">P1Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzMxMjE_d2508cf2-73d7-4001-930c-2a2ffbd6ade7">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our restricted stock activity and related information:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.721%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Grant&#160;Date Fair&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52,363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98,501)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,850)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(138,867)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,383)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at October 31, 2022, before Separation and Regrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited due to Separation, Before Regrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(366,470)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at November 1, 2022, Before Regrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;424,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73,385)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,635)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ic7e2f70f54f74635b9da899358a0eb40_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzItMS0xLTEtMTEyNjQw_5ff9e401-0893-4ccf-b5ad-62d8741224fa"
      unitRef="shares">147259</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ic7e2f70f54f74635b9da899358a0eb40_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzItMy0xLTEtMTEyNjQw_8c5adb96-f2df-4582-90f2-cf8f8ce787f4"
      unitRef="usdPerShare">125.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i18c9bf22eb2e40bdb955de4a851b78c5_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzMtMS0xLTEtMTEyNjQw_d3f13a3f-35f2-4f8a-aa79-34af6db129b9"
      unitRef="shares">111306</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i18c9bf22eb2e40bdb955de4a851b78c5_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzMtMy0xLTEtMTEyNjQw_b3ae8877-48da-4feb-b641-43573a15ee9b"
      unitRef="usdPerShare">89.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i18c9bf22eb2e40bdb955de4a851b78c5_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzQtMS0xLTEtMTEyNjQw_74953300-f6f0-45cc-ac48-eac3f7fd572d"
      unitRef="shares">52363</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i18c9bf22eb2e40bdb955de4a851b78c5_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzQtMy0xLTEtMTEyNjQw_81e636d3-8cce-4e1e-b116-e8bb9c8f3cb3"
      unitRef="usdPerShare">121.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i18c9bf22eb2e40bdb955de4a851b78c5_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzUtMS0xLTEtMTEyNjQw_a72769ca-cb95-473d-9783-9dbca6e10e8f"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i18c9bf22eb2e40bdb955de4a851b78c5_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzUtMy0xLTEtMTEyNjQw_d363348d-d2bd-4364-b064-bd1fd6a7538e"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ifc03504c5b21431cb85fbddc8d239a0b_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzYtMS0xLTEtMTEyNjQw_d2a21922-9cc3-4a07-8d12-40f643f45ded"
      unitRef="shares">206202</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ifc03504c5b21431cb85fbddc8d239a0b_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzYtMy0xLTEtMTEyNjQw_f68894e8-2d4f-4228-af93-d1f3eb93e5bd"
      unitRef="usdPerShare">106.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i70fc66a3f20848b5bb0f70e3f866d45d_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzctMS0xLTEtMTEyNjQw_421661ab-5c29-4adc-93cc-b3bfe0199fbe"
      unitRef="shares">167292</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i70fc66a3f20848b5bb0f70e3f866d45d_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzctMy0xLTEtMTEyNjQw_665df8a5-c873-4051-b413-78ba6520faba"
      unitRef="usdPerShare">169.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i70fc66a3f20848b5bb0f70e3f866d45d_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzgtMS0xLTEtMTEyNjQw_78475939-1b75-4f02-86fb-91d4f9aa96d3"
      unitRef="shares">98501</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i70fc66a3f20848b5bb0f70e3f866d45d_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzgtMy0xLTEtMTEyNjQw_1ec72de0-1431-4427-b3df-6527cd4679b2"
      unitRef="usdPerShare">125.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i70fc66a3f20848b5bb0f70e3f866d45d_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzktMS0xLTEtMTEyNjQw_2257c153-f279-44c8-8be4-512e05b11c4e"
      unitRef="shares">10850</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i70fc66a3f20848b5bb0f70e3f866d45d_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzktMy0xLTEtMTEyNjQw_40de1b8b-27b9-48bd-8ec9-69429fa6b727"
      unitRef="usdPerShare">141.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="id7b81ae076014d259846e22ddab69ac4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzEwLTEtMS0xLTExMjY0MA_e2424297-0dea-480a-a00b-d8133efb381d"
      unitRef="shares">264143</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="id7b81ae076014d259846e22ddab69ac4_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzEwLTMtMS0xLTExMjY0MA_f685ebb3-4f16-44e3-8c6b-2e3a1fe0f183"
      unitRef="usdPerShare">138.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i34a7906b62e04f2a93fcbf8c96e0b8c5_D20220101-20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzExLTEtMS0xLTExMjY0MA_aa7d090f-6029-4a6a-a3be-4817661553e5"
      unitRef="shares">260577</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i34a7906b62e04f2a93fcbf8c96e0b8c5_D20220101-20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzExLTMtMS0xLTExMjY0MA_1880533e-0f10-4788-8467-bbb61da381ef"
      unitRef="usdPerShare">89.99</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i34a7906b62e04f2a93fcbf8c96e0b8c5_D20220101-20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzEyLTEtMS0xLTExMjY0MA_5ecc115e-6271-42d7-82bb-605d686c9cbe"
      unitRef="shares">138867</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i34a7906b62e04f2a93fcbf8c96e0b8c5_D20220101-20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzEyLTMtMS0xLTExMjY0MA_8ddbe6fc-0c36-4ea7-946e-f951a6267088"
      unitRef="usdPerShare">120.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i34a7906b62e04f2a93fcbf8c96e0b8c5_D20220101-20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzEzLTEtMS0xLTExMjY0MA_f9cb7ebb-1b81-4de0-845d-58abf0598d8b"
      unitRef="shares">19383</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i34a7906b62e04f2a93fcbf8c96e0b8c5_D20220101-20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzEzLTMtMS0xLTExMjY0MA_c487d890-ce6c-40ae-9ca7-f7bb936d999b"
      unitRef="usdPerShare">58.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i0b64d9bdb1cd4eceb9508d306b942d87_I20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzE0LTEtMS0xLTExMjY0MA_8420b04b-99fc-43b5-9136-df246201dcf0"
      unitRef="shares">366470</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i0b64d9bdb1cd4eceb9508d306b942d87_I20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzE0LTMtMS0xLTExMjY0MA_8d21d5e7-23bf-4710-8e0d-4958c271ec42"
      unitRef="usdPerShare">114.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i2ffc7c8d47654559a26bf1224c8dac2c_D20221101-20221101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzE1LTEtMS0xLTEzNDI1NQ_1537d734-6ff2-4aa3-94e2-b98a7fe50798"
      unitRef="shares">366470</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i82b4fc5c5a994b2db38284c45930d10d_I20221101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzE2LTEtMS0xLTEzNTg1MA_881aeaee-065a-4e16-b067-756fccf13191"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i6bbc8a04f4fe422fbc818ec598c0b7f1_D20221102-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzE3LTEtMS0xLTEyMjUzOQ_1f7ab0dc-5ef3-403e-aeec-71afac7cc570"
      unitRef="shares">424473</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i6bbc8a04f4fe422fbc818ec598c0b7f1_D20221102-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzE3LTMtMS0xLTEyMjUzOQ_e31a28a5-1b6a-4b45-b976-a7ee8c0f0877"
      unitRef="usdPerShare">75.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i6bbc8a04f4fe422fbc818ec598c0b7f1_D20221102-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzE4LTEtMS0xLTEyMjUzOQ_83a77471-d0c8-422c-b8e1-673877343848"
      unitRef="shares">73385</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i6bbc8a04f4fe422fbc818ec598c0b7f1_D20221102-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzE4LTMtMS0xLTEyMjUzOQ_76012a4b-bd14-4771-9f66-c4df1289878d"
      unitRef="usdPerShare">75.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i6bbc8a04f4fe422fbc818ec598c0b7f1_D20221102-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzE5LTEtMS0xLTEyMjUzOQ_b051dc27-dc0a-40db-b69d-f94102c33948"
      unitRef="shares">2635</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i6bbc8a04f4fe422fbc818ec598c0b7f1_D20221102-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzE5LTMtMS0xLTEyMjUzOQ_f72def91-371d-447d-96c7-81a2fdea8ef9"
      unitRef="usdPerShare">89.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i47a751f245b748f0843958f32f5f80c0_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzIwLTEtMS0xLTEzNTg0Ng_5e14c36f-c18d-4777-918d-79305c57cd0f"
      unitRef="shares">348453</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i47a751f245b748f0843958f32f5f80c0_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90YWJsZTo2NmI5ZWEzNmJiZWM0OGEwOGU1ZTIzOTMxZTI5MjI5OC90YWJsZXJhbmdlOjY2YjllYTM2YmJlYzQ4YTA4ZTVlMjM5MzFlMjkyMjk4XzIwLTMtMS0xLTEyMjU0OQ_c1c63328-5670-4bd8-890a-b2728a7d016a"
      unitRef="usdPerShare">75.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i0687f0c421e14290af9f6cd6184a6b5e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzE0NzY_3605e09a-5434-4641-ab6a-2c6c73044169"
      unitRef="usd">12400000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i5e816eb25c2e46aa9b39c605fe0b678f_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzE1NTM_d1cc31a5-a030-4b9e-90e0-1016dbdc2775">P1Y8M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i955aaff5ae7f47659be272a78642d979_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzU0OTc1NTgyODA5Ng_2a587d80-fda0-44c6-900d-e18d254b13d7"
      unitRef="usd">1200000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i041cfa14d0e74eefad61ffd3960940a4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzM4NDgyOTA3MTE0NjM_82af9a8d-19bb-45f2-a839-2b2ab14c4f86">P1Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i2739bb11c12f4306b4cbdc98a749e080_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzE1OTg_d39fa261-0f56-424c-9657-f9fb9ae331d1"
      unitRef="shares">35881</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
      contextRef="i747d4f67a97149e1a99e9c59c6e2de2d_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzE3NzM_a4f60d17-0c07-47b1-8a0e-b3d6190e067c"
      unitRef="shares">1250</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i747d4f67a97149e1a99e9c59c6e2de2d_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzE5MzE_8274eda5-8e64-44ad-a91d-8d94ae719917"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="i747d4f67a97149e1a99e9c59c6e2de2d_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzU0OTc1NTgxNzQ5MQ_5c9dfd1a-7406-42d9-a5ac-9757cb8e123d"
      unitRef="shares">8479</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="icf5e0295a2234a42822346d8b0a38103_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzIwNzI_62a46b00-447c-40c9-96ab-c9e999907e66"
      unitRef="shares">8448</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="i2298a5c46c60467d9749217af84898cd_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzIwNzY_f7e6ac45-73d8-4848-a41e-9af095994748"
      unitRef="shares">6455</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="iac54b9d00e76487d9a441f663e698e18_I20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzIyODc_72d66d47-ede1-473f-8468-c584f4df2c5f"
      unitRef="usd">500000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramPeriodInForce1
      contextRef="i8364d475253b452d820d30294b040699_D20190901-20190930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzIzNDI_e2f438c3-ad2e-489e-868e-096de38a833f">P3Y</us-gaap:StockRepurchaseProgramPeriodInForce1>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzI5ODQ_7b19a186-3446-4aca-831f-5525a51812a8"
      unitRef="usd">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzI5ODQ_a8ffe9ee-f192-4534-bde0-4d77f5cb7d0f"
      unitRef="usd">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzMwNTc_f3093cf5-04c5-405c-b6b6-ca182078f2e9"
      unitRef="shares">934079</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzMwNzE_97a3d343-eb7e-4dfa-b0bc-2eab1180bb04"
      unitRef="usd">78000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <lgnd:SaleOfStockAuthorizedOfferingAmount
      contextRef="i73ee438cb9984aaa8e59bf39f453f651_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzEwOTk1MTE2NDExNzI_a694121d-763b-4c0b-9985-eeb24d46af16"
      unitRef="usd">100000000</lgnd:SaleOfStockAuthorizedOfferingAmount>
    <lgnd:SaleOfStockAuthorizedOfferingAmount
      contextRef="i73ee438cb9984aaa8e59bf39f453f651_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTIvZnJhZzoyZmI5OGU5YzAzNzU0MmYwYmUxN2UzNGRkYjlmNTVlNC90ZXh0cmVnaW9uOjJmYjk4ZTljMDM3NTQyZjBiZTE3ZTM0ZGRiOWY1NWU0XzEwOTk1MTE2NDExODg_c232053d-1913-419d-bc18-b2690139d4ad"
      unitRef="usd">100000000</lgnd:SaleOfStockAuthorizedOfferingAmount>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTUvZnJhZzozODBjZDU4MTZiMWI0NGRmYTdhNTdjMDViZTViODBmYS90ZXh0cmVnaW9uOjM4MGNkNTgxNmIxYjQ0ZGZhN2E1N2MwNWJlNWI4MGZhXzY3ODY_2bdab6cb-5bf4-4921-8d7c-2d70238a3592">Commitment and Contingencies: Legal Proceedings&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record an estimate of a loss when the loss is considered probable and estimable. Where a liability is probable and there is a range of estimated loss and no amount in the range is more likely than any other number in the range, we record the minimum estimated liability related to the claim in accordance with ASC 450, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. As additional information becomes available, we assess the potential liability related to our pending litigation and revises our estimates. Revisions in our estimates of potential liability could materially impact our results of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 31, 2019, we received three civil complaints filed in the U.S. District Court for the Northern District of Ohio on behalf of several Indian tribes. The Northern District of Ohio is the Court that the Judicial Panel on Multi-District Litigation (&#x201c;JPML&#x201d;) has assigned more than one thousand civil cases which have been designated as a Multi-District Litigation (&#x201c;MDL&#x201d;) and captioned In Re: National Prescription Opiate Litigation. The allegations in these complaints focus on the activities of defendants other than the Company and no individualized factual allegations have been advanced against us in any of the three complaints. We reject all claims raised in the complaints and intend to vigorously defend these matters. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CyDex, a wholly owned subsidiary of Ligand, and Baxter Healthcare Corp. (&#x201c;Baxter&#x201d;) are parties to a license agreement relating to Ligand&#x2019;s Captisol&#xae; technology and, more specifically, relating to Captisol&#xae;-enabled Nexterone&#xae; (amiodarone HCl premixed injection). CyDex contended that Baxter has not paid all of the royalties due to CyDex under the terms of the license agreement and Baxter contends that it has overpaid royalties for several years. On April 6, 2021, Baxter initiated an arbitration with AAA pursuant to the arbitration provision of the license agreement. On April 21, 2021, CyDex filed an answering statement and counterdemand. On December 2, 2021, Baxter filed an Amended Notice of Arbitration Demand seeking a declaration limiting the &#x201c;royalty term&#x201d; of the license agreement to &#x201c;the later of i) the expiration of the licensed [p]atent; or ii) when there are no longer any CyDex patents listed in the Orange Book for [Nexterone&#xae;].&#x201d; Baxter later clarified its position, and asserted that royalties should have ceased being due upon the May 4, 2022 expiry of CyDex&#x2019;s U.S. Patent No. 6,869,939. The parties conducted a three-day arbitration hearing May 24-26, 2022. In a September 9, 2022 Final Award, the Tribunal ruled in CyDex&#x2019;s favor by (1) denying Baxter&#x2019;s request for a partial refund of previously paid royalties, (2) granting CyDex&#x2019;s request for underpaid royalties, and (3) concluding that &#x201c;[g]oing forward Baxter shall pay CyDex&#x201d; a royalty consistent with CyDex&#x2019;s construction of the license agreement until, at least, the March 13, 2029 expiry of CyDex&#x2019;s U.S. Patent No. 7,635,773. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 22, 2022, Pfenex Inc. (&#x201c;Pfenex&#x201d;), a wholly owned subsidiary of Ligand, received a notice of alleged breach from Beijing Kangchen Biological Technology Co., Ltd. (&#x201c;Kangchen&#x201d;) with respect to a Development and License Agreement , dated April 18, 2018, between Pfenex and Kangchen (&#x201c;License Agreement&#x201d;) pertaining to the development and commercialization of teriparatide in certain Southeast Asian countries. The allegations in the notice focused on the activities of Pfenex and other parties. On June 16, 2022, we rejected all claims raised by Kangchen in the notice. On June 24, 2022, Kangchen served Pfenex a notice of termination of the License Agreement and demanded initiation of the dispute resolution process in accordance with the License Agreement. On June 29, 2022, we again rejected all claims raised by Kangchen in the notice of termination and agreed to engage in the applicable dispute resolution process, including good faith negotiations between the parties. On October 20, 2022, we agreed to make a single lump sum payment to Kangchen in connection with a termination agreement that, among other things, terminates the License Agreement and releases all claims between the parties arising from the License Agreement. The payment was recorded as general and administrative expense during the year ended December&#160;31, 2022. A termination agreement between Pfenex and Kangchen went into effect in December 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, we may also become subject to other legal proceedings or claims arising in the ordinary course of our business. We currently believe that none of the claims or actions pending against us is likely to have, individually or in the aggregate, a material adverse effect on our business, financial condition or results of operations. Given the unpredictability inherent in litigation, however, we cannot predict the outcome of these matters.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzQ4NjM_f29b3e13-68a0-4a9d-99ee-99e5ae918ca5">Income Taxes&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the income tax expense (benefit) for continuing operations are as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.092%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.092%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.686%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current expense (benefit):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred expense (benefit):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,656)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,901)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,685)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,234)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,586)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,690)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total income tax expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of income tax expense (benefit) from continuing operations to the amount computed by applying the statutory federal income tax rate to the net income (loss) from continuing operations is summarized as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.048%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax at federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FDII&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,395)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(637)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,652)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate change for changes in federal, foreign or state law&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(535)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,963)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(673)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sale of Vernalis R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,993)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(266)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign tax differential on income/loss of foreign subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,839)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt repurchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subpart F income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,080)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(623)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision to return adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,920)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Officer compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(121,864)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,823)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We remeasured certain deferred tax assets and liabilities based on the rates at which they are expected to reverse in the future, which is generally 21%. Significant components of our deferred tax assets and liabilities as of December&#160;31, 2022 and 2021 are shown below. We assess the positive and negative evidence to determine if sufficient future taxable income will be generated to use the existing deferred tax assets. Our evaluation of evidence resulted in management concluding that the majority of our deferred tax assets will be realized. However, we maintain a valuation allowance to offset certain net deferred tax assets as management believes realization of such assets are uncertain as of December&#160;31, 2022, 2021 and 2020. The valuation allowance increased $21.5 million in 2022, increased $11.4 million in 2021 and decreased $116.5 million in 2020.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We offset all deferred tax assets and liabilities by jurisdiction, as well as any related valuation allowance, and present them on our consolidated balance sheet as a non-current deferred income tax asset or liability (as applicable). Deferred tax assets &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(liabilities) are comprised of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.807%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.662%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.813%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance for deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,931)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:13pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identified intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,696)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66,848)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,886)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,459)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75,582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72,307)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:13pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,085)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in 2022, the Tax Cuts and Jobs Act of 2017 requires taxpayers to capitalize and amortize R&amp;amp;D expenditures over five years for domestic research and 15 years for foreign research pursuant to Section 174 of the Internal Revenue Code of 1986, as amended. We recorded an increase of $4.7&#160;million to our current federal income tax expense and deferred tax assets for continuing operations during 2022 due to the capitalization of R&amp;amp;D under Section 174. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As of December&#160;31, 2022, we had federal net operating loss carryforwards set to expire through 2037 of $81.1 million and $168.3 million of state net operating loss carryforwards that begin to expire in 2028. We also have $8.5 million of federal research and development credit carryforwards, which expire through 2040. We have $29.0 million of California research and development credit carryforwards that have no expiration date. In addition, we have approximately $96.1 million of non-U.S. net operating loss carryovers and approximately $15.6 million of non-U.S. capital loss carryovers that have no expiration date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2021 we had federal net operating loss carryforwards set to expire through 2037 of  $117.5&#160;million and $170.1&#160;million of state net operating loss carryforwards that begin to expire in 2028. We also had $9.3 million in federal research and development credit carryforwards, which expire through 2040, and $29.0 million of California research and development credit carryforwards that have no expiration date. In addition, we had approximately $101.6 million of non-U.S. capital loss carryovers and approximately $17.5 million of non-U.S. capital loss carryovers that have no expiration date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to Section 382 and 383 of the Internal Revenue Code of 1986, as amended, utilization of our net operating losses and credits may be subject to annual limitations in the event of any significant future changes in its ownership structure. These annual limitations may result in the expiration of net operating losses and credits prior to utilization. The deferred tax assets as of December&#160;31, 2022 are net of any previous limitations due to Section 382 and 383.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for income taxes by evaluating a probability threshold that a tax position must meet before a financial statement benefit is recognized. The minimum threshold is a tax position that is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. Our remaining liabilities for uncertain tax positions are presented net of the deferred tax asset balances on the accompanying consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the amount of unrecognized tax benefits at December&#160;31, 2022, 2021 and 2020 is as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Additions based on tax positions related to the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Additions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Reductions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,072)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(954)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in the balance of unrecognized tax benefits at December&#160;31, 2022 is $27.3 million of tax benefits that, if recognized would impact the effective rate. There are no positions for which it is reasonably possible that the uncertain tax benefit will significantly increase or decrease within twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;We recognize interest and penalties related to uncertain tax positions in income tax expense. As of December&#160;31, 2022 and December&#160;31, 2021, we recognized an immaterial amount of interest and penalties. We file income tax returns in the United States, various state jurisdictions, United Kingdom, and Canada with varying statutes of limitations. The federal statute of limitation remains open for the 2019 tax year to the present.&#160;The state income tax returns generally remain open for the 2018 tax year through the present.&#160;Net operating loss and research credit carryforwards arising prior to these years are also open to examination if and when utilized. The Ligand California tax returns for 2019 and 2020 are currently under audit. We believe our reserve for unrecognized tax benefits and contingent tax issues is adequate with respect to all open years.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzQ4NjQ_2f3c5e3b-5c82-4cc1-8ee3-a545ce15230c">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the income tax expense (benefit) for continuing operations are as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.092%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.092%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.686%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current expense (benefit):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred expense (benefit):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,656)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,901)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,685)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,234)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,586)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,690)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total income tax expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzMtMS0xLTEtMTEyNjQw_b9573318-7ee3-4517-90d8-e0c9d2a5f992"
      unitRef="usd">10097000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzMtMy0xLTEtMTEyNjQw_a709f56c-9e83-4fd3-a061-6fd8c6fc2712"
      unitRef="usd">460000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzMtNS0xLTEtMTEyNjQw_8307aefc-def7-4343-a749-13712f29154f"
      unitRef="usd">10820000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzQtMS0xLTEtMTEyNjQw_363068d3-6ab0-4b27-a201-b468e526379a"
      unitRef="usd">193000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzQtMy0xLTEtMTEyNjQw_f62d1bf7-8bc0-4140-8fa4-8d19ff97944d"
      unitRef="usd">-22000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzQtNS0xLTEtMTEyNjQw_503812ca-daa6-430d-9586-67d6a55ee032"
      unitRef="usd">541000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzUtMS0xLTEtMTEyNjQw_a207bab6-9ad3-4b02-8a77-6ecc0815f06d"
      unitRef="usd">452000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzUtMy0xLTEtMTEyNjQw_7b0d75e4-2024-4a87-993b-25382167597a"
      unitRef="usd">0</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzUtNS0xLTEtMTEyNjQw_59e67a74-0961-42eb-83a9-7458d5324ac6"
      unitRef="usd">23000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzYtMS0xLTEtMTEyNjQw_2f540271-39fd-43a5-9248-7c8a09561ac1"
      unitRef="usd">10742000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzYtMy0xLTEtMTEyNjQw_03a568ff-32f1-4960-b856-354890e31a29"
      unitRef="usd">438000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzYtNS0xLTEtMTEyNjQw_b8400e06-fa34-438f-976b-0884ea30e390"
      unitRef="usd">11384000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzgtMS0xLTEtMTEyNjQw_7f84fdbe-d608-4852-8fca-e57a619f87da"
      unitRef="usd">-3656000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzgtMy0xLTEtMTEyNjQw_cdaf260c-33bf-468f-8147-ebc9904b128d"
      unitRef="usd">-2901000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzgtNS0xLTEtMTEyNjQw_9a5ea8ff-4818-4a52-a081-893c4c6d98f1"
      unitRef="usd">-13456000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzktMS0xLTEtMTEyNjQw_b1f66634-7b45-4695-bfa6-ba6a7843b535"
      unitRef="usd">34144000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzktMy0xLTEtMTEyNjQw_1309601e-ba28-4b85-ab8f-182b1c46fb5a"
      unitRef="usd">-1685000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzktNS0xLTEtMTEyNjQw_06166449-0c1b-43f2-ae1b-86afe5ef212a"
      unitRef="usd">-3234000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzEwLTEtMS0xLTExMjY0MA_825fbe05-b16a-4eff-af49-c62ddc112644"
      unitRef="usd">30488000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzEwLTMtMS0xLTExMjY0MA_852e95dc-05e6-43a9-a84b-2c9585602063"
      unitRef="usd">-4586000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzEwLTUtMS0xLTExMjY0MA_a0bdf08a-f244-4a19-8be0-a6a1ca75caef"
      unitRef="usd">-16690000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzExLTEtMS0xLTExMjY0MA_b3dec597-bb33-48f6-bd0a-5af7a7310a72"
      unitRef="usd">41230000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzExLTMtMS0xLTExMjY0MA_fa17537a-821e-409f-a77b-0710d8574d9b"
      unitRef="usd">-4148000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZToyZmFmZDAyZjc2ZGU0NmM5OGFlMTk4MGY5NmFlNmU5NC90YWJsZXJhbmdlOjJmYWZkMDJmNzZkZTQ2Yzk4YWUxOTgwZjk2YWU2ZTk0XzExLTUtMS0xLTExMjY0MA_cbd0470e-e84a-4f1d-9835-e420ac81730e"
      unitRef="usd">-5306000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzQ4NjY_54085fca-97af-4551-8e1f-48697cd520c2">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of income tax expense (benefit) from continuing operations to the amount computed by applying the statutory federal income tax rate to the net income (loss) from continuing operations is summarized as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.048%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax at federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FDII&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,395)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(637)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,652)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate change for changes in federal, foreign or state law&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(535)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,963)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(673)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sale of Vernalis R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,993)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(266)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign tax differential on income/loss of foreign subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,839)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt repurchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subpart F income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,080)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(623)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision to return adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,920)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Officer compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(121,864)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,823)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzItMS0xLTEtMTEyNjQw_7490f567-4deb-4909-aebc-f3517063aae6"
      unitRef="usd">7562000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzItMy0xLTEtMTEyNjQw_547c2b85-bbcb-493d-8086-8cffcedc8e00"
      unitRef="usd">15163000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzItNS0xLTEtMTEyNjQw_c7b2b1e2-e612-453a-8aee-6fc8ea44b51d"
      unitRef="usd">272000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzMtMS0xLTEtMTEyNjQw_5340467b-a148-4aa3-b77e-fdce617a4e05"
      unitRef="usd">264000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzMtMy0xLTEtMTEyNjQw_14a3a635-7590-4ad9-a0c0-fd7813216bd2"
      unitRef="usd">-82000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzMtNS0xLTEtMTEyNjQw_89c94d5d-d329-4aff-9a5e-66ef609cc063"
      unitRef="usd">-1231000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationFdiiAmount
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzQtMS0xLTEtMTQxMzE0_fc513c1a-ecdc-4b55-bfa9-384af50b68c8"
      unitRef="usd">2395000</us-gaap:EffectiveIncomeTaxRateReconciliationFdiiAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationFdiiAmount
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzQtMy0xLTEtMTQxMzE0_c6a98e47-d158-479e-8414-8f41d25503fe"
      unitRef="usd">637000</us-gaap:EffectiveIncomeTaxRateReconciliationFdiiAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationFdiiAmount
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzQtNS0xLTEtMTQxMzE0_4667b1a2-ced7-4941-b489-aa938e739104"
      unitRef="usd">1652000</us-gaap:EffectiveIncomeTaxRateReconciliationFdiiAmount>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzUtMS0xLTEtMTQxMzI0_65fd1631-498d-4d4d-842e-aa5214c84577"
      unitRef="usd">-535000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzUtMy0xLTEtMTQxMzI0_9e7d3e1b-c625-4135-b966-2d61d3375b5b"
      unitRef="usd">-7963000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzUtNS0xLTEtMTQxMzI0_cfec9402-73cd-48f1-9eb1-098aed77c2db"
      unitRef="usd">-164000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <lgnd:EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzYtMS0xLTEtMTQxMzM0_ac220273-5a83-459e-a6db-a2a5c88696ef"
      unitRef="usd">158000</lgnd:EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions>
    <lgnd:EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzYtMy0xLTEtMTQxMzM0_e3c85b01-bc90-4603-9cde-0206418c93a9"
      unitRef="usd">-480000</lgnd:EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions>
    <lgnd:EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzYtNS0xLTEtMTQxMzM0_41e2e8a1-fff7-4033-8f94-d092b31ccbe7"
      unitRef="usd">673000</lgnd:EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions>
    <us-gaap:IncomeTaxReconciliationDispositionOfBusiness
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzctMS0xLTEtMTEyNjQw_58d270bf-35f1-40e1-a9e1-e16c4437cc93"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationDispositionOfBusiness>
    <us-gaap:IncomeTaxReconciliationDispositionOfBusiness
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzctMy0xLTEtMTEyNjQw_eb0fbe29-5dc3-435e-ae48-3ab9da297886"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationDispositionOfBusiness>
    <us-gaap:IncomeTaxReconciliationDispositionOfBusiness
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzctNS0xLTEtMTEyNjQw_2c48fbda-cfaf-4281-b8fd-a68c86249c8c"
      unitRef="usd">127372000</us-gaap:IncomeTaxReconciliationDispositionOfBusiness>
    <lgnd:IncomeTaxReconciliationContingentValueRights
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzgtMS0xLTEtMTEyNjQw_1b977afd-a031-4e1c-81fe-ed6d7abb4583"
      unitRef="usd">15000</lgnd:IncomeTaxReconciliationContingentValueRights>
    <lgnd:IncomeTaxReconciliationContingentValueRights
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzgtMy0xLTEtMTEyNjQw_c691afba-3e09-47ad-84c2-0f6f5d90fee3"
      unitRef="usd">-7993000</lgnd:IncomeTaxReconciliationContingentValueRights>
    <lgnd:IncomeTaxReconciliationContingentValueRights
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzgtNS0xLTEtMTEyNjQw_6a921937-0d9c-4f1f-8cba-d3aeae73dc27"
      unitRef="usd">-266000</lgnd:IncomeTaxReconciliationContingentValueRights>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzktMS0xLTEtMTEyNjQw_05c355ed-a124-4a5d-8525-1b341552db91"
      unitRef="usd">103000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzktMy0xLTEtMTEyNjQw_a3479493-b59b-44ed-b32f-e755965dd9cc"
      unitRef="usd">-114000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzktNS0xLTEtMTEyNjQw_a96cd0e0-8df6-417e-9da0-a9c75f4b4fc4"
      unitRef="usd">-3839000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <lgnd:EffectiveIncomeTaxRateReconciliationExpiredTaxCreditsResearch
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzEwLTEtMS0xLTExMjY0MA_b827b851-87bf-4392-b947-852675ea6b59"
      unitRef="usd">256000</lgnd:EffectiveIncomeTaxRateReconciliationExpiredTaxCreditsResearch>
    <lgnd:EffectiveIncomeTaxRateReconciliationExpiredTaxCreditsResearch
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzEwLTMtMS0xLTExMjY0MA_878dc462-9ce1-498d-bf9b-d2653daec16f"
      unitRef="usd">-1628000</lgnd:EffectiveIncomeTaxRateReconciliationExpiredTaxCreditsResearch>
    <lgnd:EffectiveIncomeTaxRateReconciliationExpiredTaxCreditsResearch
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzEwLTUtMS0xLTExMjY0MA_ac970280-5ba6-44e8-89f2-6c06a048c9e1"
      unitRef="usd">-168000</lgnd:EffectiveIncomeTaxRateReconciliationExpiredTaxCreditsResearch>
    <lgnd:EffectiveIncomeTaxRateReconciliationDebtRepurchasesAmount
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzExLTEtMS0xLTExMjY0MA_668863e2-14d5-4512-abfc-5c330993859f"
      unitRef="usd">626000</lgnd:EffectiveIncomeTaxRateReconciliationDebtRepurchasesAmount>
    <lgnd:EffectiveIncomeTaxRateReconciliationDebtRepurchasesAmount
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzExLTMtMS0xLTExMjY0MA_788edf00-1135-4542-9d82-b59a26e782cd"
      unitRef="usd">0</lgnd:EffectiveIncomeTaxRateReconciliationDebtRepurchasesAmount>
    <lgnd:EffectiveIncomeTaxRateReconciliationDebtRepurchasesAmount
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzExLTUtMS0xLTExMjY0MA_f2ead9c8-25e7-4b66-b891-a248b3e3c96d"
      unitRef="usd">0</lgnd:EffectiveIncomeTaxRateReconciliationDebtRepurchasesAmount>
    <lgnd:EffectiveIncomeTaxRateReconciliationOtherIncome
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzEyLTEtMS0xLTExMjY0MA_ce22b93e-c6b8-43e8-931f-61def4901039"
      unitRef="usd">853000</lgnd:EffectiveIncomeTaxRateReconciliationOtherIncome>
    <lgnd:EffectiveIncomeTaxRateReconciliationOtherIncome
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzEyLTMtMS0xLTExMjY0MA_6f047e18-4ede-49ed-a210-be4ae2741585"
      unitRef="usd">1392000</lgnd:EffectiveIncomeTaxRateReconciliationOtherIncome>
    <lgnd:EffectiveIncomeTaxRateReconciliationOtherIncome
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzEyLTUtMS0xLTExMjY0MA_f84e316b-45e8-4818-9675-4c3b8076fcf8"
      unitRef="usd">25000</lgnd:EffectiveIncomeTaxRateReconciliationOtherIncome>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzE2LTEtMS0xLTE0MTA4MA_432e80ef-58b3-4ff6-9bca-b41e01650ffc"
      unitRef="usd">1279000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzE2LTMtMS0xLTE0MTEzMQ_56e30abf-5718-46be-9bf6-e82fb58a5d5d"
      unitRef="usd">-12080000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzE2LTUtMS0xLTE0MTEzOA_f4b78a06-2fa4-49c2-95fc-4007391acd13"
      unitRef="usd">-623000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <lgnd:EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsAmount
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzE3LTEtMS0xLTE0MTA4Nw_af2e7d16-c515-4ff3-8bdc-c358992b8982"
      unitRef="usd">-2232000</lgnd:EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsAmount>
    <lgnd:EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsAmount
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzE3LTMtMS0xLTE0MTA5NA_e08de744-92c2-4297-9693-5f82667d3a11"
      unitRef="usd">1347000</lgnd:EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsAmount>
    <lgnd:EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsAmount
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzE3LTUtMS0xLTE0MTEwMQ_2f0504c3-31cd-4eb8-8d7a-9c7260c2f0b1"
      unitRef="usd">5920000</lgnd:EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsAmount>
    <lgnd:EffectiveIncomeTaxRateReconciliationOfficerCompensationAmount
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzE4LTEtMS0xLTE0MTEwOA_dc6c60c0-e0aa-44c4-9e93-a0933319ff44"
      unitRef="usd">5869000</lgnd:EffectiveIncomeTaxRateReconciliationOfficerCompensationAmount>
    <lgnd:EffectiveIncomeTaxRateReconciliationOfficerCompensationAmount
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzE4LTMtMS0xLTE0MTExNw_daf83051-cb1a-4c31-9d79-110cdc8a3b63"
      unitRef="usd">3239000</lgnd:EffectiveIncomeTaxRateReconciliationOfficerCompensationAmount>
    <lgnd:EffectiveIncomeTaxRateReconciliationOfficerCompensationAmount
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzE4LTUtMS0xLTE0MTEyNA_4d44aaf6-d6f3-407f-af2f-710b951ea81a"
      unitRef="usd">2410000</lgnd:EffectiveIncomeTaxRateReconciliationOfficerCompensationAmount>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzE2LTEtMS0xLTExMjY0MA_89835f26-0699-4ba4-bc48-752c0881c0bf"
      unitRef="usd">24799000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzE2LTMtMS0xLTExMjY0MA_578e7a59-291b-4a0b-bf10-1680cc88ea91"
      unitRef="usd">11245000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzE2LTUtMS0xLTExMjY0MA_0f53f36d-a29b-4beb-b8ad-2acd5e652dc1"
      unitRef="usd">-121864000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzIxLTEtMS0xLTE0MTM0NA_6a54da90-f6d7-4964-969c-126c26fede8f"
      unitRef="usd">460000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzIxLTMtMS0xLTE0MTM0NA_5232d83d-1b67-4e79-a4f8-1bcc23042a45"
      unitRef="usd">-3823000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzIxLTUtMS0xLTE0MTM0NA_87c0a685-b911-43a3-828d-d6e322c1a2a0"
      unitRef="usd">1015000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzE3LTEtMS0xLTExMjY0MA_24dc9b24-d5df-4c82-a792-b013bbb50ae0"
      unitRef="usd">41230000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzE3LTMtMS0xLTExMjY0MA_89854f17-24bd-4eb7-b838-1fc335a82e3d"
      unitRef="usd">-4148000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo5ZjExNWRlMzcyZmY0MGNkYTA2OWMwMDRhNWQyY2VkOC90YWJsZXJhbmdlOjlmMTE1ZGUzNzJmZjQwY2RhMDY5YzAwNGE1ZDJjZWQ4XzE3LTUtMS0xLTExMjY0MA_058f6545-2b80-40e8-b0f9-b8d1098b0dee"
      unitRef="usd">-5306000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzExMTI_a51ff14e-109a-4474-9b82-3856072d9bb1"
      unitRef="usd">21500000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzExMzQ_5343ccd5-e994-43a1-9de9-3fdb78a985dd"
      unitRef="usd">11400000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzExNTk_6107ca0c-71c1-4696-93bc-9d145cc5f876"
      unitRef="usd">-116500000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzQ4NjA_baea4a84-45fc-43f6-8040-c781c5a475cb">Deferred tax assets &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(liabilities) are comprised of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.807%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.662%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.813%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance for deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,931)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:13pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identified intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,696)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66,848)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,886)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,459)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75,582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72,307)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:13pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,085)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzQtMS0xLTEtMTEyNjQw_792df382-e415-43b0-82ab-bcad0b7c97bf"
      unitRef="usd">53960000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzQtMy0xLTEtMTEyNjQw_45f83502-b146-498e-b665-940bd74e8a17"
      unitRef="usd">63471000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzUtMS0xLTEtMTEyNjQw_a43493d0-eda2-4896-bbf7-cb25c9591708"
      unitRef="usd">26309000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzUtMy0xLTEtMTEyNjQw_3634ed4f-210b-4888-8ae1-fc0ea083e0d4"
      unitRef="usd">26908000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzYtMS0xLTEtMTEyNjQw_7d317011-3e5d-4dc6-8da0-f1151165bc77"
      unitRef="usd">11158000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzYtMy0xLTEtMTEyNjQw_4da5e617-edbb-4f48-8fde-be0f188233e0"
      unitRef="usd">9743000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzctMS0xLTEtMTEyNjQw_7af50f17-f308-4fa3-9491-5d919192e62c"
      unitRef="usd">19542000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzctMy0xLTEtMTEyNjQw_f84178ff-c451-4960-9a99-f4d6bac7cf82"
      unitRef="usd">12989000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzgtMS0xLTEtMTEyNjQw_52c06fd9-063d-4373-a8a7-973c1bda02c9"
      unitRef="usd">110969000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzgtMy0xLTEtMTEyNjQw_2dd8b681-7c12-4846-b5e5-3a27e297c9e9"
      unitRef="usd">113111000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzktMS0xLTEtMTEyNjQw_571e29ed-c480-4516-b9fc-b8bd486316a3"
      unitRef="usd">57472000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzktMy0xLTEtMTEyNjQw_1e9f2bfa-fcec-4196-b967-1858070ea02f"
      unitRef="usd">35931000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzEwLTEtMS0xLTExMjY0MA_b7849a31-9577-4933-9448-33254f7e80a3"
      unitRef="usd">53497000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzEwLTMtMS0xLTExMjY0MA_1ce126d9-fd48-45bd-855f-c8d897ffe4b3"
      unitRef="usd">77180000</us-gaap:DeferredTaxAssetsNet>
    <lgnd:DeferredTaxLiabilitiesFiniteLivedIntangibleAssets
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzEzLTEtMS0xLTExMjY0MA_f8758714-ff65-4b6d-bba6-95ae1b697459"
      unitRef="usd">64696000</lgnd:DeferredTaxLiabilitiesFiniteLivedIntangibleAssets>
    <lgnd:DeferredTaxLiabilitiesFiniteLivedIntangibleAssets
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzEzLTMtMS0xLTExMjY0MA_153a0a76-1c18-429d-b050-01654c6f7fa5"
      unitRef="usd">66848000</lgnd:DeferredTaxLiabilitiesFiniteLivedIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzE0LTEtMS0xLTExMjY0MA_b593224d-6ed3-4f91-8e54-37c2cf08f0df"
      unitRef="usd">10886000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzE0LTMtMS0xLTExMjY0MA_799dd124-1ded-43f2-9520-64c39765609b"
      unitRef="usd">5459000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzE1LTEtMS0xLTExMjY0MA_98a29762-6a02-447e-97f4-d4a410e51d9e"
      unitRef="usd">75582000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzE1LTMtMS0xLTExMjY0MA_ee2bea64-6646-492b-8fa4-8ba6771823ca"
      unitRef="usd">72307000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzE3LTEtMS0xLTExMjY0MA_0d7763ba-3845-434f-8e61-dcf288444d20"
      unitRef="usd">22085000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTphNTA3NGM5YWViMzM0NjZjYjUzOGU5ZmMzMjRjOWU0MS90YWJsZXJhbmdlOmE1MDc0YzlhZWIzMzQ2NmNiNTM4ZTlmYzMyNGM5ZTQxXzE3LTMtMS0xLTExMjY0MA_a03aec17-9c7a-4730-80f6-b8e5ffa3e34e"
      unitRef="usd">4873000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzQzOTgwNDY1MjE5MzA_790148a9-824f-4edf-98c6-0b08cae1d922"
      unitRef="usd">4700000</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i4e9e56a3dff444f1b28980b0d2c80207_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzE1NjM_2b402356-73ff-4072-b46c-1347f945f9cf"
      unitRef="usd">81100000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i7793ca8a70014fca9041f46a2bcbbb00_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzE1NzA_cda957a5-3ff8-4537-9978-d5b4f5f5384a"
      unitRef="usd">168300000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i4d2fbdca41684dfa9a100d455115d767_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzE2NTY_b9709fb4-48a0-492f-85f4-c9ac575cb1fd"
      unitRef="usd">8500000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="iff27bbd909ef454a889168bc2e1dc2ab_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzE3NTA_c8c06cf2-e05d-43a3-aa98-761f42bb85fc"
      unitRef="usd">29000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ia1547d40c4f44431b0ac46de39c392f7_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzE4Nzg_d94b34a2-df63-4c02-98e5-237da68f376e"
      unitRef="usd">96100000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i761a3b7f76b64061bb3f971fa489c7c9_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzE5NDE_76f6618b-dacd-4c92-829f-aadf27ebc911"
      unitRef="usd">15600000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i52ab528f20684598afd7cd8e8d6192f8_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzIwNTI_6a2a2681-8d5e-4316-a802-04f091d4988a"
      unitRef="usd">117500000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i1e13a6f6bcd64e4eba32eae14ed422df_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzIxMTU_43836ae3-a2b3-497e-a563-711378abddc0"
      unitRef="usd">170100000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i9181deee2e7d45b3a86be0f8af806dcc_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzU0OTc1NTgyMTEwNQ_f703d922-47e6-44ab-9a8b-396ad37ec2e6"
      unitRef="usd">9300000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="ib4dfcde4db4a4453ae87a69ae3dc6bb1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzU0OTc1NTgyMTIzNw_4250dcc6-4c20-4760-9794-360fe09e8f22"
      unitRef="usd">29000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i8e5c23045c2d4ab0af6422e7ac56c5dd_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzU0OTc1NTgyMTQwMQ_8b6a4046-1e15-4c69-82cc-81c6e338deaf"
      unitRef="usd">101600000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i6f417214d42c4bd5a425fd3e6b350310_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzU0OTc1NTgyMTY0Mw_b8726df6-b605-4424-839f-c2e5379f17d2"
      unitRef="usd">17500000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzQ4NjI_7acae623-6281-488c-aff1-7c9d848b0b4f">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the amount of unrecognized tax benefits at December&#160;31, 2022, 2021 and 2020 is as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Additions based on tax positions related to the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Additions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Reductions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,072)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(954)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo3Y2EwN2RmNGY1OTg0ZDU4YWU4MWI3OWE3NzZlMzYwZi90YWJsZXJhbmdlOjdjYTA3ZGY0ZjU5ODRkNThhZTgxYjc5YTc3NmUzNjBmXzItMS0xLTEtMTM4NTg1_6ed09bc2-c090-44cf-8e07-01d982797fca"
      unitRef="usd">29550000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo3Y2EwN2RmNGY1OTg0ZDU4YWU4MWI3OWE3NzZlMzYwZi90YWJsZXJhbmdlOjdjYTA3ZGY0ZjU5ODRkNThhZTgxYjc5YTc3NmUzNjBmXzItMS0xLTEtMTEyNjQw_22eb46a5-5189-437a-8a78-f076c3c14a0d"
      unitRef="usd">31619000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i859e9607437a43d8adb4d3dc08e60773_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo3Y2EwN2RmNGY1OTg0ZDU4YWU4MWI3OWE3NzZlMzYwZi90YWJsZXJhbmdlOjdjYTA3ZGY0ZjU5ODRkNThhZTgxYjc5YTc3NmUzNjBmXzItMy0xLTEtMTEyNjQw_6cc5d6b6-d56f-4b86-9da9-b095a592077c"
      unitRef="usd">28647000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo3Y2EwN2RmNGY1OTg0ZDU4YWU4MWI3OWE3NzZlMzYwZi90YWJsZXJhbmdlOjdjYTA3ZGY0ZjU5ODRkNThhZTgxYjc5YTc3NmUzNjBmXzMtMS0xLTEtMTM3MjY4_15c0e019-22c0-4267-9d02-8779790523fc"
      unitRef="usd">58000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo3Y2EwN2RmNGY1OTg0ZDU4YWU4MWI3OWE3NzZlMzYwZi90YWJsZXJhbmdlOjdjYTA3ZGY0ZjU5ODRkNThhZTgxYjc5YTc3NmUzNjBmXzMtMS0xLTEtMTEyNjQw_f15a61e3-6552-453e-b743-e11149f6a333"
      unitRef="usd">252000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo3Y2EwN2RmNGY1OTg0ZDU4YWU4MWI3OWE3NzZlMzYwZi90YWJsZXJhbmdlOjdjYTA3ZGY0ZjU5ODRkNThhZTgxYjc5YTc3NmUzNjBmXzMtMy0xLTEtMTEyNjQw_2ca48ce7-34f4-4f9c-9b16-4ff4cbe33d72"
      unitRef="usd">3911000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo3Y2EwN2RmNGY1OTg0ZDU4YWU4MWI3OWE3NzZlMzYwZi90YWJsZXJhbmdlOjdjYTA3ZGY0ZjU5ODRkNThhZTgxYjc5YTc3NmUzNjBmXzQtMS0xLTEtMTM3MjY4_8ea570af-a9f4-4ce1-a1bf-c20d89c3778e"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo3Y2EwN2RmNGY1OTg0ZDU4YWU4MWI3OWE3NzZlMzYwZi90YWJsZXJhbmdlOjdjYTA3ZGY0ZjU5ODRkNThhZTgxYjc5YTc3NmUzNjBmXzQtMS0xLTEtMTEyNjQw_fc5e7f58-f2f2-4f78-961f-91490cc3edc5"
      unitRef="usd">751000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo3Y2EwN2RmNGY1OTg0ZDU4YWU4MWI3OWE3NzZlMzYwZi90YWJsZXJhbmdlOjdjYTA3ZGY0ZjU5ODRkNThhZTgxYjc5YTc3NmUzNjBmXzQtMy0xLTEtMTEyNjQw_bd339102-10d1-4fce-bf96-a191f5fc209c"
      unitRef="usd">15000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo3Y2EwN2RmNGY1OTg0ZDU4YWU4MWI3OWE3NzZlMzYwZi90YWJsZXJhbmdlOjdjYTA3ZGY0ZjU5ODRkNThhZTgxYjc5YTc3NmUzNjBmXzUtMS0xLTEtMTM3MjY4_939613db-e7c6-4ed4-9ce7-88c0ba1a13e7"
      unitRef="usd">512000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo3Y2EwN2RmNGY1OTg0ZDU4YWU4MWI3OWE3NzZlMzYwZi90YWJsZXJhbmdlOjdjYTA3ZGY0ZjU5ODRkNThhZTgxYjc5YTc3NmUzNjBmXzUtMS0xLTEtMTEyNjQw_58174f2a-5c38-414d-8856-f84412db3ea0"
      unitRef="usd">3072000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i722c9276c7584a49823e2aa504120dab_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo3Y2EwN2RmNGY1OTg0ZDU4YWU4MWI3OWE3NzZlMzYwZi90YWJsZXJhbmdlOjdjYTA3ZGY0ZjU5ODRkNThhZTgxYjc5YTc3NmUzNjBmXzUtMy0xLTEtMTEyNjQw_dca67072-e84e-48d7-b1ea-b9b166ae172a"
      unitRef="usd">954000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo3Y2EwN2RmNGY1OTg0ZDU4YWU4MWI3OWE3NzZlMzYwZi90YWJsZXJhbmdlOjdjYTA3ZGY0ZjU5ODRkNThhZTgxYjc5YTc3NmUzNjBmXzYtMS0xLTEtMTM4NTg1_fd3ff5c2-8562-40ec-b241-4db25dc2de6a"
      unitRef="usd">29096000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i23fb82cd64a44e6a878e6fee6dd6477d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo3Y2EwN2RmNGY1OTg0ZDU4YWU4MWI3OWE3NzZlMzYwZi90YWJsZXJhbmdlOjdjYTA3ZGY0ZjU5ODRkNThhZTgxYjc5YTc3NmUzNjBmXzYtMS0xLTEtMTEyNjQw_519d014e-67fb-4297-846a-a6986c607537"
      unitRef="usd">29550000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90YWJsZTo3Y2EwN2RmNGY1OTg0ZDU4YWU4MWI3OWE3NzZlMzYwZi90YWJsZXJhbmdlOjdjYTA3ZGY0ZjU5ODRkNThhZTgxYjc5YTc3NmUzNjBmXzYtMy0xLTEtMTEyNjQw_22eb46a5-5189-437a-8a78-f076c3c14a0d"
      unitRef="usd">31619000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV8xMTgvZnJhZzpiOWVlODU3NGIzZjA0MGMzYTI1ZTlmNjRiYmEyNDM1OC90ZXh0cmVnaW9uOmI5ZWU4NTc0YjNmMDQwYzNhMjVlOWY2NGJiYTI0MzU4XzM4MTQ_52109afa-148d-453e-9dd2-82ac44ce3f98"
      unitRef="usd">27300000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:QuarterlyFinancialInformationTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90ZXh0cmVnaW9uOjBhMzU5M2RhMTgzMjQzNmY5MGM0NmVlNjVjYjBhMWFjXzI3NDg3NzkwNzIzOTI_258627c1-c4f4-4a38-944a-7f23983a716b">Selected Quarterly Financial Data (Unaudited)&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table contains quarterly financial information for 2022 and 2021. The Company believes that the following information reflects all normal recurring adjustments necessary for a fair presentation of the information for the periods presented. The operating results for any quarter are not necessarily indicative of results for any future period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.832%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;36,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;50,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;59,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;50,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;196,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;36,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total operating costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;41,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;46,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;193,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(12,929)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(14,534)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,219)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net loss from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(13,494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(28,142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(15,385)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(895)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17,485)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(33,361)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Basic net income (loss) from continuing operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.86)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Basic net loss from discontinued operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Diluted net income (loss) from continuing operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.86)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Diluted net loss from discontinued operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Shares used in the computation of basic  net income (loss) per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Shares used in the computation of diluted  net income (loss) per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.832%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;46,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;78,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;59,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;56,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;241,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;46,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total operating costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;36,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;41,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;137,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;36,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;76,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net loss from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,660)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,717)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6,615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(19,215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,417)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;57,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Basic net income (loss) from continuing operations per share &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Basic net loss from discontinued operations per share &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Diluted net income (loss) from continuing operations per share &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Diluted net loss from discontinued operations per share &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Shares used in the computation of basic net income (loss) per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Shares used in the computation of diluted net income (loss) per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
    <us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90ZXh0cmVnaW9uOjBhMzU5M2RhMTgzMjQzNmY5MGM0NmVlNjVjYjBhMWFjXzI3NDg3NzkwNzIzOTM_0b61ffb2-711b-46b2-8411-12c412b3a745">The operating results for any quarter are not necessarily indicative of results for any future period.&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.832%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;36,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;50,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;59,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;50,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;196,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;36,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total operating costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;41,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;46,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;193,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(12,929)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(14,534)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,219)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net loss from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(13,494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(28,142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(15,385)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(895)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17,485)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(33,361)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Basic net income (loss) from continuing operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.86)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Basic net loss from discontinued operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Diluted net income (loss) from continuing operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.86)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Diluted net loss from discontinued operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Shares used in the computation of basic  net income (loss) per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Shares used in the computation of diluted  net income (loss) per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.832%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;46,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;78,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;59,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;56,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;241,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;46,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total operating costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;36,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;41,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;137,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;36,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;76,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net loss from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,660)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,717)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6,615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(19,215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,417)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;57,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Basic net income (loss) from continuing operations per share &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Basic net loss from discontinued operations per share &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Diluted net income (loss) from continuing operations per share &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Diluted net loss from discontinued operations per share &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Shares used in the computation of basic net income (loss) per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Shares used in the computation of diluted net income (loss) per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6992767e8dd8406c922375c93b5376c2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzMtMS0xLTEtMTI0NDE1_a63f24d3-caa9-430b-bfa1-ae9cf3f42aeb"
      unitRef="usd">36516000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2b403a13d95c4618a2a1ecf0b72f5ec3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzMtMi0xLTEtMTI0NDE1_578bc1fb-d4d7-440f-a5f3-2e0461e4ff1f"
      unitRef="usd">50126000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i897d788652aa45e480cac84774ce09ff_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzMtMy0xLTEtMTI0NDE1_e21f7742-8f30-41ea-9603-ba1a78596772"
      unitRef="usd">59221000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9f4b841dc87a45f4876ae68269b5ee3f_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzMtNC0xLTEtMTI0NDE1_c46b1d54-c745-4ac5-8418-e0ebb48e25e2"
      unitRef="usd">50382000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzMtNS0xLTEtMTI0NDE1_86d9af69-325a-44cd-b819-5e8558498e70"
      unitRef="usd">196245000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i6992767e8dd8406c922375c93b5376c2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzUtMS0xLTEtMTQwNDI0_b2227538-b803-4dc1-88a1-4d9c7f84a831"
      unitRef="usd">9179000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i2b403a13d95c4618a2a1ecf0b72f5ec3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzUtMi0xLTEtMTQwNDI0_ffd0e0d6-dc4a-4621-b2ed-19cb37bc62e6"
      unitRef="usd">8467000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i897d788652aa45e480cac84774ce09ff_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzUtMy0xLTEtMTQwNDI0_0a9a523c-1c2d-4679-9e39-66f6bf4b4096"
      unitRef="usd">9239000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i9f4b841dc87a45f4876ae68269b5ee3f_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzUtNC0xLTEtMTQwNDI0_953a013d-1761-4547-9360-74fc9bcbf133"
      unitRef="usd">9197000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzUtNS0xLTEtMTQwNzIz_ddf01d79-b4a5-47f3-8e5a-b5b1b3b79081"
      unitRef="usd">36082000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i6992767e8dd8406c922375c93b5376c2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzYtMS0xLTEtMTQwNDI0_d1eb6e07-629c-4f28-9e40-c6d8fe08b724"
      unitRef="usd">11925000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i2b403a13d95c4618a2a1ecf0b72f5ec3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzYtMi0xLTEtMTQwNDI0_44b20c72-ba6e-4238-901b-ee265f7fa9f8"
      unitRef="usd">12086000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i897d788652aa45e480cac84774ce09ff_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzYtMy0xLTEtMTQwNDI0_a781219b-b44b-4dd0-a454-8305650f7f26"
      unitRef="usd">14920000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i9f4b841dc87a45f4876ae68269b5ee3f_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzYtNC0xLTEtMTQwNDI0_495f0acf-6396-4f3e-84e9-6ab012779053"
      unitRef="usd">31131000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzYtNS0xLTEtMTQwNzIz_45401ac3-9f93-449d-8b95-be99a9406813"
      unitRef="usd">70062000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i6992767e8dd8406c922375c93b5376c2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzQtMS0xLTEtMTI0NDE1_6a265b1b-23be-4735-b9ff-86cef5fb622a"
      unitRef="usd">34383000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i2b403a13d95c4618a2a1ecf0b72f5ec3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzQtMi0xLTEtMTI0NDE1_b3e10cce-b58b-42d0-a10c-9ee181ed0231"
      unitRef="usd">41464000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i897d788652aa45e480cac84774ce09ff_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzQtMy0xLTEtMTI0NDE1_2b05e2ad-6b00-406a-af7e-dff690f80127"
      unitRef="usd">46880000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i9f4b841dc87a45f4876ae68269b5ee3f_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzQtNC0xLTEtMTI0NDE1_9b18a231-1a9f-4ccd-bbbc-55ebaa654605"
      unitRef="usd">70481000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzQtNS0xLTEtMTI0NDE1_28eed8cc-6ceb-4ad5-9174-99fa0081fa95"
      unitRef="usd">193208000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i6992767e8dd8406c922375c93b5376c2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzYtMS0xLTEtMTI0NDE1_925389f8-54d7-4e68-bf2a-a538e2784c35"
      unitRef="usd">-12929000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i2b403a13d95c4618a2a1ecf0b72f5ec3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzYtMi0xLTEtMTI0NDE1_61e52ea8-333a-408d-8ae1-360b8453c6c5"
      unitRef="usd">12599000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i897d788652aa45e480cac84774ce09ff_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzYtMy0xLTEtMTI0NDE1_48cce4ef-38b0-4125-89d8-e23f6a751cf7"
      unitRef="usd">9645000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i9f4b841dc87a45f4876ae68269b5ee3f_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzYtNC0xLTEtMTI0NDE1_103e4b41-ff1f-4916-b231-2440cc295f54"
      unitRef="usd">-14534000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzYtNS0xLTEtMTI0NDE1_574da136-56ec-4273-b27d-7bb1e59d9d57"
      unitRef="usd">-5219000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i6992767e8dd8406c922375c93b5376c2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzctMS0xLTEtMTI0NDE1_7213a0a5-9846-46a5-8b4b-b06ea50855b4"
      unitRef="usd">-2456000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i2b403a13d95c4618a2a1ecf0b72f5ec3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzctMi0xLTEtMTI0NDE1_589a941a-ded7-4f6e-8cc7-515bab7005b2"
      unitRef="usd">-13494000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i897d788652aa45e480cac84774ce09ff_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzctMy0xLTEtMTI0NDE1_76a8faee-8369-4578-b9b9-78cb7d30c139"
      unitRef="usd">-9241000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i9f4b841dc87a45f4876ae68269b5ee3f_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzctNC0xLTEtMTI0NDE1_92679411-9af0-47ce-8529-e8edb2649b54"
      unitRef="usd">-2951000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzctNS0xLTEtMTI0NDE1_ed7a978a-f8a1-4a14-bd1f-4061765f30a2"
      unitRef="usd">-28142000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:NetIncomeLoss
      contextRef="i6992767e8dd8406c922375c93b5376c2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzgtMS0xLTEtMTI0NDE1_2ed89e6a-53cb-46dd-8d28-41bda84c8650"
      unitRef="usd">-15385000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2b403a13d95c4618a2a1ecf0b72f5ec3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzgtMi0xLTEtMTI0NDE1_feeb465b-18dc-441b-a6c2-fc03224cd628"
      unitRef="usd">-895000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i897d788652aa45e480cac84774ce09ff_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzgtMy0xLTEtMTI0NDE1_ea49655d-48fe-48e5-b917-641dc912fe20"
      unitRef="usd">404000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9f4b841dc87a45f4876ae68269b5ee3f_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzgtNC0xLTEtMTI0NDE1_d58eb7e6-eeb2-444b-88f7-a4f0bd5d79ee"
      unitRef="usd">-17485000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzgtNS0xLTEtMTI0NDE1_30039bff-2b88-44cd-90ec-0834719cdbbc"
      unitRef="usd">-33361000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i6992767e8dd8406c922375c93b5376c2_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzktMS0xLTEtMTI0NDE1_8f3b4cba-59f5-4f58-ac06-1a2de0a8d453"
      unitRef="usdPerShare">-0.77</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i6992767e8dd8406c922375c93b5376c2_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzktMS0xLTEtMTI0NDE1_c1aaea08-458d-42ef-a16b-3ba72095e6af"
      unitRef="usdPerShare">-0.77</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i2b403a13d95c4618a2a1ecf0b72f5ec3_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzktMi0xLTEtMTI0NDE1_57747f5b-c903-4ffe-8588-28a7c09e685b"
      unitRef="usdPerShare">0.75</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i2b403a13d95c4618a2a1ecf0b72f5ec3_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzktMi0xLTEtMTI0NDE1_fa0ca5c3-3c18-40c0-be5c-b56ca2eed121"
      unitRef="usdPerShare">0.75</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i897d788652aa45e480cac84774ce09ff_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzktMy0xLTEtMTI0NDE1_53b35d2e-d70c-445a-9240-0244318b62f6"
      unitRef="usdPerShare">0.57</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i897d788652aa45e480cac84774ce09ff_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzktMy0xLTEtMTI0NDE1_6c4b6145-26a2-410d-a87a-4343bc1d20e8"
      unitRef="usdPerShare">0.57</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i9f4b841dc87a45f4876ae68269b5ee3f_D20221001-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzktNC0xLTEtMTI0NDE1_bdbb93b3-a446-4e8a-ae19-a4a8ce5b057f"
      unitRef="usdPerShare">-0.86</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i9f4b841dc87a45f4876ae68269b5ee3f_D20221001-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzktNC0xLTEtMTI0NDE1_e0bb6f3e-c2ca-4f78-a680-50ea56462252"
      unitRef="usdPerShare">-0.86</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzktNS0xLTEtMTI0NDE1_71898ad9-67c6-4674-9164-d6b05e8be192"
      unitRef="usdPerShare">-0.31</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzktNS0xLTEtMTI0NDE1_799255c5-cccf-4136-a82f-0078788d835a"
      unitRef="usdPerShare">-0.31</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i6992767e8dd8406c922375c93b5376c2_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzEwLTEtMS0xLTEyNDQxNQ_22e2ad92-3ce8-4a5c-beb4-f29227c164b2"
      unitRef="usdPerShare">-0.15</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i6992767e8dd8406c922375c93b5376c2_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzEwLTEtMS0xLTEyNDQxNQ_e2fd0ee1-ddf9-4a3f-bfc5-0bba96a6d176"
      unitRef="usdPerShare">-0.15</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i2b403a13d95c4618a2a1ecf0b72f5ec3_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzEwLTItMS0xLTEyNDQxNQ_2a41f966-f9e9-4ded-9fcb-4ece6866024e"
      unitRef="usdPerShare">-0.80</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i2b403a13d95c4618a2a1ecf0b72f5ec3_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzEwLTItMS0xLTEyNDQxNQ_b786f5f5-c2ff-497c-932b-2e6b9ca4abb8"
      unitRef="usdPerShare">-0.80</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i897d788652aa45e480cac84774ce09ff_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzEwLTMtMS0xLTEyNDQxNQ_5a58cb9a-8177-480d-b899-08e341cc2109"
      unitRef="usdPerShare">-0.55</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i897d788652aa45e480cac84774ce09ff_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzEwLTMtMS0xLTEyNDQxNQ_b682ffae-58eb-4cc8-978d-9a04351fb631"
      unitRef="usdPerShare">-0.55</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i9f4b841dc87a45f4876ae68269b5ee3f_D20221001-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzEwLTQtMS0xLTEyNDQxNQ_5b212ab5-16ee-4f5e-be80-4f6ba3342e6a"
      unitRef="usdPerShare">-0.17</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i9f4b841dc87a45f4876ae68269b5ee3f_D20221001-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzEwLTQtMS0xLTEyNDQxNQ_e28bafce-edfe-4459-a68b-c0a1aa7b964a"
      unitRef="usdPerShare">-0.17</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzEwLTUtMS0xLTEyNDQxNQ_614e920e-7a87-4eb0-bb4f-96052564e804"
      unitRef="usdPerShare">-1.67</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzEwLTUtMS0xLTEyNDQxNQ_ce6e8e90-670d-407c-b63d-64e9f4e11d99"
      unitRef="usdPerShare">-1.67</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6992767e8dd8406c922375c93b5376c2_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzE1LTEtMS0xLTE0MTU0Mg_2554957f-2c9b-49ed-9814-4a1e4f7d795e"
      unitRef="shares">16824000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2b403a13d95c4618a2a1ecf0b72f5ec3_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzE1LTItMS0xLTE0MTU0Mg_2e01f794-d39f-4573-bde3-4b2d4e148dd6"
      unitRef="shares">16868000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i897d788652aa45e480cac84774ce09ff_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzE1LTMtMS0xLTE0MTU0Mg_d15dba41-c0f3-42e2-a927-d7dad8459bd9"
      unitRef="shares">16888000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9f4b841dc87a45f4876ae68269b5ee3f_D20221001-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzE1LTQtMS0xLTE0MTU0Mg_67eb6ad7-4cdc-4042-b4a3-6bf3594695af"
      unitRef="shares">16890000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if45af0da2212401f917e14836fcf8e57_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphZmFjODcwOWUzNTI0NWQwOTA4OGRiZDliOTIyZjhhMy90YWJsZXJhbmdlOmFmYWM4NzA5ZTM1MjQ1ZDA5MDg4ZGJkOWI5MjJmOGEzXzE1LTUtMS0xLTE0MTU0Mg_f112d4c5-bbb9-4fd1-9233-c36c836bfd1b"
      unitRef="shares">16868000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1be8c52ea4fa41c8b69ccfc9a0092bb8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzQtMS0xLTEtMTMwMDA5_57174592-c55c-4c27-928d-32a55cecd487"
      unitRef="usd">46592000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i290c867cc3064c3584ca75424dac7e37_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzQtMi0xLTEtMTMwMDA5_29e4a5c2-8964-4ad8-b315-606bbe3586ff"
      unitRef="usd">78854000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i85bfaefbe85344cbbe2d82fd78da0834_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzQtMy0xLTEtMTMwMDA5_e655bdf9-2e44-4e8a-a3ee-be0be14a5557"
      unitRef="usd">59694000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic08f18c873f549b8b87bea293a4ae096_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzQtNC0xLTEtMTMwMDA5_b2adade0-290c-4e25-94de-ddf85393f96b"
      unitRef="usd">56404000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzQtNS0xLTEtMTM1ODcy_c1b3e1f8-5149-441d-9068-8df98557c4c8"
      unitRef="usd">241544000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i1be8c52ea4fa41c8b69ccfc9a0092bb8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzUtMS0xLTEtMTQwNDM0_4e0bef9c-c236-4c95-a646-cc79ead083db"
      unitRef="usd">9046000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i290c867cc3064c3584ca75424dac7e37_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzUtMi0xLTEtMTQwNDM0_91fbd95d-0685-41b5-8fd9-370dc82499c5"
      unitRef="usd">7482000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i85bfaefbe85344cbbe2d82fd78da0834_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzUtMy0xLTEtMTQwNDM0_50c8958e-9b20-4d7f-8e08-f7929346eb1a"
      unitRef="usd">7430000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ic08f18c873f549b8b87bea293a4ae096_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzUtNC0xLTEtMTQwNDM0_771b89d4-f56a-4b0f-9747-48d3429a4afd"
      unitRef="usd">8147000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzUtNS0xLTEtMTQwNzI1_c1d124df-c22c-4fa4-ad6c-10e449a6a500"
      unitRef="usd">32105000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i1be8c52ea4fa41c8b69ccfc9a0092bb8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzYtMS0xLTEtMTQwNDM0_2d36784d-e3f9-4f19-9305-5d552b2d2ac9"
      unitRef="usd">10815000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i290c867cc3064c3584ca75424dac7e37_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzYtMi0xLTEtMTQwNDM0_c3cc1fd4-4ba6-4b46-acee-447ccfa4e80e"
      unitRef="usd">12412000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i85bfaefbe85344cbbe2d82fd78da0834_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzYtMy0xLTEtMTQwNDM0_f241ace6-477a-48ba-8b9c-3035000a6315"
      unitRef="usd">10967000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ic08f18c873f549b8b87bea293a4ae096_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzYtNC0xLTEtMTQwNDM0_d1a4e4ec-9ccf-439a-b511-79096f29c9a1"
      unitRef="usd">12596000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzYtNS0xLTEtMTQwNzI1_f4fd23c8-74cc-4771-9aa1-3774bb46a262"
      unitRef="usd">46790000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i1be8c52ea4fa41c8b69ccfc9a0092bb8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzUtMS0xLTEtMTMwMjMw_22295aa8-4e82-4653-99ee-525bb83b893b"
      unitRef="usd">36875000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i290c867cc3064c3584ca75424dac7e37_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzUtMi0xLTEtMTMwMjMw_df312fee-ca7e-42b3-9248-80d4f60e4716"
      unitRef="usd">24941000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i85bfaefbe85344cbbe2d82fd78da0834_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzUtMy0xLTEtMTMwMjMw_ea139fb5-b9af-4f42-974a-86ac832d0eef"
      unitRef="usd">34597000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="ic08f18c873f549b8b87bea293a4ae096_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzUtNC0xLTEtMTMwMjMw_9ca31e38-b93b-4afa-86a4-06aa8d7c0a76"
      unitRef="usd">41280000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzUtNS0xLTEtMTMwMjMw_f304518c-afd3-4693-a918-5b63b0cd7846"
      unitRef="usd">137693000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i1be8c52ea4fa41c8b69ccfc9a0092bb8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzYtMS0xLTEtMTMwMjMw_0a7ecf0d-5df8-4de6-a9eb-141a2ea4cf9f"
      unitRef="usd">22767000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i290c867cc3064c3584ca75424dac7e37_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzYtMi0xLTEtMTMwMjMw_cce9dae9-49bc-4688-9de5-3f1cd2768f7b"
      unitRef="usd">36442000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i85bfaefbe85344cbbe2d82fd78da0834_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzYtMy0xLTEtMTMwMjMw_a63eaa7b-0c13-4642-915a-75b0cdcf20b0"
      unitRef="usd">20338000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ic08f18c873f549b8b87bea293a4ae096_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzYtNC0xLTEtMTMwMjMw_6651ff51-d2e0-4ef1-bf3a-6ed9a1ac609a"
      unitRef="usd">-3194000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzYtNS0xLTEtMTMwMjMw_b1225244-5df5-45f9-ba03-9249354fb487"
      unitRef="usd">76353000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i1be8c52ea4fa41c8b69ccfc9a0092bb8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzctMS0xLTEtMTMwMjUw_dd57b433-d15f-4ed0-9d11-a1fa7f8f3d9c"
      unitRef="usd">-4660000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i290c867cc3064c3584ca75424dac7e37_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzctMi0xLTEtMTMwMjUw_f8612669-70c9-45f6-9d7f-2aa69e7fa522"
      unitRef="usd">-5717000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i85bfaefbe85344cbbe2d82fd78da0834_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzctMy0xLTEtMTMwMjUw_1cc3f0c7-ee27-488a-ab1b-20ccc6f5248f"
      unitRef="usd">-6615000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="ic08f18c873f549b8b87bea293a4ae096_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzctNC0xLTEtMTMwMjUw_1da9654d-80b0-4c1b-bab3-9ff16c10783c"
      unitRef="usd">-2223000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzctNS0xLTEtMTM1ODcy_a3ae0e9c-b849-451c-a730-899c3ccbdcd6"
      unitRef="usd">-19215000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:NetIncomeLoss
      contextRef="i1be8c52ea4fa41c8b69ccfc9a0092bb8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzgtMS0xLTEtMTMwMjUw_2d8e4d1c-a94f-4614-b2fc-5eadac0f1b29"
      unitRef="usd">18107000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i290c867cc3064c3584ca75424dac7e37_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzgtMi0xLTEtMTMwMjUw_4fd37cab-5743-48d5-9ebe-2da7a6471a57"
      unitRef="usd">30725000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i85bfaefbe85344cbbe2d82fd78da0834_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzgtMy0xLTEtMTMwMjUw_c6c970bf-0b70-4f05-84f3-fd095646f9cb"
      unitRef="usd">13723000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic08f18c873f549b8b87bea293a4ae096_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzgtNC0xLTEtMTMwMjUw_97297db2-be71-4b9e-bece-9b93f4a48c66"
      unitRef="usd">-5417000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzgtNS0xLTEtMTM1ODcy_193a13c9-1896-475c-aebf-b57c1e627aef"
      unitRef="usd">57138000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i1be8c52ea4fa41c8b69ccfc9a0092bb8_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzktMS0xLTEtMTMwMjU3_df8b0e62-0f4b-45bf-bdf8-cba9448eedba"
      unitRef="usdPerShare">1.39</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i290c867cc3064c3584ca75424dac7e37_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzktMi0xLTEtMTMwMjU3_c827596f-00de-4b2c-91f5-00636e0e6cb2"
      unitRef="usdPerShare">2.19</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i85bfaefbe85344cbbe2d82fd78da0834_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzktMy0xLTEtMTMwMjU3_842dcae8-6b5a-45a2-8fa6-f64d57bae4b3"
      unitRef="usdPerShare">1.22</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ic08f18c873f549b8b87bea293a4ae096_D20211001-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzktNC0xLTEtMTMwMjU3_f22c8804-5fd2-42ae-8371-6805be5554b6"
      unitRef="usdPerShare">-0.19</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzktNS0xLTEtMTMwMjU3_3f168c5b-40ce-4666-bd90-5f6adeb6060c"
      unitRef="usdPerShare">4.59</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i1be8c52ea4fa41c8b69ccfc9a0092bb8_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzEwLTEtMS0xLTEzMDI1Nw_97e5107d-ec2c-4ff5-9c3c-dc2f8b565de5"
      unitRef="usdPerShare">-0.28</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i290c867cc3064c3584ca75424dac7e37_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzEwLTItMS0xLTEzMDI1Nw_2cb32623-a717-459c-82ce-2e200776c7d2"
      unitRef="usdPerShare">-0.34</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i85bfaefbe85344cbbe2d82fd78da0834_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzEwLTMtMS0xLTEzMDI1Nw_83dc8c5f-493f-4361-88ac-5c55782cd673"
      unitRef="usdPerShare">-0.40</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ic08f18c873f549b8b87bea293a4ae096_D20211001-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzEwLTQtMS0xLTEzMDI1Nw_c01cb890-f76e-46ad-ba68-5f6cbc108537"
      unitRef="usdPerShare">-0.13</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzEwLTUtMS0xLTEzMDI1Nw_f5be0ac5-1c8f-4a70-929b-54782e571744"
      unitRef="usdPerShare">-1.16</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i1be8c52ea4fa41c8b69ccfc9a0092bb8_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzExLTEtMS0xLTEzMDI1Nw_02fb4ddc-20ec-4d2d-8caf-4e7b40e6e3e1"
      unitRef="usdPerShare">1.32</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i290c867cc3064c3584ca75424dac7e37_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzExLTItMS0xLTEzMDI1Nw_554cbf8a-3071-41df-bf34-0350d77ff094"
      unitRef="usdPerShare">2.12</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i85bfaefbe85344cbbe2d82fd78da0834_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzExLTMtMS0xLTEzMDI1Nw_b7864234-6b65-41e0-b894-e4ca69d9558c"
      unitRef="usdPerShare">1.19</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ic08f18c873f549b8b87bea293a4ae096_D20211001-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzExLTQtMS0xLTEzMDI1Nw_aea6ef35-e97a-4cb6-9c0b-9b5dd74b57bb"
      unitRef="usdPerShare">-0.19</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzExLTUtMS0xLTEzMDI1Nw_7b4fef08-4dbb-4c6c-8fe6-b9c177939cb5"
      unitRef="usdPerShare">4.43</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i1be8c52ea4fa41c8b69ccfc9a0092bb8_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzEyLTEtMS0xLTEzMDI1Nw_eab4e6dd-adca-453f-b5fc-ecec2bc7f5d9"
      unitRef="usdPerShare">-0.27</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i290c867cc3064c3584ca75424dac7e37_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzEyLTItMS0xLTEzMDI1Nw_6c994cef-c2dd-4d09-9fcc-ac8629edbb14"
      unitRef="usdPerShare">-0.33</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i85bfaefbe85344cbbe2d82fd78da0834_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzEyLTMtMS0xLTEzMDI1Nw_a9f4c9f0-7498-4aee-89a9-9bfb5e862ab3"
      unitRef="usdPerShare">-0.39</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ic08f18c873f549b8b87bea293a4ae096_D20211001-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzEyLTQtMS0xLTEzMDI1Nw_0e0b15d7-dc18-4b94-83b8-f8f0494fe306"
      unitRef="usdPerShare">-0.13</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzEyLTUtMS0xLTEzMDI1Nw_8c89e5ea-1c64-4941-84ea-f964af82e9af"
      unitRef="usdPerShare">-1.11</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i1be8c52ea4fa41c8b69ccfc9a0092bb8_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzEzLTEtMS0xLTEyOTk5Ng_f6064fd2-fe24-4603-8e48-1cf0c4226b24"
      unitRef="shares">16435000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i290c867cc3064c3584ca75424dac7e37_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzEzLTItMS0xLTEyOTk5Ng_04cd9f1e-8d14-4b6e-93e4-1b68a23cd489"
      unitRef="shares">16659000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i85bfaefbe85344cbbe2d82fd78da0834_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzEzLTMtMS0xLTEyOTk5Ng_bacb38d0-0652-4862-b5c7-934b6aa1d598"
      unitRef="shares">16688000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic08f18c873f549b8b87bea293a4ae096_D20211001-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzEzLTQtMS0xLTEyOTk5Ng_abdfb500-9211-425b-8157-064708fcc840"
      unitRef="shares">16733000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzEzLTUtMS0xLTEyOTk5Ng_904cb74a-ba73-4140-b221-6d800bd8e71d"
      unitRef="shares">16630000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i1be8c52ea4fa41c8b69ccfc9a0092bb8_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzE0LTEtMS0xLTEyOTk5Ng_4b1c5032-2bf4-481b-a896-0d578f068b9e"
      unitRef="shares">17248000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i290c867cc3064c3584ca75424dac7e37_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzE0LTItMS0xLTEyOTk5Ng_b3e2bd80-d0ed-4e4b-863e-36261df170f6"
      unitRef="shares">17172000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i85bfaefbe85344cbbe2d82fd78da0834_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzE0LTMtMS0xLTEyOTk5Ng_0fe8a0b5-66c8-47b2-92cf-3ead6240f2a4"
      unitRef="shares">17142000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic08f18c873f549b8b87bea293a4ae096_D20211001-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzE0LTQtMS0xLTEyOTk5Ng_5dac1355-25c9-495c-99c8-1f782d620a80"
      unitRef="shares">16733000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4ZTZiODc1NzZkNjQ0NjQ4NmEzYjI5NTMzYTVjZjZhL3NlYzo5OGU2Yjg3NTc2ZDY0NDY0ODZhM2IyOTUzM2E1Y2Y2YV83NDIvZnJhZzowYTM1OTNkYTE4MzI0MzZmOTBjNDZlZTY1Y2IwYTFhYy90YWJsZTphNWE3YzU0N2MxNGE0ZTk3ODg4MTI2ZGQ5ZGRlMGQ1Zi90YWJsZXJhbmdlOmE1YTdjNTQ3YzE0YTRlOTc4ODgxMjZkZDlkZGUwZDVmXzE0LTUtMS0xLTEyOTk5Ng_02e206a7-017a-4727-93bd-e94b72dfefde"
      unitRef="shares">17246000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>95
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MJ!GU *;4JM1*#^#4\@#Y=$0>V*8E9<JTXX3.(V9P\QCY/@$AD D*224_HU[
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M@A4E[,4;05=Y4?><"D&3_# D&&[#\@+X?$&IV+V17[#_CP3#_P)02P,$%
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M/RXXT^P-0/_]3N@!9//%O*6Q>RMG]A]02P,$%     @ <8!<5I#&]+KZ @
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M]AW56SB6MWXL]\ZM';!'VVS.1@FK#OJ\):5U_VV4;K\/P8#JY\_4)Z+W(2$
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M.F=]C$E6G;N::+$J>]E<:.R,Y3##RPY( \#W"R'TX\1\H+D^A7\ 4$L#!!0
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M'Y2L^,)Z%W_]BVD;?U<=14C8= NS-[!Z]/QR8=IC.C0,XVSPY?#00&;UD;
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M'A?]\^!2*E-KWZ*3N$D;%:DRAX8A79K8:>8<DC'&?6/?( X)(\Z>N^/30 3
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MU1J0R1)I]2EK'2/-1'X(\$ $* <(K%6BNM'SHG$BKR*&_-/LTQKLV"EZEJ"
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M8H>_D:!Y9[T4]P]U]' <+@WV1.G#Q+892S[T0;"5%E6M)U=<$R8<LLI)G S
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M:XB%?(,/P/?+NN["'[C!KFZ^$'BO_B]02P,$%     @ <8!<5@5(=4%G#
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M;2 N')('S()%2@(C4T<PDVD/@0B&-(LT?80E]+=;#&WR&7"NI 6\=25+[WX
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MJ^ALQ?)M8T#UY08.T&S*&O$)'T71J2%A'+,"FUI)&(53<J2ZG*@.GJK[G'@
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MM"3%? >_:1A9?IPBY(UC.PQ$: <AW7@6X>P[O;F)@U8.Q]R>G?H]_4MQY6*
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M]>PXF5T&ONU'L,$A-!\VV_9)_?W0CO$PBJR 4_NX#V"* D*AV65(/847IU8
MAR&R(Y_K 81>+O8I9JN%>Q>V#&V38*9^1 @[278A)F< 3?AADEA1$/>WE[#S
MB8L>L0W<('OK)60*59.()TD3//3U/>@+$[@&L\LHMAV 5AQ;3N#!-,=D2Z/
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M8S<;G'7/K3.G;\/^]&UX]O2M\:KN^"#\S4+9BC=T/J1HCAW#/3O<\6.X9^?
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M<E"F?V@OGY.&])LYW3N/3E3";ES!;*0NC-?/=;:4HJ2L$80B\/2_3XWC4B!
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M3'%#3!ZXT<F:EB$T'XR'*636M&?O-8L"..H'J9,H!U12?%EH#!N<-7 D)G(
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M00MGP?B(>@D3ZL\>Q,UR04"<G&?AF%J"4)@:N@,LY^FDY$^F@^8T?]T_<"!
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M!NZ6 $V4C6$.O>OJID,> P#'+5^M:TODPV16&"(OAL DR>3,Z9FITTVR.!>
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MV;*S4UB0171 (.35#MC-%O@_;@BV(&2;K."T&P +'CQ\5U0[?+\"QHD$6A.
M;;HIJZ):(^C;C6F3C2UVR>" ^(JNC_8K@P(;RD"ZPV)GR>^ ?3M+/ 2.N"JM
MY\B-72.>O-3/'&H#RT M#I>V&M@-X\EL1))=.$EV,2Z/3NHR-P",- =91#]'
M(GQ([/T;IDD^ #:D[@F<VLJI"8U7$S;F#D!J+3##&CD"O(>DE*)X@;<M,X'?
M9K>SY&]75S<T*].+)?PSK)TUBG\X!!R#8@R]#K^RE)CVI$2.)WQ5%$Q9^DW
M7YB:EZ; I82+M4BA)6T+EIN&&Q\[V.?N8)^/0OP-8B7JG!U,\('P#U<S='1?
M,5#E!DH^ >BN9;\9*"PU[(:T%B"8/ED/\"S<M%. 2")L+7^8UL"XZMP K<+Q
M%X#KI$<SQB#!9X,K&CKTJ]MKT,F7+5!Y"I-<3!=GD^1!D(E@_L+!_,4HJ'X#
M20V[_1F8-=@^=A#87S<"09G1VNG*]U,$XQ.J),CS>^A?HRBHB;79I./YK)L/
MD14@WFUW?,ITG&:U HG*Q+)E6H$E5;7@+AW:O8M2U0'/B+ &N1M(*B*@M.W@
M;5@5&(8-V&K(]6'2.EG5U18^JV"=;I%CY''ICNIR%-# :(##MHK,  .'F!_S
MYO/0R?U+ P863@["O&:5@\&[ R  /AI40H&Q_ -A#?(4)'<3&)'IT00IL+J\
M36H<'N$/2AC@"L"HS@O27DF_P..^,X4[@[R\ TC2]"2;^._$?DEQK?3)CGDR
M+0C.][>2- FRS)IDC;*N)$F5V64+,BSM:M)3)L'8R;HV&:)%#7B"HN_HW6U'
M9[[JRLR;)DSI+ LR0#'0F&F1Z"LA#:FIMC;0F_H;='R6D'X5P9P4*(_3-8EC
MV;;PJ+<6K!-X_0U/#9I*T]7$3JYE(\QH]"DI60Q&8NRP>0/J?K,!<*V[/+.(
M)0VKG:"0XI%F.6KT 4=#F\6T A9>F]^M6=GV(!H!;!..^S!#G@#D$(R/>P$^
MEE<9:@=P:* 2Y7:/JC>.#H]7N:B"YC-08'8'" 4*'&T;A%U&+..0VR)3'&$U
M$:VO<7K[WM';]^/D@2?U<W!2?S7;W0_)[0:XR!2%!\#:X>40]7WE\-=]S% "
M@2UO\O4&@,00#>F!L28X#4(+4.8!AN1N 8%4(+H(5[)DX)"=Z,V[V8E-A8_#
M.3W%!DL,7\A+)AX\&%'C/1T1[HF0/)#ZT@Q/ Y)33!MS9_("T-1.04),&X"/
MF#6P\@Y,M.BK&JD-;$_$I399F;Q. *(=& ($JZZLK2GR/Q#? 6'%=*E /6U8
MQ8Z(7M4N)S6<>&"YM@5)MT&]]PYI,T52?XR#@>%96GJG-5_8"+UGXB,X^:F/
MI%6T"*_@$&2=8B.?'9\.NC?)G&"=QZ9(V@F09MEZ(@?59E-E R/V-H'XY?9
M \+I$'X=G5FXMZY1PW!\ :'JVQ!(3P.1-"T\$C!8!#1D0LNYP$KMEQV<%6M:
M0UI (/M[@'W30XL \4\(@<F8),%5!Z/!5UY&39L=K@F- @0(O<"LFG0:Q+2
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M8%/YX \?!VU.1T4[-PAVTC"JF/G17!(]??K>/;^107S.-IBU("4SF02#K3O
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M1:5PV(0[FSA(2%3+C1G"Q!T[*814;>+"7"I]&;1N$ 8Z+?D/6U>N)*[F9*:
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M*#G=-#5%*KY9M)(Z8%6[XN#(#'9)?_B,A;$ST)CL"1 XX\MI#$*D(XJ2#S/
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MC?+L<?R[)ZH_!0 \&MVY[X<W^P-ASV,8JPZH@\H7@T#:8\K:>B*N2^Y0UL
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M/W2*%/)R4<'V^F!TNT-X2YZ&]9<PD;VSXY<+N<PW:3*O)AL:OIA)(!<JF '
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M PB12]A=,FY8X!\PI5FMM%-,K32SRL*GNI.'75B%O[FJ0"OFA/TNN&:",,2
M %'?"CV@@'X"=LB/J..[3F\1F[(X.6!Q=L"2X& 8O6!!>L""$/^R[>@E>U/9
M=Z3:\]9)U!(:MP(-3*@I1PQ;\CO!;H4@_K):F58X$JH>&"__0')#6ZN(VXBD
MF%T*)N9S=%U&TN=,P%$.6\=[@IT,P4Y^.MB7JJZ%=D#]519@6<$<(^\,\EZQ
MNQ$Z=3:\C 7E#,7#8\56@ZK7@"85[$8H"]6H6N)XIQ06XQXP=N.7+NY$0H>R
MP8A:&>PU1R<[3GP^$K!?$ K#IBX$78(>!D?L7[@"=\R$W<STNWQ03L%+I3]Q
MJ^4]>PU\>.DD1>=PXB51?H1>[@5)_FPJ3H-N*HP2Q+02]\ [R;J2G,P$X+W4
M#]EA[B49I(2>'\:/!K,P.V*!EV<)^^+RX#4+(6Q"YQP&.#%(23XV!'GX8C+/
M-Y.![RR=]O#4HNW8"Y=CL:I7%2=$ KS:]HQ'\&RU!*&U.!7.?QT$QRDNHJK:
M$&"A12DMJ\AQ_)'C:'%ZG&S7[@;$,=L#['0 =OK3P+Z2AB\66BP&2NY):!>P
M]XN]40^\L@\;U@'JM-.YAU$/9=^- Z"X%%<$251,7<["(2 P>!D.[8CMEJJ@
M%YC]:_)RQ_SSH=6X? R"&5$P"5QAYL69"WGB!6G,WM^I6E3<17N24>-G$Y9Z
M49:Q+R"GCDY*P63S1U\8!8F7Y0E+O##UV9M7>1B$[]C-0\6_"R V X9#+PZW
M4Y]=@@+=4<0BA_'0"Y,$.F2AEX09.G'N35PGBIR +T]2UE*UL 4?F/]%R"YY
M:R5NV@YA<"U=GD_BL-O??].SPW%#YRVEN:"T26'\A!P<H1-1)_:2-'VR]//7
MCU?N%LASS\=<$/M>#@?DB1=-(I=\L1=/$B<OAK=\-S;Q)LF$:HK.O!F8$T0X
MW,-8@B@[-WI91.W$BR)_X.L/ K57Z.4Q AR!+H()^R11AUG5""P-< I(*,EC
MBBWD=(%+O<#/\!NC]@)FXH#.F7AA9UON16G6C>181C:],/11Y#810=2&96;5
MMI6$QRE,*T-0HZZC%PKO6MHE-M:E,/).:@\QQI^E/CC&XFGA&,1M=P>^#2;[
M;K]L((GL_[G]VM6V:*,JN.@)N5I1KA+E?VQP10EV^"NH[8BN=C9;(J%W\<C>
MDW=?D+MR8O KW7$%KXJ-SZ#CVCTPB$;N />%8(:4,>1A5T5LE@MZI?36E+TU
MLK>D&BQQFW>GR_N_3)???J *'GW&0A0,.J'$R=.<FA2811. 9)Q[40&Q5ED8
M2G<_E0&PL!-Q O"C4I8%20>0BV\#[8!&DA1%-8VIMDOWS5P"I0CGLV<N<5$6
MS]VPM7^C8^:%<>J^P@3/FEXUE&GE1M_>0G%?5"MRCRMH'T>H1!98Y8#\=MC5
M57-(MA!I%H,*(S!JC/)@%YS'CUYQ*(P6[JU*E0_NZNY!-XP.S^%I]PK<+N_>
MTI^X7DCXIQ)S;/6/,Q1PNGN?=A]6M>Y->*LL7IBNN\237FA:@/FY@A/Z#SI@
M^$^"\_\!4$L#!!0    ( '& 7%:#>FEUE@<   D@   9    >&PO=V]R:W-H
M965T<R]S:&5E=#(S+GAM;.U9ZV_;.!+_5PAOL4@ MI:H=YH$<!YM@VV;7)S=
MP^)P'VB)MHE*HI:DDV;_^INA9$5);6_V[C[ZBZW'<-[SFQGH^$'I;V8IA"7?
MJ[(V)Z.EM<W1>&SRI:BX>:<:4<.;N=(5MW"K%V/3:,$+=Z@JQ\SSXG'%93TZ
M/7;/;O3IL5K94M;B1A.SJBJN'\]$J1Y.1OYH_>!6+I86'XQ/CQN^$%-A?VUN
M--R->RZ%K$1MI*J)%O.3T<0_.HN0WA'\)L6#&5P3M&2FU#>\N2I.1AXJ)$J1
M6^3 X>]>G(NR1$:@QA\=SU$O$@\.K]?</SC;P989-^)<E?^4A5V>C-(1*<2<
MKTI[JQX^B<X>IV"N2N-^R4-+&P%QOC)65=UAT*"2=?O/OW=^&!Q(O2T'6'>
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ME9NL!YF"ILBB<P9B$"#A8=L_84;!(@#@!-$P(N>R)7(=9]C<,"?\E/C0,:(
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MK:K<Y5)P\"D2P/NY4G9]@P+ZK_^G_P%02P,$%     @ <8!<5L]G-T I!0
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MO%E18>B47MUGB'?'7?]YPK202JBUHT><M IGT9S,[3A\XJ(GW45/?OBBJ?K
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M+954YJ(P4A5,B^59[R(Z?CFF]6[!C10;TQDSTF2AU&>:O$W/>B$))#*16*+
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MX/;X#?W*:R<M*3-XKL1OGMOE)!@%D..<5<+>JO5WW.CI.[Q,">._L*Y]AX,
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M<Z)?QIRK>P D!?H+5 0O[F1)T32S[&Y_GMDC-%0Y^"1#?I269AY/ =,@W]/
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MT +,+[2VNPXQZ/Y^N/P/4$L#!!0    ( '& 7%8KI4U]CPD  .09   9
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M#I'@JE$&3\$9C-SS^1M'J8DTN8+74L0OX0"?734'?_8/>%+-+J;3RDTADWW
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M.E2X@1UAR&<'?)BR$ "<1!CPPF$Y >'ZR:183^-'F9Z\7] 9!0T<N2GOI4G
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MKX074ISG),*(G(;0.&8D1W_ +=+HRG0*'4"OV$.TZDT'N!KP!V]B-&:TASX
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M5+-0S48U!]5<5/-0S4>U -5"5(M0+4:U!-525,LHK9U)38>!H7R&];(AVE(
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MEO-8SF>Y@.5"EHM8+F:YA.52ELLP[B!HQGM!(VZ!\+PH=^H-$%[Q^L<,VN>
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ME@M8+F2YB.5BEDM8+F6Y#.,.HDC9BR)Q1X2K5>7E=55^/;V 2"SV?V_$-D5
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MA4!RER1$?+^&F._'%K8>+WRFZXTR%^S):$O6L 3U9;L0^LPNJD0T 28I9TC
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M4\DJP^X/L(EDE:Y;UH'IM$W'Z,/IF.MT765EOI"V"YJ+034'U5Q4\U#-1[4
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M9#MJ:%TM977MQT]G6O?7(:*"1207+XCR7[,Z]6\U"BC- :6YH+09*&T.2EN
MTCQ0F@]*6X+25E"T2Z^>_<RM_QIE;3T.*,]#TAQ0F@M*FX'2YJ"T!2C- Z7Y
MH+0E*&T%1;OTO/'#\\;_5^-VL]_L8TB: TIS06DS4-H<E+8 I7F@-+^F=16[
MDI"A(?GY3Q9GF^V"5SU;-I;B8E<NAJ2H7-]5+1YI6IL%EQ_+96>OVA_T.T^7
MM/MB@6:Y3.T'OEK=^104NSBC*,%;WI7V83144%$MF*QV&,G+16O/A#&2EIM[
M'$2X$ '\^)9P3]<[HH-FV>KT.U!+ P04    " !Q@%Q68M8<6B($  #L%P
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MW6'.L58<O?9!8I**-^@5(A1]VK!"8!J+J2V5<XVPH]K1HG+D'7$T0+>,RHU
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M;PY6)X+ORU?CGK@0/"D/=XRN65;\0'Z_X5R<3XJW[9KW-Y?_ U!+ P04
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M69YPRALMLF+/OQ#:G""*R\2<"E': /-^*83>WM@!ZG/FY"=02P,$%     @
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MESG]3\ X [K?:6V/&Q>@_T,E?P!02P,$%     @ <8!<5NP$ZX<0!0  FA<
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M@M(A.-4A+!U")[1@YF1=4TV3D10;)*VU0;,7+C;.VZAAW*;Q3DOSE!D_G=R
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M/@,  (T,   9    >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;+67;6^;,!"
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M0FD!E!:B:&).=":BJ3817[;>HQHR6NY0QQ!*<Z$T:@X]RM=+^3H T, ^E!9
M:2&*)BJ^\R9-M3<Y>I$EOJWY?VJX.X>Z@W!]R/-J9L6G>H#M+^2?]]+9=NI=
M&IT_4*,32G.A- JE>5":#Z4%4%J(HHDIUKFN9N.GP7[@ VJH0FD.E.9":11*
M\Z T'TH+H+0011/3H[.#3;4=_,+1,6K*Z*P8SN(T#*G[XD #NU :A=(\*,V'
MT@(H+4311,EW+K'YG$O<'VLC53S4'38E:^$:<]FX+ <:V(72*)3F06D^E!9
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M;$OM9G\IL_A;^P2JS)/;6YX594;B;504R?IQL.(LB0H2M\.FGE^/4QU\=(I
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M"14[\H'1+>.VMI)E)04(HXG<DQLFJ"B8.)!W2E%Q@-+U7*S!4,;U*V3I#_#
M' 513"9&OKM=DXL7KQ:^085VGG[1JGG?J(F>4+.&XHK$X6L[0C0"7ST?'H[
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M>866WJJ#.C>UM8PFSJIEO!>Y_#:6=F)Q31.:+1FXK^^9]\LE+S,!;IF@<5*
M"W"7[5DAY+H)<$,%V_ \9@5XW0#>2,3G^UOP^M4;\ K$&?AKR\N"9JMB/A62
M776-Z;)A<GU@@@:8W++E)<#P+4 >0@;SF]/-8==\*G/2)@:UB4&U/SSH[T&
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MN#90WR\8D[L;W4!UZ#OY'U!+ P04    " !Q@%Q6WJQUGJ0"  !.!P  &0
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M#,!J7PJ6-\Y209X6I__D>U.(,P<86AQ0XX#Z.N#& =>)GI35:3T00>93SHZ
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M((\_,R9>=ZJO,-JO;N;_ U!+ P04    " !Q@%Q6#:,=@K #  #H$@  &0
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M%E+F >;^0@C]<I*_/*I>%L[^!U!+ P04    " !Q@%Q6%Y)DFUT#  #2"@
M&0   'AL+W=O<FMS:&5E=',O<VAE970V,"YX;6RMEMMNXS80AE^%4!?%+M!&
M$G6PG-H"$@=%"[1H$'?;BZ(7M#R.B*5$+4G%NV]?DI(5VZ*4O>B-S</\PV]&
MY)"K(Q>?9 F@T)>*U7+ME4HUM[XOBQ(J(F]X [6>.7!1$:6[XMF7C0"RMZ**
M^3@(4K\BM/;RE1U[%/F*MXK1&AX%DFU5$?'U'A@_KKW0.PT\T>=2F0$_7S7D
M&;:@/C:/0O?\P<N>5E!+RFLDX+#V[L+;38B-P%K\1>$HS]K(A++C_)/I_+I?
M>X$A @:%,BZ(_GN!#3!F/&F.S[U3;UC3",_;)^\_V^!U,#LB8</9WW2ORK67
M>6@/!](R]<2/OT ?4&+\%9Q)^XN.O6W@H:*5BE>]6!-4M.[^R9<^$6>",)X0
MX%Z OU40]8+(!MJ1V; >B"+Y2O C$L9:>S,-FQNKUM'0VGS&K1)ZEFJ=RN\)
M(W4!:&OWS%U1\+96Z $4H4RB'\V(:&&/?J-D1QE5%"1ZWT]_T/,?MP_H_;L/
MZ!VB-?JSY*TD]5ZN?*79S I^T7/<=QQX@N,!BAL4A3\@'&#LD&^^71Y>RGV=
MD2$M>$@+MOZB"7]_J!($NDS.*2G_W.VD$GK__>L*L_,;N_V:0WDK&U+ VM.G
M3H)X 2___KLP#7YR!?T_.;M(032D()KSGF]XI6N%).:TN0+MU(E5FV+QDJ<X
MT+E_.0_ 891$>#"Z (L'L'@6[%'P TA31PA#!P#G;NM<I.<+I_@*;FR#@SAU
MPR4#7#(+=U>9 R01/^I#HS@RA5;O)$8+G<L)UF3$$2VSY17LV"B- C=K.K"F
MLZQ/_"MA]D2?:%5)Q1XU1)A1%VHZH@BOL^HPB9=NT,4 NI@'!=4*<VO8/8YT
MA>E+H\ZLKOKM1,59C$B"*]:Q!8[Q1%:S 3:;WP'%YY9*JKI[CA&E4\M>JZ<+
M-'L3=&P1!L$$Z'( 7<Z";MM=P6M;R;AP82W?Q!I;A(MDXF.'P>N5%+P!UC2,
M@I.IEUZ>@_@*RV&4Q=D$UME-&<YBV3O!R12.EHO#++J&&EOA<)E,4+U>5.'L
M)9"?+N@WMECOY;P2ATF:7==KE]DB65Q_4O_LP6%>>[\3\4QKB1@<M"ZX66@'
MHGM =1W%&_L&V7&ECZUMEOK1"<(8Z/D#Y^K4,<^:X1F;_P=02P,$%     @
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M?"QO/>HD_D*37YGN,%W$&4,)S 6E<=D5.='\%I)W.%FJ<_F,<''*5\U(W-R
MR@#Q?$X(WW7D"\J[X/ _4$L#!!0    ( '& 7%9.:%@U4PD  !U9   9
M>&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;,6<;7/BNAF&_XJ&=MH],[O!EB%
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M=<"1Z(BC'DK5K*DI&4C'($L@CCROIM9]!V*SID9"1JDK(@"-'#VID<VD1NF
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MM[W8;B:9S5X3(]M, 'DEV=Y]^TI B"UD@J?.18S@G"/I2-^GG\F>LA>^)D2
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MO'0/PQX8Z=HF*I$N2<?)L!\_ZB.2Z2A,'=!^2"29]_#>(]Y+'I/CC53?]!+
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MYLA+YK5%9"I>EOPH2+AQ2E@;0U[$?8M62# :",QA\KAF\OAP\\!Q2$I#@M%
M8 ZE)S6E)][!F8_)N!R3\0MC\N1IUAX_J?LMC4ZZ_6C[@W?F *^#KPP?1\TR
M+WJAU!E0PM:U:[@#80O9S';!8[O.N[R>O6M=RWD!]QU)0=%H*#27S*TU,SY<
M@E;8H7@-B49#H;F\DH97XAVD#:]ISNM+F5JAN:F*N]')]F<G<?T>[,U7(#27
MKT8O8._:>3(S=AU7+$,^RMCF]M5:<9WP0E&W$A94) 1%HZ'07"H;G8 '!TQI
MKPC9F]>0:#04FLMK(U&P7Z/LF](M"@0/CY](D-9VHZB[.^GZO7MM](V^P'Z!
MX4M0])\=92FW9 C.BC:?88.N0&EX0*]93/M]V7L4!A4FH=#<]]!($SPZ8'8'
M52E!T6@H-)?71JA@[Z)]GV5UA33<_FGAR>3\<AOJ]^BU$3<Z ON%Q&<I/MS,
M6@,,M,"OJ B)1D.AN3_2-N*#1(=+/Q)4AP1%HZ'07%X;'4*\Z_%])]<*S56M
M0_]ZN<T&1[@[W$E+OZ>O9:)1#L2O',JT+*;4%3=VIGTRT%H)"2D&ID'1:"@T
ME]!&6I #[D60H#HC*!H-A>;RVN@,XM^0V&/&)&V[!D>[F3=];.8NA7=_L:)^
MOUX;=Z,#B%\'4)F!-CPN%K3G:[.4BIN'UK!#;B],@Z+14&@NB8V<(,,#)F50
M>1 4C89"<WEMY 'Q;UWL.X\&%005VL[F8$L"!UWJ][:.#&2@%L71"QMZOA]:
M[K_73^OC'>?%H8:=YQ?XE):'-!J8\LS()Z867&B4PMQ"1MV131Y5'L,H;XQ<
M%0<3;J4Q,BLNE\ 24'D#^_U<2O-XDW=0'X:9_ ]02P,$%     @ <8!<5E>X
M1[Z- P  3@T  !D   !X;"]W;W)K<VAE971S+W-H965T-CDN>&ULK5==CYLX
M%/TK%ENM9J3-@,U'R&P2J0FMM@^51IUI^^R!FP05[*SM3&;__=I " $GBJJ\
M)-C<<WS.-5RNIWLN?LD-@$+O9<'DS-DHM7UT79ENH*3R@6^!Z3LK+DJJ]%"L
M7;D50+,*5!8N\;S(+6G.G/FTFGL2\RG?J2)G\"20W)4E%?\MH.#[F8.=P\2W
M?+U19L*=3[=T#<^@OF^?A!ZY+4N6E\!DSAD2L)HY'_%C@HD!5!$_<MC+SC4R
M5EXY_V4&7[*9XQE%4$"J# 75?V^PA*(P3%K'OPVITZYI@-WK _OGRKPV\THE
M+'GQ,\_49N;$#LI@17>%^L;W_T!C*#1\*2]D]8OV3:SGH'0G%2\;L%90YJS^
MI^]-(CH ')T!D 9 ^H#@#,!O /ZU@* !!%5F:BM5'A*JZ'PJ^!X)$ZW9S$65
MS JM[>?,[/NS$OINKG%J_H6EO 3T0M]!HA%:\G++&3 E$5^AXTWTZ5T_:1+0
MW0(8K')UC^X24#0OY+V&?7].T-V'>_0!Y0R];/A.4I;)J:NT0K..FS9J%K4:
M<D8-)N@K9VHCT2>6079*X&IKK3]R\+<@%QD32!^0C_]"Q"/$(FAY/1Q;X,GU
M<.^"&[_=+;_B\\_P+7="Z,U!<-B-UV8W'FVYKKD".Y<I*(]R2U.8.;IB2!!O
MX,S__ -'WM^V/-V2++D1V4D.@S:'P27V^6?(0-#"EK :&%9 4S#?YMCS)N.I
M^];-Q# JB+S3F,3&%)-CU(GRL%4>7E3^K*@"F^X:%G57F_@]U<.8D7DA3E0/
M8\( VS5'K>;H<K:YT*67V51'@]6"L*=H.8SI9WH807R[Y'$K>7Q1\@M7M-"U
M]\RK9K,R'FZ -P[Z9H91@1_W[%B8L!\'=D=QZRB^6#826(%VDUU9-^);UHU;
MDB4W(CM)XJ1-XN1WZ\9D^&[Y41CUMM\2128>[CT EBCL!QVR$_'8.W[GO=\K
M'@VNNZ(?X"#HJ;>$C7 4ASWYMC"?^&<>8-QI4_ 5+V5V]D&V.L-#9UX0QWUG
MP[!1$,91WYDE#$?1Y$Q1Q^1HC5QA+:][+:5[K>O,D>%G"!/?ZYL;AHWT[O;+
MCBTL]+W^4^=V&LT2Q+IJV"5*^8ZINB=K9]M#P<>J%>[-+\QAH6I@CS3U2>,K
M%>N<253 2E-Z#V.M2=3->SU0?%NULZ]<Z>:XNMSH P\($Z#OKSA7AX%9H#U"
MS?\'4$L#!!0    ( '& 7%8:+?J2< 4    4   9    >&PO=V]R:W-H965T
M<R]S:&5E=#<P+GAM;*U836_;.!#]*X2W*!H@KD7JPW::&&BB!IM#T2!INX?%
M'FB)CKF51"])V>F_WZ&D6#9)*SWTDDCRF]$\S@SGB9<[(7^H-6,:/9=%I:Y&
M:ZTW%Y.)RM:LI.J]V+ *?ED)65(-M_)IHC:2T;PQ*HL)"8)D4E)>C1:7S;-[
MN;@4M2YXQ>XE4G594OGSFA5B=S7"HY<'#_QIK<V#R>)R0Y_8(]/?-O<2[B9[
M+SDO6:6XJ)!DJZO11WR1DL 8-(COG.W4P34R5)9"_# W=_G5*# 1L8)EVKB@
M\&_+;EA1&$\0QW^=T]'^G<;P\/K%^VU#'L@LJ6(WHOB+YWI]-9J-4,Y6M"[T
M@]C]R3I"L?&7B4(U?]&NPP8CE-5*B[(SA@A*7K7_Z7.W$ <&.#EA0#H#8AM$
M)PS"SB#\58.H,XB:E6FI-.N04DT7EU+LD#1H\&8NFL5LK($^KTS>'[6$7SG8
MZ<5=E8F2H:_TF2DT1@\L$U7&"TZ;K(@5Z@'HTS-4FV+HW36KV(KK,_0N99KR
M0IV!Z;?'%+U[<X;>(%ZAKVM1*UKEZG*B(4KSKDG6173=1D1.1(0)^BPJO5;H
M4Y6S_-C!!.CM.9(7CM=DT&/*LO<HQ.>(!(1X KKY=7/L,4]_W3P88!/N,Q8V
M_L)7,^8FY!S=P-+QJN;5$_JR8;))HSH_S**5XK\_+I66T'[_^%+5AA+Y0S%[
MTH7:T(Q=C6#344QNV6CQ]@^<!!]\R_P[G:6_R=E1"J)]"J(A[PNSC%2C%<MA
MA0ND--6U%O(G@O5FOF5LW<6-.[,3;Q?3.(%2W!XNCPO",4["8U3JHLBT]W1$
M)][3B0?I/$+\[!Q5,&6@X5]8+=N:\M%IW26',221Q<;%C&<6X]2#P23$?C;)
MGDTRR*;M@"=6:00UOH1"UYQY]Z'$>3V.+18N9#R=S^V<>% D2?PTIGL:T^&D
MK*ED8S/2<@2]:QJ]:5@?D:E+A$SG%A47!(L=S *+BP>6D-#/9;;G,AOD<IO>
MW?GBGGG6+9S;.?"@DG!JA>T!X20^T1CS?=SSP;@?8.>@,ELCF&0@)K:@DC:E
M*:Q,LIQK;U'-W=Z($XN1BX%@R<RBY$7-_(QPT,_[8+@]UA2:P\SHNLJ8A/%=
M(0W[V48HW@P+[\0./+'$5L W'E3DU)?/53(]46#X0,;@X53!%H:REANHX>Y2
M&9[=AG9NGH,,!%4CFRV;H8+NO&RQ&V(<VF7I0TWGSG[M@^&#W?*8+^GYDD&^
M]U)L>2.^M0#]K6L)&CK_%P2C*5!_$HE;FB2TIY '-<9A9/>;#Q;/27""5R]N
M\.#@7MQV.3(EF?/5BDF@PV$< 5/>B)A)(91J!E4'5?52\9Q3>6*;[]YXM#T&
MH4W;!8TQCFS6'E0X"^<G6/=Z @\+BKXIM[2H6V%&"_@FH]"C7DZ1F\L()I/-
MRH5A3*+8IN7"8#;@V<DR[94%?D5:T(*97'UGLJ(%5^CA+2TW'U(O)U<.!#:?
M5R&I!P+#,#RED7 O*_"PKDC94D.G;6H8"#"5_:7F*H&$V+N_!^20&((<Q]_K
M"?R*H*B7&RHUNNWZR!N_._UGL=,J'KD1SFUMYT&1^ 2'7D?@82'Q9;7B,+1>
M%438E0/Q+'&ZPT6%))S;1%P4B?"I=/32 @]KBR]ZS:0W=G?N1XG3"!YQ$,Z(
M,WQ<& [PB3207D.080WQ56C8D=LR:G9J]O(AVGTTG/F(=4X//UTBD/LV-0]L
M'.'(5D<^6!P&MNJ>'!R-E$P^-4=,"@JHKG1[@K!_NC_&^M@<WEC/K_%%VAY&
M]6[:L['/5#[Q2J&"K<!E\'X*,<GVN*F]T6+3', LA=:B;"[7C((H,0#X?26$
M?KDQ+]@?^BW^!U!+ P04    " !Q@%Q6*7]J6J4#  "+#0  &0   'AL+W=O
M<FMS:&5E=',O<VAE970W,2YX;6RME]MNVS@0AE^%T!9%"S21J+-2VT ;8]%<
M[&Z0]'!-2V.+B"2Z)!VG;[^DI,BV1"END1M;I&9^?L/###7;,_X@<@")GLJB
M$G,KEW)[9=LBS:$DXI)MH5)OUHR71*HFW]ABRX%DM5-9V*[CA'9):&4M9G7?
M+5_,V$X6M();CL2N+ G_]1D*MI];V'KNN*.;7.H.>S';D@W<@_RVO>6J97<J
M&2VA$I15B,-Z;GW"5]<XT ZUQ7<*>W'TC'0H*\8>=.,FFUN.)H("4JDEB/I[
MA&LH"JVD.'ZVHE8WIG8\?GY6_[L.7@6S(@*N6?&#9C*?6[&%,EB372'OV/X+
MM '5@"DK1/V+]HUM&%@HW0G)RM99$92T:O[)4SL11P[8'W%P6P?W7 >O=?#J
M0!NR.JPED60QXVR/N+96:OJAGIO:6T5#*[V,]Y*KMU3YR<5-E;(2T%?R! )=
MH"6L@7/(VHYW2Y"$%N*]>O7M?HG>O7F/WB!:H:\YVPE296)F2T6AM>RT'?%S
M,Z([,N(2TDODX0_(=5S7X'Y]OCL^=;=5[-T$N-T$N+6>-ZK71BS)$R)"@!17
MIJ :%=^LH@_;E=B2%.:6.DT"^"-8B[=_X=#Y: KQE<1. O:Z@+TI]<6_*C>H
M+,")I-4&%4P(E!+.?ZF4L"?<O**-8E KZL3PN B\)'1F]N-Q5$.KT/,CW%F=
MX/H=KC^)>Z<F@/ T1ZE:)"I?9FWDPB,*-_2<I,=JLDJ<V,P:=*S!).N]9.D#
M4@=*)5E!=)HR 0:#H3'&0=P#'%HED>^9^<*.+YSD^T_FP$U(X1 I"7RWAV2P
M<I,X,3-%'5,TR60X?R;"R#!I3A+VE]5DYJGI-3/&'6,\R?B=%#O25)U"U3U2
MI8#4%M3EXASV> !U$41^U)]>@YD7)-X(>]*Q)R\>]S,YDP% X/E)U,,<6D41
MCATS)78.=<@Y/P\7E*QH024%<S)NM5XI&[^6VFGD1Q483Z[030:5I&NJ8J>5
M)-6&K@HP%U8\W"*A'R9A;XF,=F'LCZ0W?*B5>+(RC2>0UN]D1.S$\8#,8!?X
MP4@.P8>:AE\N:MG(#C+R>D..* CB_IDTVKF>$XT 'ZH:GBYKW7:GS05,ZOO6
M!U2!-.+Z@])ZX;I.'/1Q)P?]TYU\*']XNO[]9E"38K]]B(/!%/EQU"^8]M%-
M67^F_$/XAE8"%;!6;LYEI/QY<_-O&I)MZ\OSBDEU%:\?<_6U!%P;J/=KQN1S
M0]_'N^^OQ?]02P,$%     @ <8!<5L6U+\!D P  > H  !D   !X;"]W;W)K
M<VAE971S+W-H965T-S(N>&ULK59=;]LV%/TKA%8,+=!&7Y9L9[: .&JQ/A0(
MG&9[&/; 2-<648G42"I.]^MW22F:+2F&-_3%%LES#N_AY<=='83\I@H 39ZK
MDJNU4VA=7[NNR@JHJ+H2-7 <V0E948U-N7=5+8'FEE25;N!YL5M1QIUD9?ON
M9+(2C2X9ASM)5%-55'[?0"D.:\=W7CJV;%]HT^$FJYKNX1[T0WTGL>7V*CFK
M@"LF.)&P6SLW_G6Z,'@+^(W!01U]$^/D48AOIO$Y7SN>"0A*R+11H/CW!+=0
MED8(P_BKTW3Z*0WQ^/M%_9/UCEX>J8);4?[.<EVLG85#<MC1IM1;<?@5.C^1
MT<M$J>PO.718SR%9H[2H.C)&4#'>_M/G;AV."'[\"B'H",&0,'N%$':$\%+"
MK"/,[,JT5NPZI%339"7%@4B#1C7S81?3LM$^XR;M]UKB*$.>3C[S3%1 OM)G
M4.0#V4(F>,9*1FU6Q(X\<(E]>\[^AMS R 8X[)A6Y&T*FK)2O4/>PWU*WKYY
M1]X0QLG70C2*\ERM7(TAFHG<K MGTX83O!*.'Y O@NM"D8\\A_Q4P$5OO<'@
MQ> F.*N80G9%0O\]";P@F CH]G*Z/T%/+Z=[9]R$?;I"JQ>^HO<?\O.>?'S.
MRB9G?$]N*M%P3-D=2$P9-UU:X#C%'=71MJ ;R17Y8RO*DN"9.E"9_SF5P3;"
MV72$YIJZ5C7-8.W@/:1 /H&3_/R3'WN_3*W^CQ1+?Y#8269F?69FY]23#2TI
MSX!031YAS[A=9,Q/#9*)?&H=6[W(ZIG;^2D)EE&$N^3I>('&J-"/_>4I*IW0
M6L2S>8\ZL13UEJ*SEF[RG)EMINS-FA/<<!IW2BU4URVAI!H'<"_I O"ZDA*X
M)M^!RBG#[6SQ49#18N!V# FB8.!UC F7OC]M->ZMQA=:Q9=TX-(D$7,HK:_)
M.RT>133,XA@QC_R!KS'&CZ9=S7M7\[.NMI WV?^W-1\%]"'R!]FXG0"%WGR8
MLPG4,II-NUOT[A:7GCC@^?FSMI@X:]XR'GB90HU.9#I&G9[(UHQ[]"97(/>V
MME$D,Q=Q^WKUO7WY=&.KAD'_!LNJM@KZ5Z:MR;Y0B1>-(B7L4-*[FF-,LJUS
MVH86M7WY'X7&.L)^%E@:@C0 '-\)H5\:9H*^V$S^ 5!+ P04    " !Q@%Q6
MFS@1I[D'  ")*   &0   'AL+W=O<FMS:&5E=',O<VAE970W,RYX;6RMFMMR
MVS80AE\%HV8ZSDQB$0>"I&MK)K;.4CII'+<7G5[0$FQQ0I$J2=G)VQ<@91T6
M*YIIE(M8I+Y=++ _%B#$R^<T^YHOE"K(MV6<Y%>M15&L+MKM?+90RS _3U<J
MT=\\I-DR+/1E]MC.5YD*YZ71,FXSQY'M91@EK<YE>>]3UKE,UT4<)>I31O+U
M<AEFWZ]5G#Y?M6CKY<;GZ'%1F!OMSN4J?%2WJKA;?<KT57OK91XM59)':4(R
M]7#5^D OIE0:@Y+X,U+/^=YG8KIRGZ9?S<5H?M5R3$0J5K/"N CUGR=UH^+8
M>-)Q_+MQVMJV:0SW/[]X[Y>=UYVY#W-UD\9_1?-B<=7R6V2N'L)U7'Q.GX=J
MTR'7^)NE<5[^3YXWK-,BLW5>I,N-L8Y@&275W_#;9B#V#+0?W(!M#!@T$$<,
M^,: -S40&P/1U,#=&+A-#>3&0#8U\#8&7E,#?V/@-S4(-@8!-)#'$N>\9,YI
MV@;=)MO*]E&3EW33,M_M2EBE*KMA$78NL_299(;7_LR'4MJEO19CE)A9>%MD
M^MM(VQ6=VW(^J#GY8QUFA<KB[Z0?)6$RB\*8&(_D["X)U_-(,V_)>W);S59R
MUE5%&,6YN7=WVR5G;]Z2-Z1-\D68J9Q$";E+HB)_IV_JSU\6Z3H/DWE^V2YT
MT*;I]FP3X'45(#L2("<?TZ18Y*27S-4<L1_7VU-6XZ"M1VL[9.QER*Y9K<>N
MFIT33M\1YC"&!'13;WZK5MK<.6K>K3<?KY-:\UZ]^<<PJPV^W[SO%#$?-.\[
M9CYLWG?,?-2\[YCY^.?R/OFYH9LV-W=J5,RW$Y^7_O@1?]A\'R75LFZ6QVZ4
MS^(T7V>*_/WA/B\RO5[^@TW?JAF!-V,V$1?Y*IRIJY;>)>0J>U*MSJ^_4.G\
MADV=4SKKGM)9[Y3.^J=T-CBEL^$IG8U.Z6Q\2F>34SJ;GLC9P306VVDLZKQW
MOJ2%GKB9>E+)6J'+:V7OEO9F3_[4<1WNZP+VM#_Q$"I@ID[M4UW,%V7RD.K9
M%)<N!50?\26%(PZI 1:7#  UM"G/]UU C6Q*2-W+0VIL4S203+B'V,3&F*"N
M &U.$6^2NW+7Z$'6W6W6W=JL?]8Z"K/9@N@]E7[F>-(/4RO]:%1@^:\\R;T(
M AIX(/T(Q'@ LF]#OI# 4P]KS@.>^H@G*H"G@0UY@CL@\Q@$Q3U"8G($T./8
MAKATH*L)0C'J '%,;4HX>M;A29?;I,O:I ]4HC(]V4W.P[E^&HC,JFP>8K&T
M2SM02CF8T#<V147 P"!W$8HY/ISV"$4#!H:FC_G24QKD'J&< &IMB/D2%&8?
M\^53$-?8ICS'D3#]-J5G0 #&:VI3TG'HD3GO;=/O-:CTZ4J9G">/9);F15Z*
M07U;J23'J[^'=$OX4 8V):3O0QD@%!425+R>37'!?0YD@/EBL,4!YLN%Q6MH
M4TP$ O1QA/B2O@=E8%,TX%KL0 <(QCT9@%Y.$4QPZDE<"?Y6"7ZM$GY7A7ZH
MGJ5+1<[T%ET_@S]DZ5(+(M'"6!MM;%22)J@F?"NJ]U2X'"3RQL8""9?!K@V9
MZ0SJ?0]KD04,+@L(QBE<[ <VQ1S.08:&-L6E$+ V(+Z8!^O,&(G+911$/[$I
M3R_U4!(VI?<@/BZ(8"N(X%5!&"%4.ICK)[=*"FK^BA("NV,L<&%U0*B P?G5
M12C*!<Q>#VM2N'!SB%&,@;$<()24L+(/$<KU*,CQ"*&$E* @C;&X]-8%+A/8
M6 0,1C;%!M;UCVP3J+,[TG-^K#Z@IVZ.M3-]3_7>"<1X@W#6+KV+.?,#X*J'
M-NERV&0?XUP!,S9 ,%V$H4B&",8=#^Y+1I@WGSJP%&"Q<<XEF T3A-.B@U5J
MBKECP=Z('$I@[U27UDK@.LRC&4E^8*$@9^885U]61[BX9JI&_?UHG7.X$;Q!
M,.?<]:!F, JNQSV\2<^#DD$Q6*('"$;/&8.*L2EF^1JAON STQ@/#.[#)P@F
MSMT J@4;LKU"?"@6MA,+^_]B.;*:-))+U6P D@*?/7',A3L-'/.A7O VK1*#
M8W"!P3%X^H!3<#\UPC'F0\4@&#V'>Y()CL%3ENF1P0V.:&9W>DQK3[4ZW2A>
MFY^-3EYB.)IEJ\38&%9B,,HN,6B3=HE!,;O$V!BUJ"%"Z1(#=Z>H+PX/K/#
M[!)C8^)<P.TI.F3\F%QVIY2T_ICR%;G\3)$1:.6WB@R*V44&Q:PB@[=I%1D<
MLXH,BL&59'@$XU S*,:L?0R"854&Q2B%JL%'USLBF]TQ)ZT_Y[RM?DU>YUH6
M44**A=*59;E:%]5O5.F#>0,#7;NVHB%GVK#Z51K7CWU61Z4?./H?E!!*^KY%
M=G%2VF0/)YFPR#Y*>IQ;Y  E)1+G$"?=P")'*"FX:Y'CQGV?X*US>^2G*$G]
M@]8/%;8[4Z7UAZJO*VQ^M'0UUUAM##_Z&^E)O75/ZJUW4F]]BAS='M$\0GKZ
MN1S1/$IZ-CE"229L)8_1.''-XSXEHGG4)T,TW]Y[^V>ILL?RG;9<RWB=%-7[
M -N[V_?F/I1O#X'[U_1B1)'[8_.>7?FVT<Y]]9+>QS![C/0Z':L'W9396[5(
M5KWW5ET4Z:I\]^@^+8IT67Y<J'"N,@/H[Q_2M'BY, ULWS[L_ =02P,$%
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M:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " !Q@%Q6$#XQ^*@%   ),0
M#P   'AL+W=O<FMB;V]K+GAM;,6;WW/:.!" _Q4-+Y=[X #_HNTDG2% KDR3
MP,5<7CN*+4 36^(D.6G[UY]L0F[=P,Z];'@BEHW]6<;Z=E?*^;,VCP]:/[+O
M9:'L16?CW/93KV>SC2BY_4-OA?)[5MJ4W/E-L^[9K1$\MQLA7%GT@GX_Z95<
MJL[G\_VY%J8'-[03F9-:^<:ZX5Z*9_O?_GJ3/4DK'V0AW8^+3O-W(3JLE$J6
M\J?(+SK]#K,;_?Q%&_E3*\>+-#.Z*"XZ@]V.>V&<S-XTIS7DDC_8IL7QASON
M02XZ2=^?<"6-=<T1S?FY9WP2_N#=5N7TE2R<,!/NQ)]&5UNIUO5I_%WTP&TT
M_;#_W'7B)_-_NE&O5C(3$YU5I5!NUX]&%#6@LANYM1VF>"DN.F/])$Q]/_X"
MLWQW;\Y#@9XRGZ3?869Y@T>',JIRZ=A,[;[L]P*L ,$*:+'&\]MT?CV;C);3
M";L<78]NQU.6?IE.ERD #!' \&2 [&S! 62$0$;O")DN_<?-]-8#SJ_8?#&]
M Y Q AF?#'(\OUD R 2!3$X!63.FR_GX*X <(I##T_7D*/T"(#\@D!]H(2^Y
ME9;I%5L88?VAS1&,JYRE55G"%^<C OF1%C+U:NCZHVO.>:GDZ &.UGULN.X3
MDVVT<5TOL=(/VD_"NOIX^VV_ 3%1JU!K)?NG\A=MVB$3II0!L5.NN#3LGA>5
M8#>"V\J(^@N0#O/)@%@HUQY)M/H*$\> VAS:_YY\ .:ORE*AI#;LU@=]+3[,
M&0-B:5SR@JO,LS57&&69KI1C$^&X+%J0F#,&Q-)(G<X>-[K(A;&_L:E_(]P/
MR(:I8D#M"EV6LAD\FK'7/V_GHV&A,BG\:'(-,3%9#(AM,5.9+@5;\N_MWQ[F
MA@&U'$3ALQ^1L[\J;OQ(7/Q@5U+YGZ/D!9M @P68*0)B4Z"B_19 3,P4 ;$I
M<,P08J+Y"+$\WD8$[,QGEH6POT-$S" !L4&@<P_"84()B(5R6+X',3&O!,1>
MV5GX(!9FDH Z_3BBXQ=0B(E))2"6"FIE=@8Q,:D$Q%(YY.6#CQRS3$!L&6B^
M0W AYI:0.@O!%-AR2XBY)3RI6R*(B;DE)'8+CAE#3+3B1>P7'#.!F)AI0F+3
MX)A#B(F9)B3/8##,#Q 3,T](G<.\C7NZ[)8;P^O:.H.8F'E"8O,<Q$S]B?/*
M*U-#3,P\(;5Y,,SVN(FY)WSW\A?$A#%YA%DH.F4MK-6;$6:AZ!UK8:V7YZR)
MC" F9J&(V$*_8(ZL%<ZRIM5XTT-,S$+1>V8Y7?^L'5?KFF''"C'1F1=B"_V"
MN3":7=7G>8F3("9FH8C80D?2LOWCAYB8A2)B"QW%O!.9;O<F9J&(V$*',5]?
M>HB)62@BMM!+DOMV*"I:&4:$*2@B5M KXWPK:D:U;F*CW=O3BCMB3$$QL8)>
M,6^XJXQ_W443T^VA(2:FH)A804?K![O? ,3$%!13S_H?QZRS=(B)*2@F3X2P
M,D<78F(*BLD3(02S%1[%Z/3_*:=R6L%FC"DH)E80C@EK"3&FH/B4);A6+2'&
M%!23KP+ ,&$M(<8L%!-;",>$M80$LU!"/M6#8<):0H)9*"&VT,&ZJT\L-]R(
M[B4,CQ+,0@GU5,]AS'VP!#$Q"R7$%CK6FW6S#T @)F:AA-A"1S OC>"/N7Z&
MF)B%$F(+'<'T:5!5;AT,/1)T&=H)EA0T:9!U1F9P,4N"62@AME!K\@(M>228
MA9)W7%W@,<>ZW&K59&P^AI_!Z#W!+)2\YU30/N>5A=R5C&%Q<XA9:$ALH5\P
M)V(E3%TY>IG"@IB8A8;$%D)[LQ46#S$+#:DMA$ZQP;!XB%EH2&RAOU7FK[RN
M5_%[UID39=VIQ5KEW: ?M'H3L]"PL5"O.=A^/L_%2BJ1W_I+6-^>\2);&%9_
M[%811G&] FA5%<78M\W5M>;Y?B7__K\0/O\+4$L#!!0    ( '& 7%;'UW-/
M1P(  -4K   :    >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'/-VDMNHT 4
MA>&M6"P@N.ZKDE:<44\RC;(!Y)0?BFT0T$JR^[:<@7U0#WH2<4:H0%S^ ?J$
M@,>7<FC&?7L:=OMN6'P>#Z=A5>W&L?M5U\-Z5X[-<-=VY70^LFG[8S.>E_VV
M[IKU>[,MM2R74?>W,ZJGQ]N9B]>OKOS/Q':SV:_+[W;]YUA.XS\&UQ]M_S[L
M2AFKQ6O3;\NXJNK/PW7W4%\VZ>X\N5H\OZVJ_ODM5?7<00)!,G^00I#.'V00
M9/,'.03Y_$$!03%_4(:@/'_0/03=SQ_T $$/\P>E)<JX)$B:8$V@=4*N$X'7
M"<%.!&(G)#L1F)T0[42@=D*V$X';">%.!'(GI#L1V)T0[T2@MZ#>0J"WH-Y"
MH+=,'K8)]!;46PCT%M1;"/06U%L(]!;46PCT%M1;"/06U%L(]!;46PCT5M1;
M"?16U%L)]%;46PGTULG+$@*]%?56 KT5]58"O17U5@*]%?56 KT5]58"O17U
M5@*]#?4V KT-]38"O0WU-@*]#?4V KUM\K*;0&]#O8U ;T.]C4!O0[V-0&]#
MO8U ;T.]C4!O1[V=0&]'O9U ;T>]G4!O1[V=0&]'O9U ;Y]\K"30VU%O)]#;
M46\GT-M1;R?0VU%O)] [4.\@T#M0[R#0.U#O(- [4.\@T#M0[R#0.U#O(- [
M)C^;$.@=J'<0Z!VH=Q#H':AW$.B=4>],H'=&O3.!WAGUS@1Z9]0[$^B=4>_\
MDWH/X]>A#->>[S5>_R>I'L_GENOE+\OOG9.[]X)S?5LQ//T%4$L#!!0    (
M '& 7%8?G85O"0(  -@J   3    6T-O;G1E;G1?5'EP97-=+GAM;,W:S4[C
M,!0%X%>ILD6-Z]\PB+(!M@.+>0%/<MM&36++=COE[7%20)H15* BS=DT:FW?
M<^,K?:M>_WKR%&>'OAOBLMBDY*\8B_6&>AM+YVG(*RL7>IORU[!FWM9;NR8F
M%@O#:C<D&M(\C36*F^L[6ME=EV;WA_QS;-VP+ )UL9C='C>.6<O">M^UM4UY
MG>V'YI^4^4M"F4].>^*F]?$B;RC8NPGCRL<!+^<>]A1"V]#LT8;TT_9Y%SMT
M+*:GCF)YNL0[/;K5JJVI<?6NST?*Z /9)FZ(4M^5QZ(7IY-3OF$Z?O*S\Z<R
MIP+SSL?@?,P3"_3UN->1C*?G/A>BD-K3K_B6F$N?_7XT3KNAYI/9^7K_N+"=
MYA'9]#C_CO^>\5O]+_8A0/J0('THD#XT2!\&I(\*I(]+D#Y^@/3!%RB-H(C*
M44CE**9R%%0YBJH<A56.XBI'@96CR"I09!4HL@H4606*K )%5H$BJT"15:#(
M*E!D%2BR2A19)8JL$D56B2*K1)%5HL@J4625*+)*%%DEBJP*15:%(JM"D56A
MR*I09%4HLBH4616*K I%5H4BJT:15:/(JE%DU2BR:A19-8JL&D56C2*K1I%5
MH\AJ4&0U*+(:%%D-BJP&15:#(JM!D=6@R&I09#4HLE8HLE8HLE8HLE8HLE;_
M4];?SFV_.7YZEKUMA]=\-OVA]>894$L! A0#%     @ <8!<5@=!36*!
ML0   !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M    " !Q@%Q6 *TK,>T    K @  $0              @ &O    9&]C4')O
M<',O8V]R92YX;6Q02P$"% ,4    " !Q@%Q6F5R<(Q &  "<)P  $P
M        @ '+ 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( '&
M7%9=X_.Z$ @  %0P   8              " @0P(  !X;"]W;W)K<VAE971S
M+W-H965T,2YX;6Q02P$"% ,4    " !Q@%Q6)[$I?CX"  #'!0  &
M        @(%2$   >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%
M  @ <8!<5JW0.F6F!P  H2,  !@              ("!QA(  'AL+W=O<FMS
M:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( '& 7%:0QO2Z^@(  /\)   8
M              " @:(:  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"
M% ,4    " !Q@%Q6L*=%SR4(   _+0  &               @('2'0  >&PO
M=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ <8!<5IHZ;<E  P
M2@D  !@              ("!+28  'AL+W=O<FMS:&5E=',O<VAE970V+GAM
M;%!+ 0(4 Q0    ( '& 7%9WT,_N_0H  $QN   8              " @:,I
M  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " !Q@%Q6U6M6
MD*X+    .0  &               @('6-   >&PO=V]R:W-H965T<R]S:&5E
M=#@N>&UL4$L! A0#%     @ <8!<5I,H1N^?*   $X8  !@
M ("!ND   'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( '&
M7%8%2'5!9PP  /4?   9              " @8]I  !X;"]W;W)K<VAE971S
M+W-H965T,3 N>&UL4$L! A0#%     @ <8!<5AY*#8CZ P  /0D  !D
M         ("!+78  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4
M    " !Q@%Q6XDA7@% +   T'0  &0              @(%>>@  >&PO=V]R
M:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( '& 7%:YOZWM+ P  -0A
M   9              " @>6%  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL
M4$L! A0#%     @ <8!<5LY50!DA"@  $2\  !D              ("!2)(
M 'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " !Q@%Q63;PL
M4B\.   B+P  &0              @(&@G   >&PO=V]R:W-H965T<R]S:&5E
M=#$U+GAM;%!+ 0(4 Q0    ( '& 7%:]@:F1K@L  %H>   9
M  " @0:K  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @
M<8!<5IS8Y#F &0  NDD  !D              ("!Z[8  'AL+W=O<FMS:&5E
M=',O<VAE970Q-RYX;6Q02P$"% ,4    " !Q@%Q6=75SB>X)  "!&   &0
M            @(&BT   >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4
M Q0    ( '& 7%8DJ]9+C@P   4B   9              " @<?:  !X;"]W
M;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ <8!<5CU+GUV]!0
M@Q   !D              ("!C.<  'AL+W=O<FMS:&5E=',O<VAE970R,"YX
M;6Q02P$"% ,4    " !Q@%Q6X#G<ZNPN  "OGP  &0              @(&
M[0  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( '& 7%;&
MM,.=RP8  # 0   9              " @:,< 0!X;"]W;W)K<VAE971S+W-H
M965T,C(N>&UL4$L! A0#%     @ <8!<5H-Z:766!P  "2   !D
M     ("!I2,! 'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4
M" !Q@%Q6SV<W0"D%  #E"P  &0              @(%R*P$ >&PO=V]R:W-H
M965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( '& 7%:,N.T[BPD  $T:   9
M              " @=(P 0!X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L!
M A0#%     @ <8!<5CO]DTV^ P  / L  !D              ("!E#H! 'AL
M+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    " !Q@%Q6%UCUYP@#
M  ">!@  &0              @(&)/@$ >&PO=V]R:W-H965T<R]S:&5E=#(W
M+GAM;%!+ 0(4 Q0    ( '& 7%:!5J\ M0@  (H8   9              "
M@<A! 0!X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ <8!<
M5BNE37V/"0  Y!D  !D              ("!M$H! 'AL+W=O<FMS:&5E=',O
M<VAE970R.2YX;6Q02P$"% ,4    " !Q@%Q6U(,$UL8&  "T$   &0
M        @(%Z5 $ >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0
M   ( '& 7%:',]!]9P4  %X/   9              " @7=; 0!X;"]W;W)K
M<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ <8!<5LD>-!O_*@  RX<#
M !D              ("!%6$! 'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q0
M2P$"% ,4    " !Q@%Q66!/5E30#  "V#@  &0              @(%+C $
M>&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( '& 7%936VGS
M"00  ,<1   9              " @;:/ 0!X;"]W;W)K<VAE971S+W-H965T
M,S0N>&UL4$L! A0#%     @ <8!<5E)N,F4>"P  $*,  !D
M ("!]I,! 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    " !Q
M@%Q6Y?Q&>9 %  #"*@  &0              @(%+GP$ >&PO=V]R:W-H965T
M<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( '& 7%9BUAQ:(@0  .P7   9
M          " @1*E 0!X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#
M%     @ <8!<5M:;X(P.!@  RRD  !D              ("!:ZD! 'AL+W=O
M<FMS:&5E=',O<VAE970S."YX;6Q02P$"% ,4    " !Q@%Q6^^0^H5D%  !K
M&0  &0              @(&PKP$ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM
M;%!+ 0(4 Q0    ( '& 7%;]>LUIOP0  "D4   9              " @4"U
M 0!X;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ <8!<5K<?
M+E^= P  [0T  !D              ("!-KH! 'AL+W=O<FMS:&5E=',O<VAE
M970T,2YX;6Q02P$"% ,4    " !Q@%Q6.E,0OE0(  "G3P  &0
M    @($*O@$ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    (
M '& 7%9[.$2O=@0  !(9   9              " @97& 0!X;"]W;W)K<VAE
M971S+W-H965T-#,N>&UL4$L! A0#%     @ <8!<5IW1E 45!   Z18  !D
M             ("!0LL! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"
M% ,4    " !Q@%Q6RB-,000#  ##"   &0              @(&.SP$ >&PO
M=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    ( '& 7%:OSSM&B@H
M !AS   9              " @<G2 0!X;"]W;W)K<VAE971S+W-H965T-#8N
M>&UL4$L! A0#%     @ <8!<5J'SJKFL P  <PX  !D              ("!
MBMT! 'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q02P$"% ,4    " !Q@%Q6
MZEVH%# "  "M!   &0              @(%MX0$ >&PO=V]R:W-H965T<R]S
M:&5E=#0X+GAM;%!+ 0(4 Q0    ( '& 7%;L!.N'$ 4  )H7   9
M      " @=3C 0!X;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%
M  @ <8!<5EC;V+V  P  CPT  !D              ("!&^D! 'AL+W=O<FMS
M:&5E=',O<VAE970U,"YX;6Q02P$"% ,4    " !Q@%Q6I5Y7^3X#  "-#
M&0              @('2[ $ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+
M 0(4 Q0    ( '& 7%;%1C5BS T  *.@   9              " @4?P 0!X
M;"]W;W)K<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @ <8!<5H!6W>,W
M P  O D  !D              ("!2OX! 'AL+W=O<FMS:&5E=',O<VAE970U
M,RYX;6Q02P$"% ,4    " !Q@%Q6[;^&%AP&  "Q)@  &0
M@(&X 0( >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( '&
M7%;'2.L W00    >   9              " @0L( @!X;"]W;W)K<VAE971S
M+W-H965T-34N>&UL4$L! A0#%     @ <8!<5MZL=9ZD @  3@<  !D
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M=#8P+GAM;%!+ 0(4 Q0    ( '& 7%8D*^_\EP0  %88   9
M  " @<,A @!X;"]W;W)K<VAE971S+W-H965T-C$N>&UL4$L! A0#%     @
M<8!<5H-=DA-7 P  %PX  !D              ("!D28" 'AL+W=O<FMS:&5E
M=',O<VAE970V,BYX;6Q02P$"% ,4    " !Q@%Q63FA8-5,)   =60  &0
M            @($?*@( >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4
M Q0    ( '& 7%9;%P"W< <  )DL   9              " @:DS @!X;"]W
M;W)K<VAE971S+W-H965T-C0N>&UL4$L! A0#%     @ <8!<5@V?S?S>"
M7D$  !D              ("!4#L" 'AL+W=O<FMS:&5E=',O<VAE970V-2YX
M;6Q02P$"% ,4    " !Q@%Q6*9W0;(\#  ![#P  &0              @(%E
M1 ( >&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    ( '& 7%;/
M2HDQL 0  $,6   9              " @2M( @!X;"]W;W)K<VAE971S+W-H
M965T-C<N>&UL4$L! A0#%     @ <8!<5JG4FF!_!0  &",  !D
M     ("!$DT" 'AL+W=O<FMS:&5E=',O<VAE970V."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( '& 7%:;.!&GN0<  (DH   9              "
M@:IC @!X;"]W;W)K<VAE971S+W-H965T-S,N>&UL4$L! A0#%     @ <8!<
M5O,OT!KH 0  6@0  !D              ("!FFL" 'AL+W=O<FMS:&5E=',O
M<VAE970W-"YX;6Q02P$"% ,4    " !Q@%Q6X+M-K&@#  !_%P  #0
M        @ &Y;0( >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( '& 7%:7BKL<
MP    !,"   +              "  4QQ @!?<F5L<R\N<F5L<U!+ 0(4 Q0
M   ( '& 7%80/C'XJ 4   DQ   /              "  35R @!X;"]W;W)K
M8F]O:RYX;6Q02P$"% ,4    " !Q@%Q6Q]=S3T<"  #5*P  &@
M    @ $*> ( >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M" !Q@%Q6'YV%;PD"  #8*@  $P              @ &)>@( 6T-O;G1E;G1?
@5'EP97-=+GAM;%!+!08     4@!2 '46  ##? (    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>377</ContextCount>
  <ElementCount>567</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>113</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>11</UnitCount>
  <MyReports>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Spin-off of OmniAb</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/SpinoffofOmniAb</Role>
      <ShortName>Spin-off of OmniAb</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Short-term Investments: Investment in Viking</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/ShorttermInvestmentsInvestmentinViking</Role>
      <ShortName>Short-term Investments: Investment in Viking</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/Acquisitions</Role>
      <ShortName>Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Fair Value Measurement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurement</Role>
      <ShortName>Fair Value Measurement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Convertible Senior Notes</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotes</Role>
      <ShortName>Convertible Senior Notes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Balance Sheet Account Details</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BalanceSheetAccountDetails</Role>
      <ShortName>Balance Sheet Account Details</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Commitment and Contingencies: Legal Proceedings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings</Role>
      <ShortName>Commitment and Contingencies: Legal Proceedings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Selected Quarterly Financial Data (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/SelectedQuarterlyFinancialDataUnaudited</Role>
      <ShortName>Selected Quarterly Financial Data (Unaudited)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Spin-off of OmniAb (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/SpinoffofOmniAbTables</Role>
      <ShortName>Spin-off of OmniAb (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/SpinoffofOmniAb</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Acquisitions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/AcquisitionsTables</Role>
      <ShortName>Acquisitions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/Acquisitions</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Fair Value Measurement (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurementTables</Role>
      <ShortName>Fair Value Measurement (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/FairValueMeasurement</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/Leases</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Convertible Senior Notes (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotesTables</Role>
      <ShortName>Convertible Senior Notes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/ConvertibleSeniorNotes</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Balance Sheet Account Details (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BalanceSheetAccountDetailsTables</Role>
      <ShortName>Balance Sheet Account Details (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BalanceSheetAccountDetails</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/StockholdersEquity</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/IncomeTaxes</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Selected Quarterly Financial Data (Unaudited) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/SelectedQuarterlyFinancialDataUnauditedTables</Role>
      <ShortName>Selected Quarterly Financial Data (Unaudited) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/SelectedQuarterlyFinancialDataUnaudited</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Revenue from Significant Partners (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuefromSignificantPartnersDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Revenue from Significant Partners (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Commercial License Rights (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Commercial License Rights (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Royalty Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRoyaltyRevenueDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Royalty Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Calculation of Earnings per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCalculationofEarningsperShareDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Calculation of Earnings per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Spin-off of OmniAb - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/SpinoffofOmniAbNarrativeDetails</Role>
      <ShortName>Spin-off of OmniAb - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Spin-off of OmniAb - Schedule of transfers of assets and liabilities to OmniAb (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails</Role>
      <ShortName>Spin-off of OmniAb - Schedule of transfers of assets and liabilities to OmniAb (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Spin-off of OmniAb - Schedule of revenue and expenses of the discontinued operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails</Role>
      <ShortName>Spin-off of OmniAb - Schedule of revenue and expenses of the discontinued operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Spin-off of OmniAb - Schedule of non-cash items and capital expenditures of the discontinued operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails</Role>
      <ShortName>Spin-off of OmniAb - Schedule of non-cash items and capital expenditures of the discontinued operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Short-term Investments: Investment in Viking - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/ShorttermInvestmentsInvestmentinVikingNarrativeDetails</Role>
      <ShortName>Short-term Investments: Investment in Viking - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Acquisitions - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/AcquisitionsNarrativeDetails</Role>
      <ShortName>Acquisitions - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Acquisitions - Assets Acquired and Liabilities Assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails</Role>
      <ShortName>Acquisitions - Assets Acquired and Liabilities Assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Acquisitions - Intangibles Acquired and Weighted Average Useful Life (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/AcquisitionsIntangiblesAcquiredandWeightedAverageUsefulLifeDetails</Role>
      <ShortName>Acquisitions - Intangibles Acquired and Weighted Average Useful Life (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Acquisitions - Pro Forma Financial Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails</Role>
      <ShortName>Acquisitions - Pro Forma Financial Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Fair Value Measurement - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurement - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Fair Value Measurement - Reconciliation of Level 3 Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurementReconciliationofLevel3FinancialInstrumentsDetails</Role>
      <ShortName>Fair Value Measurement - Reconciliation of Level 3 Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Leases - Operating and Finance Lease Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails</Role>
      <ShortName>Leases - Operating and Finance Lease Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Leases - Maturities of Operating and Finance Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Maturities of Operating and Finance Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Convertible Senior Notes - Narrative (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails</Role>
      <ShortName>Convertible Senior Notes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Convertible Senior Notes - Equity and Liability Components of Financing Arrangements (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotesEquityandLiabilityComponentsofFinancingArrangementsDetails</Role>
      <ShortName>Convertible Senior Notes - Equity and Liability Components of Financing Arrangements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Balance Sheet Account Details - Investment Categories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BalanceSheetAccountDetailsInvestmentCategoriesDetails</Role>
      <ShortName>Balance Sheet Account Details - Investment Categories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Balance Sheet Account Details - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BalanceSheetAccountDetailsNarrativeDetails</Role>
      <ShortName>Balance Sheet Account Details - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Balance Sheet Account Details - Available-for-Sale Debt Securities by Contractual Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesbyContractualMaturityDetails</Role>
      <ShortName>Balance Sheet Account Details - Available-for-Sale Debt Securities by Contractual Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - Balance Sheet Account Details - Available-for-Sale Debt Securities in an Unrealized Loss Position (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails</Role>
      <ShortName>Balance Sheet Account Details - Available-for-Sale Debt Securities in an Unrealized Loss Position (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - Balance Sheet Account Details - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BalanceSheetAccountDetailsPropertyandEquipmentDetails</Role>
      <ShortName>Balance Sheet Account Details - Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Balance Sheet Account Details - Goodwill and Other Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BalanceSheetAccountDetailsGoodwillandOtherIntangibleAssetsDetails</Role>
      <ShortName>Balance Sheet Account Details - Goodwill and Other Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - Balance Sheet Account Details - Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BalanceSheetAccountDetailsAccruedLiabilitiesDetails</Role>
      <ShortName>Balance Sheet Account Details - Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - Balance Sheet Account Details - Contingent Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BalanceSheetAccountDetailsContingentLiabilitiesDetails</Role>
      <ShortName>Balance Sheet Account Details - Contingent Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - Stockholders' Equity - Share-Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquityShareBasedCompensationDetails</Role>
      <ShortName>Stockholders' Equity - Share-Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - Stockholders' Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquityNarrativeDetails</Role>
      <ShortName>Stockholders' Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - Stockholders' Equity - Stock Option Plan Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquityStockOptionPlanActivityDetails</Role>
      <ShortName>Stockholders' Equity - Stock Option Plan Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - Stockholders' Equity - Breakdown of Options Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquityBreakdownofOptionsOutstandingDetails</Role>
      <ShortName>Stockholders' Equity - Breakdown of Options Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - Stockholders' Equity - Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquityAssumptionsDetails</Role>
      <ShortName>Stockholders' Equity - Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - Stockholders' Equity - Restricted Stock Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquityRestrictedStockActivityDetails</Role>
      <ShortName>Stockholders' Equity - Restricted Stock Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - Income Taxes - Components of Income Tax Expense (Benefit) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails</Role>
      <ShortName>Income Taxes - Components of Income Tax Expense (Benefit) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - Income Taxes - Reconciliation of Income Tax Expense (Benefit) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails</Role>
      <ShortName>Income Taxes - Reconciliation of Income Tax Expense (Benefit) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - Income Taxes - Deferred Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/IncomeTaxesDeferredTaxesDetails</Role>
      <ShortName>Income Taxes - Deferred Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - Income Taxes - Reconciliation of Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Reconciliation of Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - Selected Quarterly Financial Data (Unaudited) - Summary (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/SelectedQuarterlyFinancialDataUnauditedSummaryDetails</Role>
      <ShortName>Selected Quarterly Financial Data (Unaudited) - Summary (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/SelectedQuarterlyFinancialDataUnauditedTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="lgnd-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9999.htm</HtmlFileName>
      <LongName>Uncategorized Items - lgnd-20221231.htm</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/role/uncategorizedFacts</Role>
      <ShortName>Uncategorized Items - lgnd-20221231.htm</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 6 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:DebtInstrumentConvertibleConversionRatio1, us-gaap:PropertyPlantAndEquipmentUsefulLife, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage -  lgnd-20221231.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-K" original="lgnd-20221231.htm">lgnd-20221231.htm</File>
    <File>exhibit1014_ligand-separat.htm</File>
    <File>exhibit1015_ligand-severan.htm</File>
    <File>exhibit_108xligand-amended.htm</File>
    <File>exhibit_109xliganddirector.htm</File>
    <File>lgnd-20221231.xsd</File>
    <File>lgnd-20221231_cal.xml</File>
    <File>lgnd-20221231_def.xml</File>
    <File>lgnd-20221231_lab.xml</File>
    <File>lgnd-20221231_pre.xml</File>
    <File>lgnd_123122xexhibit211.htm</File>
    <File>lgnd_123122xexhibit231.htm</File>
    <File>lgnd_123122xexhibit311.htm</File>
    <File>lgnd_123122xexhibit312.htm</File>
    <File>lgnd_123122xexhibit321.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>lgnd-20221231_g1.jpg</File>
    <File>lgnd-20221231_g2.jpg</File>
    <File>lgnd-20221231_g3.jpg</File>
    <File>lgnd-20221231_g4.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1526">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="37">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>101
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "lgnd-20221231.htm": {
   "axisCustom": 0,
   "axisStandard": 34,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 1526,
    "http://xbrl.sec.gov/dei/2022": 37
   },
   "contextCount": 377,
   "dts": {
    "calculationLink": {
     "local": [
      "lgnd-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "lgnd-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "lgnd-20221231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "lgnd-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lgnd-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "lgnd-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 854,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 11,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 15
   },
   "keyCustom": 91,
   "keyStandard": 476,
   "memberCustom": 59,
   "memberStandard": 53,
   "nsprefix": "lgnd",
   "nsuri": "http://www.ligand.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.ligand.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Spin-off of OmniAb",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.ligand.com/role/SpinoffofOmniAb",
     "shortName": "Spin-off of OmniAb",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Short-term Investments: Investment in Viking",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.ligand.com/role/ShorttermInvestmentsInvestmentinViking",
     "shortName": "Short-term Investments: Investment in Viking",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Acquisitions",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.ligand.com/role/Acquisitions",
     "shortName": "Acquisitions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Fair Value Measurement",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.ligand.com/role/FairValueMeasurement",
     "shortName": "Fair Value Measurement",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Leases",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.ligand.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Convertible Senior Notes",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotes",
     "shortName": "Convertible Senior Notes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Balance Sheet Account Details",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.ligand.com/role/BalanceSheetAccountDetails",
     "shortName": "Balance Sheet Account Details",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Stockholders' Equity",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.ligand.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Commitment and Contingencies: Legal Proceedings",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings",
     "shortName": "Commitment and Contingencies: Legal Proceedings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.ligand.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0000002 - Document - Audit Information",
     "menuCat": "Cover",
     "order": "2",
     "role": "http://www.ligand.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Selected Quarterly Financial Data (Unaudited)",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.ligand.com/role/SelectedQuarterlyFinancialDataUnaudited",
     "shortName": "Selected Quarterly Financial Data (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "lgnd:BusinessSpinOffAndMigrationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "21",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "lgnd:BusinessSpinOffAndMigrationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "22",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Spin-off of OmniAb (Tables)",
     "menuCat": "Tables",
     "order": "23",
     "role": "http://www.ligand.com/role/SpinoffofOmniAbTables",
     "shortName": "Spin-off of OmniAb (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Acquisitions (Tables)",
     "menuCat": "Tables",
     "order": "24",
     "role": "http://www.ligand.com/role/AcquisitionsTables",
     "shortName": "Acquisitions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Fair Value Measurement (Tables)",
     "menuCat": "Tables",
     "order": "25",
     "role": "http://www.ligand.com/role/FairValueMeasurementTables",
     "shortName": "Fair Value Measurement (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "lgnd:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Leases (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://www.ligand.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "lgnd:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Convertible Senior Notes (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotesTables",
     "shortName": "Convertible Senior Notes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Balance Sheet Account Details (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.ligand.com/role/BalanceSheetAccountDetailsTables",
     "shortName": "Balance Sheet Account Details (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Stockholders' Equity (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.ligand.com/role/StockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONSOLIDATED BALANCE SHEETS",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Income Taxes (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.ligand.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Selected Quarterly Financial Data (Unaudited) (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.ligand.com/role/SelectedQuarterlyFinancialDataUnauditedTables",
     "shortName": "Selected Quarterly Financial Data (Unaudited) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "lgnd:BusinessSpinOffAndMigrationPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)",
     "menuCat": "Details",
     "order": "32",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "lgnd:BusinessSpinOffAndMigrationPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "i72f4dbdc77184f48bcecf231e8e2ca80_D20220101-20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Revenue from Significant Partners (Details)",
     "menuCat": "Details",
     "order": "33",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuefromSignificantPartnersDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Revenue from Significant Partners (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "i72f4dbdc77184f48bcecf231e8e2ca80_D20220101-20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "lgnd:ScheduleofCommercialLicenseRightsTableTextBlock",
       "lgnd:CommercialLicenseRightsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Commercial License Rights (Details)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Commercial License Rights (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "lgnd:ScheduleofCommercialLicenseRightsTableTextBlock",
       "lgnd:CommercialLicenseRightsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "i753bf04acd14417f84584d364adb5bb8_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "i9f4b841dc87a45f4876ae68269b5ee3f_D20221001-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Royalty Revenue (Details)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRoyaltyRevenueDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Royalty Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "i9ec9717cd1d246078b4b569036ffdc49_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "i9f4b841dc87a45f4876ae68269b5ee3f_D20221001-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Calculation of Earnings per Share (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCalculationofEarningsperShareDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Calculation of Earnings per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "i6992767e8dd8406c922375c93b5376c2_D20220101-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Spin-off of OmniAb - Narrative (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://www.ligand.com/role/SpinoffofOmniAbNarrativeDetails",
     "shortName": "Spin-off of OmniAb - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "i6992767e8dd8406c922375c93b5376c2_D20220101-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Spin-off of OmniAb - Schedule of transfers of assets and liabilities to OmniAb (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails",
     "shortName": "Spin-off of OmniAb - Schedule of transfers of assets and liabilities to OmniAb (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "i71db46073a8c4e54a85cdb15a16cda65_I20221101",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Spin-off of OmniAb - Schedule of revenue and expenses of the discontinued operations (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails",
     "shortName": "Spin-off of OmniAb - Schedule of revenue and expenses of the discontinued operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "lgnd:PaymentsToContingentValueRightHoldersFinancingActivity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Spin-off of OmniAb - Schedule of non-cash items and capital expenditures of the discontinued operations (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails",
     "shortName": "Spin-off of OmniAb - Schedule of non-cash items and capital expenditures of the discontinued operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "i98bd76f6dbb242cfb241b2dc0cc0dde8_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "lgnd:DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Short-term Investments: Investment in Viking - Narrative (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.ligand.com/role/ShorttermInvestmentsInvestmentinVikingNarrativeDetails",
     "shortName": "Short-term Investments: Investment in Viking - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ifeea5a6633434f93bbe3e33fea893ad4_D20200101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "lgnd:NumberOfAcquisitions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "acquisition",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Acquisitions - Narrative (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
     "shortName": "Acquisitions - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ifeea5a6633434f93bbe3e33fea893ad4_D20200101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "lgnd:NumberOfAcquisitions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "acquisition",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Acquisitions - Assets Acquired and Liabilities Assumed (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails",
     "shortName": "Acquisitions - Assets Acquired and Liabilities Assumed (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if6722b1819674d1ca58d43ab78f42fee_I20201001",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if6722b1819674d1ca58d43ab78f42fee_I20201001",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Acquisitions - Intangibles Acquired and Weighted Average Useful Life (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.ligand.com/role/AcquisitionsIntangiblesAcquiredandWeightedAverageUsefulLifeDetails",
     "shortName": "Acquisitions - Intangibles Acquired and Weighted Average Useful Life (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if6722b1819674d1ca58d43ab78f42fee_I20201001",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "i67ed4423d4894d809c0e43396ff89fb7_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Acquisitions - Pro Forma Financial Information (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails",
     "shortName": "Acquisitions - Pro Forma Financial Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "i67ed4423d4894d809c0e43396ff89fb7_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "iefe06608d69a4810b5ef7844034e3616_I20100131",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "lgnd:NumberOfContingentValueRightAgreements",
      "reportCount": 1,
      "unitRef": "agreement",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Fair Value Measurement - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
     "shortName": "Fair Value Measurement - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "i21d27e0d975f4344a297876b55e27170_I20100131",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "i8b5a6c6d475f4fd9955fe20a8666d3a9_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "lgnd:PaymentsToContingentValueRightHolders",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Fair Value Measurement - Reconciliation of Level 3 Financial Instruments (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.ligand.com/role/FairValueMeasurementReconciliationofLevel3FinancialInstrumentsDetails",
     "shortName": "Fair Value Measurement - Reconciliation of Level 3 Financial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "i80eaf9a4b47f4c988d4ed66997f6cdfc_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.ligand.com/role/FairValueMeasurementsNarrativeDetails",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "lgnd:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Leases - Narrative (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.ligand.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostDirectMaterial",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Leases - Operating and Finance Lease Assets and Liabilities (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails",
     "shortName": "Leases - Operating and Finance Lease Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "lgnd:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "lgnd:LeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Leases - Maturities of Operating and Finance Lease Liabilities (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails",
     "shortName": "Leases - Maturities of Operating and Finance Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Convertible Senior Notes - Narrative (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
     "shortName": "Convertible Senior Notes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "i3316b5508b924ffc8fd7ec36b3aa455e_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Convertible Senior Notes - Equity and Liability Components of Financing Arrangements (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotesEquityandLiabilityComponentsofFinancingArrangementsDetails",
     "shortName": "Convertible Senior Notes - Equity and Liability Components of Financing Arrangements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "i3316b5508b924ffc8fd7ec36b3aa455e_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:MarketableSecuritiesTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Balance Sheet Account Details - Investment Categories (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.ligand.com/role/BalanceSheetAccountDetailsInvestmentCategoriesDetails",
     "shortName": "Balance Sheet Account Details - Investment Categories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:MarketableSecuritiesTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "position",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Balance Sheet Account Details - Narrative (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.ligand.com/role/BalanceSheetAccountDetailsNarrativeDetails",
     "shortName": "Balance Sheet Account Details - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "position",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Balance Sheet Account Details - Available-for-Sale Debt Securities by Contractual Maturity (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesbyContractualMaturityDetails",
     "shortName": "Balance Sheet Account Details - Available-for-Sale Debt Securities by Contractual Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Balance Sheet Account Details - Available-for-Sale Debt Securities in an Unrealized Loss Position (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails",
     "shortName": "Balance Sheet Account Details - Available-for-Sale Debt Securities in an Unrealized Loss Position (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - Balance Sheet Account Details - Property and Equipment (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.ligand.com/role/BalanceSheetAccountDetailsPropertyandEquipmentDetails",
     "shortName": "Balance Sheet Account Details - Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Balance Sheet Account Details - Goodwill and Other Intangible Assets (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.ligand.com/role/BalanceSheetAccountDetailsGoodwillandOtherIntangibleAssetsDetails",
     "shortName": "Balance Sheet Account Details - Goodwill and Other Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsNetIncludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Balance Sheet Account Details - Accrued Liabilities (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.ligand.com/role/BalanceSheetAccountDetailsAccruedLiabilitiesDetails",
     "shortName": "Balance Sheet Account Details - Accrued Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "iefb8443bc64f4ed39eb1baccbdf34aa5_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Balance Sheet Account Details - Contingent Liabilities (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.ligand.com/role/BalanceSheetAccountDetailsContingentLiabilitiesDetails",
     "shortName": "Balance Sheet Account Details - Contingent Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "i859e9607437a43d8adb4d3dc08e60773_I20191231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "lgnd:BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - Stockholders' Equity - Share-Based Compensation (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.ligand.com/role/StockholdersEquityShareBasedCompensationDetails",
     "shortName": "Stockholders' Equity - Share-Based Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "iac54b9d00e76487d9a441f663e698e18_I20190930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - Stockholders' Equity - Narrative (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.ligand.com/role/StockholdersEquityNarrativeDetails",
     "shortName": "Stockholders' Equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "iac54b9d00e76487d9a441f663e698e18_I20190930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "i1e08d73fd52941c8b0a838aeb83cbe3b_I20221031",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - Stockholders' Equity - Stock Option Plan Activity (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.ligand.com/role/StockholdersEquityStockOptionPlanActivityDetails",
     "shortName": "Stockholders' Equity - Stock Option Plan Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ieaaf4e1776ca4ee3b882116a392a5b8c_D20221102-20221231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - Stockholders' Equity - Breakdown of Options Outstanding (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.ligand.com/role/StockholdersEquityBreakdownofOptionsOutstandingDetails",
     "shortName": "Stockholders' Equity - Breakdown of Options Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "idbafb024b44d43f0b4a9e4440b3833cb_D20220101-20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - Stockholders' Equity - Assumptions (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.ligand.com/role/StockholdersEquityAssumptionsDetails",
     "shortName": "Stockholders' Equity - Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "idbafb024b44d43f0b4a9e4440b3833cb_D20220101-20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "i0b64d9bdb1cd4eceb9508d306b942d87_I20221031",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - Stockholders' Equity - Restricted Stock Activity (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.ligand.com/role/StockholdersEquityRestrictedStockActivityDetails",
     "shortName": "Stockholders' Equity - Restricted Stock Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ic7e2f70f54f74635b9da899358a0eb40_I20191231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - Income Taxes - Narrative (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.ligand.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - Income Taxes - Components of Income Tax Expense (Benefit) (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.ligand.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails",
     "shortName": "Income Taxes - Components of Income Tax Expense (Benefit) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "i357eff174d874e71a3e0da8d3f8ba240_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
     "shortName": "CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "i357eff174d874e71a3e0da8d3f8ba240_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - Income Taxes - Reconciliation of Income Tax Expense (Benefit) (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails",
     "shortName": "Income Taxes - Reconciliation of Income Tax Expense (Benefit) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - Income Taxes - Deferred Taxes (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.ligand.com/role/IncomeTaxesDeferredTaxesDetails",
     "shortName": "Income Taxes - Deferred Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "ib94e4f2b99f84ea7a88c1d2bcc0322c5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "i23fb82cd64a44e6a878e6fee6dd6477d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - Income Taxes - Reconciliation of Unrecognized Tax Benefits (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.ligand.com/role/IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails",
     "shortName": "Income Taxes - Reconciliation of Unrecognized Tax Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "i859e9607437a43d8adb4d3dc08e60773_I20191231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "i9f4b841dc87a45f4876ae68269b5ee3f_D20221001-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - Selected Quarterly Financial Data (Unaudited) - Summary (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.ligand.com/role/SelectedQuarterlyFinancialDataUnauditedSummaryDetails",
     "shortName": "Selected Quarterly Financial Data (Unaudited) - Summary (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "i9f4b841dc87a45f4876ae68269b5ee3f_D20221001-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20221231.htm",
      "contextRef": "if45af0da2212401f917e14836fcf8e57_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9999": {
     "firstAnchor": null,
     "groupType": "",
     "isDefault": "false",
     "longName": "Uncategorized Items - lgnd-20221231.htm",
     "menuCat": "Cover",
     "order": "74",
     "role": "http://xbrl.sec.gov/role/uncategorizedFacts",
     "shortName": "Uncategorized Items - lgnd-20221231.htm",
     "subGroupType": "",
     "uniqueAnchor": null
    }
   },
   "segmentCount": 113,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r836",
      "r837",
      "r838"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r836",
      "r837",
      "r838"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r836",
      "r837",
      "r838"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r836",
      "r837",
      "r838"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r839"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r834"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r833"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r833"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r833"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r840"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r833"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r833"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r833"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r833"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r841"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-Known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r836",
      "r837",
      "r838"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r835"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "lgnd_AccountsReceivableCreditLossExpenseReversalCOVID19": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable, Credit Loss Expense (Reversal), COVID-19",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal), COVID-19",
        "negatedTerseLabel": "Additional reserve for credit losses due to COVID-19"
       }
      }
     },
     "localname": "AccountsReceivableCreditLossExpenseReversalCOVID19",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AccruedAssetAcquisitionsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAccruedLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Asset Acquisitions, Current",
        "label": "Accrued Asset Acquisitions, Current",
        "terseLabel": "Acquisition related liabilities"
       }
      }
     },
     "localname": "AccruedAssetAcquisitionsCurrent",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AccruedInventoryPurchases": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Inventory Purchases",
        "label": "Accrued Inventory Purchases",
        "terseLabel": "Accrued inventory purchases"
       }
      }
     },
     "localname": "AccruedInventoryPurchases",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AccruedSalesReturns": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Sales Returns",
        "label": "Accrued Sales Returns",
        "terseLabel": "Return reserve and customer refunds"
       }
      }
     },
     "localname": "AccruedSalesReturns",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AccruedSubcontractorExpensesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAccruedLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Subcontractor Expenses, Current",
        "label": "Accrued Subcontractor Expenses, Current",
        "terseLabel": "Subcontractor"
       }
      }
     },
     "localname": "AccruedSubcontractorExpensesCurrent",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AccruedSupplierExpensesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAccruedLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Supplier Expenses, Current",
        "label": "Accrued Supplier Expenses, Current",
        "terseLabel": "Supplier"
       }
      }
     },
     "localname": "AccruedSupplierExpensesCurrent",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AdditionalRoyaltiesReceivableUnderSalesbasedMilestones": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional Royalties Receivable Under Sales-based Milestones",
        "label": "Additional Royalties Receivable Under Sales-based Milestones",
        "terseLabel": "Additional royalties receivable under sales-based milestones"
       }
      }
     },
     "localname": "AdditionalRoyaltiesReceivableUnderSalesbasedMilestones",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AdjustmentsToAdditionalPaidInCapitalBondHedgeTransaction": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Additional Paid In Capital, Bond Hedge Transaction",
        "label": "Adjustments to Additional Paid In Capital, Bond Hedge Transaction",
        "terseLabel": "Bond hedge transaction"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalBondHedgeTransaction",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AdjustmentsToAdditionalPaidInCapitalDecreaseDueToSeparation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Additional Paid in Capital, Decrease Due To Separation",
        "label": "Adjustments to Additional Paid in Capital, Decrease Due To Separation",
        "negatedTerseLabel": "Distribution of OmniAb"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalDecreaseDueToSeparation",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions",
        "label": "Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions",
        "terseLabel": "Warrant and bond hedge unwind transactions"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AmendedESPPMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amended ESPP [Member]",
        "label": "Amended ESPP [Member]",
        "terseLabel": "Amended ESPP"
       }
      }
     },
     "localname": "AmendedESPPMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization of Commercial License and Other Economic Rights",
        "label": "Amortization of Commercial License and Other Economic Rights",
        "terseLabel": "Amortization of commercial license and other economic rights"
       }
      }
     },
     "localname": "AmortizationOfCommercialLicenseAndOtherEconomicRights",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets and Liabilities, Lessee",
        "label": "Assets and Liabilities, Lessee [Table Text Block]",
        "terseLabel": "Schedule of Operating and Finance Lease Assets and Liabilities"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_AtTheMarketEquityOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "At-The Market Equity Offering",
        "label": "At-The Market Equity Offering [Member]",
        "terseLabel": "At-The Market Equity Offering"
       }
      }
     },
     "localname": "AtTheMarketEquityOfferingMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_AuditInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Audit Information [Abstract]",
        "label": "Audit Information [Abstract]"
       }
      }
     },
     "localname": "AuditInformationAbstract",
     "nsuri": "http://www.ligand.com/20221231",
     "xbrltype": "stringItemType"
    },
    "lgnd_AziyoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aziyo [Member]",
        "label": "Aziyo [Member]",
        "terseLabel": "Aziyo"
       }
      }
     },
     "localname": "AziyoMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_AziyoandCorMatrixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aziyo and CorMatrix [Member]",
        "label": "Aziyo and CorMatrix [Member]",
        "terseLabel": "Aziyo and CorMatrix"
       }
      }
     },
     "localname": "AziyoandCorMatrixMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis Of Presentation And Principles Of Consolidation",
        "label": "Basis Of Presentation And Principles Of Consolidation [Policy Text Block]",
        "terseLabel": "Basis of Presentation and Principles of Consolidation"
       }
      }
     },
     "localname": "BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_BasisOfPresentationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis of presentation.",
        "label": "Basis of Presentation [Line Items]",
        "terseLabel": "Basis of Presentation [Line Items]"
       }
      }
     },
     "localname": "BasisOfPresentationLineItems",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_BasisOfPresentationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis of Presentation.",
        "label": "Basis of Presentation [Table]",
        "terseLabel": "Basis of Presentation [Table]"
       }
      }
     },
     "localname": "BasisOfPresentationTable",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Browse Taxonomy Disposal Group, Including Discontinued Operation, Other Income (Expense)",
        "label": "Browse Taxonomy Disposal Group, Including Discontinued Operation, Other Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "BrowseTaxonomyDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition Contingent Consideration Potential Cash Payment at End of Period",
        "label": "Business Acquisition Contingent Consideration Potential Cash Payment at End of Period",
        "periodEndLabel": "Commercial rights, end of period",
        "periodStartLabel": "Commercial rights, beginning of period"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationContingentConsiderationLiabilityAmountPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Liability, Amount per Share",
        "label": "Business Combination, Contingent Consideration, Liability, Amount per Share",
        "terseLabel": "Contingent consideration liability per share (USD per share)"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityAmountPerShare",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Liability, Fair Value Disclosure",
        "label": "Business Combination, Contingent Consideration, Liability, Fair Value Disclosure",
        "terseLabel": "Fair value of contingent earn-out payment"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities, Current",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities, Current",
        "negatedTerseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets",
        "terseLabel": "Intangibles acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Discount Rate",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Discount Rate",
        "terseLabel": "Discount rate used to value intangible assets acquired (as a percent)"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Lease Liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Lease Liabilities",
        "negatedTerseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restricted Cash",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restricted Cash",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-of-Use Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-of-Use Assets",
        "terseLabel": "Right-of-use asset"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessSpinOffAndMigrationPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Spin-Off And Migration",
        "label": "Business Spin-Off And Migration [Policy Text Block]",
        "terseLabel": "Business"
       }
      }
     },
     "localname": "BusinessSpinOffAndMigrationPolicyTextBlock",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_CaliforniaAndNewJerseyResearchTaxCreditCarryforwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "California and New Jersey Research Tax Credit Carryforward [Member]",
        "label": "California and New Jersey Research Tax Credit Carryforward [Member]",
        "terseLabel": "California and New Jersey Research Tax Credit Carryforward"
       }
      }
     },
     "localname": "CaliforniaAndNewJerseyResearchTaxCreditCarryforwardMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_CashCashEquivalentsandShorttermInvestmentsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash, Cash Equivalents, and Short-term Investments [Policy Text Block]",
        "label": "Cash, Cash Equivalents, and Short-term Investments [Policy Text Block]",
        "verboseLabel": "Cash Equivalents &amp; Short-term Investments"
       }
      }
     },
     "localname": "CashCashEquivalentsandShorttermInvestmentsPolicyTextBlock",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_CashPaidDuringTheYearAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Paid During the Year",
        "label": "Cash Paid During the Year [Abstract]",
        "terseLabel": "Cash paid during the year:"
       }
      }
     },
     "localname": "CashPaidDuringTheYearAbstract",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_CommercialLicenseRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial License Rights",
        "label": "Commercial License Rights",
        "terseLabel": "Commercial license and other economic rights"
       }
      }
     },
     "localname": "CommercialLicenseRights",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_CommercialLicenseRightsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial License Rights [Policy Text Block]",
        "label": "Commercial License Rights [Policy Text Block]",
        "terseLabel": "Commercial license and other economic rights"
       }
      }
     },
     "localname": "CommercialLicenseRightsPolicyTextBlock",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_ComputerEquipmentAndSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Computer equipment and software.",
        "label": "Computer Equipment And Software [Member]",
        "verboseLabel": "Computer equipment and software"
       }
      }
     },
     "localname": "ComputerEquipmentAndSoftwareMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ContingentLiabilityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Liability [Roll Forward]",
        "label": "Contingent Liability [Roll Forward]",
        "terseLabel": "Contingent Liability [Roll Forward]"
       }
      }
     },
     "localname": "ContingentLiabilityRollForward",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsContingentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_ContractRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract Revenue",
        "label": "Contract Revenue [Member]",
        "terseLabel": "Contract revenue"
       }
      }
     },
     "localname": "ContractRevenueMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRoyaltyRevenueDetails",
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ContractualRelationshipsAlvogenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual Relationships - Alvogen",
        "label": "Contractual Relationships - Alvogen [Member]",
        "terseLabel": "Contractual Relationships - Alvogen"
       }
      }
     },
     "localname": "ContractualRelationshipsAlvogenMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsIntangiblesAcquiredandWeightedAverageUsefulLifeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ContractualRelationshipsArcellxMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual Relationships - Arcellx",
        "label": "Contractual Relationships - Arcellx [Member]",
        "terseLabel": "Contractual Relationships - Arcellx"
       }
      }
     },
     "localname": "ContractualRelationshipsArcellxMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsIntangiblesAcquiredandWeightedAverageUsefulLifeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ContractualRelationshipsJazzMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual Relationships - Jazz",
        "label": "Contractual Relationships - Jazz [Member]",
        "terseLabel": "Contractual Relationships - Jazz"
       }
      }
     },
     "localname": "ContractualRelationshipsJazzMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsIntangiblesAcquiredandWeightedAverageUsefulLifeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ContractualRelationshipsMerckMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual Relationships - Merck",
        "label": "Contractual Relationships - Merck [Member]",
        "terseLabel": "Contractual Relationships - Merck"
       }
      }
     },
     "localname": "ContractualRelationshipsMerckMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsIntangiblesAcquiredandWeightedAverageUsefulLifeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ContractualRelationshipsSIIMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual Relationships - SII",
        "label": "Contractual Relationships - SII [Member]",
        "terseLabel": "Contractual Relationships - SII"
       }
      }
     },
     "localname": "ContractualRelationshipsSIIMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsIntangiblesAcquiredandWeightedAverageUsefulLifeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ConvertibleSeniorNotesDue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Senior Notes due 2023",
        "label": "Convertible Senior Notes due 2023 [Member]",
        "terseLabel": "2023 Convertible Senior Notes"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDue2023Member",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesEquityandLiabilityComponentsofFinancingArrangementsDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_CorMatrixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CorMatrix [Member]",
        "label": "CorMatrix [Member]",
        "terseLabel": "CorMatrix"
       }
      }
     },
     "localname": "CorMatrixMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_CorporateShareRepurchaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate Share Repurchase [Abstract]",
        "label": "Corporate Share Repurchase [Abstract]",
        "terseLabel": "Corporate Share Repurchase"
       }
      }
     },
     "localname": "CorporateShareRepurchaseAbstract",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_CurrentPortionOfLiabilityForContingentValueRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current portion of liability for contingent value rights.",
        "label": "Current Portion of Liability for Contingent Value Rights",
        "terseLabel": "Current contingent liabilities"
       }
      }
     },
     "localname": "CurrentPortionOfLiabilityForContingentValueRights",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_CydexPharmaceuticalsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cydex Pharmaceuticals, Inc.",
        "label": "Cydex Pharmaceuticals, Inc [Member]",
        "verboseLabel": "Cydex"
       }
      }
     },
     "localname": "CydexPharmaceuticalsIncMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Maximum Threshold Percentage of Debt Trading Price Trigger",
        "label": "Debt Instrument, Convertible, Maximum Threshold Percentage of Debt Trading Price Trigger",
        "terseLabel": "Maximum threshold of debt trading price trigger (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lgnd_DebtInstrumentRepurchasedAmountDuringPeriod": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Repurchased Amount During Period",
        "label": "Debt Instrument, Repurchased Amount During Period",
        "terseLabel": "Repurchased amount"
       }
      }
     },
     "localname": "DebtInstrumentRepurchasedAmountDuringPeriod",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DeferredTaxLiabilitiesFiniteLivedIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesDeferredTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Finite-Lived Intangible Assets",
        "label": "Deferred Tax Liabilities, Finite-Lived Intangible Assets",
        "negatedTerseLabel": "Identified intangibles"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesFiniteLivedIntangibleAssets",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties",
        "label": "Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties [Member]",
        "terseLabel": "Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties"
       }
      }
     },
     "localname": "DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Assets",
        "label": "Disposal Group, Including Discontinued Operation, Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAssetsAbstract",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsFinanceLeaseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Assets, Finance Lease Assets",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Finance Lease Assets",
        "terseLabel": "Finance lease assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAssetsFinanceLeaseAssets",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DisposalGroupIncludingDiscontinuedOperationAssetsOperatingLeaseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Assets, Operating Lease Assets",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Operating Lease Assets",
        "terseLabel": "Operating lease assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAssetsOperatingLeaseAssets",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Change in Amount of Contingent Consideration",
        "label": "Disposal Group, Including Discontinued Operation, Change in Amount of Contingent Consideration",
        "terseLabel": "Change in fair value of contingent consideration"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsideration",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Contingent Liabilities, Current",
        "label": "Disposal Group, Including Discontinued Operation, Contingent Liabilities, Current",
        "terseLabel": "Current contingent liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesCurrent",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Disposal Group, Including Discontinued Operation, Contingent Liabilities, Noncurrent",
        "label": "\"Disposal Group, Including Discontinued Operation, Contingent Liabilities, Noncurrent",
        "terseLabel": "Long-term contingent liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesNoncurrent",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Finance Lease Liabilities, Current",
        "label": "Disposal Group, Including Discontinued Operation, Finance Lease Liabilities, Current",
        "terseLabel": "Current finance lease liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilitiesCurrent",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Financing Activities",
        "label": "Disposal Group, Including Discontinued Operation, Financing Activities [Abstract]",
        "terseLabel": "Financing activities:"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationFinancingActivitiesAbstract",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails": {
       "order": 2.0,
       "parentTag": "lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Gain (Loss) On Short-Term Investments",
        "label": "Disposal Group, Including Discontinued Operation, Gain (Loss) On Short-Term Investments",
        "terseLabel": "Gain from short-term investments"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationGainLossOnShortTermInvestments",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Liabilities And Stockholder's Equity",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities And Stockholder's Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_DisposalGroupIncludingDiscontinuedOperationLiabilitiesOperatingLeaseNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Liabilities, Operating Lease, Noncurrent",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Operating Lease, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationLiabilitiesOperatingLeaseNoncurrent",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DisposalGroupIncludingDiscontinuedOperationNetAssetsTransferred": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Net Assets Transferred",
        "label": "Disposal Group, Including Discontinued Operation, Net Assets Transferred",
        "totalLabel": "Net assets transferred to OmniAb"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationNetAssetsTransferred",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Nonoperating Income (Expense)",
        "label": "Disposal Group, Including Discontinued Operation, Nonoperating Income (Expense)",
        "totalLabel": "Total other expense, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Operating Costs and Expenses",
        "label": "Disposal Group, Including Discontinued Operation, Operating Costs and Expenses [Abstract]",
        "verboseLabel": "Operating costs and expenses:"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingCostsAndExpensesAbstract",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease Liabilities, Current",
        "label": "Disposal Group, Including Discontinued Operation, Operating Lease Liabilities, Current",
        "terseLabel": "Current operating lease liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails": {
       "order": 3.0,
       "parentTag": "lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Other Income (Expense)",
        "label": "Disposal Group, Including Discontinued Operation, Other Income (Expense)",
        "terseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Payments to Acquire Businesses, Net of Cash Acquired",
        "label": "Disposal Group, Including Discontinued Operation, Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Cash paid for acquisition, net of cash acquired"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Percentage Of Voting Interests Disposed",
        "label": "Disposal Group, Including Discontinued Operation, Percentage Of Voting Interests Disposed",
        "terseLabel": "Ownership percentage"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPercentageOfVotingInterestsDisposed",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "lgnd_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Research and Development",
        "label": "Disposal Group, Including Discontinued Operation, Research and Development",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Share-Based Payment Arrangement, Expense",
        "label": "Disposal Group, Including Discontinued Operation, Share-Based Payment Arrangement, Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementExpense",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operations, Capital Expenditures Incurred but Not yet Paid",
        "label": "Disposal Group, Including Discontinued Operations, Capital Expenditures Incurred but Not yet Paid",
        "verboseLabel": "Purchases of property, plant and equipment included in accounts payable and accrued expenses"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationsCapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Change in Uncertain Tax Positions",
        "label": "Effective Income Tax Rate Reconciliation, Change in Uncertain Tax Positions",
        "negatedTerseLabel": "Change in uncertain tax positions"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_EffectiveIncomeTaxRateReconciliationDebtRepurchasesAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Debt Repurchases, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Debt Repurchases, Amount",
        "terseLabel": "Debt repurchases"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDebtRepurchasesAmount",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_EffectiveIncomeTaxRateReconciliationExpiredTaxCreditsResearch": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails": {
       "order": 16.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Expired Tax Credits, Research",
        "label": "Effective Income Tax Rate Reconciliation, Expired Tax Credits, Research",
        "terseLabel": "Research and development credits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationExpiredTaxCreditsResearch",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_EffectiveIncomeTaxRateReconciliationOfficerCompensationAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Officer Compensation, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Officer Compensation, Amount",
        "terseLabel": "Officer compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOfficerCompensationAmount",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_EffectiveIncomeTaxRateReconciliationOtherIncome": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Other Income",
        "label": "Effective Income Tax Rate Reconciliation, Other Income",
        "terseLabel": "Subpart F income"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherIncome",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Provision to Return Adjustments, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Provision to Return Adjustments, Amount",
        "negatedTerseLabel": "Provision to return adjustments"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsAmount",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_EmployeeStockPurchasePlanAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan [Abstract]",
        "label": "Employee Stock Purchase Plan [Abstract]",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanAbstract",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_ExercisePriceRangeEightMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise Price Range Eight [Member]",
        "label": "Exercise Price Range Eight [Member]",
        "terseLabel": "$99.80-$99.80"
       }
      }
     },
     "localname": "ExercisePriceRangeEightMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityBreakdownofOptionsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ExercisePriceRangeFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise Price Range Five [Member]",
        "label": "Exercise Price Range Five [Member]",
        "terseLabel": "$58.28-$67.03"
       }
      }
     },
     "localname": "ExercisePriceRangeFiveMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityBreakdownofOptionsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ExercisePriceRangeFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise Price Range Four [Member]",
        "label": "Exercise Price Range Four [Member]",
        "terseLabel": "$54.81-$57.22"
       }
      }
     },
     "localname": "ExercisePriceRangeFourMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityBreakdownofOptionsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ExercisePriceRangeNineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise Price Range Nine [Member]",
        "label": "Exercise Price Range Nine [Member]",
        "terseLabel": "$103.42-$103.42"
       }
      }
     },
     "localname": "ExercisePriceRangeNineMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityBreakdownofOptionsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ExercisePriceRangeOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise Price Range One [Member]",
        "label": "Exercise Price Range One [Member]",
        "terseLabel": "$12.78-$43.36"
       }
      }
     },
     "localname": "ExercisePriceRangeOneMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityBreakdownofOptionsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ExercisePriceRangeSevenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise Price Range Seven [Member]",
        "label": "Exercise Price Range Seven [Member]",
        "terseLabel": "70.04"
       }
      }
     },
     "localname": "ExercisePriceRangeSevenMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityBreakdownofOptionsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ExercisePriceRangeSixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise Price Range Six [Member]",
        "label": "Exercise Price Range Six [Member]",
        "terseLabel": "$67.24-$69.70"
       }
      }
     },
     "localname": "ExercisePriceRangeSixMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityBreakdownofOptionsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ExercisePriceRangeTenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise Price Range Ten [Member]",
        "label": "Exercise Price Range Ten [Member]",
        "terseLabel": "$114.15-$114.15"
       }
      }
     },
     "localname": "ExercisePriceRangeTenMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityBreakdownofOptionsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ExercisePriceRangeThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise Price Range Three [Member]",
        "label": "Exercise Price Range Three [Member]",
        "terseLabel": "$52.84-$52.84"
       }
      }
     },
     "localname": "ExercisePriceRangeThreeMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityBreakdownofOptionsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ExercisePriceRangeTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise Price Range Two [Member]",
        "label": "Exercise Price Range Two [Member]",
        "terseLabel": "$46.20-$52.78"
       }
      }
     },
     "localname": "ExercisePriceRangeTwoMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityBreakdownofOptionsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Repurchases, Contingent Liabilities",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Repurchases, Contingent Liabilities",
        "negatedTerseLabel": "Repurchases"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Fair Value Adjustment, Contingent Liabilities",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Fair Value Adjustment, Contingent Liabilities",
        "verboseLabel": "Fair Value Adjustment"
       }
      }
     },
     "localname": "FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease And Operating Lease, Right-of-Use Asset, Amortization",
        "label": "Finance Lease And Operating Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Lease amortization expense"
       }
      }
     },
     "localname": "FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Assets, Accumulated Amortization, Research &amp; Development Expense, and Credit Loss Adjustments",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization, Research &amp; Development Expense, and Credit Loss Adjustments",
        "negatedLabel": "Adjustments"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortizationResearchDevelopmentExpenseAndCreditLossAdjustments",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-lived Intangible Assets, Credit Loss Adjustments",
        "label": "Finite-lived Intangible Assets, Credit Loss Adjustments",
        "negatedLabel": "Credit loss adjustments on finite-lived intangible assets",
        "terseLabel": "Credit loss adjustments on finite-lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsCreditLossAdjustments",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_ForecastedCashFlowsEffectiveInterestRatePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forecasted Cash Flows, Effective Interest Rate, Percent",
        "label": "Forecasted Cash Flows, Effective Interest Rate, Percent",
        "terseLabel": "Effective interest rate of forecasted cash flows (as a percent)"
       }
      }
     },
     "localname": "ForecastedCashFlowsEffectiveInterestRatePercent",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lgnd_GainLossOnShortTermInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) on Short-Term Investments",
        "label": "Gain (Loss) on Short-Term Investments",
        "negatedTerseLabel": "Loss (gain) short-term investments"
       }
      }
     },
     "localname": "GainLossOnShortTermInvestments",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_IncomeTaxReconciliationContingentValueRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Reconciliation, Contingent Value Rights",
        "label": "Income Tax Reconciliation, Contingent Value Rights",
        "terseLabel": "Contingent liabilities"
       }
      }
     },
     "localname": "IncomeTaxReconciliationContingentValueRights",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_IncreaseDecreaseInDebtDiscount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Debt Discount",
        "label": "Increase (Decrease) in Debt Discount",
        "negatedTerseLabel": "Reduction in debt discount"
       }
      }
     },
     "localname": "IncreaseDecreaseInDebtDiscount",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability",
        "label": "Lease, Liability",
        "totalLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "LeaseLiability",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LeaseLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "lgnd_LeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Current",
        "label": "Lease, Liability, Current",
        "totalLabel": "Current lease liabilities"
       }
      }
     },
     "localname": "LeaseLiabilityCurrent",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LeaseRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Right-of-Use Asset",
        "label": "Lease, Right-of-Use Asset",
        "totalLabel": "Total lease assets"
       }
      }
     },
     "localname": "LeaseRightOfUseAsset",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LiabilityForContingentValueRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability for contingent value rights.",
        "label": "Liability for Contingent Value Rights",
        "verboseLabel": "Long-term contingent liabilities"
       }
      }
     },
     "localname": "LiabilityForContingentValueRights",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LiabilityForContingentValueRightsCompanyCydexMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Contingent Value Rights Company, Cydex",
        "label": "Liability For Contingent Value Rights Company, Cydex [Member]",
        "verboseLabel": "Contingent liabilities - CyDex"
       }
      }
     },
     "localname": "LiabilityForContingentValueRightsCompanyCydexMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Contingent Value Rights Company, Metabasis",
        "label": "Liability For Contingent Value Rights Company, Metabasis [Member]",
        "terseLabel": "Contingent liabilities - Metabasis"
       }
      }
     },
     "localname": "LiabilityForContingentValueRightsCompanyMetabasisMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability for Restricted Investments Owed to Former Licensees [Member]",
        "label": "Liability for Restricted Investments Owed to Former Licensees [Member]",
        "terseLabel": "Liability for restricted investments owed to former licensees"
       }
      }
     },
     "localname": "LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LicenseFeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License Fees",
        "label": "License Fees [Member]",
        "terseLabel": "License Fees"
       }
      }
     },
     "localname": "LicenseFeesMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRoyaltyRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LicenseFeesMilestonesAndOtherProductOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License Fees, Milestones, and Other Product, Other",
        "label": "License Fees, Milestones, and Other Product, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "LicenseFeesMilestonesAndOtherProductOtherMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRoyaltyRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LicenseUpfrontPayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License Upfront Payment",
        "label": "License Upfront Payment",
        "terseLabel": "Upfront payment for license"
       }
      }
     },
     "localname": "LicenseUpfrontPayment",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LigandCoreBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ligand Core Business",
        "label": "Ligand Core Business [Member]",
        "terseLabel": "Ligand Core Business"
       }
      }
     },
     "localname": "LigandCoreBusinessMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MaterialSalesCaptisolCOVIDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Material Sales, Captisol, COVID",
        "label": "Material Sales, Captisol, COVID [Member]",
        "terseLabel": "Captisol - COVID"
       }
      }
     },
     "localname": "MaterialSalesCaptisolCOVIDMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRoyaltyRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MaterialSalesCaptisolCoreMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Material Sales, Captisol, Core",
        "label": "Material Sales, Captisol, Core [Member]",
        "terseLabel": "Captisol - Core"
       }
      }
     },
     "localname": "MaterialSalesCaptisolCoreMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRoyaltyRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MaterialSalesCaptisolMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Material Sales, Captisol [Member]",
        "label": "Material Sales, Captisol [Member]",
        "terseLabel": "Captisol"
       }
      }
     },
     "localname": "MaterialSalesCaptisolMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRoyaltyRevenueDetails",
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MaturityPeriodOfHighlyLiquidSecuritiesMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maturity period of highly liquid securities maximum.",
        "label": "Maturity Period Of Highly Liquid Securities Maximum",
        "terseLabel": "Maturity period of cash and cash equivalents, maximum"
       }
      }
     },
     "localname": "MaturityPeriodOfHighlyLiquidSecuritiesMaximum",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lgnd_MetabasisTherapeuticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Metabasis Therapeutics [Member]",
        "label": "Metabasis Therapeutics [Member]",
        "terseLabel": "Metabasis Therapeutics",
        "verboseLabel": "Metabasis"
       }
      }
     },
     "localname": "MetabasisTherapeuticsMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsContingentLiabilitiesDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MilestoneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone",
        "label": "Milestone [Member]",
        "terseLabel": "Milestone"
       }
      }
     },
     "localname": "MilestoneMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRoyaltyRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Cash Provided by (Used in) Discontinued Operations, Investing Actives",
        "label": "Net Cash Provided by (Used in) Discontinued Operations, Investing Actives [Abstract]",
        "terseLabel": "Investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInDiscontinuedOperationsInvestingActivesAbstract",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Cash Provided by (Used in) Discontinued Operations, Operating Activities",
        "label": "Net Cash Provided by (Used in) Discontinued Operations, Operating Activities [Abstract]",
        "terseLabel": "Operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInDiscontinuedOperationsOperatingActivitiesAbstract",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Cash Change In Estimated Fair Value Of Contingent Value Rights.",
        "label": "Non-Cash Change In Estimated Fair Value Of Contingent Value Rights",
        "negatedLabel": "Change in estimated fair value of contingent liabilities"
       }
      }
     },
     "localname": "NonCashChangeInEstimatedFairValueOfContingentValueRights",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes Repurchased During Current Period, Two",
        "label": "Notes Repurchased During Current Period, Two [Member]",
        "terseLabel": "Notes Repurchased During Current Period, Two"
       }
      }
     },
     "localname": "NotesRepurchasedDuringCurrentPeriodTwoMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_NovanMolluscumProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Novan Molluscum Products",
        "label": "Novan Molluscum Products [Member]",
        "terseLabel": "Novan"
       }
      }
     },
     "localname": "NovanMolluscumProductsMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_NumberOfAcquisitions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Acquisitions",
        "label": "Number of Acquisitions",
        "terseLabel": "Number of acquisitions"
       }
      }
     },
     "localname": "NumberOfAcquisitions",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_NumberOfContingentValueRightAgreements": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Contingent Value Right Agreements",
        "label": "Number Of Contingent Value Right Agreements",
        "terseLabel": "Number of CVR agreements"
       }
      }
     },
     "localname": "NumberOfContingentValueRightAgreements",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_NumberOfContingentValueRightsIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Contingent Value Rights Issued",
        "label": "Number of Contingent Value Rights Issued",
        "terseLabel": "Number of contingent value rights"
       }
      }
     },
     "localname": "NumberOfContingentValueRightsIssued",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_NumberOfOptionsUnderConvertibleBondHedges": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Options under Convertible Bond Hedges",
        "label": "Number of Options under Convertible Bond Hedges",
        "terseLabel": "Number of options under convertible bond hedges"
       }
      }
     },
     "localname": "NumberOfOptionsUnderConvertibleBondHedges",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_NumberOfSharesSoldOfEquityMethodInvestee": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Shares Sold Of Equity Method Investee",
        "label": "Number Of Shares Sold Of Equity Method Investee",
        "terseLabel": "Stock sold of equity method investee (in shares)"
       }
      }
     },
     "localname": "NumberOfSharesSoldOfEquityMethodInvestee",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/ShorttermInvestmentsInvestmentinVikingNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "lgnd_OmniabSeparationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Omniab Separation",
        "label": "Omniab Separation [Member]",
        "terseLabel": "Omniab Separation"
       }
      }
     },
     "localname": "OmniabSeparationMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_OtherBalanceSheetDetailsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Balance Sheet Details [Abstract]",
        "label": "Other Balance Sheet Details [Abstract]"
       }
      }
     },
     "localname": "OtherBalanceSheetDetailsAbstract",
     "nsuri": "http://www.ligand.com/20221231",
     "xbrltype": "stringItemType"
    },
    "lgnd_PalvellaTherapeuticsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Palvella Therapeutics, Inc.",
        "label": "Palvella Therapeutics, Inc. [Member]",
        "terseLabel": "Palvella"
       }
      }
     },
     "localname": "PalvellaTherapeuticsIncMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_PartnerAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Partner A [Member]",
        "label": "Partner A [Member]",
        "terseLabel": "Partner A"
       }
      }
     },
     "localname": "PartnerAMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuefromSignificantPartnersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_PartnerBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Partner B [Member]",
        "label": "Partner B [Member]",
        "terseLabel": "Partner B"
       }
      }
     },
     "localname": "PartnerBMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuefromSignificantPartnersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_PartnerCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Partner C [Member]",
        "label": "Partner C [Member]",
        "terseLabel": "Partner C"
       }
      }
     },
     "localname": "PartnerCMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuefromSignificantPartnersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_PaymentsForSeparation": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For Separation",
        "label": "Payments For Separation",
        "negatedTerseLabel": "Net cash transferred to OmniAb at separation"
       }
      }
     },
     "localname": "PaymentsForSeparation",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Acquire Businesses, Gross, Attributable to Vested Portion of Stock Options",
        "label": "Payments to Acquire Businesses, Gross, Attributable to Vested Portion of Stock Options",
        "terseLabel": "Gross payments to acquire business attributable to vested portion of stock options"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PaymentsToContingentValueRightHolders": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to contingent value right holders",
        "label": "Payments to Contingent Value Right Holders",
        "negatedLabel": "Payments to CVR holders and other contingency payments",
        "negatedTerseLabel": "Payments"
       }
      }
     },
     "localname": "PaymentsToContingentValueRightHolders",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsContingentLiabilitiesDetails",
      "http://www.ligand.com/role/FairValueMeasurementReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PaymentsToContingentValueRightHoldersFinancingActivity": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Contingent Value Right Holders, Financing Activity",
        "label": "Payments to Contingent Value Right Holders, Financing Activity",
        "negatedLabel": "Payments to CVR Holders",
        "negatedTerseLabel": "Payments to CVR Holders"
       }
      }
     },
     "localname": "PaymentsToContingentValueRightHoldersFinancingActivity",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PaymentsToContingentValueRightHoldersInvestingActivity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Contingent Value Right Holders, Investing Activity",
        "label": "Payments to Contingent Value Right Holders, Investing Activity",
        "negatedTerseLabel": "Payments to CVR Holders"
       }
      }
     },
     "localname": "PaymentsToContingentValueRightHoldersInvestingActivity",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PaymentsToUnwindWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Unwind Warrants",
        "label": "Payments to Unwind Warrants",
        "terseLabel": "Payments to unwind warrants"
       }
      }
     },
     "localname": "PaymentsToUnwindWarrants",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PaymentsforConvertibleBondHedges": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for Convertible Bond Hedges",
        "label": "Payments for Convertible Bond Hedges",
        "terseLabel": "Payments for convertible bond hedges"
       }
      }
     },
     "localname": "PaymentsforConvertibleBondHedges",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PfenexMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pfenex",
        "label": "Pfenex [Member]",
        "terseLabel": "Pfenex"
       }
      }
     },
     "localname": "PfenexMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.ligand.com/role/AcquisitionsIntangiblesAcquiredandWeightedAverageUsefulLifeDetails",
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails",
      "http://www.ligand.com/role/BalanceSheetAccountDetailsContingentLiabilitiesDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_Phase3ClinicalTrialMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Phase 3 Clinical Trial",
        "label": "Phase 3 Clinical Trial [Member]",
        "terseLabel": "Phase 3 Clinical Trial"
       }
      }
     },
     "localname": "Phase3ClinicalTrialMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ProceedsFromCommercialLicenseRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from Commercial License Rights",
        "label": "Proceeds from Commercial License Rights",
        "terseLabel": "Proceeds from commercial license rights"
       }
      }
     },
     "localname": "ProceedsFromCommercialLicenseRights",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_ProceedsFromUnwindingConvertibleBondHedges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from Unwinding Convertible Bond Hedges",
        "label": "Proceeds from Unwinding Convertible Bond Hedges",
        "terseLabel": "Proceeds from unwinding convertible bond hedges"
       }
      }
     },
     "localname": "ProceedsFromUnwindingConvertibleBondHedges",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_ProductRoyaltyPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product Royalty Percentage",
        "label": "Product Royalty Percentage",
        "terseLabel": "Product royalty (as a percent)"
       }
      }
     },
     "localname": "ProductRoyaltyPercentage",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lgnd_PurchaseCommitmentConsiderationPaidAllocatedToInventory": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase Commitment, Consideration Paid, Allocated to Inventory",
        "label": "Purchase Commitment, Consideration Paid, Allocated to Inventory",
        "terseLabel": "Portion of consideration allocated to inventory"
       }
      }
     },
     "localname": "PurchaseCommitmentConsiderationPaidAllocatedToInventory",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PurchaseCommitmentConsiderationPaidToDate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase Commitment, Consideration Paid to Date",
        "label": "Purchase Commitment, Consideration Paid to Date",
        "terseLabel": "Consideration paid to date"
       }
      }
     },
     "localname": "PurchaseCommitmentConsiderationPaidToDate",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_RepaymentsOfNotesPayableInterestPortion": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayments Of Notes Payable, Interest Portion",
        "label": "Repayments Of Notes Payable, Interest Portion",
        "terseLabel": "Accrued interest portion of repurchased amount of debt instrument"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayableInterestPortion",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_RestrictedStockUnitsAndPerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Units and Performance Shares",
        "label": "Restricted Stock Units and Performance Shares [Member]",
        "terseLabel": "RSUs and PSUs"
       }
      }
     },
     "localname": "RestrictedStockUnitsAndPerformanceSharesMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_RoyaltyAgreementExpirationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty Agreement, Expiration Period",
        "label": "Royalty Agreement, Expiration Period",
        "terseLabel": "Expiration period of royalty agreement"
       }
      }
     },
     "localname": "RoyaltyAgreementExpirationPeriod",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lgnd_RoyaltyEvomelaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty, Evomela",
        "label": "Royalty, Evomela [Member]",
        "terseLabel": "Evomela"
       }
      }
     },
     "localname": "RoyaltyEvomelaMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRoyaltyRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_RoyaltyKyprolisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty, Kyprolis",
        "label": "Royalty, Kyprolis [Member]",
        "terseLabel": "Kyprolis"
       }
      }
     },
     "localname": "RoyaltyKyprolisMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRoyaltyRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_RoyaltyOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty, Other",
        "label": "Royalty, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "RoyaltyOtherMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRoyaltyRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_RoyaltyRylazeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty, Rylaze",
        "label": "Royalty, Rylaze [Member]",
        "terseLabel": "Rylaze"
       }
      }
     },
     "localname": "RoyaltyRylazeMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRoyaltyRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_RoyaltyTeriparatideInjectionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty, Teriparatide Injection",
        "label": "Royalty, Teriparatide Injection [Member]",
        "terseLabel": "Teriparatide injection"
       }
      }
     },
     "localname": "RoyaltyTeriparatideInjectionMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRoyaltyRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_SaleOfStockAuthorizedOfferingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Authorized Offering Amount",
        "label": "Sale Of Stock, Authorized Offering Amount",
        "terseLabel": "Sale of stock, authorized offering amount"
       }
      }
     },
     "localname": "SaleOfStockAuthorizedOfferingAmount",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_ScheduleofCommercialLicenseRightsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Commercial License Rights [Table Text Block]",
        "label": "Schedule of Commercial License Rights [Table Text Block]",
        "terseLabel": "Schedule of Commercial License Rights"
       }
      }
     },
     "localname": "ScheduleofCommercialLicenseRightsTableTextBlock",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_ScheduleofContingentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Contingent Liabilities [Table Text Block]",
        "label": "Schedule of Contingent Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Contingent Liabilities"
       }
      }
     },
     "localname": "ScheduleofContingentLiabilitiesTableTextBlock",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsTables",
      "http://www.ligand.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_SelexisAndDianomiMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Selexis and Dianomi",
        "label": "Selexis and Dianomi [Member]",
        "terseLabel": "Selexis and Dianomi"
       }
      }
     },
     "localname": "SelexisAndDianomiMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_SelexisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Selexis",
        "label": "Selexis [Member]",
        "terseLabel": "Selexis"
       }
      }
     },
     "localname": "SelexisMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_TwoThousandTwoStockIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand two Stock Incentive Plan.",
        "label": "Two thousand Two Stock Incentive Plan [Member]",
        "terseLabel": "2002 Stock Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandTwoStockIncentivePlanMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_VernalisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vernalis",
        "label": "Vernalis [Member]",
        "terseLabel": "Vernalis"
       }
      }
     },
     "localname": "VernalisMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_VestingPeriodOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting Period One [Member]",
        "label": "Vesting Period One [Member]",
        "terseLabel": "Vest 1/8 on the six month anniversary of the date of grant"
       }
      }
     },
     "localname": "VestingPeriodOneMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_VestingPeriodTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting Period Two [Member]",
        "label": "Vesting Period Two [Member]",
        "terseLabel": "Vest 1/48 each month for forty-two months"
       }
      }
     },
     "localname": "VestingPeriodTwoMember",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_VikingTherapeuticsInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Viking Therapeutics, Inc. [Member]",
        "label": "Viking Therapeutics, Inc. [Member]",
        "terseLabel": "Viking Therapeutics, Inc."
       }
      }
     },
     "localname": "VikingTherapeuticsInc.Member",
     "nsuri": "http://www.ligand.com/20221231",
     "presentation": [
      "http://www.ligand.com/role/ShorttermInvestmentsInvestmentinVikingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r331",
      "r332",
      "r476",
      "r505",
      "r791",
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember": {
     "auth_ref": [
      "r843",
      "r864",
      "r866",
      "r878",
      "r923",
      "r924",
      "r925",
      "r931",
      "r932",
      "r936",
      "r937",
      "r938",
      "r945"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjusted Balance [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjusted Balance"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r281",
      "r337",
      "r344",
      "r350",
      "r417",
      "r577",
      "r578",
      "r579",
      "r608",
      "r609",
      "r644",
      "r647",
      "r649",
      "r650",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r281",
      "r337",
      "r344",
      "r350",
      "r417",
      "r577",
      "r578",
      "r579",
      "r608",
      "r609",
      "r644",
      "r647",
      "r649",
      "r650",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r281",
      "r337",
      "r344",
      "r350",
      "r417",
      "r577",
      "r578",
      "r579",
      "r608",
      "r609",
      "r644",
      "r647",
      "r649",
      "r650",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r395",
      "r809",
      "r893",
      "r961"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuefromSignificantPartnersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r460",
      "r461",
      "r462",
      "r463",
      "r542",
      "r744",
      "r765",
      "r786",
      "r787",
      "r806",
      "r819",
      "r827",
      "r889",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsIntangiblesAcquiredandWeightedAverageUsefulLifeDetails",
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BalanceSheetAccountDetailsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/LeasesNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r460",
      "r461",
      "r462",
      "r463",
      "r542",
      "r744",
      "r765",
      "r786",
      "r787",
      "r806",
      "r819",
      "r827",
      "r889",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsIntangiblesAcquiredandWeightedAverageUsefulLifeDetails",
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BalanceSheetAccountDetailsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r395",
      "r809",
      "r893",
      "r961"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuefromSignificantPartnersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/ShorttermInvestmentsInvestmentinVikingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/ShorttermInvestmentsInvestmentinVikingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r393",
      "r747",
      "r807",
      "r826",
      "r884",
      "r885",
      "r893",
      "r960"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRoyaltyRevenueDetails",
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/LeasesNarrativeDetails",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r393",
      "r747",
      "r807",
      "r826",
      "r884",
      "r885",
      "r893",
      "r960"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRoyaltyRevenueDetails",
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/LeasesNarrativeDetails",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r460",
      "r461",
      "r462",
      "r463",
      "r535",
      "r542",
      "r571",
      "r572",
      "r573",
      "r717",
      "r744",
      "r765",
      "r786",
      "r787",
      "r806",
      "r819",
      "r827",
      "r883",
      "r889",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsIntangiblesAcquiredandWeightedAverageUsefulLifeDetails",
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BalanceSheetAccountDetailsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/LeasesNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r460",
      "r461",
      "r462",
      "r463",
      "r535",
      "r542",
      "r571",
      "r572",
      "r573",
      "r717",
      "r744",
      "r765",
      "r786",
      "r787",
      "r806",
      "r819",
      "r827",
      "r883",
      "r889",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsIntangiblesAcquiredandWeightedAverageUsefulLifeDetails",
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BalanceSheetAccountDetailsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/LeasesNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r331",
      "r332",
      "r476",
      "r505",
      "r792",
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201613Member": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-13 Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.",
        "label": "Accounting Standards Update 2016-13 [Member]",
        "terseLabel": "Accounting Standards Update 2016-13"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201613Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate202006Member": {
     "auth_ref": [
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2020-06 Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity.",
        "label": "Accounting Standards Update 2020-06 [Member]",
        "terseLabel": "Accounting Standards Update 2020-06"
       }
      }
     },
     "localname": "AccountingStandardsUpdate202006Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r338",
      "r339",
      "r340",
      "r399",
      "r400",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r577",
      "r578",
      "r579",
      "r608",
      "r609",
      "r625",
      "r626",
      "r627",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r679",
      "r680",
      "r684",
      "r685",
      "r686",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r865"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "terseLabel": "Accounting Standards Update [Extensible List]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r44",
      "r825"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r396",
      "r397"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedTerseLabel": "Amortization/accretion of premium (discount) on investments, net"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "totalLabel": "Accrued liabilities",
        "verboseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAccruedLiabilitiesDetails",
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAccruedLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedRoyaltiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r247",
      "r269"
     ],
     "calculation": {
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAccruedLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties.",
        "label": "Accrued Royalties",
        "terseLabel": "Royalties owed to third parties"
       }
      }
     },
     "localname": "AccruedRoyaltiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalesCommissionCurrentAndNoncurrent": {
     "auth_ref": [
      "r32",
      "r34",
      "r241",
      "r262"
     ],
     "calculation": {
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAccruedLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions.",
        "label": "Accrued Sales Commission",
        "terseLabel": "Amounts owed to former licensees"
       }
      }
     },
     "localname": "AccruedSalesCommissionCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r138",
      "r293"
     ],
     "calculation": {
      "http://www.ligand.com/role/BalanceSheetAccountDetailsPropertyandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r56",
      "r57",
      "r58",
      "r299",
      "r761",
      "r773",
      "r777"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r55",
      "r58",
      "r213",
      "r710",
      "r768",
      "r769",
      "r848",
      "r849",
      "r850",
      "r861",
      "r862",
      "r863"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "verboseLabel": "Estimated useful life (in years)"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsIntangiblesAcquiredandWeightedAverageUsefulLifeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r39",
      "r825"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r577",
      "r578",
      "r579",
      "r861",
      "r862",
      "r863",
      "r937"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r338",
      "r339",
      "r340",
      "r341",
      "r350",
      "r399",
      "r400",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r577",
      "r578",
      "r579",
      "r606",
      "r607",
      "r608",
      "r609",
      "r625",
      "r626",
      "r627",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r679",
      "r680",
      "r684",
      "r685",
      "r686",
      "r687",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r749",
      "r750",
      "r751",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt": {
     "auth_ref": [
      "r148"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.",
        "label": "Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt",
        "negatedTerseLabel": "Reduction to additional paid in capital",
        "terseLabel": "Reacquisition of equity due to 2023 debt extinguishment, net of tax"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).",
        "label": "Adjustments to Additional Paid in Capital, Other",
        "terseLabel": "Other tax adjustments"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r178",
      "r179",
      "r544"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "auth_ref": [
      "r147",
      "r155",
      "r161"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.",
        "label": "Adjustments to Additional Paid in Capital, Warrant Issued",
        "negatedTerseLabel": "Warrant derivative"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Expense, after Tax",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpenseNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityShareBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r65",
      "r495",
      "r682",
      "r856"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r495",
      "r682",
      "r804",
      "r805",
      "r856"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of debt discount and issuance fees"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Potentially dilutive shares excluded from calculation due to anti-dilutive effect (shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCalculationofEarningsperShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r88",
      "r134"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Asset impairment charges"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r238",
      "r261",
      "r297",
      "r328",
      "r380",
      "r385",
      "r391",
      "r412",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r632",
      "r637",
      "r663",
      "r825",
      "r887",
      "r888",
      "r946"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets",
        "verboseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r288",
      "r303",
      "r328",
      "r412",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r632",
      "r637",
      "r663",
      "r825",
      "r887",
      "r888",
      "r946"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "verboseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r221"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "verboseLabel": "Assets, fair value"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r0",
      "r1",
      "r22",
      "r140",
      "r286",
      "r287"
     ],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails": {
       "order": 1.0,
       "parentTag": "lgnd_DisposalGroupIncludingDiscontinuedOperationNetAssetsTransferred",
       "weight": 1.0
      },
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r22",
      "r135",
      "r140",
      "r286",
      "r287"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Current",
        "terseLabel": "Current assets of discontinued operations",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposal Group, Including Discontinued Operation, Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.ligand.com/role/BalanceSheetAccountDetailsInvestmentCategoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross unrealized gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.ligand.com/role/BalanceSheetAccountDetailsInvestmentCategoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Gross unrealized losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r402",
      "r425"
     ],
     "calculation": {
      "http://www.ligand.com/role/BalanceSheetAccountDetailsInvestmentCategoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "totalLabel": "Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "After one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r119",
      "r404",
      "r759"
     ],
     "calculation": {
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "After one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate": {
     "auth_ref": [
      "r870",
      "r871",
      "r958"
     ],
     "calculation": {
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.",
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r119",
      "r403",
      "r758"
     ],
     "calculation": {
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r116",
      "r401",
      "r425",
      "r754"
     ],
     "calculation": {
      "http://www.ligand.com/role/BalanceSheetAccountDetailsInvestmentCategoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Estimated fair value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Number of Positions [Abstract]",
        "terseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r546",
      "r547",
      "r548",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCalculationofEarningsperShareDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r623",
      "r817",
      "r818"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.ligand.com/role/AcquisitionsIntangiblesAcquiredandWeightedAverageUsefulLifeDetails",
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails",
      "http://www.ligand.com/role/BalanceSheetAccountDetailsContingentLiabilitiesDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r194",
      "r195",
      "r623",
      "r817",
      "r818"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.ligand.com/role/AcquisitionsIntangiblesAcquiredandWeightedAverageUsefulLifeDetails",
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails",
      "http://www.ligand.com/role/BalanceSheetAccountDetailsContingentLiabilitiesDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.",
        "label": "Business Acquisition, Transaction Costs",
        "terseLabel": "Post-combination expense"
       }
      }
     },
     "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.ligand.com/role/AcquisitionsIntangiblesAcquiredandWeightedAverageUsefulLifeDetails",
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails",
      "http://www.ligand.com/role/BalanceSheetAccountDetailsContingentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic": {
     "auth_ref": [
      "r934",
      "r935"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Earnings Per Share, Basic",
        "terseLabel": "Basic (USD per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted": {
     "auth_ref": [
      "r934",
      "r935"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Earnings Per Share, Diluted",
        "terseLabel": "Diluted (USD per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r934",
      "r935"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Schedule of Pro Forma Information"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r621",
      "r622"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Net Income (loss)"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r621",
      "r622"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r192"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Acquisition-related costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r206",
      "r207",
      "r209"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Consideration transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r630",
      "r855"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "negatedTerseLabel": "Reduction in contingent liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r205",
      "r208",
      "r629"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "auth_ref": [
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure contingent consideration liability from business combination.",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "terseLabel": "Contingent consideration liability, measurement input (as a percent)"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r210",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/Acquisitions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationIntegrationRelatedCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.",
        "label": "Business Combination, Integration Related Costs",
        "terseLabel": "Integration related costs"
       }
      }
     },
     "localname": "BusinessCombinationIntegrationRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual": {
     "auth_ref": [
      "r193"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.",
        "label": "Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual",
        "negatedTerseLabel": "Income before income taxes of acquiree since acquisition date included in comprehensive income"
       }
      }
     },
     "localname": "BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual": {
     "auth_ref": [
      "r193"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.",
        "label": "Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual",
        "terseLabel": "Revenue of acquiree since acquisition date included in comprehensive income"
       }
      }
     },
     "localname": "BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r197"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "verboseLabel": "Cash"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r197"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Accounts and unbilled receivables"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r197"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "negatedTerseLabel": "Accounts payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": {
     "auth_ref": [
      "r197"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue",
        "negatedLabel": "Deferred revenue"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r197"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedLabel": "Deferred tax liabilities, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r197"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Approximate Fair Value"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsIntangiblesAcquiredandWeightedAverageUsefulLifeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r196",
      "r197"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "totalLabel": "Total consideration"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r197"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "negatedLabel": "Other liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r197"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 14.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r196",
      "r197"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalExpenditureDiscontinuedOperations": {
     "auth_ref": [
      "r21"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of capital expenditure attributable to discontinued operations.",
        "label": "Capital Expenditure, Discontinued Operations",
        "negatedTerseLabel": "Purchase of property, plant and equipment"
       }
      }
     },
     "localname": "CapitalExpenditureDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r92",
      "r93",
      "r94"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Purchase of fixed assets recorded in accounts payable"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalLossCarryforwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deductions derived from capital losses that cannot be utilized on the tax return during a period that have been carried forward to reduce taxable income or taxes payable in a future year.",
        "label": "Capital Loss Carryforward [Member]",
        "terseLabel": "Capital Loss Carryforward"
       }
      }
     },
     "localname": "CapitalLossCarryforwardMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r90",
      "r291",
      "r788"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r83",
      "r90",
      "r95"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of year",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of year"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r83",
      "r231"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Supplemental schedule of non-cash investing and financing activities:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Exercise price of warrants (USD per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ShorttermInvestmentsInvestmentinVikingNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "terseLabel": "Warrants issued in public offering (shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails",
      "http://www.ligand.com/role/BalanceSheetAccountDetailsInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r52",
      "r248",
      "r267"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "verboseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r144",
      "r458",
      "r459",
      "r783",
      "r886"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitment and Contingencies: Legal Proceedings"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividend declared (USD per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r861",
      "r862",
      "r937"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "verboseLabel": "Common stock, par value (USD per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "verboseLabel": "Common stock authorized (shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "verboseLabel": "Common stock issued (shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r38",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock outstanding (shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r38",
      "r825"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock, $0.001 par value; 60,000 shares authorized; 16,951 and 16,767 shares issued and outstanding at December\u00a031, 2022 and 2021, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r59",
      "r308",
      "r310",
      "r316",
      "r755",
      "r762"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r105",
      "r106",
      "r228",
      "r229",
      "r395",
      "r782"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuefromSignificantPartnersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r105",
      "r106",
      "r228",
      "r229",
      "r395",
      "r778",
      "r782"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuefromSignificantPartnersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r105",
      "r106",
      "r228",
      "r229",
      "r395",
      "r782",
      "r963"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuefromSignificantPartnersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r256",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "verboseLabel": "Concentrations of Business Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r105",
      "r106",
      "r228",
      "r229",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Total revenues (as a percent)"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuefromSignificantPartnersDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r105",
      "r106",
      "r228",
      "r229",
      "r395",
      "r782"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuefromSignificantPartnersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetGross": {
     "auth_ref": [
      "r398",
      "r422",
      "r891",
      "r892"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer, when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, before Allowance for Credit Loss",
        "terseLabel": "Gross contract asset"
       }
      }
     },
     "localname": "ContractWithCustomerAssetGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r520",
      "r521",
      "r532"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r533"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Revenue recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualRightsMember": {
     "auth_ref": [
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights that arise from a contractual arrangement with a third party (not including franchise rights and license agreements).",
        "label": "Contractual Rights [Member]",
        "terseLabel": "Contractual relationships"
       }
      }
     },
     "localname": "ContractualRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsGoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtCurrent": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Convertible Debt, Current",
        "terseLabel": "2023 convertible senior notes, net"
       }
      }
     },
     "localname": "ConvertibleDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtFairValueDisclosures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt, Fair Value Disclosures",
        "verboseLabel": "Fair value of convertible senior notes outstanding (Level 2)"
       }
      }
     },
     "localname": "ConvertibleDebtFairValueDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesEquityandLiabilityComponentsofFinancingArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtNoncurrent": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Convertible Debt, Noncurrent",
        "verboseLabel": "2023 convertible senior notes, net"
       }
      }
     },
     "localname": "ConvertibleDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleNotesPayable": {
     "auth_ref": [
      "r33",
      "r242",
      "r263",
      "r276"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.",
        "label": "Convertible Notes Payable",
        "negatedTerseLabel": "Increase in carrying amount of notes"
       }
      }
     },
     "localname": "ConvertibleNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleNotesPayableMember": {
     "auth_ref": [
      "r31",
      "r239",
      "r258",
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.",
        "label": "Convertible Notes Payable [Member]",
        "terseLabel": "Convertible Notes"
       }
      }
     },
     "localname": "ConvertibleNotesPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesEquityandLiabilityComponentsofFinancingArrangementsDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r814",
      "r816",
      "r962"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate bonds"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails",
      "http://www.ligand.com/role/BalanceSheetAccountDetailsInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostDirectMaterial": {
     "auth_ref": [
      "r851"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of material used for good produced and service rendered.",
        "label": "Cost, Direct Material",
        "terseLabel": "Cost of Captisol"
       }
      }
     },
     "localname": "CostDirectMaterial",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldAmortization": {
     "auth_ref": [
      "r851"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.",
        "label": "Cost, Amortization",
        "terseLabel": "Amortization of intangibles"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsNarrativeDetails",
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r860",
      "r929",
      "r933"
     ],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r860",
      "r929"
     ],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r190",
      "r603",
      "r613",
      "r860"
     ],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current expense (benefit)"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current expense (benefit):"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r860",
      "r929",
      "r933"
     ],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r104",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuefromSignificantPartnersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships",
        "verboseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BalanceSheetAccountDetailsGoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r154",
      "r326",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r489",
      "r496",
      "r497",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Convertible Senior Notes"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r31",
      "r32",
      "r33",
      "r239",
      "r242",
      "r258",
      "r333",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r479",
      "r485",
      "r486",
      "r487",
      "r488",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r683",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r858"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesEquityandLiabilityComponentsofFinancingArrangementsDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r33",
      "r242",
      "r258",
      "r500"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Outstanding principal amount of debt"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r150",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Debt conversion price per share (USD per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r49",
      "r156",
      "r157",
      "r159",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Convertible debt conversion ratio"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining amortization period for discount on the liability component of convertible debt which may be settled in cash upon conversion, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Convertible, Remaining Discount Amortization Period",
        "terseLabel": "Amortization period"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "terseLabel": "Number of consecutive trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.",
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Stock price trigger to classify convertible debt as current (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Trading Days",
        "terseLabel": "Number of trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdTradingDays",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r233",
      "r236",
      "r473",
      "r683",
      "r802",
      "r803"
     ],
     "calculation": {
      "http://www.ligand.com/role/ConvertibleSeniorNotesEquityandLiabilityComponentsofFinancingArrangementsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermNotesPayable",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Principal amount of 2023 Notes outstanding"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesEquityandLiabilityComponentsofFinancingArrangementsDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r48",
      "r233",
      "r501",
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r48",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest on debt instrument (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesEquityandLiabilityComponentsofFinancingArrangementsDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r50",
      "r333",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r479",
      "r485",
      "r486",
      "r487",
      "r488",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r683",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r858"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesEquityandLiabilityComponentsofFinancingArrangementsDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "auth_ref": [
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "terseLabel": "Redemption Period One"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "auth_ref": [
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "terseLabel": "Redemption Period Two"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRepurchaseAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value amount of debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchase Amount",
        "terseLabel": "Repurchased amount of debt instrument"
       }
      }
     },
     "localname": "DebtInstrumentRepurchaseAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r50",
      "r156",
      "r158",
      "r159",
      "r160",
      "r232",
      "r233",
      "r236",
      "r255",
      "r333",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r479",
      "r485",
      "r486",
      "r487",
      "r488",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r498",
      "r683",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r858"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesEquityandLiabilityComponentsofFinancingArrangementsDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r232",
      "r236",
      "r890"
     ],
     "calculation": {
      "http://www.ligand.com/role/ConvertibleSeniorNotesEquityandLiabilityComponentsofFinancingArrangementsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermNotesPayable",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedTerseLabel": "Unamortized discount (including unamortized debt issuance cost)"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesEquityandLiabilityComponentsofFinancingArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": {
     "auth_ref": [
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r890"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount (premium).",
        "label": "Debt Instrument, Unamortized Discount (Premium), Net",
        "terseLabel": "Unamortized discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedPremium": {
     "auth_ref": [
      "r232",
      "r236",
      "r890"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt premium.",
        "label": "Debt Instrument, Unamortized Premium",
        "terseLabel": "Debt issuance costs related to the liability component of convertible debt"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedPremium",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "auth_ref": [
      "r410",
      "r430",
      "r799"
     ],
     "calculation": {
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "terseLabel": "12 months or greater"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r410",
      "r430",
      "r799"
     ],
     "calculation": {
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "terseLabel": "Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "auth_ref": [
      "r410",
      "r430"
     ],
     "calculation": {
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "negatedTerseLabel": "Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsInvestmentCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r873"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table Text Block]",
        "terseLabel": "Schedule of Available-for-Sale Debt Securities by Contractual Maturity"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Unrealized Gain (Loss)",
        "terseLabel": "Unrealized net gain (loss) on available-for-sale securities, net of deferred tax"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": {
     "auth_ref": [
      "r408",
      "r427",
      "r799"
     ],
     "calculation": {
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable": {
     "auth_ref": [
      "r426",
      "r799"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table]",
        "terseLabel": "Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": {
     "auth_ref": [
      "r407",
      "r799",
      "r879"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Available-for-Sale Debt Securities in an Unrealized Loss Position"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": {
     "auth_ref": [
      "r409",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions",
        "terseLabel": "Number of positions in an unrealized loss position"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r860",
      "r930",
      "r933"
     ],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r234"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "terseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r586",
      "r587"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred income taxes, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r88",
      "r190",
      "r604",
      "r612",
      "r613",
      "r860"
     ],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "totalLabel": "Total deferred expense (benefit)"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred expense (benefit):"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r35",
      "r36",
      "r240",
      "r257",
      "r597"
     ],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesDeferredTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Net deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r586",
      "r587"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "negatedTerseLabel": "Decrease of deferred tax liabilities",
        "terseLabel": "Deferred income taxes, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r860",
      "r930",
      "r933"
     ],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r598"
     ],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesDeferredTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGrossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Gross [Abstract]",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsGrossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r927"
     ],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesDeferredTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Deferred income taxes, net"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r927"
     ],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesDeferredTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r188",
      "r928"
     ],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesDeferredTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r188",
      "r928"
     ],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesDeferredTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r186",
      "r188",
      "r928"
     ],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesDeferredTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "terseLabel": "Research credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r188",
      "r928"
     ],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesDeferredTaxesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "terseLabel": "Stock compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r599"
     ],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesDeferredTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Valuation allowance for deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r181",
      "r927"
     ],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesDeferredTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Deferred income taxes, net"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r188",
      "r928"
     ],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesDeferredTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DemandDepositsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts that may or may not bear interest and that depositor is entitled to withdraw at anytime without prior notice. Checking and negotiable order of withdrawal (NOW) accounts are the most common forms of demand deposits.",
        "label": "Demand Deposits [Member]",
        "terseLabel": "Bank deposits"
       }
      }
     },
     "localname": "DemandDepositsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails",
      "http://www.ligand.com/role/BalanceSheetAccountDetailsInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r88",
      "r136"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "verboseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortizationDiscontinuedOperations": {
     "auth_ref": [
      "r285",
      "r856"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deprecation and amortization expense attributable to property, plant and equipment and intangible assets of discontinued operations.",
        "label": "Depreciation and Amortization, Discontinued Operations",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortizationDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r88",
      "r375"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "verboseLabel": "Depreciation of fixed assets and amortization of intangible assets"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRoyaltyRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r531",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRoyaltyRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r893"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "auth_ref": [
      "r163",
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of share-based payment arrangement.",
        "label": "Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]",
        "terseLabel": "Schedule of Share-Based Compensation Expense"
       }
      }
     },
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax": {
     "auth_ref": [
      "r6",
      "r7",
      "r8",
      "r9",
      "r12",
      "r19",
      "r62",
      "r272"
     ],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax",
        "totalLabel": "Loss before income tax"
       }
      }
     },
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation": {
     "auth_ref": [
      "r7",
      "r8",
      "r9",
      "r12",
      "r19",
      "r24",
      "r588",
      "r611",
      "r616"
     ],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.",
        "label": "Discontinued Operation, Tax Effect of Discontinued Operation",
        "negatedTerseLabel": "Income tax benefit"
       }
      }
     },
     "localname": "DiscontinuedOperationTaxEffectOfDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationsPolicyTextBlock": {
     "auth_ref": [
      "r13",
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for discontinued operations. Includes, but is not limited to, method of interest allocation to a discontinued operation.",
        "label": "Discontinued Operations, Policy [Policy Text Block]",
        "terseLabel": "Discontinued Operations"
       }
      }
     },
     "localname": "DiscontinuedOperationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbNarrativeDetails",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbNarrativeDetails",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r22",
      "r133",
      "r140",
      "r286",
      "r287"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 9.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Noncurrent",
        "terseLabel": "Non-current assets of discontinued operations"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": {
     "auth_ref": [
      "r0",
      "r1",
      "r22",
      "r140"
     ],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r22",
      "r135",
      "r140"
     ],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as deferred revenue attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Deferred Revenue, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities": {
     "auth_ref": [
      "r0",
      "r1",
      "r22",
      "r140"
     ],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as deferred tax liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Deferred Tax Liabilities",
        "terseLabel": "Deferred income taxes, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of depreciation and amortization expense attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Depreciation and Amortization",
        "terseLabel": "Amortization of intangibles"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of general and administrative expense attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r22",
      "r133",
      "r140"
     ],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as goodwill attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Goodwill, Noncurrent",
        "terseLabel": "Intangible assets, net",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbNarrativeDetails",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r22",
      "r133",
      "r140"
     ],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Intangible Assets, Noncurrent",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense": {
     "auth_ref": [
      "r10",
      "r11",
      "r20",
      "r28"
     ],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails": {
       "order": 1.0,
       "parentTag": "lgnd_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Interest Expense",
        "negatedTerseLabel": "Interest expense"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Operating Expense",
        "totalLabel": "Total operating costs and expenses"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets": {
     "auth_ref": [
      "r0",
      "r1",
      "r22",
      "r135",
      "r140"
     ],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets": {
     "auth_ref": [
      "r0",
      "r1",
      "r22",
      "r133",
      "r140"
     ],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities": {
     "auth_ref": [
      "r0",
      "r1",
      "r22",
      "r133",
      "r140"
     ],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r22",
      "r133",
      "r140"
     ],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Noncurrent",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": {
     "auth_ref": [
      "r20",
      "r287"
     ],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Revenue",
        "terseLabel": "Total revenues"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r29",
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "Spin-off of OmniAb"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAb"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Domestic Tax Authority"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r317",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r351",
      "r353",
      "r356",
      "r357",
      "r358",
      "r360",
      "r650",
      "r651",
      "r756",
      "r763",
      "r796"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "totalLabel": "Basic net income (loss) per share (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r317",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r353",
      "r356",
      "r357",
      "r358",
      "r360",
      "r650",
      "r651",
      "r756",
      "r763",
      "r796"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "totalLabel": "Diluted net income (loss) per share (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]",
        "terseLabel": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareDilutedLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCalculationofEarningsperShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r98",
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "verboseLabel": "Income (Loss) Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareProFormaAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Pro Forma [Abstract]",
        "terseLabel": "Net income (loss) per common share:"
       }
      }
     },
     "localname": "EarningsPerShareProFormaAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount": {
     "auth_ref": [
      "r926"
     ],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reported income tax benefit from difference to expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to foreign-derived intangible income (FDII).",
        "label": "Effective Income Tax Rate Reconciliation, FDII, Amount",
        "negatedLabel": "FDII"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationFdiiAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount": {
     "auth_ref": [
      "r926"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to Tax Cuts and Jobs Act.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act, Amount",
        "terseLabel": "Increase to current federal income tax expense due to Tax Cuts and Jobs Act"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards": {
     "auth_ref": [
      "r576"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate cash paid by the entity during the period to settle equity instruments granted under equity-based payment arrangements.",
        "label": "Share-Based Payment Arrangement, Cash Used to Settle Award",
        "terseLabel": "Cash to settle unvested stock options recognized as share-based compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "verboseLabel": "Weighted-average period in which cost is expected to be recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r922"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "verboseLabel": "Unrecognized compensation cost, restricted stock"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r922"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "verboseLabel": "Unrecognized compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCalculationofEarningsperShareDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EntityWideRevenueMajorCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Major Customer [Line Items]",
        "terseLabel": "Revenue, Major Customer"
       }
      }
     },
     "localname": "EntityWideRevenueMajorCustomerLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuefromSignificantPartnersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r155",
      "r281",
      "r312",
      "r313",
      "r314",
      "r334",
      "r335",
      "r336",
      "r339",
      "r347",
      "r349",
      "r364",
      "r417",
      "r519",
      "r577",
      "r578",
      "r579",
      "r608",
      "r609",
      "r649",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r710",
      "r768",
      "r769",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r298",
      "r662",
      "r790"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Investment in Viking common stock"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ShorttermInvestmentsInvestmentinVikingNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiMeasurementInput": {
     "auth_ref": [
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Measurement Input",
        "terseLabel": "Measurement input (as a percent)"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r124",
      "r259",
      "r829",
      "r830",
      "r831"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Corporate equity securities",
        "verboseLabel": "Investment in Viking common stock (2)"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsInvestmentCategoriesDetails",
      "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAxis": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information pertaining to the debt extinguished including the amount of gain (loss), the income tax effect on the gain (loss), and the amount of gain (loss), net or the related income tax, by debt instrument.",
        "label": "Extinguishment of Debt [Axis]",
        "terseLabel": "Extinguishment of Debt [Axis]"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ExtinguishmentOfDebtTypeDomain": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of debt extinguished.",
        "label": "Extinguishment of Debt, Type [Domain]",
        "terseLabel": "Extinguishment of Debt, Type [Domain]"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r653",
      "r654",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "auth_ref": [
      "r221",
      "r222",
      "r223",
      "r226",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.",
        "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]",
        "terseLabel": "Schedule of Assets and Liabilities Measured at Fair Value"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Fair Value by Asset Class [Domain]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r221",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r487",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r654",
      "r714",
      "r715",
      "r716",
      "r802",
      "r803",
      "r814",
      "r815",
      "r816"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r225",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r653",
      "r654",
      "r656",
      "r657",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r487",
      "r536",
      "r541",
      "r654",
      "r714",
      "r814",
      "r815",
      "r816"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "verboseLabel": "Quoted Prices in Active Markets for Identical Assets (Level 1)"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r487",
      "r536",
      "r541",
      "r654",
      "r715",
      "r802",
      "r803",
      "r814",
      "r815",
      "r816"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "verboseLabel": "Significant Other Observable Inputs (Level 2)"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r487",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r654",
      "r716",
      "r802",
      "r803",
      "r814",
      "r815",
      "r816"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3",
        "verboseLabel": "Significant Unobservable Inputs (Level 3)"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r224",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Level 3 Financial Instruments"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Fair Value, Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r658"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "negatedTerseLabel": "Fair value adjustments to contingent liabilities"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r224"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Fair value of level 3 financial instruments at end of period",
        "periodStartLabel": "Fair value of level 3 financial instruments at beginning of period"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r487",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r714",
      "r715",
      "r716",
      "r802",
      "r803",
      "r814",
      "r815",
      "r816"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r659",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "verboseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList": {
     "auth_ref": [
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement in which net income is reported that includes gain (loss) from liability measured at fair value using unobservable input (level 3).",
        "label": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "terseLabel": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]"
       }
      }
     },
     "localname": "FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseImpairmentLoss": {
     "auth_ref": [
      "r688"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss from right-of-use asset from finance lease.",
        "label": "Finance Lease, Impairment Loss",
        "terseLabel": "Finance lease, impairment charges"
       }
      }
     },
     "localname": "FinanceLeaseImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r692",
      "r697",
      "r824"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Finance lease expense"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r694",
      "r699"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Cash paid for amounts included in finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid [Abstract]",
        "terseLabel": "Finance Leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r690",
      "r703"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r690"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "lgnd_LeaseLiabilityCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Current finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r944"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Schedule of Maturity of Finance Lease Liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r690"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "lgnd_LeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Long-term finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent finance lease liability.",
        "label": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r703"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r703"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r703"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r703"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r703"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r703"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r703"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r703"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less imputed interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r693",
      "r699"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedTerseLabel": "Payments under finance lease obligations"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r689"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "lgnd_LeaseRightOfUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance lease assets",
        "verboseLabel": "ROU asset"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesNarrativeDetails",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r702",
      "r824"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate of finance leases (as a percent)"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r701",
      "r824"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term of finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r405",
      "r406",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r429",
      "r431",
      "r432",
      "r498",
      "r516",
      "r639",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r799",
      "r874",
      "r875",
      "r876",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails",
      "http://www.ligand.com/role/BalanceSheetAccountDetailsInvestmentCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.",
        "label": "Financial Instruments Disclosure [Text Block]",
        "terseLabel": "Fair Value Measurement"
       }
      }
     },
     "localname": "FinancialInstrumentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "verboseLabel": "Finite-lived intangible asset, useful life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r295",
      "r451"
     ],
     "calculation": {
      "http://www.ligand.com/role/BalanceSheetAccountDetailsGoodwillandOtherIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Less: Accumulated amortization",
        "negatedTerseLabel": "Accumulated amortization on finite-lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsGoodwillandOtherIntangibleAssetsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r132"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "verboseLabel": "Estimated amortization expense for 2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r132"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Estimated amortization expense for 2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r132"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Estimated amortization expense for 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r132"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Estimated amortization expense for 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r449",
      "r450",
      "r451",
      "r452",
      "r748",
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsIntangiblesAcquiredandWeightedAverageUsefulLifeDetails",
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BalanceSheetAccountDetailsGoodwillandOtherIntangibleAssetsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r131",
      "r752"
     ],
     "calculation": {
      "http://www.ligand.com/role/BalanceSheetAccountDetailsGoodwillandOtherIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill",
       "weight": 1.0
      },
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Definite-lived intangible assets",
        "verboseLabel": "Gross"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsGoodwillandOtherIntangibleAssetsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsGoodwillandOtherIntangibleAssetsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r127",
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsIntangiblesAcquiredandWeightedAverageUsefulLifeDetails",
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BalanceSheetAccountDetailsGoodwillandOtherIntangibleAssetsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r131",
      "r748"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Finite-lived intangible assets, net",
        "totalLabel": "Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Non-US"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GainLossOnDispositionOfIntangibleAssets": {
     "auth_ref": [
      "r856"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of intangible assets.",
        "label": "Gain (Loss) on Disposition of Intangible Assets",
        "terseLabel": "Gain from sale of Vernalis R&amp;D"
       }
      }
     },
     "localname": "GainLossOnDispositionOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnInvestments": {
     "auth_ref": [
      "r69",
      "r115",
      "r842"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment.",
        "label": "Gain (Loss) on Investments",
        "terseLabel": "Gain (loss) from short-term investments"
       }
      }
     },
     "localname": "GainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r636",
      "r856"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "negatedTerseLabel": "Gain from sale of Vernalis R&amp;D"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r88",
      "r151",
      "r152"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss (gain) on debt extinguishment"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative",
        "verboseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SelectedQuarterlyFinancialDataUnauditedSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r294",
      "r437",
      "r753",
      "r800",
      "r825",
      "r880",
      "r881"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 10.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.ligand.com/role/BalanceSheetAccountDetailsGoodwillandOtherIntangibleAssetsDetails",
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/SpinoffofOmniAbNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r447",
      "r448",
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "terseLabel": "Goodwill, Intangible Assets and Other Long-Lived Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "auth_ref": [
      "r122",
      "r123"
     ],
     "calculation": {
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at amortized cost (held-to-maturity), in continuous loss position for 12 months or longer.",
        "label": "Debt Securities, Held-to-Maturity, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
        "negatedTerseLabel": "12 months or greater"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at amortized cost (held-to-maturity), in unrealized loss position.",
        "label": "Debt Securities, Held-to-Maturity, Unrealized Loss Position, Accumulated Loss",
        "negatedTotalLabel": "Total"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Held-to-Maturity, Unrealized Loss Position, Accumulated Loss [Abstract]",
        "terseLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis": {
     "auth_ref": [
      "r872",
      "r957"
     ],
     "calculation": {
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date.",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "auth_ref": [
      "r856",
      "r882"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.",
        "label": "Impairment of Intangible Assets, Finite-Lived",
        "terseLabel": "Impairment of intangible assets with finite lives"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r66",
      "r89",
      "r211",
      "r342",
      "r343",
      "r344",
      "r345",
      "r355",
      "r358"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "totalLabel": "Net income (loss) from continuing operations",
        "verboseLabel": "Net income (loss) from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SelectedQuarterlyFinancialDataUnauditedSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r61",
      "r237",
      "r250",
      "r275",
      "r380",
      "r384",
      "r390",
      "r392",
      "r757",
      "r798"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income tax from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r60",
      "r249",
      "r251",
      "r271",
      "r317",
      "r338",
      "r342",
      "r343",
      "r344",
      "r345",
      "r353",
      "r356",
      "r357",
      "r651",
      "r756"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "terseLabel": "Basic net income (loss) from continuing operations (USD per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SelectedQuarterlyFinancialDataUnauditedSummaryDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "auth_ref": [
      "r60",
      "r271",
      "r274",
      "r317",
      "r338",
      "r342",
      "r343",
      "r344",
      "r345",
      "r353",
      "r356",
      "r357",
      "r358",
      "r651",
      "r756",
      "r763"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "terseLabel": "Diluted net income (loss) from continuing operations (USD per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SelectedQuarterlyFinancialDataUnauditedSummaryDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": {
     "auth_ref": [
      "r6",
      "r7",
      "r8",
      "r9",
      "r12",
      "r24",
      "r272",
      "r287",
      "r617"
     ],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity": {
     "auth_ref": [
      "r6",
      "r7",
      "r8",
      "r9",
      "r12",
      "r19",
      "r24",
      "r212"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent",
        "terseLabel": "Net loss from discontinued operations",
        "verboseLabel": "Net loss from discontinued operations"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SelectedQuarterlyFinancialDataUnauditedSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": {
     "auth_ref": [
      "r62",
      "r272",
      "r274",
      "r317",
      "r354",
      "r356",
      "r357",
      "r955",
      "r959"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share",
        "terseLabel": "Basic net income (loss) from discontinued operations (USD per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SelectedQuarterlyFinancialDataUnauditedSummaryDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": {
     "auth_ref": [
      "r219",
      "r354",
      "r356",
      "r357"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share",
        "terseLabel": "Diluted net income (loss) from discontinued operations (USD per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SelectedQuarterlyFinancialDataUnauditedSummaryDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Condensed Statement of Operations:"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbNarrativeDetails",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r1",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r23",
      "r25",
      "r26",
      "r27",
      "r141",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbNarrativeDetails",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r453",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityShareBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r329",
      "r590",
      "r595",
      "r602",
      "r610",
      "r614",
      "r618",
      "r619",
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r330",
      "r348",
      "r349",
      "r378",
      "r588",
      "r611",
      "r615",
      "r764"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": -1.0
      },
      "http://www.ligand.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax benefit (expense)",
        "totalLabel": "Total income tax expense (benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/IncomeTaxesComponentsofIncomeTaxExpenseBenefitDetails",
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]",
        "terseLabel": "Income Tax Expense (Benefit), Continuing Operations, Income Tax Reconciliation [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r311",
      "r584",
      "r585",
      "r595",
      "r596",
      "r601",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "verboseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r926"
     ],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": {
     "auth_ref": [
      "r583",
      "r589"
     ],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount",
        "terseLabel": "Rate change for changes in federal, foreign or state law"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationDispositionOfBusiness": {
     "auth_ref": [
      "r926"
     ],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the disposition of a business not qualifying as a discontinued operation.",
        "label": "Effective Income Tax Rate Reconciliation, Disposition of Business, Amount",
        "terseLabel": "Sale of Vernalis R&amp;D"
       }
      }
     },
     "localname": "IncomeTaxReconciliationDispositionOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r926"
     ],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "Foreign tax differential on income/loss of foreign subsidiaries"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r589"
     ],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Tax at federal statutory rate"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r926"
     ],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails": {
       "order": 14.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r926"
     ],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails": {
       "order": 15.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r926"
     ],
     "calculation": {
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State, net of federal benefit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesReconciliationofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r85",
      "r91"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r246",
      "r270",
      "r845"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "terseLabel": "Income taxes receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r745",
      "r855"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedLabel": "Deferred income taxes, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInIncomeTaxesReceivable": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid.",
        "label": "Increase (Decrease) in Income Taxes Receivable",
        "negatedTerseLabel": "Income taxes receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInIncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, net of acquisitions:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedTerseLabel": "Other assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r126",
      "r129"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "verboseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetIncludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BalanceSheetAccountDetailsGoodwillandOtherIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.",
        "label": "Intangible Assets, Net (Including Goodwill)",
        "totalLabel": "Total goodwill and other identifiable intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetIncludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsGoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r234",
      "r253",
      "r315",
      "r374",
      "r681"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r71",
      "r493",
      "r502",
      "r804",
      "r805"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebtExcludingAmortization": {
     "auth_ref": [
      "r73",
      "r494",
      "r804",
      "r805"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.",
        "label": "Interest Expense, Debt, Excluding Amortization",
        "terseLabel": "Contractual interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebtExcludingAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r320",
      "r323",
      "r325"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InternalRevenueServiceIRSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity.",
        "label": "Internal Revenue Service (IRS) [Member]",
        "terseLabel": "Internal Revenue Service (IRS)"
       }
      }
     },
     "localname": "InternalRevenueServiceIRSMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r301",
      "r789",
      "r825"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory",
        "verboseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r290",
      "r300",
      "r361",
      "r433",
      "r435",
      "r436",
      "r746",
      "r794"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "verboseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r434"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write-down",
        "terseLabel": "Write-downs related to obsolete inventory"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r68",
      "r373"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r268"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "verboseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeaseRemainingLeaseTerm": {
     "auth_ref": [
      "r942"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining lease term of finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Finance Lease, Remaining Lease Term",
        "terseLabel": "Remaining lease term of finance leases"
       }
      }
     },
     "localname": "LesseeFinanceLeaseRemainingLeaseTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r944"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Maturity of Operating Lease Liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r703"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r703"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r703"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r703"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r703"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r703"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r703"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r703"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "auth_ref": [
      "r942"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Remaining Lease Term",
        "terseLabel": "Remaining lease term of operating leases"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r943"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Renewal term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r45",
      "r328",
      "r412",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r633",
      "r637",
      "r638",
      "r663",
      "r797",
      "r887",
      "r946",
      "r947"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "verboseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r43",
      "r243",
      "r265",
      "r825",
      "r859",
      "r877",
      "r940"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "verboseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r47",
      "r289",
      "r328",
      "r412",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r633",
      "r637",
      "r638",
      "r663",
      "r825",
      "r887",
      "r946",
      "r947"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:",
        "verboseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r221"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Liabilities, Fair Value Disclosure",
        "verboseLabel": "Liabilities, fair value"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Noncurrent [Abstract]",
        "terseLabel": "Noncurrent liabilities:"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r0",
      "r1",
      "r22",
      "r140",
      "r286",
      "r287"
     ],
     "calculation": {
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails": {
       "order": 2.0,
       "parentTag": "lgnd_DisposalGroupIncludingDiscontinuedOperationNetAssetsTransferred",
       "weight": -1.0
      },
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r22",
      "r135",
      "r140",
      "r286",
      "r287"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current",
        "terseLabel": "Current liabilities of discontinued operations",
        "totalLabel": "Current liabilities of discontinued operations"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r22",
      "r133",
      "r140",
      "r286",
      "r287"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent",
        "terseLabel": "Non-current liabilities of discontinued operations"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "Licensing Agreements"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage investment held by members or limited partners of limited liability company (LLC) or limited partnership (LP).",
        "label": "Limited Liability Company or Limited Partnership, Members or Limited Partners, Ownership Interest",
        "terseLabel": "Ownership interest (as a percent)"
       }
      }
     },
     "localname": "LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ShorttermInvestmentsInvestmentinVikingNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LongTermNotesPayable": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.ligand.com/role/ConvertibleSeniorNotesEquityandLiabilityComponentsofFinancingArrangementsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Notes Payable, Noncurrent",
        "totalLabel": "Total long-term portion of notes payable"
       }
      }
     },
     "localname": "LongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesEquityandLiabilityComponentsofFinancingArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesEquityandLiabilityComponentsofFinancingArrangementsDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r50",
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesEquityandLiabilityComponentsofFinancingArrangementsDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes Payable, Current and Noncurrent [Abstract]",
        "terseLabel": "Notes Payable, Current and Noncurrent"
       }
      }
     },
     "localname": "LongtermNotesPayableCurrentAndNoncurrentTotalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesEquityandLiabilityComponentsofFinancingArrangementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.",
        "label": "Marketable Securities [Table Text Block]",
        "terseLabel": "Schedule of Investment Categories"
       }
      }
     },
     "localname": "MarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r939"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Discount Rate"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "auth_ref": [
      "r939"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.",
        "label": "Measurement Input, Expected Dividend Rate [Member]",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "MeasurementInputExpectedDividendRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MutualFundMember": {
     "auth_ref": [
      "r895"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulated investment instrument that pools funds from multiple investors to invest principally in a portfolio of securities and money market instruments to match the investment objective.",
        "label": "Mutual Fund [Member]",
        "terseLabel": "Mutual fund"
       }
      }
     },
     "localname": "MutualFundMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r322"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "Financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r322"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "Investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r83",
      "r86",
      "r89"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r63",
      "r89",
      "r252",
      "r273",
      "r287",
      "r307",
      "r309",
      "r314",
      "r328",
      "r338",
      "r342",
      "r343",
      "r344",
      "r345",
      "r348",
      "r349",
      "r355",
      "r380",
      "r384",
      "r390",
      "r392",
      "r412",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r651",
      "r663",
      "r798",
      "r887"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss):"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SelectedQuarterlyFinancialDataUnauditedSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Accounting Standards Updates, Recently Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Supplemental cash flow disclosures:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other expense, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r869"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of business segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r869"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OfficeEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine.",
        "label": "Office Equipment [Member]",
        "verboseLabel": "Lab and office equipment"
       }
      }
     },
     "localname": "OfficeEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.",
        "label": "Operating Costs and Expenses",
        "terseLabel": "Total operating costs and expenses",
        "totalLabel": "Total operating costs and expenses"
       }
      }
     },
     "localname": "OperatingCostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SelectedQuarterlyFinancialDataUnauditedSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingCostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Costs and Expenses [Abstract]",
        "verboseLabel": "Operating costs and expenses:"
       }
      }
     },
     "localname": "OperatingCostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r380",
      "r384",
      "r390",
      "r392",
      "r798"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from continuing operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r941"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r690"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "verboseLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r690"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "lgnd_LeaseLiabilityCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r690"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "lgnd_LeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r695",
      "r699"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating lease payments"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r689"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "lgnd_LeaseRightOfUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r702",
      "r824"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate of operating leases (as a percent)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r701",
      "r824"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term of operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r186"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating loss carryforward"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "terseLabel": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r30",
      "r96",
      "r111",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "terseLabel": "Basis of Presentation and Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAccruedLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r302",
      "r825"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "verboseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r296"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "verboseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r304",
      "r305",
      "r306"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Unrealized net gain (loss) on available-for-sale securities, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "verboseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "verboseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "verboseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.",
        "label": "Other Operating Income (Expense), Net",
        "negatedLabel": "Other operating (income) expense"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PatentedTechnologyMember": {
     "auth_ref": [
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patented technology to exploit the technology for a period of time specified by law.",
        "label": "Patented Technology [Member]",
        "verboseLabel": "Complete technology"
       }
      }
     },
     "localname": "PatentedTechnologyMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsGoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r852",
      "r853"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Other, net"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Share repurchases"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfWarrants": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount paid by the entity to reacquire the right to purchase equity shares at a predetermined price, usually issued together with corporate debt.",
        "label": "Payments for Repurchase of Warrants",
        "negatedLabel": "Repurchase of warrants"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for financing costs associated with business combinations.",
        "label": "Payments of Merger Related Costs, Financing Activities",
        "negatedTerseLabel": "Cash paid for OmniAb transaction costs"
       }
      }
     },
     "localname": "PaymentsOfMergerRelatedCostsFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r319"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedTerseLabel": "Taxes paid related to net share settlement of equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r76",
      "r628"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Cash consideration"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Cash paid for acquisition, net of cash and restricted cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "negatedLabel": "Cash paid for equity method investment"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireShortTermInvestments": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Payments to Acquire Short-Term Investments",
        "negatedTerseLabel": "Purchases of short-term investments"
       }
      }
     },
     "localname": "PaymentsToAcquireShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "PSUs"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r37",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (USD per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock authorized (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r37",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock issued (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock outstanding (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r37",
      "r825"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.001 par value; 5,000 shares authorized; zero issued and outstanding at December 31, 2022 and 2021"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "auth_ref": [
      "r318"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "terseLabel": "Net proceeds from debt issuance"
       }
      }
     },
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds on sale of Vernalis R&amp;D, net"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromHedgeFinancingActivities": {
     "auth_ref": [
      "r324",
      "r854"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.",
        "label": "Proceeds from Hedge, Financing Activities",
        "terseLabel": "Proceeds from bond hedge settlement"
       }
      }
     },
     "localname": "ProceedsFromHedgeFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r79",
      "r177"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised",
        "verboseLabel": "Cash received from options exercised"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments": {
     "auth_ref": [
      "r75",
      "r78"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Proceeds from Maturities, Prepayments and Calls of Short-Term Investments",
        "terseLabel": "Proceeds from maturity of short-term investments"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRoyaltiesReceived": {
     "auth_ref": [
      "r84"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received for royalties during the current period.",
        "label": "Proceeds from Royalties Received",
        "terseLabel": "Proceeds from royalties received"
       }
      }
     },
     "localname": "ProceedsFromRoyaltiesReceived",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfShortTermInvestments": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Proceeds from Sale of Short-Term Investments",
        "verboseLabel": "Proceeds from sale of short-term investments"
       }
      }
     },
     "localname": "ProceedsFromSaleOfShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r79",
      "r177"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Net proceeds from stock option exercises and ESPP"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r287",
      "r307",
      "r309",
      "r321",
      "r328",
      "r338",
      "r348",
      "r349",
      "r380",
      "r384",
      "r390",
      "r392",
      "r412",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r631",
      "r634",
      "r635",
      "r651",
      "r663",
      "r757",
      "r798",
      "r822",
      "r823",
      "r850",
      "r887"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r137",
      "r292"
     ],
     "calculation": {
      "http://www.ligand.com/role/BalanceSheetAccountDetailsPropertyandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "verboseLabel": "Property and equipment , gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r139",
      "r266",
      "r760",
      "r825"
     ],
     "calculation": {
      "http://www.ligand.com/role/BalanceSheetAccountDetailsPropertyandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "totalLabel": "Property and equipment, net",
        "verboseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsPropertyandEquipmentDetails",
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r139",
      "r784",
      "r785"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property and equipment, useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_QuarterlyFinancialInformationDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Quarterly Financial Information Disclosure [Abstract]"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_QuarterlyFinancialInformationTextBlock": {
     "auth_ref": [
      "r101",
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.",
        "label": "Quarterly Financial Information [Text Block]",
        "terseLabel": "Selected Quarterly Financial Data (Unaudited)"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SelectedQuarterlyFinancialDataUnaudited"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": {
     "auth_ref": [
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.",
        "label": "Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedLabel": "Repayment of debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r81"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "terseLabel": "Repayments of notes"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r180",
      "r278",
      "r954"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development",
        "verboseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SelectedQuarterlyFinancialDataUnauditedSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development Expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchMember": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes.",
        "label": "Research Tax Credit Carryforward [Member]",
        "terseLabel": "Research Tax Credit Carryforward"
       }
      }
     },
     "localname": "ResearchMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r844",
      "r857"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "verboseLabel": "Restricted cash in other current assets"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCalculationofEarningsperShareDetails",
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r40",
      "r161",
      "r264",
      "r772",
      "r777",
      "r825"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r281",
      "r334",
      "r335",
      "r336",
      "r339",
      "r347",
      "r349",
      "r417",
      "r577",
      "r578",
      "r579",
      "r608",
      "r609",
      "r649",
      "r768",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retain earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r371",
      "r372",
      "r383",
      "r388",
      "r389",
      "r393",
      "r394",
      "r395",
      "r530",
      "r531",
      "r747"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRoyaltyRevenueDetails",
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SelectedQuarterlyFinancialDataUnauditedSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r534",
      "r795"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "verboseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "verboseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r700",
      "r824"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Right-of-use asset recognized"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RoyaltyAgreementsMember": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual arrangement, generally for a defined period of time, entitling the entity to use the rights and property of another party. Examples include, but not limited to, licensing the use of copyrighted materials and leasing the extraction of natural resources.",
        "label": "Royalty Agreements [Member]",
        "terseLabel": "Royalty Agreements"
       }
      }
     },
     "localname": "RoyaltyAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RoyaltyMember": {
     "auth_ref": [
      "r894"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Money for usage-based right to asset.",
        "label": "Royalty [Member]",
        "terseLabel": "Royalties"
       }
      }
     },
     "localname": "RoyaltyMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRoyaltyRevenueDetails",
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r395",
      "r868"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuefromSignificantPartnersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsInvestmentCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r194",
      "r195",
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.ligand.com/role/AcquisitionsIntangiblesAcquiredandWeightedAverageUsefulLifeDetails",
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails",
      "http://www.ligand.com/role/BalanceSheetAccountDetailsContingentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Tax Benefit"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Equity and Liability Components of the Convertible Senior Notes"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r1",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r23",
      "r25",
      "r26",
      "r27",
      "r141",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Schedule of transfers of assets and liabilities to OmniAb",
        "verboseLabel": "Schedule of discontinued operations"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r867"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "verboseLabel": "Schedule of Computation of Basic and Diluted Net Income (Loss) per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable": {
     "auth_ref": [
      "r97",
      "r100",
      "r353",
      "r354",
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Complete disclosure pertaining to an entity's diluted earnings per share.",
        "label": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]",
        "terseLabel": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCalculationofEarningsperShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure about the extent of the entity's reliance on its major customers.",
        "label": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]",
        "terseLabel": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuefromSignificantPartnersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.",
        "label": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangibles Acquired"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r127",
      "r130",
      "r748"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsGoodwillandOtherIntangibleAssetsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "verboseLabel": "Schedule of Goodwill and Other Identifiable Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Investments [Line Items]",
        "terseLabel": "Schedule of Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInvestmentsTable": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A container table for all schedule of investment items. It ties in the \"Legal Entity [Axis]\" to all of its contained line items.",
        "label": "Schedule of Investments [Table]",
        "terseLabel": "Schedule of Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "verboseLabel": "Schedule of Restricted Stock Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "verboseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.",
        "label": "Quarterly Financial Information [Table Text Block]",
        "terseLabel": "Schedule of Quarterly Financial Information"
       }
      }
     },
     "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SelectedQuarterlyFinancialDataUnauditedTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Allocation of Consideration / Recognized Identified Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r543",
      "r545",
      "r546",
      "r547",
      "r548",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityAssumptionsDetails",
      "http://www.ligand.com/role/StockholdersEquityBreakdownofOptionsOutstandingDetails",
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityRestrictedStockActivityDetails",
      "http://www.ligand.com/role/StockholdersEquityShareBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": {
     "auth_ref": [
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]",
        "terseLabel": "Schedule of Stock Option Plan Activity by Exercise Price Range"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r164",
      "r169",
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "verboseLabel": "Schedule of Stock Option Plan Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Stock Option Weighted-Average Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock": {
     "auth_ref": [
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits, excluding amounts pertaining to examined tax returns.",
        "label": "Schedule of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns Roll Forward [Table Text Block]",
        "terseLabel": "Schedule of Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "auth_ref": [
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r632",
      "r633",
      "r637",
      "r638",
      "r725",
      "r726",
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table]",
        "terseLabel": "Schedule of Variable Interest Entities [Table]"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ShorttermInvestmentsInvestmentinVikingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": {
     "auth_ref": [
      "r103",
      "r105",
      "r106",
      "r107",
      "r228",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]",
        "terseLabel": "Schedule of Revenue from Significant Partners"
       }
      }
     },
     "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDiscontinuedOperationsMember": {
     "auth_ref": [
      "r2",
      "r3",
      "r4",
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of or classified as held-for-sale and representing a strategic shift that has or will have a major effect on operations and financial results. Includes a business or nonprofit activity on acquisition classified as held-for-sale.",
        "label": "Discontinued Operations [Member]",
        "terseLabel": "Discontinued Operations"
       }
      }
     },
     "localname": "SegmentDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbNarrativeDetails",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofnoncashitemsandcapitalexpendituresofthediscontinuedoperationsDetails",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleofrevenueandexpensesofthediscontinuedoperationsDetails",
      "http://www.ligand.com/role/SpinoffofOmniAbScheduleoftransfersofassetsandliabilitiestoOmniAbDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r395",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r456",
      "r457",
      "r800",
      "r960"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r807"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Service Revenue"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRoyaltyRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "verboseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Forfeited (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "verboseLabel": "Granted (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r558",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Outstanding at end of period (shares)",
        "periodStartLabel": "Outstanding at beginning of period (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "verboseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r558",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Outstanding at end of period (USD per share)",
        "periodStartLabel": "Outstanding at beginning of period (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant\u00a0Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Vested (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "verboseLabel": "Risk-free interest rate (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityAssumptionsDetails",
      "http://www.ligand.com/role/StockholdersEquityBreakdownofOptionsOutstandingDetails",
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityRestrictedStockActivityDetails",
      "http://www.ligand.com/role/StockholdersEquityShareBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee": {
     "auth_ref": [
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The highest quantity of shares an employee can purchase under the plan per period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee",
        "verboseLabel": "Shares allowed to purchase in employee stock purchase plan per employee (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Increase the number of shares under the 2002 Stock Incentive Plan (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "verboseLabel": "Shares available for future option grants (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "verboseLabel": "Exercisable at end of period (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "verboseLabel": "Exercisable at end of period (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r565"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "verboseLabel": "Intrinsic value of options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Forfeited (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "verboseLabel": "Granted (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Weighted-average grant date fair value per share of stock options (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r176"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "verboseLabel": "Aggregate Intrinsic Value (In thousands)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r550",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Balance at end of period (shares)",
        "periodStartLabel": "Balance at beginning of period (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "verboseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r550",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Balance at end of period (USD per share)",
        "periodStartLabel": "Balance at beginning of period (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r566"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "verboseLabel": "Aggregate intrinsic value, vested and expected to vest"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "verboseLabel": "Options vested and expected to vest at end of period (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "verboseLabel": "Options vested and expected to vest at end of period (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "auth_ref": [
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period",
        "verboseLabel": "Common stock issued under amended ESSP (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r546",
      "r547",
      "r548",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCalculationofEarningsperShareDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "verboseLabel": "Exercised (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "verboseLabel": "Forfeited (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "verboseLabel": "Granted (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r549",
      "r568",
      "r569",
      "r570",
      "r571",
      "r574",
      "r580",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "verboseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by range of option prices pertaining to options granted.",
        "label": "Exercise Price Range [Axis]",
        "terseLabel": "Exercise Price Range [Axis]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityBreakdownofOptionsOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "auth_ref": [
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Exercise Price Range [Domain]",
        "terseLabel": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityBreakdownofOptionsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "auth_ref": [
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit",
        "terseLabel": "Lower range of exercise prices (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityBreakdownofOptionsOutstandingDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": {
     "auth_ref": [
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable",
        "terseLabel": "Options exercisable (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityBreakdownofOptionsOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding",
        "terseLabel": "Options outstanding (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityBreakdownofOptionsOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "auth_ref": [
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit",
        "terseLabel": "Upper range of exercise prices (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityBreakdownofOptionsOutstandingDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r896"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Award vesting right (as a percent)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r821"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "terseLabel": "Award expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r176"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "verboseLabel": "Aggregate intrinsic value, exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Weighted average remaining contractual term, exercisable (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Weighted Average Remaining Contractual Term in Years"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Weighted average remaining contractual term, vested and expected to vest (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Proportion of fair market value of common stock at which stock is purchased under ESPP (as a percent)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": {
     "auth_ref": [
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price (USD per share)"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityBreakdownofOptionsOutstandingDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price (USD per share)"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityBreakdownofOptionsOutstandingDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining life in years"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityBreakdownofOptionsOutstandingDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Balance at end of period (shares)",
        "periodStartLabel": "Balance at beginning of period (shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r244",
      "r245",
      "r260",
      "r846"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-Term Investments",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermInvestmentsMember": {
     "auth_ref": [
      "r779",
      "r780",
      "r781",
      "r828"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet.",
        "label": "Short-Term Investments [Member]",
        "verboseLabel": "Short-term investments"
       }
      }
     },
     "localname": "ShortTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local Jurisdiction"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r284",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r395",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r454",
      "r456",
      "r457",
      "r800",
      "r960"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SpinoffofOmniAbNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r53",
      "r155",
      "r281",
      "r312",
      "r313",
      "r314",
      "r334",
      "r335",
      "r336",
      "r339",
      "r347",
      "r349",
      "r364",
      "r417",
      "r519",
      "r577",
      "r578",
      "r579",
      "r608",
      "r609",
      "r649",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r710",
      "r768",
      "r769",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Condensed Balance Sheet:"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r334",
      "r335",
      "r336",
      "r364",
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r37",
      "r38",
      "r155",
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under employee stock compensation plans, net (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r37",
      "r38",
      "r155",
      "r161",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r37",
      "r38",
      "r161",
      "r170"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under employee stock compensation plans, net"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramPeriodInForce1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Stock Repurchase Program, Period in Force",
        "terseLabel": "Stock repurchase program, period in force"
       }
      }
     },
     "localname": "StockRepurchaseProgramPeriodInForce1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r37",
      "r38",
      "r155",
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedTerseLabel": "Repurchase of common stock (shares)",
        "terseLabel": "Shares repurchased in period (shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r37",
      "r38",
      "r155",
      "r161"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedTerseLabel": "Repurchase of common stock",
        "terseLabel": "Shares repurchased in period"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r38",
      "r41",
      "r42",
      "r114",
      "r825",
      "r859",
      "r877",
      "r940"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "negatedTerseLabel": "Decrease (increase) in stockholder's equity",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "verboseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r162",
      "r327",
      "r504",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r517",
      "r519",
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "verboseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubleaseIncome": {
     "auth_ref": [
      "r698",
      "r824"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sublease income excluding finance and operating lease expense.",
        "label": "Sublease Income",
        "terseLabel": "Sublease income"
       }
      }
     },
     "localname": "SubleaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r847"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "terseLabel": "Balance Sheet Account Details"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetails",
      "http://www.ligand.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "verboseLabel": "Supplemental disclosure of cash flow information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r186"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Tax credit carryforward"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]",
        "terseLabel": "Tax Credit Carryforward [Axis]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Name [Domain]",
        "terseLabel": "Tax Credit Carryforward, Name [Domain]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "verboseLabel": "Acquired Technologies"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsIntangiblesAcquiredandWeightedAverageUsefulLifeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
     "auth_ref": [
      "r812",
      "r893"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by timing of transfer of good or service to customer.",
        "label": "Timing of Transfer of Good or Service [Axis]",
        "terseLabel": "Timing of Transfer of Good or Service [Axis]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
     "auth_ref": [
      "r812",
      "r893"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.",
        "label": "Timing of Transfer of Good or Service [Domain]",
        "terseLabel": "Timing of Transfer of Good or Service [Domain]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "verboseLabel": "Trade name"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsGoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferredOverTimeMember": {
     "auth_ref": [
      "r812"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred over time.",
        "label": "Transferred over Time [Member]",
        "terseLabel": "Transferred over Time"
       }
      }
     },
     "localname": "TransferredOverTimeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r405",
      "r406",
      "r498",
      "r516",
      "r639",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r874",
      "r875",
      "r876",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails",
      "http://www.ligand.com/role/BalanceSheetAccountDetailsInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r338",
      "r339",
      "r340",
      "r341",
      "r350",
      "r399",
      "r400",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r577",
      "r578",
      "r579",
      "r606",
      "r607",
      "r608",
      "r609",
      "r625",
      "r626",
      "r627",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r679",
      "r680",
      "r684",
      "r685",
      "r686",
      "r687",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r749",
      "r750",
      "r751",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentDebtSecuritiesMember": {
     "auth_ref": [
      "r956"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by the United States government.",
        "label": "US Government Debt Securities [Member]",
        "terseLabel": "U.S. government securities"
       }
      }
     },
     "localname": "USGovernmentDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails",
      "http://www.ligand.com/role/BalanceSheetAccountDetailsInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "auth_ref": [
      "r88"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment.",
        "label": "Unrealized Gain (Loss) on Investments",
        "terseLabel": "Unrealized loss on available-for-sale investments"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r582",
      "r591"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r592"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedTerseLabel": "Reductions for tax positions of prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r593"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Additions based on tax positions related to the current year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r592"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Additions for tax positions of prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r594"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits that would impact effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r108",
      "r109",
      "r110",
      "r365",
      "r366",
      "r368",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "verboseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r600"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "negatedTerseLabel": "Valuation allowance, change in amount"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableInterestEntityDisclosureTextBlock": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.",
        "label": "Variable Interest Entity Disclosure [Text Block]",
        "terseLabel": "Short-term Investments: Investment in Viking"
       }
      }
     },
     "localname": "VariableInterestEntityDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ShorttermInvestmentsInvestmentinViking"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Variable Interest Entity [Line Items]",
        "terseLabel": "Variable Interest Entity [Line Items]"
       }
      }
     },
     "localname": "VariableInterestEntityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ShorttermInvestmentsInvestmentinVikingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BalanceSheetAccountDetailsInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.",
        "label": "Warrants and Rights Outstanding",
        "terseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ShorttermInvestmentsInvestmentinVikingNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r867"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCalculationofEarningsperShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment",
        "terseLabel": "Dilutive potential common shares (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCalculationofEarningsperShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r352",
      "r358"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCalculationofEarningsperShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "netLabel": "Shares used in diluted per share calculation (shares)",
        "totalLabel": "Shares used to compute diluted income per share",
        "verboseLabel": "Shares used in the computation of diluted net income (loss) per share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCalculationofEarningsperShareDetails",
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SelectedQuarterlyFinancialDataUnauditedSummaryDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r351",
      "r358"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCalculationofEarningsperShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "netLabel": "Shares used in basic per share calculation (shares)",
        "terseLabel": "Weighted-average common shares outstanding - basic (shares)",
        "verboseLabel": "Shares used in the computation of basic net income (loss) per share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCalculationofEarningsperShareDetails",
      "http://www.ligand.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SelectedQuarterlyFinancialDataUnauditedSummaryDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 11
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1060-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "270",
   "URI": "https://asc.fasb.org/topic&trid=2126967",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1063-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5144-111524",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27405-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2510-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2473-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466103&loc=SL6014347-161799",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=7516071&loc=d3e13374-112631",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721491-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613673-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6228884-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.E)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120398118&loc=d3e355146-122828",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL7498348-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28567-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611133-123010",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=26872618&loc=d3e7436-122677",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/subtopic&trid=2122178",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3581-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900988&loc=d3e1280-108306",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900988&loc=SL124452896-108306",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721501-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL82887624-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922890-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/subtopic&trid=2144439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721503-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(k)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32059-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868656-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(14))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e7008-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123399704&loc=SL77918425-209957",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "8",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r832": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r833": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r834": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r835": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r836": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r837": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r838": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r839": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r840": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r841": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "https://asc.fasb.org/topic&trid=2122208",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r892": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r901": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r902": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r903": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r904": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r905": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r906": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r907": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r908": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r909": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r910": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r911": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r912": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r913": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r914": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r915": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r916": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r917": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r918": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r919": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r920": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r921": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r922": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r923": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r924": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r925": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r926": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r927": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r928": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r929": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r930": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r931": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r932": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r933": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r934": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r935": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r936": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r937": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r938": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r939": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r940": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r941": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r942": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r943": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r944": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r945": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r946": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r947": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r948": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r949": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r950": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r951": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r952": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r953": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r954": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r955": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r956": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r957": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r958": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r959": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r960": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r961": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r962": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r963": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r964": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r965": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r966": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r967": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r968": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r969": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r970": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>102
<FILENAME>0000886163-23-000007-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000886163-23-000007-xbrl.zip
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M7AD]0]^_3FXU0,1\;B ,5=1*,=G85PFZ7)6L\!K4TOMO2H&CDZSE?0*.N8W
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M@@\%*,_QADUS6K@U)(08:^*VLY7RBCB@2#H+_(2\XA*40EIB\4\V[_$H,U9
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M.%U8&IJ0H_#P+6;@W*94P3AAKY>XYE*&K/0:(V*;QO3)Y=P5"D;:U.)M;A_
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MLJ4Z65WN0D]!:G &A64=%D0Z+1WG3#-CDF;ICCF-=<39B4DOM8U-S/KRS%#
MZGYB,_,.8SM8_M) /LC3[X"!\W=8#2GMI1.CCG8I..R*E=N5K21N._I EI$G
M<"ZEMSJ^H#,"*=.CTO%@&!ZRT*=)1<E$=<!TKHEK5%*H9CMU(8P[E-F<A+E"
M X,THJ@A)M,&?SO>%!8?%1.VDW.%]BI2QPEJQ5X, L_B[ZTD8?L$/3,8H?5
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MKE WO<-(Z38D85%BHTUM$9X(F9IZX49B(.+:DHU@-0$PH)57F7XI+O9$8?9
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MK0*C14;,0Q9<C?IK*54S$YB1 36RCMN"&*<"" [\FC1Q(GO#7UPX=SVUXR$
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M<.*IIRTI+@MAVLHI -?!-)P4,;1'F(HH,\ZY3OCUY1I>ZJ8J0!$N5#..B\F
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M=OVZ;]1KKDV=S#4MJ06?.$J#K!E?,\0H!O7%7&F+)S4BJW(7J'>#](OXP%7
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MY.LW:1/F&IXBNPY=\]AY-N*<$DHQGZV=\T0/B/$)U #M\.:!>.UE#:-;B80
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M]E7DS)UW?(*MWSKV^<6V;3X\V:!Z?)Y@>3I+HS7\;U$LXQ__/U!+ P04
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M[(R\4'[(HF:ILZ&R3I3_BO)O9G-:"_\3S47_)FX-PS;V[IJH$G[:,I%9['[
MN?HL\Z2 9[O/Y7EWI/ A"<3X&!+@)IF/NNSYV 6EFE0C,MHX@^RPG&HDD<YW
M[!"1J@@OXT<US].,+$>'7AZX3@OS]=N8/' 7Z>&#<I%Z9W24GEL?^<!R+A#'
M'6FBK)2>ILFSXY)NT^1AK@;J[$()^;KD]]D^^WOG_SQ9F-;"7$VBFZ2;0;)
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M;*N[GK(-F^^\I[:[H:UK8:1YIFZBM,S)81.A"$;= A2\J9\!&\![_L-Y,^:
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MH3H<T]A5V',:ZA&H?5&!'6#2C$B7QMH*UP,DWGN(> LO-EJK1)9/7;"BDFR
M;JF9HC^C'N..D4;"<JF\L9!)!BH)?P7!QB -!.80%:7^P:,R"]&JB'YC(K$T
MJY3&UT"D6J_AMAA4KFB@%3.%A[X,(T8.9C$WSE4B&(MV4O@2T5D8Q+I:IB4P
MWLR\:,]@X)474>M=C4O*9(+4/"Y!!&(ML FF5*[4(A(-T32[&^O*RNO;+$VN
M$8<5M%QL)<)%_T;E[7$()M)K!UHT'#QYS@M669Q)YI>PS?"0K-)U"15$H$"]
MA-%8Q3@^PM4P2Y2*> CQ-"#HY9LHC<UVS<LQ7.[-4_@O-W.GQGN5)40ZC&"M
M(X7ICXR<CM]?IRG"3'-'>/H$\U,P;E(#I(K567'18FU4"P5J*(TB2'BLL\*F
MIP.B@AO%>(X=1_&H,]]@%XJ$/0; _)%BS5]['8R.,%$J[S_>)G\=;+L#IR#N
M*]5$KZ%1NDU/4G&"9=IQ8'49THK@L!?L#-/'P<<>NZQ(:ZB9.PAL*]INJI*F
M*R>YVEA^.(<E>;"J"+7Z0*2#,-2ZQZ+MTCJ8+=>%IVZ6DSU0F;6VHKM'&5C6
MX[XH!AVETA>E94!6(;1#0=#W%=U5[%-8EN#\)_"<FK%C1G_W\'U/G /PA%6R
MTL!G&R0H.DWX:2 (0"[%:!:C:RK ODYIJ ]&1\Q:< I66QW5Z&R.F@X*F 5.
M0_I"50^HZJEK#UV&KV(-BY1P-N/2>M.%] E+^ %J:FY5N60G-GE6]"XG>0/1
M4*(@ GXHOJCX_.!E__F/DS;X,+(&.Y8!N(ZRLJ$--5Q0*,]T,',;PJ"R7U*[
M^+&T6'#]&+HK!AP&W NB5^L47/<\+S]N,A4H1W?4HZ%7.KUFM+/%Q=!"7;8E
M@XN=ZOJPNUEUUN&)!&=+P&J"N,7,881>$.UJT!UKAI\XW<PYC'KVXB,ZX?"L
M>E,R(M)5YM/X6R\_1H<7>RM ^/PW4D1 T]*6_%W'UIW;V+9YV E@Y:K,_(^L
MWH4FPU[:;60$<XI)^$ 85E&YG8*!$ZLQ]MO*:D"HU90\!(X2;Y]_DT:,((DZ
M1EJ.BS9M,U'<=0[1_R>DV*1C@SLGV&^"GV;LJ@H\<XH>URR(1&-MF/:LJ>"X
MR@RUB5F:J55JKU V!>W82U.E?.,G<+V+6X-M=+RJ66)]4'=Z17E]>4^KM]:0
M]9S']*KZGNSLZP5C<V8-/&F.G]@W.;\UE,IZ.ZEFZJ2.HI#BGYB <[L:^KJ%
M!)%TT6[@YIMM.G&S89*)39NK&:W4[5(8^RZXT];1-LL8@V@X]UG;E#Z'G".*
M+0T;'10K'>;<MHB^P3XU?GW'.5.W,M;(/$,7*OJ8Q#M(.DI81V'L;JY/=:!=
MB!K=*]?G03D:NM==5:>N>X.C_W-Z]N%D>/S;\-*[>CNX,EGMWMO!I?=Z.#SU
M!L>_CRZ'QYC'CU@<HTOOS>#=Z&0TN$#DG+=PV] [OSB#BT9GIY>4[C\X&;TY
MNS@=#;RCT>^C$^_H['CH70Z/KN *;_=@?Z_G?7@[.GK+]QW#N^%E;\Y.3LX^
M7*[.<^BPTK8LY?HN+(1O.]9EZ?TDDP;>;\/3X<7@Q-/%&L=GL!FG9T '?UP-
M8;>OSJ1X@ZD#]_KH8G@\NCJ[\.#_?-OH]#?O?'!Q]:>]'<D*+[A\?WD.^X[/
M&?XQNKSR1J?>6R A^.GM\ (HZ7?X) ^^&KVC:I'A'\.C]U?X4/Q61M8CXL-!
M]+S1&WK^J??Z3WC8.WD8T-39^Y-C(-S?A]Z[P=7P8C0X.?G3&[QY R,  G;>
M>SF\NCH94C6GH>'CX>O*K. .FE1?)-37H,E[P^\])$'W>HA[-O@PN*!MO!R,
MCBN<WW.$R_!B")LW_./\8GAY"9OT83#Z'<7 Z9_>Q>BWMU>7< G1SUO<RS]Y
M4Z_P-BJVZ:' ^# \.<%_N?P&;SV[HLV]&ER]OQK29A^=O7L',N=D\ %DS>CT
M:'1^,B09=3D"&08B;$C4T?<>KY^[RWV/*RW4JIHZ=186E[6KR7$J0J/KF=5!
M:SJ8]&&K@I+F3N*V=$7=-7V4,-U.>]\;.G!;T_J[.[<]DD3FO8>8R(SA>"<T
MN&E8:*>/L0R+3:);/\O\1 S6IV3/[ZP0NXW8,X7M=ZVT<1OOZL_S#)T]%+-:
MV5%W2X+T4S_Q*O>1L'.?/JTW2)^CA"DTI*09(0SJHU)S1TXY[7K;I)-%NM]>
MG;#5XT0IA7FETS11/2_VYT4Z)VN]+#B9E!!P.&7@T=)G!R/#KI,##\7T5H6<
M.T)A?W%>PA_C-.%,7)U)X+I:>IY#CIQYHE,AD<;:J&=U^P>38",^(<PZ+C&4
M<^/;.MVY'X6<=YE.)I[RF;?DO>3_E*BCPRK8V;1 /V Q;3]2'S<%=L]E<,RM
MP7$C,)4R;V\>[V8V62<M;#_2; Z+[!L_^%\E5=50"+[JQYN1I[NF]E4]AHZ_
M;E7D71RH%>DN7G,55L>!:4D-=R(5<B0%%LZ8UN] ZU1M^JT';ARBCY;(NVR8
M(*4@S4:8.T6N79)R(8B@W,\B/W:B7]4<9)W-?E=.=<]6<#7+MGK5I'CN#D>U
M'MQ#KD WODGDX1*%'@PX8[/)B8]X>:H%Z(2"7J8E3EW?\%&?T @)UEAZ)*;+
M\X=DNF \(8O8/#V2M$*=?"E11KBC.X8,$C8F0S7. RZD*:GV8AQ+V%,;ZSJO
M_:4.S>"YCOT7X8@(.9?5.46X>4TMR%I1S[&8H\)EH(W,!8"]&9@2<:X(>41A
M26@]@L;G ^B]F"1:#=RNRDGZ$3-0FM!%3QDH#P@MIEH38]+@,8T8*/TO,!B#
MZI'GU!SIGH?B1B/W7 !,VJH?AJ5)U4!& UD0F;J3FK7=/#-#5D%7F2,-H;!U
M1T:K[1NMJ)+@QH]BW5/:?0X)$D=H8,)#P$H@B8B;2-U*!:<?%&5=8&!IXWP.
MI@^]I%A3).$@KO$,*/!)LS19..TB$2Z)NM=QQ0KI(%BP/D_AN+#F'_>DIIW+
MI7 4O1LDD;$RK,7'@7K%#2JI^DO=5RP7A1?57UW*1_V?L.B'4'%6N4)D^QQO
MA=VX;3[<-A4C7Y*%)6E4F^TPVJTUD82RS2X)9SOI-#3-++6,'=N)&0PR4#BP
ME^.XS$ /S9%<->-B=O22'O"L<&-Y4#!5<+_BN"WFZ4@B#:8O)=?8D LD'RKL
M6-2R3I9J1U7G]F#Q_@9;A]];=?XPN#CUSB:37!6;#+"#&ONA7A^L]=W#K?&V
MZ<1<<6HYYU$E,F8:W7%TH*>#6A;FY Z$NS5"5+TF [2$V>J94K5@&S,=%9F$
M9;"T*:MDZ/$)U7Q+#S.^"$ @4B6N%)^V%MG%9&#:<?D+?6S;([TJ$$AJC!4=
M5OIRAD9(9&/:Q4"MBL_1-MS%J*?NT;'K@!K>6;SU666R[;6E+76-)>^ K6]\
M<+*I_3 X>$AF/3,+GQT;-=XW*1F];ZW1K&[307G);@9T%6XGT\D%P,3HBICH
MJ)V@G,*U4Q6'TA0.='QL[,Y)NBJA7KIX9P][D5H%Q*=< ^)PTPB>W'AR0Z2K
M^QQGGW[C(^'3%P^)3X^FJ5A4)_[MQIOM.N3))!4E8J:1IPHK*J263K*1J5J=
M,K3QR@!FR(G\QCCF='-10'1QE4$JK8#>?M59?^."M\/-6B4VM,ZP2>P6X3I[
MW _!13(2@)H;@P&29C-&&;"V_;6?2>R(2]9S79\[!Q,ZB.;QH^G$??B0Y )V
MXKX6")RC&)&'.B0<Q+?3U,G1!Z]+<@1/21<[<U?N>L&*I;\:[,]=$5\<0%ZB
MV:Q")4Z^>>P'2@Y1*@<R"%_4S1[?D>9*LPM"1S$:+2P_H4)@ZDJADGY5$*+K
M24Q[+OBB,QB+NR;14JM#XEYD?&#]#/"D5*CK!!E":V43JH+XYGOD/M"E3/@V
M1G!DW K&=:S5T3P2!GWYD!AT:-"[8$^/TA(=/+CWF\[Y:]#NV&D83#:H':H]
MIG-_1A[F@(G09*P2)@LRSY0R:-P'^1Y"LB"(O;ALL7+.#\@\5!:+.!=-@KRW
MZ[P*J!Y(%BU*\XA'0M^O'A)]XP'$[@8@H-?8B7KCA%UK@QV !34I,9T@4WY8
MR[KF)@M\Z!12:,@7TQP)]L3ZNG":>#WC;)"V9 PW6RW(?;K=N]#- ^87O'A"
M)$O82A$#JJ2L.LN0/Y>$-QIJW;HTB.+GZ'E^P_"PVW?-A3 O]OO[G]5R=ATF
MOK.CX1-H1\=MF IHQYA/!M5P"C^A<=R1:?24"_&0<R%&IU@2>#J\O/0^8+W9
MV9N><] (8L!8//P84\1CN.=:5WP2&K6L"F@@^4C<LRB?(@3Q6($ 7\Y#]^N=
M]\^_%P*PX\I:!('WY[GZ17_X-8QR,,T6OT0)+0'=U")[ZUUY<2S\LVS_J\/^
MSNX^4H!T.987"W'TB3ATA^#*;_LO^Z]VEO^\T]]=^MM7>NR#;LZ\I(>'5%@^
M^-[,[=,[&?V&9<#G;P<7[P9'P_=7HZ/!R:4W.CTZNS@_NQA<#8_;VF_7CJ,7
MK!>LUZ=\J=AZ6<^WWF/]77]'^"/RY6>H7-U[_'>4Q'L'*PKJ:X?+W13^M)4/
M:"L?M%!N5RE._5E+1_G'/K\U-U(SYR-;$X*+_^Q%>4@SQ:K!QTS=[?.CC?R9
MU.;OZSWY$4WJ_8=A4H=KM\7>W7GJB[UF7^RC;CMI[]L5^WAX-1B=#(\UK-+Y
MQ=G1\/C]Q?#.]MCH/WS>?_7Y_MM[%X<^>_X-'*AK[O_WZIFX=M*Q[K#DG6,M
M15AFZMOXSK^W;'5;0S3!=*I9O;I.2-H@-Y*+=(;SP<YS2A:X&%T.3%I"%4Y5
M]V31^:@Y-Q6B-_<IKE1-8.8Q,/8I?-#YSG*O;\J'!/53DNEH<CZ%00?F#XK
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MJ+.Z[OA 3ZJDNW-.B-;LJ[M<[UXPYA+X1'<3KD*!'.SL;?G;CNW04!$DIXN
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M#2),&A^R.SS?Q[ID$:KOX^TS/Y?D-,)RR^KJQE"W^GW5UUB0J^P^"&?]Y(J
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M93)EKT0E*BX1!"@;,RMMBP%>&<CV>8J](9<M' ][PZ,;\& W@D]TB9-7 6Q
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MP!)7R.C=:K0T/WRH35FBK\9S FO$044!IA@;#-G@EKA+K<B8?;<MLK'1>I+
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M62^DK*D)=?+6.TC:HRXQ4&E[B4A8WJDQT36%/TOA7U=$EGRX7  *6E>=SI1
MMV)*RA&P"<4&*&360F)-X247$AR<IP":N7C@I',N+M@J!"9RA=Q:2*PIO.1"
MPAJ5HRE$:"K40*G5!?(LZH*2MC:MA<0J4?C>*@J)+!*B5E 80+0P0IOM8*RV
M6*M+S6LAL:;PL@L)9TL6 G-@1+!H$K<RH[J&:$.V$-9"8DWA)1<2JOCHD'+(
M+:L7.1;=)'!(8I'E9XDG,Y=CJX(;F:XD.5L-JGK#$4PLB4(4!RF_ GAF7NZ<
MQZ4"97[YC%^SF^L2HK./PR-^GW:ZTQOV!J>#5128#K6*MB"XVO9)2C&H%(PW
MQ"$J$W5' <,WJPI8,3HY8ZFE"H-)OLW?FXJQ*JO8&KA8CZ^6#Z=+5?+KZ:0W
MY,EDD_[GM#?IO<_P/M<1E8?\YD;-G0@#-:>\^Z(H1I,10@0OT@"#)<82JPLU
M)3,KM23:MJM@[/ 4,TYZDX-C'N,)GTY[=+-EL&;Z[IO39<:]H^._29:9O?7%
MF0%!16H;V1LH5;R9CR9E<.+L*.N$3,NK "^!?B ^;,J/>J^X; ^E38]ZN<^;
MDPE/)[^>G:OZ/DX^RI1Z),I$SC,\VCP:\RRSZG/H7\M:WQN=2MN.3\1>GNWB
MX*KXV7S;.QOAL-P;C44'C7LW:PGFIT:=QE"RBAET:=LH9:T8O"XU$')R>GG5
MZ)H@M[/2ITJ0 I6*LPR9(9E<6RHY&*4"HE];D#D1Y GW69YMBL3J8=M]N2,6
MA+"B<,0$EQ5X&]%SAE #0TW%X1+'LVN"W$ZY!F=S58!4-( .-8*+4*P'+-GE
MW('\[%LBR++T:%,+65U28 *PWB9K&!U8[9FCI[4F6+8>QL!%5U+BG"68:Z-8
MVD9V@,Y6+0!>5*IV%Y6JE?OND?M66[P[>H7#G5&_?SJAT\'%H.@-[QG5JGF[
M:U?SED/GLTLABVLO(56?&) Q8LCH4]MJSX6DZ+PJ\\I1ZF)_^94CU <%H#_@
MR#?8GQI2MEY,6C)MBWI.*G' JA-BF^? Y>7(5P^:K]FW-.P#C5%S2<4H!(<V
MD::*,5<C'E#HM[SL6SZ.?-5\Q/?-/B[>*QTEKD&P$'*;BPK>51%B0I59=*/C
M,HKESZ#R&/NON-_'JT/HVT/JE%W\-I+$^4TO*\-.>\J$&CR;:'T0/^F2(R/!
ME5Z39"7=\K+0+^D*;1&2$#" 1(59M[H@+AE*S@2MUO1;2;^\+/33X( 4JIS
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M5E1-96=J$;^8T(?2:0-ZRP NQH*"]#ZM(#C6@*!2PK9M&Z16%4+3"@P W!Z
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M<]&/'%6IT#$NV"X>5N,M*U?*Q<1LD%0,/,)BX*=FM6K!"?,4P:OG8XTI"".
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MO98+Y]N$\ZI5/QKVFZ4Y]&_,HW^9:I_:YQ?L<&T4K:11]$;4>++MT8AO9 C
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M5D0>?P'R3-6Q 15+P-6^FE5UHJ(L:/P3X0)GJN'E"Z\'!@U=*?2?@/ 7;!Z
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MR#1C&\@I]S9C0T$->U]SD;KJ3)MLZ):5UQP+R %G4A&W&069@V8;SH$)(+(
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MON=J;W, 9\>!S:B^)84D&\69Z!8W<8=7JMET8B>9;G@2=SB(&Q-8R&?&*M1
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MHI5N(J,Y7&3J7MK<T5O5/&BJPH,&*+'<+J7" ZA0^/8I= ',I"=!^QYPBJ0
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M!;]8&]W4@>7++CR"WB"IW HJT19#2I0;0T9[(,+049ZG.1_4A= .L"7H3\[
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MB;TD8&Y84H>T/O*Q5%; 9RTFV^@N5*K<O**2K(^( F/EL>'?3N<:)*J:RDC
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M!\X, UP^9DG3#J/T(AYS6]"XF/V/;6WJF^$C?SDH:N<=$+(QJ2+ )]V;@HU
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M]00T]?G$,=@Q.]R'UI>0R[Z!R<:U$)#"*V#(*)I@R;"O'BGTZJN"./3XKTC
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MMBI5;O=2':166]+4M\*=?<NP-'@?*5- !H4P!(Q!78'JEW,#,\<MQZ1C(_S
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MS^5[;0+U=F2>\Y=<%V=(>JO]PC%;_T*NH#:3@E^2-\K9V5%.TLJLF:Z DHW
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M+ZN -.B8Z,&M(X90>W%)V<$D1(-JZEE3:TT+-^[71<'IU[H%X1.<J=];4:W
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MYA>:N_Q-9S_;(GB0;0A6*"$?[0 ?#79MHOVYK==S@5QT196<1.$W]XKQ/.L
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MM0P$MJP_;G,%[&XS5\!M:0GTS98MHG/Y@KH]CV".G"$**KAR>(FSI8LF2[T
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MI$JTW<\CJXXQF_(SV0@(U(07,D1T#@3S26<:&B7$\.H\4)6][/<"1TO-C44
MBG. 34SF@?/3DL"-@) Z1 M/_4K0GZVFU^0<UR?X'B3!)Q.\Q#.^QAKW,2G
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M^@+2%X1/H.O3.1T>TESQ)<-0VS>44O1T^+H)P)R\S)PF[#AJU"896VUCF0L
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M23TH3$6WC3SO:L&SCF/Q%0HW7<.J\$PP?5E(E0=?$4^7\9-CJM>&15;A$1^
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MDL#-7'PC=?FXS&)TW@7I(A3P*3D(6B->Z#FE4U5D%4.?]HQP/Y52 XEM6@O
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M5>V;+."ZUFF:@)DEOCAZK>^RJPK;94V2RB0T^HFZ6#JX/2&+0C?2#_WH"\\
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M-%4X8P1;+%%7A(TAI9H$F174PV^>H=&><X.5A!HMEX]RS0R?"(?#(*YB=TD
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M<!B&PV@H&V8QC4-&*3*D9XBKA\8E:;Q1^TF09M/$G[-<NS,0917T!BZ^ 8E
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M>$#YZ%O<(8B"X$EBTKU&=PN25\@OO$27[49%6 +)A2^@4$J_\]19B,USX#[
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M0-7B"Y.4'($B3OEK@1W6T)3*>&E*Q"B@:@OB')X,@VOST>" 3\>1%'%&3KX
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M,DJ;7+L X*R0(S$%,J#;09;=>E]X').4I@OI5[T:G8&9/PK8/CC<VI1NPY'
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MO4A"[TIBEFDZ.16[^9]#.8I<G?LEATF##.CE1SDZE]I.(\".8T2CH!\UUZD
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MOER*JIHZ;[XM3&QIW*AXW537UBB*J26DJ(X)?G51*]A+LP<FBP%K_YND$M:
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M+6 "71[O6"__W[)EN$_<^M?Z7O^AX/5JR4Y;Z%V=F_AY,=!CH*&YM!DP3#.
MG8- AD /RQT7A&:"YF1GEU'4I91O"]_ABN) +;*UR+9&0M<6V5:*;/,!,(*M
M@C:3 'E',1B5#O!,:^"-26W\4>0(%C$ )EB7B%55YVP+EVOSKMI[.'9T/SK)
MENKDB\.]/P]?')X>'KSN[!WO=UZ?GCS[O_\^>;%_\.IU=/C9'YV#O]\<GK[K
M7!D;N\::-#8K]]MAAM- [S:_6U<ZYJMP[M?SE"MR3#;6'RGG)_5[4O7ZO4G/
MCG__)4&X;B;H/J_Q:&+B>UK[UYB,.Q?R<MEL[EM'P;;7Y%KVA@_%JEJ9OUB(
MS\LD/2U?_LI#=TO((854P?)U0""D #8N!T(P!"A"TF7>2"8&[>R2;IZQ#0K<
MK>@4;P'I00+2RMR\%I#6#T@+?!+$(HP$!8XC#C!WWN-31@/!28ZMA<)1&NCP
M<?90,PF;;N.-0G%#PW)O"RC7;QB%-7]1+WD+12N'HB6DEUQ;232"(,.YAR(%
M*?#6D@,*,8B4T](:M[,+29?R3:K!:JLH-]:<:-7X#M1XWJ+0$L%<Y KDDJ!
M&Y$#*7,*,","*^.XLD&-69>P6T_FN+M22M,;7_3E97A8^V/-OZM//IHX5QF]
M3'5'9W.!S+;8<ZTTG6GM7PY'X78GKD33R[^&HV?5?OPC^].*_J_%SQO@YQ*.
M3L<$1-[K C37#F#),.!$,* MUSG2V"*M=W;) XP/M:J[4G[.5G77K;KSI@]D
M CME0QPET.OF%@.)C :4P,SD2C$99B"331HL^-!3GVEE?_S/:@SJR'ZQ@ZGM
M=*Y.DS]V[VQ509: 0.%V;WN3C\^F8__J=E0A5.6HM8!T T!:0LNI,G^$4!L&
M)*(P1X0H(')$ #7$*&JARYT-4Q+;.60/5V-7%4]I-78=&KM@0DCE&$<,6$:]
M"6%@#CB##E">,\ZDX5G(QU"R241WCRX2,9SCX&S#$?=%Q-D"T*T : G9)L56
MD PJX(@5WI%A OB=8P!39KABWJ<1S ,0VR0GIHT_;*;)\#-=;?,P*U3DA3R,
M$<C*,#DP=UZ1H71 6A)X^3.1Y\J[ #JPYG;SVS<J;5X\8GML"3=#N=G6>=P/
M[V9K1]P*?I9P:]J,<T4P#^.2PQP!G0&AK0/"::%S1!S39F<7MY&'AZNHZR#6
M;!7UMHHZ;R?DEBDF./.6%W8 9X9X.T%F@&0.220%EQIMF*(^FH"#UX\\Z%1\
MGM#&-K:#WG#4&0PG=MP.%;NC1$6Y^OM635K?9=68]/V@:3SDQ]\/OWXPC.0L
M9QI8G"F _1$"I&8*2)-!B*5SG-E L]"E+3/W ];A%:8N?JK#+17=KZOO95-]
MC[Y^P!1QB1P)5'008*H@$)G%0$O"3*85M$IL(A7=HPL^-,(-J^;3? P.SJIL
MC$:-^HF[ >]>"V2K!+)Y3LVSKQ^\6#NML &*$^\;\9P $9I3)#8Z\T<35@BO
M#,C:2,;&*OJJ#)&5*GKK==Q2VV=X-<\N/TB1$<Y1!BC3R)LMW +E- 0998(0
M8Z#@(HX^)723:/Q7&0W9 EI-O6B[W"8(<CM6NFT&M358+RU.K3QBNV3:""*"
MPLQ1H 6D !/KK1+GN$<LRXQ%TCI.=W8%[_+;3U&\J99L4>CD\6K^&LR95O/7
MH?GSN1K&),TPSH"".018( >D4MY@4;FRR.^=E&IG%\,NI:N*BVX>0^.V!EW6
ME,QY#/[7FI(Y[5B2%4/6$L9L[RL9R?/ F.W7%!--@2). )N1#.&<YDJH-H3R
M\%5X3;F<=NC(FO1X87([TI R!H&'7@<P$AQX[\,"HS++\LQRA>#.;HZR+H.W
M[DW?T.C(1IL7+X:#,S"QH_.6*.,>B#*NT5W?PM-:,C5%IZN2F&46 B5A#K#A
M(>7,O:/D?\F8,IG)L(>G+B:W#MVV!2,;J\HK(<YH5?F^TC"%I>'5F&>8 JP5
M!MA)!830Q'L,3D)IB$*.!%6F&\6!\VC"&!5;1F^@A^>V,Y'?VO#%'<U=+9;^
M,*[\J?S6", >V]8#6E=1:M$9"R%SAG- !9<>ET)9"(44<(H\COAS)9.YQZ6L
M2^$F%<NW@8S-LC%:9;[?$M6"90]2J1E6@&#" 4:* "ZH D[#7!"+N;,T*C._
MO</01C-N$\UHR38VCFRC#;JN Z66C(O!F1 P-.,Y)T)]!\F!5"'H*OV/%@N7
M8;2S"[-NGK=AC8>KSFOFXVC5>4WJO!#9D$P3A#6 C,"0"\5 69<!"351C%FN
MB?<@4!=M5)#RT40V3B8?[:C3KRR/EHSC#BV-L/9-#ZC%I#5@TI*I*Y19;V(8
M#*B 62 NAD"YG +);4X4LE2CS&,2[(J-*GIOHQH;:F*T>GPW>CQO6U!E"=2&
M <VD 'X+!1!089!K_VM.D$7*13UF!&V0'C^:@(97!+"D=675;;>/P1VZ[[;;
MMFQTQ7"FYSMOLP]("T4H%@!1X>&,0N,M$FP T9J%OT%)R"92"+2AC\VT2U:M
MZZW]<DN%GVV^11\$1QQJ8@'7@@+L]S:$1230!FME$<HR:'=V">D2]%#Y2K>@
M^79%(9''VWJW!MNE!:;5 =.2>6P*2R(@I "2$"!1"@+%$ <2!3IE"1TC<F<7
M4M*%_-8SLF^J'UL4/GF\.K\&&Z;5^97J_,(4%BY#';D T BO\PPRP)ES@$(J
M/7P39@,3"&:TB_-5S:+>O$;;Y6;2QEHHSX;GY[W)N3?5QQTY,'4;C/Z1M7*-
M!;C6SI30N!Y3X-NX]_N@U_\_.Y/1U"ZVQ%4OOC<PSYJOW0+ -0!@R> T 25%
MB"@/ )H +'D&.'4,9 X1@215*G=!K^8T?STQ@/L3T9N<7*V(KE=$Y\\HGON%
M5UXF;1YXNX65@$/E!4-9C04FN<S,E2+ZT,=^OIX,]>>/P[Y7BG$,$K(_.O9_
MIKW)Y>^_=!)<UPZ^SVO<Z?EN>E\V=I[KRU'9HC(.8M#M_.M'D/?2CEY_E".[
M$D?]\/BO>>BKGB;*Y$LY.AF]GLB)-;&CK+Y[8;-G+1Y>+X#X;!8/_?7Z]M^O
M+M^_-1<*87IT?G3Y[NVK3\>G9_ (O?EZO/_>/_,A.OI^].UXWZ_9]\_YT=LW
ME^_._Q/F(GQ  @GI#W: ,HD SK0$"@D-B#;>Y"<>6G/^X[/S"D'Z->^O%:1M
M%22;.P(S8H 0U)N."%N@5 9!K@W+J<@LA6AG-WN:98N>X\(O.A=RU/D2]O>/
MSI6R-P[[/EY3T&%6ZJ*(C?>FDX_#D0=MT\8A-E44C_<//D"!O(5(,L RE@$,
ML3<1B<F!)=CEACE_G-D?8-I2N5I5 +N5J^V5*R]3CD*IO#2%T8)$"* ()@ 9
M*[3FR.:A$Y)TO25X#8A+8M:1U>;?%.K6*9*'X_%T7AS;.H_-D,1/1Q\P$D9S
M[B41Y@I@*FR0200THS0/7,XV8S=%N'6>G*TX;;0X262Y=<B"3.'<.P%Y!E0.
M(4"24DD%9#@ V^:@T\ET,I[(07#?6YG:4)E2F#EB& 0T9Q3@W)@ 5AHHJVE&
M$<PLQYL$4:U,;;Y,>3N+998X@)#SQY[S)QX7T@$3FC@4R;QMIG9VPU;]W/ZZ
MAH76BZ=63*H-:^GHR$EGWVI[KNRHD\-N)^!8_% 0OBK,&B.%;5WCG9P*,1+4
M:NWJBY(++EOIE<YO&"!<:H"-#9. " <YS;5'\SQ'9G7C@-JBY(U5WO4<OZWR
MKJG N$CI8R9S2C, A?7**Y@$ CH*3"9SRRC4SLA-5-X[3=7ZP[J\</Q\;V#L
MP&L(BD!P3T4]P\%&)/+2H[3)E]5IZ=E/#>/W^__T3I[_U?=_0T>?]K+CYV_R
MX[<'7X_V]^#[T\_?C_?].GWZ\_SX^5_NZ/3S!Z(<=\()('(EO+.%(9 Z8T!E
M'IX9D2ASZ'ZS>*T4;;X4.959CPX***7"(#A_7@B+O-^><8$Q\B) ^1VD\%8W
M]:(2N3;/LC5R^-V[^5A@;C4'%@?&R9PC(!RU0&%"$>'(Y)+<5^BH%:HM%2H+
ML:094H!QJKP=G)E0GX#]$4F\&"!.O)&\LTNS;<O>+0CDE8',5B(W1R*/3]]\
MR"!S@@@#K#4V=%@I?]PZ"9!53C'#2*;D?65=%J1J60:O%:C-$B@/8HY(+0#1
MW+OZ.<L!]^<;H!":$ )@7)#0LM<5Y#H&7 AI;\@AVTK?ADO?I\,/C#FMJ,/
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MC +<8@HLHCG#WFIR>9A=R;L$MPWG6Z;+=]SW=46?2*O5Z]?J>2\:6J,SAC,
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MS_Q<2.TLC/M<;SWLLL6X3SC[U_I>_\' ^/H<.B^-[7CFM6>F4JK=XX'@@N;
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MY*==3M?0[':?!7/K(9E\;."P\D[7%APVH9:V&+T..;4R!-,S"[W_E7EPX)(
M+5EFC36&:!K!@2X9@-."PZ,'AY6ST+;@L FUI\4T/Z@()LP +$28NB$A4()P
M@*2RS&N#E9I%<(!+FD8W$AP*EZE\C%+P453]5?.Z7>,:UWC=_Y^]=VUJX]JZ
MA?^*BG/JJ?U4:3KK?G%V445L)YO]!G!LG%3RQ;6N1@E('$G8QK_^G:L!&Y"P
MP6JA%JP/(5A"K>Z>/<::8\W;(H>OISCW\(]&.#\?')X@ERZ[?KBFS71N%>]4
MX/9612/GSVI-E[GSTOUIYWH2\NE;DK*.5"1P*:0R,$N"23X#SX9D:0AS);-O
MP5K@FME7*6JM@[J5F)9.3)=3CC]ML[=1.D-H(.!SZ4.CK"C$Q" *SJ2@AF5#
M2_&N:&O>366GRDX/N-:VLM,"['0ER_C3-G^K'17:HL>D2$E'<2Z"]SP #\A+
MF5"//E7C-BW<6J"F&B\F9Y=15%OS;CI'PQW6L=\L_ZC4_-W4_-NLHE7)>A>#
M!BY,&95())2^A9 ,U\E;SVQT"Y?5UB3!2E:/LZRVDM4B9'5=Y3*2H]+" 2?2
M@[ B@Q<A0B3!>2XB,\0VA;4MM.*K9%7):MTSFBM9W1]9S8A>;S73FG'(NO33
M"XR"(3Y!,9_W1E!E=%-:VQ'/JH9O:XSV(6PQ=DK;7J\I.7_V*KO>B5VW9M.O
MDQ(T:<W!J<1!F"C ,I2QV:5@4[8Y2KUP>6V-=50B6NM(;*6?ENAG-L$[L<!2
M0K\NRI+#:<$3H2 SG1A73MO@2X'MG$20&F^M'-1I9^C>"FPK&WT?&\UDE/-H
M5!*< :6V=#-.'JP3'HRQF1(>%8M^X1+;&EI=N,0VGBO/]HILKZ9JG]WEF6SM
M1UQ(<U\EN)>WSB[7T]12FO:([W(1[O:'W><[]"T71#"G'%"M4 5FE<&GY$#G
M$$AV@;!(VRK";1-J*PXH5&I9HP+>2BWW0BVG5ZB%OQ71\1P-!VV"0I_*HD_%
M:>FCY*/62@>I,E*+[C,QV\:W4DNEEC4H_ZW4<A_4LGO%:T&YIHS ]<%(,#Z5
M9'T9P5+AP-D08J)9V NOA2U< -P%:FGDW@]3AP?%_\?!^\U_XX^+<SYRXW>#
MX<67G\-S\]]^_,/FYZML^3/V*EN$A-@;MTT,E%PP0W/$IX,I?EOX.E>P1C2F
MU',AC([P;$Y+%>EP-,7OFXYZTX,T284JFM&_KDC)/!BZ81BX0SQO?.$(+V7R
M9/8>-$"U)BEOM-0J*B&4,,IQSZSDW,F0E7NKR<:<&W?3G?K&_:X?JQ][(!\[
MAZ=@3[1$4!^/)H/"Q4_'J6S=O$\_?AC$Z<'%4G_I@^=\2[Y\Q'G$+BZZ-WYD
M 5[:&B,/W,!&]EMN2D,]DEZ]!Y=_'GSN[W",+@3X<7+_@,MXAD_=X0=W.MGX
MX2K?(ME>NW'7K_GFF[^>STG+'UO"4G1N?3W7^K]N_[*U^[SW\C];KW:VGKUX
ML[_];.O7U[WMW6=[KU[NO=K:?_&\\]?0>[:W^WKOU^WGY6Q[K_?Q?SLO=O=?
M]_9^QK=V7KYZ\9\7NZ^W?W_17-;.B]Z_?MU[_?I_.W]=_QH,<?D?G> QXN3B
M;-L]$7:K$[G;K6J<OB]LV+B9>*:'[GB2GE[\\F,<3(X/W>G3P;#YON9#/Y[[
M:^<46NCC^JY^^;ZSM\^9Q=HG4M%"+N?!A?,O/N>=)PWO7'.9S]Y3^@DU],:W
MR9.;W_O:8>T31>UW'?7K[TDN'O6YZB>:\EL=]1NAIF]N8U"Y<>WQ+0*B**'&
M!^]= .Z:3IJ5%ZO9C9C!<+/V_IG<N/=B&%$_/$\AE<V 'J?]WA55N>B=XP_P
MQI48T8UQNCM>\&.[<;3>N.^[<>0NL+QMW'XU^3C?5"'-->]>3\Q>H-W=U\V_
MXO2DV]V..Z<GW?[R5[1G?KOK_FKN4OMQ_AN2EO!A_%)&LQ8;XWSGV<7&^#M\
MI6R&AT_X']][_IO<.=J1>W_\=83'HGO/=_"U+?;7W]L?OVR,'QS^>?3;Z=XO
M.Q]W/FW1O_[^[>/>_@NQ\_>[3W_]L4W^VM_"\_SK:/?3-KV^,;[WR^^#OYYO
MBS\_O?BT\_SWH]WG+^3._KO3O>=X#7^_.MQY_H[A-_.=OW_/.X/S3?'7Y./.
M_C;;?;[U-C"?O"$!9# $!$D!'/<&HB&.*)54L&)CD_,^5RWTU[K+&M'E=,M*
M=@^![.[ =:TG'E2*6Q;%?;I.<5(+XVF0(*-/()#HP$CJ03D>.<W$\& W-J7N
M4[Z$J0&5YSJ#]\?*<W=QZEI(@ZA.W3TS'KW.>(+9H#P1H+BV(#RZ=\8X!08M
MIJ6TU&6*,K=OYS0[[YY/=]^9ZZN$ZIOA..%9?#HOE7[G!L.+0FG$K7OO!H=E
MHQX0/3!Q99L_A9/Q8#I(DW[SB5'N3=W'1?+:NY3HM4ZB=6]ZD,;/1D?'XW20
MAI/!^_2%[K8N#/?S:/P:S?;ZL]6VXM\GDVE)(;EH"E'9[R[L=SHK:2GG7G(I
MROA-!2+*!,ZBKN5$$T.9HC&EC<T'UERK(KQ%J581WBF$SRBZR TC06C@UAL0
M1',PW)=6IS0$$5R(06QL4CJ;)%XA_A @OCR14B&^&HC/2!@2=.;(V!!5C CQ
M(, EQ<$R[Z)FB@032[XVZP;$[[N1TRJ1BH\__G/8PZ=_G(;AM#<=X\'."FI[
M[C,4%AE@NW[T=;\2Y/:D=6ZL9^>VVB^F.CO%K6'<_V*X>11V>8LF#SZF")_2
M>%2I[0[4MOML5I\PSFU@*D"V!+V7+ B8[#4DDV((5$9<VC8V_^?_&#3]CP^O
ME4GE@67%E"H/=)D'9E0,H5Y9?/2!92E!**W!9I* 9^%"QD4A95YY8$UYH/MR
M9A%&J,B_"_)GQ(UWF@@F+6A<\D$$3\ 3:L!JHZ@2S!(9-C8%FQT<M<ZM@[JL
M::Y@Y#L3(6]3]DNN5OY>#9@]Y(AZRS?GP7#_\N)1<VA_ODM7H^\+L/OK67WG
MH_(TH*!SUG@0(G,P03!@-!+JHD$GSS8IE8(MTANN741U?-S"]U]EY=4[WI].
M4^LJY74EU/LAU%FAG++4VC%0U&@0EI4<]<#+9,/2<$ZA,463P-E4BBV_=\N=
M\+3.Q%I=U47O3*?)M!M[%)56[X=69W8AC&=9N8@&LX:"D)X"OE2V(F0FQ!/A
M<RG]Z4M-ENRF+ME'_7HOK.XW$&F.N-)>5K5CSY6./>SJ/;C>/N>6C;_XY\9?
MW6SSLTZM<"XUFI/WVVCNJY<TOS%.Z8OS>G_OV?_WG[U?G[]X];H)\>@?>R]^
M>[.]_V>O"Y1S^[XXGU>"^VT[@T_Z$W+VM-^U[PSG3YA4K?=',4^LT4OIY7+S
M=WY_WQEFON^H]5SKN:[F7&^'K?-8U36?A)V)XN_LJF-G_G3%;4S4$WFK1B8H
MK8Y0UKV>CL(_M^@$<YMF+^/1A^M1^^\-\]WGRG;;.[:%EU(\4'>XNE7XMN=Z
M[ 81!L/NGVAPQT6\7'-#[_9P/>9G,H23HS*P)L7NVWI4,DZZ?YKA\J93]T]W
M?D)"Q=&=;N*K-"WEM.E\(EJ]C=]W&_=',US>Q=.<%*?G8'2(,G1R+K"[?]+I
M_YT,IJ=SGLSY;FW1Z]_OUJY7Z[[;WL*SP1JU[^'WN1I'HY.O5.Y\X^&ZIS:)
M1X,8#U/;MTC/W*+Y0;.?W*$;AM1STZM]7!FA=I&2IP5"K?<86+SM7;K;[!TN
M-=X"JD4T6B1-'4\D.A-Y-MXQ0=YNE[O[[0R-]1RJPW<^#]4)'_YZ_@J/?WBP
M<_3[P<ZGWS[L[+^0.^PWL7/TANT>[;"]/W[[\-<O+TZ_!!#_._CKCVVQN_\/
M^W/_KW_^_%3.[=7@KU]VV%^_[/ZS]\>?'W?V=P=_[?]&K@<0=X[^>]@$)O?_
M.M@]>O7W[O/?V.XO_\5CX''8;_*OOU]\W&'_/=Q]_BKO[,\9"$^D5S2P"(XS
M"L(1 XYQ!<8K%KPP)%MR/E1'++NS5I=*&Y:(]?M+J[@MU-OKJM6)U(F%&6XV
M=Z(U>KODTKYH/,5*87>EL)FA\CDHH@4%%ZP#H2(%KR0#EGWTU(J,5%9&#E;Z
MJO3U2.DK68(+.55!AB0\I29SKH,.46HCB-&+T%=US]KCMID1]51%):4+$$D@
M( QWX)&TP#+NHT$/32MTS[C2?<X6GJ=:":X27)<N^R[)K5+FJ%3@(H8LI,U.
M92ZYL9$&RY*.-S/<#3FMU5-;G,VN>VHL:\J\]:!3D,AF.8%1E@%5E%GB-#K6
M=F.3+=3TJY)8);$N7?8=.(QX2Y@/7A$2!4G1"&0N;GPBE$<F4O72NL%K>S->
MFLTD,VX!O6OD-4H4.(;^FB5<"I2A3G%4H/A\]"E9>#1U);A*<%VZ[+O4<TJ;
M;-FKX=H)'HV+7D0> S$)7]6\$EPW"&[GO,P(2>[CSM]_DIVMMX0SX:CF(+(O
M_4YB0@W*."3&/,G6,W2^-S8U"E'&%Z[@O!>*NZ>6**L-=6Y/)B=-K'.4\2*;
M5-(FJP)1BK>VEXZ.#T>G*9V_6%*JTG!RU@;R^!"_N.E(_U!:T2\G\IFL\"$3
M;7QT(G!B94Z>YH0OL:"YN$59Y1QV*X9+\?G)&&_>2[R.43R+C#8_?W*3%)]=
M,E9EN#LQW(O9.*A)PGE/"<CBO0GN#'@J%4I37+((R]D'O;%)[6P=Y?=5IW>H
MOORAP_F\_5ZU4\?M= ='TJ$[(B.S0A@AJ##><D54%E);QXW.;7'N[^[P)-U$
MN=7C;(^/9P(?0B84"9% MA8EM44JMCX*($(1?.J35\X@'_<E7UA05Z171JYV
MJG9:7SO=;Q.8NG)V:>6<LU?C,J?&)@E!:P9"$ <N4 I.T:15YE%0U[VU\U&D
MGC>( %\@<66WY:%,VECNRE([H%<[53MU33M_Z2X_V1]]J;Y_Z09Q>_CLK'"\
MX3U_W1-X58KE)H-I>IW&[P<AG;D.KU(8O1LV1VF\B.HOM.<O;,\J;96-4H(G
M2#$F$%Y8<(P1L(%;)9W0S)<40]+7K*T4ZDH,E<"KG:J=UM!.JY3:=:%=IX5V
MCC"7B7#NK -%> 21K0)O&8-,K&31&15R[N!2^R@R)5ZEXY-Q.$#D7,^5>&SI
M#S>GW=]C_L,7<\Q)@JA<="<NVIE-=[#.2X-F C0' V&D 2L(@T08-=9P([/=
MV+1\MN:[CM]>1^3.*PF\1]B>NQ<5M7=#[?7ZF60H&HPA:KT4Z#\P#9;E!)$*
M$S.5(MF2I%0Q^T QNYRTEZ]CMDJ"]@ ]L_>6\($-21)(M  Z$ 0TI0&\B8J3
M(AREV]C4NF_MK""HJ.XNJFOF1+53M=-J5LGEI+C45?+>W-[9C3,1<Y*26##9
M1A!1:O#2"M#1YTPR9]3Q\W6RA7F<-9OEEJA\,QPG/(]/*98RH5YI;=Q#;+KW
M;G!8IH( P@(FKLP420%!,QVDLXJBLL464T[C,7YTZC[6])<:[:EVJG:J=GK8
M=KK36'5<X6T4-D0C!-'611]#YMF'Y*C/ZOO'53Y/?OKZ\X*T=;%:_3P:O\:U
MZLNB]HL;#'_%-:UZ<'?RX'Z;;?R3F6,I,@>F]#(3FDEPACJ(U&O#F1,Z\])E
M=K9R_,Z-?RJ:*^M6.W5P2'!EW26S[AS=G*+.C%$-S(H$@ND$GN8(UFNO'!'1
M<=,AWGT4B2;XP.,_ASU$PC@-PVEO.L;#'9XUW7"?4[P>6]9)W8FM=JIVJG9Z
M;';JAB3>*S/_GEV>J+?=S*LKCMCY@O7L?+W:+\O5V;EN#>/^E\7K2WKR;IKN
MY7WWL;IP=W+AWLP*9V6=M]0Q8#$I$%X+L,EG2)8SP;P0EM*-3<%X-Z(>%?.5
MFQ^0G;HAG"LW=X*;YS5:,-Z[TO(W<.U %(IVU!A4VU$[Y@0G472(G1]%3/I5
M<N&LV*D =I1[9P,Y>_$D]::C'F*/(^S\M(<7@1>%?WE08/$Y+%VCT74?M]JI
MVFE]4KIO<!MN4RUZUCR[^!:C(?[A7GXV&C:WTA^FLE]?$]O:\R#^G-/DD)G(
MM7"@@I,@!&=@60F06JJ,S9&XS#8V>9_Q%B:B5 *H1%WM5.VTAG;JA@ZO"VK7
M%M0YDMQ$=* ")2!R]E *(L$;;O'!-,[ADFIX4IU:4A]%S/O*M^)1 @P^P@&>
M4AH^K4_Y5Y_R,-UY=LUMY#YQ1;D&K7T9"FH=6"TLA.QY,EIG:_S&YK.3HY.R
M^?<^ 3ZK*4PO)1?T\GATA/\>'9_ODIPM@5NOW_20$A50/G<_I&8DU%WZ:J=J
MIVJG:J=JIU7;Z2ZJR'.BI2+!1N*$H@K=Y!RDM#['K%7TK8Q'KM*F/:=O9L:H
M$4J3P .0&#D(6094*8D21WL6C#?&:[:Q*?MHVVY$&RN*VP\6Q*"I<RY$RX10
MV;'LA$W<$9^,T;2BN&,HGE?*3G7BD5 P:"L0B5OP24L(#E]56AIB?:=P_"BR
M!IH<FZ)U+XGD2<T#J-OAU4[53@]U*$-#>G5-O].:_FXVBD^-)#D8!2GZ!**X
MYR92!<IR87(.F=,2Q>]00^>*W\JSU4[53MU=#U<R.Z&NA]^S'L[3N$+QJ!)#
MC>LS"!4B.)8U+HLDH#&SYS%T:T5\%%'XW?,>;3606[="JYVJG:J=JIVJG59O
MIVZDMZ)W\*6NM(:!VG.1_YD-YC*IC/;H%FMB/0@J#3CO!9#D?3)41\?TQB;K
M6S,[H;L&<RN2*Y)7A.0Y8I<R+X-D#(0V^$-8"\YY#DIP0;4F6@?:*2P_BH#N
M3^[0#4/JN6GO>0KIR*=QC]-^J?\FB\1U_6@<TQBFH^.GY?Y/1H>#V"O7LY9\
M=;=)?\8S9"@?J3-9F( +EB:.VR2DYSQ*4M)/;C5/H3GXWLET,G7#<L\J1[7&
M47]OS0[[8RQJSH,&H[( X9T#BYX&^&B8(,%K1UWI MDGAK2T)W<[F*S1?OOE
M"WK"Y .&_JRGTAKNYV2;56S?#=O7&X0YQ;2QL0P2UHAMYBC@PT@AQ_(RR3EI
M6["]!%Q_%085VNL![2B4],F6+!/! K<Z.Y^#H%%1:45>!-IU36\/]S-))XZG
M1(F(X+/4('@*X S2@&DZ048=HD/<<VKZ7,XFDE;P/UCPWV4+0B6GC(E24&Y%
ML,IR)UCV-BC.F4ON9O3?(9^\(OUN2+^^PD<D8Z<Y 9X]!R%HJ6C7$GS(.GHA
M,Q+WQJ8ABXS]K0!?/<!-VVM[I(JS)++FB0HCF0]4<J\\JD#C$.)U;>\&XF>B
M \$PDB(*=.5"!F$)KNT$Y3M*>$'1GY=!<%S;+>U;.3NYH:[M:P?])3CV*7LC
M!/=!B2Q21+7N*=ZHX&/FPCE9P=\-\,\)*"#JT9\G$:*0 82*I><W(\ $I8Q%
M$HD5&YN:V+YDLR&%CL+_4238;4\F)TW4893Q(H^.1N44$#\(5+R[O71T?#@Z
M3>G\1?R+XS2<G U^.3[$+VZ:KCRV[+R[Q2"BI@;EBHCEAQ/(:U%+$@J[18XJ
MN(F:THNH*;TEP17#79WK?!:C:'[^5&8^/[MDK$IR=R*Y%[,1"4(UU<Q$$-0I
M$%IH,#D3P!>MI4D&EE#3**,7I;>: M$9.,\1*/>$Y69&>X5R.U"^OCU!',K+
MR!)0%)H@"!?@B=&@!;$JA"!L* &("N0'#&22$Q>H2ZDR2:3L?!E.PX@P1)'@
MO;X7(%=5TA[*9\(-G',J,L*:H(8$$3P#GT01)H1YU"HH,4O"HNYK(2K4UPWJ
M-5&\VJG::46Y-=*IH*+0,HL<K94R)T:<44I%[FQ=.M=LZ9PWA5D:G2W*6T1O
M N&, R>"@BAX4D8E%60Z7SP7WL^K><)W@VH#"? %$U<VY&KOI]I#H=JIVFD=
MU?-M>ETTO.>ONP*OTMGHO/0ZC=\/0CKS'5ZE,'HW;([2N!'586C/8=B>U=K)
MD)*P3X!3:D PA>M3MAY8"CQ%JU00>6.3F[XV76JA48FA$GBU4[53=Q?:UK5V
M76C7::&=UZ@J6I)BYA"<LB 4SV!E-. MKK39)2UM%Y?:1Y%,\V8X3G@>GU"8
M#\\;5_40W^Z]&QPZ?Y@ L0$31$!ODL+)&%&3)I^G%L64TWB,'_W><<YKO/M8
M=XFKG:J=JIT>FYWN4OE4W+Z<=$"M;84.RD2M2)+:"?S/Z'@+5_"&$J@RY?/U
MYP5IZV*U^GDT?HUKU9=%[1<W&)[U9ZENW!W<N-]F"Z2LLM8JWI1 $W3B3 #+
M8P#-N F!!>H).C%T3@UT;:747317UET/.]V%=5L0X)5U5\.Z<\1SI")PM!QD
M$TKF)Y5@C#2 3[)U-"EOL^H0[SZ*</:KY,+9SM+97-]>:FJV>O$D]::CTOV*
M(Z#\M(<7@1>%?WE0MJ_F3OM])!N(=:.WVJG::34.00NA[QL<@MMLS9_5LY9M
M^=$0_W O/QL-FUN)GD-Q*.KV>WL>Q)O9.'?DW"AN+?@R($($)L"S9A)BS#IF
MC_\K;>E87Y#9.K [][:H#%"9NMJIVFD-[=0-B5U7U*ZMJ',TN=719*DY:$(T
M"*T\.&,%.,VXB,P[S4VWUM1'$<O^PXW';CCMN6'L^1'^.$CQ74(<?QC@/Z;X
MWN3,!G4V4]WFK7:J=EJKO//#=\-X*_?@G :WAO$G),'_% Y\TU#@_B4&K&[
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M-KM-.\4ZJWAY3/5N=C* QP4D.ZU Y. !%QL/)I,(S$LBDS?64-;,*M:JK>$
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MGV$?BA\*;22CZN51H4H7*'.9=P5>5ZI=IC5UF=(DE&7PI:+L81I5;U)Q2W/
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M0AF;*R,)T7[9YUX*QWUI/-@DAN>&FZ!!^@KI/(LUNP\3K.RV^=*;7W?R-V
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MAR@.5D,OPMA",[RG"*@AXX6E -!!MQ/'\C(H*DMA$* +*K8 _<%(@LU2ZUN
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M<V2<H RM#F^L :M#A4Q*93(:"B5E8&4AL#:2[JQZEVI]UZ^8)]'$ !%W)>N
M<('\\!_(EI$"N[Q:<T$D*Q1K>$/]V P'QQ&B1U0^_C!P\",H0_PF",B:P>'7
M],&:MA=&GG2N2*Y1?ONY/SJ,CZ\VXJ&_*@'F9_C4;6A:>$J%$RJ4RG/MM=3"
MZ%)I&4PA5!X[=J^2\LO]%PNTO-LL^54M3E[%*:'G[ U(^\EK%"5XIY7;:^30
MEM@O(7:V]^G-$0#MHA" [:A6*N.<Q48]-G/,ETHRJ4J"1?WY%<0>!6<#.1JU
M,#]#,Q))R9X,@! C%9J+BD3AG5J13/PQ6G)C@ RM]H@T'&D3*7=9E*_(XV2,
MM%"C'6BG!ZJR9I::NE>GVZ]&/H<UX5\"E_: P)!E6]T5H=*E9 ^D!5AMB?*#
M4(:5 -L4U5SD7F&C!!V(TCH/)=4WH_QJE8GL+_Z 17I4=KXAWXS^>/1;[']Z
M>V1!2)>$R"P4,F0\2)5)!O1;Z+S03#%I2OKHB5A#OO]"8KC=87*B)?%..9IK
MCL-;8H.6)E!0SW":V\/\_,,\>/;RJ%3*EBP$$$;>H>9UF;&<9$%997-6J)(+
MC.RL/<TH]B.\/ ;=A?H2A )8(L,U(/-F,@5DTSZ85R>]W>@?U _#+&B,;*!%
M>2>VP1]Z"&\,];4H 67GYX,$P+UE"7,606K.N#"@@(0HBP H.)<RYB03N>P$
MVH*$^^1+>['WZ?D1D3ZW 1B12,4R+@N9&97[S-J\]"!X?:'XHR?R[C!"37%=
MF&#'D[/Q!-BZ7_L&:KJ]%#_\<?C_93FEMS0ISV R%^/1!4Q)(X4>>Z!9?6,<
MT<S]KJ&$RZDO2&F-U827GDI6"D 4A2HL9=23F_''5ONLH7*R=_C\J+",".),
M%A@'[2,DR530.O/.&N^9('GN'CTI[@9**!*XY!J/4W"P[0TA6A6%HE85%#ZU
M/<PO.4Q[!-!/*VIX)K"M$<<+)Z6F+"/6<$*YTTS@!6H[JTEP5R&)\_%DZ,[1
M_%[ % @E*EG3>)GZO0'\<(;FNG?]WG1NWGD;%6<M(-"%1,0OT^3%Q%] 1,RM
MCY*E]MJBP)NB2#S5[U%>-:(3)6(M&0<3@"W3&<A$M'?^!KFDT4/PQ:XHP@MN
M<YT;Q4MN\4HZ"_@7U#0I#. T$EU10*3)%;5"K5M7U!=0<;3.%>5@87B=,47P
M&D"?9T8+^!-LD ++4G//+@'$RZZH1BW=SAM5D?7G^J.:KZ(ZOHD[JOG>U9'Z
ME;#1C3.F*KC,Z8XH %*O7I8.[#T[J5,+.R]6V#YO7]%F.A[.9Y>_\@7WTN].
M8%\NL074C4R!0BUM8>=_3R9M4.W89P9PS_M,!YCASWIXKB^FC_Z]:-Z ;;.T
M<<MKOGSST_^N35O(<]"K)@^4 . OO9$ ,"G+M?&,&V)(DD?PCG>[*"+ U"]%
M*&7PA08QKB2UI1)4:TZ-U**\+#T"1%-A/,BG,@_ .\XH Q:E)[+0\ ^GE[\3
M,#9N U%>*RZUEF#6LP F"0O4$2T?;:3Q]S=R+YPAG)9/S+P<*(M$GOBV#E>X
MED>G)]'-:WS/GFB4(S"-3QB? XOPNG :"(>)!JB<C,'9R1QC/W50KG9(GZ+6
MPK^;.-15R;K<??VT)U@.&J3?,/T][=[-4VWB?K[JKK53X=#;[:[UGN=\Y0R3
M^1-!PW@^29%2/"X\>SRP%!KU6)&!A]=X7[O'OM/;71><Q[AB>OA$NQ0R0Y,>
M!MX&LQX$@CB^V/_T\BZ"62LHLE+YD9[FTT@_T[D]Z4<:7!^A7Q$\2%1@58V
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MQ26,EDB]24ELW-<5>ET355@B3^1W[ , +(HEW,/AV*96)%%NP@S!KJ^M[#K
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MV&Q:!W=CE[-&[N $3S%Q%V4'_'#=VC$D7'%O)97:Y5T".1,_WO.>]WMF/HM
M\/J-CX1R#8ULO-3817 'FPR:)<4XQV<S)(O=UV]B##XC;--\HB\::GTYFLXF
M\Z2T8LTF^:67&DKVL*.DG_[<VTN"I,ZP?-IVQ4P)6NL'>WPX/AO8'J/E3]_6
M[7J.5LEY)]$9^1+4ZWF$W5%"HRTUZD+BY25>J5"[Y:_5FY/!]'UEX'U>3K0
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M[?L?C GVGUE@@+TCJ@0)'N0CP#DPF0K",FT+"\83=;0DA:>E6<&V3F G9<H
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M]%NC&$%2W,K?3KH^M+-(A!=TNH-*$E=ND1G=HMF O[4-:$;)<Q&ZL3F<X:Q
M?@9:?=*Y_TB301\=B/[01SN@%R95,]LE*"G36;?.*P2K<]8O-VVH <WIP;%2
M&T_/>J!0)<]3N:M)&T_&S[SM,Z2%T@*H]@((XJ2Z7/FY\IYG6^![-^U@4OU
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M9WQL[]+P\LTEA=0$,D4@>UO;AQH;:[0& L%,(&ZB0I9$(! ;101E/7!+@$#
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MT.T <[1BB5'C)ZY@'GAWF0'?/^LG%^S09QY^P P[)2>EM$SS(TNI,P#L7D4
M4WF$@^"..SGRF?3:P2AL.1S >M(\)I^? )KR6Z$ZKI#RU$9X.\E#$V(C!;1
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M&'ZL;?!FH5G-_2^:^Y=N_-3<OVK</V<2"5%H#H(>16H<XD2![!>"(ARU"82
MO<3CVH9J<G%OI^JR0X>_Y0IABXH=7E7>-UEA8E3;=U$E_8<MOI>HO1>.0Z</
M#%&6PBX+I-=ETG<OWQUJ@PTC2J*(-45<*HIT] II(B@HI!H3XIYGV?.IC6],
M%4%?^9+4TV.?KB#8"Z-*A?.5SJ>*;.9"AF5?K+FRW/UAO<.R%T*JT%NVUFH<
MF595?C>]LFRC->I(A."]J _H#S+(#B8:J#=SJQY C:J90RH-W8,5J%P#T_4\
M<VE?US;]?BL"WLS>D0<_,Q[X2S6<JL51'O;< I15M>=F,WZZ[&N5BCJ/:YZ_
M[7:RCRA7DO\XT3XG-JXAHANJ^3XLJOU9+O;;:JWWTU*7$J*_V?'[XY7OUS"W
M>^D.*;4F1B\0I0$4;H$#LJ+@B%L):&=4%,8\3YBK**$Q)(7&Q.:O/,XE9OTC
M 4C_N/$^Z2W ?J&7VS&=FW[5SJV3Z3H=;A].L>K?U#^S?=!U3>^BV?@W]."6
M5G]86SX]#DR=42+"S8/CQG_.3&]0]B\8MA]LA*DBC0U&FJDD/UYO_#G1I/"J
MNX9UD'NI9'ZW['^PL ]7+NUO<\_':G,R? VZC4_K']<;6ZD::]D*<5$5;,4P
M8BM7"'N"S-**_CF:]QA 'WC UPYOO;%Y=<O*B5TP@[2[J!M155Z_;!T)1-0.
MN?U=YZSJQ5&5JE_TAF&INME.EW-2=ZJ-4",!]O>RD6#W6^I3EUKZO?O/6?I3
MJS_SC;+'7JY67WYF6&Z_;"Z6OC/1\.\*V5N6O1\*T-0T*>=%=3NA+-0/Y%>^
M(PG'7%#;7:V)W+_Q]")KX%F [@-+=QCW)@!!:B[=.7K?ZW:ZJ=E<WL':=BF%
M>NJG7L0 ]C)8SU:D%"5E,++1<D2\X=03[@0N9BN%NZ@MC51P"3:XYE;+P**S
MWBDE",-SE<+'^Y" K>-S<_%/ITE7!%GS(:22H>V+QJ;OG@+37%7$>\PA=0<_
MR5>_@]\M.O(M?.Y&ZEI)+6R[T]@\.P(9,:'5_+GY\8_<Y @DP>;'3_D*PG+5
MM)"M9(6B1OY/5IC>CEOZ) &YEX787M53YI>/9W;0/07$Y@4&]/TUW[.5&F-G
M'BN%ZO\$?Y3X':67#9+C+<OT=[#9@W&+I;WSSE!6CU^KB$ <__JF,0$;R9@M
M1S7(_6FW.WV EDH<P^>F/F*N^<Y3JE.-7]* */Y]@A;R7\COE<U]=-8J]=9^
MZ^2T#79]U0U[HH$JV/M=4!&3<I'W*C6CNDA+E+7@OS8WW^?%JMJJ3JC2K8DE
MRT^Z8Y.6#.;2'[1<MM2G=+RDKN4U6V_LI X\J:-5=C6TVQ<E?8.\[?BAM\&=
M]8>^@-$T\D@FMJTULVU^1#6-ONN>EJVE,IT-'YW:U3"]JUW8U>$(WPZ[Q@_2
MX,S45[.79?SI)M@\H#Q6IM%LUZ_)!F3#CI>F),3*(Y0UOM1MJAW&C34;)[F-
M5*EFID8KYB3UO"I[-?4'N3-,IUOI@R!R4Q?FU+,7A@]+:UOQK#?TX92.G=3I
MJ?QW?V*9^B6==( @1XMLVOWN\$WEG%H15?.'SY<=K:H.5;EUV7 >[?:UFS-Z
MY; 1%A!1:F8#>FL:_/HDI.5VXUE?3WN9WAY;*<!1]:>W < @]X_.<FAL!1*1
MK4"P!4N%.MV2^X^V3D8^ME$+\-3:?O*USZ K_&=8\E*K@?'#&HTV;;Q8_VM
M^O4N&J4]3"=:DYUT?8* M!.#7G?44 [VL-=-O<R&QDMN(M0KV:C5*8-.B7*.
M@73*3NQ@-*<V8*49U/$C=:Y?D<78C5G:SMG@Z@[IONS[/=3;QI99Z1Y-NU)M
M54F<$Q;4N!'8A!LU>14F6IGEKK,3]M6P31W 0:88:]IYQ> EL YE2^UQ@_2R
M7;VO^MWFM1XR4?)N3+0&3%8;<&"["V/HC3ANZ$/HA[R$DQP]!L"Q?5=-<=S9
M;MR?;;I[86X.63EGAU;BM9@QC1?#QKENTJLZ7(G^<0B#D7.Z,HH7NU?H.NC9
MV7RM%@8&.LFV\)<9^FN6G;\3%61B6; S$[,<SV6T1,UK>MQ/(,FI:7D$+ IV
M0E)4*L29V=^TVJDOW'@(B7@F6Y9.MMUTIM>[&'?H6[ IJ0E6!'@N6W-E97CH
M4@HE<]QQG]8;?R:W6.BE9O"W6+I2%*6VEVDCTQNJEEQF,>']<O6*_3I!E1.@
MT3<GF9]/6OW0K":\Z*O7KL#<D+J=-@C93]57AGZ54D"5 J;RXUW%^Q-04L$
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MZH4P=&".?.0)NLJE;OQQUH?/],>95#NAE_SKHP>;C=.S7O(\YE>4"M/F]Q9
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M;L/8ON[^M7.1TI0.X(F#_2]?]_[:H3#.'[N7_QMW+B:+C1_0W?UOAYBJH)G
MB&O&TD$FC8PM,"),!>RELTZ9M0W25'P^]_/9]T OT8BML*@KBU2X*8'W4AHF
MO 3(ROM3Z2-E5;$:KI8%5]-=YTJX*DC FH5T(H9ZQ"4+R' 54%$$J:AWSD>
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M-@6[=YNMVN]U=W9]WTMIHA-5PT[+6'6M9:T4;@VWZ7W;=%*"R[OA3M5 ]A!
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M:&76:/Q2Q:!^K2MO/--!OIZ44-/JE*Z _G&W-T"I*S>0\??0SQVTZ_(;*W>
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M+&FK1H2'B(GD\U3!1$<*KQ$3OD#<IQ(V&D<4K'9>>VR-+]8V^+(J#=> L/*
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MX) 0++1D0.E6AE38,%7&LARE#9?" $W0=$BI"12P0K'(&M%J1+L:T4)4+M#
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MXFI<JG'IH5K4>JZHE<[[!/H2]X92BK40DNA\I'5G%V]MJZT6?^;U(JH%#0D
MAQGE$&>8(D,H1P1PR7(KHU=AW6RU9Y,T?*W?JQF'UME!:_ 8LX99G35\6S2
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MQ_07C'*_MPT:[*,HXO831.>;?(1YL9M[?IR^P<W3ST<)*RI3<BB"9$)<J(!
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M$FYKRAPS9'%KT=Q'5 E7X4VI?U E7/E-K[WYFJ8_:+!ZE65[KQ2WO7>%WZK
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MHZ5=@YBZ\$*]+"0E^'8XWF3T9SRQ]=ZNB=T>$YO+;M^W^3B+0&[UKMOV]&P
M_RWK0+;]OO$D6LDY,LHPQ(DGR 0FD(R*1!J JZ;86 ?RN ]MVG+!\O"F/3QX
M.,PRFA"U..;J0XFTI1X)Y7&]W%'Z]=SE,G[,&6QNV^MR?9F+O66!^Z-L;[CG
MVJ;6(W_XO!;A1>V\8>:A"VAN>XUIOCZ;= 2;_:$+G:Q9YB:=E7+AI@_PN 2=
M;7MZKQD>+W5+T!7BUKO^7O&MN&%N;MZ(AQ:RW-M/60U=F>[;@U%EBVS8>>A
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M(D:G%.E=E8PUAO" F!UW>IUCD.O1C,<36\_S.>F?UK5KHX;2.GS?.  (XS^
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M<8T?;SV38HJEFSW5_\9)58\\'W1D_2[JR6/#\5B8:I_>[;=G#<;% 0Z.1DV
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M^-_4^[(Q>ZBMHWTTI;CQ/\V+DR<*PW]OG#Y=\SK^F#W?OA]^[!W,'D,WX/O
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ME!<R)PIB;4-W)6N)Q2\[IG%--G;Y$=?OGG)]ZEEFR^^@=J-HFR) 6U"!<8G
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M PQD1E/[K+G&2FJL9/GNU ,0E.I.W3O(?5RD+"QG;;74!*D)NE-> 7%."Q)
M,>$T8\X4:<*N,HMJS#54\B1L^P'H2K7MA[#MA0RB2),'04DY<TPD!86VC=Z)
MLP['G#. 6*2VNE(N'D:ND9)'2# Y&F%GP%07 D=AM-<[K 4?KR[X:!G./)J
M,2E!V<"53A8BC<;XI%F-FK0/ICXO4A!A*=6!(R[ID(CD)A$OI"0T2 0H[:,K
MF]*\2,$O;M?4L,F3,6?TK6F*6@>IG=1<A^QMIE);21UC4=:P22O->9YUY)"Y
M2,Z0P(KR,<O(.B@ X3+F[(,+C(46FG.-F]2XR?)]JP>@*-6WNG>4>WW<(-R$
MN'S%=M#-E[LJ20$XIH1Y9HKRCR<N*4N$-ARDX2S0LA%MNMK4+),G:MX/0%FJ
M>3^(>6_.FW?@WCBC#(E">R)] .(X%41E@\Z*2<9ZC>:MN\P^K^C)HQKGCT[H
M'(S+$!SY?HVA7%,Z4$IE5,H"^T]"H"XKKBR^XHR%[&L,I8UX]?42.F)X$  6
M2#":$IEBJ:B;([$\6_Q?Y,KSM0VA>9>VRN^J891EZ_G;Z)!_:L&C12;BK!7.
M@0$G-+69\1I&::=%+S 0%F*@)7V,,2&(Y#83KX(AAGF(R0/GB;;1HI<426GN
MS56;0RHU+')+O^D!6$?UF^X?M4XNX2'4NQAXEB1QSXIZCB2!6T&<\RHSP[DO
MF\Y:75J+I(9%GH1Y/P %J>;](.:]0$I\R%Q%B"1IKI&4(#/Q%#F*SMDFIG)F
M6A=2TN5LL9C!4PZ+/!X+V1Z,?;_S\;P6\F"\5PJ(?%<1N=LY@/%2RSY=0P?R
M"8N&+:5KVKT&/(+FX3SN;\'X35/& +NL"I'= ^A_NX3319VCM8 S7K!(I(F,
M^,P",9X9!BPEQ^3:AI2VR_@BZM]#@;EKFE/+E10KF%8P?5#EQ@JF#P^F"PPZ
M A-*J$0$CAV1CE'BM<C$LH0N$UBMBZZCM+R+'W@"8/H#_CVKH($/"=_'WX?Z
MY/4*BUY=7Z>%54?/N\BE LKW!2R758HTPX5*I.6/H\,?%<]<0NV?J\,&/ZB>
M6:I"KBBPW;X*T!N\Q\XNJ"25S9((%3V1.B(@">I(#@&"9"$:'DMUAWF#F%32
M7.]<F&%M*5#YZV T?IO+RE:J/OT-PR^]"*._!_U;Q(R>88$[OO7J,_X=\?I1
MX3UV;<S.4*.(E1R(!*6)RS@:P#7EPF:6DU_;$')]\4!T2^I8UAFQS!GQ<5>)
ME*1&,H,S0A")<X!8X(;0$)T-B0)RG!_.B$<O=UEGQ1)GQ?:[79P"$KR-A/*(
M.)&U(5YH31#618[<.F5*!06VOJC0]*.JF,UR<X=JF.N=UZ=$Q5^V9BW<J-"?
M2^\D\'-(MC_NE3],(4TWF<2W#) MS-WO[9&<>[[7D\?;P:?:/A[4J7P%%Z*;
MWTI%1!J]-(*$G)L]CD@\RT"B$D$9[EE4]"&"H4L8Z]\&1\,ZV-\;;*ER5BQ;
MXE(1B^2XEH7L8BFS( 6ZXL*7TMRM'^PMO/]V4S%X<U *!M=!_]Z@&V0*R@5'
M!-)+7*"2(4XQ7NA"4-$Z[ZA:@4%OT'QO"%!'^WNC'0WZ#-$B214!1UL[3W"4
M-5$T.W Q)N-D0U(7$U)N\<(I@SF$8<,BUCN_(:< '_=FX9#;D)BRHPL-*WHX
MIOQFZ[>%$/+^H>\-]^%@O%A9>3)YFZ#2Q0F9>U\AD6\P')S.1?H,Y^+;[;BK
M)2XK+DH2-9-$!D&)T](2'",(E(H(]&;<XHY!DSK$RQ]B:T,6.9,<&/K$)5[B
M4PB$(?QD2#E''(*;#/$=HR!UB)<^Q!&-+*D )$M;RJ)(1BPU0)*0R5NPB3$<
MXH/!K98/]$V'/=_O]$X'J:P;BU'ZX]YX;QK)[Y3A&JW?:!_B?F/P?\<]2$=]
M>)M?QC@\@O2_/1]Z_=ZX!Z/MLK6RC7?[I3^(GY_=%-K$=OVY"UP5)*!$6^?*
M\6%%7)""6(>O"D&%R,C7  WM$+MUC%UX?WM'S15?],:^WXO?K_$\V4V:C"A.
MNM,A+?-GU!N-9PPG#_K]P7$)G?S4.\!7!D?8A#3ZUXO9%&VVU^9J7^,3]?WA
M"%[,?OEYMCW7.VA:T7SIYXN3N1P0F$_%*_N3D[=_GM:'IW2=3G;=ISN1%^K#
M?Z^TO*'KSNC[J5A_N\M^_STEKK[IG1IKKW79:U:2?]2DE?E*YM\[:GKE(0YW
MG6=J7WWV!7?C)L7:G\[HG<OJNDZ!]948VK(4+^N!KU,[\BEU'+N)&:R^%E I
M90D'HTN/J?WH(:\][D\M-?'&S_]D\@^7E<S]>O^P/S@!^ N:@SOG7()?CX9#
MQ(7GD'R(WWG_3FV^>L<W/WU6'_:+J_"?_MM7_WS>VO_P:?/3RV_X/;[S_O6W
M#W_/)1]^^D__P_;GXZWM'6Q3?__#JS^_;NZ_DUOO_^0?]C=/-E]MHJOQ86]G
M>ZN/GNHE8L].!&ZD(=D4L6<7'0F16\)<$D[8I).S:QNZBZ[=71,/;VHLCWQX
MKX)>!;U[2KJNH/>PH#>O1TF]HU3F0$P4ADA%*;'<&H(C*;V/4E+N"N@I<><R
M'@\%>D_^2.,?PT&&T0B'P/<[:'-5P.G>N=DTJ'>^YW^#<QA58>@&,+2YR+U,
MT0#UW!$-/!"9F"$V!(\_% W,LQP%1QC2;:HE5+696LHI?F2LE5 LT9(7BJ@G
M'"VJ(E&@!2D:]<3G((BQ7)O(/8=0!*Z[5"ZFMZZ\*E.KW9J7^_@ XU%G< RI
MG#,J9@##3K\72[;4+5G$ZDJV/!Z+^!L19O3K8'^_UZ#3%)=>'J2MP4&L(+5L
MD/ISD6X$[V3*D$C0NN0914.<EYXD2Y-+,:NH\MJ&Z#KKEN3UM"B:4^WZG@C'
MM>RZFN[-3'>>7^C@3-2>$1 4B/34$:]=("PS&JD&IQL%-7%GS<?5$UEZ5+/[
M:W#B^TVRRXQ?C/=ZP]0Y],/R:@U1/!"Y.!V'"C]WAI]WB\PAZR+=EX%85Q3>
MA.<D4)$(E5$(JKFPKM2UJ'&*)VRQ2Z8-U6*7:K'SA,$SRZV5CD0;'1(&K9#K
M1T&\\L C2*LXH,7*.S/]&HZX&6& \='PH!P_AN$7:,[RQ+,2GQD?KD8D[HTT
M]#\>I MNRV0T1C\\TU!AZ#HPM+-(')*(C+H4B'2RZ-5K1UP 2Y3.GFH/22A6
M$C,MCMK/+?)=:M"A9>SA>J9;0X9WM-]Y&I&L <5E.2&;D48H:XB3,9*HM*$I
M<2E4J</;E;Q&'AYX7R/^WU%OU&OL;CA)(SI_^*9&'AZ"1#2G(\^-Q.6[K950
MW!*0XB*AX-Y(:B$2'TL@E 9.+#>1:'"420U&%[]F282BAB/::\;+)!37,^-*
M+NYHR_/D@HDD@TD)C==X(H%:XA6:MK(Z2.:0>]@257R:I:Q:32[^/@K%V$IG
M#X8U'O$@\8CS73[5\JET8JD0]'&13K@090PZ$4\I0SHA K')(;%0028O,@U6
MU_C$,S#EI<8GKFW*E5+<T9[G*84TV8"6.'<==45**1-+G2/)@$R2(N.PL5 *
MH]J4XO0<XA5_'QT>]GMP.S;Q+#R:Y;*)26\OH$\%F!L S.=%PD CY\DI3AQC
M"#!6 /$\>V*5P94C6I94+(E8RZK246,/+;34Y9*%:JE+L=1Y*@ .P'B0A%&+
MELJ2)([C;YX%2\$H'!VUMF'ELHJ3U=C"]>SL;5$MK3&%^TZ,;+IY46>ONB%+
MQY[7QY>41W0Q:EV*Y2A<(0BZ)9$X7#2(T9FKP!QZ)K"V(;O,BA8Y(C6LT#*F
M4*WY,:QYH3Z?L(#35 >2)9=$*F:(=S02JAGD*)2W(9<T".94BZSYKF&%I=8N
MI=\K*OC4%7.6WT%/!B&7?!"D@N.]@N/72ZB.2LX(ISG1SE($QRB(A6P)3<%8
MF93,(JUM,-75]LX28DLWI%4N!UTAM4+J YS4J9!ZWY"ZP#>I%*"%T"33LAF-
MPT6"%9(H8$DJH"$QY)O,=)59U@&>QX?4U:RQ?$.=_%_Q$]A1I8##N6S=%VUX
MDN]6BWYS4##F ";@TY29:(HXG\M"'N3.KR>OX&NG=]#YCS\X\L.3#J>,=3O'
MT.F-1J4\@.^4^Y?CTOCA?_X:-0>@$'X&I8 %CC6NJCA%?*^YVR4=M=YY#YU]
M?]()T!D"WGLX.76][S]C8W .CB?Z<(?^I!3)&'6.#K%E/N[UX O,RF:<W@(?
ML\S&IA%#^'C4]^,!-AJ[#T;CP0$VLSG0#=/G&NWY(>P-^F@&DX9?U)+I3-^Z
M6<F-]@[F)J M^E%O-#>@M!G01K%[4BE\<'7Y*?]Q"$V_SRU1D(%J36W2SDO+
M:%"0D2Q**B0(S719HG#=8U=6K6FV4! = @S?YC.C^L?WC^"O\J@O9W<>+9;U
MQA7K&-%L! ?/N&K-9E/CFUFP ":3X$,YI<4-<9I2$C65C.68'8MK&WEP-%RL
M2H,&W#D=X&GMF;-)<]Y:UCO;Q8J*P>-'>V-<5LJ$F]D2SJ#H1WMG5NM'G5S,
M&__HGY2_T'IQ\HUZ7SO[@U+*L+QV.!Q$@(2_#PL81&@JUX>3SM'4[)L"]3BZ
MG<',1DOQ$9S9_N!D5I3DK+UI>/01Y]H7Z \.&Z3 ZW\<^OV)J9]>< Y+2A79
M7N[AC<]0H_T 4(K/3>!W-!K$7G-XY!0&_LAP %^[B-30*9EO_(Q,//0:>GGK
MMP9CZ/PD_]7MG,_9ON<V?K=%33>QGYM"P?L#G(Z]@PGF8,/:/QONJ>Q3 ]&S
MFD^#<R!=RSZ=+_OT>M=:B9V;$K$.,F)P24<U/I 010*E#8M\ZN+U#LIIA;*2
M&16#%X%:[8+4E'E</R/-5E&JC7%JODS4]H4"3--*2T?[. 5QHHPZ0WR+X)0]
M]L/44*1+V5=!77QS5B^FJ4HY*T?)%JLZS5/X\V90WIP^D9\4/3MG&-/9*?FZ
M*:6<#@<3$W_1G'-#E#^KX%1F[[DO3DV)GGW%!W14CL97?V6A"LGUC?!E*<EV
MA>FY:UF>L7.]<N[GWO"LQ,Y'(&$(_C/Q&5OXPO>/_<EH[=\7T02A9*[CYI_Y
M:M]I 9LNZY:Y(9L8*X_>9JYM\M)(B#E()9*3P*FC&3W7J[[WPPG\T/7 G%H7
MG-VF'!BGZ\ZJI5?8LNM*\^M>]9)@Y*QCT ;AWN__R%=UZ^SZ!=FNWU?WT*MF
MW4GW%'OU1FV]WE6O67KL&H6I6E)[RMRH'EMG6OF97J."U_4G\$IUQ1]3C_ :
M/;!2S_6;[PT[3;"B\S)].AJ-RU,^M8><G\=LJ?.XSOB5>JYG,>/_@L.C8=SS
MH^\(<*SHH\T;\\6RDBN=N'R]ZJ&_GB3XNK2R/VW:F[_>\R^O/E@KMMVO]] W
M2F2B1J0$CCLAM<A>4*".@_4QI6@G6QKN!X="?CD:81M&HW.!S;.XV:^EGC9V
M:>-%_S$8EU"Z[__J1WO31>/E^/5!>IO_P$<=I*>R#T\_[/_V:?/WUZ+LC6^]
M?X/_;HJW[W?$UOL=N?4M[;W=_I.^_?T-W^S-[\/_M;_S?O-X9SN6$R%LI_S[
M+:H/GR+[4-K.7ZNM5W_*G4\[)__]]OH2O7QK0*J0"<U&$6FY)#9*2F0.(+2,
MBJ>\MJ&HN>\:8?>8L?1]=[;BVA/%M9]N &Q M<LI<!8Y2&^RRSI[GR-/U@CP
MN=D"H+,M /H#A)OQV^W!9;NV_]]D1[!BUTVQ:U&X3TJE,R/.*T,DEYXXYP-Q
M*05G4Y""F8)="]#UK]:A5L6BBD5+Q*(1/B_^=@&4BG/:@- F^-'1L-G=+_OA
M[PX&H0@UESV%-P>'1^/17X#MB;U^KR%A^-?1<(C=_$M)(9CM:YZ<7N[,T[UT
M][/"W UA;NO7>;T/Y&"**4DH#8G(F!#P. >2*$LB2K015Q(EZ>(AWXIS%>=:
MZTM&QTR,2L<0F80LG53&4YN=0;0+@3<9W#]B6M67?$2@ZLT#E60*+#,D)5DJ
MJ+A$?.2>1)VYB,I"\&)M0]R]'D/[?,GJ=58$O#$"2N9RT)Y&[;.DBH88HTE*
M"^ZXRB(T1(_-B-Z/M%:NZ70^;97%!P._M_.!-"5QY7+)$6M9.3X==2E!J9&T
M\<RE3#H5H=?EJBQ6NE;!ZL'<TB6@575+5Q?P-K=?SI_@XTGCR"=+7"S:U@H8
ML2$8XA4/GJM@$O-K&UPOZD54Q[0BW3.A99?AV_O;X]NY[(LK<*T2O"7AW8((
M!,LZLN@TT9Q&Q#MIT;\MQ3F$L3X[+1282O$J\+7JH6\ ?,PK*$<47#924D>]
M,CYFGI(+463)KB7Y62-RCXE9;Q94%BCW+D5)M([(T:2Q)&2?"0_": 6:4O!%
M(70EX&JE-<2O9ZZG9W6?BH;XTE%*: _6<8A2,"D==R%;J3EH::@+0CU\#MHS
M$(IY( A[<XD8N6<6I/4D,U^4M[@@MA1YEI%)KZD';=W:ANA:WO[*[#_:/'CN
MI@W.<\<2>EQ)2QX54A!ML@Z9FF1U-/>2A57]I>48[GQV%A=!Q" L4;94$?#&
MH.$&2JP26F>#9BN7YRW=D^D^28.\42[2W2VR!GU7UZ@7<I&XD\&B6TAT8NA.
M,%>BO0D(@V+&3DFNV=J&U(O^Q/5#OM66[X<W\RA J"2B!\F4=\Q[D[/SUCN3
M(WOX?)O*FY=HJ?/).%RA2Y1U)%GG(GJE74F3S@3_PA&/);W4%]XL5)N*@]SW
M@=GG#@(95V^5J%=@K<S%D=8:O2@;(L00+=24D_::^$+*"<U.)./0Q(7-1 K%
MB:465V0;L\F<99-X9=C/R2 KKUX-4[XDF2+F)!,P1AR(2*1%>AT"LR2FS!.7
M2=D0UC;,LM3EJQVOFAW7I(%5L.O%RA'1,>E!D!@%(](S03Q%'LY3L@*2L**<
MWJF+=)N-VV=G!$?+%LPCS4H(T2[@N$D5@W0L//S&>'6=EVFT"[OF6G+#I%3$
M"UV<YPS$46Y(8N!U!+ 29'&>)5]6:8('V!Z_#]FI^LDV?;).@&?^R6<@4351
M;G\JM77O(3M&*I=\8,IJ"=QXYUQ(,7'0EE/M:W;,ZE*5=XO9,3PS]#E#(!K9
M*9$0@'@K-#$^4RH=#R 4$A73U711!J5M-7CO$KQ_#K:M#20IN4C2.IDL=9&"
M%,+IG*W+H:;'M-ERY]-C(I7, DU$6H&6*Z@G5EI%7*+.H%5;="V7?9C@(>,"
M*VN0-TF/68)%MBH]IJ[5R[/XA=R9:)B*R7-B4B[R&"JBL6=*/#"9%#-9@KMR
MK;[QB<EJZTL^%:BR8T&4N%"2R3@;#;?>R5A$F(06CYL^4U?FV]OI?.8,"(VT
M.4G"1%%RT/C#&2H()*:C L.E:?W*_-"Y,\\! 82.(8ALF1%*9BJ#,DEKQ:5E
MUC@I:NY,>XU\(7<FVA0X$C:T;T6)##&08+,@5ND8-4@%=GG;<G5)7@&#; 7I
MKB9^>P][,:?&41_!^T"@R))(DQLCYX0;P9+E 3Q;7H)<-?(5-?*:6+,*QKV0
M6!.28=0'70Z&!C3NP$EP5!'EA3;!)&G]TM4XJG$O67$"5.0V)2\REU$SZRDX
MDU.0*6AO^>,FUE1[O8.]+N341(V4.W$@D:94%N-$+ XVL519GV+R,H8VVFM-
MJGCFG[P'U9%'Q.S+*Y]M#\:^W[EITMJ5:B\MEX>ZO ^N+P]UX\=O]=C?8+VV
MRH'3U$AAO!0)<1M7:I$BM8"O&E&S2U9WT8Z79)=H)ZSSAG#A1*'8CC@A+;$6
MEW*6E<H&EVS)NNZ2/-B9-3T" [U="NZUS?EQJY/]J+7/&7A7"'5ODF9@.(^.
M&QV-LM)+9[D [KVBDG&:?*C5R5H G@O5R:@RU"9#J.>FU%/TQ)<DO6P9BPZ$
MY<;=L3K9C<SA/C1"*Q95++HY%M64IR>*@0LI3R%%] J$)]:73$>N*/%<&6(A
MY"B8$L(6$1+;9691O:_B8,7!UGK"D(.54H2H99:0A(/ L&]B2%E(A,.JIK32
M0#:?$Q:4 J^ $T:AG.(6H9SB9L0JPZ).VDJJRX%0<TFA[*?C"+<Y3:UB<\7F
M690R**_1*J516>;DG%(9./56:YV$=S51K[W(>XG(E8DX5($DJSQ22$I)H.")
MRYHBAS0^2WWUMF'%WLIAGQ=.WL277P)0MLJ7KUA[LY#E8L9D1N\E:L:(BEP0
MF9(GWBI!;.)1".6\YW1M@[DEZ/M6I*M(MYJ,L":1KBK>+221(K9%ACX\NO2:
M$QD@DQ!!$ A,9*XIQ5E3V67%W(JY-\9<+G*PO-2-\%*"]M98T!E )WS)F%1%
M\U8;2Q<2? TR1VY-(,$(2J0VD7AF.!+(D'3 :6!](YJGF*A(>HV<XW^/"Y'8
M:/HJ-I/^R$\[:_&5U/NR\3_X8S)['9I:L$89C;8FM;3:B\"=$L*KF+7?9>7@
MT]FW)AV_\3]A^._3H;C>F[..VO?#C[T#,GF,%_IPO&Q\8O1' ,7+:+KUSA2C
MMH[V\1)Q3J97*I]I\AS7<TE9=LP DU;H'+,%-1'LX#,BR"?H-,&CHQ'YZ/WA
MB[_'@_AY;Q+V>XVH-#[90NAYU1O%_J"PP6V\V2]]_,QC(\GVFS,DV7]3OJMV
MOKW\MO7M'=W<WSG>V7_W=8N_^[;U^U^?=S[U][>V_^EO_>KHA__NT;C_SX%_
M[X[>?OK/_D[3SOZGS5>;>-\_$95^Z7W8?BT^;&_2#[__U4-T:=#IO]\V\9ZO
M=[E,S(&C)$:),)"Y(SZZ0*AWC-KL='0P62IP^D)Z60 Y,]#&.AXYEU(X8Z5B
M$)-@V> ;'D$9$)\/<13&PR-8VS@_!@TY,S]W)F,Q0Y;IZ,]-V#F[F0S0CV]^
ML;$Z&%ET'XRRQ9F(00K(T67T*HQSP:P]EF$T5WS1&R.BQ&N8RM][?@@DH-^1
M.K\.]@_A8#3IE==?R^^PT'7W:%1GYO,V-^WZI33K?*M>#H<>5_TF%/_+R=EG
M9DO]L1^FYVUZ;W8#R$"M4"0ECMY,+H?:@V0$C'+)2AZ=D/.F]+@@OK D-S-S
M>P^0K/7[@V-<2#O-,M@9'>UC\_ BH\[HW,2-YR<N3"9N)P\'^S.C+5<8'$Y)
MXJCS4^^@,]X;'&'STNA?+V9S?'J/Z:(_6=OQ:?O^< 0O9K_\/-MZ[!TT;6Z^
M]//%3E.'"TM[L_1/WO[YN)?&>X5XK-,)GYZ>*YG>>?KV>O/6'!69O*?ENI+B
MRK?I.KORO>]=UJU;+6]UU>^_I\35]WPN;777NNH/3AG-6"4MG/*R#7*F%CY[
MB1,=$2IAV":/\A5$V \P[ C6O4#"[]HAYTYHW2"QO]V=59;/*Z5O;_C =^FX
M6PL&GUML%CKZT;J4W8OWJ=;Y-1KP\^%@$M9X,80^KE%?X.?2W82OV\65I"QY
MY0)K&S_Y?UVD9W4V+&LVT*<R&U9:#/S'3)'.^S"74D$_ZOCFG<$!3JO.(+^X
M#GY>U35+,Z4?]?U=KO%C.UVQ%M[# >S63>2_8 1^&/<ZZ)=T$GR!_N"P^+6S
MB3RZ2T&11]Y/N687W'A#I0W;)M=\MAOLFR@;+0A33MYJR37W-KD<@F4\1:J<
MNC2:<MD&RBRV\A(=Z>C'D"X/K$RC/5LP?INW_=<5V2:Y981ENDTB-K^]/MEZ
M]5?_[?8_O<WM'?KATV^?=MZ_8YN_[WS]L+W#/^R_QGN_^;;U]_PV2?R&]Z9;
M>+^M]V^^;GWZ:W_S_=;>A^UWQWB-_M:G#_L[VW_*S4^;[+_?-L\=J7Y#-_$9
M=H$+DTTRA#/)B#2<$QM9*314-LN >DO9V@:C76?N+-A_3]7 ;H"\\XM$!:TG
M"EI4)R-EMC0E)[-@CGJ?/;4F!2Z3-==.L*F@U2;0FN9@F^RT F9(5$83"=*3
MX)0A(EDA/2_E\-S:ANL*V=;RI!6S*F8ME&PU "XYPS7.:!F<B\[:R$-402<N
M\[55%2IFM0"S%N079 A4\T L TED]*%@EB Z9NFLURE)M;9A+\U&:6T)QR<1
ML_D=#F#H^XVGZ]-^[Z W&@^;8->5SNZJ"F8N'[1DI-0PP8L(K@Q%#I=QEGUF
MP)!QA5"]PY4!K3\7O<.D':/" 4D9$I&:>N*5<L1206G6E&LNUC:$ZSIV9Z9U
M[Y4G;A]"?/963J73*=J@C.!2&^6L=%'9F#F HI95=VHEK7Q*3832"GEG( *R
M)3)+3O O(#$[E8)E1I7L3(96;E6U\J=KY3G([( FIHR5&IWH+$"CIRV<=2X;
M7AV05;+R>0<D,)N8<Y:X'/)$G]X[F8FU-)<"@=JP$NG57<T6M8]:*W>]]/#)
M="]PFCXGL-5I<%22\6:FNBHBP_<5?%EB!ST=Y+Q-QG%%SC8BY[LY+VCGVVYF
M7AMN,P&N(I%146(S*(+NCPO1>!JT+\J976N7%6]>GI&U/%I=X;;"[>,=GZ]P
MVR:XG=4[]8J"EY3XZ!V1GCDDJL:3:'C6*1A-(:]M<-<57%>XK7!;X?:>X79I
M<N\5;EL M_-Q 0>>!PJ:!%8JSR+*$@<:X=9+2"8AQ64*X59U&;]S]*\U<'OQ
M0/N#'QX_3?Z_\HCLY0<1?_+_ZOPQ[ V&G<-&0Z+C][%[QZ/.GO\"G0!PT!G"
M>#@8'4(L&YC]DXYO1,H@=<8#?"_W\8W.> \ZD#/^.NH,<O/GWW#H)V<2U^=2
M]^?.+[?P /X-SQG_.CC N3$JH%>V?#<'J9=QHC0HB+TQ.;?=:0[PCCIOC\:C
M,7ZL'-OTXW/=U'F% -:&I__NA'ES4*#\ "887T3OFM%^NW_0>QG./PW^?VOP
M97+RC74[)4K1Q34!K;#YPN%P\*4W:DZL3B<,?.V-BNY)Y["/[>MVCN%LJ@V.
MAOCO6<?!I$O]I$M[V.\QHH7[@PAG;=J$X4>\V\N/0VA.59<)>SB$(F %S0=Z
M!^-A[V#4BYTO1>QJUI#95??W(?5P3'#.!\ 5 R8;^GD\?81795N_%XZ:.=YY
M=S@X6'BYVX']P_[@!'  RFG^TO91.=K?&1PVQW6[:$+EX[$\Y>2=LFZ.FENA
M238+57FJ*SZ6X&"PWSLH2U_I!GP\<O[^G?_M?2Q7FGQE"!'0AO$9.KCHE8'!
M)QY@FX?'O1'@-,#YXH>SYX=>>:>YZF T_LYE!\V'FD,HH31E.NU_\*WRVW36
M3%Z8G'$9-/-K9D[-7!J5H2\S,95UNP,^[G7**G!8[G+6O[V#*T9]#\T,)U-S
MZ*KI)IP'O<NG\<4A+:>T+\ZTZ;5P*GP<^H/2Z8<->.(5-YO##7PRTR>?F3Q(
M^=39O&^.=D^$'3K[,-X;))SIV,^ +5J<*U?/^=.Q7# %A(B]65>?=?)ZY[?2
M=Q<^/'N&R92^\ #=IJNG5SEM5[=YA+.YL] K@XO@=G$=F'P$#?]P,"Q_3TSK
MU,:;<?G!I,%/['O\H)\.MO^(P_P1+_0#6YZV)95/+JQ//S?/.IV+C_JL%^SA
M7IYU,JGG+:QS[ N4X"S8;\SLU!3+EV<']28W:^!Z.B9H\/N#@VESIZTL8B6<
M_HPM/2I8<NQ/FE?8S\U<G+X+7TDZ]]RS3^ :]QD*J!T-&UD$O-R]'%5D\R<5
M+U_J[NGFUUMG,_8X&0]],[V2/YGQLU.\*;U3%$4:F)@,<YAJB9U'XO76,PJ<
MD"/H[#>DJ8#19!:?+DN%?_IF5HZ.0C&X(H&&MM2 *3J!G3)K)^LE3NO4FRZK
MO8/8/VHZK[S?O/T%IOSBE'JL=UZFR3?*)1O*<=SK]SL'@W&Y )(.?W#2R4?C
MHP;-SYV^C&B[$\N8$.&+P+H'?32BDP5,F9Q]ZR%VCP=#O/O[Z?TF][K.?697
MO/1VA26=WJL5 W]3P9X&2?XH_*\-K?\1$?[/T0%,5\O2]:-SFDT=?UBF61FT
M@LQ(1%)#1LH$*%0.QW-_<ERW^< 44/] <K#O(QPU?N:H\^8 62VN(,WH<TIY
M9])#^'J1 D1,+GW5^>D<\#:?*J].0?5?$\1O6@#I_/VG5RR?+12DAXM_K_"*
M#,/A9+)-:8D?G4?VOV;?/G>39OV8W:)A5W$(N(:<,1Y\^XM'=EE\\K+:]D:C
MHX;7XK2],G T^>9<[,B#5#Y*&63,4C/AE !(&02+)@O)ICNC>KHS2K6@%V)'
M:D'N[$=J3%>),6TUW.!M/L.0YG.CET=(ZXJ0SS45&?6*!IIN+^;TFF^]^GRR
M]2EBNSZ*S>UWNUQ12W/TQ(@ 1%H;B)< 1"BN1'0YT:S6-MCZXI'!#MIVOV$V
MK8>,MP4R<.GBKGL.-L( YU(!@M.%X8)!_U+>GAGS15BY'FJ@-_*Z610:P'ES
MD([B!'LNP0[\[-P'+L+(9*V=@M9E'^^@ <PMU#.W<LI9+ESB IB<N6'P-4+C
M'T_H=N\4[B[XSL@73YJE.D"#)Q?\K,L;=W#*+W[PR7+IP4'C^<^N75;Y?N]C
MKT 8#E3OL%>4VLY=",<&E[D&XK;\*/G_PP&:,(Z_COJX(#<]>.G=&OA,^%C0
MK./E8LVP-SV"?L;YI64Z!7R_<W@T+"#:Q#7*'3I*"_53_-=/\E^S_KVZ'9/K
M[_GB,O:F(S6-C:2.H+2+IC"#[NG%"CPB'YK*$8XNTO\+H'Z^97.^YO?[?06,
M^&73'S-1ITFX6IP&N IKA8GS=[-EC4F(G/.LN+12:^&L,=)SI5FVDDK>B DO
MYODL?S6;KF&SU?JWP?#W,G1U*;M"EU#B$H;M>"F:/9/MU[M**!L96)*"2+B4
ME7-9R@D"H$66@K)DFJ5L\536;"F[G#)-W8,)^$WL:51B;Y-EX\SXSBSL(KH6
M\+O2[A9#]!?E=\\9XM0:)%\W10MP4=#G5 +P_[VH@#0U77KV%1]&@_[1^.JO
MW$$TZ>400>T*4W?7LG3CYGKEW,^]X9E,VT<@ >GN9]+$T5[X_K$_&:W]^R)Z
M(73-==S\,U^]"?(=:=<?2K7.2;L6K8W@N8G @DPR^Q1 *6^ED,$S4&OWK8/Z
M=]R#A,O052JHC8/S=K+ ORQ;3NCG;A<;>-[2IW_NXDJ0@I>,:&THP=7"$A?Q
M3\O1^:$FTACE_&@KZ:)1W 6:DV0.9XI@@JF "TUD3.I5D$K][50FM5>4KB8J
MJ2?-SL7,YYYAXF$#<]-),W5U^].MD<GJ54#G"OGOI3W7]<#EXC[WPZJS.K?.
M)Z*=-Q5GE6Y]TOSEBH@RNNZ,OA?%T]M=M3;VD1K+Y?6$;Y>GG;I2\J@3<GX-
M@;_E=,"*:5N^;_Z =*4/V9)VOL0N1=;8]F:^_@K#V)N7R6]?._] GCK7R&H9
MU3+NL9E_0=F9QZG1]H:64E(ENG#D^VUOZG;9INT=M+V9.^"'HPHVWS7B6:)*
MV\?RS2R/INT-;6IQMKV1/[TY7WCD\>2ZQX/#1SH!\8OO-Q%8/^[\QQ\<^>')
MQ,N?[ [0*VG[-70B[E!6<H5.BERZ,V*5 Z>ID<)X*9+U*<@D4J06\%4CRLX(
M<_,[(V^V?EO:UL@T''DN<WNR67*]/1&ZH@'+V3F2K=]W^-:W?_:V7KT1'UZ]
MH3O\'=OY]-OG3?X;MF5K[\/^?_8V]U]_W3I9.$="/WPJA1E?T\U/Z?/FI[\^
M?2AG4=[_^6WG_3^?\/O[._NO3W:V7XNFX.+\L3U%P4@K#+$N,B)+L34;.2,F
M&YFSUYH'M[;!ND[IKBC!^J5(3-Q[!=EE2,S<(URL\(F[FSW\BF+DT2C] <,&
MJ)8"E/P>87+F=D[=NEE H7'8*S[>%!_GS]DQ!Q1G/!#-G2>R[#9;DP0QR>64
MI3:&(CX:LZ[D<\+&Y=;I6"5"=>F>;=3&"A8=9XY*KH2W)@0IF5:9:P&-"#"^
M-=FSG<'#)8@0?HP(X<:(<!I(.1>H*($ ?H%:8;?$%^EH>(*^=P6+:X'%UCR9
M2HE9IGT@48 @,M-,7*EBS:TWTJ0<>;9K&VI=JBL+S%;^4OG+O8BOW(JW+(H
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MCS^-\.PJ$9Y+SZ?<RL.MRKLK;_L+!U& 6I6%Y67'61.II"+6!T4<:":C=09
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M.<LD. Y$<^! ?5 *_-J&HETI[R)WW;[$L9J84KGHPW+16I[E?K%M@8ZF@!.
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MT4";%C' GZR)8N(OM'/L1YW_YQ9>9=8:LF,Q<T6E,\S2E&U(/J,ETTCE?&7
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M\U9/3IQ'QBMPW95SC H0%R%!6-4BI65+W0.:UB@1&,72T&BX)LYI36QNQ&I
M'PDM_4#G6W/'::)DG%"5#++:@K8IEL 5)@9)Y@.6,A\.&W,_4-*D^M']0&>O
M2O5M;JE[D'DN>;MYQ(/QT%BB#$N:%!+1Q=R()2'#HT.,T:@"Q=9ZE;?470;&
MRI:Z4D3^\.9/#V(C)6\W3Q@TF;<SP20I,,). "?1AB'+G4;&^0CH)%B0%CP
M6;;4%6>EY.WF&!@FMM1I3")30$D\#7G3/T4&J]P.A'-"; HZRH4E8C0X*VS^
MH*&PH<*&2N)NSD!N(G$GHQ?$DH"HRFV$>3ZAA1&+?$B6,*L9%[1F/X]N(ERV
MU+U XBYAT&B+C0N4<Q6Q4U83DUC4FAGC<$G<O6+]_79[+F0/YF.C=9X_AW<4
M[16/V_03WMK;S6/A[?-/N 7_WZ:?\Y8Z03PG+EF4-U(C;BU!QG"#0#ZT4(%[
M97+-HEZD3W2.WR/%LVRI>S/">;I-/!@@"P;)RT@0-^"=:QHT8"T/.ABE@],+
M2U(MXDGV7;;4W>KM)M! ZRU3+("1!^4SH/$!E,XX(BG')34WU[HZ$0;S1&O/
M& JTZJT@/7(X"@3L, 9!,:MV5W.EFIA/IL)??9GJV]Q2]R!S7%)S\X@'$U7K
M2G'#O$:&YB.>33#(Y*-TA;3.A2 XSMTNQ956TV5+7:DB?W PZF%LI*3FY@F#
M)E)S,F'N\QE7.GG@),&(O,W?(2QX2$&1$(P'#X ODLE*TOEA),59F75GI:3F
MGAD8QLF)%,YA$RDRG $P)*^024(AI83VUC#AO,FM^7E3D3GL_U'84&%#)34W
M9R WD9K37 N<=PN'D+<F!&*0%DXC'1P&\J,$3P38#UTTCRZ5+GOJ7B U)YBU
M'M,DE9!<@H5*H-LAPKHR[Y@IW2Y?L_YNWIK]:*WLG+97_'GKX$.G&N/*A[W6
M^?[9VL8JWCQHG;7V]N%Y[[N;&U]S:B[ZI ))%CDK..*1.Z0ESSS'!(XCT2R2
M*OLQI2SQ0:FY1XIG2<V]&>',_?<TUD;D:&!D8)HL0P8;@KQ(GF(F"<[[>*19
M5).FJ>R:N]7;#18HGU3:>&9Y$M@I15UPRG&5K/#E(+KYUM5Q(FA!J5A2 J4D
M(N*8*N3  T;5;FK)-8V$+2QQS)I$/[J#S.P5HK[-77,/,L<E-3>/># >_:+@
MJV$='1(N4L29!I*8F$9&*YU8TLJ[:M><*0?1E3KQQP>C'L9&2FINGC!H<M><
M,!PGJY'$SB/NF4*6!(8("Q@3Q4@P"3!(+YI9.HJE[)I[:\Y*2<T],S!,U UQ
MBZWBN7 0_!0>F$$&_!0DB9(&Y" F1Q:6*%9-,Z7_TZN'AL*&"ALJJ;DY [G)
M@^@,XX1CA1+-/0.(S4=1.8MPPE0Y37V,OF(_<I:Z&)5=<S<IM722"<FT81%S
M'KG6G'A#G4A1B:!_=0?!DII[C/[Z6[,?:Q]716OE[^[6^J?3UGJ+Y/&V/Z[^
M:)VOLM;*/F_137CGSWN;YQ\F.P@2 OQ&)HVTSM$8;"FR#/B/-B)ZR:2WT2TL
M*;R(GRA1]TAA+8FZ-RFJ=6?6((66"<FH.>*<,*15BLA0CY/VRHH(3KMAB^1)
MFUV^E2)5S6@47CGO0^2@=@ZTSP,M<(;"[Y:5M-U<:^Y$3W213R>S!D47-.*>
M!^1D8(@E(WWD#'NFP1,6O*G8HX-DLU>D^C9WU#W(.)>TW3SBP7ADC*68*%B#
MW-TR-UL0$@$\<&0(>(W,!R5T[HN^*&3945=JR!]_+LN#V$A)V\T3!DVD[;C@
M+MDHD32)()X$129@A41**AI&G:9B84FK137/>_R+LS+KSDI)VSTS,(R3$RNL
M<<*E[*P(("?@L3@6*6+*)<Q2/J;.Y;0=;P)[F3]H*&RHL*&2MILSD)M(VSE'
ML+%6(!><1IP(C2Q3&F%,@N/,L20!Y+19I+/43Z#LJ+LY$Z*X5Y&+I#U7W%@-
M'K;&DC"%*>&RI.U>L?[NW)H+V5K9$:V/7P\VZ3>QM=[=;Z^\[\(<L:V5?;:V
MTN*MCU].V_03S&'5[-+P*!AQ"N5 #% <9Y!-R2.JA21:)D&R[V/,XI2CAQZ8
MJ'N4>)9$W9L1SM-MHH@66F*4C\%"G%F)G/08"4>-UU@G8?E-PEEVU-WJ[3*+
M W8B:AX8YSXY+QPSQ(!K8RA/OJ3FYEI7)^JW)*%$Q+R/3A/$<>#(4?@U$A<4
M2(*P@BTLL2;3C^X>,WLEJF]S/]V#C'%)S,TC&HS'OKCC(!9,(JNP0=PQCVST
M!$7LF/:4>A5X3LQ=GEU>]M.5"O('AZ(>QD5*8FZ>,&@B,4<)CL2ZW$R#@G,J
M24+.N82"BS($')5+[B;^/S^,I+@JL^ZJE,3<,P/#!#G!UJ1@-0*8Y;G53LJ;
M_2DR-EH=.,.)JKEU50H7*ERHI.7F#.(FTG+<>^,,D<@$!_Z7<A;99"3RV L=
MI: )T]GC/F4WW4U*;8G76B1#G$H\26V\<MIJ;T*B+!I=TG*O6'_W;\]\[.V<
MML^7V=:>%RT*\_1Q"^ZW ^-;/MO<V"2;Y[O=UL>ON^V]*BT70(!C\!A)(33B
M-FKD,&? ( G5- BK:3YF%[/%*><./2@O]TCY+'FY-R.=I]L:1TG Q""F<J=+
M83"RS'E$F=5&)IP"P3=*9]DS=ZNW:Q4S5+%@L,6<.**M)\FH$'6P1/*2F)MO
M91VG@H%*DKB,B-H$ZB8ID$),&#(^&>T4UDJ2?.8Z:Q+UZ%:7LU>&^C;WS#W(
M'I?4W#SBP7CT"^N$!<YGSS%&@1R:A PE&N&@F([PDQ!@?M65T\G+GKE2)?[@
M<-3#V$A)S<T3!DVDY@CA%GM%D*T<5.P9LH%X1!+US 1+0R[-N\$%F!]*4KR5
M6?=62F[NF9%AHM>E#\X::9#V.F?N!466QH2P)9I04 IC[<*2QDW@*?.'#(4-
M%394DG-SAG$3R3G#J3-,.X29 8QS#B-'N4#!1,%H<,I;,X/LIVR:NTFK3<3!
M!4RC,)0SCAUU,B9M.&%1L11*=NX5*_#JZ;_6ET=AU1^MO4W<@C%L_7L7^X._
M#^V&.5G;:^^OK>R<;1[ NZU[OK;^M=M>^=J!.=O+]VX??(.?/N^V-U;%O\^_
M;"LN$\% ;P+6"G'*);(\1*084880$*/<& !\I$4RR7$>E)Y[I("6]-S;$4^_
MK:WQED2+E$T6<0*6R7DP5,0RH"O"*J+LC>)9-L[=ZO%2)76DSDM,.7?2&"*\
MB\PI);#"I/2TG'-M7;VNK<M@#YP.C#D41?*(2X.1IB0B##S0:D59I!$4CC:-
ME#-4K57VSCTB0?<@BUP2=',)"*UQ0- Z1B.]0Y)Z((A&JMQ>Q2()CJ,4-GA)
M6=X]QU79/5<JQA\=E'H8(2DINOE"H6_C*!1  @P.*I_"$!#7B2-+I$>4,HPY
M)];Q<*,?,#^TI+@LL^ZRE"3=<V.#G\ &@ -EDD.)28>X!>?%!D*0<!A+J6QN
M 3&_+DMA1(41E33=W*'<_CC*B>2\D5&@A'E$G,%/E@/H$4>)8S8  =(SR( >
MNXWN,?5*KM<':4;'O:-W>?B#7K<3&B,=GWN>Y R//%%G3-(\6F6U]B0 D'C,
M*/6BA';G&$%^3 WM"J!%U"*9*""(<!)I*S72WK/ D[$D]T$"FF1(DROV1-G^
M.ROAK!1"OJF]&8D+FW"P&0@X)LD0%0G73":?=!2JA'[?#F!,A'Y5DD8)[I"P
M.B'N%48VRH  )[C#RCN!W<*27,1/$_HM]8AONQ[Q882EA'[G"X4F0K]8IR02
M)TCJO&<TJH@R4T&,)F\9-TJ+?!@W662SU-6_N#O%W2EAX1?$C8FP<(Q2<I,"
M$MG3X0%39")7B"<;%#91"B,6EDA3"-.4\JF*FU^+NU/85&%3)6P\=R@X$39V
MCA-NI$71)8RXTPII86)U7K4'GU\'EGTXO*B?*N#S9%'C?QYG0;DHWQWS,"\V
M92S]I^O_<ZS6]YDC'GXWAA.0X73)%?ZT9P?Q\'CYU/;#%448_&V[)Y7*+ \&
M)P?UW];S>ZW#B-YWX8NO5+:O5W5_/MBLQMG=:ZVTX+E?0#[?=[;65]G6>@MO
M??S:6=O8).V-;_C?YRV03:#U25C,4D))\2R8W",'R(1\RB6'F'BPRPN-" AP
M!%-_W#^)]4Z<D?P=V#XX6ZB6FW>R,FXO#,TT0_/Z;FS8R[5MG( P9&K7.(8/
M!D> K*D#?^G'HQX(_.%.XPB>TPN#!GB5U7< 2$^ZU2=Q< PP? QCZZ7&Z1 9
MD:VAL;'3MX?'C0"?-Y+M]!O?0;)BOENCXL/YFMYP#-578WAW72FJ?RJ=NM#A
MFJS 5'7MT2"^&_WP>^@,CKKV[%WGL'KAZJ+?K\^X.)K<+95UO/[X]]-..-[-
MUFL1UQ9LF ,:/GGX\6+UT1BRU)\)NJ@PN?%CO'CS9S^[+6&+3+$'W?;GGQEI
MGF.PE*JW/EC!^)VNO"75>,^M?\_#]_2=Z-YTPWOQ3D3?Y:5>,A,Q_EIJZFMM
M1MMOK )5#(V5Z&/VC.LW9:1Y[67?S$I><>!N\AMG)=ETMR7.E.E)WO8NZ;FY
MF3)2INR^4X:??LI>M./SKX@B?.T,]E'JQ]CHY!4%NMGH YU\3++N/N&N.^/T
M%98_(8:S%H YK *\8[&7X&QRF.:#IP)G"3MN3>2<YP.G&//NEBW.[&XAZ>5^
M/P=5LMOY_FRZ)_H!'(7L@<8KWF>6@@\@!)^&,O 51. BTH+H*W5'ZU#+$3RW
MVP6WD[;.OYUO'L!SUC_#]_;/VN<MTEZ':]:7SUOG7\[:XZ&6@_;!VL;?W=;Z
MYGE[O=W9VOLB6@?@MJY_8G O L_;!=?VO+WRB?S[_-.5UJ;Y'7;.)_H0KW_8
MVSS_L ]CJ3YO?VS#];O=]MX.;:TLXZWU_1_M@_RWSPG<90'O1]965L_A>7B;
M*NQMTA)IAP7BT>3&0RH@330(D]-4J+S;89%/A&S^ ]U/4H7-F_^#Y0+<<"Z-
M5M@H*JF/2F.J29'4(JDW2FJ+;-LHM"#1(<:$S"4B'CE%,<):,FZ5E,GYA26^
M.!E<_(];=N>_4"E7,6!388'3O+T*%I51KIW7(8#ADLF(:#,.5+! 1K! "BR\
M9EB8WDA_$\8(*L[;  &;>W\?M#]^.&AOK)ZV-]H'%2RL?.YN;JS">WW(QSRH
MI 3%6")%G<[9!8.,"A0%I5A2.&&ER<(2?@*3%0AS1$63(F' L(@3GAJ05.UQ
MT('$(IM%-J_*YNFVET1CD$]$53Z R$F.M) ""8^]BXJY%'./H\7)&H!BI&;8
M2"FLC#$B5W80+@5UR2;E V8!BWRD9@4$> 0$N #!*P2"LUM.>_G8HJWU[O[6
MQJ?3UL96M[WR8:^UMP_O^>VT?;Z#-^E6%\9!AD;*42VU%PE%&2WB/'ID")4H
M)8X)]XDF;K*1F@($]S124N5=69IYI2V7--A L?->>O#E(HABD<TBFU=E\W1;
M>!9"$@)A(<%(86*1L;E00S&@4#0E7)V3-8U /9.1>M$>F[_"W*S^.(K^.(;&
M]UX7]*G;.3Y[BIXU;\X0/S+<><>.C@\$N]$B_WVQQ@7N[@]WK:MAI//6RK>S
M"4Z^\0E@,,#\_+W;WOO$VA];? O@#CAYI[V^N[>V\>T,^/HIS.7U,-+*_MDV
MSW5H6D3$!/'@/1+P'K41*(5$J- \&(D7EOCD$<@O'.\LHOK&195O$R&TEB"J
M0@>PSN!_(.>P143SR+BPV.5]^&)R#_YCS/3+M"V<;ROUR)AF4?W7I?HW18Y6
MZ=;&W_MM^O5@\Z"]WU[YO-_:6.6M@V_P3@ %Z]V#7+&ZMA*RP\@=HX$GB82S
M/&^9YT@;YI%-41AEN-14@5V:/*KPA8.:13C?G'">;F-@US@E@[13/!^>IT$X
M*4.2JF2U-8EH\!CETZ;>BB7ZY8'+HNRO0MEO"0]MTJT#4.1N^WQ?;*WO_&A_
M_);W!?UHK^S#_5MD:^,;S,$.;YV_SY:($NDB)@XQ92W03N">EI.(3-(R>$)\
M8/))+-$C(Y=%.-^<<)YN6^L%]98AEW+3>).3OR0XY",!AD0MUY(M+*G)_?G/
M98GFOI3S(G0)-N_@*;JMS(\1GKKK[T$ARKOLA)T$,G<?(,NMB\A\MBYZ*33[
M,A;OV23C:-8"'@WS<+"Y_K4#SSMMKWPYA>?MMU:^T$VX9NM@J[.YOG_>VOM[
MK,)MF6U;82,/$>2"48DX=Q[IJ!0*SFE"!7B'F"PLT?']J8NX<=QK_$PD'Q2*
M+"+YYD7R=-MY%EDP%H'5=8@GR<'P*HRTH))[ $-G:.[+)<:%LI%7<# ;-2UO
MQ/ \*.I8M/RU:?ET&MW>^P#C^ SSM K7?^BV/[8RG3[=6O_TH_5Q,P=[  $^
M=%KK5;31>,*=Y@R<.B/R67SP4] 812+@?ZUVG)I<3#W1;N\V4_.@Z&(1PK<G
MA*WUY6VEB-9&,R3!FT/Y>$BD:50(&$J@'%PY%RKKPHIU^>76Y4&1Q*+8KT2Q
M;PO2 %_<RN^[Y]GF.<P17-_>^+#?II].UU;:>^V]%JX*T/:VLG7Q%B?'B$-!
M8HZ BR1DJ<-(!? ^K"%"VO@@Z_*@B&$1PK<GA-FZ, />;@H1X2# NF ND0-&
MC#17()PA>1Y)/DZ.O*AUN25>.&J' \.)/S=(;^.;=VO/=<V0=@X#Z.P[JBX:
M-4WKVS6#_9V6JVY,$_U*&MEY:^8&3OW8.+6#QD^/PA[+L1 >/:4T"7 )N93,
M:*6XI4*2I$$EZ/3>?$B,P^;JP5&W=Q;C7['_O>/C]%1+NW?X/0YRC[T,F(/U
MWK'M7OW\C][@N-T[WHPP.-_;.<S]_*YV,+M;HU+Y2O'TX6W,5N&9F]LD<$J%
M\,@JR1!/+B++A$'$82#*BC&'^<(2HXN3F;D&2&LW2PK(UW%>%1"9_L42@,1<
MKA'\DILUQ*ZM8OZ]!MP'U:L*^@!K=='ZZR1W8JSZBH')I8W<B'&QL;YKC^M;
M= :->)$ZZ#5<;C]V\<0>L.*&O>@\UAAU'JL[EN5A_I2+@C/)I+0)6\I=8DYI
M%@CF+'!BH_5WB&<^FSS_6;W!AUY_^*?\O;FC!H\09: -R]M!LJAT3,@)"Z(<
ME /3G'?-216]#999D<\'F4(0*].\^#:A7#-L??(IFL"5259A(11F!M =/#-=
MH/P5R/\WH,_P+NL[9VLKRZ25Z_[ IS%<(.V$0-Q'8*D$&Q0H%X1:ZUW4V5?2
M-_1,?1ID7SLX["R[,8"'^\3.=_CTY BNMK"@E8,$GV5;< 1ZUDLIRRB ]P#^
M^D+H[R-C3'+O@I <3)_6G)H$4X4-2]+?Y0SQ@OZ_J!\K;Z^ Y*\O,W#R,(QQ
M.Q&I;' 8\#\Y$'_/D8TJ(: XG )W#=38O!=-WV )&F-N&GPI"TOGL&Z%>R?C
M<(M[, 1V#N8H=R(]Z@VJ97U7:1+HQV4#TO^X'M8;/@A?7F+=H-<].;[YDD=$
M I?['=N]P6J9.QDM3<8F\\J_N_W+EH@[$;E^M/O()ACA.]L]M6>#A7]>GVN8
MZ+&)&W_GFR?_HK/RU:6L=44*QHA@@)I,<9&DM9KQ)+A18!0I4;7-A&M ;;/"
MF2B82\DF9R0'@FR8#]93D2CAB>?-^+^(/E1W?-<!3.GXG_>AJ];F*R 1B'U&
MR\K,-I;!"'R_NHWP1;M17V#CY;BJ87T#R!N,AE::3^^M;@<JL/:)(L6"0J!X
M!!F&/:*6IN2"M"&JU])\.O6ZW=YI[A\-YMTV!B<',+JSJAWT23]WEQZ):,TC
M[% .JO[3(][1.:R-88;#D>P^Z?O<#>O&NJ7>X$?D-ABBFO*7;69MS*+"ZB&]
MK"5<29^EES4G\EDZ+C^L0_9/!TL7P55ZBD;.OVI3PNSU0:V/X7B*/>OSOH_C
M;O,Y.HT$#8\CN1&)9F2\'W.?_QHT5_*Y #D;-NMCKK)U4](X<U^R?>4HP08X
MY)\M4&BPTW7\Z>9VQH\Y^&W^3WWS*M+<7D[PI+ADPIE@M3%,:(NCXSB'WXAY
M\*EO=]BFLOJ_)\"F/AT"S3K)?QRLY4#B^JX]' ;=+EAY>[C=Y@V<^T;;<,U6
M[L!V\+FSM='":Q]73^$>9&O]4^[<]@/^*UHPSK4_QM+3>_#\O6YW<[U%-P\^
MP[B_\,WU97C7O[NMO9;(!4RMO?TS^'\^K5/<MDC)1/"D$-:&Y=!%%<X.2-*@
M%2>4\I1#%UPUJ9AL)_'$9[Z]I@/?'@$BK_\HN#N^_"M%SIL/B7L8?#[='K^[
M@^?807$5\\F<YZ( J$#G?:%SK+)G6WL 2F<D2C0DQ(6FR."43^322>==*2IQ
M@$XJ%LE3G;3[O,@Y]PW,/M;G?#V(.TYYU[EDB$1[XQ*ET5'@!0X$7(@0N=6"
M. 4B?\M^YA>EBM5Z#CX=U@FKPA2?#NXFFV]L!Y8(LRPA)@#D>-(66:L,8MPF
M&1RAQAF .T*:#,O'XMUT9'E6/GA+A.?1P/"*6=^T5WREF'<SMWLD\+T@R;L.
M>X7I/3GTC3,]QVS46BG$=;  ?=$A)SE!G G%+!$Q&K>PI,VB>O2AP$\(?',?
M(?R[\G0>$PE\A6SNM_FE<_5Z%CKW])@VN>MQ6W$C&,,8)9D/.A?>(^NY1M%Z
MEE0*0M&PL"1HDTWIB/:/7W'(^0L%]N:9R$U[Q=F&N[DF<M<!KQ"Y)P>]B9 =
MB9+)P) &34 \DH@<(1)%[9SQ.C'O6 [9D47Y5,F.$IB[@Y9_Z/53[)30W/QP
MN8L5G4[G4N='#.@\]GL%U.X%:M\FF9Q55$GC+?(NMT%1+""C=.Z%XKR5D>"H
M4ZX5U)30WV?(/RV!N1*8FR\^-P2]$X#N.Y"Y@H=/@X?C)"^ Q\JX#BA0%Q!G
MN=T;SO\$DH*T2C =9Q$/YSY>]].*/E(J^AY$"I/'3&#NA:.$,^*=%LF%X'6@
MS%CLJ@VUOY8+EHJ^9X._S2EY6FHI,90BXSU#W&*%=" 4<9PD9XF#[0P+2Q3+
M)@C&JZA+*8&_$OB["U%\&!26ZKRY@,%Q%IBDUH9'C?*!1(A3JI%-AB$@@2PZ
MPZ)P (,$RT5]4U>"$NJ;S1J\*]:&P32'WDG>UO@VZ)["R4MI6:)8<^V$<S@I
M'%G24@:P[;<<?%7*\^8"[_PD[>.42$FL0[E7,="^X)%AWB/'7(J8&),<>+U$
MJB8UCZ9]]U/$$B L <+GY'V/Q,12N3<_J#C. J44(6DKD-<*G&$L"'*<,*2T
MLU)0G*S+V]ND69Q2Y5)"@:5T[Q>6[KTFJE=*]YX+U':FE.YIKH1AN6FJ$H@G
M3)&6R>4SY'@RUAH9V,*2T4V!)S>>E=*]68*$$L%[I4RNE.X],^B-,SD2O:(A
M8I1#NXASJL"U#0D!BU,^<*F,H_5NVR?K4U#B>:5T[RV2N5MJ]PJ?>PRT[4_R
M.4J%\D0PE*@R &U>(^TB1X+0B(4CQ/,<NL--+? C^%PIW9LE/E<B<S/%Y^Y7
MNE<0[WZ(-T[F. Z1..T05<[DL[4"TM$;)$WN@FZE4U3EKE-D48L2EOME%7I3
MCWXHA7H/R]P&Y32Q$2N)"0]4&,UEI#0$ZZ2QGE?5*;^6^)5"O6<#P=73"@!K
MZO>CM;>)6\O;D7+X7Z,0P*$%&,0668P="IHP%I-CFN12/<F;X/264KT2Z'ME
M.'@S,7P8&)92O?D PM8X$":I170N'PA')'C ,>_0E4 /([,D19R(SOMRF5ZD
M3]5*KP3W2K'><U,^QJTR6#I)(^:)6L.2=TE[(R-VHYUK5TXKP:58;QX1[\<4
MZF>M"MC@A"2NRO4D4#_F(I! HJ0D0K H,O7#3:$FC\(LY7KSR?W>1%#PD:A8
MRO7F"!<GF"#1&@MP?A%P/HRXTAJ!:Z"0<TZ28,$CCJEJM6<>G>4M@<%2K_>4
M*=[7Q/9*O=ZSH=K9%+8GHO>$B(@D501Q&A32U#D@?R)(+;WQU>8,IIM:3K*]
M4K(W2ZA0(GFOE,V5DKWGQKT)-J=#<%$FC[!G$O%H%3)<1I2,(%92J;#6N6@/
M+XI'.[DEKE>*]MXPHRM%>\\);N=32%T"UJ8BL#CB-)"Z7)NLN0A(:.L2%D8'
M[0#<3)/IQW10+F5[L\3I2H1NICA=*=M[5LR;('2>:Q6TP<A'Z1''-B+C@=4E
MY9QA,AB33\(0>I&7NKU?5[>WYH][+O8;PXH]VFRX"&0@-OZ*1[9?*5]UG/W7
MN).UI!3T/2B[BYWDP;C@B \\^NB,P#HPP$W#\^FI50W+KR6%I:#O^> 13Z&$
MFE/L,'?(&'!Z.7,"&0*>;TB42S"8P2>\L,2D;'(UN96C%/3-)65\$V' AX%A
M*>B;#R"<$OBC)(BH$&4N(:X(^,81!\2-T)XJ$CW/NW4)7YSB&Y? W_,'_AKA
M)#:.>U<88;/QOB:)CV&%<UGT=\^H(4W)*Z\#5U)P(8RETB5"*8>_64]][3V3
M"^\9?BA1P[E$1G*%(IZW5SZ1]I=M(I@*BG$D4SY&UUJ&#(\4.:.M2E%@9?3-
M%/'>8</74?/WZ'O,O8?_WG;MH8_9NV_WOE>[\AH7WOT3 '=QYS5U/'GAA36&
M.QH<TU1SSX5A.! <A@SV5Z+U3]WY<H3(0V&:7H/I]1V2"6S>GF1C1%@*FT^*
MD_D0$864D,G[1!@QY,D.$7E-GORC[S'W'+MLFGD4#DOGO+:8)YXBIS3!;T1'
M+XSVV*E$+N@SK>ESZ7 ]EZ#,KH R_.W;^1IPYZ2LP\$C$5/NYLHB HCV2!&;
M+/A<7BB\L,0I!^[\5.U<7P>!+BGY.8^O/A(5RZ:9.<+%UC@N1D8LS5VNB9-
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M3Q:5-VJ)R,+4.^EG,W70.QR9'^!+=K06>0D:Z22G(\&H#$ZJG,REM[L,:QG
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MR_N/*OXRE-^J:/J",-3-LG+PM=OMG0X:OU54I4[?#/[Q;J0^59?M2_BISC"
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M-0$;;L&&6ZP)TH9Y#L!N=,IA<];DLV+$WTZ=W,.WQKR)W/R3Y^]&@'2M.K?
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M"%@8>.E"G,6/N<':Q]J/4A3&7C5CS]H4EG%EN&'(">,0Y\#BCM&$HA+"2!%
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M;/@T'H[R08UR0F.-;?1N[#ZYV+/#_MMJQUY<;ECI$[IR&&.S5LO^V9%--*I
M)/*"B&RU,*1=\,@SH8VA3H/LRLV\*2NNT\<& @_2T;LP_\8R_[2I\D+LOSB*
M6(>H.$>&@OK"J5'(2,.02)I*J6#?":GB)KST 7^B?+_^F$GA^W7S_17;Y6SO
MS1%-&#;8,\1([MX7G48Z*(N,5U1B#Y<=\+UH&[J,AZ)$66[.L@<I=7P<E C+
MIN9DU?LS[4@I6+5RK.)7#9379P<OCH('M11[C"*V%G'N05N)H*-8;!ACQ*3$
M><8J+4M8Y0FS_ ,D<!667P_+7XF@?-T_.PHV:88%0=X1FY,_"#)!&40(]L%K
MRYQDN?X-75#_IK#\DV'Y!TCG*BR_'I:_8I&<[[\XXH%S:Y-$02:&.%8)V403
M4@0[(TBTFMCLAN1DZ=:>):ARE[;B7VQW7#%$RW:[_3/;\^7,R(-G@$W:DKZ*
M*0[JZA@OAL,X&OYGLELO)IM5$.R>TK\NRN,8S42B$F%I#.+.<N0\UT@)ZK'6
MQ&.7 ,%X6YFEM9;B4=U<WE]7I\#"^P^?\C7A?:%T5%881 UQB%OLD$L$(R(U
M]E[K:*O2VZ1-^2;EKA?>W\!HRNWRO@H*/'Q&V 0%<!(L,9G/GN4ZW2X""F@;
M$+4^B"@%#3ZC "5M+9>IU5WB*K>(J^0#6B60\M"&2K4-4W'> C>W@IO=KU<#
M(WMX_\61M((':S!*,BC$C>0Y><,C0J6G,L40-1@<7&Z2PZ3X2#<P;^MV&L<\
M*Q>U8I5\OC?+YX(R&C0+B#@)?!Z5098G#7]Z3QGFU')1=0/8E%3SPN2;&@@I
MK/V@K/UNEK6U\MA*+9 SA"#.+$.:ZH""C SVG%AJ<<Z_Q,OW!=Z@J,<LH__H
M/M<?A#A ]2!^93#JT!^[;FQ-F+3Y 5@9O^8Y#?O=3J@N_A@7%EDK#PH+_^>V
M9N"J5N?)H.7]V33-N;K?8R^F3HD)W]?1E(D_A?+@C:,<!1$2XEY39%5N.(()
M<\X);".@(R=MT()6Y%5=$3,]L$/V_F99,/6V"[39L+IAEF8!V+4<_YD*60N>
MB$*4N^H8@$).,[ LDV=,6$TC"P"P;9">R[NK5\=3!5TW"D,*NCZ2R&%!U[4<
MLKH(!PJ=I. "4:<QXCAJT%R3 8@-!!OM<(@Q'UQ@>+ZCQ2-$U\HK\,O(PDOA
M?T/GR\YD5OOC$^ ?O_/?U9?UO-S@EYV+.5;?PS^369[8P<=.;S(96:'OFOF7
M9O[])[8&\23:X7B0B]_![&VG!TQ7A]I;(_NU9:M@>]46M-NQKM/MC#HP@+I<
M7JY%<0S/L"/XRHY:9\<=?YR_.F_906Q%X$<_R@_*!2M@<8=5IF6^)8U'\,YV
M<T=GV/H(3#NPW>YYBY+_=[OU-ZQ_)\%>Y!:D_9/3?B_[ZUK]U.J/!S<:H:U^
M_2KZ>.+BH+:6&&FWLDE<_3CK<-4PA\?]LU[+Q6[_;+L%2Y(?.!Q6PSSM#SLY
MI;JZH1<_VNJ/^*438L_'/*\01W%P BO;ZJ36<)SSJSNY;VH]P3S 3#!-$?+6
M6:?;A3<ULVV69@S+DE\6OW:&(Z#21=/;;AW O.-EDBK,[6(8@S@<=_/#8'&!
M)NS'6+=N[?=\=YSI'AX/NY/?<6(_]0>=T?GW5G(RR$$$-O@6PW;K_^N?Y>V#
M[<I/Z/0J,K&+4F;S?/HIP7,NR*D'GQ=NV'!ZL+#\'7C'L'GKQ22'X]R4MKD#
M%G3<FSSW>QO<;G:WWF:\W3J$N2\:+NP+O##3\O]9HP=&S(JP^626V7R721[,
M;=+UY2.5;1_^YQC[D__T[#]F?'"R*S[\\X[#^_#[3_LG>Z] 3GW;/][[!,_[
MYSW=__-?'7@.WOOVKNK1L'>X>V0%28GPB$ ,Y1-UBB/C-$5,"XD5#<;ET[^4
M;,\[G5N LMV\^T!@-2'=C4*6M24+A=P?A7Q[<R089]X'@:(Q/,<E\@&L:!!+
M(1>] K,QY!)V9'L^C6F&0DC3,?LN1+*L2BRN58D+M:R*6O8//Q])@I6WV"-%
M/$%<&HD,<QY(AG#AO4A:R4PM\L>  J*H]1C4PD:&@Z"\F3IXWOHT'G2&H5/-
MNIV%\UF$FVW^[3D(]6ZE[2P0P>WJ8:>@PV0U '24DZQ69MT$>*72XJL[G>U6
M GMX'/.XX+$M6&;DQS"TWI2"T2A:%V-M]0<7(SUO_91O/#WM@F()6MG/VZW_
MOJ+!KT#*7^7#O_UQ#.-N/$AS^:LO>N'?ERMXF,=S"*_^O=OWGY\=G\'8/[TX
M<C9:;C4 <E5GD"6)-.88>:6)%Q9DJ7<UA'9ZXQA>9+@*AEBB,&R*X[ WS "6
M4X\IMX8'[NA6*P)ZG<*>C ;CF#N/SE/SG!UWA4'SQ>:=%>E>8=F&;SC=5@)X
MJ[87^F!/9H('6^&WLTX8'4]B?%,W-DR.+V^Q#JA]/+K^EBESU0/-Q\'-X>'%
MH&.[UX""N1$F:#ZS*E/_'@\F0S@%=1XY$(6?D4TPPE]M]\R>#[=^N8IS '(S
M"S<[Y^O-Z/K?F3VI^44;"8!L DA4S$&V.I\\XX([:4A,AL_2CA<*&\J9,2KW
M &;.1".MH0X+@W&06S]$YX7#^"%)/@RJ_S0%V#]7ME0VK &TLR&?:JN\GU$Y
M.THF:UZY.RYIMG*QP("[]G08?YU\^"UTAJ==>_YKIU>]MKKIMZOKE3=Y-FDZ
MTW-]N=E_H[8U5ID$FNR+YL4-=6Q7U#'C,:JO*;G-E;[V,MXFUU[[WF/-MI3T
M3D_]_C7!U3V,51-VHZ?^(+_EEKGO]^.!UC=R0"\.@E_,R=QD3C66/LRLU#7=
ML6=\&E<F^&QV;RJ$=0O?[F9O;5845S7A:_-)YY[38/!,0L>-4STV?DG)\V00
M\P09Y*<J0- ?PR/"\.?;[.OC+T:QP#;Y]29@<>?SK _YC!6=S*LS"-@F;^M^
M]D*<YGA/#L5T^\-AR]O!X#SU!V=V$.8JMR]]%N 19U LFN)FYT#<PM_K#(\\
M46=,[@-GE=7:DT"=]SAGPXNCW9OEZ\[YD@XFU/5O(*Z7T[3U')(@3H_W#U_
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M)H%S,8/$L ;LL0P9;@@2P1#X?QHE]:!^F+;@I9/Q$V;B^PO.%"9>.1//*A"
MNT3IE)#G@N2:MA@9:PQ*/$B@9^53[D9.:-OH3?)P+NL+6<:86*+XW:/F\WL3
MUG\.^L/B\UPAGW^<%]:Y)XY,P2 L64"<*8:LM@H9Q3QQP6+J3?85X+9965O/
MS2C=5CA_<R5\X?S5<_ZLA*<A:"<U0<J3',/D$CD1!6*6JDB-\B96G,_:A*PJ
MU>)^.?_)YUW_9T%A$."112>?GYEOX38%ONY-7WF>G7[6!6&?%R@OB@!21:!?
MG@M["0(09I)'3KO M61$6K:U(U2;JWE/PX.T^2E.AE5S\[WI((6;[YF;9Q42
M$@V@<K(H^>@1)SFIRDB%B!8:JYR"0=/6#A-MP^;UD=*TZ[Y.!-U N;BSVG<C
M$^GQ)]\_E3*JFZ!D 4D6'%X=#K\^6U#OWRG-C64$&:%R0S.6(SA<(\:HX$E%
MC2N]BK6Y4?=M&6Z86ZA 78&Z=6F@!>I6#G5SE?>)CX3*8% "BQ%,2!>0%B(A
MKX,V*J7('4"=4FVB5W4P<CT%H$<7M:XF=,TJ(-N48_6;\HPGK\-?*=8P55KK
M;A4;;AHU><AG/)\TLMT0>Z-.ZE3U)$>V]['CNK'X?N_/+.E^[(5I03U5&?./
M#KPV_KOS)8;=B[VH!7F1XBN4XM\6&"Q)*Z$5X2@E*1!W,B#GK 3[Q4;BI%%<
MF*T=R=O2K*#%0W$$;R)K+ZN&%];>!-:>5] %L]@JB8@GH*!3 ZR-!4:82,&]
M3"I9 :PMVWH5O;&*5_C&U=ZN^_?NJ>V/]U#. X>?IZ"JY,:N&I3P(@>I,+!7
M/" 9 T,\&8)T%!PQY:E/6"<<TM8.P6VME]$WRN&Z#>;C>W#[%3Z^7SZ>4RZ4
M,2$0RA$),6>_)@HF \5(<L^,DD)BXW)G.# ?-H.-GWR*VUS$><IC=<=6?,^Z
M&_WC;C;_D'K51;?.*50N@+Q"0"8+%"NC+07@I4A:3'-'M(B,2AP%$+($1T&"
MB5L[2K2%7D%&WV8<1%A-E^."<L\"Y5:M=1:4NW^4FU,[8Z0N6LF1E%612^J0
M3I8C[:Q4BFC*O 64HVV&Y_-K-@SE5A)L?@Q1Q0V*3&ZN^OYJOKU='+9S:]V5
M]M$N0F_II7DZ(O%^':I%&*Y0&+(%*C\.2DGF+&*:Y]+T/"%0:0@*/E&M.>>!
MXJT=2MM8SW<MO:LP7(IW'H=!4)#S62+G)B2N3L%GR6%=.8+.F1,6,QL]4<AX
M91%7#".-DT1.1Y&299'QN+7#VUHM7>QM U"TTJ%_J5IW[BSH>;NQS:I_CS",
M7NZL5'?8INVJE2DP3>OEN&E5_:^^&[9>^%'N<THQ4:U!_-]Q9P"# $7ZU)['
M 7SJM[P][8Q@;;[%ZBY[TH?U@C_>_I<].?WM52OFHHRA,QKG._NPFJW4^1);
MY]'"_=6!<=#-A[#$K<&DFG]^#A%3/X'_PNA[E[\X'0^&8YM;7_=;?\<:7(CB
MDY:LN[E!6\]V6V_CE]@;Q];+?LCMN5O$:%GUV0;,Z(48MEO_1'BJST0"8\\-
MQ^N>]/G'M^E*?Z>VUU>[TE_%L=<IY7E]B1=.D;=V%-_"4'L>X*PBL%R8>UPU
MQ<Y[!5MUD/)&E>[TW^V:_>W@\.,9C(GL?7HM]K[EP!N&K;(&:0KZ'H\A(:.]
M1-AA[6TDP5 *D+5]W?&B2;-ZH,6J WO373U% !Z@P:GFZK$N4%H1^*(.\9G6
M&P3)O-GT/^OWAJTP'N1O,NW YYC?E0G]@OGJ2@Q M!.V YP$5IOBC>W6U9;0
MFX5*1  JO1CF&<PU<FT ZBRVCFVX6-;>#QK$M7(?>U@F6', +5@MD!T?C^%9
M3-V6N7DT44C+0DI@ B3BJ#8:J"-0KS'%ZAJC;HZGEVWD\_R8]379_[1W1!W'
ME F)%$O H%A1Y+CTB#"NDN$B&9^V=C39GC^*W9HP9V:YV^RY4H;Y7'T* S@D
M;PWF)'%IP91WSF%<]OP>]QQ V0=KA+("P9;GLU ,-$JC- K"\222  /=;NT0
MJ;?G]<B+30<^'XY ;/X8+$;'=M1R62N:PHQ:-]*5D@#;VP?\ <WE5L@1:'+!
M6PX#Y2%98\$P"EP( +R@Y(V18V$+CB+GOTM&=/_P_9$S"IOD. (!CW-T(R$M
M$D?>6"^4\(ZD -"Q/>_-F2:BB<RYHJ$&T"V[_=.3+.L7]9\"B77<@=_."2".
M*XJZ-3&E1)5SP6 30=WD5FL#9.4\!17%4^L*,=T?,<&X ).TQ](GBB+.O0R8
M9<A:HY&2(!JH<T!9?FN'FNWYTYG3U/02%#98YE['WHZ@:I"JR*;78%2M]@6
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MH'\,^B<OZSWZ"Z;9S[_^:[*9!0=OA8-[TP8MV_OTGA\1X7$$.84H]6#04JD
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M)3"&P_!I__ -W/\:OS]\VSTX]!SN_;KWZ</G#Z^ZGS_\^>[LPZO_G/S/MXN
MYFCO<.]L[]4+<20445P8BKP0'G%/%3)4!\2HA2^B#URKK1TNV_";98,E)8^]
M8,X/,8<:[+54WC,LN6="<V^5X)0'ZU5DJL$</L&<F7S$@CF;ASF=&<RA)N8>
M+Q1I(W.Z<-#(,2*0Q-*Y"%LN4]K:4;JMQ=*)PP5S"N;\$'.T<,G&!-J.8)Q[
M($(:-$U!Z6"Q9KS!'#7!'%,P9],QYWP&<Z(4PN5V031RWG0N9C&7F<4N$H C
M(4#/$:8M3<&<@CGWCSD>ZT2TUXHEP8W33BL7+37,<ANQD37F3')%R6P66L&<
MC<.<RU;8#>8X:H,-$:.LTP+F4($,#S&W+0-!8U@RT@'FR#;'!7,*YJQ!SW'"
M2B\#5R+Q%(P1(D6*K992!F;-C#^G8,[F8\ZE/X? 6IP?>>)8)$DC0;A!G).
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M1B+3@"S,(6Y3!2H<80DF4E >6P4Z"R=MJLOQD((LC]"S79!ES=G;#;(DAKD
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M#K;;>R\3V+<Z;>W(MEQ0)ZZ@44&CQ^B(+VBT(6ATU5^?T2A8(P4/2&.'$?<
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MQX/Q:#BRO;RDU<&7TC)AA8CV;<K[#'/X+/8_'B6))<]EZ4 ^ :))S)".7 /
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M,WZ5=N0VI]XH7Q7O8U92FC&I&,[EU0A.P]2/"3I+DHQ%DHW96O )GOHIK_.
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M/BOW4FRW1@G4JK%$0*W:R<;V= &U@%H5:FFJ^7T!6G&%6KK\U%H38G./XR%
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M4;;=EF2;E\@,(RV-2K;)GG)H11J'G^"NS,]G _. >9*(=>FE$7NG#4U2ZKE
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M_!+SSSC7'X4.]::Q'R";64-=;2W,/UV36S])>=P/0_P\U0??'G1U?B*;[02
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M4105:U<2N2)E;YY2( =#8CT<<#$82?2O/[C,!>1<@!F.)"1DJI)0)+H;P-<
M&HU&X]>_/RU\YP&2$.'@T\'QVZ,#!P93[*)@]NG@?GS9^>7@[Y]_^NG7_^ET
M_GU^=^U<X&FT@ %U>@0""EWG$=&Y\\V%X7?'(WCA?,/D.WH G<YG0=3#RQ5!
MLSEU3HY.3C=_)6?3HX]')Q""#CAY!SOOCJ?O.A^]]Z!S>G3L?GC_$4!X_/[_
M9F>_O#MZYQU[)YV/[\%QYYW[8=(!'S^>=ECYTZ,/IS\?'Q][@NE3>!9.YW !
M'-:P(#Q["C\=S"E=GAT>/CX^OGT\?8O)[/#DZ.CX\-\WUR-1]" NZZ/@^UKI
MIPGQD_*GA_SG"0AA6GP6N&O%?30#@?MVBA>,X.3D^.3T."G+.;DT+:TR?G\H
M?U2+HHIJH""D()BFU7 IZ=#5$H;%-.SG0_XSK])1Y^BX<\(J!2@E:!)1>(G)
MX@)Z(/)9Y:+@OQ'PD8>@R[3 AQSGM0+*SQ20&:2W8 '#)9A";3]\_LEQ.#AH
ML<2$.D&.T /A1%0X)%20'3@2R&L\!51H)R\9)KV7*W\(?1KROSK\K[=/H7MP
M:"XU"CLS ):U)*LT4GK\39T:*%IY_/'CQ\,GKF;%-2A4!U&^PS]VCD\ZI\<U
MQ);IE;EL]E<GH6NC#MD0JU>'A&[+.A2.E3)=T%&*OT/#:A1/"(:=D!#PUK^O
M(S"$T[<S_'#H0F2B^)O%^8<"50=!@*F@Y]_$WRV7*/"P_()]Q0$[2U"[@UXR
M]^6FX(*A(?YW!LB48%\SC@Z7!"\AH0B&ZO0M&,P)]#X=\$F\D\Q2?_A@\I;5
M)"F2$["N>OSG0T8"_>NL)0DM1__30<@ \*'L&YL;OB2P;L,92<@6" 'TG[[]
M4^#7;3\CF4;^7Z/Y+O3J-I^1H  U:#VG'K/?'<2LIQYFMN>!P[^[O[LJLR*$
M0%DTX95PRZKQ^4C\<^QT,B.UXPBJ7P\WRVYPB4+H#H+/XO.F7L?$<9$*P@V%
M,*9;[\E"LOC+I.LJ.K0;N8A>L:F6+$1-S/HV1Z7MYI/U;A8,'(7##G5Y;W [
M&EQ?773'_8OS[G7WMM<??>GWQR-#O2XEUX)PRGI^Q+H-)LJNL')B7HYDML=C
M/!H"PEHUAQ2Q>FX)SCHO+5+OS)%RWJSQ_MN.(C<:L__>]&_'H\'E8-B_ZXZO
MV*_U42OAHT7L?15B&5-G<.ED;/=87?8&-\.[_I?^[>CJ:__JEOW9OQZ,M@2N
MC*D6Q0_F**[)<*00YPT7L_-#<' Y&@]Z__PRN+[HWXWZ_[J_&O^^!:"%[+10
M_FP$)4=2Y?Z_CN2_ZQ#R0=0=?;F\'GS;=BRF;+20_5)C]#&NCF"[0TB=@Q"%
MV!LJC6 0C*+% I 5]D9H%B"/&0$![4ZG. HH"F9#[*,IV]>9@;B5!"V^'_DF
M (53'X<1@>P/(<[!GJ,*=)A$)Q;)?U.$.IE4)Q&[0_B/EBC GH>]P2) W8D9
MI)M$.I2.CS91XAPZC 4'0S+9I3Z?8T(I)(NKX &&E,],8?81!5_1=Z:-AE"8
M\=(B=)Q#B#/N<,Z.POI,^<-!@2/9[Q!VW>E_(Q0*;H;SWQJ%%H>331Q4\AWJ
MYTN R%?@1_ & MX37.',^KN04MOOIYO]SMDX@H^C,-HA!*Y9JTW7^+BLMI??
M;?:R)-RA7NUA-G\2BB8^',$ 87*+J6DOE]!J>_W]9J\KC!S)R1&L=@B'<^#S
M$^/1',+$[KR %"#?V*HMI=?B\2%OLPIFCN"6&*1.S&^'0!E1//T^Q[X+2=AG
MRQY=&1I!>3HM"#_G#!Z%"=NR"S8[U/<]O%@@8=>QKF43!-\0P8#OAJ[A#/A#
M@J<0\I@LX\G*F)\6JU_R$UC"7.SLUMB?.4* HTC8(1BO H8 '(,GTT5%)= "
MD=MM2VI'D.]0+X^@#Z<4NO^* &%;)']UB0(V@R/@7P *[@/ SR)YC)K1[&7(
M3(?.27Z7'7-V4M9.RMOAS)TW*?M=\C!OXY)Z.>>7L1/L)+=Y;\,)YKQ)/NU5
MPPRP,6 &]0LH1BQ'JQ8Y7T([:B'%[Y)2;/@[Z^!<3*J%+N>.R#M,=Q$(U1E6
M!X4".BT$.5^%RF07.[_(L58'A IZ+1@Y%T:Q>VX789$NM#I K%%HNS[GK9#D
MN]C5Q0ZX.EU?R4$+1<YG4>;(VT5PRCUR]>PR#1<M2#EG1:5W;Q>1RKOK:EE4
M9=1:9'+>BR*7WRX"HOB ZB"1)]-!<)IS4:@.I%WL>D/G3ZT!4HNE%K)\9$ =
MK](N8KK-WOX6$,(H'F#-TZ@6)6HUXGG\"ATGK8GS)J[+7FO,,+R##S"((+_]
MKI0;LN$9L*7MQ53)K!I:_<HY/UK2K[AZ,DF 6CRIX5[O:@+.S^$@X1/_-9K"
M((1W/,_"RRF<1KY6TW(^GI8T+:N7$U?,D37;:UC=*06O@$]7\=!]N9FL4*Q6
MGW)NJK9F+EF== ;;:U'->2)K /;Z@ 0\*F )R6@.R,LIE5$MM#I6$#W4SIR5
MU8X3)/5S6 4=4<.=U+J-\YMFYKF.B1;S?+!2_CAHU^WGC4[F>97<R(?8HP0$
MH<?,.^R!,(0T9-CX"$R0CWAV HHEP3:(-A:F13[G32Q$/I'/OTQKP/^0=1"3
M@5(+A^+T$'&O*1EX1"ZOK+?@TY);;0Q%RGYD_2\BS"+H\IP6HOKUC-QV16JU
M)N_IU&E-7 ^A*4E-A#;-H:-6QLEJL]<=%<@ !U,0SA&%"S[FIV")*/!%5[J(
M,A2>7Y=:J8).M]X9W.7:T"U6KPZOF"-J)E0LKINC5FZO;@7J9G2]JZ%5THRW
M5D&VNDJV\V:,&F72#-=*#EKT*B^@[=%1.J,K;"OQ#8$N@^ ZL[#8;]$"NHUQ
MJ\%;BVC.G;J!J)3E),+$_*R(<V)Y.X_W%;_*,..Q%BHPWR!W[$&W^\ 6JAF\
M#Z$7^=?(:SYF&\K1ZD%U0!L_BDWEKBM#(MJ)93M2N,.E[[Q6# GF"6I!>@2J
M9"!KK (F3+5XYYR1&W@S(8Z0HAS?*G)V$MFB&,5NLH]7)L7X9Q?0E ('=W :
M$<*,&.&1JP7^,\C5ZD?.D5@24YFN$)L+0U(9!U"5EJE.6J/8.;E7)=F7K%_8
M'HWU7^P$OF:[;O]4&>4A)2*?X?;:4U^45F%R7LA2A5D7SC=V0KQSNC;5I#78
MZT?<=0TM?C-66GQSOL9B?/>[ !D!W0RK$EHM.#F77AR&O<>"=\- NHD"WM=R
MBH'BAZ(UM %<3=CK$'V?<Z2EB*;BQ)(;"Y0_EZW%NPO]#: 1$9V O3*<MD._
MH02M N0<9:D"9!*%4[5"'?8ZT!RA/XZ?7PO^.-[KP4OH0?'%FF9+M"$O+:XY
M5VKI=9U=7\2+>UQ>R%!6UU4/+Y8XX#8H]N*=1##KLIX+9K#^MJEUJ5J-R+EB
M*S0BOHZB+O0K)ZL*GQ#2RCAJ;792@\KO;66G3#U X0R3ND9 ,]9:72B(/:VZ
M)]91C\LR<7NPUQ!I>GW"F)\6UH(0T&I8=WOF+^_Z[@/[+[\[Y&$R CY#8$)'
MW*\HC)S)BB=](F!*(^#'9M*J)="WD*Q5CWJYW[CO-:E,A]6FPZOC\/HX686<
MR<I1JI08C:N]/M5 E:^D]P&!P$<_H'N-PW"(Y5')BRB57KQ6LW+>V18T"_$X
M8B>KF,-KYB15VRO8&L)#^> 5-QVY[;;D*W5+RE/%6JL8-2^DBX-!(4W8GJF\
M/=IKD/R&L?N(?/:S.Z!S2++3<^FA:PEY4S%:+2A(E%^M!8EDH05"MA(AD+@A
M]SJQ-L=/IR2"C7W-31CK</^0\S)KEP4I:^<]2N5HI.E&:?M(5_+6@EV0"+ :
M[$S<SN.=SRLB;CV= \:/NUU@$-8/ZJG+5(MPSJ=8F,.D(V]L=80<1Q6TAU;T
M4,.(:3T?+8#YS'[% .ZV6Z!@W/!O!DO.?\CFM.Z4]4W=+7]MKEHT<TZ\LN'(
MOW:D((=+<A)1>WA%'YVS+>9W%S\&_'!-1"@.(LI?=><)O+<$V8BW%NJ<8Z\$
MZE2:/+*3T9:*P#W@HJ=$5+GLG2WA+>"D!3/GABL!4^&]QTUTRAT,*4$\_Y/X
MK:5Y6,-5BZ?1:PXB,#&1$T_).ST-*PG<FAE$50RTF.7\4FNYX';= E*Z5CU_
M3K_NRTNZYS!@4NOY&9NQUN)9^3B$3(JCG%UG/SJQ/.=-+/%ONP[X9NQVRZ#7
M9*\#_N?JI(Y%T>![\,O!OX >)(3G9WRJZ572,=$"F7,?;0"9<$W2=>XV4)O#
MB!^33?$LX =EK$"LSXTAK,E>"V[.<Z0=I:I$,583F3N)O&%:U3CG4CU[N!%K
M+>)Y5U.MS*V=-'_47QSN7P^?PC.P7*+ P_P;^7<08%EW\17[AG6>S%7 E,&?
M!>X?XF[;8"T7F$AV>^" 22C",3X=4!*QOP.P@'$&L\+R 3_A8Y^2\D\3XJ.S
M)20(N[R>GP[<2*;!.'#"B#%'-.)__49PM/QTP(N[]&S.2I)I-(%7%"X.'"H(
M)2N^ZPEF_'O.[N"PO$U1B (8<L-PPE2#"[E+)X$KER>&\!!(CQ^3>\+=HAOJ
MV6:K!\*YVBL>\,.L6YY1I+YC4< =,S3Y:2(/3%B'PPFBI;V-SE"NCQ?,N*5L
MN!CTLA*N<P>EIH=SM S_ 7[\N(&+"21E.F1"V8(VK;?/I:3#/X5G+EX %!BT
M4&;S&,\A 4O(N$]#MMR\K6Y;-8T-K>JZ_XGB]"5CW'5=,=D ?PB0>Q7T9$Z;
M<QRX7Z [@V.>B(LU4M2H1/>;,ZS3'1NJ/66CY_ET^YS@QY";,,QH6:S8^K/$
M(? %?P:G'PFGJY+B9Y!D^(GC&[A1$F\*NG&GE4ZHSR&J=3VK.0.S:A%^I>,"
MRO]?!3PJ2S0C"FBI)NG(MM"79YT*NS_0"HLG0LD-8'WT5#U'E!:W87KH/_&D
MOR$<LB4(WO& _!%/JU;=(@V1#>VJ,;*R^Q'2L<J79LTH;HO[:P_<.$FOF%NJ
M(2\J:0/.;$0Q><#GL: A6WTH"K'/1AJL;HZ6S(:V<7N0+ZL7$9%&QN\0$)UJ
M:HA>6^/6[ARN2I>&S6+-C>+GM1QJ3 1#L$J,)KD=2#81,+R%=.!QX)*-0FF_
M/)L\:VVS_%ISRUI1=WU2:6P8VGW/@WP]@*GW[([-2.O^+&;F(>D/[8D>#ME.
MD8WE:?FV=$NNMMI;-93^-];]/.!_$(@,CN/U5)%M#"N=A#_10+K$D6;5KZ:Q
M82#50*XP3O66#8V($%BQ36E3Q%]@'9,NK7Q*D3;ZKYRWI5ZQ-AV!F_<D7L3[
MF!=J:4]_95,L?YA"U&.@LP#*2MLP927^T/AE%#/GZ49A&]HQ?L3C.8YX+B'V
M4<0FL='-M>\!\GC1ZH:94MO0TOPR.*[O(AG;Y2 I\\IW_0<\T[7.D-B&=MY&
MO"X#3\TD6CJS%A=^ICTS"BB<0?(<JW.+_JM-AJ_M0+B#RWAC._!$WA&VS^7U
M80L9)&S6'S*CO.KXPIC>6D.^RT^[E:RW.K#+R[\VEIF+XCYX1('[C8=/5NW3
MR@FL12MU8EUBDFT/1(9*^;X>CS$$P>J&,9SPT_;JF;<Q.QOFXI*W#TOA+BUO
MJ8U:4E_Q8MEJ#)_HN<_,G+K-S9$_(Y0TD=+4]=[ [6Z3AF833-'@^B*#\PVF
MITIJ:^>J[%V>$E44L3]Z1:[-QQ*-[DDW36P"##SM9%L^E.MS^@NXADKR2O;:
M<[#I)-C:B<TUZ4^L.?$;U;WJ-6&SE W+@,E!RL#SV)1&U)OJW45EO,N67&T]
MGDE-334,3F,'5)%8H0 Y]TV?#[:Z/I\U(AO:51#/>XT"$7T;EC6KFN:U]Y!%
M#PD\(CJ_#_ DA.1![NV7$=VXG;#^ DDVRR;LLC#'PD.=TD'^:O6QUJK,#PNM
M^[Z2Q(9Q%&<<&D63:>P*Q20.R]2:.T:TMJ[I)FM8;\X1NPKN67T(91W*2B4)
M^,H'3@N<K1T"%;$X3$@8=BF;[B81%=LBS ^OH)ON'92$'R9;SZTE6-N+ZT%A
MNF%64MK6@16;P>=&QO*Y37/AMO$1+6X/J_G;"GUQ,.K@Z]5%DR!6E<X&]8B7
M.W&.I)ZK&2Z3Y72VPID<(A;NUJ_",*J([S2BK='PUSZ.S%+'Q0N4DO4_MGG:
M&/=&8FS=/_<72Q^O(!2K\# BTSEKB$CMI3G8,R!\[=U9#0S#^.Y87WE?_4I&
MSKGG$;W%]'=(>61[&PI30YBUYE"2-#T.<O*^L$G"7UTC-E6Z64+L&_"$%M&B
MM--J<GDFA4J(C ( UO(NW0>(AMW 9?47)]PB1RF;#30>J+I<;%A)!XN 634C
MN 124G4+RTK;T)+X-E%W1F R1Z/XUH*H1WGTAI;P]14T/NFZA#H=+"AH SC<
M]QPQRS)-H\[&Q0A[]!'H;E694-K0PJVNW;:Q_!1QM7:=X=N+V$?0C>@<$QYF
M// \R&T S9&'$:VMAGR=C6?LF))-4NUW]BE$+DR0:V&/:RK*5GMW"/P'R*JV
MD35!Y_BH)/J3S2IJ''[@%N0';2]^TUS4:^\5U)/NS#Q3+E<-'J$[QNS7!23Q
MVJE?8K?A:8-6B>P!!@D&K*JS08J0).G#103'.+-2MTH[4LK3UJFPX); G%FV
MM:\6J$0V*(#)6<Z0X <4L@]C? ?9'C10$&XAD,*$O;TF%_OF"?$)^P*! "]0
MM4:4%K=!%X8>#* F1<IZ&2MJ'9^GL97!8'(J*6VM?A7<("PQ(],%5(X9MLL6
M?I$Z=Q/K<F[;O9VAOXQEF"QA\MK+VI7):WZ<"@UC8,T96!+\&I^W<-LHH)BL
M$H=R^9ES!86M"VYLXMTO/<*T,AZV%;&7A:6M'=8) #SJ&B6Q0MF(X[92UV?J
MP!9+9O2FN)5/:TWY67H_XP;YS.['NNBC7#$;%J1;2$5J'V[6N- ]7]V'?.@5
MGV[(#4Z2=$J?SZHEYJ^_@YS)/&MI](MN=UA6W@;$C6Z3;*87JQC,#=E9.]LQ
M8PM.01@G3KWT\6.H; SD;4Z^+V"6Q;1JEJ_-YQF58REEU##AE-"($D-KB"G[
M"@%?I@:3Y^.T'[@#3W/:TJH,6[V\97?91U=7S2[!*X0V3",%X=O\H)--J5.T
M9 N=\""'V$=NC*399<5MV5IB];(ESXVF-#Y7C(<XF)5O<,H)GG7?8C@KF'C)
MXDO3#*TT3:^\3:TDZZTP^MN38.W*$C\ZRB/T(1(1^S)7&L_[%9_7\7PL) 0R
MW.[X8]4>J38K6S=/3/6G$+KA)<&+NE>YC6AM;?AS)EQ*TAUS"^-5,CZM5\ *
MVZ;.2;K\$,QZ.!3NEN0F18M': 8R7GOGDRC(:(GX%4)6QQLT(_46]!HL+%F\
MVQP6^??*=0'*+R3=5KLYMH#N5C[XH7&H%!:UP3;.WQ=8W6'?9SO"1T#<*L._
MBNJU)P/E)2U%H2[Y0S/PFFUJS3,--N!DJ[HVS S[ITWWVBQ$)%WJQ.VI=I.C
M&HFQ57V2BQDR*GB$?7?@R0":&TCG. XI@>4FG#F#YYH^A.!V3A'&^*+*7*W!
MP5:\U10V!7?*&B3",>!BB5DETN+=P66,8OR40)+21M;F41.35(^'#;9 E_WI
M0K<_&@XUX5;Y@C;4OR!7-UNA:^?W5FAL:)5IOKO>RM4%F31B94,?<)\Z_Y<O
M%P_ YX8'"%QAC]!U>\0XTUQSCI;,44D2!7[U5<9W:>,4ULO:NO#4,*AN(956
MMW"K2DN]#4.MF*^E9_HUVI6\=,'CY. #]/&R,OJC!<ZV.C33%"3+I8]@_<PE
M)62VCJG8_\ V;T@&Y[GP*O@/%.<01IZ+2DH;EH@L$'8]7TJM5'/UF-BJVT9Q
M#NLQ+%N'312PL]<Q "?TB@U#$O'O%1-=QF%*0UT3&%"+AZV*TNHCOEP9!MZ]
M]C&4YQ5JZ1K=I>,YO 'D.Z32Y9'< -1LM'1D-LR\%<Y0MEQ&"_XJN!@7A*(?
M:\:"8BDD+[H&;G8ZK!RTEX<NO8AP6Y?UJF0IZ0UQ_6,/.O+73K=2^M@&F4+?
MUVQZ#8EM&$FU'Z58]R*W_0I5,7=+9]B"%WEUSQ)7DEBA#]D4=0=G?"K#9)7%
MCJ11VOQ$?LRV(VQ!%-8ZTET*;8&Q#?V3S%]QXK[[P.5Y@YDERB9[5K4T]$H_
M QIP>.U)\"LD ?!UKV-LEK(!IG@+^<_5DF!M TH*V]"..D_/IE&1 ^\KYG-H
M$D<=2BXMO7!K(N9Y%)=M>$QND96MOC>LYM^;+=QKI#;H184-VIHQ^R<S3!.?
M@8=K3LAZ0FO="O$=9*.+RC:IKTC%<R[[:#2'D%ZP%B-?&S^HIWOM,"!QCC6<
M [( 4Y$PA6F:-L^*AL@&Q+*@\]0LRZ*KA0TC3GHFW!^5V7(5 >W-V%FZ$UA[
M/#=PUW<Q&QXCU3%0-2TW9&BKXV_(796G/9^M-TR]QSR%KB8]03F!#0.B22CS
M,[[1HY=AZ[H=6]_]![Q@)I>1I;Y1U@9UZ&&RQ$R(S&"9.>=U*YJ>[K57M ;)
M)=+W,[BJ^IB_R-%F[HI"]K:J]RUK#P_\B!/(]9F(!?</IXTHR3M=[C]HS-!:
M,[;H^99OS9]OR491N/TS,L]:#VL18=/2#6 SA-;1O5',AJDX?JZA:_2H0]>F
MFM<)%\(!3I;\UC.E5C"W5F/73\>5C7R<19NG:PMY$L;,@84]3C0F@'>$\,@S
M*W,V6]>9BB/X;858<>VO:$=1_;Q+KK"EF[*"E'VZ .I*$AMF"/5&K[S=+6Y(
MUG)WU6!AZV:R!WSD81(@P#;'M_#Q'Y"$<)4<LX_!D_1=]@ A*T_>$-,L9,T9
MVJ 6)KD9^32D6"0M9'LLX6BMTF0Z/H(!PD1<E[B(X,G1R:GV7$!/:H,B?)41
M<8;W1<I*V]"26MFQ4N]'' J(6LZ^5<G_M3?HZHL&ZBFZ<);'F5/$9_.'$8S8
MV* EJN]SD'_X/*E^GV&*%VBJV5HWY&;KA'>+'T!P@WT_"J?1(H90<UA436,#
MY$8/.F=//6SW,+3*QU:8VXQNW?0>OTA(;5[HJSOS?CUD/1U.YW !/O_T_U!+
M P04    " !Q@%Q6&VH_-*(]   $DP( %0   &QG;F0M,C R,C$R,S%?8V%L
M+GAM;.U]6W-;1Y+F^_P*K_=ULUWW2\?T;,BZ=#M"MA22/+W[A,BJRI*P P$:
M )2M_?6;!9 42?$"$G6 0^U$=,L42>%\5?F=O%56YK_^SS\_SG[X3,O5=#'_
MVX_R+^+''VB>%V4Z?_^W'W]_]P+"C__SW_[E7_[UOP'\KY_?O/SAV2*??*3Y
M^H>G2\(UE1_^F*X__/#/0JO_^*$N%Q]_^.=B^1_3SPCP;YM_]'3QZ<MR^O[#
M^@<EE+[ZT^5?LXA"$2&@,@1&9@.Q6@0M9'$V(I&T_^/]7X,1ILJJ(%J48(I+
M@#%JX-_7PFDOI:R;#YU-Y__QU_9'PA7]P(N;KS9__=N/'];K3W_]Z:<__OCC
M+W^FY>POB^7[GY00^J>SW_[Q]-?__.;W_]";WY8QQI\V/SW_U=7TNE_DCY4_
M_:]?7[[-'^@CPG2^6N,\MP>LIG]=;;[Y<I%QO=GS.W']<.-OM+_!V:]!^Q9(
M!5K^Y<]5^?'?_N6''[;;L5S,Z W5']I_?W_SRZ5'SJ;O<5[^DA<??VH__NGI
MJ]_>OGKYR[,G[YX_^_G)RR>_/7W^]A_/G[][R^ W'[;^\HG^]N-J^O'3C,Z^
M]V%)]6\_SM[/"X-02JHMA/]^\X?]]!5=QED^F6TVXR7__?0C&Y@>0.G/-<T+
M;;?C[)&S1;[T2[,FC,7R[%_.,-%L\]W)R0K>(WZ:/%FM:+UZ>K)<,O<G-D3$
M:!U8P@S&E@H)E0+BKZ+S619=+N]-6\B*5[*17\55V@CQ]--_:IOV$\W6J[/O
M;+9QLX77 MANW\-7\Q17'Y[,2_O/\_\\X?=QQA^Z>K)^BLOE%W[S_QUG)S1A
M.OF4302'RH)!G0%],) HZFJK4U%@YU7N!.SRZB_0Y\DR_[!8%EJR(OOQAS^H
MJ9U3G;9%B<O\#:\NOU&GO_'3ZN3CQ\UGPG1-'\_^?5-PO7BQ7@PMDRT;>$7[
MTN47-@@?Z1W^2:LWE(FQI1E-JC.V!D;A3 A@'#E R3H<%0JG! E5=&=Z7 MD
M%SJH1T>'_?>\F_B?Y+PX82Y^Q?$;K<_6&*/$VHQO\IX-LQ$>0DD";(K2ZJ"=
MU+6W*KP%SRYDT(^.#-TDT(\3F[6]JL^FJT^+%<[^OER<?&+.SDZ:Y\C?S8OY
M>CH_H?+J$RTWNW6.U]48;"H0368.QX(03"@@>'=J4L;$0(,8SX>@W85/YO'Q
MZ3#2ZVB /O.S%\LO3/L)JS_6=>39U76&$>0*L5@/U6B+3DNOL;=;<O'YNS#"
M/CI&/'B'N\GXU?H#+2\O2&4MG<L<#"I48&KA\$]RY.>3E$4I&V2-G27]+8I=
MY.T>G;SWW.UN4G_[8;%<OZ/EQT; U;IE%E83GU0U41O(R1.8I"VDK R(9*)*
M1?E@<V>Y7X=C%\G[1R?YO7>\LP\QD3*:Z"U',R*(]D=A_R4XYIV0[+Y8'U0:
MQ!]X*/Z6YY@\77S\2,L\Q=G+::;YBMXT%JPF5-@?\\F %!Y9-"I"M,("^:(=
M1EZ,$Y=7\VW:Y+8'C"_XO9< S]C8;0^[L?'%=-YR="\)3W&\JK^O:+/$29)H
MM:4 (=C"@)P%1/9\%$5^5:+*(?562+? &5_ ^R *]-[X?I[(UN>=O[\64DFA
M:"H9^+\>#-7"(7C*D&62(3?]:T1OI^0V0..+>/=B0[_-[\:'9U2)[6XY3\EL
ME]D\Y5K9<BH907%,Q#Y3]A!1*[ ZLK+R/M7B.I/A9C3CBU7W8D*G;>_LKIS'
MP;EX=I8Y#K:95Z:4@.2S@MPP!.V$Q>YYK_N&)8<-0_<2]L,W=X@ ]+?%/)]"
MJ=H'=(5 &^186"5D* 9!.'+5B2!#ZIWEOA;(^,+0_=3\WIO=3>ZOEPNV.>LO
MKV<X7S^9EW;Z\JF%14W36)N31C8SJCIV135EB%438$HHI,O>YMZO^6UXQA>2
M[L6";EO?,=.XQOG[:9K1N;5Y_N=I7O3OBT7Y8SJ;31)Z(5$+"%$PLF 1(NLG
MR,ZH2EH*A?U/ON[&M0LYPN,A1W=1]',(=T^;?Z/B9$#IC?0@I5=@$BF(0B=P
M3&=A=/&4;6^/\>%P=Z%4?#R4.I3@NC'MG.<"<S+D!#C;RJ38-8;H^:\Z4ZH>
MJ:#N39O[J!4I'@\)'K2GW23Z<HII.INNI[2:Z(BIVFH@Q<"44I0@:"5!JZQ3
M4,I9H3H+]<+C]TI_GGW.EQ>+Y=/-R_.>7Y)-C<II$L]+Y8OD=0EJE2HQ9 @.
M/91 D3==%)'#3HG0.Q\UII3H0\5[*2_:=W.'H.Y9H.94=M8:SZ\0VV!CI(-(
M$3E0\QEU5CZ:WH5PWZ(84SYT7_EWVNN^0?$%,!<,HA8D@JX>4C"2.:@]<[!J
M(!T87$(G8^^D^,UHQI0%[<6!3GL_7![T(C8.V)P.UF([L<',]C14CMZ359"J
M4LD7)5/L'2O? 6E,&=%>K.@IA6[48"OUF0/Y%JP]H[2^R%1-*$*2X)1H*1W&
M%&-H7XE 3%?KHNQ,BAO!C"EGVHL.?79^"!_A7N5E%W&CB<YP#%]M0QL3^_88
MV+=QJ@9OB]!DAO,I'HAZ3.G9 7R00\ARH//;<V?Z BR3K4D<S(,L'- ;4]F5
MLK:";N]+C8F,[VVI[@0UIM1N-P^FJR3Z%9VM%_D_/BQFO*>KEG)>?YDD4M62
M"5!$X(#*, 0TSD,[CT"-PF#H753Z+8K]3S).?8/-1V\OC,3" 6%EW5]<BQJT
M2(#:&_!6\$9;587H[:5? V-,(?J>TO_V#&._3>_H@WW\N)A?0"&ED=5RF%CY
M#0/#F"!XJ2$YYP75;+#T=[TN8QA3:-Y9[GMM=[^BA%*F;>TX>XU3C@F>XJ?I
M&F<37YT*467PNAE>],Q $R)PI&B#M#7J[HF9&Z",*3+O3($>F]_SEM;)Q[:U
M[(FUQ 'S\].2/M!\-?U,VV#QY6+50L17E:/&"4K%(A0*2N#E\C(#),.<S35B
M,<+)'+LSY'X0QQ2]]V;.@,+JQJ@WM,;IG,IS7,[9AUM= /V,ZC1/UQ,E34BQ
M5%#!%#";DIV(!IR6)25E&&[O$XR[48TIS._,F\XB&2+L?S(OURP:8VE<C9!E
ME*W- P(*)/!5$UJ9I;"A,U'NPM3S)$^RD7>D"A0I,B]/& C!)1 JU"A\E-[V
MOL-PXTG>: [ ]F?"+1F)>VUY5Q][NKTST^[JGYW-Y0:(!63Y)6,SK]K"/"EH
M=Q5 B."3KC9YW[U=PLUPQN1Y#\J)7B(9,KN@4] 4+<<"1K8KVKI"R%X :555
MJEZQ?3]P=F$T1V3]&;&G (8\+Y?2!X'" ZKJP% 2C"-DR(D# VSWFFKOD/RN
M\_('11K+$RK7+"_F*FTP&D3DP-?8P,O34;'\)&I^_5A=]T[=WPAFI$;Q(4RX
M)GKH(("A#O_.L(1@5<F(0(;\ME=)RBH ZN"MLVR>:^_,X_5(1FH*>S"AP]8/
M<H'R/-5_AB@%D2)I @J.HQ+*O%Q>&) 3QIE89>F>;;@-STAM80]*=!/#WL38
MWO'=/OGU8MFVXE6]N[;-9F:IM@&4SK%=_@D08K$@C!">C7;PYDIU_4TWJ._[
MZ#$EG#JQX@ RZ&E'UDO,ZW].UQ^>GJS6BX]?RY_.&8PR498F06$=!R8']NE0
M6L B-=H23$J]"Z%WP36FG%-_&]-7+$,?])];0:$M/U="4H(7C10!?6R=1ENO
M/!D"^>X%BK<B&FF12 ^2=!1%][YUK_%+:YEVAL7KF%W+H.M26@<K52$BY@8M
M<W 94>$ 0<HU2$9:\=$I0MEWZX]>DG8&NJ2"T0D)07IVIB-6P& -.*-<++5:
M@0/>TABJ:=VA+@)V)M8AA7F%@?_ZT]7M?,E_W[_+\MMW_.>OSW][]_;5BU>O
MG[]Y\NX7_NEE$/=OMWS#I_;MN[P+]$X-F,\-S-/%:I/I??[GI]8R:#41V5=E
MB, GRR(5I36#L E<E=53\H9,;X_P1C#[N\"K]:O:;JAM\J*T_#S-M'J[F)4G
M'YOW_G\WXIH$ZS)N;D57;3B^3YF7S-Y6L0&]$K&$TKM^<3=D8TJZ]6',M]YP
M=PEU/+!?$7],:R/]C#[3;+&Y2W^Z[(D5(4K5DM[),*0<(T36Q%"3EE74Z%SN
MG7N^%="8TG+#<*6?//K>YSI?[;;2Y!10NSQ"UI<@<H+,EI!7*]@\^E9&H'1,
MN;"!+KW/,&]'=,]$'3Q"EG042<=4S&K];+JDO/X5U[2<XFSB;-1:60M"6?;=
MB\\0& ,X9=')$G)5O5M=?8MB3!FZX>S+'CO?K_, S7EY,U[6D_)Q.I^NUFVQ
MG\^8.2E"\?\R 9JDV)$F"Y$=> A8I)3*V2QZ%_3< 6E,*;AAN-%3)IV'0[1J
MQ1>\#=MT\@FO_#ST6DVJ"J28LA!C9!66:[NMRE\5[T,6GO],O5LFWHVJVU",
MT]W_F853I^M)3"30D ,G%0LA. TAZ +1R:14I%!E[Z;5-T"YIS,^K.WL3),;
MQV7L(8T#OA(_4UTLZ<*,C^=_\KO,,IG.<?GE%][)S6WOEGE?S&8;MX"- :W6
MDV1JX"5Y$"0C&)OY]2;>LZ*SR\K&H@>BUR#+&5,,<!"&'I\4W5A^5H/\FI9O
M/^"2?L;5-$\4.G97:X%:-I56%=D:\5?95F=-B479WE'FM4"&?X?Y<9LG;9XY
MB:AC-E:"]ZGUK,X:$ED$9RII'PT:>W@;=PGBF'(S^W/G_J_7P^4UD&&X-E%]
M?N?C,EP4#ET2 K)PF5V[IH-,M= Z?3BB0M;VKI]Y,-@Q*?6AB3:4#/N?D7_%
M/;$N4$@R@[;$RP^:@;29']9+S 6UU]T'^UT#8_]LYV?B;3][W:^6*)SWBFPM
MX_A_I=VCLH9BSH']OU!:8^%4(6AG03O'NV"CK]T3YP^ .29-O2]_OLV)#BNU
M_B_.-R%\>RPIO^F[M&FL8B%9+, 1140AI:NJMXNSXX'3G;KV0/G13ESI(X)^
M*3&<SMN:7LVW!\_3;37=U3ZU$^6+P^H4^^#LDALE-43;;O^;3*V)&SK?VQ7<
M$=J8REY[DV4(Z72C#L=MBVLS_!.4HNC6I(M]@N:*^ 2AU<6TCK(N:=1.]E8F
M-X+I]X)<FBU%J*J4!4J5O*[H/*"5":0K_+9F03GWKK>Z%LB8K&H?/MS\"CQT
M_[M.;-P"V"[O/%6A/#]1.0)1VY0YIR2$Q.H[.VFRCE'4[O6[-V$94YPR#"&Z
M2*%G;_W-T\^/*[+UGL,>4*F%X+)UR9$UMCGV&84PHKC>SO@5"*,Z71Z* @_?
M]+Y5!S>O3RN=?&(DY%-B-K)K'TW,(!+++X@8T76OX+H5T9B.F8>A14>)]'.2
M:'W!%]3%^%@I0!5M31S_0:1<09@BG,[5V.X=V2X!.&2N[\EZO9RFDW6KE7ZW
M>$.?6B79_/US_@?K+Y.29$B&!,@H+9@:V("3YYVP6;5<?Q#%'S'W=ROX43E=
M#^;7/CG ?K(]Y)%]JL%1Y3T1N@W:T]&T7"5;C=KTC';&N][5/O<]LC^RPS80
MF?:6QF#G>\^FLY,UE4D0(5N7"E!H(W=$: $TNY*A:A]##2'YWM;Z!B@'/HXY
M?>HVF6^"2K*J=@K,SI2I14/KM@QL&;/PA50HO2^7[0%W3&JX!Z_V/)1YL"0/
MJ(*OPG15&DQ1LK?G',-T!9)3"G0E'=E52U4-2[@=0(Y)00]/L]Y2>Q3U1SH6
MJZ)H!2:MQM!39$NG)4B2MF3?CC@/[QATJC_JFM=-K=]*F]$BL+6>TDRS@I8=
MA&!+JF2T/E)>][C:?RS<O/IJ]Y'DH,?V3E-L&JK-PN2@W&#A>#]Z$+54$7TB
M#AD.?6P_]I*]XY!I7^D=X>;ITU>_OG[S_!_/?WO[R[\__^4W_NOSEZ_>=KV&
M>M,CAKN3NM.B.EU0O::%[WG[WF \EA($Q-K.K)-B+T!PM)@UNR):*.,E=7YS
M;X'3.4\7*20LK<.49'_*F "I)N:U3PD#LUIA=T-W<Y[NN,:M%P>^,4X/WO&^
M*?P;VE2_8!4[?7]ZQSY_>;?$^0KS1@;SLOG;J43*_SG9'D>=[XIQRJEL#<CJ
M7;N/S\95Z0CHO*-$50?7NYQ]F)6,R2P.1<,1<. @?'[R&:>SEJ_E1;W%&;VE
M?++<-BO]%KWSNK(=5U"PM6:7;>*#R@6B030N.S;YW6<)=<(^IG*@8W!V,#D?
MPW][\O8?+UZ^^F=?C^W\0P?TT:X'WLDK8_$]Q=6'U\O%YRE_VL]??E^UT8G;
MPHA69LHJZO.VH;@)F8(4!-8[S5ZZ::/DQ2:E+YE^&K'TSFOOCF[OT5#X95,-
M]&[Q)/_GR71)/Y^LIO-68;O-BS88IS\I$Y.,#!0S5%G;_!+!KH:Q$6I(-G'\
M(Y/N?;?W/OA&=:]Q(()],V5J*/EU,ZC?(.0MX3!X_>7U#.?K5KS+W]TTP)@4
M])IJZV'0 F!CR4+R+D'5_'W;4J/4.V38'=VH*JJ/Q:X^LAN.6V\_+);K=[3\
M>+'0T22AC2 "16TBA*\)@E,1@J)<?6CEC[T5^$[ QE5E=B1&[2VQ/NV(>=V9
MJ)SF"S]^I&6>XNSE-+=4[VGS6V-55<)9()%XW8XU9S3!0*NC=:V!871W>E2[
M/FQ4E6;#4F.0_>^G8BX :[' JWHM8ZOT55F. A*5RJ%(1D@V5"C5D+51ZJA[
M#_K9#=F8NI\<2L?T%]D@=/H5UZ=AY>LE?3I5C&U6#<YFJU/0ZRN@G93D(A*0
M,QSRZB AM,1(T425/+\3W<OD]X0\IN;&1R#@T$(>SI?:CLCYE=8?%N4B.HK*
MRB#Y1<'4>C;;!-B*%&LUPF974.;!H\ ;L-VS<_+WZ5'UD-L@^N[9=+-R?A]8
M)7^-4R>Y-=UQ'#!H[3E^D.0AI1C U>@M;P#ZV+MT9 =88VJ6? 2]U4-8W773
MB\7R(L9-#O>Z3:B6L23M(==-/W&7 6UF3U&ZW,8#2B/U0"IJ1XB[L"M^IYIJ
M""GVO&QRW5YLI^=<QI==2C:) M7IQ H5%;!FM1!1&.F<*3[TKKS<'5U/Q?T/
M*N_INAU0616C=019=9LG50.DXA.;%"^JL5%IU[OR:!=<8SKZ'XA/MZGN+N+J
MV'SZS.M]55\NYN];&-9FDDVL0WY>UJP[,(,)"@%UFP(28E2!'6#;/=M[$Y;'
MD-OMS9@N<AG"PC.PDV7^@"MV/%HJ:#'?#.Z<F(K6H!00#2_1!*$A2>E (YLD
M&W.TIKNRN1/58\CA=M<U?64UR*#!U\LI+_D3SL[ 3E(5LMU?A^+;G0YM"T35
M.N^C;-T;S0"S=F\%=,\,[W?!G'X2&B:_V[C[ZM.F0/CYGRT%S;LP\=$6J;7A
M94J.>%R[BHF6(.0JLQ J2>S=MN=.4(\@JSNDA[._H+H;KC?$ J#R;O$._VR-
MR]J<:5Y\JR Z[2](I94;T7RUV=2)JH2ZLG'552LP)D=(BC*0-M8H&V3MWACT
MH5COF<+]+E350>0ZM/OT3UPN<7/6D5VUK=X#DT8PR0C VL+VX!DKJ]JH>[<)
MO0/28TC5'LAQ>I"4.AU[?T7TEN.![>682:V2J&8VQ*:R(?9&MUN0K34IH65H
M->@K+39N.NB^[N/OF5A]U)+OM,E]A?UN<=UPWW^P8J/EZNK*OS!0941);M-5
MH)5A,S];\H_WPCO>!O0JW(L-]WO^8\B4#D*7 <74W>Z\JK_2\CTM3ZWEIB_G
M=9O"(:'R7@<@TUQ\(SQ'B)E=-)0HG669=!_W?D^(.^4.Q7?"MT.(<>C,_/F=
MRHN)3LI&:B7!*=$N5H8"R12$*J.1RF"JOG=GI-W1=8A8ZW2]N?'%YB/ZC*T_
MG^)UIJ0!L]60J8J<?=&U]KX_^/7ICR#+OB\WKHE!'[+U W0:WM8UG9W+3F+(
M(O!#06Z:5P2)K4V)AIAE*Z4,K!AZEY_=A.4QY-)[\Z*+7/HX>;\MYFW%3S\@
M.PZ_S)^OUM./39>_P.ERXT6T1.VW;L5J(HVM.:,&$5HO*6DRA,S:/=10<B0=
M94T[N7D/1? 84NF]B',X4773/<_HTY+R=+-Y_/6,3N]P7AIO2U%A\2(RWR4C
M\^P3)*H1A*Z)%6;,6?>^]+@+KD=03=U;)7475Q_U=$%37E>3JWST@1U((!=:
M*.PY*$8;0)**R:@J?*P[*:';GW//]/GC5S4=M[V;0GF2\W++R@N4?%4W3=I.
MMD6RKY?T<7KR<741*VL[2U9Y(,P1C'(<YQJR8 650I)J,KVK!1^&]#%DS7MK
MG0/(M!__+D$\#W//9HJ<8YX08DTA5+ ..=JM0@*Z[" I6;)6T3GL[5SOBNV>
M6?3O@F)#B*V/<;L,[9MK3(QN4^OX/"_FBX_3?.K-*>U))F? Z5@9Y^;FI ^@
M/-M@&VRKS=[)YCWH\8^@S+FK)1Q>1MT4U T'C$2^2M?:A*7$RE)J"T$38RDN
MB9"SQ=*[ ?K#CX7C]T&=CB+IV<USV0IIGM'VO[^PGU]IN6SK/F]K-T&5?*[1
M0XFJU7PF!X%*FY^DJTV>,G:OLMP)V*/(L_>F3W^1]>U[=,UZV[:\F"W^>+M&
MWL%VTQ]]5$YFMJ:">6ZP9,":,R@KI8\D8NP^<G1G<#NQZCM+2@\CN0'5% <)
M&P_M#66:?FY]EB:%="M"5VQ5VUP1I-9\N;(6]4&@2+:X(;JFWXEK)SI];\GL
M[@(;D$HMB)SS/]H<@)JLBJ\.9/O#A%9X)6V$;$B&-IM&RMYAVJV =B+/]Y+0
M[B^B RB@U_BED;EE17->GE!Y.<4TG6UW(7DKG'$9*M;6U28+]NZ, >\-><7;
M(,0 D[4?@'0GGGUGV>T#R'10K77N[%U0J:IH00T2*2G 4.3]8+/,7U$H29)2
MW5N([ AM)X9]+_GR(<4V(*>N&YI]1OTO$TJ5=\(+T#FV<5*,-&DAVAPB@QEU
MQM#[[M0](>[$L2/W"1F>8OVD."#5+@<<3_'3=(TSWK))K!C(> 7!M ;4RA-@
MZPV 6M;B58YD>E^QVAW=3@0[=L7Y\ SK(KRN!4VK=C!)JU?SYW\V2"?3U8<6
MK;ZJF]NHT8>2+54HH<@VEU1"1..AEI0=IA)2]Q*W.T'M1*5CE[ /4>/43U1]
M#EPNWB=LF?NS)6^^L4G=OZJ\&YL)[Y<*'Z0D6TQVX*+58 3O1@A%@[>%% JG
M\6H.ZX8SEX<BV(E"WTGR_'"BZJ:7-G59_/_62^DSSK87P5;KY32WLNC64W=>
M+G_CPF^^IN6TM5ZZK'J?_YEG)^WJ&'^QJ?AZ@VMZ7BOE]23ER/MGV]"&F,%8
MFX%U<8102+! A'>^=_KKL"L\8.TWFS!!SA$0LQ%,HK:7@E@I530IL%-^M4OG
MT6J_CSR49+P<OV;.R1#B'_IJPG5-C80M6?J206Z:);,3#Y$:R&2J$2ZXHGI'
M^0_M)G_D826/GI[[BO\8/:U,*4;H*,%3:^/M1-N&%/EMJM*4&#G$'$M/JR//
M)7GT]-Q7_ ,.,_D95]/5HKY>THJW:_-A_/.W333++XOZ=OI^/JW3W'K0;].^
MO(K7B]DTMV//Z[M'/Z,U3F>KR^!WFX(R()K]QZ<<:JLZS5UATO%[]7+ZN3%P
MS22?MF1]<_K;O(I)B)9$( NM[!,,)0W1) $^9'04<_&B=VW3[8@Z]"2ZZ=/_
MOMR.?\S:\;L%WO$[;90F0%4-:-01=;">9.\;$W=A&I.3VI$OUS0CZB>:;OF,
MFR#QVWOR\61S+?=B>,PFAOBI'Y[19YHM-J,X3N?3MA[32RK;ZXI?YU:M)B%[
MZ;)EQ\.PHN> FD-XKR/_H8I/6K7&!+OF/@9'.ZK;A .0<9QB'ZMI_PI@4<_F
MN'\ZF^-^) ._"Z8CF_E[;ULG8__/S5O)S/W,<?I[^NWD8Z)ENPTR.^'O;AZ_
M>G6R7C'EF]L[<=+6S6U9(9"#(XT(44@)R9)2)?L<<N^K/?>$N*\[<.WC;GK8
MU[=W0M:+7).!J-LAL]"\,[8(R!ES53&8FGN'90^$.B;G84C^7?4F#B'9;@F!
M&S;F&YQ-Z^1)DAZ+J!*T4Y:W17L."G,!03*FV&R;[MU-XUX QY2U.CKENDAQ
M0/O_]M.4K5!=U%<?Y],GZ6W^0.5D1HNZ;K. *RW9RN'&]>%_-OM:N[5>;/_!
M'F:^UZ/WM^:#;$(GH[WU.S=W-C\M5CCC6.CDTR_ST]34YGI=\RY.Z.P,;W$Z
MW'D]R4F21H%@A?5@T'O F!7$[+U,L1CO>T^&>3C:O?LA[/[$[:SA[6.W@"?>
M8K8^:@BYY8&E2("E1*" PK J"#7WGE"Q%^ QF?4#,?2;C@H'$WB_GAWWV*%M
MROI*HGKB"0W'KP0)@SZ=Q"BR9'9)[4QUU79O++0WZ#'Y ^/G:@?!][N2?__=
MFDAVD&WR$7QR"DR6O$TE$:-55>=4E:J]Z_0? /. ;_(WJ:G%/)]2BBIZ*[T$
MJS>'XR@AE!H!,QH411J'O?>J"_!';GWNQ=$]7N5.DC^&^?G[8E'^F,YF%R!'
M:T/$P&&*2A6,BP2QMA-0;W*I(NBD>V>#]@+\R,W.H4BZIZ2/0<Z-._<5[ZE'
MIU*QK7L6I!*HE4(&0"$#.)4Y>$?%F]>]U]F>F,=40#%BBNXO[S['@?> O,5X
MJ<CV-.X0I/)FBLJF>D2WZTDD!%2'LE1?LY2[53IW #.F-GR'HM]1!'DD^ETN
MZC[%':+-KHTPKL*T>R6LX5/,_(=P$8N2SM%NQ\U=X(QI<,ZX*;BW,(]AJ5\O
M%_SE^LOK63L)G9<6T6Y.QR]X&YEJL;:V4%:QMR%BA)3YE6)W6%#P4>AV\>)8
M=GN'%8QIHOJ(K7AO+APSRW&6$]+>L#>L.(*+H@T-:??S;+'@0M64$R-6O;G;
M*\-^W.:$A^;I@63<C9,7NB3<;Y-$, (5HR5)C#8S9*22VZTP4W5**@?;F9$/
MQ7I .W36UNL=_GFQ_X0WGFE##EC'!##5*\"("*U)0)L-9I+MO5E[@QY3[NT@
M+-W#Y'00^]'?Z#,U9(7&F'4 [16'NR)SX&M4 2D,:<DAL#2]3<V>D,>4@#L*
M4P\I\A'DX2Z^8M8'9:1UX-H 4".T@*A3@TXU>AVIN",FBV\&/J:,W-BU:R?Q
M'SPY<G%?+P75%P(11SIJ)2R@;-, -?("<LZ@JW4V9&W#U<%H^V=)=L UIHS=
M0>EY;!D?G*1?)\U<6,H%\,D9YTU"J*[=#!2A720P%7)6BC15;4+L3= [,(TI
MES=J<O:4[6C\4V)]+X-LG;9;>4RMK9Z5D6?$J+)*2<;>E4E=_=/A7N6+AP<7
M()]O7&!A&^5!^9;6"*WBW&$$1P4-[YN/*'N_R;=#^AY"S(?0\J'O<T<!C\/.
MG"%'!AB\9/4C7 5CV9?#Y ,(##%3DM*3/XB1^8XBRD,2LYMPCQ%=GB5OWM!G
MXA^<PW:58?H"6;2W29.'V'JH>\6Q!JF",?6^_;(WZ.\AJMR'M\>1_L%UZ>5(
MXYI73JF*C#8 D<GLV*$'M+R!0L80-:\F4'>G_2Y0WT-(>4B=VE7(Q[C8M=R^
M4?S+M+VBOEK4-?_PPF(79XO=ITU+7P #7O+:?T/VO.IU7PK^1J<U<.].KZ>Q
MGIS48)05F0-7"@:,#Q'05&PR0:^B]#9W#R.N W*,.P=H8B#A-0C5QH&U2[N!
MC 69E8]&9IV[CRO9^\[!<<*J@U.MPT'\O<1[]'S(Q*FJ58D!<LIU.[PU.BG
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MT-I+=ZPT]=%-S,')^=!,0Q_QCL5CS,7;X)4 )VIM.M!!2AQNI1(9KDO-9([
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M0+%$ K,-N72_=[0SNEVH$QXE=0:65+\VH>TXY.:E!XU*%VD93F!V)^DA*5%
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M(O-()DEA<5)J&8C-!_=(OH%X>*ZT4>[63LKNBNGD*'_SK>Y;X(5'Q:WA+'D
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MWT:N'9R[OQM]A<'TZ^\S]Z<'QBBT63&I%#DS@G,6?53,DB?C7%$I-;^=^0;
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M^0?KGOWT=^<F4KVMY9WG1MW 4T_F%H@F"VIO JIAJMZ=0 Z?N+>_CFXKO)&
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M.-PZ!C.V$7L7C%A8RUL0E^FPR09E_"P;BM?^OHX<NT!;>8'$:VUCXJUO0QZ
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M?J:H8@ +0%$HQ. U 2(86G/+8@;- L1 YB<9SO,VVOOFTY^Z\G875<,+L9N
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MRRJMLS)+LIZ\'PWR69G;QM]Q^FF4YQXKUA8>]9*FCJP"4YOK*V11<\]4B8$
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M?D^3R>5Y;9,W)7>Y?_7+LP)!\IO?T5I[9+B#4.B9310'ZN@%"UX&AIZ#":#
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MM8LZ V:?)@$:]K_LO=O"P.NDBM81DI6TL&P]1%ZG*"F34'&I,.>#;\*K*,^
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MUS"<_%>XN,(_,$RO)G.C9'%5<G^Z^O+'.<QN_L:\9<;59$)V>/7JIGM<3O2
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MQVBE J%KO@7:.JB0S!W)(N-,%^Y71[)MRDG?XJF'=Z];JFM\"%D?;RCDHL<
M_>+OPQ"'%W?[#4S'MQW1WM0BG"_SO-AI\_&1>V#H:=!D*ZFLCJ3,5KKD&!+[
M%(84-&T\24NOT"FI_8:TICW0]#.\LLCBI*!W1SOB-UEA@KPFI!>(6>=EP,AS
MOSUP;Z"TRL^X>UN\?)_?C/+[\2@MOOD\GH6+-Y&>'U+MNZ%2K*&X$&L%DJ'_
M!"8DG2PF,<V=C+:O+*ZM@!X[L+D;8S9E=_2GH]ZCXG=F=99<G*)W'CC&&G'
M J$6K) %(ES*S)G2[Q7*,:>B'D"576>F;J.'WF_<[O39O^DQQ6TD>R$7*!P3
M*"TS^*@\).<M<\5B$OT6$*T!]?(8LZ]F>DHP_;PBD@%9L>3"U(YD-M5,:L8@
M:FT@)DG0=(YFM<JPR9&TBN,E$&1O^?>0.;32&>S7,)S\5[BXPLK9B_'T:H+3
M@<JA^$R+5 5KW;1*A,[0PM'[8FSPBK>VVCK .@\;I;7\>S]Q%N%4:QEM9;*
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MNU80[[E(W(!C(=+.1ZY3S'48N3#9FQ*8L/V6J9U>UXI>>+"-G(_1M<(XHWU
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MWMO=O[3^LWJ71)#KP<'7WT\'!J,7&#)H4S(H2\Z#+_32<LY]S)B*T::Q6)H
M/^;-\=[\VN[:KP]5]A!@^G,R)I]T]N-/>M]K4X%J-GZ;-X>88KFZ^'U8<,!4
M3C*@ ^MS(5>UEH(8^E8%';W7Y*WJUO=]'6"=%9=:JZ&7BHEO$R3+H<IX(#2Y
M#MQ+<,Q:8FUBM:S<@S5!!A.LR,W[,=Y]_EGI?F?!]A 6^K4*$G^GXSV_&\W"
MZ$O-YW\SG>)=(LI0I"*K#CR:VE?8D'E'-@1D;UC"PI+7K:<==,%U5J1HKHA>
M&K-,9Q_*;^-QOO4_</II?)&76<L+2G/.%&?20;92TFZ5:S\:1U!5-L%9C3&V
M=LNZ(3LKPO2@C![B/YMI/;T+\Y=_ON%HBN_);?G\-UY\QS_&H]G7Z2 Q)YCD
M!;+6)""DC3%&%:!V.(FQ<&E<ZTY0^R$^*XH=4'D]Q(JV0_]_,$P^_ST>H&>6
MI^0AL4A;;"X<O#0*0I6?8?2VI-8W(3L!?<%$VT55&Z-.!^47$08'FB=MC/5@
M>$AU3$>"*"R"B"$H)3,]J74ES(Y07SK'ME;70Y;9P[/LU_'59)"L3<HS!EK6
M5AZI$&I&@G-19F:**RJW3@7?#>D+Y]C6RGI(,;<OQ=Y=?@O#R:*[_"KLQ8HN
MZHH&QG$M+%=0G#.@6*&MEA4VWW0UO1Q.J]8M4SI".RL2]:&.AZSQ^PUJ6(8U
MWY*E-QQ](:SS#I$?AU^^SMY\H6US+H\!]R5Q&^H<(X]T0OL,T2D+R3L=M/7>
MYA5/<-.(AD[/.PL:]"7?-1'"O8/):Y?_>=E#-@6K70:I:J)*C5L&EA!DM-+'
M&+*4K?/0-J,Y? E2\UVAD:B/76IT?V)=*DH7EC(=?*DFVY(9[[AE4&1&'3UJ
MYSI%BDY]6&8KY:V=F;F-$!M>$ZR.L.L"X_QF9FXE_ TS%W>17(^*M$8Q0YP$
M>K:NO?H\."3CPMO"O*XU_;'3SGUL!7::F=E"?]L(K+'>_B!)W<Y_]-EK7H<_
MT7E"YH 7#()BM+9D57:J%.6:S,R\^]#CS<S<2NSC%C)K>!W_<'AG#(H;<O4
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M6Z3QVJO,$%P-8"D2-SC)+)C,6"Z2%Z9+XW?@( M[<>_"Z='EX3NA3_:=6)R
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M:O%W3W?77_U7??75SY!&2=/ R1O*:LH ! (!XL /0)HYN:WD;6<# !H:P 4
M "@!<LA5X @X.@$>W BW \C!,00<Z[]\]?TOP 8 )WM7V $H>.XX>"P'*L"^
M\ON]O^27_))?\DM^R2_Y_U0472PL?(3NVMF:N[F#AQ1Q9+_S"0:0-[R.(__'
MN#HA_O<QF:@X "0D_#G^DUM0IGQ_WB]N\4M^R2_Y);_DE_S_+6(B8B+2(J+2
MXB)<HN+28I>DQ27_Y3F0A0 N@ 7X\0&$@+N '6 +F -NP'="0IJAAMWW\'"5
M%A9V=A<RMW*QL!:R='$2]C9W%185$A$&9.#>KN:6#M8>7!;6MG;.LGR;-0U\
M7'96LGQZDAHB&J[7K._;J?JZ6=_VO77'TM?!4LJ*#RYW@DK&6]K;R=7)VL.<
MR]O)T=E=VEN6^_>G2X/C[Z>%N>5DW*QLI'6N*_]Q!7@DR_W'7+R\O(2\Q(5<
MW&R%1:6DI(1%Q(3%Q 3!*P3=?9P]S+T%G=UY_GC =6MW2S<[5P\[%V>N[\?F
M%BZ>'K+<GIYV5M(VYC:2%E96DH(6YN)6@J*B5N:"YE;BHH)6XN)6ER5%KXC9
MB%IP_V'>RO(?UET]W1Q_MVUE*6SM:.UD[>SA#KX-46%NX?]<F^ K^H?1?_GZ
M01_!:Z2ON5F;>UA?!U7N^P(+BH@*BHO<^?L""XF*79(1_LMU,L)_F>A_P=N2
MD[&RE+;\/B<7M[^9OVW]X#^VVHYV<C]2ZK]Y"9[\VP!\/!A[QXX=DQ'^T?(_
MOPKA/T(/'/TC4,$[N?X?R"\COXS\,O++R"\COXS\,O+?R\B?9-?:&62X7B"5
M)8T#UP H!<51"G+H48JCE% H)14=-<@QJ!AI3QZG8V%D8V5A9&$^S<EWYC3'
M60YF%FXA[K/\YP4N"K!Q"8L+7Q#CNR!PX?M#(%!*2JIC5 S4U P7V%G8+_P?
M"^D#0$<)$3]230;A!H[00<CH(*06  8 $ K([_+WO@!RA(R<XBB4\A@5-7A!
MV4G@"(2,[ @Y&04%.3GX;0#X/4!.1W'JC*C"47IM<RCW P:Q1_$9E#R*;QL9
M=?JV>,4MW(*/43$QL["RG3W'QW_^@H3DI<M7I*2O75=25E%5NW'[CNY=/7T#
M0TLK:QO;^W;V[AZ>#[V\?7Q#'H>&A4=$1B4\_2TQ*?G9\Y3,K.R<U[EY^07O
MWI>6E5=45E4W-;>TMK5W='[L'Q@<&AX9_3(V,SLW_VUA<6EY!;V]LXO9V\<>
MX+[[!0'(('^7?^D7'>C7$7)R,G+H=[\@1[R^7T!'3G%&].@I!6VH^0-Z;K%'
ME R*\1EO&X_QB.ML,5JX]5$Q\4K,G$5_=^UWS_[W' O^O_+L'X[]Z=<8<)P,
M BX>&1T !W#*4?SI1W[I+_TG=>B(/^-CHJVBTP[HPM?K!(C!#Q'8DPUS\LQY
M>4X;ZR4CGL4MMVGU)RYOY^<!F5'\_^5:HMEJ=M)11M3[8G=MLI<?V6\ZC'<X
MGUL2("7O:L5GP_'(9#CF(YQ KG7T -LM=.LK';#^XBD):!DNB41;-.O4APWC
MVM3//6^Z&*S ?<2;=9KN0"_VSC "30)<2(")WL$ Z^XW!FU5!>.'67-^+V(,
M-02:I+WV<@:-U<4OG8DF^!$MQR7?SAY^\=B$KNA=FB\JA% U%SS=7MSZ[!"2
M.G+(/%TJ/JJZU>.Q?/%=6ZM!Q>6;L:,?6@$7C0+LOD;TQ-<E7, N=5?[_4_L
MM,ZW$(!#^M9BI*._1NZ+)TP7EAYV41.6>AHJZGS*TWR.IY[KX]X**\[3O/KF
M<J2[Z/9>-!.+HVW,A/LX^_!2C <\1KO9YM*U@G'F%,GEFN/N2)/.-"Q=.NVU
MO[PQLN9 OLD)S;DGA7;6-F%?+/6S^+X9MQ5Y8WA'8"8J+6D'_(;)A'<DH$_-
MN$[TJ:')A/[7L]TO>X[WO2S,:&3<';QIRN ^]!M]U$%@?6H%"4#J-TS /@;Q
M9D:=I^3/C +^*U6@68X?T7'@3@*,LTA KY+?*V_;5MH#F!!B]3<$CC*=1O'U
M>W#&APC<2L/GC/PB$C!'G")6HW9>BR]_Y,^,B_)M>YE2'^.5^_%A<<O-%PW5
MJM-$:,KVDHVXMYLF&39L5E9H>TS+O#*-8/1Z;0Z.A&8PKI9=N].[V^U,QUEH
MS?@1]55(SAHG,A_( .G$EG3=M.[#B!<;C'7G)%[M<A:'A)1".@\;\O/\^1A[
MHF3LW&?'GQF>OO);LT6)% ]+S[R1W/JZT<,&&KRPP^64%,..YO0D94_8HROP
M&(^\)VSD2E0%(@S' 7[(_;^XO646"=_6*A,^M"8!F0E5OBMRO"2@4W&P83V9
M&'7CVW*TP/(J HMY0FC$%RZPX7RGB+(6), 5<0%(B.+/YOH_R#8RGA;<"A:A
MY%>7\<V&KB4\PW)U/4C#1V/Q2=GX%^K._!Z8%#7UP3W$U)62YMD7=.:Y)=YB
M53Q;L#E3!S/!E%G[ N)GH4Z8T6\S^7X4.MHU-K^9<@_?NV<YY'+T*NLHLN.E
MGM\T@F5B941%8XC2IYPIZAX@&)O^:*H^(,8GU!DK^-&[ZY; R">>'1V!IQ11
MA51HX\_=HVOMYG9W,O@^ECSUDBV(XD>5RK'\=XFGX'\#9FDIL" $G:76(0'E
M9KCS LDE6;.:^-\$U8E?$$O9):;/FGY(K7IS5&XQ^.1AX7WH=OHQ<%Z*5/R9
M07]J";050:\<6MCU>E3_2:3YAP0#&!5+]#1D!%4&> WJ(4E T\S0/J)#KLM9
MVO^@9]$HD V;3R@L-%K&O0K^,$+#$ZO_,KYR"P(=W.\&? 49M.4I?M?H1H;W
M)PN.JO'E/*B>:B'0W[")^E2>);T7- ,A 0B\N#S'*\;9?1+ Y+F:T/3QJ@.O
M+-7K/=B3![B[$O4R:)DO4T6WQ D?"O%!Z;3I]U&I3]LFSR*O>K[(2MN\M+EH
MR)1&[Z]I?Y"P?361.-]; I<$B*60C5*]%TLD@'G=QAII],[!PEM<W@LUF#\?
MR%I";-9^/R1X=_%65>PLTQ*Z'$&V%)!']@S[-%?=9P:[8:[3UJ_Q&6K%0T[T
M1O&C,CK(3RHKK)RX]Q7+U[R?P,H[,,2.$17GPC]J]7Z&+]>/2NU_,?)IWPW?
MS^(;^#'SX;:,875/N*]C1> Y]3>YG:5W;9S'([AH1^"A#_O\X5N[-X^]]Q%Q
MW_DTU3M,*'Y5%E,9_)ER.L)#=1"B;^[V?* @5[M8LG>I=9%A1<=CF<_K=?:@
MMNJGO)Q7P071";< QEV5;FHEMY2*%@3-LE*\<\J>-IXIRYL$U%>:#5>=)@'1
M>K'Z=BE6HC3=5Y/A<6UP0P"3(M"X$<B+S9R)E810D8"'_%J!V?2X(3XT*I)7
MRLEF"5&-)=Z![ HR[JP%7D5+>(\7W7*%1P@@1 T?IC'@U1U5T@3K1C<7FJ#$
MD"A@#R?PV2/MR;#XN_8B S5[M<8D^@6N?9X\O+C)>EB6;8%A\>=7[APM@GUS
MCD1H[Z$61<KOD?5:0\QHO%,B]QA;LN42T)D.[3/5]$+'KDU<'I6HO,N.KW=/
M:/%]>8]V.!TYQU1 =5#M]()V=LS '9<"8' " LV^NW*\O;.#]V(R)V[4.KII
MAVNG8@KE*1A?%&%#;O8*XM=UEL] -W+O(C)C-7PF4>A@&XL4CN"VNIQJ*4L2
M (&2[4A 5@;U'AGC%=%*7:?&"MMHMUJB@@(5"]OG$*=: DULP&"I'6]X!010
M*WD[);?"3HV)[)2<J3';Z*:$%4R/.*3C[PY(0E4E[[_03*S<$:_FP<BJS(IN
MRG.L,XS.JUD:<'MZF"=:2Y'[AMSZ(4///]7@J!6\N'WQ07K7U?(C2)W[D%T]
MBF*\?G\1:V:_>8"B0AM^#;FS@KCH-W(Z *W9DGPSL(>7R=Z7TH)\;N5+.JU+
M9KW?TW;.L\F;#I=Y7N*SA;<9>3GET+)5IR5]7L!V^G1)P#,)R"X%X[RA7BM!
MD5EW:"VC"EG3O'UEOYV+F+A431OE@:)K;M"H/"HOM@7OX@Y0P; R0-Z:LJ*O
M$56ZTG#?8,1@@8G5O^ 3X,8HF89'C). $5VBYPD-6Q( VR,!F"'$*]&T6]I*
M#(\9M)6 ?Z7>PC\7?D_8*<1\AKW97A<)4#KKMMO&N(MIP/NV$J>)NCLG F1!
M;L3Y%E$)3P34E!AT3H*/!OZN>CWUTB0@?A'TL62J5Z]7=V<SMF'>9PBQ6K'+
M .D9S@V#SSOWD8!5'"V!14"H3$:4!/ \!%'*K!>QU'C3MF]06^D,Q=U!3VHG
M <V4/9PVP\F2!4M\>/Y>H>0LXE2MSMCG4H]5 W%+JU9O&34^Q:EP!2RNEP+.
M[+T!TKKW,J+BALL?\&_.-R*\>% #Z02'Q,PH2RJ!^JV>IO%N'8::86N'TUZL
M^HD(WV;T#((]S7ZC& 1$TR_R#D=?O8T9N-F2]N$D_ :PY2LP=0[K-6/W%*I^
M1S;JQHK*JG%;Q588SVGU=%/IRGD%]PZYQG#-%E@QX*-[__[81D:Z&76QV,-(
M$A#I6Q32%_Y =[/(N72\4U!XVILO>B:^G0>O4J<'8F'MV=EQ38;EP]D6O0>/
M%L>??CQ$ZDKVZG6GG'OKGKYZTIY)(SP"WY7*X9>_)[E[ZWE>8Z'=P_V]F&K6
M7NE#WY -6H;'AM]+<2K:Y<FZS'FKX@L'^SJ+G4'LSOM\;U L([5&A=C8:X0,
MM^M2'\?;M]L:PA'YG<5I44\EZJ_$G\[64GZRV[:YH/'@MS:&.\-)7I?WJ2D2
M:RM.55R/I(9UZ-GF^/./""O6'3;GMOE)39* N#E,.@U;%.;0)61,A__0-,M'
MP$N40AYQY(0)"0C5G.DQZCG$PYN"9&Y%8<8;0JH=V@(;\[]>)T1_?$?;*^@Z
MR;,E]':F3-Q8N8+I.5C2(L3N(&JE4=O[Z33.I:4:?EI;A.VO=D^?C?/X<NHH
M+#4W'+3:],G#KF'U6O;J^?N5!LFZGLL9S/"=NT1,WY.L,),#(U5XIN>4@NLG
MI=+'*JY5TQF;6$\PQD=Z[\U;N9VGO! +5DYN8@8),'V'6#J'TN5P(2H1KA'K
MK, ,T0#\1Y08;K.NIQTC ?/J<,PN2)3LA=GPRN'7[20(,*O]N6\^M.>AV(H*
MA:G^RJNT;!I96)Y#GIN"'(,#5]6OS%F</,J >^FYCEG^>,H@TC+!AW<__=BF
M2TG9Z8KJ^E>+KSX;3,RG[2QK:8_D>*;P-0?XZ<?8>-]M.SHOV]G(\T4%GLI/
M]C2S3D'N^*NTVA&1R>'G9&"*%A'49YB*G>CE7GE1;$Q-\WRTP=GR[' 'R1"C
M4C8^+S0MKZ/N)1R+FTE0:F0\ 7@&'D>W3H65)%&'^>R.P&6D.I&$G%V<![S8
M+[%X\')YO/%8Q[OF"V$JMQN/UEN@;F(U9I75(R5.YQ[P'C5R3(T92D:S$Z'#
M0;*&?R-_CN^R3]:^OZ(ZI_/YDRL#C9H$1,5H>*WTA)#ZNK)&/(HJ:_/J0ZVK
M*5M3#-[MVFC9OIV)9IOB9^MQ^*P)$N!]2-3/]1YH%<.F&=HQ/G?,..N4M4=$
M<^;BH?:+=M'\F642FB=64L^\;,\9*XW*I3U_H"U7A$@V!+HRZ\1ZIB?6HL;"
M4.Q.7\\\;B#*J!)U)=L;,]Y?JN[\NGRV 8H^T0KX.*DYN4N^:C(V_+C5S?I1
M-28X=W3D6HDWU*0W_G7*A/$XZIR#>R5D0QK9Q=BM!7V#Y9F5MD=QOBA)C$+7
MZ^<NO8==6YK*V-MLPVN!H+2]2*Q2(0'I4?,76K]A/F>(=?N):US(?+VW(L_"
M*HM-I\+\6_@)!$C]%>A^4,ATPT]XB1GT5R,!":'YB'%A D-BUP"+WL P"4"O
M,A^&'.A]DOP'F-Z!G/W>7"HQ:$'^KF9RV%6BRBL]8@U"P4SA9S35@L(-4UG
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M\=\:HR4$"#_W&D"P,2,\TT.-Q/ES@.@33 *(=8@]<].&/TN2L68K\N!4.R&
M;]M^O3 2^Q9$)7WPOFRBACPGWS\U60[E)7PS<'RD+;$^[4#PX>!C-S/Z--N@
MDC;5*5X'S$$C,7%&=\.,X4[:D<_RRQ)6A_Y#,Z5MC"M31^.57A=-^[?.DA\"
M4[,.'QV&ZD^(7/)]M[APZKKJWIF&IB!9L1\WL5''L2 T\GSK(;@A0;\8-SQG
MTAC@\_Y5('_6!A&5.TB**J6'"%\'<PSD$M)A/R#$LY[<?]Y=_5-EF'\"@6KD
MS[ONEE0_[*P?A/V[_QP16)SB0'3L@!,8<5D26+KP(T8 BS]76<;DOU#^U^)+
M*R!X1;LP8H/A)["!#HO-ZOM<U_#.OH$<:GN,.U^[/XTDZQA_5>WO%F#V<B[2
M]-V4$UIQ@D<(EGYS^6K87 LRZ],(3!"^VP<C&GI_Q10VY!%A_D+[;0KE@E;'
M6JW[:&K[Z(Z1&8V$-P;)HBC$['\ISYE54YDK*&N'B\BXD=#*CI:XW?9.N?EX
M;!6Y7X@\3$3;=#4?+[ZUD-G:/Z;.)VLXM(<\G)\/5'S#AY5T[B;&%'6Q["9,
MP+?-Y3EO*_DF^+-J-0=6W]@_,@ E =>*K\(?&_)>9-M8V)A'SDS0:<Z+XWJA
M,9D2L70,[T4_ %8IFS+"6V YO.U1-4(V.N:Y'='RCC9WBRASJ)=O9WJZ;U?S
MX*C=U@=L^_,*]S0L72?!X=:CD_JCXW;EVF/Z36\46)HR:2@TE1B"+EQ]$E$L
M:%U9Z1JO&/H5J:0EIJ%FC&P9WWN[I=24Y>20?PI0R9A'=JJFT\+03%4@^G5B
MJ*.#%NG.P%=Z X9(@&QG437_:S$C!SN44%9%661.REVJB)"S,;Z;87),H_HM
MR6Q8YN3KMIT]&W-@WWB?F#KT?"M$*5:Y=MA&J_MT0.HIQ..YBX&5%^#2&&D@
MEO),>:A%>21W3."*<H8\GD+MCPTZ]WHY<+UI[X A>XT$*#+N$,#RN7EP$J.)
MFX?OGC&##_S.'$A G% 66(+!XIX^$O_7,[W0S*&?MCY,?\Y_13D',"JC=^$A
M#=LB9F @HHB?!$96.^1HP$ZD$0'2BX9#$939GYE5PC?;CH^T)-8_/9!\.-2"
M!Y,]_B)BI!]Q+IV6_ONC]GH>DX#MLVDX'&*^;%SO+Q1!"A&Q];R6+&]])=6(
MJ".$N#D2/-(W>:[L<CWCX'JO=>JP1M;@.F]@V4Z,:*BO66/5WM3*&]ODJ,OM
MASGAQ&Y3.Y/PIL,9V[D([5B*04V: '1E8 %T3I[SVT^<(,S_IRY_7WJK(7(>
MQFER+R1B#CH^SP#I^#<9=]O_K ;?F[E%67".<+."SXWVHV2)?4W/$^EK8]Z)
MDF?-)B;;("XJVL%PP89B5X^VAV;4F B)!B8?+^=\CGEEQH?3T Z!@SF8CL"$
MP+>QE5VS"!PQAJIQ4<7GR%:^6TX44OY#R,%"D.QDU'9EO;@J_?X8]U7?G#[M
M R=).SDQPU.7EW8@4_1DR/XXY(W,6K2<J)V*G,TK[_H7-])6+NAB&S,8#];*
M3@:0WT?L^0*;>27GY02\G6)9ON9R&,*V)'-MYS:/3[Y4*;S&NOM, E$(\)-E
M9CX_CC:^?K8B\6Q,M;3(/02=9OJ1VL,YL'I$V701&Z#$H*$ER1:\7NEE3NJ=
M(!!5'1['I5DF$AWYR5J^DU_9FADU3:RBGJU9J5K#:OMNZ\/$;V:4GI6S29O*
MSYM*VWN"8+-<YN$C .S#2$'_'TMLZY"RC@PO7:@=S*',>JRPG^VRD;=QGTQ@
M]FR+B#>SED'V';&"['NI!A5DC[!D!WJ/AA>C_&_[S,:H]U01)H[%GZB4TF_'
MR+U^LQPM,!+X/6>8P?*""@4SS:&C\"]G[I/UV?^[VY)G8)+?F;8OK''J@$48
M+$TC),"&<14S#_NI'/?_&>GT:$OB=;#FFJGA4VKL_P5IMVU"')SJ(03 MPV_
MEV=-T#K(+E"Y1'63LC,0()BR0U8!E8(IEBTM=MMK?02S?1YG6QW2B%<^$7#>
M%(YV4;I4/<%6I'Y8T_+E#%EVE"BN!,XCS^EW>W12/7>%:3]I\=1XQSN^0?9!
ML-+O?GZ%H,E_;31EQ-[Z@"4^X)UT@,J-]Z9*6UUMHLO]"(L5-_**Q/<N/)P\
M[D.:;XD(0\S8'U6VY':;G/3[K4\GR"F</<_!>+GF53:(:;=R,>G'9!SF*/V%
M<YV0CBF//QS0<3X$R?AD,P:_VB0D=+:F*F%V03G)3K^FACV)+S_?DT-Y5;<A
M:9MHD^)SRP"YS1DR5GB;Y<Y_4GM]&WU>%1N2ET!)?EV% ^&1V 6V;L8-]+6W
M(AB=9YJB:2>$L7H\2H G"=@JE0$7'>Y* J; A:>"S]SWSB(&SI" !FHB8X>V
M/ <"+TC+@.B9@._/()J06$-.?A*05HG8!,M;J!MH&D1BZFNML)U]6@+6;"N+
MR!0>!5_<@!UN-<P8AS) EJ1I6P4M#RTF!?6;98O>D?LK,\9QBE'NKIHVFPD?
M3SKM_A(=A0N+"_ZQS:@/1J7Y@W/C^5SXG=NFI],$_N6?+@:>^3/(@].E"!PQ
MA 0H4UG*Q7YG+)]'/*["3RZ+Z9N5:%?IP7POK35/U@JWI-(-R8B[W=WF.?OV
M2NR"Z&\NJ(P]>+'?9$Z^X;*T?T7UXZ[C=,??P^9EU791U&BOZ$U_;6\%08K'
M3L^<&DE ^XM!$B TN4;C''6!B,R<<A@+-EA^\]S*66TI3U9_C^%XAI(7WPQ?
MQ+63Y][(S=XE ;/V/%NY+4%I28.'!U,$>V!VJ:02+X*6AZ&7Z?9V!O#V]%M3
MK?=.>62UY[2 H&F33F,:-5:[A8AP9"C['._!X&FE,1UP8^&M*E><,N4*_Y&%
M5X5FR^('8T[SPSU378YD& [:.=/D&;.H?-=EVUGYMU(SSKWFX/K??XB+E0WU
M ;$?0_7&^GCV264%CI62XER50COFN_2NR71B](2)6-II']0EK,GL ?EJNKU8
MDC)T+;9]([Y3\[44+#G'-^<,3,S,H"?7K,?6X\6Y1Q^O[$,/[C"NI='YTXP-
M(L:J;_K4QSRX>(UHQ+^,W M?D0NN?9 8'U6=:'V%*_JD771 74MYLNB$D6J?
M!CU4Y79PMH?D"I$=B[*3.0^-&!S_?%1N@&U#99_+C7: 9]E430D(X'"9=:)9
M]E(H_ *O2$U'?GC9]V V@*;/70YE56O+Z9N  -S-KO3)<S:6^!L.%&?=W^4W
MW'/N[\CA@3TZ0 X@BWV<BXNF5I.[O?(G)+93C_KR[Y*E,RHGTF5[J@Z^%VTJ
MB$X(X(?P<Q6>;"9W55@WS9U."PN[C-1!\R)$KF:^=WZP!,9O))X@$(2&@S6K
MG8  <2?K!& ]\C^.KU!UHB^%,D>44L?(&0N\^4J?-OV@EP1H9D@6*P'^[5YV
MLC'SY14/2F\KMG*<SN/.0#FB-Q_=;A%Y09 @'\PRINN]!;7<7$*0K<_N- J6
M;IYH<6)X^ZHD5N0.CNZFE>>XM^VL<TYF4WGU8\084V'3AJ-J2._E!VL(Z=G[
MZ;3.9=C"F:JYH[95Y<ZKO+QSQ(-NP9Y6S1,*K*)J[FY^%UWC24"&1:UB%+")
M 6LD+A$GP2;!HQFQ9<WGD>W'^027YCN=JI*DG'#7]J&4C66"9K[$F+](UP.Q
M:RZGU05>7N">?[M[)(C5*)G(6-N/%W8IG$+R?KUYBE_UH'R=[\'N\H>2PT:S
M$TR=68.UUY_PSIU@1.E&XRKR]Y9D#S71X42E0F'<(0Q'I@5%_M\"+/,<$D#2
M=R27BU]D[GO=Q NUBI*VY:"5]2EA)C)J1L)K'$@ H@$WM#ZH!8T@ 4T%:+Y]
M0<3F/@DP1&)U37F)WU $(E@F]2JTY3EY0* M;$F;* -1%@0(^(RN]]/#I(;]
M0Q)0;/I5"?!&XB^@3B'<1L [$)@\$&AU9S4W#$&(WB26^7DR0&;A6P6U:H0N
MLT,""1@&&V^]2'C5#S.(6S*CPMS'%-IYVE2HZV?3S/!.](2\2K>L\\6 _IAJ
MSR'"J[OW(YP]!<])5$=-AXM&'JEF!P+W(,NC(X5@LD%( "4TZO(ZL2,9OOD:
M+@,2Q<?U[ X/'/:\QK(%;"F*NBZQ*=FXY7(!V?L<JZ/?]Z $F-O87MAQT@TZ
MSSF]NVC$PY-G<U4!?ZP;\(&W:#+*U167Y=2 66%0I?]!1I4 YH_".J9$#@SJ
MFFP[/>G)0HK0J(TDFP]\F;'SAQ!3$C#30V/@[:"NKGZ6HN/3>[JPQ#K-78["
M&*Q"-J^OTV0Q=^">G<RSSK4HR!7<4Q(0.Y+])Q.^2QOASY'M'<MT:%+=[HY,
M6C@3#ITZ;!X=QC! =IRKLHR7V%K& I8XK53".#@TE6&&/2AU;*<+VY2='D K
MICJO++N5HPHF=(Q/CFC"V$2GK<^)0:CCFXYW9W:YYO7Z][S.^UE2#!IGHXN>
M[)K'XU<7I'$"3=?3CBZS2H'-X?<FG@'RUK@GTA^:C8TK[3]?5LM#E#O#7G'8
MG(6 ^R[G9?,T8\Q"B5P#HR_TYQJ>O%<<=?3+;U].62CQ<+K5'?5U>40K?N13
M:/@N*@?,K63[;R7(_*F3%W</\W<&ND)?'%#A#*,L9315L7HE4^_ &$K.5?1]
M3K/8_@ZYHN1K%N[/F(5U/"9X1MS$\NB"L]'66D.HAX3.2;T8,$<GZ_@B7%PD
M#CUK@E>\GM]032^9>WE2%;-NV@E&W1%_.?2UMV2J<2<??(J /T?=Q@;,O&@X
MOC30GE<:&-!2;Z[Z6?$X )&K<R@"F5#8QH3)%TW'=FH))U:>-SR,D@R0&;V&
MXW@-!]?.$RE?E6F[>'5*:*=5N0MRFTD @U33\JG8!SO2M L.4TOI-+0S(R'"
M>*FSW0N%W[('TF/,E2?NV/(F7-E=-OGV0^KIRXGWGD7SA<V_+8^W?";=R8JH
M5EU#B!N!,?ZH>VNS5>0]6<[[1U_/*D,QF;#PP///?SLA&,>Y>8$?5NSWC0'R
M:+J'MFNFX42[I3MWI^C#!,4T#_K10,6*I3_V2!K1L! /%+W*B]%H+RYS9XN9
M]K<8SO;=XA60IV,0H2GK(>+ZE!@6E6NL8]C]VX1C)8:+2D,7GQ5/OO(\!H7)
M7(3G! B X%JCYP2N'/:1;:Z)9FK8%8/P!0KPO&BJ0!;^PO#FLTO9E@,9F[7A
M[KO:[0M*OB[A_F>RL?;P71:O";JPJN1DE_8W>XPU2F<HW(AR6T,CD:4LZVL<
M3-XVIPHZ7&'!E#V6W9X@ @5U;AVVBEXZK1:W@TRZ[C+OH'(=:S=[#*/*AAMR
M7.]7LO7AU7&EN07P+M25_P=_1!B#S?LD0\NE'3?0=CHU!#X7M5;X"KWP<BPM
MV),RBS5!@IZ?#.X:!D^7@.P0&+1OVE;Z7TR1\J<]I1+3I\G=,")%O*YG;4H[
M;<92$5K&K!YJ=U&(<D?7-X.#!:$]M85R'L!<%33L<_98?;9QQF56^;-LQ%I
MS!FFO+]/(>O*JK%PM!ROP;*(FFWFQV2]>:<=YH58F)LO_?H!3@MZ!FVDJ[[)
MD/-2L.JBQ>@H\= -H9&U5<+VBA<I@;I8TL/SUL9&ZJ*FCL:E9ZW7[7COR!L\
M"P(V')9C+@VLL6GD/%MV.:)$ OSS8/VU1C,5X>,&: DOG==.CI2)G>P@FN,/
M\ (3^?_E/PW^)^4ZJ< *S9, ZP?U7-JQKIEBZTG^SH$-EE(:*/64^3XL#^^0
MC'KMLGMHHM.FKJ%(GGKL*"M[8'W[9&UN"X+*Q8DC=^N0\(ZF_EH<KUG&]Y\8
M2+3Y?--_-R@L\:5EF/FVD1IAZ64^/-G0:2BG-:99P8<\[D:=SIT+*M/V;,":
M8_UY[Z0^^20'OS?PQ5HX_I: H7"TUQSGPT1'_,X[93,TZDIFD*Q@O=@$XX'$
M_4>8R^0D8*WLQN+L7AE7:]FKEV2#A5)$;X+ H\R@2YYF3*LI_>_LV:)[Z#TC
M:5K@NL9DV&%)1EZF'9.;;\:5>/LKOH+D#?9!B]PS*^.^7OV9P?XN3:3[9:'%
MC;:&2;[^:A0M7F!(\JA:61BQIWSE=E&1W"OHW(%>X=(89UJZ_A,3H:\6MXJ^
M&O04<BX$\6QM/'*8J>.\2BWZTK]?5?EXK"_8A<H*Z/PW^/GWOZ7!&VW]1-@%
MW/#I9R2@YJ)Y^*KQT&:SYO')4UTV>Y_\&L_#,CH( B *RVRXA%0;V:[A$B<"
M4^_=)<KKJF#%<I#))8FFC<5B"-G9.KDH8'L3>YNS>I\(M@A[GLZPD!2WM*F5
MY%OP426SQ91=>WXRY'NLV<R+FZR""S4\M3NP^4K& ?WE)&DK4]-7MA3OO.B4
MF>'&GH5W_B4S^J7_<Q5*^O*_ %!+ P04    " !Q@%Q6=O\18>;J 0#T;0(
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M\"%'J$Z<.'7R%!TU-1T/*R,KS__R(%<#-">.B5.%4!SA ([2'*&@.4*N!Z
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MD@$T&2"F]JWTS< +T 3_,D4BB@RLWLZZYF;<6(P=VC0W0?MN-[U^4G;C2Y>
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M7N<+-[ETN?DG1\A E-+D)/%Y.AEX';.75VZ%*[!PQJ?K:%5Z!1Q035GZ\!;
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MHF3@B9*5!$BY%MH%2;3K%_ S:MT%5><G-&(=8Y3F=5K/\30S&)]2W/6;>^!
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MQ50;7Z+4)Z>*H D.$.^4F9AS,>.-K\K%KX[%UF1#4K?;T>9@WA+$-O;N9(+
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MK8()0[XL(^-OA.NFO)>QIOI"J0#68VIC[_0;Z/[1@Z7'F45G_G)N2.']%%3
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MR*3&/GWZ_>(C:::CI*31 :](4/*C;Y;C-9M1D!J5:1^5JVN2<1&6BMDT!A&
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MSE[>*1XUO/>MN4I.E'LALM1%_9N/>=06NH[_F=:0%$E.*DLATUWHNF!>-%O
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M5WD$RK6/%S=/J(W\[B;U.DM5!(H+3!A<<*H0%>;.%;0@Z[VC _9VL"VJ*QU
M&E'L1WRED>U)UG3 [!<=2)6'F^A"IVYTS@Y=&OTNXW1T6:^/-*JJ)G'U+,_F
M-9V.YM.5WMB^P4TZ$("<]>K%K&Q*4)GT!CB"1694LV-N+3VF@GV3%B;V<3<
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M!V9L0%A%3;.23Z"I>[$'7V(3&>XNW@7+-2BW9?9[AYYIZ&F4#]VL><^[./3
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M#;!<]GYA,NB^D6:J&]C>SB6P5_U4ATA*6/=$G8=]H=ZNEO R@A- X<YKYF>
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M;P^Z.I4710<5M3:^(H&3VR.,;_MC.W%51[%AH%QG(\A.:[+G!>GB 5X2RQD
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M$MD*U@V37+N 8:S3:@(M7)9/4[2N(B1OQCV<;K!MR:"+;]5&F" ^?!];KWU
MS9WRT%+B<<#V]<>4&X-<R?)5E@34K>,8( $JJJ* ?>M#;]B9! >-S^V&VP5N
M;J M?#!B\M2F9$ENUT"QS.1>7='S(QF'OTW09H-Y@T+E=5S^=^W=&/KB;F/
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M+V_O(IX''$[!?J4O#(-7U)-[#Q>TZV/6N]^$0'IU^F8CVG/OB2_[& GX/Q.
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M?3]WP4H<WZ:!!OP%KG)N*AF,A8X5\]:]WS_R#=ZJK;@&,)3L0&,+;'&F7TB
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M868Y?%ND2=:!DW+Q+PMR-:C4:9%"B6>ZH([-K*)KL"A#K_9L_WP@5P]#[4D
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M1);J]<&9GY"VN7[H)"PU.#QG&O94R H#\OM3-C-J%?9@?]S<H</;27/#EL@
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MTP<D_?B/\V('3 =?Y#0C(DH%L]4UL[*I/H:BVV3N5Y97AAEM[^R5>:#CK,B
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MBM=;_IY?,.A)US3E!+IE0"/1\=;7)  TP8A.+C<,'5+<%N*4R;A'!NB93C$
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MUMAWBB0*+5WZ<E=C[Y><K<SSALF.>FMI1W/8R[*C5R5&I#,F]!WWJ;GK!DC
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MU(Y9@2=8=RJ,!0-J1TP9AQ$ITL^FP3,(?R*H8Z2X7WCK]@.4%2];;??MO6<
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M@&=^D#[#"HJ;(I>Y6V18>Q9=D\3V2$53D#D%,,XPCM6] ]?>-0SZV7Z.H+9
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M\3WYZ=Z&\Y]U4!LX)_]A:10MMR;YE8(</4DF)]2+W'D[_EMEB9>7:O4VV+$
M&/>_*BH[&8'(@-?;*O56PRFZD,KC"8-")Z-K9PM%E39D@#1/'^@+"/-97&]Z
MV[ UI#*(9V&$^HJLF-EI'N%8@0B_Y)CV6=ILSO#P)[L?AIE'8*HL\.V5QI*3
M),GW=<A CHO3D9S^>B7_B[WWC&JJZ]J%-R*B(" (THD*B(* 2 \EH-+%T'L1
M$2D1D-X)BH" $$%!I2.])$CO1.E%BA! >N\UU  A.='[OM_G.>\8YQO?O_<\
M8YP?<PS&8&<G>ZVUYW5=<\TUY[L7!NZ07"24767!NV8+U,R$%F<*(W]>'1ZV
M79,Z5 ,!"<D^!!%\%<*.(H#%?[9O!#*W+V]@]>Q\U2X7K9A-..$$*W U79Q=
M='CWOG-*HSY> SF'-E;'":&H-8%2\P;M42^"A_I?;;)7Z\Q/NMD54D^&:M4.
M&XG _EH<JJ#9'R?3M$%HHNLG/<T_#;4/>L^H+7H_:1OE"%1AFO581]/1^HO8
M$^:(P/*S(/#H?^N]_?_L_VS\JR#L&HX$?)82ZFZB,:=S^+45016"'!JT#%ML
MFU4^3MAWW2K?.86RBYV ('V.C-H6>7-_HE0J3<6IK(H;EU/[JT]V:W5JY$NE
MB4!;E#N$-EK6AJY.!\Z_Y!PJSAZS(D $1(U4<#M[EGD#PH?>Q^B^5S50"AR4
MP%"O;)<R/?;]S#E/[7AI63*S";OEFLWTF9,!CZS>!=6N\I>L!EROV?J_O _6
M&N]\_RK!S5!IB\7;JDZ@4# M=8->@R56DIN2E?ML@-)CKC@_@R'A\JZ#.LSB
M;O95(9>@-$_RK_E\66 ']5L:+GHN;D[4][]BB[J^>'M 5@8@7T@H'!9UU"\+
MGFAH0_R$(0J_$H$F2\B/,2:\X0[^G7[O>O*#%2+@?$+3-@)90L=[!GH\JD\1
M?L/%;GD>9</>@HY_7L'9O-$Z[MZ&5A?02Y9Q;3VD8DS7P>^4(UA^-_[^A$Z/
MFKPVT(;\ 3^^A!3F3,+UG(P])@V1DJT=']?U 406YO<_0)P7O?M/QG,(00*4
M> \2!1%S+SKT6D7?<!ODN=P%<^$XV+2.OT$;#<[CI%%1<G+C?%:,!9D.N7L.
MY%S!JES?B)N]QZ:XTO&MM]S575O[O#+53P,A#S[M2:<E*[ZN[6C001%B%S)C
M%N!YV6T[>NHT<0X_6G7<$S:Z_^P7HIC 2)K/HDS_FP,H,98L=$W5R=.?81/T
M9-;M[2QMXOJP>[&/'OQ,!W?GNLM^J;$,ZZIM]:Q>CX9C1YO_%%,P+6#]4TRA
ME#:,$NGD+R>%3:ZL<X*HZR<O=Z":F@H,(P)^AN6+!%A@:][+_#YQ78.[KS8@
M6,?W]/9TZ(,4"A^.W!O*W$G'NZT"C1[7*@UJN=ZC":\=!A%O]J/N#B++3M5G
M)\_Q?%">#I"#4'76L^IG?S"/>K$_IYR9Q>LZ%?6\<(\(L%B.V7\WH'CA*?S@
M"1F_?&CB-&9JCE/*5QTZGSG$+2KST?/V#U>CI-@ F/-W1&DKV&7_':);%?DL
MR:Y\X9AE(#;.?0.&QA3-VD[-)JL2@8$F1/MLR9IN<UYI"_@=$<CY"/G<;3,X
M@&-.9X*'"VMOMRU!.8S'ZAOG#SI:_"9R7LK*.68A$^V_=N_,+,2XK@=X>8!"
MO&D\#5(9917MLP73)'9*4(,I#WB_X;>A&$-Y_CB3<#\)#RL![>RI,L,[LDK9
M;1FXZ.-&2F$.AKA[4*E5LL/%4GZUI?C%6;5_6@+RAJ\Z@%<C['EZ;HG-CY+W
MS3:\V<Z4>($SA++90:^E&702@<OTNY>WDH9[]M.MBQQ&G]*<2\T=-VUNX^5^
M]Y((#*&>:U*:W.*S+KKP1H]GS+"Z',O%+B7KZ%Y!QLBDRY^C>(V#"$!;JTT,
M/6.Z:J\\D[[=QI.@OOS:YTG&K\4\(9]JD^';OU8E:YZWFLNOPNS/?[=+0JF@
MD7)"*.?]-S=J$S3"4YYVM;=\PC<-E;M#SCF8M%\&G\8.Y*58O45831T9X-#;
MAZ\Q;1GWQ-FW[PS?=64\ 2U#P O(\"QH=_(G?UZ'BH:8J]C>5_NI#-[-O587
M8<^O/MA=>$?1WJ,,)L0I"X<10/TO)J\/OT:!OSN($/B.],WO-_NBLKL/$CLD
M)/&E]\M5I@7NUL$=Q;GT?)V%FCHS\L0]]S&K3X9EI;^XS&R<DWCGGC)MTU W
M3P3X<^!SG Y$X.H$RR4B<);<>6UXOY"_/GMY-/KK>HUCYD<*>:QVXRE4O:/B
M4";C_'<3_O;,S7YI>]9DA$X;3[_>8;PA.&# =$IA^V&]=BN-HBI)K/_:G@I%
MX37]MTWN-L>@5FP"(V0"- 'KG^8JX7@:GYE:_=K=_M5?7PT\S+,NK,2LF-7_
MD5H>%G>.]J+.6&Z96.]98E$&-47,^ 1(V"QA(QNN1 2H%NS^A/#SL<S=TT5T
MZ)/;HCA# 7/#-U+;D+#A$<2*&1+PXCJS[1&-ALEM9IO/14,%KRN/O0]2XROR
M39]#7S3U=M,*7A=JG9Q1.[_$>WZMUZ7;%N?78H((G7_WBV52VL<[2T<OU>+\
M50S;8GW +/6,1VY-O/[HFV"JX#XJH!M5]$UVE>T5W+<;_0FE4X,&7/*F*K,2
MX2(*')].,E8T5.67CW7Z_A+A+*#[YH;-9*1EV&5]NO8 DH<R9)VM*7H#VF$K
MXXJ/) +IXH!KV3]QA?(9<L257W[M*@0P[$J%_W71V0D(H09T>K:/ GZ)IH$'
MHY+51 3 /4C0I23<1VW(W@X1Z"G-_6LKI<#BJ(XR3;*6;HG$=TRVN,CZ5$X>
MPI-)M\\E5TU/=(@EDP\>BHT ]N#,WAH*_?BKPK=I.X9M/_)]KNWM8#W&]C(M
M,69]RM5I#EF^,*VC16;1M$U:%2VBL+WW)! 4GQM<!]&>DQ5WW%H$X?W[*&W^
MITMS_@<9!0R;Z-QVS'94,>]8\\E7M6F_*'-+V;%WJ.$%AOE9GF<.SM:%""#8
M]N^>+NS(^@_8X3LQVDJ^;1%_<CW0=#VR-HZ;T1#L:,O@N8DGV[Z/B, Q/1)*
MWK& ZVDZS;;!8P9!ETA4]+TV5..S"!$(8/L.YSP6[DX6/IWP17>P8O[L))S[
M'3K (KIGT+204QGK/::V8:M9X2E_R/;ZQ(#K91Q\OP!1>(<(4-1-+;K/HL/A
MO$=7_\#U;_):F5F%,"EQ^^ET*?5DV6 8T9?S%E6*5W\-GQ+O:1P3XG;>K((@
M/2#T'PG\=HM$(*6B?:KG:WS<WY&#F855M.[[_[K9^O73K48U+!&X[:P,)_W>
M%D.0>6@(X?WVG$4EYQ./CZ 8(C!"(AXWEQ?KB$#[2E'A8SS:@&G,/I71(T!&
M1>.R,T53<R)WRCU78"5FBJGYI\FC)'X!-;/.9.,!K^!BP9;F2B^=<3-I'QO7
MS;9J.1CL.\.1Q=VOTJV+I*$:HK#L0\EWS5)?Z/BF\9KGY*GM7I:.9/;P.YVX
M?&5H#><L2UTJ@X/(WI@KZ>7*O2X6S2!^^\<+)F4U)!'@-$V$LUI@7]X8H9S-
M. XVEVP\OYZH@[9_Q3ZHM./E0=TS"U'O'=W1TI?\R>['Y7\_Q\^A5R:>]>J[
M3&R=$[@@CW)'W*]I(-*2P7Y74JGJX:EHQ%YOY,\1N-6HVE5%OZ4GW'@ED=U
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M7W\>]:PVE0,W.6!1C( .,$!Y5'EBC9F=5)<!/"Q,7V@ULN,)P+5'AL$5'5J
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M9D=7^L0&Z)-H :[, R8WD^T&9!J_?)9CB:24,7VP4,!=,!O@]''6T5KY9?I
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MW\W?E1*JWV\]7.B=M3O#_S=(@='41"#=V]8, Z7LO)1^R$T$4 (?. P- X@
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M\&DHS1RW2R@;8O:^^\#;9OG;WO7<H<KP<C1.57REJ)%E[O$5,;E[T9\/"Q.
MP>W)6N$PC]RM6:BXPBT>G]8%.64X-\[0:A84_LYRN7]DQ;.4Y^-Y[?F/Y$]2
MJKY+BR_I_1TBM0US7W://(>]\K5*#[3\KM*8O9@(T/6D]\E"J,;@SV%+'5\1
MBP^<2KG&?>'@GN']D?VN+9&VC\Z@2XU@DO9B W)R+7OSIKJ\W,<RWRV-J#R6
M"S'XD_-57B>9P0DS5#6-]";X3/U4<6X-DG!_203.+[W>%/<Y)[2E$N= I]6
M'MYF:F=0ZY"6ZW;$Y1BS5>153"V45G"948$?>^'A\0(,050K@K)^12,K,&N:
MSN?ZH[%WSZS*D:&<(@"#9YZWYTM%.GAV-'F9W%0'4O4'D>MS1" >L0M2VH3S
M \M0O%H@YS2^DBTS-;J7"&B=PF)18:T)K\QA<)M*(H#PX[F4QGF7I,C#9LSV
M_XH$\];1N'DPTN_T5RGN\S%QN@>>+S&-@F^(PO-*[XM>_GW !=08Q(/%K-9D
M5233'1>P, %<.42@D,*-":93YWA?K[K6J535R(]V*IL?^5\9U!J.Y&8336<"
M5I[J@<);W"UDDTW-(_HAU?9G6BG398G ;7UGBM& HA:)9D0L8./\G!:B(R!C
M7'L26.GCEA3.^P3]<#KP YGZWU*(MJ@1LIP@5)W+)5L+%X16G_V=AA^<Y1%%
M@NRM4 >P?+I+:GXP$?@US$="39UW^E^_O0*_$E&X\)M\ZV_OC/5@;WUDW;GV
M#*3[\E33#XS"4"^+6%AOUPQ GE=!FE=8#MOXCH9S^O['0>D_R?0\_*P\<CHN
MNY8(< ><;['(W61VIP5C$X"C%&^3R5G5IR<_J^_O4S)Q.N-&N];EA>JU[I1\
MC8-/WX?TBK^TU+[@IJ11O</$W2')]5V)4?\24_&,QM17[_S&)R^RM:+VG"!(
MZ_X"QL?M+SI=Z=+S/OA\F3V.NR"EIN8NX6]N<P"Z8ME\CBESEWEYG CH&I7_
MPBT8' ^H#LUQF)N^?D<$RJ0)F8%,;0;NO-V:EL?%J.O\XN854UN8/G,_??/;
M*P6Y9M1W1>;#CEQ6]@X*CV\B=32LF6\<4JV7T>$2O2D-^WN[>?.81>@P1(#[
M:)C='/32@\QZ]HWU!\+JQD-:ND>^@1G[A079*Q-.Y2=1V_WJ7Z"V.9-N'_1/
MW:!@@VJOI\IG=2XUK/J TO.9"DUB:^Y\,#-]>/-+Q),_BAIT5C4A*C1OYJB'
M8EQ9U6VD[8AR&W5/=9+50OK<L#+_MP-NI$F_.&5_N1_LUW'3U2=R*BY'SRIE
MO7)X*RHJ#WY)U+RZ$!/V\) 0AD5Y;!K ,M%B'I!)+6@AG(\(G/T=^_^KUBGM
M@&);N"R[5WIU]T3JUH8;!@'%(%JK!J-&%=DRF/G(%#IZLP6*MFW#RKWWI<2?
M4PL811LOS?D> K[6U2B$<>U W9US&5GVQ9IR)Z*"0ZYI)Z!A<J8E*#W;Y5B3
M*<O/JTW4L@^N+V25[9O3PM2W>;HIQ_SO@U<J@F,+E4E.@VYIPS '^R@UP[0\
M]?5ZO\CO;M2E?KL=>#C_DKB@R:%!:C<Z.0O26,\4&%RN6P1&7<^R#%_V_? "
MLUSD 1M/6-V</9C)KOV\&%-3FH01TS9;4OOI;6@4.K+0OW^''5I_9.KUP-ER
M=QT&L?B9U;<O4?%>D-W_I]KI/LE'=Z.:5&LKL?+18G*/%#[&7!SIF2 "(Y"E
MF+TT6OF(E(/. /".AFE5IP;K=ZZ&N=&TM#,YI7557VLU$M4NZJ2W6^$;XB@8
MR4;ILW&C5^_S1I<4M$,\G7>/$+X+PGLGR+L;R"(KNTQ.A/(A957^:HO1W=A"
M6D7*LX:Z5K-5SH[]3<T'C9L<,T+ Z:P?$=AO6U.X\CR0$RKW1</'_ZJ7UJ1)
M6ZTS9M[- #YC4G1* 260$X$#_0EMA1YF E,^$>C3(ZEZ"!&P4<$+Z!.!M#PB
M\ U.Z"P)O.V]ULP%PMPN2Z4X$LX-B ^XMZ[&\OXY_=L]N1[V'>0)(MQ$*)&D
MJ-6Q%IG/KIB\:D97*[1PAEU]&TU&"5$'D$2 :A"^S _?!A&!DHS__;MT5T!,
M_B+(28<K\:X362U1M>9B;F,L/W[>[/#^OBJR%JPG1@2B)FDP3NZXC(0#)@RH
M*]H>J=Z,2#IKVP&<WCVGK)I&#=I&&A)>D:"!C B<\$/^_>E$<'DS4SB-G.U?
MIHL8Q\WX4273YU_>XVU>SE"ZN@SE%;6BS\GG"U)T_WJ9O<.L)8$\T"&DV.ZW
M0JB Q/^O,2D"A;-12;X9LO:X[/WB7+WAFS.*R[JIG[@FP!%%7EA=A;+0]C?B
M,I\WUUM(T^^(O!C[W4G9OP.0TH[V?:_PNYIFN>4Q52J>D@BLYY(0Q0&]QP3!
MT9&NU8^RG"T*<??3%)K9S*EGR_>I*#96L(F9VVSQ_L9QLNT]6R)/BRO2QCX-
MO%&%$9ZO?T6CGU$JE.YYOT/K'-E*=%T?!1' &100 45=(A!$!$[C^/#7P<YA
M^ON"SQ90TZ^C8FY[CT^\G!_V,EN*)@+S.JF$&A62*M6B)$.M#8,7AH[07F=<
M&*D"]4!S6\9]3;S-V":JC['*YR-D8E]0W,TNK8GM/*;.=5E4O-Y>O4\I=G[S
M*4[7.\$J3GC.[VOUCFS=+?F7I:<"+VUNMAA9?9@._C6<WX$UU"3\$&9"MHU1
M8>G)[9P/ZP4ZYST3GL54^[ 4M[EJ N#SO-55T><OU97<T=<>'S8NT&0.*1->
M-Y6@"7!/1RU8SE!6[AT'V!\'E%G0]:/+Q9EH\L9O71E:PE'F$=!QKLR7NSQ<
M> YI+8Q92D4V[<Z _PD*K]6!,^YM;RS62S67%+UWH'-;.R)Y5;/-]]E=!0[O
M1KX/*1\EGA2,#[6]]6#)K O3*)X=@%K>)NNK=,.YXY?)DY[=;OFT\&G^_3BF
MHL)+LN3(TW.G!]=A]*Z8?#L7UM_ LGILGIWJ 7,3,SC4%-KIOV.^%GT'FB/K
MUT>9V/&',-\%)]W]^IUR11.5,4N;897GG=217:*:=TF-]U'TU##YVV%ADKRO
MF,+RX/QDEQ:J!D%/?-=7\*5'P]+9OSKR'+2,6PZS_[0&7#"UD*A7$S?:.W'&
M'7Y]^R#-?6+JF*XQ2+KFWU+)P;TT1*"YLK&FM=#;T[*T.8#$P\P0G=7@-7\-
M$ETIHK8W 6.Y$?)66T1@#9+EJO<GZJ]%]HS,AV>:2L"T\0 RRL53^OKM%_0G
M(J"T&"3N[Z!4"#:(#XN$/?XAUPOJ(WAT&A2%;Z'+9-5\[DAK$4P"F",ZTVC0
MYQVNL-F&(S?+]2:<TD-G:RM$."3D"J"S5TJS8."LTA6*IR*M#TKYF>AZR5.J
MEG91RK]I:YQ>;?[-#NN@F^3#!(Z1@,2F=](LHE<^$/C(]YA&#)S"[&[OM:=K
MOV2[#3>CZO\?CXG_IQG=-5Q!CH]AA5>^U..^XD,.Q)J%G\44%O3PQ#G4R5C9
MXBJ?)8[.<D!\EFES.J=;?0*1]./6SA#ZQ9<(@;(_S>%E!,A.B[<[#X:W-+.[
M%].VRG;QE8'ZK</:T^P+E5CF7XN+[,L_;M.Y8>!A<T8F69'V">7=[_=#[V6,
M>T+B!5)2:W6TCI+% XZU4COP%7BJ#W]"TH^BE4/U8D7#E"]F>G+':/ZF))S*
ME7WV"7OD\W6O>5Y[NO3B$(U5J^MX22)P>>K<J@F[FQSZ6/,K(1A+<L8%;U&^
M7*ON4]"N]($WAPFY#<-+F)O_%56H-1<E\%N2F=GG+-8/T"52%O#E[(+B7/0+
M9NJMRN1<J;]"XY+?W]P,*\(1F*+LJI6Q$PY1RYK*GO&]RC;:YI[HZ9,.675#
MI4I14W,$6-*"GFSUPC+D>#]0F,Y.GEDIL?ERY,FXC:/U@N*QUW&*7('TDSQE
M?LVMOB$6_H'$"%./93<3OI!].9_O96%/61=]I!3W]O$".:IUDC-TQY$.L/$Y
M!] \1-=XM.VM\+[8'=/9SKZ+Y].G8S;A:;/5QSMK3U;U?MHAGH12)0M:% X.
MR:KEKCU2PM1>Z[W4UHC XF&639*7UM@>$CC0SZ_\B(\%S3A5$=#)KNZX9[&3
M[@E7;O$\9S7RO%[5,S-LT#\RH>;XHI8W/.+K86Y!\=!51 L;PYJG*L5&S7IM
MN-_+J>-3^;BVO[BT>F'[ZG*+\2,2C6!;7L=3%%G:PP)HZJPXO3*=;W"VY8+F
M(I8XV:19>70*,T-UI"G[@V1NWJC$HA(J*IW>P2363O*@9ZR6X;WUKH;Q;K_,
MY<K'G]W2FOE !%+BV&1:KM<]U_[3)U#\E\FJA(50J0:-_="4CN(;(6P4H0U_
MDSSJ2Y'#J-QBE/OC!H13X%RT?ENNN'(0E=[)VC[C!RW*FB6Y6["N0KQ/P:A)
MV[DQG]?6=CY:\6T-YTDX//-D=6IWRY8(^)/6"I/"CX\XK]DM>KP2EO*-4WEX
MW=W8ES:V"RJ<35#'MQSXJ9M2E)P^XJTX1-/D]>W4[U,XE?U:#_H17"AD?2TT
MQM@V/)+C7:'ZV]U@1+U%#!&@9C8@ JE^D),9-"X_O= [':]H%U\S%)<SJ<@1
MR=]V79X\.BPT3<D'+S-;;]H"[HVL,\X>M1<Q6G8;,?WN_.+&;KCRT0Y8F"\X
MN.])M3,5SJME4@SG,L-)*R?1.:7P:FT#D4\=9);?/@(5SG6JBZ;C%*BKPAYD
M>#D*UG=G?7CW(X3G7E2HSAV5R;U<,32+F5W"4[#G^^Q?)L;?SD>P_#S(Y7D_
M6*^6]NQCB/^UO%'OIK9#D[C*$:1'!Y,C'X, LR;JPC=IEG$I*10W@8DDOG.V
MQ4"T?/UBRWN?MF2'AH96?!"!F]PG8_78C2WS<%QD_E(D[ YDW)G _YYP18C$
MU^0/X(=-<*P>60B6>B:^OL"[7V)[W:HLV6)H<L#P0V>^]I.81^L,%SISE^GN
MJT3)<ZYA_152S;8W$V\4Y$R.9!7&QX^6&LF:,MZD>,G^'G#IM8BK_6]C"OEO
MT\=B/PUE]%9I3F$?QO.ECTRRFXN-F-F76$R;BHJ*V,34(%)SEX+;Q/OPW-NM
M]3-5>-7)&V41HP'W=6&?\)^98C!+/(^3+J:$G?M"HE.1!:3UF'JZ/877!VT7
M>S@?'982@09V(A"11J>.<FN#[]R"$@%S[M\>Y=/_?OTSF,5-C'B[#GN1D-2'
MS1&&=Q?VI6\$B>1^R7QUP2E'U7'.WL8M1(GUQDOZE^]?=L@)?.TO*X#3C*!*
MBW)WL8FF]P\C/7E\B0!_0$6J]?2:1_W@@=GJ<U&*_*0WO:0E"^JL#M#0K1DL
M,ED]T-R<H+3A"O)D!!Q\XWJ0@8=>SM5C:>L97[D&=2)6\:+3 FAZ(_:A:@TC
M:J:W<>-FT3E<'\@ZM4W BY%N:0XE1I..S[18S7W!*:\-/ !&;7.Z$'<[U.)[
M'<S7A(#4'PLU,K0N"FQ7%+RAC1L!-UNS<H5^,>Y'R<&+%LQ<>&+5.F1C_8;B
MZPO5D*M%[D=&;5T,< ^_0/%$!0I.N]]L(F\=R8MN"!TB^WSC10%!C*P?IR/>
M[QY)!"Z9"8OD18R#9JT)"OBUN%B5>(-8Y?'-ED\I\\/0.?8J9 @J^"G<Y4GP
MCS:LO P1@+3^71;\S]E$PR8P_"#U#?(QMTC8+@\1\/ IS%_SE_O= H_*@6W
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M2P&T=N03;9,@DR,Y>"7T)?X^1XK"]H>&:P)Y:A?E;3"0.S(8T$=GJ/]P_Y5
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MRT8&E=D$F4:_M-M/0DY1YRT;RJ]XC7RQ)@0$>A@RQN74]. #WQVRUW[6:?#
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M3Q5$UM.R3'=('!&@XKF ]P73ONJYV"F^PT;K<3D1KXO\O.24^'_%\;"M9E[
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M7A<S.%C=T,2\VU?U. =:$MV\ 8/B2H][V5O;QOH+\$^BRB)[E9.Y?=;!?4R
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M;1"EPJ&?YC=2CV0C:C)VO,^H=H=DUU#L:<AP78X5[I(77M&:._/C6K9ZCJX
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MPW4RB#:OPL-R%U ^PZJN1?SQ<U-5M>-/0D5+=YD6308#L+2 GJ*P@Z=?Z7J
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MXU$8RH6I8X<Z)C%3-[T5ZED3[D'[)<%C2--\/X]^C3IFRWN\-J=3B<4*Z$=
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M4_CNTAM"@C )L-D^%:0<;O8G =<4\XDHZ#K$1MB>;M:)'=N;E?*@:'*/C^X
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MQQSJCE6T?PBRJ+!UCWREOKKOGOC")Y?)>52D6:;4T><XX=U3>W='CS"-IV8
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MG*[W[7KKUJVZ5?>YQ<OUS^LEP%T5!64%  X.#J 5^P%<+]_=E(?8VP  :FH
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M2(2M4'T7< ,'%_<&'N[-FWAXV%_]L;\#\,ANDM\7E+M%H6F._\"54B@H+IN
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MDL>N]>XT5Z=1+9>B_K;&B3D?JV05)7,)]4-ZX]4\QDNP6\]7Z<<YD1R _UW
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M9Q"V%FF<XX?--L6Y:J(_ADJS^ IUF1:*6ZP\O,SNHLV\[WLW*A=QLHN'+N<
MXY=TRO@185%514E*U3LE;YM>[J'7G"T;V _+X:W FSR-RLOZGM'.+^I#RMO
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M;DII9JCO+WJA)2PUOODK:E57AEU9_^@COS)X"QQJGOP>Q%N6\XXL'/$X4@9
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M2YND7=VDE4W2\W#>W+4UEO$1GX1KP%3)R%5R>S-9N/%751.^OJ>5UX W(AO
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MF!&3S2;"=V3[/=WLO]I-Y[ &'6#6S2:I87=I=W?+CF41;XXI)F[+?*=[[Z\
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M13CWAO+#D3WW"GHIK 5/LFC:(UX6 ;+':WBM9>I.DZSQ.@1WDY>E;VJ>L4L
M?#2&%5/T]U4S744:=0?+_:PTDUO^,7P;IPEH9.%X\ZO@3CB+B^G3M"^3["HG
M 2_@A^;HNZA7A8^YTXUO6O-9S<Z2!/*@Y,/*DY@-M#FTZE',+PS^6R@PPY7
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MO]"/DZ&5Z"35;3"=N<8/B*I^6?R)FZ-3Y%VEB+P9 TP\^(XKX<-FW>QQ!G_
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M9)X_6>D9L087 "MLL41%6"M"XVI<F['A=C-OQC T<,D=J&8CH#.:75%NU,O
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M[G3('R[D?IZV@]^$*/DJ7\5B<1K1A[."*KH,/750SI =]=6U&9H0Z0$S-&G
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MB&/FL5V6<'BV917V)9O+<J<,_01 $VALH<V08,#;T_ZB<,E'J#LX8NJP[-)
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M8J0/[*@$'\E*C2CON.BL-!$$/0H,8Y!4>,F$=]?C=L;(*/G(1S3;/$/G>$V
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M:?]Q2M63[IX\#[FS/DTT1-ZA5F+<+1_]G"Q8;QT^LS;HE%^PCMOQ4%9B#([
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M6%6J</:\.-D^^VI*$)OT -P\FO3I-/#-N35_CK-WW\/!>1QISVW\TS6,H6>
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M#XJA6 +67P :IGLA*P,*%X!:\ 5@SQ[RV[&'1NF^[_ JA$.PG>FRN=[5WR\
M/1GI%P#/U O _.H__W**L%HB_)N*51S#\S0VR/%<$15MP&+HEK_2K6O2V(_O
MGP^HT\V#O$4?KU>%G#I%7P#\<X?X2_KE7ZJJQ$J7T]IEII1#4.I74T_?\S$R
M5XNY777-59H2> %H<X&@8CU;\O=KRY)RP1B'X]2L__)TX2#=)8BUQ_N0@_QJ
M"G'@Y2D-/W<SSV]"]G5T,<]"?KMXT_0"P'3FM4$,2?!87:?/T\607,W$,5T
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MAK?U="0W@C5%R'>;CZ'<MTH+QOU)\9E[CM]2+;O.NJGJ.NQZ+K%HYR*<\^C
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MIL7ZXLQSW8/7$M3^(_%I!&T'778?'K=IZ'*@O= XM-PB76?*##>]$>MA(T-
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M=$,CL_L=XPJ4?AR9/9O-<_$ 5L]? /"NMEN$->LC:Q$G7^^4GFBR1^D%&EP
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M+PU!TAU13(H^*?EF&E9(D5*GS),:I[%%AF6+B<H9,KY\L<N'<U\ P#OH\ O
MYKJ13OP]6[=(>4*55%,F_8[5?(DAD?M!G))5-0(S,4AC2FV?$<NM'#G.VL %
MX JWTGI#3A5%&TPBG<X$=JDG#;)?RN(7.3TH3:R)&%<^6Z"F%A8VOH[\D5?Q
MZ9X.R]HXR#7S\9DR3FEV,;ZS++QH0K+8<^L@_O1 F4'20*GFV:7KY/A;^H )
MTI!XKV)/>[!O0IZ8J(ZX?2=,PB[PVD@FXDTZ*:N)N=(3AJN&78<>PD*\BN"5
MW(E%C_H_-0@]O"82@P>)M&9(UVG+Q6=AF9P^J9$/G^2QEKP Z*:_8E+,]E0M
M2'\CK*&RHAFQFO_::_9PRS)C11W*\+,MZ#'SM=-M,C3,?P_;=T>(-X<[$J4P
M.AE&-Q7J(4ZOF@D>_Q7^M,::_NQ(J<3'GLLKRKT1N\B:9+I.*DT_V7E[\^,%
M0$@%!+4G1$D@6@=J!I )6?!E%S?.T,08;C#\CDRHL'0D>:BO4&1HB+C#- G*
MS6U>AJJTS8XB,H:&)K!R;-=:BNR1PXIPSG#M;LN!=/_,VQ\U(6]]:-D>JR&?
M@P>#I?A.!ZO$:5EEUC4:5:Q7P+USEZ1P=.4?1J)W"#@LJ'W<X8CW\IJ4B*I\
M5-'Z]O?A)19,CRER4?(@NJ?;0UQFBKCDPQ]SL8@J_KF-_/NF#2U="T&?R2@6
MZ7"^?W1U$#K,&ZLAD%Y*8M.2^ JY<\FY1YS^C1R^F4XDARMWW;1W20"Z*?2S
MV<-U9#FV[R/3K),5EV<2XSSL0J%;FR)WI[H,PTP%TASM^'K""ESB//PG^4\-
MXS<4/\O)VR@F_T)9=Q9\AA@E=]Q0Z@\<8.YMOP.U)\4/_A[<.C&=L7O\"9%$
M1&,WT?1CK!RTQE%"/#L[ZR!\7K8A/]X8G7B*.SJXLEB2R2]N7\.^ZXM^JCC>
MBMQ!G">K%RV93WP&C?-OR.UF?LI'*^0+2)64&#O&3-F5G=+OR$R\#$\\)1Q5
M0B9VC\<W V<V0#A6YEPK%0-6 V_9/W?=#="_*["UN'AFHW53P$$/K$,PGRUA
MGY"1>XE/8X._\VEC+5@0^6#<4J3,(\W/G \T>F!%B/+^K0:-*KOK3IUVB%:$
M0G9PLXQU"I31_V\]!*N0B+2!K_>:#'^X,1!&_-,Z%1">5*=@0>O(%><HSL@T
MH#J[$'&":+JG'TDR1I6XLZ8%\G,'N<Q5@W/S&\*#]G[Z+H5Z2"[U%V;J)$@:
M%YE^,RV.YAKV409.K>KB6B%DN=D<< <'^I7QR4F/2P9Z0T.AW7M&'W>JV.YI
MQ41M]P4/,#Y1"%IMC/>P$[ORR/+@*F[CQH36EY$IE?)X:-[RO5OAE.FLR<#T
MXO+]_\7>6\;%U2Y[HIV0A @2"*Y)< CN'D+P ,&#NS;NWB$)$!KI  &".P2:
MQANWX.[NVK@[-,V%]\Q^SYN]9\X^]\Z=>\_,;W]8GWJMZF<]J^1?54]5H=YL
MV;<H2+XF@VC%-.MCL#KKLLAMR@W7@?%9&<]]M1G#,C 2%F-&&9P<]=]?P&P5
M?'6Q2, 3>V,!K#5*/[EKPX:E&RS-0%4W$L$YAC99=5GP^93!:ML4VN(@$/;2
MW?7?7.>$S:$OE2;'^#=^UA^>\RS8N[_#3NA;KS]-*%B ;46:[V6L-M&?Z17/
M^E_]ODTYR7QL<Q0O4:N8?4M73)VWT4J\2]K<>V]%SLIE)@)[_,Z<SL=H.<\P
MMAM -:S)RYYJ>$IZ=XY2_V?S/LJY)55I#&;&'U-,(M=?D]^;?;7/4N*#H7XZ
M)O?BQ8M/ V!L \#F&:*6LFT07M]$$ZCF EPGN$=W.?@ILQT9EYAIP8-"VSN=
M,A[*'CZVQ&/R2:*B(A#:)D*W"ENM$_E4L]FBXA[_H<)&2F>H@'D^^ NF]3K9
M\V_L$8()CI[[>E8K,&6A(/J6JU48BR=>1M;4]YAI3X+OV(&^V/%0UH@%V#N4
M 9K@7"KR#F64^ID*3,\J6B T*UTH1D2<*KU[90KSFZ2B7<PQU-/>[JDW)<&)
MN/><,=L7<KEL(J2]J$#V7H%4]: U-]., C'SVVXPE /OQ7MVYL]3B"NF))VZ
MWFR>4P'CGFU+1R3/U1-]+*ZOKUA<SHW>$1T_8L8[;GRQ?N/_^'XJ%'JTV".N
MO']4-*O;0TW8^.9;->Y/J6XV 0R A#,E)MR"^UG^UWA$I))72H;!=F3J-: -
MF+1'^>484["MN,/+DE'<B/H)9ZJ:H^][U=-VZE.H:ZV^96UX' ).:0Z?6[T&
M8+T_ P^MU0E%K[ZKC!O4ACJ'SSYZ3.%.135FP.VU4#EZ/..0;^=B\T:.B;TR
M:B<A+\QW(SQ)2MGW\V@1BG:NS6?),OI9A?;;;[C8]T(BSPG:%G3KP.A??'%K
M]R;+<1ML>8VA'1^3>R2 O-9":G!72:[!:%I;U)9M+^4B3_T5?-$M@* '%F8(
MF2DY+$>P'RGI1-U;7CY.JU[_]8:1*14Q_'-#ON?X-AKR\=9?G$2^I!9]B/>Z
ML_@J;M68]_74\B_NQ8+$[:1*1&UR(TH#R1!Y$G*N;U(U5YX_,VA.Z>_^JW4I
M+':QPKZ>7%&EOQ6$%9/R74G"C<+];X#&6=>*]^1DTDB&:U]2]I=U['-<F04I
ME0B/3;VF[" AJKV&_*HN1 :+4-K$2DF9:,%S7]\H](](7HJ@!>>1P:%MS\1A
M$2M  WF&J9+,O(E!).IN)0AW341P'[-+9T.=U!!"RZ>\R!P.,:R.W!VMZ8ST
MMSS0I<\^38(+.*5B6YHMCTW7],8O^%24[ F=6J''<A6+^'PWP.Y'N?1X,PRS
M4+:,.70Q\57Y9432"2:P"4+JF<]';[!R_-FN$*M+9O7B!VKC\KHV<I#P"';3
M[@,K3_2O=JS<TJ-\2T&I09_1$*9^TVSN1'HH>,)RVD:.;8\AL8R2_80M<.U"
M1PFI/&;;0.I?0P.:F.6_4CG.9[P&J%4&+PET4]M%GPAZFS^7M,_P?9L,<]8C
MV6>NW6UA-L1];U0M$?9@IHDH@$VDGOVG;0WFSYY]&1?65R!SGU3;D*DVI<_E
MY+Y[;?T##U)YMT5CCAYE*S^9 '$B6Y'*45PSH*;)E!#!%BIV<MZ'$T08*+I#
MF!V>NY$BN;9E3)F;G4DX]!EY\RNB!VU\2_>,]X]S11A'N"Z3@R8Q0Z>H),Q:
M,JGWBD5GT/?5;O3'(E;,(G1;:^0(O8(GF(!GJF<E*I*.^D#0&'W\:)>]2G5D
M:^O8M+=GQ!6AH<4:GKAOK*YD:9[VT(R9-"C.31F_,-/^T>6<%QTY7P%;@>%9
M&)2P:4KZV#Q,_BW7:[Z-P3N'X=MC1P44^5ND>EWB?6UTV_ ;%JSJ?7IKV*&>
M!HEPOOOI>4ZVY\07:+MJC$!%JFV'JQ*W\.1D.YT_<L,7'W]8<09':\1T"TYX
M/MM6R]5.IMM6]HEQBZS8FADCSV4D:#B]H?CCTQ]Y/YJKW1/0B;-*)W.2^ L_
M;(SE.Q'H>I]RQZ!(UKV6*DO0U.G[H!UJ,X).>U?&B$?$2P[/0VX+9(&JH?1.
MTG/8LFK9'0269P\Z5YLH,"LJQN*W!F(XOTX?DABXD =190_5OC]3P=61@5GY
MW8W=N9M[#7!V; 8M-1WD70/P+7T%]X5_:7(UW8\H,RZ3^U%T;%P=>>&I.O?(
M3J3#(]=B[(-,TR-\SB0-QJ6AP9KUUJ-LP:R9 MO G$=:<#[-G]#)*\VHA1Z%
M9:1AA%049)+%#"R6L&(_)=5OH]]9+=?#PN#+\F&F\%Y^TJ#Q54J+T[GH^H=)
M.K]C0=:@2"L-'#]#LL$>LFJ_0UXTOY!EG.HAN+S3(M!P/^QA<TI#]#7 R&SF
M(.@1\S4@U4:+D9L?M7O^)L+>_^8-V/N\94=88#4^][ZU=UJGAZ82\Z$+!K75
M@S)=K@$XZN.3:QHQ8F\=-AP>F),__:0M,D>/A+*VSJ(/P^>(IF8T6TD&G=\F
MR<\3%=HK8)>QAPSYLF[8!S-A,CSDB!4Z>>^[^%'583?R7 7R:H:&?/MG5N9]
M+97)C=; %F%6U1&N^!>93<S=2IVM%H;*W3( )@-72MY5#>Y@XOH%Y0Z[7"CI
M5VN\.D0'5@I.7[Z$@67P/J4"'-PZ2V3^&2#EP$1EK<RW^GS>ZQ-0L4TKMA_Y
MH,IT9&Z2F[04IR2IH%>W:-R%\FO>8(1]5IRK#Z9.VO!&Z<B8+H0D#<PT*?3G
M@8&]G<NWOIIWRC$S3OBA<8,S+#G/ZR/XS1JZI/KWVPQ5TZ<0K+&)L:1%ZRIS
M5Y';H5?)]>T-4_4%"E:^ _HFL+_&+S7+A^V8F<W+RBHBB&QYSCM#0\]Z[YR<
M0_ W0(^/@J]8%6OKA\7*X!5J[!F!Q&C4E>0!#Q%%*((SO2GE"!LC%'<L<\;!
M?&@EZ=XC(\%Y'$A!(4R?:/)LKOF9C+EQ5KP/&^Y=6+-8%@7LT/D$N=G;K!JR
MO)85X]JG@BFKN@@MG3,)<*>5\S%?5*B$-MP)4OT:)K#SW!;Y)KFWR&5& <$:
M$L06%1CI@B'+.?#PO<::XUQL3AUI31WE?NUH>"[])\NT@TX"]%4B PXL 3.X
MBS[:AAOHV=)P>@BY,"+,+=[^W-4OJM4I0F.H5L[!W[S[:*6_-%OYBX=ZS62X
MMW&9"D&4,QL15WB2 .0[9!DDD+QP#0CAUL=Q#]VVBZ,N#^@ M^ :V&)]Q%50
ML%?T[#ZKS940R33.?GL9-T$B\UKXB3'@<MY\/[?^(6C9MNH:4$!X#1@('WRO
MKUH3G3N_P1U:JA<*O6K5;X:<TPO$7!7?_"JCY[<4)2#5=*^DE);["0:ZY:^I
MN<,V4:W#&W&F/'COPGII>@U(BZ@EU"R/;*W'6+#AM([!"F_/J<"HVNM*UDM+
ME*>2J"V]NIM4DA]]@<H$!3SCR9X'!@L6S$J1#;Y&<SK@^ Q!NH^%:L#=K0:0
MF'LG&SX?'F9/'Y::^C4]Q5>AJFQ RKO#; )*<I3E@#^,=G*&0LH+;WSR28^%
M_X;A'B25EH-'Y^SB^&6^>IB)=*VYDXV::M=?$JS5ER"[K2G,K@&[7FJR/[94
M4<__A. EYC]UUWN8/DS+V Y)&KF&S$>U\_79OLX=&4?R[G53/!_-C+MZ&UTF
MFS>0%-8F*'8RG]Q8DD/?B*4\/OB=1MF*?29>]-&1C00W/]P29['80O9N,X0_
MB,QO&H,"='%L->NEZ[7T(6XZ+USSK:_AP(0&,?*);U3V$O6^/VJ;MVG2+=S@
MP6@L7:B64MAGYBC]L7,-P@5I6R3E_H->3-L75D,,H7XNUNCW&#HC1/;P5PMF
M&52KJK6H/2&G"GAY6TFP_,P^L*=_MPA7Z8&9R>6KAWOS5Z.O%*3JT0[P![U5
M@VQK"&U<!M(K),E<39]#AGW55-IF'X]P[^)IZ5H.!'Z2'F70*:10)SH0$PJA
MF V(69Q-QR#ACHY\ACI>P2U&&\![RGE,=Y3S.221AGQ #2\-RK]UPG$#Z:Z4
MESX,'#$/2)E2K+QXAK#'^=K!O[L.!K52GF-:7@..=T!'C*LH"E#[51:HYAIP
MP0Q-.6NZ!KR B:)J^U#^VA6M?#\GG&_<@/O\<O=9S,>08?H2^P'0A2N6Q2XY
MB[1G=2??LU95/O+UD=<R#:!80>WIP!M7O>.&NY8+2 M,SFJO 2]#"ZY =*C@
M"/  N$ ^LQJ44GCXO?#XF1?-11*O!)Z&!^+/2(WE'//\P)9\\T!M9=]WZ&G,
M9HN96C6DR <\MS5K/LE_6.Y\TB(W@T\>J_S7TQ!)G2>K"E7:\0QQCX;9-)_.
MYXNI0!KBMD1(+04R3\%I(QK=!/W1G K+J+UODM,W:KOC!HV.:(H\VKMPCVP>
MT-)Y=N+>W\.&?N_G<^-]ZL?'V'@%02]*(')[MC^*M+\V +]$<$V*5GTL;!NC
M5-1:;%:3N>0&UA44K1E:E-7F%9B<Z&KZ+U9NN]2#M6CCB35%.I?ZJ)*<*K*7
MZV$2^V#$^PNUXDH<(YG'GW\9?L1>B#R/6X%M<2L^.(.^JQTS8+--X*>5<.Q*
MX#^7V0+6GH4OA(HWRV3KK T$1Q*LF&*EKU@_;8@,<;@ MPYDJR?5;2=EG29J
MJ3F?QFOA EO@=I^!#O9369?4'#&&'08:=/NKA_FDC7JL(Z\H%0>82>BW,VOE
M=YZQB//=,]D/\3*K%B7MH@RL(YY:VZ;GQ97"K]I><ITFM/9T@+36U#?-'7"N
M@X[/L5$!C(5[RIE,,)8M25I'?XN)39/8=4JB^F7"+-"8^36@7\+CBV?BEH#3
M>),3M6NQR&D0Z9U>]KX"<N@0BAW4SOKN&I#?=PU( 4/WRAM'#Z?J*D$/HZ+?
M1+<W/3>&7CDU'+7@64DF$<N*-RM'Z6A_ <$P%0/B=!%^*7JSFZ]L;!!3+Z48
MVJ)SL716LQQ%=^,.0O766>'5FQ5B.-,Z,HQWV3]V2Z-<UNJ8B_;'@DPMJ 8G
MIQ0P#UZS&'5=$ I6BLR@;^J9N]@P)RZ/EC,46U!;+.M\AOO](B9SP<\BIF-0
MM=$]TL5PD&]ESXHLWK@(OU5*]G]S44F\[$ +I#.K4B>B@E?Z^P^.UX?V\SK+
M4?Y7,=< 9I&I>A1:6>[O62+E*1TY2Q?\GNJM.$)<R0:?4?3G*!=\2W<O&1NW
M9@)/J[)?@@L_7-\_,A+>PV3@BK0S;.&ECD9D?RG=-FZF8"JK]D>$IR::)&U(
MTEF@TS%/AS=0#E;-!6OT3W=EK3^-\BI@:Y^^:G '7#E=:,CE35E-T@9AQ<_[
M,#R:%(OIEL#Q6O@ZW3:\NE] />8MNDA./J8T]L)]UM(]-EO*S+?V1]+(ZE $
M3$V^%%:\X1EER(B7R!5?MYNZ-H>7L(YZ""\IO9IF%GBCYM[)&(&.2#_(\292
M@.W!MFTU$QYFE7>YDBT=W/-5HPOA.O>VG/?2/'I/^ZU*1XIBGA?CJ0;=1\G=
MP?324"3^7K[$\&,)MQ69+[T@]_/)&A<J*E%QG9QL"3%OG39M>8WO<TU=!T)]
MXONN.0M3I/$VKUHH)XDXI3LJO_N%<;8A,#W=6NXJ^MT1BN0"C=:HUT(70<BO
MQJAJB2M@ 0Y1[O"D=OT!7^%09*H2;YH^PD/$W] +NA&4:7EZE["Z,W%'C0B@
MC1FRFIWIV?=%B%_4KW1J,U1A>?J\6@8\R/N-9?K@ 8=,7\JZGO["#)KF"&K
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M:Q53Q6#]&W*_'\\LN:L0(558$3&S$M+:1_R+49K:O%QLL+K/7X G;;)I8ZN
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M%F/=47N_K@']T.@]RF!NT6UFJJ:U 2F38I'MG,,*P?A[R4Y3Y$R@Q:Q43$B
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M^?3C)B&3BC'1.[]N@/.WOT0TX0O@ONTB*:(#J>\J9S%ABL) COR-N]-2=B?
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M T?6K@$O+\.[?M\VR.]/:RA)4$P6'(K6B!1(G1-.A^FC\.O]1=?PKP&1N->
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M50] @%[8[%<V.76@DWEG'^4+#/-;\37L-"WBK3,H2CJ7JKV CB>:K.NY7UI
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MT@:_3($!(&.O=^^,7P>*+?DO-!UW>K\X#$BOS^]Q-'=]DIRZH&MN]DN*C%$
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MOVFLB5R9D4Q@^,@IF!J(D5ED'ZMI^?[CRGS<Q'WQ+?R7LE3DZMZ2\H6SRZM
M>U:F@S%.J4#FZKDFPW2FGLC3_WI_P]^;.N24B>R)5\O9PJQPE*"ZPJU)LN(N
M[?AD@ED1T=5^G"M])/QC1=KO)697S,Z,GSS>@<ESSY7O>3_#$_H2"OGN!:IQ
M'BPK9PKQOOHP,EA?3'DTYBH#!6;I=CZ)).W4:K=]G+F(WU^'GE7.(FSXT\#"
M7ZEZ(CMVL_R#[Z?'U&5?V<'H'[,9K$*^(\AHSWGOYSSV7Y8M"UV+S:=P:ZYN
MIZ8;5LSC\;?-SY(#XJ\2RAK]UJ35GA1=H")$-2U_IQM[Z);_;=5F>K:UCQ%>
M$N\DD^?3[FIAA'N8^@=-;=T!O#3F/\]GBO*5@_>6 4\);N(S3E' $?@5^)&Y
MLNOF8)%5L^9I8;/D"PV3?Q-4'[Y,($K^]H;I^I--ML;<,U"'C[LI1BO=<>%F
M5MKODC\GU:/;_YLM\=]9N7-MLYZ:')&[!!^2I!4L[&,R[<HV6'\0G@YL8+(H
M$WX74U.>_1)NH, $'+ J>==T&;<J''[E>CV9"PSNA[;=N![S_5/)T3_N1#/N
MC"NUQPJAXSNZ#(^MT1#]M.R%,72%/9D5ZA 7UTC+H:+QE^;'&%EI[>66H_@X
MWH5Y?]8V44!WK^,!Z!P0U0U54102"BDN?OJI1UC0JTG3X1*.]:RDPC=B%S#@
M39><'LI@@R-Y'QSTQ']7AM"BEM,8X3(P([\>I3H8PCSL!X1&\ZO=X]UB]AZ
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M:]%NH6O?6N.JNID[ /NPXR8G&+LR/TE'H9J/G:6I^P7G^S1JZVQ&$=^5JCM
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MB$DDVS?=>D=P,W???CH;PVE3Z,7P0?+^<\'Y MRYN\R(2D)R8)+45)$[' -
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MI?(93)5!E8BS'Q< 7-:J.W$C2%S "6;X$.[QQ;;2Q_T"A<GRJ41UIO4XY8K
M;7!&W-<^_2H]=G@\\_IP4UM@7W306F6"_7*]G\1HU%;+**5Z6-VNII=JH7
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MS6>#\E]D"MH+>)(A Z]-%)-R]QS45)&A3F3O9XY##]R5=>^NF/8"5WHR[IV
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MOJO,719(CJ(660[1[L6PE#'5IS>Q8=6#[8)=Q4_?]A9L 75ANR0RB&$,I\!
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M\0W@H\%U;!L>CQ!YO7/IVL^>WS@B6U$*)=F!Q<*%+^M+4/$_62@EU+83-FX
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MW6RE)BD2R;E A*-P:68PN8>0)$$0]:RG_1IQM[++"UD<R: Z2PXS8E#914:
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M*<SZ &^,P,&>25VSMQ3;KT23&K:#"W6-X8F.7THQ!:VG+  _P2TZJD-7*E"
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MI^J4!5=DB;[O?6&M1@Q.40+0FJO4)2^K24<6'5,&J[:Z+H:N3U?]4&YY9YO
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MS/?P[8ZIU_=TT/7I9ZC^0>E;LMR]%R\+UX<Z5 ,DTI9.)#B6GV%"]#.O0F\
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MS@0TN@^+L>_^^)7<D7"E]3>L7A&H&PZ7#GJ5-)Y7.K;K@WL#8.!.NM7$:&R
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M_NKHV@+?PEF%T25RLU_1SB5ZU^B_DM!Z(87D)B%4 >!SX\/"2Q+CZ6)=/99
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M-<<J9Z;+4>!>INT.JR]G;$ZDV\1C\00WS:%M'+F9IS&]W)"D_N3, >,>9M!
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MXGM';]IP@=HS7DR4[#F4";*Z4?><4[QXYH0BCD[^PH0S(.J],>OEQBJ7T*;
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M:PB5[-@YNX'4<6*A-R1"Y4/5NU55WN_V&GNY$4YM$M5\(,;1YT3!C">"?A3
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M@&1B]T%\PH!(;_0\#0N;,5J0J$2IVGHQN=C5O'!(D K.0 A?T,+UM(S+YIP
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M!>Q+L#,/24*KX=#'MGY09D?-U_B-=5T\O<IXX^I!WTE<7P^J"L4^=PDD<F[
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MAUA<]A*JX]S?NXT")33LQ5",)*&([]!SQ%$J-GALCCQKL(AO)L_:.8]RT].
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M%4G$&K7'W/V^8=[3M\(9G/O5GS;C7>NBLI_5;7SRR"GB'&6TJ>HM8;%W<:]
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M-@.T7[28.6-^<Q,\U=7$E*%PRR:5._6YAW=&A3T/-3[Q%%[I>K<<Z=L)SV>
MN,\X(S<N;\*H,N(,T!1?A[F007*%DQSDW8[818(IGY.5X(.S#[C[T[5'[VP,
M+/VPBXU]ICJ813OWL?8<LPL?!JC.VHL! F2DFP[#&M01!ZN)#<Z5M_M')]U,
MW /3.J-U7UUR16V^^_[<:Z86FY\]$'5Y_?PX6+%1Y.S;GWXM"3,EM)2;<8^K
M[:)L7?D'<[\Q9[R;]/<<$ZZ7$/P'!F@M!0E(6]+Z,33#Y<75G=^"_2]"<A'
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M0=K];G"= =J^AJ7RY-(7+.EIY,TMVNXW@OU<3"=VD3G*6MB5=.0"! 9%=K-
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M%4($X%;*!O?2.>^.=>H/G%'K@Q27;2^_?9FPS%+&L=SLB@>'8-DA;A! FBL
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ML4QB@%26 .V7GK72C<\Y<B)>6S9I?!*GRR+"UU[PZ&W2\A@@=]-@IKF!!3)
M)=6/,?HP7U7'I9*D1R99"X)36X_OBSA%+=UB6:C'RD*<H8"L90L2.,45?1]X
M02R_.% "Y7JXKUDU2JC#=KPI&593N7W!P'.=X],Y$26XNR[K7PY5LP;2*0Y
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MT_J][X<7B%+VUW)$ !2=72/#KZB!O(^T;^+D8+5VCC.:^!JXK):1]-$D<UQ
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MY%>6LU_FL$K$O8*F@LO 5(%<:P"69^N')+PIQ..._3A58NX:1JA*TC;V_?D
M]V(I]3%KRC=_O4#8@<+\T$PCNT<[WWGPR;-A2M!;[<X58Y-ONE')GS;LDFK#
MT!_!)2'+M_'@$<6ZPQB_]4:+9Z=S#_ 3E=85,,G(?6<*[ SFN^\ZR9^;P<HP
M0 ^1@#RTJ6LLH5F<L+L5G( M<2(^I\)?L&1 >;$R9TM1XND:CTB,T+:![V5+
MM3B*'K).OE8;67<%;H$[HB?K%W"3N!*?H_BVLK:"QQ3Y+.6FS:B[R1_K=5*J
M(/]7(7P[)A0Y>ETYN!"SNS\KG!U))-<;O3X]D:81Z)[1K[;G[+<^44-YE5:S
M0+MVN>!-DO;S/ZA09M1%BQ@F.H&0 @G*W])ZD'M>5V_-N.Q4Y6<7_T0/6](/
M V5]HUV-.)&"H,V>QC;"<_: GQ\6(W*#SGHNQ!Q19OW^-1[39WH0@!@1N8*7
M-EYPF13V;*3H*?'EI[QFW\<_!PDR.W=(S[\"]O\_Y06C@@^];KU'M?HUH%0*
MI!II#NIY/Q,:]G\2IPLNK_O&+8R,]]R1_O=/I?U)["QF6U+&^>K_)*1_EB:0
MKY<EVZ^$]!<RS_*W=7Z=U5?? _TG*47]Z?7/B?[F\3>/OWG\S>/_;3S>0474
M@ORX6G9^)+ZIP:,/+CY[G9.SY;NC6_-MA=?^O.^%1I:OL^'I?V._B::>C_2D
M2MD\>^(B5I),B2<9H."K@"4#=*F+:67I/&5(JGLEY@# <Q'P3F. G "D?J^7
M*.2;,BWI6DGTH.BLD%LHJ.UK6[-?@>O?Y,%DRZ07J6/>3BZVQ);>-O)YXH:0
M_YN]GYQHE?]&+AI7- /TB]06ZA2MS(MYJQ6R;G>/ZE0D,69AAS.WBLYO.,(
M%7N%,?^4H\L"OK!U!2<<.D%P+%*L0I F\H],?5G#1B*+I(/I&O1N'!M"<F%H
M=+JVANB^>*.ZYVY)HD1)Y7.*>O';.[D&W^L<[EDZ?#C<)J]9 /Y+2K(]%4*K
M]89P+"8.%DYA0<!ZW0/];JHKWM:MQ/3(?,P5)7DV#[ZZ,$INFH.T^W@G.DWF
M/=<[I*,I(-%2#QUQ^&JGT_,-(07$YU!OOASUZVNLU1VPN3.D8^;NH'10H4#(
M4DG^T<V3IZ*?/'F*40'D=C]?PH4!;=+%^F?379%ZZGZ+#4@N6)PYT?=5M>V4
MD3?T$'!E1B?4L;CX_G[KXY=-E7YP;.D,_>B_SIIJ2^]"/Z1E+2-DD/6/29R0
M(L"[6ILYP:^??<>QF[S[AG-_?CIY(G+[GAO58,_R*E21ZL-\OSUP,( CF3>E
M'B\C)33C0,YH;ACX.BDS "XZ==8+S>'7_!1T^U--\<&QR)PS=)N,I;C^..CC
MGG-@%7H_A&B$#426;-6C0^@"1X X0F=+O7.C'2N)]56I98\WENUXF+VLB\>'
MLER#G+R"/,[NRS]8\I'#IG2V8CS7\(&QQBV$2+^.XQ27H-_DI!SZ*-#2_*S#
M5>S$T*BD[,$O%8[7+=0D3N5DB=;I#'6K_C?Y3'0'TK(Z:E@'+MIZY4@2B*[6
MSP205Z^&?EM^5Y#,L>W16/$42GN];RKN5=S_<[:+)/R6,X'8[9F<\OI>DAO9
MZ.'(#\MOT'(PE<^7@%HR<GN<:6>'K#>;NG5QV@]Y-?YJH;HFY6IU?N7&8D+=
M/O%#@#3Y"W.:AZG&M'RX.5,<!+[6@.\05] YK6YW$[^+:X2J/6* /#NZ1NI$
M)I7O..C=%>(;IS>@B;#EYOS'L$DL2J!WY2WMO=^]]I\E14H_:073IG85EZ.O
MG5]GE;/S*HS+V3[33H?=1Y#> +?BB?1C9S'@(;+1HHB.Z$)7VPA3+XK[\O!=
M>TD"C;!1&SJ[ ^FHB;1Q:2+XX.AWC9$QE1$ :22TWWK2'*UU_:QP>5O_1Y8_
M(!>P]A#@)*X!.2*W]&PK5#RDI58KY)'_S@X+^;3>->P<>5;\^$;,EMXYN6()
MRT&[/0#R _4T,24U@% C;=J]X::K4^4J)\,O:"_6_IXC]=.F=%R<#5^Z"(>#
MHHO9NG&5CI@\*4 XNIX!<OBI.LB^I^3F_+RLXFK;[:K-*T.4:S9!O&:V+5/_
MZ^PCOBDD&()_SQ0]!NB!BBI"%0@C=*KOB(3T$=#+"0N&#K"#3PTSKKQ:M1IJ
MO)$F]JS7S';,""&M)\YGR,7E8O=0:674>-6IR R:P "!L?@9Q8-S)UVAP;5[
M!G4N:L5&( NNE?%_98">WD-]BQD:B71"/P+'(%21=3>1KHJCKG76J36N6:YV
M/$23 D2?)R'J[,:8L/OCDHGDCB\;[+/WR7QK7[YK=CA/J-ID#:WEZVTYPM0\
M)SVYCBJ''VX.B'=1^,/ZQ4K[Q,-9)N+OBM+H&/D>4TI>P2%$#H$W+?7D +$S
M,:%C;!7"]AU(KO@8\>?'=@(1..0>*V3;0\"8 0I"H!F@%M?MF('2Y_G/;R2N
M[2Q,DM?FO\69Z@0;23H,O$N2B%MP74(!4BW4H[#=->,P/QZ+_M-T.62]7+YS
M\;:OM;F?AUV,$*5('OTP\@^_KM8SEW_.U)K*3<EW\82GR.M*:FCX-;4/&CU*
M<GF$6?2!&QA/<CZ.:.Y/"_J8HX5*5'IB'"_I*C5JJH^T*28GT847\:8T?DP@
M%K"<9UJ!9R@ AGD%V;"N/<H $:"9#!!I@4IB@$+O,.&A CG]C@$:[T<V*B W
M[V#7OC% *PL[J.5K3!/W7I-IM!XS0#]1A?212=R.0 L3DPT9H%C(12RAMI9I
M8GO^IP%@NB3!.P#3G.KG$A3I?#M(!D@,TP4&@KKHN0GTVVC:N"'UPBP#=*N#
M:5F[Z"MI%/-0!FB.$P*((+>/_^[@=P>_._C=P=^G@]R?-#DZN^Z'12CQYEL$
MV&HQT62K@;U#L@<_<.)+M/%M;_43C?/*L?E"X,I](D==IV!C8_2#\1_I=3B6
M@FJ7'.I]K::6Y++!8_> FS:E&RTI5?3AL7-[XTH+6_B(?/#OWDW;!<?R9(8^
M9;>I2;V.JUQ:&H^C=*$F%?X'>^\9U=3WK8W&BDI7D4Y4JE2E]_PL@(" B(#4
MB"A(E]Y"HB*]1$! 4(@(B( 8E2HMTI6J])Z"2)>$$C:DW<T9MXQ[S_^]][[C
M/>^Y]\/YL!F#C)&=M?>:\YG/L^9:<^KVDX.7B!155Q-+3[,+%YQ"0GQ_,!:V
M\SAZ_$_^$)9/^WY([L+WNQ$\'B-T"K,+\RENC9>20;2E2\&/T*_U^9SNXZBI
MMTAT,&VJ20OXYX%;@J&Q-\]O=]VQ<B@H5UH,86Z4S9*.\NU:0E954@?[DRZ%
MFCF8X]YK2N[>"1$/RR%K+Q=9F28_OMYFFD24C7"[[)=BH6TRWVVA^A>VRK45
M;]'3GG)DY@"3?89V$W&ZT0$N"+BWU=YR]Y)J($ZEZ =N;?R./]2R7((3RR\F
M* %:>T0.?Z"0R*%\G[XCY-QH=4CO;?JI?-C2F]^1E!&CU( <'7-S[GZEK:]3
M1NT?4OVR/LR;45_ EP*WZQ/I-#(W722&K-3^5G,[3[AK5OCE7&1?25O@08;0
MA:37J#KML>JP4TQV49H:XHHU#=IA=J;;<#FWN+H_[].<IE38+Q3/]1WLO3B>
M!YFX.&>8>@8M+V?=I:Y<NAW%?HK;2 (SO3KP[OW'J]]05=#'R N98@*4KF>Z
MAO=IA::C/NL: 6QB#OF_N3OK][8+;JDX_@QU-JHU_R"KZ.FC-O_>TH#/\'^D
MV/K_[PJN_U\W7&THT?FO,BUK24HTX49^%J34%PUW^A?[<2%1P?^9V\K_'Z^[
M=&M*-_TB "=9G%*K=%:*"VJHN#$5M]%+$L@U>_4I9,%7)3IY2VVWX=_U+(WQ
M-M,V'Q%%?R&BN('H^-+A\@R7F3M#'L:;5]3]K"G&2+;E(U??>ZKO&3P;L[5J
M\_+R$395':R[3C(0E.\-@QQ(MSB(NS@/JNN709;"WL#5,A77Q[/GD@\B<>ZP
M[F9_RL[:$=IU<*H>(L^9$;&<2SLVS:<2K94][".KF]$E[P*PX8_&-^^X/N(R
MEC1.O1@@EQN>J5!*&_BB3[M YHXOUG#0^]WB\@:KG?%:R/2'H?GZ2$<X_NH*
M=G\/\ H1_@SO0UYH%?!!N)-.]UI4]&%6DZ06;X2=^W@GXNGG#:X%0?M=5P*4
M?JIP;H'.9]3E3_\'R*E8SM6(\_LT9S_JJA_<ZQ1R9Q)1X+H0_2PI_?*]8S!?
M9BN*?)4%B<-5\H]OLR!"['[QSJI)WHD[%UF0=JRY_\#?NW[;R=STJFSIQ]8W
MQZ8A=VW\6T<^['Y6LIB'EZ[<:[S^7=,\^0OS4&&?=;DIGZ6S'T["_E=$,?0O
M+)Z"GX!2>0 OVFD OJI__&=ATLW\2Z)_/X<F5,LQ69#&[$/LS[G:3SS>K-52
M6[UMZ?S"5>#CG7)Q,J)'I>./0,(]RHCDK:+J@ P?W"NZCO?31)DRS2O_\N3*
M=PJNG9.-F!\M54XR\[M.9F9S[_7TF6SHF :M]WR_@FX?^PX#!4,SM'*GY8E:
M<\8'SWS8<&'WKC9GP4.^!C?2O;3,G63<8)U_3M:I8]B$]X7+V[L*^.^;@1QS
MAYZ@U14_N"P/^OWR95ZGV10V-L695Z632 _7"#&F/R22^7B-;AD3#BQ[44))
M.W01.TKT'%<%(XE<V:)M$2O1&)75?FUO]OU"34OUO1\K5>TL"-S99(AYG 6A
M>:%:KGXL;*3,C\5_"'KU[N112NJ[T3.?\K\Z'#DRQ#P$$97[X^E?+/2%&AXL
M.(HT+M[T<4+\HHSH7BFP-\^RNO+NO+/Q>_J4&3879L:$H5I<4.ZXB;F!N)N4
M[;AX-4UE_1;B"',X\V6P$X4Y?R>H[7OC6#L<BB+\R;L%]'F0<<29BL0:&SVC
M]NRCX5R1C-R#947!@IF=D1$[. B*, &&30#UO0'(G&MR;\]FW]2+33JX1 7%
M6W Q2MF8?^::^\;"VL!C^"?I%MQ$C OJ,%V7_"<CTN]I[K,L%L0+Q\9L=E.2
MV?[F'6F#[$FXA!,IC$-G-RF-(&70KAT3:(HTASS48-UB&QZ8L,M-M9AJ8)ZP
M!,-X:SAWG!^LV;8M0L<P"A<D;;DJX5>*O0^P@>/Y@9_>U8"?:A9WF%0Z:J;3
M9M/I+LYL=C]Q&KU':L.GHIQD*MX_LN'LF9QSEQU<EUK;44!2^\A,48((H\95
MBR0]&Q!"R\))36S"OD$!">Y5&DWGI?L0$KHT^:?D&)1RD7)<NZBWK?!P]B7Q
MR"(OIZZU4-I)X"IU$'!U); @IV>\)D.B2Z85NAT6QRYXBF:&O/<NY"P[_@T2
MC+W[MCE=R_FDJK/8:=*;'6,)3 6Z(M;L<:PHT<50]G65AT3&=LT"".$4+M@J
MC06!X7EA9'_PD<3'L,@N*-E$*1;W::!=!WL2$+]%26MLJO;2(@RK"?RIS3S.
MEGGGQ6^>8UIK<#-+QRI-E&*AI76QX:7TB2)_8AW\0MN(]7N7.4&CVX,C1TY;
M.K>L_W?OJ#Q.\]H/0@AV6B0GGZ[_^[ RX:C#L(DW@^OIL^<'4GI;"A&U$"0?
M ?[O!X\_;9N1\/T+W<#(ODFFVR)DM"0NF=B(Y;,>:_^97+3CXY1_G'8:]6_W
M/ISBH<L-WMLK*DQZ\NZ(4CKI[(^\#P6N-S0DD&KK099.@+>"O)Z:R;/;]VI,
M78=:"(LN'K("8>\[O+.^)U([14U&"NIBY>+O$PO3#LE%728UUH*T*+O%+Z$;
M/X4Y@83BN^F"_3&^V:*7F-4W->G<&UC;MWF.>K)E(^>+ES/HW14QA78!HT_3
M-XV9[EW-^J"XYF7VB6ENBD$/X\.0I!M_G.3L&M ;QJ)S E1+8"P1V&%R9@'N
M9>$I1$R\L\8ONR^W/7D=/(_%Z4%N/R-P:7EO_=YAR+]M3*2K9-H BT:_*W;O
MD/UU1=-MF5)"4$G0DHO&Z1X4/%U8<*Y/MY8N#CW5*/Z!F\@<_E0W%#B&S5Z8
MJ\5:+0V(P0B9N%JV5;)&F([]F%0L_L^A-J2&^O=_%AB.Z:UW@G=#7B\4]"'G
M+)UO _SR.#6Q"#_:%U3%P,F2V*]ZNY_H6Y@=-Q;$ 1,'(P_BR3<')KKFAS\@
MI9SMIBCB\#!GO7L'(4RY)QS/@E?^<,PU<SX,"V5R*0,4\@8+LJJO0/9[&BQX
M;N!EME#4*"8\_S7)J? Y:A[CR)"C3E;2C8@*<IWJT <C6WTPZVH]E\8:XSD8
M^<SA$&BFT1XVM9BYDIJ[D=VTQXQ%+3L_,&(,*+]O+%['=A0#T&S]0V"0Q*A&
MIB>0T,\B,K/TZ9/.==D.7Y?%TV4H73X+)<YA5!S(95K:X96XI,;/I69S%B<J
M[UX:KO)3LQIF00IUV]%MNEMKSCMS X!4R3=H@DYJ*3GN&_(^)L)43U9'4!@K
M23C6OCF,L;CL+#>'!S3&J'Z4^ P:S("B$7,C&K(4\?N+MV:GT22"N-YO&%57
MN-QH9G1GM,0RO!S6HM2K7]*I&>7BG&G-6-S T3.5>K>Q!U MUC!W>,)!V"H^
M:98SND_0LG1&5'YKX/RB4?1J^("HUT2C*$6N#<.KT+@.L@>#,9?.T*6=7TZ*
MF@LR[:'0E]@^"RBJY1.3%[?)'<.4#4.;+%L&.\F*7ET\GD*@4X 0?;4Y;D =
M2]J)]67^(OJ) <*W+[XNM) <S?,?@[R_\_NF_P!>=&\'5KVY!^MJ*47%FF[L
MO$3Y^1M"&0M*5DY$M5UG"S+,\SVV+8W&Q<3C*S]QOO%$ZM5]?DRN-TH>7#YH
MU <JI#5]"S"BRU/Z=0@8,ADS-40-GFN?M$C^*%^QV]] >/Z3YZC%^N!A>2U!
M?9=.G4"CO=^EJ":B9QMSIIXV$\T\?["0R7A:83&0M;(> O-_C^W 'D&U@ ;-
MIWH<@3Z-T".;?_B9E\ZN7C]4+/$HU#?\'^_MUB>K<I,($!/8M,.$+>58D.-&
MK2S(F8<LR"RS9]AG6SYHZ0\[8F>+!>$J$_')&/XU,H_TP [B$Z9B*:?.5116
M=+,@38)*G7U(Z:5Y/HK?8QP!!Z^$)].KFRB*3<0$B6_L90]#V0Z_OEM=EVDT
M_)IC>\5YA  %9&J_H1/R[1=9$'[=0ZJ#KO?YA=K5,YK#25J)6G0VOM6?_8_X
M<#'V2LQ96QHV$-_F?]0NGLEU_N3&K?W_)V7*(J#Q^XF7I970=WB[Y3,?'E4Z
MW*@T#&-;OR!>P$8ISUR2RJW7"Y88^6EI<)KC_TUQK/]J"?T?W=\'R2A$$=ZC
M#L/<#NB*G:4T8Z+*6YX'Y0FP( ^=?05W!5V[VZ=1/3;FLV_?!8L?"=<1R[+-
M<-W4[N',MLRTHSYSQ!#RLE_]W#M:OEQ?\3'F75]X5*"?N[MWK'%)_F41?YGE
MWBX(R-XV+*B/P9E(1EB3:"6#S:?"Q/!&_-R_6U ?,+5P$^/6U5HT;R&UQ>/R
M@,FFCQQ5C/$91BB*>":$3OVXO<)YQOUDT:Q\@X]^OPA(%&QD&K+%"^Y<R=?W
M)&2YGME]6"(-0#\3$.Q=Q,4/[J=)2W<OP!;27^"+K"J1CF/,)2H+LC8'"L(H
M0!CD&=%,97)J-BEP3HG'RU[O3_9I[<,HS]I8XX*PS'Q"&M=/!VG72@AW=]@
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ML/7EC@[HYLY_1$U?UT"U^7W;"@#G<L-;M:EHJ;YR7:,/E95&Y]( ?7.50K
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M[G8XCZ[>)=I[)86_:V-8<J,. S9?XJD5]C;.WEH?I'+489%&][B)7Q^:/<
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ME _9&R-.@V+(>F *1NW*J6!"E^PS\XI6+;-;0-&;IE][\D.?F,ZGM(=#( =
MXVNDUX(C1?'M9FZD3L'XYZ9SW*?UYD!?<9-)7BWY9?)1^Y'<=Q;$,2]*F:YF
MDA_RA;9-]PZ#4WC$I&]@V6QJ\[ZZ[M#P*>CA]60H^;;?!'A/OY?U.QT6)YIZ
MM3A]WID'F\:XT.6S6@VMF%38B5WW_0-1U>3:5J:W,R<9GM1HYP^=2:>0!M?N
MZ_?EW.\:O>2(:H4"ZBI7*C?>4=8[.&UO2A\U=6(S3_VI]/[4C?LSVQNCS27
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ML&0@32QK7E>\P_1)(.W:F/P_"X0^]_FH#_Y^(2E35[4]..J!S?5P* 6>D&#
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M6,FFXF?MV,\08AYT-^Z!Y:@"K6RP+ ;",1,BIQ!J&55]:U=3]18EGPGJM4P
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M33B)4M@"01SNBF<I]FVR048#:[]AMV>P[2>*5]>PALQ'363(Y.W0L-J))=P
M2W$=-10KKG2Y;\<56'[&$@1G V2LHHD8AHP&Q;45>=E DX**JQ7QE=<R]RQZ
M.&@5.-7?IC+%L]R'&X+N1A$_$TJPBUR3V>%(%;BF>5YL@%_J\QF:4U_B\.UJ
MD1KP+8& BE8,<,ARH8:*^9[,$MNDO%NK8H/,*%.,05W(6(2R)V1Y !%%Q;($
M]/L4U"PI,^2Q]4*U*3MXHKEYW'A:X:'CZ"91S$/]9'YRO>3WF%7'CG54-+B(
MR( UZKSQGZ[* 'P@=1DTP9%IW0[X=/C%UY(W='0TIWSU0O820W3[YC<9VT<4
MZ[+&P$7[5QP16H,:YAVZ?F?4 (66KETP0IJ;/7>B?K_Q\)IZ-8PA7D/[Q8R!
M?2P!4CZ,/12^@"@2BJL]=BR1L_U*U"_L\?G=@C&8X 2"!(]":%2VS3<:R@\7
MPXF+FB'P.._:>R?&;::2Q[#D'N8.*^@+'&=Z%H2$QC=/,RX"%OENE0VO5_'5
M;_V?U5T*\1(G9*<2[+?F.1,M$4IS!D8.QT.B-.LEZI,+L%'*Q_H0N(TLWVWB
MRK*>( ,NZGCW:[$%8T$=E"KB1*663I.[@Y"2?_0T]!]5;PN\2A(-F'VUNE03
M(R=SO XKAJRL7U0^;UX?O2*:_@;^$PNQ'\$*6GGYO9[I^G8F9NIE":_BQ\P7
M__E*I!7H2!!M#C"E2S\H"*""V^S!$4=5-Q-L]<;]/GCK'EC,$%"+I;ZHE/E:
MH-B3>_/A.\4JK1XE7)7T;<JZ>]>U#(GC^B\M*E9,"JS!^^!I%I3[SWT_NTL]
MCT_,LOWP>GIEQ3>$[XF,W5BDM>PD&2>#<L< .H%!V96]2&Y NN/79;="^'M/
M;Y_8%E=1ES&[27UCESFEAEH-.C=R%$JQ60PD.%/7-R)/ZFFI17VLHS[I^C3[
MY3A+R6'7U0#GN(.''6(KO[O/?V%(.Y^F;29=^A&Q\6Z2*<&0W@3[AG%(O2BO
MNVC:0+P49B/5&QE-WW1FF?Q&;7LV;C""AYE^<]Z2\J@"(ZYG*'C5)*,BX5,&
M>GE<)^DVJ_^XHD'9YNH$"CBALIC&L9MV5(NA<*2X6^IT3,971-43SD<.==5-
M<0WTFQ_;G@1P[THY$E>RX;ZT/,S'$L@ E"G:]@^APDOK*M&I:]I^T?.:.A<]
MSQZHB(MICX_H2DAZ.L5MQMQ+,7FZ!@E/ERSK06AEN#F#>Q:2/>KBT]QD"DJY
M>EQB=T,;;G+"]2IYIZR=Z/)4NL_H)(ZH,,UYM@=EZ7J6783OG$K%=9@U&!!!
MNDY %CC>84\Y'-TR)#*/.<AX4JWS"_).,XXT+>'?N\\;,5JU(PY\]GOSJX,S
MCS6V0NDG4(UG67RLEG(K+)ZPX_?(E8^Y1>L!&5J!F</TX:KD)T]E/]T(6[-R
M'C6"VV%$I@\PE?H1N&^E4&_"C,]T2;QREYINOH5-!R/O$K,#]:XI6A'+O_GE
M/ZF,.]&1#(TLH,VPNG<]V*#-N@]VO:.RM/:9:X@O:SYC9[Y^)/89ZI$0P EO
MB-!%_E-E*KL_S32A1"Y+)I4^IQN_6@JJ2WNQWX^/KYG[ _9'M%(-5^H=RO69
MIGXOI /$NF0SH[?#)]83"G$+_4QDI*,''K$>L!"U4(YGG6:608@)XW+55 F\
MOKGC0"U$=+.8 !C<KR][9W)HS.U[YEO%R=(K,:&K&U@?9@**.%M38. 0#)Y(
M?E:+EUS)'$*<J3EZ3;NSW+N<9ZGS)?\MLL$ 70.JSQJ"4LQ5GN'*^VU$X82&
M+11MH>,9UBUT0>>C;'.7K-XOG^=O=&+7L)_1HK>H'8G:^%S(3/C+S0WZXF1P
M/KQ#I3.YI)ORV9*%-!S#=/ER/O7%E$@LME/2:%]_L,8HA#8=<)3D]<[4;V<O
M:]$R!LW==G:&EMN=TX_"VF+QZ!%_ED R\(%BZ,0&A6405>)P) 56]XMNUWN^
MC]7CO'^@:Z8<CPM_)2R*1V!W5@F%02B.F)$,%L_,Q%Z$#+4$;X^.4?;0#"^F
M.N6G(K\<.>@933EUCQN;<J*K)E;SA&O3*U4OWS.!<]D;]S*3IU W7XI=V8N?
M^#@W>>#- &NR;AA;/[3^4*F32?M8K\)$;S>L_$>SE7LT)P/8/G!$O7PE)[*X
M![PM^*B;&&ODD\@U250\53@,5KAJ\#W\7F74W;C7ER9W)+V:/*V_5V/E3:>@
M' _$-2HT9A6:C$J@ (P2B6>Y"T5/?AV;+MAX@LSQW6_E&+'W#TO[7R@W=,(Q
ML#P[4P_?75HW5X^;'DGBRGQ*.T0Q&<SZ^-3 !QCB3$<"DV- 'PAI,(PH$4W'
M?37MEM;2?#(==<%D-^7+CV:8Y. 5I4EH'(3RD- $$=_L@X/;D.H4CV:,G])/
MTL"BG$%[9&;;X'5H3K]-41B9OT. (=5K7N(/]:G69PB)W0?T3P-11ZNU?#=T
ML0T,4>H,0_HVW13!-3AJ!]R;4!&$AP0AF.E.*C?3+@[HS !-K775ED.K^=?I
M5JA&8]RMA(KF%XC+];V/@%0+_TM0$=LO,JEK)S.#+S9@ EG/<K#>>A[.'Z?:
MK)Y;STA#<+"&+5L@*BJ_2NVDOLX\O:>$OFZ^!!%!;O^T@SS=>_DJXB)@0UIT
M0RXDV^_Y<"KM"'HYX#H/'NSQ6VVVMQ(*')]A'-0H0 X@A7L9:I1X0G,ZJ.>G
M<FN>O]<)HQS+$U^4#GKP?;%ME%0X^RCV&;284(I=D*8DTLHHK=G9 *$!*3EP
MJDS1_O!G#L]M3GV7)_O2R%NBTYB;.[RQ=>^A%ZAW..#X]CD&&RU0RA5TM(>'
MU\Q#ED#_E$NF^TX]'HE2[QU-E>!GV$Q2U:3VPK57BD$Z>=;BHS%KL[XC'57K
M;^6NAZOI/7Q[>OQ;J:^5MZ=*[Y:37_'R[!9G=^RJX=#KL%HAJBC) A?!TH&G
M=C>-G^Z9$$$]'&M3&%Y_?J#Y>8)99D2E=ONN^++UP42.%GLR4]9SQCX PQ3F
MSH-@R'4';V2(12;3Z!\_LJM B$]9AYB5C)WCZM2L*A31DM?1*RLR?]"ARX3Y
MI?#<Q8U#,Q45_2-8AA2,Q/,)^H5QEWJLVF5:]/?53E/:D1MMD^[?NU;&I>-/
M>24%G"=8B\&SAQ^PYG\'V-$LFTZWW0@K.I.M-'^@\$'V@)(1<^@'<_<7SA9,
M1'9+)7VT +=!PWA?NNZ$2LQ2M6<.YID=0!ZI5@*/*I'V9*M;C2)N AY>1YOW
M#JJ(VNE>LKR\0^$L#=N1MPRHI_*<&BM &ECP[V)$J82$Q>-N2GP3FE1*J^/,
MSF6&A4QM.&'B9NC)!D2,0L2].%MZ@J[(IM0JI+@R$"JH@;6%K)@D,*.:7@)J
M/"KVWFS0I!5=Y!/B">5*C??M(BKZ.4S>>OR:@#W/ 2%';H6#Z.\5I1AA6_??
MBR[!KH%%+PXVGOFZ'^.42<8)KD,!#5'R$\VY1\CC<$&RTT\E_8)?)R32O<4V
M9ULA8$<9!Y: -;#(GT<#RR".5:+!JND;5\-"%\2[5M>_9M"YY)/Q:*@V9/4\
M*X^R5L_?I6(/8X->FBS[B@&\$.+(\D@&'O/;3_8DA:<T@FE72CVV\'BU?21K
M^-+DVRF3LUN]*/P+G*<'?P ->30EJPQ_0;G6_R@LH>_VR??@RPDF6R7)D BP
M4&H%ZQ=XSN\:B[\7T^7 !GE"D+^Q#=<YRM3.68H7<$NFDL40ZX@&'KG C""_
M-#ITO7T**^SRK#58.X,E>9W%&TS,F&*#'B+NIW5OEK!!?(("A@<FL*-06)^<
M.NHSW)7BD@NA!ZCT0_H11W$1*58HV@HTE[YNA-P9Q\>YFX1=4U&;4$^WI 87
M\M7.8-;3TORARP>?+$9#2.]1Q.QQ65G_GP9JIC1(&I@2?MZW!D:'W(.I95\^
M2.]C@ZY-LOBM%=@@&*KA-ALD3/-FR6J&LD$5'#>FMC$7S=@-H5A9 L?]P[Y6
M]Y="HN,\+5_O7FZ*_!!;-/OMY^%N[MBM'RAB,>>&BM#O7=?QJ37JC#8:&Q11
MP /R'2T_VNV\^8GU<0*,OYFVQMDLDX:LPX6W6+QK]V:UV*"O&-P-&Z(B1ZG"
M<>[+@J@/!, &;^$K1-!"BE;'>P9(6B>=(\8^UFX;S"SE7)0#>:!DFF&.W<,X
MG'+G5C%ZH<[X[$&ANN[1Q_D!,YX[%D?0ZWSJ*"&EM60&B V*='D'"4W8,F?M
MH"\:(45G,11?7$MDH;\S0@WP]Q(4ZN!/?E&.&C_SA:'J,&+"D$%/*%[$P("S
MI+2W$Z[#Z^W$T?EW/09!@4B-MY42V@[7+5GCZ,TWYGA'IH<IA!X(R3-9'! #
MVK,XFWQ4PLK^Q#AB5TC BK^>@;KJX;5-BQCP8+6T"J"KBR]6ASP % HNYIND
MNE!/7GNT/IKF.Q8_W!J<Q_/8V1LWU<VR +,N32='(,Z#-R/8H/8/' %C;]A,
MG4KAN&0.WM?S'C--W3(.^-#D\)7!^]VP5\7HP8I2-*"#)3HV658 HN26<M62
M!5H@@E[G4[VH.CI$R3_69%<]'LJ =,XD[YSI(0BH-+(N,_4^XK1+"8".',VK
MOFR?>0;C>HGWI96LG@)S(3IY-GF],+R-)6C-3%[J-+B?-Z$$5?.<./7L\(K/
MD-^@YSO:3+9D_CW\V7S_#RJ5,\G<,UX$/@AC-^XK?24:0%MP5B@2=W=^_L-!
MG'"9DOHAC"9,X*&1"9/*I37KL&7"D,B@F0\RNA7(ZZD!MMTCZLK7"&>[+<\,
M^_25>[7EY-][,6U%$((P=D(G?3K"?>#+SW/9H*?F##3V ?:-^C*@++10\7DD
MZB/01;(V/GKGMIYR&UWE .23$U6"(;9*<Z,L/U_2,*0F-U0DX'G>.(S,F6IT
MUMX]T6S@T9:E^B*07,1J;U-P-48!?&R0'(8N=,8RB32#HG >D)F#G3&A<30L
M9(-Q _A$OS-;?Y9B4!! (O "QK.))KUB7\.WN)[[>-<=_+J#B'YUNDU.8ZVM
M%07H#.!(SK:C# /@/H1T(G788G&ISH?US%73X/;^T^6;R9#F7I.^I;=#/3>(
MCKTGTL*N>]O/):LDXF9_!]^#":CEM":&[7\[^'G6VZ 7E^P^[SM//XS*.?_)
MMLMW^\"/P=]W7]LY'O4Z](]3R@5-]97(D)%EEN!>)@9U;[WJ2Z]O.U(>_G+?
M#5O@;CXMA[#62TG8ZWP:42+'Q=#8C,AFB&VW@BBM*"*X7X='(20"#KT\NQYU
M)8)4F?RY]N9<1C=7%D!.JG,H"*ZC'^9H\1<P'TLB./$&4$06,"=K%LC*E(Y:
MC'B^B!MR]S! 5.IOM.Z=>TNN8.&_>3-]S!BKT#OI.'DVB)F8S73XNH(-.MM,
M-\5N^IM#$Y,W5[8PAQ@W.#,Z@AR$4JQ0![I(X% =P5R2@T,">H&CU?;M ;GY
M=YFSV.BE6*'-V0-/06>7G;(7<)S8KHUQ!>C.4XDRT($/0GAB9B0D;FHF"CC8
M5RDL!Y2\O!V'W@BU6%*BI9%L&G$\##[**QVA4#V-#X"-407]=:#3*[\O,P=^
M68-^M=4<3.Q/=#IVSR'VF+%@O+6QNLOX4.(Z;+UF5;79:^T+!8Z(#WM,6?9T
MPW'B3P><VHSE,)C%8T)1H!T7'W+FIYS"*$0J/Y5S'L"1;W_V!+<6?]T;EDX6
MBP6;;9V*5IHL.O#Y9Q3=;,4[V6\)H:DB&=ER@U:94M51XX%K5OP8W3#UE\2/
M_ZQ,L4XQ]E%0;<M[+4ALD#3<Q9#J'*/:83?WVM3W@&?GAV<C^))3>Q>,?/=;
M7_ .>_5Q8>B&M<[+L%?$A<&N!]T=0J-<+ %_P)\JXEEF&3I^M)ZR)Z>AV$TJ
M)=C$-*'FQ%?3RC"?C:CD]TW10,\"Q!,*'+'N.,!Q0SM^5DV?\5WF,TN9G, 4
M+ZT?X1'45]J2RFJ7ZI*6^US\!7]<<E>@U%8G^ "9)'0[SJS,H,\&A9I;"F[E
M0A?]R%Y'-*DV7UO4\%])1FFF;-K0P:C&GOJ=U,VR7M89N/-J0VJ,A_&@^HNM
M\%<S-;6V6L)H(RNM&IM9SO*B9?F8'VH/R^*(T/V_G4_V3#70;R;#D_?&HI[3
M7EJU^=XZX+^S_LYVHET8@1-Q>='R:)1NQB&D?&4'RAT.]7B]L?Z:X!9R.=UV
M03!@L\V>,0AP?/*NH\P<R"T5B?8)<(B!8CW5MR[=S!E^9\Y"S?Y2X_>CI2KT
M 3V!A-J:FD*EO+FSXO<*Q3/P_2P[=W#B[ 8C?GEA2;)KO=$:;H]=Z+;5FE*:
MW=BZR%SYB.-G@^Y#@;/^Y+8&?11+!(IVYH'MYS#8KX=J:J)'Z6#G$CELV@XK
M_ECM3;^F@*-%V![T<]P_.DV5D+N;@J^WW$0)YS\I[\D?65DU'AA:L,^_;6QV
M]*27VA-PE=N>2Y)8A=.D1QU[F7.>I@L3RPH;#^O=9 7=&NWJ=]/7WI)IK_0G
ME\M'\C8S@]V,$)R ;!>9L_UFX**T5> =%FXPAV<),[WY<J4-XZ>)9^;%GY(N
M*4C?E['3N17[1&/#*$![ 2<2FK?@I>J50)ZV<U;:X3 '5&IW!!ET4VX;[;>1
MG/F[MZ)_6K;_=X@W2K)^-QQ""Z?<39>E5D0\(>Q[4'RI.,WA9T6.[^&D9\20
MO3)[UV:=[HE=S54T-1/L\C7JR]7QOA[J5I#:\[$P[N,PX&-:\:5OT6,A/W]"
MY/PND<B)*.X=UB8@H8=E1F):]?GAH_ZW_V?'OUB-V;<%>1Q5,SGXX]LG&1E#
MI=!^8?BA_E=7N74_(PY1TJL\)L<!*+[BQ9+ 5'<6_LC,T.Y+7;?F",6PIKJ
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MM3+ZDU*=R8-#'E/#[=E.^'+I1O66V[O]GB>%)/8/J7EP'IP+?**$-M>+#QA
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MT,=M(Z-P3BRI9P8;VR077-_.=^?W*0X>O>\D+4(5DMG6<*N[6#I)(Q0KA@W
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MD7BU37[VB-A/;86U34 F7^(2YR2VU9%OS84!N#:2"BJ(!N4:0!^0"PCTGM<
M5_6;M>+(;U[(;TY>[X%7[9_G'(Z[=9KR3W1?]7F0GM(8G\-Q$L8 .9(_-KUQ
MEM!%$4&YG.4]_)./M1\U"^8JA-V-8IT--S9!G1RHVS%T*<SSWI'ZM&=-YB=$
MCL J'WO.(YD4H<S;P?+G0I498P/QJ7!)N[PBU!!]/JE9-?-'SAZY\Q3[$MLY
MIXO+3MM?*[\*/&/\?$7FUMG-Q> UEB>[@!='BNA_P!<'%UAA[7"UY@VL/[6&
MUH/K_:UL_G9\:VYG;:FO?1@L@\E."?%SE/&Z\/&$Z$WJTM^WG$E[^9O!%;80
M0^X_Y1H.6Q_F&H$48.GOYZ5:R3^ 14R$E8)TI2(I*"S20(98^N8$FA.R._B)
MQ<3C.'=QB>N%*;RW0N)2AY=KMA'Z\Q]>/D;KA]<([D,XC'ZS^&VP$+=W>8/N
M+DK>W,,M[X+JEVF5O6+>I6]>G3%&ZL7"3-2'1=9?L$H91O$"2!#V08$6:RPU
MRF@1*P':N^1YC!"(_8;=$X8OW9<=9SO*-6DVEF[G<1=#\^N9"M0[Y6&MJI?!
M/">?TW3;5SE\U7>//D??;FF^*IFDG:XHPM8Z6=;Y>-/,<]J3#6O= )Z]!I:+
M<>7DV$]87[(X;NA=O!<Z@%+L_"AW)P,N'?PPQ%=S* +3;Q47Y:/<-0IL\G?1
M,LZ@:<V\;N@GXVBK720A-P<\*.-W.KR,NEW XQ%6'E0?)[<Z%_#HHI$P%_(U
MM/X2[AKP*0DSDUZY#*F?:-SGN"L&?N$[H1,V>8<OV7*MC$]&R#6+A7$NH(+8
M+E\Q<@OAM 7+:T#)0O?MG)1?EUSW%A?82-J$B?8]>:2)-%V+Z$LMOQ.]&"V
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M\EQ88^T(A1#K_4#!F_,7APVT#/*&:8RH'5;7]_Q,5XBW.U+QD[0/'HA0#J,
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MQ+W"K%VW=F:HQ:?5[]A11RVOV<R3?AD#MR9*\MNPM4$=4%#7I54 P<%A5B%
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MT/-@^+=.Q1K,+@4SX$((^+U]1]HH0W =&H!P'"0#JE<6CI("\/+D QAS4.E
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MK ;[^5OR7:;PZ<(LT'L-IG^[EUU[V]S,.*H/2 D#2R/78,80([O[771E-4$
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M) Y"29X40YR%(<0Q3T(2>EG&C)S3"^/-C2"WXH)*R0N*P3'63U4C_>E0XU&
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M'EO<SX4E[4;^6;;/[ ( GP2+;37LJPYJE!IT;D\W 8&6[3K;N,"K[>LL0-#
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M THST*NV&-2#'N=%6;"Q'K]-:SG'+*C5F\R*T4:U<;2#L\7^CE<*-'GC1SL
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MCB#7$894I#3+$9,T0GY5<=T"G1Z*46O=2GV;TV0[KJ\Z>/ZI7[GR&;C=>"4
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M++.89Q!IR2".$@HIS23$&8V)8"F6B5,B]K,[3^W=MU,.6.W<:/(Y7-WOJHM
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M9-ZYH\/J/#7>:K0$WW=J7IX!.O"RN]'BQ!9S1(+MF1/:&A31LGP&=E^1O?'
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M=4R@2(GMVY>FD.<ZAEF:DT@G'*74JSC!5X&I\7"COPW5[*;_M4V8V8S1UB_
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M0H!U:8I' H;C G1S[$"P#LR?+41KC4&E,OBC4AJXA.-Z0^J1NA(>VI$R5,)
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MG)N3+VE:59D>K0612K&<(N["BAYDFAI3=C*5>%<!L-@YN.YW.H!YY<YZ1TM
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MFVP\O -3D%7KP5W<] 5H='O65RXJ&C(':7J;_5VOKGI[W?ZY"K@.<6;C!_D
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M=%$5%/]^)^7FWUU;P5K ;7<@XQO$P,RX%=?8;UN!02LQ^-'*[+,TC@-$WAK
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M7$CL=J;K=P+&.8U]TRFPV]7ZA36PP?&YP?++#LN=Q+M%J=1[4%F5[;VA/R_
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M%2S6BUHB(:6809ZF*N$*I32UVDOY$6=J2]4V0,14.!4[.</T[#XR1?UKSOC
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M1'U%F%XLIU5,T3XS@^#-S[?JAX<CU6="'/S3@4$>V-#MI+?M#]J%*Y4"H-8
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MJ,Z-!YHG!,LH-G]QHB(^NO/D[$XM'+#2@;NW;I;E&*]NRW$5"D-;!D< G(W
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M[=RYV;019F1@0U=OP2S;41/ZL+MQ*R\X5,GXN\U<//]>6[&;AHT]G%V\$N%
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M*!;J;JT>RUF&D.8TM?,56W;]3$.FL8:8YZE6*K'+43^R0(?1I[8"'56H['2
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MP,BENS;$M/ZY7\#*C^MO:G7_C2V:BJ+WRY56]B3FKEG29DF.D8JCQ+B]F2T
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MKDAR:U-<SU!F=@T)E5"(/((("61?VA1JG(B(Y$P+P7OVEVB/X_.0_F_H#W&
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MUT8583IC"<3:1OJC2$*""8:$(F9V.8QE-)T]U?3@:[9:NWD0(TGO\U8]UV'
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M]QNP+1NNU*^2.O8 @!8"MLCT,/)=7@Y]E^!W"T7--N78[N4EGC W]WRBS\W
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M5-6*6Y\@HT<".R:>^9L\.UI[G2F9W,[LX?P=:^=OSRX<Y+[2Z?P)-FX*GG=
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MI3G^91RD/@DS+\&<%[E2429ARC&!*)(8TC0B,$\ICDD:TXBC%N9W2\M2.]Y
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MKMW*#K<Q[EKZ?_T_<1[]A]'AH$FM8U>9:>%NV[IF6E)/:#6IU8:UWN 0&W
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M!!9,J4CDD:"1_1IU=HBIK3VM=."Q3?LS)<P6C> .1'<>38NE93!&H3=;&_G
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MKZ;+\?+J]7@"[RXO LQ'H"-"VB2B#:"=$PF(#S81:330X!1$KX]"P_:*>Z%
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M/!I.?%82Z]#9S\+#''Q'MV5:&<DM$:S0;30CEIMR]QE!.*=TT/0H.&RNMA\
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M362.#OG1AF2E74X1DN3?;7NUWU+-)*WJPZ8'63>15K_W3F9#BJ4.U5&4CW-
M0";<#! 9\3X+HJPR4<B4V*.# JN\3KI+4C.IJOYL4TVE-. B/9 NV:P>8]93
M:C4Z>9W/YS0)'L]TRW3I8!@M0.T2\^\2U4SFJC^<U55,"T@KM8F;F^66$Z99
MU($SDIB+1*J0B>=XJN<L8L@V8Z3\V("R@^M =U+33!JK1VS54443A^2A(>T&
MS]( MZ431\H"Y9E]("YA_".RDT$ZGZ6L[=T?3W4SR;*3U-><0K4-V,@-CD<I
M>YFR9@3\ZCU^()YF34 ;Q<K0<\IZ1&4SZ:^3P.M)PFXB4W%Q,5[UNBOM$Z_#
MG5A8$249%] /R,49D,$J$JB2Z"68(BT+(57O7?DP.<VDNOK,5M111A/'Z2,R
M$M[JS)C">,:6VRZ.>T3P,F0H"*:B@5C]F#RR?KF_AQ,G 58E732!J_?7*W=,
MK?NZ!IFS*7T^?+"EV0<RH2*>U<G(Q#!R9K'VL\$=9 S=WKN.CN^]7SY.W WX
M0AOS,U?T<PY!4>=)\KID5H"B/'+I#>-]YLQ2H6J_IMBF8>A7$[U@Y2A!-V%<
MGJ74/1WQD_=^G-Y,7_@O8W2U1E$KGH,TQ-#R\#$[CO+AQ19S3JV*W+O:[TL?
M(&78['M/P*DA]C;P$^/EQ>6DS%CM4B-EN/<<SF&Z&'^%5:+W[6Q1TKMG^9/_
MA@SJF+06A"HHQ:\6B+<6_\H2CP'C2U/=Q7XBB<,FXOO"6X]J:N# ^P!+/YY"
M>N7G4XP@%AOLOH0\CN/EB%L'N33E0\^1$<G*0UDE M%,FQBI"DG5SL5_GZIA
MD_$]8:VR,IHP<_=%-0)AE?&T'/4">4@L$9=!DA!CL)91DVAM0-VG8MB,>T\
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M'S_AUU]?O?OT\>SUV?M7'YY]>H,_/39C^L"G5LZ6[D-[I4SIZM;X!G@W*-,
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MP2V5L:6;H,<PUPE*><QVOSJ+8ZW5%EWM NX03#S%FAVCH :<JAUO9".3VFD
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MB<I>M=? @=S3XRYM&*4:CPAI8VDZ)12QD'&K1D<#8](!_$#/_'KK0'U*I#>
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MFVACLK'Z<ZRC"!XV3=HFQ)^DQ".GNJ,$YLL&<$NU8-I:27R6OI0;1^)#SAB
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M07A%B:71D> \V&@=#[[V#=!^E UKR/K$T[9QZT%3;9JY8YX6#_6DNI6GU7^
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M;DUO<JU;K%,*7J2(&PY*? I:$I=9(DQ10;/1&+G43K95)'^8(&]H]/:GX0;
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M9;+IU* ^FJMABT=."?K3 J!1.[YY0&V:@9).76F]/ /]<OMB>S/WA>$=<T!
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MW3*VL365\1$<L\27T362E\@O,TYR5"E*Y:D))P3>+A('GD#4%U3VA^31>FL
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MZ %+Y)L$XR0!KRB>JYFI[4;SQ[\'[8&/84/9(V"U_1AT:!TW@/-7%U\FLRN
MC4:2:UL.#H47C2"6EY&;W0 <*QG163)6^I]R4_M1]X/$#(NXX7$RZT-I0^=?
M=O:$1#G!O'N'W<VF*(U\KST4Z8Q4L7@4G!*IT,MP$@\EIQ+#4\@GN=V4YX&4
MS-/6'39+TPST^M98 Z;P(3:438QJFXDPJ[I]13RZRD1"#MX)SA2K?25U#!;[
M>?;9I^JWA[-5T$,#</H[2JQ<U!8O16N>@C*.*,E**M538H641#C.-?/)L>JS
MK3:6'W#24"^!Q:&2;0<4:T-,O6<BEGA;9H9"*.WT%(=R$R?!.' VUIZ,<X>
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M?9!)FZT>I[8#R'T"ABN .%RG]P%RH("'=CAUQ4X=!_@1?^#D<I-=8<+HF.?
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M*.<R1"$1 E?9*5\8UUM.&KKUN<.$!\?5]CXBZR#?N!<AW9+-]9,^VJPHABZ
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MN8!E)PCL7,"RBSXZ -@VI1*"J[HG+8((-<-=+H6/Y(28-$I*[S!AZUOA%U#
MLA,0]BA@V44K'0#ME+EP"JD8(Q045(%$XTDTA6(ETHC'Q)U0[OR*KG=[_#OC
M2^3#@X!>L79&CRRK%>97V8<AC^D$"\ BUGG#/$!TV8"V42:NL\MWRV0/?T^Y
M3<)+#WWW1-2>3R<'J+<#7[*BOG9J;LWPZ]5EY?70.:NS#DI!)(C6TAD.4?H(
MR%B(5IN 1C9V$8=3/>#*@A-AZVZGXVD5W0&T=^$TS+^2\:G_^.V_+\<_PL7R
MU5]$:Z+*'FI+$R@7ZC8SF\$JAC8_M+'QE$\T#Q,]\#BV$Z-L_]>7!BH_+XPO
MI]1OA+U4T\@BA8:L>D9>=_0)HVL37P%K77!8<F@_Q/8@@H<-U\\'VP>JN@-<
M[R_KD6"*8KZTG#%%3C(%#H'G!*$$$X4)EIG65RS[4SML@<C B#Z1DCN8'[(#
MAV](_Y,O8\K;5^*Y41U@K(S6A@QRN<TPHH400H$@4@I6Q2":3P-K0OB NZ*&
MB;5/K^X.3/9AE2]1>+(7/)-7$IX.-"H(1M(OG*-CFCO5?//'\:NACK,/JWM,
M'ZC>O;'\ V=Q>GHT?YA-Z;>+GW7 :KW"JNG$]WJU=;.P2SB*P!@"&L]!&5E;
ME[(#S9G++#,NS8"9Y!8<#+C1JWN\MP; V=UMK_]U\N4MAOG:D=7(D/['!<B"
M]<B3(XO*4*#H JIDC$[JSFMZJWONA\C9"K_Z!>!W( V>'697:U3P)K_!"HV*
ML@AEE:SO9$A.*A<ZHPE]\LADVJZ%M@$Q6^'5_(_%ZX':.Z]P>7F=<^U+UORB
M$<$X.IC9E@R*98JFDJPS"%U*6C(M4^NVED-IW@K4]@6 >A E=P#J/6YT1H5S
MKQ6=5FDRL>A2!!^]!<N"4T)2$IQ;#TC<@\RMH.M>$'2/K<H!;^5VE>K;ZP8-
MBNZ72R^^3B](X_,:Z2]^7LE;11-3C9"RT1%4J9LW0^ 0"Y/!,)V<:%[:L2UQ
M+[W4Z;1%'T>!1 <&_ 9?!ST+U(I*H[(&;\@<**<<!.T\6"<"X]X+9EH')XU(
M/X_"D./@;SH\&,XHCWR]_"]?B-,;@MH\4.F SICH@85B02DO(*:$(%(./I"Y
MCW<;7@YW!4\1-&Q9R"!(VM.T-U-K!^9\![9_75.XW@"^8;C(["A2E,"4(_MA
MA*YC]BFK=IB\,]*KNW<BI\PR'R9ZV%!G2*P/H_<SLMFW[SD?..#,*JD9EZ!1
M>E!1UD%9@4$JW(40N;-2M[;;SQ$U;)'(.=GNINH](UC?O Y]@&O)D_.U[DO(
ME,AK+1^?M(2D770JZEC:/\4\3=*PPT3."=(-5=M!0'*@Y$?*"9FY2Y""R,1N
M73O!.4$UA2A$E,7*UGWD!Y(\S,-C#T@?0N=G=*OX8)YQHV) A9(3DP70U-?7
M;"UXQ10X8X,IIL1<GAV)TYBF\RCD.^K=R)!:[L!^[Y%8? Y_W6!]Y(UUH6B2
M,J^#EFUF$#4/0,Q2^,5,R<WGZQ],]'D4^YWD3O"T #BC$/RFE[N5A=PX[%P$
M.N7>0^#>D2<3'.IL<=#!*6NU\4J4([X//4;7>=3V=6766VO[O$S[G5J%FZ?;
ME9($*E/#0PH4A:WY2(QU+6<T&)/5(G53E;*KB1^\/K W$]\("!V@?]\D962"
MU2%:!X9Y7<O.!#B?>!6\9ESQPDIKP.]+ZWG4%';]M+F3NL\H&7V'ZXJSS^L!
MI43J"#%&+2G?1\5)P,%&\+8H,(H2_F1]N;?0[_!PY2%"SJ-LL*OXY&!]-L/N
M::8+SU:O5_2'\:_O.)GC?%K(-^4;LIE>E0H=8\;P7@0<<]+PX1(9:-YPYH7$
MK3PPR2U96$H2G4D!)&>>HXE*X;\79F\U]XM@RT*0"-DF\E7)&_#&4 )"1J8$
MLCFN^83Y?\\;/A#10\T;W@4K'83KMSA\8# I<[$8B088#Y1]E!@@)D9R]XYC
M<%R86(Z9AOY/G3>\$XQVG#>\BT[[ANAZK&E&61(R!\HX XJK )[+#)R)G$KF
M.OK6VSV?)6IPR]H. CO/&]Y%'QT ;)O)MEPS8;+G@$4G4#$7B#*0Z_$UV\A<
M\A :0^P%S!O>"0A[S!O>12L# FT^6XP^S*;Y,BW>SS[A[,<XX?(8>J^3$"6
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M&Q5:3_YH0?=V #VIQ/S1U=D/DN]E?7&Q^'&9.ZG&&:SPV2@+J>10]SE$"+4
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MWY"/77F_JX-)%-879B7$=8,'SPS020>(/*LD3&:I=0VR*0/C]DWTC_OV*.C
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MZNARNI*\<]G&UF7IO5='G<9VLIU0L<WJJ%U4U ',GMX-4Q(Z[GP!B9Z1=&P
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M.)0/_/"M@*%/!QA-A-@)"-:1ZJOX?R^FFU%&UU>V\R9YD@F+@0!MF0''189
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MEQ^W?G?9#V8UUZ;( +%8!%5;)QS' L4G8[P-*:76F>M=:>RY2+(+,!Y_-CB
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M6T-ZM@*M?Z&@'4NOW9_ FW;P.Q+Y=4J"JDJ=XMG$,&Z\-0&2+^0KE:0!I4G
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MTF&7%B[3[CA/,WS-YTI+#!E3Y'_0R@D5G!$:>07D^N2$#"Z%U">PJ70J=!7
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M>Z3*&/H$UFP$?1LX)8U:L@)0@91#^BFUQEA%$/M@:"!E3'ES&VN4"BH NS0
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M_IFBN=AZ%W@-$?)J;]V$3X$DI=MN\L3KP]6G?Y.9WJD^^Q]02P,$%     @
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M$!=.AWH[%12/N+74++!*2N\YC+O1IX5K#(R!(:77?# &5HB$ 8T'U10T!TL
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MM;UN0B= DMSM-GGB*]_B&#XX]I\^7_X/4$L#!!0    ( '& 7%9WQ4<.%0<
M -XR   :    ;&=N9%\Q,C,Q,C)X97AH:6)I=#,R,2YH=&WM&VM/XSCP^_T*
M7]'MLE*;9]]ED;A2=-5Q@*![>_?IY"9.8Y'$.=NE='_]C9V$%MJR!14*MT6H
M2NSQ>&8\GF=[\//Q>7?P]T4/A3*.T,677T_[752JF.97MVN:QX-C]-O@CU-4
M-2P;#3A.!)64)3@RS=Y9"95"*=.V:4XF$V/B&HR/S,&EJ5!5S8@Q00Q?^J7#
M S4"GP3[AS\=_%RIH&/FC6.22.1Q@B7QT5C09(2^^D1<HTHEA^JR=,KI*)3(
ML1P7?67\FM[@;%Y2&9'# L^!F;T?F'J3@R'SIX<'/KU!U/]<HDVOV?1]'%A.
MPZM:07WHM*R65[-<@JNV0\@_-A!I GBV1LAI1#Z78II40J+V;S><5'8FU)=A
MV[:L7TH:[O @8(F$S3@LSAXS' N8)+F5%1S14=+6_)2RI<6TQR+&VWN6_NNH
MF4J 8QI-VQ\'-"8"G9$)NF0Q3CZ6!9Q!11!.@PQ0T&\$: +R].LDIQ?P1#0A
M!?UVPP6B>[<A'5*)7,>P[U/\?5J7L#DO*LQ'(*TADY+%[3I0,X?&@P,B?$L\
M=WN7@_Y)OWLTZ)^?H?,3=''9/^OV+XY.4>^O7O?+H/]G#X8!HG?YN$QHX@,C
M;1>X>W%>JDMYZ2?(8TE"/'4'T83*$,F0H*,D&>,(79*4<8E8@$[I""<^N@@Q
MC[%'QI)Z.!*HGWB, XR^</MJY8>]IN-8G2Z+4YQ,]9O=^80 ^0GC,;*MRN\H
M8%SO,B68(P(R\-$Q\4@\)/S#GEVW.JY=5O?3*2,L4$ C +@C[8IX8PXF V2@
M*.K=>B%.1@1N=AQ3(10;\*\@?: *A803H'^>MHRK@K0RZI?1@/D^ZAKH&-]0
M44;=D)( 4,-6DMX0=!X$U"-<"4+AR9DK(QB3-("'=,S%&,/Q28;L)OIB7!F
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M960N:'1M4$L! A0#%     @ <8!<5I4P:O2W$   #G(  !X
M ( !Y_D  &5X:&EB:71?,3 Y>&QI9V%N9&1I<F5C=&]R+FAT;5!+ 0(4 Q0
M   ( '& 7%;!\?_$]YD$ !0.,P 1              "  =H* 0!L9VYD+3(P
M,C(Q,C,Q+FAT;5!+ 0(4 Q0    ( '& 7%:Z%E;(<QH  'HX 0 1
M      "  0"E!0!L9VYD+3(P,C(Q,C,Q+GAS9%!+ 0(4 Q0    ( '& 7%8;
M:C\THCT   23 @ 5              "  :*_!0!L9VYD+3(P,C(Q,C,Q7V-A
M;"YX;6Q02P$"% ,4    " !Q@%Q6>C\JR06=  !,Z@8 %0
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M &QG;F0M,C R,C$R,S%?9S0N:G!G4$L! A0#%     @ <8!<5KFNC-]"FP$
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M:6)I=#,Q,2YH=&U02P$"% ,4    " !Q@%Q6KP\)0BT(  !5/0  &@
M        @ $-CPX ;&=N9%\Q,C,Q,C)X97AH:6)I=#,Q,BYH=&U02P$"% ,4
M    " !Q@%Q6=\5'#A4'  #>,@  &@              @ %REPX ;&=N9%\Q
J,C,Q,C)X97AH:6)I=#,R,2YH=&U02P4&     !, $P J!0  OYX.

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
